data_2jyz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jyz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 109.164 -0.68 . . . . 73.42 109.164 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.91 -71.53 0.76 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.925 0.713 . . . . 74.43 112.925 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -82.69 48.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.407 0.622 . . . . 74.23 112.05 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.9 p -120.21 143.32 35.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 75.23 110.992 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.531 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 58.5 Cg_endo -97.19 26.2 19.76 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 124.712 -0.954 . . . . 74.34 112.215 0.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.79 -41.76 98.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 72.34 110.967 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.9 m -152.7 -51.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 113.409 0.892 . . . . 75.11 113.409 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' ALA . 55.0 tp -157.61 141.49 15.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.146 0.498 . . . . 75.33 112.275 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -74.9 36.53 0.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.89 -0.596 . . . . 73.42 110.948 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 178.33 145.58 0.13 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.466 -0.333 . . . . 63.51 111.047 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.54 102.38 6.59 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 75.41 111.189 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -72.97 136.88 25.73 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.868 2.379 . . . . 75.22 113.007 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.03 -28.83 67.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.909 -0.587 . . . . 73.53 110.108 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.54 -133.59 3.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.302 -0.863 . . . . 64.12 111.486 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.414 ' N ' ' HB2' ' A' ' 158' ' ' ALA . 10.2 t -163.7 177.57 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.719 . . . . 74.41 111.758 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 160' ' ' ASN . 26.6 mt -124.24 143.96 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.094 . . . . 73.14 108.084 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 5.7 mtpm? -107.64 102.85 12.06 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.381 -0.528 . . . . 73.34 111.58 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 63.1 t -103.18 110.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.485 -0.779 . . . . 73.42 109.633 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.702 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 62.7 mt -95.24 114.9 32.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.43 -0.805 . . . . 75.51 110.647 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -82.53 -85.23 0.11 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.155 -0.475 . . . . 72.24 112.1 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 24' ' ' ASP . . . -68.15 2.97 6.11 Favored Glycine 0 N--CA 1.461 0.34 0 CA-C-N 116.117 -0.492 . . . . 75.32 113.596 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.702 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 13.6 t70 78.92 -41.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.232 -0.655 . . . . 75.34 109.232 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 22' ' ' GLY . 4.1 t70 -74.02 -27.93 61.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 75.22 109.725 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.478 ' H ' HD21 ' A' ' 25' ' ' LEU . 2.5 pt? -124.93 -174.35 3.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.402 0.62 . . . . 73.23 112.157 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 18.2 pt-20 -156.97 157.79 35.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.319 -0.855 . . . . 71.25 111.038 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 4.2 m -85.35 143.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 75.12 111.689 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.562 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 50.1 mttp -144.2 126.81 16.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.466 0.65 . . . . 74.33 112.047 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.3 mp0 35.09 61.75 0.6 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.344 1.238 . . . . 75.52 114.344 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 16.94 55.62 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.859 -0.61 . . . . 74.33 114.247 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.89 156.52 8.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.104 0.478 . . . . 75.43 111.042 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 73.41 110.125 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.4 mp -105.41 130.51 53.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.338 -0.392 . . . . 73.04 110.124 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -146.92 158.37 45.41 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.566 . . . . 75.55 110.502 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.82 121.98 3.62 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.257 -1.143 . . . . 73.34 113.266 0.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.8 p 44.44 25.9 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.842 -0.617 . . . . 65.15 112.551 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 39' ' ' LYS . 12.0 pt20 -80.3 0.1 34.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.098 0.475 . . . . 75.32 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.24 26.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.1 -0.5 . . . . 74.51 111.879 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -106.15 -9.12 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 74.52 111.58 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -84.54 148.79 26.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.218 0.532 . . . . 70.22 111.79 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.4 pm0 -63.02 133.14 95.3 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.631 -0.713 . . . . 74.34 111.847 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 90.5 Cg_endo -85.37 128.74 3.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.868 2.379 . . . . 74.14 113.075 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 41.4 mm -103.32 105.92 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 74.41 110.419 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 p -84.92 137.08 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.829 0.678 . . . . 75.15 112.829 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -165.33 137.0 4.09 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.84 0.311 . . . . 54.21 111.84 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.525 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p90 -107.53 12.51 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.283 -0.417 . . . . 75.51 109.995 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.3 t -31.95 115.91 0.18 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.103 -0.953 . . . . 73.5 112.204 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 108.7 -30.66 8.53 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 74.1 112.661 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.4 mt -85.12 -35.52 21.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.97 0.414 . . . . 73.14 110.663 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 16.1 pm0 -56.59 -171.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 74.25 110.165 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.16 -77.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.102 -1.047 . . . . 74.34 112.662 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -148.49 111.24 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.414 0.626 . . . . 74.4 110.867 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 m -157.34 147.34 20.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.632 -0.877 . . . . 71.13 108.632 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -64.69 -41.84 95.76 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.675 0.75 . . . . 63.33 109.606 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.484 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 35.7 mt -155.91 178.07 10.69 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.249 -1.341 . . . . 72.42 110.031 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.3 mt -140.93 163.79 32.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.087 -0.708 . . . . 75.51 109.087 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.44 ' HG1' ' HB2' ' A' ' 121' ' ' GLN . 58.1 m -135.05 119.63 18.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 75.5 111.115 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -107.41 110.89 22.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.627 -0.715 . . . . 60.32 109.234 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -115.89 137.11 52.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 74.43 111.22 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.445 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -94.89 146.77 23.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.739 -0.664 . . . . 75.04 110.444 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 99.0 t -141.62 118.37 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 70.0 111.033 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' H ' ' HD3' ' A' ' 63' ' ' PRO . 22.2 t70 173.03 48.84 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.673 -1.149 . . . . 72.04 108.375 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.543 ' HD3' ' H ' ' A' ' 62' ' ' ASP . 58.3 Cg_endo -70.0 83.87 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.045 1.83 . . . . 75.21 113.824 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -145.93 101.22 3.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.078 -0.965 . . . . 63.5 109.09 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -166.14 136.69 2.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 73.33 111.482 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 14.8 Cg_exo -71.12 -5.17 10.89 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 123.56 -1.433 . . . . 72.43 111.313 -0.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 146.29 7.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.888 . . . . 71.41 110.222 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.599 ' HD2' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -64.04 -15.47 59.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.466 . . . . 75.32 110.408 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.599 HE21 ' HD2' ' A' ' 68' ' ' ARG . 88.2 mm-40 -92.01 -23.32 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 74.42 111.979 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t70 -144.13 73.96 16.11 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 75.3 110.241 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.87 62.54 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.434 2.756 . . . . 74.24 112.406 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -48.86 -36.48 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.928 -0.578 . . . . 65.22 111.511 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 5.9 p90 -165.01 48.98 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 74.2 111.51 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HG2' ' CA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -81.2 144.06 31.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.226 -0.657 . . . . 75.0 109.226 177.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' CA ' ' HG2' ' A' ' 74' ' ' ARG . 39.0 mt-10 -89.91 163.74 14.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.044 0.938 . . . . 65.11 111.297 0.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.534 ' CG2' ' H ' ' A' ' 77' ' ' LEU . 21.2 mm -84.76 -129.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.182 -1.414 . . . . 75.15 107.182 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.534 ' H ' ' CG2' ' A' ' 76' ' ' ILE . 49.9 mt -86.84 151.67 23.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.165 -1.05 . . . . 71.52 108.165 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.442 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 0.0 OUTLIER -149.65 160.93 43.11 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 121.075 -0.25 . . . . 74.12 111.075 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -100.31 79.8 2.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.659 0.743 . . . . 75.33 111.025 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 97' ' ' LEU . 24.5 p -94.67 133.25 38.53 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.664 -1.153 . . . . 74.13 110.92 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.72 138.42 22.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 120.728 -0.389 . . . . 74.24 111.19 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 97' ' ' LEU . 29.5 m -142.21 167.74 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.645 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 125' ' ' ILE . 1.7 m-20 64.24 33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.528 -0.305 . . . . 71.31 111.413 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 15.6 mm -80.78 124.14 81.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.613 -0.514 . . . . 74.23 109.613 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.582 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 51.5 Cg_exo -52.16 129.79 32.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.292 1.328 . . . . 74.34 110.98 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.42 50.03 0.29 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 114.739 0.656 . . . . 73.43 114.739 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t -176.73 32.56 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.402 0.601 . . . . 73.12 111.914 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.582 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 51.4 m-20 -113.19 0.55 14.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.567 0.222 . . . . 74.41 111.07 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 51.9 mt-10 68.14 -34.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 65.25 112.276 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 88' ' ' ASN . 4.0 p30 -133.81 155.45 80.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.529 . . . . 65.12 111.447 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.89 59.36 2.84 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.49 2.793 . . . . 65.43 113.267 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.1 m -104.29 -54.8 2.47 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.817 0.673 . . . . 63.54 112.817 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.11 -0.55 15.71 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.6 1.0 . . . . 64.15 115.6 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -100.34 176.43 27.8 Favored Glycine 0 N--CA 1.461 0.313 0 C-N-CA 120.423 -0.894 . . . . 73.12 113.258 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 128' ' ' THR . 43.4 t60 -70.46 121.34 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 74.11 111.284 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 43.7 m -80.99 96.94 7.26 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.336 -0.616 . . . . 73.45 109.336 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 127' ' ' GLU . 43.7 mt -48.02 -50.13 28.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.304 0.573 . . . . 73.42 109.549 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -141.86 107.97 5.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.834 -1.075 . . . . 64.24 108.249 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.546 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 44.7 t0 -41.91 144.57 0.41 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 75.34 112.966 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -60.59 139.85 57.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.89 -1.05 . . . . 74.43 112.137 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 133' ' ' ASN . 14.4 p -148.15 113.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.586 -0.734 . . . . 74.22 110.651 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.11 18.79 3.14 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.204 -0.522 . . . . 70.54 113.194 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.1 p -69.18 -64.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 73.03 111.083 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.429 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . 76.08 163.7 15.33 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.516 -0.766 . . . . 62.15 112.601 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.88 160.49 25.18 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.046 2.497 . . . . 75.22 113.114 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.6 161.3 32.37 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.665 2.91 . . . . 65.3 113.967 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -44.7 -37.81 3.97 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.342 -0.845 . . . . 73.53 111.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -50.83 -22.05 1.99 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.503 0.557 . . . . 65.31 112.503 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 11.3 t -80.97 -25.45 37.32 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.558 0.948 . . . . 73.54 113.558 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.62 -163.91 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.577 -0.821 . . . . 74.34 112.444 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 39.7 tp -46.19 109.23 0.17 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.085 0.469 . . . . 75.43 111.745 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -113.2 142.52 45.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.732 -0.667 . . . . 72.54 109.691 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.586 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -95.55 88.08 4.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.704 . . . . 74.53 112.579 -177.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 9.8 t80 -73.5 120.13 18.67 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.127 -0.629 . . . . 74.54 109.513 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.474 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 25.9 mt -113.42 130.82 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.894 -0.594 . . . . 74.42 111.979 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -102.45 125.18 49.08 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.712 -0.676 . . . . 74.54 109.585 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 tt -119.27 135.26 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.378 . . . . 74.41 110.498 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 64.6 tp -119.46 136.39 54.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.718 -0.674 . . . . 62.32 110.47 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.638 ' CD2' HD23 ' A' ' 153' ' ' LEU . 64.0 t80 -144.14 135.67 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 65.23 111.029 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.83 130.39 43.29 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.787 -0.365 . . . . 75.21 110.185 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.484 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 26.8 tt0 -107.74 127.48 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.556 -0.535 . . . . 70.41 109.556 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -99.84 -39.02 8.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.6 0.593 . . . . 75.42 112.6 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.446 ' HB2' ' HE2' ' A' ' 151' ' ' HIS . 5.4 m120 -102.8 136.91 41.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.181 0.808 . . . . 74.12 113.181 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -72.13 114.19 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.261 -0.881 . . . . 74.02 109.787 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.446 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 5.3 pt -115.71 132.59 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.006 -0.543 . . . . 62.54 112.178 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -59.18 -53.09 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.276 0.56 . . . . 71.33 109.977 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.52 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 6.0 mm-40 60.72 38.45 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.159 -0.928 . . . . 73.31 111.531 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 41.0 p 54.84 149.84 0.05 OUTLIER Pre-proline 0 C--O 1.223 -0.322 0 O-C-N 123.741 0.651 . . . . 73.43 112.632 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.45 147.37 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.16 2.573 . . . . 75.21 112.755 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 96' ' ' SER . 1.4 m -58.44 119.61 7.3 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.285 -0.416 . . . . 74.51 110.471 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 42.0 mm -80.89 133.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.461 -0.336 . . . . 73.14 110.653 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -73.95 148.01 42.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.967 -0.561 . . . . 75.24 111.143 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.546 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 19.7 p-10 -62.92 -41.24 99.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 73.32 109.994 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -75.02 22.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.626 -0.716 . . . . 74.31 110.974 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 133' ' ' ASN . 2.9 t -62.33 119.55 9.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.404 0.621 . . . . 74.21 112.627 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 137' ' ' THR . 23.5 tpt180 -65.48 167.3 8.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.931 -1.032 . . . . 75.11 110.621 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 138' ' ' GLY . 11.0 m -44.47 151.04 0.29 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 64.24 111.521 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 139' ' ' ARG . . . 116.14 -8.86 18.27 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.974 -0.631 . . . . 64.51 113.605 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD3' ' C ' ' A' ' 138' ' ' GLY . 0.9 OUTLIER -152.87 50.72 0.74 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.399 0.599 . . . . 71.23 111.288 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.22 -56.82 2.35 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.617 -0.512 . . . . 72.11 109.617 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.0 OUTLIER -62.91 119.79 10.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.703 -0.68 . . . . 70.3 111.165 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 175.46 133.48 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 72.14 110.081 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -80.6 124.06 28.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.992 0.425 . . . . 73.12 111.915 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.91 96.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.453 -0.34 . . . . 53.24 111.808 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -46.49 -27.39 1.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 73.2 111.714 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.561 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 28.3 t70 -56.92 -42.75 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.602 -0.272 . . . . 72.42 111.47 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.485 ' CE2' HD12 ' A' ' 97' ' ' LEU . 24.3 m-85 -54.94 -38.14 67.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.59 0.71 . . . . 75.3 109.531 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -70.83 -41.13 71.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.078 -0.965 . . . . 63.34 110.55 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.39 -47.64 78.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 74.45 111.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.37 -53.25 59.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.056 0.761 . . . . 73.22 113.056 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.538 ' N ' ' HD2' ' A' ' 150' ' ' LYS . 18.1 t-80 -94.69 11.64 30.55 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.8 -0.76 . . . . 61.34 111.716 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 64.27 37.51 94.61 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.676 -0.773 . . . . 74.34 113.837 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.638 HD23 ' CD2' ' A' ' 119' ' ' TYR . 9.5 mt -79.78 16.02 1.24 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.618 -0.342 . . . . 74.3 110.469 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -36.65 -72.43 0.15 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.701 -0.681 . . . . 75.14 114.766 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.52 113.09 16.69 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 117.05 0.425 . . . . 72.24 111.316 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 134.82 10.55 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.805 2.337 . . . . 74.44 113.424 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 119' ' ' TYR . 43.1 pt -75.85 -37.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.44 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 16' ' ' THR . . . -152.03 134.92 15.62 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.612 -0.267 . . . . 70.51 110.734 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -140.0 151.83 45.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 75.45 111.301 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 t-20 -154.15 142.37 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.698 -1.223 . . . . 73.54 107.698 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -146.8 162.99 37.45 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.461 0.541 . . . . 73.33 112.461 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 1.4 p90 -154.28 153.81 32.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.263 -0.88 . . . . 73.34 110.875 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 52.3 mt-30 -110.86 135.07 51.97 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.953 -0.388 . . . . 71.12 109.953 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.47 149.48 25.58 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.918 1.081 . . . . 54.43 113.918 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -137.61 157.34 46.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.359 -1.292 . . . . 74.13 107.825 177.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.429 ' HH ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -163.92 167.53 20.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 74.03 111.864 -178.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' TYR . 53.3 m-20 -56.68 150.12 16.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.328 -0.851 . . . . 74.41 111.327 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.637 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 19.3 t0 -54.79 -8.87 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 72.33 110.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' ASP . 22.2 t80 -60.02 -40.98 91.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.905 -0.589 . . . . 75.33 111.221 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 21.5 t -63.66 -53.84 47.49 Favored Pre-proline 0 C--O 1.235 0.308 0 N-CA-C 109.464 -0.569 . . . . 74.55 109.464 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.637 ' HD2' ' C ' ' A' ' 168' ' ' ASP . 50.9 Cg_exo -52.01 -31.62 44.88 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.872 1.715 . . . . 74.34 111.79 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 168' ' ' ASP . 50.7 mt -50.46 -34.52 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.495 -0.321 . . . . 75.13 110.431 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.459 ' O ' ' CG2' ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.94 -37.69 14.94 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.647 -0.501 . . . . 73.13 109.647 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -56.46 -35.63 68.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.109 -0.496 . . . . 74.55 111.454 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 12.9 mptt -57.37 -33.23 67.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.368 -0.207 . . . . 72.32 111.422 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 173' ' ' ARG . 10.9 t -69.59 -10.3 57.61 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.617 -0.433 . . . . 74.33 111.254 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 83.8 mt -63.62 127.23 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.562 -0.29 . . . . 74.24 110.529 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.25 3.31 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.169 0.433 . . . . 74.52 112.169 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.396 -1.225 . . . . 61.22 112.519 -179.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.202 0 N-CA-C 110.557 -0.164 . . . . 74.32 110.557 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -109.8 -72.86 0.7 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.891 0.7 . . . . 62.34 112.891 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -89.15 53.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.594 0.712 . . . . 75.32 111.588 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 10' ' ' ASP . 8.8 p -135.13 139.31 31.45 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.095 -0.957 . . . . 73.1 110.459 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 78.0 Cg_endo -83.98 35.69 2.62 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.83 -1.321 . . . . 75.32 113.177 0.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -61.38 -52.56 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.062 0.458 . . . . 74.52 110.238 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -158.88 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 65.14 111.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.513 ' O ' HG13 ' A' ' 4' ' ' ILE . 15.9 tp -157.34 140.22 15.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.319 0.581 . . . . 72.53 111.444 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.508 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 3.5 p-10 -58.82 -26.74 64.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 75.1 112.169 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.96 130.93 13.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 72.03 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.82 115.12 19.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.571 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 31.7 Cg_endo -94.22 143.94 1.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.965 2.443 . . . . 74.24 112.174 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.9 -30.84 47.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.39 0.614 . . . . 70.52 110.026 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.3 -166.96 15.62 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.819 -1.082 . . . . 73.14 110.63 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 9.7 t -121.99 172.95 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.498 0.649 . . . . 74.21 111.183 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 44' ' ' VAL . 6.4 mt -105.47 128.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 75.44 110.426 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 3.2 mmmp? -73.8 107.07 5.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.915 -0.772 . . . . 70.55 108.915 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 61.2 t -123.0 109.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 74.44 110.689 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 mt -100.93 123.11 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.183 -0.917 . . . . 75.03 109.871 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.521 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.98 -36.54 64.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.581 -0.736 . . . . 72.55 111.877 -178.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.443 ' H ' HD12 ' A' ' 25' ' ' LEU . . . -126.81 -63.07 0.15 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 120.232 -0.985 . . . . 73.02 112.675 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -166.81 -61.21 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.522 -0.547 . . . . 73.33 109.522 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.98 -48.88 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.676 -0.693 . . . . 72.04 110.67 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 22' ' ' GLY . 1.6 pp -69.57 147.74 50.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.415 0.626 . . . . 73.21 111.602 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 11.3 tt0 -143.37 144.95 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.525 -0.761 . . . . 75.25 110.699 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 19' ' ' VAL . 24.3 m -79.93 106.37 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 74.44 109.513 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 56.2 mttm -103.64 124.75 49.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.179 1.177 . . . . 70.54 114.179 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.4 mp0 26.9 67.45 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.985 1.476 . . . . 70.51 114.985 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' CA ' ' CD2' ' A' ' 161' ' ' TYR . . . 74.76 5.56 74.82 Favored Glycine 0 CA--C 1.51 -0.241 0 N-CA-C 115.083 0.793 . . . . 50.43 115.083 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.12 161.95 2.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.591 0.696 . . . . 73.23 110.029 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.461 ' CD ' HE22 ' A' ' 165' ' ' GLN . 32.5 tt0 -109.8 143.71 39.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 72.51 110.389 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 mp -116.35 120.16 37.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.76 -0.459 . . . . 74.51 109.76 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -150.49 163.92 22.36 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.846 -0.616 . . . . 74.33 110.082 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 94.4 Cg_endo -86.92 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.772 -1.345 . . . . 73.23 112.841 0.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.436 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 70.2 p -104.27 22.62 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.55 -0.295 . . . . 74.32 111.686 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -81.79 -7.64 59.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.317 -0.553 . . . . 70.21 110.061 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 24.6 m -91.29 26.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 72.25 111.642 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -85.71 -14.57 44.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.648 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.3 141.44 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.805 -0.634 . . . . 75.23 112.487 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.557 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.17 134.89 95.99 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 115.513 -0.767 . . . . 74.31 110.849 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.2 Cg_endo -73.5 135.88 22.85 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.881 2.388 . . . . 73.1 113.508 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 48.5 mm -107.19 125.83 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.352 . . . . 73.25 110.423 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 17' ' ' ILE . 3.1 p -98.54 146.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.391 0.515 . . . . 65.24 112.391 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -165.12 146.49 7.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.132 0.492 . . . . 71.41 111.579 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.534 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 5.2 p90 -121.39 29.9 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.402 -0.592 . . . . 75.44 109.402 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 t -43.29 131.21 4.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.603 -0.726 . . . . 74.34 110.696 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.16 -35.76 3.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 64.1 112.683 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.24 -33.87 67.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.557 0.694 . . . . 74.23 109.341 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.5 tt0 -58.06 142.08 47.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.163 -0.926 . . . . 74.4 109.194 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.29 -65.74 0.02 OUTLIER Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.036 -1.078 . . . . 62.54 112.863 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.74 109.34 4.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.838 0.352 . . . . 71.31 110.162 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m -158.36 141.17 14.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.104 -0.498 . . . . 71.43 110.528 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -70.15 -40.42 74.78 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.198 0.999 . . . . 73.01 108.328 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 27.1 mt -155.16 161.26 41.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.76 -1.564 . . . . 74.23 109.269 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.9 mt -125.07 146.54 49.4 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.178 0.514 . . . . 73.15 110.358 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 4.2 m -106.91 127.35 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.744 . . . . 74.12 109.993 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.3 tm? -130.93 118.5 20.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.363 -0.606 . . . . 75.55 109.363 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' CD1' ' CG ' ' A' ' 147' ' ' PHE . 70.4 mt -149.36 132.09 15.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.968 -0.693 . . . . 74.33 112.043 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 48.3 ttp -94.73 148.4 22.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.731 -0.841 . . . . 73.53 108.731 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 144' ' ' ALA . 52.9 t -139.33 145.02 27.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.534 0.683 . . . . 74.13 112.57 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -175.9 82.93 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 114.067 -1.424 . . . . 74.31 109.361 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.52 84.39 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.8 2.333 . . . . 74.41 111.84 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.574 ' CB ' HH12 ' A' ' 113' ' ' ARG . 3.2 t0 -170.22 122.5 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.753 0.649 . . . . 73.35 112.753 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.507 ' CB ' ' CE1' ' A' ' 73' ' ' TYR . . . -173.13 130.74 0.58 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.97 -0.292 . . . . 72.31 111.554 175.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.06 -12.54 24.12 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.257 -1.56 . . . . 72.55 109.025 -4.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -151.99 142.82 22.95 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.992 -1.458 . . . . 72.01 109.661 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -58.87 -31.13 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.408 . . . . 75.33 110.751 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -60.32 -41.62 93.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.442 -0.799 . . . . 75.31 111.819 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -138.1 71.3 48.05 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 74.42 110.449 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 27.6 Cg_exo -61.29 112.65 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.242 1.961 . . . . 74.13 111.122 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -101.27 -51.43 3.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.86 0.362 . . . . 75.3 111.631 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.507 ' CE1' ' CB ' ' A' ' 65' ' ' ALA . 18.3 p90 -116.24 24.81 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 75.1 109.997 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 1.3 tmt_? -73.84 138.03 44.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.154 -0.93 . . . . 75.55 109.643 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HG3' ' HA ' ' A' ' 143' ' ' ASN . 4.9 mm-40 -75.11 170.12 16.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.63 1.172 . . . . 64.11 111.346 0.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.462 ' CG2' ' HA3' ' A' ' 104' ' ' GLY . 6.8 tp -119.27 168.38 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 75.5 111.189 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.452 ' N ' HG13 ' A' ' 76' ' ' ILE . 73.2 mt -54.83 133.72 47.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.357 0.598 . . . . 65.51 111.747 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.8 -169.38 2.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.183 -0.917 . . . . 74.31 109.119 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.465 ' CZ3' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -98.6 104.47 16.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.219 -1.03 . . . . 71.34 108.219 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.424 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 1.5 m -119.0 117.37 28.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 73.12 110.985 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 58' ' ' LEU . 1.7 t -141.73 130.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 74.01 109.405 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.5 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 32.2 m -141.69 166.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.057 0.456 . . . . 70.02 111.559 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 22.9 p30 64.16 39.22 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.655 -1.157 . . . . 73.15 109.524 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 2.8 mm -77.2 115.44 48.94 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 114.408 -1.269 . . . . 73.1 108.991 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 87' ' ' SER . 51.0 Cg_exo -53.1 127.67 25.97 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.692 1.594 . . . . 74.52 111.774 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.43 69.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.33 -0.462 . . . . 73.44 112.854 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' PRO . 29.3 t 177.31 48.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.66 0.384 . . . . 65.53 110.097 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 90' ' ' ASN . 70.2 m-80 -135.68 -22.36 1.46 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.029 0.752 . . . . 71.55 113.029 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 70.87 -22.18 0.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.867 0.365 . . . . 74.2 110.784 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 88' ' ' ASN . 10.3 p30 -152.17 158.16 33.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 115.873 -0.603 . . . . 72.15 109.575 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 90' ' ' ASN . 81.9 Cg_endo -70.92 48.2 0.81 Allowed 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 123.29 2.66 . . . . 75.05 114.307 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 t -97.53 -8.29 29.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.06 -0.656 . . . . 73.05 111.797 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.35 -40.74 1.46 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.585 -0.816 . . . . 72.5 114.26 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -61.21 171.87 7.65 Favored Glycine 0 N--CA 1.459 0.208 0 C-N-CA 120.847 -0.692 . . . . 74.04 113.037 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.462 ' CB ' HD22 ' A' ' 83' ' ' ASN . 52.5 t60 -70.89 118.82 14.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.584 0.23 . . . . 74.44 111.455 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.3 p -81.05 91.05 6.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.936 -0.764 . . . . 75.22 108.936 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.475 HD22 ' CG2' ' A' ' 82' ' ' VAL . 10.6 mt -49.3 -52.4 27.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 63.35 110.048 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.08 117.41 13.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 73.52 108.885 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 50.6 t0 -55.78 151.08 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.767 0.667 . . . . 72.2 111.649 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.5 p90 -60.35 151.3 28.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 73.25 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.21 152.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.424 -0.353 . . . . 71.45 110.149 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' CA ' HG13 ' A' ' 170' ' ' VAL . . . -46.19 -72.84 0.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.963 -0.637 . . . . 72.34 112.429 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -171.15 124.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 72.43 110.471 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.462 ' HA3' ' CG2' ' A' ' 76' ' ' ILE . . . -68.29 -49.15 47.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.524 -0.846 . . . . 62.42 111.511 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 2.7 Cg_exo -77.78 114.59 3.67 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.851 2.367 . . . . 73.41 112.017 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.69 160.91 30.53 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.135 2.556 . . . . 74.12 111.861 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.98 -28.05 2.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.343 -0.389 . . . . 72.14 111.419 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 87.0 m-20 -51.64 -40.0 59.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 74.52 112.025 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -71.06 -2.91 17.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.755 -0.378 . . . . 55.2 111.254 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 69.95 -126.72 17.64 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 116.106 -0.497 . . . . 73.33 113.673 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.464 ' CD1' ' HG3' ' A' ' 165' ' ' GLN . 31.0 tp -66.96 145.48 55.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.8 0.809 . . . . 75.04 112.505 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 19.0 m80 -120.02 167.05 12.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.99 -1.459 . . . . 71.22 110.037 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.575 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -141.0 75.4 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.38 120.79 22.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.581 -0.736 . . . . 74.15 109.659 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.418 HG12 ' HB3' ' A' ' 161' ' ' TYR . 11.9 mt -116.02 122.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.094 0.473 . . . . 54.22 112.025 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -91.01 130.57 36.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.43 -0.805 . . . . 74.42 109.064 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 118' ' ' LEU . 1.3 tm? -119.27 136.19 54.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 71.32 110.168 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 57' ' ' THR . 3.6 tt -136.84 129.68 30.65 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.338 -0.392 . . . . 74.21 110.053 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.461 ' HA ' HG12 ' A' ' 157' ' ' ILE . 62.8 t80 -144.16 143.65 31.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 71.14 110.971 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -63.13 119.99 10.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.848 -0.427 . . . . 74.05 109.848 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 7.0 tt0 -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.493 -0.558 . . . . 71.31 109.493 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.4 -31.08 14.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 61.25 111.047 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 123' ' ' ASN . 1.6 m120 -98.16 129.99 44.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.81 -0.632 . . . . 71.4 111.19 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 125' ' ' ILE . 19.7 tptp -74.11 129.85 38.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.706 -0.479 . . . . 73.1 109.706 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 pt -141.95 137.6 30.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 65.51 112.045 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -79.49 -39.54 31.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.963 -0.562 . . . . 74.02 111.111 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.597 ' CD ' ' HE2' ' A' ' 151' ' ' HIS . 61.5 mm-40 56.69 39.65 29.62 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.531 0.567 . . . . 75.2 112.531 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.2 p 56.71 161.3 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.702 0.626 . . . . 75.44 112.171 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.6 157.05 7.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.775 2.317 . . . . 75.33 113.515 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 p -59.51 120.54 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.444 -0.798 . . . . 75.51 112.085 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 21.6 mm -83.91 127.2 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.181 0.515 . . . . 74.24 110.715 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -63.69 140.77 58.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.976 -1.011 . . . . 75.14 112.322 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 134' ' ' THR . 19.8 p30 -57.76 -47.88 81.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.255 0.55 . . . . 73.1 110.421 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.485 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.4 p -79.69 24.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.417 -0.81 . . . . 75.32 111.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.7 t -60.77 125.29 23.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.329 0.585 . . . . 74.34 111.304 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 137' ' ' THR . 22.3 tpt180 -71.53 173.25 8.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.204 -0.907 . . . . 74.35 110.573 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.428 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 35.6 m -39.37 146.17 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.879 0.371 . . . . 72.25 111.32 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.29 -10.08 28.79 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.177 -0.535 . . . . 61.43 112.264 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 1.9 mmp_? -141.68 32.15 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.721 -0.282 . . . . 71.21 111.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.5 mt -101.45 -55.8 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.247 0.546 . . . . 75.52 110.262 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.8 m120 -64.7 112.03 3.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 73.31 110.84 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -163.51 109.81 1.12 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.165 -0.471 . . . . 74.11 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 51.7 t30 -64.18 91.8 0.08 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.561 -0.745 . . . . 74.51 111.221 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -48.92 -40.63 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.41 0.624 . . . . 73.22 110.091 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -46.62 -36.41 6.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.96 -1.018 . . . . 75.51 110.902 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.41 -42.46 53.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.35 110.382 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.466 ' CG ' ' CD1' ' A' ' 59' ' ' LEU . 20.5 m-85 -48.91 -39.24 25.35 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.112 -0.495 . . . . 73.23 110.617 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -35.57 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.645 -0.707 . . . . 62.42 109.833 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.92 -59.27 2.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.802 -0.636 . . . . 74.23 111.849 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.586 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 10.6 ptpt -63.82 -45.12 91.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.416 0.525 . . . . 75.31 112.416 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.597 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 58.3 m170 -91.61 8.19 37.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 75.13 110.589 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.63 25.0 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.79 -0.641 . . . . 73.54 114.183 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 119' ' ' TYR . 14.6 mt -76.71 16.72 0.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.902 0.334 . . . . 74.31 111.902 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.53 -45.59 29.7 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.75 -0.738 . . . . 54.33 112.564 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -108.81 83.13 1.99 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.886 0.374 . . . . 72.04 110.116 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 44.3 Cg_endo -68.33 137.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.762 2.308 . . . . 73.11 113.456 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 119' ' ' TYR . 30.6 pt -79.33 -33.41 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.235 -0.654 . . . . 74.13 109.235 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 118' ' ' LEU . . . -142.34 142.87 32.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.665 -0.698 . . . . 72.44 110.734 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 16' ' ' THR . . . -153.58 157.88 40.36 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 74.23 109.215 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -165.61 118.62 1.15 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.632 -0.507 . . . . 75.34 109.632 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.2 OUTLIER -103.13 151.26 22.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.308 -0.86 . . . . 73.31 110.936 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -145.96 130.64 17.96 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.422 -0.808 . . . . 74.51 111.005 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.425 ' HB3' HD12 ' A' ' 111' ' ' LEU . 46.1 mt-30 -110.59 134.75 52.12 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.894 -0.594 . . . . 75.54 110.366 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.81 152.9 25.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.106 0.41 . . . . 75.02 112.106 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HG3' ' CD1' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -135.18 133.03 38.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.572 -1.269 . . . . 75.54 107.572 176.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.13 152.96 30.09 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.033 -0.358 . . . . 72.41 110.033 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.4 m-20 -52.84 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.742 0.782 . . . . 52.33 111.533 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.56 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.1 t70 -58.93 -3.29 0.32 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.141 -0.936 . . . . 74.14 111.078 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 167' ' ' ASP . 42.2 t80 -42.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.897 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.59 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 4.9 t -57.25 -51.83 78.75 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.184 -0.673 . . . . 73.14 109.184 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.3 Cg_exo -49.57 -18.7 2.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.523 2.149 . . . . 73.13 112.622 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 168' ' ' ASP . 73.1 mt -50.68 -41.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.395 -0.595 . . . . 74.41 109.395 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -55.19 -31.68 61.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.582 -0.736 . . . . 72.44 110.694 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -53.29 -43.05 67.2 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.426 -0.953 . . . . 71.41 108.426 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 168' ' ' ASP . 9.9 mptt -62.3 -31.04 71.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.381 -0.827 . . . . 74.54 110.09 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.1 m -66.43 -26.68 67.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.44 110.393 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.5 mm -48.72 107.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 74.42 111.017 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.9 m -154.15 25.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.69 0.256 . . . . 72.4 111.69 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.665 -1.075 . . . . 65.14 112.597 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.467 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 p-10 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 112.481 0.549 . . . . 71.5 112.481 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.504 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 54.6 t0 -71.0 -52.16 21.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 71.11 110.578 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 9' ' ' LEU . 9.7 pt -135.4 49.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.212 0.53 . . . . 73.43 111.099 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.8 p -133.5 140.06 35.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.866 -0.607 . . . . 75.04 110.305 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.38 29.74 3.38 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.752 -1.353 . . . . 73.32 112.954 0.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.21 -47.26 78.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 74.35 109.839 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m -163.69 -41.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 75.42 111.452 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 4' ' ' ILE . 31.4 tp -157.1 158.84 37.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.843 0.354 . . . . 75.13 111.319 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -52.34 -46.58 66.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.394 -0.595 . . . . 72.53 109.394 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -152.59 146.71 25.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.642 -0.708 . . . . 53.44 110.369 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.92 118.54 33.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.067 0.395 . . . . 75.34 112.067 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.06 -120.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 75.24 112.261 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.58 -43.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 74.32 110.345 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.52 -173.54 13.27 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.975 -0.631 . . . . 74.34 111.801 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -131.73 162.95 29.26 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.206 0.527 . . . . 75.14 111.052 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.31 137.75 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.21 -0.904 . . . . 75.43 110.758 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 29.1 mmmt -73.61 102.24 3.84 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.594 -0.521 . . . . 74.45 109.594 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 88.7 t -110.07 109.84 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 119.994 -0.682 . . . . 62.01 109.726 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.8 mp -100.38 124.03 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.661 -0.7 . . . . 73.43 109.771 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -76.74 -32.05 57.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.908 -0.587 . . . . 74.21 111.893 -178.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.13 -61.89 0.14 Allowed Glycine 0 N--CA 1.459 0.227 0 C-N-CA 120.767 -0.73 . . . . 73.23 112.175 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' HG22 ' A' ' 20' ' ' ILE . 32.6 t70 -173.42 -58.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 75.33 108.235 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -83.67 -45.15 13.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.944 -0.762 . . . . 72.21 108.944 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -69.67 131.6 44.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.25 -0.886 . . . . 74.0 112.389 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.543 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 5.9 tt0 -135.91 146.78 47.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 72.1 110.245 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 34.1 m -82.95 106.55 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.182 0.515 . . . . 74.31 111.912 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 11.6 mptt -74.57 92.5 2.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.307 0.575 . . . . 73.32 111.452 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.4 mp0 24.67 66.79 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 114.379 1.252 . . . . 74.32 114.379 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.07 -3.06 55.3 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 115.07 0.788 . . . . 53.22 115.07 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -58.84 167.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.33 0.565 . . . . 73.02 112.453 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 33' ' ' LEU . 4.0 tt0 -101.89 141.83 34.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.739 -1.119 . . . . 75.15 110.026 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 10.7 mp -108.73 130.38 55.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 72.01 110.983 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.1 p -148.34 164.19 23.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.665 . . . . 74.13 110.542 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 64.3 Cg_endo -73.32 -40.76 1.13 Allowed 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.855 -1.31 . . . . 72.32 112.899 0.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.3 p -150.88 30.6 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.451 0.644 . . . . 63.31 110.837 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.03 -2.88 4.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 55.13 110.463 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 40' ' ' ASP . 30.3 m -68.74 -3.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.411 0.624 . . . . 74.2 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -65.72 6.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 75.22 112.282 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' CG ' HE22 ' A' ' 41' ' ' GLN . 14.1 t0 -136.18 148.72 48.27 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.048 0.451 . . . . 73.43 111.648 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.448 HE22 ' CG ' ' A' ' 40' ' ' ASP . 2.0 pm0 -73.13 144.41 84.77 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.849 . . . . 72.34 113.14 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.53 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 72.9 Cg_endo -77.1 131.61 12.06 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.18 2.587 . . . . 74.3 113.928 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -105.29 117.24 50.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.079 -0.51 . . . . 63.4 110.049 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 HG22 ' N ' ' A' ' 45' ' ' SER . 2.7 p -88.85 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.783 0.66 . . . . 73.32 112.783 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 66.7 m -160.77 133.25 6.17 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.49 -0.323 . . . . 73.1 111.438 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 9.4 p90 -106.35 24.98 11.65 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.86 0.362 . . . . 75.55 110.787 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 m -43.29 118.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.777 -0.647 . . . . 73.24 111.367 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.447 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 104.67 -33.84 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.092 -0.504 . . . . 71.05 112.245 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 8.0 mp -75.33 -37.74 60.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.913 0.387 . . . . 73.14 110.409 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 48' ' ' GLY . 10.0 pm0 -49.86 153.08 1.37 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.145 -0.48 . . . . 63.45 109.918 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.41 -73.24 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.679 -0.772 . . . . 75.0 111.937 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -148.89 108.93 4.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.773 -0.454 . . . . 73.43 109.773 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.49 ' HG ' ' HA3' ' A' ' 86' ' ' GLY . 2.8 p -158.83 143.13 15.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 72.33 110.999 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 10.7 t30 -74.09 -33.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.458 0.647 . . . . 73.02 109.328 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.403 ' HG ' ' ND2' ' A' ' 54' ' ' ASN . 59.6 mt -157.32 178.38 10.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 74.15 110.632 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 83.1 mt -142.44 165.02 28.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.696 -0.853 . . . . 74.21 108.696 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 119' ' ' TYR . 26.7 m -136.93 123.4 20.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.507 0.194 . . . . 73.54 110.689 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -122.75 127.3 49.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.059 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 147' ' ' PHE . 86.9 mt -146.79 141.03 26.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 74.43 111.278 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.8 ttm -94.28 129.55 40.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 75.35 109.629 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' C ' ' CD ' ' A' ' 63' ' ' PRO . 38.9 t -103.6 62.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.502 -0.317 . . . . 75.42 111.637 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 25.6 p-10 -112.45 46.55 0.3 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.066 0.395 . . . . 74.12 112.066 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HD2' HH22 ' A' ' 113' ' ' ARG . 57.5 Cg_endo -70.5 84.8 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.327 2.018 . . . . 71.34 114.289 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -168.87 114.35 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.391 0.615 . . . . 73.12 110.711 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.557 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -170.75 139.58 1.34 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.076 -0.965 . . . . 61.3 110.933 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.7 Cg_exo -65.0 -18.4 6.47 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.986 -1.256 . . . . 73.35 110.994 -0.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 t -165.17 146.48 7.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.169 -0.923 . . . . 65.44 110.036 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -49.3 -29.68 6.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.451 0.643 . . . . 75.35 110.481 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 69' ' ' GLN . 1.3 mp0 -69.9 -31.87 69.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.577 -1.192 . . . . 75.24 112.948 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' HD3' ' A' ' 71' ' ' PRO . 14.2 t0 -144.23 61.06 8.57 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 121.155 0.503 . . . . 55.24 110.031 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.52 ' CB ' ' HE ' ' A' ' 74' ' ' ARG . 7.5 Cg_exo -72.77 55.14 2.67 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.019 2.479 . . . . 74.33 113.627 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 70' ' ' ASP . 31.6 mttp -48.98 -54.8 14.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.405 0.52 . . . . 74.25 112.405 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.456 ' CE2' HD11 ' A' ' 76' ' ' ILE . 6.2 p90 -117.47 41.7 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.417 . . . . 74.11 110.956 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.52 ' HE ' ' CB ' ' A' ' 71' ' ' PRO . 2.4 tmm_? -82.87 141.87 31.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 72.23 110.424 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' OE2' ' ND1' ' A' ' 78' ' ' HIS . 11.8 pt-20 -94.9 178.5 5.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.917 0.887 . . . . 61.52 111.126 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 65' ' ' ALA . 13.0 mm -97.89 -120.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.673 . . . . 75.31 109.184 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.97 174.31 7.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.972 -0.751 . . . . 70.12 108.972 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.44 ' ND1' ' OE2' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -172.91 165.16 5.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.574 0.225 . . . . 73.12 110.791 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -99.76 120.86 40.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.788 -0.819 . . . . 75.24 108.788 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 12.5 p -141.41 127.9 20.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 75.55 112.454 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.18 136.48 20.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.87 -0.605 . . . . 73.44 109.472 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG22 ' OD1' ' A' ' 83' ' ' ASN . 31.3 m -138.11 166.62 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.554 -0.294 . . . . 71.04 111.112 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 125' ' ' ILE . 2.4 m120 63.68 33.15 13.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.363 -0.38 . . . . 63.32 110.502 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 4.0 mm -77.34 127.88 81.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.28 -0.568 . . . . 74.13 110.125 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.507 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 34.8 Cg_exo -54.07 127.91 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.26 1.307 . . . . 74.24 109.931 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 53' ' ' SER . . . -64.17 56.75 0.07 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.146 0.819 . . . . 23.53 115.146 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 7.4 t 178.05 38.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 117.528 0.664 . . . . 74.03 111.572 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 69.6 m-80 -119.87 13.84 12.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.845 0.313 . . . . 75.44 111.845 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' SER . 20.8 pt-20 39.2 26.54 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.397 0.517 . . . . 73.23 112.397 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 17.3 p30 169.94 151.21 0.15 Allowed Pre-proline 0 C--O 1.236 0.356 0 CA-C-O 121.12 0.486 . . . . 74.42 110.731 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 83.3 Cg_endo -75.5 63.2 6.39 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 123.542 2.828 . . . . 61.21 112.86 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -104.12 -48.18 3.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.685 0.624 . . . . 74.44 112.685 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.44 -39.96 79.72 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 115.345 0.898 . . . . 63.34 115.345 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -61.52 171.74 8.43 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.65 -0.786 . . . . 63.01 114.044 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' VAL . 65.1 t60 -66.42 121.34 15.08 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.624 0.37 . . . . 74.24 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.7 t -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.876 -1.157 . . . . 72.15 107.876 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 127' ' ' GLU . 74.4 mt -63.68 -50.96 67.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.939 -0.763 . . . . 75.05 108.939 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 131' ' ' ILE . . . -143.24 125.6 15.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.762 -1.108 . . . . 73.44 109.367 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 133' ' ' ASN . 37.4 t0 -52.67 145.92 11.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.583 0.586 . . . . 53.44 112.583 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -65.15 151.15 46.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.301 -0.863 . . . . 73.34 110.685 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.501 ' CG2' ' H ' ' A' ' 102' ' ' GLY . 9.6 p -158.52 174.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.119 -0.491 . . . . 73.01 110.071 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.501 ' H ' ' CG2' ' A' ' 101' ' ' VAL . . . -67.76 178.88 18.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.391 -0.909 . . . . 73.25 111.994 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.6 m -55.33 159.01 2.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.869 0.335 . . . . 72.34 111.371 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.41 -57.32 1.06 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.827 -0.624 . . . . 61.31 113.263 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 88.8 Cg_endo -79.23 123.01 5.41 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.914 2.409 . . . . 75.11 113.58 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 108' ' ' ASP . 24.6 Cg_exo -62.67 162.49 24.63 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.041 2.494 . . . . 71.42 112.754 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.567 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -39.82 -24.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.743 -0.662 . . . . 74.43 112.456 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.567 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.8 m-20 -51.95 -39.34 59.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.005 -0.278 . . . . 62.54 110.604 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 9.1 t -72.83 -14.92 61.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.459 0.647 . . . . 72.43 109.596 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 -130.01 9.42 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.136 -0.938 . . . . 72.41 112.187 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 163' ' ' GLN . 16.1 tp -66.48 127.83 33.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.455 -0.373 . . . . 75.05 111.966 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 164' ' ' ALA . 49.0 m170 -83.61 97.95 9.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.363 -0.38 . . . . 75.12 111.3 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.586 HH22 ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -75.89 68.35 2.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.565 . . . . 73.0 109.473 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.43 146.79 30.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.728 -0.669 . . . . 63.23 111.632 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 54.7 mt -144.41 140.88 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 112.689 0.625 . . . . 72.55 112.689 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -107.75 134.72 50.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.011 -0.995 . . . . 74.12 109.28 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.81 132.22 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.234 -0.284 . . . . 72.32 110.234 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.15 136.8 54.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.464 -0.335 . . . . 72.11 110.952 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' THR . 53.6 t80 -141.97 134.96 28.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 73.3 110.417 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -72.62 133.4 44.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.383 -0.599 . . . . 74.42 109.383 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 151' ' ' HIS . 6.6 tp-100 -115.07 149.3 37.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.46 0.648 . . . . 63.33 112.452 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 88.1 tt0 -122.47 -38.97 2.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.009 -0.996 . . . . 73.34 111.24 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.72 134.6 34.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.308 0.484 . . . . 72.45 112.308 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -82.89 111.65 18.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.224 0.535 . . . . 72.22 110.932 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.512 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 1.3 pt -105.02 154.53 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.057 -0.974 . . . . 64.13 112.259 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -81.47 -49.97 9.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.924 0.392 . . . . 73.31 110.555 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 6.4 mm-40 59.71 36.62 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.776 1.028 . . . . 73.32 113.776 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.602 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 68.6 p 52.16 145.38 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 123.51 0.724 . . . . 71.42 112.798 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -44.05 143.07 3.48 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.494 2.129 . . . . 75.24 112.204 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.8 t -59.08 143.4 48.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.765 -0.652 . . . . 70.34 111.691 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 98' ' ' ALA . 6.6 tp -110.89 133.37 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.52 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 m -70.99 142.12 50.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.805 -0.634 . . . . 74.55 110.623 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 135' ' ' THR . 18.8 p-10 -51.87 -38.99 58.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 64.23 110.199 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.511 ' HA ' ' CD1' ' A' ' 177' ' ' ILE . 15.3 t -67.82 22.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.165 -0.47 . . . . 63.41 111.58 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 133' ' ' ASN . 11.7 t -64.11 128.31 35.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.869 0.366 . . . . 54.11 110.233 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.532 ' CB ' ' HA3' ' A' ' 179' ' ' GLY . 32.5 ttt180 -92.94 173.75 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.612 0.597 . . . . 71.41 112.612 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ARG . 20.9 m -26.32 131.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.557 -1.201 . . . . 75.02 111.61 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.3 4.86 32.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.468 -0.872 . . . . 62.23 111.16 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -146.93 35.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.741 0.305 . . . . 72.41 110.296 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 142' ' ' PHE . 13.6 mt -111.11 -71.04 0.78 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.219 -0.446 . . . . 75.35 111.257 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -51.61 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.356 -0.384 . . . . 73.32 110.154 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 1.5 t80 -150.47 72.49 1.1 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.249 0.833 . . . . 75.35 113.249 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -52.58 114.22 1.31 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.925 0.393 . . . . 74.22 110.752 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -48.26 -34.88 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.451 0.537 . . . . 74.33 112.451 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.4 ptt180 -43.69 -33.34 1.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.225 0.536 . . . . 75.21 111.099 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 145' ' ' ARG . 19.1 t70 -52.52 -46.1 66.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.571 -0.74 . . . . 64.53 111.306 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 142' ' ' PHE . 85.4 m-85 -53.28 -50.39 64.96 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.337 0.589 . . . . 65.41 110.905 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -56.25 -42.24 77.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.795 -0.639 . . . . 71.42 110.437 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.73 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 72.42 111.466 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.618 ' CG ' ' N ' ' A' ' 151' ' ' HIS . 45.8 pttt -75.2 -59.08 2.9 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.72 0.295 . . . . 75.11 111.535 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.618 ' N ' ' CG ' ' A' ' 150' ' ' LYS . 18.4 t-160 -80.7 4.97 17.03 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.055 0.391 . . . . 73.44 112.055 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.83 27.98 65.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.72 -0.752 . . . . 74.12 113.286 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 151' ' ' HIS . 25.6 mt -66.65 17.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 111.771 0.286 . . . . 72.4 111.771 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.65 -61.77 3.6 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.999 -0.62 . . . . 75.23 113.477 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.77 109.33 4.92 Favored Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.723 0.262 . . . . 72.41 111.145 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 154' ' ' GLY . 57.6 Cg_endo -89.86 132.46 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.402 2.068 . . . . 65.34 112.563 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.8 pt -80.95 -35.37 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 74.31 110.711 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.88 149.83 22.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.956 0.408 . . . . 72.33 111.46 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 9' ' ' LEU . . . -148.48 159.09 44.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.424 0.63 . . . . 73.34 111.319 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -155.2 144.61 21.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.042 -1.466 . . . . 72.23 107.042 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -149.76 176.25 10.86 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.718 -0.393 . . . . 73.31 111.398 -176.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 10.2 p90 -167.68 150.58 5.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.982 -0.554 . . . . 73.32 110.82 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.555 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 43.6 mt-30 -110.66 124.23 51.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 71.32 109.852 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -156.16 140.64 16.8 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.696 -0.402 . . . . 62.31 112.002 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -98.7 149.98 22.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.47 -0.567 . . . . 73.35 109.47 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.33 137.17 25.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.852 0.358 . . . . 73.32 111.165 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -150.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.679 -0.691 . . . . 72.15 112.648 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.491 ' O ' HG13 ' A' ' 172' ' ' ILE . 49.7 t0 -84.79 -23.6 29.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.133 -0.94 . . . . 73.2 111.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.417 ' CE1' ' NH2' ' A' ' 173' ' ' ARG . 17.2 t80 -41.81 -54.76 3.27 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.82 0.304 . . . . 72.34 111.82 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.62 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 69.2 t -65.64 -57.25 14.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.388 -0.525 . . . . 73.13 110.235 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 88.5 Cg_exo -45.18 -31.58 6.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.985 1.79 . . . . 74.03 112.05 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 168' ' ' ASP . 61.4 mt -51.91 -37.35 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.885 0.374 . . . . 74.33 110.307 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.417 ' NH2' ' CE1' ' A' ' 169' ' ' TYR . 0.2 OUTLIER -53.7 -33.6 55.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.775 -0.454 . . . . 74.31 109.775 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.515 ' HA ' HG12 ' A' ' 177' ' ' ILE . 69.0 m-80 -58.19 -31.65 67.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 71.22 111.031 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 2.6 mptp? -61.31 -13.57 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.29 -0.633 . . . . 75.32 109.29 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.2 m -98.32 8.23 45.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.318 -0.856 . . . . 75.33 111.292 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 174' ' ' ASN . 27.4 mm -69.83 117.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.015 -0.365 . . . . 72.14 110.015 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.34 -27.91 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 113.523 0.934 . . . . 55.02 113.523 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.325 -1.264 . . . . 53.03 112.294 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.851 0.358 . . . . 71.13 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.37 -57.15 2.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.853 -0.612 . . . . 72.42 112.242 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.559 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 12.9 pt -129.02 65.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.253 0.549 . . . . 74.34 111.085 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.2 p -141.37 143.92 32.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.028 -0.533 . . . . 73.14 111.17 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 2.7 Cg_exo -76.16 22.27 2.73 Favored 'Cis proline' 0 C--N 1.358 1.039 0 C-N-CA 124.454 -1.061 . . . . 73.41 112.334 0.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -49.51 -53.87 20.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.169 -0.923 . . . . 73.23 111.276 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 2.8 m -165.79 -40.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.73 0.641 . . . . 71.21 112.73 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 4' ' ' ILE . 22.8 tp -157.1 152.19 26.1 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.494 0.664 . . . . 75.21 112.372 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -60.54 -35.81 76.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.795 -0.639 . . . . 74.53 111.07 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.15 13.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 75.14 111.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.9 124.51 77.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.145 -0.48 . . . . 74.53 111.574 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -85.66 -117.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.957 2.438 . . . . 73.23 112.724 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.72 -46.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 122.931 0.492 . . . . 74.43 109.741 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.83 -158.72 13.63 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.371 -0.692 . . . . 71.14 111.371 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -147.92 167.59 24.45 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.519 0.676 . . . . 75.1 111.488 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.441 ' H ' ' HB2' ' A' ' 160' ' ' ASN . 13.1 mt -105.5 152.97 7.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.333 -1.303 . . . . 75.04 108.416 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.0 mmpt? -108.48 102.4 11.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.103 -0.499 . . . . 73.4 110.601 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 35.3 t -105.92 109.93 29.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.966 -0.753 . . . . 62.3 108.966 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 26' ' ' GLU . 67.6 mt -98.45 137.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.579 . . . . 74.32 110.846 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.83 -97.23 0.18 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.214 -0.903 . . . . 74.14 112.543 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.82 -44.59 88.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.601 -0.809 . . . . 75.43 113.544 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' HD22 ' A' ' 25' ' ' LEU . 12.2 t70 174.34 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.272 -0.64 . . . . 61.32 109.272 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.22 -42.49 15.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.452 -0.795 . . . . 73.12 109.361 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 pt? -69.51 138.51 53.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.277 -0.874 . . . . 71.22 110.359 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 pt-20 -150.36 151.49 32.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.728 -1.123 . . . . 72.52 108.822 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 3.0 m -73.21 120.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.956 0.724 . . . . 64.33 112.956 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 3.4 mptp? -104.11 111.97 24.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.455 -0.793 . . . . 72.41 112.512 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.0 mp0 29.04 67.77 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.606 1.336 . . . . 75.54 114.606 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' N ' ' HD1' ' A' ' 161' ' ' TYR . . . 76.92 5.17 84.2 Favored Glycine 0 N--CA 1.465 0.63 0 C-N-CA 121.043 -0.598 . . . . 51.1 112.844 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -47.62 147.07 1.94 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.697 -0.752 . . . . 70.25 111.933 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -101.76 131.72 47.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.459 -1.246 . . . . 75.4 109.85 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 9.6 mp -96.96 124.92 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.157 0.503 . . . . 71.31 111.166 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 p -149.87 145.09 18.38 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.496 -0.775 . . . . 75.45 109.688 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -83.78 -113.26 0.0 OUTLIER 'Cis proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.936 -1.277 . . . . 75.14 112.965 0.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.0 p -67.47 61.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.532 0.568 . . . . 72.23 112.532 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.8 pt20 -119.11 -3.57 10.62 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.746 0.307 . . . . 65.5 111.226 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 33' ' ' LEU . 30.9 m -78.22 32.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.824 0.345 . . . . 73.11 110.921 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -105.64 -23.21 12.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.149 0.796 . . . . 73.12 113.149 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 1.4 m-20 -71.5 139.91 49.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.265 0.555 . . . . 62.43 112.032 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.31 130.53 93.19 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 115.496 -0.775 . . . . 71.32 110.045 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.15 126.31 13.56 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.999 1.799 . . . . 73.41 112.442 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -107.95 109.51 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 75.12 110.678 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.45 138.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.165 0.431 . . . . 74.44 112.165 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -165.3 164.07 19.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.758 0.313 . . . . 63.22 110.734 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p90 -141.16 37.12 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.817 -0.628 . . . . 75.22 110.27 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.1 t -50.78 112.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 74.02 111.355 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.72 -14.64 61.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.114 -0.565 . . . . 71.52 112.935 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -78.53 -28.12 46.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 71.52 110.943 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -72.75 -82.92 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.936 0.398 . . . . 72.4 111.429 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.559 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 78.77 -52.83 3.97 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.155 -0.545 . . . . 74.23 111.969 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.64 109.03 4.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.823 0.344 . . . . 72.43 110.139 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.488 ' HG ' ' HA3' ' A' ' 86' ' ' GLY . 3.0 p -157.95 141.33 15.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.529 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -86.3 -40.58 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.915 0.864 . . . . 74.42 109.41 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -149.98 157.52 43.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.044 -1.435 . . . . 74.41 107.528 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.8 mt -128.46 144.49 51.15 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.32 -0.552 . . . . 75.31 111.023 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -115.85 132.52 56.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.408 -0.814 . . . . 73.14 110.541 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.37 131.44 40.07 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.257 0.348 . . . . 72.34 110.348 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 mt -151.39 167.11 28.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.915 0.388 . . . . 75.01 111.732 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -94.88 146.03 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.633 -0.712 . . . . 73.32 109.469 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 49.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.056 0.455 . . . . 75.52 110.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 p30 -133.66 54.82 13.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.543 -0.753 . . . . 75.33 111.425 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.35 83.29 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.39 1.394 . . . . 75.51 112.048 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -150.18 109.11 3.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.19 -0.914 . . . . 61.3 110.211 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -167.54 137.83 2.32 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 60.54 110.348 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.614 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -78.38 -23.89 13.29 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.114 -1.203 . . . . 73.44 111.851 -0.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 109' ' ' THR . 5.8 t -145.86 140.85 27.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.366 -0.834 . . . . 72.31 111.064 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.528 HH11 ' CB ' ' A' ' 68' ' ' ARG . 5.6 ttp-105 -52.59 -29.18 24.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 70.41 111.743 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG2' ' OG1' ' A' ' 67' ' ' THR . 8.1 pt20 -80.0 -27.17 39.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.448 0.536 . . . . 73.31 112.448 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -144.67 60.41 7.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-O 120.988 0.423 . . . . 72.13 111.711 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 56.8 Cg_endo -69.24 58.98 1.35 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.063 2.509 . . . . 73.1 112.876 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 8.7 ptpt -57.37 -47.72 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.175 0.805 . . . . 71.22 113.175 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.614 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -105.71 35.66 2.8 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.106 -0.638 . . . . 73.33 112.221 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 25.2 ttp180 -70.24 131.61 44.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.179 -0.674 . . . . 73.41 109.179 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 42.6 mt-10 -93.65 169.34 10.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 72.12 110.618 -0.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 77' ' ' LEU . 10.6 tp -110.4 -134.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.467 -0.197 . . . . 73.03 110.467 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.543 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.1 mt -72.41 152.07 42.23 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.451 -0.574 . . . . 75.52 109.451 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.518 ' NE2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -163.87 157.07 18.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.722 0.267 . . . . 72.12 111.722 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 5.0 t-105 -99.96 117.65 34.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.915 -0.584 . . . . 74.04 109.978 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 6.1 p -141.13 134.45 29.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.995 -0.548 . . . . 61.02 112.073 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG21 ' CZ2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -142.76 142.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 70.1 110.021 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 14.5 m -140.85 159.14 23.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.475 0.546 . . . . 71.21 112.475 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.556 HD22 ' HB2' ' A' ' 95' ' ' HIS . 15.0 p30 62.36 35.87 14.76 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 114.567 -1.197 . . . . 73.34 111.185 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.576 ' CG2' ' HA ' ' A' ' 91' ' ' PRO . 3.6 mm -73.62 127.63 88.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 70.31 109.742 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 23.9 Cg_exo -63.5 126.87 18.5 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 121.958 1.772 . . . . 75.24 111.755 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.488 ' HA3' ' HG ' ' A' ' 53' ' ' SER . . . -60.79 62.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.248 0.342 . . . . 63.02 113.602 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' PRO . 31.9 p -179.2 39.69 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.16 0.48 . . . . 74.01 110.942 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.31 -4.05 2.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.255 -0.429 . . . . 72.53 111.816 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 67.62 -36.64 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.222 0.609 . . . . 75.54 112.5 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 88' ' ' ASN . 1.6 p30 -127.71 153.42 77.8 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 64.21 110.609 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 77.5 Cg_endo -70.78 47.08 0.68 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.646 2.897 . . . . 74.21 113.803 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.8 m -93.49 -40.32 10.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 73.25 112.147 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.07 -13.11 61.44 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.906 -0.588 . . . . 74.11 114.241 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.468 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -98.33 172.08 26.11 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.405 -0.902 . . . . 72.54 113.404 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.556 ' HB2' HD22 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.69 126.61 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 75.43 111.496 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.414 ' H ' HG23 ' A' ' 130' ' ' THR . 85.3 p -88.11 94.5 9.83 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.999 -0.546 . . . . 71.23 109.895 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 131' ' ' ILE . 77.2 mt -50.06 -38.24 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 74.24 109.189 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -156.67 115.49 3.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.692 -1.14 . . . . 52.13 109.089 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.493 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 50.2 t0 -52.36 146.71 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.439 0.462 . . . . 73.35 111.982 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.617 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 47.7 p90 -69.81 129.61 40.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.212 -0.449 . . . . 75.42 110.598 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 102' ' ' GLY . 13.7 p -158.61 174.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.326 -0.397 . . . . 74.2 110.217 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.484 ' H ' ' CG2' ' A' ' 101' ' ' VAL . . . -72.04 -129.18 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.234 -0.984 . . . . 74.23 111.703 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.52 ' C ' ' HD3' ' A' ' 105' ' ' PRO . 47.6 t -175.48 -165.67 0.18 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.838 -0.801 . . . . 64.24 108.838 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.537 ' N ' ' HD3' ' A' ' 105' ' ' PRO . . . -128.58 54.89 0.77 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.766 -0.731 . . . . 74.33 111.65 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 104' ' ' GLY . 14.3 Cg_endo -87.96 120.7 1.39 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.499 2.133 . . . . 74.42 112.676 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' CG2' ' A' ' 109' ' ' THR . 73.5 Cg_endo -74.31 162.11 39.09 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.79 2.327 . . . . 73.23 111.759 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 109' ' ' THR . 17.6 pttp -43.55 -45.64 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.443 -0.344 . . . . 74.21 111.764 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.442 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -63.4 5.95 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.159 0.429 . . . . 71.44 112.159 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.527 ' HA ' ' HB ' ' A' ' 67' ' ' THR . 13.0 t -75.14 -25.68 58.58 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.144 0.497 . . . . 74.22 110.196 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.9 -165.11 42.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 71.14 112.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.8 tp -71.33 111.56 6.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.867 0.365 . . . . 72.04 111.492 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -88.85 131.99 34.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.31 110.987 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -103.55 90.54 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.742 -0.663 . . . . 75.24 109.922 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 10.2 m-85 -74.94 136.48 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.407 . . . . 73.53 111.242 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 161' ' ' TYR . 35.0 mt -130.03 138.22 54.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.83 -0.623 . . . . 75.3 112.053 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -120.74 136.81 54.77 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.465 -0.789 . . . . 73.34 109.439 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 117' ' ' LEU . 2.3 pp -118.47 149.32 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 75.14 109.895 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 157' ' ' ILE . 2.8 tt -133.94 134.87 43.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 73.34 109.592 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.456 ' HA ' HG12 ' A' ' 157' ' ' ILE . 53.3 t80 -139.88 136.71 34.22 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 75.02 111.448 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -73.7 124.71 26.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.752 -0.658 . . . . 74.35 109.71 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -110.78 145.31 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 75.1 112.351 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -118.63 -39.92 2.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.982 -1.008 . . . . 75.41 109.968 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.98 130.75 34.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.234 -0.439 . . . . 72.35 111.106 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -79.06 131.91 36.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.514 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.449 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -125.33 154.55 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.712 -0.676 . . . . 73.01 112.414 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -33.79 15.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.747 -0.661 . . . . 70.42 111.786 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER 36.76 36.27 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.12 1.155 . . . . 75.53 114.12 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p 59.11 159.49 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-O 121.154 0.502 . . . . 73.14 112.165 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -53.88 152.45 23.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.637 2.225 . . . . 73.14 113.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 96' ' ' SER . 22.9 p -59.02 127.15 30.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.192 -0.913 . . . . 74.42 110.707 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.467 HG13 ' NH1' ' A' ' 139' ' ' ARG . 20.4 mm -91.85 124.94 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 74.15 111.644 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.0 m -69.76 147.98 49.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.998 -1.001 . . . . 73.04 112.09 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.493 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 16.6 p30 -50.55 -43.63 56.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 74.51 111.427 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.7 t -68.71 21.91 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.481 0.549 . . . . 64.1 112.481 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.6 t -65.16 122.34 16.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 74.11 110.884 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.682 ' HD2' ' N ' ' A' ' 137' ' ' THR . 5.0 tmm_? -82.49 160.76 22.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.53 -0.759 . . . . 73.11 111.652 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.682 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 6.0 m -39.94 158.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.348 -0.842 . . . . 75.42 111.093 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.543 ' H ' HD13 ' A' ' 140' ' ' LEU . . . 116.81 3.95 17.51 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.127 -0.488 . . . . 75.2 112.483 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.467 ' NH1' HG13 ' A' ' 131' ' ' ILE . 17.8 ttm180 -167.86 48.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.888 0.375 . . . . 73.14 110.731 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.543 HD13 ' H ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -114.65 -56.45 2.38 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.321 -0.399 . . . . 73.14 110.314 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.597 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.1 m120 -63.81 66.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.853 -0.612 . . . . 73.12 111.691 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LEU . 14.3 t80 -138.77 121.72 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.522 -0.548 . . . . 71.12 109.522 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.566 HD21 ' HB2' ' A' ' 146' ' ' ASP . 22.3 t30 -63.6 122.28 15.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.215 0.531 . . . . 74.22 111.75 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.68 72.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.625 -0.716 . . . . 63.41 111.45 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -50.44 -35.14 27.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.459 . . . . 75.14 110.223 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.566 ' HB2' HD21 ' A' ' 143' ' ' ASN . 34.1 t70 -64.62 -44.12 91.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.426 0.631 . . . . 74.45 109.382 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.506 ' CD1' ' HD3' ' A' ' 150' ' ' LYS . 1.2 t80 -62.9 -38.35 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 61.42 109.574 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.511 ' HA ' HD13 ' A' ' 153' ' ' LEU . . . -65.36 -46.6 79.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.578 -0.737 . . . . 74.5 110.564 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.19 -55.08 23.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 52.25 110.624 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.22 -48.13 83.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 63.41 110.583 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.543 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 38.4 m170 -67.64 3.39 1.42 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 121.221 -0.191 . . . . 73.12 111.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 72.86 7.77 71.12 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.86 -0.686 . . . . 64.24 112.19 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 148' ' ' ALA . 9.5 mt -72.14 16.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.392 0.277 . . . . 75.43 110.883 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.91 -69.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.432 -0.889 . . . . 71.04 112.127 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 21.2 pt-20 -80.39 120.03 78.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.579 0.228 . . . . 73.24 110.839 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.38 125.44 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.936 1.757 . . . . 73.31 112.077 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 119' ' ' TYR . 27.2 pt -76.26 -33.94 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.476 -0.49 . . . . 74.42 110.012 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -146.52 144.61 29.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.924 -0.58 . . . . 65.03 110.507 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.68 31.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.424 -0.353 . . . . 74.25 110.884 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.441 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.0 t-20 -150.97 148.98 29.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.928 -1.138 . . . . 75.22 107.928 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.5 ' HB3' HG12 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -152.34 165.73 34.07 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.272 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.489 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.4 p90 -154.14 152.92 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.582 -0.735 . . . . 74.21 110.778 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.68 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.41 -0.589 . . . . 72.21 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.16 138.72 15.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.273 0.559 . . . . 61.21 111.856 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -118.28 144.97 45.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 73.31 109.153 178.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.9 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.156 -0.313 . . . . 75.54 110.156 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -100.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.511 -0.768 . . . . 75.3 112.322 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t0 -147.78 21.48 1.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.658 0.742 . . . . 72.22 109.949 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -76.45 -47.95 21.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.676 -0.693 . . . . 75.45 111.359 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 60.2 t -43.02 -50.34 13.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.052 -0.522 . . . . 74.34 112.271 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 51.2 Cg_exo -57.84 -37.01 97.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.068 1.845 . . . . 73.3 112.392 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.0 mm -50.12 -39.86 16.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.057 0.456 . . . . 75.32 110.977 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -69.98 -30.18 67.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 74.1 111.212 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 171' ' ' PRO . 1.6 m120 -56.02 -14.94 2.9 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.512 -0.313 . . . . 73.23 110.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.52 -20.08 7.07 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.605 -0.517 . . . . 73.02 109.605 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.0 m -68.34 -28.01 66.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.69 -0.686 . . . . 75.35 110.783 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 35.6 mm -54.6 130.79 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.703 . . . . 74.43 111.978 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 20.1 m -146.7 -14.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.066 0.765 . . . . 74.44 113.066 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.451 ' N ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.225 -1.32 . . . . 64.24 112.577 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 3.3 p-10 . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 109.596 -0.52 . . . . 73.4 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.09 -71.21 0.42 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.637 0.977 . . . . 72.43 113.637 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 9' ' ' LEU . 7.5 pt -97.11 46.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.528 0.68 . . . . 71.25 112.568 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 2' ' ' ASP . 7.1 p -128.14 142.37 44.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.551 -0.749 . . . . 72.02 110.372 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 64.0 Cg_endo -86.62 35.58 4.13 Favored 'Cis proline' 0 C--N 1.35 0.619 0 C-N-CA 124.115 -1.202 . . . . 74.55 112.932 0.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.33 -48.37 75.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 71.41 111.032 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 ' HB ' ' OH ' ' A' ' 161' ' ' TYR . 3.6 m -160.36 -37.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.689 0.626 . . . . 74.24 112.689 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 4' ' ' ILE . 48.9 tp -157.13 164.27 38.03 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.884 0.373 . . . . 71.24 110.899 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.88 -42.35 94.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.098 0.475 . . . . 72.44 110.095 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.87 -174.59 3.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.491 -0.777 . . . . 72.13 111.187 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.29 111.96 57.46 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.96 -0.564 . . . . 75.34 111.555 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 64.9 Cg_endo -83.95 -134.89 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.124 2.549 . . . . 70.34 112.117 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -150.46 -38.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.508 -0.314 . . . . 63.13 111.098 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -138.24 166.58 25.19 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.561 -0.828 . . . . 71.33 112.533 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -102.12 159.65 15.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.263 0.554 . . . . 73.25 111.506 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.41 131.24 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.698 -0.853 . . . . 71.31 108.698 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.552 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 6.8 mtpm? -74.03 102.98 4.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.516 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.611 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 46.9 t -117.52 110.59 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.111 0.481 . . . . 75.35 110.654 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.52 131.48 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.048 -0.524 . . . . 70.41 110.34 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.505 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -72.31 -51.08 22.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.36 -0.382 . . . . 71.04 111.516 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.1 -61.23 0.16 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.559 -0.829 . . . . 74.34 113.273 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.484 ' H ' HD23 ' A' ' 25' ' ' LEU . 1.9 m-20 -153.16 -59.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.028 0.442 . . . . 74.02 110.343 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -97.57 -38.5 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.684 -0.689 . . . . 74.15 111.071 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 pt? -69.71 135.62 50.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.396 0.617 . . . . 74.32 110.723 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -140.67 136.92 33.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.35 -0.841 . . . . 74.52 111.827 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.611 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 28.2 m -76.62 139.22 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.312 -0.858 . . . . 75.31 110.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HA ' HD22 ' A' ' 160' ' ' ASN . 41.6 pttt -155.12 122.32 5.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.857 1.058 . . . . 75.31 113.857 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 11.8 mp0 27.42 67.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.357 1.614 . . . . 73.32 115.357 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 161' ' ' TYR . . . 86.81 -7.98 77.69 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.993 -0.622 . . . . 72.41 114.3 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -50.44 129.93 22.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.597 0.236 . . . . 60.24 110.65 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -94.76 142.1 27.85 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.843 -0.428 . . . . 72.4 109.843 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 1.3 tp -101.86 127.99 48.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 74.33 110.995 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 66.9 p -149.91 157.42 37.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.478 -0.783 . . . . 70.41 109.692 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.5 Cg_exo -76.33 -47.88 0.29 Allowed 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.988 -1.255 . . . . 62.44 112.102 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 38' ' ' VAL . 74.2 p -151.46 25.69 0.69 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 72.23 111.395 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 39' ' ' LYS . 13.8 pt20 -63.33 0.41 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.37 0.605 . . . . 74.13 111.039 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 36' ' ' THR . 35.4 m -74.21 32.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.49 -0.777 . . . . 74.41 111.605 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -76.55 -31.69 57.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.977 0.418 . . . . 74.32 111.139 -179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 14.9 m-20 -87.16 142.86 27.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.498 0.555 . . . . 71.1 112.498 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.05 139.05 92.65 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 115.6 -0.727 . . . . 73.43 111.092 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.505 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 20.2 Cg_exo -63.19 126.6 18.19 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.724 1.616 . . . . 70.12 112.078 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 mm -108.39 112.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.24 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HA ' HG22 ' A' ' 19' ' ' VAL . 57.2 t -86.07 142.23 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.554 0.576 . . . . 74.31 112.554 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.4 m -165.05 133.82 3.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.801 0.334 . . . . 70.2 111.253 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 15.0 p90 -108.66 32.41 4.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.44 0.638 . . . . 72.45 110.227 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.5 m -43.77 134.45 4.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.396 -0.82 . . . . 72.23 111.082 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.47 -29.86 4.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.86 -0.686 . . . . 71.02 112.975 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.73 -38.88 27.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.275 0.538 . . . . 73.45 110.25 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 13.1 tp10 -50.15 163.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.888 -0.597 . . . . 73.44 110.688 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 50' ' ' GLU . . . -170.12 -76.91 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.283 -0.727 . . . . 70.34 111.283 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -148.53 109.76 4.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.815 0.341 . . . . 73.4 110.295 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -151.31 141.72 22.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.028 -0.533 . . . . 72.45 110.02 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.89 -36.56 62.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.327 0.584 . . . . 73.43 109.474 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 121' ' ' GLN . 30.6 mt -155.28 164.84 38.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.998 -1.001 . . . . 74.44 110.455 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 35.0 mt -135.83 157.29 47.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.946 0.403 . . . . 74.23 110.92 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -117.94 121.89 41.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 72.43 109.674 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 1.1 tm? -127.07 128.71 46.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.256 -0.646 . . . . 72.51 109.256 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 80' ' ' SER . 43.5 mt -154.29 154.0 32.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.99 -0.284 . . . . 73.43 111.137 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -134.1 145.38 49.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.671 -0.492 . . . . 71.52 109.671 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 144' ' ' ALA . 8.8 t -150.62 164.76 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.867 1.062 . . . . 73.42 113.867 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -172.85 86.08 0.41 Allowed Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 113.594 -1.639 . . . . 73.15 107.211 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.98 84.69 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 123.204 2.602 . . . . 72.01 115.342 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -170.49 124.05 0.68 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.134 -0.484 . . . . 64.04 111.896 177.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.489 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.31 136.95 1.27 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.453 -0.34 . . . . 70.12 111.731 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HG3' ' CE2' ' A' ' 73' ' ' TYR . 18.6 Cg_exo -66.26 -33.48 2.8 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.752 -1.353 . . . . 72.14 110.945 -0.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 3.5 t -130.21 157.34 42.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 72.43 109.872 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' NH2' ' A' ' 113' ' ' ARG . 23.8 ttt85 -58.37 -26.69 63.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.199 0.523 . . . . 75.5 109.785 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -78.2 -15.59 58.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.065 -0.97 . . . . 73.43 111.664 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 60.5 t0 -143.98 94.97 5.76 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.233 -0.439 . . . . 62.43 111.284 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.78 50.51 3.59 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.123 2.549 . . . . 75.43 112.027 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 7.2 ttmt -58.6 -54.74 43.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.309 0.855 . . . . 75.52 113.309 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.542 ' CE2' ' HG3' ' A' ' 66' ' ' PRO . 16.9 p90 -132.2 25.6 4.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.687 0.625 . . . . 75.51 112.687 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.483 ' HB2' ' N ' ' A' ' 65' ' ' ALA . 2.8 tmm_? -58.19 134.7 56.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 73.32 109.694 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -90.31 178.22 6.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.542 1.137 . . . . 64.2 111.177 0.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.2 mp -98.04 -61.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.357 0.599 . . . . 74.43 109.962 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -171.23 141.8 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.504 -0.925 . . . . 73.04 108.504 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.515 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 5.0 p-80 -137.57 176.01 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 74.23 111.581 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.553 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.4 t-105 -100.48 113.77 26.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.946 -0.761 . . . . 75.51 108.946 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.472 ' HB2' ' CD2' ' A' ' 59' ' ' LEU . 43.3 p -131.54 114.52 14.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.645 -0.707 . . . . 70.33 111.078 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.542 HG22 ' CZ2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -127.33 117.91 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 74.14 109.239 178.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -114.87 164.8 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.332 -0.849 . . . . 64.23 111.758 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.578 HD22 ' CG ' ' A' ' 95' ' ' HIS . 24.8 p30 52.16 43.9 30.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 71.15 112.374 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 4.4 mm -75.43 118.06 67.95 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.89 -1.152 . . . . 73.43 107.89 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.45 125.72 18.56 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.689 1.593 . . . . 74.34 111.725 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.07 61.23 0.08 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.371 0.419 . . . . 51.1 113.656 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -171.09 39.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.419 0.688 . . . . 71.03 109.318 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 55.7 m-80 -130.08 -28.07 2.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.511 -0.768 . . . . 74.43 111.787 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' HA ' ' NE1' ' A' ' 46' ' ' TRP . 2.2 tt0 76.0 -9.24 1.48 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.071 0.463 . . . . 72.41 110.776 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 88' ' ' ASN . 15.9 p30 -155.91 155.27 29.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.294 -0.866 . . . . 70.14 110.111 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 84.4 Cg_endo -73.75 60.75 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.655 0 C-N-CA 123.684 2.922 . . . . 75.14 113.21 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -90.96 -55.08 3.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.188 0.81 . . . . 70.31 113.188 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -10.85 75.13 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 116.445 1.338 . . . . 72.11 116.445 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.527 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -71.19 164.42 53.76 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.789 -1.196 . . . . 73.14 113.662 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.578 ' CG ' HD22 ' A' ' 83' ' ' ASN . 13.5 m80 -65.21 121.35 14.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.805 0.336 . . . . 61.51 111.597 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.412 ' H ' HG23 ' A' ' 130' ' ' THR . 8.9 m -87.81 89.38 7.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 71.52 111.305 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 127' ' ' GLU . 16.7 mt -61.66 -17.36 55.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.536 0.684 . . . . 72.34 111.339 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' N ' ' HG ' ' A' ' 80' ' ' SER . . . -167.92 116.06 0.75 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.344 -0.844 . . . . 74.51 108.957 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' HB3' ' CA ' ' A' ' 133' ' ' ASN . 28.4 t0 -60.06 151.82 25.65 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.595 0.559 . . . . 61.23 111.992 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -70.12 148.38 48.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 65.04 112.394 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.31 133.0 52.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.827 -0.624 . . . . 74.41 110.03 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.63 66.95 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.412 -0.899 . . . . 63.14 112.819 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.436 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 34.4 m -164.83 127.65 2.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 73.01 111.123 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.87 -73.32 1.09 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.84 -0.618 . . . . 62.02 112.659 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 31.7 Cg_exo -57.84 133.57 56.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.848 2.366 . . . . 74.53 112.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 32.3 Cg_exo -58.38 151.59 59.91 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.107 2.538 . . . . 63.35 113.563 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 168' ' ' ASP . 21.8 pttm -46.12 -26.94 0.84 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.178 -0.919 . . . . 74.24 111.344 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.54 -30.36 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 72.11 110.462 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 2.3 t -92.16 -26.7 18.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.278 0.561 . . . . 72.24 109.804 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.35 -100.5 0.81 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.578 -0.737 . . . . 75.15 114.886 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.91 125.41 22.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.661 0.744 . . . . 74.33 112.976 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 69.1 m-70 -116.04 123.01 46.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.622 -1.172 . . . . 74.14 110.097 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.526 ' NH2' ' NH1' ' A' ' 68' ' ' ARG . 36.8 mtm180 -94.47 85.25 4.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.811 -0.44 . . . . 71.1 109.811 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.436 ' OH ' ' HA ' ' A' ' 103' ' ' SER . 29.6 m-85 -70.33 114.5 8.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.128 -0.629 . . . . 74.43 110.676 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 60' ' ' MET . 38.4 mm -104.97 121.98 57.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 110.261 -0.274 . . . . 75.34 110.261 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 0.5 OUTLIER -102.54 128.51 49.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.856 0.462 . . . . 74.54 109.828 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.91 133.65 54.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 72.31 110.313 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 33.7 tp -128.64 131.76 48.08 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.169 -0.469 . . . . 75.3 110.459 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' THR . 60.7 t80 -144.02 138.2 28.2 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.744 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.4 ' NH1' ' CB ' ' A' ' 120' ' ' ARG . 12.7 ttp-105 -71.06 133.38 46.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.711 0.291 . . . . 72.31 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 1.2 mt-30 -109.39 109.73 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 71.24 110.467 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.98 -43.46 11.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.045 -0.724 . . . . 75.51 109.045 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 123' ' ' ASN . 1.0 OUTLIER -90.83 122.18 33.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.916 -1.038 . . . . 70.43 110.34 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 58.6 tttm -70.9 128.08 34.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.337 0.589 . . . . 72.03 111.385 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.74 132.65 59.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.972 -1.013 . . . . 75.01 110.541 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -56.35 -59.48 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 65.53 110.337 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 150' ' ' LYS . 27.8 mm-40 58.33 32.64 22.31 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.397 -0.82 . . . . 74.33 113.192 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.503 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 39.9 p 49.38 171.62 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 113.079 0.77 . . . . 71.24 113.079 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.503 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 36.9 Cg_exo -61.51 158.33 37.01 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.146 2.564 . . . . 65.45 113.295 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 96' ' ' SER . 20.7 p -58.75 124.71 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.843 -0.617 . . . . 72.52 111.398 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.17 121.82 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 73.52 111.243 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -73.42 147.36 44.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.597 -0.729 . . . . 75.13 112.27 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 135' ' ' THR . 10.9 t-20 -55.11 -35.01 64.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.03 -0.532 . . . . 64.51 111.962 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.8 t -67.06 21.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.622 0.248 . . . . 74.13 111.483 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.568 ' H ' ' C ' ' A' ' 133' ' ' ASN . 10.1 t -62.52 113.29 2.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.393 0.616 . . . . 72.21 111.089 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.532 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 41.8 ttt85 -89.08 173.21 8.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.849 . . . . 74.53 110.96 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 77.4 m -34.08 143.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.109 -0.496 . . . . 64.14 111.546 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.11 3.9 19.01 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.133 -0.556 . . . . 75.32 112.213 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -160.01 29.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.959 0.409 . . . . 74.5 110.775 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.278 0.561 . . . . 70.21 110.277 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 5.9 m120 -67.95 44.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.283 -0.872 . . . . 53.23 112.799 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 4.0 t80 -109.38 90.35 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.822 -0.436 . . . . 71.22 109.822 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.09 112.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 74.12 111.049 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.521 ' HA ' ' CE1' ' A' ' 147' ' ' PHE . . . -57.63 -32.9 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.072 -0.513 . . . . 74.43 111.203 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -50.41 -32.71 18.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.384 -0.371 . . . . 65.42 111.07 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -56.12 -34.51 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.104 0.478 . . . . 71.43 110.284 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.4 m-85 -49.76 -38.11 32.52 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.559 0.695 . . . . 75.21 109.687 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.47 91.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.221 -0.899 . . . . 73.33 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.39 -48.34 42.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 72.23 111.949 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -59.01 -41.12 86.93 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.167 0.432 . . . . 74.42 112.167 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.474 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 46.3 t60 -109.25 5.52 23.8 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.01 -0.676 . . . . 74.42 111.533 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 63.46 34.64 90.49 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.888 -0.673 . . . . 53.14 113.982 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 155' ' ' GLU . 11.3 mt -69.69 16.33 0.06 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.517 -0.402 . . . . 72.3 111.016 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -55.74 1.66 0.07 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 114.241 0.457 . . . . 75.14 114.241 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 153' ' ' LEU . 4.9 pt-20 -135.11 72.66 66.73 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.258 0.551 . . . . 65.14 110.154 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 31.9 Cg_exo -57.03 129.37 34.12 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.452 2.102 . . . . 72.14 112.131 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.1 pt -79.9 -38.18 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.495 -0.557 . . . . 75.41 109.495 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' GLY . . . -146.31 148.64 32.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.889 -0.596 . . . . 74.44 110.877 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -150.68 157.74 43.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.982 0.42 . . . . 70.24 111.568 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 1.8 t-20 -157.19 145.07 19.09 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.415 -0.958 . . . . 63.22 108.415 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 30' ' ' GLY . 17.9 p90 -155.03 157.46 37.64 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.759 -0.588 . . . . 75.15 111.945 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.53 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 5.6 p90 -153.54 163.78 39.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.613 -0.721 . . . . 74.5 111.24 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 44.5 mt-30 -122.53 124.89 44.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 73.14 110.469 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.14 152.11 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 75.34 112.411 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -127.18 148.1 50.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.346 -0.983 . . . . 73.32 108.346 177.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -137.38 152.69 49.94 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.02 0.378 . . . . 75.14 112.02 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.5 m-20 -54.93 163.34 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.765 -0.652 . . . . 74.14 111.865 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 171' ' ' PRO . 6.3 t0 -68.03 27.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.689 -0.687 . . . . 74.24 111.3 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 167' ' ' ASP . 21.2 t80 -82.28 -60.86 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.74 0.644 . . . . 75.22 112.74 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 14.6 p -62.14 -32.09 9.05 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 113.337 0.866 . . . . 71.43 113.337 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 81.7 Cg_exo -47.97 -30.02 13.03 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.74 1.626 . . . . 74.31 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.3 mm -49.35 -37.77 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.68 -0.691 . . . . 75.1 109.401 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -45.87 -42.79 12.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.471 -0.786 . . . . 72.02 109.953 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.446 ' HA ' HG12 ' A' ' 177' ' ' ILE . 72.1 m-80 -58.28 -39.4 79.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 73.31 111.465 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.54 -28.25 63.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 72.25 110.492 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.5 m -84.61 -4.13 58.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.954 -0.566 . . . . 70.2 112.335 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 33.0 mm -62.11 99.14 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.088 0.47 . . . . 73.14 111.006 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.83 -6.94 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.588 -0.733 . . . . 73.53 112.491 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.482 -1.177 . . . . 61.43 112.42 -178.515 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.523 -0.071 0 N-CA-C 109.302 -0.629 . . . . 73.23 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.519 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 64.3 t0 -89.63 -70.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.571 . . . . 65.42 112.38 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.8 58.94 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.389 0.614 . . . . 75.4 111.02 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.3 p -130.07 139.48 35.78 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 74.45 109.947 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.7 Cg_endo -85.57 35.13 3.64 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.139 -1.192 . . . . 75.31 113.113 0.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -49.92 73.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.952 0.406 . . . . 73.34 110.42 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 m -163.65 -44.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.912 -0.586 . . . . 74.21 110.927 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' ALA . 29.2 tp -157.25 137.84 13.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.44 110.797 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.56 13.93 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.364 0.505 . . . . 61.24 112.364 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -171.2 137.52 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.319 0.247 . . . . 75.03 110.643 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.67 112.24 14.32 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.796 0.331 . . . . 72.52 111.698 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' ' 156' ' ' PRO . 52.2 Cg_endo -88.7 134.52 2.77 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.893 2.396 . . . . 71.33 112.761 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.52 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.461 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.82 -159.05 7.98 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.757 -0.656 . . . . 51.22 111.77 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -135.9 162.94 31.43 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.178 0.513 . . . . 73.5 111.31 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' CG2' HG21 ' A' ' 44' ' ' VAL . 10.2 mt -105.31 135.17 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 70.22 110.484 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 30.9 mmmt -74.56 106.05 5.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.686 -0.688 . . . . 71.4 109.683 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 60.1 t -121.58 110.45 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.666 0.746 . . . . 74.34 110.747 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 3.0 mp -96.01 134.63 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.216 -0.902 . . . . 63.42 109.465 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.456 ' CD2' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -81.67 -85.34 0.1 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.67 -0.412 . . . . 71.32 111.782 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -67.58 -49.84 47.47 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.35 -0.928 . . . . 70.23 112.447 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 34.9 t70 172.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.716 0.769 . . . . 74.15 109.019 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.58 -49.72 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.741 -1.118 . . . . 72.41 110.522 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 2.1 pt? -69.66 139.57 53.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.3 0.572 . . . . 61.45 111.581 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 69.5 tt0 -120.82 150.01 41.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.267 -0.879 . . . . 74.41 111.857 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 10.5 m -98.7 119.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.85 -0.796 . . . . 74.14 108.85 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HD2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -139.08 128.58 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.757 0.789 . . . . 75.22 112.7 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.529 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.9 mp0 46.41 63.15 1.99 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.035 -1.438 . . . . 73.22 114.854 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 11.39 44.63 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 115.739 1.056 . . . . 74.31 115.739 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.24 139.48 35.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.779 0.789 . . . . 62.12 110.701 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.92 123.02 29.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.726 -0.472 . . . . 74.32 109.726 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.75 114.21 26.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.735 -0.386 . . . . 73.11 110.741 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -150.12 156.96 37.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 73.14 110.488 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.23 -100.4 0.0 OUTLIER 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.156 -1.185 . . . . 74.33 113.869 0.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -70.2 54.35 0.14 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.653 0.612 . . . . 74.42 112.653 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HZ2' ' A' ' 39' ' ' LYS . 18.0 pt20 -120.39 -6.32 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.98 0.419 . . . . 74.14 110.983 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.36 -6.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.12 -0.491 . . . . 74.53 111.911 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.516 ' HZ1' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -81.44 -10.57 59.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.49 -0.323 . . . . 65.13 111.79 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' HZ1' ' A' ' 39' ' ' LYS . 87.3 m-20 -79.07 144.76 34.29 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.162 0.506 . . . . 61.02 112.193 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.8 pm0 -76.31 138.47 67.93 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.697 -0.683 . . . . 72.54 109.878 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -78.88 126.88 7.46 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.319 2.013 . . . . 71.14 113.215 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.6 mm -104.25 105.93 19.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.015 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 45' ' ' SER . 2.6 p -87.14 143.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 113.234 0.827 . . . . 74.22 113.234 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.473 ' N ' HG21 ' A' ' 44' ' ' VAL . 60.9 m -162.24 132.55 4.77 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.023 0.44 . . . . 65.54 110.965 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.683 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -112.34 26.92 10.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.023 -0.535 . . . . 75.42 110.399 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 t -41.41 123.35 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 63.51 111.644 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.89 -29.64 7.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.06 -0.591 . . . . 73.41 113.28 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.15 -31.19 58.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.145 0.472 . . . . 70.42 111.336 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -70.48 -65.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.858 -0.61 . . . . 74.2 110.922 -179.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.527 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 65.76 -75.88 0.11 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.737 -0.665 . . . . 74.33 112.499 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -148.71 110.08 4.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 73.13 111.492 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -151.4 145.01 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.645 . . . . 65.22 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 11.2 t30 -65.75 -39.5 91.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.775 0.798 . . . . 62.12 109.369 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 46.2 mt -158.48 162.17 37.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.522 -1.217 . . . . 73.14 110.06 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 81.5 mt -128.85 142.48 50.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.774 0.321 . . . . 75.31 110.393 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.1 m -113.63 118.14 33.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 74.33 111.245 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 59' ' ' LEU . 1.8 tm? -116.36 140.29 49.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.73 -0.47 . . . . 73.55 109.73 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 58' ' ' LEU . 89.5 mt -141.89 154.85 45.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.373 . . . . 72.44 111.207 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 79' ' ' TRP . 23.5 ttt -117.63 124.38 48.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 75.44 110.674 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 40.7 t -108.96 132.74 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.32 109.778 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 7.9 t70 -176.94 62.07 0.19 Allowed Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 22.4 Cg_endo -91.59 83.39 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.692 1.595 . . . . 75.33 114.073 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -171.13 107.93 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.279 -0.873 . . . . 73.44 110.796 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.686 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.07 135.58 1.24 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 121.127 -0.229 . . . . 75.53 111.299 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.686 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 Cg_endo -52.28 -15.28 0.44 Allowed 'Cis proline' 0 C--N 1.356 0.957 0 C-N-CA 124.32 -1.116 . . . . 72.43 111.946 -2.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 109' ' ' THR . 6.7 t -165.15 -175.89 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.505 -0.77 . . . . 74.45 110.003 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HD2' ' HB3' ' A' ' 64' ' ' ASP . 13.7 tpt180 -67.73 -34.9 77.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.03 0.443 . . . . 75.52 109.838 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -71.0 -45.21 64.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.506 -0.77 . . . . 72.42 112.957 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.493 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 49.0 t0 -108.8 103.15 50.92 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.628 -0.429 . . . . 73.34 111.11 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.22 52.92 2.99 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.66 2.24 . . . . 75.54 110.865 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -48.57 -31.48 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.909 -0.587 . . . . 74.42 110.287 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.512 ' HB2' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -166.47 56.17 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.328 -0.851 . . . . 71.24 109.736 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 74' ' ' ARG . 4.9 tmm_? -99.26 135.27 40.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.911 -1.495 . . . . 72.44 109.417 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 63' ' ' PRO . 21.6 mp0 -76.15 177.81 6.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.711 0.804 . . . . 72.32 111.9 0.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.577 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.4 tp -109.75 -173.55 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.822 -1.177 . . . . 70.53 107.822 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.8 mt -64.99 120.37 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.078 0.399 . . . . 71.34 110.917 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 60' ' ' MET . 36.5 m170 -107.78 169.24 8.72 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.102 -0.239 . . . . 74.3 110.724 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.6 t-105 -100.01 85.27 3.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.741 0.782 . . . . 71.11 110.215 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -98.99 127.21 44.86 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.784 -1.098 . . . . 73.02 112.704 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.91 124.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.553 -0.748 . . . . 74.42 109.115 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 127' ' ' GLU . 23.6 m -138.13 -176.5 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.012 0.434 . . . . 70.4 111.732 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 15.6 p30 52.13 37.26 21.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.962 -1.017 . . . . 74.4 109.518 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.503 ' CD1' ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm -78.93 106.56 4.52 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 114.891 -1.05 . . . . 73.2 108.737 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 87' ' ' SER . 2.3 Cg_endo -48.13 129.04 17.95 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.759 1.64 . . . . 73.42 111.788 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.3 69.67 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 O-C-N 123.412 0.445 . . . . 65.41 113.823 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' PRO . 44.0 t 179.81 47.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.378 -0.601 . . . . 73.41 109.378 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 90' ' ' ASN . 55.0 m-80 -135.16 -22.39 1.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.173 -0.921 . . . . 74.21 112.309 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 67.86 -15.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.869 0.322 . . . . 75.34 111.869 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 88' ' ' ASN . 5.3 p30 -153.84 156.45 32.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.882 -0.599 . . . . 65.11 109.666 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.54 56.67 1.75 Allowed 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.334 2.689 . . . . 74.42 113.975 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -104.15 -40.08 6.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.503 . . . . 73.23 112.02 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.43 -41.56 58.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.887 0.715 . . . . 45.24 114.887 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.503 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -63.07 170.35 14.71 Favored Glycine 0 N--CA 1.46 0.287 0 C-N-CA 120.993 -0.622 . . . . 63.44 113.179 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.441 ' HB2' HD22 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.14 121.28 18.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.876 -0.19 . . . . 75.15 111.296 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.8 p -82.09 116.22 21.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.837 -1.172 . . . . 52.22 107.837 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.457 HD22 ' HG3' ' A' ' 127' ' ' GLU . 11.2 mt -67.36 -55.01 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 72.14 109.968 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.03 125.05 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.293 -0.867 . . . . 71.45 109.146 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 9.9 t0 -52.17 148.57 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.86 0.362 . . . . 65.51 111.318 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.446 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 37.6 p90 -65.03 128.74 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.261 0.553 . . . . 73.43 111.071 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 9.9 p -106.38 113.79 43.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.472 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.81 6.97 23.14 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.679 -0.772 . . . . 50.12 112.25 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.421 ' H ' HG21 ' A' ' 101' ' ' VAL . 38.2 t -59.98 -97.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.02 0.378 . . . . 75.11 112.02 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.24 161.88 37.82 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.928 -0.653 . . . . 52.21 112.254 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HB2' ' CE1' ' A' ' 112' ' ' HIS . 31.8 Cg_exo -60.72 137.59 74.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.932 2.421 . . . . 75.22 112.565 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.76 161.26 42.73 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.727 2.285 . . . . 74.34 113.211 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -42.36 -23.28 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.185 -0.916 . . . . 73.44 112.026 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.2 m-20 -50.8 -35.4 31.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.514 -0.312 . . . . 74.1 111.582 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 12.4 t -103.75 8.8 37.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.335 -0.546 . . . . 70.13 110.968 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.488 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 54.45 -110.96 1.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.977 -0.556 . . . . 74.22 113.751 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 27.6 tp -63.83 162.38 13.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.437 0.637 . . . . 74.42 111.899 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.609 ' NE2' ' H ' ' A' ' 166' ' ' TYR . 8.2 m-70 -147.04 144.62 29.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 74.02 109.303 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -109.05 108.65 19.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.022 -0.362 . . . . 73.33 110.022 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -104.55 133.31 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.523 -0.547 . . . . 75.33 109.523 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 26.8 mt -132.96 147.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.192 0.52 . . . . 64.34 111.54 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -120.84 134.31 55.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.237 -0.892 . . . . 75.22 109.395 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.9 140.15 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.144 0.277 . . . . 74.41 110.475 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 62.6 tp -134.79 135.49 41.84 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.39 -0.368 . . . . 71.51 111.09 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' HA ' HG12 ' A' ' 157' ' ' ILE . 37.7 t80 -144.25 142.85 30.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 75.32 110.553 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -71.47 128.33 35.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.024 0.44 . . . . 75.51 110.626 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.409 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 56.8 tp60 -103.91 115.15 29.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.534 -0.757 . . . . 73.2 110.437 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.451 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 37.2 tt0 -87.04 -37.98 16.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.231 -0.44 . . . . 74.35 111.413 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -112.19 135.12 53.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.701 0.286 . . . . 74.23 111.253 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 125' ' ' ILE . 26.2 tptp -65.42 119.33 10.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.928 -0.578 . . . . 74.11 111.471 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 2.9 pt -98.73 131.89 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 75.1 109.754 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.16 -57.89 5.91 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 65.32 110.906 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.569 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 66.11 13.0 8.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.84 1.052 . . . . 74.54 113.84 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.532 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 25.2 p 51.21 162.98 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.613 0.968 . . . . 74.11 113.613 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.532 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 18.6 Cg_endo -58.24 151.4 60.07 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.88 2.387 . . . . 65.51 112.974 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 89.1 m -60.0 151.3 26.65 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.008 0.744 . . . . 74.32 113.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.93 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.802 -1.09 . . . . 72.02 109.595 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.547 ' C ' ' H ' ' A' ' 134' ' ' THR . 27.6 t -71.12 148.31 47.56 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.643 0.258 . . . . 73.54 111.528 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.488 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 24.9 p30 -65.4 5.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.156 0.503 . . . . 75.44 110.348 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 132' ' ' SER . 64.5 p -114.26 15.19 18.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.497 -0.774 . . . . 70.12 111.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -62.82 133.91 55.44 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.555 -0.458 . . . . 62.11 110.698 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 137' ' ' THR . 22.4 tpp180 -71.83 170.99 12.48 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.34 -0.391 . . . . 75.31 110.668 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.535 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 66.2 m -40.57 145.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.619 . . . . 75.23 110.231 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.33 -22.04 11.42 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.993 -0.843 . . . . 74.31 110.993 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -131.21 24.16 4.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 74.51 110.113 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.2 mt -94.07 -56.37 2.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.53 0.681 . . . . 73.45 109.501 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.512 HD22 ' HB2' ' A' ' 73' ' ' TYR . 4.3 m120 -79.55 121.36 25.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 74.31 111.66 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' HE2' ' CZ ' ' A' ' 147' ' ' PHE . 5.7 t80 -167.79 115.87 0.76 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.938 -1.028 . . . . 74.53 109.993 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -71.44 110.65 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.736 -0.666 . . . . 74.14 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.65 -28.88 57.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.401 0.62 . . . . 73.13 110.073 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -52.63 -23.54 6.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.178 -0.919 . . . . 75.54 111.001 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.41 -46.94 81.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.878 0.37 . . . . 72.11 111.248 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.519 ' HA ' ' CD ' ' A' ' 150' ' ' LYS . 76.1 m-85 -45.33 -49.15 13.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.114 -0.494 . . . . 74.25 111.847 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.21 51.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.912 -0.586 . . . . 74.55 111.073 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.07 -51.85 6.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.306 0.484 . . . . 64.35 112.306 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.519 ' CD ' ' HA ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -53.68 -50.55 65.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 73.51 111.817 -178.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.507 ' HB2' ' HG ' ' A' ' 153' ' ' LEU . 33.7 m-70 -103.63 11.38 36.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.692 0.282 . . . . 75.51 111.494 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 53.26 28.93 36.12 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.619 -0.8 . . . . 73.33 112.722 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 11.6 mt -67.6 7.44 0.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.904 0.335 . . . . 75.12 111.904 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -30.23 -59.96 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.375 -0.44 . . . . 64.52 113.836 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.31 112.69 19.88 Favored Pre-proline 0 N--CA 1.465 0.284 0 N-CA-C 111.631 0.234 . . . . 74.03 111.631 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HG2' ' HA ' ' A' ' 13' ' ' PRO . 69.7 Cg_endo -92.15 127.32 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.536 2.157 . . . . 73.11 112.888 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 119' ' ' TYR . 42.9 pt -75.98 -34.65 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 71.11 110.452 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.14 149.7 26.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 63.13 111.246 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 9' ' ' LEU . . . -151.49 154.41 36.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.804 -0.635 . . . . 74.44 110.081 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -152.46 133.61 14.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.245 -1.02 . . . . 72.32 108.245 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.529 ' CE2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 p90 -138.71 156.08 47.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.457 -0.338 . . . . 75.31 111.486 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.49 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 p90 -154.34 150.42 27.93 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.363 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -110.98 133.1 53.66 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.905 -0.589 . . . . 71.32 111.179 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.71 149.44 25.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.249 -0.887 . . . . 72.31 109.852 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.513 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -103.34 132.9 49.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.562 -0.533 . . . . 73.03 109.562 178.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.609 ' H ' ' NE2' ' A' ' 112' ' ' HIS . 2.3 m-85 -109.29 129.18 55.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.657 0.265 . . . . 73.04 110.768 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -125.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.59 . . . . 71.34 111.942 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.607 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 22.7 t0 -129.77 -20.63 3.17 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.882 -0.599 . . . . 65.51 111.281 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.509 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 17.9 t80 -68.32 -69.22 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.142 0.793 . . . . 75.11 113.142 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.643 ' CG1' ' HD3' ' A' ' 171' ' ' PRO . 7.5 p -50.01 -37.36 25.9 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 111.996 0.369 . . . . 74.43 111.996 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.643 ' HD3' ' CG1' ' A' ' 170' ' ' VAL . 50.2 Cg_exo -54.03 -12.25 3.38 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.512 2.141 . . . . 73.33 111.688 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.8 tp -45.77 -30.57 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.662 -0.699 . . . . 73.1 111.842 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -53.19 -46.76 69.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 119.906 -0.718 . . . . 71.15 109.513 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.446 ' HA ' HG13 ' A' ' 177' ' ' ILE . 44.6 t30 -63.83 -37.12 86.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.316 -0.624 . . . . 75.45 109.316 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -68.67 -27.97 66.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.576 -0.738 . . . . 71.45 110.18 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.9 m -97.1 13.1 30.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.929 -0.578 . . . . 74.23 112.524 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.513 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 31.6 mt -64.95 140.86 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 74.35 109.382 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.51 ' HA ' ' NH2' ' A' ' 136' ' ' ARG . 29.3 m -143.17 -25.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.72 1.007 . . . . 64.44 113.72 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.317 -1.269 . . . . 75.32 112.728 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.336 0.588 . . . . 73.44 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.7 t70 -67.47 -48.09 68.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 74.43 111.513 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.4 pt -114.95 44.7 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.245 0.545 . . . . 71.03 111.845 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.5 p -110.9 137.74 20.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.994 -0.548 . . . . 71.31 111.013 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 68.2 Cg_endo -93.55 32.92 10.11 Favored 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.129 -1.196 . . . . 74.31 112.113 -0.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.45 -51.58 53.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 61.34 110.563 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 m -160.32 -35.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 74.1 111.706 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' HD3' ' A' ' 13' ' ' PRO . 27.6 tp -157.25 172.39 18.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 74.1 111.056 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 3' ' ' ASP . 9.4 p-10 -78.3 -38.04 43.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.089 -0.708 . . . . 72.2 109.089 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -152.55 131.65 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.611 -0.722 . . . . 75.22 109.905 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 7.2 p -59.82 126.4 83.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.134 0.42 . . . . 74.3 112.134 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.467 ' HD3' HD22 ' A' ' 9' ' ' LEU . 71.6 Cg_endo -96.22 -117.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.758 2.972 . . . . 74.24 111.9 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.46 -42.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.607 -0.269 . . . . 72.51 111.33 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 158.36 17.98 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.778 -0.725 . . . . 64.44 113.575 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -102.83 152.17 21.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.011 0.434 . . . . 64.31 110.48 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 9.2 mt -105.73 123.4 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.962 -0.755 . . . . 74.13 108.962 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.3 OUTLIER -73.98 102.57 4.18 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.455 -0.793 . . . . 72.14 109.581 -178.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 59.2 t -111.0 110.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.875 -0.787 . . . . 75.01 108.875 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 2.6 mp -104.54 128.5 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.794 -0.639 . . . . 73.42 111.302 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -96.64 -84.93 0.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.159 -0.928 . . . . 74.31 110.867 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.69 3.15 0.27 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.594 -0.73 . . . . 62.32 113.274 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.566 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER 85.37 -43.96 0.06 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.896 -1.149 . . . . 74.23 107.896 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.76 -37.39 19.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.999 -1.0 . . . . 72.14 108.712 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -79.31 163.14 25.14 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.215 -0.902 . . . . 74.05 112.496 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 23.2 tt0 -151.7 127.75 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.758 -1.11 . . . . 64.14 110.288 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' CB ' ' HB3' ' A' ' 162' ' ' TYR . 4.3 m -71.64 128.18 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.322 0.582 . . . . 71.0 111.711 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 73.4 mmtt -112.59 111.37 22.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.518 0.932 . . . . 73.32 113.518 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.446 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 7.4 mp0 31.06 67.54 0.13 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.804 1.409 . . . . 73.21 114.804 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.69 4.58 89.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.343 -0.456 . . . . 74.14 113.448 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -55.57 146.76 19.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.311 0.577 . . . . 63.12 112.297 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.37 140.85 32.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.98 -1.009 . . . . 72.34 111.191 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.27 132.4 52.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 72.1 110.761 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 8.8 p -140.66 161.72 52.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 75.33 109.849 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 83.8 Cg_endo -82.09 -33.16 3.12 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 124.142 -1.191 . . . . 74.31 113.404 0.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 36' ' ' THR . 85.1 m -156.65 42.92 0.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.285 0.564 . . . . 64.21 111.462 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -92.76 0.23 57.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.413 0.625 . . . . 73.51 110.797 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.65 -7.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.479 -0.782 . . . . 74.15 111.284 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -11.32 60.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.145 -0.479 . . . . 73.14 110.608 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.35 133.3 35.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 62.12 111.434 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.7 pm0 -62.9 138.69 97.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 71.24 110.087 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.16 126.51 13.13 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 121.8 1.666 . . . . 74.13 112.516 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.5 mm -100.77 114.73 40.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 62.41 110.288 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 p -85.54 140.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.399 0.518 . . . . 72.12 112.399 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 14.4 m -161.98 139.21 8.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.952 0.406 . . . . 71.04 110.347 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.4 p90 -121.68 29.8 7.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 74.24 110.352 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.7 t -44.94 137.15 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 65.42 110.225 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.19 -32.51 3.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.654 -0.784 . . . . 63.45 112.239 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.5 -41.29 27.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.708 0.766 . . . . 75.35 109.094 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.0 tt0 -53.52 105.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.698 -1.137 . . . . 73.23 110.558 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.3 -114.86 1.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.1 -1.2 . . . . 72.22 110.1 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -80.56 109.19 14.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.635 -0.826 . . . . 71.01 109.373 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.78 141.79 15.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.444 -0.344 . . . . 62.42 111.532 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.7 t30 -89.26 -42.19 11.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.791 0.805 . . . . 75.21 109.583 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 76.9 mt -152.36 170.0 21.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.686 -1.143 . . . . 71.13 108.595 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.4 mt -138.38 153.15 48.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.466 -0.494 . . . . 71.4 111.764 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -121.42 130.62 53.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.743 -0.662 . . . . 74.11 110.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -128.87 123.91 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.253 -0.647 . . . . 71.24 109.253 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -143.16 161.78 37.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 75.43 113.017 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -94.89 146.69 24.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.203 -1.362 . . . . 73.12 109.974 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 76.8 t -134.09 137.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.363 . . . . 73.44 111.288 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' CG ' HH21 ' A' ' 68' ' ' ARG . 52.5 t0 83.32 59.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 114.945 -1.025 . . . . 71.44 111.52 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 57.4 Cg_endo -71.28 123.01 9.21 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.509 2.14 . . . . 75.24 111.9 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 25.8 p-10 -118.36 120.76 38.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.68 0.622 . . . . 74.21 112.68 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.575 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.65 135.98 1.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.434 0.531 . . . . 74.3 112.434 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 55.3 Cg_endo -74.2 -3.75 17.53 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.217 -1.576 . . . . 75.11 109.794 -2.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -165.01 156.72 15.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.967 -1.015 . . . . 72.51 110.373 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG2' ' CB ' ' A' ' 64' ' ' ASP . 6.5 mtp-105 -68.33 -12.74 61.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.812 -0.631 . . . . 74.31 110.951 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.32 -32.94 24.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.889 -0.596 . . . . 61.44 112.252 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -144.08 116.13 5.6 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-O 120.713 0.292 . . . . 64.03 110.471 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.09 52.5 4.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.039 2.493 . . . . 73.24 112.302 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 95.9 mttt -48.93 -27.29 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 75.1 111.637 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 25.3 p90 -155.55 29.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.299 0.571 . . . . 74.34 110.781 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 5.7 tmm_? -70.52 136.13 49.12 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.144 -1.058 . . . . 71.1 108.144 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 14.2 mp0 -88.61 159.09 18.04 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.236 1.014 . . . . 73.44 111.873 0.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.575 ' HB ' ' CB ' ' A' ' 65' ' ' ALA . 9.1 tp -97.37 171.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.442 -0.799 . . . . 74.11 109.696 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.505 ' H ' HG13 ' A' ' 76' ' ' ILE . 13.9 tp -42.72 112.89 0.4 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.553 0.692 . . . . 74.13 110.297 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.401 ' ND1' ' OG ' ' A' ' 80' ' ' SER . 19.6 p80 -104.22 160.28 15.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.572 -1.195 . . . . 65.45 113.285 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.5 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 10.5 t-105 -100.43 116.19 31.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.579 -1.267 . . . . 73.2 107.579 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.401 ' OG ' ' ND1' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -141.04 135.4 31.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.229 0.825 . . . . 72.22 113.229 -176.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.66 138.5 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.58 -0.737 . . . . 70.42 110.893 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.2 m -142.05 169.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.603 . . . . 75.53 112.44 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 24.8 p30 51.82 36.18 17.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.562 -1.199 . . . . 72.22 112.132 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' CG2' ' HA ' ' A' ' 91' ' ' PRO . 5.1 mm -69.02 125.81 92.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.715 -0.846 . . . . 73.02 108.715 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.75 126.28 20.75 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 121.429 1.419 . . . . 74.33 110.902 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.81 60.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.321 0.488 . . . . 54.04 114.321 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.1 m -174.97 43.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.935 0.494 . . . . 55.04 110.255 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.1 m-80 -135.31 8.94 3.44 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.528 0.936 . . . . 74.54 113.528 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER 64.65 -26.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.062 0.393 . . . . 74.01 112.062 177.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.623 ' H ' ' C ' ' A' ' 88' ' ' ASN . 14.8 p30 -154.05 172.63 5.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.187 0.595 . . . . 74.43 109.932 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.591 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 6.1 Cg_exo -79.74 23.9 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.643 2.896 . . . . 72.44 115.529 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -79.63 1.11 27.39 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.856 -1.138 . . . . 53.51 112.985 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.11 2.1 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.495 -0.86 . . . . 54.51 113.609 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.7 176.49 10.98 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.229 -0.51 . . . . 72.42 113.669 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -66.36 121.12 14.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.389 0.514 . . . . 73.02 112.389 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.1 p -86.26 89.32 7.81 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.924 -0.769 . . . . 74.22 108.924 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.4 mt -50.28 -53.83 25.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 74.4 110.484 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.66 120.38 13.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.958 -1.019 . . . . 62.32 108.714 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 54.5 t0 -60.21 146.82 42.2 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.6 0.563 . . . . 74.11 112.084 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.5 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 21.2 p90 -66.38 142.82 57.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.892 -0.595 . . . . 74.43 110.295 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 133' ' ' ASN . 21.4 m -140.38 145.03 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.696 0.284 . . . . 75.5 111.528 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -85.03 0.07 89.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.925 -0.655 . . . . 51.23 111.642 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 t -58.93 -91.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.561 -0.319 . . . . 73.42 110.604 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 -167.99 5.03 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.909 -0.662 . . . . 74.42 114.224 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.68 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 44.8 Cg_endo -65.74 145.5 81.28 Favored 'Trans proline' 0 N--CA 1.476 0.477 0 C-N-CA 123.67 2.913 . . . . 72.3 113.107 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.58 160.68 48.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.066 2.51 . . . . 74.43 113.332 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.481 ' CE ' ' HA ' ' A' ' 167' ' ' ASP . 35.8 ttmt -44.03 -25.09 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.092 -0.504 . . . . 75.54 111.055 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.46 -37.87 40.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 64.35 111.422 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.414 ' CG2' ' CE1' ' A' ' 112' ' ' HIS . 11.4 t -76.4 -19.44 58.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.525 -0.47 . . . . 75.44 111.839 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.92 -129.8 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.599 -0.81 . . . . 74.3 113.32 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 44.7 tp -67.49 135.28 52.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.01 0.744 . . . . 75.24 113.01 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.68 ' CE1' ' HG2' ' A' ' 105' ' ' PRO . 67.1 m-70 -108.71 142.87 38.59 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.511 -0.768 . . . . 75.5 108.947 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.628 HH12 ' NE2' ' A' ' 163' ' ' GLN . 5.5 ptm85 -130.38 84.5 2.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.145 -0.687 . . . . 73.41 109.145 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.11 136.28 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.476 -0.784 . . . . 75.45 111.995 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 161' ' ' TYR . 48.5 mt -113.99 137.02 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.753 -1.112 . . . . 75.2 111.034 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -99.91 141.97 32.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.294 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.24 129.74 46.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.544 -0.298 . . . . 74.21 110.447 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 2.7 tt -126.44 134.31 51.0 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.257 -0.428 . . . . 75.14 110.613 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.517 ' HA ' HG12 ' A' ' 157' ' ' ILE . 49.9 t80 -144.01 148.52 35.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.913 0.387 . . . . 75.41 111.408 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -83.43 134.68 34.86 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.628 -0.508 . . . . 75.23 109.628 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -118.06 139.15 51.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.708 -0.224 . . . . 75.02 110.457 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -110.5 -34.79 6.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.415 -0.357 . . . . 71.42 110.96 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 123' ' ' ASN . 2.4 m120 -96.09 130.4 43.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 74.02 111.107 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 23.3 tptm -73.08 143.04 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.566 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.402 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.9 OUTLIER -141.29 144.55 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 75.32 111.732 -179.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -86.73 -31.09 21.15 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.86 0.725 . . . . 73.33 109.733 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' ND2' ' A' ' 83' ' ' ASN . 0.4 OUTLIER 29.17 56.33 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.39 -1.277 . . . . 75.04 113.712 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.465 ' OG1' ' NH2' ' A' ' 139' ' ' ARG . 51.8 p 60.96 138.2 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 114.585 1.328 . . . . 75.32 114.585 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.03 158.24 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.996 3.131 . . . . 61.42 113.764 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.5 p -62.18 138.88 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.428 -0.805 . . . . 73.14 113.067 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.82 129.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.03 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 t -72.33 153.19 41.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.985 0.735 . . . . 70.54 112.985 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.489 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 17.3 p30 -57.92 -26.58 62.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.158 -0.928 . . . . 72.01 109.595 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -85.97 14.74 5.71 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.279 -0.873 . . . . 75.14 111.953 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.6 t -67.79 130.89 44.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.274 0.559 . . . . 64.13 112.204 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.602 ' HG2' ' N ' ' A' ' 179' ' ' GLY . 17.2 mmm180 -77.37 173.21 12.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 73.42 110.501 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 m -54.25 159.55 1.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 75.15 110.144 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.22 -7.8 18.56 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.698 -0.763 . . . . 74.34 112.417 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.534 ' HG3' HH11 ' A' ' 139' ' ' ARG . 16.8 ttt85 -152.94 8.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.132 0.491 . . . . 75.05 110.956 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 142' ' ' PHE . 0.9 OUTLIER -88.72 -39.77 13.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.007 -0.738 . . . . 75.43 109.007 177.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 4.3 m120 -63.24 69.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.43 -0.805 . . . . 75.44 109.408 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 140' ' ' LEU . 60.0 t80 -127.73 128.81 46.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 74.21 111.741 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 145' ' ' ARG . 17.8 p-10 -95.36 135.04 37.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 72.23 111.36 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.48 71.56 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.324 0.583 . . . . 73.42 110.435 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.517 ' HB3' HD21 ' A' ' 143' ' ' ASN . 26.3 tpt85 -43.81 -29.93 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.939 -1.028 . . . . 74.34 111.549 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' OD2' ' NZ ' ' A' ' 150' ' ' LYS . 13.6 t70 -60.17 -58.34 8.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.185 0.517 . . . . 75.25 110.392 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -64.79 -37.78 88.77 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.788 -0.642 . . . . 73.33 109.877 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.7 76.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 74.34 109.898 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.512 ' CB ' ' NH1' ' A' ' 145' ' ' ARG . . . -75.64 -53.75 8.07 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.396 0.517 . . . . 74.22 112.396 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.424 ' NZ ' ' OD2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -82.33 -51.13 8.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.18 0.807 . . . . 74.31 113.18 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -67.99 -0.46 4.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 120.086 -0.646 . . . . 72.43 110.741 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 61.09 31.41 76.62 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 114.956 0.742 . . . . 63.34 114.956 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.3 16.49 0.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.084 0.442 . . . . 72.44 111.376 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -47.94 -18.96 0.85 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.334 0.494 . . . . 74.43 114.334 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -135.16 93.31 17.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 117.309 0.555 . . . . 75.13 111.107 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.76 134.3 32.09 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.384 2.056 . . . . 70.53 112.766 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 119' ' ' TYR . 24.9 pt -84.74 -34.98 9.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.274 -0.421 . . . . 72.42 110.553 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -139.24 147.09 41.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.123 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -162.35 159.46 25.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.18 0.514 . . . . 73.24 111.301 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' NE2' ' A' ' 29' ' ' GLN . 57.1 t30 -164.6 167.58 19.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.424 -1.325 . . . . 75.42 107.424 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.472 ' HB3' HG12 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -154.51 157.43 38.35 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.292 -0.563 . . . . 74.41 111.448 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.509 ' HB3' ' CB ' ' A' ' 27' ' ' VAL . 3.3 p90 -149.9 153.04 36.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.026 -0.534 . . . . 74.24 111.603 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.628 ' NE2' HH12 ' A' ' 113' ' ' ARG . 44.7 mt-30 -112.15 134.81 53.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.74 -0.664 . . . . 74.11 111.027 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.24 145.77 22.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.963 -0.562 . . . . 74.11 111.778 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 2.0 pm0 -133.94 156.87 47.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.033 -1.099 . . . . 72.13 108.033 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.401 ' CD1' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER -157.33 159.25 37.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 72.41 112.224 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.481 ' HA ' ' CE ' ' A' ' 107' ' ' LYS . 1.7 m-20 -71.15 157.13 38.69 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.652 -0.704 . . . . 73.15 110.516 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.561 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 14.5 t70 -48.75 -23.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.737 -0.665 . . . . 63.42 110.673 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.403 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 23.8 t80 -53.08 -38.22 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 74.3 110.99 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.573 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 73.7 t -68.16 -57.57 8.93 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.028 -0.669 . . . . 72.41 109.604 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 83.9 Cg_exo -44.99 -29.55 3.88 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.284 1.989 . . . . 74.45 111.921 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 168' ' ' ASP . 38.2 mm -47.67 -23.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.176 0.512 . . . . 74.11 109.791 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -44.49 -27.96 0.52 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.272 -0.876 . . . . 73.41 109.514 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 171' ' ' PRO . 12.7 p30 -46.11 -33.88 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.522 -0.763 . . . . 73.31 111.456 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 174' ' ' ASN . 10.9 mptt -52.48 -30.78 31.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.776 0.322 . . . . 75.03 111.377 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.9 m -66.95 -28.05 67.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.361 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.3 mm -62.79 134.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 74.4 110.808 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.7 m -149.34 2.95 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.684 0.624 . . . . 75.43 112.684 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.602 ' N ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.466 -1.185 . . . . 71.41 112.871 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.951 -0.389 . . . . 63.22 109.951 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.48 -71.04 0.67 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.817 0.673 . . . . 72.4 112.817 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 7.2 pt -121.17 63.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.295 0.569 . . . . 74.23 111.856 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 12.7 p -128.55 138.66 33.55 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.689 -0.687 . . . . 75.11 110.341 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.6 Cg_endo -85.55 34.22 4.22 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.767 -1.347 . . . . 73.34 112.588 0.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 62.5 t0 -57.74 -53.76 54.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 73.41 110.056 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 20.1 m -162.72 -37.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.505 -0.771 . . . . 73.44 111.073 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.433 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 22.1 tp -157.08 140.64 15.84 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-O 121.432 0.634 . . . . 74.33 111.227 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 20.5 p-10 -75.79 6.19 5.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.812 -0.631 . . . . 72.34 112.009 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . . . -157.7 133.94 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 61.25 111.343 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -85.93 109.86 25.88 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.213 -0.448 . . . . 72.14 112.09 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 42.8 Cg_endo -86.87 -130.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.303 2.669 . . . . 74.21 112.187 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -159.94 -41.19 0.05 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.427 -0.351 . . . . 65.34 110.697 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -161.58 20.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.953 -0.641 . . . . 63.2 112.44 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.541 ' N ' ' HB3' ' A' ' 158' ' ' ALA . 5.1 t -150.37 170.02 20.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.077 0.465 . . . . 72.43 111.377 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 2.3 mp -105.88 127.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 64.53 109.186 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.9 mmpt? -84.15 102.95 12.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 74.01 109.649 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 48.3 t -116.89 110.68 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.165 0.507 . . . . 64.23 109.709 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG21 ' N ' ' A' ' 21' ' ' TYR . 25.8 mt -92.08 143.35 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.7 -0.682 . . . . 73.32 109.951 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.578 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 2.4 t80 -84.83 -77.8 0.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.733 -0.787 . . . . 73.31 111.584 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.553 ' H ' ' CD1' ' A' ' 25' ' ' LEU . . . -99.83 -32.87 5.48 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.611 -0.804 . . . . 72.21 113.884 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -173.48 -75.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.444 0.535 . . . . 63.24 112.444 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -90.97 -40.16 11.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.178 0.513 . . . . 73.12 110.76 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD1' ' H ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -69.53 135.98 50.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.79 -0.641 . . . . 74.42 110.469 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 22.4 pt-20 -134.26 159.18 41.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.101 -0.5 . . . . 74.24 111.528 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 162' ' ' TYR . 4.1 m -69.38 134.21 30.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 72.45 110.172 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -138.64 108.51 6.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 75.25 112.228 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.508 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 3.7 mp0 52.06 49.12 21.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.965 . . . . 72.13 113.603 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.604 ' N ' ' HB2' ' A' ' 161' ' ' TYR . . . 62.17 12.54 38.08 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 114.812 0.685 . . . . 62.02 114.812 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -55.09 157.51 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 117.483 0.642 . . . . 75.22 110.233 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -98.2 129.31 44.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 73.25 110.051 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.2 mp -92.78 112.83 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.557 0.694 . . . . 75.32 110.988 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 2.8 p -110.54 165.63 12.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.747 -1.115 . . . . 75.5 111.35 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 17.7 Cg_exo -67.39 -42.32 0.7 Allowed 'Cis proline' 0 C--N 1.352 0.733 0 C-N-CA 124.161 -1.183 . . . . 73.55 112.033 0.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -162.53 44.47 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 71.25 109.889 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.577 ' C ' ' H ' ' A' ' 39' ' ' LYS . 17.7 pt20 -76.75 -4.83 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.629 -0.714 . . . . 73.45 111.215 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 34.3 m -73.37 31.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.695 0.76 . . . . 74.12 110.082 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -93.37 6.0 49.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.688 -1.142 . . . . 74.4 112.498 -178.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -135.3 162.99 31.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.845 0.313 . . . . 72.35 111.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -72.31 146.0 88.78 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.138 -0.483 . . . . 70.3 111.519 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -95.33 126.96 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.146 2.564 . . . . 70.35 113.424 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.1 mm -80.17 128.4 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 74.3 110.932 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.22 137.17 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.917 0.339 . . . . 75.22 111.917 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -162.21 153.84 18.5 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.137 0.494 . . . . 74.34 111.366 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.691 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.8 p90 -128.59 34.4 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.839 0.828 . . . . 73.21 109.485 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 m -49.54 107.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.457 -1.247 . . . . 73.15 111.069 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.57 -33.88 5.3 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.768 -0.651 . . . . 64.14 111.489 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 2.4 mm? -76.89 -40.12 48.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.14 -0.689 . . . . 73.14 109.14 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 29.2 tt0 -65.92 111.48 3.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.879 -0.601 . . . . 74.11 109.649 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.97 -63.52 0.26 Allowed Glycine 0 C--N 1.324 -0.111 0 C-N-CA 120.812 -0.709 . . . . 74.55 112.33 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -148.27 111.04 4.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.38 -0.6 . . . . 74.42 109.38 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.487 ' HB3' ' CD ' ' A' ' 120' ' ' ARG . 12.2 p -157.29 141.8 16.54 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.85 -0.34 . . . . 62.45 111.319 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 35.2 t30 -77.91 -33.61 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.538 0.685 . . . . 72.15 109.292 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -155.15 157.0 36.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.966 -1.015 . . . . 75.23 109.35 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.9 mt -127.03 152.4 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 73.43 110.976 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.534 ' HG1' ' HG2' ' A' ' 121' ' ' GLN . 95.0 m -121.51 134.01 55.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.054 -0.521 . . . . 71.4 110.154 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -136.42 132.96 36.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 74.22 109.638 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.1 mt -153.82 159.69 41.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.02 0.438 . . . . 73.1 111.884 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.3 ttt -94.92 156.62 16.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 72.41 109.971 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.47 146.12 32.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 73.15 111.515 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.632 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 46.2 t0 65.01 40.69 0.28 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.303 -0.862 . . . . 72.51 111.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.632 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 76.4 Cg_exo -51.21 139.84 42.91 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.884 1.723 . . . . 75.15 111.587 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.76 122.66 36.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.51 0.559 . . . . 64.14 112.51 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.505 ' HB1' ' HB ' ' A' ' 76' ' ' ILE . . . -170.83 135.91 1.08 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.056 0.391 . . . . 71.3 112.056 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 13.2 Cg_exo -68.1 -32.56 3.47 Favored 'Cis proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.883 -1.299 . . . . 71.34 109.809 -3.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 109' ' ' THR . 4.8 t -141.26 140.25 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.336 -1.302 . . . . 74.32 108.932 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -56.12 -21.56 23.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.345 0.593 . . . . 75.4 110.606 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.265 -0.879 . . . . 72.52 111.234 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 23.0 t70 -140.15 62.06 19.48 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-O 121.126 0.489 . . . . 75.2 110.272 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.52 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -67.84 53.8 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.458 2.772 . . . . 75.43 113.434 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -50.96 -52.17 45.15 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.888 0.329 . . . . 74.01 111.888 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.61 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 2.1 p90 -106.9 39.53 1.84 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.323 0.582 . . . . 62.02 111.081 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 3.7 tmm_? -79.29 139.96 37.7 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.781 -1.192 . . . . 74.23 107.781 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 25.6 mp0 -89.13 178.05 6.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.555 1.142 . . . . 74.15 112.594 0.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.595 HG13 ' H ' ' A' ' 77' ' ' LEU . 4.7 tp -105.98 -173.24 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.118 -0.946 . . . . 75.25 109.886 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.595 ' H ' HG13 ' A' ' 76' ' ' ILE . 3.0 mp -68.03 64.46 0.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.99 0.424 . . . . 75.42 111.016 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -58.55 178.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 73.23 110.85 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.471 ' CZ2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t-105 -100.29 122.06 42.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.004 -0.739 . . . . 75.11 109.004 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 20.0 m -141.1 129.74 22.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.4 111.507 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.471 ' CG2' ' CZ2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -142.52 127.73 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 74.1 109.388 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.86 166.07 28.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.402 0.62 . . . . 71.22 112.366 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.589 HD22 ' HB2' ' A' ' 95' ' ' HIS . 15.9 p30 52.95 44.88 29.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.25 -1.341 . . . . 75.2 112.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 2.9 mm -79.89 118.02 70.34 Favored Pre-proline 0 C--O 1.231 0.105 0 N-CA-C 108.328 -0.99 . . . . 72.41 108.328 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 87' ' ' SER . 45.6 Cg_exo -56.51 125.95 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.839 1.693 . . . . 72.23 112.003 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.74 73.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.386 -0.435 . . . . 72.51 113.143 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 85' ' ' PRO . 34.3 t 177.15 45.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.846 0.458 . . . . 73.22 110.034 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 54.8 m-80 -135.36 -28.23 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.201 0.815 . . . . 72.5 113.201 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 3.9 tt0 74.56 -0.59 3.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.304 0.573 . . . . 71.24 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -167.8 157.62 9.12 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.225 -0.898 . . . . 75.32 109.914 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.34 53.84 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.9 2.4 . . . . 73.1 112.559 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.7 t -102.59 -5.09 24.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.865 -0.334 . . . . 70.33 111.669 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.19 -42.0 1.33 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.041 -0.6 . . . . 64.34 114.214 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -64.49 173.75 15.48 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.968 -0.634 . . . . 60.34 113.975 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.589 ' HB2' HD22 ' A' ' 83' ' ' ASN . 0.7 OUTLIER -65.8 119.21 10.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.077 0.399 . . . . 75.4 112.077 -178.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.418 ' H ' ' CG2' ' A' ' 130' ' ' THR . 43.7 m -82.53 90.28 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 74.42 109.498 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 15.1 mt -50.47 -28.69 8.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.594 -0.73 . . . . 72.24 111.004 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -165.13 93.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.178 -0.919 . . . . 73.41 108.86 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -41.85 140.24 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.425 0.631 . . . . 53.31 112.494 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -56.38 146.9 22.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 71.42 110.922 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 133' ' ' ASN . 14.8 p -156.91 161.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.942 0.401 . . . . 71.24 111.341 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.24 -176.62 11.19 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.636 -0.711 . . . . 74.41 113.011 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t -65.92 122.86 18.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 70.45 111.762 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -86.65 -48.88 4.31 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.478 -0.649 . . . . 53.34 111.478 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 51.1 Cg_exo -56.37 142.43 88.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.647 2.231 . . . . 71.14 113.124 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.92 143.54 99.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.75 2.3 . . . . 74.41 112.025 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB3' ' C ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -46.21 -43.29 15.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.944 0.72 . . . . 71.41 112.944 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.99 0.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.714 0.635 . . . . 71.21 112.714 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 75.9 p -78.64 -27.64 45.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.905 0.383 . . . . 74.54 110.913 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.41 -167.69 14.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.824 -0.703 . . . . 74.31 113.353 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -60.01 138.19 57.91 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 112.492 0.553 . . . . 72.2 112.492 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -106.39 129.91 54.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.117 -0.947 . . . . 75.33 109.032 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 ptm85 -112.23 120.13 40.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.15 0.5 . . . . 74.21 111.288 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -109.15 140.99 42.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.819 -0.628 . . . . 74.54 110.659 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.576 HG21 ' CD2' ' A' ' 161' ' ' TYR . 24.6 mt -132.47 132.2 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.828 -0.804 . . . . 75.32 108.828 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -106.02 137.08 44.55 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.443 0.464 . . . . 65.23 111.493 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 118' ' ' LEU . 2.5 tm? -127.08 137.8 53.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.874 -0.603 . . . . 74.21 109.812 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 117' ' ' LEU . 57.0 tp -128.25 137.4 51.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.772 0.429 . . . . 64.51 110.466 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.455 ' HB3' ' HB ' ' A' ' 57' ' ' THR . 81.2 t80 -144.07 132.59 22.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.595 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 53' ' ' SER . 42.8 ttp180 -76.58 128.25 34.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 74.21 110.613 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.534 ' HG2' ' HG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.26 149.16 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.975 0.731 . . . . 74.3 112.975 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 30.2 tt0 -112.59 -55.49 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.686 -1.143 . . . . 75.32 109.857 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 123' ' ' ASN . 1.7 m120 -100.19 131.38 46.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 73.32 110.717 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 9.7 tmtt? -59.55 125.08 22.19 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.004 -0.369 . . . . 75.34 110.004 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.5 ' N ' ' HD3' ' A' ' 124' ' ' LYS . 5.5 pt -87.15 125.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 71.52 112.233 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.81 118.04 10.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.903 -1.518 . . . . 74.24 106.903 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.41 32.31 1.69 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.033 1.123 . . . . 71.33 114.033 -176.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.502 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 68.7 p 51.04 172.53 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 112.446 0.535 . . . . 73.2 112.446 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 50.4 Cg_exo -58.46 150.4 68.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.517 2.145 . . . . 72.22 114.037 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.418 ' CG2' ' H ' ' A' ' 96' ' ' SER . 25.5 p -60.91 132.18 53.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 72.54 110.809 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 32.4 mm -85.99 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.379 0.609 . . . . 74.21 112.224 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -73.46 141.32 46.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 71.04 111.983 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 134' ' ' THR . 22.3 p30 -56.42 -47.1 79.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.515 0.674 . . . . 75.3 110.427 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.555 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.3 t -84.49 22.93 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.066 -0.97 . . . . 70.12 111.451 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.0 t -62.21 155.46 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.551 0.691 . . . . 64.25 112.121 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.549 ' HB2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 tpt180 -69.02 164.94 21.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.771 -1.104 . . . . 72.13 112.422 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.4 m -53.13 175.28 0.03 OUTLIER 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.685 -0.689 . . . . 73.15 110.258 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.22 90.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 119.937 -1.125 . . . . 74.43 111.822 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -139.81 45.71 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.262 0.553 . . . . 75.11 111.304 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 140' ' ' LEU . 2.6 mp -112.77 -63.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.187 -0.915 . . . . 73.14 108.784 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.2 m120 -63.39 121.38 13.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 74.01 111.447 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 40.8 t80 -176.94 109.38 0.08 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.82 -0.627 . . . . 75.43 111.306 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -68.63 120.98 15.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.705 -0.68 . . . . 74.34 111.921 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.74 -43.44 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 52.03 111.601 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -45.15 -33.92 2.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.218 -0.447 . . . . 73.15 111.914 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.93 -49.33 50.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.591 0.71 . . . . 72.13 109.386 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 10.0 m-30 -62.14 -41.95 98.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.053 -0.976 . . . . 74.23 110.189 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.73 -46.38 87.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.805 0.336 . . . . 62.51 111.244 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.3 -51.73 41.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.913 -0.585 . . . . 71.52 112.458 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -75.36 -48.57 22.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.632 0.604 . . . . 64.54 112.632 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 52.9 m170 -67.76 -10.85 56.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.94 -0.475 . . . . 72.34 110.724 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 76.7 24.22 67.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.092 -0.575 . . . . 74.23 113.155 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 7.4 mt -76.02 15.85 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.063 0.145 . . . . 74.4 111.195 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -35.29 -73.01 0.1 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.021 -0.609 . . . . 73.52 113.44 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.67 112.46 17.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.544 0.172 . . . . 75.55 110.849 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.55 130.75 5.31 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.194 1.93 . . . . 73.51 113.116 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 118' ' ' LEU . 38.8 pt -78.49 -34.7 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.916 -0.314 . . . . 74.11 111.426 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.541 ' HB3' ' N ' ' A' ' 16' ' ' THR . . . -151.05 151.0 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.207 0.447 . . . . 72.2 112.207 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.15 158.15 43.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 74.3 111.533 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.6 ' C ' ' CD1' ' A' ' 161' ' ' TYR . 0.8 OUTLIER -158.97 175.09 13.99 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.004 -1.11 . . . . 75.13 108.004 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.604 ' HB2' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -157.95 155.53 29.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.686 0.675 . . . . 74.02 111.055 -178.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 1.4 t80 -155.94 131.84 9.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.13 0.572 . . . . 75.43 110.995 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mt-30 -115.86 138.63 50.98 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.282 -0.261 . . . . 72.33 111.455 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.43 153.18 29.95 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.062 0.764 . . . . 53.11 113.062 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.99 161.5 37.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.776 -0.824 . . . . 72.13 108.776 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.432 ' O ' ' CB ' ' A' ' 107' ' ' LYS . 1.7 t80 -165.61 168.75 16.06 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.191 -0.604 . . . . 71.01 111.36 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.493 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.8 t0 -79.46 -159.92 0.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.714 0.634 . . . . 74.43 110.912 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.499 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 50.2 t0 -69.0 -23.87 64.15 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.092 0.472 . . . . 71.1 111.036 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -42.88 -44.48 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.166 -0.47 . . . . 75.11 112.108 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 67.8 t -80.38 -54.39 0.83 Allowed Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 120.464 -0.494 . . . . 73.53 111.494 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 77.8 Cg_exo -48.39 -49.84 13.54 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.051 1.834 . . . . 72.13 112.644 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.5 tt -46.01 -33.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.027 0.381 . . . . 74.42 112.027 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.03 -29.53 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 75.24 111.342 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.478 HD21 ' N ' ' A' ' 174' ' ' ASN . 2.1 m120 -56.51 -14.92 3.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.176 0.806 . . . . 74.41 113.176 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.36 -20.29 42.57 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.794 0.664 . . . . 74.34 112.794 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 p -88.1 16.59 5.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.864 0.69 . . . . 74.11 112.864 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 174' ' ' ASN . 27.7 mm -72.46 124.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 122.037 -0.415 . . . . 64.51 110.296 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.58 -13.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.114 0.783 . . . . 74.41 113.114 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.555 -1.136 . . . . 64.42 112.301 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.464 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 120.795 0.331 . . . . 74.53 111.458 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 5.5 t70 -71.18 -40.83 71.0 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.728 0.299 . . . . 71.13 111.196 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 9' ' ' LEU . 12.8 pt -149.24 48.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 72.43 110.615 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 13.6 p -136.45 140.9 33.79 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.214 -0.903 . . . . 75.5 109.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.515 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 Cg_exo -78.28 26.43 2.5 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.205 -1.164 . . . . 73.54 113.591 0.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' N ' ' HA ' ' A' ' 5' ' ' VAL . 9.5 t0 -54.56 -53.21 57.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.393 . . . . 73.22 110.431 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 m -161.32 -43.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.997 -0.547 . . . . 75.24 111.917 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 4' ' ' ILE . 62.2 tp -144.21 160.08 41.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.65 0.262 . . . . 75.21 110.851 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -60.43 -42.58 96.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.718 -0.793 . . . . 72.32 109.732 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.57 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -156.59 135.14 11.54 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.818 0.303 . . . . 72.21 111.818 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.39 125.88 80.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.995 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 45.7 Cg_endo -89.73 -145.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.892 2.395 . . . . 62.31 112.201 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.37 -31.05 6.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 73.15 110.842 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.36 -136.54 3.16 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.919 -0.582 . . . . 75.41 111.834 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.432 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 1.5 t -162.81 164.41 26.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 65.24 111.734 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' CG2' HG23 ' A' ' 44' ' ' VAL . 3.1 mp -104.9 133.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.406 -0.961 . . . . 73.11 108.406 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 45' ' ' SER . 13.5 mmmm -83.62 101.96 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.442 -0.503 . . . . 71.54 109.707 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.401 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 94.2 t -108.86 108.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.599 0.714 . . . . 64.43 111.198 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.88 138.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 74.32 107.898 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -93.42 -46.96 7.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.937 0.717 . . . . 71.03 112.937 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.86 -48.39 0.5 Allowed Glycine 0 N--CA 1.459 0.175 0 C-N-CA 120.277 -0.963 . . . . 53.3 112.857 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.62 -80.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.777 0.322 . . . . 74.44 110.261 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -82.31 -31.85 29.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.599 . . . . 75.42 109.384 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.61 129.08 38.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.687 0.756 . . . . 71.21 111.443 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 28.3 tt0 -125.61 150.77 47.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.702 -1.136 . . . . 72.44 110.836 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 31.3 m -85.42 107.01 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.282 0.563 . . . . 73.23 111.535 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -75.21 50.53 0.5 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.429 0.9 . . . . 74.14 113.429 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.666 HE21 ' ND2' ' A' ' 160' ' ' ASN . 9.5 mp0 59.31 69.67 0.7 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.667 0.988 . . . . 71.43 113.667 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.38 -6.21 57.64 Favored Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 110.835 -0.906 . . . . 75.33 110.835 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.14 139.02 57.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.932 -1.134 . . . . 73.13 110.868 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -102.72 138.02 40.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 75.53 110.24 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.551 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.1 mp -109.3 154.19 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 75.1 111.353 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -149.36 157.79 38.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 75.22 110.477 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.95 -51.88 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 124.093 -1.211 . . . . 72.33 112.77 0.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.2 m -143.41 35.81 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 74.35 110.836 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -80.21 -4.37 52.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.6 . . . . 70.11 111.494 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.596 ' HB ' ' CE2' ' A' ' 21' ' ' TYR . 27.5 m -85.54 33.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.572 -0.74 . . . . 71.34 111.935 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.74 -30.08 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.848 1.055 . . . . 74.04 113.848 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.607 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 45.1 m-20 -72.33 152.62 41.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.825 0.676 . . . . 74.22 112.825 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.7 pm0 -63.25 128.72 92.79 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.718 -0.674 . . . . 73.33 109.33 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 125.75 19.31 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.348 2.032 . . . . 74.41 114.243 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.18 111.09 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.5 -0.773 . . . . 73.12 109.936 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 17' ' ' ILE . 6.0 p -93.55 142.02 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.365 . . . . 71.54 111.719 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 50.7 m -158.07 137.9 12.2 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.263 0.468 . . . . 71.22 112.263 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.575 ' CZ2' HD11 ' A' ' 56' ' ' LEU . 3.5 p90 -115.84 23.26 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.263 -0.643 . . . . 75.41 109.263 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.2 m -40.31 120.96 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.395 -0.82 . . . . 70.51 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 91.08 -35.46 3.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.267 -0.492 . . . . 73.34 112.187 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.0 mm? -65.54 -20.86 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.87 0.367 . . . . 75.13 110.031 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 16.6 pm0 -67.57 -159.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.249 -0.649 . . . . 74.31 109.249 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.17 -66.6 0.48 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 119.96 -1.114 . . . . 63.41 113.083 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' C ' ' HG ' ' A' ' 53' ' ' SER . 22.4 pttm -149.42 106.88 3.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.086 0.47 . . . . 75.1 109.77 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 52' ' ' LYS . 3.3 m -160.19 140.41 11.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.776 -0.647 . . . . 70.15 110.224 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -74.88 -38.17 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.733 -0.84 . . . . 75.12 108.733 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.594 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 22.5 mt -155.86 160.4 40.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.7 -1.136 . . . . 73.42 109.885 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.575 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 15.5 mt -122.08 151.8 40.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.974 -0.29 . . . . 73.33 110.527 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.555 HG23 HG11 ' A' ' 82' ' ' VAL . 91.4 m -129.01 114.41 16.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.928 0.394 . . . . 74.03 112.027 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 134.29 50.15 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.54 -0.541 . . . . 74.03 109.54 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -144.75 171.58 14.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.166 0.508 . . . . 70.43 111.754 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.8 OUTLIER -133.64 123.13 24.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.176 -0.92 . . . . 74.21 108.638 178.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.87 102.09 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.123 0.487 . . . . 73.5 112.127 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -178.79 67.68 0.19 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.226 -0.897 . . . . 75.51 109.605 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.48 129.0 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.254 1.97 . . . . 64.24 111.589 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -162.36 87.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.291 0.478 . . . . 72.22 112.291 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.623 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -171.61 133.54 0.84 Allowed Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 112.883 0.697 . . . . 72.05 112.883 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.551 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.6 Cg_exo -63.36 -20.45 5.17 Favored 'Cis proline' 0 C--N 1.354 0.822 0 C-N-CA 123.558 -1.434 . . . . 75.52 110.276 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 148.49 16.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.838 -1.074 . . . . 71.03 109.912 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -49.13 -31.8 8.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.676 0.75 . . . . 73.52 110.617 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.45 -32.83 74.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.927 -1.033 . . . . 74.14 111.956 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.6 t0 -144.91 98.37 4.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 75.42 111.072 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 72.5 Cg_endo -76.51 60.3 6.46 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.974 2.449 . . . . 75.33 111.901 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.473 ' NZ ' ' OD2' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -47.17 -39.82 14.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.931 -0.577 . . . . 72.45 110.78 -178.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.544 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 4.7 p90 -148.0 48.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.721 0.772 . . . . 75.34 109.707 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -74.37 136.24 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.652 -1.158 . . . . 73.53 109.459 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 142' ' ' PHE . 1.1 pm0 -89.12 176.61 6.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.998 0.919 . . . . 74.23 112.013 0.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.648 HG13 ' H ' ' A' ' 77' ' ' LEU . 3.2 tp -114.46 -163.14 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.216 -0.902 . . . . 75.12 109.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.648 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.9 mp -65.04 135.9 56.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.058 -0.349 . . . . 72.53 110.058 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -147.87 171.72 15.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 65.33 110.086 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.618 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.7 t90 -97.99 123.18 41.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 72.34 112.052 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.403 ' HG ' ' CB ' ' A' ' 98' ' ' ALA . 85.5 p -142.96 133.58 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.847 -0.615 . . . . 74.32 109.841 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' HIS . 21.3 t -149.24 117.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.6 . . . . 74.11 109.379 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.577 ' CG2' ' HG2' ' A' ' 127' ' ' GLU . 10.7 m -115.23 -173.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.724 0.774 . . . . 65.23 112.649 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.581 HD22 ' CG ' ' A' ' 95' ' ' HIS . 27.9 p30 44.21 43.45 5.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.996 -1.457 . . . . 73.25 113.166 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 56' ' ' LEU . 2.4 mm -67.42 121.84 80.57 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.55 -1.278 . . . . 73.0 107.55 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.45 103.13 1.64 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.155 1.903 . . . . 75.54 115.189 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.89 -84.79 1.57 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 116.507 1.363 . . . . 73.51 116.507 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 89' ' ' GLU . 78.3 p -174.39 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 117.484 0.642 . . . . 64.23 111.642 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 90' ' ' ASN . 38.9 m-80 -73.71 28.98 0.07 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.907 -0.588 . . . . 74.2 110.391 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 87' ' ' SER . 16.3 pt-20 44.52 5.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.928 -1.033 . . . . 72.23 112.952 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 88' ' ' ASN . 17.8 p30 -179.71 163.11 0.91 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.237 -0.653 . . . . 70.02 109.237 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 90' ' ' ASN . 66.6 Cg_endo -68.65 44.84 0.33 Allowed 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 122.872 2.381 . . . . 74.22 113.219 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD1' ' A' ' 90' ' ' ASN . 22.1 t -69.36 -43.22 74.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.177 0.436 . . . . 74.44 112.177 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.75 10.13 32.35 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.912 -0.661 . . . . 73.54 114.264 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -86.58 166.51 37.92 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.661 -0.78 . . . . 64.03 114.093 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.581 ' CG ' HD22 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.31 104.78 0.8 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.865 0.32 . . . . 75.41 111.865 178.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' HG23 ' A' ' 130' ' ' THR . 51.1 m -73.51 83.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.718 0.77 . . . . 75.32 109.047 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.49 HD22 ' CG ' ' A' ' 127' ' ' GLU . 55.2 mt -68.31 -20.86 64.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.149 -0.932 . . . . 73.41 110.496 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.403 ' CB ' ' HG ' ' A' ' 80' ' ' SER . . . -158.53 106.22 1.9 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.185 -0.916 . . . . 75.44 109.475 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -60.12 142.3 54.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 63.04 110.846 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.618 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 20.5 p90 -67.46 140.28 57.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 73.44 111.798 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.33 145.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 73.41 109.67 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.68 -47.0 72.99 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.896 -0.669 . . . . 72.31 113.394 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -173.52 98.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.964 0.382 . . . . 62.32 111.955 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.636 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -57.12 -50.1 66.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.068 -1.063 . . . . 73.42 110.664 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.675 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 38.4 Cg_endo -65.63 140.21 61.4 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.22 2.613 . . . . 73.41 112.385 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.27 147.24 77.87 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.095 2.53 . . . . 61.25 113.374 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -45.96 -34.38 3.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.154 0.502 . . . . 74.31 111.502 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -51.8 -20.2 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.689 -0.687 . . . . 53.0 111.901 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.623 HG22 ' CE1' ' A' ' 112' ' ' HIS . 10.9 t -69.14 -17.2 63.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 74.33 111.071 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.83 -142.37 34.73 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.902 -0.59 . . . . 65.55 113.82 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.21 117.59 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.393 . . . . 71.43 111.7 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.675 ' CE1' ' HG2' ' A' ' 105' ' ' PRO . 48.5 m-70 -82.79 -176.11 6.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.83 0.824 . . . . 74.23 111.325 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.522 HH12 ' CD1' ' A' ' 115' ' ' ILE . 65.6 ttt-85 -147.52 112.04 5.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.113 -1.81 . . . . 71.12 106.113 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 134.74 54.78 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.603 -0.439 . . . . 73.42 111.653 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CD1' HH12 ' A' ' 113' ' ' ARG . 36.8 mt -130.84 121.36 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.573 -0.739 . . . . 75.3 111.933 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.92 131.44 46.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.429 -0.805 . . . . 75.22 109.154 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.49 143.87 45.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.26 -0.427 . . . . 73.02 110.447 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.3 tp -126.99 131.2 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 75.55 109.886 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 53.1 m-85 -132.61 143.95 50.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.227 0.536 . . . . 64.44 111.226 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -77.15 117.03 18.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.554 -0.748 . . . . 71.13 109.523 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.594 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 39.4 tp60 -91.85 122.77 34.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.038 0.447 . . . . 74.33 110.101 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -90.94 -49.8 6.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.455 -0.793 . . . . 74.14 112.403 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.71 146.16 33.93 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.241 0.46 . . . . 62.25 112.241 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.9 tptm -64.69 123.32 19.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.587 -0.733 . . . . 75.34 110.091 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 151' ' ' HIS . 3.1 pt -111.06 129.03 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.707 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.45 -46.99 70.09 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.353 -0.61 . . . . 64.55 109.353 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.577 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 2.2 tp10 53.92 15.15 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.139 -0.937 . . . . 63.55 113.112 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.467 ' O ' ' CD2' ' A' ' 95' ' ' HIS . 58.7 p 51.16 169.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 111.924 0.342 . . . . 74.15 111.924 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 52.1 Cg_exo -58.83 148.72 82.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.095 1.864 . . . . 75.23 113.406 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 96' ' ' SER . 17.2 p -58.38 136.94 57.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.18 -0.918 . . . . 74.4 110.752 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 38.6 mm -92.79 129.5 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 113.337 0.865 . . . . 74.33 113.337 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.1 m -86.85 133.49 33.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.19 -1.368 . . . . 74.12 109.302 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -53.45 -26.16 19.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.912 -0.315 . . . . 74.3 111.383 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.45 ' C ' HG23 ' A' ' 177' ' ' ILE . 9.3 t -64.83 -2.47 2.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.945 0.402 . . . . 73.45 111.055 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -64.3 108.4 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.253 0.549 . . . . 74.24 109.789 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 37.9 ttt85 -65.14 171.17 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.68 -0.691 . . . . 73.45 112.315 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ARG . 50.4 m -28.29 136.82 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.245 -0.889 . . . . 65.52 111.577 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.94 5.84 14.86 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.772 -0.649 . . . . 65.22 111.927 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -152.0 35.76 0.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.782 0.325 . . . . 74.44 111.192 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 142' ' ' PHE . 3.3 mp -109.86 -62.53 1.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.375 -0.375 . . . . 75.3 110.773 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 2.0 m120 -61.57 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.699 -0.682 . . . . 73.21 112.535 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 11.5 t80 -144.17 118.1 9.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.399 . . . . 74.45 111.346 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.514 HD22 ' CB ' ' A' ' 145' ' ' ARG . 28.6 t30 -85.41 131.0 34.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 73.13 110.489 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.04 -37.49 87.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.738 0.644 . . . . 75.32 112.738 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.514 ' CB ' HD22 ' A' ' 143' ' ' ASN . 30.5 ttp180 -44.02 -31.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 64.12 110.933 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.8 OUTLIER -47.05 -41.01 16.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.044 0.45 . . . . 74.43 110.63 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 97' ' ' LEU . 66.2 m-85 -56.79 -38.83 73.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.759 -0.655 . . . . 73.33 110.639 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -63.28 -28.14 69.82 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.72 -0.673 . . . . 64.34 110.174 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.63 2.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 70.12 111.226 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 0.9 OUTLIER -54.08 -44.35 71.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.823 0.344 . . . . 74.34 110.961 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CE1' HG23 ' A' ' 125' ' ' ILE . 29.5 m-70 -85.74 4.76 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.476 -0.329 . . . . 70.4 110.7 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 56.08 26.11 48.33 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.019 -0.537 . . . . 74.1 113.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 19.6 mt -64.47 -25.86 68.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.434 -0.58 . . . . 71.42 109.434 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.64 -89.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.06 -0.973 . . . . 45.11 113.963 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' LEU . 21.9 pt-20 -73.06 125.72 90.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.088 0.403 . . . . 71.44 112.088 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 119' ' ' TYR . 60.3 Cg_endo -76.22 124.78 8.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.692 1.595 . . . . 42.32 110.34 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.436 HG12 ' HA ' ' A' ' 119' ' ' TYR . 47.5 pt -71.5 -33.8 50.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.115 -0.634 . . . . 73.55 110.551 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.401 ' HB1' ' N ' ' A' ' 16' ' ' THR . . . -147.15 149.77 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.946 -0.302 . . . . 74.11 111.564 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.38 152.34 38.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.127 -0.488 . . . . 74.21 111.122 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.666 ' ND2' HE21 ' A' ' 29' ' ' GLN . 1.7 t-20 -157.28 145.27 19.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.48 -1.304 . . . . 70.3 107.48 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -149.03 176.84 10.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.882 0.327 . . . . 74.41 111.882 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 2.3 p90 -168.84 164.82 11.83 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.067 -0.515 . . . . 74.24 111.343 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -126.36 124.81 41.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.489 -0.56 . . . . 74.11 109.489 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.62 152.85 25.91 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.16 0.429 . . . . 74.54 112.16 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.561 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -109.08 136.49 48.51 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 74.1 109.348 178.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -125.5 135.07 51.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.699 -0.482 . . . . 63.24 109.699 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.84 173.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.316 0.579 . . . . 73.43 112.293 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -72.75 51.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.167 -0.924 . . . . 71.5 110.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -91.69 -46.57 7.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 73.15 110.872 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.423 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 53.4 t -80.82 -46.89 1.21 Allowed Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 113.162 0.801 . . . . 74.44 113.162 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.423 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.4 Cg_exo -46.06 -43.35 20.46 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.918 1.745 . . . . 71.12 111.748 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.1 mm -51.14 -39.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 75.44 110.076 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -53.32 -26.42 18.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.614 -0.721 . . . . 74.22 110.796 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -52.31 -42.68 64.02 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.543 0.211 . . . . 75.43 111.295 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -15.5 62.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.064 0.459 . . . . 73.21 110.498 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.8 m -92.37 -28.14 17.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.58 -0.736 . . . . 75.32 110.812 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 52.1 mt -56.51 119.74 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.962 -0.563 . . . . 74.45 110.956 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.87 37.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.895 0.379 . . . . 74.13 111.531 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.978 -1.457 . . . . 54.44 111.34 -179.126 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.072 0.463 . . . . 74.03 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -51.15 -64.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.774 -0.648 . . . . 75.03 112.19 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' LEU . 3.5 pt -131.63 49.14 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.502 0.667 . . . . 74.51 111.361 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.9 p -111.61 142.32 26.35 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 65.3 110.203 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 56.2 Cg_endo -95.62 33.44 9.86 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.363 -1.099 . . . . 75.52 112.83 0.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.55 -42.82 82.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.22 109.741 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -154.38 -47.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.724 -0.671 . . . . 75.5 112.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 25.2 tp -158.51 154.88 27.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.316 0.488 . . . . 73.3 112.316 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.63 -1.97 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.346 -0.613 . . . . 62.22 109.346 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.485 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -144.86 -158.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.155 -0.93 . . . . 62.44 109.827 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.62 113.91 5.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 75.32 111.437 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 45.1 Cg_endo -88.75 -138.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.448 . . . . 74.24 112.519 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -153.31 -37.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 61.14 111.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.38 161.67 24.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.177 -1.011 . . . . 65.12 113.274 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 t -104.46 157.05 17.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.869 0.366 . . . . 71.22 110.947 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 1.8 mp -104.01 135.25 42.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.889 -0.596 . . . . 72.3 109.605 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.9 mmmt -73.57 118.19 16.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.53 -0.305 . . . . 74.33 110.232 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.556 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 84.1 t -128.18 109.18 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.278 -0.638 . . . . 72.33 109.278 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 26' ' ' GLU . 37.2 mt -99.64 142.07 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 74.21 112.452 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.516 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 1.6 m-85 -101.57 -94.3 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.716 -0.674 . . . . 74.02 111.123 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -61.72 -50.22 68.29 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.157 -1.02 . . . . 75.51 111.586 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.4 t70 171.36 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.999 -0.741 . . . . 62.14 108.999 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 71.21 108.789 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.06 141.37 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.617 -1.174 . . . . 63.35 111.476 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 pt-20 -149.04 153.73 38.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.83 -1.077 . . . . 74.12 110.752 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 35.8 m -82.56 133.69 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 74.24 109.899 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 14.7 pttm -153.35 130.02 10.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.055 0.931 . . . . 74.01 113.182 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' CE1' ' A' ' 161' ' ' TYR . 7.1 mp0 32.55 63.89 0.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.859 -1.519 . . . . 74.53 114.759 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.3 10.83 63.41 Favored Glycine 0 N--CA 1.454 -0.13 0 N-CA-C 114.876 0.71 . . . . 73.41 114.876 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -61.0 146.39 47.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.874 0.837 . . . . 65.32 109.906 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -96.5 126.28 41.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.92 -0.4 . . . . 75.32 109.92 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.07 108.9 20.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.137 0.494 . . . . 74.31 109.791 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -150.22 155.49 37.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.39 -0.823 . . . . 71.52 110.648 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -93.86 136.09 6.55 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.286 -1.131 . . . . 71.33 112.64 0.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.427 ' O ' ' HE3' ' A' ' 39' ' ' LYS . 17.9 m 56.38 33.65 22.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.237 0.541 . . . . 74.22 110.649 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -93.87 -1.9 54.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.682 -0.69 . . . . 75.12 110.83 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.4 m -92.13 -14.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 73.4 112.289 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -74.39 5.8 4.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 73.52 111.094 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 53.2 m-20 -96.81 146.15 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.256 0.55 . . . . 75.05 111.737 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 21' ' ' TYR . 1.7 pm0 -62.63 132.33 94.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.189 -0.914 . . . . 71.21 111.796 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 89.6 Cg_endo -81.61 125.14 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.947 1.765 . . . . 64.32 112.227 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.9 mm -109.27 106.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 75.13 109.921 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -89.94 136.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.337 0.495 . . . . 75.32 112.337 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 75.3 m -159.66 116.23 2.56 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.77 -0.65 . . . . 74.42 110.089 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 89' ' ' GLU . 16.1 p90 -91.77 32.4 1.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 74.31 110.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 m -46.85 128.43 10.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.338 -0.846 . . . . 63.13 110.586 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.19 -33.16 4.83 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.708 -0.678 . . . . 54.31 112.406 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 16' ' ' THR . 2.9 mm? -80.29 -26.39 38.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.432 . . . . 75.01 110.479 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 23.1 tt0 -59.33 158.89 8.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.852 -0.613 . . . . 75.52 110.983 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.85 33.1 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.216 -1.154 . . . . 75.23 110.216 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -48.15 109.55 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 74.11 110.44 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 p -149.23 142.6 25.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.327 -0.851 . . . . 75.45 109.582 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -64.77 -38.76 92.08 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.58 0.705 . . . . 74.44 109.45 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 ' C ' ' HB3' ' A' ' 121' ' ' GLN . 82.1 mt -156.86 154.58 30.05 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.642 -1.163 . . . . 72.3 111.179 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.0 mt -120.67 150.9 40.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.579 -0.526 . . . . 72.22 109.579 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.5 m -122.24 114.32 20.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.776 0.322 . . . . 73.33 110.665 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.68 134.19 47.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.154 -0.684 . . . . 74.34 109.154 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.04 152.51 44.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.349 0.595 . . . . 71.4 111.851 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.7 ttt -127.2 110.29 12.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.201 -0.909 . . . . 73.53 108.607 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' ASP . 5.1 t -94.32 -133.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.025 -0.27 . . . . 74.3 111.712 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' VAL . 2.2 m-20 51.84 73.04 1.03 Allowed Pre-proline 0 CA--C 1.518 -0.256 0 N-CA-C 112.341 0.497 . . . . 75.24 112.341 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . 32.0 Cg_endo -62.19 129.4 26.91 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.737 1.625 . . . . 75.14 110.008 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -159.46 92.49 1.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.769 1.026 . . . . 72.44 113.769 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.549 ' HB1' HG12 ' A' ' 76' ' ' ILE . . . -172.88 134.39 0.7 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 112.481 0.549 . . . . 64.23 112.481 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 65.3 Cg_endo -85.64 3.18 65.38 Favored 'Cis proline' 0 C--N 1.347 0.468 0 C-N-CA 124.315 -1.119 . . . . 73.14 110.243 -2.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 t -164.81 134.04 3.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.332 -1.304 . . . . 65.11 109.636 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.541 ' HD3' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -55.14 -24.05 24.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.852 0.358 . . . . 75.21 110.726 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.541 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -62.43 -41.18 98.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 75.15 110.417 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -144.7 109.51 4.8 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.101 -0.5 . . . . 74.21 111.231 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.64 63.83 4.72 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.5 2.133 . . . . 73.43 111.518 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.546 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 39.6 ttmt -47.91 -27.82 2.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.199 -0.455 . . . . 75.31 111.113 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.575 ' HB2' HD22 ' A' ' 141' ' ' ASN . 2.9 p90 -152.78 45.36 0.69 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.734 0.642 . . . . 74.52 112.734 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.586 ' NE ' ' HB2' ' A' ' 63' ' ' PRO . 25.9 ttm180 -66.82 139.57 57.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.534 -0.913 . . . . 70.4 108.534 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -106.64 165.55 11.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.55 1.14 . . . . 75.12 110.23 -0.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.637 ' CG2' ' H ' ' A' ' 77' ' ' LEU . 38.0 mm -80.55 176.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.233 0.457 . . . . 72.23 112.233 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.637 ' H ' ' CG2' ' A' ' 76' ' ' ILE . 2.9 mm? -71.44 55.99 0.24 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.705 -0.68 . . . . 71.12 110.07 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 76' ' ' ILE . 6.5 p-80 -53.92 169.91 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 75.44 111.956 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 12.3 t90 -99.86 112.52 24.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.744 -0.662 . . . . 75.42 110.457 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 p -141.44 136.56 31.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.689 -0.687 . . . . 74.51 110.442 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.76 142.49 32.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.994 -0.548 . . . . 75.41 109.909 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.523 ' CG2' ' HG3' ' A' ' 127' ' ' GLU . 16.4 m -137.71 163.52 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.581 0.585 . . . . 73.4 112.581 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' ND2' HG23 ' A' ' 82' ' ' VAL . 45.8 m-20 71.87 32.89 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.63 -1.168 . . . . 74.31 111.243 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' CD1' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -76.96 111.96 19.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.102 -0.639 . . . . 74.03 109.695 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' SER . 47.9 Cg_exo -54.56 134.24 60.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.813 1.675 . . . . 62.43 110.75 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.91 70.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.949 -0.643 . . . . 72.24 112.839 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' PRO . 23.2 t 176.46 47.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.88 -0.785 . . . . 72.04 108.88 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.44 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 68.7 m-80 -135.66 -29.86 1.03 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.76 . . . . 75.0 112.146 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 12.7 pt-20 50.06 20.55 0.61 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.515 0.674 . . . . 72.04 110.201 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -170.25 148.01 2.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.643 -1.162 . . . . 72.44 109.654 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.09 49.42 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.796 2.331 . . . . 65.53 112.741 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -92.51 -56.02 3.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 74.34 111.5 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.32 33.73 1.33 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.823 -0.626 . . . . 72.41 113.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -133.81 159.12 23.6 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.864 -0.684 . . . . 54.41 113.238 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.5 ' CE1' ' CG2' ' A' ' 130' ' ' THR . 78.3 t60 -68.73 116.69 9.52 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.253 0.221 . . . . 74.24 111.418 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -76.94 106.31 8.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.441 -0.948 . . . . 74.4 108.441 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.443 HD21 ' HG3' ' A' ' 127' ' ' GLU . 4.9 mt -61.93 -54.57 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.376 -0.972 . . . . 73.53 108.376 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.84 121.16 29.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.244 -1.343 . . . . 63.14 107.536 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.56 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.6 t0 -52.75 152.07 4.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.219 -0.446 . . . . 55.22 111.872 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -59.49 127.2 30.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.897 -0.592 . . . . 72.42 109.688 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.1 148.95 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.521 0.677 . . . . 73.44 112.355 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.83 72.01 0.45 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.224 -1.15 . . . . 71.42 110.224 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.456 ' HA ' ' CG1' ' A' ' 170' ' ' VAL . 28.3 t -169.73 -89.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.68 -0.489 . . . . 62.31 109.68 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.75 33.6 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.993 -0.623 . . . . 72.14 114.329 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' ' HA ' ' A' ' 65' ' ' ALA . 35.2 Cg_endo -64.02 154.65 69.13 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.404 2.736 . . . . 73.43 114.061 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.528 ' HA ' ' HG3' ' A' ' 171' ' ' PRO . 5.6 Cg_exo -78.14 163.42 27.97 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.555 2.837 . . . . 74.41 112.89 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 166' ' ' TYR . 64.8 tttm -38.4 -26.13 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.076 -0.511 . . . . 64.44 111.511 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' PRO . 10.8 t70 -50.56 -41.52 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 74.43 111.898 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t -73.73 -14.28 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.983 0.735 . . . . 71.11 112.983 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.05 -144.9 41.52 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.054 -1.07 . . . . 55.33 112.13 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 163' ' ' GLN . 43.8 tp -67.46 130.87 44.43 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.405 -0.468 . . . . 73.45 111.016 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 6.5 p80 -130.48 126.31 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 73.44 110.307 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -88.22 125.39 34.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.672 -0.694 . . . . 74.04 110.588 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -116.59 140.41 49.42 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.446 0.466 . . . . 75.45 110.231 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 161' ' ' TYR . 39.1 mt -123.91 125.51 71.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.554 0.692 . . . . 75.23 111.971 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.56 136.34 33.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.138 -0.937 . . . . 75.33 109.681 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.421 ' HB3' ' CE1' ' A' ' 119' ' ' TYR . 3.0 mm? -124.34 137.52 54.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 71.4 111.033 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 119' ' ' TYR . 4.7 tt -127.05 135.29 50.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.385 -0.598 . . . . 61.24 109.385 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 153' ' ' LEU . 8.5 m-85 -132.29 143.46 49.91 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.138 -0.483 . . . . 65.41 111.159 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -72.45 139.58 47.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 75.4 109.278 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.436 ' HB3' ' C ' ' A' ' 55' ' ' LEU . 4.5 tt0 -123.91 127.31 47.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.483 0.658 . . . . 74.51 112.653 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -104.2 -38.89 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.085 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.05 129.28 54.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.326 -0.852 . . . . 75.1 110.947 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -67.51 152.32 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.853 -0.612 . . . . 74.52 111.927 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pt -136.0 147.71 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.891 -0.595 . . . . 75.21 111.228 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -49.97 12.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.414 -0.357 . . . . 73.21 111.399 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.543 ' OE1' ' NZ ' ' A' ' 150' ' ' LYS . 6.4 mm-40 61.24 33.34 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 63.5 112.02 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.7 p 53.32 156.57 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 112.851 0.686 . . . . 72.34 112.851 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.32 148.6 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.622 2.215 . . . . 72.42 113.188 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.5 ' CG2' ' CE1' ' A' ' 95' ' ' HIS . 2.7 p -59.86 116.12 3.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 74.23 112.611 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.75 120.99 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.046 -0.724 . . . . 74.22 109.046 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.5 m -75.39 149.07 38.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 70.24 112.15 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.56 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 34.2 t30 -55.5 -36.38 66.61 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 121.411 0.624 . . . . 74.33 109.538 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.4 p -78.39 8.78 4.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.552 -0.749 . . . . 74.51 111.727 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 1.7 m -64.1 131.59 47.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.642 0.258 . . . . 75.23 110.729 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.542 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 26.1 ttt85 -76.3 169.98 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 75.21 113.212 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 138' ' ' GLY . 88.5 m -49.77 160.37 0.31 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.4 -1.273 . . . . 73.42 112.037 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.413 ' N ' ' CG2' ' A' ' 137' ' ' THR . . . 96.04 -38.22 3.18 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.994 -1.003 . . . . 74.12 112.038 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 139' ' ' ARG . 23.3 mmt180 -82.82 -37.75 24.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 74.44 111.462 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -56.35 -50.37 71.7 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.602 0.593 . . . . 72.21 112.602 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' A' ' 73' ' ' TYR . 7.2 m120 -44.26 68.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.82 1.415 . . . . 72.33 114.82 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 140' ' ' LEU . 23.4 t80 -149.9 126.7 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 73.42 110.893 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 145' ' ' ARG . 0.6 OUTLIER -78.76 100.14 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 73.14 111.183 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -47.61 -33.81 7.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.086 -0.506 . . . . 73.24 111.728 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.534 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 49.7 ttp85 -47.66 -35.11 8.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.736 0.303 . . . . 74.44 110.874 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -51.9 -40.63 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.885 0.374 . . . . 75.41 110.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 142' ' ' PHE . 28.9 m-85 -46.83 -43.13 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.483 . . . . 70.22 110.086 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.76 -38.16 86.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.706 -0.679 . . . . 74.31 110.941 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.98 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 74.13 111.367 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -53.79 -51.28 63.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.517 -0.311 . . . . 74.35 111.173 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.597 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 28.9 t-80 -78.42 -5.7 53.13 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.536 -0.542 . . . . 73.01 109.536 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.67 69.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.661 -0.78 . . . . 74.33 112.236 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.602 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . 14.7 mt -63.05 -25.31 68.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.169 -0.678 . . . . 71.01 109.169 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 31.62 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.788 -1.096 . . . . 74.53 113.888 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' LEU . 9.9 pt-20 -73.63 124.17 90.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.47 0.544 . . . . 74.41 112.47 -177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 73.2 Cg_endo -81.51 137.33 10.25 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.438 2.092 . . . . 73.5 111.692 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 118' ' ' LEU . 37.6 pt -83.27 -35.23 11.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.3 0.571 . . . . 75.2 110.712 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.74 150.67 40.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 55.4 111.059 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -152.09 158.91 43.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.461 . . . . 73.24 111.931 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -154.82 122.34 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.541 -0.911 . . . . 73.41 108.541 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.494 ' HB3' HG12 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -126.85 157.33 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 75.44 112.163 -177.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 4.1 p90 -162.53 163.04 27.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 72.01 110.767 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.428 ' HB2' HD11 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -110.7 136.79 49.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.181 0.515 . . . . 71.0 111.282 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.6 134.91 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.375 -0.83 . . . . 70.11 110.411 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.574 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -106.87 149.0 27.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.022 -0.362 . . . . 75.24 110.022 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 18.3 m-30 -128.46 125.28 38.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 74.42 110.998 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.14 -135.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.525 -0.761 . . . . 74.21 111.303 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 7.1 t70 -94.99 -43.44 8.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.903 -0.589 . . . . 74.54 110.989 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -51.95 -29.82 22.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 74.21 110.83 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.492 ' HB ' ' CD ' ' A' ' 171' ' ' PRO . 23.3 t -71.38 -58.16 4.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.955 -0.566 . . . . 74.43 111.955 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.528 ' HG3' ' HA ' ' A' ' 106' ' ' PRO . 18.0 Cg_endo -57.55 -28.45 81.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.641 2.227 . . . . 73.22 112.727 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 168' ' ' ASP . 65.2 mt -45.53 -39.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.591 0.234 . . . . 71.31 111.193 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -46.91 -36.44 7.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 75.22 110.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.447 ' ND2' ' HG ' ' A' ' 103' ' ' SER . 76.0 m-80 -54.62 -34.47 62.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.67 -0.695 . . . . 63.13 111.692 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -53.83 -40.46 66.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.937 0.399 . . . . 75.1 111.362 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.2 m -77.45 0.81 21.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.604 0.594 . . . . 74.12 112.604 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 14.3 mt -70.4 129.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 75.01 111.933 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.7 m -165.34 88.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.695 -0.684 . . . . 71.31 110.816 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.537 ' C ' ' HA ' ' A' ' 135' ' ' THR . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.779 -1.012 . . . . 71.23 112.086 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.927 0.394 . . . . 75.42 111.776 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.575 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 8.8 t70 -51.77 -54.8 24.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 70.34 110.695 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 9' ' ' LEU . 3.1 pt -148.48 60.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.514 0.673 . . . . 74.43 109.959 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 8.3 p -127.71 138.25 32.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 74.54 110.159 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 82.6 Cg_endo -85.0 34.02 3.92 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.974 -1.261 . . . . 74.11 112.858 0.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 59.6 t0 -59.4 -54.0 51.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.415 -0.357 . . . . 73.24 110.973 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 7.0 m -164.24 -32.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.03 -0.532 . . . . 75.53 111.986 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 35.3 tp -157.03 144.56 18.94 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.332 0.587 . . . . 74.14 112.028 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.37 -19.1 63.84 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.974 0.731 . . . . 64.44 112.974 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -161.22 135.46 7.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.523 0.194 . . . . 64.13 111.523 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.24 116.12 45.72 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.708 0.29 . . . . 74.24 111.521 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -95.72 -125.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.687 2.925 . . . . 72.44 112.151 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -158.35 -42.05 0.06 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.456 -0.338 . . . . 70.43 110.923 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.11 173.48 14.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.641 -0.79 . . . . 73.21 112.733 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 1.8 t -121.59 161.69 21.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.435 0.636 . . . . 61.4 111.519 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.1 mt -105.44 154.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.683 -1.144 . . . . 72.22 109.25 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.1 mmpt? -102.9 102.33 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.926 -0.579 . . . . 74.5 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 54.8 t -109.66 109.69 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.098 -0.704 . . . . 73.45 109.098 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.14 144.37 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.209 0.528 . . . . 74.52 111.082 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.75 -94.39 0.34 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.266 -0.879 . . . . 71.13 112.524 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.52 99.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.068 -0.587 . . . . 73.31 113.522 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' H ' HD23 ' A' ' 25' ' ' LEU . 2.4 m-20 179.14 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.923 0.868 . . . . 73.13 109.811 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -98.52 -40.88 8.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.465 -1.243 . . . . 75.23 111.411 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.6 pt? -69.41 141.05 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 74.54 111.127 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 6.0 pm0 -139.28 148.75 43.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 75.11 110.101 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 9.3 m -62.46 147.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.279 -0.418 . . . . 74.51 111.842 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 70.0 mttt -140.93 103.44 4.48 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.953 0.723 . . . . 74.33 112.953 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.503 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 10.2 mp0 35.63 67.72 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.691 0.997 . . . . 74.33 113.691 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.95 -10.42 57.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.222 -0.513 . . . . 62.31 113.629 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 t30 -47.0 129.67 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 74.02 110.985 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' GLN . 62.6 tt0 -102.79 132.63 48.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.46 -0.791 . . . . 74.25 111.246 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HG ' HE21 ' A' ' 37' ' ' GLN . 0.1 OUTLIER -100.86 135.49 42.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.087 0.47 . . . . 73.11 110.948 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.522 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 7.8 p -138.64 164.79 37.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.455 -0.793 . . . . 74.44 109.974 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 84.9 Cg_endo -81.85 -29.31 5.97 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.303 -1.124 . . . . 64.12 113.155 0.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.2 t -161.45 35.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.154 0.502 . . . . 71.22 111.315 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.44 HE21 ' HG ' ' A' ' 33' ' ' LEU . 15.2 pt20 -84.42 0.27 50.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.31 110.025 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 40' ' ' ASP . 33.4 m -83.91 -3.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.736 -1.12 . . . . 75.35 112.646 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -65.88 6.19 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.856 0.317 . . . . 75.41 111.856 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -96.89 145.84 25.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.39 0.614 . . . . 73.41 111.749 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.633 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.4 pm0 -62.75 130.83 94.07 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 75.12 109.318 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.0 126.09 13.36 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.721 1.614 . . . . 74.33 112.664 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -100.13 105.27 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.752 -0.462 . . . . 72.45 109.752 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -82.41 140.81 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.525 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 33.1 m -164.98 121.91 1.52 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.672 0.272 . . . . 64.22 111.679 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 6.1 p90 -84.87 29.38 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.127 -0.694 . . . . 75.44 109.127 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 45' ' ' SER . 11.1 t -46.29 123.14 4.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.2 -0.909 . . . . 73.41 110.738 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.95 -24.83 30.64 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.481 -0.648 . . . . 61.53 111.481 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 6.6 mp -87.68 -37.17 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.608 0.242 . . . . 74.21 110.75 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -50.27 138.39 16.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.802 -0.359 . . . . 71.1 110.761 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.13 -71.78 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.831 -0.699 . . . . 73.31 111.909 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -148.73 108.94 4.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 74.33 110.366 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.528 ' HG ' ' HA3' ' A' ' 86' ' ' GLY . 5.1 p -158.1 141.53 15.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.59 -0.732 . . . . 72.41 110.194 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -73.16 -38.9 66.03 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.584 0.707 . . . . 74.43 109.513 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 26.2 mt -155.8 162.4 40.49 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.867 -1.061 . . . . 71.21 109.961 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' CD1' ' CZ2' ' A' ' 46' ' ' TRP . 80.6 mt -128.27 168.04 16.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.778 0.323 . . . . 74.32 110.42 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.401 ' CG2' HG13 ' A' ' 82' ' ' VAL . 99.1 m -143.47 133.11 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.426 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.77 138.62 52.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.957 -0.565 . . . . 75.11 110.032 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 80' ' ' SER . 52.3 mt -149.04 131.66 15.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.775 0.657 . . . . 72.44 112.775 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 37.8 ttm -94.84 122.18 37.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.139 -0.937 . . . . 75.13 108.797 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' H ' ' A' ' 62' ' ' ASP . 4.9 t -109.13 -131.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.712 0.264 . . . . 72.3 111.712 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.544 ' H ' ' CG1' ' A' ' 61' ' ' VAL . 8.6 t70 54.84 80.94 0.27 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 121.278 0.561 . . . . 74.44 111.162 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.9 84.49 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.297 1.998 . . . . 61.34 112.405 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -126.23 87.57 2.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 75.22 110.564 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.469 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.6 135.14 1.09 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 72.02 110.858 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 15.4 Cg_exo -67.67 -18.37 9.21 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.752 -1.353 . . . . 64.15 109.501 -1.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -157.25 131.7 8.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.781 -1.554 . . . . 74.34 107.934 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 4.3 tmm_? -50.97 -31.92 19.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.454 0.645 . . . . 74.33 109.832 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.41 -37.97 89.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.192 -0.913 . . . . 63.34 111.766 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -141.21 72.16 27.04 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-O 121.195 0.521 . . . . 75.51 109.744 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 13.8 Cg_exo -67.04 65.48 0.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.105 2.537 . . . . 74.22 112.692 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -48.69 -45.88 39.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.587 -0.733 . . . . 75.22 112.346 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HB2' HD22 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -123.04 44.98 2.52 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.087 0.403 . . . . 71.44 112.087 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -70.69 133.0 46.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 71.2 110.896 179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 144' ' ' ALA . 86.9 mt-10 -91.32 178.47 5.96 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.478 0.711 . . . . 74.24 110.465 -0.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.571 HG13 ' H ' ' A' ' 77' ' ' LEU . 7.3 tp -113.85 176.35 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.789 -0.641 . . . . 75.34 109.591 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.571 ' H ' HG13 ' A' ' 76' ' ' ILE . 2.8 mm? -49.0 117.56 2.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.58 -0.526 . . . . 73.21 109.58 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.7 173.64 10.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.739 -0.664 . . . . 75.3 110.296 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.556 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.5 t-105 -99.51 113.1 25.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 74.24 111.007 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 14.4 m -131.85 128.22 38.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.594 -0.73 . . . . 74.53 109.848 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.426 ' CG1' HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.49 143.06 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.233 0.54 . . . . 73.43 110.225 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 57' ' ' THR . 29.5 m -142.52 161.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.771 -0.649 . . . . 71.14 112.29 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' A' ' 95' ' ' HIS . 23.4 p30 55.57 43.06 28.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.677 -1.147 . . . . 65.11 112.522 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.53 ' CD1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 mm -83.01 130.65 56.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.926 -0.768 . . . . 71.12 108.926 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 84' ' ' ILE . 31.5 Cg_exo -58.04 128.88 30.51 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 121.454 1.436 . . . . 65.54 111.111 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.528 ' HA3' ' HG ' ' A' ' 53' ' ' SER . . . -64.85 57.74 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.642 0.617 . . . . 74.22 114.642 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.5 p -178.69 36.91 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.579 0.689 . . . . 51.3 111.378 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.7 m-80 -121.3 -2.0 9.62 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.49 -0.323 . . . . 72.23 110.93 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 70.05 -38.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 72.44 111.387 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 88' ' ' ASN . 13.6 p30 -129.32 155.63 79.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.967 0.413 . . . . 74.52 110.391 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 84' ' ' ILE . 92.6 Cg_endo -71.59 55.52 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.226 2.617 . . . . 73.15 113.289 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.7 t -97.16 -54.97 3.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.342 0.497 . . . . 72.54 112.342 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.59 -10.75 25.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 115.21 0.844 . . . . 72.22 115.21 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -96.51 173.11 29.49 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.268 -0.968 . . . . 71.52 113.647 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.519 ' HB2' HD22 ' A' ' 83' ' ' ASN . 5.9 m80 -68.35 128.82 37.96 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.618 0.599 . . . . 72.51 112.618 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.508 ' H ' ' CG2' ' A' ' 130' ' ' THR . 86.1 p -96.5 97.25 9.27 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.379 -0.373 . . . . 75.21 110.288 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.465 ' CD2' ' HB2' ' A' ' 127' ' ' GLU . 79.4 mt -56.94 -40.04 75.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 65.22 109.787 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.87 120.69 8.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.563 -1.199 . . . . 73.53 109.1 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.621 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 47.8 t0 -59.96 148.46 35.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 71.44 112.676 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 17.3 p90 -70.29 152.7 43.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.719 -0.673 . . . . 73.21 110.682 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.42 166.51 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 72.1 111.244 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.91 3.38 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.855 -0.611 . . . . 54.21 112.839 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.3 p -162.94 105.63 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 74.03 110.454 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -53.05 -47.38 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.533 -0.758 . . . . 71.03 113.044 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 74.9 Cg_endo -78.26 129.01 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.418 2.079 . . . . 74.1 112.217 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.58 158.87 53.57 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.731 2.287 . . . . 73.31 113.566 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 5.0 pttp -39.89 -27.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.119 -0.946 . . . . 73.24 112.158 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -50.38 -34.12 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.126 -0.488 . . . . 75.35 111.627 -178.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 6.8 t -93.62 4.7 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.566 -0.454 . . . . 71.43 111.433 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.17 -98.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.206 -0.452 . . . . 71.25 112.865 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.0 145.23 51.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.575 0.703 . . . . 74.43 111.416 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 109' ' ' THR . 17.3 m-70 -139.75 114.02 9.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.191 -1.04 . . . . 74.12 108.191 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.514 ' HG3' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -100.3 123.87 45.06 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -119.64 138.46 53.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.967 0.413 . . . . 73.41 110.353 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 58.7 mt -122.66 122.3 65.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.311 -0.859 . . . . 74.44 111.923 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -98.9 137.28 37.69 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.748 -0.66 . . . . 74.21 109.86 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.545 ' HG ' HH12 ' A' ' 145' ' ' ARG . 1.1 tm? -123.97 138.28 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.552 -0.536 . . . . 74.45 109.552 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.66 141.54 50.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 122.578 0.351 . . . . 75.13 110.744 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.528 ' CD2' ' CD2' ' A' ' 153' ' ' LEU . 37.7 t80 -142.44 136.73 29.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.868 -0.606 . . . . 74.3 111.047 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -79.51 121.25 24.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.785 -0.45 . . . . 74.11 109.785 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.577 HE22 HG12 ' A' ' 125' ' ' ILE . 1.9 tt0 -98.93 130.85 45.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.014 0.435 . . . . 74.31 110.871 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -99.07 -41.28 7.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.834 -0.621 . . . . 70.41 110.202 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -111.92 130.6 55.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 75.53 110.949 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.23 146.84 52.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 65.54 112.085 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.577 HG12 HE22 ' A' ' 121' ' ' GLN . 22.3 pt -126.68 140.24 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.957 -0.565 . . . . 73.05 110.783 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.1 -44.17 60.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.087 0.47 . . . . 75.31 111.66 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 29.7 38.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.154 1.168 . . . . 63.31 114.154 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 p 56.91 158.34 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.803 0.668 . . . . 74.41 112.803 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.2 158.26 9.79 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.73 2.286 . . . . 72.13 113.11 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.508 ' CG2' ' H ' ' A' ' 96' ' ' SER . 41.2 p -58.89 131.19 50.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.318 -0.855 . . . . 72.32 111.963 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mm -103.56 124.96 58.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.522 0.201 . . . . 62.53 110.491 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.8 t -80.2 154.99 27.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.171 0.51 . . . . 75.34 111.268 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.621 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.1 p30 -52.69 -35.14 54.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 63.13 110.137 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -68.56 11.49 0.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.231 -0.895 . . . . 74.53 112.503 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 177' ' ' ILE . 15.0 t -62.02 132.39 52.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.79 0.329 . . . . 72.21 110.681 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 137' ' ' THR . 44.1 tpt85 -58.03 159.56 5.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.124 -0.489 . . . . 74.24 111.71 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.491 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 27.8 m -51.57 146.95 6.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 75.15 110.119 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.34 4.73 17.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 73.05 111.758 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 45.9 ttm-85 -144.05 37.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 74.24 110.776 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.564 ' HG ' ' H ' ' A' ' 141' ' ' ASN . 0.3 OUTLIER -114.92 -56.97 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 75.23 110.605 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' A' ' 73' ' ' TYR . 3.0 m120 -62.24 67.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.07 -0.513 . . . . 73.02 111.986 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 146' ' ' ASP . 44.4 t80 -140.4 131.35 26.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.017 0.437 . . . . 75.53 111.061 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -71.05 108.02 4.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 74.53 109.458 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.437 ' H ' ' CD ' ' A' ' 75' ' ' GLU . . . -52.27 -40.28 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.303 0.573 . . . . 61.4 111.464 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.545 HH12 ' HG ' ' A' ' 117' ' ' LEU . 1.6 tpt180 -57.4 -28.68 63.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.438 -0.801 . . . . 74.22 111.996 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 6.0 t70 -48.72 -47.48 41.22 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.882 -0.784 . . . . 64.12 108.882 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 12.2 m-30 -59.14 -40.05 84.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.151 -0.931 . . . . 73.23 109.852 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.762 -0.654 . . . . 71.12 111.15 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.74 24.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.063 -0.517 . . . . 71.41 111.887 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.6 ' HB2' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -68.7 -44.23 74.38 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.841 0.682 . . . . 75.13 112.841 -178.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 34.2 m170 -72.69 7.77 1.78 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.845 -0.342 . . . . 74.35 110.734 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.24 2.78 63.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.117 -0.563 . . . . 73.55 112.332 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 3.2 mt -68.71 16.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.543 0.211 . . . . 75.45 110.589 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.21 -66.24 1.25 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.874 -0.679 . . . . 72.55 112.189 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.52 122.18 84.63 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.036 -0.357 . . . . 73.41 110.036 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.72 127.94 2.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.513 2.142 . . . . 72.43 113.014 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -77.04 -34.14 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.127 0.489 . . . . 71.22 110.209 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.67 157.86 37.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 74.45 110.851 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' THR . . . -154.16 171.34 19.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.008 0.433 . . . . 75.21 111.156 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -170.58 133.57 1.02 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.079 -1.082 . . . . 75.54 108.079 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.489 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -135.4 158.41 44.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.76 -0.2 . . . . 70.33 111.466 -177.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.606 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.9 p90 -146.6 156.83 43.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.974 -0.557 . . . . 75.11 112.338 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.514 ' HG2' ' HG3' ' A' ' 113' ' ' ARG . 14.2 mt-30 -119.09 124.68 47.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.128 -0.942 . . . . 75.33 109.759 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -156.68 138.43 14.22 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.635 -0.426 . . . . 71.04 111.498 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.592 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.17 135.52 41.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.27 -0.641 . . . . 73.41 109.27 178.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.484 ' HB3' ' CG1' ' A' ' 170' ' ' VAL . 6.2 m-85 -121.21 142.64 49.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.341 -0.391 . . . . 74.24 111.814 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.467 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.4 m-20 -66.24 -168.21 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.191 -0.913 . . . . 60.43 113.022 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.6 t70 -85.9 -32.77 21.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.986 -1.006 . . . . 74.45 111.57 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -61.14 -32.58 72.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.521 0.563 . . . . 74.03 112.521 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 171' ' ' PRO . 1.5 p -72.29 -48.79 9.79 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.761 1.023 . . . . 72.35 113.761 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 170' ' ' VAL . 20.0 Cg_endo -59.25 -17.22 38.22 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.777 1.651 . . . . 74.44 112.519 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.9 tp -46.15 -30.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.012 0.434 . . . . 72.13 111.156 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -44.79 -25.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 71.52 110.588 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -50.5 -36.22 32.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.957 -0.565 . . . . 65.11 111.339 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 175' ' ' LYS . 8.4 mtpm? -56.7 -22.19 33.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.368 . . . . 73.13 111.128 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.6 m -74.96 -7.89 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.802 -0.635 . . . . 74.54 111.457 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.443 HG21 ' O ' ' A' ' 135' ' ' THR . 44.2 mm -68.52 79.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 74.21 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 m -139.33 13.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.41 0.522 . . . . 55.24 112.41 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-O 118.125 -1.375 . . . . 71.24 112.932 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' OD2' ' NH2' ' A' ' 145' ' ' ARG . 6.4 m-20 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 110.526 -0.176 . . . . 72.41 110.526 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.18 -71.12 0.77 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.598 0.592 . . . . 64.25 112.598 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.573 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 6.9 pt -99.39 65.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 74.0 112.266 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 8.8 p -141.61 143.53 29.8 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.07 -0.514 . . . . 73.23 110.659 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 8.0 Cg_exo -73.57 17.81 2.65 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 124.905 -0.873 . . . . 75.53 112.626 0.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.573 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 2.3 m-20 -45.8 -59.23 2.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.851 . . . . 73.25 111.941 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 m -161.79 -40.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 55.04 111.54 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' ALA . 47.0 tp -151.24 135.26 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.36 0.6 . . . . 73.31 111.951 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -75.48 37.46 0.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 73.34 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 179.03 -148.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.608 -0.724 . . . . 71.2 109.856 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.33 119.2 3.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.55 0.215 . . . . 74.12 110.85 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -97.13 135.91 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.077 2.518 . . . . 75.1 112.77 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -24.89 67.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 74.45 110.334 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.54 -129.64 1.75 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.414 -0.812 . . . . 71.11 111.487 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t -164.32 159.58 20.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.513 . . . . 75.43 109.614 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -105.24 135.0 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.218 -0.446 . . . . 73.04 110.963 -179.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -77.69 102.3 7.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.386 -0.598 . . . . 74.45 109.386 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 97.6 t -107.97 110.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.402 0.62 . . . . 74.25 109.735 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -101.5 124.49 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 71.21 110.264 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 1.3 m-85 -73.98 -40.01 63.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.333 -0.849 . . . . 74.33 112.112 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.38 -55.14 0.15 Allowed Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.179 -1.01 . . . . 75.53 112.754 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -179.69 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 72.53 108.328 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -93.08 -45.13 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.725 -1.125 . . . . 73.33 109.214 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.538 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.3 pt? -69.22 138.5 54.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.768 -0.651 . . . . 72.2 109.375 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.462 ' CD ' ' NZ ' ' A' ' 28' ' ' LYS . 53.4 tt0 -143.74 139.05 29.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.072 -0.967 . . . . 74.33 111.001 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.598 HG12 ' CE1' ' A' ' 21' ' ' TYR . 16.0 m -86.57 106.81 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.22 0.533 . . . . 72.4 110.645 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' CD ' ' A' ' 26' ' ' GLU . 27.1 mttp -98.44 119.84 37.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.064 0.935 . . . . 75.31 112.949 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.8 mp0 30.28 67.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.566 -1.652 . . . . 72.51 115.049 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.42 8.81 76.56 Favored Glycine 0 C--N 1.329 0.184 0 N-CA-C 115.528 0.971 . . . . 74.51 115.528 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.76 149.92 21.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.864 0.832 . . . . 74.11 110.742 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -91.25 133.4 35.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 73.13 109.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.429 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 10.3 mp -106.0 126.34 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 72.41 110.648 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 17.0 p -143.79 160.88 48.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.467 -0.788 . . . . 63.51 109.937 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.1 Cg_exo -75.98 -40.03 1.28 Allowed 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.522 -1.032 . . . . 75.42 112.908 0.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.7 p -151.98 28.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 70.4 111.591 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.429 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 1.8 pt20 -60.0 -10.4 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.521 0.677 . . . . 65.24 109.999 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 36' ' ' THR . 34.5 m -82.97 25.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.962 -1.017 . . . . 75.14 110.858 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.562 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -75.99 -21.19 57.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.285 -0.871 . . . . 74.21 111.085 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.562 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -107.76 152.52 24.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.155 0.503 . . . . 72.33 111.481 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.8 pm0 -63.98 146.39 97.3 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.449 -0.796 . . . . 64.21 111.793 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.603 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 94.7 Cg_endo -79.13 129.24 8.7 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.695 2.264 . . . . 71.31 112.805 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.3 mm -104.19 117.65 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.509 -0.182 . . . . 73.44 110.509 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.9 t -86.55 142.5 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 73.43 111.788 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -156.38 145.02 20.06 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.125 0.488 . . . . 72.45 110.668 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.678 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 3.3 p90 -126.32 35.34 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.187 0.518 . . . . 74.44 110.904 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -47.7 125.57 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 72.21 110.529 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -28.56 8.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 75.14 112.931 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -79.23 -42.18 26.55 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 109.228 -0.656 . . . . 75.22 109.228 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.678 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 31.6 tt0 -59.32 167.25 1.91 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.571 -0.74 . . . . 75.2 110.171 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . -177.48 -71.33 0.06 OUTLIER Glycine 0 C--O 1.229 -0.202 0 C-N-CA 120.708 -0.758 . . . . 64.11 112.14 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -148.86 109.74 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.124 0.488 . . . . 75.31 110.721 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 37.6 m -157.09 141.95 16.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 55.14 109.57 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.424 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t30 -67.01 -38.08 85.33 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.643 0.735 . . . . 74.25 109.482 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 64.6 mt -155.47 175.99 13.17 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.494 -1.23 . . . . 74.24 110.519 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 22.1 mt -146.71 158.91 44.01 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.222 -0.445 . . . . 72.44 109.944 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 3.2 m -123.21 127.79 49.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.226 -0.443 . . . . 74.51 111.119 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.84 117.58 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.454 -1.314 . . . . 75.34 107.454 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.77 139.96 47.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.464 0.542 . . . . 62.12 112.464 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 78' ' ' HIS . 46.5 ttm -94.74 134.37 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.639 -0.875 . . . . 74.44 108.639 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.39 136.0 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.308 -0.406 . . . . 72.32 111.022 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 5.2 t70 164.53 94.43 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 115.414 -0.812 . . . . 73.42 110.281 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.56 84.02 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.583 1.522 . . . . 73.43 110.833 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 84.49 1.64 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.766 0.654 . . . . 75.1 112.766 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.637 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.3 133.71 1.07 Allowed Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.45 -0.5 . . . . 71.25 112.28 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.637 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 Cg_exo -57.63 -23.34 1.82 Allowed 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 122.997 -1.668 . . . . 74.11 108.893 -3.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.451 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 12.2 t -161.93 143.57 11.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 113.889 -1.505 . . . . 74.44 108.706 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 53.1 ttp180 -53.69 -17.59 2.38 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.226 0.536 . . . . 73.53 111.185 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 69' ' ' GLN . 1.8 mp0 -72.49 -32.44 66.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.397 -0.82 . . . . 72.24 111.445 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.2 t0 -143.83 63.33 11.8 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 108.82 -0.807 . . . . 70.32 108.82 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.502 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 53.8 Cg_endo -72.3 51.74 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.23 2.62 . . . . 74.44 112.857 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -51.35 -44.11 61.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.391 -0.368 . . . . 74.1 111.945 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.486 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 15.6 p90 -108.22 34.76 3.44 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.523 -0.471 . . . . 71.43 111.629 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.502 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 35.8 ttp85 -76.44 144.49 39.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.814 -0.439 . . . . 72.4 109.814 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 29.8 mp0 -92.28 142.69 27.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.759 0.823 . . . . 63.54 110.602 0.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.6 tp -72.47 174.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.771 -0.372 . . . . 72.35 110.241 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.558 ' H ' HG13 ' A' ' 76' ' ' ILE . 3.2 mm? -52.15 133.46 33.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.428 0.633 . . . . 64.34 111.33 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 60' ' ' MET . 2.0 p-80 -129.64 157.05 43.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.861 -1.063 . . . . 73.42 109.458 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -99.35 117.67 34.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 62.34 109.923 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.3 m -141.38 138.02 32.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.443 0.639 . . . . 75.15 111.7 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.52 123.21 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 114.666 -1.152 . . . . 64.15 108.666 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' HG3' ' A' ' 127' ' ' GLU . 18.7 m -123.71 -177.4 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.066 -0.515 . . . . 74.32 110.367 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 125' ' ' ILE . 7.1 m120 62.82 30.2 16.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 74.54 109.951 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 1.2 mm -77.86 108.99 8.45 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.184 -0.606 . . . . 65.42 109.673 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 87' ' ' SER . 19.2 Cg_endo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.43 1.42 . . . . 74.04 110.69 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.05 71.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.433 -0.413 . . . . 64.4 113.655 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' PRO . 32.3 m -175.16 43.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.297 0.639 . . . . 71.33 110.179 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 90' ' ' ASN . 57.2 m-80 -135.78 -26.59 1.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.412 0.893 . . . . 75.13 113.412 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 9.0 tt0 77.57 -16.42 0.65 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.314 0.578 . . . . 74.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 88' ' ' ASN . 19.9 p30 -150.96 154.43 34.3 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.142 -0.935 . . . . 70.13 110.386 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 84' ' ' ILE . 96.2 Cg_endo -77.02 45.67 1.75 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.374 2.716 . . . . 74.54 112.994 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -103.97 -1.96 26.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 73.31 111.829 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.2 -14.89 13.58 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.751 -0.738 . . . . 71.34 114.338 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -87.97 177.24 46.19 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.572 -0.823 . . . . 71.24 113.637 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -68.23 114.29 6.58 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.812 0.301 . . . . 74.12 111.812 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.7 m -70.84 96.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.947 -0.76 . . . . 71.42 108.947 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 127' ' ' GLU . 24.6 mt -60.51 -59.52 5.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 75.41 110.503 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.61 125.17 35.52 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.25 -0.886 . . . . 64.33 109.223 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -59.96 156.15 15.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.596 0.712 . . . . 75.43 112.614 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 3.3 t80 -68.59 141.99 55.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.822 -1.081 . . . . 74.24 112.138 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.404 ' N ' ' CD1' ' A' ' 100' ' ' TYR . 7.4 p -142.87 113.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 72.44 109.866 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.39 -64.62 1.31 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.891 -0.671 . . . . 74.51 112.981 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.3 p 178.85 98.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 73.04 110.487 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.614 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -72.83 -35.62 58.33 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.066 -0.587 . . . . 73.51 113.573 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 38.6 Cg_exo -62.27 143.14 93.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.149 2.566 . . . . 65.33 113.294 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.48 144.85 99.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.223 2.616 . . . . 74.54 113.165 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -48.92 -22.36 0.83 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.455 -0.793 . . . . 74.34 111.642 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.3 m-20 -50.82 -29.93 12.98 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.57 0.581 . . . . 74.33 112.57 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 112' ' ' HIS . 12.9 t -70.62 -15.22 62.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.326 0.584 . . . . 71.25 110.418 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.68 -138.01 24.26 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.337 -0.847 . . . . 64.34 113.105 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 164' ' ' ALA . 31.7 tp -65.27 118.95 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.413 -0.394 . . . . 74.42 111.991 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 109' ' ' THR . 94.3 m-70 -79.93 148.07 31.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.334 -0.617 . . . . 63.42 109.334 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -114.04 58.98 0.68 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 75.33 110.805 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 54.4 m-85 -69.14 132.72 47.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.49 0.662 . . . . 75.14 112.357 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.25 134.31 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.102 . . . . 74.34 110.672 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 14.0 m-30 -104.21 137.79 41.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.061 -0.348 . . . . 73.3 110.061 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 118' ' ' LEU . 2.0 tm? -119.69 131.97 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.43 110.699 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.498 HD13 ' CE3' ' A' ' 46' ' ' TRP . 3.0 tt -131.81 122.69 26.18 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.751 0.31 . . . . 73.33 111.633 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.502 ' HA ' HG12 ' A' ' 157' ' ' ILE . 30.6 t80 -144.92 141.85 29.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.363 -0.38 . . . . 64.03 111.678 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HB3' ' NH1' ' A' ' 120' ' ' ARG . 16.6 mtm105 -63.2 144.8 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.566 0.222 . . . . 74.41 111.295 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 30.4 tp60 -117.62 124.83 49.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.822 -0.807 . . . . 74.22 108.822 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -86.38 -38.97 16.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 75.22 112.753 -178.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -110.18 150.07 29.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.278 0.844 . . . . 74.4 113.278 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 1.7 tppp? -72.64 133.59 44.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.941 -1.027 . . . . 74.13 110.496 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.575 ' N ' ' HD3' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -135.67 144.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 73.32 111.43 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -44.03 23.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.135 0.493 . . . . 74.42 110.848 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.687 ' CD ' ' HE2' ' A' ' 151' ' ' HIS . 47.8 mm-40 54.71 40.43 31.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.318 0.859 . . . . 73.3 113.318 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p 53.37 154.17 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 N-CA-C 113.673 0.99 . . . . 73.14 113.673 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.48 158.22 8.11 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.094 2.529 . . . . 64.31 113.009 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -58.86 122.45 13.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 72.44 111.164 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.45 121.11 44.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.42 0.629 . . . . 73.3 111.751 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.7 m -73.68 135.88 43.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.896 -1.047 . . . . 74.52 111.156 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' THR . 19.2 p-10 -58.71 -43.48 90.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.989 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.411 ' HA ' HG12 ' A' ' 177' ' ' ILE . 41.0 p -70.09 22.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.202 -0.454 . . . . 74.15 112.189 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.9 t -74.1 133.56 42.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 74.1 111.285 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.539 ' HG2' ' H ' ' A' ' 179' ' ' GLY . 14.8 mmm-85 -58.05 173.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.877 0.846 . . . . 75.41 112.873 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -41.04 157.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.148 -1.387 . . . . 74.53 113.036 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.71 -36.83 1.21 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.048 -0.978 . . . . 73.53 112.948 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -86.24 26.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.018 0.409 . . . . 75.1 111.324 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.29 -54.82 2.56 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.06 -0.718 . . . . 75.1 109.06 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 3.2 m120 -53.75 121.98 8.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.425 -0.807 . . . . 73.45 110.924 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.455 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 9.8 t80 -173.53 123.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 74.43 110.488 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 17.1 p-10 -84.67 117.14 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 65.14 111.913 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.02 74.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 73.53 110.408 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' NH2' ' OD2' ' A' ' 2' ' ' ASP . 87.8 mtt180 -43.91 -36.89 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.623 -0.717 . . . . 74.44 111.406 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 24.5 t70 -49.41 -53.92 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.39 0.614 . . . . 73.23 110.498 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.509 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 5.3 m-30 -63.63 -34.53 78.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.495 -0.775 . . . . 73.0 110.482 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.481 ' HA ' ' CG ' ' A' ' 153' ' ' LEU . . . -59.81 -44.18 94.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.38 -0.6 . . . . 73.41 109.38 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.26 -57.32 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 71.14 111.908 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' A' ' 151' ' ' HIS . 3.0 ptmm? -60.87 -53.14 60.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.717 0.265 . . . . 73.42 111.717 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.687 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 46.2 m170 -69.42 -12.15 61.42 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.478 -0.489 . . . . 74.31 111.178 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.11 25.21 71.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 71.24 112.34 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 10.6 mt -64.16 16.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.835 0.454 . . . . 74.23 111.759 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -51.77 -21.31 7.0 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.035 -0.602 . . . . 72.24 113.224 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.05 95.93 14.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.227 0.537 . . . . 74.53 110.579 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.29 141.57 18.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.065 2.51 . . . . 74.43 114.106 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 119' ' ' TYR . 35.8 pt -82.79 -36.33 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 72.54 110.659 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -141.19 145.14 35.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.44 111.543 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.17 39.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.445 -0.798 . . . . 74.23 109.33 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 2.4 t-20 -171.12 127.28 0.69 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.264 -1.013 . . . . 72.33 108.264 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.8 156.86 25.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.912 -0.585 . . . . 74.25 111.047 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 3.3 p90 -139.41 136.94 35.21 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.725 -0.671 . . . . 74.41 110.175 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 39.8 mt-30 -122.1 124.45 43.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.819 -0.628 . . . . 75.51 109.699 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.416 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -155.99 151.14 26.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 72.2 110.713 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.559 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -111.33 133.76 53.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.409 -0.36 . . . . 73.44 110.146 178.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -115.57 131.39 56.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.305 -0.628 . . . . 74.4 109.305 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 169' ' ' TYR . 72.9 m-20 -66.53 -178.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 74.42 112.413 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.47 28.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.542 -0.754 . . . . 64.2 111.959 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.543 ' H ' ' C ' ' A' ' 167' ' ' ASP . 28.3 t80 -97.05 -45.71 6.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 73.34 110.526 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.595 ' CG2' ' HD3' ' A' ' 171' ' ' PRO . 16.0 m -60.38 -35.17 24.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 112.836 0.68 . . . . 72.5 112.836 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.595 ' HD3' ' CG2' ' A' ' 170' ' ' VAL . 73.1 Cg_exo -51.49 -35.61 56.14 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.187 1.258 . . . . 73.21 111.034 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.52 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 66.8 mt -48.31 -42.45 11.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 74.11 110.227 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.513 ' HA ' ' HE ' ' A' ' 173' ' ' ARG . 1.9 tpm_? -57.22 -37.91 72.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.252 -0.886 . . . . 74.32 111.235 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 177' ' ' ILE . 8.4 p30 -65.73 -35.19 80.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.434 -0.506 . . . . 62.43 110.789 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -57.6 -27.42 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.282 -0.567 . . . . 75.4 109.597 179.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 m -73.68 -0.12 14.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.623 -0.717 . . . . 72.31 111.587 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.519 ' O ' ' CG1' ' A' ' 178' ' ' VAL . 66.4 mt -64.64 129.74 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.803 -0.181 . . . . 64.52 110.584 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 177' ' ' ILE . 2.4 m -176.4 69.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 122.894 0.478 . . . . 74.11 111.297 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 118.768 -1.018 . . . . 70.34 112.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 72.9 m-20 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.956 0.408 . . . . 64.24 111.445 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -75.57 -62.64 1.51 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.205 -0.452 . . . . 64.43 111.501 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 9' ' ' LEU . 18.5 pt -104.22 51.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.357 0.599 . . . . 75.33 111.014 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 2' ' ' ASP . 11.1 p -135.56 139.94 32.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.639 -0.709 . . . . 75.41 109.862 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 86.5 Cg_endo -82.15 37.7 1.33 Allowed 'Cis proline' 0 C--N 1.346 0.447 0 C-N-CA 123.744 -1.357 . . . . 75.22 112.762 0.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' H ' ' CA ' ' A' ' 5' ' ' VAL . 67.8 t0 -64.73 -50.88 65.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.34 . . . . 73.25 110.471 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HB ' ' HH ' ' A' ' 161' ' ' TYR . 7.8 m -163.74 -36.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.642 0.608 . . . . 65.13 112.642 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 4' ' ' ILE . 29.7 tp -157.31 164.23 37.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.093 0.473 . . . . 73.24 112.182 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -67.85 -38.0 82.58 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.869 0.366 . . . . 75.25 110.621 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -146.32 128.92 16.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 61.1 110.594 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -60.53 123.78 75.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.339 0.496 . . . . 74.51 112.339 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 156' ' ' PRO . 46.0 Cg_endo -87.58 -121.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.37 2.714 . . . . 75.11 112.295 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -163.42 -45.96 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.075 -0.511 . . . . 63.44 110.186 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.93 -135.07 8.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.874 -0.679 . . . . 65.22 112.474 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -164.12 177.42 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 73.34 110.834 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.405 ' CG2' HG23 ' A' ' 44' ' ' VAL . 53.0 mt -124.3 128.56 73.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.981 -0.554 . . . . 65.12 110.895 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.8 mmpt? -86.87 108.77 18.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.433 -0.803 . . . . 74.32 109.372 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 74.7 t -124.68 110.9 26.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.122 0.487 . . . . 74.44 110.434 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.25 137.94 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 75.31 110.937 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -86.53 0.32 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 75.55 111.77 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' ' CG ' ' A' ' 40' ' ' ASP . . . -69.54 -45.91 57.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.854 -0.688 . . . . 74.42 113.809 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 174.41 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.162 -0.681 . . . . 64.42 109.162 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -91.86 -42.97 9.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.179 -0.919 . . . . 73.35 109.33 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.527 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 pt? -69.5 137.22 52.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.179 -0.919 . . . . 74.11 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 23.7 pt-20 -140.85 159.65 41.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.693 -1.139 . . . . 73.43 109.772 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.52 HG23 ' ND2' ' A' ' 160' ' ' ASN . 10.8 m -80.34 119.11 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.32 0.581 . . . . 75.21 111.307 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 41.1 mttp -120.87 113.22 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.723 -0.671 . . . . 65.14 111.822 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.8 mp0 46.43 67.08 0.82 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.54 1.311 . . . . 74.34 114.54 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.51 16.22 14.93 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.301 0.481 . . . . 62.32 114.301 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -51.77 145.47 9.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.131 0.491 . . . . 75.43 110.875 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -91.76 116.39 28.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.223 -0.899 . . . . 73.34 110.533 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mp -92.84 118.0 30.64 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.513 -0.475 . . . . 74.42 110.141 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 p -150.51 154.95 36.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.758 -0.656 . . . . 72.14 111.006 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 36' ' ' THR . 93.2 Cg_endo -89.19 -93.78 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 C-N-CA 124.039 -1.234 . . . . 75.51 111.267 -0.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.439 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 p -75.05 47.97 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.787 0.803 . . . . 75.3 109.631 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 35' ' ' PRO . 42.4 tt0 -107.66 -2.78 19.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 71.42 110.734 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 m -101.14 27.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 65.44 112.038 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HZ1' ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.18 -40.6 62.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.095 0.474 . . . . 74.15 110.642 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.421 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 29.2 m-20 -71.79 138.91 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.612 -0.722 . . . . 62.24 112.146 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.8 pm0 -66.98 152.57 95.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.245 -0.889 . . . . 73.12 111.503 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.1 Cg_endo -81.97 126.94 5.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.786 2.324 . . . . 74.32 112.829 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 43.5 mm -107.07 106.08 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.215 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 HG11 ' CD ' ' A' ' 91' ' ' PRO . 10.4 p -79.02 143.23 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.732 0.641 . . . . 75.01 112.732 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' LYS . 36.9 m -165.46 152.32 10.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.018 0.437 . . . . 71.2 111.784 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 3.4 p90 -124.7 34.2 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.689 0.757 . . . . 74.41 109.556 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -44.42 121.9 2.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 75.53 111.197 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.44 -28.15 7.86 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.952 -0.642 . . . . 61.12 113.699 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 7.1 mp -75.68 -36.3 60.11 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.564 0.682 . . . . 74.22 110.096 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -51.55 158.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.409 -0.814 . . . . 71.43 109.994 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.38 -64.56 0.05 OUTLIER Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.423 -0.894 . . . . 71.15 112.135 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -148.16 109.35 4.32 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 74.24 108.845 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.503 ' HB3' ' HD2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -157.72 141.84 16.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.276 -0.875 . . . . 75.22 111.215 -178.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -77.13 -45.04 28.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.325 -0.991 . . . . 74.54 108.325 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 121' ' ' GLN . 80.0 mt -154.64 163.45 40.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.871 -1.513 . . . . 75.03 109.076 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' CD1' ' CZ2' ' A' ' 46' ' ' TRP . 32.7 mt -129.66 153.62 47.94 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.804 -0.443 . . . . 72.34 109.804 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.418 HG22 ' CG1' ' A' ' 82' ' ' VAL . 4.8 m -117.77 114.73 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 64.53 110.394 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -108.1 119.37 39.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.67 -0.863 . . . . 75.11 108.67 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.8 mt -150.24 151.86 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.949 -0.7 . . . . 73.41 112.442 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.541 ' HG2' ' HB2' ' A' ' 78' ' ' HIS . 3.9 ppp? -94.99 154.91 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.268 -0.878 . . . . 73.2 109.177 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 62' ' ' ASP . 46.1 t -132.56 163.22 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.048 0.452 . . . . 73.22 111.725 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' CG1' ' A' ' 61' ' ' VAL . 21.9 t70 64.18 54.91 1.53 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 74.5 110.187 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 35.1 Cg_exo -36.0 140.07 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.02 2.48 . . . . 73.31 112.22 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.05 85.53 2.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.623 0.601 . . . . 74.32 112.623 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.13 136.28 1.27 Allowed Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 112.301 0.482 . . . . 62.21 112.301 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 17.0 Cg_exo -68.36 -28.12 5.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.633 -1.403 . . . . 73.52 111.626 -1.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 t -150.03 150.11 31.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.14 -0.936 . . . . 75.41 111.123 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.9 -23.36 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.293 -0.867 . . . . 73.51 109.823 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.92 -39.82 29.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.619 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.587 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 8.4 t0 -144.37 81.08 11.55 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-O 120.613 0.244 . . . . 75.13 110.614 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.75 55.82 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.116 2.544 . . . . 73.02 111.935 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -48.9 -47.44 43.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.151 0.426 . . . . 75.42 112.151 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 1.7 p90 -114.34 33.42 5.3 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.489 -0.484 . . . . 74.3 111.081 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 63' ' ' PRO . 9.9 ttm180 -54.9 132.26 46.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.032 -1.099 . . . . 74.44 108.032 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 10.4 tp10 -103.26 166.67 10.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.871 1.668 . . . . 64.24 109.906 -0.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 77' ' ' LEU . 7.6 tp -94.51 -45.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.747 -0.835 . . . . 74.11 108.747 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' N ' HG23 ' A' ' 76' ' ' ILE . 3.2 pp -174.96 146.75 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.883 -1.053 . . . . 74.25 108.777 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 19.4 p-80 -158.73 176.6 12.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.579 -0.282 . . . . 75.33 110.386 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 12.2 t90 -102.91 125.28 49.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.034 0.445 . . . . 75.3 111.238 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 27.2 p -141.55 133.56 27.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 71.31 111.035 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 58' ' ' LEU . 16.1 t -147.8 132.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.225 -0.443 . . . . 72.01 110.275 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' A' ' 57' ' ' THR . 19.8 m -137.16 171.14 16.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.78 0.324 . . . . 75.21 110.973 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.67 ' ND2' HE22 ' A' ' 121' ' ' GLN . 1.3 m120 73.88 25.82 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.718 -0.674 . . . . 53.31 110.527 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.584 ' CG2' ' HA ' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -72.35 115.16 36.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.382 -0.927 . . . . 74.1 110.215 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 129.21 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.795 1.663 . . . . 74.54 110.659 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.92 62.79 0.05 OUTLIER Glycine 0 CA--C 1.525 0.683 0 O-C-N 123.52 0.512 . . . . 63.33 113.441 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -173.95 37.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.675 0.79 . . . . 72.42 108.942 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.24 -10.33 2.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.864 -0.607 . . . . 72.41 112.489 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 71.88 -32.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.87 0.367 . . . . 54.33 111.264 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -153.69 166.14 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.45 110.546 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.584 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 69.8 Cg_endo -67.93 43.96 0.27 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.62 2.88 . . . . 71.42 113.508 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 t -74.04 -38.28 64.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 74.41 110.014 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.63 5.34 35.03 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.874 -0.603 . . . . 61.22 112.648 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.51 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -80.76 160.89 43.65 Favored Glycine 0 N--CA 1.454 -0.111 0 C-N-CA 120.746 -0.74 . . . . 74.25 112.394 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 106.75 4.03 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.249 0.524 . . . . 63.25 111.262 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.7 m -73.68 100.76 3.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 73.42 108.672 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 87.4 mt -58.39 -50.25 74.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.267 -0.424 . . . . 73.5 110.579 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.77 122.45 20.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.329 -0.396 . . . . 75.11 111.016 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -48.63 132.68 17.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CD1' ' O ' ' A' ' 100' ' ' TYR . 1.9 p90 -76.53 126.1 30.4 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.013 0.435 . . . . 75.21 110.522 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.401 ' HB ' ' HD3' ' A' ' 173' ' ' ARG . 1.2 m -148.05 159.81 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.857 -0.61 . . . . 60.42 111.061 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 173' ' ' ARG . . . -58.15 111.9 3.48 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.677 -0.692 . . . . 71.14 113.049 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 48.8 m -63.65 95.47 0.11 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.273 0.229 . . . . 75.32 110.815 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 170' ' ' VAL . . . -56.61 101.67 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.067 -0.515 . . . . 73.33 113.027 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HB3' ' NE2' ' A' ' 112' ' ' HIS . 87.8 Cg_endo -104.35 139.65 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.695 2.93 . . . . 64.25 112.912 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.35 134.24 62.72 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.181 1.254 . . . . 75.43 109.586 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -42.08 -35.83 1.0 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.301 0.572 . . . . 74.44 110.446 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -60.63 -42.53 97.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.928 -1.033 . . . . 75.3 112.803 -178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 3.6 t -72.56 -33.28 66.69 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.083 -0.386 . . . . 73.45 111.568 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.95 -88.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.531 0.972 . . . . 72.45 115.531 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.0 tp -66.88 122.4 17.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.824 1.046 . . . . 73.33 113.824 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.511 ' NE2' ' HB3' ' A' ' 105' ' ' PRO . 2.9 m-70 -97.46 137.03 37.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.513 -0.767 . . . . 72.34 110.185 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.448 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 5.9 mmt85 -104.8 118.02 35.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.288 -0.634 . . . . 64.22 109.288 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.87 133.57 54.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.177 0.513 . . . . 65.3 111.952 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.448 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 28.3 mm -125.74 121.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.058 -0.973 . . . . 64.41 108.868 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.33 131.94 51.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 74.42 110.771 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.81 130.93 51.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.435 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.5 tp -124.75 122.47 37.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.855 -0.611 . . . . 74.22 110.682 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 155' ' ' GLU . 37.0 t80 -134.62 138.24 44.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 75.24 109.777 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HD2' ' HB3' ' A' ' 53' ' ' SER . 37.3 ttp180 -68.95 124.53 23.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 73.42 111.72 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.67 HE22 ' ND2' ' A' ' 83' ' ' ASN . 39.7 tt0 -87.99 107.31 18.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.479 ' C ' HD21 ' A' ' 123' ' ' ASN . 2.0 tp10 -73.89 -37.12 64.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.007 -0.542 . . . . 74.35 111.192 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.479 HD21 ' C ' ' A' ' 122' ' ' GLU . 4.4 m120 -121.66 141.82 50.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.982 0.42 . . . . 74.52 111.513 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.509 ' HA ' HE21 ' A' ' 121' ' ' GLN . 3.8 tppp? -62.62 111.52 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.255 -0.276 . . . . 73.41 110.255 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.577 ' H ' ' NE2' ' A' ' 121' ' ' GLN . 6.1 pt -90.73 128.21 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.667 -0.494 . . . . 74.23 109.667 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.63 -46.85 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.929 0.714 . . . . 72.42 112.929 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.67 -117.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 75.24 109.675 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.9 p -162.77 160.19 19.54 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.378 -0.601 . . . . 74.31 109.378 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.59 154.88 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.189 1.926 . . . . 64.23 111.738 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.9 m -58.42 125.58 23.91 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.056 -0.35 . . . . 74.22 110.056 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.9 mm -90.69 126.24 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 74.54 112.178 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.4 m -82.94 134.86 35.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.063 -0.971 . . . . 64.02 109.727 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 135' ' ' THR . 15.0 p-10 -51.0 -40.94 59.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 75.43 111.273 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.9 t -65.47 4.04 0.6 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.184 -0.462 . . . . 60.32 111.895 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 133' ' ' ASN . 11.3 t -64.12 135.45 56.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.159 0.504 . . . . 72.31 110.255 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.52 ' HB2' ' HA2' ' A' ' 179' ' ' GLY . 8.9 ttt85 -84.98 173.24 10.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.813 -0.63 . . . . 75.21 110.765 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.402 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 1.9 m -35.72 151.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.259 -0.882 . . . . 62.34 112.187 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.19 2.7 19.91 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.984 -0.627 . . . . 73.41 113.573 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -169.75 44.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.237 0.518 . . . . 74.32 110.377 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD12 ' ND2' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -114.27 -59.66 1.99 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.984 -0.553 . . . . 72.51 111.984 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.549 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 2.4 m120 -65.07 42.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.657 0.984 . . . . 75.43 113.657 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 2.0 t80 -99.31 111.34 23.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 74.34 109.812 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.583 HD22 ' HB3' ' A' ' 145' ' ' ARG . 30.1 t30 -66.35 129.88 41.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.666 -0.697 . . . . 65.44 111.404 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.564 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . . . -72.24 -35.12 68.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.64 0.607 . . . . 75.52 112.64 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.583 ' HB3' HD22 ' A' ' 143' ' ' ASN . 30.1 ttm180 -47.04 -39.27 12.52 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.39 -0.524 . . . . 73.43 110.85 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.69 -37.71 63.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.185 -0.461 . . . . 72.21 110.894 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 m-85 -49.65 -40.54 40.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.365 0.602 . . . . 72.21 109.407 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.16 86.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 54.55 110.818 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.9 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 63.4 111.606 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.1 -43.27 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.371 0.508 . . . . 75.53 112.371 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.425 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 66.0 m-70 -91.4 1.48 57.09 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 70.42 110.912 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.4 32.65 73.23 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 121.108 -0.568 . . . . 64.04 113.662 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.32 16.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 73.4 110.733 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -64.33 -4.08 11.32 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.059 -0.519 . . . . 63.23 113.153 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 20.3 pt-20 -134.34 72.55 70.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.716 0.769 . . . . 71.55 109.018 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.435 ' HG2' ' HB3' ' A' ' 13' ' ' PRO . 42.1 Cg_endo -68.18 131.14 22.85 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.154 2.569 . . . . 75.31 113.874 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.0 pt -75.51 -34.46 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 75.51 109.276 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -146.06 146.25 30.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.543 -0.753 . . . . 75.31 110.141 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -158.69 159.38 35.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 73.33 110.521 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 27' ' ' VAL . 59.1 t30 -170.48 175.37 4.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.207 -1.035 . . . . 72.23 108.207 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.497 ' HH ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -155.42 167.05 31.65 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.181 -0.608 . . . . 74.02 111.589 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -162.03 150.62 15.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.702 -0.681 . . . . 72.11 110.258 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 113' ' ' ARG . 57.9 mt-30 -124.64 138.16 54.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 75.2 110.378 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -155.11 138.89 16.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.834 -0.621 . . . . 74.34 110.373 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.635 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.43 138.08 37.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.086 -0.338 . . . . 63.13 110.086 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -127.63 126.58 42.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 74.4 110.135 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.3 m-20 -62.73 -174.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.324 0.583 . . . . 52.31 110.448 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 13.9 t70 -72.82 32.68 0.07 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.59 -0.732 . . . . 63.13 109.752 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.6 ' H ' ' C ' ' A' ' 167' ' ' ASP . 20.2 t80 -91.14 -53.69 4.26 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.339 -0.846 . . . . 75.22 111.752 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 28.3 m -59.81 -31.01 8.34 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 112.917 0.71 . . . . 65.13 112.917 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 83.7 Cg_exo -48.83 -21.41 3.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.51 1.473 . . . . 72.35 111.427 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.8 tt -51.7 -38.93 22.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.886 -0.597 . . . . 70.32 109.868 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.416 ' CD ' ' H ' ' A' ' 102' ' ' GLY . 85.2 mtt-85 -58.18 -34.97 70.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 74.4 109.881 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 171' ' ' PRO . 35.1 m-20 -62.19 -41.31 98.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.15 -0.685 . . . . 74.34 109.15 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -59.09 -17.24 24.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 74.33 109.831 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 m -88.21 6.12 38.27 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.981 -0.554 . . . . 62.54 111.778 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.07 124.36 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.919 -0.128 . . . . 73.34 111.11 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.51 -21.3 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.365 1.246 . . . . 74.32 114.365 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.245 0.795 0 CA-C-O 118.126 -1.375 . . . . 64.2 112.679 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.071 -0.344 . . . . 74.03 110.071 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.19 -71.2 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.426 0.528 . . . . 72.42 112.426 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 13.3 pt -125.37 59.95 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.616 0.722 . . . . 74.24 110.804 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 12.3 p -128.75 140.89 39.82 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.141 -0.936 . . . . 75.05 110.642 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.505 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 92.8 Cg_endo -85.29 33.13 4.77 Favored 'Cis proline' 0 C--N 1.35 0.606 0 C-N-CA 123.849 -1.313 . . . . 72.45 112.632 0.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.14 -54.54 45.6 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.219 -0.659 . . . . 71.41 109.219 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 161' ' ' TYR . 4.9 m -160.5 -39.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.419 -0.81 . . . . 75.41 111.676 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 22.8 tp -157.41 143.03 17.37 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.094 0.473 . . . . 71.53 111.458 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -78.84 25.73 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.821 -0.55 . . . . 63.24 110.333 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . -175.36 156.02 1.95 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.079 -0.51 . . . . 75.51 110.037 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.59 113.52 58.02 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.721 0.267 . . . . 61.24 111.721 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 87.9 Cg_endo -85.0 134.03 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.646 2.231 . . . . 73.55 112.482 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.62 88.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.09 -0.504 . . . . 75.24 110.562 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -135.09 3.32 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.683 -0.689 . . . . 63.51 111.483 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 t -161.29 176.94 10.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.45 -0.574 . . . . 75.32 109.45 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.6 mt -116.65 135.79 55.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.551 -0.295 . . . . 72.51 111.016 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 45' ' ' SER . 31.0 mmmt -73.92 102.31 4.06 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.438 -1.319 . . . . 74.23 107.438 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 95.7 t -117.28 110.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 73.52 109.654 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mt -99.61 126.7 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.472 -0.785 . . . . 75.23 110.185 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.451 ' OH ' ' CE1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -72.48 -77.48 0.1 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.134 -0.939 . . . . 74.42 110.61 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.86 -61.49 1.76 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.773 -0.727 . . . . 70.13 112.627 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.12 -53.75 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.374 0.607 . . . . 74.43 109.667 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -100.41 -37.34 8.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.268 -0.878 . . . . 75.45 111.24 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -69.27 124.6 24.27 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.998 0.904 . . . . 74.02 110.687 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -113.15 139.87 48.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.989 -1.46 . . . . 75.21 110.71 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 33.1 m -73.51 108.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.519 0.676 . . . . 70.4 110.343 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -86.01 82.41 8.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.96 0.726 . . . . 73.35 112.96 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 13.8 mp0 29.84 67.33 0.11 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.424 1.268 . . . . 72.44 114.424 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.87 -21.44 29.74 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.933 -0.651 . . . . 74.52 112.913 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.82 145.63 2.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.394 0.616 . . . . 73.24 112.348 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' CG ' ' A' ' 163' ' ' GLN . 88.9 tt0 -110.72 136.05 50.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.856 -1.065 . . . . 75.33 110.291 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -98.1 142.5 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.781 0.324 . . . . 64.53 111.156 178.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.2 p -150.17 146.33 19.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.883 -0.599 . . . . 75.23 109.791 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 36' ' ' THR . 58.3 Cg_endo -83.93 -115.24 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 124.08 -1.217 . . . . 71.12 112.636 0.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 35' ' ' PRO . 28.8 p -72.02 48.38 0.17 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.775 0.287 . . . . 53.4 111.775 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.405 HE21 ' HG ' ' A' ' 33' ' ' LEU . 19.2 pt20 -99.98 0.01 40.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.368 0.604 . . . . 72.35 109.82 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 33' ' ' LEU . 34.4 m -87.45 21.65 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.197 -0.911 . . . . 75.14 110.957 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -70.72 -34.13 71.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 73.5 111.711 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.41 135.18 35.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.745 0.307 . . . . 74.12 111.422 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -68.44 152.48 96.57 Favored Pre-proline 0 C--N 1.335 -0.023 0 N-CA-C 109.691 -0.485 . . . . 72.01 109.691 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.75 126.61 15.64 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.046 1.831 . . . . 73.3 113.673 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 47.0 mm -96.85 107.33 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.967 -0.753 . . . . 72.35 108.967 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' HA ' HG21 ' A' ' 19' ' ' VAL . 3.9 p -78.72 139.93 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.433 0.901 . . . . 73.22 113.433 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 57.7 m -164.9 134.07 3.55 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.161 -0.472 . . . . 73.54 110.359 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.715 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 2.4 p90 -114.24 35.95 3.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.484 0.659 . . . . 74.02 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -36.4 98.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.013 -0.994 . . . . 72.11 113.117 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.32 -15.16 41.46 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 116.075 -0.511 . . . . 70.41 114.251 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.23 -20.4 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.511 0.656 . . . . 74.43 110.703 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.715 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -71.35 -61.59 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.65 0.738 . . . . 74.21 109.403 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -64.24 4.34 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 109.522 -1.431 . . . . 51.43 109.522 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 2.0 ttmp? -149.1 116.79 6.23 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.199 -0.5 . . . . 75.52 110.134 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 p -157.02 141.57 16.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.216 0.531 . . . . 72.51 112.345 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 22.1 t30 -83.45 -36.66 24.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 74.4 109.061 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 25.3 mt -158.11 169.8 23.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.333 -1.303 . . . . 64.15 108.737 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 69.4 mt -141.57 159.82 41.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.922 0.391 . . . . 65.13 111.656 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 119' ' ' TYR . 2.1 m -121.56 132.82 54.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.271 -0.877 . . . . 64.35 108.77 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 1.2 tm? -127.84 132.56 49.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 73.54 109.59 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 80' ' ' SER . 54.9 mt -145.97 129.79 17.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.877 -0.329 . . . . 74.22 111.018 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.06 135.49 45.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.106 -1.072 . . . . 64.53 108.106 178.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.518 ' N ' ' SD ' ' A' ' 60' ' ' MET . 10.2 t -147.43 143.53 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.941 0.877 . . . . 74.32 112.6 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 55.9 t0 -160.24 81.27 2.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 113.988 -1.46 . . . . 70.55 107.065 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 37.4 Cg_endo -66.97 84.2 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.625 1.55 . . . . 73.42 112.47 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' CG ' ' HG2' ' A' ' 68' ' ' ARG . 31.3 m-20 -169.36 84.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.547 -0.751 . . . . 64.33 110.003 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -153.48 137.33 10.52 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.726 -0.842 . . . . 74.42 108.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.687 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 4.7 Cg_exo -77.31 -16.39 25.36 Favored 'Cis proline' 0 CA--C 1.515 -0.447 0 C-N-CA 124.287 -1.131 . . . . 65.33 111.927 0.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 2.3 t -138.77 140.72 38.73 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.468 -0.787 . . . . 71.43 110.867 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG2' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -45.94 -26.92 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.864 -1.062 . . . . 73.44 111.296 -178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -93.96 -45.14 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.52 1.304 . . . . 73.11 114.52 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.64 83.01 5.27 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 113.174 0.805 . . . . 64.32 113.174 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 63.7 Cg_endo -71.57 51.76 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.236 2.624 . . . . 74.31 111.696 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' CD ' ' A' ' 66' ' ' PRO . 17.7 ptpt -48.66 -33.59 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.885 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 6.2 p90 -138.68 45.46 2.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.437 0.637 . . . . 75.14 111.743 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -73.74 138.51 44.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.457 -0.942 . . . . 75.52 108.457 177.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 29.3 mp0 -91.71 178.3 5.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.772 0.829 . . . . 72.24 111.385 0.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 77' ' ' LEU . 6.6 tp -106.67 169.81 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.536 -1.211 . . . . 75.02 109.409 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 77' ' ' LEU . 3.8 mp -45.87 125.04 5.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.578 0.228 . . . . 74.34 110.593 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -124.96 171.98 9.77 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.085 0.469 . . . . 75.01 111.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 6.7 t-105 -100.16 121.83 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.355 -0.839 . . . . 72.24 109.866 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -141.49 137.17 31.91 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.437 0.532 . . . . 72.14 112.437 -177.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.48 149.79 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.514 -0.312 . . . . 73.51 110.885 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 127' ' ' GLU . 22.2 m -142.05 155.66 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.988 0.366 . . . . 75.11 111.988 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 83' ' ' ASN . 1.0 OUTLIER 72.07 37.55 0.99 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.122 -0.49 . . . . 74.5 112.262 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 1.2 mm -83.71 116.0 62.44 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 119.436 -0.906 . . . . 73.14 109.624 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 35.5 Cg_endo -66.77 126.78 15.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 121.816 1.677 . . . . 74.42 111.676 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.35 71.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.903 -0.589 . . . . 61.32 114.103 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' PRO . 91.8 p -178.27 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.032 0.416 . . . . 70.55 110.999 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.503 ' ND2' ' HG2' ' A' ' 85' ' ' PRO . 65.5 m-20 -135.4 -2.47 2.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.256 -0.429 . . . . 75.43 111.327 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 13.1 pt-20 40.94 34.01 0.25 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.038 -0.528 . . . . 74.23 111.991 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 p30 175.48 152.62 0.31 Allowed Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 121.34 0.59 . . . . 72.4 110.761 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HA ' HG21 ' A' ' 84' ' ' ILE . 95.9 Cg_endo -74.68 61.17 5.34 Favored 'Trans proline' 0 CA--C 1.527 0.173 0 C-N-CA 123.339 2.693 . . . . 75.34 112.93 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 m -96.78 -55.3 2.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.348 0.87 . . . . 65.41 113.348 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.82 -40.97 89.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.032 0.773 . . . . 70.12 115.032 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -57.61 157.8 14.49 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.68 -0.771 . . . . 74.42 114.134 -178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.555 ' CE1' ' CG2' ' A' ' 130' ' ' THR . 80.3 t60 -61.63 125.6 24.37 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.079 0.551 . . . . 74.22 111.095 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.9 m -83.87 97.25 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.658 -0.868 . . . . 74.25 108.658 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 13.0 mt -54.16 -48.83 70.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.471 -0.937 . . . . 73.53 108.471 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 117.62 8.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.494 -1.23 . . . . 73.51 108.822 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.7 t0 -54.39 152.48 6.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.65 0.594 . . . . 70.21 111.556 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -70.48 129.26 38.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.31 -0.405 . . . . 71.31 110.342 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 77' ' ' LEU . 7.5 p -130.02 113.73 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.56 0.695 . . . . 73.45 110.873 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.46 72.97 2.74 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.427 -0.806 . . . . 70.2 113.455 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 29.8 p -171.03 11.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.891 1.071 . . . . 71.42 113.891 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 106' ' ' PRO . . . -55.38 -84.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.229 -0.986 . . . . 75.32 112.258 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.416 ' C ' HG23 ' A' ' 109' ' ' THR . 23.8 Cg_exo -64.54 105.85 0.66 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.144 1.896 . . . . 70.31 111.389 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 66' ' ' PRO . 18.3 Cg_endo -59.37 160.54 19.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.235 1.957 . . . . 73.31 112.428 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 167' ' ' ASP . 7.7 ttmm -39.69 -41.0 1.01 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.296 -0.866 . . . . 71.22 111.303 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.06 -39.21 55.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.308 -0.86 . . . . 54.31 112.223 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 14.0 t -70.73 -7.02 41.76 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.813 0.339 . . . . 73.34 111.572 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.18 -119.47 18.75 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.099 -0.572 . . . . 64.31 114.225 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 163' ' ' GLN . 29.3 tp -58.06 119.84 7.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.802 1.038 . . . . 74.1 113.802 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 32.4 m170 -88.11 91.92 8.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.596 -0.729 . . . . 73.22 111.081 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HD2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -76.82 63.86 2.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 75.43 110.125 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.7 m-85 -65.73 131.62 46.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.248 -0.433 . . . . 63.24 111.057 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 33.9 mt -127.25 122.17 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.765 -0.652 . . . . 72.34 111.657 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 3.9 m-30 -90.4 145.95 24.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.876 -0.602 . . . . 73.31 110.207 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.69 131.88 38.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.415 HD21 ' CD1' ' A' ' 157' ' ' ILE . 1.5 tt -126.27 131.47 51.88 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.954 -0.387 . . . . 74.41 109.954 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 153' ' ' LEU . 65.7 t80 -131.75 139.24 48.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.972 0.415 . . . . 63.41 110.476 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.621 HH12 ' HB3' ' A' ' 122' ' ' GLU . 0.6 OUTLIER -71.89 130.54 41.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 74.55 110.513 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -116.03 148.52 40.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.627 0.251 . . . . 73.13 111.231 -178.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.621 ' HB3' HH12 ' A' ' 120' ' ' ARG . 23.2 pt-20 -148.03 17.66 1.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.178 0.514 . . . . 75.41 110.941 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 5.8 m120 -143.91 129.13 18.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.053 -0.976 . . . . 75.45 108.415 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -76.64 111.58 12.29 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.78 -0.768 . . . . 64.35 111.202 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.44 ' CG1' HD22 ' A' ' 83' ' ' ASN . 9.2 pt -103.68 128.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.812 -1.085 . . . . 74.01 110.661 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -56.17 -57.67 11.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.411 0.624 . . . . 74.02 110.954 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.543 ' CD ' ' HE2' ' A' ' 151' ' ' HIS . 21.9 mm-40 63.09 31.87 15.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.985 -1.007 . . . . 75.25 112.763 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.4 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 44.5 p 57.72 151.6 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 112.631 0.604 . . . . 73.23 112.631 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -45.21 157.58 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.471 2.781 . . . . 75.42 113.561 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.555 ' CG2' ' CE1' ' A' ' 95' ' ' HIS . 8.2 p -62.5 131.1 48.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.524 -0.762 . . . . 74.22 112.524 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.4 HG13 ' CZ ' ' A' ' 139' ' ' ARG . 45.3 mm -104.56 118.49 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.929 -0.767 . . . . 72.3 108.929 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.3 t -69.46 153.1 44.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 73.3 111.77 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.467 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.5 p30 -54.42 -29.36 48.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.552 -0.749 . . . . 64.22 110.296 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 p -78.12 21.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.718 -0.674 . . . . 71.02 111.554 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 133' ' ' ASN . 8.5 t -62.71 126.47 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.311 0.577 . . . . 74.23 111.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -89.01 173.31 8.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.5 -0.773 . . . . 74.54 111.242 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.483 ' HA ' ' CD1' ' A' ' 140' ' ' LEU . 37.5 m -36.87 150.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.492 -0.777 . . . . 71.31 112.457 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.13 25.43 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.017 -0.611 . . . . 74.4 112.972 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 55.8 ttt180 -163.96 37.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.252 0.549 . . . . 73.41 111.03 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.591 HD11 ' N ' ' A' ' 140' ' ' LEU . 7.2 mp -82.52 -64.06 1.25 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.437 -1.32 . . . . 74.15 107.437 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -68.6 117.73 10.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.914 -1.143 . . . . 73.0 107.914 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.455 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 21.5 t80 -170.77 80.19 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.331 -0.395 . . . . 74.54 111.305 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -62.36 117.34 6.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.139 -0.482 . . . . 73.21 111.899 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.53 -25.25 36.49 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.266 0.555 . . . . 71.23 109.861 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -46.57 -32.47 3.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.373 -0.83 . . . . 75.34 109.111 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 1.5 t70 -61.26 -56.47 20.21 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.147 -0.686 . . . . 61.33 109.147 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.532 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 3.5 m-30 -56.4 -35.31 67.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.94 -0.573 . . . . 74.45 109.737 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -65.55 -41.5 92.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.45 -0.795 . . . . 71.02 109.592 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.89 -55.01 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.922 -0.581 . . . . 74.14 110.826 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.575 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 2.1 ptpp? -59.14 -45.15 91.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 74.25 111.763 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.543 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 89.6 m-70 -92.58 9.0 36.51 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.751 -0.38 . . . . 74.11 111.75 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 56.59 30.09 58.64 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.767 -0.73 . . . . 72.33 113.371 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HA ' ' CE1' ' A' ' 119' ' ' TYR . 13.3 mt -71.95 16.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.812 -0.228 . . . . 73.44 111.048 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.04 -63.75 1.92 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.323 -0.465 . . . . 62.23 114.002 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.17 112.29 15.05 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.726 0.263 . . . . 74.24 111.671 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 66.9 Cg_endo -79.97 123.35 5.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.094 1.863 . . . . 72.31 112.52 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.415 ' CD1' HD21 ' A' ' 118' ' ' LEU . 50.3 pt -74.87 -33.5 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.571 -0.452 . . . . 73.23 110.411 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.52 139.65 15.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.316 -0.402 . . . . 74.34 110.762 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -142.78 159.99 41.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 74.45 109.935 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 1.3 t-20 -161.38 123.38 2.97 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.563 -0.903 . . . . 72.11 108.563 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.468 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.81 169.54 11.44 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.984 -0.553 . . . . 74.22 111.698 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 2.1 p90 -164.1 160.95 22.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 72.1 109.996 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.452 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . 1.3 pt20 -132.65 129.0 38.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.516 -0.311 . . . . 71.4 110.848 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.44 140.4 17.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.317 -0.402 . . . . 73.23 111.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.86 133.03 43.74 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.547 -0.538 . . . . 74.23 109.547 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -105.83 113.72 27.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.239 0.542 . . . . 74.42 110.293 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.637 ' O ' ' NZ ' ' A' ' 107' ' ' LYS . 31.1 m-20 -49.81 -52.53 31.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.238 -0.892 . . . . 63.35 112.751 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -167.48 45.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.325 -0.55 . . . . 75.22 111.661 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 31.8 t80 -101.37 -40.58 7.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 73.52 111.553 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.63 ' CG1' ' HD3' ' A' ' 171' ' ' PRO . 0.1 OUTLIER -53.2 -47.46 95.86 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.924 1.083 . . . . 75.02 113.924 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.63 ' HD3' ' CG1' ' A' ' 170' ' ' VAL . 77.4 Cg_exo -53.01 -50.52 13.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.88 1.72 . . . . 60.2 113.521 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.537 ' CD1' ' H ' ' A' ' 172' ' ' ILE . 1.7 mp -45.83 -55.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 73.2 110.84 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 12.1 tpp180 -56.32 -44.66 80.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.39 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -51.87 -38.74 57.19 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.044 -0.525 . . . . 74.22 111.327 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 6.5 mmpt? -55.13 -29.68 58.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 73.41 110.964 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -67.64 -29.8 69.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 73.52 111.994 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.85 103.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.485 -0.325 . . . . 74.31 110.902 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.39 1.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.389 0.514 . . . . 74.2 112.389 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.641 -1.089 . . . . 51.14 112.224 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.555 0.205 . . . . 74.44 111.555 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -106.95 -71.02 0.77 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.674 0.62 . . . . 72.25 112.674 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 9' ' ' LEU . 14.7 pt -80.84 41.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.558 0.694 . . . . 73.22 111.847 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.2 p -114.04 138.92 23.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.606 -0.724 . . . . 75.12 111.361 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 59.8 Cg_endo -93.57 39.42 4.67 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.388 -1.088 . . . . 73.31 112.594 -0.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 9.3 t70 -58.2 -44.41 88.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.437 -0.347 . . . . 74.2 110.412 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 5.9 m -165.75 -36.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.968 -0.56 . . . . 74.51 111.811 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 4' ' ' ILE . 18.7 tp -157.08 175.01 14.64 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.669 -0.493 . . . . 73.55 109.669 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 6.6 p-10 -69.0 -52.44 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.42 -1.326 . . . . 75.41 107.42 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 137.82 22.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 74.43 110.739 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.41 ' N ' HD13 ' A' ' 4' ' ' ILE . 10.9 p -59.89 129.23 87.79 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.152 -0.476 . . . . 72.2 111.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -88.61 -138.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.089 2.526 . . . . 74.12 111.904 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.42 -29.7 7.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.519 -0.31 . . . . 51.33 111.214 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -159.94 -175.58 31.07 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.909 -0.476 . . . . 70.52 111.909 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 2.2 t -117.82 163.12 17.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.341 0.591 . . . . 74.13 112.069 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.57 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.185 -0.916 . . . . 75.05 109.691 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.2 mmmm -82.38 102.97 11.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.563 -0.289 . . . . 74.2 110.596 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 95.6 t -110.24 110.82 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.318 -0.623 . . . . 72.23 109.318 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.2 mt -96.57 130.92 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.566 . . . . 74.23 110.071 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 2.8 t80 -103.17 -15.14 16.12 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 112.362 0.505 . . . . 74.11 112.362 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.16 2.93 7.83 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.181 0.832 . . . . 64.13 115.181 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 76.19 20.81 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.372 -1.344 . . . . 72.14 107.372 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -175.16 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 112.753 -2.021 . . . . 74.14 107.134 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.62 136.02 50.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.984 -1.007 . . . . 74.55 108.976 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 73.0 tt0 -126.61 143.6 51.17 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.227 0.825 . . . . 72.33 113.227 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 3.8 m -86.66 140.34 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.824 -0.626 . . . . 75.52 110.284 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 26' ' ' GLU . 10.7 mptt -131.67 114.77 15.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.483 0.549 . . . . 73.44 112.483 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.3 mp0 25.09 67.21 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.297 1.221 . . . . 73.54 114.297 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.56 6.28 89.04 Favored Glycine 0 C--N 1.33 0.225 0 N-CA-C 114.28 0.472 . . . . 61.11 114.28 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 18.9 t30 -55.99 131.07 46.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.849 0.357 . . . . 73.44 110.789 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -89.54 136.04 33.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 64.33 109.673 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 8.1 mp -92.73 138.99 31.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.319 . . . . 75.35 111.208 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -147.6 154.91 45.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 75.52 110.562 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.46 -52.62 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.826 -1.323 . . . . 63.23 112.879 0.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -120.38 28.92 7.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.747 0.784 . . . . 72.44 110.484 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.606 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 3.1 pt20 -80.98 -6.54 58.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.22 -0.9 . . . . 73.2 110.635 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.69 32.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.485 -0.78 . . . . 73.45 111.227 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -96.93 -38.11 9.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.819 1.044 . . . . 74.15 113.819 -177.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -82.64 143.93 30.64 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.071 0.767 . . . . 75.33 113.071 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.49 153.09 83.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.474 -1.239 . . . . 75.01 111.659 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.77 126.79 6.75 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.492 2.128 . . . . 74.12 112.745 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 51.6 mm -108.09 117.74 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 64.1 109.698 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.42 142.02 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.11 0.781 . . . . 74.11 113.11 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 68.5 m -161.43 113.73 1.83 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.848 -0.614 . . . . 73.34 109.46 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 1.3 p90 -93.67 35.95 1.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.154 0.502 . . . . 75.1 110.708 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.2 m -49.21 118.94 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 65.14 111.393 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.22 -11.31 72.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.172 -0.537 . . . . 71.32 112.805 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.39 10.63 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.826 0.346 . . . . 73.24 110.541 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -104.0 -62.85 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.151 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 50' ' ' GLU . . . 74.36 -99.43 1.09 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.469 -0.652 . . . . 71.41 111.469 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -148.82 109.96 4.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.966 0.412 . . . . 74.23 111.121 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -144.49 147.93 33.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.456 . . . . 71.42 110.225 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.463 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 31.5 t30 -63.34 -39.74 95.38 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.42 0.628 . . . . 72.22 109.852 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 30.2 mt -153.98 162.1 41.47 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.828 -1.078 . . . . 73.32 111.341 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.4 mt -132.82 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.957 0.408 . . . . 74.52 109.983 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 13.1 m -113.17 123.62 50.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.337 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 81' ' ' VAL . 1.3 tm? -124.51 129.81 51.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.777 -0.453 . . . . 74.23 109.777 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -152.46 169.16 23.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 72.42 111.506 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -95.06 131.63 40.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.833 -0.621 . . . . 73.23 110.537 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.682 ' CG2' ' HB2' ' A' ' 117' ' ' LEU . 6.1 t -106.71 160.19 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.773 -0.194 . . . . 74.52 111.349 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 54.36 57.34 12.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 72.14 109.941 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 10.3 Cg_endo -53.95 139.98 69.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.821 1.681 . . . . 73.34 110.662 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 105' ' ' PRO . 35.9 t0 -165.91 117.01 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.429 0.529 . . . . 74.01 112.429 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -170.43 144.73 2.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.481 -0.781 . . . . 72.13 109.392 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 73.3 Cg_endo -83.12 -14.56 35.05 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.483 -1.049 . . . . 74.34 111.759 0.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -164.92 154.12 12.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.106 -0.952 . . . . 63.53 109.715 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.636 ' NE ' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.59 -1.83 12.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.927 -0.579 . . . . 75.42 111.719 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.636 HE21 ' NE ' ' A' ' 68' ' ' ARG . 85.0 mm-40 -86.34 -45.13 11.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.395 -0.366 . . . . 74.13 111.756 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.4 96.63 5.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 74.41 109.787 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.23 57.13 4.61 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.347 2.031 . . . . 74.53 113.047 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -54.35 -37.43 64.91 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 121.038 -0.265 . . . . 75.44 111.489 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.601 ' HB2' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -149.41 77.21 1.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.11 0.957 . . . . 73.25 110.072 177.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.504 ' NE ' ' O ' ' A' ' 63' ' ' PRO . 72.5 ttt180 -98.72 109.78 22.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.053 -1.43 . . . . 73.24 110.415 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.3 mt-10 -108.0 178.06 4.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.033 1.333 . . . . 75.44 110.61 -0.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.503 HG13 ' CE2' ' A' ' 73' ' ' TYR . 1.6 mp -75.64 -58.34 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.73 -0.841 . . . . 74.22 108.73 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 1.4 mm? -140.56 -171.05 3.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.255 -1.339 . . . . 74.33 108.263 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 p80 176.27 156.92 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.4 -0.222 . . . . 65.33 110.4 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.704 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 1.2 t-105 -100.12 111.57 23.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.218 0.533 . . . . 73.5 110.041 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 m -127.93 125.34 39.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.503 -0.771 . . . . 72.34 110.704 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -147.66 125.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.497 -0.774 . . . . 74.41 110.441 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' A' ' 97' ' ' LEU . 27.4 m -126.66 174.44 10.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.053 0.454 . . . . 74.34 111.498 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 13.8 p30 54.02 40.24 31.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.956 -1.02 . . . . 65.12 111.019 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 7.4 mm -77.89 122.23 85.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.976 -0.749 . . . . 73.14 108.976 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.74 127.77 25.67 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 121.934 1.756 . . . . 70.13 112.323 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.92 58.65 0.08 OUTLIER Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.416 0.448 . . . . 72.35 113.542 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -168.06 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.143 0.577 . . . . 64.25 109.664 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 90' ' ' ASN . 73.1 m-80 -135.13 -16.1 1.92 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 64.33 112.134 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 71.57 -36.23 0.35 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 73.14 111.338 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 88' ' ' ASN . 8.5 p30 -129.22 152.55 79.63 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.088 0.47 . . . . 72.23 110.254 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.52 ' HB2' ' CG2' ' A' ' 81' ' ' VAL . 80.4 Cg_endo -70.82 52.47 1.35 Allowed 'Trans proline' 0 N--CA 1.473 0.307 0 C-N-CA 123.572 2.848 . . . . 71.02 113.602 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -104.24 -1.92 26.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.483 -0.487 . . . . 75.4 111.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.21 -42.12 1.32 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.953 -0.642 . . . . 74.25 113.51 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -63.57 172.59 13.44 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 120.871 -0.68 . . . . 63.41 113.136 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.46 ' HB3' ' OE2' ' A' ' 127' ' ' GLU . 72.2 t60 -66.19 130.82 44.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.745 0.307 . . . . 73.02 111.73 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.438 ' HA ' ' CG1' ' A' ' 81' ' ' VAL . 36.8 m -87.21 102.63 14.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.837 -0.801 . . . . 64.21 108.837 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.409 ' CD1' HG11 ' A' ' 82' ' ' VAL . 94.0 mt -62.68 -37.44 86.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.539 0.685 . . . . 73.33 109.655 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.56 127.28 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.711 -1.131 . . . . 72.32 108.653 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -55.38 152.34 8.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.285 0.846 . . . . 73.34 113.285 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.704 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 3.1 p90 -83.67 142.61 30.65 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.394 -0.821 . . . . 74.44 112.836 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 5.2 m -158.35 113.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 71.45 111.346 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.83 2.81 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 62.35 112.297 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 t -172.03 49.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.925 0.343 . . . . 75.33 111.925 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.87 -75.68 0.61 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.465 -1.054 . . . . 75.41 110.465 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 64' ' ' ASP . 15.8 Cg_exo -74.17 123.5 8.35 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.941 2.427 . . . . 61.52 111.49 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 66' ' ' PRO . 31.6 Cg_exo -59.01 159.35 21.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.862 2.375 . . . . 75.31 112.978 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 168' ' ' ASP . 18.4 pttp -43.66 -20.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.949 -0.569 . . . . 64.45 111.322 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 106' ' ' PRO . 29.8 t70 -50.42 -46.54 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.223 -0.444 . . . . 72.51 110.41 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 4.2 t -79.54 -4.04 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.152 -0.476 . . . . 73.04 111.519 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.75 -101.18 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.184 -1.167 . . . . 53.2 110.184 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.5 tp -66.66 112.17 4.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.945 -0.391 . . . . 75.34 109.945 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.431 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 10.9 p80 -109.83 92.1 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.988 0.423 . . . . 75.21 110.303 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.43 ' H ' ' NE ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -58.67 130.57 47.5 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.62 -0.718 . . . . 75.43 110.583 -179.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.06 128.54 45.11 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 120.95 0.405 . . . . 74.31 109.916 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 161' ' ' TYR . 4.7 mm -115.86 141.83 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.446 -0.797 . . . . 75.12 111.286 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.25 141.46 48.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.937 -0.574 . . . . 72.1 110.245 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.682 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 5.5 tt -124.5 140.39 52.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.374 . . . . 74.44 110.72 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' THR . 60.2 tp -130.29 134.04 46.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.668 -0.696 . . . . 74.41 110.583 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.474 ' HA ' HG12 ' A' ' 157' ' ' ILE . 66.8 t80 -144.14 139.49 28.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.207 0.527 . . . . 72.43 111.295 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -68.78 135.35 51.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 74.22 111.544 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 123' ' ' ASN . 3.5 tp60 -119.8 127.62 52.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.576 -0.527 . . . . 71.52 109.576 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.463 ' C ' HD21 ' A' ' 123' ' ' ASN . 62.9 tt0 -109.09 -8.57 15.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.63 -0.714 . . . . 71.31 111.332 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.463 HD21 ' C ' ' A' ' 122' ' ' GLU . 4.3 m120 -125.81 148.86 49.0 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.817 0.341 . . . . 73.04 111.809 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.403 ' HD2' ' CD1' ' A' ' 55' ' ' LEU . 13.2 mmmm -76.69 149.15 36.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 75.55 110.14 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.62 143.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 111.994 0.368 . . . . 75.41 111.994 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -81.07 -16.15 54.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.655 -0.702 . . . . 73.41 111.355 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 95' ' ' HIS . 0.0 OUTLIER 4.81 60.65 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.295 1.591 . . . . 74.41 115.295 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 126' ' ' GLU . 25.7 p 51.78 150.9 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 115.213 1.56 . . . . 74.15 115.213 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.82 158.19 29.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.659 2.906 . . . . 74.11 112.532 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -58.79 141.33 53.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.247 -0.433 . . . . 70.23 111.58 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.63 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.117 0.484 . . . . 75.32 111.673 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.7 m -87.38 143.03 27.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.551 -0.75 . . . . 75.2 111.244 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 135' ' ' THR . 11.5 p30 -51.86 -37.21 51.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.001 0.429 . . . . 72.12 110.817 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 p -70.29 12.87 0.2 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.654 0.613 . . . . 73.41 112.654 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.7 t -68.48 123.94 22.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 74.45 110.507 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.511 ' H ' ' CA ' ' A' ' 179' ' ' GLY . 27.3 ttt-85 -62.89 165.67 6.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.221 -0.445 . . . . 74.11 111.344 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.408 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 11.6 m -37.34 155.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.121 -0.945 . . . . 72.22 111.873 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.0 -3.25 20.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.973 -0.632 . . . . 74.44 111.819 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -165.54 41.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.168 0.509 . . . . 74.33 111.128 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.29 -64.62 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.027 -1.101 . . . . 65.14 108.027 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.601 HD22 ' HB2' ' A' ' 73' ' ' TYR . 2.1 m120 -73.0 114.9 11.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.484 -1.235 . . . . 75.54 109.636 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -148.21 135.65 20.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 74.41 111.001 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.48 HD21 ' HG3' ' A' ' 145' ' ' ARG . 19.0 p-10 -101.69 106.66 17.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 61.21 110.505 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -49.12 -37.05 20.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 51.31 111.243 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.48 ' HG3' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -49.4 -25.94 2.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.973 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.488 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -52.46 -52.64 53.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.623 -0.88 . . . . 73.2 108.623 177.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 4.6 m-85 -62.12 -29.58 70.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.058 -0.974 . . . . 72.44 110.194 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -62.83 -37.05 85.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.457 -0.572 . . . . 72.13 109.457 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.17 39.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.708 -0.678 . . . . 74.13 111.182 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.567 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 3.7 ptpp? -66.58 -49.45 66.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.199 0.444 . . . . 75.42 112.199 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.424 ' ND1' HD23 ' A' ' 153' ' ' LEU . 22.0 t-160 -86.83 3.12 46.6 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.199 -0.313 . . . . 75.44 111.222 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 58.63 34.12 75.16 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.113 -0.565 . . . . 75.34 113.565 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 18.1 mt -68.27 16.55 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 122.739 0.415 . . . . 65.44 112.072 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -52.68 -33.8 42.56 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.549 -0.834 . . . . 62.32 112.765 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.7 78.74 0.13 Allowed Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.3 0.24 . . . . 71.42 111.441 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 154' ' ' GLY . 32.5 Cg_endo -61.56 130.4 31.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 121.526 1.484 . . . . 71.42 111.549 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 119' ' ' TYR . 26.9 pt -81.03 -34.85 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 120.603 -0.439 . . . . 75.02 110.126 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' GLY . . . -150.35 161.03 43.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 71.21 111.466 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' THR . . . -161.09 173.76 14.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.784 -0.643 . . . . 74.52 110.528 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -171.03 135.14 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.581 -0.896 . . . . 63.24 108.581 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.505 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -136.97 149.01 47.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.586 -0.279 . . . . 73.33 111.657 -177.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 1.7 p90 -142.25 152.61 43.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.8 -0.636 . . . . 71.51 111.264 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -113.98 124.85 53.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.669 -0.493 . . . . 72.53 109.669 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.18 148.51 24.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 74.31 111.694 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.81 177.46 4.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.608 -0.724 . . . . 73.44 109.602 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.607 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -162.18 -135.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.05 -0.26 . . . . 74.02 110.409 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 169' ' ' TYR . 44.7 m-20 -144.3 164.23 31.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.014 0.435 . . . . 75.22 111.532 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.554 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 36.8 t70 -67.16 12.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.579 -0.737 . . . . 74.52 110.154 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.614 ' H ' ' C ' ' A' ' 167' ' ' ASP . 45.7 t80 -84.4 -46.6 11.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.397 -0.819 . . . . 74.55 111.592 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 13.1 p -67.72 -34.31 6.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.523 0.564 . . . . 75.03 112.523 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 42.4 Cg_exo -58.12 -22.92 58.61 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.96 1.773 . . . . 75.04 111.882 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.83 -31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 73.33 111.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.29 -33.79 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.693 0.282 . . . . 73.13 111.291 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.42 ' O ' HG12 ' A' ' 177' ' ' ILE . 12.3 p30 -47.57 -36.34 10.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 63.01 110.727 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -52.09 -31.81 32.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 75.0 111.385 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 77.4 p -79.98 15.75 1.38 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.912 0.386 . . . . 73.23 111.666 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.501 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 10.6 mm -73.04 135.04 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.323 -0.398 . . . . 74.41 110.057 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.7 -21.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.275 0.843 . . . . 74.45 113.275 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.511 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.409 -1.217 . . . . 74.23 112.49 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 ttp . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.513 0.197 . . . . 71.43 110.603 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.21 113.32 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 73.42 109.164 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.91 -71.53 0.76 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.925 0.713 . . . . 74.43 112.925 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -82.69 48.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.407 0.622 . . . . 74.23 112.05 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.9 p -120.21 143.32 35.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 75.23 110.992 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.531 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 58.5 Cg_endo -97.19 26.2 19.76 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 124.712 -0.954 . . . . 74.34 112.215 0.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.79 -41.76 98.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 72.34 110.967 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.9 m -152.7 -51.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 113.409 0.892 . . . . 75.11 113.409 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' ALA . 55.0 tp -157.61 141.49 15.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.146 0.498 . . . . 75.33 112.275 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -74.9 36.53 0.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.89 -0.596 . . . . 73.42 110.948 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 178.33 145.58 0.13 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.466 -0.333 . . . . 63.51 111.047 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -92.54 102.38 6.59 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 75.41 111.189 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -72.97 136.88 25.73 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.868 2.379 . . . . 75.22 113.007 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.03 -28.83 67.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.909 -0.587 . . . . 73.53 110.108 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.54 -133.59 3.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.302 -0.863 . . . . 64.12 111.486 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.414 ' N ' ' HB2' ' A' ' 158' ' ' ALA . 10.2 t -163.7 177.57 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.719 . . . . 74.41 111.758 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 160' ' ' ASN . 26.6 mt -124.24 143.96 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.094 . . . . 73.14 108.084 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 5.7 mtpm? -107.64 102.85 12.06 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.381 -0.528 . . . . 73.34 111.58 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 63.1 t -103.18 110.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.485 -0.779 . . . . 73.42 109.633 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.702 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 62.7 mt -95.24 114.9 32.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.43 -0.805 . . . . 75.51 110.647 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -82.53 -85.23 0.11 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.155 -0.475 . . . . 72.24 112.1 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 24' ' ' ASP . . . -68.15 2.97 6.11 Favored Glycine 0 N--CA 1.461 0.34 0 CA-C-N 116.117 -0.492 . . . . 75.32 113.596 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.702 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 13.6 t70 78.92 -41.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.232 -0.655 . . . . 75.34 109.232 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 22' ' ' GLY . 4.1 t70 -74.02 -27.93 61.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 75.22 109.725 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' H ' HD21 ' A' ' 25' ' ' LEU . 2.5 pt? -124.93 -174.35 3.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.402 0.62 . . . . 73.23 112.157 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 18.2 pt-20 -156.97 157.79 35.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.319 -0.855 . . . . 71.25 111.038 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 4.2 m -85.35 143.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 75.12 111.689 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.562 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 50.1 mttp -144.2 126.81 16.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.466 0.65 . . . . 74.33 112.047 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.3 mp0 35.09 61.75 0.6 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.344 1.238 . . . . 75.52 114.344 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 16.94 55.62 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.859 -0.61 . . . . 74.33 114.247 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.89 156.52 8.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.104 0.478 . . . . 75.43 111.042 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 73.41 110.125 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.4 mp -105.41 130.51 53.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.338 -0.392 . . . . 73.04 110.124 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -146.92 158.37 45.41 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.566 . . . . 75.55 110.502 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.82 121.98 3.62 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.257 -1.143 . . . . 73.34 113.266 0.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.8 p 44.44 25.9 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.842 -0.617 . . . . 65.15 112.551 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 39' ' ' LYS . 12.0 pt20 -80.3 0.1 34.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.098 0.475 . . . . 75.32 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 m -73.24 26.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.1 -0.5 . . . . 74.51 111.879 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -106.15 -9.12 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 74.52 111.58 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -84.54 148.79 26.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.218 0.532 . . . . 70.22 111.79 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.4 pm0 -63.02 133.14 95.3 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.631 -0.713 . . . . 74.34 111.847 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 90.5 Cg_endo -85.37 128.74 3.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.868 2.379 . . . . 74.14 113.075 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 41.4 mm -103.32 105.92 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 74.41 110.419 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 p -84.92 137.08 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.829 0.678 . . . . 75.15 112.829 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -165.33 137.0 4.09 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.84 0.311 . . . . 54.21 111.84 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.525 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p90 -107.53 12.51 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.283 -0.417 . . . . 75.51 109.995 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.3 t -31.95 115.91 0.18 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.103 -0.953 . . . . 73.5 112.204 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 108.7 -30.66 8.53 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 74.1 112.661 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.4 mt -85.12 -35.52 21.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.97 0.414 . . . . 73.14 110.663 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 16.1 pm0 -56.59 -171.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 74.25 110.165 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.16 -77.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.102 -1.047 . . . . 74.34 112.662 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -148.49 111.24 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.414 0.626 . . . . 74.4 110.867 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 m -157.34 147.34 20.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.632 -0.877 . . . . 71.13 108.632 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -64.69 -41.84 95.76 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.675 0.75 . . . . 63.33 109.606 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.484 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 35.7 mt -155.91 178.07 10.69 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.249 -1.341 . . . . 72.42 110.031 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 89.3 mt -140.93 163.79 32.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.087 -0.708 . . . . 75.51 109.087 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.44 ' HG1' ' HB2' ' A' ' 121' ' ' GLN . 58.1 m -135.05 119.63 18.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 75.5 111.115 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -107.41 110.89 22.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.627 -0.715 . . . . 60.32 109.234 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -115.89 137.11 52.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 74.43 111.22 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.445 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -94.89 146.77 23.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.739 -0.664 . . . . 75.04 110.444 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 99.0 t -141.62 118.37 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 70.0 111.033 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' H ' ' HD3' ' A' ' 63' ' ' PRO . 22.2 t70 173.03 48.84 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.673 -1.149 . . . . 72.04 108.375 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.543 ' HD3' ' H ' ' A' ' 62' ' ' ASP . 58.3 Cg_endo -70.0 83.87 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.045 1.83 . . . . 75.21 113.824 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -145.93 101.22 3.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.078 -0.965 . . . . 63.5 109.09 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -166.14 136.69 2.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 73.33 111.482 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 14.8 Cg_exo -71.12 -5.17 10.89 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 123.56 -1.433 . . . . 72.43 111.313 -0.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 146.29 7.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.888 . . . . 71.41 110.222 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.599 ' HD2' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -64.04 -15.47 59.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.466 . . . . 75.32 110.408 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.599 HE21 ' HD2' ' A' ' 68' ' ' ARG . 88.2 mm-40 -92.01 -23.32 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 74.42 111.979 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.542 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t70 -144.13 73.96 16.11 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 75.3 110.241 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.87 62.54 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.434 2.756 . . . . 74.24 112.406 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -48.86 -36.48 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.928 -0.578 . . . . 65.22 111.511 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 5.9 p90 -165.01 48.98 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 74.2 111.51 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HG2' ' CA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -81.2 144.06 31.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.226 -0.657 . . . . 75.0 109.226 177.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' CA ' ' HG2' ' A' ' 74' ' ' ARG . 39.0 mt-10 -89.91 163.74 14.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.044 0.938 . . . . 65.11 111.297 0.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.534 ' CG2' ' H ' ' A' ' 77' ' ' LEU . 21.2 mm -84.76 -129.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.182 -1.414 . . . . 75.15 107.182 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.534 ' H ' ' CG2' ' A' ' 76' ' ' ILE . 49.9 mt -86.84 151.67 23.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.165 -1.05 . . . . 71.52 108.165 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.442 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 0.0 OUTLIER -149.65 160.93 43.11 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 121.075 -0.25 . . . . 74.12 111.075 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -100.31 79.8 2.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.659 0.743 . . . . 75.33 111.025 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 97' ' ' LEU . 24.5 p -94.67 133.25 38.53 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.664 -1.153 . . . . 74.13 110.92 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.72 138.42 22.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 120.728 -0.389 . . . . 74.24 111.19 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 97' ' ' LEU . 29.5 m -142.21 167.74 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.645 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 125' ' ' ILE . 1.7 m-20 64.24 33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.528 -0.305 . . . . 71.31 111.413 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 15.6 mm -80.78 124.14 81.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.613 -0.514 . . . . 74.23 109.613 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.582 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 51.5 Cg_exo -52.16 129.79 32.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.292 1.328 . . . . 74.34 110.98 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.42 50.03 0.29 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 114.739 0.656 . . . . 73.43 114.739 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t -176.73 32.56 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.402 0.601 . . . . 73.12 111.914 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.582 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 51.4 m-20 -113.19 0.55 14.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.567 0.222 . . . . 74.41 111.07 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 51.9 mt-10 68.14 -34.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 65.25 112.276 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 88' ' ' ASN . 4.0 p30 -133.81 155.45 80.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.529 . . . . 65.12 111.447 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.89 59.36 2.84 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.49 2.793 . . . . 65.43 113.267 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.1 m -104.29 -54.8 2.47 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.817 0.673 . . . . 63.54 112.817 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.11 -0.55 15.71 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.6 1.0 . . . . 64.15 115.6 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -100.34 176.43 27.8 Favored Glycine 0 N--CA 1.461 0.313 0 C-N-CA 120.423 -0.894 . . . . 73.12 113.258 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.416 ' NE2' ' O ' ' A' ' 128' ' ' THR . 43.4 t60 -70.46 121.34 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 74.11 111.284 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 43.7 m -80.99 96.94 7.26 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.336 -0.616 . . . . 73.45 109.336 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 127' ' ' GLU . 43.7 mt -48.02 -50.13 28.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.304 0.573 . . . . 73.42 109.549 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -141.86 107.97 5.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.834 -1.075 . . . . 64.24 108.249 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.546 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 44.7 t0 -41.91 144.57 0.41 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 75.34 112.966 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -60.59 139.85 57.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.89 -1.05 . . . . 74.43 112.137 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 133' ' ' ASN . 14.4 p -148.15 113.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.586 -0.734 . . . . 74.22 110.651 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.11 18.79 3.14 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.204 -0.522 . . . . 70.54 113.194 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.1 p -69.18 -64.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 73.03 111.083 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.429 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . 76.08 163.7 15.33 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.516 -0.766 . . . . 62.15 112.601 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.88 160.49 25.18 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.046 2.497 . . . . 75.22 113.114 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.6 161.3 32.37 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.665 2.91 . . . . 65.3 113.967 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -44.7 -37.81 3.97 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.342 -0.845 . . . . 73.53 111.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -50.83 -22.05 1.99 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.503 0.557 . . . . 65.31 112.503 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 11.3 t -80.97 -25.45 37.32 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.558 0.948 . . . . 73.54 113.558 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.62 -163.91 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.577 -0.821 . . . . 74.34 112.444 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 39.7 tp -46.19 109.23 0.17 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.085 0.469 . . . . 75.43 111.745 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -113.2 142.52 45.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.732 -0.667 . . . . 72.54 109.691 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.586 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -95.55 88.08 4.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.704 . . . . 74.53 112.579 -177.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 9.8 t80 -73.5 120.13 18.67 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.127 -0.629 . . . . 74.54 109.513 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.474 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 25.9 mt -113.42 130.82 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.894 -0.594 . . . . 74.42 111.979 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -102.45 125.18 49.08 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.712 -0.676 . . . . 74.54 109.585 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 tt -119.27 135.26 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.378 . . . . 74.41 110.498 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 64.6 tp -119.46 136.39 54.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.718 -0.674 . . . . 62.32 110.47 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.638 ' CD2' HD23 ' A' ' 153' ' ' LEU . 64.0 t80 -144.14 135.67 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 65.23 111.029 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -64.83 130.39 43.29 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.787 -0.365 . . . . 75.21 110.185 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.484 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 26.8 tt0 -107.74 127.48 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.556 -0.535 . . . . 70.41 109.556 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -99.84 -39.02 8.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.6 0.593 . . . . 75.42 112.6 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.446 ' HB2' ' HE2' ' A' ' 151' ' ' HIS . 5.4 m120 -102.8 136.91 41.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.181 0.808 . . . . 74.12 113.181 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -72.13 114.19 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.261 -0.881 . . . . 74.02 109.787 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.446 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 5.3 pt -115.71 132.59 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.006 -0.543 . . . . 62.54 112.178 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -59.18 -53.09 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.276 0.56 . . . . 71.33 109.977 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 6.0 mm-40 60.72 38.45 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.159 -0.928 . . . . 73.31 111.531 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 41.0 p 54.84 149.84 0.05 OUTLIER Pre-proline 0 C--O 1.223 -0.322 0 O-C-N 123.741 0.651 . . . . 73.43 112.632 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.45 147.37 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.16 2.573 . . . . 75.21 112.755 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 96' ' ' SER . 1.4 m -58.44 119.61 7.3 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.285 -0.416 . . . . 74.51 110.471 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 42.0 mm -80.89 133.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.461 -0.336 . . . . 73.14 110.653 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -73.95 148.01 42.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.967 -0.561 . . . . 75.24 111.143 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.546 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 19.7 p-10 -62.92 -41.24 99.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 73.32 109.994 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -75.02 22.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.626 -0.716 . . . . 74.31 110.974 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 133' ' ' ASN . 2.9 t -62.33 119.55 9.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.404 0.621 . . . . 74.21 112.627 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 137' ' ' THR . 23.5 tpt180 -65.48 167.3 8.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.931 -1.032 . . . . 75.11 110.621 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 138' ' ' GLY . 11.0 m -44.47 151.04 0.29 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 64.24 111.521 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 139' ' ' ARG . . . 116.14 -8.86 18.27 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.974 -0.631 . . . . 64.51 113.605 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD3' ' C ' ' A' ' 138' ' ' GLY . 0.9 OUTLIER -152.87 50.72 0.74 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.399 0.599 . . . . 71.23 111.288 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.22 -56.82 2.35 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.617 -0.512 . . . . 72.11 109.617 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.0 OUTLIER -62.91 119.79 10.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.703 -0.68 . . . . 70.3 111.165 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 175.46 133.48 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 72.14 110.081 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -80.6 124.06 28.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.992 0.425 . . . . 73.12 111.915 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.91 96.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.453 -0.34 . . . . 53.24 111.808 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -46.49 -27.39 1.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 73.2 111.714 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.561 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 28.3 t70 -56.92 -42.75 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.602 -0.272 . . . . 72.42 111.47 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.485 ' CE2' HD12 ' A' ' 97' ' ' LEU . 24.3 m-85 -54.94 -38.14 67.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.59 0.71 . . . . 75.3 109.531 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -70.83 -41.13 71.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.078 -0.965 . . . . 63.34 110.55 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.39 -47.64 78.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 74.45 111.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.37 -53.25 59.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.056 0.761 . . . . 73.22 113.056 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.538 ' N ' ' HD2' ' A' ' 150' ' ' LYS . 18.1 t-80 -94.69 11.64 30.55 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.8 -0.76 . . . . 61.34 111.716 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 64.27 37.51 94.61 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.676 -0.773 . . . . 74.34 113.837 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.638 HD23 ' CD2' ' A' ' 119' ' ' TYR . 9.5 mt -79.78 16.02 1.24 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.618 -0.342 . . . . 74.3 110.469 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -36.65 -72.43 0.15 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.701 -0.681 . . . . 75.14 114.766 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.52 113.09 16.69 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 117.05 0.425 . . . . 72.24 111.316 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 134.82 10.55 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.805 2.337 . . . . 74.44 113.424 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 119' ' ' TYR . 43.1 pt -75.85 -37.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.44 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 16' ' ' THR . . . -152.03 134.92 15.62 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.612 -0.267 . . . . 70.51 110.734 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -140.0 151.83 45.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 75.45 111.301 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 2.4 t-20 -154.15 142.37 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.698 -1.223 . . . . 73.54 107.698 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -146.8 162.99 37.45 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.461 0.541 . . . . 73.33 112.461 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 1.4 p90 -154.28 153.81 32.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.263 -0.88 . . . . 73.34 110.875 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 52.3 mt-30 -110.86 135.07 51.97 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.953 -0.388 . . . . 71.12 109.953 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.47 149.48 25.58 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.918 1.081 . . . . 54.43 113.918 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -137.61 157.34 46.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.359 -1.292 . . . . 74.13 107.825 177.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.429 ' HH ' ' HA3' ' A' ' 104' ' ' GLY . 0.2 OUTLIER -163.92 167.53 20.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 74.03 111.864 -178.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' TYR . 53.3 m-20 -56.68 150.12 16.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.328 -0.851 . . . . 74.41 111.327 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.637 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 19.3 t0 -54.79 -8.87 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 72.33 110.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' ASP . 22.2 t80 -60.02 -40.98 91.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.905 -0.589 . . . . 75.33 111.221 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 21.5 t -63.66 -53.84 47.49 Favored Pre-proline 0 C--O 1.235 0.308 0 N-CA-C 109.464 -0.569 . . . . 74.55 109.464 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.637 ' HD2' ' C ' ' A' ' 168' ' ' ASP . 50.9 Cg_exo -52.01 -31.62 44.88 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.872 1.715 . . . . 74.34 111.79 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 168' ' ' ASP . 50.7 mt -50.46 -34.52 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.495 -0.321 . . . . 75.13 110.431 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.459 ' O ' ' CG2' ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.94 -37.69 14.94 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.647 -0.501 . . . . 73.13 109.647 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -56.46 -35.63 68.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.109 -0.496 . . . . 74.55 111.454 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 12.9 mptt -57.37 -33.23 67.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.368 -0.207 . . . . 72.32 111.422 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 173' ' ' ARG . 10.9 t -69.59 -10.3 57.61 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.617 -0.433 . . . . 74.33 111.254 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 83.8 mt -63.62 127.23 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.562 -0.29 . . . . 74.24 110.529 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.25 3.31 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.169 0.433 . . . . 74.52 112.169 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.396 -1.225 . . . . 61.22 112.519 -179.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' SD ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 tpp . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.552 -0.166 . . . . 73.03 110.552 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -64.12 103.47 0.61 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.188 0.305 . . . . 74.32 110.557 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -109.8 -72.86 0.7 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.891 0.7 . . . . 62.34 112.891 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -89.15 53.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.594 0.712 . . . . 75.32 111.588 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 10' ' ' ASP . 8.8 p -135.13 139.31 31.45 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.095 -0.957 . . . . 73.1 110.459 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 78.0 Cg_endo -83.98 35.69 2.62 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.83 -1.321 . . . . 75.32 113.177 0.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -61.38 -52.56 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.062 0.458 . . . . 74.52 110.238 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -158.88 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 65.14 111.789 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' O ' HG13 ' A' ' 4' ' ' ILE . 15.9 tp -157.34 140.22 15.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.319 0.581 . . . . 72.53 111.444 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.508 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 3.5 p-10 -58.82 -26.74 64.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 75.1 112.169 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.96 130.93 13.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 72.03 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.2 p -65.82 115.12 19.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 73.33 110.571 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 31.7 Cg_endo -94.22 143.94 1.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.965 2.443 . . . . 74.24 112.174 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.9 -30.84 47.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.39 0.614 . . . . 70.52 110.026 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.3 -166.96 15.62 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.819 -1.082 . . . . 73.14 110.63 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 9.7 t -121.99 172.95 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.498 0.649 . . . . 74.21 111.183 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 44' ' ' VAL . 6.4 mt -105.47 128.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 75.44 110.426 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 3.2 mmmp? -73.8 107.07 5.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.915 -0.772 . . . . 70.55 108.915 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 61.2 t -123.0 109.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 74.44 110.689 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 mt -100.93 123.11 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.183 -0.917 . . . . 75.03 109.871 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.521 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.98 -36.54 64.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.581 -0.736 . . . . 72.55 111.877 -178.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.443 ' H ' HD12 ' A' ' 25' ' ' LEU . . . -126.81 -63.07 0.15 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 120.232 -0.985 . . . . 73.02 112.675 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -166.81 -61.21 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.522 -0.547 . . . . 73.33 109.522 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.98 -48.88 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.676 -0.693 . . . . 72.04 110.67 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 22' ' ' GLY . 1.6 pp -69.57 147.74 50.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.415 0.626 . . . . 73.21 111.602 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 11.3 tt0 -143.37 144.95 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.525 -0.761 . . . . 75.25 110.699 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 19' ' ' VAL . 24.3 m -79.93 106.37 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 74.44 109.513 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 56.2 mttm -103.64 124.75 49.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.179 1.177 . . . . 70.54 114.179 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.486 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.4 mp0 26.9 67.45 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.985 1.476 . . . . 70.51 114.985 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' CA ' ' CD2' ' A' ' 161' ' ' TYR . . . 74.76 5.56 74.82 Favored Glycine 0 CA--C 1.51 -0.241 0 N-CA-C 115.083 0.793 . . . . 50.43 115.083 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.12 161.95 2.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.591 0.696 . . . . 73.23 110.029 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' CD ' HE22 ' A' ' 165' ' ' GLN . 32.5 tt0 -109.8 143.71 39.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 72.51 110.389 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.5 mp -116.35 120.16 37.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.76 -0.459 . . . . 74.51 109.76 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -150.49 163.92 22.36 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.846 -0.616 . . . . 74.33 110.082 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 94.4 Cg_endo -86.92 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.772 -1.345 . . . . 73.23 112.841 0.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.436 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 70.2 p -104.27 22.62 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.55 -0.295 . . . . 74.32 111.686 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -81.79 -7.64 59.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.317 -0.553 . . . . 70.21 110.061 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 24.6 m -91.29 26.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 72.25 111.642 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -85.71 -14.57 44.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.648 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.3 141.44 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.805 -0.634 . . . . 75.23 112.487 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.557 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.17 134.89 95.99 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 115.513 -0.767 . . . . 74.31 110.849 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.2 Cg_endo -73.5 135.88 22.85 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.881 2.388 . . . . 73.1 113.508 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 48.5 mm -107.19 125.83 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.352 . . . . 73.25 110.423 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 17' ' ' ILE . 3.1 p -98.54 146.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.391 0.515 . . . . 65.24 112.391 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -165.12 146.49 7.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.132 0.492 . . . . 71.41 111.579 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.534 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 5.2 p90 -121.39 29.9 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.402 -0.592 . . . . 75.44 109.402 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 t -43.29 131.21 4.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.603 -0.726 . . . . 74.34 110.696 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.16 -35.76 3.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 64.1 112.683 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.24 -33.87 67.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.557 0.694 . . . . 74.23 109.341 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.5 tt0 -58.06 142.08 47.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.163 -0.926 . . . . 74.4 109.194 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.29 -65.74 0.02 OUTLIER Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.036 -1.078 . . . . 62.54 112.863 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.74 109.34 4.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.838 0.352 . . . . 71.31 110.162 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m -158.36 141.17 14.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.104 -0.498 . . . . 71.43 110.528 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -70.15 -40.42 74.78 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.198 0.999 . . . . 73.01 108.328 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 27.1 mt -155.16 161.26 41.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.76 -1.564 . . . . 74.23 109.269 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.9 mt -125.07 146.54 49.4 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.178 0.514 . . . . 73.15 110.358 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 4.2 m -106.91 127.35 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.744 . . . . 74.12 109.993 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.3 tm? -130.93 118.5 20.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.363 -0.606 . . . . 75.55 109.363 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' CD1' ' CG ' ' A' ' 147' ' ' PHE . 70.4 mt -149.36 132.09 15.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.968 -0.693 . . . . 74.33 112.043 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 48.3 ttp -94.73 148.4 22.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.731 -0.841 . . . . 73.53 108.731 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 144' ' ' ALA . 52.9 t -139.33 145.02 27.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.534 0.683 . . . . 74.13 112.57 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -175.9 82.93 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 114.067 -1.424 . . . . 74.31 109.361 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.52 84.39 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.8 2.333 . . . . 74.41 111.84 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.574 ' CB ' HH12 ' A' ' 113' ' ' ARG . 3.2 t0 -170.22 122.5 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.753 0.649 . . . . 73.35 112.753 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.507 ' CB ' ' CE1' ' A' ' 73' ' ' TYR . . . -173.13 130.74 0.58 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.97 -0.292 . . . . 72.31 111.554 175.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.06 -12.54 24.12 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.257 -1.56 . . . . 72.55 109.025 -4.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 t -151.99 142.82 22.95 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.992 -1.458 . . . . 72.01 109.661 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -58.87 -31.13 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.408 . . . . 75.33 110.751 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -60.32 -41.62 93.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.442 -0.799 . . . . 75.31 111.819 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -138.1 71.3 48.05 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 74.42 110.449 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 27.6 Cg_exo -61.29 112.65 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.242 1.961 . . . . 74.13 111.122 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -101.27 -51.43 3.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.86 0.362 . . . . 75.3 111.631 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.507 ' CE1' ' CB ' ' A' ' 65' ' ' ALA . 18.3 p90 -116.24 24.81 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 75.1 109.997 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.516 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 1.3 tmt_? -73.84 138.03 44.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.154 -0.93 . . . . 75.55 109.643 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HG3' ' HA ' ' A' ' 143' ' ' ASN . 4.9 mm-40 -75.11 170.12 16.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.63 1.172 . . . . 64.11 111.346 0.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.462 ' CG2' ' HA3' ' A' ' 104' ' ' GLY . 6.8 tp -119.27 168.38 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 75.5 111.189 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' N ' HG13 ' A' ' 76' ' ' ILE . 73.2 mt -54.83 133.72 47.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.357 0.598 . . . . 65.51 111.747 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.8 -169.38 2.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.183 -0.917 . . . . 74.31 109.119 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.465 ' CZ3' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -98.6 104.47 16.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.219 -1.03 . . . . 71.34 108.219 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.424 ' HB3' ' CD2' ' A' ' 59' ' ' LEU . 1.5 m -119.0 117.37 28.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 73.12 110.985 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 58' ' ' LEU . 1.7 t -141.73 130.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 74.01 109.405 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.5 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 32.2 m -141.69 166.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.057 0.456 . . . . 70.02 111.559 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 22.9 p30 64.16 39.22 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.655 -1.157 . . . . 73.15 109.524 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 2.8 mm -77.2 115.44 48.94 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 114.408 -1.269 . . . . 73.1 108.991 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 87' ' ' SER . 51.0 Cg_exo -53.1 127.67 25.97 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.692 1.594 . . . . 74.52 111.774 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.43 69.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.33 -0.462 . . . . 73.44 112.854 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' PRO . 29.3 t 177.31 48.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.66 0.384 . . . . 65.53 110.097 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 90' ' ' ASN . 70.2 m-80 -135.68 -22.36 1.46 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.029 0.752 . . . . 71.55 113.029 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 70.87 -22.18 0.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.867 0.365 . . . . 74.2 110.784 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 88' ' ' ASN . 10.3 p30 -152.17 158.16 33.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 115.873 -0.603 . . . . 72.15 109.575 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 90' ' ' ASN . 81.9 Cg_endo -70.92 48.2 0.81 Allowed 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 123.29 2.66 . . . . 75.05 114.307 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 t -97.53 -8.29 29.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.06 -0.656 . . . . 73.05 111.797 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.35 -40.74 1.46 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.585 -0.816 . . . . 72.5 114.26 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -61.21 171.87 7.65 Favored Glycine 0 N--CA 1.459 0.208 0 C-N-CA 120.847 -0.692 . . . . 74.04 113.037 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.462 ' CB ' HD22 ' A' ' 83' ' ' ASN . 52.5 t60 -70.89 118.82 14.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.584 0.23 . . . . 74.44 111.455 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.3 p -81.05 91.05 6.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.936 -0.764 . . . . 75.22 108.936 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.475 HD22 ' CG2' ' A' ' 82' ' ' VAL . 10.6 mt -49.3 -52.4 27.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 63.35 110.048 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.08 117.41 13.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 73.52 108.885 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 50.6 t0 -55.78 151.08 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.767 0.667 . . . . 72.2 111.649 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.5 p90 -60.35 151.3 28.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 73.25 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.21 152.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.424 -0.353 . . . . 71.45 110.149 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' CA ' HG13 ' A' ' 170' ' ' VAL . . . -46.19 -72.84 0.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.963 -0.637 . . . . 72.34 112.429 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -171.15 124.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 72.43 110.471 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.462 ' HA3' ' CG2' ' A' ' 76' ' ' ILE . . . -68.29 -49.15 47.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.524 -0.846 . . . . 62.42 111.511 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 2.7 Cg_exo -77.78 114.59 3.67 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.851 2.367 . . . . 73.41 112.017 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.69 160.91 30.53 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.135 2.556 . . . . 74.12 111.861 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.98 -28.05 2.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.343 -0.389 . . . . 72.14 111.419 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 87.0 m-20 -51.64 -40.0 59.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 74.52 112.025 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.7 t -71.06 -2.91 17.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.755 -0.378 . . . . 55.2 111.254 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 69.95 -126.72 17.64 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 116.106 -0.497 . . . . 73.33 113.673 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.464 ' CD1' ' HG3' ' A' ' 165' ' ' GLN . 31.0 tp -66.96 145.48 55.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.8 0.809 . . . . 75.04 112.505 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 19.0 m80 -120.02 167.05 12.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.99 -1.459 . . . . 71.22 110.037 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.575 ' HD2' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -141.0 75.4 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.38 120.79 22.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.581 -0.736 . . . . 74.15 109.659 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.418 HG12 ' HB3' ' A' ' 161' ' ' TYR . 11.9 mt -116.02 122.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.094 0.473 . . . . 54.22 112.025 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -91.01 130.57 36.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.43 -0.805 . . . . 74.42 109.064 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 118' ' ' LEU . 1.3 tm? -119.27 136.19 54.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 71.32 110.168 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 57' ' ' THR . 3.6 tt -136.84 129.68 30.65 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.338 -0.392 . . . . 74.21 110.053 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.461 ' HA ' HG12 ' A' ' 157' ' ' ILE . 62.8 t80 -144.16 143.65 31.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 71.14 110.971 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -63.13 119.99 10.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.848 -0.427 . . . . 74.05 109.848 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 7.0 tt0 -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.493 -0.558 . . . . 71.31 109.493 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.4 -31.08 14.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 61.25 111.047 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 123' ' ' ASN . 1.6 m120 -98.16 129.99 44.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.81 -0.632 . . . . 71.4 111.19 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 125' ' ' ILE . 19.7 tptp -74.11 129.85 38.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.706 -0.479 . . . . 73.1 109.706 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.484 ' N ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 pt -141.95 137.6 30.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 65.51 112.045 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -79.49 -39.54 31.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.963 -0.562 . . . . 74.02 111.111 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.597 ' CD ' ' HE2' ' A' ' 151' ' ' HIS . 61.5 mm-40 56.69 39.65 29.62 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.531 0.567 . . . . 75.2 112.531 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.2 p 56.71 161.3 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.702 0.626 . . . . 75.44 112.171 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.6 157.05 7.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.775 2.317 . . . . 75.33 113.515 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 p -59.51 120.54 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.444 -0.798 . . . . 75.51 112.085 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 21.6 mm -83.91 127.2 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.181 0.515 . . . . 74.24 110.715 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -63.69 140.77 58.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.976 -1.011 . . . . 75.14 112.322 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 134' ' ' THR . 19.8 p30 -57.76 -47.88 81.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.255 0.55 . . . . 73.1 110.421 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.485 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.4 p -79.69 24.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.417 -0.81 . . . . 75.32 111.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.7 t -60.77 125.29 23.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.329 0.585 . . . . 74.34 111.304 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.428 ' HG3' ' H ' ' A' ' 137' ' ' THR . 22.3 tpt180 -71.53 173.25 8.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.204 -0.907 . . . . 74.35 110.573 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.428 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 35.6 m -39.37 146.17 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.879 0.371 . . . . 72.25 111.32 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.29 -10.08 28.79 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.177 -0.535 . . . . 61.43 112.264 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 1.9 mmp_? -141.68 32.15 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.721 -0.282 . . . . 71.21 111.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.5 mt -101.45 -55.8 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.247 0.546 . . . . 75.52 110.262 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.8 m120 -64.7 112.03 3.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 73.31 110.84 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -163.51 109.81 1.12 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.165 -0.471 . . . . 74.11 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 51.7 t30 -64.18 91.8 0.08 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.561 -0.745 . . . . 74.51 111.221 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 61' ' ' VAL . . . -48.92 -40.63 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.41 0.624 . . . . 73.22 110.091 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.523 ' NH2' ' SD ' ' A' ' 1' ' ' MET . 11.1 tpt180 -46.62 -36.41 6.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.96 -1.018 . . . . 75.51 110.902 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.41 -42.46 53.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 75.35 110.382 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.466 ' CG ' ' CD1' ' A' ' 59' ' ' LEU . 20.5 m-85 -48.91 -39.24 25.35 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.112 -0.495 . . . . 73.23 110.617 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -35.57 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.645 -0.707 . . . . 62.42 109.833 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.92 -59.27 2.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.802 -0.636 . . . . 74.23 111.849 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.586 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 10.6 ptpt -63.82 -45.12 91.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.416 0.525 . . . . 75.31 112.416 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.597 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 58.3 m170 -91.61 8.19 37.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 75.13 110.589 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.63 25.0 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.79 -0.641 . . . . 73.54 114.183 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 119' ' ' TYR . 14.6 mt -76.71 16.72 0.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.902 0.334 . . . . 74.31 111.902 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.53 -45.59 29.7 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.75 -0.738 . . . . 54.33 112.564 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -108.81 83.13 1.99 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.886 0.374 . . . . 72.04 110.116 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 44.3 Cg_endo -68.33 137.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.762 2.308 . . . . 73.11 113.456 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 119' ' ' TYR . 30.6 pt -79.33 -33.41 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.235 -0.654 . . . . 74.13 109.235 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 118' ' ' LEU . . . -142.34 142.87 32.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.665 -0.698 . . . . 72.44 110.734 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 16' ' ' THR . . . -153.58 157.88 40.36 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 74.23 109.215 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -165.61 118.62 1.15 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.632 -0.507 . . . . 75.34 109.632 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.2 OUTLIER -103.13 151.26 22.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.308 -0.86 . . . . 73.31 110.936 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -145.96 130.64 17.96 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.422 -0.808 . . . . 74.51 111.005 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.425 ' HB3' HD12 ' A' ' 111' ' ' LEU . 46.1 mt-30 -110.59 134.75 52.12 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.894 -0.594 . . . . 75.54 110.366 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.81 152.9 25.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.106 0.41 . . . . 75.02 112.106 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HG3' ' CD1' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -135.18 133.03 38.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.572 -1.269 . . . . 75.54 107.572 176.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.13 152.96 30.09 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.033 -0.358 . . . . 72.41 110.033 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.4 m-20 -52.84 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.742 0.782 . . . . 52.33 111.533 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.56 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.1 t70 -58.93 -3.29 0.32 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.141 -0.936 . . . . 74.14 111.078 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 167' ' ' ASP . 42.2 t80 -42.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.897 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.59 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 4.9 t -57.25 -51.83 78.75 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.184 -0.673 . . . . 73.14 109.184 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.3 Cg_exo -49.57 -18.7 2.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.523 2.149 . . . . 73.13 112.622 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 168' ' ' ASP . 73.1 mt -50.68 -41.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.395 -0.595 . . . . 74.41 109.395 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -55.19 -31.68 61.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.582 -0.736 . . . . 72.44 110.694 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -53.29 -43.05 67.2 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.426 -0.953 . . . . 71.41 108.426 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 168' ' ' ASP . 9.9 mptt -62.3 -31.04 71.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.381 -0.827 . . . . 74.54 110.09 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 7.1 m -66.43 -26.68 67.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.44 110.393 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.5 mm -48.72 107.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 74.42 111.017 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.9 m -154.15 25.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.69 0.256 . . . . 72.4 111.69 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.665 -1.075 . . . . 65.14 112.597 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 ttp . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 110.153 -0.314 . . . . 74.21 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 5.2 p-10 -69.19 67.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.481 0.549 . . . . 71.5 112.481 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.504 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 54.6 t0 -71.0 -52.16 21.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 71.11 110.578 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 9' ' ' LEU . 9.7 pt -135.4 49.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.212 0.53 . . . . 73.43 111.099 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.8 p -133.5 140.06 35.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.866 -0.607 . . . . 75.04 110.305 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.38 29.74 3.38 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.752 -1.353 . . . . 73.32 112.954 0.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.21 -47.26 78.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 74.35 109.839 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.5 m -163.69 -41.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 75.42 111.452 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.469 ' O ' HG13 ' A' ' 4' ' ' ILE . 31.4 tp -157.1 158.84 37.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.843 0.354 . . . . 75.13 111.319 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -52.34 -46.58 66.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.394 -0.595 . . . . 72.53 109.394 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -152.59 146.71 25.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.642 -0.708 . . . . 53.44 110.369 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.92 118.54 33.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.067 0.395 . . . . 75.34 112.067 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.06 -120.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 75.24 112.261 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.58 -43.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 74.32 110.345 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.52 -173.54 13.27 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.975 -0.631 . . . . 74.34 111.801 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -131.73 162.95 29.26 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.206 0.527 . . . . 75.14 111.052 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.31 137.75 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.21 -0.904 . . . . 75.43 110.758 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 29.1 mmmt -73.61 102.24 3.84 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.594 -0.521 . . . . 74.45 109.594 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 88.7 t -110.07 109.84 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 119.994 -0.682 . . . . 62.01 109.726 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.8 mp -100.38 124.03 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.661 -0.7 . . . . 73.43 109.771 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -76.74 -32.05 57.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.908 -0.587 . . . . 74.21 111.893 -178.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.13 -61.89 0.14 Allowed Glycine 0 N--CA 1.459 0.227 0 C-N-CA 120.767 -0.73 . . . . 73.23 112.175 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' HG22 ' A' ' 20' ' ' ILE . 32.6 t70 -173.42 -58.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 75.33 108.235 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -83.67 -45.15 13.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.944 -0.762 . . . . 72.21 108.944 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -69.67 131.6 44.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.25 -0.886 . . . . 74.0 112.389 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.543 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 5.9 tt0 -135.91 146.78 47.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 72.1 110.245 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 34.1 m -82.95 106.55 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.182 0.515 . . . . 74.31 111.912 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 11.6 mptt -74.57 92.5 2.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.307 0.575 . . . . 73.32 111.452 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.4 mp0 24.67 66.79 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 114.379 1.252 . . . . 74.32 114.379 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.07 -3.06 55.3 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 115.07 0.788 . . . . 53.22 115.07 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.464 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -58.84 167.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.33 0.565 . . . . 73.02 112.453 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 33' ' ' LEU . 4.0 tt0 -101.89 141.83 34.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.739 -1.119 . . . . 75.15 110.026 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' N ' ' HG2' ' A' ' 32' ' ' GLU . 10.7 mp -108.73 130.38 55.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 72.01 110.983 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.1 p -148.34 164.19 23.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.665 . . . . 74.13 110.542 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.469 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 64.3 Cg_endo -73.32 -40.76 1.13 Allowed 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.855 -1.31 . . . . 72.32 112.899 0.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.3 p -150.88 30.6 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.451 0.644 . . . . 63.31 110.837 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.03 -2.88 4.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 55.13 110.463 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 40' ' ' ASP . 30.3 m -68.74 -3.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.411 0.624 . . . . 74.2 109.937 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -65.72 6.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 75.22 112.282 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' CG ' HE22 ' A' ' 41' ' ' GLN . 14.1 t0 -136.18 148.72 48.27 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.048 0.451 . . . . 73.43 111.648 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.448 HE22 ' CG ' ' A' ' 40' ' ' ASP . 2.0 pm0 -73.13 144.41 84.77 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.849 . . . . 72.34 113.14 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.53 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 72.9 Cg_endo -77.1 131.61 12.06 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.18 2.587 . . . . 74.3 113.928 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -105.29 117.24 50.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.079 -0.51 . . . . 63.4 110.049 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 HG22 ' N ' ' A' ' 45' ' ' SER . 2.7 p -88.85 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.783 0.66 . . . . 73.32 112.783 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 66.7 m -160.77 133.25 6.17 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.49 -0.323 . . . . 73.1 111.438 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 9.4 p90 -106.35 24.98 11.65 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.86 0.362 . . . . 75.55 110.787 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 m -43.29 118.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.777 -0.647 . . . . 73.24 111.367 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 104.67 -33.84 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.092 -0.504 . . . . 71.05 112.245 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 8.0 mp -75.33 -37.74 60.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.913 0.387 . . . . 73.14 110.409 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 48' ' ' GLY . 10.0 pm0 -49.86 153.08 1.37 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.145 -0.48 . . . . 63.45 109.918 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.41 -73.24 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.679 -0.772 . . . . 75.0 111.937 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -148.89 108.93 4.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.773 -0.454 . . . . 73.43 109.773 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.49 ' HG ' ' HA3' ' A' ' 86' ' ' GLY . 2.8 p -158.83 143.13 15.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 72.33 110.999 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 10.7 t30 -74.09 -33.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.458 0.647 . . . . 73.02 109.328 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' HG ' ' ND2' ' A' ' 54' ' ' ASN . 59.6 mt -157.32 178.38 10.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 74.15 110.632 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 83.1 mt -142.44 165.02 28.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.696 -0.853 . . . . 74.21 108.696 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 119' ' ' TYR . 26.7 m -136.93 123.4 20.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.507 0.194 . . . . 73.54 110.689 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -122.75 127.3 49.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.152 -0.477 . . . . 74.44 111.059 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 147' ' ' PHE . 86.9 mt -146.79 141.03 26.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 74.43 111.278 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.8 ttm -94.28 129.55 40.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 75.35 109.629 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' C ' ' CD ' ' A' ' 63' ' ' PRO . 38.9 t -103.6 62.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.502 -0.317 . . . . 75.42 111.637 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 25.6 p-10 -112.45 46.55 0.3 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.066 0.395 . . . . 74.12 112.066 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HD2' HH22 ' A' ' 113' ' ' ARG . 57.5 Cg_endo -70.5 84.8 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.327 2.018 . . . . 71.34 114.289 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -168.87 114.35 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.391 0.615 . . . . 73.12 110.711 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.557 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -170.75 139.58 1.34 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.076 -0.965 . . . . 61.3 110.933 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.7 Cg_exo -65.0 -18.4 6.47 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.986 -1.256 . . . . 73.35 110.994 -0.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.0 t -165.17 146.48 7.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.169 -0.923 . . . . 65.44 110.036 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -49.3 -29.68 6.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.451 0.643 . . . . 75.35 110.481 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' CD ' ' N ' ' A' ' 69' ' ' GLN . 1.3 mp0 -69.9 -31.87 69.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.577 -1.192 . . . . 75.24 112.948 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' HD3' ' A' ' 71' ' ' PRO . 14.2 t0 -144.23 61.06 8.57 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 121.155 0.503 . . . . 55.24 110.031 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.52 ' CB ' ' HE ' ' A' ' 74' ' ' ARG . 7.5 Cg_exo -72.77 55.14 2.67 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.019 2.479 . . . . 74.33 113.627 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 70' ' ' ASP . 31.6 mttp -48.98 -54.8 14.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.405 0.52 . . . . 74.25 112.405 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.456 ' CE2' HD11 ' A' ' 76' ' ' ILE . 6.2 p90 -117.47 41.7 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.417 . . . . 74.11 110.956 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.52 ' HE ' ' CB ' ' A' ' 71' ' ' PRO . 2.4 tmm_? -82.87 141.87 31.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 72.23 110.424 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' OE2' ' ND1' ' A' ' 78' ' ' HIS . 11.8 pt-20 -94.9 178.5 5.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.917 0.887 . . . . 61.52 111.126 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 65' ' ' ALA . 13.0 mm -97.89 -120.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.673 . . . . 75.31 109.184 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.97 174.31 7.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.972 -0.751 . . . . 70.12 108.972 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.44 ' ND1' ' OE2' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -172.91 165.16 5.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.574 0.225 . . . . 73.12 110.791 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.421 ' HA ' ' HE3' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -99.76 120.86 40.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.788 -0.819 . . . . 75.24 108.788 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 12.5 p -141.41 127.9 20.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 75.55 112.454 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.18 136.48 20.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.87 -0.605 . . . . 73.44 109.472 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG22 ' OD1' ' A' ' 83' ' ' ASN . 31.3 m -138.11 166.62 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.554 -0.294 . . . . 71.04 111.112 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 125' ' ' ILE . 2.4 m120 63.68 33.15 13.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.363 -0.38 . . . . 63.32 110.502 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 4.0 mm -77.34 127.88 81.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.28 -0.568 . . . . 74.13 110.125 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.507 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 34.8 Cg_exo -54.07 127.91 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.26 1.307 . . . . 74.24 109.931 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.49 ' HA3' ' HG ' ' A' ' 53' ' ' SER . . . -64.17 56.75 0.07 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.146 0.819 . . . . 23.53 115.146 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 7.4 t 178.05 38.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 117.528 0.664 . . . . 74.03 111.572 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 69.6 m-80 -119.87 13.84 12.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.845 0.313 . . . . 75.44 111.845 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' SER . 20.8 pt-20 39.2 26.54 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.397 0.517 . . . . 73.23 112.397 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 17.3 p30 169.94 151.21 0.15 Allowed Pre-proline 0 C--O 1.236 0.356 0 CA-C-O 121.12 0.486 . . . . 74.42 110.731 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 83.3 Cg_endo -75.5 63.2 6.39 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 123.542 2.828 . . . . 61.21 112.86 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -104.12 -48.18 3.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.685 0.624 . . . . 74.44 112.685 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.44 -39.96 79.72 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 115.345 0.898 . . . . 63.34 115.345 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -61.52 171.74 8.43 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.65 -0.786 . . . . 63.01 114.044 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' VAL . 65.1 t60 -66.42 121.34 15.08 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.624 0.37 . . . . 74.24 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.7 t -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.876 -1.157 . . . . 72.15 107.876 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 127' ' ' GLU . 74.4 mt -63.68 -50.96 67.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.939 -0.763 . . . . 75.05 108.939 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 131' ' ' ILE . . . -143.24 125.6 15.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.762 -1.108 . . . . 73.44 109.367 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 133' ' ' ASN . 37.4 t0 -52.67 145.92 11.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.583 0.586 . . . . 53.44 112.583 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -65.15 151.15 46.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.301 -0.863 . . . . 73.34 110.685 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.501 ' CG2' ' H ' ' A' ' 102' ' ' GLY . 9.6 p -158.52 174.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.119 -0.491 . . . . 73.01 110.071 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.501 ' H ' ' CG2' ' A' ' 101' ' ' VAL . . . -67.76 178.88 18.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.391 -0.909 . . . . 73.25 111.994 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.6 m -55.33 159.01 2.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.869 0.335 . . . . 72.34 111.371 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.41 -57.32 1.06 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.827 -0.624 . . . . 61.31 113.263 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 88.8 Cg_endo -79.23 123.01 5.41 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.914 2.409 . . . . 75.11 113.58 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 108' ' ' ASP . 24.6 Cg_exo -62.67 162.49 24.63 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.041 2.494 . . . . 71.42 112.754 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.567 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -39.82 -24.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.743 -0.662 . . . . 74.43 112.456 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.567 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.8 m-20 -51.95 -39.34 59.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.005 -0.278 . . . . 62.54 110.604 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 66' ' ' PRO . 9.1 t -72.83 -14.92 61.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.459 0.647 . . . . 72.43 109.596 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 -130.01 9.42 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.136 -0.938 . . . . 72.41 112.187 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 163' ' ' GLN . 16.1 tp -66.48 127.83 33.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.455 -0.373 . . . . 75.05 111.966 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 164' ' ' ALA . 49.0 m170 -83.61 97.95 9.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.363 -0.38 . . . . 75.12 111.3 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.586 HH22 ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -75.89 68.35 2.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.565 . . . . 73.0 109.473 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.43 146.79 30.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.728 -0.669 . . . . 63.23 111.632 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 54.7 mt -144.41 140.88 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 112.689 0.625 . . . . 72.55 112.689 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -107.75 134.72 50.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.011 -0.995 . . . . 74.12 109.28 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -121.81 132.22 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.234 -0.284 . . . . 72.32 110.234 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.9 tp -124.15 136.8 54.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.464 -0.335 . . . . 72.11 110.952 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' THR . 53.6 t80 -141.97 134.96 28.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 73.3 110.417 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -72.62 133.4 44.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.383 -0.599 . . . . 74.42 109.383 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 151' ' ' HIS . 6.6 tp-100 -115.07 149.3 37.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.46 0.648 . . . . 63.33 112.452 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 88.1 tt0 -122.47 -38.97 2.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.009 -0.996 . . . . 73.34 111.24 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.72 134.6 34.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.308 0.484 . . . . 72.45 112.308 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -82.89 111.65 18.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.224 0.535 . . . . 72.22 110.932 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.512 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 1.3 pt -105.02 154.53 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.057 -0.974 . . . . 64.13 112.259 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -81.47 -49.97 9.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.924 0.392 . . . . 73.31 110.555 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 6.4 mm-40 59.71 36.62 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.776 1.028 . . . . 73.32 113.776 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.602 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 68.6 p 52.16 145.38 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 123.51 0.724 . . . . 71.42 112.798 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -44.05 143.07 3.48 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.494 2.129 . . . . 75.24 112.204 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.8 t -59.08 143.4 48.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.765 -0.652 . . . . 70.34 111.691 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 98' ' ' ALA . 6.6 tp -110.89 133.37 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 116.121 -0.49 . . . . 74.42 111.52 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 m -70.99 142.12 50.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.805 -0.634 . . . . 74.55 110.623 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 135' ' ' THR . 18.8 p-10 -51.87 -38.99 58.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 64.23 110.199 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.511 ' HA ' ' CD1' ' A' ' 177' ' ' ILE . 15.3 t -67.82 22.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.165 -0.47 . . . . 63.41 111.58 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 133' ' ' ASN . 11.7 t -64.11 128.31 35.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.869 0.366 . . . . 54.11 110.233 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.532 ' CB ' ' HA3' ' A' ' 179' ' ' GLY . 32.5 ttt180 -92.94 173.75 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.612 0.597 . . . . 71.41 112.612 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ARG . 20.9 m -26.32 131.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.557 -1.201 . . . . 75.02 111.61 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.3 4.86 32.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.468 -0.872 . . . . 62.23 111.16 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -146.93 35.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.741 0.305 . . . . 72.41 110.296 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 142' ' ' PHE . 13.6 mt -111.11 -71.04 0.78 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.219 -0.446 . . . . 75.35 111.257 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -51.61 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.356 -0.384 . . . . 73.32 110.154 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 1.5 t80 -150.47 72.49 1.1 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.249 0.833 . . . . 75.35 113.249 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -52.58 114.22 1.31 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.925 0.393 . . . . 74.22 110.752 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -48.26 -34.88 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.451 0.537 . . . . 74.33 112.451 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.4 ptt180 -43.69 -33.34 1.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.225 0.536 . . . . 75.21 111.099 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 145' ' ' ARG . 19.1 t70 -52.52 -46.1 66.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.571 -0.74 . . . . 64.53 111.306 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 142' ' ' PHE . 85.4 m-85 -53.28 -50.39 64.96 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.337 0.589 . . . . 65.41 110.905 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -56.25 -42.24 77.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.795 -0.639 . . . . 71.42 110.437 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.73 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 72.42 111.466 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.618 ' CG ' ' N ' ' A' ' 151' ' ' HIS . 45.8 pttt -75.2 -59.08 2.9 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.72 0.295 . . . . 75.11 111.535 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.618 ' N ' ' CG ' ' A' ' 150' ' ' LYS . 18.4 t-160 -80.7 4.97 17.03 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.055 0.391 . . . . 73.44 112.055 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.83 27.98 65.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.72 -0.752 . . . . 74.12 113.286 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 151' ' ' HIS . 25.6 mt -66.65 17.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 111.771 0.286 . . . . 72.4 111.771 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.65 -61.77 3.6 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.999 -0.62 . . . . 75.23 113.477 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.77 109.33 4.92 Favored Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.723 0.262 . . . . 72.41 111.145 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 154' ' ' GLY . 57.6 Cg_endo -89.86 132.46 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.402 2.068 . . . . 65.34 112.563 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.8 pt -80.95 -35.37 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 74.31 110.711 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.88 149.83 22.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.956 0.408 . . . . 72.33 111.46 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 9' ' ' LEU . . . -148.48 159.09 44.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.424 0.63 . . . . 73.34 111.319 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -155.2 144.61 21.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.042 -1.466 . . . . 72.23 107.042 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -149.76 176.25 10.86 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.718 -0.393 . . . . 73.31 111.398 -176.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 10.2 p90 -167.68 150.58 5.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.982 -0.554 . . . . 73.32 110.82 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.555 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 43.6 mt-30 -110.66 124.23 51.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 71.32 109.852 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -156.16 140.64 16.8 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.696 -0.402 . . . . 62.31 112.002 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -98.7 149.98 22.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.47 -0.567 . . . . 73.35 109.47 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.33 137.17 25.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.852 0.358 . . . . 73.32 111.165 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -150.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.679 -0.691 . . . . 72.15 112.648 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.491 ' O ' HG13 ' A' ' 172' ' ' ILE . 49.7 t0 -84.79 -23.6 29.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.133 -0.94 . . . . 73.2 111.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.417 ' CE1' ' NH2' ' A' ' 173' ' ' ARG . 17.2 t80 -41.81 -54.76 3.27 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.82 0.304 . . . . 72.34 111.82 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.62 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 69.2 t -65.64 -57.25 14.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.388 -0.525 . . . . 73.13 110.235 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 88.5 Cg_exo -45.18 -31.58 6.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.985 1.79 . . . . 74.03 112.05 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 168' ' ' ASP . 61.4 mt -51.91 -37.35 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.885 0.374 . . . . 74.33 110.307 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' NH2' ' CE1' ' A' ' 169' ' ' TYR . 0.2 OUTLIER -53.7 -33.6 55.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.775 -0.454 . . . . 74.31 109.775 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.515 ' HA ' HG12 ' A' ' 177' ' ' ILE . 69.0 m-80 -58.19 -31.65 67.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 71.22 111.031 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 2.6 mptp? -61.31 -13.57 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.29 -0.633 . . . . 75.32 109.29 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.2 m -98.32 8.23 45.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.318 -0.856 . . . . 75.33 111.292 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 174' ' ' ASN . 27.4 mm -69.83 117.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.015 -0.365 . . . . 72.14 110.015 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.34 -27.91 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 113.523 0.934 . . . . 55.02 113.523 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.325 -1.264 . . . . 53.03 112.294 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mmm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 111.534 0.198 . . . . 75.43 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.78 112.2 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 71.13 110.981 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -109.37 -57.15 2.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.853 -0.612 . . . . 72.42 112.242 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.559 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 12.9 pt -129.02 65.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.253 0.549 . . . . 74.34 111.085 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.2 p -141.37 143.92 32.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.028 -0.533 . . . . 73.14 111.17 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 2.7 Cg_exo -76.16 22.27 2.73 Favored 'Cis proline' 0 C--N 1.358 1.039 0 C-N-CA 124.454 -1.061 . . . . 73.41 112.334 0.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -49.51 -53.87 20.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.169 -0.923 . . . . 73.23 111.276 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 2.8 m -165.79 -40.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.73 0.641 . . . . 71.21 112.73 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 4' ' ' ILE . 22.8 tp -157.1 152.19 26.1 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.494 0.664 . . . . 75.21 112.372 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -60.54 -35.81 76.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.795 -0.639 . . . . 74.53 111.07 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.15 13.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 75.14 111.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.9 124.51 77.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.145 -0.48 . . . . 74.53 111.574 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -85.66 -117.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.957 2.438 . . . . 73.23 112.724 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.72 -46.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 122.931 0.492 . . . . 74.43 109.741 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.83 -158.72 13.63 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.371 -0.692 . . . . 71.14 111.371 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -147.92 167.59 24.45 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.519 0.676 . . . . 75.1 111.488 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.441 ' H ' ' HB2' ' A' ' 160' ' ' ASN . 13.1 mt -105.5 152.97 7.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.333 -1.303 . . . . 75.04 108.416 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.0 mmpt? -108.48 102.4 11.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.103 -0.499 . . . . 73.4 110.601 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 35.3 t -105.92 109.93 29.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.966 -0.753 . . . . 62.3 108.966 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 26' ' ' GLU . 67.6 mt -98.45 137.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.579 . . . . 74.32 110.846 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.83 -97.23 0.18 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.214 -0.903 . . . . 74.14 112.543 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.82 -44.59 88.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.601 -0.809 . . . . 75.43 113.544 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' H ' HD22 ' A' ' 25' ' ' LEU . 12.2 t70 174.34 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.272 -0.64 . . . . 61.32 109.272 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.22 -42.49 15.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.452 -0.795 . . . . 73.12 109.361 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 pt? -69.51 138.51 53.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.277 -0.874 . . . . 71.22 110.359 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 pt-20 -150.36 151.49 32.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.728 -1.123 . . . . 72.52 108.822 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 3.0 m -73.21 120.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.956 0.724 . . . . 64.33 112.956 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 31' ' ' ASN . 3.4 mptp? -104.11 111.97 24.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.455 -0.793 . . . . 72.41 112.512 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.0 mp0 29.04 67.77 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.606 1.336 . . . . 75.54 114.606 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' N ' ' HD1' ' A' ' 161' ' ' TYR . . . 76.92 5.17 84.2 Favored Glycine 0 N--CA 1.465 0.63 0 C-N-CA 121.043 -0.598 . . . . 51.1 112.844 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.2 OUTLIER -47.62 147.07 1.94 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.697 -0.752 . . . . 70.25 111.933 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -101.76 131.72 47.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.459 -1.246 . . . . 75.4 109.85 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 9.6 mp -96.96 124.92 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.157 0.503 . . . . 71.31 111.166 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 p -149.87 145.09 18.38 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.496 -0.775 . . . . 75.45 109.688 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -83.78 -113.26 0.0 OUTLIER 'Cis proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.936 -1.277 . . . . 75.14 112.965 0.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.0 p -67.47 61.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.532 0.568 . . . . 72.23 112.532 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.54 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.8 pt20 -119.11 -3.57 10.62 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.746 0.307 . . . . 65.5 111.226 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 33' ' ' LEU . 30.9 m -78.22 32.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.824 0.345 . . . . 73.11 110.921 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -105.64 -23.21 12.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.149 0.796 . . . . 73.12 113.149 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 1.4 m-20 -71.5 139.91 49.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.265 0.555 . . . . 62.43 112.032 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.31 130.53 93.19 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 115.496 -0.775 . . . . 71.32 110.045 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.15 126.31 13.56 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.999 1.799 . . . . 73.41 112.442 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -107.95 109.51 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 75.12 110.678 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.45 138.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.165 0.431 . . . . 74.44 112.165 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -165.3 164.07 19.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.758 0.313 . . . . 63.22 110.734 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p90 -141.16 37.12 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.817 -0.628 . . . . 75.22 110.27 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.1 t -50.78 112.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 74.02 111.355 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.72 -14.64 61.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.114 -0.565 . . . . 71.52 112.935 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -78.53 -28.12 46.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 71.52 110.943 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -72.75 -82.92 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.936 0.398 . . . . 72.4 111.429 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.559 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 78.77 -52.83 3.97 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.155 -0.545 . . . . 74.23 111.969 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.64 109.03 4.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.823 0.344 . . . . 72.43 110.139 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.488 ' HG ' ' HA3' ' A' ' 86' ' ' GLY . 3.0 p -157.95 141.33 15.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.529 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -86.3 -40.58 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.915 0.864 . . . . 74.42 109.41 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -149.98 157.52 43.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.044 -1.435 . . . . 74.41 107.528 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.8 mt -128.46 144.49 51.15 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.32 -0.552 . . . . 75.31 111.023 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.3 m -115.85 132.52 56.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.408 -0.814 . . . . 73.14 110.541 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.37 131.44 40.07 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.257 0.348 . . . . 72.34 110.348 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.0 mt -151.39 167.11 28.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.915 0.388 . . . . 75.01 111.732 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -94.88 146.03 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.633 -0.712 . . . . 73.32 109.469 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -131.28 49.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.056 0.455 . . . . 75.52 110.722 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 p30 -133.66 54.82 13.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.543 -0.753 . . . . 75.33 111.425 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.35 83.29 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.39 1.394 . . . . 75.51 112.048 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -150.18 109.11 3.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.19 -0.914 . . . . 61.3 110.211 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -167.54 137.83 2.32 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 60.54 110.348 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.614 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -78.38 -23.89 13.29 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.114 -1.203 . . . . 73.44 111.851 -0.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 109' ' ' THR . 5.8 t -145.86 140.85 27.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.366 -0.834 . . . . 72.31 111.064 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.528 HH11 ' CB ' ' A' ' 68' ' ' ARG . 5.6 ttp-105 -52.59 -29.18 24.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 70.41 111.743 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG2' ' OG1' ' A' ' 67' ' ' THR . 8.1 pt20 -80.0 -27.17 39.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.448 0.536 . . . . 73.31 112.448 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -144.67 60.41 7.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-O 120.988 0.423 . . . . 72.13 111.711 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 56.8 Cg_endo -69.24 58.98 1.35 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.063 2.509 . . . . 73.1 112.876 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 8.7 ptpt -57.37 -47.72 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.175 0.805 . . . . 71.22 113.175 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.614 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -105.71 35.66 2.8 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.106 -0.638 . . . . 73.33 112.221 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 25.2 ttp180 -70.24 131.61 44.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.179 -0.674 . . . . 73.41 109.179 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 42.6 mt-10 -93.65 169.34 10.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 72.12 110.618 -0.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.543 HG13 ' H ' ' A' ' 77' ' ' LEU . 10.6 tp -110.4 -134.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.467 -0.197 . . . . 73.03 110.467 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.543 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.1 mt -72.41 152.07 42.23 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.451 -0.574 . . . . 75.52 109.451 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.518 ' NE2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -163.87 157.07 18.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.722 0.267 . . . . 72.12 111.722 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.617 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 5.0 t-105 -99.96 117.65 34.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.915 -0.584 . . . . 74.04 109.978 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 6.1 p -141.13 134.45 29.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.995 -0.548 . . . . 61.02 112.073 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG21 ' CZ2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -142.76 142.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 70.1 110.021 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 83' ' ' ASN . 14.5 m -140.85 159.14 23.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.475 0.546 . . . . 71.21 112.475 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.556 HD22 ' HB2' ' A' ' 95' ' ' HIS . 15.0 p30 62.36 35.87 14.76 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 114.567 -1.197 . . . . 73.34 111.185 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.576 ' CG2' ' HA ' ' A' ' 91' ' ' PRO . 3.6 mm -73.62 127.63 88.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 70.31 109.742 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 23.9 Cg_exo -63.5 126.87 18.5 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 121.958 1.772 . . . . 75.24 111.755 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.488 ' HA3' ' HG ' ' A' ' 53' ' ' SER . . . -60.79 62.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.248 0.342 . . . . 63.02 113.602 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' PRO . 31.9 p -179.2 39.69 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.16 0.48 . . . . 74.01 110.942 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.31 -4.05 2.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.255 -0.429 . . . . 72.53 111.816 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 67.62 -36.64 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.222 0.609 . . . . 75.54 112.5 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 88' ' ' ASN . 1.6 p30 -127.71 153.42 77.8 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 64.21 110.609 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.576 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 77.5 Cg_endo -70.78 47.08 0.68 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.646 2.897 . . . . 74.21 113.803 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.8 m -93.49 -40.32 10.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 73.25 112.147 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.07 -13.11 61.44 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.906 -0.588 . . . . 74.11 114.241 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.468 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -98.33 172.08 26.11 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.405 -0.902 . . . . 72.54 113.404 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.556 ' HB2' HD22 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.69 126.61 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 75.43 111.496 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.414 ' H ' HG23 ' A' ' 130' ' ' THR . 85.3 p -88.11 94.5 9.83 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.999 -0.546 . . . . 71.23 109.895 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 131' ' ' ILE . 77.2 mt -50.06 -38.24 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 74.24 109.189 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -156.67 115.49 3.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.692 -1.14 . . . . 52.13 109.089 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.493 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 50.2 t0 -52.36 146.71 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.439 0.462 . . . . 73.35 111.982 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.617 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 47.7 p90 -69.81 129.61 40.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.212 -0.449 . . . . 75.42 110.598 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 102' ' ' GLY . 13.7 p -158.61 174.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.326 -0.397 . . . . 74.2 110.217 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' H ' ' CG2' ' A' ' 101' ' ' VAL . . . -72.04 -129.18 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.234 -0.984 . . . . 74.23 111.703 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.52 ' C ' ' HD3' ' A' ' 105' ' ' PRO . 47.6 t -175.48 -165.67 0.18 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.838 -0.801 . . . . 64.24 108.838 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.537 ' N ' ' HD3' ' A' ' 105' ' ' PRO . . . -128.58 54.89 0.77 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.766 -0.731 . . . . 74.33 111.65 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 104' ' ' GLY . 14.3 Cg_endo -87.96 120.7 1.39 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.499 2.133 . . . . 74.42 112.676 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' CG2' ' A' ' 109' ' ' THR . 73.5 Cg_endo -74.31 162.11 39.09 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.79 2.327 . . . . 73.23 111.759 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 109' ' ' THR . 17.6 pttp -43.55 -45.64 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.443 -0.344 . . . . 74.21 111.764 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.442 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -63.4 5.95 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.159 0.429 . . . . 71.44 112.159 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.527 ' HA ' ' HB ' ' A' ' 67' ' ' THR . 13.0 t -75.14 -25.68 58.58 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.144 0.497 . . . . 74.22 110.196 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.9 -165.11 42.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 71.14 112.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.8 tp -71.33 111.56 6.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.867 0.365 . . . . 72.04 111.492 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -88.85 131.99 34.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.31 110.987 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -103.55 90.54 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.742 -0.663 . . . . 75.24 109.922 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 10.2 m-85 -74.94 136.48 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.407 . . . . 73.53 111.242 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 161' ' ' TYR . 35.0 mt -130.03 138.22 54.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.83 -0.623 . . . . 75.3 112.053 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -120.74 136.81 54.77 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.465 -0.789 . . . . 73.34 109.439 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 117' ' ' LEU . 2.3 pp -118.47 149.32 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 75.14 109.895 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 157' ' ' ILE . 2.8 tt -133.94 134.87 43.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 73.34 109.592 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.456 ' HA ' HG12 ' A' ' 157' ' ' ILE . 53.3 t80 -139.88 136.71 34.22 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 75.02 111.448 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -73.7 124.71 26.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.752 -0.658 . . . . 74.35 109.71 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -110.78 145.31 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 75.1 112.351 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -118.63 -39.92 2.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.982 -1.008 . . . . 75.41 109.968 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.98 130.75 34.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.234 -0.439 . . . . 72.35 111.106 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -79.06 131.91 36.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.514 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.449 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -125.33 154.55 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.712 -0.676 . . . . 73.01 112.414 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.97 -33.79 15.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.747 -0.661 . . . . 70.42 111.786 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' A' ' 125' ' ' ILE . 0.5 OUTLIER 36.76 36.27 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.12 1.155 . . . . 75.53 114.12 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p 59.11 159.49 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-O 121.154 0.502 . . . . 73.14 112.165 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -53.88 152.45 23.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.637 2.225 . . . . 73.14 113.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 96' ' ' SER . 22.9 p -59.02 127.15 30.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.192 -0.913 . . . . 74.42 110.707 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.467 HG13 ' NH1' ' A' ' 139' ' ' ARG . 20.4 mm -91.85 124.94 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 74.15 111.644 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.0 m -69.76 147.98 49.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.998 -1.001 . . . . 73.04 112.09 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.493 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 16.6 p30 -50.55 -43.63 56.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 74.51 111.427 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.7 t -68.71 21.91 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.481 0.549 . . . . 64.1 112.481 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.6 t -65.16 122.34 16.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 74.11 110.884 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.682 ' HD2' ' N ' ' A' ' 137' ' ' THR . 5.0 tmm_? -82.49 160.76 22.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.53 -0.759 . . . . 73.11 111.652 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.682 ' N ' ' HD2' ' A' ' 136' ' ' ARG . 6.0 m -39.94 158.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.348 -0.842 . . . . 75.42 111.093 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.543 ' H ' HD13 ' A' ' 140' ' ' LEU . . . 116.81 3.95 17.51 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.127 -0.488 . . . . 75.2 112.483 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.467 ' NH1' HG13 ' A' ' 131' ' ' ILE . 17.8 ttm180 -167.86 48.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.888 0.375 . . . . 73.14 110.731 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.543 HD13 ' H ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -114.65 -56.45 2.38 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.321 -0.399 . . . . 73.14 110.314 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.597 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.1 m120 -63.81 66.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.853 -0.612 . . . . 73.12 111.691 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LEU . 14.3 t80 -138.77 121.72 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.522 -0.548 . . . . 71.12 109.522 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.566 HD21 ' HB2' ' A' ' 146' ' ' ASP . 22.3 t30 -63.6 122.28 15.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.215 0.531 . . . . 74.22 111.75 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.68 72.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.625 -0.716 . . . . 63.41 111.45 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -50.44 -35.14 27.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.459 . . . . 75.14 110.223 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' HB2' HD21 ' A' ' 143' ' ' ASN . 34.1 t70 -64.62 -44.12 91.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.426 0.631 . . . . 74.45 109.382 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.506 ' CD1' ' HD3' ' A' ' 150' ' ' LYS . 1.2 t80 -62.9 -38.35 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 61.42 109.574 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.511 ' HA ' HD13 ' A' ' 153' ' ' LEU . . . -65.36 -46.6 79.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.578 -0.737 . . . . 74.5 110.564 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.19 -55.08 23.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 52.25 110.624 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.22 -48.13 83.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 63.41 110.583 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.543 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 38.4 m170 -67.64 3.39 1.42 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 121.221 -0.191 . . . . 73.12 111.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 72.86 7.77 71.12 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.86 -0.686 . . . . 64.24 112.19 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 148' ' ' ALA . 9.5 mt -72.14 16.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.392 0.277 . . . . 75.43 110.883 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.91 -69.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.432 -0.889 . . . . 71.04 112.127 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 21.2 pt-20 -80.39 120.03 78.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.579 0.228 . . . . 73.24 110.839 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.38 125.44 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.936 1.757 . . . . 73.31 112.077 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 119' ' ' TYR . 27.2 pt -76.26 -33.94 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.476 -0.49 . . . . 74.42 110.012 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -146.52 144.61 29.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.924 -0.58 . . . . 65.03 110.507 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.68 31.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.424 -0.353 . . . . 74.25 110.884 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.441 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.0 t-20 -150.97 148.98 29.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.928 -1.138 . . . . 75.22 107.928 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.5 ' HB3' HG12 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -152.34 165.73 34.07 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.462 -0.495 . . . . 74.31 111.272 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.489 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.4 p90 -154.14 152.92 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.582 -0.735 . . . . 74.21 110.778 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.68 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.41 -0.589 . . . . 72.21 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.16 138.72 15.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.273 0.559 . . . . 61.21 111.856 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -118.28 144.97 45.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 73.31 109.153 178.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.9 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.156 -0.313 . . . . 75.54 110.156 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -100.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.511 -0.768 . . . . 75.3 112.322 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.438 ' OD1' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t0 -147.78 21.48 1.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.658 0.742 . . . . 72.22 109.949 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -76.45 -47.95 21.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.676 -0.693 . . . . 75.45 111.359 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 60.2 t -43.02 -50.34 13.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.052 -0.522 . . . . 74.34 112.271 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 51.2 Cg_exo -57.84 -37.01 97.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.068 1.845 . . . . 73.3 112.392 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.0 mm -50.12 -39.86 16.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.057 0.456 . . . . 75.32 110.977 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -69.98 -30.18 67.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 74.1 111.212 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 171' ' ' PRO . 1.6 m120 -56.02 -14.94 2.9 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.512 -0.313 . . . . 73.23 110.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.52 -20.08 7.07 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.605 -0.517 . . . . 73.02 109.605 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.0 m -68.34 -28.01 66.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.69 -0.686 . . . . 75.35 110.783 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 35.6 mm -54.6 130.79 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.703 . . . . 74.43 111.978 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 20.1 m -146.7 -14.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.066 0.765 . . . . 74.44 113.066 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.451 ' N ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.225 -1.32 . . . . 64.24 112.577 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.806 -0.442 . . . . 65.41 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.521 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 3.3 p-10 -67.41 72.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.606 -0.725 . . . . 73.4 109.596 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.09 -71.21 0.42 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.637 0.977 . . . . 72.43 113.637 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 9' ' ' LEU . 7.5 pt -97.11 46.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.528 0.68 . . . . 71.25 112.568 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 2' ' ' ASP . 7.1 p -128.14 142.37 44.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.551 -0.749 . . . . 72.02 110.372 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.514 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 64.0 Cg_endo -86.62 35.58 4.13 Favored 'Cis proline' 0 C--N 1.35 0.619 0 C-N-CA 124.115 -1.202 . . . . 74.55 112.932 0.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -64.33 -48.37 75.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 71.41 111.032 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 ' HB ' ' OH ' ' A' ' 161' ' ' TYR . 3.6 m -160.36 -37.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.689 0.626 . . . . 74.24 112.689 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 4' ' ' ILE . 48.9 tp -157.13 164.27 38.03 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.884 0.373 . . . . 71.24 110.899 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.88 -42.35 94.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.098 0.475 . . . . 72.44 110.095 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.87 -174.59 3.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.491 -0.777 . . . . 72.13 111.187 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.0 p -110.29 111.96 57.46 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.96 -0.564 . . . . 75.34 111.555 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 64.9 Cg_endo -83.95 -134.89 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.124 2.549 . . . . 70.34 112.117 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -150.46 -38.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.508 -0.314 . . . . 63.13 111.098 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -138.24 166.58 25.19 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.561 -0.828 . . . . 71.33 112.533 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -102.12 159.65 15.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.263 0.554 . . . . 73.25 111.506 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.41 131.24 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.698 -0.853 . . . . 71.31 108.698 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.552 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 6.8 mtpm? -74.03 102.98 4.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.516 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.611 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 46.9 t -117.52 110.59 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.111 0.481 . . . . 75.35 110.654 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.52 131.48 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.048 -0.524 . . . . 70.41 110.34 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.505 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -72.31 -51.08 22.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.36 -0.382 . . . . 71.04 111.516 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.1 -61.23 0.16 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.559 -0.829 . . . . 74.34 113.273 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.484 ' H ' HD23 ' A' ' 25' ' ' LEU . 1.9 m-20 -153.16 -59.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.028 0.442 . . . . 74.02 110.343 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -97.57 -38.5 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.684 -0.689 . . . . 74.15 111.071 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 pt? -69.71 135.62 50.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.396 0.617 . . . . 74.32 110.723 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -140.67 136.92 33.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.35 -0.841 . . . . 74.52 111.827 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.611 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 28.2 m -76.62 139.22 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.312 -0.858 . . . . 75.31 110.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HA ' HD22 ' A' ' 160' ' ' ASN . 41.6 pttt -155.12 122.32 5.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.857 1.058 . . . . 75.31 113.857 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 11.8 mp0 27.42 67.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.357 1.614 . . . . 73.32 115.357 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 161' ' ' TYR . . . 86.81 -7.98 77.69 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.993 -0.622 . . . . 72.41 114.3 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -50.44 129.93 22.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.597 0.236 . . . . 60.24 110.65 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -94.76 142.1 27.85 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.843 -0.428 . . . . 72.4 109.843 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 1.3 tp -101.86 127.99 48.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 74.33 110.995 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 66.9 p -149.91 157.42 37.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.478 -0.783 . . . . 70.41 109.692 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.5 Cg_exo -76.33 -47.88 0.29 Allowed 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.988 -1.255 . . . . 62.44 112.102 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 38' ' ' VAL . 74.2 p -151.46 25.69 0.69 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 72.23 111.395 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 39' ' ' LYS . 13.8 pt20 -63.33 0.41 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.37 0.605 . . . . 74.13 111.039 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 36' ' ' THR . 35.4 m -74.21 32.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.49 -0.777 . . . . 74.41 111.605 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -76.55 -31.69 57.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.977 0.418 . . . . 74.32 111.139 -179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 21' ' ' TYR . 14.9 m-20 -87.16 142.86 27.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.498 0.555 . . . . 71.1 112.498 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.05 139.05 92.65 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 115.6 -0.727 . . . . 73.43 111.092 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.505 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 20.2 Cg_exo -63.19 126.6 18.19 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.724 1.616 . . . . 70.12 112.078 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 mm -108.39 112.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.24 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HA ' HG22 ' A' ' 19' ' ' VAL . 57.2 t -86.07 142.23 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.554 0.576 . . . . 74.31 112.554 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.4 m -165.05 133.82 3.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.801 0.334 . . . . 70.2 111.253 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 15.0 p90 -108.66 32.41 4.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.44 0.638 . . . . 72.45 110.227 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.5 m -43.77 134.45 4.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.396 -0.82 . . . . 72.23 111.082 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.47 -29.86 4.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.86 -0.686 . . . . 71.02 112.975 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.73 -38.88 27.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.275 0.538 . . . . 73.45 110.25 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 13.1 tp10 -50.15 163.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.888 -0.597 . . . . 73.44 110.688 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.448 ' N ' ' HG3' ' A' ' 50' ' ' GLU . . . -170.12 -76.91 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.283 -0.727 . . . . 70.34 111.283 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -148.53 109.76 4.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.815 0.341 . . . . 73.4 110.295 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -151.31 141.72 22.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.028 -0.533 . . . . 72.45 110.02 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.89 -36.56 62.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.327 0.584 . . . . 73.43 109.474 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 121' ' ' GLN . 30.6 mt -155.28 164.84 38.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.998 -1.001 . . . . 74.44 110.455 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 35.0 mt -135.83 157.29 47.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.946 0.403 . . . . 74.23 110.92 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -117.94 121.89 41.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 72.43 109.674 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 1.1 tm? -127.07 128.71 46.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.256 -0.646 . . . . 72.51 109.256 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 80' ' ' SER . 43.5 mt -154.29 154.0 32.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.99 -0.284 . . . . 73.43 111.137 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -134.1 145.38 49.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.671 -0.492 . . . . 71.52 109.671 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 144' ' ' ALA . 8.8 t -150.62 164.76 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.867 1.062 . . . . 73.42 113.867 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -172.85 86.08 0.41 Allowed Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 113.594 -1.639 . . . . 73.15 107.211 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.98 84.69 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 123.204 2.602 . . . . 72.01 115.342 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -170.49 124.05 0.68 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.134 -0.484 . . . . 64.04 111.896 177.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.489 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.31 136.95 1.27 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.453 -0.34 . . . . 70.12 111.731 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.542 ' HG3' ' CE2' ' A' ' 73' ' ' TYR . 18.6 Cg_exo -66.26 -33.48 2.8 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.752 -1.353 . . . . 72.14 110.945 -0.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 3.5 t -130.21 157.34 42.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 72.43 109.872 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' NH2' ' A' ' 113' ' ' ARG . 23.8 ttt85 -58.37 -26.69 63.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.199 0.523 . . . . 75.5 109.785 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -78.2 -15.59 58.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.065 -0.97 . . . . 73.43 111.664 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 60.5 t0 -143.98 94.97 5.76 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.233 -0.439 . . . . 62.43 111.284 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.78 50.51 3.59 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.123 2.549 . . . . 75.43 112.027 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 7.2 ttmt -58.6 -54.74 43.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.309 0.855 . . . . 75.52 113.309 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.542 ' CE2' ' HG3' ' A' ' 66' ' ' PRO . 16.9 p90 -132.2 25.6 4.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.687 0.625 . . . . 75.51 112.687 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.483 ' HB2' ' N ' ' A' ' 65' ' ' ALA . 2.8 tmm_? -58.19 134.7 56.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 73.32 109.694 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -90.31 178.22 6.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.542 1.137 . . . . 64.2 111.177 0.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.2 mp -98.04 -61.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.357 0.599 . . . . 74.43 109.962 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -171.23 141.8 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.504 -0.925 . . . . 73.04 108.504 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.515 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 5.0 p-80 -137.57 176.01 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 74.23 111.581 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.553 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.4 t-105 -100.48 113.77 26.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.946 -0.761 . . . . 75.51 108.946 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.472 ' HB2' ' CD2' ' A' ' 59' ' ' LEU . 43.3 p -131.54 114.52 14.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.645 -0.707 . . . . 70.33 111.078 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.542 HG22 ' CZ2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -127.33 117.91 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 74.14 109.239 178.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -114.87 164.8 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.332 -0.849 . . . . 64.23 111.758 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.578 HD22 ' CG ' ' A' ' 95' ' ' HIS . 24.8 p30 52.16 43.9 30.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 71.15 112.374 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 4.4 mm -75.43 118.06 67.95 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.89 -1.152 . . . . 73.43 107.89 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.45 125.72 18.56 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.689 1.593 . . . . 74.34 111.725 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.07 61.23 0.08 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.371 0.419 . . . . 51.1 113.656 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -171.09 39.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.419 0.688 . . . . 71.03 109.318 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 55.7 m-80 -130.08 -28.07 2.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.511 -0.768 . . . . 74.43 111.787 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' HA ' ' NE1' ' A' ' 46' ' ' TRP . 2.2 tt0 76.0 -9.24 1.48 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.071 0.463 . . . . 72.41 110.776 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 88' ' ' ASN . 15.9 p30 -155.91 155.27 29.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.294 -0.866 . . . . 70.14 110.111 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 84.4 Cg_endo -73.75 60.75 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.655 0 C-N-CA 123.684 2.922 . . . . 75.14 113.21 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -90.96 -55.08 3.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.188 0.81 . . . . 70.31 113.188 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -10.85 75.13 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 116.445 1.338 . . . . 72.11 116.445 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.527 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -71.19 164.42 53.76 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.789 -1.196 . . . . 73.14 113.662 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.578 ' CG ' HD22 ' A' ' 83' ' ' ASN . 13.5 m80 -65.21 121.35 14.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.805 0.336 . . . . 61.51 111.597 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.412 ' H ' HG23 ' A' ' 130' ' ' THR . 8.9 m -87.81 89.38 7.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 71.52 111.305 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 127' ' ' GLU . 16.7 mt -61.66 -17.36 55.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.536 0.684 . . . . 72.34 111.339 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' N ' ' HG ' ' A' ' 80' ' ' SER . . . -167.92 116.06 0.75 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.344 -0.844 . . . . 74.51 108.957 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' HB3' ' CA ' ' A' ' 133' ' ' ASN . 28.4 t0 -60.06 151.82 25.65 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.595 0.559 . . . . 61.23 111.992 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.553 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -70.12 148.38 48.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 65.04 112.394 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.31 133.0 52.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.827 -0.624 . . . . 74.41 110.03 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.63 66.95 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.412 -0.899 . . . . 63.14 112.819 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.436 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 34.4 m -164.83 127.65 2.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 73.01 111.123 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.87 -73.32 1.09 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.84 -0.618 . . . . 62.02 112.659 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 31.7 Cg_exo -57.84 133.57 56.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.848 2.366 . . . . 74.53 112.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 32.3 Cg_exo -58.38 151.59 59.91 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.107 2.538 . . . . 63.35 113.563 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 168' ' ' ASP . 21.8 pttm -46.12 -26.94 0.84 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.178 -0.919 . . . . 74.24 111.344 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.54 -30.36 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 72.11 110.462 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 2.3 t -92.16 -26.7 18.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.278 0.561 . . . . 72.24 109.804 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.35 -100.5 0.81 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.578 -0.737 . . . . 75.15 114.886 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.91 125.41 22.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.661 0.744 . . . . 74.33 112.976 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 69.1 m-70 -116.04 123.01 46.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.622 -1.172 . . . . 74.14 110.097 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.526 ' NH2' ' NH1' ' A' ' 68' ' ' ARG . 36.8 mtm180 -94.47 85.25 4.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.811 -0.44 . . . . 71.1 109.811 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.436 ' OH ' ' HA ' ' A' ' 103' ' ' SER . 29.6 m-85 -70.33 114.5 8.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.128 -0.629 . . . . 74.43 110.676 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 60' ' ' MET . 38.4 mm -104.97 121.98 57.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 110.261 -0.274 . . . . 75.34 110.261 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 0.5 OUTLIER -102.54 128.51 49.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.856 0.462 . . . . 74.54 109.828 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.91 133.65 54.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 72.31 110.313 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 33.7 tp -128.64 131.76 48.08 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.169 -0.469 . . . . 75.3 110.459 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' THR . 60.7 t80 -144.02 138.2 28.2 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.744 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' NH1' ' CB ' ' A' ' 120' ' ' ARG . 12.7 ttp-105 -71.06 133.38 46.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.711 0.291 . . . . 72.31 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 1.2 mt-30 -109.39 109.73 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 71.24 110.467 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.98 -43.46 11.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.045 -0.724 . . . . 75.51 109.045 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 123' ' ' ASN . 1.0 OUTLIER -90.83 122.18 33.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.916 -1.038 . . . . 70.43 110.34 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 58.6 tttm -70.9 128.08 34.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.337 0.589 . . . . 72.03 111.385 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.74 132.65 59.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.972 -1.013 . . . . 75.01 110.541 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -56.35 -59.48 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 65.53 110.337 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' OE2' ' NZ ' ' A' ' 150' ' ' LYS . 27.8 mm-40 58.33 32.64 22.31 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.397 -0.82 . . . . 74.33 113.192 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.503 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 39.9 p 49.38 171.62 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 113.079 0.77 . . . . 71.24 113.079 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.503 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 36.9 Cg_exo -61.51 158.33 37.01 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.146 2.564 . . . . 65.45 113.295 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 96' ' ' SER . 20.7 p -58.75 124.71 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.843 -0.617 . . . . 72.52 111.398 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.17 121.82 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 73.52 111.243 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -73.42 147.36 44.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.597 -0.729 . . . . 75.13 112.27 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 135' ' ' THR . 10.9 t-20 -55.11 -35.01 64.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.03 -0.532 . . . . 64.51 111.962 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.8 t -67.06 21.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.622 0.248 . . . . 74.13 111.483 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.568 ' H ' ' C ' ' A' ' 133' ' ' ASN . 10.1 t -62.52 113.29 2.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.393 0.616 . . . . 72.21 111.089 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.532 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 41.8 ttt85 -89.08 173.21 8.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.849 . . . . 74.53 110.96 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 77.4 m -34.08 143.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.109 -0.496 . . . . 64.14 111.546 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.11 3.9 19.01 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.133 -0.556 . . . . 75.32 112.213 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -160.01 29.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.959 0.409 . . . . 74.5 110.775 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.278 0.561 . . . . 70.21 110.277 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 5.9 m120 -67.95 44.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.283 -0.872 . . . . 53.23 112.799 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 4.0 t80 -109.38 90.35 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.822 -0.436 . . . . 71.22 109.822 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.09 112.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 74.12 111.049 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.521 ' HA ' ' CE1' ' A' ' 147' ' ' PHE . . . -57.63 -32.9 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.072 -0.513 . . . . 74.43 111.203 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -50.41 -32.71 18.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.384 -0.371 . . . . 65.42 111.07 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -56.12 -34.51 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.104 0.478 . . . . 71.43 110.284 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.4 m-85 -49.76 -38.11 32.52 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.559 0.695 . . . . 75.21 109.687 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.47 91.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.221 -0.899 . . . . 73.33 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.39 -48.34 42.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 72.23 111.949 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.478 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -59.01 -41.12 86.93 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.167 0.432 . . . . 74.42 112.167 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.474 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 46.3 t60 -109.25 5.52 23.8 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.01 -0.676 . . . . 74.42 111.533 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 63.46 34.64 90.49 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.888 -0.673 . . . . 53.14 113.982 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 155' ' ' GLU . 11.3 mt -69.69 16.33 0.06 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.517 -0.402 . . . . 72.3 111.016 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -55.74 1.66 0.07 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 114.241 0.457 . . . . 75.14 114.241 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 153' ' ' LEU . 4.9 pt-20 -135.11 72.66 66.73 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.258 0.551 . . . . 65.14 110.154 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 31.9 Cg_exo -57.03 129.37 34.12 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.452 2.102 . . . . 72.14 112.131 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.1 pt -79.9 -38.18 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.495 -0.557 . . . . 75.41 109.495 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' GLY . . . -146.31 148.64 32.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.889 -0.596 . . . . 74.44 110.877 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -150.68 157.74 43.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.982 0.42 . . . . 70.24 111.568 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 1.8 t-20 -157.19 145.07 19.09 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.415 -0.958 . . . . 63.22 108.415 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 30' ' ' GLY . 17.9 p90 -155.03 157.46 37.64 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.759 -0.588 . . . . 75.15 111.945 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.53 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 5.6 p90 -153.54 163.78 39.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.613 -0.721 . . . . 74.5 111.24 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 44.5 mt-30 -122.53 124.89 44.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 73.14 110.469 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.14 152.11 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 75.34 112.411 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -127.18 148.1 50.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.346 -0.983 . . . . 73.32 108.346 177.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -137.38 152.69 49.94 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.02 0.378 . . . . 75.14 112.02 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.5 m-20 -54.93 163.34 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.765 -0.652 . . . . 74.14 111.865 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 171' ' ' PRO . 6.3 t0 -68.03 27.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.689 -0.687 . . . . 74.24 111.3 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 167' ' ' ASP . 21.2 t80 -82.28 -60.86 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.74 0.644 . . . . 75.22 112.74 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 14.6 p -62.14 -32.09 9.05 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 113.337 0.866 . . . . 71.43 113.337 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 81.7 Cg_exo -47.97 -30.02 13.03 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.74 1.626 . . . . 74.31 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.3 mm -49.35 -37.77 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.68 -0.691 . . . . 75.1 109.401 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -45.87 -42.79 12.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.471 -0.786 . . . . 72.02 109.953 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.446 ' HA ' HG12 ' A' ' 177' ' ' ILE . 72.1 m-80 -58.28 -39.4 79.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 73.31 111.465 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.54 -28.25 63.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 72.25 110.492 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.5 m -84.61 -4.13 58.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.954 -0.566 . . . . 70.2 112.335 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.532 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 33.0 mm -62.11 99.14 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.088 0.47 . . . . 73.14 111.006 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.83 -6.94 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.588 -0.733 . . . . 73.53 112.491 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.482 -1.177 . . . . 61.43 112.42 -178.515 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 110.104 -0.332 . . . . 73.31 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 110.22 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 73.23 109.302 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 64.3 t0 -89.63 -70.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.571 . . . . 65.42 112.38 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.8 58.94 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.389 0.614 . . . . 75.4 111.02 -178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.3 p -130.07 139.48 35.78 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 74.45 109.947 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.7 Cg_endo -85.57 35.13 3.64 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.139 -1.192 . . . . 75.31 113.113 0.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.67 -49.92 73.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.952 0.406 . . . . 73.34 110.42 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 m -163.65 -44.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.912 -0.586 . . . . 74.21 110.927 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' ALA . 29.2 tp -157.25 137.84 13.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.44 110.797 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.56 13.93 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.364 0.505 . . . . 61.24 112.364 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -171.2 137.52 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.319 0.247 . . . . 75.03 110.643 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.67 112.24 14.32 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.796 0.331 . . . . 72.52 111.698 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' ' 156' ' ' PRO . 52.2 Cg_endo -88.7 134.52 2.77 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.893 2.396 . . . . 71.33 112.761 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.52 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.461 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.82 -159.05 7.98 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.757 -0.656 . . . . 51.22 111.77 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -135.9 162.94 31.43 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.178 0.513 . . . . 73.5 111.31 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' CG2' HG21 ' A' ' 44' ' ' VAL . 10.2 mt -105.31 135.17 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 70.22 110.484 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 30.9 mmmt -74.56 106.05 5.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.686 -0.688 . . . . 71.4 109.683 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 60.1 t -121.58 110.45 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.666 0.746 . . . . 74.34 110.747 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 3.0 mp -96.01 134.63 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.216 -0.902 . . . . 63.42 109.465 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.456 ' CD2' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -81.67 -85.34 0.1 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.67 -0.412 . . . . 71.32 111.782 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -67.58 -49.84 47.47 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.35 -0.928 . . . . 70.23 112.447 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 34.9 t70 172.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.716 0.769 . . . . 74.15 109.019 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.58 -49.72 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.741 -1.118 . . . . 72.41 110.522 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 2.1 pt? -69.66 139.57 53.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.3 0.572 . . . . 61.45 111.581 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 69.5 tt0 -120.82 150.01 41.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.267 -0.879 . . . . 74.41 111.857 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 10.5 m -98.7 119.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.85 -0.796 . . . . 74.14 108.85 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' HD2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -139.08 128.58 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.757 0.789 . . . . 75.22 112.7 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.9 mp0 46.41 63.15 1.99 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.035 -1.438 . . . . 73.22 114.854 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 11.39 44.63 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 115.739 1.056 . . . . 74.31 115.739 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.24 139.48 35.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.779 0.789 . . . . 62.12 110.701 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.92 123.02 29.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.726 -0.472 . . . . 74.32 109.726 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.75 114.21 26.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.735 -0.386 . . . . 73.11 110.741 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -150.12 156.96 37.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 73.14 110.488 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.23 -100.4 0.0 OUTLIER 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.156 -1.185 . . . . 74.33 113.869 0.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -70.2 54.35 0.14 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.653 0.612 . . . . 74.42 112.653 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HZ2' ' A' ' 39' ' ' LYS . 18.0 pt20 -120.39 -6.32 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.98 0.419 . . . . 74.14 110.983 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.36 -6.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.12 -0.491 . . . . 74.53 111.911 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' HZ1' ' CG ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -81.44 -10.57 59.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.49 -0.323 . . . . 65.13 111.79 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.516 ' CG ' ' HZ1' ' A' ' 39' ' ' LYS . 87.3 m-20 -79.07 144.76 34.29 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.162 0.506 . . . . 61.02 112.193 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.8 pm0 -76.31 138.47 67.93 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.697 -0.683 . . . . 72.54 109.878 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -78.88 126.88 7.46 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.319 2.013 . . . . 71.14 113.215 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.6 mm -104.25 105.93 19.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.015 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 45' ' ' SER . 2.6 p -87.14 143.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 113.234 0.827 . . . . 74.22 113.234 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.473 ' N ' HG21 ' A' ' 44' ' ' VAL . 60.9 m -162.24 132.55 4.77 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.023 0.44 . . . . 65.54 110.965 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.683 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -112.34 26.92 10.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.023 -0.535 . . . . 75.42 110.399 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 t -41.41 123.35 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 63.51 111.644 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.89 -29.64 7.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.06 -0.591 . . . . 73.41 113.28 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.15 -31.19 58.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.145 0.472 . . . . 70.42 111.336 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -70.48 -65.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.858 -0.61 . . . . 74.2 110.922 -179.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.527 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 65.76 -75.88 0.11 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.737 -0.665 . . . . 74.33 112.499 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -148.71 110.08 4.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 73.13 111.492 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -151.4 145.01 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.645 . . . . 65.22 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 11.2 t30 -65.75 -39.5 91.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.775 0.798 . . . . 62.12 109.369 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 46.2 mt -158.48 162.17 37.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.522 -1.217 . . . . 73.14 110.06 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 81.5 mt -128.85 142.48 50.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.774 0.321 . . . . 75.31 110.393 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.1 m -113.63 118.14 33.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 74.33 111.245 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 59' ' ' LEU . 1.8 tm? -116.36 140.29 49.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.73 -0.47 . . . . 73.55 109.73 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 58' ' ' LEU . 89.5 mt -141.89 154.85 45.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.373 . . . . 72.44 111.207 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 79' ' ' TRP . 23.5 ttt -117.63 124.38 48.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 75.44 110.674 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 40.7 t -108.96 132.74 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.32 109.778 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 7.9 t70 -176.94 62.07 0.19 Allowed Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.408 -0.96 . . . . 74.24 108.408 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 22.4 Cg_endo -91.59 83.39 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.692 1.595 . . . . 75.33 114.073 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -171.13 107.93 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.279 -0.873 . . . . 73.44 110.796 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.686 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.07 135.58 1.24 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 121.127 -0.229 . . . . 75.53 111.299 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.686 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 Cg_endo -52.28 -15.28 0.44 Allowed 'Cis proline' 0 C--N 1.356 0.957 0 C-N-CA 124.32 -1.116 . . . . 72.43 111.946 -2.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 109' ' ' THR . 6.7 t -165.15 -175.89 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.505 -0.77 . . . . 74.45 110.003 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HD2' ' HB3' ' A' ' 64' ' ' ASP . 13.7 tpt180 -67.73 -34.9 77.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.03 0.443 . . . . 75.52 109.838 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -71.0 -45.21 64.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.506 -0.77 . . . . 72.42 112.957 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.493 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 49.0 t0 -108.8 103.15 50.92 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.628 -0.429 . . . . 73.34 111.11 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.22 52.92 2.99 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.66 2.24 . . . . 75.54 110.865 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -48.57 -31.48 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.909 -0.587 . . . . 74.42 110.287 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.512 ' HB2' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -166.47 56.17 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.328 -0.851 . . . . 71.24 109.736 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 74' ' ' ARG . 4.9 tmm_? -99.26 135.27 40.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.911 -1.495 . . . . 72.44 109.417 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 63' ' ' PRO . 21.6 mp0 -76.15 177.81 6.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.711 0.804 . . . . 72.32 111.9 0.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.577 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.4 tp -109.75 -173.55 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.822 -1.177 . . . . 70.53 107.822 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.8 mt -64.99 120.37 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.078 0.399 . . . . 71.34 110.917 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 60' ' ' MET . 36.5 m170 -107.78 169.24 8.72 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.102 -0.239 . . . . 74.3 110.724 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.6 t-105 -100.01 85.27 3.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.741 0.782 . . . . 71.11 110.215 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -98.99 127.21 44.86 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.784 -1.098 . . . . 73.02 112.704 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.91 124.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.553 -0.748 . . . . 74.42 109.115 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 127' ' ' GLU . 23.6 m -138.13 -176.5 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.012 0.434 . . . . 70.4 111.732 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 15.6 p30 52.13 37.26 21.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.962 -1.017 . . . . 74.4 109.518 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.503 ' CD1' ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm -78.93 106.56 4.52 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 114.891 -1.05 . . . . 73.2 108.737 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 87' ' ' SER . 2.3 Cg_endo -48.13 129.04 17.95 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.759 1.64 . . . . 73.42 111.788 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.3 69.67 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 O-C-N 123.412 0.445 . . . . 65.41 113.823 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' PRO . 44.0 t 179.81 47.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.378 -0.601 . . . . 73.41 109.378 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 90' ' ' ASN . 55.0 m-80 -135.16 -22.39 1.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.173 -0.921 . . . . 74.21 112.309 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 67.86 -15.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.869 0.322 . . . . 75.34 111.869 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 88' ' ' ASN . 5.3 p30 -153.84 156.45 32.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.882 -0.599 . . . . 65.11 109.666 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.54 56.67 1.75 Allowed 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.334 2.689 . . . . 74.42 113.975 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -104.15 -40.08 6.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.503 . . . . 73.23 112.02 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.43 -41.56 58.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.887 0.715 . . . . 45.24 114.887 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -63.07 170.35 14.71 Favored Glycine 0 N--CA 1.46 0.287 0 C-N-CA 120.993 -0.622 . . . . 63.44 113.179 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' HB2' HD22 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.14 121.28 18.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.876 -0.19 . . . . 75.15 111.296 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 95.8 p -82.09 116.22 21.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.837 -1.172 . . . . 52.22 107.837 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.457 HD22 ' HG3' ' A' ' 127' ' ' GLU . 11.2 mt -67.36 -55.01 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 72.14 109.968 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -137.03 125.05 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.293 -0.867 . . . . 71.45 109.146 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 9.9 t0 -52.17 148.57 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.86 0.362 . . . . 65.51 111.318 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.446 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 37.6 p90 -65.03 128.74 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.261 0.553 . . . . 73.43 111.071 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 9.9 p -106.38 113.79 43.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 75.11 110.472 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.81 6.97 23.14 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.679 -0.772 . . . . 50.12 112.25 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.421 ' H ' HG21 ' A' ' 101' ' ' VAL . 38.2 t -59.98 -97.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.02 0.378 . . . . 75.11 112.02 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.24 161.88 37.82 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.928 -0.653 . . . . 52.21 112.254 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HB2' ' CE1' ' A' ' 112' ' ' HIS . 31.8 Cg_exo -60.72 137.59 74.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.932 2.421 . . . . 75.22 112.565 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.76 161.26 42.73 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.727 2.285 . . . . 74.34 113.211 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -42.36 -23.28 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.185 -0.916 . . . . 73.44 112.026 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.2 m-20 -50.8 -35.4 31.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.514 -0.312 . . . . 74.1 111.582 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 12.4 t -103.75 8.8 37.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.335 -0.546 . . . . 70.13 110.968 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.488 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 54.45 -110.96 1.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.977 -0.556 . . . . 74.22 113.751 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 27.6 tp -63.83 162.38 13.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.437 0.637 . . . . 74.42 111.899 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.609 ' NE2' ' H ' ' A' ' 166' ' ' TYR . 8.2 m-70 -147.04 144.62 29.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 74.02 109.303 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -109.05 108.65 19.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.022 -0.362 . . . . 73.33 110.022 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -104.55 133.31 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.523 -0.547 . . . . 75.33 109.523 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 61' ' ' VAL . 26.8 mt -132.96 147.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.192 0.52 . . . . 64.34 111.54 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -120.84 134.31 55.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.237 -0.892 . . . . 75.22 109.395 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 18.5 tp -119.9 140.15 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.144 0.277 . . . . 74.41 110.475 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 62.6 tp -134.79 135.49 41.84 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.39 -0.368 . . . . 71.51 111.09 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' HA ' HG12 ' A' ' 157' ' ' ILE . 37.7 t80 -144.25 142.85 30.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 75.32 110.553 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -71.47 128.33 35.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.024 0.44 . . . . 75.51 110.626 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.409 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 56.8 tp60 -103.91 115.15 29.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.534 -0.757 . . . . 73.2 110.437 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.451 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 37.2 tt0 -87.04 -37.98 16.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.231 -0.44 . . . . 74.35 111.413 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -112.19 135.12 53.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.701 0.286 . . . . 74.23 111.253 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.531 ' NZ ' ' O ' ' A' ' 125' ' ' ILE . 26.2 tptp -65.42 119.33 10.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.928 -0.578 . . . . 74.11 111.471 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 2.9 pt -98.73 131.89 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 75.1 109.754 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.16 -57.89 5.91 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 65.32 110.906 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.569 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 66.11 13.0 8.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.84 1.052 . . . . 74.54 113.84 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.532 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 25.2 p 51.21 162.98 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.613 0.968 . . . . 74.11 113.613 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.532 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 18.6 Cg_endo -58.24 151.4 60.07 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.88 2.387 . . . . 65.51 112.974 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 89.1 m -60.0 151.3 26.65 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.008 0.744 . . . . 74.32 113.008 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.93 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.802 -1.09 . . . . 72.02 109.595 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.547 ' C ' ' H ' ' A' ' 134' ' ' THR . 27.6 t -71.12 148.31 47.56 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.643 0.258 . . . . 73.54 111.528 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.488 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 24.9 p30 -65.4 5.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.156 0.503 . . . . 75.44 110.348 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 132' ' ' SER . 64.5 p -114.26 15.19 18.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.497 -0.774 . . . . 70.12 111.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -62.82 133.91 55.44 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.555 -0.458 . . . . 62.11 110.698 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 137' ' ' THR . 22.4 tpp180 -71.83 170.99 12.48 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.34 -0.391 . . . . 75.31 110.668 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.535 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 66.2 m -40.57 145.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.619 . . . . 75.23 110.231 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.33 -22.04 11.42 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.993 -0.843 . . . . 74.31 110.993 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -131.21 24.16 4.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 74.51 110.113 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.2 mt -94.07 -56.37 2.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.53 0.681 . . . . 73.45 109.501 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.512 HD22 ' HB2' ' A' ' 73' ' ' TYR . 4.3 m120 -79.55 121.36 25.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 74.31 111.66 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' HE2' ' CZ ' ' A' ' 147' ' ' PHE . 5.7 t80 -167.79 115.87 0.76 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.938 -1.028 . . . . 74.53 109.993 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -71.44 110.65 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.736 -0.666 . . . . 74.14 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.65 -28.88 57.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.401 0.62 . . . . 73.13 110.073 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -52.63 -23.54 6.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.178 -0.919 . . . . 75.54 111.001 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.41 -46.94 81.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.878 0.37 . . . . 72.11 111.248 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.519 ' HA ' ' CD ' ' A' ' 150' ' ' LYS . 76.1 m-85 -45.33 -49.15 13.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.114 -0.494 . . . . 74.25 111.847 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.21 51.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.912 -0.586 . . . . 74.55 111.073 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.07 -51.85 6.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.306 0.484 . . . . 64.35 112.306 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.519 ' CD ' ' HA ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -53.68 -50.55 65.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 73.51 111.817 -178.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.507 ' HB2' ' HG ' ' A' ' 153' ' ' LEU . 33.7 m-70 -103.63 11.38 36.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.692 0.282 . . . . 75.51 111.494 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 53.26 28.93 36.12 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.619 -0.8 . . . . 73.33 112.722 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 11.6 mt -67.6 7.44 0.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.904 0.335 . . . . 75.12 111.904 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -30.23 -59.96 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.375 -0.44 . . . . 64.52 113.836 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.31 112.69 19.88 Favored Pre-proline 0 N--CA 1.465 0.284 0 N-CA-C 111.631 0.234 . . . . 74.03 111.631 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HG2' ' HA ' ' A' ' 13' ' ' PRO . 69.7 Cg_endo -92.15 127.32 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.536 2.157 . . . . 73.11 112.888 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.525 HG12 ' HA ' ' A' ' 119' ' ' TYR . 42.9 pt -75.98 -34.65 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 71.11 110.452 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.14 149.7 26.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 63.13 111.246 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' CB ' HD21 ' A' ' 9' ' ' LEU . . . -151.49 154.41 36.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.804 -0.635 . . . . 74.44 110.081 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -152.46 133.61 14.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.245 -1.02 . . . . 72.32 108.245 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.529 ' CE2' ' HA ' ' A' ' 29' ' ' GLN . 2.1 p90 -138.71 156.08 47.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.457 -0.338 . . . . 75.31 111.486 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.49 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 p90 -154.34 150.42 27.93 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.171 -0.468 . . . . 73.23 111.363 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -110.98 133.1 53.66 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.905 -0.589 . . . . 71.32 111.179 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.71 149.44 25.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.249 -0.887 . . . . 72.31 109.852 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.513 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -103.34 132.9 49.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.562 -0.533 . . . . 73.03 109.562 178.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.609 ' H ' ' NE2' ' A' ' 112' ' ' HIS . 2.3 m-85 -109.29 129.18 55.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.657 0.265 . . . . 73.04 110.768 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -125.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.59 . . . . 71.34 111.942 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.607 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 22.7 t0 -129.77 -20.63 3.17 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.882 -0.599 . . . . 65.51 111.281 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.509 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 17.9 t80 -68.32 -69.22 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.142 0.793 . . . . 75.11 113.142 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.643 ' CG1' ' HD3' ' A' ' 171' ' ' PRO . 7.5 p -50.01 -37.36 25.9 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 111.996 0.369 . . . . 74.43 111.996 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.643 ' HD3' ' CG1' ' A' ' 170' ' ' VAL . 50.2 Cg_exo -54.03 -12.25 3.38 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.512 2.141 . . . . 73.33 111.688 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.8 tp -45.77 -30.57 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.662 -0.699 . . . . 73.1 111.842 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -53.19 -46.76 69.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 119.906 -0.718 . . . . 71.15 109.513 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.446 ' HA ' HG13 ' A' ' 177' ' ' ILE . 44.6 t30 -63.83 -37.12 86.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.316 -0.624 . . . . 75.45 109.316 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -68.67 -27.97 66.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.576 -0.738 . . . . 71.45 110.18 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.9 m -97.1 13.1 30.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.929 -0.578 . . . . 74.23 112.524 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.513 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 31.6 mt -64.95 140.86 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 74.35 109.382 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.51 ' HA ' ' NH2' ' A' ' 136' ' ' ARG . 29.3 m -143.17 -25.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.72 1.007 . . . . 64.44 113.72 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.317 -1.269 . . . . 75.32 112.728 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.64 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.033 -0.358 . . . . 74.32 110.033 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 60.92 33.46 19.85 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.336 0.588 . . . . 73.44 111.248 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.7 t70 -67.47 -48.09 68.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 74.43 111.513 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.4 pt -114.95 44.7 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.245 0.545 . . . . 71.03 111.845 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.5 p -110.9 137.74 20.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.994 -0.548 . . . . 71.31 111.013 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 68.2 Cg_endo -93.55 32.92 10.11 Favored 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.129 -1.196 . . . . 74.31 112.113 -0.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -51.45 -51.58 53.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 61.34 110.563 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.2 m -160.32 -35.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 74.1 111.706 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' HD3' ' A' ' 13' ' ' PRO . 27.6 tp -157.25 172.39 18.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 74.1 111.056 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 3' ' ' ASP . 9.4 p-10 -78.3 -38.04 43.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.089 -0.708 . . . . 72.2 109.089 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -152.55 131.65 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.611 -0.722 . . . . 75.22 109.905 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 7.2 p -59.82 126.4 83.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.134 0.42 . . . . 74.3 112.134 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.467 ' HD3' HD22 ' A' ' 9' ' ' LEU . 71.6 Cg_endo -96.22 -117.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.758 2.972 . . . . 74.24 111.9 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -166.46 -42.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.607 -0.269 . . . . 72.51 111.33 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 158.36 17.98 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.778 -0.725 . . . . 64.44 113.575 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -102.83 152.17 21.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.011 0.434 . . . . 64.31 110.48 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.432 ' CD1' ' HB2' ' A' ' 118' ' ' LEU . 9.2 mt -105.73 123.4 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.962 -0.755 . . . . 74.13 108.962 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.3 OUTLIER -73.98 102.57 4.18 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.455 -0.793 . . . . 72.14 109.581 -178.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 59.2 t -111.0 110.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.875 -0.787 . . . . 75.01 108.875 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 2.6 mp -104.54 128.5 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.794 -0.639 . . . . 73.42 111.302 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -96.64 -84.93 0.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.159 -0.928 . . . . 74.31 110.867 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.69 3.15 0.27 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.594 -0.73 . . . . 62.32 113.274 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.566 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER 85.37 -43.96 0.06 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.896 -1.149 . . . . 74.23 107.896 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.76 -37.39 19.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.999 -1.0 . . . . 72.14 108.712 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -79.31 163.14 25.14 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.215 -0.902 . . . . 74.05 112.496 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 23.2 tt0 -151.7 127.75 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.758 -1.11 . . . . 64.14 110.288 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' CB ' ' HB3' ' A' ' 162' ' ' TYR . 4.3 m -71.64 128.18 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.322 0.582 . . . . 71.0 111.711 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 73.4 mmtt -112.59 111.37 22.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.518 0.932 . . . . 73.32 113.518 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.446 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 7.4 mp0 31.06 67.54 0.13 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.804 1.409 . . . . 73.21 114.804 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.69 4.58 89.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.343 -0.456 . . . . 74.14 113.448 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -55.57 146.76 19.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.311 0.577 . . . . 63.12 112.297 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.37 140.85 32.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.98 -1.009 . . . . 72.34 111.191 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.27 132.4 52.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 72.1 110.761 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.454 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 8.8 p -140.66 161.72 52.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 75.33 109.849 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 83.8 Cg_endo -82.09 -33.16 3.12 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 124.142 -1.191 . . . . 74.31 113.404 0.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.444 ' O ' ' CG2' ' A' ' 36' ' ' THR . 85.1 m -156.65 42.92 0.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.285 0.564 . . . . 64.21 111.462 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -92.76 0.23 57.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.413 0.625 . . . . 73.51 110.797 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.65 -7.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.479 -0.782 . . . . 74.15 111.284 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -11.32 60.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.145 -0.479 . . . . 73.14 110.608 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.35 133.3 35.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 62.12 111.434 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.7 pm0 -62.9 138.69 97.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 71.24 110.087 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.16 126.51 13.13 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 121.8 1.666 . . . . 74.13 112.516 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.5 mm -100.77 114.73 40.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 62.41 110.288 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 p -85.54 140.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.399 0.518 . . . . 72.12 112.399 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 14.4 m -161.98 139.21 8.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.952 0.406 . . . . 71.04 110.347 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.634 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.4 p90 -121.68 29.8 7.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 74.24 110.352 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.7 t -44.94 137.15 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 65.42 110.225 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.19 -32.51 3.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.654 -0.784 . . . . 63.45 112.239 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -79.5 -41.29 27.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.708 0.766 . . . . 75.35 109.094 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.634 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.0 tt0 -53.52 105.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.698 -1.137 . . . . 73.23 110.558 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.3 -114.86 1.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.1 -1.2 . . . . 72.22 110.1 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -80.56 109.19 14.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.635 -0.826 . . . . 71.01 109.373 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.78 141.79 15.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.444 -0.344 . . . . 62.42 111.532 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.7 t30 -89.26 -42.19 11.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.791 0.805 . . . . 75.21 109.583 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 76.9 mt -152.36 170.0 21.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.686 -1.143 . . . . 71.13 108.595 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.4 mt -138.38 153.15 48.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.466 -0.494 . . . . 71.4 111.764 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.5 m -121.42 130.62 53.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.743 -0.662 . . . . 74.11 110.215 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -128.87 123.91 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.253 -0.647 . . . . 71.24 109.253 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -143.16 161.78 37.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 75.43 113.017 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -94.89 146.69 24.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.203 -1.362 . . . . 73.12 109.974 179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 76.8 t -134.09 137.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.363 . . . . 73.44 111.288 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' CG ' HH21 ' A' ' 68' ' ' ARG . 52.5 t0 83.32 59.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 114.945 -1.025 . . . . 71.44 111.52 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 57.4 Cg_endo -71.28 123.01 9.21 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.509 2.14 . . . . 75.24 111.9 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 25.8 p-10 -118.36 120.76 38.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.68 0.622 . . . . 74.21 112.68 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.575 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.65 135.98 1.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.434 0.531 . . . . 74.3 112.434 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 55.3 Cg_endo -74.2 -3.75 17.53 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.217 -1.576 . . . . 75.11 109.794 -2.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -165.01 156.72 15.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.967 -1.015 . . . . 72.51 110.373 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG2' ' CB ' ' A' ' 64' ' ' ASP . 6.5 mtp-105 -68.33 -12.74 61.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.812 -0.631 . . . . 74.31 110.951 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.32 -32.94 24.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.889 -0.596 . . . . 61.44 112.252 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -144.08 116.13 5.6 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-O 120.713 0.292 . . . . 64.03 110.471 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.09 52.5 4.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.039 2.493 . . . . 73.24 112.302 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 95.9 mttt -48.93 -27.29 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 75.1 111.637 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.428 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 25.3 p90 -155.55 29.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.299 0.571 . . . . 74.34 110.781 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.492 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 5.7 tmm_? -70.52 136.13 49.12 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.144 -1.058 . . . . 71.1 108.144 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 14.2 mp0 -88.61 159.09 18.04 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.236 1.014 . . . . 73.44 111.873 0.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.575 ' HB ' ' CB ' ' A' ' 65' ' ' ALA . 9.1 tp -97.37 171.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.442 -0.799 . . . . 74.11 109.696 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' H ' HG13 ' A' ' 76' ' ' ILE . 13.9 tp -42.72 112.89 0.4 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.553 0.692 . . . . 74.13 110.297 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.401 ' ND1' ' OG ' ' A' ' 80' ' ' SER . 19.6 p80 -104.22 160.28 15.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.572 -1.195 . . . . 65.45 113.285 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.5 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 10.5 t-105 -100.43 116.19 31.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.579 -1.267 . . . . 73.2 107.579 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.401 ' OG ' ' ND1' ' A' ' 78' ' ' HIS . 0.1 OUTLIER -141.04 135.4 31.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.229 0.825 . . . . 72.22 113.229 -176.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.66 138.5 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.58 -0.737 . . . . 70.42 110.893 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.2 m -142.05 169.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.603 . . . . 75.53 112.44 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 24.8 p30 51.82 36.18 17.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.562 -1.199 . . . . 72.22 112.132 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' CG2' ' HA ' ' A' ' 91' ' ' PRO . 5.1 mm -69.02 125.81 92.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.715 -0.846 . . . . 73.02 108.715 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -58.75 126.28 20.75 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 121.429 1.419 . . . . 74.33 110.902 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.81 60.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.321 0.488 . . . . 54.04 114.321 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.1 m -174.97 43.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.935 0.494 . . . . 55.04 110.255 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.1 m-80 -135.31 8.94 3.44 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.528 0.936 . . . . 74.54 113.528 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER 64.65 -26.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.062 0.393 . . . . 74.01 112.062 177.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.623 ' H ' ' C ' ' A' ' 88' ' ' ASN . 14.8 p30 -154.05 172.63 5.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.187 0.595 . . . . 74.43 109.932 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.591 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 6.1 Cg_exo -79.74 23.9 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.643 2.896 . . . . 72.44 115.529 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -79.63 1.11 27.39 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.856 -1.138 . . . . 53.51 112.985 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.11 2.1 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.495 -0.86 . . . . 54.51 113.609 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 84' ' ' ILE . . . -64.7 176.49 10.98 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.229 -0.51 . . . . 72.42 113.669 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -66.36 121.12 14.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.389 0.514 . . . . 73.02 112.389 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.1 p -86.26 89.32 7.81 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.924 -0.769 . . . . 74.22 108.924 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.4 mt -50.28 -53.83 25.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 74.4 110.484 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.66 120.38 13.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.958 -1.019 . . . . 62.32 108.714 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 54.5 t0 -60.21 146.82 42.2 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.6 0.563 . . . . 74.11 112.084 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.5 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 21.2 p90 -66.38 142.82 57.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.892 -0.595 . . . . 74.43 110.295 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 133' ' ' ASN . 21.4 m -140.38 145.03 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.696 0.284 . . . . 75.5 111.528 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -85.03 0.07 89.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.925 -0.655 . . . . 51.23 111.642 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 t -58.93 -91.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.561 -0.319 . . . . 73.42 110.604 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 -167.99 5.03 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.909 -0.662 . . . . 74.42 114.224 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.68 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 44.8 Cg_endo -65.74 145.5 81.28 Favored 'Trans proline' 0 N--CA 1.476 0.477 0 C-N-CA 123.67 2.913 . . . . 72.3 113.107 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.58 160.68 48.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.066 2.51 . . . . 74.43 113.332 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.481 ' CE ' ' HA ' ' A' ' 167' ' ' ASP . 35.8 ttmt -44.03 -25.09 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.092 -0.504 . . . . 75.54 111.055 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.46 -37.87 40.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 64.35 111.422 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.414 ' CG2' ' CE1' ' A' ' 112' ' ' HIS . 11.4 t -76.4 -19.44 58.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.525 -0.47 . . . . 75.44 111.839 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.92 -129.8 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.599 -0.81 . . . . 74.3 113.32 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 44.7 tp -67.49 135.28 52.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.01 0.744 . . . . 75.24 113.01 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.68 ' CE1' ' HG2' ' A' ' 105' ' ' PRO . 67.1 m-70 -108.71 142.87 38.59 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.511 -0.768 . . . . 75.5 108.947 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.628 HH12 ' NE2' ' A' ' 163' ' ' GLN . 5.5 ptm85 -130.38 84.5 2.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.145 -0.687 . . . . 73.41 109.145 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.11 136.28 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.476 -0.784 . . . . 75.45 111.995 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 161' ' ' TYR . 48.5 mt -113.99 137.02 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.753 -1.112 . . . . 75.2 111.034 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -99.91 141.97 32.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.132 -0.485 . . . . 75.31 110.294 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.24 129.74 46.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.544 -0.298 . . . . 74.21 110.447 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . 2.7 tt -126.44 134.31 51.0 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.257 -0.428 . . . . 75.14 110.613 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.517 ' HA ' HG12 ' A' ' 157' ' ' ILE . 49.9 t80 -144.01 148.52 35.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.913 0.387 . . . . 75.41 111.408 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -83.43 134.68 34.86 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.628 -0.508 . . . . 75.23 109.628 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -118.06 139.15 51.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.708 -0.224 . . . . 75.02 110.457 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -110.5 -34.79 6.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.415 -0.357 . . . . 71.42 110.96 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 123' ' ' ASN . 2.4 m120 -96.09 130.4 43.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 74.02 111.107 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 23.3 tptm -73.08 143.04 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.566 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.402 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.9 OUTLIER -141.29 144.55 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 75.32 111.732 -179.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -86.73 -31.09 21.15 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.86 0.725 . . . . 73.33 109.733 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' ND2' ' A' ' 83' ' ' ASN . 0.4 OUTLIER 29.17 56.33 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.39 -1.277 . . . . 75.04 113.712 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.465 ' OG1' ' NH2' ' A' ' 139' ' ' ARG . 51.8 p 60.96 138.2 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 114.585 1.328 . . . . 75.32 114.585 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.03 158.24 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.996 3.131 . . . . 61.42 113.764 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 18.5 p -62.18 138.88 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.428 -0.805 . . . . 73.14 113.067 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.82 129.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.03 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 t -72.33 153.19 41.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.985 0.735 . . . . 70.54 112.985 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.489 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 17.3 p30 -57.92 -26.58 62.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.158 -0.928 . . . . 72.01 109.595 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 69.7 p -85.97 14.74 5.71 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.279 -0.873 . . . . 75.14 111.953 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.6 t -67.79 130.89 44.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.274 0.559 . . . . 64.13 112.204 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.602 ' HG2' ' N ' ' A' ' 179' ' ' GLY . 17.2 mmm180 -77.37 173.21 12.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 73.42 110.501 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.3 m -54.25 159.55 1.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 75.15 110.144 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.22 -7.8 18.56 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.698 -0.763 . . . . 74.34 112.417 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.534 ' HG3' HH11 ' A' ' 139' ' ' ARG . 16.8 ttt85 -152.94 8.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.132 0.491 . . . . 75.05 110.956 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 142' ' ' PHE . 0.9 OUTLIER -88.72 -39.77 13.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.007 -0.738 . . . . 75.43 109.007 177.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 4.3 m120 -63.24 69.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.43 -0.805 . . . . 75.44 109.408 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 140' ' ' LEU . 60.0 t80 -127.73 128.81 46.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 74.21 111.741 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 145' ' ' ARG . 17.8 p-10 -95.36 135.04 37.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 72.23 111.36 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.48 71.56 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.324 0.583 . . . . 73.42 110.435 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.517 ' HB3' HD21 ' A' ' 143' ' ' ASN . 26.3 tpt85 -43.81 -29.93 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.939 -1.028 . . . . 74.34 111.549 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' OD2' ' NZ ' ' A' ' 150' ' ' LYS . 13.6 t70 -60.17 -58.34 8.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.185 0.517 . . . . 75.25 110.392 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -64.79 -37.78 88.77 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.788 -0.642 . . . . 73.33 109.877 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.7 76.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 74.34 109.898 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.512 ' CB ' ' NH1' ' A' ' 145' ' ' ARG . . . -75.64 -53.75 8.07 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.396 0.517 . . . . 74.22 112.396 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.424 ' NZ ' ' OD2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -82.33 -51.13 8.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.18 0.807 . . . . 74.31 113.18 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -67.99 -0.46 4.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 120.086 -0.646 . . . . 72.43 110.741 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 61.09 31.41 76.62 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 114.956 0.742 . . . . 63.34 114.956 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.3 16.49 0.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.084 0.442 . . . . 72.44 111.376 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -47.94 -18.96 0.85 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.334 0.494 . . . . 74.43 114.334 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -135.16 93.31 17.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 117.309 0.555 . . . . 75.13 111.107 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.76 134.3 32.09 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.384 2.056 . . . . 70.53 112.766 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 119' ' ' TYR . 24.9 pt -84.74 -34.98 9.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.274 -0.421 . . . . 72.42 110.553 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -139.24 147.09 41.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.123 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -162.35 159.46 25.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.18 0.514 . . . . 73.24 111.301 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.446 ' OD1' ' NE2' ' A' ' 29' ' ' GLN . 57.1 t30 -164.6 167.58 19.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.424 -1.325 . . . . 75.42 107.424 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.472 ' HB3' HG12 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -154.51 157.43 38.35 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.292 -0.563 . . . . 74.41 111.448 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.509 ' HB3' ' CB ' ' A' ' 27' ' ' VAL . 3.3 p90 -149.9 153.04 36.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.026 -0.534 . . . . 74.24 111.603 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.628 ' NE2' HH12 ' A' ' 113' ' ' ARG . 44.7 mt-30 -112.15 134.81 53.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.74 -0.664 . . . . 74.11 111.027 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.24 145.77 22.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.963 -0.562 . . . . 74.11 111.778 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 2.0 pm0 -133.94 156.87 47.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.033 -1.099 . . . . 72.13 108.033 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.401 ' CD1' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER -157.33 159.25 37.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 72.41 112.224 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.481 ' HA ' ' CE ' ' A' ' 107' ' ' LYS . 1.7 m-20 -71.15 157.13 38.69 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.652 -0.704 . . . . 73.15 110.516 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.561 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 14.5 t70 -48.75 -23.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.737 -0.665 . . . . 63.42 110.673 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.403 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 23.8 t80 -53.08 -38.22 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 74.3 110.99 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.573 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 73.7 t -68.16 -57.57 8.93 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.028 -0.669 . . . . 72.41 109.604 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 83.9 Cg_exo -44.99 -29.55 3.88 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.284 1.989 . . . . 74.45 111.921 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 168' ' ' ASP . 38.2 mm -47.67 -23.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.176 0.512 . . . . 74.11 109.791 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -44.49 -27.96 0.52 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.272 -0.876 . . . . 73.41 109.514 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 171' ' ' PRO . 12.7 p30 -46.11 -33.88 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.522 -0.763 . . . . 73.31 111.456 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 174' ' ' ASN . 10.9 mptt -52.48 -30.78 31.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.776 0.322 . . . . 75.03 111.377 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.9 m -66.95 -28.05 67.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.361 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.3 mm -62.79 134.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 74.4 110.808 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.7 m -149.34 2.95 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.684 0.624 . . . . 75.43 112.684 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.602 ' N ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.466 -1.185 . . . . 71.41 112.871 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.673 0.273 . . . . 65.1 110.668 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.83 117.14 0.57 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.69 -0.686 . . . . 63.22 109.951 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.48 -71.04 0.67 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.817 0.673 . . . . 72.4 112.817 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 7.2 pt -121.17 63.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.295 0.569 . . . . 74.23 111.856 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 12.7 p -128.55 138.66 33.55 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.689 -0.687 . . . . 75.11 110.341 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.6 Cg_endo -85.55 34.22 4.22 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.767 -1.347 . . . . 73.34 112.588 0.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 62.5 t0 -57.74 -53.76 54.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 73.41 110.056 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 20.1 m -162.72 -37.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.505 -0.771 . . . . 73.44 111.073 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.433 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 22.1 tp -157.08 140.64 15.84 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-O 121.432 0.634 . . . . 74.33 111.227 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 20.5 p-10 -75.79 6.19 5.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.812 -0.631 . . . . 72.34 112.009 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . . . -157.7 133.94 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 61.25 111.343 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 p -85.93 109.86 25.88 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.213 -0.448 . . . . 72.14 112.09 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 42.8 Cg_endo -86.87 -130.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.303 2.669 . . . . 74.21 112.187 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -159.94 -41.19 0.05 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.427 -0.351 . . . . 65.34 110.697 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -161.58 20.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.953 -0.641 . . . . 63.2 112.44 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.541 ' N ' ' HB3' ' A' ' 158' ' ' ALA . 5.1 t -150.37 170.02 20.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.077 0.465 . . . . 72.43 111.377 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 2.3 mp -105.88 127.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 64.53 109.186 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.9 mmpt? -84.15 102.95 12.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 74.01 109.649 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 48.3 t -116.89 110.68 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.165 0.507 . . . . 64.23 109.709 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG21 ' N ' ' A' ' 21' ' ' TYR . 25.8 mt -92.08 143.35 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.7 -0.682 . . . . 73.32 109.951 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.578 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 2.4 t80 -84.83 -77.8 0.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.733 -0.787 . . . . 73.31 111.584 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.553 ' H ' ' CD1' ' A' ' 25' ' ' LEU . . . -99.83 -32.87 5.48 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.611 -0.804 . . . . 72.21 113.884 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -173.48 -75.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.444 0.535 . . . . 63.24 112.444 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -90.97 -40.16 11.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.178 0.513 . . . . 73.12 110.76 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.553 ' CD1' ' H ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -69.53 135.98 50.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.79 -0.641 . . . . 74.42 110.469 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 22.4 pt-20 -134.26 159.18 41.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.101 -0.5 . . . . 74.24 111.528 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 162' ' ' TYR . 4.1 m -69.38 134.21 30.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 72.45 110.172 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -138.64 108.51 6.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 75.25 112.228 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.508 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 3.7 mp0 52.06 49.12 21.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.965 . . . . 72.13 113.603 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.604 ' N ' ' HB2' ' A' ' 161' ' ' TYR . . . 62.17 12.54 38.08 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 114.812 0.685 . . . . 62.02 114.812 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -55.09 157.51 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 117.483 0.642 . . . . 75.22 110.233 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -98.2 129.31 44.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 73.25 110.051 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.2 mp -92.78 112.83 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.557 0.694 . . . . 75.32 110.988 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 2.8 p -110.54 165.63 12.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.747 -1.115 . . . . 75.5 111.35 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.5 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 17.7 Cg_exo -67.39 -42.32 0.7 Allowed 'Cis proline' 0 C--N 1.352 0.733 0 C-N-CA 124.161 -1.183 . . . . 73.55 112.033 0.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -162.53 44.47 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 71.25 109.889 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.577 ' C ' ' H ' ' A' ' 39' ' ' LYS . 17.7 pt20 -76.75 -4.83 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.629 -0.714 . . . . 73.45 111.215 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 34.3 m -73.37 31.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.695 0.76 . . . . 74.12 110.082 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -93.37 6.0 49.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.688 -1.142 . . . . 74.4 112.498 -178.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -135.3 162.99 31.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.845 0.313 . . . . 72.35 111.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -72.31 146.0 88.78 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.138 -0.483 . . . . 70.3 111.519 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -95.33 126.96 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.146 2.564 . . . . 70.35 113.424 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.1 mm -80.17 128.4 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 74.3 110.932 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.22 137.17 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.917 0.339 . . . . 75.22 111.917 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -162.21 153.84 18.5 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.137 0.494 . . . . 74.34 111.366 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.691 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.8 p90 -128.59 34.4 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.839 0.828 . . . . 73.21 109.485 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 m -49.54 107.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.457 -1.247 . . . . 73.15 111.069 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.57 -33.88 5.3 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.768 -0.651 . . . . 64.14 111.489 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 2.4 mm? -76.89 -40.12 48.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.14 -0.689 . . . . 73.14 109.14 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 29.2 tt0 -65.92 111.48 3.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.879 -0.601 . . . . 74.11 109.649 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.97 -63.52 0.26 Allowed Glycine 0 C--N 1.324 -0.111 0 C-N-CA 120.812 -0.709 . . . . 74.55 112.33 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -148.27 111.04 4.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.38 -0.6 . . . . 74.42 109.38 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.487 ' HB3' ' CD ' ' A' ' 120' ' ' ARG . 12.2 p -157.29 141.8 16.54 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.85 -0.34 . . . . 62.45 111.319 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 35.2 t30 -77.91 -33.61 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.538 0.685 . . . . 72.15 109.292 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -155.15 157.0 36.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.966 -1.015 . . . . 75.23 109.35 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.9 mt -127.03 152.4 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 73.43 110.976 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.534 ' HG1' ' HG2' ' A' ' 121' ' ' GLN . 95.0 m -121.51 134.01 55.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.054 -0.521 . . . . 71.4 110.154 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -136.42 132.96 36.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 74.22 109.638 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.1 mt -153.82 159.69 41.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.02 0.438 . . . . 73.1 111.884 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.3 ttt -94.92 156.62 16.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 72.41 109.971 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.47 146.12 32.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 73.15 111.515 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.632 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 46.2 t0 65.01 40.69 0.28 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.303 -0.862 . . . . 72.51 111.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.632 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 76.4 Cg_exo -51.21 139.84 42.91 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.884 1.723 . . . . 75.15 111.587 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.76 122.66 36.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.51 0.559 . . . . 64.14 112.51 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.505 ' HB1' ' HB ' ' A' ' 76' ' ' ILE . . . -170.83 135.91 1.08 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.056 0.391 . . . . 71.3 112.056 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 13.2 Cg_exo -68.1 -32.56 3.47 Favored 'Cis proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.883 -1.299 . . . . 71.34 109.809 -3.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 109' ' ' THR . 4.8 t -141.26 140.25 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.336 -1.302 . . . . 74.32 108.932 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -56.12 -21.56 23.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.345 0.593 . . . . 75.4 110.606 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.265 -0.879 . . . . 72.52 111.234 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 23.0 t70 -140.15 62.06 19.48 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-O 121.126 0.489 . . . . 75.2 110.272 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.52 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -67.84 53.8 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.458 2.772 . . . . 75.43 113.434 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -50.96 -52.17 45.15 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.888 0.329 . . . . 74.01 111.888 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.61 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 2.1 p90 -106.9 39.53 1.84 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.323 0.582 . . . . 62.02 111.081 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 3.7 tmm_? -79.29 139.96 37.7 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.781 -1.192 . . . . 74.23 107.781 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 25.6 mp0 -89.13 178.05 6.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.555 1.142 . . . . 74.15 112.594 0.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.595 HG13 ' H ' ' A' ' 77' ' ' LEU . 4.7 tp -105.98 -173.24 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.118 -0.946 . . . . 75.25 109.886 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.595 ' H ' HG13 ' A' ' 76' ' ' ILE . 3.0 mp -68.03 64.46 0.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.99 0.424 . . . . 75.42 111.016 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -58.55 178.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 73.23 110.85 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.471 ' CZ2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t-105 -100.29 122.06 42.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.004 -0.739 . . . . 75.11 109.004 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 20.0 m -141.1 129.74 22.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.4 111.507 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.471 ' CG2' ' CZ2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -142.52 127.73 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 74.1 109.388 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.6 m -129.86 166.07 28.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.402 0.62 . . . . 71.22 112.366 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.589 HD22 ' HB2' ' A' ' 95' ' ' HIS . 15.9 p30 52.95 44.88 29.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.25 -1.341 . . . . 75.2 112.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 2.9 mm -79.89 118.02 70.34 Favored Pre-proline 0 C--O 1.231 0.105 0 N-CA-C 108.328 -0.99 . . . . 72.41 108.328 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 87' ' ' SER . 45.6 Cg_exo -56.51 125.95 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.839 1.693 . . . . 72.23 112.003 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.74 73.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.386 -0.435 . . . . 72.51 113.143 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 85' ' ' PRO . 34.3 t 177.15 45.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.846 0.458 . . . . 73.22 110.034 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 54.8 m-80 -135.36 -28.23 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.201 0.815 . . . . 72.5 113.201 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 3.9 tt0 74.56 -0.59 3.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.304 0.573 . . . . 71.24 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -167.8 157.62 9.12 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.225 -0.898 . . . . 75.32 109.914 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -77.34 53.84 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.9 2.4 . . . . 73.1 112.559 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.7 t -102.59 -5.09 24.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.865 -0.334 . . . . 70.33 111.669 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.19 -42.0 1.33 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.041 -0.6 . . . . 64.34 114.214 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -64.49 173.75 15.48 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.968 -0.634 . . . . 60.34 113.975 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.589 ' HB2' HD22 ' A' ' 83' ' ' ASN . 0.7 OUTLIER -65.8 119.21 10.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.077 0.399 . . . . 75.4 112.077 -178.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.418 ' H ' ' CG2' ' A' ' 130' ' ' THR . 43.7 m -82.53 90.28 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 74.42 109.498 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 15.1 mt -50.47 -28.69 8.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.594 -0.73 . . . . 72.24 111.004 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -165.13 93.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.178 -0.919 . . . . 73.41 108.86 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -41.85 140.24 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.425 0.631 . . . . 53.31 112.494 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -56.38 146.9 22.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 71.42 110.922 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 133' ' ' ASN . 14.8 p -156.91 161.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.942 0.401 . . . . 71.24 111.341 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.24 -176.62 11.19 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.636 -0.711 . . . . 74.41 113.011 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t -65.92 122.86 18.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 70.45 111.762 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -86.65 -48.88 4.31 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.478 -0.649 . . . . 53.34 111.478 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 51.1 Cg_exo -56.37 142.43 88.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.647 2.231 . . . . 71.14 113.124 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.92 143.54 99.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.75 2.3 . . . . 74.41 112.025 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.493 ' HB3' ' C ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -46.21 -43.29 15.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.944 0.72 . . . . 71.41 112.944 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.99 0.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.714 0.635 . . . . 71.21 112.714 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 75.9 p -78.64 -27.64 45.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.905 0.383 . . . . 74.54 110.913 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.41 -167.69 14.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.824 -0.703 . . . . 74.31 113.353 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -60.01 138.19 57.91 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 112.492 0.553 . . . . 72.2 112.492 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -106.39 129.91 54.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.117 -0.947 . . . . 75.33 109.032 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 ptm85 -112.23 120.13 40.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.15 0.5 . . . . 74.21 111.288 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -109.15 140.99 42.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.819 -0.628 . . . . 74.54 110.659 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.576 HG21 ' CD2' ' A' ' 161' ' ' TYR . 24.6 mt -132.47 132.2 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.828 -0.804 . . . . 75.32 108.828 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -106.02 137.08 44.55 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.443 0.464 . . . . 65.23 111.493 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 118' ' ' LEU . 2.5 tm? -127.08 137.8 53.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.874 -0.603 . . . . 74.21 109.812 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 117' ' ' LEU . 57.0 tp -128.25 137.4 51.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.772 0.429 . . . . 64.51 110.466 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.455 ' HB3' ' HB ' ' A' ' 57' ' ' THR . 81.2 t80 -144.07 132.59 22.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.151 -0.477 . . . . 73.45 110.595 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.487 ' CD ' ' HB3' ' A' ' 53' ' ' SER . 42.8 ttp180 -76.58 128.25 34.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 74.21 110.613 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.534 ' HG2' ' HG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.26 149.16 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.975 0.731 . . . . 74.3 112.975 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 30.2 tt0 -112.59 -55.49 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.686 -1.143 . . . . 75.32 109.857 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 123' ' ' ASN . 1.7 m120 -100.19 131.38 46.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 73.32 110.717 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 9.7 tmtt? -59.55 125.08 22.19 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.004 -0.369 . . . . 75.34 110.004 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.5 ' N ' ' HD3' ' A' ' 124' ' ' LYS . 5.5 pt -87.15 125.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 71.52 112.233 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.81 118.04 10.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.903 -1.518 . . . . 74.24 106.903 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.41 32.31 1.69 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.033 1.123 . . . . 71.33 114.033 -176.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.502 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 68.7 p 51.04 172.53 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 112.446 0.535 . . . . 73.2 112.446 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 50.4 Cg_exo -58.46 150.4 68.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.517 2.145 . . . . 72.22 114.037 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.418 ' CG2' ' H ' ' A' ' 96' ' ' SER . 25.5 p -60.91 132.18 53.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 72.54 110.809 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 32.4 mm -85.99 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.379 0.609 . . . . 74.21 112.224 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -73.46 141.32 46.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 71.04 111.983 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 134' ' ' THR . 22.3 p30 -56.42 -47.1 79.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.515 0.674 . . . . 75.3 110.427 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.555 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.3 t -84.49 22.93 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.066 -0.97 . . . . 70.12 111.451 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.0 t -62.21 155.46 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.551 0.691 . . . . 64.25 112.121 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.549 ' HB2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 tpt180 -69.02 164.94 21.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.771 -1.104 . . . . 72.13 112.422 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.4 m -53.13 175.28 0.03 OUTLIER 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.685 -0.689 . . . . 73.15 110.258 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 4.22 90.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 119.937 -1.125 . . . . 74.43 111.822 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -139.81 45.71 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.262 0.553 . . . . 75.11 111.304 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 140' ' ' LEU . 2.6 mp -112.77 -63.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.187 -0.915 . . . . 73.14 108.784 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 141' ' ' ASN . 1.2 m120 -63.39 121.38 13.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 74.01 111.447 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 40.8 t80 -176.94 109.38 0.08 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.82 -0.627 . . . . 75.43 111.306 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -68.63 120.98 15.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.705 -0.68 . . . . 74.34 111.921 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.74 -43.44 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 52.03 111.601 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -45.15 -33.92 2.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.218 -0.447 . . . . 73.15 111.914 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.93 -49.33 50.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.591 0.71 . . . . 72.13 109.386 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 10.0 m-30 -62.14 -41.95 98.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.053 -0.976 . . . . 74.23 110.189 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.73 -46.38 87.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.805 0.336 . . . . 62.51 111.244 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.3 -51.73 41.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.913 -0.585 . . . . 71.52 112.458 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -75.36 -48.57 22.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.632 0.604 . . . . 64.54 112.632 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 52.9 m170 -67.76 -10.85 56.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.94 -0.475 . . . . 72.34 110.724 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 76.7 24.22 67.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.092 -0.575 . . . . 74.23 113.155 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 7.4 mt -76.02 15.85 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.063 0.145 . . . . 74.4 111.195 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -35.29 -73.01 0.1 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.021 -0.609 . . . . 73.52 113.44 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.67 112.46 17.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.544 0.172 . . . . 75.55 110.849 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.55 130.75 5.31 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.194 1.93 . . . . 73.51 113.116 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 118' ' ' LEU . 38.8 pt -78.49 -34.7 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.916 -0.314 . . . . 74.11 111.426 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.541 ' HB3' ' N ' ' A' ' 16' ' ' THR . . . -151.05 151.0 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.207 0.447 . . . . 72.2 112.207 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.15 158.15 43.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 74.3 111.533 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.6 ' C ' ' CD1' ' A' ' 161' ' ' TYR . 0.8 OUTLIER -158.97 175.09 13.99 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.004 -1.11 . . . . 75.13 108.004 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.604 ' HB2' ' N ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -157.95 155.53 29.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.686 0.675 . . . . 74.02 111.055 -178.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 1.4 t80 -155.94 131.84 9.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.13 0.572 . . . . 75.43 110.995 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mt-30 -115.86 138.63 50.98 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.282 -0.261 . . . . 72.33 111.455 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.43 153.18 29.95 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.062 0.764 . . . . 53.11 113.062 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.99 161.5 37.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.776 -0.824 . . . . 72.13 108.776 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.432 ' O ' ' CB ' ' A' ' 107' ' ' LYS . 1.7 t80 -165.61 168.75 16.06 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.191 -0.604 . . . . 71.01 111.36 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.493 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.8 t0 -79.46 -159.92 0.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.714 0.634 . . . . 74.43 110.912 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.499 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 50.2 t0 -69.0 -23.87 64.15 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.092 0.472 . . . . 71.1 111.036 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -42.88 -44.48 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.166 -0.47 . . . . 75.11 112.108 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 67.8 t -80.38 -54.39 0.83 Allowed Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 120.464 -0.494 . . . . 73.53 111.494 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 77.8 Cg_exo -48.39 -49.84 13.54 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.051 1.834 . . . . 72.13 112.644 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.5 tt -46.01 -33.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.027 0.381 . . . . 74.42 112.027 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.03 -29.53 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 75.24 111.342 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.478 HD21 ' N ' ' A' ' 174' ' ' ASN . 2.1 m120 -56.51 -14.92 3.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.176 0.806 . . . . 74.41 113.176 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.36 -20.29 42.57 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.794 0.664 . . . . 74.34 112.794 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 p -88.1 16.59 5.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.864 0.69 . . . . 74.11 112.864 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 174' ' ' ASN . 27.7 mm -72.46 124.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 122.037 -0.415 . . . . 64.51 110.296 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.58 -13.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.114 0.783 . . . . 74.41 113.114 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.555 -1.136 . . . . 64.42 112.301 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 109.938 -0.393 . . . . 73.14 109.938 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -70.5 64.38 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 74.53 111.458 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 5.5 t70 -71.18 -40.83 71.0 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.728 0.299 . . . . 71.13 111.196 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 9' ' ' LEU . 12.8 pt -149.24 48.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 72.43 110.615 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 13.6 p -136.45 140.9 33.79 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.214 -0.903 . . . . 75.5 109.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.515 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 Cg_exo -78.28 26.43 2.5 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.205 -1.164 . . . . 73.54 113.591 0.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' N ' ' HA ' ' A' ' 5' ' ' VAL . 9.5 t0 -54.56 -53.21 57.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.393 . . . . 73.22 110.431 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 m -161.32 -43.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.997 -0.547 . . . . 75.24 111.917 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 4' ' ' ILE . 62.2 tp -144.21 160.08 41.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.65 0.262 . . . . 75.21 110.851 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -60.43 -42.58 96.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.718 -0.793 . . . . 72.32 109.732 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.57 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -156.59 135.14 11.54 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.818 0.303 . . . . 72.21 111.818 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.39 125.88 80.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.995 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 45.7 Cg_endo -89.73 -145.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.892 2.395 . . . . 62.31 112.201 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.37 -31.05 6.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 73.15 110.842 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.36 -136.54 3.16 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.919 -0.582 . . . . 75.41 111.834 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.432 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 1.5 t -162.81 164.41 26.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 65.24 111.734 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' CG2' HG23 ' A' ' 44' ' ' VAL . 3.1 mp -104.9 133.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.406 -0.961 . . . . 73.11 108.406 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 45' ' ' SER . 13.5 mmmm -83.62 101.96 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.442 -0.503 . . . . 71.54 109.707 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 94.2 t -108.86 108.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.599 0.714 . . . . 64.43 111.198 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.88 138.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 74.32 107.898 177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -93.42 -46.96 7.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.937 0.717 . . . . 71.03 112.937 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.86 -48.39 0.5 Allowed Glycine 0 N--CA 1.459 0.175 0 C-N-CA 120.277 -0.963 . . . . 53.3 112.857 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.62 -80.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.777 0.322 . . . . 74.44 110.261 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -82.31 -31.85 29.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.599 . . . . 75.42 109.384 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.61 129.08 38.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.687 0.756 . . . . 71.21 111.443 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 28.3 tt0 -125.61 150.77 47.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.702 -1.136 . . . . 72.44 110.836 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 31.3 m -85.42 107.01 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.282 0.563 . . . . 73.23 111.535 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -75.21 50.53 0.5 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.429 0.9 . . . . 74.14 113.429 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.666 HE21 ' ND2' ' A' ' 160' ' ' ASN . 9.5 mp0 59.31 69.67 0.7 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.667 0.988 . . . . 71.43 113.667 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.38 -6.21 57.64 Favored Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 110.835 -0.906 . . . . 75.33 110.835 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.14 139.02 57.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.932 -1.134 . . . . 73.13 110.868 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -102.72 138.02 40.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 75.53 110.24 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.551 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 5.1 mp -109.3 154.19 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 75.1 111.353 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -149.36 157.79 38.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 75.22 110.477 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.95 -51.88 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 124.093 -1.211 . . . . 72.33 112.77 0.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.2 m -143.41 35.81 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 74.35 110.836 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -80.21 -4.37 52.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.6 . . . . 70.11 111.494 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.596 ' HB ' ' CE2' ' A' ' 21' ' ' TYR . 27.5 m -85.54 33.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.572 -0.74 . . . . 71.34 111.935 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.74 -30.08 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.848 1.055 . . . . 74.04 113.848 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.607 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 45.1 m-20 -72.33 152.62 41.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.825 0.676 . . . . 74.22 112.825 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.558 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.7 pm0 -63.25 128.72 92.79 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.718 -0.674 . . . . 73.33 109.33 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 125.75 19.31 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.348 2.032 . . . . 74.41 114.243 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.18 111.09 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.5 -0.773 . . . . 73.12 109.936 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 17' ' ' ILE . 6.0 p -93.55 142.02 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.365 . . . . 71.54 111.719 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 50.7 m -158.07 137.9 12.2 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.263 0.468 . . . . 71.22 112.263 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.575 ' CZ2' HD11 ' A' ' 56' ' ' LEU . 3.5 p90 -115.84 23.26 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.263 -0.643 . . . . 75.41 109.263 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.2 m -40.31 120.96 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.395 -0.82 . . . . 70.51 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 91.08 -35.46 3.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.267 -0.492 . . . . 73.34 112.187 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.0 mm? -65.54 -20.86 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.87 0.367 . . . . 75.13 110.031 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 16.6 pm0 -67.57 -159.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.249 -0.649 . . . . 74.31 109.249 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.17 -66.6 0.48 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 119.96 -1.114 . . . . 63.41 113.083 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' C ' ' HG ' ' A' ' 53' ' ' SER . 22.4 pttm -149.42 106.88 3.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.086 0.47 . . . . 75.1 109.77 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 52' ' ' LYS . 3.3 m -160.19 140.41 11.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.776 -0.647 . . . . 70.15 110.224 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -74.88 -38.17 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.733 -0.84 . . . . 75.12 108.733 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.594 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 22.5 mt -155.86 160.4 40.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.7 -1.136 . . . . 73.42 109.885 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.575 HD11 ' CZ2' ' A' ' 46' ' ' TRP . 15.5 mt -122.08 151.8 40.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.974 -0.29 . . . . 73.33 110.527 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.555 HG23 HG11 ' A' ' 82' ' ' VAL . 91.4 m -129.01 114.41 16.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.928 0.394 . . . . 74.03 112.027 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 134.29 50.15 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.54 -0.541 . . . . 74.03 109.54 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -144.75 171.58 14.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.166 0.508 . . . . 70.43 111.754 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' C ' ' A' ' 60' ' ' MET . 0.8 OUTLIER -133.64 123.13 24.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.176 -0.92 . . . . 74.21 108.638 178.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.87 102.09 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.123 0.487 . . . . 73.5 112.127 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -178.79 67.68 0.19 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.226 -0.897 . . . . 75.51 109.605 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.48 129.0 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.254 1.97 . . . . 64.24 111.589 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -162.36 87.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.291 0.478 . . . . 72.22 112.291 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.623 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -171.61 133.54 0.84 Allowed Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 112.883 0.697 . . . . 72.05 112.883 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.551 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.6 Cg_exo -63.36 -20.45 5.17 Favored 'Cis proline' 0 C--N 1.354 0.822 0 C-N-CA 123.558 -1.434 . . . . 75.52 110.276 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 148.49 16.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.838 -1.074 . . . . 71.03 109.912 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -49.13 -31.8 8.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.676 0.75 . . . . 73.52 110.617 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.45 -32.83 74.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.927 -1.033 . . . . 74.14 111.956 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.6 t0 -144.91 98.37 4.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 75.42 111.072 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 72.5 Cg_endo -76.51 60.3 6.46 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.974 2.449 . . . . 75.33 111.901 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.473 ' NZ ' ' OD2' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -47.17 -39.82 14.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.931 -0.577 . . . . 72.45 110.78 -178.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.544 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 4.7 p90 -148.0 48.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.721 0.772 . . . . 75.34 109.707 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -74.37 136.24 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.652 -1.158 . . . . 73.53 109.459 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 142' ' ' PHE . 1.1 pm0 -89.12 176.61 6.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.998 0.919 . . . . 74.23 112.013 0.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.648 HG13 ' H ' ' A' ' 77' ' ' LEU . 3.2 tp -114.46 -163.14 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.216 -0.902 . . . . 75.12 109.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.648 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.9 mp -65.04 135.9 56.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.058 -0.349 . . . . 72.53 110.058 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -147.87 171.72 15.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 65.33 110.086 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.618 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.7 t90 -97.99 123.18 41.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 72.34 112.052 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HG ' ' CB ' ' A' ' 98' ' ' ALA . 85.5 p -142.96 133.58 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.847 -0.615 . . . . 74.32 109.841 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' HIS . 21.3 t -149.24 117.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.6 . . . . 74.11 109.379 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.577 ' CG2' ' HG2' ' A' ' 127' ' ' GLU . 10.7 m -115.23 -173.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.724 0.774 . . . . 65.23 112.649 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.581 HD22 ' CG ' ' A' ' 95' ' ' HIS . 27.9 p30 44.21 43.45 5.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.996 -1.457 . . . . 73.25 113.166 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 56' ' ' LEU . 2.4 mm -67.42 121.84 80.57 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.55 -1.278 . . . . 73.0 107.55 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.45 103.13 1.64 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.155 1.903 . . . . 75.54 115.189 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.89 -84.79 1.57 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 116.507 1.363 . . . . 73.51 116.507 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 89' ' ' GLU . 78.3 p -174.39 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 117.484 0.642 . . . . 64.23 111.642 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 90' ' ' ASN . 38.9 m-80 -73.71 28.98 0.07 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.907 -0.588 . . . . 74.2 110.391 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 87' ' ' SER . 16.3 pt-20 44.52 5.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.928 -1.033 . . . . 72.23 112.952 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 88' ' ' ASN . 17.8 p30 -179.71 163.11 0.91 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.237 -0.653 . . . . 70.02 109.237 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 90' ' ' ASN . 66.6 Cg_endo -68.65 44.84 0.33 Allowed 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 122.872 2.381 . . . . 74.22 113.219 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.472 ' HB2' ' OD1' ' A' ' 90' ' ' ASN . 22.1 t -69.36 -43.22 74.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.177 0.436 . . . . 74.44 112.177 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.75 10.13 32.35 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.912 -0.661 . . . . 73.54 114.264 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -86.58 166.51 37.92 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.661 -0.78 . . . . 64.03 114.093 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.581 ' CG ' HD22 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.31 104.78 0.8 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.865 0.32 . . . . 75.41 111.865 178.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.507 ' N ' HG23 ' A' ' 130' ' ' THR . 51.1 m -73.51 83.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.718 0.77 . . . . 75.32 109.047 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.49 HD22 ' CG ' ' A' ' 127' ' ' GLU . 55.2 mt -68.31 -20.86 64.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.149 -0.932 . . . . 73.41 110.496 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.403 ' CB ' ' HG ' ' A' ' 80' ' ' SER . . . -158.53 106.22 1.9 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.185 -0.916 . . . . 75.44 109.475 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -60.12 142.3 54.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 63.04 110.846 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.618 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 20.5 p90 -67.46 140.28 57.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 73.44 111.798 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.33 145.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 73.41 109.67 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.68 -47.0 72.99 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.896 -0.669 . . . . 72.31 113.394 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -173.52 98.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.964 0.382 . . . . 62.32 111.955 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.636 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -57.12 -50.1 66.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.068 -1.063 . . . . 73.42 110.664 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.675 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 38.4 Cg_endo -65.63 140.21 61.4 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.22 2.613 . . . . 73.41 112.385 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.27 147.24 77.87 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.095 2.53 . . . . 61.25 113.374 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -45.96 -34.38 3.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.154 0.502 . . . . 74.31 111.502 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -51.8 -20.2 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.689 -0.687 . . . . 53.0 111.901 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.623 HG22 ' CE1' ' A' ' 112' ' ' HIS . 10.9 t -69.14 -17.2 63.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 74.33 111.071 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.83 -142.37 34.73 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.902 -0.59 . . . . 65.55 113.82 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.21 117.59 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.393 . . . . 71.43 111.7 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.675 ' CE1' ' HG2' ' A' ' 105' ' ' PRO . 48.5 m-70 -82.79 -176.11 6.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.83 0.824 . . . . 74.23 111.325 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.522 HH12 ' CD1' ' A' ' 115' ' ' ILE . 65.6 ttt-85 -147.52 112.04 5.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.113 -1.81 . . . . 71.12 106.113 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -118.32 134.74 54.78 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.603 -0.439 . . . . 73.42 111.653 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CD1' HH12 ' A' ' 113' ' ' ARG . 36.8 mt -130.84 121.36 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.573 -0.739 . . . . 75.3 111.933 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.92 131.44 46.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.429 -0.805 . . . . 75.22 109.154 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.49 143.87 45.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.26 -0.427 . . . . 73.02 110.447 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.3 tp -126.99 131.2 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 75.55 109.886 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 53.1 m-85 -132.61 143.95 50.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.227 0.536 . . . . 64.44 111.226 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -77.15 117.03 18.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.554 -0.748 . . . . 71.13 109.523 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.594 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 39.4 tp60 -91.85 122.77 34.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.038 0.447 . . . . 74.33 110.101 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -90.94 -49.8 6.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.455 -0.793 . . . . 74.14 112.403 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.71 146.16 33.93 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.241 0.46 . . . . 62.25 112.241 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.9 tptm -64.69 123.32 19.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.587 -0.733 . . . . 75.34 110.091 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 151' ' ' HIS . 3.1 pt -111.06 129.03 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.707 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -53.45 -46.99 70.09 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.353 -0.61 . . . . 64.55 109.353 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.577 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 2.2 tp10 53.92 15.15 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.139 -0.937 . . . . 63.55 113.112 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.467 ' O ' ' CD2' ' A' ' 95' ' ' HIS . 58.7 p 51.16 169.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 111.924 0.342 . . . . 74.15 111.924 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 52.1 Cg_exo -58.83 148.72 82.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.095 1.864 . . . . 75.23 113.406 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 96' ' ' SER . 17.2 p -58.38 136.94 57.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.18 -0.918 . . . . 74.4 110.752 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 38.6 mm -92.79 129.5 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 113.337 0.865 . . . . 74.33 113.337 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.1 m -86.85 133.49 33.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.19 -1.368 . . . . 74.12 109.302 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -53.45 -26.16 19.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.912 -0.315 . . . . 74.3 111.383 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.45 ' C ' HG23 ' A' ' 177' ' ' ILE . 9.3 t -64.83 -2.47 2.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.945 0.402 . . . . 73.45 111.055 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.0 t -64.3 108.4 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.253 0.549 . . . . 74.24 109.789 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.466 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 37.9 ttt85 -65.14 171.17 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.68 -0.691 . . . . 73.45 112.315 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ARG . 50.4 m -28.29 136.82 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.245 -0.889 . . . . 65.52 111.577 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.94 5.84 14.86 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.772 -0.649 . . . . 65.22 111.927 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -152.0 35.76 0.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.782 0.325 . . . . 74.44 111.192 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 142' ' ' PHE . 3.3 mp -109.86 -62.53 1.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.375 -0.375 . . . . 75.3 110.773 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 2.0 m120 -61.57 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.699 -0.682 . . . . 73.21 112.535 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 11.5 t80 -144.17 118.1 9.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.399 . . . . 74.45 111.346 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.514 HD22 ' CB ' ' A' ' 145' ' ' ARG . 28.6 t30 -85.41 131.0 34.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 73.13 110.489 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.04 -37.49 87.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.738 0.644 . . . . 75.32 112.738 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.514 ' CB ' HD22 ' A' ' 143' ' ' ASN . 30.5 ttp180 -44.02 -31.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 64.12 110.933 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.8 OUTLIER -47.05 -41.01 16.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.044 0.45 . . . . 74.43 110.63 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 97' ' ' LEU . 66.2 m-85 -56.79 -38.83 73.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.759 -0.655 . . . . 73.33 110.639 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -63.28 -28.14 69.82 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.72 -0.673 . . . . 64.34 110.174 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.63 2.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 70.12 111.226 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 0.9 OUTLIER -54.08 -44.35 71.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.823 0.344 . . . . 74.34 110.961 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.539 ' CE1' HG23 ' A' ' 125' ' ' ILE . 29.5 m-70 -85.74 4.76 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.476 -0.329 . . . . 70.4 110.7 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 56.08 26.11 48.33 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.019 -0.537 . . . . 74.1 113.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 19.6 mt -64.47 -25.86 68.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.434 -0.58 . . . . 71.42 109.434 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.64 -89.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.06 -0.973 . . . . 45.11 113.963 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' LEU . 21.9 pt-20 -73.06 125.72 90.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.088 0.403 . . . . 71.44 112.088 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 119' ' ' TYR . 60.3 Cg_endo -76.22 124.78 8.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.692 1.595 . . . . 42.32 110.34 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.436 HG12 ' HA ' ' A' ' 119' ' ' TYR . 47.5 pt -71.5 -33.8 50.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.115 -0.634 . . . . 73.55 110.551 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.401 ' HB1' ' N ' ' A' ' 16' ' ' THR . . . -147.15 149.77 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.946 -0.302 . . . . 74.11 111.564 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.38 152.34 38.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.127 -0.488 . . . . 74.21 111.122 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.666 ' ND2' HE21 ' A' ' 29' ' ' GLN . 1.7 t-20 -157.28 145.27 19.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.48 -1.304 . . . . 70.3 107.48 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -149.03 176.84 10.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.882 0.327 . . . . 74.41 111.882 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 2.3 p90 -168.84 164.82 11.83 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.067 -0.515 . . . . 74.24 111.343 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -126.36 124.81 41.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.489 -0.56 . . . . 74.11 109.489 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.62 152.85 25.91 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.16 0.429 . . . . 74.54 112.16 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.561 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -109.08 136.49 48.51 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 74.1 109.348 178.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -125.5 135.07 51.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.699 -0.482 . . . . 63.24 109.699 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.84 173.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.316 0.579 . . . . 73.43 112.293 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -72.75 51.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.167 -0.924 . . . . 71.5 110.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -91.69 -46.57 7.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 73.15 110.872 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.423 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 53.4 t -80.82 -46.89 1.21 Allowed Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 113.162 0.801 . . . . 74.44 113.162 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.423 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.4 Cg_exo -46.06 -43.35 20.46 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.918 1.745 . . . . 71.12 111.748 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.1 mm -51.14 -39.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 75.44 110.076 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -53.32 -26.42 18.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.614 -0.721 . . . . 74.22 110.796 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -52.31 -42.68 64.02 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.543 0.211 . . . . 75.43 111.295 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -15.5 62.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.064 0.459 . . . . 73.21 110.498 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.8 m -92.37 -28.14 17.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.58 -0.736 . . . . 75.32 110.812 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 52.1 mt -56.51 119.74 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.962 -0.563 . . . . 74.45 110.956 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.87 37.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.895 0.379 . . . . 74.13 111.531 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.978 -1.457 . . . . 54.44 111.34 -179.126 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 10' ' ' ASP . 18.3 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.648 -0.501 . . . . 62.55 109.648 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -158.53 46.23 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.072 0.463 . . . . 74.03 110.837 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -51.15 -64.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.774 -0.648 . . . . 75.03 112.19 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' LEU . 3.5 pt -131.63 49.14 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.502 0.667 . . . . 74.51 111.361 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.9 p -111.61 142.32 26.35 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 65.3 110.203 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 56.2 Cg_endo -95.62 33.44 9.86 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.363 -1.099 . . . . 75.52 112.83 0.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.55 -42.82 82.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.22 109.741 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -154.38 -47.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.724 -0.671 . . . . 75.5 112.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 25.2 tp -158.51 154.88 27.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.316 0.488 . . . . 73.3 112.316 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 1' ' ' MET . 12.9 p-10 -74.63 -1.97 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.346 -0.613 . . . . 62.22 109.346 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -144.86 -158.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.155 -0.93 . . . . 62.44 109.827 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.62 113.91 5.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 75.32 111.437 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 45.1 Cg_endo -88.75 -138.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.448 . . . . 74.24 112.519 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -153.31 -37.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 61.14 111.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.38 161.67 24.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.177 -1.011 . . . . 65.12 113.274 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 t -104.46 157.05 17.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.869 0.366 . . . . 71.22 110.947 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 1.8 mp -104.01 135.25 42.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.889 -0.596 . . . . 72.3 109.605 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.9 mmmt -73.57 118.19 16.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.53 -0.305 . . . . 74.33 110.232 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.556 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 84.1 t -128.18 109.18 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.278 -0.638 . . . . 72.33 109.278 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 26' ' ' GLU . 37.2 mt -99.64 142.07 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 74.21 112.452 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.516 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 1.6 m-85 -101.57 -94.3 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.716 -0.674 . . . . 74.02 111.123 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -61.72 -50.22 68.29 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.157 -1.02 . . . . 75.51 111.586 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.4 t70 171.36 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.999 -0.741 . . . . 62.14 108.999 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 71.21 108.789 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.06 141.37 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.617 -1.174 . . . . 63.35 111.476 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 13.2 pt-20 -149.04 153.73 38.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.83 -1.077 . . . . 74.12 110.752 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 35.8 m -82.56 133.69 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 74.24 109.899 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 14.7 pttm -153.35 130.02 10.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.055 0.931 . . . . 74.01 113.182 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' CE1' ' A' ' 161' ' ' TYR . 7.1 mp0 32.55 63.89 0.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.859 -1.519 . . . . 74.53 114.759 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.3 10.83 63.41 Favored Glycine 0 N--CA 1.454 -0.13 0 N-CA-C 114.876 0.71 . . . . 73.41 114.876 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -61.0 146.39 47.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.874 0.837 . . . . 65.32 109.906 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -96.5 126.28 41.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.92 -0.4 . . . . 75.32 109.92 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mp -93.07 108.9 20.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.137 0.494 . . . . 74.31 109.791 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -150.22 155.49 37.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.39 -0.823 . . . . 71.52 110.648 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -93.86 136.09 6.55 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.286 -1.131 . . . . 71.33 112.64 0.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.427 ' O ' ' HE3' ' A' ' 39' ' ' LYS . 17.9 m 56.38 33.65 22.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.237 0.541 . . . . 74.22 110.649 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -93.87 -1.9 54.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.682 -0.69 . . . . 75.12 110.83 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.4 m -92.13 -14.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 73.4 112.289 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -74.39 5.8 4.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 73.52 111.094 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 53.2 m-20 -96.81 146.15 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.256 0.55 . . . . 75.05 111.737 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 21' ' ' TYR . 1.7 pm0 -62.63 132.33 94.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.189 -0.914 . . . . 71.21 111.796 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 89.6 Cg_endo -81.61 125.14 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.947 1.765 . . . . 64.32 112.227 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.9 mm -109.27 106.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 75.13 109.921 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -89.94 136.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.337 0.495 . . . . 75.32 112.337 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 75.3 m -159.66 116.23 2.56 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.77 -0.65 . . . . 74.42 110.089 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 89' ' ' GLU . 16.1 p90 -91.77 32.4 1.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 74.31 110.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 m -46.85 128.43 10.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.338 -0.846 . . . . 63.13 110.586 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.19 -33.16 4.83 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.708 -0.678 . . . . 54.31 112.406 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 16' ' ' THR . 2.9 mm? -80.29 -26.39 38.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.432 . . . . 75.01 110.479 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 23.1 tt0 -59.33 158.89 8.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.852 -0.613 . . . . 75.52 110.983 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.85 33.1 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.216 -1.154 . . . . 75.23 110.216 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -48.15 109.55 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 74.11 110.44 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 p -149.23 142.6 25.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.327 -0.851 . . . . 75.45 109.582 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -64.77 -38.76 92.08 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.58 0.705 . . . . 74.44 109.45 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 ' C ' ' HB3' ' A' ' 121' ' ' GLN . 82.1 mt -156.86 154.58 30.05 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.642 -1.163 . . . . 72.3 111.179 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.0 mt -120.67 150.9 40.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.579 -0.526 . . . . 72.22 109.579 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.5 m -122.24 114.32 20.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.776 0.322 . . . . 73.33 110.665 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.68 134.19 47.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.154 -0.684 . . . . 74.34 109.154 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.04 152.51 44.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.349 0.595 . . . . 71.4 111.851 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.7 ttt -127.2 110.29 12.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.201 -0.909 . . . . 73.53 108.607 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.58 ' CG1' ' H ' ' A' ' 62' ' ' ASP . 5.1 t -94.32 -133.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.025 -0.27 . . . . 74.3 111.712 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.58 ' H ' ' CG1' ' A' ' 61' ' ' VAL . 2.2 m-20 51.84 73.04 1.03 Allowed Pre-proline 0 CA--C 1.518 -0.256 0 N-CA-C 112.341 0.497 . . . . 75.24 112.341 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . 32.0 Cg_endo -62.19 129.4 26.91 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.737 1.625 . . . . 75.14 110.008 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -159.46 92.49 1.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.769 1.026 . . . . 72.44 113.769 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.549 ' HB1' HG12 ' A' ' 76' ' ' ILE . . . -172.88 134.39 0.7 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 112.481 0.549 . . . . 64.23 112.481 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 65.3 Cg_endo -85.64 3.18 65.38 Favored 'Cis proline' 0 C--N 1.347 0.468 0 C-N-CA 124.315 -1.119 . . . . 73.14 110.243 -2.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 t -164.81 134.04 3.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.332 -1.304 . . . . 65.11 109.636 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' HD3' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -55.14 -24.05 24.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.852 0.358 . . . . 75.21 110.726 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.541 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -62.43 -41.18 98.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 75.15 110.417 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -144.7 109.51 4.8 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.101 -0.5 . . . . 74.21 111.231 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.64 63.83 4.72 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.5 2.133 . . . . 73.43 111.518 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.546 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 39.6 ttmt -47.91 -27.82 2.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.199 -0.455 . . . . 75.31 111.113 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.575 ' HB2' HD22 ' A' ' 141' ' ' ASN . 2.9 p90 -152.78 45.36 0.69 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.734 0.642 . . . . 74.52 112.734 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.586 ' NE ' ' HB2' ' A' ' 63' ' ' PRO . 25.9 ttm180 -66.82 139.57 57.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.534 -0.913 . . . . 70.4 108.534 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -106.64 165.55 11.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.55 1.14 . . . . 75.12 110.23 -0.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.637 ' CG2' ' H ' ' A' ' 77' ' ' LEU . 38.0 mm -80.55 176.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.233 0.457 . . . . 72.23 112.233 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.637 ' H ' ' CG2' ' A' ' 76' ' ' ILE . 2.9 mm? -71.44 55.99 0.24 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.705 -0.68 . . . . 71.12 110.07 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 76' ' ' ILE . 6.5 p-80 -53.92 169.91 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 75.44 111.956 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 12.3 t90 -99.86 112.52 24.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.744 -0.662 . . . . 75.42 110.457 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 p -141.44 136.56 31.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.689 -0.687 . . . . 74.51 110.442 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.76 142.49 32.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.994 -0.548 . . . . 75.41 109.909 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.523 ' CG2' ' HG3' ' A' ' 127' ' ' GLU . 16.4 m -137.71 163.52 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.581 0.585 . . . . 73.4 112.581 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' ND2' HG23 ' A' ' 82' ' ' VAL . 45.8 m-20 71.87 32.89 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.63 -1.168 . . . . 74.31 111.243 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' CD1' ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -76.96 111.96 19.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.102 -0.639 . . . . 74.03 109.695 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' SER . 47.9 Cg_exo -54.56 134.24 60.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.813 1.675 . . . . 62.43 110.75 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.91 70.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.949 -0.643 . . . . 72.24 112.839 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' PRO . 23.2 t 176.46 47.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.88 -0.785 . . . . 72.04 108.88 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.44 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 68.7 m-80 -135.66 -29.86 1.03 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.76 . . . . 75.0 112.146 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 12.7 pt-20 50.06 20.55 0.61 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.515 0.674 . . . . 72.04 110.201 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -170.25 148.01 2.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.643 -1.162 . . . . 72.44 109.654 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.09 49.42 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.796 2.331 . . . . 65.53 112.741 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -92.51 -56.02 3.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 74.34 111.5 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.32 33.73 1.33 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.823 -0.626 . . . . 72.41 113.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -133.81 159.12 23.6 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.864 -0.684 . . . . 54.41 113.238 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.5 ' CE1' ' CG2' ' A' ' 130' ' ' THR . 78.3 t60 -68.73 116.69 9.52 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.253 0.221 . . . . 74.24 111.418 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -76.94 106.31 8.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.441 -0.948 . . . . 74.4 108.441 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.443 HD21 ' HG3' ' A' ' 127' ' ' GLU . 4.9 mt -61.93 -54.57 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.376 -0.972 . . . . 73.53 108.376 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.84 121.16 29.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.244 -1.343 . . . . 63.14 107.536 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.56 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.6 t0 -52.75 152.07 4.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.219 -0.446 . . . . 55.22 111.872 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -59.49 127.2 30.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.897 -0.592 . . . . 72.42 109.688 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.1 148.95 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.521 0.677 . . . . 73.44 112.355 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.83 72.01 0.45 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.224 -1.15 . . . . 71.42 110.224 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.456 ' HA ' ' CG1' ' A' ' 170' ' ' VAL . 28.3 t -169.73 -89.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.68 -0.489 . . . . 62.31 109.68 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.75 33.6 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.993 -0.623 . . . . 72.14 114.329 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HB3' ' HA ' ' A' ' 65' ' ' ALA . 35.2 Cg_endo -64.02 154.65 69.13 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.404 2.736 . . . . 73.43 114.061 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.528 ' HA ' ' HG3' ' A' ' 171' ' ' PRO . 5.6 Cg_exo -78.14 163.42 27.97 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.555 2.837 . . . . 74.41 112.89 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 166' ' ' TYR . 64.8 tttm -38.4 -26.13 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.076 -0.511 . . . . 64.44 111.511 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' PRO . 10.8 t70 -50.56 -41.52 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 74.43 111.898 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 t -73.73 -14.28 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.983 0.735 . . . . 71.11 112.983 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.05 -144.9 41.52 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.054 -1.07 . . . . 55.33 112.13 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 163' ' ' GLN . 43.8 tp -67.46 130.87 44.43 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.405 -0.468 . . . . 73.45 111.016 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 6.5 p80 -130.48 126.31 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 73.44 110.307 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -88.22 125.39 34.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.672 -0.694 . . . . 74.04 110.588 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -116.59 140.41 49.42 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.446 0.466 . . . . 75.45 110.231 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 161' ' ' TYR . 39.1 mt -123.91 125.51 71.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.554 0.692 . . . . 75.23 111.971 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -88.56 136.34 33.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.138 -0.937 . . . . 75.33 109.681 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.421 ' HB3' ' CE1' ' A' ' 119' ' ' TYR . 3.0 mm? -124.34 137.52 54.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 71.4 111.033 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 119' ' ' TYR . 4.7 tt -127.05 135.29 50.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.385 -0.598 . . . . 61.24 109.385 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.602 ' CD2' ' HB3' ' A' ' 153' ' ' LEU . 8.5 m-85 -132.29 143.46 49.91 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.138 -0.483 . . . . 65.41 111.159 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -72.45 139.58 47.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 75.4 109.278 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.436 ' HB3' ' C ' ' A' ' 55' ' ' LEU . 4.5 tt0 -123.91 127.31 47.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.483 0.658 . . . . 74.51 112.653 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -104.2 -38.89 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.085 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.05 129.28 54.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.326 -0.852 . . . . 75.1 110.947 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -67.51 152.32 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.853 -0.612 . . . . 74.52 111.927 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pt -136.0 147.71 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.891 -0.595 . . . . 75.21 111.228 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -49.97 12.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.414 -0.357 . . . . 73.21 111.399 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.543 ' OE1' ' NZ ' ' A' ' 150' ' ' LYS . 6.4 mm-40 61.24 33.34 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 63.5 112.02 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.7 p 53.32 156.57 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 112.851 0.686 . . . . 72.34 112.851 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.32 148.6 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.622 2.215 . . . . 72.42 113.188 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.5 ' CG2' ' CE1' ' A' ' 95' ' ' HIS . 2.7 p -59.86 116.12 3.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 74.23 112.611 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.4 mm -81.75 120.99 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.046 -0.724 . . . . 74.22 109.046 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.5 m -75.39 149.07 38.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 70.24 112.15 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.56 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 34.2 t30 -55.5 -36.38 66.61 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 121.411 0.624 . . . . 74.33 109.538 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 33.4 p -78.39 8.78 4.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.552 -0.749 . . . . 74.51 111.727 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 1.7 m -64.1 131.59 47.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.642 0.258 . . . . 75.23 110.729 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.542 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 26.1 ttt85 -76.3 169.98 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 75.21 113.212 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 138' ' ' GLY . 88.5 m -49.77 160.37 0.31 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.4 -1.273 . . . . 73.42 112.037 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.413 ' N ' ' CG2' ' A' ' 137' ' ' THR . . . 96.04 -38.22 3.18 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.994 -1.003 . . . . 74.12 112.038 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 139' ' ' ARG . 23.3 mmt180 -82.82 -37.75 24.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 74.44 111.462 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -56.35 -50.37 71.7 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.602 0.593 . . . . 72.21 112.602 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.575 HD22 ' HB2' ' A' ' 73' ' ' TYR . 7.2 m120 -44.26 68.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.82 1.415 . . . . 72.33 114.82 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 140' ' ' LEU . 23.4 t80 -149.9 126.7 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 73.42 110.893 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 145' ' ' ARG . 0.6 OUTLIER -78.76 100.14 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 73.14 111.183 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -47.61 -33.81 7.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.086 -0.506 . . . . 73.24 111.728 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.534 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 49.7 ttp85 -47.66 -35.11 8.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.736 0.303 . . . . 74.44 110.874 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -51.9 -40.63 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.885 0.374 . . . . 75.41 110.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 142' ' ' PHE . 28.9 m-85 -46.83 -43.13 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.483 . . . . 70.22 110.086 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.76 -38.16 86.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.706 -0.679 . . . . 74.31 110.941 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.98 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 74.13 111.367 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.543 ' NZ ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -53.79 -51.28 63.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.517 -0.311 . . . . 74.35 111.173 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.597 ' O ' ' ND1' ' A' ' 151' ' ' HIS . 28.9 t-80 -78.42 -5.7 53.13 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.536 -0.542 . . . . 73.01 109.536 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.67 69.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.661 -0.78 . . . . 74.33 112.236 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.602 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . 14.7 mt -63.05 -25.31 68.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.169 -0.678 . . . . 71.01 109.169 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 31.62 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.788 -1.096 . . . . 74.53 113.888 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' LEU . 9.9 pt-20 -73.63 124.17 90.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.47 0.544 . . . . 74.41 112.47 -177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 73.2 Cg_endo -81.51 137.33 10.25 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.438 2.092 . . . . 73.5 111.692 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 118' ' ' LEU . 37.6 pt -83.27 -35.23 11.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.3 0.571 . . . . 75.2 110.712 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.74 150.67 40.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 55.4 111.059 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -152.09 158.91 43.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.461 . . . . 73.24 111.931 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -154.82 122.34 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.541 -0.911 . . . . 73.41 108.541 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.494 ' HB3' HG12 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -126.85 157.33 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 75.44 112.163 -177.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 4.1 p90 -162.53 163.04 27.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 72.01 110.767 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.428 ' HB2' HD11 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -110.7 136.79 49.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.181 0.515 . . . . 71.0 111.282 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.6 134.91 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.375 -0.83 . . . . 70.11 110.411 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.574 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -106.87 149.0 27.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.022 -0.362 . . . . 75.24 110.022 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 18.3 m-30 -128.46 125.28 38.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 74.42 110.998 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.14 -135.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.525 -0.761 . . . . 74.21 111.303 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 7.1 t70 -94.99 -43.44 8.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.903 -0.589 . . . . 74.54 110.989 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -51.95 -29.82 22.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 74.21 110.83 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.492 ' HB ' ' CD ' ' A' ' 171' ' ' PRO . 23.3 t -71.38 -58.16 4.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.955 -0.566 . . . . 74.43 111.955 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.528 ' HG3' ' HA ' ' A' ' 106' ' ' PRO . 18.0 Cg_endo -57.55 -28.45 81.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.641 2.227 . . . . 73.22 112.727 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 168' ' ' ASP . 65.2 mt -45.53 -39.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.591 0.234 . . . . 71.31 111.193 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -46.91 -36.44 7.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 75.22 110.632 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.447 ' ND2' ' HG ' ' A' ' 103' ' ' SER . 76.0 m-80 -54.62 -34.47 62.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.67 -0.695 . . . . 63.13 111.692 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -53.83 -40.46 66.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.937 0.399 . . . . 75.1 111.362 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.2 m -77.45 0.81 21.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.604 0.594 . . . . 74.12 112.604 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.542 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 14.3 mt -70.4 129.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 75.01 111.933 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.7 m -165.34 88.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.695 -0.684 . . . . 71.31 110.816 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.537 ' C ' ' HA ' ' A' ' 135' ' ' THR . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.779 -1.012 . . . . 71.23 112.086 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.135 -0.691 . . . . 74.34 109.135 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 37.41 50.3 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.927 0.394 . . . . 75.42 111.776 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.575 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 8.8 t70 -51.77 -54.8 24.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 70.34 110.695 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 9' ' ' LEU . 3.1 pt -148.48 60.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.514 0.673 . . . . 74.43 109.959 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 8.3 p -127.71 138.25 32.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 74.54 110.159 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 82.6 Cg_endo -85.0 34.02 3.92 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.974 -1.261 . . . . 74.11 112.858 0.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 59.6 t0 -59.4 -54.0 51.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.415 -0.357 . . . . 73.24 110.973 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 7.0 m -164.24 -32.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.03 -0.532 . . . . 75.53 111.986 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 35.3 tp -157.03 144.56 18.94 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.332 0.587 . . . . 74.14 112.028 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.37 -19.1 63.84 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.974 0.731 . . . . 64.44 112.974 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -161.22 135.46 7.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.523 0.194 . . . . 64.13 111.523 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.24 116.12 45.72 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.708 0.29 . . . . 74.24 111.521 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -95.72 -125.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.687 2.925 . . . . 72.44 112.151 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -158.35 -42.05 0.06 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.456 -0.338 . . . . 70.43 110.923 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.11 173.48 14.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.641 -0.79 . . . . 73.21 112.733 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 1.8 t -121.59 161.69 21.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.435 0.636 . . . . 61.4 111.519 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.1 mt -105.44 154.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.683 -1.144 . . . . 72.22 109.25 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.1 mmpt? -102.9 102.33 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.926 -0.579 . . . . 74.5 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 54.8 t -109.66 109.69 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.098 -0.704 . . . . 73.45 109.098 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.14 144.37 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.209 0.528 . . . . 74.52 111.082 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.75 -94.39 0.34 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.266 -0.879 . . . . 71.13 112.524 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.52 99.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.068 -0.587 . . . . 73.31 113.522 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' H ' HD23 ' A' ' 25' ' ' LEU . 2.4 m-20 179.14 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.923 0.868 . . . . 73.13 109.811 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -98.52 -40.88 8.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.465 -1.243 . . . . 75.23 111.411 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.6 pt? -69.41 141.05 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 74.54 111.127 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 6.0 pm0 -139.28 148.75 43.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 75.11 110.101 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.606 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 9.3 m -62.46 147.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.279 -0.418 . . . . 74.51 111.842 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 70.0 mttt -140.93 103.44 4.48 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.953 0.723 . . . . 74.33 112.953 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.503 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 10.2 mp0 35.63 67.72 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.691 0.997 . . . . 74.33 113.691 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.95 -10.42 57.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.222 -0.513 . . . . 62.31 113.629 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 t30 -47.0 129.67 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 74.02 110.985 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' GLN . 62.6 tt0 -102.79 132.63 48.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.46 -0.791 . . . . 74.25 111.246 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' HG ' HE21 ' A' ' 37' ' ' GLN . 0.1 OUTLIER -100.86 135.49 42.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.087 0.47 . . . . 73.11 110.948 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.522 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 7.8 p -138.64 164.79 37.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.455 -0.793 . . . . 74.44 109.974 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 84.9 Cg_endo -81.85 -29.31 5.97 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.303 -1.124 . . . . 64.12 113.155 0.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.2 t -161.45 35.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.154 0.502 . . . . 71.22 111.315 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.44 HE21 ' HG ' ' A' ' 33' ' ' LEU . 15.2 pt20 -84.42 0.27 50.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.31 110.025 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 40' ' ' ASP . 33.4 m -83.91 -3.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.736 -1.12 . . . . 75.35 112.646 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -65.88 6.19 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.856 0.317 . . . . 75.41 111.856 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -96.89 145.84 25.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.39 0.614 . . . . 73.41 111.749 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.633 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.4 pm0 -62.75 130.83 94.07 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 75.12 109.318 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.0 126.09 13.36 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.721 1.614 . . . . 74.33 112.664 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -100.13 105.27 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.752 -0.462 . . . . 72.45 109.752 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -82.41 140.81 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.43 111.525 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 33.1 m -164.98 121.91 1.52 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.672 0.272 . . . . 64.22 111.679 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 6.1 p90 -84.87 29.38 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.127 -0.694 . . . . 75.44 109.127 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 45' ' ' SER . 11.1 t -46.29 123.14 4.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.2 -0.909 . . . . 73.41 110.738 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.95 -24.83 30.64 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.481 -0.648 . . . . 61.53 111.481 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 6.6 mp -87.68 -37.17 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.608 0.242 . . . . 74.21 110.75 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -50.27 138.39 16.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.802 -0.359 . . . . 71.1 110.761 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.13 -71.78 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.831 -0.699 . . . . 73.31 111.909 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -148.73 108.94 4.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 74.33 110.366 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.528 ' HG ' ' HA3' ' A' ' 86' ' ' GLY . 5.1 p -158.1 141.53 15.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.59 -0.732 . . . . 72.41 110.194 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -73.16 -38.9 66.03 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.584 0.707 . . . . 74.43 109.513 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 26.2 mt -155.8 162.4 40.49 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.867 -1.061 . . . . 71.21 109.961 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' CD1' ' CZ2' ' A' ' 46' ' ' TRP . 80.6 mt -128.27 168.04 16.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.778 0.323 . . . . 74.32 110.42 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.401 ' CG2' HG13 ' A' ' 82' ' ' VAL . 99.1 m -143.47 133.11 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.426 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.77 138.62 52.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.957 -0.565 . . . . 75.11 110.032 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 80' ' ' SER . 52.3 mt -149.04 131.66 15.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.775 0.657 . . . . 72.44 112.775 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 37.8 ttm -94.84 122.18 37.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.139 -0.937 . . . . 75.13 108.797 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' H ' ' A' ' 62' ' ' ASP . 4.9 t -109.13 -131.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.712 0.264 . . . . 72.3 111.712 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.544 ' H ' ' CG1' ' A' ' 61' ' ' VAL . 8.6 t70 54.84 80.94 0.27 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 121.278 0.561 . . . . 74.44 111.162 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.9 84.49 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.297 1.998 . . . . 61.34 112.405 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -126.23 87.57 2.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 75.22 110.564 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.6 135.14 1.09 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 72.02 110.858 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 15.4 Cg_exo -67.67 -18.37 9.21 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.752 -1.353 . . . . 64.15 109.501 -1.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 t -157.25 131.7 8.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.781 -1.554 . . . . 74.34 107.934 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 4.3 tmm_? -50.97 -31.92 19.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.454 0.645 . . . . 74.33 109.832 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.41 -37.97 89.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.192 -0.913 . . . . 63.34 111.766 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 2.0 m-20 -141.21 72.16 27.04 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-O 121.195 0.521 . . . . 75.51 109.744 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 13.8 Cg_exo -67.04 65.48 0.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.105 2.537 . . . . 74.22 112.692 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -48.69 -45.88 39.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.587 -0.733 . . . . 75.22 112.346 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HB2' HD22 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -123.04 44.98 2.52 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.087 0.403 . . . . 71.44 112.087 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.53 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -70.69 133.0 46.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 71.2 110.896 179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 144' ' ' ALA . 86.9 mt-10 -91.32 178.47 5.96 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.478 0.711 . . . . 74.24 110.465 -0.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.571 HG13 ' H ' ' A' ' 77' ' ' LEU . 7.3 tp -113.85 176.35 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.789 -0.641 . . . . 75.34 109.591 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.571 ' H ' HG13 ' A' ' 76' ' ' ILE . 2.8 mm? -49.0 117.56 2.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.58 -0.526 . . . . 73.21 109.58 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.7 173.64 10.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.739 -0.664 . . . . 75.3 110.296 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.556 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.5 t-105 -99.51 113.1 25.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 74.24 111.007 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 14.4 m -131.85 128.22 38.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.594 -0.73 . . . . 74.53 109.848 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.426 ' CG1' HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.49 143.06 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.233 0.54 . . . . 73.43 110.225 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 57' ' ' THR . 29.5 m -142.52 161.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.771 -0.649 . . . . 71.14 112.29 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' A' ' 95' ' ' HIS . 23.4 p30 55.57 43.06 28.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.677 -1.147 . . . . 65.11 112.522 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.53 ' CD1' ' HA3' ' A' ' 94' ' ' GLY . 2.0 mm -83.01 130.65 56.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.926 -0.768 . . . . 71.12 108.926 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 84' ' ' ILE . 31.5 Cg_exo -58.04 128.88 30.51 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 121.454 1.436 . . . . 65.54 111.111 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.528 ' HA3' ' HG ' ' A' ' 53' ' ' SER . . . -64.85 57.74 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.642 0.617 . . . . 74.22 114.642 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.5 p -178.69 36.91 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.579 0.689 . . . . 51.3 111.378 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.7 m-80 -121.3 -2.0 9.62 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.49 -0.323 . . . . 72.23 110.93 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 70.05 -38.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 72.44 111.387 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 88' ' ' ASN . 13.6 p30 -129.32 155.63 79.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.967 0.413 . . . . 74.52 110.391 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 84' ' ' ILE . 92.6 Cg_endo -71.59 55.52 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.226 2.617 . . . . 73.15 113.289 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.7 t -97.16 -54.97 3.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.342 0.497 . . . . 72.54 112.342 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.59 -10.75 25.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 115.21 0.844 . . . . 72.22 115.21 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -96.51 173.11 29.49 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.268 -0.968 . . . . 71.52 113.647 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.519 ' HB2' HD22 ' A' ' 83' ' ' ASN . 5.9 m80 -68.35 128.82 37.96 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.618 0.599 . . . . 72.51 112.618 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.508 ' H ' ' CG2' ' A' ' 130' ' ' THR . 86.1 p -96.5 97.25 9.27 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.379 -0.373 . . . . 75.21 110.288 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' CD2' ' HB2' ' A' ' 127' ' ' GLU . 79.4 mt -56.94 -40.04 75.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 65.22 109.787 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.87 120.69 8.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.563 -1.199 . . . . 73.53 109.1 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.621 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 47.8 t0 -59.96 148.46 35.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 71.44 112.676 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 17.3 p90 -70.29 152.7 43.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.719 -0.673 . . . . 73.21 110.682 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.42 166.51 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 72.1 111.244 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.91 3.38 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.855 -0.611 . . . . 54.21 112.839 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.3 p -162.94 105.63 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 74.03 110.454 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -53.05 -47.38 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.533 -0.758 . . . . 71.03 113.044 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 74.9 Cg_endo -78.26 129.01 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.418 2.079 . . . . 74.1 112.217 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.58 158.87 53.57 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.731 2.287 . . . . 73.31 113.566 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 5.0 pttp -39.89 -27.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.119 -0.946 . . . . 73.24 112.158 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -50.38 -34.12 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.126 -0.488 . . . . 75.35 111.627 -178.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 6.8 t -93.62 4.7 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.566 -0.454 . . . . 71.43 111.433 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.17 -98.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.206 -0.452 . . . . 71.25 112.865 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.3 tp -61.0 145.23 51.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.575 0.703 . . . . 74.43 111.416 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 109' ' ' THR . 17.3 m-70 -139.75 114.02 9.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.191 -1.04 . . . . 74.12 108.191 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.514 ' HG3' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -100.3 123.87 45.06 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -119.64 138.46 53.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.967 0.413 . . . . 73.41 110.353 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 58.7 mt -122.66 122.3 65.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.311 -0.859 . . . . 74.44 111.923 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -98.9 137.28 37.69 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.748 -0.66 . . . . 74.21 109.86 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.545 ' HG ' HH12 ' A' ' 145' ' ' ARG . 1.1 tm? -123.97 138.28 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.552 -0.536 . . . . 74.45 109.552 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.3 tp -120.66 141.54 50.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 122.578 0.351 . . . . 75.13 110.744 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.528 ' CD2' ' CD2' ' A' ' 153' ' ' LEU . 37.7 t80 -142.44 136.73 29.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.868 -0.606 . . . . 74.3 111.047 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -79.51 121.25 24.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.785 -0.45 . . . . 74.11 109.785 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.577 HE22 HG12 ' A' ' 125' ' ' ILE . 1.9 tt0 -98.93 130.85 45.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.014 0.435 . . . . 74.31 110.871 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -99.07 -41.28 7.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.834 -0.621 . . . . 70.41 110.202 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -111.92 130.6 55.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 75.53 110.949 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.23 146.84 52.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 65.54 112.085 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG12 HE22 ' A' ' 121' ' ' GLN . 22.3 pt -126.68 140.24 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.957 -0.565 . . . . 73.05 110.783 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.1 -44.17 60.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.087 0.47 . . . . 75.31 111.66 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 29.7 38.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.154 1.168 . . . . 63.31 114.154 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 p 56.91 158.34 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.803 0.668 . . . . 74.41 112.803 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.2 158.26 9.79 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.73 2.286 . . . . 72.13 113.11 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.508 ' CG2' ' H ' ' A' ' 96' ' ' SER . 41.2 p -58.89 131.19 50.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.318 -0.855 . . . . 72.32 111.963 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.9 mm -103.56 124.96 58.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.522 0.201 . . . . 62.53 110.491 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.8 t -80.2 154.99 27.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.171 0.51 . . . . 75.34 111.268 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.621 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.1 p30 -52.69 -35.14 54.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 63.13 110.137 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -68.56 11.49 0.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.231 -0.895 . . . . 74.53 112.503 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 177' ' ' ILE . 15.0 t -62.02 132.39 52.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.79 0.329 . . . . 72.21 110.681 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 137' ' ' THR . 44.1 tpt85 -58.03 159.56 5.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.124 -0.489 . . . . 74.24 111.71 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.491 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 27.8 m -51.57 146.95 6.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 75.15 110.119 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.34 4.73 17.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 73.05 111.758 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 45.9 ttm-85 -144.05 37.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 74.24 110.776 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.564 ' HG ' ' H ' ' A' ' 141' ' ' ASN . 0.3 OUTLIER -114.92 -56.97 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 75.23 110.605 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' A' ' 73' ' ' TYR . 3.0 m120 -62.24 67.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.07 -0.513 . . . . 73.02 111.986 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 146' ' ' ASP . 44.4 t80 -140.4 131.35 26.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.017 0.437 . . . . 75.53 111.061 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -71.05 108.02 4.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 74.53 109.458 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.437 ' H ' ' CD ' ' A' ' 75' ' ' GLU . . . -52.27 -40.28 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.303 0.573 . . . . 61.4 111.464 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.545 HH12 ' HG ' ' A' ' 117' ' ' LEU . 1.6 tpt180 -57.4 -28.68 63.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.438 -0.801 . . . . 74.22 111.996 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 6.0 t70 -48.72 -47.48 41.22 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.882 -0.784 . . . . 64.12 108.882 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.505 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 12.2 m-30 -59.14 -40.05 84.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.151 -0.931 . . . . 73.23 109.852 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.762 -0.654 . . . . 71.12 111.15 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.74 24.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.063 -0.517 . . . . 71.41 111.887 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.6 ' HB2' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -68.7 -44.23 74.38 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.841 0.682 . . . . 75.13 112.841 -178.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.505 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 34.2 m170 -72.69 7.77 1.78 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.845 -0.342 . . . . 74.35 110.734 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.24 2.78 63.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.117 -0.563 . . . . 73.55 112.332 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 3.2 mt -68.71 16.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.543 0.211 . . . . 75.45 110.589 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.21 -66.24 1.25 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.874 -0.679 . . . . 72.55 112.189 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.52 122.18 84.63 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.036 -0.357 . . . . 73.41 110.036 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -87.72 127.94 2.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.513 2.142 . . . . 72.43 113.014 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -77.04 -34.14 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.127 0.489 . . . . 71.22 110.209 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.67 157.86 37.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 74.45 110.851 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' THR . . . -154.16 171.34 19.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.008 0.433 . . . . 75.21 111.156 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -170.58 133.57 1.02 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.079 -1.082 . . . . 75.54 108.079 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.489 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -135.4 158.41 44.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.76 -0.2 . . . . 70.33 111.466 -177.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.606 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.9 p90 -146.6 156.83 43.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.974 -0.557 . . . . 75.11 112.338 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.514 ' HG2' ' HG3' ' A' ' 113' ' ' ARG . 14.2 mt-30 -119.09 124.68 47.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.128 -0.942 . . . . 75.33 109.759 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -156.68 138.43 14.22 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.635 -0.426 . . . . 71.04 111.498 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.592 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.17 135.52 41.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.27 -0.641 . . . . 73.41 109.27 178.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.484 ' HB3' ' CG1' ' A' ' 170' ' ' VAL . 6.2 m-85 -121.21 142.64 49.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.341 -0.391 . . . . 74.24 111.814 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.467 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.4 m-20 -66.24 -168.21 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.191 -0.913 . . . . 60.43 113.022 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.6 t70 -85.9 -32.77 21.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.986 -1.006 . . . . 74.45 111.57 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -61.14 -32.58 72.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.521 0.563 . . . . 74.03 112.521 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 171' ' ' PRO . 1.5 p -72.29 -48.79 9.79 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.761 1.023 . . . . 72.35 113.761 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 170' ' ' VAL . 20.0 Cg_endo -59.25 -17.22 38.22 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.777 1.651 . . . . 74.44 112.519 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.9 tp -46.15 -30.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.012 0.434 . . . . 72.13 111.156 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.6 tpp85 -44.79 -25.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 71.52 110.588 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -50.5 -36.22 32.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.957 -0.565 . . . . 65.11 111.339 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.5 ' NZ ' ' HB3' ' A' ' 175' ' ' LYS . 8.4 mtpm? -56.7 -22.19 33.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.368 . . . . 73.13 111.128 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.6 m -74.96 -7.89 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.802 -0.635 . . . . 74.54 111.457 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.443 HG21 ' O ' ' A' ' 135' ' ' THR . 44.2 mm -68.52 79.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 74.21 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.6 m -139.33 13.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.41 0.522 . . . . 55.24 112.41 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-O 118.125 -1.375 . . . . 71.24 112.932 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.392 -0.225 . . . . 64.41 110.392 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' OD2' ' NH2' ' A' ' 145' ' ' ARG . 6.4 m-20 -68.87 112.61 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 72.41 110.526 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.18 -71.12 0.77 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.598 0.592 . . . . 64.25 112.598 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.573 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 6.9 pt -99.39 65.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 74.0 112.266 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 8.8 p -141.61 143.53 29.8 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.07 -0.514 . . . . 73.23 110.659 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 8.0 Cg_exo -73.57 17.81 2.65 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 124.905 -0.873 . . . . 75.53 112.626 0.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.573 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 2.3 m-20 -45.8 -59.23 2.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.851 . . . . 73.25 111.941 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 m -161.79 -40.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 55.04 111.54 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 11' ' ' ALA . 47.0 tp -151.24 135.26 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.36 0.6 . . . . 73.31 111.951 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -75.48 37.46 0.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 73.34 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 179.03 -148.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.608 -0.724 . . . . 71.2 109.856 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.33 119.2 3.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.55 0.215 . . . . 74.12 110.85 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -97.13 135.91 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.077 2.518 . . . . 75.1 112.77 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -24.89 67.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 74.45 110.334 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.54 -129.64 1.75 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.414 -0.812 . . . . 71.11 111.487 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t -164.32 159.58 20.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.513 . . . . 75.43 109.614 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -105.24 135.0 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.218 -0.446 . . . . 73.04 110.963 -179.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -77.69 102.3 7.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.386 -0.598 . . . . 74.45 109.386 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 97.6 t -107.97 110.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.402 0.62 . . . . 74.25 109.735 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -101.5 124.49 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 71.21 110.264 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 1.3 m-85 -73.98 -40.01 63.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.333 -0.849 . . . . 74.33 112.112 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.38 -55.14 0.15 Allowed Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.179 -1.01 . . . . 75.53 112.754 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -179.69 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 72.53 108.328 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -93.08 -45.13 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.725 -1.125 . . . . 73.33 109.214 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.538 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.3 pt? -69.22 138.5 54.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.768 -0.651 . . . . 72.2 109.375 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' CD ' ' NZ ' ' A' ' 28' ' ' LYS . 53.4 tt0 -143.74 139.05 29.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.072 -0.967 . . . . 74.33 111.001 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.598 HG12 ' CE1' ' A' ' 21' ' ' TYR . 16.0 m -86.57 106.81 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.22 0.533 . . . . 72.4 110.645 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' CD ' ' A' ' 26' ' ' GLU . 27.1 mttp -98.44 119.84 37.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.064 0.935 . . . . 75.31 112.949 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.8 mp0 30.28 67.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.566 -1.652 . . . . 72.51 115.049 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.42 8.81 76.56 Favored Glycine 0 C--N 1.329 0.184 0 N-CA-C 115.528 0.971 . . . . 74.51 115.528 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.76 149.92 21.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.864 0.832 . . . . 74.11 110.742 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -91.25 133.4 35.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 73.13 109.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 10.3 mp -106.0 126.34 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 72.41 110.648 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 17.0 p -143.79 160.88 48.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.467 -0.788 . . . . 63.51 109.937 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.1 Cg_exo -75.98 -40.03 1.28 Allowed 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.522 -1.032 . . . . 75.42 112.908 0.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 38' ' ' VAL . 19.7 p -151.98 28.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 70.4 111.591 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.429 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 1.8 pt20 -60.0 -10.4 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.521 0.677 . . . . 65.24 109.999 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 36' ' ' THR . 34.5 m -82.97 25.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.962 -1.017 . . . . 75.14 110.858 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.562 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -75.99 -21.19 57.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.285 -0.871 . . . . 74.21 111.085 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.562 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -107.76 152.52 24.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.155 0.503 . . . . 72.33 111.481 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.8 pm0 -63.98 146.39 97.3 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.449 -0.796 . . . . 64.21 111.793 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.603 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 94.7 Cg_endo -79.13 129.24 8.7 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.695 2.264 . . . . 71.31 112.805 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.3 mm -104.19 117.65 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.509 -0.182 . . . . 73.44 110.509 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.9 t -86.55 142.5 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 73.43 111.788 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -156.38 145.02 20.06 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.125 0.488 . . . . 72.45 110.668 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.678 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 3.3 p90 -126.32 35.34 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.187 0.518 . . . . 74.44 110.904 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -47.7 125.57 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 72.21 110.529 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -28.56 8.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 75.14 112.931 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -79.23 -42.18 26.55 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 109.228 -0.656 . . . . 75.22 109.228 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.678 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 31.6 tt0 -59.32 167.25 1.91 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.571 -0.74 . . . . 75.2 110.171 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . -177.48 -71.33 0.06 OUTLIER Glycine 0 C--O 1.229 -0.202 0 C-N-CA 120.708 -0.758 . . . . 64.11 112.14 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -148.86 109.74 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.124 0.488 . . . . 75.31 110.721 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 37.6 m -157.09 141.95 16.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 55.14 109.57 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.424 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t30 -67.01 -38.08 85.33 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.643 0.735 . . . . 74.25 109.482 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 64.6 mt -155.47 175.99 13.17 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.494 -1.23 . . . . 74.24 110.519 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 22.1 mt -146.71 158.91 44.01 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.222 -0.445 . . . . 72.44 109.944 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 3.2 m -123.21 127.79 49.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.226 -0.443 . . . . 74.51 111.119 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.84 117.58 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.454 -1.314 . . . . 75.34 107.454 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -132.77 139.96 47.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.464 0.542 . . . . 62.12 112.464 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 78' ' ' HIS . 46.5 ttm -94.74 134.37 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.639 -0.875 . . . . 74.44 108.639 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.39 136.0 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.308 -0.406 . . . . 72.32 111.022 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 5.2 t70 164.53 94.43 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 115.414 -0.812 . . . . 73.42 110.281 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.56 84.02 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.583 1.522 . . . . 73.43 110.833 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 84.49 1.64 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.766 0.654 . . . . 75.1 112.766 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.637 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.3 133.71 1.07 Allowed Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.45 -0.5 . . . . 71.25 112.28 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.637 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 Cg_exo -57.63 -23.34 1.82 Allowed 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 122.997 -1.668 . . . . 74.11 108.893 -3.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.451 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 12.2 t -161.93 143.57 11.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 113.889 -1.505 . . . . 74.44 108.706 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 53.1 ttp180 -53.69 -17.59 2.38 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.226 0.536 . . . . 73.53 111.185 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 69' ' ' GLN . 1.8 mp0 -72.49 -32.44 66.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.397 -0.82 . . . . 72.24 111.445 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.2 t0 -143.83 63.33 11.8 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 108.82 -0.807 . . . . 70.32 108.82 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.502 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 53.8 Cg_endo -72.3 51.74 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.23 2.62 . . . . 74.44 112.857 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -51.35 -44.11 61.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.391 -0.368 . . . . 74.1 111.945 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.486 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 15.6 p90 -108.22 34.76 3.44 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.523 -0.471 . . . . 71.43 111.629 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.502 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 35.8 ttp85 -76.44 144.49 39.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.814 -0.439 . . . . 72.4 109.814 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 29.8 mp0 -92.28 142.69 27.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.759 0.823 . . . . 63.54 110.602 0.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.6 tp -72.47 174.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.771 -0.372 . . . . 72.35 110.241 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.558 ' H ' HG13 ' A' ' 76' ' ' ILE . 3.2 mm? -52.15 133.46 33.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.428 0.633 . . . . 64.34 111.33 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 60' ' ' MET . 2.0 p-80 -129.64 157.05 43.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.861 -1.063 . . . . 73.42 109.458 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -99.35 117.67 34.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 62.34 109.923 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.3 m -141.38 138.02 32.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.443 0.639 . . . . 75.15 111.7 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.52 123.21 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 114.666 -1.152 . . . . 64.15 108.666 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' HG3' ' A' ' 127' ' ' GLU . 18.7 m -123.71 -177.4 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.066 -0.515 . . . . 74.32 110.367 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 125' ' ' ILE . 7.1 m120 62.82 30.2 16.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 74.54 109.951 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 1.2 mm -77.86 108.99 8.45 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.184 -0.606 . . . . 65.42 109.673 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 87' ' ' SER . 19.2 Cg_endo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.43 1.42 . . . . 74.04 110.69 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.05 71.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.433 -0.413 . . . . 64.4 113.655 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' PRO . 32.3 m -175.16 43.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.297 0.639 . . . . 71.33 110.179 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 90' ' ' ASN . 57.2 m-80 -135.78 -26.59 1.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.412 0.893 . . . . 75.13 113.412 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 9.0 tt0 77.57 -16.42 0.65 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.314 0.578 . . . . 74.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 88' ' ' ASN . 19.9 p30 -150.96 154.43 34.3 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.142 -0.935 . . . . 70.13 110.386 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 84' ' ' ILE . 96.2 Cg_endo -77.02 45.67 1.75 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.374 2.716 . . . . 74.54 112.994 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -103.97 -1.96 26.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 73.31 111.829 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.2 -14.89 13.58 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.751 -0.738 . . . . 71.34 114.338 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -87.97 177.24 46.19 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.572 -0.823 . . . . 71.24 113.637 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -68.23 114.29 6.58 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.812 0.301 . . . . 74.12 111.812 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.7 m -70.84 96.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.947 -0.76 . . . . 71.42 108.947 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 127' ' ' GLU . 24.6 mt -60.51 -59.52 5.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 75.41 110.503 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.61 125.17 35.52 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.25 -0.886 . . . . 64.33 109.223 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -59.96 156.15 15.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.596 0.712 . . . . 75.43 112.614 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 3.3 t80 -68.59 141.99 55.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.822 -1.081 . . . . 74.24 112.138 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.404 ' N ' ' CD1' ' A' ' 100' ' ' TYR . 7.4 p -142.87 113.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 72.44 109.866 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.39 -64.62 1.31 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.891 -0.671 . . . . 74.51 112.981 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.3 p 178.85 98.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 73.04 110.487 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.614 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -72.83 -35.62 58.33 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.066 -0.587 . . . . 73.51 113.573 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 38.6 Cg_exo -62.27 143.14 93.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.149 2.566 . . . . 65.33 113.294 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.48 144.85 99.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.223 2.616 . . . . 74.54 113.165 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -48.92 -22.36 0.83 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.455 -0.793 . . . . 74.34 111.642 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.3 m-20 -50.82 -29.93 12.98 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.57 0.581 . . . . 74.33 112.57 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 112' ' ' HIS . 12.9 t -70.62 -15.22 62.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.326 0.584 . . . . 71.25 110.418 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.68 -138.01 24.26 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.337 -0.847 . . . . 64.34 113.105 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 164' ' ' ALA . 31.7 tp -65.27 118.95 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.413 -0.394 . . . . 74.42 111.991 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 109' ' ' THR . 94.3 m-70 -79.93 148.07 31.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.334 -0.617 . . . . 63.42 109.334 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -114.04 58.98 0.68 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 75.33 110.805 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.51 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 54.4 m-85 -69.14 132.72 47.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.49 0.662 . . . . 75.14 112.357 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.25 134.31 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.102 . . . . 74.34 110.672 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 14.0 m-30 -104.21 137.79 41.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.061 -0.348 . . . . 73.3 110.061 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.41 HD11 ' N ' ' A' ' 118' ' ' LEU . 2.0 tm? -119.69 131.97 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.43 110.699 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.498 HD13 ' CE3' ' A' ' 46' ' ' TRP . 3.0 tt -131.81 122.69 26.18 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.751 0.31 . . . . 73.33 111.633 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.502 ' HA ' HG12 ' A' ' 157' ' ' ILE . 30.6 t80 -144.92 141.85 29.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.363 -0.38 . . . . 64.03 111.678 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HB3' ' NH1' ' A' ' 120' ' ' ARG . 16.6 mtm105 -63.2 144.8 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.566 0.222 . . . . 74.41 111.295 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 30.4 tp60 -117.62 124.83 49.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.822 -0.807 . . . . 74.22 108.822 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -86.38 -38.97 16.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 75.22 112.753 -178.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -110.18 150.07 29.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.278 0.844 . . . . 74.4 113.278 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 1.7 tppp? -72.64 133.59 44.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.941 -1.027 . . . . 74.13 110.496 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.575 ' N ' ' HD3' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -135.67 144.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 73.32 111.43 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -44.03 23.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.135 0.493 . . . . 74.42 110.848 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.687 ' CD ' ' HE2' ' A' ' 151' ' ' HIS . 47.8 mm-40 54.71 40.43 31.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.318 0.859 . . . . 73.3 113.318 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p 53.37 154.17 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 N-CA-C 113.673 0.99 . . . . 73.14 113.673 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.48 158.22 8.11 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.094 2.529 . . . . 64.31 113.009 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.8 p -58.86 122.45 13.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 72.44 111.164 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.45 121.11 44.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.42 0.629 . . . . 73.3 111.751 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.7 m -73.68 135.88 43.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.896 -1.047 . . . . 74.52 111.156 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' A' ' 135' ' ' THR . 19.2 p-10 -58.71 -43.48 90.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.989 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.411 ' HA ' HG12 ' A' ' 177' ' ' ILE . 41.0 p -70.09 22.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.202 -0.454 . . . . 74.15 112.189 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.9 t -74.1 133.56 42.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 74.1 111.285 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.539 ' HG2' ' H ' ' A' ' 179' ' ' GLY . 14.8 mmm-85 -58.05 173.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.877 0.846 . . . . 75.41 112.873 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -41.04 157.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.148 -1.387 . . . . 74.53 113.036 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.71 -36.83 1.21 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.048 -0.978 . . . . 73.53 112.948 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -86.24 26.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.018 0.409 . . . . 75.1 111.324 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.29 -54.82 2.56 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.06 -0.718 . . . . 75.1 109.06 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 3.2 m120 -53.75 121.98 8.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.425 -0.807 . . . . 73.45 110.924 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.455 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 9.8 t80 -173.53 123.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 74.43 110.488 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 17.1 p-10 -84.67 117.14 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 65.14 111.913 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.02 74.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 73.53 110.408 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' NH2' ' OD2' ' A' ' 2' ' ' ASP . 87.8 mtt180 -43.91 -36.89 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.623 -0.717 . . . . 74.44 111.406 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 24.5 t70 -49.41 -53.92 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.39 0.614 . . . . 73.23 110.498 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.509 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 5.3 m-30 -63.63 -34.53 78.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.495 -0.775 . . . . 73.0 110.482 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.481 ' HA ' ' CG ' ' A' ' 153' ' ' LEU . . . -59.81 -44.18 94.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.38 -0.6 . . . . 73.41 109.38 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.26 -57.32 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 71.14 111.908 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' A' ' 151' ' ' HIS . 3.0 ptmm? -60.87 -53.14 60.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.717 0.265 . . . . 73.42 111.717 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.687 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 46.2 m170 -69.42 -12.15 61.42 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.478 -0.489 . . . . 74.31 111.178 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.11 25.21 71.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 71.24 112.34 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 10.6 mt -64.16 16.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.835 0.454 . . . . 74.23 111.759 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -51.77 -21.31 7.0 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.035 -0.602 . . . . 72.24 113.224 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.05 95.93 14.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.227 0.537 . . . . 74.53 110.579 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.29 141.57 18.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.065 2.51 . . . . 74.43 114.106 -178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 119' ' ' TYR . 35.8 pt -82.79 -36.33 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 72.54 110.659 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -141.19 145.14 35.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.44 111.543 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.17 39.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.445 -0.798 . . . . 74.23 109.33 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 2.4 t-20 -171.12 127.28 0.69 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.264 -1.013 . . . . 72.33 108.264 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -115.8 156.86 25.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.912 -0.585 . . . . 74.25 111.047 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 3.3 p90 -139.41 136.94 35.21 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.725 -0.671 . . . . 74.41 110.175 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 39.8 mt-30 -122.1 124.45 43.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.819 -0.628 . . . . 75.51 109.699 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.416 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -155.99 151.14 26.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 72.2 110.713 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.559 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -111.33 133.76 53.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.409 -0.36 . . . . 73.44 110.146 178.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -115.57 131.39 56.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.305 -0.628 . . . . 74.4 109.305 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 169' ' ' TYR . 72.9 m-20 -66.53 -178.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 74.42 112.413 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.47 28.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.542 -0.754 . . . . 64.2 111.959 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.543 ' H ' ' C ' ' A' ' 167' ' ' ASP . 28.3 t80 -97.05 -45.71 6.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 73.34 110.526 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.595 ' CG2' ' HD3' ' A' ' 171' ' ' PRO . 16.0 m -60.38 -35.17 24.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 112.836 0.68 . . . . 72.5 112.836 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.595 ' HD3' ' CG2' ' A' ' 170' ' ' VAL . 73.1 Cg_exo -51.49 -35.61 56.14 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.187 1.258 . . . . 73.21 111.034 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.52 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 66.8 mt -48.31 -42.45 11.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 74.11 110.227 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.513 ' HA ' ' HE ' ' A' ' 173' ' ' ARG . 1.9 tpm_? -57.22 -37.91 72.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.252 -0.886 . . . . 74.32 111.235 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.41 ' O ' HG13 ' A' ' 177' ' ' ILE . 8.4 p30 -65.73 -35.19 80.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.434 -0.506 . . . . 62.43 110.789 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -57.6 -27.42 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.282 -0.567 . . . . 75.4 109.597 179.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 m -73.68 -0.12 14.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.623 -0.717 . . . . 72.31 111.587 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.519 ' O ' ' CG1' ' A' ' 178' ' ' VAL . 66.4 mt -64.64 129.74 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.803 -0.181 . . . . 64.52 110.584 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 177' ' ' ILE . 2.4 m -176.4 69.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 122.894 0.478 . . . . 74.11 111.297 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 118.768 -1.018 . . . . 70.34 112.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.643 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 45.8 ttm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.075 -0.343 . . . . 73.02 110.075 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 72.9 m-20 59.53 56.72 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.956 0.408 . . . . 64.24 111.445 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -75.57 -62.64 1.51 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.205 -0.452 . . . . 64.43 111.501 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 9' ' ' LEU . 18.5 pt -104.22 51.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.357 0.599 . . . . 75.33 111.014 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 2' ' ' ASP . 11.1 p -135.56 139.94 32.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.639 -0.709 . . . . 75.41 109.862 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 86.5 Cg_endo -82.15 37.7 1.33 Allowed 'Cis proline' 0 C--N 1.346 0.447 0 C-N-CA 123.744 -1.357 . . . . 75.22 112.762 0.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' H ' ' CA ' ' A' ' 5' ' ' VAL . 67.8 t0 -64.73 -50.88 65.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.34 . . . . 73.25 110.471 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HB ' ' HH ' ' A' ' 161' ' ' TYR . 7.8 m -163.74 -36.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.642 0.608 . . . . 65.13 112.642 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' O ' HG13 ' A' ' 4' ' ' ILE . 29.7 tp -157.31 164.23 37.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.093 0.473 . . . . 73.24 112.182 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -67.85 -38.0 82.58 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.869 0.366 . . . . 75.25 110.621 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -146.32 128.92 16.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 61.1 110.594 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -60.53 123.78 75.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.339 0.496 . . . . 74.51 112.339 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 156' ' ' PRO . 46.0 Cg_endo -87.58 -121.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.37 2.714 . . . . 75.11 112.295 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -163.42 -45.96 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.075 -0.511 . . . . 63.44 110.186 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.93 -135.07 8.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.874 -0.679 . . . . 65.22 112.474 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -164.12 177.42 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 73.34 110.834 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.405 ' CG2' HG23 ' A' ' 44' ' ' VAL . 53.0 mt -124.3 128.56 73.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.981 -0.554 . . . . 65.12 110.895 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.8 mmpt? -86.87 108.77 18.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.433 -0.803 . . . . 74.32 109.372 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 74.7 t -124.68 110.9 26.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.122 0.487 . . . . 74.44 110.434 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.25 137.94 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 75.31 110.937 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -86.53 0.32 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 75.55 111.77 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA2' ' CG ' ' A' ' 40' ' ' ASP . . . -69.54 -45.91 57.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.854 -0.688 . . . . 74.42 113.809 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 174.41 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.162 -0.681 . . . . 64.42 109.162 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -91.86 -42.97 9.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.179 -0.919 . . . . 73.35 109.33 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' H ' ' CD2' ' A' ' 25' ' ' LEU . 1.4 pt? -69.5 137.22 52.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.179 -0.919 . . . . 74.11 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 23.7 pt-20 -140.85 159.65 41.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.693 -1.139 . . . . 73.43 109.772 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG23 ' ND2' ' A' ' 160' ' ' ASN . 10.8 m -80.34 119.11 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.32 0.581 . . . . 75.21 111.307 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 41.1 mttp -120.87 113.22 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.723 -0.671 . . . . 65.14 111.822 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.8 mp0 46.43 67.08 0.82 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.54 1.311 . . . . 74.34 114.54 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.51 16.22 14.93 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.301 0.481 . . . . 62.32 114.301 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -51.77 145.47 9.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.131 0.491 . . . . 75.43 110.875 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -91.76 116.39 28.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.223 -0.899 . . . . 73.34 110.533 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 mp -92.84 118.0 30.64 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.513 -0.475 . . . . 74.42 110.141 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 p -150.51 154.95 36.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.758 -0.656 . . . . 72.14 111.006 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HG2' ' H ' ' A' ' 36' ' ' THR . 93.2 Cg_endo -89.19 -93.78 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 C-N-CA 124.039 -1.234 . . . . 75.51 111.267 -0.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.439 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 p -75.05 47.97 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.787 0.803 . . . . 75.3 109.631 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 35' ' ' PRO . 42.4 tt0 -107.66 -2.78 19.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 71.42 110.734 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.8 m -101.14 27.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 65.44 112.038 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.402 ' HZ1' ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.18 -40.6 62.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.095 0.474 . . . . 74.15 110.642 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 29.2 m-20 -71.79 138.91 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.612 -0.722 . . . . 62.24 112.146 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 2.8 pm0 -66.98 152.57 95.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.245 -0.889 . . . . 73.12 111.503 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.1 Cg_endo -81.97 126.94 5.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.786 2.324 . . . . 74.32 112.829 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 43.5 mm -107.07 106.08 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.215 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 HG11 ' CD ' ' A' ' 91' ' ' PRO . 10.4 p -79.02 143.23 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.732 0.641 . . . . 75.01 112.732 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' LYS . 36.9 m -165.46 152.32 10.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.018 0.437 . . . . 71.2 111.784 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 3.4 p90 -124.7 34.2 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.689 0.757 . . . . 74.41 109.556 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -44.42 121.9 2.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 75.53 111.197 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.44 -28.15 7.86 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.952 -0.642 . . . . 61.12 113.699 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 7.1 mp -75.68 -36.3 60.11 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.564 0.682 . . . . 74.22 110.096 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -51.55 158.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.409 -0.814 . . . . 71.43 109.994 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.38 -64.56 0.05 OUTLIER Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.423 -0.894 . . . . 71.15 112.135 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -148.16 109.35 4.32 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 74.24 108.845 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.503 ' HB3' ' HD2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -157.72 141.84 16.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.276 -0.875 . . . . 75.22 111.215 -178.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -77.13 -45.04 28.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.325 -0.991 . . . . 74.54 108.325 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 121' ' ' GLN . 80.0 mt -154.64 163.45 40.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.871 -1.513 . . . . 75.03 109.076 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' CD1' ' CZ2' ' A' ' 46' ' ' TRP . 32.7 mt -129.66 153.62 47.94 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.804 -0.443 . . . . 72.34 109.804 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.418 HG22 ' CG1' ' A' ' 82' ' ' VAL . 4.8 m -117.77 114.73 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 64.53 110.394 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.0 OUTLIER -108.1 119.37 39.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.67 -0.863 . . . . 75.11 108.67 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.8 mt -150.24 151.86 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.949 -0.7 . . . . 73.41 112.442 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.541 ' HG2' ' HB2' ' A' ' 78' ' ' HIS . 3.9 ppp? -94.99 154.91 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.268 -0.878 . . . . 73.2 109.177 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 62' ' ' ASP . 46.1 t -132.56 163.22 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.048 0.452 . . . . 73.22 111.725 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' N ' ' CG1' ' A' ' 61' ' ' VAL . 21.9 t70 64.18 54.91 1.53 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 74.5 110.187 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 35.1 Cg_exo -36.0 140.07 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.02 2.48 . . . . 73.31 112.22 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.05 85.53 2.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.623 0.601 . . . . 74.32 112.623 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.13 136.28 1.27 Allowed Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 112.301 0.482 . . . . 62.21 112.301 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.666 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 17.0 Cg_exo -68.36 -28.12 5.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.633 -1.403 . . . . 73.52 111.626 -1.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 t -150.03 150.11 31.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.14 -0.936 . . . . 75.41 111.123 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.9 -23.36 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.293 -0.867 . . . . 73.51 109.823 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.92 -39.82 29.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 72.33 112.619 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.587 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 8.4 t0 -144.37 81.08 11.55 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-O 120.613 0.244 . . . . 75.13 110.614 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.75 55.82 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.116 2.544 . . . . 73.02 111.935 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -48.9 -47.44 43.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.151 0.426 . . . . 75.42 112.151 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 1.7 p90 -114.34 33.42 5.3 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.489 -0.484 . . . . 74.3 111.081 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 63' ' ' PRO . 9.9 ttm180 -54.9 132.26 46.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.032 -1.099 . . . . 74.44 108.032 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 10.4 tp10 -103.26 166.67 10.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.871 1.668 . . . . 64.24 109.906 -0.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 77' ' ' LEU . 7.6 tp -94.51 -45.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.747 -0.835 . . . . 74.11 108.747 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' N ' HG23 ' A' ' 76' ' ' ILE . 3.2 pp -174.96 146.75 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.883 -1.053 . . . . 74.25 108.777 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 19.4 p-80 -158.73 176.6 12.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.579 -0.282 . . . . 75.33 110.386 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 100' ' ' TYR . 12.2 t90 -102.91 125.28 49.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.034 0.445 . . . . 75.3 111.238 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 27.2 p -141.55 133.56 27.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 71.31 111.035 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 58' ' ' LEU . 16.1 t -147.8 132.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.225 -0.443 . . . . 72.01 110.275 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' A' ' 57' ' ' THR . 19.8 m -137.16 171.14 16.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.78 0.324 . . . . 75.21 110.973 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.67 ' ND2' HE22 ' A' ' 121' ' ' GLN . 1.3 m120 73.88 25.82 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.718 -0.674 . . . . 53.31 110.527 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.584 ' CG2' ' HA ' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -72.35 115.16 36.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.382 -0.927 . . . . 74.1 110.215 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 129.21 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.795 1.663 . . . . 74.54 110.659 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.92 62.79 0.05 OUTLIER Glycine 0 CA--C 1.525 0.683 0 O-C-N 123.52 0.512 . . . . 63.33 113.441 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -173.95 37.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.675 0.79 . . . . 72.42 108.942 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.24 -10.33 2.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.864 -0.607 . . . . 72.41 112.489 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 71.88 -32.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.87 0.367 . . . . 54.33 111.264 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -153.69 166.14 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.45 110.546 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.584 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 69.8 Cg_endo -67.93 43.96 0.27 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.62 2.88 . . . . 71.42 113.508 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 t -74.04 -38.28 64.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 74.41 110.014 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.63 5.34 35.03 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.874 -0.603 . . . . 61.22 112.648 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.51 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -80.76 160.89 43.65 Favored Glycine 0 N--CA 1.454 -0.111 0 C-N-CA 120.746 -0.74 . . . . 74.25 112.394 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 106.75 4.03 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.249 0.524 . . . . 63.25 111.262 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 47.7 m -73.68 100.76 3.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 73.42 108.672 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HB2' ' OG ' ' A' ' 80' ' ' SER . 87.4 mt -58.39 -50.25 74.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.267 -0.424 . . . . 73.5 110.579 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.77 122.45 20.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.329 -0.396 . . . . 75.11 111.016 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -48.63 132.68 17.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CD1' ' O ' ' A' ' 100' ' ' TYR . 1.9 p90 -76.53 126.1 30.4 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.013 0.435 . . . . 75.21 110.522 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.401 ' HB ' ' HD3' ' A' ' 173' ' ' ARG . 1.2 m -148.05 159.81 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.857 -0.61 . . . . 60.42 111.061 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 173' ' ' ARG . . . -58.15 111.9 3.48 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.677 -0.692 . . . . 71.14 113.049 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 48.8 m -63.65 95.47 0.11 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.273 0.229 . . . . 75.32 110.815 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 170' ' ' VAL . . . -56.61 101.67 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.067 -0.515 . . . . 73.33 113.027 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HB3' ' NE2' ' A' ' 112' ' ' HIS . 87.8 Cg_endo -104.35 139.65 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.695 2.93 . . . . 64.25 112.912 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.35 134.24 62.72 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.181 1.254 . . . . 75.43 109.586 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -42.08 -35.83 1.0 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.301 0.572 . . . . 74.44 110.446 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -60.63 -42.53 97.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.928 -1.033 . . . . 75.3 112.803 -178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 3.6 t -72.56 -33.28 66.69 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.083 -0.386 . . . . 73.45 111.568 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.95 -88.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.531 0.972 . . . . 72.45 115.531 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.0 tp -66.88 122.4 17.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.824 1.046 . . . . 73.33 113.824 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.511 ' NE2' ' HB3' ' A' ' 105' ' ' PRO . 2.9 m-70 -97.46 137.03 37.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.513 -0.767 . . . . 72.34 110.185 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.448 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 5.9 mmt85 -104.8 118.02 35.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.288 -0.634 . . . . 64.22 109.288 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.87 133.57 54.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.177 0.513 . . . . 65.3 111.952 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.448 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 28.3 mm -125.74 121.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.058 -0.973 . . . . 64.41 108.868 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.33 131.94 51.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 74.42 110.771 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.81 130.93 51.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 74.33 110.435 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.5 tp -124.75 122.47 37.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.855 -0.611 . . . . 74.22 110.682 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 155' ' ' GLU . 37.0 t80 -134.62 138.24 44.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 75.24 109.777 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HD2' ' HB3' ' A' ' 53' ' ' SER . 37.3 ttp180 -68.95 124.53 23.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 73.42 111.72 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.67 HE22 ' ND2' ' A' ' 83' ' ' ASN . 39.7 tt0 -87.99 107.31 18.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.479 ' C ' HD21 ' A' ' 123' ' ' ASN . 2.0 tp10 -73.89 -37.12 64.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.007 -0.542 . . . . 74.35 111.192 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.479 HD21 ' C ' ' A' ' 122' ' ' GLU . 4.4 m120 -121.66 141.82 50.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.982 0.42 . . . . 74.52 111.513 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.509 ' HA ' HE21 ' A' ' 121' ' ' GLN . 3.8 tppp? -62.62 111.52 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.255 -0.276 . . . . 73.41 110.255 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.577 ' H ' ' NE2' ' A' ' 121' ' ' GLN . 6.1 pt -90.73 128.21 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.667 -0.494 . . . . 74.23 109.667 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.63 -46.85 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.929 0.714 . . . . 72.42 112.929 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 61.67 -117.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 75.24 109.675 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.9 p -162.77 160.19 19.54 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.378 -0.601 . . . . 74.31 109.378 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.59 154.88 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.189 1.926 . . . . 64.23 111.738 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.9 m -58.42 125.58 23.91 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.056 -0.35 . . . . 74.22 110.056 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.9 mm -90.69 126.24 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 74.54 112.178 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.4 m -82.94 134.86 35.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.063 -0.971 . . . . 64.02 109.727 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 135' ' ' THR . 15.0 p-10 -51.0 -40.94 59.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 75.43 111.273 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.9 t -65.47 4.04 0.6 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.184 -0.462 . . . . 60.32 111.895 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 133' ' ' ASN . 11.3 t -64.12 135.45 56.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.159 0.504 . . . . 72.31 110.255 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.52 ' HB2' ' HA2' ' A' ' 179' ' ' GLY . 8.9 ttt85 -84.98 173.24 10.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.813 -0.63 . . . . 75.21 110.765 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.402 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 1.9 m -35.72 151.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.259 -0.882 . . . . 62.34 112.187 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.19 2.7 19.91 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.984 -0.627 . . . . 73.41 113.573 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -169.75 44.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.237 0.518 . . . . 74.32 110.377 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD12 ' ND2' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -114.27 -59.66 1.99 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.984 -0.553 . . . . 72.51 111.984 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.549 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 2.4 m120 -65.07 42.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.657 0.984 . . . . 75.43 113.657 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 2.0 t80 -99.31 111.34 23.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 74.34 109.812 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.583 HD22 ' HB3' ' A' ' 145' ' ' ARG . 30.1 t30 -66.35 129.88 41.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.666 -0.697 . . . . 65.44 111.404 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.564 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . . . -72.24 -35.12 68.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.64 0.607 . . . . 75.52 112.64 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.643 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 30.1 ttm180 -47.04 -39.27 12.52 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.39 -0.524 . . . . 73.43 110.85 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.69 -37.71 63.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.185 -0.461 . . . . 72.21 110.894 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.6 m-85 -49.65 -40.54 40.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.365 0.602 . . . . 72.21 109.407 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.16 86.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 54.55 110.818 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.9 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 63.4 111.606 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.1 -43.27 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.371 0.508 . . . . 75.53 112.371 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.425 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 66.0 m-70 -91.4 1.48 57.09 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 70.42 110.912 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.556 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.4 32.65 73.23 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 121.108 -0.568 . . . . 64.04 113.662 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.3 mt -70.32 16.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 73.4 110.733 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -64.33 -4.08 11.32 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.059 -0.519 . . . . 63.23 113.153 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 20.3 pt-20 -134.34 72.55 70.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.716 0.769 . . . . 71.55 109.018 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.435 ' HG2' ' HB3' ' A' ' 13' ' ' PRO . 42.1 Cg_endo -68.18 131.14 22.85 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.154 2.569 . . . . 75.31 113.874 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.0 pt -75.51 -34.46 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 75.51 109.276 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -146.06 146.25 30.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.543 -0.753 . . . . 75.31 110.141 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -158.69 159.38 35.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 73.33 110.521 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 27' ' ' VAL . 59.1 t30 -170.48 175.37 4.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.207 -1.035 . . . . 72.23 108.207 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.497 ' HH ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -155.42 167.05 31.65 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.181 -0.608 . . . . 74.02 111.589 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.524 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -162.03 150.62 15.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.702 -0.681 . . . . 72.11 110.258 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 113' ' ' ARG . 57.9 mt-30 -124.64 138.16 54.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 75.2 110.378 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -155.11 138.89 16.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.834 -0.621 . . . . 74.34 110.373 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.635 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.43 138.08 37.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.086 -0.338 . . . . 63.13 110.086 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -127.63 126.58 42.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 74.4 110.135 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.3 m-20 -62.73 -174.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.324 0.583 . . . . 52.31 110.448 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 13.9 t70 -72.82 32.68 0.07 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.59 -0.732 . . . . 63.13 109.752 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.6 ' H ' ' C ' ' A' ' 167' ' ' ASP . 20.2 t80 -91.14 -53.69 4.26 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.339 -0.846 . . . . 75.22 111.752 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 28.3 m -59.81 -31.01 8.34 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 112.917 0.71 . . . . 65.13 112.917 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 83.7 Cg_exo -48.83 -21.41 3.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.51 1.473 . . . . 72.35 111.427 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.8 tt -51.7 -38.93 22.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.886 -0.597 . . . . 70.32 109.868 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.416 ' CD ' ' H ' ' A' ' 102' ' ' GLY . 85.2 mtt-85 -58.18 -34.97 70.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 74.4 109.881 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 171' ' ' PRO . 35.1 m-20 -62.19 -41.31 98.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.15 -0.685 . . . . 74.34 109.15 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -59.09 -17.24 24.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 74.33 109.831 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 m -88.21 6.12 38.27 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.981 -0.554 . . . . 62.54 111.778 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mm -74.07 124.36 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.919 -0.128 . . . . 73.34 111.11 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.51 -21.3 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.365 1.246 . . . . 74.32 114.365 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.245 0.795 0 CA-C-O 118.126 -1.375 . . . . 64.2 112.679 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.802 -0.444 . . . . 72.34 109.802 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -66.83 119.17 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.071 -0.344 . . . . 74.03 110.071 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.19 -71.2 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.426 0.528 . . . . 72.42 112.426 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 13.3 pt -125.37 59.95 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.616 0.722 . . . . 74.24 110.804 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 12.3 p -128.75 140.89 39.82 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.141 -0.936 . . . . 75.05 110.642 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.505 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 92.8 Cg_endo -85.29 33.13 4.77 Favored 'Cis proline' 0 C--N 1.35 0.606 0 C-N-CA 123.849 -1.313 . . . . 72.45 112.632 0.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -57.14 -54.54 45.6 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.219 -0.659 . . . . 71.41 109.219 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 161' ' ' TYR . 4.9 m -160.5 -39.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.419 -0.81 . . . . 75.41 111.676 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' CG1' ' A' ' 4' ' ' ILE . 22.8 tp -157.41 143.03 17.37 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.094 0.473 . . . . 71.53 111.458 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -78.84 25.73 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.821 -0.55 . . . . 63.24 110.333 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . -175.36 156.02 1.95 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.079 -0.51 . . . . 75.51 110.037 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.59 113.52 58.02 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.721 0.267 . . . . 61.24 111.721 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 87.9 Cg_endo -85.0 134.03 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.646 2.231 . . . . 73.55 112.482 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.62 88.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.09 -0.504 . . . . 75.24 110.562 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -135.09 3.32 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.683 -0.689 . . . . 63.51 111.483 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 t -161.29 176.94 10.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.45 -0.574 . . . . 75.32 109.45 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.6 mt -116.65 135.79 55.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.551 -0.295 . . . . 72.51 111.016 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 45' ' ' SER . 31.0 mmmt -73.92 102.31 4.06 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.438 -1.319 . . . . 74.23 107.438 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 95.7 t -117.28 110.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 73.52 109.654 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.6 mt -99.61 126.7 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.472 -0.785 . . . . 75.23 110.185 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.451 ' OH ' ' CE1' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -72.48 -77.48 0.1 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.134 -0.939 . . . . 74.42 110.61 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.86 -61.49 1.76 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.773 -0.727 . . . . 70.13 112.627 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -161.12 -53.75 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.374 0.607 . . . . 74.43 109.667 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -100.41 -37.34 8.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.268 -0.878 . . . . 75.45 111.24 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -69.27 124.6 24.27 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.998 0.904 . . . . 74.02 110.687 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -113.15 139.87 48.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.989 -1.46 . . . . 75.21 110.71 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 33.1 m -73.51 108.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.519 0.676 . . . . 70.4 110.343 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -86.01 82.41 8.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.96 0.726 . . . . 73.35 112.96 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 13.8 mp0 29.84 67.33 0.11 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.424 1.268 . . . . 72.44 114.424 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.87 -21.44 29.74 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.933 -0.651 . . . . 74.52 112.913 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.82 145.63 2.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.394 0.616 . . . . 73.24 112.348 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' CG ' ' A' ' 163' ' ' GLN . 88.9 tt0 -110.72 136.05 50.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.856 -1.065 . . . . 75.33 110.291 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -98.1 142.5 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.781 0.324 . . . . 64.53 111.156 178.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.2 p -150.17 146.33 19.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.883 -0.599 . . . . 75.23 109.791 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 36' ' ' THR . 58.3 Cg_endo -83.93 -115.24 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 124.08 -1.217 . . . . 71.12 112.636 0.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 35' ' ' PRO . 28.8 p -72.02 48.38 0.17 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.775 0.287 . . . . 53.4 111.775 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.405 HE21 ' HG ' ' A' ' 33' ' ' LEU . 19.2 pt20 -99.98 0.01 40.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.368 0.604 . . . . 72.35 109.82 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 33' ' ' LEU . 34.4 m -87.45 21.65 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.197 -0.911 . . . . 75.14 110.957 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -70.72 -34.13 71.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 73.5 111.711 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.41 135.18 35.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.745 0.307 . . . . 74.12 111.422 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -68.44 152.48 96.57 Favored Pre-proline 0 C--N 1.335 -0.023 0 N-CA-C 109.691 -0.485 . . . . 72.01 109.691 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.75 126.61 15.64 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.046 1.831 . . . . 73.3 113.673 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 47.0 mm -96.85 107.33 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.967 -0.753 . . . . 72.35 108.967 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' HA ' HG21 ' A' ' 19' ' ' VAL . 3.9 p -78.72 139.93 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.433 0.901 . . . . 73.22 113.433 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 57.7 m -164.9 134.07 3.55 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.161 -0.472 . . . . 73.54 110.359 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.715 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 2.4 p90 -114.24 35.95 3.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.484 0.659 . . . . 74.02 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -36.4 98.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.013 -0.994 . . . . 72.11 113.117 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.32 -15.16 41.46 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 116.075 -0.511 . . . . 70.41 114.251 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.23 -20.4 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.511 0.656 . . . . 74.43 110.703 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.715 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -71.35 -61.59 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.65 0.738 . . . . 74.21 109.403 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -64.24 4.34 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 109.522 -1.431 . . . . 51.43 109.522 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 2.0 ttmp? -149.1 116.79 6.23 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.199 -0.5 . . . . 75.52 110.134 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 p -157.02 141.57 16.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.216 0.531 . . . . 72.51 112.345 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 22.1 t30 -83.45 -36.66 24.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 74.4 109.061 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 25.3 mt -158.11 169.8 23.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.333 -1.303 . . . . 64.15 108.737 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 69.4 mt -141.57 159.82 41.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.922 0.391 . . . . 65.13 111.656 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 119' ' ' TYR . 2.1 m -121.56 132.82 54.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.271 -0.877 . . . . 64.35 108.77 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 91' ' ' PRO . 1.2 tm? -127.84 132.56 49.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 73.54 109.59 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 80' ' ' SER . 54.9 mt -145.97 129.79 17.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.877 -0.329 . . . . 74.22 111.018 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.06 135.49 45.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.106 -1.072 . . . . 64.53 108.106 178.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.518 ' N ' ' SD ' ' A' ' 60' ' ' MET . 10.2 t -147.43 143.53 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.941 0.877 . . . . 74.32 112.6 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 55.9 t0 -160.24 81.27 2.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 113.988 -1.46 . . . . 70.55 107.065 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' O ' ' CG ' ' A' ' 64' ' ' ASP . 37.4 Cg_endo -66.97 84.2 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.625 1.55 . . . . 73.42 112.47 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' CG ' ' HG2' ' A' ' 68' ' ' ARG . 31.3 m-20 -169.36 84.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.547 -0.751 . . . . 64.33 110.003 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -153.48 137.33 10.52 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.726 -0.842 . . . . 74.42 108.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.687 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 4.7 Cg_exo -77.31 -16.39 25.36 Favored 'Cis proline' 0 CA--C 1.515 -0.447 0 C-N-CA 124.287 -1.131 . . . . 65.33 111.927 0.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 2.3 t -138.77 140.72 38.73 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.468 -0.787 . . . . 71.43 110.867 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG2' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -45.94 -26.92 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.864 -1.062 . . . . 73.44 111.296 -178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -93.96 -45.14 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.52 1.304 . . . . 73.11 114.52 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.64 83.01 5.27 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 113.174 0.805 . . . . 64.32 113.174 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 63.7 Cg_endo -71.57 51.76 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.236 2.624 . . . . 74.31 111.696 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HG2' ' CD ' ' A' ' 66' ' ' PRO . 17.7 ptpt -48.66 -33.59 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.885 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.687 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 6.2 p90 -138.68 45.46 2.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.437 0.637 . . . . 75.14 111.743 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -73.74 138.51 44.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.457 -0.942 . . . . 75.52 108.457 177.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 29.3 mp0 -91.71 178.3 5.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.772 0.829 . . . . 72.24 111.385 0.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 77' ' ' LEU . 6.6 tp -106.67 169.81 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.536 -1.211 . . . . 75.02 109.409 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' CD1' ' H ' ' A' ' 77' ' ' LEU . 3.8 mp -45.87 125.04 5.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.578 0.228 . . . . 74.34 110.593 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -124.96 171.98 9.77 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.085 0.469 . . . . 75.01 111.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 6.7 t-105 -100.16 121.83 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.355 -0.839 . . . . 72.24 109.866 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -141.49 137.17 31.91 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.437 0.532 . . . . 72.14 112.437 -177.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.48 149.79 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.514 -0.312 . . . . 73.51 110.885 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 127' ' ' GLU . 22.2 m -142.05 155.66 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.988 0.366 . . . . 75.11 111.988 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.582 ' N ' HD21 ' A' ' 83' ' ' ASN . 1.0 OUTLIER 72.07 37.55 0.99 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.122 -0.49 . . . . 74.5 112.262 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 1.2 mm -83.71 116.0 62.44 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 119.436 -0.906 . . . . 73.14 109.624 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 35.5 Cg_endo -66.77 126.78 15.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 121.816 1.677 . . . . 74.42 111.676 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.35 71.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.903 -0.589 . . . . 61.32 114.103 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' PRO . 91.8 p -178.27 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.032 0.416 . . . . 70.55 110.999 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.503 ' ND2' ' HG2' ' A' ' 85' ' ' PRO . 65.5 m-20 -135.4 -2.47 2.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.256 -0.429 . . . . 75.43 111.327 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 13.1 pt-20 40.94 34.01 0.25 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.038 -0.528 . . . . 74.23 111.991 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 p30 175.48 152.62 0.31 Allowed Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 121.34 0.59 . . . . 72.4 110.761 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HA ' HG21 ' A' ' 84' ' ' ILE . 95.9 Cg_endo -74.68 61.17 5.34 Favored 'Trans proline' 0 CA--C 1.527 0.173 0 C-N-CA 123.339 2.693 . . . . 75.34 112.93 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 m -96.78 -55.3 2.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.348 0.87 . . . . 65.41 113.348 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.82 -40.97 89.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.032 0.773 . . . . 70.12 115.032 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -57.61 157.8 14.49 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.68 -0.771 . . . . 74.42 114.134 -178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.555 ' CE1' ' CG2' ' A' ' 130' ' ' THR . 80.3 t60 -61.63 125.6 24.37 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.079 0.551 . . . . 74.22 111.095 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.9 m -83.87 97.25 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.658 -0.868 . . . . 74.25 108.658 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 13.0 mt -54.16 -48.83 70.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.471 -0.937 . . . . 73.53 108.471 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 117.62 8.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.494 -1.23 . . . . 73.51 108.822 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.467 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.7 t0 -54.39 152.48 6.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.65 0.594 . . . . 70.21 111.556 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -70.48 129.26 38.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.31 -0.405 . . . . 71.31 110.342 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 77' ' ' LEU . 7.5 p -130.02 113.73 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.56 0.695 . . . . 73.45 110.873 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.46 72.97 2.74 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.427 -0.806 . . . . 70.2 113.455 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 29.8 p -171.03 11.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.891 1.071 . . . . 71.42 113.891 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 106' ' ' PRO . . . -55.38 -84.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.229 -0.986 . . . . 75.32 112.258 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.416 ' C ' HG23 ' A' ' 109' ' ' THR . 23.8 Cg_exo -64.54 105.85 0.66 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.144 1.896 . . . . 70.31 111.389 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.435 ' HG2' ' O ' ' A' ' 66' ' ' PRO . 18.3 Cg_endo -59.37 160.54 19.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.235 1.957 . . . . 73.31 112.428 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 167' ' ' ASP . 7.7 ttmm -39.69 -41.0 1.01 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.296 -0.866 . . . . 71.22 111.303 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.06 -39.21 55.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.308 -0.86 . . . . 54.31 112.223 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 14.0 t -70.73 -7.02 41.76 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.813 0.339 . . . . 73.34 111.572 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.18 -119.47 18.75 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.099 -0.572 . . . . 64.31 114.225 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.452 ' CG ' ' HB2' ' A' ' 163' ' ' GLN . 29.3 tp -58.06 119.84 7.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.802 1.038 . . . . 74.1 113.802 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 32.4 m170 -88.11 91.92 8.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.596 -0.729 . . . . 73.22 111.081 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HD2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -76.82 63.86 2.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 75.43 110.125 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.7 m-85 -65.73 131.62 46.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.248 -0.433 . . . . 63.24 111.057 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 33.9 mt -127.25 122.17 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.765 -0.652 . . . . 72.34 111.657 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 3.9 m-30 -90.4 145.95 24.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.876 -0.602 . . . . 73.31 110.207 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.69 131.88 38.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.415 HD21 ' CD1' ' A' ' 157' ' ' ILE . 1.5 tt -126.27 131.47 51.88 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.954 -0.387 . . . . 74.41 109.954 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.552 ' CE1' ' HA ' ' A' ' 153' ' ' LEU . 65.7 t80 -131.75 139.24 48.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.972 0.415 . . . . 63.41 110.476 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.621 HH12 ' HB3' ' A' ' 122' ' ' GLU . 0.6 OUTLIER -71.89 130.54 41.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 74.55 110.513 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -116.03 148.52 40.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.627 0.251 . . . . 73.13 111.231 -178.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.621 ' HB3' HH12 ' A' ' 120' ' ' ARG . 23.2 pt-20 -148.03 17.66 1.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.178 0.514 . . . . 75.41 110.941 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 5.8 m120 -143.91 129.13 18.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.053 -0.976 . . . . 75.45 108.415 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -76.64 111.58 12.29 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.78 -0.768 . . . . 64.35 111.202 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.44 ' CG1' HD22 ' A' ' 83' ' ' ASN . 9.2 pt -103.68 128.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.812 -1.085 . . . . 74.01 110.661 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -56.17 -57.67 11.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.411 0.624 . . . . 74.02 110.954 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.543 ' CD ' ' HE2' ' A' ' 151' ' ' HIS . 21.9 mm-40 63.09 31.87 15.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.985 -1.007 . . . . 75.25 112.763 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.4 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 44.5 p 57.72 151.6 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 112.631 0.604 . . . . 73.23 112.631 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -45.21 157.58 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.471 2.781 . . . . 75.42 113.561 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.555 ' CG2' ' CE1' ' A' ' 95' ' ' HIS . 8.2 p -62.5 131.1 48.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.524 -0.762 . . . . 74.22 112.524 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.4 HG13 ' CZ ' ' A' ' 139' ' ' ARG . 45.3 mm -104.56 118.49 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.929 -0.767 . . . . 72.3 108.929 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.3 t -69.46 153.1 44.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 73.3 111.77 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.467 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.5 p30 -54.42 -29.36 48.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.552 -0.749 . . . . 64.22 110.296 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 p -78.12 21.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.718 -0.674 . . . . 71.02 111.554 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 133' ' ' ASN . 8.5 t -62.71 126.47 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.311 0.577 . . . . 74.23 111.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -89.01 173.31 8.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.5 -0.773 . . . . 74.54 111.242 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.483 ' HA ' ' CD1' ' A' ' 140' ' ' LEU . 37.5 m -36.87 150.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.492 -0.777 . . . . 71.31 112.457 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.13 25.43 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.017 -0.611 . . . . 74.4 112.972 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 55.8 ttt180 -163.96 37.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.252 0.549 . . . . 73.41 111.03 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.591 HD11 ' N ' ' A' ' 140' ' ' LEU . 7.2 mp -82.52 -64.06 1.25 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.437 -1.32 . . . . 74.15 107.437 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -68.6 117.73 10.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.914 -1.143 . . . . 73.0 107.914 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.455 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 21.5 t80 -170.77 80.19 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.331 -0.395 . . . . 74.54 111.305 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -62.36 117.34 6.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.139 -0.482 . . . . 73.21 111.899 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.53 -25.25 36.49 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.266 0.555 . . . . 71.23 109.861 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -46.57 -32.47 3.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.373 -0.83 . . . . 75.34 109.111 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 1.5 t70 -61.26 -56.47 20.21 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.147 -0.686 . . . . 61.33 109.147 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.532 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 3.5 m-30 -56.4 -35.31 67.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.94 -0.573 . . . . 74.45 109.737 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -65.55 -41.5 92.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.45 -0.795 . . . . 71.02 109.592 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.89 -55.01 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.922 -0.581 . . . . 74.14 110.826 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.575 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 2.1 ptpp? -59.14 -45.15 91.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 74.25 111.763 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.543 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 89.6 m-70 -92.58 9.0 36.51 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.751 -0.38 . . . . 74.11 111.75 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 56.59 30.09 58.64 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.767 -0.73 . . . . 72.33 113.371 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HA ' ' CE1' ' A' ' 119' ' ' TYR . 13.3 mt -71.95 16.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.812 -0.228 . . . . 73.44 111.048 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.04 -63.75 1.92 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.323 -0.465 . . . . 62.23 114.002 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.17 112.29 15.05 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.726 0.263 . . . . 74.24 111.671 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 66.9 Cg_endo -79.97 123.35 5.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.094 1.863 . . . . 72.31 112.52 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.415 ' CD1' HD21 ' A' ' 118' ' ' LEU . 50.3 pt -74.87 -33.5 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.571 -0.452 . . . . 73.23 110.411 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.52 139.65 15.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.316 -0.402 . . . . 74.34 110.762 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -142.78 159.99 41.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 74.45 109.935 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 1.3 t-20 -161.38 123.38 2.97 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.563 -0.903 . . . . 72.11 108.563 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.468 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.81 169.54 11.44 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.984 -0.553 . . . . 74.22 111.698 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 2.1 p90 -164.1 160.95 22.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 72.1 109.996 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.452 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . 1.3 pt20 -132.65 129.0 38.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.516 -0.311 . . . . 71.4 110.848 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.44 140.4 17.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.317 -0.402 . . . . 73.23 111.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.86 133.03 43.74 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.547 -0.538 . . . . 74.23 109.547 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -105.83 113.72 27.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.239 0.542 . . . . 74.42 110.293 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.637 ' O ' ' NZ ' ' A' ' 107' ' ' LYS . 31.1 m-20 -49.81 -52.53 31.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.238 -0.892 . . . . 63.35 112.751 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -167.48 45.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.325 -0.55 . . . . 75.22 111.661 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 31.8 t80 -101.37 -40.58 7.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 73.52 111.553 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.63 ' CG1' ' HD3' ' A' ' 171' ' ' PRO . 0.1 OUTLIER -53.2 -47.46 95.86 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.924 1.083 . . . . 75.02 113.924 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.63 ' HD3' ' CG1' ' A' ' 170' ' ' VAL . 77.4 Cg_exo -53.01 -50.52 13.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.88 1.72 . . . . 60.2 113.521 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.537 ' CD1' ' H ' ' A' ' 172' ' ' ILE . 1.7 mp -45.83 -55.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 73.2 110.84 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 12.1 tpp180 -56.32 -44.66 80.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.39 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -51.87 -38.74 57.19 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.044 -0.525 . . . . 74.22 111.327 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 6.5 mmpt? -55.13 -29.68 58.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 73.41 110.964 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -67.64 -29.8 69.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 73.52 111.994 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.85 103.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.485 -0.325 . . . . 74.31 110.902 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -148.39 1.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.389 0.514 . . . . 74.2 112.389 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.641 -1.089 . . . . 51.14 112.224 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 3' ' ' ASP . 49.9 ttm . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.442 -0.207 . . . . 74.12 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER -61.17 68.77 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.705 0.402 . . . . 74.44 111.555 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 1' ' ' MET . 9.6 t70 -106.95 -71.02 0.77 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.674 0.62 . . . . 72.25 112.674 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 9' ' ' LEU . 14.7 pt -80.84 41.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.558 0.694 . . . . 73.22 111.847 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.2 p -114.04 138.92 23.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.606 -0.724 . . . . 75.12 111.361 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 59.8 Cg_endo -93.57 39.42 4.67 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.388 -1.088 . . . . 73.31 112.594 -0.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 9.3 t70 -58.2 -44.41 88.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.437 -0.347 . . . . 74.2 110.412 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 7' ' ' ASP . 5.9 m -165.75 -36.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.968 -0.56 . . . . 74.51 111.811 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 4' ' ' ILE . 18.7 tp -157.08 175.01 14.64 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.669 -0.493 . . . . 73.55 109.669 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 6.6 p-10 -69.0 -52.44 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.42 -1.326 . . . . 75.41 107.42 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 137.82 22.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 74.43 110.739 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.41 ' N ' HD13 ' A' ' 4' ' ' ILE . 10.9 p -59.89 129.23 87.79 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.152 -0.476 . . . . 72.2 111.861 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.476 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -88.61 -138.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.089 2.526 . . . . 74.12 111.904 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.42 -29.7 7.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.519 -0.31 . . . . 51.33 111.214 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -159.94 -175.58 31.07 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.909 -0.476 . . . . 70.52 111.909 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 2.2 t -117.82 163.12 17.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.341 0.591 . . . . 74.13 112.069 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.57 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.185 -0.916 . . . . 75.05 109.691 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.2 mmmm -82.38 102.97 11.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.563 -0.289 . . . . 74.2 110.596 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 95.6 t -110.24 110.82 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.318 -0.623 . . . . 72.23 109.318 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.2 mt -96.57 130.92 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.566 . . . . 74.23 110.071 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 2.8 t80 -103.17 -15.14 16.12 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 112.362 0.505 . . . . 74.11 112.362 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.16 2.93 7.83 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.181 0.832 . . . . 64.13 115.181 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 76.19 20.81 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.372 -1.344 . . . . 72.14 107.372 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -175.16 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 112.753 -2.021 . . . . 74.14 107.134 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.62 136.02 50.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.984 -1.007 . . . . 74.55 108.976 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 73.0 tt0 -126.61 143.6 51.17 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.227 0.825 . . . . 72.33 113.227 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 3.8 m -86.66 140.34 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.824 -0.626 . . . . 75.52 110.284 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 26' ' ' GLU . 10.7 mptt -131.67 114.77 15.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.483 0.549 . . . . 73.44 112.483 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.3 mp0 25.09 67.21 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.297 1.221 . . . . 73.54 114.297 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.56 6.28 89.04 Favored Glycine 0 C--N 1.33 0.225 0 N-CA-C 114.28 0.472 . . . . 61.11 114.28 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 18.9 t30 -55.99 131.07 46.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.849 0.357 . . . . 73.44 110.789 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -89.54 136.04 33.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 64.33 109.673 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 8.1 mp -92.73 138.99 31.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.319 . . . . 75.35 111.208 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -147.6 154.91 45.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 75.52 110.562 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.46 -52.62 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.826 -1.323 . . . . 63.23 112.879 0.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -120.38 28.92 7.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.747 0.784 . . . . 72.44 110.484 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.606 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 3.1 pt20 -80.98 -6.54 58.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.22 -0.9 . . . . 73.2 110.635 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.69 32.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.485 -0.78 . . . . 73.45 111.227 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -96.93 -38.11 9.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.819 1.044 . . . . 74.15 113.819 -177.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -82.64 143.93 30.64 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.071 0.767 . . . . 75.33 113.071 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.49 153.09 83.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.474 -1.239 . . . . 75.01 111.659 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.77 126.79 6.75 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.492 2.128 . . . . 74.12 112.745 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 51.6 mm -108.09 117.74 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 64.1 109.698 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.6 p -91.42 142.02 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.11 0.781 . . . . 74.11 113.11 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 68.5 m -161.43 113.73 1.83 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.848 -0.614 . . . . 73.34 109.46 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.558 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 1.3 p90 -93.67 35.95 1.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.154 0.502 . . . . 75.1 110.708 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.2 m -49.21 118.94 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 65.14 111.393 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.22 -11.31 72.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.172 -0.537 . . . . 71.32 112.805 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.39 10.63 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.826 0.346 . . . . 73.24 110.541 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -104.0 -62.85 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.151 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 50' ' ' GLU . . . 74.36 -99.43 1.09 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.469 -0.652 . . . . 71.41 111.469 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.497 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -148.82 109.96 4.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.966 0.412 . . . . 74.23 111.121 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -144.49 147.93 33.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.456 . . . . 71.42 110.225 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.463 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 31.5 t30 -63.34 -39.74 95.38 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.42 0.628 . . . . 72.22 109.852 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 30.2 mt -153.98 162.1 41.47 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.828 -1.078 . . . . 73.32 111.341 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.4 mt -132.82 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.957 0.408 . . . . 74.52 109.983 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 13.1 m -113.17 123.62 50.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 74.11 110.337 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 81' ' ' VAL . 1.3 tm? -124.51 129.81 51.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.777 -0.453 . . . . 74.23 109.777 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -152.46 169.16 23.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 72.42 111.506 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -95.06 131.63 40.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.833 -0.621 . . . . 73.23 110.537 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.682 ' CG2' ' HB2' ' A' ' 117' ' ' LEU . 6.1 t -106.71 160.19 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.773 -0.194 . . . . 74.52 111.349 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 54.36 57.34 12.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 72.14 109.941 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 10.3 Cg_endo -53.95 139.98 69.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.821 1.681 . . . . 73.34 110.662 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 105' ' ' PRO . 35.9 t0 -165.91 117.01 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.429 0.529 . . . . 74.01 112.429 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ARG . . . -170.43 144.73 2.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.481 -0.781 . . . . 72.13 109.392 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 73.3 Cg_endo -83.12 -14.56 35.05 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.483 -1.049 . . . . 74.34 111.759 0.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.9 t -164.92 154.12 12.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.106 -0.952 . . . . 63.53 109.715 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.636 ' NE ' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.59 -1.83 12.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.927 -0.579 . . . . 75.42 111.719 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.636 HE21 ' NE ' ' A' ' 68' ' ' ARG . 85.0 mm-40 -86.34 -45.13 11.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.395 -0.366 . . . . 74.13 111.756 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.4 96.63 5.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 74.41 109.787 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.23 57.13 4.61 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.347 2.031 . . . . 74.53 113.047 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -54.35 -37.43 64.91 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 121.038 -0.265 . . . . 75.44 111.489 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.601 ' HB2' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -149.41 77.21 1.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.11 0.957 . . . . 73.25 110.072 177.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.504 ' NE ' ' O ' ' A' ' 63' ' ' PRO . 72.5 ttt180 -98.72 109.78 22.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.053 -1.43 . . . . 73.24 110.415 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.3 mt-10 -108.0 178.06 4.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.033 1.333 . . . . 75.44 110.61 -0.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.503 HG13 ' CE2' ' A' ' 73' ' ' TYR . 1.6 mp -75.64 -58.34 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.73 -0.841 . . . . 74.22 108.73 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 101' ' ' VAL . 1.4 mm? -140.56 -171.05 3.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.255 -1.339 . . . . 74.33 108.263 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 p80 176.27 156.92 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.4 -0.222 . . . . 65.33 110.4 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.704 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 1.2 t-105 -100.12 111.57 23.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.218 0.533 . . . . 73.5 110.041 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 m -127.93 125.34 39.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.503 -0.771 . . . . 72.34 110.704 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -147.66 125.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.497 -0.774 . . . . 74.41 110.441 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG11 ' CD1' ' A' ' 97' ' ' LEU . 27.4 m -126.66 174.44 10.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.053 0.454 . . . . 74.34 111.498 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 13.8 p30 54.02 40.24 31.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.956 -1.02 . . . . 65.12 111.019 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 7.4 mm -77.89 122.23 85.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.976 -0.749 . . . . 73.14 108.976 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.74 127.77 25.67 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 121.934 1.756 . . . . 70.13 112.323 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.92 58.65 0.08 OUTLIER Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.416 0.448 . . . . 72.35 113.542 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -168.06 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.143 0.577 . . . . 64.25 109.664 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 90' ' ' ASN . 73.1 m-80 -135.13 -16.1 1.92 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 64.33 112.134 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 71.57 -36.23 0.35 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 73.14 111.338 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 88' ' ' ASN . 8.5 p30 -129.22 152.55 79.63 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.088 0.47 . . . . 72.23 110.254 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.52 ' HB2' ' CG2' ' A' ' 81' ' ' VAL . 80.4 Cg_endo -70.82 52.47 1.35 Allowed 'Trans proline' 0 N--CA 1.473 0.307 0 C-N-CA 123.572 2.848 . . . . 71.02 113.602 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -104.24 -1.92 26.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.483 -0.487 . . . . 75.4 111.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.21 -42.12 1.32 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.953 -0.642 . . . . 74.25 113.51 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -63.57 172.59 13.44 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 120.871 -0.68 . . . . 63.41 113.136 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.46 ' HB3' ' OE2' ' A' ' 127' ' ' GLU . 72.2 t60 -66.19 130.82 44.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.745 0.307 . . . . 73.02 111.73 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.438 ' HA ' ' CG1' ' A' ' 81' ' ' VAL . 36.8 m -87.21 102.63 14.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.837 -0.801 . . . . 64.21 108.837 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.409 ' CD1' HG11 ' A' ' 82' ' ' VAL . 94.0 mt -62.68 -37.44 86.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.539 0.685 . . . . 73.33 109.655 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.56 127.28 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.711 -1.131 . . . . 72.32 108.653 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -55.38 152.34 8.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.285 0.846 . . . . 73.34 113.285 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.704 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 3.1 p90 -83.67 142.61 30.65 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.394 -0.821 . . . . 74.44 112.836 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 77' ' ' LEU . 5.2 m -158.35 113.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 71.45 111.346 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.83 2.81 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 62.35 112.297 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.3 t -172.03 49.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.925 0.343 . . . . 75.33 111.925 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.87 -75.68 0.61 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.465 -1.054 . . . . 75.41 110.465 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' A' ' 64' ' ' ASP . 15.8 Cg_exo -74.17 123.5 8.35 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.941 2.427 . . . . 61.52 111.49 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 66' ' ' PRO . 31.6 Cg_exo -59.01 159.35 21.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.862 2.375 . . . . 75.31 112.978 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.408 ' CD ' ' HB2' ' A' ' 168' ' ' ASP . 18.4 pttp -43.66 -20.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.949 -0.569 . . . . 64.45 111.322 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 106' ' ' PRO . 29.8 t70 -50.42 -46.54 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.223 -0.444 . . . . 72.51 110.41 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.469 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 4.2 t -79.54 -4.04 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.152 -0.476 . . . . 73.04 111.519 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.75 -101.18 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.184 -1.167 . . . . 53.2 110.184 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.5 tp -66.66 112.17 4.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.945 -0.391 . . . . 75.34 109.945 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.431 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 10.9 p80 -109.83 92.1 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.988 0.423 . . . . 75.21 110.303 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.43 ' H ' ' NE ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -58.67 130.57 47.5 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.62 -0.718 . . . . 75.43 110.583 -179.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.06 128.54 45.11 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 120.95 0.405 . . . . 74.31 109.916 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 161' ' ' TYR . 4.7 mm -115.86 141.83 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.446 -0.797 . . . . 75.12 111.286 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.25 141.46 48.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.937 -0.574 . . . . 72.1 110.245 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.682 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 5.5 tt -124.5 140.39 52.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.374 . . . . 74.44 110.72 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 57' ' ' THR . 60.2 tp -130.29 134.04 46.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.668 -0.696 . . . . 74.41 110.583 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.474 ' HA ' HG12 ' A' ' 157' ' ' ILE . 66.8 t80 -144.14 139.49 28.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.207 0.527 . . . . 72.43 111.295 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -68.78 135.35 51.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 74.22 111.544 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.43 ' NE2' ' O ' ' A' ' 123' ' ' ASN . 3.5 tp60 -119.8 127.62 52.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.576 -0.527 . . . . 71.52 109.576 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' C ' HD21 ' A' ' 123' ' ' ASN . 62.9 tt0 -109.09 -8.57 15.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.63 -0.714 . . . . 71.31 111.332 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.463 HD21 ' C ' ' A' ' 122' ' ' GLU . 4.3 m120 -125.81 148.86 49.0 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.817 0.341 . . . . 73.04 111.809 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.403 ' HD2' ' CD1' ' A' ' 55' ' ' LEU . 13.2 mmmm -76.69 149.15 36.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 75.55 110.14 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.62 143.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 111.994 0.368 . . . . 75.41 111.994 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -81.07 -16.15 54.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.655 -0.702 . . . . 73.41 111.355 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 95' ' ' HIS . 0.0 OUTLIER 4.81 60.65 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.295 1.591 . . . . 74.41 115.295 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 126' ' ' GLU . 25.7 p 51.78 150.9 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 115.213 1.56 . . . . 74.15 115.213 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.82 158.19 29.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.659 2.906 . . . . 74.11 112.532 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -58.79 141.33 53.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.247 -0.433 . . . . 70.23 111.58 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.63 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.117 0.484 . . . . 75.32 111.673 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.7 m -87.38 143.03 27.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.551 -0.75 . . . . 75.2 111.244 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 135' ' ' THR . 11.5 p30 -51.86 -37.21 51.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.001 0.429 . . . . 72.12 110.817 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.9 p -70.29 12.87 0.2 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.654 0.613 . . . . 73.41 112.654 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.7 t -68.48 123.94 22.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 74.45 110.507 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.511 ' H ' ' CA ' ' A' ' 179' ' ' GLY . 27.3 ttt-85 -62.89 165.67 6.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.221 -0.445 . . . . 74.11 111.344 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.408 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 11.6 m -37.34 155.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.121 -0.945 . . . . 72.22 111.873 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.0 -3.25 20.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.973 -0.632 . . . . 74.44 111.819 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -165.54 41.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.168 0.509 . . . . 74.33 111.128 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.29 -64.62 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.027 -1.101 . . . . 65.14 108.027 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.601 HD22 ' HB2' ' A' ' 73' ' ' TYR . 2.1 m120 -73.0 114.9 11.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.484 -1.235 . . . . 75.54 109.636 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -148.21 135.65 20.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 74.41 111.001 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.48 HD21 ' HG3' ' A' ' 145' ' ' ARG . 19.0 p-10 -101.69 106.66 17.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 61.21 110.505 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -49.12 -37.05 20.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 51.31 111.243 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.48 ' HG3' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -49.4 -25.94 2.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.973 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.488 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -52.46 -52.64 53.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.623 -0.88 . . . . 73.2 108.623 177.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 4.6 m-85 -62.12 -29.58 70.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.058 -0.974 . . . . 72.44 110.194 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -62.83 -37.05 85.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.457 -0.572 . . . . 72.13 109.457 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.17 39.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.708 -0.678 . . . . 74.13 111.182 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.567 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 3.7 ptpp? -66.58 -49.45 66.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.199 0.444 . . . . 75.42 112.199 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.424 ' ND1' HD23 ' A' ' 153' ' ' LEU . 22.0 t-160 -86.83 3.12 46.6 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.199 -0.313 . . . . 75.44 111.222 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 58.63 34.12 75.16 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.113 -0.565 . . . . 75.34 113.565 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 148' ' ' ALA . 18.1 mt -68.27 16.55 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 122.739 0.415 . . . . 65.44 112.072 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -52.68 -33.8 42.56 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.549 -0.834 . . . . 62.32 112.765 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.7 78.74 0.13 Allowed Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.3 0.24 . . . . 71.42 111.441 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 154' ' ' GLY . 32.5 Cg_endo -61.56 130.4 31.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 121.526 1.484 . . . . 71.42 111.549 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.474 HG12 ' HA ' ' A' ' 119' ' ' TYR . 26.9 pt -81.03 -34.85 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 120.603 -0.439 . . . . 75.02 110.126 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' GLY . . . -150.35 161.03 43.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 71.21 111.466 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' THR . . . -161.09 173.76 14.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.784 -0.643 . . . . 74.52 110.528 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -171.03 135.14 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.581 -0.896 . . . . 63.24 108.581 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.505 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -136.97 149.01 47.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.586 -0.279 . . . . 73.33 111.657 -177.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.536 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 1.7 p90 -142.25 152.61 43.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.8 -0.636 . . . . 71.51 111.264 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -113.98 124.85 53.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.669 -0.493 . . . . 72.53 109.669 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.18 148.51 24.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 74.31 111.694 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.81 177.46 4.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.608 -0.724 . . . . 73.44 109.602 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.607 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -162.18 -135.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.05 -0.26 . . . . 74.02 110.409 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 169' ' ' TYR . 44.7 m-20 -144.3 164.23 31.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.014 0.435 . . . . 75.22 111.532 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.554 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 36.8 t70 -67.16 12.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.579 -0.737 . . . . 74.52 110.154 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.614 ' H ' ' C ' ' A' ' 167' ' ' ASP . 45.7 t80 -84.4 -46.6 11.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.397 -0.819 . . . . 74.55 111.592 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 13.1 p -67.72 -34.31 6.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.523 0.564 . . . . 75.03 112.523 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 42.4 Cg_exo -58.12 -22.92 58.61 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.96 1.773 . . . . 75.04 111.882 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.83 -31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 73.33 111.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.29 -33.79 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.693 0.282 . . . . 73.13 111.291 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.42 ' O ' HG12 ' A' ' 177' ' ' ILE . 12.3 p30 -47.57 -36.34 10.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 63.01 110.727 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -52.09 -31.81 32.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 75.0 111.385 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 77.4 p -79.98 15.75 1.38 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.912 0.386 . . . . 73.23 111.666 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.501 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 10.6 mm -73.04 135.04 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.323 -0.398 . . . . 74.41 110.057 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.7 -21.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.275 0.843 . . . . 74.45 113.275 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.511 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.409 -1.217 . . . . 74.23 112.49 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.418 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.0 m-20 . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 109.164 -0.68 . . . . 51.329999999999998 109.164 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.91 -71.53 0.76 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.925 0.713 . . . . 65.439999999999998 112.925 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -82.69 48.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.407 0.622 . . . . 60.409999999999997 112.05 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.9 p -120.21 143.32 35.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 75.230000000000004 110.992 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 58.5 Cg_endo -97.19 26.2 19.76 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 124.712 -0.954 . . . . 74.340000000000003 112.215 0.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.79 -41.76 98.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 72.340000000000003 110.967 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 9' ' ' LEU . 16.9 m -152.7 -51.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 113.409 0.892 . . . . 75.109999999999999 113.409 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 115' ' ' ILE . 55.0 tp -157.61 141.49 15.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.146 0.498 . . . . 75.329999999999998 112.275 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -74.9 36.53 0.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.89 -0.596 . . . . 73.420000000000002 110.948 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 13' ' ' PRO . . . 178.33 145.58 0.13 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.466 -0.333 . . . . 63.509999999999998 111.047 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 4' ' ' ILE . 55.8 t -92.54 102.38 6.59 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 74.239999999999995 111.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -72.97 136.88 25.73 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.868 2.379 . . . . 75.219999999999999 113.007 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.03 -28.83 67.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.909 -0.587 . . . . 52.25 110.108 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.54 -133.59 3.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.302 -0.863 . . . . 64.120000000000005 111.486 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.559 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t -163.7 177.57 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.719 . . . . 74.409999999999997 111.758 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 118' ' ' LEU . 26.6 mt -124.24 143.96 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.094 . . . . 54.200000000000003 108.084 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 5.7 mtpm? -107.64 102.85 12.06 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.381 -0.528 . . . . 44.030000000000001 111.58 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.685 ' HB ' HG22 ' A' ' 27' ' ' VAL . 63.1 t -103.18 110.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.485 -0.779 . . . . 73.129999999999995 109.633 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.694 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 62.7 mt -95.24 114.9 32.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.43 -0.805 . . . . 72.030000000000001 110.647 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -82.53 -85.23 0.11 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.155 -0.475 . . . . 72.239999999999995 112.1 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -68.15 2.97 6.11 Favored Glycine 0 N--CA 1.461 0.34 0 CA-C-N 116.117 -0.492 . . . . 75.319999999999993 113.596 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.694 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 13.6 t70 78.92 -41.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.232 -0.655 . . . . 75.340000000000003 109.232 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' GLY . 4.1 t70 -74.02 -27.93 61.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 71.400000000000006 109.725 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.5 pt? -124.93 -174.35 3.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.402 0.62 . . . . 73.230000000000004 112.157 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 18.2 pt-20 -156.97 157.79 35.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.319 -0.855 . . . . 63.509999999999998 111.038 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.2 m -85.35 143.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 71.319999999999993 111.689 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 50.1 mttp -144.2 126.81 16.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.466 0.65 . . . . 74.329999999999998 112.047 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.3 mp0 35.09 61.75 0.6 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.344 1.238 . . . . 73.209999999999994 114.344 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 16.94 55.62 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.859 -0.61 . . . . 43.109999999999999 114.247 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.616 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.89 156.52 8.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.104 0.478 . . . . 75.430000000000007 111.042 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 33' ' ' LEU . 28.7 tt0 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 73.409999999999997 110.125 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.4 mp -105.41 130.51 53.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.338 -0.392 . . . . 73.040000000000006 110.124 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -146.92 158.37 45.41 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.566 . . . . 75.549999999999997 110.502 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.82 121.98 3.62 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.257 -1.143 . . . . 73.340000000000003 113.266 0.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.8 p 44.44 25.9 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.842 -0.617 . . . . 60.130000000000003 112.551 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 39' ' ' LYS . 12.0 pt20 -80.3 0.1 34.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.098 0.475 . . . . 75.319999999999993 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 33' ' ' LEU . 35.8 m -73.24 26.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.879 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -106.15 -9.12 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 64.329999999999998 111.58 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -84.54 148.79 26.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.218 0.532 . . . . 70.219999999999999 111.79 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.4 pm0 -63.02 133.14 95.3 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.631 -0.713 . . . . 71.329999999999998 111.847 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 90.5 Cg_endo -85.37 128.74 3.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.868 2.379 . . . . 63.100000000000001 113.075 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 41.4 mm -103.32 105.92 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 64.549999999999997 110.419 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 17' ' ' ILE . 3.2 p -84.92 137.08 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.829 0.678 . . . . 71.040000000000006 112.829 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -165.33 137.0 4.09 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.84 0.311 . . . . 54.210000000000001 111.84 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.536 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p90 -107.53 12.51 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.283 -0.417 . . . . 75.510000000000005 109.995 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.3 t -31.95 115.91 0.18 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.103 -0.953 . . . . 73.5 112.204 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 108.7 -30.66 8.53 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 74.099999999999994 112.661 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 16' ' ' THR . 39.4 mt -85.12 -35.52 21.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.97 0.414 . . . . 64.519999999999996 110.663 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 16.1 pm0 -56.59 -171.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 74.25 110.165 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.16 -77.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.102 -1.047 . . . . 65.310000000000002 112.662 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -148.49 111.24 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.414 0.626 . . . . 72.129999999999995 110.867 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 m -157.34 147.34 20.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.632 -0.877 . . . . 71.129999999999995 108.632 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.69 -41.84 95.76 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.675 0.75 . . . . 61.240000000000002 109.606 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 35.7 mt -155.91 178.07 10.69 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.249 -1.341 . . . . 72.109999999999999 110.031 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 120' ' ' ARG . 89.3 mt -140.93 163.79 32.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.087 -0.708 . . . . 72.140000000000001 109.087 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 HG12 ' A' ' 82' ' ' VAL . 58.1 m -135.05 119.63 18.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 75.239999999999995 111.115 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 tm? -107.41 110.89 22.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.627 -0.715 . . . . 60.32 109.234 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 153' ' ' LEU . 81.0 mt -115.89 137.11 52.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 70.439999999999998 111.22 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.89 146.77 23.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.739 -0.664 . . . . 73.049999999999997 110.444 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 99.0 t -141.62 118.37 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 63.32 111.033 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.603 ' H ' ' HD3' ' A' ' 63' ' ' PRO . 22.2 t70 173.03 48.84 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.673 -1.149 . . . . 63.299999999999997 108.375 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HD3' ' H ' ' A' ' 62' ' ' ASP . 58.3 Cg_endo -70.0 83.87 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.045 1.83 . . . . 75.209999999999994 113.824 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -145.93 101.22 3.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.078 -0.965 . . . . 63.5 109.09 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -166.14 136.69 2.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 73.329999999999998 111.482 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 14.8 Cg_exo -71.12 -5.17 10.89 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 123.56 -1.433 . . . . 70.409999999999997 111.313 -0.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 146.29 7.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.888 . . . . 70.340000000000003 110.222 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.493 ' HD3' ' C ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -64.04 -15.47 59.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.466 . . . . 65.109999999999999 110.408 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -92.01 -23.32 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 74.420000000000002 111.979 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t70 -144.13 73.96 16.11 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 75.299999999999997 110.241 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.87 62.54 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.434 2.756 . . . . 74.239999999999995 112.406 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -48.86 -36.48 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.928 -0.578 . . . . 65.219999999999999 111.511 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.01 48.98 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 74.129999999999995 111.51 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HG2' ' CA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -81.2 144.06 31.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.226 -0.657 . . . . 75.0 109.226 177.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.454 ' CA ' ' HG2' ' A' ' 74' ' ' ARG . 39.0 mt-10 -89.91 163.74 14.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.044 0.938 . . . . 64.349999999999994 111.297 0.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 77' ' ' LEU . 21.2 mm -84.76 -129.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.182 -1.414 . . . . 75.120000000000005 107.182 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.658 ' H ' HG22 ' A' ' 76' ' ' ILE . 49.9 mt -86.84 151.67 23.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 0.0 OUTLIER -149.65 160.93 43.11 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 121.075 -0.25 . . . . 74.120000000000005 111.075 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.403 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 1.4 t-105 -100.31 79.8 2.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.659 0.743 . . . . 75.329999999999998 111.025 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 97' ' ' LEU . 24.5 p -94.67 133.25 38.53 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.664 -1.153 . . . . 74.129999999999995 110.92 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -144.72 138.42 22.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 120.728 -0.389 . . . . 73.340000000000003 111.19 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.009 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.21 167.74 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 62.100000000000001 110.645 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' HD22 ' A' ' 55' ' ' LEU . 1.7 m-20 64.24 33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.528 -0.305 . . . . 71.310000000000002 111.413 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.023 HD13 ' HA3' ' A' ' 94' ' ' GLY . 15.6 mm -80.78 124.14 81.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.613 -0.514 . . . . 73.209999999999994 109.613 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.442 ' HB2' ' OD1' ' A' ' 88' ' ' ASN . 51.5 Cg_exo -52.16 129.79 32.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.292 1.328 . . . . 71.409999999999997 110.98 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.42 50.03 0.29 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 114.739 0.656 . . . . 35.539999999999999 114.739 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t -176.73 32.56 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.402 0.601 . . . . 65.319999999999993 111.914 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 90' ' ' ASN . 13.5 m120 -113.19 0.55 14.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.567 0.222 . . . . 64.400000000000006 111.07 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 51.9 mt-10 68.14 -34.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 64.239999999999995 112.276 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' ASN . 4.0 p30 -133.81 155.45 80.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.529 . . . . 65.120000000000005 111.447 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 84' ' ' ILE . 91.9 Cg_endo -71.89 59.36 2.84 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.49 2.793 . . . . 54.409999999999997 113.267 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.1 m -104.29 -54.8 2.47 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.817 0.673 . . . . 63.539999999999999 112.817 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.11 -0.55 15.71 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.6 1.0 . . . . 64.150000000000006 115.6 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 1.023 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -100.34 176.43 27.8 Favored Glycine 0 N--CA 1.461 0.313 0 C-N-CA 120.423 -0.894 . . . . 73.120000000000005 113.258 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -70.46 121.34 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 74.109999999999999 111.284 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.596 ' HA ' HG13 ' A' ' 81' ' ' VAL . 43.7 m -80.99 96.94 7.26 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.638 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 43.7 mt -48.02 -50.13 28.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 109.549 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -141.86 107.97 5.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.834 -1.075 . . . . 63.32 108.249 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.566 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 44.7 t0 -41.91 144.57 0.41 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 73.200000000000003 112.966 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -60.59 139.85 57.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.89 -1.05 . . . . 74.430000000000007 112.137 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 14.4 p -148.15 113.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.586 -0.734 . . . . 74.030000000000001 110.651 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.11 18.79 3.14 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.204 -0.522 . . . . 44.149999999999999 113.194 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.611 ' O ' HG12 ' A' ' 170' ' ' VAL . 80.1 p -69.18 -64.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 73.030000000000001 111.083 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 163.7 15.33 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.516 -0.766 . . . . 62.149999999999999 112.601 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG2' HG21 ' A' ' 109' ' ' THR . 28.8 Cg_endo -60.88 160.49 25.18 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.046 2.497 . . . . 73.510000000000005 113.114 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 109' ' ' THR . 26.3 Cg_exo -63.6 161.3 32.37 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.665 2.91 . . . . 50.409999999999997 113.967 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -44.7 -37.81 3.97 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.342 -0.845 . . . . 64.219999999999999 111.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -50.83 -22.05 1.99 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.503 0.557 . . . . 65.099999999999994 112.503 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 106' ' ' PRO . 11.3 t -80.97 -25.45 37.32 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.558 0.948 . . . . 62.219999999999999 113.558 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.62 -163.91 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.577 -0.821 . . . . 62.020000000000003 112.444 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 39.7 tp -46.19 109.23 0.17 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.085 0.469 . . . . 62.109999999999999 111.745 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -113.2 142.52 45.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.732 -0.667 . . . . 72.540000000000006 109.691 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.584 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -95.55 88.08 4.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.704 . . . . 74.530000000000001 112.579 -177.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 9.8 t80 -73.5 120.13 18.67 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.127 -0.629 . . . . 74.109999999999999 109.513 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.837 HG21 HD13 ' A' ' 9' ' ' LEU . 25.9 mt -113.42 130.82 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 111.979 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -102.45 125.18 49.08 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.712 -0.676 . . . . 74.540000000000006 109.585 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 118' ' ' LEU . 6.5 tt -119.27 135.26 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 110.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.675 ' N ' HD23 ' A' ' 117' ' ' LEU . 64.6 tp -119.46 136.39 54.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.718 -0.674 . . . . 62.32 110.47 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 153' ' ' LEU . 64.0 t80 -144.14 135.67 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 65.230000000000004 111.029 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.621 ' HA ' HD23 ' A' ' 56' ' ' LEU . 94.8 mtt180 -64.83 130.39 43.29 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.787 -0.365 . . . . 71.310000000000002 110.185 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.749 ' NE2' HD11 ' A' ' 125' ' ' ILE . 26.8 tt0 -107.74 127.48 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.556 -0.535 . . . . 70.409999999999997 109.556 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -99.84 -39.02 8.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.6 0.593 . . . . 75.420000000000002 112.6 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -102.8 136.91 41.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.181 0.808 . . . . 74.120000000000005 113.181 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' HD22 ' A' ' 83' ' ' ASN . 22.8 tptm -72.13 114.19 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.261 -0.881 . . . . 74.019999999999996 109.787 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.749 HD11 ' NE2' ' A' ' 121' ' ' GLN . 5.3 pt -115.71 132.59 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.006 -0.543 . . . . 62.329999999999998 112.178 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -59.18 -53.09 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.276 0.56 . . . . 65.450000000000003 109.977 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.736 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.0 mm-40 60.72 38.45 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.159 -0.928 . . . . 73.310000000000002 111.531 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 127' ' ' GLU . 41.0 p 54.84 149.84 0.05 OUTLIER Pre-proline 0 C--O 1.223 -0.322 0 O-C-N 123.741 0.651 . . . . 70.239999999999995 112.632 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.45 147.37 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.16 2.573 . . . . 75.209999999999994 112.755 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.502 ' CG2' ' HB2' ' A' ' 96' ' ' SER . 1.4 m -58.44 119.61 7.3 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 110.471 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 42.0 mm -80.89 133.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.461 -0.336 . . . . 61.009999999999998 110.653 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 134' ' ' THR . 29.0 t -73.95 148.01 42.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.967 -0.561 . . . . 73.109999999999999 111.143 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.566 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 19.7 p-10 -62.92 -41.24 99.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 73.319999999999993 109.994 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 12.2 t -75.02 22.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.626 -0.716 . . . . 74.310000000000002 110.974 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 133' ' ' ASN . 2.9 t -62.33 119.55 9.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.404 0.621 . . . . 61.200000000000003 112.627 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 137' ' ' THR . 23.5 tpt180 -65.48 167.3 8.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.931 -1.032 . . . . 70.200000000000003 110.621 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.808 ' HA ' HD11 ' A' ' 140' ' ' LEU . 11.0 m -44.47 151.04 0.29 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 61.299999999999997 111.521 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 139' ' ' ARG . . . 116.14 -8.86 18.27 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.974 -0.631 . . . . 43.0 113.605 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.526 ' H ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -152.87 50.72 0.74 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.399 0.599 . . . . 70.310000000000002 111.288 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.808 HD11 ' HA ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -114.22 -56.82 2.35 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.617 -0.512 . . . . 62.32 109.617 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -62.91 119.79 10.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.703 -0.68 . . . . 70.299999999999997 111.165 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 175.46 133.48 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 72.140000000000001 110.081 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 146' ' ' ASP . 31.0 p30 -80.6 124.06 28.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.992 0.425 . . . . 73.120000000000005 111.915 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.91 96.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.453 -0.34 . . . . 53.240000000000002 111.808 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -46.49 -27.39 1.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 63.399999999999999 111.714 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 28.3 t70 -56.92 -42.75 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.602 -0.272 . . . . 72.420000000000002 111.47 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 24.3 m-85 -54.94 -38.14 67.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.59 0.71 . . . . 75.299999999999997 109.531 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -70.83 -41.13 71.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.078 -0.965 . . . . 54.100000000000001 110.55 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.39 -47.64 78.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 64.310000000000002 111.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.37 -53.25 59.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.056 0.761 . . . . 73.219999999999999 113.056 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.542 ' HB3' HD21 ' A' ' 153' ' ' LEU . 18.1 t-80 -94.69 11.64 30.55 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.8 -0.76 . . . . 61.340000000000003 111.716 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.51 94.61 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.676 -0.773 . . . . 74.340000000000003 113.837 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.781 HD13 HG21 ' A' ' 57' ' ' THR . 9.5 mt -79.78 16.02 1.24 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.618 -0.342 . . . . 74.299999999999997 110.469 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -36.65 -72.43 0.15 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.701 -0.681 . . . . 75.140000000000001 114.766 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.52 113.09 16.69 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 117.05 0.425 . . . . 61.5 111.316 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 134.82 10.55 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.805 2.337 . . . . 74.439999999999998 113.424 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.607 HD13 ' HG3' ' A' ' 120' ' ' ARG . 43.1 pt -75.85 -37.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.44 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 16' ' ' THR . . . -152.03 134.92 15.62 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.612 -0.267 . . . . 65.519999999999996 110.734 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -140.0 151.83 45.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 75.209999999999994 111.301 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.507 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.4 t-20 -154.15 142.37 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.698 -1.223 . . . . 73.540000000000006 107.698 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.648 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -146.8 162.99 37.45 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.461 0.541 . . . . 73.329999999999998 112.461 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p90 -154.28 153.81 32.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.263 -0.88 . . . . 73.340000000000003 110.875 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.495 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 52.3 mt-30 -110.86 135.07 51.97 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.953 -0.388 . . . . 71.120000000000005 109.953 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.417 ' CA ' HD12 ' A' ' 111' ' ' LEU . . . -155.47 149.48 25.58 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.918 1.081 . . . . 51.530000000000001 113.918 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.4 OUTLIER -137.61 157.34 46.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.359 -1.292 . . . . 71.200000000000003 107.825 177.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.92 167.53 20.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 74.030000000000001 111.864 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 169' ' ' TYR . 53.3 m-20 -56.68 150.12 16.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.328 -0.851 . . . . 74.409999999999997 111.327 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.651 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 19.3 t0 -54.79 -8.87 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 72.329999999999998 110.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.455 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 22.2 t80 -60.02 -40.98 91.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.905 -0.589 . . . . 75.329999999999998 111.221 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.703 HG13 ' NH1' ' A' ' 173' ' ' ARG . 21.5 t -63.66 -53.84 47.49 Favored Pre-proline 0 C--O 1.235 0.308 0 N-CA-C 109.464 -0.569 . . . . 74.549999999999997 109.464 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 50.9 Cg_exo -52.01 -31.62 44.88 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.872 1.715 . . . . 74.340000000000003 111.79 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 168' ' ' ASP . 50.7 mt -50.46 -34.52 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.495 -0.321 . . . . 75.129999999999995 110.431 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 1.015 ' O ' HG22 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.94 -37.69 14.94 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.647 -0.501 . . . . 73.129999999999995 109.647 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -56.46 -35.63 68.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.109 -0.496 . . . . 74.549999999999997 111.454 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 12.9 mptt -57.37 -33.23 67.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.368 -0.207 . . . . 62.200000000000003 111.422 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 1.015 HG22 ' O ' ' A' ' 173' ' ' ARG . 10.9 t -69.59 -10.3 57.61 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.617 -0.433 . . . . 74.329999999999998 111.254 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.637 ' CD1' HD11 ' A' ' 77' ' ' LEU . 83.8 mt -63.62 127.23 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.562 -0.29 . . . . 61.310000000000002 110.529 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.25 3.31 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.169 0.433 . . . . 74.519999999999996 112.169 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.396 -1.225 . . . . 44.240000000000002 112.519 -179.257 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.202 0 N-CA-C 110.557 -0.164 . . . . 74.319999999999993 110.557 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -109.8 -72.86 0.7 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.891 0.7 . . . . 60.32 112.891 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -89.15 53.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.594 0.712 . . . . 52.549999999999997 111.588 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 10' ' ' ASP . 8.8 p -135.13 139.31 31.45 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.095 -0.957 . . . . 73.099999999999994 110.459 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 5' ' ' VAL . 78.0 Cg_endo -83.98 35.69 2.62 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.83 -1.321 . . . . 75.319999999999993 113.177 0.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.4 t0 -61.38 -52.56 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.238 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 7' ' ' ASP . 15.8 m -158.88 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 65.140000000000001 111.789 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.716 HD23 ' HD3' ' A' ' 13' ' ' PRO . 15.9 tp -157.34 140.22 15.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.319 0.581 . . . . 72.530000000000001 111.444 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 3.5 p-10 -58.82 -26.74 64.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 112.169 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.96 130.93 13.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 72.030000000000001 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 12' ' ' VAL . 8.2 p -65.82 115.12 19.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.571 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.716 ' HD3' HD23 ' A' ' 9' ' ' LEU . 31.7 Cg_endo -94.22 143.94 1.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.965 2.443 . . . . 74.239999999999995 112.174 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.9 -30.84 47.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.39 0.614 . . . . 41.009999999999998 110.026 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.3 -166.96 15.62 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.819 -1.082 . . . . 73.140000000000001 110.63 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 9.7 t -121.99 172.95 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.498 0.649 . . . . 74.209999999999994 111.183 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 158' ' ' ALA . 6.4 mt -105.47 128.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 75.439999999999998 110.426 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 3.2 mmmp? -73.8 107.07 5.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.915 -0.772 . . . . 70.340000000000003 108.915 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.2 t -123.0 109.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 60.210000000000001 110.689 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 25' ' ' LEU . 39.2 mt -100.93 123.11 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.183 -0.917 . . . . 62.009999999999998 109.871 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.98 -36.54 64.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.581 -0.736 . . . . 60.0 111.877 -178.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.81 -63.07 0.15 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 120.232 -0.985 . . . . 73.019999999999996 112.675 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -166.81 -61.21 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.522 -0.547 . . . . 73.329999999999998 109.522 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.98 -48.88 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 110.67 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.6 pp -69.57 147.74 50.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.415 0.626 . . . . 73.209999999999994 111.602 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 11.3 tt0 -143.37 144.95 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.525 -0.761 . . . . 75.25 110.699 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 19' ' ' VAL . 24.3 m -79.93 106.37 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 71.549999999999997 109.513 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 56.2 mttm -103.64 124.75 49.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.179 1.177 . . . . 70.540000000000006 114.179 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.4 mp0 26.9 67.45 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.985 1.476 . . . . 54.439999999999998 114.985 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' CA ' ' CD2' ' A' ' 161' ' ' TYR . . . 74.76 5.56 74.82 Favored Glycine 0 CA--C 1.51 -0.241 0 N-CA-C 115.083 0.793 . . . . 42.200000000000003 115.083 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -57.12 161.95 2.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.591 0.696 . . . . 70.239999999999995 110.029 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.491 ' C ' HD12 ' A' ' 33' ' ' LEU . 32.5 tt0 -109.8 143.71 39.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 72.510000000000005 110.389 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 32' ' ' GLU . 9.5 mp -116.35 120.16 37.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.76 -0.459 . . . . 74.510000000000005 109.76 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -150.49 163.92 22.36 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.846 -0.616 . . . . 72.109999999999999 110.082 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 94.4 Cg_endo -86.92 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.772 -1.345 . . . . 73.230000000000004 112.841 0.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.415 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 70.2 p -104.27 22.62 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.55 -0.295 . . . . 74.319999999999993 111.686 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -81.79 -7.64 59.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.317 -0.553 . . . . 70.209999999999994 110.061 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.514 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 24.6 m -91.29 26.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 72.25 111.642 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -85.71 -14.57 44.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 110.648 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.3 141.44 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.805 -0.634 . . . . 73.239999999999995 112.487 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.17 134.89 95.99 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 115.513 -0.767 . . . . 65.420000000000002 110.849 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.2 Cg_endo -73.5 135.88 22.85 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.881 2.388 . . . . 71.299999999999997 113.508 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 48.5 mm -107.19 125.83 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.352 . . . . 73.25 110.423 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.1 p -98.54 146.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.391 0.515 . . . . 65.239999999999995 112.391 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -165.12 146.49 7.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.132 0.492 . . . . 65.439999999999998 111.579 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HH2' HG21 ' A' ' 84' ' ' ILE . 5.2 p90 -121.39 29.9 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.402 -0.592 . . . . 71.310000000000002 109.402 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 t -43.29 131.21 4.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.603 -0.726 . . . . 55.210000000000001 110.696 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.16 -35.76 3.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 64.099999999999994 112.683 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -72.24 -33.87 67.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.557 0.694 . . . . 72.340000000000003 109.341 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.5 tt0 -58.06 142.08 47.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.163 -0.926 . . . . 74.400000000000006 109.194 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.29 -65.74 0.02 OUTLIER Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.036 -1.078 . . . . 45.200000000000003 112.863 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.74 109.34 4.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.838 0.352 . . . . 55.409999999999997 110.162 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m -158.36 141.17 14.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 110.528 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -70.15 -40.42 74.78 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.198 0.999 . . . . 63.329999999999998 108.328 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 83' ' ' ASN . 27.1 mt -155.16 161.26 41.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.76 -1.564 . . . . 74.230000000000004 109.269 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.9 mt -125.07 146.54 49.4 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.178 0.514 . . . . 61.420000000000002 110.358 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.726 HG21 HD21 ' A' ' 153' ' ' LEU . 4.2 m -106.91 127.35 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.744 . . . . 74.120000000000005 109.993 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.3 tm? -130.93 118.5 20.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.363 -0.606 . . . . 75.219999999999999 109.363 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 147' ' ' PHE . 70.4 mt -149.36 132.09 15.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.968 -0.693 . . . . 74.329999999999998 112.043 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 48.3 ttp -94.73 148.4 22.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.731 -0.841 . . . . 73.530000000000001 108.731 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.456 HG22 ' HB1' ' A' ' 144' ' ' ALA . 52.9 t -139.33 145.02 27.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.534 0.683 . . . . 74.129999999999995 112.57 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -175.9 82.93 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 114.067 -1.424 . . . . 74.310000000000002 109.361 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.52 84.39 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.8 2.333 . . . . 72.209999999999994 111.84 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.597 ' CB ' HH12 ' A' ' 113' ' ' ARG . 3.2 t0 -170.22 122.5 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.753 0.649 . . . . 73.349999999999994 112.753 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -173.13 130.74 0.58 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.97 -0.292 . . . . 72.310000000000002 111.554 175.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.06 -12.54 24.12 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.257 -1.56 . . . . 62.109999999999999 109.025 -4.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.4 t -151.99 142.82 22.95 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.992 -1.458 . . . . 72.010000000000005 109.661 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -58.87 -31.13 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.408 . . . . 75.329999999999998 110.751 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -60.32 -41.62 93.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.442 -0.799 . . . . 73.230000000000004 111.819 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 28.1 m-20 -138.1 71.3 48.05 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.449 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 27.6 Cg_exo -61.29 112.65 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.242 1.961 . . . . 72.019999999999996 111.122 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -101.27 -51.43 3.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.86 0.362 . . . . 71.019999999999996 111.631 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 18.3 p90 -116.24 24.81 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 75.099999999999994 109.997 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 1.3 tmt_? -73.84 138.03 44.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.154 -0.93 . . . . 63.25 109.643 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 143' ' ' ASN . 4.9 mm-40 -75.11 170.12 16.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.63 1.172 . . . . 64.109999999999999 111.346 0.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.756 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.8 tp -119.27 168.38 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 75.5 111.189 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' N ' HG13 ' A' ' 76' ' ' ILE . 73.2 mt -54.83 133.72 47.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.357 0.598 . . . . 65.150000000000006 111.747 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.8 -169.38 2.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.183 -0.917 . . . . 72.120000000000005 109.119 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.486 ' HA ' ' HE3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -98.6 104.47 16.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.219 -1.03 . . . . 71.340000000000003 108.219 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.729 ' HA ' HD23 ' A' ' 59' ' ' LEU . 1.5 m -119.0 117.37 28.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 73.120000000000005 110.985 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 96' ' ' SER . 1.7 t -141.73 130.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 74.010000000000005 109.405 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.801 HG21 ' HG3' ' A' ' 127' ' ' GLU . 32.2 m -141.69 166.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.057 0.456 . . . . 70.019999999999996 111.559 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.689 ' O ' HD22 ' A' ' 55' ' ' LEU . 22.9 p30 64.16 39.22 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.655 -1.157 . . . . 73.150000000000006 109.524 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.983 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.8 mm -77.2 115.44 48.94 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 114.408 -1.269 . . . . 72.310000000000002 108.991 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' SER . 51.0 Cg_exo -53.1 127.67 25.97 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.692 1.594 . . . . 74.519999999999996 111.774 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.43 69.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.33 -0.462 . . . . 73.439999999999998 112.854 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 85' ' ' PRO . 29.3 t 177.31 48.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.66 0.384 . . . . 65.530000000000001 110.097 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 90' ' ' ASN . 70.2 m-80 -135.68 -22.36 1.46 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.029 0.752 . . . . 60.149999999999999 113.029 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 70.87 -22.18 0.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.867 0.365 . . . . 74.200000000000003 110.784 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.537 ' H ' ' C ' ' A' ' 88' ' ' ASN . 10.3 p30 -152.17 158.16 33.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 115.873 -0.603 . . . . 64.530000000000001 109.575 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 44' ' ' VAL . 81.9 Cg_endo -70.92 48.2 0.81 Allowed 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 123.29 2.66 . . . . 73.439999999999998 114.307 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 t -97.53 -8.29 29.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.06 -0.656 . . . . 72.430000000000007 111.797 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.35 -40.74 1.46 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.585 -0.816 . . . . 72.5 114.26 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.983 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.21 171.87 7.65 Favored Glycine 0 N--CA 1.459 0.208 0 C-N-CA 120.847 -0.692 . . . . 74.040000000000006 113.037 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.646 ' CE1' HG23 ' A' ' 130' ' ' THR . 52.5 t60 -70.89 118.82 14.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.584 0.23 . . . . 74.439999999999998 111.455 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 81' ' ' VAL . 66.3 p -81.05 91.05 6.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.936 -0.764 . . . . 75.219999999999999 108.936 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 82' ' ' VAL . 10.6 mt -49.3 -52.4 27.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 63.219999999999999 110.048 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -137.08 117.41 13.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 53.329999999999998 108.885 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.484 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 50.6 t0 -55.78 151.08 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.767 0.667 . . . . 72.200000000000003 111.649 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.414 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.5 p90 -60.35 151.3 28.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 73.209999999999994 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.21 152.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.424 -0.353 . . . . 71.340000000000003 110.149 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.457 ' C ' HG12 ' A' ' 170' ' ' VAL . . . -46.19 -72.84 0.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.963 -0.637 . . . . 71.219999999999999 112.429 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -171.15 124.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 72.430000000000007 110.471 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -68.29 -49.15 47.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.524 -0.846 . . . . 62.420000000000002 111.511 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CB ' HG21 ' A' ' 109' ' ' THR . 2.7 Cg_exo -77.78 114.59 3.67 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.851 2.367 . . . . 73.409999999999997 112.017 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 109' ' ' THR . 26.6 Cg_exo -62.69 160.91 30.53 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.135 2.556 . . . . 62.43 111.861 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.546 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.98 -28.05 2.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.343 -0.389 . . . . 63.329999999999998 111.419 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.546 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 87.0 m-20 -51.64 -40.0 59.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 74.519999999999996 112.025 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 106' ' ' PRO . 14.7 t -71.06 -2.91 17.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.755 -0.378 . . . . 53.219999999999999 111.254 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 69.95 -126.72 17.64 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 116.106 -0.497 . . . . 73.329999999999998 113.673 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 163' ' ' GLN . 31.0 tp -66.96 145.48 55.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.8 0.809 . . . . 72.409999999999997 112.505 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 19.0 m80 -120.02 167.05 12.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.99 -1.459 . . . . 71.219999999999999 110.037 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.597 HH12 ' CB ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -141.0 75.4 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.972 -0.751 . . . . 73.109999999999999 108.972 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.38 120.79 22.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.581 -0.736 . . . . 73.439999999999998 109.659 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' A' ' 161' ' ' TYR . 11.9 mt -116.02 122.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.094 0.473 . . . . 54.219999999999999 112.025 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -91.01 130.57 36.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.43 -0.805 . . . . 74.420000000000002 109.064 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.3 tm? -119.27 136.19 54.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 64.540000000000006 110.168 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.6 tt -136.84 129.68 30.65 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.338 -0.392 . . . . 73.549999999999997 110.053 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.732 ' N ' HD23 ' A' ' 118' ' ' LEU . 62.8 t80 -144.16 143.65 31.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 71.140000000000001 110.971 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -63.13 119.99 10.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.848 -0.427 . . . . 55.520000000000003 109.848 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 7.0 tt0 -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.493 -0.558 . . . . 71.310000000000002 109.493 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.4 -31.08 14.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 61.25 111.047 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -98.16 129.99 44.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.81 -0.632 . . . . 70.319999999999993 111.19 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 125' ' ' ILE . 19.7 tptp -74.11 129.85 38.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.706 -0.479 . . . . 72.530000000000001 109.706 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 pt -141.95 137.6 30.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 61.409999999999997 112.045 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -79.49 -39.54 31.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.963 -0.562 . . . . 63.43 111.111 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.801 ' HG3' HG21 ' A' ' 82' ' ' VAL . 61.5 mm-40 56.69 39.65 29.62 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.531 0.567 . . . . 75.200000000000003 112.531 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 65.2 p 56.71 161.3 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.702 0.626 . . . . 70.299999999999997 112.171 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 76.6 Cg_exo -52.6 157.05 7.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.775 2.317 . . . . 75.329999999999998 113.515 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.646 HG23 ' CE1' ' A' ' 95' ' ' HIS . 12.2 p -59.51 120.54 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.444 -0.798 . . . . 75.510000000000005 112.085 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 131' ' ' ILE . 21.6 mm -83.91 127.2 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.715 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -63.69 140.77 58.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.976 -1.011 . . . . 64.340000000000003 112.322 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.731 ' OD1' HG23 ' A' ' 134' ' ' THR . 19.8 p30 -57.76 -47.88 81.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.255 0.55 . . . . 73.099999999999994 110.421 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.85 ' HA ' HD13 ' A' ' 177' ' ' ILE . 13.4 p -79.69 24.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.417 -0.81 . . . . 74.5 111.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.7 t -60.77 125.29 23.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.304 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 137' ' ' THR . 22.3 tpt180 -71.53 173.25 8.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.204 -0.907 . . . . 74.349999999999994 110.573 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 35.6 m -39.37 146.17 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.879 0.371 . . . . 72.25 111.32 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.29 -10.08 28.79 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.177 -0.535 . . . . 31.440000000000001 112.264 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 1.9 mmp_? -141.68 32.15 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.721 -0.282 . . . . 71.209999999999994 111.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 76' ' ' ILE . 29.5 mt -101.45 -55.8 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.247 0.546 . . . . 75.519999999999996 110.262 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -64.7 112.03 3.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 61.32 110.84 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -163.51 109.81 1.12 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.584 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 51.7 t30 -64.18 91.8 0.08 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.561 -0.745 . . . . 74.030000000000001 111.221 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -48.92 -40.63 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.41 0.624 . . . . 42.030000000000001 110.091 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -46.62 -36.41 6.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.96 -1.018 . . . . 71.209999999999994 110.902 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.41 -42.46 53.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.382 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 59' ' ' LEU . 20.5 m-85 -48.91 -39.24 25.35 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.112 -0.495 . . . . 64.450000000000003 110.617 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.55 -35.57 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.645 -0.707 . . . . 62.240000000000002 109.833 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.92 -59.27 2.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.802 -0.636 . . . . 74.230000000000004 111.849 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 10.6 ptpt -63.82 -45.12 91.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.416 0.525 . . . . 75.310000000000002 112.416 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.605 ' CD2' ' HD3' ' A' ' 150' ' ' LYS . 58.3 m170 -91.61 8.19 37.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 75.129999999999995 110.589 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.63 25.0 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.79 -0.641 . . . . 73.540000000000006 114.183 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' THR . 14.6 mt -76.71 16.72 0.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.902 0.334 . . . . 65.209999999999994 111.902 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.53 -45.59 29.7 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.75 -0.738 . . . . 51.119999999999997 112.564 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -108.81 83.13 1.99 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.886 0.374 . . . . 72.040000000000006 110.116 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 44.3 Cg_endo -68.33 137.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.762 2.308 . . . . 65.219999999999999 113.456 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.57 HD11 HD22 ' A' ' 118' ' ' LEU . 30.6 pt -79.33 -33.41 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.235 -0.654 . . . . 74.129999999999995 109.235 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -142.34 142.87 32.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.665 -0.698 . . . . 64.230000000000004 110.734 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.614 ' HB3' ' HG3' ' A' ' 13' ' ' PRO . . . -153.58 157.88 40.36 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 74.230000000000004 109.215 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.457 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.2 t-20 -165.61 118.62 1.15 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.632 -0.507 . . . . 75.219999999999999 109.632 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -103.13 151.26 22.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.308 -0.86 . . . . 72.319999999999993 110.936 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 164' ' ' ALA . 3.7 t80 -145.96 130.64 17.96 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.422 -0.808 . . . . 73.310000000000002 111.005 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.499 ' HB3' HD11 ' A' ' 111' ' ' LEU . 46.1 mt-30 -110.59 134.75 52.12 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.894 -0.594 . . . . 75.540000000000006 110.366 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -157.81 152.9 25.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.106 0.41 . . . . 63.310000000000002 112.106 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.487 ' HG3' ' CD1' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -135.18 133.03 38.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.572 -1.269 . . . . 64.310000000000002 107.572 176.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.13 152.96 30.09 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.033 -0.358 . . . . 72.409999999999997 110.033 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.4 m-20 -52.84 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.742 0.782 . . . . 52.329999999999998 111.533 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.559 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.1 t70 -58.93 -3.29 0.32 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.141 -0.936 . . . . 72.030000000000001 111.078 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 167' ' ' ASP . 42.2 t80 -42.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 111.897 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.614 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 4.9 t -57.25 -51.83 78.75 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.184 -0.673 . . . . 62.119999999999997 109.184 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.3 Cg_exo -49.57 -18.7 2.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.523 2.149 . . . . 71.409999999999997 112.622 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 168' ' ' ASP . 73.1 mt -50.68 -41.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.395 -0.595 . . . . 73.150000000000006 109.395 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -55.19 -31.68 61.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.582 -0.736 . . . . 72.439999999999998 110.694 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -53.29 -43.05 67.2 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.426 -0.953 . . . . 71.409999999999997 108.426 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 168' ' ' ASP . 9.9 mptt -62.3 -31.04 71.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.381 -0.827 . . . . 64.25 110.09 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 178' ' ' VAL . 7.1 m -66.43 -26.68 67.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.393 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.5 mm -48.72 107.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 73.319999999999993 111.017 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 176' ' ' THR . 27.9 m -154.15 25.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.69 0.256 . . . . 71.230000000000004 111.69 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.665 -1.075 . . . . 65.140000000000001 112.597 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.581 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.2 p-10 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 112.481 0.549 . . . . 71.5 112.481 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 54.6 t0 -71.0 -52.16 21.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 71.109999999999999 110.578 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 9' ' ' LEU . 9.7 pt -135.4 49.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.212 0.53 . . . . 73.430000000000007 111.099 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 2' ' ' ASP . 9.8 p -133.5 140.06 35.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.866 -0.607 . . . . 71.329999999999998 110.305 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.533 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.38 29.74 3.38 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.752 -1.353 . . . . 61.539999999999999 112.954 0.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.5 t70 -56.21 -47.26 78.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 74.349999999999994 109.839 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 7' ' ' ASP . 6.5 m -163.69 -41.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 75.150000000000006 111.452 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HD3' ' A' ' 13' ' ' PRO . 31.4 tp -157.1 158.84 37.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.843 0.354 . . . . 75.129999999999995 111.319 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -52.34 -46.58 66.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.394 -0.595 . . . . 70.329999999999998 109.394 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -152.59 146.71 25.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.642 -0.708 . . . . 53.439999999999998 110.369 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.92 118.54 33.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.067 0.395 . . . . 72.450000000000003 112.067 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.673 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.1 Cg_endo -90.06 -120.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 74.409999999999997 112.261 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -158.58 -43.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 51.350000000000001 110.345 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.52 -173.54 13.27 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.975 -0.631 . . . . 74.340000000000003 111.801 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -131.73 162.95 29.26 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.206 0.527 . . . . 71.329999999999998 111.052 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 44' ' ' VAL . 8.2 mt -105.31 137.75 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.21 -0.904 . . . . 75.430000000000007 110.758 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.1 mmmt -73.61 102.24 3.84 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.594 -0.521 . . . . 65.340000000000003 109.594 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 27' ' ' VAL . 88.7 t -110.07 109.84 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 119.994 -0.682 . . . . 62.009999999999998 109.726 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' LEU . 2.8 mp -100.38 124.03 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.661 -0.7 . . . . 73.430000000000007 109.771 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -76.74 -32.05 57.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.908 -0.587 . . . . 74.209999999999994 111.893 -178.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.13 -61.89 0.14 Allowed Glycine 0 N--CA 1.459 0.227 0 C-N-CA 120.767 -0.73 . . . . 73.230000000000004 112.175 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.421 ' CA ' HG21 ' A' ' 20' ' ' ILE . 32.6 t70 -173.42 -58.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 75.329999999999998 108.235 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -83.67 -45.15 13.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.944 -0.762 . . . . 72.209999999999994 108.944 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -69.67 131.6 44.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.25 -0.886 . . . . 70.510000000000005 112.389 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' ILE . 5.9 tt0 -135.91 146.78 47.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 72.099999999999994 110.245 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 19' ' ' VAL . 34.1 m -82.95 106.55 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.182 0.515 . . . . 74.310000000000002 111.912 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 11.6 mptt -74.57 92.5 2.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.307 0.575 . . . . 64.430000000000007 111.452 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.4 mp0 24.67 66.79 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 114.379 1.252 . . . . 74.319999999999993 114.379 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.07 -3.06 55.3 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 115.07 0.788 . . . . 53.219999999999999 115.07 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.458 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -58.84 167.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.33 0.565 . . . . 71.219999999999999 112.453 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' LEU . 4.0 tt0 -101.89 141.83 34.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.739 -1.119 . . . . 75.150000000000006 110.026 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 27' ' ' VAL . 10.7 mp -108.73 130.38 55.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 53.340000000000003 110.983 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.1 p -148.34 164.19 23.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.665 . . . . 52.030000000000001 110.542 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 64.3 Cg_endo -73.32 -40.76 1.13 Allowed 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.855 -1.31 . . . . 72.319999999999993 112.899 0.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.3 p -150.88 30.6 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.451 0.644 . . . . 62.530000000000001 110.837 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.584 ' OE1' HD13 ' A' ' 25' ' ' LEU . 15.5 pt20 -66.03 -2.88 4.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 55.130000000000003 110.463 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.74 -3.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.411 0.624 . . . . 70.430000000000007 109.937 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -65.72 6.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 75.219999999999999 112.282 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.18 148.72 48.27 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.048 0.451 . . . . 73.430000000000007 111.648 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -73.13 144.41 84.77 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.849 . . . . 64.129999999999995 113.14 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 72.9 Cg_endo -77.1 131.61 12.06 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.18 2.587 . . . . 74.299999999999997 113.928 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -105.29 117.24 50.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.079 -0.51 . . . . 52.030000000000001 110.049 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.92 HG23 HG21 ' A' ' 17' ' ' ILE . 2.7 p -88.85 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.783 0.66 . . . . 73.319999999999993 112.783 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 66.7 m -160.77 133.25 6.17 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.49 -0.323 . . . . 73.099999999999994 111.438 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 9.4 p90 -106.35 24.98 11.65 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.86 0.362 . . . . 75.549999999999997 110.787 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 m -43.29 118.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.777 -0.647 . . . . 65.340000000000003 111.367 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 104.67 -33.84 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.092 -0.504 . . . . 45.219999999999999 112.245 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 8.0 mp -75.33 -37.74 60.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.913 0.387 . . . . 53.530000000000001 110.409 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 48' ' ' GLY . 10.0 pm0 -49.86 153.08 1.37 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.145 -0.48 . . . . 55.450000000000003 109.918 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.41 -73.24 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.937 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -148.89 108.93 4.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.773 -0.454 . . . . 73.430000000000007 109.773 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 2.8 p -158.83 143.13 15.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 72.329999999999998 110.999 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 12.3 t-20 -74.09 -33.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.458 0.647 . . . . 73.019999999999996 109.328 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 83' ' ' ASN . 59.6 mt -157.32 178.38 10.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 74.150000000000006 110.632 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 120' ' ' ARG . 83.1 mt -142.44 165.02 28.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.696 -0.853 . . . . 65.420000000000002 108.696 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.888 HG23 HG12 ' A' ' 82' ' ' VAL . 26.7 m -136.93 123.4 20.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.507 0.194 . . . . 73.400000000000006 110.689 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.75 127.3 49.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.152 -0.477 . . . . 71.340000000000003 111.059 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 HD12 ' A' ' 97' ' ' LEU . 86.9 mt -146.79 141.03 26.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 73.420000000000002 111.278 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.8 ttm -94.28 129.55 40.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 61.43 109.629 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' C ' ' CD ' ' A' ' 63' ' ' PRO . 38.9 t -103.6 62.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.502 -0.317 . . . . 74.239999999999995 111.637 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 25.6 p-10 -112.45 46.55 0.3 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.066 0.395 . . . . 74.120000000000005 112.066 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' HH22 ' A' ' 113' ' ' ARG . 57.5 Cg_endo -70.5 84.8 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.327 2.018 . . . . 71.340000000000003 114.289 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -168.87 114.35 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.391 0.615 . . . . 73.120000000000005 110.711 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.574 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -170.75 139.58 1.34 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.076 -0.965 . . . . 61.299999999999997 110.933 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.7 Cg_exo -65.0 -18.4 6.47 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.986 -1.256 . . . . 73.349999999999994 110.994 -0.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 70' ' ' ASP . 10.0 t -165.17 146.48 7.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.169 -0.923 . . . . 65.439999999999998 110.036 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -49.3 -29.68 6.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.451 0.643 . . . . 75.349999999999994 110.481 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 1.3 mp0 -69.9 -31.87 69.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.577 -1.192 . . . . 71.209999999999994 112.948 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 71' ' ' PRO . 14.2 t0 -144.23 61.06 8.57 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 121.155 0.503 . . . . 55.240000000000002 110.031 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.561 ' CB ' ' HE ' ' A' ' 74' ' ' ARG . 7.5 Cg_exo -72.77 55.14 2.67 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.019 2.479 . . . . 74.329999999999998 113.627 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 70' ' ' ASP . 31.6 mttp -48.98 -54.8 14.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.405 0.52 . . . . 73.219999999999999 112.405 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -117.47 41.7 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.956 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' A' ' 71' ' ' PRO . 2.4 tmm_? -82.87 141.87 31.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 72.230000000000004 110.424 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' OE2' ' ND1' ' A' ' 78' ' ' HIS . 11.8 pt-20 -94.9 178.5 5.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.917 0.887 . . . . 61.520000000000003 111.126 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.574 HG12 ' CB ' ' A' ' 65' ' ' ALA . 13.0 mm -97.89 -120.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.673 . . . . 73.519999999999996 109.184 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 HG22 ' A' ' 135' ' ' THR . 4.4 mm? -89.97 174.31 7.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.972 -0.751 . . . . 51.119999999999997 108.972 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.44 ' ND1' ' OE2' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -172.91 165.16 5.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.574 0.225 . . . . 63.100000000000001 110.791 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.484 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -99.76 120.86 40.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.788 -0.819 . . . . 75.239999999999995 108.788 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.645 ' HB2' HD12 ' A' ' 97' ' ' LEU . 12.5 p -141.41 127.9 20.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 112.454 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -145.18 136.48 20.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.87 -0.605 . . . . 73.439999999999998 109.472 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.888 HG12 HG23 ' A' ' 57' ' ' THR . 31.3 m -138.11 166.62 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.554 -0.294 . . . . 71.040000000000006 111.112 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.644 ' O ' HD22 ' A' ' 55' ' ' LEU . 2.4 m120 63.68 33.15 13.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.363 -0.38 . . . . 63.32 110.502 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.005 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.0 mm -77.34 127.88 81.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.28 -0.568 . . . . 74.129999999999995 110.125 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -54.07 127.91 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.26 1.307 . . . . 74.239999999999995 109.931 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -64.17 56.75 0.07 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.146 0.819 . . . . 23.530000000000001 115.146 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 7.4 t 178.05 38.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 117.528 0.664 . . . . 64.120000000000005 111.572 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 90' ' ' ASN . 25.6 m120 -119.87 13.84 12.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.845 0.313 . . . . 71.299999999999997 111.845 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' SER . 20.8 pt-20 39.2 26.54 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.397 0.517 . . . . 73.230000000000004 112.397 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 17.3 p30 169.94 151.21 0.15 Allowed Pre-proline 0 C--O 1.236 0.356 0 CA-C-O 121.12 0.486 . . . . 72.239999999999995 110.731 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 44' ' ' VAL . 83.3 Cg_endo -75.5 63.2 6.39 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 123.542 2.828 . . . . 61.210000000000001 112.86 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -104.12 -48.18 3.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.685 0.624 . . . . 74.340000000000003 112.685 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.44 -39.96 79.72 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 115.345 0.898 . . . . 42.229999999999997 115.345 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 1.005 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.52 171.74 8.43 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.65 -0.786 . . . . 63.009999999999998 114.044 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' VAL . 65.1 t60 -66.42 121.34 15.08 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.624 0.37 . . . . 73.409999999999997 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 31.7 t -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.876 -1.157 . . . . 62.030000000000001 107.876 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' CE1' ' A' ' 147' ' ' PHE . 74.4 mt -63.68 -50.96 67.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.939 -0.763 . . . . 75.049999999999997 108.939 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 131' ' ' ILE . . . -143.24 125.6 15.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.762 -1.108 . . . . 53.200000000000003 109.367 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 133' ' ' ASN . 37.4 t0 -52.67 145.92 11.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.583 0.586 . . . . 41.100000000000001 112.583 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -65.15 151.15 46.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.301 -0.863 . . . . 73.340000000000003 110.685 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 9.6 p -158.52 174.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 110.071 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -67.76 178.88 18.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.391 -0.909 . . . . 52.549999999999997 111.994 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 112' ' ' HIS . 66.6 m -55.33 159.01 2.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.869 0.335 . . . . 72.340000000000003 111.371 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -97.41 -57.32 1.06 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.827 -0.624 . . . . 61.310000000000002 113.263 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 109' ' ' THR . 88.8 Cg_endo -79.23 123.01 5.41 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.914 2.409 . . . . 65.019999999999996 113.58 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 24.6 Cg_exo -62.67 162.49 24.63 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.041 2.494 . . . . 71.420000000000002 112.754 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.82 -24.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.743 -0.662 . . . . 70.230000000000004 112.456 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.8 m-20 -51.95 -39.34 59.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.005 -0.278 . . . . 62.539999999999999 110.604 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 105' ' ' PRO . 9.1 t -72.83 -14.92 61.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.459 0.647 . . . . 72.430000000000007 109.596 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 -130.01 9.42 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.136 -0.938 . . . . 52.140000000000001 112.187 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 163' ' ' GLN . 16.1 tp -66.48 127.83 33.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.455 -0.373 . . . . 75.049999999999997 111.966 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 164' ' ' ALA . 49.0 m170 -83.61 97.95 9.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.363 -0.38 . . . . 64.099999999999994 111.3 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.612 HH22 ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -75.89 68.35 2.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.565 . . . . 72.340000000000003 109.473 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.1 m-85 -81.43 146.79 30.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.728 -0.669 . . . . 63.229999999999997 111.632 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 54.7 mt -144.41 140.88 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 112.689 0.625 . . . . 72.219999999999999 112.689 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -107.75 134.72 50.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.011 -0.995 . . . . 73.150000000000006 109.28 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 118' ' ' LEU . 5.5 tt -121.81 132.22 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.234 -0.284 . . . . 71.400000000000006 110.234 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.739 ' N ' HD23 ' A' ' 117' ' ' LEU . 49.9 tp -124.15 136.8 54.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.464 -0.335 . . . . 72.109999999999999 110.952 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' THR . 53.6 t80 -141.97 134.96 28.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 72.019999999999996 110.417 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.586 ' HA ' HD23 ' A' ' 56' ' ' LEU . 5.1 tmm_? -72.62 133.4 44.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.383 -0.599 . . . . 64.200000000000003 109.383 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 151' ' ' HIS . 6.6 tp-100 -115.07 149.3 37.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.46 0.648 . . . . 63.329999999999998 112.452 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 88.1 tt0 -122.47 -38.97 2.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.009 -0.996 . . . . 71.439999999999998 111.24 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -90.72 134.6 34.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.308 0.484 . . . . 72.450000000000003 112.308 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -82.89 111.65 18.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.224 0.535 . . . . 70.299999999999997 110.932 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.512 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 1.3 pt -105.02 154.53 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.057 -0.974 . . . . 50.009999999999998 112.259 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -81.47 -49.97 9.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.924 0.392 . . . . 61.329999999999998 110.555 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 59.71 36.62 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.776 1.028 . . . . 73.319999999999993 113.776 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.633 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 68.6 p 52.16 145.38 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 123.51 0.724 . . . . 71.420000000000002 112.798 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -44.05 143.07 3.48 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.494 2.129 . . . . 51.299999999999997 112.204 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.8 t -59.08 143.4 48.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.765 -0.652 . . . . 64.120000000000005 111.691 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 98' ' ' ALA . 6.6 tp -110.89 133.37 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.52 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 m -70.99 142.12 50.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.805 -0.634 . . . . 74.549999999999997 110.623 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 135' ' ' THR . 18.8 p-10 -51.87 -38.99 58.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.199 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.756 ' HA ' HD13 ' A' ' 177' ' ' ILE . 15.3 t -67.82 22.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.165 -0.47 . . . . 62.149999999999999 111.58 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.686 HG22 HD11 ' A' ' 77' ' ' LEU . 11.7 t -64.11 128.31 35.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.869 0.366 . . . . 33.210000000000001 110.233 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' CB ' ' HA3' ' A' ' 179' ' ' GLY . 32.5 ttt180 -92.94 173.75 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.612 0.597 . . . . 64.140000000000001 112.612 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ARG . 20.9 m -26.32 131.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.557 -1.201 . . . . 73.040000000000006 111.61 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.3 4.86 32.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.468 -0.872 . . . . 54.509999999999998 111.16 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -146.93 35.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.741 0.305 . . . . 72.409999999999997 110.296 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 142' ' ' PHE . 13.6 mt -111.11 -71.04 0.78 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.219 -0.446 . . . . 54.119999999999997 111.257 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -51.61 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.356 -0.384 . . . . 73.319999999999993 110.154 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 1.5 t80 -150.47 72.49 1.1 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.249 0.833 . . . . 75.349999999999994 113.249 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -52.58 114.22 1.31 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.925 0.393 . . . . 74.219999999999999 110.752 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -48.26 -34.88 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.451 0.537 . . . . 74.329999999999998 112.451 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.4 ptt180 -43.69 -33.34 1.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.225 0.536 . . . . 75.209999999999994 111.099 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 145' ' ' ARG . 19.1 t70 -52.52 -46.1 66.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.571 -0.74 . . . . 64.530000000000001 111.306 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.841 ' CE1' HD13 ' A' ' 97' ' ' LEU . 85.4 m-85 -53.28 -50.39 64.96 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.337 0.589 . . . . 65.409999999999997 110.905 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -56.25 -42.24 77.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.795 -0.639 . . . . 54.420000000000002 110.437 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.73 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 72.420000000000002 111.466 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.618 ' CG ' ' N ' ' A' ' 151' ' ' HIS . 45.8 pttt -75.2 -59.08 2.9 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.72 0.295 . . . . 73.430000000000007 111.535 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.618 ' N ' ' CG ' ' A' ' 150' ' ' LYS . 18.4 t-160 -80.7 4.97 17.03 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.055 0.391 . . . . 73.349999999999994 112.055 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.83 27.98 65.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.72 -0.752 . . . . 21.239999999999998 113.286 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.55 HD21 ' ND1' ' A' ' 151' ' ' HIS . 25.6 mt -66.65 17.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 111.771 0.286 . . . . 70.409999999999997 111.771 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.65 -61.77 3.6 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.999 -0.62 . . . . 75.230000000000004 113.477 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.77 109.33 4.92 Favored Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.723 0.262 . . . . 63.350000000000001 111.145 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' GLY . 57.6 Cg_endo -89.86 132.46 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.402 2.068 . . . . 62.439999999999998 112.563 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 118' ' ' LEU . 37.8 pt -80.95 -35.37 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 62.420000000000002 110.711 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 157' ' ' ILE . . . -157.88 149.83 22.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.46 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -148.48 159.09 44.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.424 0.63 . . . . 73.340000000000003 111.319 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -155.2 144.61 21.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.042 -1.466 . . . . 72.230000000000004 107.042 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -149.76 176.25 10.86 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.718 -0.393 . . . . 71.109999999999999 111.398 -176.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 10.2 p90 -167.68 150.58 5.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.982 -0.554 . . . . 62.009999999999998 110.82 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.566 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 43.6 mt-30 -110.66 124.23 51.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 63.439999999999998 109.852 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -156.16 140.64 16.8 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.696 -0.402 . . . . 62.310000000000002 112.002 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -98.7 149.98 22.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.47 -0.567 . . . . 64.120000000000005 109.47 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.33 137.17 25.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.852 0.358 . . . . 73.319999999999993 111.165 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -150.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.679 -0.691 . . . . 72.150000000000006 112.648 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 172' ' ' ILE . 49.7 t0 -84.79 -23.6 29.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.133 -0.94 . . . . 72.310000000000002 111.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.417 ' CE1' ' NH2' ' A' ' 173' ' ' ARG . 17.2 t80 -41.81 -54.76 3.27 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.82 0.304 . . . . 71.400000000000006 111.82 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.672 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 69.2 t -65.64 -57.25 14.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.388 -0.525 . . . . 71.439999999999998 110.235 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 88.5 Cg_exo -45.18 -31.58 6.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.985 1.79 . . . . 63.420000000000002 112.05 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 168' ' ' ASP . 61.4 mt -51.91 -37.35 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.885 0.374 . . . . 74.329999999999998 110.307 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.489 ' H ' ' HD2' ' A' ' 173' ' ' ARG . 0.2 OUTLIER -53.7 -33.6 55.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.775 -0.454 . . . . 52.409999999999997 109.775 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 177' ' ' ILE . 25.8 m120 -58.19 -31.65 67.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 64.430000000000007 111.031 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 2.6 mptp? -61.31 -13.57 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.29 -0.633 . . . . 61.200000000000003 109.29 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 176' ' ' THR . 17.2 m -98.32 8.23 45.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.318 -0.856 . . . . 75.329999999999998 111.292 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.756 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.4 mm -69.83 117.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.015 -0.365 . . . . 54.409999999999997 110.015 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.34 -27.91 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 113.523 0.934 . . . . 51.409999999999997 113.523 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.325 -1.264 . . . . 53.030000000000001 112.294 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.851 0.358 . . . . 71.129999999999995 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 12' ' ' VAL . 29.1 t70 -109.37 -57.15 2.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.853 -0.612 . . . . 72.420000000000002 112.242 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.574 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 12.9 pt -129.02 65.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.253 0.549 . . . . 74.340000000000003 111.085 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.2 p -141.37 143.92 32.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.028 -0.533 . . . . 52.009999999999998 111.17 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -76.16 22.27 2.73 Favored 'Cis proline' 0 C--N 1.358 1.039 0 C-N-CA 124.454 -1.061 . . . . 73.409999999999997 112.334 0.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.705 ' O ' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -49.51 -53.87 20.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.169 -0.923 . . . . 73.230000000000004 111.276 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 7' ' ' ASP . 2.8 m -165.79 -40.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.73 0.641 . . . . 71.209999999999994 112.73 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 HD23 ' HD3' ' A' ' 13' ' ' PRO . 22.8 tp -157.1 152.19 26.1 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.494 0.664 . . . . 52.439999999999998 112.372 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -60.54 -35.81 76.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.795 -0.639 . . . . 74.530000000000001 111.07 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.15 13.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 75.140000000000001 111.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.436 HG23 ' OD2' ' A' ' 3' ' ' ASP . 61.6 t -59.9 124.51 77.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.574 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.479 ' HD3' HD23 ' A' ' 9' ' ' LEU . 66.4 Cg_endo -85.66 -117.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.957 2.438 . . . . 73.120000000000005 112.724 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -168.72 -46.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 122.931 0.492 . . . . 74.430000000000007 109.741 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.83 -158.72 13.63 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.371 -0.692 . . . . 63.200000000000003 111.371 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 4.8 t -147.92 167.59 24.45 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.519 0.676 . . . . 75.099999999999994 111.488 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 118' ' ' LEU . 13.1 mt -105.5 152.97 7.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.333 -1.303 . . . . 65.319999999999993 108.416 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.0 mmpt? -108.48 102.4 11.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.103 -0.499 . . . . 73.400000000000006 110.601 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.786 ' HB ' HG22 ' A' ' 27' ' ' VAL . 35.3 t -105.92 109.93 29.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.451 HG12 ' HB3' ' A' ' 26' ' ' GLU . 67.6 mt -98.45 137.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.579 . . . . 74.319999999999993 110.846 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.83 -97.23 0.18 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.214 -0.903 . . . . 74.140000000000001 112.543 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -66.82 -44.59 88.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.601 -0.809 . . . . 75.430000000000007 113.544 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 174.34 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.272 -0.64 . . . . 61.32 109.272 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.22 -42.49 15.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.452 -0.795 . . . . 73.120000000000005 109.361 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.51 138.51 53.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.277 -0.874 . . . . 71.219999999999999 110.359 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 pt-20 -150.36 151.49 32.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.728 -1.123 . . . . 71.510000000000005 108.822 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.0 m -73.21 120.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.956 0.724 . . . . 63.210000000000001 112.956 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 3.4 mptp? -104.11 111.97 24.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.455 -0.793 . . . . 65.540000000000006 112.512 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.496 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.0 mp0 29.04 67.77 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.606 1.336 . . . . 72.299999999999997 114.606 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' HD1' ' A' ' 161' ' ' TYR . . . 76.92 5.17 84.2 Favored Glycine 0 N--CA 1.465 0.63 0 C-N-CA 121.043 -0.598 . . . . 51.100000000000001 112.844 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -47.62 147.07 1.94 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.697 -0.752 . . . . 70.25 111.933 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -101.76 131.72 47.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.459 -1.246 . . . . 63.420000000000002 109.85 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 9.6 mp -96.96 124.92 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.157 0.503 . . . . 61.509999999999998 111.166 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 p -149.87 145.09 18.38 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.496 -0.775 . . . . 75.450000000000003 109.688 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -83.78 -113.26 0.0 OUTLIER 'Cis proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.936 -1.277 . . . . 63.399999999999999 112.965 0.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.0 p -67.47 61.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.532 0.568 . . . . 72.230000000000004 112.532 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.8 pt20 -119.11 -3.57 10.62 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.746 0.307 . . . . 63.420000000000002 111.226 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 33' ' ' LEU . 30.9 m -78.22 32.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 110.921 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -105.64 -23.21 12.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.149 0.796 . . . . 71.319999999999993 113.149 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 39' ' ' LYS . 1.4 m-20 -71.5 139.91 49.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.265 0.555 . . . . 62.43 112.032 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.54 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.31 130.53 93.19 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 115.496 -0.775 . . . . 71.319999999999993 110.045 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.15 126.31 13.56 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.999 1.799 . . . . 71.040000000000006 112.442 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -107.95 109.51 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 75.120000000000005 110.678 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.3 p -81.45 138.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.165 0.431 . . . . 73.450000000000003 112.165 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -165.3 164.07 19.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.758 0.313 . . . . 14.02 110.734 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p90 -141.16 37.12 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.817 -0.628 . . . . 75.219999999999999 110.27 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.1 t -50.78 112.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 74.019999999999996 111.355 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.72 -14.64 61.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.114 -0.565 . . . . 71.519999999999996 112.935 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -78.53 -28.12 46.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 71.519999999999996 110.943 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -72.75 -82.92 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.936 0.398 . . . . 72.400000000000006 111.429 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.56 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 78.77 -52.83 3.97 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.155 -0.545 . . . . 74.230000000000004 111.969 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.64 109.03 4.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.823 0.344 . . . . 64.030000000000001 110.139 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -157.95 141.33 15.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 70.519999999999996 111.529 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.3 -40.58 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.915 0.864 . . . . 73.120000000000005 109.41 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -149.98 157.52 43.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.044 -1.435 . . . . 54.409999999999997 107.528 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.8 mt -128.46 144.49 51.15 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.32 -0.552 . . . . 75.310000000000002 111.023 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.791 HG21 ' CD2' ' A' ' 153' ' ' LEU . 24.3 m -115.85 132.52 56.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.408 -0.814 . . . . 73.140000000000001 110.541 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -133.37 131.44 40.07 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.257 0.348 . . . . 62.109999999999999 110.348 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 97' ' ' LEU . 51.0 mt -151.39 167.11 28.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.732 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.428 ' HG3' ' CB ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.88 146.03 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.633 -0.712 . . . . 73.319999999999993 109.469 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.866 HG22 HD23 ' A' ' 117' ' ' LEU . 6.1 t -131.28 49.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.056 0.455 . . . . 75.519999999999996 110.722 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 p30 -133.66 54.82 13.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.543 -0.753 . . . . 75.329999999999998 111.425 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.35 83.29 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.39 1.394 . . . . 75.510000000000005 112.048 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -150.18 109.11 3.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.19 -0.914 . . . . 61.299999999999997 110.211 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -167.54 137.83 2.32 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 110.348 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -78.38 -23.89 13.29 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.114 -1.203 . . . . 63.340000000000003 111.851 -0.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.8 t -145.86 140.85 27.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.366 -0.834 . . . . 72.310000000000002 111.064 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 68' ' ' ARG . 5.6 ttp-105 -52.59 -29.18 24.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 64.25 111.743 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 67' ' ' THR . 7.1 pt20 -80.0 -27.17 39.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.448 0.536 . . . . 71.0 112.448 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 67' ' ' THR . 5.4 m-20 -144.67 60.41 7.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-O 120.988 0.423 . . . . 51.409999999999997 111.711 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 56.8 Cg_endo -69.24 58.98 1.35 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.063 2.509 . . . . 71.519999999999996 112.876 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 8.7 ptpt -57.37 -47.72 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.175 0.805 . . . . 55.32 113.175 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.613 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -105.71 35.66 2.8 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.106 -0.638 . . . . 73.329999999999998 112.221 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 25.2 ttp180 -70.24 131.61 44.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.179 -0.674 . . . . 73.209999999999994 109.179 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 42.6 mt-10 -93.65 169.34 10.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 72.120000000000005 110.618 -0.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.777 HG23 ' N ' ' A' ' 77' ' ' LEU . 10.6 tp -110.4 -134.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.467 -0.197 . . . . 63.549999999999997 110.467 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.777 ' N ' HG23 ' A' ' 76' ' ' ILE . 96.1 mt -72.41 152.07 42.23 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.451 -0.574 . . . . 75.519999999999996 109.451 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.518 ' NE2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -163.87 157.07 18.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.722 0.267 . . . . 65.140000000000001 111.722 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 5.0 t-105 -99.96 117.65 34.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.915 -0.584 . . . . 74.040000000000006 109.978 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 6.1 p -141.13 134.45 29.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.995 -0.548 . . . . 61.020000000000003 112.073 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.829 HG11 ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -142.76 142.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 70.099999999999994 110.021 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 HG23 ' A' ' 57' ' ' THR . 14.5 m -140.85 159.14 23.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.475 0.546 . . . . 71.209999999999994 112.475 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.0 p30 62.36 35.87 14.76 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 114.567 -1.197 . . . . 73.340000000000003 111.185 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.966 HD13 ' HA3' ' A' ' 94' ' ' GLY . 3.6 mm -73.62 127.63 88.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 63.409999999999997 109.742 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 23.9 Cg_exo -63.5 126.87 18.5 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 121.958 1.772 . . . . 75.239999999999995 111.755 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.79 62.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.248 0.342 . . . . 53.240000000000002 113.602 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' PRO . 31.9 p -179.2 39.69 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.16 0.48 . . . . 74.010000000000005 110.942 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 90' ' ' ASN . 32.4 m120 -135.31 -4.05 2.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 111.816 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 67.62 -36.64 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.222 0.609 . . . . 73.200000000000003 112.5 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 88' ' ' ASN . 1.6 p30 -127.71 153.42 77.8 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 54.130000000000003 110.609 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.897 ' HA ' HG21 ' A' ' 84' ' ' ILE . 77.5 Cg_endo -70.78 47.08 0.68 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.646 2.897 . . . . 63.409999999999997 113.803 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.8 m -93.49 -40.32 10.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 61.140000000000001 112.147 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.07 -13.11 61.44 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.906 -0.588 . . . . 61.240000000000002 114.241 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.966 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -98.33 172.08 26.11 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.405 -0.902 . . . . 72.540000000000006 113.404 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.546 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.69 126.61 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 75.430000000000007 111.496 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.691 ' H ' HG22 ' A' ' 130' ' ' THR . 85.3 p -88.11 94.5 9.83 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.999 -0.546 . . . . 71.230000000000004 109.895 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.697 HD12 HD21 ' A' ' 59' ' ' LEU . 77.2 mt -50.06 -38.24 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 74.239999999999995 109.189 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -156.67 115.49 3.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.692 -1.14 . . . . 52.130000000000003 109.089 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 50.2 t0 -52.36 146.71 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.439 0.462 . . . . 64.310000000000002 111.982 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 47.7 p90 -69.81 129.61 40.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.598 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 13.7 p -158.61 174.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.326 -0.397 . . . . 72.040000000000006 110.217 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -72.04 -129.18 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.234 -0.984 . . . . 74.230000000000004 111.703 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 170' ' ' VAL . 47.6 t -175.48 -165.67 0.18 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.838 -0.801 . . . . 43.210000000000001 108.838 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 105' ' ' PRO . . . -128.58 54.89 0.77 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.766 -0.731 . . . . 74.329999999999998 111.65 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 104' ' ' GLY . 14.3 Cg_endo -87.96 120.7 1.39 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.499 2.133 . . . . 74.420000000000002 112.676 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 109' ' ' THR . 73.5 Cg_endo -74.31 162.11 39.09 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.79 2.327 . . . . 61.25 111.759 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 109' ' ' THR . 17.6 pttp -43.55 -45.64 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.443 -0.344 . . . . 62.25 111.764 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -63.4 5.95 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.159 0.429 . . . . 71.439999999999998 112.159 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 106' ' ' PRO . 13.0 t -75.14 -25.68 58.58 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.144 0.497 . . . . 73.519999999999996 110.196 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.9 -165.11 42.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 61.43 112.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.8 tp -71.33 111.56 6.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.867 0.365 . . . . 72.040000000000006 111.492 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -88.85 131.99 34.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.310000000000002 110.987 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -103.55 90.54 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.742 -0.663 . . . . 74.340000000000003 109.922 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 10.2 m-85 -74.94 136.48 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.407 . . . . 73.530000000000001 111.242 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 161' ' ' TYR . 35.0 mt -130.03 138.22 54.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.83 -0.623 . . . . 75.299999999999997 112.053 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -120.74 136.81 54.77 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.465 -0.789 . . . . 71.319999999999993 109.439 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 61' ' ' VAL . 2.3 pp -118.47 149.32 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 63.439999999999998 109.895 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 157' ' ' ILE . 2.8 tt -133.94 134.87 43.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 73.340000000000003 109.592 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.693 ' N ' HD23 ' A' ' 118' ' ' LEU . 53.3 t80 -139.88 136.71 34.22 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 72.230000000000004 111.448 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -73.7 124.71 26.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.752 -0.658 . . . . 71.319999999999993 109.71 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -110.78 145.31 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 75.099999999999994 112.351 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -118.63 -39.92 2.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.982 -1.008 . . . . 75.409999999999997 109.968 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -83.98 130.75 34.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.234 -0.439 . . . . 72.349999999999994 111.106 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -79.06 131.91 36.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.514 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -125.33 154.55 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.712 -0.676 . . . . 70.200000000000003 112.414 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -90.97 -33.79 15.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.747 -0.661 . . . . 70.420000000000002 111.786 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 36.76 36.27 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.12 1.155 . . . . 74.010000000000005 114.12 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p 59.11 159.49 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-O 121.154 0.502 . . . . 73.140000000000001 112.165 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -53.88 152.45 23.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.637 2.225 . . . . 64.019999999999996 113.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 96' ' ' SER . 22.9 p -59.02 127.15 30.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.192 -0.913 . . . . 74.420000000000002 110.707 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.482 HG13 ' NH1' ' A' ' 139' ' ' ARG . 20.4 mm -91.85 124.94 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 74.150000000000006 111.644 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.0 m -69.76 147.98 49.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.998 -1.001 . . . . 73.040000000000006 112.09 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.517 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 16.6 p30 -50.55 -43.63 56.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 74.510000000000005 111.427 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.836 ' HA ' HD13 ' A' ' 177' ' ' ILE . 9.7 t -68.71 21.91 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.481 0.549 . . . . 64.099999999999994 112.481 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.6 t -65.16 122.34 16.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 64.230000000000004 110.884 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.689 ' HD2' ' N ' ' A' ' 137' ' ' THR . 5.0 tmm_? -82.49 160.76 22.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.53 -0.759 . . . . 72.049999999999997 111.652 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.693 HG23 HD11 ' A' ' 140' ' ' LEU . 6.0 m -39.94 158.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.348 -0.842 . . . . 65.310000000000002 111.093 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.95 17.51 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 112.483 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' NH1' HG13 ' A' ' 131' ' ' ILE . 17.8 ttm180 -167.86 48.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.888 0.375 . . . . 71.230000000000004 110.731 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.693 HD11 HG23 ' A' ' 137' ' ' THR . 0.0 OUTLIER -114.65 -56.45 2.38 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.321 -0.399 . . . . 72.319999999999993 110.314 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.442 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 4.7 m-20 -63.81 66.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 111.691 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LEU . 14.3 t80 -138.77 121.72 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.522 -0.548 . . . . 61.119999999999997 109.522 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.6 122.28 15.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.215 0.531 . . . . 74.219999999999999 111.75 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.68 72.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.625 -0.716 . . . . 63.409999999999997 111.45 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -50.44 -35.14 27.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.459 . . . . 72.329999999999998 110.223 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.62 -44.12 91.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.426 0.631 . . . . 74.450000000000003 109.382 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 150' ' ' LYS . 1.2 t80 -62.9 -38.35 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 53.240000000000002 109.574 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 153' ' ' LEU . . . -65.36 -46.6 79.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.578 -0.737 . . . . 71.040000000000006 110.564 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.19 -55.08 23.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 52.25 110.624 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.553 ' HG3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.22 -48.13 83.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 62.420000000000002 110.583 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.553 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 2.9 m-70 -67.64 3.39 1.42 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 121.221 -0.191 . . . . 43.549999999999997 111.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 72.86 7.77 71.12 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.86 -0.686 . . . . 64.239999999999995 112.19 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.5 mt -72.14 16.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.392 0.277 . . . . 74.25 110.883 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.91 -69.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.432 -0.889 . . . . 54.5 112.127 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 21.2 pt-20 -80.39 120.03 78.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.579 0.228 . . . . 72.239999999999995 110.839 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.38 125.44 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.936 1.757 . . . . 73.310000000000002 112.077 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 118' ' ' LEU . 27.2 pt -76.26 -33.94 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.476 -0.49 . . . . 74.420000000000002 110.012 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -146.52 144.61 29.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.924 -0.58 . . . . 42.130000000000003 110.507 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -148.91 149.68 31.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.424 -0.353 . . . . 52.310000000000002 110.884 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.546 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.0 t-20 -150.97 148.98 29.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.928 -1.138 . . . . 72.319999999999993 107.928 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.551 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -152.34 165.73 34.07 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.462 -0.495 . . . . 74.310000000000002 111.272 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.4 p90 -154.14 152.92 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.582 -0.735 . . . . 74.209999999999994 110.778 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.68 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.41 -0.589 . . . . 51.549999999999997 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.16 138.72 15.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.273 0.559 . . . . 61.210000000000001 111.856 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -118.28 144.97 45.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 71.129999999999995 109.153 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.9 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.156 -0.313 . . . . 73.310000000000002 110.156 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -100.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.511 -0.768 . . . . 70.150000000000006 112.322 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t0 -147.78 21.48 1.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.658 0.742 . . . . 72.219999999999999 109.949 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -76.45 -47.95 21.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.676 -0.693 . . . . 75.450000000000003 111.359 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 103' ' ' SER . 60.2 t -43.02 -50.34 13.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.052 -0.522 . . . . 71.140000000000001 112.271 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 51.2 Cg_exo -57.84 -37.01 97.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.068 1.845 . . . . 71.25 112.392 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.0 mm -50.12 -39.86 16.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.057 0.456 . . . . 73.519999999999996 110.977 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -69.98 -30.18 67.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 74.099999999999994 111.212 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' PRO . 1.6 m120 -56.02 -14.94 2.9 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.512 -0.313 . . . . 73.230000000000004 110.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.52 -20.08 7.07 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.605 -0.517 . . . . 64.010000000000005 109.605 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.0 m -68.34 -28.01 66.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.69 -0.686 . . . . 75.349999999999994 110.783 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 134' ' ' THR . 35.6 mm -54.6 130.79 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.703 . . . . 52.539999999999999 111.978 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.635 HG22 ' OG1' ' A' ' 134' ' ' THR . 20.1 m -146.7 -14.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.066 0.765 . . . . 53.520000000000003 113.066 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.225 -1.32 . . . . 64.239999999999995 112.577 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.541 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 3.3 p-10 . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 109.596 -0.52 . . . . 73.400000000000006 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.09 -71.21 0.42 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.637 0.977 . . . . 72.430000000000007 113.637 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 11' ' ' ALA . 7.5 pt -97.11 46.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.528 0.68 . . . . 71.25 112.568 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.1 p -128.14 142.37 44.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.551 -0.749 . . . . 72.019999999999996 110.372 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HA ' HG23 ' A' ' 5' ' ' VAL . 64.0 Cg_endo -86.62 35.58 4.13 Favored 'Cis proline' 0 C--N 1.35 0.619 0 C-N-CA 124.115 -1.202 . . . . 74.549999999999997 112.932 0.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.561 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.7 t70 -64.33 -48.37 75.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 61.039999999999999 111.032 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 7' ' ' ASP . 3.6 m -160.36 -37.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.689 0.626 . . . . 62.130000000000003 112.689 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.522 HD23 ' HD3' ' A' ' 13' ' ' PRO . 48.9 tp -157.13 164.27 38.03 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.884 0.373 . . . . 64.430000000000007 110.899 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.88 -42.35 94.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.098 0.475 . . . . 72.439999999999998 110.095 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 4' ' ' ILE . . . -134.87 -174.59 3.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.491 -0.777 . . . . 53.350000000000001 111.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.0 p -110.29 111.96 57.46 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.96 -0.564 . . . . 52.32 111.555 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 9' ' ' LEU . 64.9 Cg_endo -83.95 -134.89 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.124 2.549 . . . . 64.299999999999997 112.117 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -150.46 -38.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.508 -0.314 . . . . 55.109999999999999 111.098 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -138.24 166.58 25.19 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.561 -0.828 . . . . 71.329999999999998 112.533 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -102.12 159.65 15.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.263 0.554 . . . . 53.240000000000002 111.506 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.524 HG21 HG13 ' A' ' 44' ' ' VAL . 4.7 mt -105.41 131.24 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.698 -0.853 . . . . 62.229999999999997 108.698 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.8 mtpm? -74.03 102.98 4.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.142 -0.481 . . . . 70.230000000000004 110.516 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.629 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 46.9 t -117.52 110.59 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.111 0.481 . . . . 75.349999999999994 110.654 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 25' ' ' LEU . 47.2 mt -99.52 131.48 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.048 -0.524 . . . . 70.409999999999997 110.34 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -72.31 -51.08 22.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.36 -0.382 . . . . 71.040000000000006 111.516 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 40' ' ' ASP . . . -126.1 -61.23 0.16 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.559 -0.829 . . . . 74.340000000000003 113.273 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.16 -59.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.028 0.442 . . . . 74.019999999999996 110.343 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -97.57 -38.5 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 111.071 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.71 135.62 50.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.396 0.617 . . . . 64.209999999999994 110.723 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -140.67 136.92 33.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.35 -0.841 . . . . 74.519999999999996 111.827 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.751 HG11 ' CD2' ' A' ' 162' ' ' TYR . 28.2 m -76.62 139.22 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.312 -0.858 . . . . 74.129999999999995 110.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HA ' HD21 ' A' ' 160' ' ' ASN . 41.6 pttt -155.12 122.32 5.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.857 1.058 . . . . 72.140000000000001 113.857 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.466 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 11.8 mp0 27.42 67.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.357 1.614 . . . . 72.030000000000001 115.357 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 161' ' ' TYR . . . 86.81 -7.98 77.69 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.993 -0.622 . . . . 61.32 114.3 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -50.44 129.93 22.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.597 0.236 . . . . 50.210000000000001 110.65 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -94.76 142.1 27.85 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.843 -0.428 . . . . 72.400000000000006 109.843 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.764 HD21 HD12 ' A' ' 25' ' ' LEU . 1.3 tp -101.86 127.99 48.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 51.420000000000002 110.995 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 66.9 p -149.91 157.42 37.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.478 -0.783 . . . . 70.409999999999997 109.692 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.5 Cg_exo -76.33 -47.88 0.29 Allowed 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.988 -1.255 . . . . 52.420000000000002 112.102 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 38' ' ' VAL . 74.2 p -151.46 25.69 0.69 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 64.329999999999998 111.395 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' A' ' 39' ' ' LYS . 3.8 pt20 -63.33 0.41 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.37 0.605 . . . . 72.25 111.039 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.692 HG12 HD23 ' A' ' 33' ' ' LEU . 35.4 m -74.21 32.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 111.605 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.435 ' CD ' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.55 -31.69 57.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.977 0.418 . . . . 61.420000000000002 111.139 -179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HB3' ' HA2' ' A' ' 22' ' ' GLY . 14.9 m-20 -87.16 142.86 27.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.498 0.555 . . . . 65.400000000000006 112.498 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.647 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.05 139.05 92.65 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 115.6 -0.727 . . . . 72.019999999999996 111.092 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.51 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 20.2 Cg_exo -63.19 126.6 18.19 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.724 1.616 . . . . 70.120000000000005 112.078 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 mm -108.39 112.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 64.040000000000006 110.24 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 HG21 ' A' ' 17' ' ' ILE . 57.2 t -86.07 142.23 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.554 0.576 . . . . 74.310000000000002 112.554 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.4 m -165.05 133.82 3.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.801 0.334 . . . . 53.049999999999997 111.253 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 15.0 p90 -108.66 32.41 4.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.44 0.638 . . . . 70.239999999999995 110.227 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.5 m -43.77 134.45 4.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 111.082 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.47 -29.86 4.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.86 -0.686 . . . . 71.019999999999996 112.975 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 49' ' ' LEU . 6.6 mp -80.73 -38.88 27.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.275 0.538 . . . . 73.450000000000003 110.25 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 13.1 tp10 -50.15 163.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.888 -0.597 . . . . 73.439999999999998 110.688 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 50' ' ' GLU . . . -170.12 -76.91 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.283 -0.727 . . . . 70.340000000000003 111.283 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -148.53 109.76 4.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.815 0.341 . . . . 71.400000000000006 110.295 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -151.31 141.72 22.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.028 -0.533 . . . . 71.310000000000002 110.02 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.89 -36.56 62.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.327 0.584 . . . . 52.310000000000002 109.474 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 83' ' ' ASN . 30.6 mt -155.28 164.84 38.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.998 -1.001 . . . . 73.120000000000005 110.455 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 35.0 mt -135.83 157.29 47.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.946 0.403 . . . . 65.409999999999997 110.92 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.527 HG23 ' NE2' ' A' ' 121' ' ' GLN . 0.7 OUTLIER -117.94 121.89 41.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 60.409999999999997 109.674 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.1 tm? -127.07 128.71 46.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.256 -0.646 . . . . 53.549999999999997 109.256 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.609 ' N ' HD13 ' A' ' 58' ' ' LEU . 43.5 mt -154.29 154.0 32.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.99 -0.284 . . . . 73.430000000000007 111.137 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -134.1 145.38 49.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.671 -0.492 . . . . 71.519999999999996 109.671 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 62' ' ' ASP . 8.8 t -150.62 164.76 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.867 1.062 . . . . 63.039999999999999 113.867 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.585 ' N ' HG12 ' A' ' 61' ' ' VAL . 46.6 t0 -172.85 86.08 0.41 Allowed Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 113.594 -1.639 . . . . 73.019999999999996 107.211 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.98 84.69 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 123.204 2.602 . . . . 72.010000000000005 115.342 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -170.49 124.05 0.68 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.134 -0.484 . . . . 64.040000000000006 111.896 177.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -170.31 136.95 1.27 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.453 -0.34 . . . . 70.120000000000005 111.731 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HG3' ' CE2' ' A' ' 73' ' ' TYR . 18.6 Cg_exo -66.26 -33.48 2.8 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.752 -1.353 . . . . 72.140000000000001 110.945 -0.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 3.5 t -130.21 157.34 42.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 64.140000000000001 109.872 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' NH2' ' A' ' 113' ' ' ARG . 23.8 ttt85 -58.37 -26.69 63.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.199 0.523 . . . . 65.219999999999999 109.785 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -78.2 -15.59 58.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.065 -0.97 . . . . 73.430000000000007 111.664 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 60.5 t0 -143.98 94.97 5.76 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.233 -0.439 . . . . 62.43 111.284 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 85.1 Cg_endo -80.78 50.51 3.59 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.123 2.549 . . . . 72.540000000000006 112.027 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 7.2 ttmt -58.6 -54.74 43.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.309 0.855 . . . . 71.120000000000005 113.309 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 66' ' ' PRO . 16.9 p90 -132.2 25.6 4.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.687 0.625 . . . . 70.019999999999996 112.687 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.742 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 2.8 tmm_? -58.19 134.7 56.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 72.010000000000005 109.694 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 73.5 mt-10 -90.31 178.22 6.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.542 1.137 . . . . 51.43 111.177 0.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.881 HD11 ' HB2' ' A' ' 65' ' ' ALA . 1.2 mp -98.04 -61.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.357 0.599 . . . . 51.409999999999997 109.962 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HG ' HG11 ' A' ' 101' ' ' VAL . 2.0 pt? -171.23 141.8 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.504 -0.925 . . . . 63.439999999999998 108.504 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.54 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 5.0 p-80 -137.57 176.01 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.581 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.63 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 7.4 t-105 -100.48 113.77 26.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.946 -0.761 . . . . 75.510000000000005 108.946 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.587 ' HA ' HD23 ' A' ' 59' ' ' LEU . 43.3 p -131.54 114.52 14.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.645 -0.707 . . . . 70.329999999999998 111.078 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.63 HG21 ' CZ2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -127.33 117.91 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 64.319999999999993 109.239 178.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HG3' ' A' ' 127' ' ' GLU . 21.8 m -114.87 164.8 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.332 -0.849 . . . . 64.230000000000004 111.758 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.616 HD21 ' CG ' ' A' ' 95' ' ' HIS . 24.8 p30 52.16 43.9 30.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 61.340000000000003 112.374 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.4 mm -75.43 118.06 67.95 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.89 -1.152 . . . . 72.540000000000006 107.89 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.45 125.72 18.56 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.689 1.593 . . . . 71.140000000000001 111.725 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.07 61.23 0.08 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.371 0.419 . . . . 51.100000000000001 113.656 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -171.09 39.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.419 0.688 . . . . 63.32 109.318 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 55.7 m-80 -130.08 -28.07 2.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.511 -0.768 . . . . 74.430000000000007 111.787 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.445 ' HA ' ' NE1' ' A' ' 46' ' ' TRP . 2.2 tt0 76.0 -9.24 1.48 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.071 0.463 . . . . 64.329999999999998 110.776 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -155.91 155.27 29.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.294 -0.866 . . . . 70.140000000000001 110.111 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 84' ' ' ILE . 84.4 Cg_endo -73.75 60.75 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.655 0 C-N-CA 123.684 2.922 . . . . 63.119999999999997 113.21 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -90.96 -55.08 3.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.188 0.81 . . . . 70.310000000000002 113.188 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -10.85 75.13 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 116.445 1.338 . . . . 72.109999999999999 116.445 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -71.19 164.42 53.76 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.789 -1.196 . . . . 73.140000000000001 113.662 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CG ' HD21 ' A' ' 83' ' ' ASN . 13.5 m80 -65.21 121.35 14.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.805 0.336 . . . . 61.509999999999998 111.597 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 130' ' ' THR . 8.9 m -87.81 89.38 7.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 61.009999999999998 111.305 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 127' ' ' GLU . 16.7 mt -61.66 -17.36 55.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.536 0.684 . . . . 72.340000000000003 111.339 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB3' ' OG ' ' A' ' 80' ' ' SER . . . -167.92 116.06 0.75 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.344 -0.844 . . . . 64.010000000000005 108.957 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.569 ' HB3' ' CA ' ' A' ' 133' ' ' ASN . 28.4 t0 -60.06 151.82 25.65 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.595 0.559 . . . . 61.229999999999997 111.992 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -70.12 148.38 48.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 64.019999999999996 112.394 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 103' ' ' SER . 10.3 p -135.31 133.0 52.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.827 -0.624 . . . . 71.329999999999998 110.03 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.63 66.95 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.412 -0.899 . . . . 53.420000000000002 112.819 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.4 m -164.83 127.65 2.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 73.010000000000005 111.123 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.87 -73.32 1.09 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.84 -0.618 . . . . 62.020000000000003 112.659 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 31.7 Cg_exo -57.84 133.57 56.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.848 2.366 . . . . 61.32 112.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 32.3 Cg_exo -58.38 151.59 59.91 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.107 2.538 . . . . 62.32 113.563 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 168' ' ' ASP . 21.8 pttm -46.12 -26.94 0.84 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.178 -0.919 . . . . 72.150000000000006 111.344 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.54 -30.36 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 72.109999999999999 110.462 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 2.3 t -92.16 -26.7 18.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.278 0.561 . . . . 51.409999999999997 109.804 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.35 -100.5 0.81 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.578 -0.737 . . . . 75.150000000000006 114.886 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.91 125.41 22.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.661 0.744 . . . . 74.329999999999998 112.976 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 26.3 m80 -116.04 123.01 46.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.622 -1.172 . . . . 73.010000000000005 110.097 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.526 ' NH2' ' NH1' ' A' ' 68' ' ' ARG . 36.8 mtm180 -94.47 85.25 4.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.811 -0.44 . . . . 62.340000000000003 109.811 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 103' ' ' SER . 29.6 m-85 -70.33 114.5 8.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.128 -0.629 . . . . 74.430000000000007 110.676 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 60' ' ' MET . 38.4 mm -104.97 121.98 57.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 110.261 -0.274 . . . . 73.109999999999999 110.261 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.507 ' CE2' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -102.54 128.51 49.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.856 0.462 . . . . 73.409999999999997 109.828 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.91 133.65 54.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 70.219999999999999 110.313 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.717 ' N ' HD13 ' A' ' 117' ' ' LEU . 33.7 tp -128.64 131.76 48.08 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.169 -0.469 . . . . 74.510000000000005 110.459 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 57' ' ' THR . 60.7 t80 -144.02 138.2 28.2 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.744 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HA ' HD23 ' A' ' 56' ' ' LEU . 12.7 ttp-105 -71.06 133.38 46.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.711 0.291 . . . . 63.020000000000003 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.527 ' NE2' HG23 ' A' ' 57' ' ' THR . 1.2 mt-30 -109.39 109.73 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 71.239999999999995 110.467 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.98 -43.46 11.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.045 -0.724 . . . . 75.510000000000005 109.045 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -90.83 122.18 33.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.916 -1.038 . . . . 41.450000000000003 110.34 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 55' ' ' LEU . 58.6 tttm -70.9 128.08 34.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.337 0.589 . . . . 60.520000000000003 111.385 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.74 132.65 59.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.972 -1.013 . . . . 51.420000000000002 110.541 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -56.35 -59.48 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 65.329999999999998 110.337 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.734 ' HG3' HG21 ' A' ' 82' ' ' VAL . 27.8 mm-40 58.33 32.64 22.31 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.397 -0.82 . . . . 73.129999999999995 113.192 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.529 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 39.9 p 49.38 171.62 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 113.079 0.77 . . . . 53.229999999999997 113.079 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 36.9 Cg_exo -61.51 158.33 37.01 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.146 2.564 . . . . 65.450000000000003 113.295 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 96' ' ' SER . 20.7 p -58.75 124.71 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.843 -0.617 . . . . 72.519999999999996 111.398 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.17 121.82 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 73.519999999999996 111.243 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -73.42 147.36 44.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.597 -0.729 . . . . 73.010000000000005 112.27 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.569 ' CA ' ' HB3' ' A' ' 99' ' ' ASP . 10.9 t-20 -55.11 -35.01 64.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.03 -0.532 . . . . 64.340000000000003 111.962 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.8 t -67.06 21.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.622 0.248 . . . . 65.319999999999993 111.483 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 133' ' ' ASN . 10.1 t -62.52 113.29 2.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.393 0.616 . . . . 63.130000000000003 111.089 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 41.8 ttt85 -89.08 173.21 8.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.849 . . . . 74.530000000000001 110.96 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 77.4 m -34.08 143.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.109 -0.496 . . . . 55.450000000000003 111.546 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.11 3.9 19.01 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.133 -0.556 . . . . 75.319999999999993 112.213 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -160.01 29.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.959 0.409 . . . . 74.5 110.775 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.278 0.561 . . . . 70.209999999999994 110.277 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -67.95 44.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.283 -0.872 . . . . 53.229999999999997 112.799 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 4.0 t80 -109.38 90.35 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.822 -0.436 . . . . 71.219999999999999 109.822 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.09 112.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 53.32 111.049 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 147' ' ' PHE . . . -57.63 -32.9 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.203 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -50.41 -32.71 18.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.384 -0.371 . . . . 63.439999999999998 111.07 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -56.12 -34.51 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.104 0.478 . . . . 71.430000000000007 110.284 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.4 m-85 -49.76 -38.11 32.52 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.559 0.695 . . . . 75.209999999999994 109.687 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.47 91.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.221 -0.899 . . . . 64.120000000000005 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.39 -48.34 42.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 65.219999999999999 111.949 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -59.01 -41.12 86.93 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.167 0.432 . . . . 74.420000000000002 112.167 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 9.6 t-80 -109.25 5.52 23.8 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.01 -0.676 . . . . 74.420000000000002 111.533 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 63.46 34.64 90.49 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.888 -0.673 . . . . 51.119999999999997 113.982 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 155' ' ' GLU . 11.3 mt -69.69 16.33 0.06 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.517 -0.402 . . . . 61.109999999999999 111.016 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -55.74 1.66 0.07 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 114.241 0.457 . . . . 71.530000000000001 114.241 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 153' ' ' LEU . 4.9 pt-20 -135.11 72.66 66.73 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.258 0.551 . . . . 65.140000000000001 110.154 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 31.9 Cg_exo -57.03 129.37 34.12 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.452 2.102 . . . . 70.299999999999997 112.131 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 118' ' ' LEU . 21.1 pt -79.9 -38.18 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.495 -0.557 . . . . 74.450000000000003 109.495 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.31 148.64 32.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 110.877 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -150.68 157.74 43.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.982 0.42 . . . . 70.239999999999995 111.568 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 28' ' ' LYS . 1.8 t-20 -157.19 145.07 19.09 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.415 -0.958 . . . . 54.420000000000002 108.415 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.562 ' CB ' HD13 ' A' ' 115' ' ' ILE . 17.9 p90 -155.03 157.46 37.64 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.759 -0.588 . . . . 75.150000000000006 111.945 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.751 ' CD2' HG11 ' A' ' 27' ' ' VAL . 5.6 p90 -153.54 163.78 39.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.613 -0.721 . . . . 65.209999999999994 111.24 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 44.5 mt-30 -122.53 124.89 44.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 62.210000000000001 110.469 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.14 152.11 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 75.319999999999993 112.411 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.458 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 8.2 pm0 -127.18 148.1 50.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.346 -0.983 . . . . 42.240000000000002 108.346 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -137.38 152.69 49.94 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.02 0.378 . . . . 75.140000000000001 112.02 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.5 m-20 -54.93 163.34 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.765 -0.652 . . . . 74.140000000000001 111.865 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.522 ' HA ' ' HG2' ' A' ' 171' ' ' PRO . 6.3 t0 -68.03 27.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.689 -0.687 . . . . 74.239999999999995 111.3 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 167' ' ' ASP . 21.2 t80 -82.28 -60.86 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.74 0.644 . . . . 74.329999999999998 112.74 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 14.6 p -62.14 -32.09 9.05 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 113.337 0.866 . . . . 64.549999999999997 113.337 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 81.7 Cg_exo -47.97 -30.02 13.03 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.74 1.626 . . . . 74.310000000000002 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.3 mm -49.35 -37.77 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.68 -0.691 . . . . 75.099999999999994 109.401 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -45.87 -42.79 12.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.471 -0.786 . . . . 71.310000000000002 109.953 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.495 ' HA ' HG12 ' A' ' 177' ' ' ILE . 35.7 m120 -58.28 -39.4 79.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 61.25 111.465 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.54 -28.25 63.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 72.25 110.492 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 178' ' ' VAL . 42.5 m -84.61 -4.13 58.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.954 -0.566 . . . . 63.100000000000001 112.335 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.528 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 33.0 mm -62.11 99.14 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.088 0.47 . . . . 73.140000000000001 111.006 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 176' ' ' THR . 61.6 t -100.83 -6.94 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.588 -0.733 . . . . 73.530000000000001 112.491 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.482 -1.177 . . . . 61.43 112.42 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.523 -0.071 0 N-CA-C 109.302 -0.629 . . . . 73.230000000000004 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 64.3 t0 -89.63 -70.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.571 . . . . 65.420000000000002 112.38 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.874 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.9 OUTLIER -127.8 58.94 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.389 0.614 . . . . 64.349999999999994 111.02 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.3 p -130.07 139.48 35.78 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 72.349999999999994 109.947 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.7 Cg_endo -85.57 35.13 3.64 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.139 -1.192 . . . . 74.239999999999995 113.113 0.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.874 ' HB3' HG22 ' A' ' 4' ' ' ILE . 8.8 t70 -62.67 -49.92 73.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.952 0.406 . . . . 73.340000000000003 110.42 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -163.65 -44.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.912 -0.586 . . . . 60.009999999999998 110.927 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' ILE . 29.2 tp -157.25 137.84 13.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.439999999999998 110.797 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.429 ' H ' HD12 ' A' ' 9' ' ' LEU . 2.8 p30 -66.56 13.93 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.364 0.505 . . . . 55.5 112.364 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -171.2 137.52 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.319 0.247 . . . . 75.030000000000001 110.643 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -72.67 112.24 14.32 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.796 0.331 . . . . 63.340000000000003 111.698 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -88.7 134.52 2.77 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.893 2.396 . . . . 65.439999999999998 112.761 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.52 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.461 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.82 -159.05 7.98 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.757 -0.656 . . . . 51.219999999999999 111.77 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -135.9 162.94 31.43 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.178 0.513 . . . . 43.130000000000003 111.31 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 44' ' ' VAL . 10.2 mt -105.31 135.17 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 70.219999999999999 110.484 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 30.9 mmmt -74.56 106.05 5.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.686 -0.688 . . . . 71.400000000000006 109.683 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 60.1 t -121.58 110.45 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.747 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.702 HG21 ' O ' ' A' ' 23' ' ' ASP . 3.0 mp -96.01 134.63 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.216 -0.902 . . . . 63.420000000000002 109.465 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -81.67 -85.34 0.1 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.67 -0.412 . . . . 71.319999999999993 111.782 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -67.58 -49.84 47.47 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.35 -0.928 . . . . 70.230000000000004 112.447 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.702 ' O ' HG21 ' A' ' 20' ' ' ILE . 34.9 t70 172.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.716 0.769 . . . . 74.150000000000006 109.019 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.58 -49.72 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.741 -1.118 . . . . 72.409999999999997 110.522 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.1 pt? -69.66 139.57 53.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.3 0.572 . . . . 55.310000000000002 111.581 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 27' ' ' VAL . 69.5 tt0 -120.82 150.01 41.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.267 -0.879 . . . . 64.409999999999997 111.857 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 10.5 m -98.7 119.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.85 -0.796 . . . . 74.140000000000001 108.85 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HD2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -139.08 128.58 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.757 0.789 . . . . 74.430000000000007 112.7 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.565 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.9 mp0 46.41 63.15 1.99 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.035 -1.438 . . . . 72.519999999999996 114.854 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 11.39 44.63 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 115.739 1.056 . . . . 74.310000000000002 115.739 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.24 139.48 35.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.779 0.789 . . . . 50.350000000000001 110.701 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.92 123.02 29.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.726 -0.472 . . . . 74.319999999999993 109.726 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 27' ' ' VAL . 9.9 mp -92.75 114.21 26.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.735 -0.386 . . . . 52.219999999999999 110.741 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -150.12 156.96 37.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 62.32 110.488 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.23 -100.4 0.0 OUTLIER 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.156 -1.185 . . . . 74.329999999999998 113.869 0.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -70.2 54.35 0.14 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.653 0.612 . . . . 74.420000000000002 112.653 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.0 pt20 -120.39 -6.32 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.98 0.419 . . . . 70.299999999999997 110.983 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.36 -6.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.12 -0.491 . . . . 74.439999999999998 111.911 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 -10.57 59.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.49 -0.323 . . . . 65.129999999999995 111.79 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 21' ' ' TYR . 87.3 m-20 -79.07 144.76 34.29 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.162 0.506 . . . . 54.340000000000003 112.193 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -76.31 138.47 67.93 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.697 -0.683 . . . . 64.099999999999994 109.878 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -78.88 126.88 7.46 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.319 2.013 . . . . 60.340000000000003 113.215 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.6 mm -104.25 105.93 19.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.015 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 17' ' ' ILE . 2.6 p -87.14 143.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 113.234 0.827 . . . . 62.450000000000003 113.234 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.9 m -162.24 132.55 4.77 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.023 0.44 . . . . 65.540000000000006 110.965 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.717 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -112.34 26.92 10.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.023 -0.535 . . . . 75.420000000000002 110.399 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 t -41.41 123.35 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 61.530000000000001 111.644 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.89 -29.64 7.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.06 -0.591 . . . . 73.409999999999997 113.28 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.15 -31.19 58.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.145 0.472 . . . . 70.409999999999997 111.336 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.717 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -70.48 -65.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.858 -0.61 . . . . 72.239999999999995 110.922 -179.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 65.76 -75.88 0.11 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.737 -0.665 . . . . 63.030000000000001 112.499 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -148.71 110.08 4.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 63.210000000000001 111.492 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -151.4 145.01 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.645 . . . . 65.219999999999999 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 8.8 t-20 -65.75 -39.5 91.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.775 0.798 . . . . 50.009999999999998 109.369 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 83' ' ' ASN . 46.2 mt -158.48 162.17 37.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.522 -1.217 . . . . 73.140000000000001 110.06 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 81.5 mt -128.85 142.48 50.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.774 0.321 . . . . 75.030000000000001 110.393 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.765 HG23 ' CG1' ' A' ' 82' ' ' VAL . 56.1 m -113.63 118.14 33.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 111.245 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.8 tm? -116.36 140.29 49.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.73 -0.47 . . . . 73.219999999999999 109.73 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 58' ' ' LEU . 89.5 mt -141.89 154.85 45.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.373 . . . . 70.129999999999995 111.207 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.442 ' HB3' ' HB3' ' A' ' 78' ' ' HIS . 23.5 ttt -117.63 124.38 48.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.674 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 40.7 t -108.96 132.74 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 109.778 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 7.9 t70 -176.94 62.07 0.19 Allowed Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.408 -0.96 . . . . 72.109999999999999 108.408 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD3' HG12 ' A' ' 61' ' ' VAL . 22.4 Cg_endo -91.59 83.39 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.692 1.595 . . . . 55.450000000000003 114.073 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -171.13 107.93 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.279 -0.873 . . . . 73.439999999999998 110.796 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.729 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.07 135.58 1.24 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 121.127 -0.229 . . . . 75.530000000000001 111.299 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.729 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 Cg_endo -52.28 -15.28 0.44 Allowed 'Cis proline' 0 C--N 1.356 0.957 0 C-N-CA 124.32 -1.116 . . . . 64.400000000000006 111.946 -2.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.521 ' N ' ' HA ' ' A' ' 65' ' ' ALA . 6.7 t -165.15 -175.89 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.505 -0.77 . . . . 74.450000000000003 110.003 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 64' ' ' ASP . 13.7 tpt180 -67.73 -34.9 77.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.03 0.443 . . . . 75.519999999999996 109.838 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -71.0 -45.21 64.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.506 -0.77 . . . . 65.010000000000005 112.957 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 67' ' ' THR . 49.0 t0 -108.8 103.15 50.92 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.628 -0.429 . . . . 73.340000000000003 111.11 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.22 52.92 2.99 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.66 2.24 . . . . 75.540000000000006 110.865 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -48.57 -31.48 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.909 -0.587 . . . . 73.329999999999998 110.287 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -166.47 56.17 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.328 -0.851 . . . . 71.239999999999995 109.736 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' C ' ' HD2' ' A' ' 74' ' ' ARG . 4.9 tmm_? -99.26 135.27 40.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.911 -1.495 . . . . 72.439999999999998 109.417 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 21.6 mp0 -76.15 177.81 6.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.711 0.804 . . . . 72.319999999999993 111.9 0.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.4 tp -109.75 -173.55 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.822 -1.177 . . . . 64.340000000000003 107.822 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.562 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.8 mt -64.99 120.37 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.078 0.399 . . . . 65.340000000000003 110.917 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' MET . 36.5 m170 -107.78 169.24 8.72 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.102 -0.239 . . . . 74.299999999999997 110.724 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.6 t-105 -100.01 85.27 3.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.741 0.782 . . . . 61.130000000000003 110.215 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -98.99 127.21 44.86 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.784 -1.098 . . . . 62.32 112.704 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -147.91 124.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.553 -0.748 . . . . 62.439999999999998 109.115 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.765 ' CG1' HG23 ' A' ' 57' ' ' THR . 23.6 m -138.13 -176.5 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.012 0.434 . . . . 70.400000000000006 111.732 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 55' ' ' LEU . 15.6 p30 52.13 37.26 21.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.962 -1.017 . . . . 74.400000000000006 109.518 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.032 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm -78.93 106.56 4.52 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 114.891 -1.05 . . . . 73.200000000000003 108.737 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 87' ' ' SER . 2.3 Cg_endo -48.13 129.04 17.95 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.759 1.64 . . . . 73.420000000000002 111.788 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.3 69.67 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 O-C-N 123.412 0.445 . . . . 63.350000000000001 113.823 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' PRO . 44.0 t 179.81 47.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.378 -0.601 . . . . 73.409999999999997 109.378 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 90' ' ' ASN . 17.2 m120 -135.16 -22.39 1.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.173 -0.921 . . . . 61.299999999999997 112.309 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 67.86 -15.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.869 0.322 . . . . 73.0 111.869 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 88' ' ' ASN . 5.3 p30 -153.84 156.45 32.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 109.666 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' ILE . 74.3 Cg_endo -70.54 56.67 1.75 Allowed 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.334 2.689 . . . . 64.510000000000005 113.975 -178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -104.15 -40.08 6.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.503 . . . . 73.230000000000004 112.02 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.43 -41.56 58.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.887 0.715 . . . . 45.240000000000002 114.887 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 1.032 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.07 170.35 14.71 Favored Glycine 0 N--CA 1.46 0.287 0 C-N-CA 120.993 -0.622 . . . . 63.439999999999998 113.179 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.484 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.14 121.28 18.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.876 -0.19 . . . . 75.150000000000006 111.296 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.705 ' HA ' HG13 ' A' ' 81' ' ' VAL . 95.8 p -82.09 116.22 21.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.837 -1.172 . . . . 52.219999999999999 107.837 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' HG3' ' A' ' 127' ' ' GLU . 11.2 mt -67.36 -55.01 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 72.140000000000001 109.968 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 131' ' ' ILE . . . -137.03 125.05 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.293 -0.867 . . . . 61.020000000000003 109.146 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 9.9 t0 -52.17 148.57 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.86 0.362 . . . . 45.329999999999998 111.318 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 37.6 p90 -65.03 128.74 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.261 0.553 . . . . 73.230000000000004 111.071 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.9 p -106.38 113.79 43.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.472 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.81 6.97 23.14 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.679 -0.772 . . . . 50.119999999999997 112.25 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 101' ' ' VAL . 38.2 t -59.98 -97.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.02 0.378 . . . . 75.109999999999999 112.02 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.24 161.88 37.82 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.928 -0.653 . . . . 52.210000000000001 112.254 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HB2' ' CE1' ' A' ' 112' ' ' HIS . 31.8 Cg_exo -60.72 137.59 74.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.932 2.421 . . . . 62.509999999999998 112.565 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 41.0 Cg_endo -66.76 161.26 42.73 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.727 2.285 . . . . 73.230000000000004 113.211 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -42.36 -23.28 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 112.026 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.2 m-20 -50.8 -35.4 31.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.514 -0.312 . . . . 74.099999999999994 111.582 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 12.4 t -103.75 8.8 37.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.335 -0.546 . . . . 63.049999999999997 110.968 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.488 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 54.45 -110.96 1.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 113.751 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 27.6 tp -63.83 162.38 13.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.437 0.637 . . . . 61.119999999999997 111.899 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 8.2 m-70 -147.04 144.62 29.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 72.319999999999993 109.303 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -109.05 108.65 19.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.022 -0.362 . . . . 73.209999999999994 110.022 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -104.55 133.31 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.523 -0.547 . . . . 74.450000000000003 109.523 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 9' ' ' LEU . 26.8 mt -132.96 147.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.192 0.52 . . . . 43.420000000000002 111.54 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -120.84 134.31 55.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.237 -0.892 . . . . 73.319999999999993 109.395 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 156' ' ' PRO . 18.5 tp -119.9 140.15 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.144 0.277 . . . . 64.430000000000007 110.475 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 158' ' ' ALA . 62.6 tp -134.79 135.49 41.84 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.39 -0.368 . . . . 63.43 111.09 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HA ' HG12 ' A' ' 157' ' ' ILE . 37.7 t80 -144.25 142.85 30.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 75.319999999999993 110.553 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.848 ' HG3' HD13 ' A' ' 157' ' ' ILE . 98.2 mtt180 -71.47 128.33 35.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 110.626 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 56.8 tp60 -103.91 115.15 29.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.534 -0.757 . . . . 73.040000000000006 110.437 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.04 -37.98 16.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.413 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -112.19 135.12 53.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.701 0.286 . . . . 33.329999999999998 111.253 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 26.2 tptp -65.42 119.33 10.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.928 -0.578 . . . . 62.340000000000003 111.471 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.73 131.89 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 75.099999999999994 109.754 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.16 -57.89 5.91 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 63.439999999999998 110.906 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.573 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 66.11 13.0 8.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.84 1.052 . . . . 72.430000000000007 113.84 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 25.2 p 51.21 162.98 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.613 0.968 . . . . 74.010000000000005 113.613 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 18.6 Cg_endo -58.24 151.4 60.07 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.88 2.387 . . . . 54.039999999999999 112.974 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 131' ' ' ILE . 89.1 m -60.0 151.3 26.65 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.008 0.744 . . . . 74.319999999999993 113.008 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.425 ' N ' HG22 ' A' ' 130' ' ' THR . 40.8 mm -121.93 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.802 -1.09 . . . . 72.019999999999996 109.595 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' THR . 27.6 t -71.12 148.31 47.56 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.643 0.258 . . . . 71.010000000000005 111.528 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.515 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 24.9 p30 -65.4 5.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.156 0.503 . . . . 75.439999999999998 110.348 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 132' ' ' SER . 64.5 p -114.26 15.19 18.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.497 -0.774 . . . . 51.450000000000003 111.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -62.82 133.91 55.44 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.555 -0.458 . . . . 45.210000000000001 110.698 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' A' ' 137' ' ' THR . 22.4 tpp180 -71.83 170.99 12.48 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.34 -0.391 . . . . 75.310000000000002 110.668 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 66.2 m -40.57 145.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.619 . . . . 43.439999999999998 110.231 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.33 -22.04 11.42 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.993 -0.843 . . . . 74.25 110.993 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -131.21 24.16 4.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 74.510000000000005 110.113 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 177' ' ' ILE . 37.2 mt -94.07 -56.37 2.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.53 0.681 . . . . 73.450000000000003 109.501 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' GLU . 37.1 m-20 -79.55 121.36 25.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 71.230000000000004 111.66 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' HE2' ' CZ ' ' A' ' 147' ' ' PHE . 5.7 t80 -167.79 115.87 0.76 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.938 -1.028 . . . . 74.530000000000001 109.993 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -71.44 110.65 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.736 -0.666 . . . . 44.149999999999999 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.65 -28.88 57.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.401 0.62 . . . . 73.129999999999995 110.073 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -52.63 -23.54 6.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 111.001 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.41 -46.94 81.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.878 0.37 . . . . 72.109999999999999 111.248 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.537 ' HA ' ' CD ' ' A' ' 150' ' ' LYS . 76.1 m-85 -45.33 -49.15 13.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.114 -0.494 . . . . 74.25 111.847 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.21 51.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.912 -0.586 . . . . 35.229999999999997 111.073 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.07 -51.85 6.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.306 0.484 . . . . 64.349999999999994 112.306 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -53.68 -50.55 65.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 73.510000000000005 111.817 -178.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 153' ' ' LEU . 33.7 m-70 -103.63 11.38 36.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.692 0.282 . . . . 75.510000000000005 111.494 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 53.26 28.93 36.12 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.619 -0.8 . . . . 73.329999999999998 112.722 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 11.6 mt -67.6 7.44 0.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.904 0.335 . . . . 75.120000000000005 111.904 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 153' ' ' LEU . . . -30.23 -59.96 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.375 -0.44 . . . . 40.409999999999997 113.836 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.31 112.69 19.88 Favored Pre-proline 0 N--CA 1.465 0.284 0 N-CA-C 111.631 0.234 . . . . 73.239999999999995 111.631 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 117' ' ' LEU . 69.7 Cg_endo -92.15 127.32 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.536 2.157 . . . . 73.109999999999999 112.888 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.848 HD13 ' HG3' ' A' ' 120' ' ' ARG . 42.9 pt -75.98 -34.65 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 70.25 110.452 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.599 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.14 149.7 26.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 51.43 111.246 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' CB ' ' CD2' ' A' ' 9' ' ' LEU . . . -151.49 154.41 36.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.804 -0.635 . . . . 74.409999999999997 110.081 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -152.46 133.61 14.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.245 -1.02 . . . . 71.430000000000007 108.245 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 115' ' ' ILE . 2.1 p90 -138.71 156.08 47.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.457 -0.338 . . . . 75.310000000000002 111.486 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.526 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 p90 -154.34 150.42 27.93 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 111.363 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -110.98 133.1 53.66 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.905 -0.589 . . . . 71.319999999999993 111.179 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.71 149.44 25.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.249 -0.887 . . . . 71.420000000000002 109.852 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -103.34 132.9 49.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.562 -0.533 . . . . 63.130000000000003 109.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.29 129.18 55.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.657 0.265 . . . . 64.319999999999993 110.768 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -62.29 -125.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.59 . . . . 71.340000000000003 111.942 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.618 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 22.7 t0 -129.77 -20.63 3.17 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.882 -0.599 . . . . 65.510000000000005 111.281 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.533 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 17.9 t80 -68.32 -69.22 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.142 0.793 . . . . 75.109999999999999 113.142 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 171' ' ' PRO . 7.5 p -50.01 -37.36 25.9 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 111.996 0.369 . . . . 74.430000000000007 111.996 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 170' ' ' VAL . 50.2 Cg_exo -54.03 -12.25 3.38 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.512 2.141 . . . . 73.329999999999998 111.688 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 175' ' ' LYS . 8.8 tp -45.77 -30.57 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.662 -0.699 . . . . 63.409999999999997 111.842 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -53.19 -46.76 69.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 119.906 -0.718 . . . . 71.030000000000001 109.513 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.424 ' HA ' HG13 ' A' ' 177' ' ' ILE . 44.6 t30 -63.83 -37.12 86.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.316 -0.624 . . . . 75.450000000000003 109.316 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.647 ' HB2' HD12 ' A' ' 172' ' ' ILE . 61.2 mttp -68.67 -27.97 66.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.576 -0.738 . . . . 71.450000000000003 110.18 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 176' ' ' THR . 18.9 m -97.1 13.1 30.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.929 -0.578 . . . . 74.230000000000004 112.524 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 31.6 mt -64.95 140.86 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 64.439999999999998 109.382 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.515 ' HA ' ' NH2' ' A' ' 136' ' ' ARG . 29.3 m -143.17 -25.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.72 1.007 . . . . 62.329999999999998 113.72 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.451 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.317 -1.269 . . . . 73.25 112.728 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.336 0.588 . . . . 73.439999999999998 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.7 t70 -67.47 -48.09 68.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 73.209999999999994 111.513 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.4 pt -114.95 44.7 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.245 0.545 . . . . 54.409999999999997 111.845 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.9 137.74 20.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.994 -0.548 . . . . 40.030000000000001 111.013 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -93.55 32.92 10.11 Favored 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.129 -1.196 . . . . 74.310000000000002 112.113 -0.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 t70 -51.45 -51.58 53.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 55.140000000000001 110.563 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.2 m -160.32 -35.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 72.420000000000002 111.706 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' CD1' HG21 ' A' ' 115' ' ' ILE . 27.6 tp -157.25 172.39 18.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 74.099999999999994 111.056 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 3' ' ' ASP . 9.4 p-10 -78.3 -38.04 43.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.089 -0.708 . . . . 72.200000000000003 109.089 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.475 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -152.55 131.65 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.611 -0.722 . . . . 71.319999999999993 109.905 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 7.2 p -59.82 126.4 83.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.134 0.42 . . . . 64.310000000000002 112.134 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.643 ' HG3' ' HB3' ' A' ' 159' ' ' ALA . 71.6 Cg_endo -96.22 -117.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.758 2.972 . . . . 74.239999999999995 111.9 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -166.46 -42.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.607 -0.269 . . . . 72.510000000000005 111.33 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 158.36 17.98 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.778 -0.725 . . . . 60.200000000000003 113.575 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.467 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.1 t -102.83 152.17 21.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.011 0.434 . . . . 64.310000000000002 110.48 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 118' ' ' LEU . 9.2 mt -105.73 123.4 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.962 -0.755 . . . . 74.129999999999995 108.962 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.3 OUTLIER -73.98 102.57 4.18 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.455 -0.793 . . . . 72.140000000000001 109.581 -178.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 27' ' ' VAL . 59.2 t -111.0 110.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 2.6 mp -104.54 128.5 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.794 -0.639 . . . . 73.420000000000002 111.302 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -96.64 -84.93 0.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.159 -0.928 . . . . 65.230000000000004 110.867 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -59.69 3.15 0.27 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.594 -0.73 . . . . 62.32 113.274 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER 85.37 -43.96 0.06 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.896 -1.149 . . . . 74.230000000000004 107.896 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.76 -37.39 19.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.999 -1.0 . . . . 72.140000000000001 108.712 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.31 163.14 25.14 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.215 -0.902 . . . . 74.049999999999997 112.496 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 23.2 tt0 -151.7 127.75 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.758 -1.11 . . . . 64.140000000000001 110.288 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.875 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.3 m -71.64 128.18 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.322 0.582 . . . . 63.530000000000001 111.711 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 73.4 mmtt -112.59 111.37 22.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.518 0.932 . . . . 72.140000000000001 113.518 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.446 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.6 mp0 31.06 67.54 0.13 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.804 1.409 . . . . 70.200000000000003 114.804 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.69 4.58 89.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.343 -0.456 . . . . 74.140000000000001 113.448 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -55.57 146.76 19.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.311 0.577 . . . . 63.119999999999997 112.297 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.37 140.85 32.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.98 -1.009 . . . . 72.340000000000003 111.191 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 38' ' ' VAL . 7.5 mp -106.27 132.4 52.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 71.209999999999994 110.761 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 8.8 p -140.66 161.72 52.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 109.849 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 83.8 Cg_endo -82.09 -33.16 3.12 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 124.142 -1.191 . . . . 65.25 113.404 0.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 36' ' ' THR . 85.1 m -156.65 42.92 0.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.285 0.564 . . . . 51.399999999999999 111.462 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.583 ' OE1' HD12 ' A' ' 25' ' ' LEU . 23.5 pt20 -92.76 0.23 57.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.413 0.625 . . . . 73.510000000000005 110.797 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 33' ' ' LEU . 28.0 m -68.65 -7.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.479 -0.782 . . . . 71.200000000000003 111.284 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -11.32 60.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.145 -0.479 . . . . 43.130000000000003 110.608 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.35 133.3 35.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 62.119999999999997 111.434 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -62.9 138.69 97.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 60.109999999999999 110.087 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.16 126.51 13.13 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 121.8 1.666 . . . . 74.129999999999995 112.516 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.5 mm -100.77 114.73 40.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 60.439999999999998 110.288 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.8 p -85.54 140.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.399 0.518 . . . . 72.120000000000005 112.399 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 14.4 m -161.98 139.21 8.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.952 0.406 . . . . 71.040000000000006 110.347 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.4 p90 -121.68 29.8 7.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 74.239999999999995 110.352 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.7 t -44.94 137.15 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 65.420000000000002 110.225 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.19 -32.51 3.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.654 -0.784 . . . . 63.450000000000003 112.239 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 16' ' ' THR . 96.2 mt -79.5 -41.29 27.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.708 0.766 . . . . 64.239999999999995 109.094 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.658 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.0 tt0 -53.52 105.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.698 -1.137 . . . . 73.230000000000004 110.558 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.3 -114.86 1.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.1 -1.2 . . . . 71.349999999999994 110.1 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -80.56 109.19 14.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.635 -0.826 . . . . 54.439999999999998 109.373 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.78 141.79 15.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.444 -0.344 . . . . 62.420000000000002 111.532 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 25.5 t-20 -89.26 -42.19 11.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.791 0.805 . . . . 74.109999999999999 109.583 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 76.9 mt -152.36 170.0 21.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.686 -1.143 . . . . 70.340000000000003 108.595 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.4 mt -138.38 153.15 48.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.466 -0.494 . . . . 64.120000000000005 111.764 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.875 HG23 HG12 ' A' ' 82' ' ' VAL . 31.5 m -121.42 130.62 53.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.743 -0.662 . . . . 74.109999999999999 110.215 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -128.87 123.91 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.253 -0.647 . . . . 71.239999999999995 109.253 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.578 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.6 mt -143.16 161.78 37.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 74.049999999999997 113.017 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.89 146.69 24.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.203 -1.362 . . . . 73.120000000000005 109.974 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 76.8 t -134.09 137.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.288 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' HH21 ' A' ' 68' ' ' ARG . 52.5 t0 83.32 59.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 114.945 -1.025 . . . . 71.439999999999998 111.52 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 57.4 Cg_endo -71.28 123.01 9.21 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.509 2.14 . . . . 75.239999999999995 111.9 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 25.8 p-10 -118.36 120.76 38.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.68 0.622 . . . . 74.209999999999994 112.68 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.742 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -170.65 135.98 1.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.434 0.531 . . . . 70.450000000000003 112.434 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 55.3 Cg_endo -74.2 -3.75 17.53 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.217 -1.576 . . . . 75.109999999999999 109.794 -2.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.8 t -165.01 156.72 15.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.967 -1.015 . . . . 44.340000000000003 110.373 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' HG2' ' CB ' ' A' ' 64' ' ' ASP . 6.5 mtp-105 -68.33 -12.74 61.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.812 -0.631 . . . . 74.310000000000002 110.951 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.32 -32.94 24.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.889 -0.596 . . . . 61.039999999999999 112.252 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -144.08 116.13 5.6 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-O 120.713 0.292 . . . . 43.409999999999997 110.471 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.09 52.5 4.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.039 2.493 . . . . 72.209999999999994 112.302 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 95.9 mttt -48.93 -27.29 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 75.099999999999994 111.637 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.742 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 25.3 p90 -155.55 29.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.299 0.571 . . . . 74.340000000000003 110.781 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 5.7 tmm_? -70.52 136.13 49.12 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.144 -1.058 . . . . 71.099999999999994 108.144 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 14.2 mp0 -88.61 159.09 18.04 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.236 1.014 . . . . 73.439999999999998 111.873 0.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' A' ' 73' ' ' TYR . 9.1 tp -97.37 171.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.442 -0.799 . . . . 74.109999999999999 109.696 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' CD2' HG11 ' A' ' 101' ' ' VAL . 13.9 tp -42.72 112.89 0.4 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.553 0.692 . . . . 64.310000000000002 110.297 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.22 160.28 15.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.572 -1.195 . . . . 61.140000000000001 113.285 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 10.5 t-105 -100.43 116.19 31.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.579 -1.267 . . . . 73.200000000000003 107.579 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.04 135.4 31.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.229 0.825 . . . . 72.219999999999999 113.229 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -140.66 138.5 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.58 -0.737 . . . . 70.420000000000002 110.893 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.875 HG12 HG23 ' A' ' 57' ' ' THR . 26.2 m -142.05 169.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.603 . . . . 72.239999999999995 112.44 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 24.8 p30 51.82 36.18 17.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.562 -1.199 . . . . 72.219999999999999 112.132 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.99 HG21 ' HA ' ' A' ' 91' ' ' PRO . 5.1 mm -69.02 125.81 92.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.715 -0.846 . . . . 64.319999999999993 108.715 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 87' ' ' SER . 34.0 Cg_exo -58.75 126.28 20.75 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 121.429 1.419 . . . . 74.329999999999998 110.902 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.81 60.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.321 0.488 . . . . 54.039999999999999 114.321 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 85' ' ' PRO . 75.1 m -174.97 43.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.935 0.494 . . . . 55.039999999999999 110.255 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.598 ' C ' ' H ' ' A' ' 90' ' ' ASN . 34.1 m120 -135.31 8.94 3.44 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.528 0.936 . . . . 65.530000000000001 113.528 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER 64.65 -26.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.062 0.393 . . . . 74.010000000000005 112.062 177.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.598 ' H ' ' C ' ' A' ' 88' ' ' ASN . 14.8 p30 -154.05 172.63 5.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.187 0.595 . . . . 73.310000000000002 109.932 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.99 ' HA ' HG21 ' A' ' 84' ' ' ILE . 6.1 Cg_exo -79.74 23.9 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.643 2.896 . . . . 51.539999999999999 115.529 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -79.63 1.11 27.39 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.856 -1.138 . . . . 53.509999999999998 112.985 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.11 2.1 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.495 -0.86 . . . . 34.310000000000002 113.609 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.929 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.7 176.49 10.98 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.229 -0.51 . . . . 45.310000000000002 113.669 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.782 ' CE1' HG23 ' A' ' 130' ' ' THR . 46.2 t60 -66.36 121.12 14.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.389 0.514 . . . . 73.019999999999996 112.389 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.1 p -86.26 89.32 7.81 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.924 -0.769 . . . . 64.439999999999998 108.924 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 147' ' ' PHE . 12.4 mt -50.28 -53.83 25.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 64.439999999999998 110.484 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.66 120.38 13.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.958 -1.019 . . . . 62.32 108.714 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.51 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 54.5 t0 -60.21 146.82 42.2 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.6 0.563 . . . . 74.109999999999999 112.084 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.511 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 21.2 p90 -66.38 142.82 57.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.892 -0.595 . . . . 74.430000000000007 110.295 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 133' ' ' ASN . 21.4 m -140.38 145.03 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.696 0.284 . . . . 75.5 111.528 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.512 ' O ' HG12 ' A' ' 170' ' ' VAL . . . -85.03 0.07 89.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.925 -0.655 . . . . 51.229999999999997 111.642 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 t -58.93 -91.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.561 -0.319 . . . . 70.109999999999999 110.604 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 -167.99 5.03 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.909 -0.662 . . . . 74.420000000000002 114.224 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HG2' ' NE2' ' A' ' 112' ' ' HIS . 44.8 Cg_endo -65.74 145.5 81.28 Favored 'Trans proline' 0 N--CA 1.476 0.477 0 C-N-CA 123.67 2.913 . . . . 72.299999999999997 113.107 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.58 160.68 48.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.066 2.51 . . . . 71.540000000000006 113.332 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 167' ' ' ASP . 35.8 ttmt -44.03 -25.09 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.092 -0.504 . . . . 73.150000000000006 111.055 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.46 -37.87 40.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 63.119999999999997 111.422 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.4 t -76.4 -19.44 58.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.525 -0.47 . . . . 73.120000000000005 111.839 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.92 -129.8 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.599 -0.81 . . . . 61.450000000000003 113.32 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 44.7 tp -67.49 135.28 52.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.01 0.744 . . . . 75.239999999999995 113.01 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.498 ' NE2' ' HG2' ' A' ' 105' ' ' PRO . 22.6 m80 -108.71 142.87 38.59 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.511 -0.768 . . . . 64.129999999999995 108.947 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.647 HH12 ' NE2' ' A' ' 163' ' ' GLN . 5.5 ptm85 -130.38 84.5 2.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.145 -0.687 . . . . 54.310000000000002 109.145 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.11 136.28 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.476 -0.784 . . . . 63.219999999999999 111.995 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 ' HD1' ' A' ' 161' ' ' TYR . 48.5 mt -113.99 137.02 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.753 -1.112 . . . . 74.430000000000007 111.034 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -99.91 141.97 32.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.132 -0.485 . . . . 64.150000000000006 110.294 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -128.24 129.74 46.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.544 -0.298 . . . . 74.209999999999994 110.447 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.832 ' HB2' HD11 ' A' ' 17' ' ' ILE . 2.7 tt -126.44 134.31 51.0 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.257 -0.428 . . . . 75.140000000000001 110.613 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 118' ' ' LEU . 49.9 t80 -144.01 148.52 35.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.913 0.387 . . . . 73.519999999999996 111.408 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HA ' HD23 ' A' ' 56' ' ' LEU . 54.1 ttp180 -83.43 134.68 34.86 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.628 -0.508 . . . . 75.230000000000004 109.628 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 9.9 tp60 -118.06 139.15 51.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.708 -0.224 . . . . 65.310000000000002 110.457 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -110.5 -34.79 6.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.415 -0.357 . . . . 71.420000000000002 110.96 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.09 130.4 43.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 74.019999999999996 111.107 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 23.3 tptm -73.08 143.04 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 70.219999999999999 110.566 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.433 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.9 OUTLIER -141.29 144.55 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 50.32 111.732 -179.14 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -86.73 -31.09 21.15 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.86 0.725 . . . . 70.340000000000003 109.733 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' ND2' ' A' ' 83' ' ' ASN . 0.4 OUTLIER 29.17 56.33 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.39 -1.277 . . . . 75.040000000000006 113.712 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.466 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 51.8 p 60.96 138.2 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 114.585 1.328 . . . . 75.120000000000005 114.585 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.03 158.24 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.996 3.131 . . . . 54.140000000000001 113.764 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.782 HG23 ' CE1' ' A' ' 95' ' ' HIS . 18.5 p -62.18 138.88 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.428 -0.805 . . . . 44.219999999999999 113.067 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.82 129.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.03 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 t -72.33 153.19 41.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.985 0.735 . . . . 70.540000000000006 112.985 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.852 ' HB2' HG12 ' A' ' 101' ' ' VAL . 17.3 p30 -57.92 -26.58 62.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.158 -0.928 . . . . 72.010000000000005 109.595 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 176' ' ' THR . 69.7 p -85.97 14.74 5.71 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.279 -0.873 . . . . 73.030000000000001 111.953 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.6 t -67.79 130.89 44.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 112.204 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.634 ' HG2' ' N ' ' A' ' 179' ' ' GLY . 17.2 mmm180 -77.37 173.21 12.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 73.420000000000002 110.501 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.649 HG23 HD11 ' A' ' 140' ' ' LEU . 32.3 m -54.25 159.55 1.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 75.150000000000006 110.144 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 137' ' ' THR . . . 116.22 -7.8 18.56 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.698 -0.763 . . . . 74.340000000000003 112.417 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' ' 139' ' ' ARG . 16.8 ttt85 -152.94 8.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.132 0.491 . . . . 75.049999999999997 110.956 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 141' ' ' ASN . 0.9 OUTLIER -88.72 -39.77 13.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.007 -0.738 . . . . 74.329999999999998 109.007 177.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.828 ' N ' HD12 ' A' ' 140' ' ' LEU . 73.7 m-20 -63.24 69.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.43 -0.805 . . . . 75.439999999999998 109.408 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 140' ' ' LEU . 60.0 t80 -127.73 128.81 46.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 74.209999999999994 111.741 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' A' ' 145' ' ' ARG . 17.8 p-10 -95.36 135.04 37.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 72.230000000000004 111.36 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.48 71.56 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.324 0.583 . . . . 51.119999999999997 110.435 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.978 ' NH1' ' HB2' ' A' ' 149' ' ' ALA . 26.3 tpt85 -43.81 -29.93 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.939 -1.028 . . . . 74.340000000000003 111.549 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' OD2' ' NZ ' ' A' ' 150' ' ' LYS . 13.6 t70 -60.17 -58.34 8.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.185 0.517 . . . . 75.25 110.392 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 97' ' ' LEU . 19.4 m-30 -64.79 -37.78 88.77 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.788 -0.642 . . . . 73.329999999999998 109.877 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.7 76.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 53.409999999999997 109.898 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.978 ' HB2' ' NH1' ' A' ' 145' ' ' ARG . . . -75.64 -53.75 8.07 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.396 0.517 . . . . 74.219999999999999 112.396 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.424 ' NZ ' ' OD2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -82.33 -51.13 8.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.18 0.807 . . . . 74.310000000000002 113.18 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -67.99 -0.46 4.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 120.086 -0.646 . . . . 70.530000000000001 110.741 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 61.09 31.41 76.62 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 114.956 0.742 . . . . 63.340000000000003 114.956 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CD1' HD12 ' A' ' 59' ' ' LEU . 10.8 mt -74.3 16.49 0.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.084 0.442 . . . . 72.200000000000003 111.376 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -47.94 -18.96 0.85 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.334 0.494 . . . . 62.100000000000001 114.334 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -135.16 93.31 17.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 117.309 0.555 . . . . 75.129999999999995 111.107 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.651 ' HB3' HD21 ' A' ' 117' ' ' LEU . 48.1 Cg_endo -67.76 134.3 32.09 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.384 2.056 . . . . 70.530000000000001 112.766 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 119' ' ' TYR . 24.9 pt -84.74 -34.98 9.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.274 -0.421 . . . . 70.530000000000001 110.553 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -139.24 147.09 41.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.123 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 17' ' ' ILE . . . -162.35 159.46 25.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 111.301 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.768 HD21 HG23 ' A' ' 27' ' ' VAL . 57.1 t30 -164.6 167.58 19.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.424 -1.325 . . . . 74.150000000000006 107.424 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.633 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -154.51 157.43 38.35 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.292 -0.563 . . . . 74.409999999999997 111.448 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.539 ' HB3' ' CB ' ' A' ' 27' ' ' VAL . 3.3 p90 -149.9 153.04 36.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.026 -0.534 . . . . 74.239999999999995 111.603 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.647 ' NE2' HH12 ' A' ' 113' ' ' ARG . 44.7 mt-30 -112.15 134.81 53.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.74 -0.664 . . . . 70.109999999999999 111.027 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.24 145.77 22.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.963 -0.562 . . . . 62.25 111.778 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 2.0 pm0 -133.94 156.87 47.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.033 -1.099 . . . . 71.109999999999999 108.033 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER -157.33 159.25 37.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 63.140000000000001 112.224 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.494 ' HA ' ' CE ' ' A' ' 107' ' ' LYS . 1.7 m-20 -71.15 157.13 38.69 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.652 -0.704 . . . . 73.150000000000006 110.516 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.566 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 14.5 t70 -48.75 -23.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.737 -0.665 . . . . 63.119999999999997 110.673 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.424 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 23.8 t80 -53.08 -38.22 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 55.229999999999997 110.99 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.629 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 73.7 t -68.16 -57.57 8.93 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.028 -0.669 . . . . 64.340000000000003 109.604 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 83.9 Cg_exo -44.99 -29.55 3.88 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.284 1.989 . . . . 74.450000000000003 111.921 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 168' ' ' ASP . 38.2 mm -47.67 -23.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.176 0.512 . . . . 74.109999999999999 109.791 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -44.49 -27.96 0.52 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.272 -0.876 . . . . 65.450000000000003 109.514 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 175' ' ' LYS . 12.7 p30 -46.11 -33.88 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.522 -0.763 . . . . 65.129999999999995 111.456 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 10.9 mptt -52.48 -30.78 31.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.776 0.322 . . . . 64.140000000000001 111.377 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 134' ' ' THR . 1.9 m -66.95 -28.05 67.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 75.129999999999995 110.361 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.623 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.3 mm -62.79 134.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 71.219999999999999 110.808 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.7 m -149.34 2.95 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.684 0.624 . . . . 75.430000000000007 112.684 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.634 ' N ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.466 -1.185 . . . . 41.530000000000001 112.871 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.951 -0.389 . . . . 63.219999999999999 109.951 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.48 -71.04 0.67 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.817 0.673 . . . . 62.310000000000002 112.817 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.562 HD12 ' CG2' ' A' ' 8' ' ' VAL . 7.2 pt -121.17 63.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.295 0.569 . . . . 74.230000000000004 111.856 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' ASP . 12.7 p -128.55 138.66 33.55 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.689 -0.687 . . . . 75.109999999999999 110.341 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.6 Cg_endo -85.55 34.22 4.22 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.767 -1.347 . . . . 73.340000000000003 112.588 0.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 8' ' ' VAL . 62.5 t0 -57.74 -53.76 54.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 71.040000000000006 110.056 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 4' ' ' ILE . 20.1 m -162.72 -37.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.505 -0.771 . . . . 54.130000000000003 111.073 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.1 tp -157.08 140.64 15.84 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-O 121.432 0.634 . . . . 71.420000000000002 111.227 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 20.5 p-10 -75.79 6.19 5.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.812 -0.631 . . . . 72.340000000000003 112.009 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -157.7 133.94 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 61.25 111.343 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.8 p -85.93 109.86 25.88 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.213 -0.448 . . . . 72.099999999999994 112.09 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.8 Cg_endo -86.87 -130.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.303 2.669 . . . . 73.120000000000005 112.187 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -159.94 -41.19 0.05 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.427 -0.351 . . . . 64.140000000000001 110.697 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -161.58 20.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.953 -0.641 . . . . 63.200000000000003 112.44 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 5.1 t -150.37 170.02 20.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.077 0.465 . . . . 72.230000000000004 111.377 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -105.88 127.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 64.530000000000001 109.186 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.9 mmpt? -84.15 102.95 12.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 109.649 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.563 ' HB ' HG22 ' A' ' 27' ' ' VAL . 48.3 t -116.89 110.68 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.165 0.507 . . . . 64.230000000000004 109.709 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.633 HG21 ' O ' ' A' ' 23' ' ' ASP . 25.8 mt -92.08 143.35 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.7 -0.682 . . . . 64.310000000000002 109.951 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 2.4 t80 -84.83 -77.8 0.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.733 -0.787 . . . . 51.240000000000002 111.584 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.611 ' H ' ' CD1' ' A' ' 25' ' ' LEU . . . -99.83 -32.87 5.48 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.611 -0.804 . . . . 72.209999999999994 113.884 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.633 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -173.48 -75.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.444 0.535 . . . . 61.109999999999999 112.444 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -90.97 -40.16 11.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.178 0.513 . . . . 73.120000000000005 110.76 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD1' ' H ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -69.53 135.98 50.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.79 -0.641 . . . . 51.310000000000002 110.469 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 22.4 pt-20 -134.26 159.18 41.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.101 -0.5 . . . . 74.239999999999995 111.528 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.1 m -69.38 134.21 30.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 72.450000000000003 110.172 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -138.64 108.51 6.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 75.25 112.228 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.508 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.7 mp0 52.06 49.12 21.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.965 . . . . 50.450000000000003 113.603 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 161' ' ' TYR . . . 62.17 12.54 38.08 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 114.812 0.685 . . . . 35.009999999999998 114.812 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -55.09 157.51 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 117.483 0.642 . . . . 73.209999999999994 110.233 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -98.2 129.31 44.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 73.25 110.051 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.2 mp -92.78 112.83 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.557 0.694 . . . . 75.319999999999993 110.988 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 2.8 p -110.54 165.63 12.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.747 -1.115 . . . . 75.120000000000005 111.35 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 17.7 Cg_exo -67.39 -42.32 0.7 Allowed 'Cis proline' 0 C--N 1.352 0.733 0 C-N-CA 124.161 -1.183 . . . . 54.149999999999999 112.033 0.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -162.53 44.47 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 71.25 109.889 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.57 ' C ' ' H ' ' A' ' 39' ' ' LYS . 3.9 pt20 -76.75 -4.83 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.629 -0.714 . . . . 71.120000000000005 111.215 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.585 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 34.3 m -73.37 31.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.695 0.76 . . . . 52.520000000000003 110.082 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.57 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -93.37 6.0 49.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.688 -1.142 . . . . 73.109999999999999 112.498 -178.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -135.3 162.99 31.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.845 0.313 . . . . 64.239999999999995 111.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -72.31 146.0 88.78 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.138 -0.483 . . . . 70.299999999999997 111.519 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -95.33 126.96 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.146 2.564 . . . . 70.349999999999994 113.424 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.1 mm -80.17 128.4 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 64.510000000000005 110.932 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.468 HG13 ' HD2' ' A' ' 91' ' ' PRO . 4.1 p -100.22 137.17 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.917 0.339 . . . . 74.540000000000006 111.917 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -162.21 153.84 18.5 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.137 0.494 . . . . 64.430000000000007 111.366 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.735 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.8 p90 -128.59 34.4 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.839 0.828 . . . . 65.510000000000005 109.485 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 m -49.54 107.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.457 -1.247 . . . . 73.150000000000006 111.069 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.57 -33.88 5.3 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.768 -0.651 . . . . 55.049999999999997 111.489 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 2.4 mm? -76.89 -40.12 48.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.14 -0.689 . . . . 73.140000000000001 109.14 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.735 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 29.2 tt0 -65.92 111.48 3.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.879 -0.601 . . . . 63.119999999999997 109.649 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.97 -63.52 0.26 Allowed Glycine 0 C--N 1.324 -0.111 0 C-N-CA 120.812 -0.709 . . . . 74.549999999999997 112.33 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -148.27 111.04 4.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.38 -0.6 . . . . 74.420000000000002 109.38 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 120' ' ' ARG . 12.2 p -157.29 141.8 16.54 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.85 -0.34 . . . . 52.399999999999999 111.319 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 35.2 t30 -77.91 -33.61 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.538 0.685 . . . . 63.520000000000003 109.292 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -155.15 157.0 36.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.966 -1.015 . . . . 71.230000000000004 109.35 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.9 mt -127.03 152.4 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 73.409999999999997 110.976 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.643 HG23 HG12 ' A' ' 82' ' ' VAL . 95.0 m -121.51 134.01 55.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.054 -0.521 . . . . 54.549999999999997 110.154 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -136.42 132.96 36.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 64.540000000000006 109.638 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 97.1 mt -153.82 159.69 41.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.02 0.438 . . . . 51.340000000000003 111.884 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 114' ' ' TYR . 24.3 ttt -94.92 156.62 16.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 62.350000000000001 109.971 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 57.6 t -133.47 146.12 32.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 54.009999999999998 111.515 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 46.2 t0 65.01 40.69 0.28 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.303 -0.862 . . . . 72.510000000000005 111.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 76.4 Cg_exo -51.21 139.84 42.91 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.884 1.723 . . . . 62.109999999999999 111.587 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.76 122.66 36.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.51 0.559 . . . . 62.549999999999997 112.51 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.83 135.91 1.08 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.056 0.391 . . . . 64.519999999999996 112.056 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 13.2 Cg_exo -68.1 -32.56 3.47 Favored 'Cis proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.883 -1.299 . . . . 71.340000000000003 109.809 -3.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.8 t -141.26 140.25 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.336 -1.302 . . . . 32.399999999999999 108.932 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -56.12 -21.56 23.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.345 0.593 . . . . 75.400000000000006 110.606 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.265 -0.879 . . . . 72.519999999999996 111.234 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . 23.0 t70 -140.15 62.06 19.48 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-O 121.126 0.489 . . . . 75.200000000000003 110.272 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -67.84 53.8 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.458 2.772 . . . . 75.430000000000007 113.434 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -50.96 -52.17 45.15 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.888 0.329 . . . . 74.010000000000005 111.888 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.493 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 2.1 p90 -106.9 39.53 1.84 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.323 0.582 . . . . 62.020000000000003 111.081 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.538 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 3.7 tmm_? -79.29 139.96 37.7 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.781 -1.192 . . . . 74.230000000000004 107.781 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 25.6 mp0 -89.13 178.05 6.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.555 1.142 . . . . 74.150000000000006 112.594 0.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 77' ' ' LEU . 4.7 tp -105.98 -173.24 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.118 -0.946 . . . . 74.519999999999996 109.886 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.0 mp -68.03 64.46 0.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.99 0.424 . . . . 72.329999999999998 111.016 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -58.55 178.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.85 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.471 ' CZ2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t-105 -100.29 122.06 42.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.004 -0.739 . . . . 75.109999999999999 109.004 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 20.0 m -141.1 129.74 22.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 111.507 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -142.52 127.73 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 74.099999999999994 109.388 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 125' ' ' ILE . 19.6 m -129.86 166.07 28.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.402 0.62 . . . . 71.219999999999999 112.366 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.625 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.9 p30 52.95 44.88 29.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.25 -1.341 . . . . 62.409999999999997 112.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.976 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.9 mm -79.89 118.02 70.34 Favored Pre-proline 0 C--O 1.231 0.105 0 N-CA-C 108.328 -0.99 . . . . 63.530000000000001 108.328 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' SER . 45.6 Cg_exo -56.51 125.95 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.839 1.693 . . . . 54.240000000000002 112.003 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.74 73.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.386 -0.435 . . . . 72.510000000000005 113.143 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' PRO . 34.3 t 177.15 45.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.846 0.458 . . . . 71.530000000000001 110.034 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 54.8 m-80 -135.36 -28.23 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.201 0.815 . . . . 72.5 113.201 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 3.9 tt0 74.56 -0.59 3.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.304 0.573 . . . . 65.150000000000006 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 14.4 p30 -167.8 157.62 9.12 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.225 -0.898 . . . . 63.340000000000003 109.914 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.614 ' HA ' HG21 ' A' ' 84' ' ' ILE . 82.5 Cg_endo -77.34 53.84 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.9 2.4 . . . . 73.099999999999994 112.559 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.7 t -102.59 -5.09 24.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.865 -0.334 . . . . 65.219999999999999 111.669 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.19 -42.0 1.33 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.041 -0.6 . . . . 50.539999999999999 114.214 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.976 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.49 173.75 15.48 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.968 -0.634 . . . . 60.340000000000003 113.975 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.7 OUTLIER -65.8 119.21 10.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.077 0.399 . . . . 71.129999999999995 112.077 -178.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 130' ' ' THR . 43.7 m -82.53 90.28 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 74.420000000000002 109.498 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.784 HD13 ' HE2' ' A' ' 147' ' ' PHE . 15.1 mt -50.47 -28.69 8.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.594 -0.73 . . . . 63.130000000000003 111.004 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -165.13 93.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.178 -0.919 . . . . 73.409999999999997 108.86 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -41.85 140.24 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.425 0.631 . . . . 53.310000000000002 112.494 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -56.38 146.9 22.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 71.420000000000002 110.922 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 102' ' ' GLY . 14.8 p -156.91 161.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.942 0.401 . . . . 71.239999999999995 111.341 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -68.24 -176.62 11.19 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.636 -0.711 . . . . 52.219999999999999 113.011 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t -65.92 122.86 18.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 62.049999999999997 111.762 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -86.65 -48.88 4.31 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.478 -0.649 . . . . 34.219999999999999 111.478 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 51.1 Cg_exo -56.37 142.43 88.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.647 2.231 . . . . 71.140000000000001 113.124 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.608 ' O ' HG23 ' A' ' 109' ' ' THR . 18.1 Cg_endo -58.92 143.54 99.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.75 2.3 . . . . 73.230000000000004 112.025 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.504 ' HB3' ' C ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -46.21 -43.29 15.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.944 0.72 . . . . 71.409999999999997 112.944 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.99 0.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.714 0.635 . . . . 71.209999999999994 112.714 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 106' ' ' PRO . 75.9 p -78.64 -27.64 45.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.905 0.383 . . . . 51.200000000000003 110.913 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.41 -167.69 14.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.824 -0.703 . . . . 74.310000000000002 113.353 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -60.01 138.19 57.91 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 112.492 0.553 . . . . 35.409999999999997 112.492 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -106.39 129.91 54.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.117 -0.947 . . . . 75.329999999999998 109.032 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 ptm85 -112.23 120.13 40.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.15 0.5 . . . . 74.209999999999994 111.288 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' ' HE3' ' A' ' 60' ' ' MET . 6.1 m-85 -109.15 140.99 42.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.819 -0.628 . . . . 63.119999999999997 110.659 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 161' ' ' TYR . 24.6 mt -132.47 132.2 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.828 -0.804 . . . . 75.319999999999993 108.828 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -106.02 137.08 44.55 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.443 0.464 . . . . 65.230000000000004 111.493 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.785 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.5 tm? -127.08 137.8 53.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.874 -0.603 . . . . 71.340000000000003 109.812 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.785 ' N ' HD13 ' A' ' 117' ' ' LEU . 57.0 tp -128.25 137.4 51.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.772 0.429 . . . . 64.510000000000005 110.466 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.524 ' CD2' HD22 ' A' ' 153' ' ' LEU . 81.2 t80 -144.07 132.59 22.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.151 -0.477 . . . . 73.450000000000003 110.595 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 53' ' ' SER . 42.8 ttp180 -76.58 128.25 34.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 71.439999999999998 110.613 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.633 ' NE2' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -104.26 149.16 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.975 0.731 . . . . 74.299999999999997 112.975 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 30.2 tt0 -112.59 -55.49 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.686 -1.143 . . . . 75.319999999999993 109.857 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -100.19 131.38 46.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 73.319999999999993 110.717 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 9.7 tmtt? -59.55 125.08 22.19 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.004 -0.369 . . . . 71.340000000000003 110.004 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.83 HD11 ' HB ' ' A' ' 82' ' ' VAL . 5.5 pt -87.15 125.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 52.140000000000001 112.233 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.81 118.04 10.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.903 -1.518 . . . . 74.239999999999995 106.903 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.41 32.31 1.69 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.033 1.123 . . . . 60.140000000000001 114.033 -176.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 68.7 p 51.04 172.53 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 112.446 0.535 . . . . 73.010000000000005 112.446 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 50.4 Cg_exo -58.46 150.4 68.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.517 2.145 . . . . 62.009999999999998 114.037 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 96' ' ' SER . 25.5 p -60.91 132.18 53.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 72.540000000000006 110.809 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 32.4 mm -85.99 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.379 0.609 . . . . 74.209999999999994 112.224 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -73.46 141.32 46.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 70.510000000000005 111.983 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 134' ' ' THR . 22.3 p30 -56.42 -47.1 79.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.515 0.674 . . . . 63.219999999999999 110.427 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.555 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.3 t -84.49 22.93 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.066 -0.97 . . . . 51.439999999999998 111.451 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 177' ' ' ILE . 12.0 t -62.21 155.46 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.551 0.691 . . . . 25.109999999999999 112.121 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.569 ' HB2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 tpt180 -69.02 164.94 21.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.771 -1.104 . . . . 72.120000000000005 112.422 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 138' ' ' GLY . 4.4 m -53.13 175.28 0.03 OUTLIER 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.685 -0.689 . . . . 73.150000000000006 110.258 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.651 ' H ' HG22 ' A' ' 137' ' ' THR . . . 82.07 4.22 90.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 119.937 -1.125 . . . . 74.129999999999995 111.822 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.449 ' H ' HD12 ' A' ' 140' ' ' LEU . 28.7 mmt180 -139.81 45.71 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.262 0.553 . . . . 63.039999999999999 111.304 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -112.77 -63.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.187 -0.915 . . . . 71.239999999999995 108.784 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 73' ' ' TYR . 5.3 m-20 -63.39 121.38 13.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 74.010000000000005 111.447 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.565 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 40.8 t80 -176.94 109.38 0.08 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.82 -0.627 . . . . 75.430000000000007 111.306 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -68.63 120.98 15.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 111.921 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.74 -43.44 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 52.030000000000001 111.601 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' HH11 ' A' ' 145' ' ' ARG . 11.0 mtp-105 -45.15 -33.92 2.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.218 -0.447 . . . . 73.150000000000006 111.914 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.93 -49.33 50.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.591 0.71 . . . . 44.399999999999999 109.386 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.784 ' HE2' HD13 ' A' ' 97' ' ' LEU . 10.0 m-30 -62.14 -41.95 98.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.053 -0.976 . . . . 74.230000000000004 110.189 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.73 -46.38 87.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.805 0.336 . . . . 62.509999999999998 111.244 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.3 -51.73 41.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.913 -0.585 . . . . 71.420000000000002 112.458 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -75.36 -48.57 22.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.632 0.604 . . . . 61.039999999999999 112.632 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.645 ' NE2' HD12 ' A' ' 125' ' ' ILE . 7.8 m-70 -67.76 -10.85 56.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.94 -0.475 . . . . 72.340000000000003 110.724 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.22 67.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.092 -0.575 . . . . 74.230000000000004 113.155 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.524 HD22 ' CD2' ' A' ' 119' ' ' TYR . 7.4 mt -76.02 15.85 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.063 0.145 . . . . 63.210000000000001 111.195 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -35.29 -73.01 0.1 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.021 -0.609 . . . . 34.299999999999997 113.44 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 155' ' ' GLU . 11.4 pt-20 -74.67 112.46 17.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.544 0.172 . . . . 75.549999999999997 110.849 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 117' ' ' LEU . 65.5 Cg_endo -83.55 130.75 5.31 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.194 1.93 . . . . 73.510000000000005 113.116 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.725 HD11 ' HG ' ' A' ' 118' ' ' LEU . 38.8 pt -78.49 -34.7 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.916 -0.314 . . . . 73.319999999999993 111.426 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -151.05 151.0 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.207 0.447 . . . . 72.200000000000003 112.207 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.15 158.15 43.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 53.340000000000003 111.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.6 ' C ' ' CD1' ' A' ' 161' ' ' TYR . 43.4 t30 -158.97 175.09 13.99 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.004 -1.11 . . . . 75.129999999999995 108.004 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -157.95 155.53 29.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.686 0.675 . . . . 71.140000000000001 111.055 -178.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 1.4 t80 -155.94 131.84 9.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.13 0.572 . . . . 75.430000000000007 110.995 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mt-30 -115.86 138.63 50.98 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.282 -0.261 . . . . 71.030000000000001 111.455 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -155.43 153.18 29.95 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.062 0.764 . . . . 53.109999999999999 113.062 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -138.99 161.5 37.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.776 -0.824 . . . . 65.319999999999993 108.776 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.432 ' O ' ' CB ' ' A' ' 107' ' ' LYS . 1.7 t80 -165.61 168.75 16.06 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.191 -0.604 . . . . 71.010000000000005 111.36 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.504 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.8 t0 -79.46 -159.92 0.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.714 0.634 . . . . 64.209999999999994 110.912 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.5 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 50.2 t0 -69.0 -23.87 64.15 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.092 0.472 . . . . 64.209999999999994 111.036 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.4 t80 -42.88 -44.48 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 112.108 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 67.8 t -80.38 -54.39 0.83 Allowed Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 120.464 -0.494 . . . . 53.020000000000003 111.494 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 77.8 Cg_exo -48.39 -49.84 13.54 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.051 1.834 . . . . 51.399999999999999 112.644 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 168' ' ' ASP . 11.5 tt -46.01 -33.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.027 0.381 . . . . 74.420000000000002 112.027 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.03 -29.53 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 65.430000000000007 111.342 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.1 m-20 -56.51 -14.92 3.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.176 0.806 . . . . 74.409999999999997 113.176 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.36 -20.29 42.57 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.794 0.664 . . . . 74.340000000000003 112.794 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 p -88.1 16.59 5.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.864 0.69 . . . . 74.109999999999999 112.864 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 135' ' ' THR . 27.7 mm -72.46 124.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 122.037 -0.415 . . . . 64.510000000000005 110.296 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.58 -13.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.114 0.783 . . . . 74.409999999999997 113.114 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.555 -1.136 . . . . 64.319999999999993 112.301 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.654 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 120.795 0.331 . . . . 65.319999999999993 111.458 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 5.5 t70 -71.18 -40.83 71.0 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.728 0.299 . . . . 54.219999999999999 111.196 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 9' ' ' LEU . 12.8 pt -149.24 48.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 65.319999999999993 110.615 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 2' ' ' ASP . 13.6 p -136.45 140.9 33.79 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.214 -0.903 . . . . 75.5 109.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 Cg_exo -78.28 26.43 2.5 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.205 -1.164 . . . . 70.329999999999998 113.591 0.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.5 t0 -54.56 -53.21 57.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.393 . . . . 73.129999999999995 110.431 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.5 m -161.32 -43.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.997 -0.547 . . . . 63.200000000000003 111.917 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 117' ' ' LEU . 62.2 tp -144.21 160.08 41.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.65 0.262 . . . . 75.209999999999994 110.851 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -60.43 -42.58 96.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.718 -0.793 . . . . 72.319999999999993 109.732 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -156.59 135.14 11.54 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.818 0.303 . . . . 54.140000000000001 111.818 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.39 125.88 80.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 72.010000000000005 110.995 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 45.7 Cg_endo -89.73 -145.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.892 2.395 . . . . 51.539999999999999 112.201 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.37 -31.05 6.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.842 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.36 -136.54 3.16 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.919 -0.582 . . . . 75.409999999999997 111.834 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.472 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 1.5 t -162.81 164.41 26.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 65.239999999999995 111.734 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.587 HD12 ' N ' ' A' ' 17' ' ' ILE . 3.1 mp -104.9 133.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.406 -0.961 . . . . 73.109999999999999 108.406 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 13.5 mmmm -83.62 101.96 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.442 -0.503 . . . . 71.540000000000006 109.707 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 94.2 t -108.86 108.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.599 0.714 . . . . 61.409999999999997 111.198 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 23' ' ' ASP . 1.8 mp -91.88 138.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 72.150000000000006 107.898 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -93.42 -46.96 7.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.937 0.717 . . . . 71.030000000000001 112.937 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' A' ' 25' ' ' LEU . . . -115.86 -48.39 0.5 Allowed Glycine 0 N--CA 1.459 0.175 0 C-N-CA 120.277 -0.963 . . . . 53.299999999999997 112.857 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -170.62 -80.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 110.261 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -82.31 -31.85 29.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.599 . . . . 75.420000000000002 109.384 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 129.08 38.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.687 0.756 . . . . 71.209999999999994 111.443 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 28.3 tt0 -125.61 150.77 47.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.702 -1.136 . . . . 72.439999999999998 110.836 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 27' ' ' VAL . 31.3 m -85.42 107.01 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 111.535 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 31' ' ' ASN . 1.5 mptm? -75.21 50.53 0.5 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.429 0.9 . . . . 64.439999999999998 113.429 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' H ' ' A' ' 161' ' ' TYR . 3.4 mp0 59.31 69.67 0.7 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.667 0.988 . . . . 63.039999999999999 113.667 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 161' ' ' TYR . . . 100.38 -6.21 57.64 Favored Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 110.835 -0.906 . . . . 75.329999999999998 110.835 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.3 t-20 -59.14 139.02 57.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.932 -1.134 . . . . 72.109999999999999 110.868 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' C ' HD12 ' A' ' 33' ' ' LEU . 87.2 tt0 -102.72 138.02 40.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 73.219999999999999 110.24 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.1 mp -109.3 154.19 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 111.353 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -149.36 157.79 38.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 75.219999999999999 110.477 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.95 -51.88 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 124.093 -1.211 . . . . 50.200000000000003 112.77 0.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 36' ' ' THR . 6.2 m -143.41 35.81 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 72.129999999999995 110.836 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 11.9 pt20 -80.21 -4.37 52.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.6 . . . . 65.530000000000001 111.494 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.608 ' HB ' ' CE2' ' A' ' 21' ' ' TYR . 27.5 m -85.54 33.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.572 -0.74 . . . . 71.140000000000001 111.935 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.74 -30.08 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.848 1.055 . . . . 74.040000000000006 113.848 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 45.1 m-20 -72.33 152.62 41.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.825 0.676 . . . . 74.219999999999999 112.825 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.629 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -63.25 128.72 92.79 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.718 -0.674 . . . . 73.109999999999999 109.33 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 125.75 19.31 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.348 2.032 . . . . 74.409999999999997 114.243 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.18 111.09 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.5 -0.773 . . . . 70.540000000000006 109.936 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' CG2' ' A' ' 17' ' ' ILE . 6.0 p -93.55 142.02 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.365 . . . . 71.230000000000004 111.719 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 50.7 m -158.07 137.9 12.2 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.263 0.468 . . . . 64.040000000000006 112.263 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.735 ' HH2' HG21 ' A' ' 84' ' ' ILE . 3.5 p90 -115.84 23.26 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.263 -0.643 . . . . 75.409999999999997 109.263 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.2 m -40.31 120.96 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.395 -0.82 . . . . 70.510000000000005 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 91.08 -35.46 3.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.267 -0.492 . . . . 73.340000000000003 112.187 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.0 mm? -65.54 -20.86 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.87 0.367 . . . . 75.129999999999995 110.031 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 16.6 pm0 -67.57 -159.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.249 -0.649 . . . . 74.310000000000002 109.249 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.17 -66.6 0.48 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 119.96 -1.114 . . . . 62.399999999999999 113.083 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -149.42 106.88 3.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.086 0.47 . . . . 75.099999999999994 109.77 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.403 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 3.3 m -160.19 140.41 11.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.776 -0.647 . . . . 70.150000000000006 110.224 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -74.88 -38.17 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.733 -0.84 . . . . 74.109999999999999 108.733 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 22.5 mt -155.86 160.4 40.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.7 -1.136 . . . . 72.109999999999999 109.885 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 15.5 mt -122.08 151.8 40.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.974 -0.29 . . . . 73.030000000000001 110.527 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.685 HG23 HG12 ' A' ' 82' ' ' VAL . 91.4 m -129.01 114.41 16.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 112.027 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.3 tm? -106.78 134.29 50.15 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.54 -0.541 . . . . 74.030000000000001 109.54 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 58' ' ' LEU . 83.5 mt -144.75 171.58 14.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.166 0.508 . . . . 52.420000000000002 111.754 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.562 ' C ' ' SD ' ' A' ' 60' ' ' MET . 0.8 OUTLIER -133.64 123.13 24.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.176 -0.92 . . . . 74.209999999999994 108.638 178.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.602 HG13 HD22 ' A' ' 143' ' ' ASN . 48.3 t -130.87 102.09 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.123 0.487 . . . . 71.120000000000005 112.127 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -178.79 67.68 0.19 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.226 -0.897 . . . . 65.230000000000004 109.605 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 1.4 Cg_endo -45.48 129.0 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.254 1.97 . . . . 44.020000000000003 111.589 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -162.36 87.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.291 0.478 . . . . 72.219999999999999 112.291 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -171.61 133.54 0.84 Allowed Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 112.883 0.697 . . . . 52.049999999999997 112.883 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.6 Cg_exo -63.36 -20.45 5.17 Favored 'Cis proline' 0 C--N 1.354 0.822 0 C-N-CA 123.558 -1.434 . . . . 74.099999999999994 110.276 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 148.49 16.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.838 -1.074 . . . . 63.119999999999997 109.912 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -49.13 -31.8 8.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.676 0.75 . . . . 73.519999999999996 110.617 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.45 -32.83 74.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.927 -1.033 . . . . 74.140000000000001 111.956 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.6 t0 -144.91 98.37 4.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 75.420000000000002 111.072 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 72.5 Cg_endo -76.51 60.3 6.46 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.974 2.449 . . . . 75.329999999999998 111.901 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -47.17 -39.82 14.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.931 -0.577 . . . . 72.450000000000003 110.78 -178.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.0 48.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.721 0.772 . . . . 62.350000000000001 109.707 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -74.37 136.24 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.652 -1.158 . . . . 73.530000000000001 109.459 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 142' ' ' PHE . 1.1 pm0 -89.12 176.61 6.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.998 0.919 . . . . 74.140000000000001 112.013 0.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 140' ' ' LEU . 3.2 tp -114.46 -163.14 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.216 -0.902 . . . . 75.120000000000005 109.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.665 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.9 mp -65.04 135.9 56.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.43 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 6.6 p-80 -147.87 171.72 15.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 52.340000000000003 110.086 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.7 t90 -97.99 123.18 41.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 72.340000000000003 112.052 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 85.5 p -142.96 133.58 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.847 -0.615 . . . . 74.319999999999993 109.841 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 91' ' ' PRO . 21.3 t -149.24 117.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.6 . . . . 74.109999999999999 109.379 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 57' ' ' THR . 10.7 m -115.23 -173.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.724 0.774 . . . . 64.230000000000004 112.649 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.619 HD21 ' CG ' ' A' ' 95' ' ' HIS . 27.9 p30 44.21 43.45 5.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.996 -1.457 . . . . 73.25 113.166 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.735 HG21 ' HH2' ' A' ' 46' ' ' TRP . 2.4 mm -67.42 121.84 80.57 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.55 -1.278 . . . . 73.0 107.55 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.45 103.13 1.64 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.155 1.903 . . . . 75.540000000000006 115.189 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.89 -84.79 1.57 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 116.507 1.363 . . . . 42.229999999999997 116.507 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 89' ' ' GLU . 78.3 p -174.39 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 117.484 0.642 . . . . 64.230000000000004 111.642 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 90' ' ' ASN . 18.8 m120 -73.71 28.98 0.07 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.907 -0.588 . . . . 74.200000000000003 110.391 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 16.3 pt-20 44.52 5.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.928 -1.033 . . . . 62.43 112.952 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 88' ' ' ASN . 17.8 p30 -179.71 163.11 0.91 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.237 -0.653 . . . . 70.019999999999996 109.237 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 84' ' ' ILE . 66.6 Cg_endo -68.65 44.84 0.33 Allowed 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 122.872 2.381 . . . . 74.219999999999999 113.219 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 90' ' ' ASN . 22.1 t -69.36 -43.22 74.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.177 0.436 . . . . 74.439999999999998 112.177 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.75 10.13 32.35 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.912 -0.661 . . . . 73.540000000000006 114.264 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -86.58 166.51 37.92 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.661 -0.78 . . . . 64.030000000000001 114.093 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.31 104.78 0.8 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.865 0.32 . . . . 72.439999999999998 111.865 178.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.679 ' N ' HG22 ' A' ' 130' ' ' THR . 51.1 m -73.51 83.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.718 0.77 . . . . 75.319999999999993 109.047 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 55.2 mt -68.31 -20.86 64.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.149 -0.932 . . . . 73.409999999999997 110.496 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 78' ' ' HIS . . . -158.53 106.22 1.9 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.185 -0.916 . . . . 75.439999999999998 109.475 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -60.12 142.3 54.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 63.039999999999999 110.846 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 20.5 p90 -67.46 140.28 57.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 70.040000000000006 111.798 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.33 145.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 71.310000000000002 109.67 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.619 ' HA3' HG21 ' A' ' 170' ' ' VAL . . . -54.68 -47.0 72.99 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.896 -0.669 . . . . 61.140000000000001 113.394 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -173.52 98.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.964 0.382 . . . . 53.119999999999997 111.955 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.653 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -57.12 -50.1 66.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.068 -1.063 . . . . 54.340000000000003 110.664 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 38.4 Cg_endo -65.63 140.21 61.4 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.22 2.613 . . . . 43.240000000000002 112.385 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 109' ' ' THR . 37.8 Cg_exo -57.27 147.24 77.87 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.095 2.53 . . . . 61.210000000000001 113.374 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -45.96 -34.38 3.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.154 0.502 . . . . 71.409999999999997 111.502 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -51.8 -20.2 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.689 -0.687 . . . . 53.0 111.901 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.978 HG21 ' CE1' ' A' ' 112' ' ' HIS . 10.9 t -69.14 -17.2 63.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 73.319999999999993 111.071 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.83 -142.37 34.73 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.902 -0.59 . . . . 65.549999999999997 113.82 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.21 117.59 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.393 . . . . 71.430000000000007 111.7 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.978 ' CE1' HG21 ' A' ' 109' ' ' THR . 48.5 m-70 -82.79 -176.11 6.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.83 0.824 . . . . 74.230000000000004 111.325 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.978 HH12 HD11 ' A' ' 115' ' ' ILE . 65.6 ttt-85 -147.52 112.04 5.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.113 -1.81 . . . . 71.120000000000005 106.113 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 60' ' ' MET . 0.4 OUTLIER -118.32 134.74 54.78 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.603 -0.439 . . . . 72.209999999999994 111.653 -176.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.978 HD11 HH12 ' A' ' 113' ' ' ARG . 36.8 mt -130.84 121.36 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.573 -0.739 . . . . 75.299999999999997 111.933 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.557 ' C ' HD22 ' A' ' 117' ' ' LEU . 36.4 m-85 -100.92 131.44 46.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.429 -0.805 . . . . 71.530000000000001 109.154 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 9' ' ' LEU . 2.7 mm? -116.49 143.87 45.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.26 -0.427 . . . . 72.530000000000001 110.447 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 44.3 tp -126.99 131.2 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 63.229999999999997 109.886 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 53.1 m-85 -132.61 143.95 50.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.227 0.536 . . . . 64.439999999999998 111.226 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 18.7 tpp180 -77.15 117.03 18.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.554 -0.748 . . . . 70.340000000000003 109.523 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 39.4 tp60 -91.85 122.77 34.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.038 0.447 . . . . 74.329999999999998 110.101 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -90.94 -49.8 6.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.455 -0.793 . . . . 74.140000000000001 112.403 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -108.71 146.16 33.93 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.241 0.46 . . . . 62.25 112.241 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.9 tptm -64.69 123.32 19.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.587 -0.733 . . . . 70.430000000000007 110.091 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.598 HD12 ' NE2' ' A' ' 151' ' ' HIS . 3.1 pt -111.06 129.03 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 110.707 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 128' ' ' THR . 83.8 tt0 -53.45 -46.99 70.09 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.353 -0.61 . . . . 53.229999999999997 109.353 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.622 ' CG ' HD11 ' A' ' 97' ' ' LEU . 2.2 tp10 53.92 15.15 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.139 -0.937 . . . . 63.549999999999997 113.112 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 58.7 p 51.16 169.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 111.924 0.342 . . . . 74.150000000000006 111.924 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 52.1 Cg_exo -58.83 148.72 82.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.095 1.864 . . . . 75.129999999999995 113.406 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.679 HG22 ' N ' ' A' ' 96' ' ' SER . 17.2 p -58.38 136.94 57.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.18 -0.918 . . . . 70.420000000000002 110.752 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 38.6 mm -92.79 129.5 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 113.337 0.865 . . . . 74.329999999999998 113.337 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.537 ' HB3' HG22 ' A' ' 134' ' ' THR . 58.1 m -86.85 133.49 33.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.19 -1.368 . . . . 73.439999999999998 109.302 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -53.45 -26.16 19.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.912 -0.315 . . . . 74.299999999999997 111.383 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 9.3 t -64.83 -2.47 2.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.945 0.402 . . . . 71.439999999999998 111.055 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 135' ' ' THR . 13.0 t -64.3 108.4 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.253 0.549 . . . . 74.239999999999995 109.789 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HA ' HG22 ' A' ' 177' ' ' ILE . 37.9 ttt85 -65.14 171.17 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.68 -0.691 . . . . 73.450000000000003 112.315 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ARG . 50.4 m -28.29 136.82 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.245 -0.889 . . . . 65.519999999999996 111.577 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.94 5.84 14.86 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.772 -0.649 . . . . 65.219999999999999 111.927 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 140' ' ' LEU . 17.4 mmm180 -152.0 35.76 0.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.782 0.325 . . . . 63.32 111.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 76' ' ' ILE . 3.3 mp -109.86 -62.53 1.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.375 -0.375 . . . . 75.299999999999997 110.773 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.46 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 9.2 m-20 -61.57 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.699 -0.682 . . . . 62.109999999999999 112.535 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.573 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 11.5 t80 -144.17 118.1 9.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.399 . . . . 74.450000000000003 111.346 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.602 HD22 HG13 ' A' ' 61' ' ' VAL . 9.1 t-20 -85.41 131.0 34.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 52.119999999999997 110.489 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.04 -37.49 87.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.738 0.644 . . . . 75.319999999999993 112.738 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -44.02 -31.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 64.120000000000005 110.933 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.8 OUTLIER -47.05 -41.01 16.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.044 0.45 . . . . 74.430000000000007 110.63 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 66.2 m-85 -56.79 -38.83 73.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 110.639 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -63.28 -28.14 69.82 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.72 -0.673 . . . . 41.329999999999998 110.174 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.63 2.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 62.32 111.226 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 0.9 OUTLIER -54.08 -44.35 71.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.823 0.344 . . . . 74.340000000000003 110.961 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.598 ' NE2' HD12 ' A' ' 125' ' ' ILE . 29.5 m-70 -85.74 4.76 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.476 -0.329 . . . . 64.439999999999998 110.7 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 56.08 26.11 48.33 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.019 -0.537 . . . . 63.539999999999999 113.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 148' ' ' ALA . 19.6 mt -64.47 -25.86 68.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.434 -0.58 . . . . 61.210000000000001 109.434 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.64 -89.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.06 -0.973 . . . . 41.240000000000002 113.963 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' LEU . 21.9 pt-20 -73.06 125.72 90.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.088 0.403 . . . . 71.439999999999998 112.088 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 119' ' ' TYR . 60.3 Cg_endo -76.22 124.78 8.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.692 1.595 . . . . 35.409999999999997 110.34 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 119' ' ' TYR . 47.5 pt -71.5 -33.8 50.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.115 -0.634 . . . . 73.150000000000006 110.551 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -147.15 149.77 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.946 -0.302 . . . . 43.439999999999998 111.564 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.38 152.34 38.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 111.122 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.28 145.27 19.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.48 -1.304 . . . . 70.299999999999997 107.48 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.482 ' H ' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -149.03 176.84 10.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.882 0.327 . . . . 70.299999999999997 111.882 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.548 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.3 p90 -168.84 164.82 11.83 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.067 -0.515 . . . . 74.239999999999995 111.343 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -126.36 124.81 41.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.489 -0.56 . . . . 74.109999999999999 109.489 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.62 152.85 25.91 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.16 0.429 . . . . 71.439999999999998 112.16 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -109.08 136.49 48.51 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 34.25 109.348 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -125.5 135.07 51.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.699 -0.482 . . . . 61.439999999999998 109.699 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.84 173.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.316 0.579 . . . . 71.420000000000002 112.293 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -72.75 51.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.167 -0.924 . . . . 71.5 110.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -91.69 -46.57 7.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 64.519999999999996 110.872 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' HA3' ' A' ' 102' ' ' GLY . 53.4 t -80.82 -46.89 1.21 Allowed Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 113.162 0.801 . . . . 65.209999999999994 113.162 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.4 Cg_exo -46.06 -43.35 20.46 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.918 1.745 . . . . 71.120000000000005 111.748 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.1 mm -51.14 -39.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 74.420000000000002 110.076 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -53.32 -26.42 18.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.614 -0.721 . . . . 70.219999999999999 110.796 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -52.31 -42.68 64.02 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.543 0.211 . . . . 72.200000000000003 111.295 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -15.5 62.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.064 0.459 . . . . 63.32 110.498 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.8 m -92.37 -28.14 17.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.58 -0.736 . . . . 64.030000000000001 110.812 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.582 HG23 ' C ' ' A' ' 134' ' ' THR . 52.1 mt -56.51 119.74 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.962 -0.563 . . . . 74.450000000000003 110.956 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.87 37.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.895 0.379 . . . . 54.100000000000001 111.531 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.978 -1.457 . . . . 40.310000000000002 111.34 -179.126 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.072 0.463 . . . . 74.030000000000001 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 4' ' ' ILE . 9.9 t0 -51.15 -64.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.774 -0.648 . . . . 75.030000000000001 112.19 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.5 pt -131.63 49.14 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.502 0.667 . . . . 53.210000000000001 111.361 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.9 p -111.61 142.32 26.35 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 65.299999999999997 110.203 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 56.2 Cg_endo -95.62 33.44 9.86 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.363 -1.099 . . . . 72.329999999999998 112.83 0.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.55 -42.82 82.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.219999999999999 109.741 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' ' 4' ' ' ILE . 27.5 m -154.38 -47.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.724 -0.671 . . . . 73.409999999999997 112.364 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 117' ' ' LEU . 25.2 tp -158.51 154.88 27.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.316 0.488 . . . . 61.450000000000003 112.316 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.63 -1.97 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.346 -0.613 . . . . 62.219999999999999 109.346 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -144.86 -158.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.155 -0.93 . . . . 61.119999999999997 109.827 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.3 p -144.62 113.91 5.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 111.437 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 45.1 Cg_endo -88.75 -138.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.448 . . . . 74.239999999999995 112.519 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -153.31 -37.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 61.140000000000001 111.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.38 161.67 24.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.177 -1.011 . . . . 53.409999999999997 113.274 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 t -104.46 157.05 17.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 110.947 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.8 mp -104.01 135.25 42.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.889 -0.596 . . . . 72.299999999999997 109.605 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.9 mmmt -73.57 118.19 16.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.53 -0.305 . . . . 64.140000000000001 110.232 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 84.1 t -128.18 109.18 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.278 -0.638 . . . . 64.439999999999998 109.278 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 26' ' ' GLU . 37.2 mt -99.64 142.07 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 74.209999999999994 112.452 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.516 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 1.6 m-85 -101.57 -94.3 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.716 -0.674 . . . . 74.019999999999996 111.123 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.72 -50.22 68.29 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.157 -1.02 . . . . 74.239999999999995 111.586 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.4 t70 171.36 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.999 -0.741 . . . . 62.140000000000001 108.999 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 71.209999999999994 108.789 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.06 141.37 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.617 -1.174 . . . . 63.350000000000001 111.476 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 20' ' ' ILE . 13.2 pt-20 -149.04 153.73 38.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.83 -1.077 . . . . 74.120000000000005 110.752 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.572 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 35.8 m -82.56 133.69 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 65.319999999999993 109.899 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 14.7 pttm -153.35 130.02 10.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.055 0.931 . . . . 73.209999999999994 113.182 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.487 ' HA ' ' CE1' ' A' ' 161' ' ' TYR . 7.1 mp0 32.55 63.89 0.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.859 -1.519 . . . . 74.530000000000001 114.759 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.3 10.83 63.41 Favored Glycine 0 N--CA 1.454 -0.13 0 N-CA-C 114.876 0.71 . . . . 73.409999999999997 114.876 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -61.0 146.39 47.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.874 0.837 . . . . 65.319999999999993 109.906 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -96.5 126.28 41.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.92 -0.4 . . . . 75.319999999999993 109.92 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -93.07 108.9 20.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.137 0.494 . . . . 71.120000000000005 109.791 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -150.22 155.49 37.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.39 -0.823 . . . . 62.149999999999999 110.648 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -93.86 136.09 6.55 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.286 -1.131 . . . . 71.329999999999998 112.64 0.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 36' ' ' THR . 17.9 m 56.38 33.65 22.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.237 0.541 . . . . 74.219999999999999 110.649 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.87 -1.9 54.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.682 -0.69 . . . . 73.329999999999998 110.83 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.4 m -92.13 -14.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 73.400000000000006 112.289 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -74.39 5.8 4.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 73.519999999999996 111.094 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 53.2 m-20 -96.81 146.15 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.256 0.55 . . . . 75.049999999999997 111.737 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.63 132.33 94.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.189 -0.914 . . . . 64.329999999999998 111.796 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 89.6 Cg_endo -81.61 125.14 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.947 1.765 . . . . 64.319999999999993 112.227 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.9 mm -109.27 106.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 109.921 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.437 HG23 ' CZ3' ' A' ' 79' ' ' TRP . 57.9 t -89.94 136.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.337 0.495 . . . . 44.229999999999997 112.337 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 75.3 m -159.66 116.23 2.56 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.77 -0.65 . . . . 74.329999999999998 110.089 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 89' ' ' GLU . 16.1 p90 -91.77 32.4 1.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 74.310000000000002 110.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 m -46.85 128.43 10.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.338 -0.846 . . . . 55.149999999999999 110.586 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.19 -33.16 4.83 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.708 -0.678 . . . . 54.310000000000002 112.406 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -80.29 -26.39 38.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.432 . . . . 73.209999999999994 110.479 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 23.1 tt0 -59.33 158.89 8.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.852 -0.613 . . . . 72.409999999999997 110.983 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.85 33.1 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.216 -1.154 . . . . 75.230000000000004 110.216 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -48.15 109.55 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 74.109999999999999 110.44 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 p -149.23 142.6 25.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.327 -0.851 . . . . 75.450000000000003 109.582 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 8.3 t-20 -64.77 -38.76 92.08 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.58 0.705 . . . . 64.099999999999994 109.45 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 83' ' ' ASN . 82.1 mt -156.86 154.58 30.05 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.642 -1.163 . . . . 72.299999999999997 111.179 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.0 mt -120.67 150.9 40.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.579 -0.526 . . . . 64.129999999999995 109.579 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.551 HG23 HG12 ' A' ' 82' ' ' VAL . 88.5 m -122.24 114.32 20.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.776 0.322 . . . . 52.32 110.665 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.1 tm? -103.68 134.19 47.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.154 -0.684 . . . . 74.340000000000003 109.154 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 93.8 mt -141.04 152.51 44.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.349 0.595 . . . . 71.400000000000006 111.851 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.7 ttt -127.2 110.29 12.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.201 -0.909 . . . . 71.230000000000004 108.607 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.728 HG23 HD23 ' A' ' 117' ' ' LEU . 5.1 t -94.32 -133.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.025 -0.27 . . . . 71.540000000000006 111.712 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.725 ' H ' HG12 ' A' ' 61' ' ' VAL . 2.2 m-20 51.84 73.04 1.03 Allowed Pre-proline 0 CA--C 1.518 -0.256 0 N-CA-C 112.341 0.497 . . . . 71.219999999999999 112.341 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.621 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . 32.0 Cg_endo -62.19 129.4 26.91 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.737 1.625 . . . . 75.140000000000001 110.008 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -159.46 92.49 1.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.769 1.026 . . . . 63.549999999999997 113.769 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 76' ' ' ILE . . . -172.88 134.39 0.7 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 112.481 0.549 . . . . 64.230000000000004 112.481 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 65.3 Cg_endo -85.64 3.18 65.38 Favored 'Cis proline' 0 C--N 1.347 0.468 0 C-N-CA 124.315 -1.119 . . . . 72.239999999999995 110.243 -2.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 t -164.81 134.04 3.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.332 -1.304 . . . . 61.049999999999997 109.636 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.549 ' HD3' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -55.14 -24.05 24.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.852 0.358 . . . . 75.209999999999994 110.726 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.549 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -62.43 -41.18 98.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 75.150000000000006 110.417 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -144.7 109.51 4.8 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.101 -0.5 . . . . 74.209999999999994 111.231 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.64 63.83 4.72 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.5 2.133 . . . . 73.430000000000007 111.518 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 39.6 ttmt -47.91 -27.82 2.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.199 -0.455 . . . . 63.409999999999997 111.113 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.669 ' HE1' ' HB1' ' A' ' 65' ' ' ALA . 2.9 p90 -152.78 45.36 0.69 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.734 0.642 . . . . 74.519999999999996 112.734 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.621 ' NE ' ' HB2' ' A' ' 63' ' ' PRO . 25.9 ttm180 -66.82 139.57 57.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.534 -0.913 . . . . 63.520000000000003 108.534 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -106.64 165.55 11.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.55 1.14 . . . . 75.120000000000005 110.23 -0.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.778 HG22 ' N ' ' A' ' 77' ' ' LEU . 38.0 mm -80.55 176.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.233 0.457 . . . . 72.109999999999999 112.233 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.797 ' CD2' HD23 ' A' ' 140' ' ' LEU . 2.9 mm? -71.44 55.99 0.24 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.705 -0.68 . . . . 71.120000000000005 110.07 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 76' ' ' ILE . 6.5 p-80 -53.92 169.91 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 71.239999999999995 111.956 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 12.3 t90 -99.86 112.52 24.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.744 -0.662 . . . . 71.030000000000001 110.457 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 p -141.44 136.56 31.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.689 -0.687 . . . . 51.450000000000003 110.442 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 84' ' ' ILE . 25.3 t -139.76 142.49 32.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.994 -0.548 . . . . 75.409999999999997 109.909 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.919 HG21 ' HG3' ' A' ' 127' ' ' GLU . 16.4 m -137.71 163.52 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.581 0.585 . . . . 72.319999999999993 112.581 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.763 ' ND2' HG23 ' A' ' 82' ' ' VAL . 45.8 m-20 71.87 32.89 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.63 -1.168 . . . . 31.449999999999999 111.243 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.55 HD13 ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -76.96 111.96 19.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.102 -0.639 . . . . 52.549999999999997 109.695 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' SER . 47.9 Cg_exo -54.56 134.24 60.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.813 1.675 . . . . 62.43 110.75 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.91 70.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.949 -0.643 . . . . 72.239999999999995 112.839 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' PRO . 23.2 t 176.46 47.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.88 -0.785 . . . . 65.430000000000007 108.88 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 27.9 m120 -135.66 -29.86 1.03 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.76 . . . . 55.020000000000003 112.146 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' ASN . 12.7 pt-20 50.06 20.55 0.61 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.515 0.674 . . . . 72.040000000000006 110.201 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -170.25 148.01 2.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.643 -1.162 . . . . 72.319999999999993 109.654 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.09 49.42 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.796 2.331 . . . . 65.530000000000001 112.741 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -92.51 -56.02 3.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 74.040000000000006 111.5 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.32 33.73 1.33 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.823 -0.626 . . . . 72.030000000000001 113.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.55 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -133.81 159.12 23.6 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.864 -0.684 . . . . 54.409999999999997 113.238 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 130' ' ' THR . 78.3 t60 -68.73 116.69 9.52 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.253 0.221 . . . . 74.239999999999995 111.418 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.489 ' O ' HG22 ' A' ' 130' ' ' THR . 14.8 m -76.94 106.31 8.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.441 -0.948 . . . . 62.140000000000001 108.441 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 127' ' ' GLU . 4.9 mt -61.93 -54.57 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.376 -0.972 . . . . 73.530000000000001 108.376 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 78' ' ' HIS . . . -127.84 121.16 29.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.244 -1.343 . . . . 61.350000000000001 107.536 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.6 t0 -52.75 152.07 4.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.219 -0.446 . . . . 55.219999999999999 111.872 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -59.49 127.2 30.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.688 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.1 148.95 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.521 0.677 . . . . 72.329999999999998 112.355 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.83 72.01 0.45 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.224 -1.15 . . . . 71.420000000000002 110.224 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.814 ' HA ' HG12 ' A' ' 170' ' ' VAL . 28.3 t -169.73 -89.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.68 -0.489 . . . . 62.310000000000002 109.68 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.75 33.6 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.993 -0.623 . . . . 43.100000000000001 114.329 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 35.2 Cg_endo -64.02 154.65 69.13 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.404 2.736 . . . . 73.430000000000007 114.061 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.492 ' HA ' ' HG3' ' A' ' 171' ' ' PRO . 5.6 Cg_exo -78.14 163.42 27.97 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.555 2.837 . . . . 74.409999999999997 112.89 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 166' ' ' TYR . 64.8 tttm -38.4 -26.13 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.076 -0.511 . . . . 60.329999999999998 111.511 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' PRO . 10.8 t70 -50.56 -41.52 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 74.430000000000007 111.898 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 105' ' ' PRO . 13.9 t -73.73 -14.28 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.983 0.735 . . . . 70.120000000000005 112.983 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.05 -144.9 41.52 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.054 -1.07 . . . . 55.329999999999998 112.13 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 163' ' ' GLN . 43.8 tp -67.46 130.87 44.43 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.405 -0.468 . . . . 72.549999999999997 111.016 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 6.5 p80 -130.48 126.31 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 73.439999999999998 110.307 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -88.22 125.39 34.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.672 -0.694 . . . . 73.030000000000001 110.588 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -116.59 140.41 49.42 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.446 0.466 . . . . 75.450000000000003 110.231 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 161' ' ' TYR . 39.1 mt -123.91 125.51 71.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.554 0.692 . . . . 73.209999999999994 111.971 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.703 ' C ' HD22 ' A' ' 117' ' ' LEU . 20.6 m-85 -88.56 136.34 33.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.138 -0.937 . . . . 74.530000000000001 109.681 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.728 HD23 HG23 ' A' ' 61' ' ' VAL . 3.0 mm? -124.34 137.52 54.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 71.400000000000006 111.033 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 119' ' ' TYR . 4.7 tt -127.05 135.29 50.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.385 -0.598 . . . . 61.240000000000002 109.385 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.833 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.5 m-85 -132.29 143.46 49.91 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.138 -0.483 . . . . 61.240000000000002 111.159 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -72.45 139.58 47.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 72.319999999999993 109.278 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HB3' ' C ' ' A' ' 55' ' ' LEU . 4.5 tt0 -123.91 127.31 47.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 112.653 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -104.2 -38.89 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.258 -0.883 . . . . 75.239999999999995 109.085 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -107.05 129.28 54.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.326 -0.852 . . . . 75.099999999999994 110.947 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -67.51 152.32 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.853 -0.612 . . . . 74.230000000000004 111.927 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.607 HD13 ' HD2' ' A' ' 151' ' ' HIS . 2.4 pt -136.0 147.71 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.891 -0.595 . . . . 71.420000000000002 111.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -49.97 12.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.414 -0.357 . . . . 73.209999999999994 111.399 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.919 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 61.24 33.34 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 63.5 112.02 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.7 p 53.32 156.57 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 112.851 0.686 . . . . 71.439999999999998 112.851 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.32 148.6 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.622 2.215 . . . . 72.420000000000002 113.188 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.983 HG23 ' CE1' ' A' ' 95' ' ' HIS . 2.7 p -59.86 116.12 3.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 64.109999999999999 112.611 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 131' ' ' ILE . 7.4 mm -81.75 120.99 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.046 -0.724 . . . . 72.109999999999999 109.046 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.5 m -75.39 149.07 38.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 70.239999999999995 112.15 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.585 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 34.2 t30 -55.5 -36.38 66.61 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 121.411 0.624 . . . . 74.329999999999998 109.538 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 177' ' ' ILE . 33.4 p -78.39 8.78 4.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.552 -0.749 . . . . 74.510000000000005 111.727 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.55 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 1.7 m -64.1 131.59 47.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.642 0.258 . . . . 75.230000000000004 110.729 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 26.1 ttt85 -76.3 169.98 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 75.209999999999994 113.212 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 140' ' ' LEU . 88.5 m -49.77 160.37 0.31 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.4 -1.273 . . . . 63.310000000000002 112.037 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.516 ' H ' HD11 ' A' ' 140' ' ' LEU . . . 96.04 -38.22 3.18 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.994 -1.003 . . . . 64.25 112.038 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 23.3 mmt180 -82.82 -37.75 24.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 73.420000000000002 111.462 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.35 -50.37 71.7 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.602 0.593 . . . . 72.209999999999994 112.602 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.485 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 60.1 m-20 -44.26 68.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.82 1.415 . . . . 72.329999999999998 114.82 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 140' ' ' LEU . 23.4 t80 -149.9 126.7 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.893 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -78.76 100.14 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 111.183 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -47.61 -33.81 7.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 111.728 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.7 ttp85 -47.66 -35.11 8.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.736 0.303 . . . . 74.439999999999998 110.874 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -51.9 -40.63 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.885 0.374 . . . . 75.409999999999997 110.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.606 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 28.9 m-85 -46.83 -43.13 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.483 . . . . 63.149999999999999 110.086 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.76 -38.16 86.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.706 -0.679 . . . . 74.310000000000002 110.941 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.98 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 74.129999999999995 111.367 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -53.79 -51.28 63.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.517 -0.311 . . . . 55.530000000000001 111.173 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.607 ' HD2' HD13 ' A' ' 125' ' ' ILE . 28.9 t-80 -78.42 -5.7 53.13 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.536 -0.542 . . . . 73.010000000000005 109.536 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.67 69.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.661 -0.78 . . . . 74.329999999999998 112.236 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.625 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . 14.7 mt -63.05 -25.31 68.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.169 -0.678 . . . . 61.450000000000003 109.169 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 31.62 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.788 -1.096 . . . . 74.530000000000001 113.888 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' LEU . 9.9 pt-20 -73.63 124.17 90.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.47 0.544 . . . . 54.229999999999997 112.47 -177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 73.2 Cg_endo -81.51 137.33 10.25 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.438 2.092 . . . . 62.530000000000001 111.692 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 118' ' ' LEU . 37.6 pt -83.27 -35.23 11.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.3 0.571 . . . . 75.200000000000003 110.712 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.497 ' CB ' HD11 ' A' ' 17' ' ' ILE . . . -142.74 150.67 40.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 55.399999999999999 111.059 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -152.09 158.91 43.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.461 . . . . 73.239999999999995 111.931 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -154.82 122.34 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.541 -0.911 . . . . 73.409999999999997 108.541 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.543 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -126.85 157.33 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 73.129999999999995 112.163 -177.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 4.1 p90 -162.53 163.04 27.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 62.509999999999998 110.767 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -110.7 136.79 49.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.181 0.515 . . . . 71.0 111.282 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.6 134.91 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.375 -0.83 . . . . 70.109999999999999 110.411 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -106.87 149.0 27.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.022 -0.362 . . . . 75.239999999999995 110.022 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.644 ' CG ' HG11 ' A' ' 170' ' ' VAL . 18.3 m-30 -128.46 125.28 38.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 64.219999999999999 110.998 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.14 -135.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.525 -0.761 . . . . 74.209999999999994 111.303 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 7.1 t70 -94.99 -43.44 8.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.903 -0.589 . . . . 74.540000000000006 110.989 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.529 ' HA ' HD12 ' A' ' 172' ' ' ILE . 28.9 t80 -51.95 -29.82 22.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 73.030000000000001 110.83 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 103' ' ' SER . 23.3 t -71.38 -58.16 4.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.955 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.521 ' HG2' ' O ' ' A' ' 168' ' ' ASP . 18.0 Cg_endo -57.55 -28.45 81.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.641 2.227 . . . . 64.010000000000005 112.727 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 169' ' ' TYR . 65.2 mt -45.53 -39.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.591 0.234 . . . . 70.030000000000001 111.193 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 48.0 ttm-85 -46.91 -36.44 7.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 71.219999999999999 110.632 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.402 ' HA ' HG13 ' A' ' 177' ' ' ILE . 35.0 m120 -54.62 -34.47 62.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.67 -0.695 . . . . 51.219999999999999 111.692 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -53.83 -40.46 66.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.937 0.399 . . . . 71.430000000000007 111.362 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.2 m -77.45 0.81 21.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.604 0.594 . . . . 74.120000000000005 112.604 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.3 mt -70.4 129.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 75.010000000000005 111.933 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 177' ' ' ILE . 4.7 m -165.34 88.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.695 -0.684 . . . . 71.310000000000002 110.816 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 135' ' ' THR . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.779 -1.012 . . . . 71.230000000000004 112.086 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG12 ' A' ' 5' ' ' VAL . 6.0 p-10 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.927 0.394 . . . . 73.400000000000006 111.776 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 8.8 t70 -51.77 -54.8 24.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 70.340000000000003 110.695 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.1 pt -148.48 60.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.514 0.673 . . . . 63.350000000000001 109.959 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 2' ' ' ASP . 8.3 p -127.71 138.25 32.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 73.430000000000007 110.159 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 82.6 Cg_endo -85.0 34.02 3.92 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.974 -1.261 . . . . 74.109999999999999 112.858 0.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 59.6 t0 -59.4 -54.0 51.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.415 -0.357 . . . . 73.239999999999995 110.973 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.0 m -164.24 -32.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.03 -0.532 . . . . 75.530000000000001 111.986 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD23 ' HD3' ' A' ' 13' ' ' PRO . 35.3 tp -157.03 144.56 18.94 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.332 0.587 . . . . 71.450000000000003 112.028 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.37 -19.1 63.84 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.974 0.731 . . . . 64.439999999999998 112.974 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.599 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -161.22 135.46 7.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.523 0.194 . . . . 51.520000000000003 111.523 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -72.24 116.12 45.72 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.708 0.29 . . . . 74.239999999999995 111.521 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.3 Cg_endo -95.72 -125.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.687 2.925 . . . . 63.530000000000001 112.151 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.35 -42.05 0.06 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.456 -0.338 . . . . 65.430000000000007 110.923 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.11 173.48 14.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.641 -0.79 . . . . 54.140000000000001 112.733 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.8 t -121.59 161.69 21.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.435 0.636 . . . . 42.109999999999999 111.519 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 118' ' ' LEU . 8.1 mt -105.44 154.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.683 -1.144 . . . . 63.329999999999998 109.25 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.1 mmpt? -102.9 102.33 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.926 -0.579 . . . . 74.5 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.788 ' HB ' HG22 ' A' ' 27' ' ' VAL . 54.8 t -109.66 109.69 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.098 -0.704 . . . . 73.450000000000003 109.098 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 20' ' ' ILE . 2.5 mp -90.14 144.37 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.209 0.528 . . . . 71.239999999999995 111.082 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.75 -94.39 0.34 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.266 -0.879 . . . . 71.129999999999995 112.524 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.64 -43.52 99.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.068 -0.587 . . . . 60.210000000000001 113.522 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 20' ' ' ILE . 2.4 m-20 179.14 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.923 0.868 . . . . 70.530000000000001 109.811 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -98.52 -40.88 8.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.465 -1.243 . . . . 75.230000000000004 111.411 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.915 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.6 pt? -69.41 141.05 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 111.127 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 6.0 pm0 -139.28 148.75 43.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 75.109999999999999 110.101 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' A' ' 19' ' ' VAL . 9.3 m -62.46 147.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.279 -0.418 . . . . 72.239999999999995 111.842 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.49 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 70.0 mttt -140.93 103.44 4.48 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.953 0.723 . . . . 74.329999999999998 112.953 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.503 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.4 mp0 35.63 67.72 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.691 0.997 . . . . 72.120000000000005 113.691 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.95 -10.42 57.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.222 -0.513 . . . . 62.310000000000002 113.629 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 t-20 -47.0 129.67 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 63.340000000000003 110.985 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 163' ' ' GLN . 62.6 tt0 -102.79 132.63 48.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.46 -0.791 . . . . 71.030000000000001 111.246 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -100.86 135.49 42.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.087 0.47 . . . . 72.120000000000005 110.948 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.547 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 7.8 p -138.64 164.79 37.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.455 -0.793 . . . . 74.439999999999998 109.974 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 84.9 Cg_endo -81.85 -29.31 5.97 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.303 -1.124 . . . . 64.120000000000005 113.155 0.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.2 t -161.45 35.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.154 0.502 . . . . 71.219999999999999 111.315 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -84.42 0.27 50.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.310000000000002 110.025 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 33' ' ' LEU . 33.4 m -83.91 -3.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.736 -1.12 . . . . 74.129999999999995 112.646 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -65.88 6.19 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.856 0.317 . . . . 75.409999999999997 111.856 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -96.89 145.84 25.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.39 0.614 . . . . 71.140000000000001 111.749 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.686 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.4 pm0 -62.75 130.83 94.07 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 54.420000000000002 109.318 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 15.3 Cg_exo -69.0 126.09 13.36 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.721 1.614 . . . . 34.329999999999998 112.664 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -100.13 105.27 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.752 -0.462 . . . . 70.299999999999997 109.752 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 91' ' ' PRO . 6.0 p -82.41 140.81 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.525 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 33.1 m -164.98 121.91 1.52 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.672 0.272 . . . . 64.219999999999999 111.679 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 6.1 p90 -84.87 29.38 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.127 -0.694 . . . . 75.439999999999998 109.127 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' SER . 11.1 t -46.29 123.14 4.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.2 -0.909 . . . . 70.310000000000002 110.738 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.95 -24.83 30.64 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.481 -0.648 . . . . 52.020000000000003 111.481 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 16' ' ' THR . 6.6 mp -87.68 -37.17 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.608 0.242 . . . . 74.209999999999994 110.75 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -50.27 138.39 16.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.802 -0.359 . . . . 71.099999999999994 110.761 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.13 -71.78 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.831 -0.699 . . . . 60.200000000000003 111.909 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -148.73 108.94 4.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 72.140000000000001 110.366 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 p -158.1 141.53 15.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.194 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -73.16 -38.9 66.03 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.584 0.707 . . . . 74.430000000000007 109.513 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 26.2 mt -155.8 162.4 40.49 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.867 -1.061 . . . . 43.399999999999999 109.961 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD12 ' CZ2' ' A' ' 46' ' ' TRP . 80.6 mt -128.27 168.04 16.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.778 0.323 . . . . 73.219999999999999 110.42 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.879 HG23 HG12 ' A' ' 82' ' ' VAL . 99.1 m -143.47 133.11 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.426 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -127.77 138.62 52.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.957 -0.565 . . . . 75.109999999999999 110.032 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 58' ' ' LEU . 52.3 mt -149.04 131.66 15.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.775 0.657 . . . . 72.439999999999998 112.775 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 114' ' ' TYR . 37.8 ttm -94.84 122.18 37.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.139 -0.937 . . . . 74.409999999999997 108.797 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 62' ' ' ASP . 4.9 t -109.13 -131.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.712 0.264 . . . . 72.299999999999997 111.712 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.637 ' H ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.84 80.94 0.27 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 121.278 0.561 . . . . 74.439999999999998 111.162 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.9 84.49 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.297 1.998 . . . . 51.409999999999997 112.405 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -126.23 87.57 2.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 70.409999999999997 110.564 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.6 135.14 1.09 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 72.019999999999996 110.858 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 15.4 Cg_exo -67.67 -18.37 9.21 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.752 -1.353 . . . . 64.150000000000006 109.501 -1.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.9 t -157.25 131.7 8.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.781 -1.554 . . . . 74.340000000000003 107.934 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 4.3 tmm_? -50.97 -31.92 19.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.454 0.645 . . . . 74.329999999999998 109.832 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.41 -37.97 89.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.192 -0.913 . . . . 61.329999999999998 111.766 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.727 ' H ' HG23 ' A' ' 67' ' ' THR . 2.0 m-20 -141.21 72.16 27.04 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-O 121.195 0.521 . . . . 75.510000000000005 109.744 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 13.8 Cg_exo -67.04 65.48 0.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.105 2.537 . . . . 63.020000000000003 112.692 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -48.69 -45.88 39.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.587 -0.733 . . . . 75.219999999999999 112.346 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.458 ' HE1' ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -123.04 44.98 2.52 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.087 0.403 . . . . 71.010000000000005 112.087 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -70.69 133.0 46.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 64.549999999999997 110.896 179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 144' ' ' ALA . 86.9 mt-10 -91.32 178.47 5.96 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.478 0.711 . . . . 74.239999999999995 110.465 -0.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.715 HG21 ' HA3' ' A' ' 104' ' ' GLY . 7.3 tp -113.85 176.35 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.789 -0.641 . . . . 73.230000000000004 109.591 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.626 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.8 mm? -49.0 117.56 2.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.58 -0.526 . . . . 72.519999999999996 109.58 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.7 173.64 10.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.739 -0.664 . . . . 75.299999999999997 110.296 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.566 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.5 t-105 -99.51 113.1 25.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 74.239999999999995 111.007 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 14.4 m -131.85 128.22 38.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.594 -0.73 . . . . 74.530000000000001 109.848 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.49 143.06 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.233 0.54 . . . . 73.430000000000007 110.225 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.879 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.52 161.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.771 -0.649 . . . . 70.219999999999999 112.29 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 95' ' ' HIS . 23.4 p30 55.57 43.06 28.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.677 -1.147 . . . . 61.009999999999998 112.522 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.019 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.0 mm -83.01 130.65 56.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.926 -0.768 . . . . 65.510000000000005 108.926 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.04 128.88 30.51 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 121.454 1.436 . . . . 65.540000000000006 111.111 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.85 57.74 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.642 0.617 . . . . 74.219999999999999 114.642 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.5 p -178.69 36.91 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.579 0.689 . . . . 44.530000000000001 111.378 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 90' ' ' ASN . 30.5 m120 -121.3 -2.0 9.62 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.49 -0.323 . . . . 64.040000000000006 110.93 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 70.05 -38.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 51.399999999999999 111.387 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 88' ' ' ASN . 13.6 p30 -129.32 155.63 79.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.967 0.413 . . . . 74.109999999999999 110.391 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 84' ' ' ILE . 92.6 Cg_endo -71.59 55.52 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.226 2.617 . . . . 54.329999999999998 113.289 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.7 t -97.16 -54.97 3.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.342 0.497 . . . . 72.540000000000006 112.342 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.59 -10.75 25.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 115.21 0.844 . . . . 63.109999999999999 115.21 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 1.019 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -96.51 173.11 29.49 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.268 -0.968 . . . . 71.519999999999996 113.647 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.498 ' HB2' HD21 ' A' ' 83' ' ' ASN . 5.9 m80 -68.35 128.82 37.96 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.618 0.599 . . . . 72.510000000000005 112.618 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.971 ' H ' HG22 ' A' ' 130' ' ' THR . 86.1 p -96.5 97.25 9.27 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.379 -0.373 . . . . 74.430000000000007 110.288 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 147' ' ' PHE . 79.4 mt -56.94 -40.04 75.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 64.049999999999997 109.787 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.87 120.69 8.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.563 -1.199 . . . . 73.530000000000001 109.1 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.649 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 47.8 t0 -59.96 148.46 35.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 64.329999999999998 112.676 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 17.3 p90 -70.29 152.7 43.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.719 -0.673 . . . . 71.140000000000001 110.682 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.42 166.51 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 60.310000000000002 111.244 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.91 3.38 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.855 -0.611 . . . . 42.32 112.839 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.3 p -162.94 105.63 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 71.409999999999997 110.454 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.715 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -53.05 -47.38 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.533 -0.758 . . . . 64.230000000000004 113.044 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HB2' HG21 ' A' ' 109' ' ' THR . 74.9 Cg_endo -78.26 129.01 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.418 2.079 . . . . 63.450000000000003 112.217 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.58 158.87 53.57 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.731 2.287 . . . . 73.310000000000002 113.566 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 5.0 pttp -39.89 -27.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.119 -0.946 . . . . 64.140000000000001 112.158 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -50.38 -34.12 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.126 -0.488 . . . . 75.349999999999994 111.627 -178.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 105' ' ' PRO . 6.8 t -93.62 4.7 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.566 -0.454 . . . . 52.5 111.433 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.17 -98.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.206 -0.452 . . . . 71.25 112.865 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 163' ' ' GLN . 53.3 tp -61.0 145.23 51.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.575 0.703 . . . . 64.420000000000002 111.416 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 166' ' ' TYR . 17.3 m-70 -139.75 114.02 9.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.191 -1.04 . . . . 73.439999999999998 108.191 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.568 ' HG3' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -100.3 123.87 45.06 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.283 -0.636 . . . . 72.310000000000002 109.283 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.402 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 35.6 m-85 -119.64 138.46 53.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.967 0.413 . . . . 73.409999999999997 110.353 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 58.7 mt -122.66 122.3 65.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.311 -0.859 . . . . 74.439999999999998 111.923 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -98.9 137.28 37.69 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.748 -0.66 . . . . 73.129999999999995 109.86 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.1 tm? -123.97 138.28 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.552 -0.536 . . . . 74.450000000000003 109.552 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.834 ' N ' HD13 ' A' ' 117' ' ' LEU . 65.3 tp -120.66 141.54 50.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 122.578 0.351 . . . . 62.539999999999999 110.744 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.584 ' CD2' HD22 ' A' ' 153' ' ' LEU . 37.7 t80 -142.44 136.73 29.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.868 -0.606 . . . . 74.299999999999997 111.047 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' A' ' 122' ' ' GLU . 4.9 tmm_? -79.51 121.25 24.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.785 -0.45 . . . . 74.109999999999999 109.785 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.628 HE22 HG12 ' A' ' 125' ' ' ILE . 1.9 tt0 -98.93 130.85 45.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.014 0.435 . . . . 74.310000000000002 110.871 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.41 ' HB2' ' NH1' ' A' ' 120' ' ' ARG . 65.1 tt0 -99.07 -41.28 7.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.834 -0.621 . . . . 54.450000000000003 110.202 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -111.92 130.6 55.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 75.530000000000001 110.949 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.23 146.84 52.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 65.540000000000006 112.085 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.628 HG12 HE22 ' A' ' 121' ' ' GLN . 22.3 pt -126.68 140.24 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.957 -0.565 . . . . 62.32 110.783 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.1 -44.17 60.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.087 0.47 . . . . 75.310000000000002 111.66 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.767 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 29.7 38.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.154 1.168 . . . . 53.539999999999999 114.154 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 p 56.91 158.34 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.803 0.668 . . . . 74.409999999999997 112.803 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.2 158.26 9.79 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.73 2.286 . . . . 70.540000000000006 113.11 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.971 HG22 ' H ' ' A' ' 96' ' ' SER . 41.2 p -58.89 131.19 50.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.318 -0.855 . . . . 65.510000000000005 111.963 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 139' ' ' ARG . 40.9 mm -103.56 124.96 58.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.522 0.201 . . . . 62.530000000000001 110.491 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 99' ' ' ASP . 47.8 t -80.2 154.99 27.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.268 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.649 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.1 p30 -52.69 -35.14 54.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 53.240000000000002 110.137 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 176' ' ' THR . 12.2 t -68.56 11.49 0.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.231 -0.895 . . . . 74.530000000000001 112.503 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' ILE . 15.0 t -62.02 132.39 52.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.79 0.329 . . . . 72.209999999999994 110.681 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' HG3' ' N ' ' A' ' 137' ' ' THR . 44.1 tpt85 -58.03 159.56 5.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 111.71 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.487 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 27.8 m -51.57 146.95 6.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 75.150000000000006 110.119 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.34 4.73 17.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 73.049999999999997 111.758 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HD2' HG21 ' A' ' 131' ' ' ILE . 45.9 ttm-85 -144.05 37.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 110.776 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' ASN . 0.3 OUTLIER -114.92 -56.97 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 75.230000000000004 110.605 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.568 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 16.6 m-20 -62.24 67.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.07 -0.513 . . . . 72.420000000000002 111.986 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 146' ' ' ASP . 44.4 t80 -140.4 131.35 26.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.017 0.437 . . . . 75.530000000000001 111.061 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -71.05 108.02 4.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 74.530000000000001 109.458 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.466 ' H ' ' CD ' ' A' ' 75' ' ' GLU . . . -52.27 -40.28 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.303 0.573 . . . . 61.119999999999997 111.464 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.587 HH12 ' HG ' ' A' ' 117' ' ' LEU . 1.6 tpt180 -57.4 -28.68 63.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.438 -0.801 . . . . 74.219999999999999 111.996 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 6.0 t70 -48.72 -47.48 41.22 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.882 -0.784 . . . . 64.120000000000005 108.882 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 97' ' ' LEU . 12.2 m-30 -59.14 -40.05 84.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.151 -0.931 . . . . 73.230000000000004 109.852 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.646 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.762 -0.654 . . . . 71.120000000000005 111.15 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.74 24.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.063 -0.517 . . . . 71.409999999999997 111.887 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.605 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -68.7 -44.23 74.38 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.841 0.682 . . . . 71.340000000000003 112.841 -178.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 4.9 m-70 -72.69 7.77 1.78 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 110.734 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.24 2.78 63.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.117 -0.563 . . . . 62.530000000000001 112.332 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 148' ' ' ALA . 3.2 mt -68.71 16.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.543 0.211 . . . . 43.310000000000002 110.589 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.21 -66.24 1.25 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.874 -0.679 . . . . 54.450000000000003 112.189 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.52 122.18 84.63 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.036 -0.357 . . . . 73.409999999999997 110.036 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.773 ' HB3' HD21 ' A' ' 117' ' ' LEU . 89.0 Cg_endo -87.72 127.94 2.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.513 2.142 . . . . 72.430000000000007 113.014 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.547 HD11 ' HG ' ' A' ' 118' ' ' LEU . 43.3 pt -77.04 -34.14 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.127 0.489 . . . . 71.219999999999999 110.209 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.67 157.86 37.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 74.450000000000003 110.851 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.449 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -154.16 171.34 19.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.008 0.433 . . . . 64.310000000000002 111.156 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.8 t-20 -170.58 133.57 1.02 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.079 -1.082 . . . . 71.409999999999997 108.079 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.534 ' CE1' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -135.4 158.41 44.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.76 -0.2 . . . . 64.010000000000005 111.466 -177.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.661 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.9 p90 -146.6 156.83 43.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.974 -0.557 . . . . 62.409999999999997 112.338 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.568 ' HG2' ' HG3' ' A' ' 113' ' ' ARG . 14.2 mt-30 -119.09 124.68 47.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.128 -0.942 . . . . 75.329999999999998 109.759 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 166' ' ' TYR . . . -156.68 138.43 14.22 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.635 -0.426 . . . . 64.239999999999995 111.498 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.446 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 6.5 pm0 -100.17 135.52 41.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.27 -0.641 . . . . 60.210000000000001 109.27 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.866 ' HB3' HG11 ' A' ' 170' ' ' VAL . 6.2 m-85 -121.21 142.64 49.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.341 -0.391 . . . . 74.239999999999995 111.814 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.4 m-20 -66.24 -168.21 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.191 -0.913 . . . . 60.43 113.022 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t70 -85.9 -32.77 21.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.986 -1.006 . . . . 74.450000000000003 111.57 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.499 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.6 t80 -61.14 -32.58 72.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.521 0.563 . . . . 74.030000000000001 112.521 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.992 HG13 ' HD3' ' A' ' 171' ' ' PRO . 1.5 p -72.29 -48.79 9.79 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.761 1.023 . . . . 72.349999999999994 113.761 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.992 ' HD3' HG13 ' A' ' 170' ' ' VAL . 20.0 Cg_endo -59.25 -17.22 38.22 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.777 1.651 . . . . 74.439999999999998 112.519 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.542 HD11 ' HD2' ' A' ' 175' ' ' LYS . 10.9 tp -46.15 -30.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.012 0.434 . . . . 72.129999999999995 111.156 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 173' ' ' ARG . 10.6 tpp85 -44.79 -25.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 71.25 110.588 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.3 p30 -50.5 -36.22 32.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.957 -0.565 . . . . 65.109999999999999 111.339 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.542 ' HD2' HD11 ' A' ' 172' ' ' ILE . 8.4 mtpm? -56.7 -22.19 33.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.368 . . . . 73.129999999999995 111.128 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.473 HG22 ' OG1' ' A' ' 134' ' ' THR . 16.6 m -74.96 -7.89 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.802 -0.635 . . . . 74.540000000000006 111.457 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' THR . 44.2 mm -68.52 79.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 74.209999999999994 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.419 ' HA ' ' CD ' ' A' ' 136' ' ' ARG . 28.6 m -139.33 13.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.41 0.522 . . . . 51.149999999999999 112.41 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-O 118.125 -1.375 . . . . 71.239999999999995 112.932 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' OD2' ' NH2' ' A' ' 145' ' ' ARG . 6.4 m-20 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 110.526 -0.176 . . . . 55.439999999999998 110.526 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.18 -71.12 0.77 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.598 0.592 . . . . 61.399999999999999 112.598 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.578 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 6.9 pt -99.39 65.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 72.230000000000004 112.266 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 6' ' ' PRO . 8.8 p -141.61 143.53 29.8 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.07 -0.514 . . . . 73.230000000000004 110.659 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 5' ' ' VAL . 8.0 Cg_exo -73.57 17.81 2.65 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 124.905 -0.873 . . . . 62.32 112.626 0.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.578 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 2.3 m-20 -45.8 -59.23 2.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.851 . . . . 72.400000000000006 111.941 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.0 m -161.79 -40.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 40.450000000000003 111.54 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 161' ' ' TYR . 47.0 tp -151.24 135.26 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.36 0.6 . . . . 73.140000000000001 111.951 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -75.48 37.46 0.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 73.340000000000003 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 179.03 -148.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.608 -0.724 . . . . 61.420000000000002 109.856 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.5 p -152.33 119.2 3.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.55 0.215 . . . . 60.109999999999999 110.85 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.586 ' HD3' HD23 ' A' ' 9' ' ' LEU . 49.9 Cg_endo -97.13 135.91 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.077 2.518 . . . . 65.329999999999998 112.77 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -24.89 67.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 74.450000000000003 110.334 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.54 -129.64 1.75 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.414 -0.812 . . . . 71.109999999999999 111.487 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -164.32 159.58 20.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.513 . . . . 75.430000000000007 109.614 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.24 135.0 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.218 -0.446 . . . . 65.310000000000002 110.963 -179.06 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -77.69 102.3 7.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.386 -0.598 . . . . 73.219999999999999 109.386 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 97.6 t -107.97 110.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.402 0.62 . . . . 62.109999999999999 109.735 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' LEU . 61.3 mt -101.5 124.49 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 71.209999999999994 110.264 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 1.3 m-85 -73.98 -40.01 63.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.333 -0.849 . . . . 74.329999999999998 112.112 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -126.38 -55.14 0.15 Allowed Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.179 -1.01 . . . . 75.530000000000001 112.754 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -179.69 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 72.530000000000001 108.328 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -93.08 -45.13 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.725 -1.125 . . . . 70.420000000000002 109.214 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.3 pt? -69.22 138.5 54.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.768 -0.651 . . . . 71.510000000000005 109.375 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.462 ' CD ' ' NZ ' ' A' ' 28' ' ' LYS . 53.4 tt0 -143.74 139.05 29.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.072 -0.967 . . . . 65.420000000000002 111.001 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 16.0 m -86.57 106.81 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.22 0.533 . . . . 61.009999999999998 110.645 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' CD ' ' A' ' 26' ' ' GLU . 27.1 mttp -98.44 119.84 37.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.064 0.935 . . . . 75.310000000000002 112.949 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.6 mp0 30.28 67.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.566 -1.652 . . . . 72.129999999999995 115.049 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.42 8.81 76.56 Favored Glycine 0 C--N 1.329 0.184 0 N-CA-C 115.528 0.971 . . . . 74.510000000000005 115.528 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.76 149.92 21.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.864 0.832 . . . . 74.109999999999999 110.742 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -91.25 133.4 35.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 72.540000000000006 109.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 10.3 mp -106.0 126.34 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 61.539999999999999 110.648 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 17.0 p -143.79 160.88 48.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.467 -0.788 . . . . 63.509999999999998 109.937 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.1 Cg_exo -75.98 -40.03 1.28 Allowed 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.522 -1.032 . . . . 72.030000000000001 112.908 0.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.7 p -151.98 28.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 64.239999999999995 111.591 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 1.8 pt20 -60.0 -10.4 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.521 0.677 . . . . 62.340000000000003 109.999 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 164' ' ' ALA . 34.5 m -82.97 25.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.962 -1.017 . . . . 75.140000000000001 110.858 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.526 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -75.99 -21.19 57.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.285 -0.871 . . . . 74.209999999999994 111.085 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -107.76 152.52 24.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.155 0.503 . . . . 72.329999999999998 111.481 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -63.98 146.39 97.3 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.449 -0.796 . . . . 64.209999999999994 111.793 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.614 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 94.7 Cg_endo -79.13 129.24 8.7 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.695 2.264 . . . . 71.310000000000002 112.805 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.3 mm -104.19 117.65 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.509 -0.182 . . . . 62.539999999999999 110.509 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.9 t -86.55 142.5 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 71.219999999999999 111.788 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -156.38 145.02 20.06 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.125 0.488 . . . . 72.450000000000003 110.668 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 3.3 p90 -126.32 35.34 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.187 0.518 . . . . 74.439999999999998 110.904 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -47.7 125.57 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 72.209999999999994 110.529 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -28.56 8.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 62.420000000000002 112.931 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -79.23 -42.18 26.55 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 109.228 -0.656 . . . . 75.219999999999999 109.228 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.707 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 31.6 tt0 -59.32 167.25 1.91 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.571 -0.74 . . . . 73.430000000000007 110.171 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . -177.48 -71.33 0.06 OUTLIER Glycine 0 C--O 1.229 -0.202 0 C-N-CA 120.708 -0.758 . . . . 64.109999999999999 112.14 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -148.86 109.74 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.124 0.488 . . . . 65.0 110.721 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 37.6 m -157.09 141.95 16.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 44.439999999999998 109.57 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.01 -38.08 85.33 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.643 0.735 . . . . 74.25 109.482 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 83' ' ' ASN . 64.6 mt -155.47 175.99 13.17 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.494 -1.23 . . . . 64.120000000000005 110.519 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 22.1 mt -146.71 158.91 44.01 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.222 -0.445 . . . . 72.439999999999998 109.944 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.675 HG23 HG12 ' A' ' 82' ' ' VAL . 3.2 m -123.21 127.79 49.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.226 -0.443 . . . . 54.450000000000003 111.119 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -123.84 117.58 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.454 -1.314 . . . . 74.319999999999993 107.454 178.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 80' ' ' SER . 86.0 mt -132.77 139.96 47.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.464 0.542 . . . . 34.32 112.464 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 78' ' ' HIS . 46.5 ttm -94.74 134.37 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.639 -0.875 . . . . 74.439999999999998 108.639 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.39 136.0 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.308 -0.406 . . . . 54.539999999999999 111.022 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 5.2 t70 164.53 94.43 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 115.414 -0.812 . . . . 72.040000000000006 110.281 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.56 84.02 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.583 1.522 . . . . 72.150000000000006 110.833 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 84.49 1.64 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.766 0.654 . . . . 73.329999999999998 112.766 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.3 133.71 1.07 Allowed Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.45 -0.5 . . . . 54.030000000000001 112.28 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.696 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 Cg_exo -57.63 -23.34 1.82 Allowed 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 122.997 -1.668 . . . . 71.340000000000003 108.893 -3.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -161.93 143.57 11.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 113.889 -1.505 . . . . 74.439999999999998 108.706 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 53.1 ttp180 -53.69 -17.59 2.38 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.226 0.536 . . . . 73.530000000000001 111.185 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.49 -32.44 66.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.397 -0.82 . . . . 72.239999999999995 111.445 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.2 t0 -143.83 63.33 11.8 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 108.82 -0.807 . . . . 65.530000000000001 108.82 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 53.8 Cg_endo -72.3 51.74 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.23 2.62 . . . . 74.439999999999998 112.857 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -51.35 -44.11 61.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.391 -0.368 . . . . 63.020000000000003 111.945 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE1' HD13 ' A' ' 76' ' ' ILE . 15.6 p90 -108.22 34.76 3.44 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.523 -0.471 . . . . 71.430000000000007 111.629 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.518 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 35.8 ttp85 -76.44 144.49 39.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.814 -0.439 . . . . 72.340000000000003 109.814 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 29.8 mp0 -92.28 142.69 27.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.759 0.823 . . . . 63.539999999999999 110.602 0.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' CE1' ' A' ' 73' ' ' TYR . 5.6 tp -72.47 174.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.771 -0.372 . . . . 72.349999999999994 110.241 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.554 ' HB2' HG11 ' A' ' 101' ' ' VAL . 3.2 mm? -52.15 133.46 33.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.428 0.633 . . . . 64.340000000000003 111.33 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.469 ' HA ' ' SD ' ' A' ' 60' ' ' MET . 2.0 p-80 -129.64 157.05 43.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.861 -1.063 . . . . 73.329999999999998 109.458 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -99.35 117.67 34.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 54.329999999999998 109.923 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.698 ' HB3' HD12 ' A' ' 97' ' ' LEU . 74.3 m -141.38 138.02 32.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.443 0.639 . . . . 64.430000000000007 111.7 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.521 HG12 ' CD1' ' A' ' 84' ' ' ILE . 11.9 t -143.52 123.21 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 114.666 -1.152 . . . . 63.509999999999998 108.666 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 97' ' ' LEU . 18.7 m -123.71 -177.4 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.066 -0.515 . . . . 74.319999999999993 110.367 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.788 ' OD1' HG23 ' A' ' 82' ' ' VAL . 7.1 m120 62.82 30.2 16.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 109.951 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.977 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -77.86 108.99 8.45 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.184 -0.606 . . . . 65.420000000000002 109.673 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 87' ' ' SER . 19.2 Cg_endo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.43 1.42 . . . . 74.040000000000006 110.69 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.05 71.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.433 -0.413 . . . . 62.420000000000002 113.655 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' PRO . 32.3 m -175.16 43.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.297 0.639 . . . . 71.329999999999998 110.179 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 19.0 m120 -135.78 -26.59 1.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.412 0.893 . . . . 74.120000000000005 113.412 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 9.0 tt0 77.57 -16.42 0.65 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.314 0.578 . . . . 74.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 88' ' ' ASN . 19.9 p30 -150.96 154.43 34.3 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.142 -0.935 . . . . 70.129999999999995 110.386 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 45.67 1.75 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.374 2.716 . . . . 71.140000000000001 112.994 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -103.97 -1.96 26.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 61.32 111.829 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.2 -14.89 13.58 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.751 -0.738 . . . . 71.340000000000003 114.338 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.977 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -87.97 177.24 46.19 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.572 -0.823 . . . . 71.239999999999995 113.637 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -68.23 114.29 6.58 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.812 0.301 . . . . 60.329999999999998 111.812 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.513 ' O ' HG22 ' A' ' 130' ' ' THR . 30.7 m -70.84 96.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.947 -0.76 . . . . 71.420000000000002 108.947 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.82 HD21 HG22 ' A' ' 82' ' ' VAL . 24.6 mt -60.51 -59.52 5.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 75.409999999999997 110.503 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.61 125.17 35.52 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.25 -0.886 . . . . 51.119999999999997 109.223 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -59.96 156.15 15.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.596 0.712 . . . . 74.150000000000006 112.614 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 3.3 t80 -68.59 141.99 55.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.822 -1.081 . . . . 74.150000000000006 112.138 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 77' ' ' LEU . 7.4 p -142.87 113.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 72.439999999999998 109.866 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.39 -64.62 1.31 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.891 -0.671 . . . . 74.510000000000005 112.981 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.3 p 178.85 98.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 72.400000000000006 110.487 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.614 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -72.83 -35.62 58.33 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.066 -0.587 . . . . 73.510000000000005 113.573 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 38.6 Cg_exo -62.27 143.14 93.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.149 2.566 . . . . 51.32 113.294 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.48 144.85 99.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.223 2.616 . . . . 74.5 113.165 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -48.92 -22.36 0.83 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.455 -0.793 . . . . 64.319999999999993 111.642 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.3 m-20 -50.82 -29.93 12.98 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.57 0.581 . . . . 74.329999999999998 112.57 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 112' ' ' HIS . 12.9 t -70.62 -15.22 62.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.326 0.584 . . . . 71.25 110.418 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.68 -138.01 24.26 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 113.105 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.7 tp -65.27 118.95 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.413 -0.394 . . . . 60.310000000000002 111.991 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 109' ' ' THR . 94.3 m-70 -79.93 148.07 31.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -114.04 58.98 0.68 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 75.329999999999998 110.805 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 54.4 m-85 -69.14 132.72 47.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.49 0.662 . . . . 75.140000000000001 112.357 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.728 HG23 ' HD1' ' A' ' 161' ' ' TYR . 63.8 mt -122.25 134.31 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.102 . . . . 65.019999999999996 110.672 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 14.0 m-30 -104.21 137.79 41.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.061 -0.348 . . . . 65.010000000000005 110.061 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.0 tm? -119.69 131.97 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.699 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.731 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.0 tt -131.81 122.69 26.18 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.751 0.31 . . . . 60.130000000000003 111.633 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.668 ' N ' HD23 ' A' ' 118' ' ' LEU . 30.6 t80 -144.92 141.85 29.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.363 -0.38 . . . . 61.229999999999997 111.678 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.639 ' HA ' HD23 ' A' ' 56' ' ' LEU . 16.6 mtm105 -63.2 144.8 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.566 0.222 . . . . 74.409999999999997 111.295 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 30.4 tp60 -117.62 124.83 49.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.822 -0.807 . . . . 74.219999999999999 108.822 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.666 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -86.38 -38.97 16.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 73.450000000000003 112.753 -178.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -110.18 150.07 29.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.278 0.844 . . . . 74.400000000000006 113.278 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 1.7 tppp? -72.64 133.59 44.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.941 -1.027 . . . . 73.230000000000004 110.496 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.628 HD12 ' NE2' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -135.67 144.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 63.240000000000002 111.43 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -44.03 23.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.135 0.493 . . . . 74.420000000000002 110.848 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.643 ' HG3' HG21 ' A' ' 82' ' ' VAL . 47.8 mm-40 54.71 40.43 31.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.318 0.859 . . . . 64.239999999999995 113.318 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p 53.37 154.17 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 N-CA-C 113.673 0.99 . . . . 72.439999999999998 113.673 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.48 158.22 8.11 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.094 2.529 . . . . 41.109999999999999 113.009 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 96' ' ' SER . 23.8 p -58.86 122.45 13.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 72.439999999999998 111.164 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 131' ' ' ILE . 23.9 mm -94.45 121.11 44.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.42 0.629 . . . . 70.340000000000003 111.751 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.7 m -73.68 135.88 43.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.896 -1.047 . . . . 74.519999999999996 111.156 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 135' ' ' THR . 19.2 p-10 -58.71 -43.48 90.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.989 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 177' ' ' ILE . 41.0 p -70.09 22.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 112.189 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.9 t -74.1 133.56 42.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 72.549999999999997 111.285 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.903 ' HD2' HG22 ' A' ' 177' ' ' ILE . 14.8 mmm-85 -58.05 173.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.877 0.846 . . . . 75.409999999999997 112.873 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -41.04 157.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.148 -1.387 . . . . 63.229999999999997 113.036 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.71 -36.83 1.21 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.048 -0.978 . . . . 73.530000000000001 112.948 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -86.24 26.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.018 0.409 . . . . 72.530000000000001 111.324 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.2 mp -114.29 -54.82 2.56 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.06 -0.718 . . . . 71.129999999999995 109.06 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -53.75 121.98 8.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.425 -0.807 . . . . 73.329999999999998 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.461 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 9.8 t80 -173.53 123.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 74.230000000000004 110.488 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 17.1 p-10 -84.67 117.14 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 61.140000000000001 111.913 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.02 74.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 73.530000000000001 110.408 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' NH2' ' OD2' ' A' ' 2' ' ' ASP . 87.8 mtt180 -43.91 -36.89 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.623 -0.717 . . . . 74.439999999999998 111.406 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.445 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 24.5 t70 -49.41 -53.92 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.39 0.614 . . . . 73.230000000000004 110.498 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 5.3 m-30 -63.63 -34.53 78.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.495 -0.775 . . . . 73.0 110.482 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -59.81 -44.18 94.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.38 -0.6 . . . . 51.240000000000002 109.38 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.26 -57.32 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 71.140000000000001 111.908 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HG3' ' CD2' ' A' ' 151' ' ' HIS . 3.0 ptmm? -60.87 -53.14 60.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.717 0.265 . . . . 73.420000000000002 111.717 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.628 ' NE2' HD12 ' A' ' 125' ' ' ILE . 46.2 m170 -69.42 -12.15 61.42 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.478 -0.489 . . . . 74.310000000000002 111.178 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.11 25.21 71.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 71.239999999999995 112.34 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 10.6 mt -64.16 16.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.835 0.454 . . . . 74.230000000000004 111.759 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -51.77 -21.31 7.0 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.035 -0.602 . . . . 72.239999999999995 113.224 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.05 95.93 14.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.227 0.537 . . . . 74.530000000000001 110.579 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.558 ' HB3' HD21 ' A' ' 117' ' ' LEU . 78.9 Cg_endo -78.29 141.57 18.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.065 2.51 . . . . 74.430000000000007 114.106 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 119' ' ' TYR . 35.8 pt -82.79 -36.33 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 63.100000000000001 110.659 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -141.19 145.14 35.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.439999999999998 111.543 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.17 39.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.445 -0.798 . . . . 74.230000000000004 109.33 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 2.4 t-20 -171.12 127.28 0.69 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.264 -1.013 . . . . 72.329999999999998 108.264 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.728 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -115.8 156.86 25.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.912 -0.585 . . . . 74.25 111.047 -177.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 3.3 p90 -139.41 136.94 35.21 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.725 -0.671 . . . . 74.409999999999997 110.175 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 39.8 mt-30 -122.1 124.45 43.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.819 -0.628 . . . . 74.349999999999994 109.699 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -155.99 151.14 26.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 71.530000000000001 110.713 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.421 HE22 HG22 ' A' ' 34' ' ' THR . 7.0 pm0 -111.33 133.76 53.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.146 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -115.57 131.39 56.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.305 -0.628 . . . . 54.149999999999999 109.305 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 169' ' ' TYR . 72.9 m-20 -66.53 -178.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 74.420000000000002 112.413 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.47 28.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.542 -0.754 . . . . 64.200000000000003 111.959 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 167' ' ' ASP . 28.3 t80 -97.05 -45.71 6.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 63.119999999999997 110.526 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.602 ' CG2' ' HD3' ' A' ' 171' ' ' PRO . 16.0 m -60.38 -35.17 24.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 112.836 0.68 . . . . 72.5 112.836 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.602 ' HD3' ' CG2' ' A' ' 170' ' ' VAL . 73.1 Cg_exo -51.49 -35.61 56.14 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.187 1.258 . . . . 73.209999999999994 111.034 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.567 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 66.8 mt -48.31 -42.45 11.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 63.25 110.227 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 173' ' ' ARG . 1.9 tpm_? -57.22 -37.91 72.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.252 -0.886 . . . . 74.319999999999993 111.235 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 177' ' ' ILE . 8.4 p30 -65.73 -35.19 80.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.434 -0.506 . . . . 60.420000000000002 110.789 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -57.6 -27.42 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.282 -0.567 . . . . 75.400000000000006 109.597 179.281 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 m -73.68 -0.12 14.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.623 -0.717 . . . . 72.310000000000002 111.587 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.903 HG22 ' HD2' ' A' ' 136' ' ' ARG . 66.4 mt -64.64 129.74 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.803 -0.181 . . . . 50.350000000000001 110.584 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 177' ' ' ILE . 2.4 m -176.4 69.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 122.894 0.478 . . . . 73.430000000000007 111.297 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 118.768 -1.018 . . . . 62.200000000000003 112.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 72.9 m-20 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 111.445 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -75.57 -62.64 1.51 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.205 -0.452 . . . . 64.430000000000007 111.501 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' LEU . 18.5 pt -104.22 51.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.357 0.599 . . . . 73.239999999999995 111.014 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' HA ' ' A' ' 6' ' ' PRO . 11.1 p -135.56 139.94 32.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.639 -0.709 . . . . 52.219999999999999 109.862 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HA ' HG23 ' A' ' 5' ' ' VAL . 86.5 Cg_endo -82.15 37.7 1.33 Allowed 'Cis proline' 0 C--N 1.346 0.447 0 C-N-CA 123.744 -1.357 . . . . 72.140000000000001 112.762 0.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.8 t0 -64.73 -50.88 65.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.34 . . . . 65.430000000000007 110.471 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.8 m -163.74 -36.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.642 0.608 . . . . 65.129999999999995 112.642 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 4' ' ' ILE . 29.7 tp -157.31 164.23 37.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.093 0.473 . . . . 73.239999999999995 112.182 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -67.85 -38.0 82.58 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.869 0.366 . . . . 73.230000000000004 110.621 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -146.32 128.92 16.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 55.109999999999999 110.594 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 12' ' ' VAL . 8.7 p -60.53 123.78 75.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.339 0.496 . . . . 74.510000000000005 112.339 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HB3' ' HG2' ' A' ' 156' ' ' PRO . 46.0 Cg_endo -87.58 -121.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.37 2.714 . . . . 74.209999999999994 112.295 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -163.42 -45.96 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.075 -0.511 . . . . 63.439999999999998 110.186 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.93 -135.07 8.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.874 -0.679 . . . . 54.119999999999997 112.474 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 9.7 t -164.12 177.42 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 73.340000000000003 110.834 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.815 HG22 HG23 ' A' ' 19' ' ' VAL . 53.0 mt -124.3 128.56 73.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.981 -0.554 . . . . 62.140000000000001 110.895 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.8 mmpt? -86.87 108.77 18.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.433 -0.803 . . . . 72.430000000000007 109.372 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.815 HG23 HG22 ' A' ' 17' ' ' ILE . 74.7 t -124.68 110.9 26.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.122 0.487 . . . . 73.099999999999994 110.434 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 26' ' ' GLU . 29.1 mt -96.25 137.94 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 64.25 110.937 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -86.53 0.32 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 75.549999999999997 111.77 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -69.54 -45.91 57.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.854 -0.688 . . . . 61.219999999999999 113.809 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 174.41 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.162 -0.681 . . . . 64.420000000000002 109.162 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -91.86 -42.97 9.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.179 -0.919 . . . . 73.349999999999994 109.33 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.5 137.22 52.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.179 -0.919 . . . . 74.109999999999999 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 23.7 pt-20 -140.85 159.65 41.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.693 -1.139 . . . . 73.430000000000007 109.772 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 19' ' ' VAL . 10.8 m -80.34 119.11 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.32 0.581 . . . . 62.340000000000003 111.307 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 41.1 mttp -120.87 113.22 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.723 -0.671 . . . . 53.450000000000003 111.822 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.8 mp0 46.43 67.08 0.82 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.54 1.311 . . . . 74.340000000000003 114.54 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.51 16.22 14.93 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.301 0.481 . . . . 62.32 114.301 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -51.77 145.47 9.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.131 0.491 . . . . 75.430000000000007 110.875 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -91.76 116.39 28.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.223 -0.899 . . . . 73.340000000000003 110.533 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -92.84 118.0 30.64 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.513 -0.475 . . . . 65.450000000000003 110.141 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 p -150.51 154.95 36.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.758 -0.656 . . . . 72.140000000000001 111.006 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 36' ' ' THR . 93.2 Cg_endo -89.19 -93.78 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 C-N-CA 124.039 -1.234 . . . . 75.510000000000005 111.267 -0.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 p -75.05 47.97 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.787 0.803 . . . . 75.299999999999997 109.631 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HA ' ' HZ1' ' A' ' 39' ' ' LYS . 42.4 tt0 -107.66 -2.78 19.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 71.420000000000002 110.734 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 164' ' ' ALA . 30.8 m -101.14 27.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 65.439999999999998 112.038 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HZ1' ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.18 -40.6 62.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.095 0.474 . . . . 62.340000000000003 110.642 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.44 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 29.2 m-20 -71.79 138.91 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.612 -0.722 . . . . 53.549999999999997 112.146 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.8 pm0 -66.98 152.57 95.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.245 -0.889 . . . . 35.119999999999997 111.503 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.1 Cg_endo -81.97 126.94 5.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.786 2.324 . . . . 74.319999999999993 112.829 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 43.5 mm -107.07 106.08 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 65.5 110.215 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 19' ' ' VAL . 10.4 p -79.02 143.23 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.732 0.641 . . . . 75.010000000000005 112.732 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' LYS . 36.9 m -165.46 152.32 10.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.018 0.437 . . . . 71.200000000000003 111.784 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 3.4 p90 -124.7 34.2 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.689 0.757 . . . . 74.409999999999997 109.556 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -44.42 121.9 2.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 75.530000000000001 111.197 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.44 -28.15 7.86 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.952 -0.642 . . . . 61.119999999999997 113.699 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 7.1 mp -75.68 -36.3 60.11 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.564 0.682 . . . . 71.230000000000004 110.096 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -51.55 158.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.409 -0.814 . . . . 71.409999999999997 109.994 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.38 -64.56 0.05 OUTLIER Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.423 -0.894 . . . . 71.150000000000006 112.135 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -148.16 109.35 4.32 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 61.329999999999998 108.845 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -157.72 141.84 16.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.276 -0.875 . . . . 75.219999999999999 111.215 -178.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -77.13 -45.04 28.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.325 -0.991 . . . . 65.439999999999998 108.325 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD22 ' O ' ' A' ' 83' ' ' ASN . 80.0 mt -154.64 163.45 40.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.871 -1.513 . . . . 64.340000000000003 109.076 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 32.7 mt -129.66 153.62 47.94 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.804 -0.443 . . . . 64.140000000000001 109.804 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 HG12 ' A' ' 82' ' ' VAL . 4.8 m -117.77 114.73 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 64.530000000000001 110.394 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -108.1 119.37 39.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.67 -0.863 . . . . 73.230000000000004 108.67 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 153' ' ' LEU . 66.8 mt -150.24 151.86 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.949 -0.7 . . . . 72.439999999999998 112.442 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' A' ' 78' ' ' HIS . 3.9 ppp? -94.99 154.91 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.268 -0.878 . . . . 73.200000000000003 109.177 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 62' ' ' ASP . 46.1 t -132.56 163.22 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.048 0.452 . . . . 73.219999999999999 111.725 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 61' ' ' VAL . 21.9 t70 64.18 54.91 1.53 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 74.5 110.187 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 35.1 Cg_exo -36.0 140.07 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.02 2.48 . . . . 64.439999999999998 112.22 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.05 85.53 2.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.623 0.601 . . . . 74.319999999999993 112.623 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.13 136.28 1.27 Allowed Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 112.301 0.482 . . . . 43.210000000000001 112.301 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 17.0 Cg_exo -68.36 -28.12 5.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.633 -1.403 . . . . 73.519999999999996 111.626 -1.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.882 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.4 t -150.03 150.11 31.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.14 -0.936 . . . . 75.409999999999997 111.123 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.9 -23.36 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.293 -0.867 . . . . 65.420000000000002 109.823 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.92 -39.82 29.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 71.510000000000005 112.619 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.882 ' H ' HG23 ' A' ' 67' ' ' THR . 8.4 t0 -144.37 81.08 11.55 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-O 120.613 0.244 . . . . 75.129999999999995 110.614 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 6.3 Cg_exo -77.75 55.82 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.116 2.544 . . . . 73.019999999999996 111.935 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 15.4 ptpt -48.9 -47.44 43.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.151 0.426 . . . . 63.240000000000002 112.151 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 1.7 p90 -114.34 33.42 5.3 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.489 -0.484 . . . . 74.140000000000001 111.081 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 63' ' ' PRO . 9.9 ttm180 -54.9 132.26 46.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.032 -1.099 . . . . 74.439999999999998 108.032 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 10.4 tp10 -103.26 166.67 10.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.871 1.668 . . . . 64.239999999999995 109.906 -0.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.552 HG23 ' HG ' ' A' ' 77' ' ' LEU . 7.6 tp -94.51 -45.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.747 -0.835 . . . . 72.109999999999999 108.747 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 103' ' ' SER . 3.2 pp -174.96 146.75 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.883 -1.053 . . . . 64.409999999999997 108.777 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 19.4 p-80 -158.73 176.6 12.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.579 -0.282 . . . . 75.329999999999998 110.386 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.548 ' CH2' HG12 ' A' ' 44' ' ' VAL . 12.2 t90 -102.91 125.28 49.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.034 0.445 . . . . 75.299999999999997 111.238 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 27.2 p -141.55 133.56 27.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 64.549999999999997 111.035 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 84' ' ' ILE . 16.1 t -147.8 132.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.225 -0.443 . . . . 70.209999999999994 110.275 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG12 HG23 ' A' ' 57' ' ' THR . 19.8 m -137.16 171.14 16.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.78 0.324 . . . . 75.209999999999994 110.973 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.631 ' H ' ' NE2' ' A' ' 121' ' ' GLN . 5.8 m-20 73.88 25.82 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.718 -0.674 . . . . 53.219999999999999 110.527 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -72.35 115.16 36.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.382 -0.927 . . . . 74.099999999999994 110.215 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 129.21 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.795 1.663 . . . . 73.439999999999998 110.659 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.92 62.79 0.05 OUTLIER Glycine 0 CA--C 1.525 0.683 0 O-C-N 123.52 0.512 . . . . 62.329999999999998 113.441 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -173.95 37.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.675 0.79 . . . . 64.25 108.942 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 90' ' ' ASN . 33.6 m120 -135.24 -10.33 2.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.864 -0.607 . . . . 72.409999999999997 112.489 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 71.88 -32.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.87 0.367 . . . . 41.409999999999997 111.264 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -153.69 166.14 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.450000000000003 110.546 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 69.8 Cg_endo -67.93 43.96 0.27 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.62 2.88 . . . . 65.040000000000006 113.508 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 t -74.04 -38.28 64.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 65.299999999999997 110.014 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.63 5.34 35.03 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.874 -0.603 . . . . 55.420000000000002 112.648 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -80.76 160.89 43.65 Favored Glycine 0 N--CA 1.454 -0.111 0 C-N-CA 120.746 -0.74 . . . . 44.130000000000003 112.394 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 106.75 4.03 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.249 0.524 . . . . 62.350000000000001 111.262 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 130' ' ' THR . 47.7 m -73.68 100.76 3.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 73.420000000000002 108.672 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HG3' ' A' ' 127' ' ' GLU . 87.4 mt -58.39 -50.25 74.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.579 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.77 122.45 20.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.329 -0.396 . . . . 75.109999999999999 111.016 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -48.63 132.68 17.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.797 -0.638 . . . . 74.230000000000004 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 1.9 p90 -76.53 126.1 30.4 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.013 0.435 . . . . 75.209999999999994 110.522 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 HD13 ' A' ' 77' ' ' LEU . 1.2 m -148.05 159.81 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.857 -0.61 . . . . 60.420000000000002 111.061 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 173' ' ' ARG . . . -58.15 111.9 3.48 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.677 -0.692 . . . . 65.319999999999993 113.049 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.741 ' HA ' HD11 ' A' ' 77' ' ' LEU . 48.8 m -63.65 95.47 0.11 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.273 0.229 . . . . 75.319999999999993 110.815 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 170' ' ' VAL . . . -56.61 101.67 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.067 -0.515 . . . . 73.329999999999998 113.027 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' NE2' ' A' ' 112' ' ' HIS . 87.8 Cg_endo -104.35 139.65 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.695 2.93 . . . . 62.119999999999997 112.912 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 109' ' ' THR . 11.9 Cg_endo -55.35 134.24 62.72 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.181 1.254 . . . . 75.430000000000007 109.586 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -42.08 -35.83 1.0 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.446 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -60.63 -42.53 97.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.928 -1.033 . . . . 73.409999999999997 112.803 -178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.472 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 3.6 t -72.56 -33.28 66.69 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.083 -0.386 . . . . 71.200000000000003 111.568 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.95 -88.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.531 0.972 . . . . 72.450000000000003 115.531 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.0 tp -66.88 122.4 17.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.824 1.046 . . . . 73.329999999999998 113.824 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 105' ' ' PRO . 2.9 m-70 -97.46 137.03 37.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.513 -0.767 . . . . 64.140000000000001 110.185 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 5.9 mmt85 -104.8 118.02 35.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.288 -0.634 . . . . 64.140000000000001 109.288 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.87 133.57 54.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.177 0.513 . . . . 64.319999999999993 111.952 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 161' ' ' TYR . 28.3 mm -125.74 121.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.058 -0.973 . . . . 64.409999999999997 108.868 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.33 131.94 51.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 74.420000000000002 110.771 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 156' ' ' PRO . 14.8 tp -126.81 130.93 51.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 71.010000000000005 110.435 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 158' ' ' ALA . 52.5 tp -124.75 122.47 37.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.855 -0.611 . . . . 64.519999999999996 110.682 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.453 ' HD2' HD23 ' A' ' 153' ' ' LEU . 37.0 t80 -134.62 138.24 44.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 75.239999999999995 109.777 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 53' ' ' SER . 37.3 ttp180 -68.95 124.53 23.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 73.420000000000002 111.72 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 83' ' ' ASN . 14.4 tt0 -87.99 107.31 18.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.713 -0.847 . . . . 65.150000000000006 108.713 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.89 -37.12 64.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.007 -0.542 . . . . 74.349999999999994 111.192 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -121.66 141.82 50.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.513 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 83' ' ' ASN . 3.8 tppp? -62.62 111.52 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.255 -0.276 . . . . 63.409999999999997 110.255 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' CE1' ' A' ' 151' ' ' HIS . 6.1 pt -90.73 128.21 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.667 -0.494 . . . . 74.230000000000004 109.667 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.63 -46.85 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.929 0.714 . . . . 53.530000000000001 112.929 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.612 ' HG3' HD21 ' A' ' 97' ' ' LEU . 4.9 mm-40 61.67 -117.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 75.239999999999995 109.675 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 127' ' ' GLU . 17.9 p -162.77 160.19 19.54 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.378 -0.601 . . . . 74.150000000000006 109.378 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.59 154.88 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.189 1.926 . . . . 64.230000000000004 111.738 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 96' ' ' SER . 1.9 m -58.42 125.58 23.91 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.056 -0.35 . . . . 74.219999999999999 110.056 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 131' ' ' ILE . 15.9 mm -90.69 126.24 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 71.230000000000004 112.178 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.4 m -82.94 134.86 35.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.063 -0.971 . . . . 64.019999999999996 109.727 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' A' ' 101' ' ' VAL . 15.0 p-10 -51.0 -40.94 59.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 61.039999999999999 111.273 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.683 ' OG1' HG22 ' A' ' 178' ' ' VAL . 9.9 t -65.47 4.04 0.6 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.184 -0.462 . . . . 60.32 111.895 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.45 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 11.3 t -64.12 135.45 56.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.159 0.504 . . . . 72.310000000000002 110.255 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB2' ' HA2' ' A' ' 179' ' ' GLY . 8.9 ttt85 -84.98 173.24 10.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.813 -0.63 . . . . 64.409999999999997 110.765 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.44 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 1.9 m -35.72 151.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.259 -0.882 . . . . 62.340000000000003 112.187 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.19 2.7 19.91 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.984 -0.627 . . . . 73.409999999999997 113.573 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -169.75 44.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.237 0.518 . . . . 73.0 110.377 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -114.27 -59.66 1.99 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.984 -0.553 . . . . 72.510000000000005 111.984 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.586 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 17.0 m-20 -65.07 42.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.657 0.984 . . . . 75.430000000000007 113.657 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 2.0 t80 -99.31 111.34 23.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 71.209999999999994 109.812 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.61 HD21 ' HB3' ' A' ' 145' ' ' ARG . 30.1 t30 -66.35 129.88 41.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.666 -0.697 . . . . 65.329999999999998 111.404 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . . . -72.24 -35.12 68.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.64 0.607 . . . . 75.519999999999996 112.64 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.61 ' HB3' HD21 ' A' ' 143' ' ' ASN . 30.1 ttm180 -47.04 -39.27 12.52 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.39 -0.524 . . . . 73.430000000000007 110.85 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.69 -37.71 63.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.185 -0.461 . . . . 72.209999999999994 110.894 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 1.6 m-85 -49.65 -40.54 40.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.365 0.602 . . . . 63.329999999999998 109.407 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.16 86.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 54.549999999999997 110.818 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.9 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 25.41 111.606 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.1 -43.27 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.371 0.508 . . . . 75.530000000000001 112.371 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.837 ' CE1' HD12 ' A' ' 125' ' ' ILE . 66.0 m-70 -91.4 1.48 57.09 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 70.420000000000002 110.912 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.4 32.65 73.23 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 121.108 -0.568 . . . . 51.530000000000001 113.662 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 59' ' ' LEU . 8.3 mt -70.32 16.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 110.733 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -64.33 -4.08 11.32 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.059 -0.519 . . . . 45.130000000000003 113.153 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 20.3 pt-20 -134.34 72.55 70.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.716 0.769 . . . . 64.030000000000001 109.018 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.554 ' HG3' HD11 ' A' ' 117' ' ' LEU . 42.1 Cg_endo -68.18 131.14 22.85 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.154 2.569 . . . . 75.310000000000002 113.874 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.0 pt -75.51 -34.46 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 74.239999999999995 109.276 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.801 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.06 146.25 30.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.543 -0.753 . . . . 64.430000000000007 110.141 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 117' ' ' LEU . . . -158.69 159.38 35.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 64.310000000000002 110.521 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.665 ' ND2' HG23 ' A' ' 27' ' ' VAL . 59.1 t30 -170.48 175.37 4.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.207 -1.035 . . . . 72.230000000000004 108.207 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.856 ' HB3' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -155.42 167.05 31.65 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.181 -0.608 . . . . 74.019999999999996 111.589 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -162.03 150.62 15.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.702 -0.681 . . . . 63.409999999999997 110.258 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 113' ' ' ARG . 57.9 mt-30 -124.64 138.16 54.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 73.540000000000006 110.378 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -155.11 138.89 16.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.834 -0.621 . . . . 74.219999999999999 110.373 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -100.43 138.08 37.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.086 -0.338 . . . . 53.299999999999997 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -127.63 126.58 42.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 110.135 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.3 m-20 -62.73 -174.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.324 0.583 . . . . 52.310000000000002 110.448 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 13.9 t70 -72.82 32.68 0.07 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.59 -0.732 . . . . 63.130000000000003 109.752 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 167' ' ' ASP . 20.2 t80 -91.14 -53.69 4.26 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.339 -0.846 . . . . 75.219999999999999 111.752 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 28.3 m -59.81 -31.01 8.34 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 112.917 0.71 . . . . 65.129999999999995 112.917 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 83.7 Cg_exo -48.83 -21.41 3.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.51 1.473 . . . . 72.319999999999993 111.427 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 169' ' ' TYR . 11.8 tt -51.7 -38.93 22.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.886 -0.597 . . . . 61.240000000000002 109.868 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.473 ' CD ' ' H ' ' A' ' 102' ' ' GLY . 85.2 mtt-85 -58.18 -34.97 70.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 74.400000000000006 109.881 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.404 ' O ' HG12 ' A' ' 177' ' ' ILE . 7.8 m120 -62.19 -41.31 98.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.15 -0.685 . . . . 74.340000000000003 109.15 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -59.09 -17.24 24.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 74.329999999999998 109.831 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 176' ' ' THR . 18.0 m -88.21 6.12 38.27 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.981 -0.554 . . . . 54.200000000000003 111.778 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.2 mm -74.07 124.36 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.919 -0.128 . . . . 73.120000000000005 111.11 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.683 HG22 ' OG1' ' A' ' 134' ' ' THR . 18.4 m -127.51 -21.3 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.365 1.246 . . . . 62.329999999999998 114.365 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.245 0.795 0 CA-C-O 118.126 -1.375 . . . . 53.240000000000002 112.679 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.071 -0.344 . . . . 74.030000000000001 110.071 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.19 -71.2 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.426 0.528 . . . . 72.420000000000002 112.426 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 13.3 pt -125.37 59.95 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.616 0.722 . . . . 73.310000000000002 110.804 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 6' ' ' PRO . 12.3 p -128.75 140.89 39.82 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.141 -0.936 . . . . 75.049999999999997 110.642 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.8 Cg_endo -85.29 33.13 4.77 Favored 'Cis proline' 0 C--N 1.35 0.606 0 C-N-CA 123.849 -1.313 . . . . 72.450000000000003 112.632 0.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.9 t0 -57.14 -54.54 45.6 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.219 -0.659 . . . . 63.409999999999997 109.219 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.9 m -160.5 -39.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.419 -0.81 . . . . 75.409999999999997 111.676 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.8 tp -157.41 143.03 17.37 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.094 0.473 . . . . 71.530000000000001 111.458 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -78.84 25.73 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.821 -0.55 . . . . 63.240000000000002 110.333 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -175.36 156.02 1.95 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.037 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -90.59 113.52 58.02 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.721 0.267 . . . . 54.420000000000002 111.721 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 87.9 Cg_endo -85.0 134.03 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.646 2.231 . . . . 73.549999999999997 112.482 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 157' ' ' ILE . . . -60.62 -39.62 88.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.09 -0.504 . . . . 75.239999999999995 110.562 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -135.09 3.32 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.683 -0.689 . . . . 63.509999999999998 111.483 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 t -161.29 176.94 10.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.45 -0.574 . . . . 75.319999999999993 109.45 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 44' ' ' VAL . 13.6 mt -116.65 135.79 55.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.551 -0.295 . . . . 52.240000000000002 111.016 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 45' ' ' SER . 31.0 mmmt -73.92 102.31 4.06 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.438 -1.319 . . . . 74.230000000000004 107.438 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.704 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.7 t -117.28 110.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 73.519999999999996 109.654 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.678 HG21 ' O ' ' A' ' 23' ' ' ASP . 22.6 mt -99.61 126.7 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.472 -0.785 . . . . 71.200000000000003 110.185 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.423 ' CD2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.48 -77.48 0.1 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.134 -0.939 . . . . 74.420000000000002 110.61 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.86 -61.49 1.76 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.773 -0.727 . . . . 61.210000000000001 112.627 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.678 ' O ' HG21 ' A' ' 20' ' ' ILE . 3.7 m-20 -161.12 -53.75 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.374 0.607 . . . . 61.229999999999997 109.667 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -100.41 -37.34 8.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.268 -0.878 . . . . 72.439999999999998 111.24 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.2 pt? -69.27 124.6 24.27 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.998 0.904 . . . . 74.019999999999996 110.687 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -113.15 139.87 48.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.989 -1.46 . . . . 44.409999999999997 110.71 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 19' ' ' VAL . 33.1 m -73.51 108.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.519 0.676 . . . . 63.020000000000003 110.343 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 6.3 mmpt? -86.01 82.41 8.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.96 0.726 . . . . 72.030000000000001 112.96 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 13.8 mp0 29.84 67.33 0.11 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.424 1.268 . . . . 72.439999999999998 114.424 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.87 -21.44 29.74 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.933 -0.651 . . . . 74.519999999999996 112.913 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.82 145.63 2.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.394 0.616 . . . . 63.140000000000001 112.348 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' A' ' 163' ' ' GLN . 88.9 tt0 -110.72 136.05 50.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.856 -1.065 . . . . 75.329999999999998 110.291 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.618 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -98.1 142.5 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.781 0.324 . . . . 64.530000000000001 111.156 178.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.2 p -150.17 146.33 19.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.883 -0.599 . . . . 72.310000000000002 109.791 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.93 -115.24 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 124.08 -1.217 . . . . 71.120000000000005 112.636 0.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.8 p -72.02 48.38 0.17 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.775 0.287 . . . . 53.130000000000003 111.775 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 6.0 pt20 -99.98 0.01 40.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.368 0.604 . . . . 72.349999999999994 109.82 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 33' ' ' LEU . 34.4 m -87.45 21.65 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.197 -0.911 . . . . 62.509999999999998 110.957 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -70.72 -34.13 71.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 71.219999999999999 111.711 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.41 135.18 35.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.745 0.307 . . . . 74.120000000000005 111.422 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -68.44 152.48 96.57 Favored Pre-proline 0 C--N 1.335 -0.023 0 N-CA-C 109.691 -0.485 . . . . 65.140000000000001 109.691 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.75 126.61 15.64 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.046 1.831 . . . . 73.299999999999997 113.673 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 47.0 mm -96.85 107.33 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.967 -0.753 . . . . 72.349999999999994 108.967 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 17' ' ' ILE . 3.9 p -78.72 139.93 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.433 0.901 . . . . 70.019999999999996 113.433 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 57.7 m -164.9 134.07 3.55 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.161 -0.472 . . . . 71.519999999999996 110.359 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 2.4 p90 -114.24 35.95 3.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.484 0.659 . . . . 72.010000000000005 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -36.4 98.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.013 -0.994 . . . . 72.109999999999999 113.117 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.32 -15.16 41.46 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 116.075 -0.511 . . . . 70.409999999999997 114.251 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.23 -20.4 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.511 0.656 . . . . 73.049999999999997 110.703 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.743 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -71.35 -61.59 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.65 0.738 . . . . 74.209999999999994 109.403 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -64.24 4.34 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 109.522 -1.431 . . . . 51.43 109.522 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 2.0 ttmp? -149.1 116.79 6.23 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.199 -0.5 . . . . 73.120000000000005 110.134 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 p -157.02 141.57 16.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.216 0.531 . . . . 65.430000000000007 112.345 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 22.1 t30 -83.45 -36.66 24.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 74.400000000000006 109.061 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 25.3 mt -158.11 169.8 23.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.333 -1.303 . . . . 64.150000000000006 108.737 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 69.4 mt -141.57 159.82 41.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.922 0.391 . . . . 61.439999999999998 111.656 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 119' ' ' TYR . 2.1 m -121.56 132.82 54.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.271 -0.877 . . . . 64.349999999999994 108.77 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -127.84 132.56 49.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 73.150000000000006 109.59 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 58' ' ' LEU . 54.9 mt -145.97 129.79 17.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.877 -0.329 . . . . 73.439999999999998 111.018 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.06 135.49 45.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.106 -1.072 . . . . 64.530000000000001 108.106 178.236 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HD3' ' A' ' 63' ' ' PRO . 10.2 t -147.43 143.53 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.941 0.877 . . . . 62.310000000000002 112.6 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.552 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 55.9 t0 -160.24 81.27 2.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 113.988 -1.46 . . . . 51.229999999999997 107.065 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.692 ' HD3' HG12 ' A' ' 61' ' ' VAL . 37.4 Cg_endo -66.97 84.2 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.625 1.55 . . . . 71.340000000000003 112.47 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' CG ' ' HG2' ' A' ' 68' ' ' ARG . 31.3 m-20 -169.36 84.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.547 -0.751 . . . . 63.299999999999997 110.003 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -153.48 137.33 10.52 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.726 -0.842 . . . . 33.509999999999998 108.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.695 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 4.7 Cg_exo -77.31 -16.39 25.36 Favored 'Cis proline' 0 CA--C 1.515 -0.447 0 C-N-CA 124.287 -1.131 . . . . 65.329999999999998 111.927 0.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.3 t -138.77 140.72 38.73 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.468 -0.787 . . . . 71.430000000000007 110.867 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.517 ' HG2' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -45.94 -26.92 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.864 -1.062 . . . . 72.540000000000006 111.296 -178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -93.96 -45.14 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.52 1.304 . . . . 73.0 114.52 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.843 ' H ' HG23 ' A' ' 67' ' ' THR . 1.3 m-20 -112.64 83.01 5.27 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 113.174 0.805 . . . . 63.140000000000001 113.174 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 63.7 Cg_endo -71.57 51.76 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.236 2.624 . . . . 74.150000000000006 111.696 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HG2' ' CD ' ' A' ' 66' ' ' PRO . 17.7 ptpt -48.66 -33.59 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 63.350000000000001 111.885 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 6.2 p90 -138.68 45.46 2.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.437 0.637 . . . . 75.140000000000001 111.743 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -73.74 138.51 44.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.457 -0.942 . . . . 75.519999999999996 108.457 177.161 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 29.3 mp0 -91.71 178.3 5.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.772 0.829 . . . . 72.239999999999995 111.385 0.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.631 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.6 tp -106.67 169.81 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.536 -1.211 . . . . 52.100000000000001 109.409 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.8 mp -45.87 125.04 5.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.578 0.228 . . . . 72.129999999999995 110.593 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -124.96 171.98 9.77 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.085 0.469 . . . . 74.230000000000004 111.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 6.7 t-105 -100.16 121.83 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.355 -0.839 . . . . 72.239999999999995 109.866 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -141.49 137.17 31.91 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.437 0.532 . . . . 53.329999999999998 112.437 -177.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 84' ' ' ILE . 2.1 t -141.48 149.79 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.514 -0.312 . . . . 73.510000000000005 110.885 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.525 HG21 ' HG3' ' A' ' 127' ' ' GLU . 22.2 m -142.05 155.66 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.988 0.366 . . . . 75.109999999999999 111.988 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.447 ' C ' HD22 ' A' ' 55' ' ' LEU . 5.4 m-20 72.07 37.55 0.99 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.122 -0.49 . . . . 74.5 112.262 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -83.71 116.0 62.44 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 119.436 -0.906 . . . . 73.140000000000001 109.624 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 87' ' ' SER . 35.5 Cg_endo -66.77 126.78 15.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 121.816 1.677 . . . . 70.400000000000006 111.676 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.35 71.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.903 -0.589 . . . . 60.5 114.103 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 85' ' ' PRO . 91.8 p -178.27 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.032 0.416 . . . . 70.549999999999997 110.999 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -135.4 -2.47 2.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.327 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.668 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 13.1 pt-20 40.94 34.01 0.25 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.038 -0.528 . . . . 74.219999999999999 111.991 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 p30 175.48 152.62 0.31 Allowed Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 121.34 0.59 . . . . 52.439999999999998 110.761 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 44' ' ' VAL . 95.9 Cg_endo -74.68 61.17 5.34 Favored 'Trans proline' 0 CA--C 1.527 0.173 0 C-N-CA 123.339 2.693 . . . . 61.240000000000002 112.93 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 m -96.78 -55.3 2.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.348 0.87 . . . . 65.409999999999997 113.348 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.82 -40.97 89.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.032 0.773 . . . . 12.449999999999999 115.032 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -57.61 157.8 14.49 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.68 -0.771 . . . . 74.420000000000002 114.134 -178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.932 ' CE1' HG23 ' A' ' 130' ' ' THR . 80.3 t60 -61.63 125.6 24.37 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.079 0.551 . . . . 74.120000000000005 111.095 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.9 m -83.87 97.25 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.658 -0.868 . . . . 64.129999999999995 108.658 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' GLU . 13.0 mt -54.16 -48.83 70.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.471 -0.937 . . . . 73.530000000000001 108.471 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 117.62 8.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.494 -1.23 . . . . 73.510000000000005 108.822 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.7 t0 -54.39 152.48 6.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.65 0.594 . . . . 65.239999999999995 111.556 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 79' ' ' TRP . 0.3 OUTLIER -70.48 129.26 38.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.31 -0.405 . . . . 71.310000000000002 110.342 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.5 p -130.02 113.73 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.56 0.695 . . . . 73.450000000000003 110.873 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.46 72.97 2.74 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.427 -0.806 . . . . 51.140000000000001 113.455 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 29.8 p -171.03 11.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.891 1.071 . . . . 53.409999999999997 113.891 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.631 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -55.38 -84.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.229 -0.986 . . . . 75.319999999999993 112.258 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.927 ' CB ' HG21 ' A' ' 109' ' ' THR . 23.8 Cg_exo -64.54 105.85 0.66 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.144 1.896 . . . . 70.310000000000002 111.389 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 109' ' ' THR . 18.3 Cg_endo -59.37 160.54 19.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.235 1.957 . . . . 60.409999999999997 112.428 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 167' ' ' ASP . 7.7 ttmm -39.69 -41.0 1.01 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.296 -0.866 . . . . 71.219999999999999 111.303 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.06 -39.21 55.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.308 -0.86 . . . . 52.210000000000001 112.223 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.927 HG21 ' CB ' ' A' ' 105' ' ' PRO . 14.0 t -70.73 -7.02 41.76 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.813 0.339 . . . . 73.340000000000003 111.572 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.18 -119.47 18.75 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.099 -0.572 . . . . 64.310000000000002 114.225 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 163' ' ' GLN . 29.3 tp -58.06 119.84 7.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.802 1.038 . . . . 74.099999999999994 113.802 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 32.4 m170 -88.11 91.92 8.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.596 -0.729 . . . . 73.219999999999999 111.081 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.588 ' HD2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -76.82 63.86 2.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 75.230000000000004 110.125 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.7 m-85 -65.73 131.62 46.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.248 -0.433 . . . . 63.240000000000002 111.057 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 161' ' ' TYR . 33.9 mt -127.25 122.17 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.765 -0.652 . . . . 63.140000000000001 111.657 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 3.9 m-30 -90.4 145.95 24.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.876 -0.602 . . . . 72.329999999999998 110.207 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -134.69 131.88 38.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.948 -0.39 . . . . 75.310000000000002 109.948 179.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 157' ' ' ILE . 1.5 tt -126.27 131.47 51.88 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.954 -0.387 . . . . 74.409999999999997 109.954 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.711 ' N ' HD23 ' A' ' 118' ' ' LEU . 65.7 t80 -131.75 139.24 48.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.476 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.654 HH12 ' HB3' ' A' ' 122' ' ' GLU . 0.6 OUTLIER -71.89 130.54 41.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 73.439999999999998 110.513 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.547 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -116.03 148.52 40.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.627 0.251 . . . . 64.439999999999998 111.231 -178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.654 ' HB3' HH12 ' A' ' 120' ' ' ARG . 23.2 pt-20 -148.03 17.66 1.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.178 0.514 . . . . 75.409999999999997 110.941 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 5.8 m120 -143.91 129.13 18.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.053 -0.976 . . . . 42.399999999999999 108.415 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -76.64 111.58 12.29 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.78 -0.768 . . . . 64.349999999999994 111.202 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.2 pt -103.68 128.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.812 -1.085 . . . . 74.010000000000005 110.661 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -56.17 -57.67 11.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.411 0.624 . . . . 54.409999999999997 110.954 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.666 ' HB3' HD22 ' A' ' 97' ' ' LEU . 21.9 mm-40 63.09 31.87 15.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.985 -1.007 . . . . 71.329999999999998 112.763 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 44.5 p 57.72 151.6 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 112.631 0.604 . . . . 73.230000000000004 112.631 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -45.21 157.58 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.471 2.781 . . . . 75.140000000000001 113.561 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.932 HG23 ' CE1' ' A' ' 95' ' ' HIS . 8.2 p -62.5 131.1 48.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.524 -0.762 . . . . 74.109999999999999 112.524 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 135' ' ' THR . 45.3 mm -104.56 118.49 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.929 -0.767 . . . . 50.539999999999999 108.929 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.3 t -69.46 153.1 44.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 73.299999999999997 111.77 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.487 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.5 p30 -54.42 -29.36 48.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.552 -0.749 . . . . 53.520000000000003 110.296 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 p -78.12 21.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.718 -0.674 . . . . 71.019999999999996 111.554 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.49 ' HB ' HG22 ' A' ' 131' ' ' ILE . 8.5 t -62.71 126.47 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.311 0.577 . . . . 74.230000000000004 111.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 178' ' ' VAL . 39.3 ttt180 -89.01 173.31 8.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.5 -0.773 . . . . 71.140000000000001 111.242 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.598 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m -36.87 150.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.492 -0.777 . . . . 62.049999999999997 112.457 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.13 25.43 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.017 -0.611 . . . . 74.400000000000006 112.972 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 55.8 ttt180 -163.96 37.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.252 0.549 . . . . 73.409999999999997 111.03 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 137' ' ' THR . 7.2 mp -82.52 -64.06 1.25 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.437 -1.32 . . . . 63.509999999999998 107.437 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 141' ' ' ASN . 0.7 OUTLIER -68.6 117.73 10.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.914 -1.143 . . . . 65.120000000000005 107.914 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.46 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 21.5 t80 -170.77 80.19 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.331 -0.395 . . . . 74.0 111.305 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.447 HD22 ' HB3' ' A' ' 145' ' ' ARG . 16.3 p-10 -62.36 117.34 6.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.139 -0.482 . . . . 71.5 111.899 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 59' ' ' LEU . . . -55.53 -25.25 36.49 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.266 0.555 . . . . 64.230000000000004 109.861 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HB3' HD22 ' A' ' 143' ' ' ASN . 1.3 tpp180 -46.57 -32.47 3.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.111 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 1.5 t70 -61.26 -56.47 20.21 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.147 -0.686 . . . . 61.329999999999998 109.147 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CE2' HD13 ' A' ' 97' ' ' LEU . 3.5 m-30 -56.4 -35.31 67.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.94 -0.573 . . . . 74.450000000000003 109.737 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -65.55 -41.5 92.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.45 -0.795 . . . . 71.019999999999996 109.592 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.89 -55.01 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.922 -0.581 . . . . 50.020000000000003 110.826 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.575 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 2.1 ptpp? -59.14 -45.15 91.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 71.319999999999993 111.763 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 89.6 m-70 -92.58 9.0 36.51 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.751 -0.38 . . . . 74.109999999999999 111.75 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 56.59 30.09 58.64 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.767 -0.73 . . . . 72.329999999999998 113.371 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HA ' ' CE1' ' A' ' 119' ' ' TYR . 13.3 mt -71.95 16.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.812 -0.228 . . . . 63.030000000000001 111.048 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.04 -63.75 1.92 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.323 -0.465 . . . . 43.409999999999997 114.002 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.17 112.29 15.05 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.726 0.263 . . . . 74.239999999999995 111.671 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 66.9 Cg_endo -79.97 123.35 5.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.094 1.863 . . . . 72.310000000000002 112.52 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 1.011 HD11 HD22 ' A' ' 118' ' ' LEU . 50.3 pt -74.87 -33.5 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.571 -0.452 . . . . 72.510000000000005 110.411 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.52 139.65 15.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.316 -0.402 . . . . 73.129999999999995 110.762 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -142.78 159.99 41.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.935 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.469 ' ND2' HG23 ' A' ' 27' ' ' VAL . 1.3 t-20 -161.38 123.38 2.97 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.563 -0.903 . . . . 72.109999999999999 108.563 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.505 ' CD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.81 169.54 11.44 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.984 -0.553 . . . . 74.219999999999999 111.698 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 2.1 p90 -164.1 160.95 22.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 72.099999999999994 109.996 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 111' ' ' LEU . 8.6 pt20 -132.65 129.0 38.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.516 -0.311 . . . . 71.400000000000006 110.848 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.44 140.4 17.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.317 -0.402 . . . . 73.230000000000004 111.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.86 133.03 43.74 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.547 -0.538 . . . . 74.140000000000001 109.547 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -105.83 113.72 27.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.239 0.542 . . . . 73.349999999999994 110.293 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.637 ' O ' ' NZ ' ' A' ' 107' ' ' LYS . 31.1 m-20 -49.81 -52.53 31.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.238 -0.892 . . . . 63.350000000000001 112.751 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -167.48 45.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.325 -0.55 . . . . 75.219999999999999 111.661 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 31.8 t80 -101.37 -40.58 7.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 73.519999999999996 111.553 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 1.042 HG13 ' HD3' ' A' ' 171' ' ' PRO . 0.1 OUTLIER -53.2 -47.46 95.86 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.924 1.083 . . . . 75.019999999999996 113.924 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 1.042 ' HD3' HG13 ' A' ' 170' ' ' VAL . 77.4 Cg_exo -53.01 -50.52 13.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.88 1.72 . . . . 60.200000000000003 113.521 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 172' ' ' ILE . 1.7 mp -45.83 -55.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 62.299999999999997 110.84 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 12.1 tpp180 -56.32 -44.66 80.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 110.39 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -51.87 -38.74 57.19 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.044 -0.525 . . . . 64.25 111.327 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 6.5 mmpt? -55.13 -29.68 58.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.430000000000007 110.964 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -67.64 -29.8 69.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 73.519999999999996 111.994 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.85 103.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.485 -0.325 . . . . 73.010000000000005 110.902 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.416 ' C ' ' HD2' ' A' ' 136' ' ' ARG . 34.1 m -148.39 1.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.389 0.514 . . . . 74.200000000000003 112.389 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.641 -1.089 . . . . 51.140000000000001 112.224 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.555 0.205 . . . . 74.439999999999998 111.555 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -106.95 -71.02 0.77 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.674 0.62 . . . . 72.25 112.674 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 9' ' ' LEU . 14.7 pt -80.84 41.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.558 0.694 . . . . 73.219999999999999 111.847 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 11.2 p -114.04 138.92 23.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.606 -0.724 . . . . 75.120000000000005 111.361 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 59.8 Cg_endo -93.57 39.42 4.67 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.388 -1.088 . . . . 73.310000000000002 112.594 -0.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.661 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 t70 -58.2 -44.41 88.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.437 -0.347 . . . . 74.200000000000003 110.412 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -165.75 -36.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.968 -0.56 . . . . 72.200000000000003 111.811 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 4' ' ' ILE . 18.7 tp -157.08 175.01 14.64 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.669 -0.493 . . . . 73.549999999999997 109.669 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 6.6 p-10 -69.0 -52.44 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.42 -1.326 . . . . 75.409999999999997 107.42 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 137.82 22.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 74.430000000000007 110.739 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.89 129.23 87.79 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 111.861 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -88.61 -138.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.089 2.526 . . . . 65.209999999999994 111.904 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.42 -29.7 7.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.519 -0.31 . . . . 43.310000000000002 111.214 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -159.94 -175.58 31.07 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.909 -0.476 . . . . 34.520000000000003 111.909 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 2.2 t -117.82 163.12 17.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.341 0.591 . . . . 74.129999999999995 112.069 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 44' ' ' VAL . 4.0 mt -105.57 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.185 -0.916 . . . . 51.140000000000001 109.691 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.2 mmmm -82.38 102.97 11.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.563 -0.289 . . . . 74.150000000000006 110.596 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.6 t -110.24 110.82 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.318 -0.623 . . . . 72.230000000000004 109.318 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 23' ' ' ASP . 44.2 mt -96.57 130.92 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.566 . . . . 62.219999999999999 110.071 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 40' ' ' ASP . 2.8 t80 -103.17 -15.14 16.12 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 112.362 0.505 . . . . 74.109999999999999 112.362 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.16 2.93 7.83 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.181 0.832 . . . . 64.129999999999995 115.181 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 20' ' ' ILE . 24.1 t70 76.19 20.81 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.372 -1.344 . . . . 50.439999999999998 107.372 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -175.16 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 112.753 -2.021 . . . . 74.140000000000001 107.134 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.655 ' O ' HG23 ' A' ' 20' ' ' ILE . 36.4 mt -69.62 136.02 50.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.984 -1.007 . . . . 63.009999999999998 108.976 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 73.0 tt0 -126.61 143.6 51.17 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.227 0.825 . . . . 72.329999999999998 113.227 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.8 m -86.66 140.34 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.824 -0.626 . . . . 75.519999999999996 110.284 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 10.7 mptt -131.67 114.77 15.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.483 0.549 . . . . 53.420000000000002 112.483 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 9.3 mp0 25.09 67.21 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.297 1.221 . . . . 73.540000000000006 114.297 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.56 6.28 89.04 Favored Glycine 0 C--N 1.33 0.225 0 N-CA-C 114.28 0.472 . . . . 61.109999999999999 114.28 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 18.9 t30 -55.99 131.07 46.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.849 0.357 . . . . 73.439999999999998 110.789 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -89.54 136.04 33.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 43.149999999999999 109.673 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 8.1 mp -92.73 138.99 31.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.319 . . . . 74.099999999999994 111.208 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -147.6 154.91 45.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 75.519999999999996 110.562 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.46 -52.62 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.826 -1.323 . . . . 63.229999999999997 112.879 0.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -120.38 28.92 7.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.747 0.784 . . . . 72.439999999999998 110.484 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 3.1 pt20 -80.98 -6.54 58.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.22 -0.9 . . . . 62.119999999999997 110.635 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.69 32.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.485 -0.78 . . . . 73.450000000000003 111.227 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -96.93 -38.11 9.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.819 1.044 . . . . 73.519999999999996 113.819 -177.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -82.64 143.93 30.64 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.071 0.767 . . . . 75.329999999999998 113.071 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.49 153.09 83.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.474 -1.239 . . . . 75.010000000000005 111.659 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.77 126.79 6.75 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.492 2.128 . . . . 72.549999999999997 112.745 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 51.6 mm -108.09 117.74 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 64.099999999999994 109.698 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.6 p -91.42 142.02 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.11 0.781 . . . . 45.149999999999999 113.11 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 68.5 m -161.43 113.73 1.83 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.848 -0.614 . . . . 73.340000000000003 109.46 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 1.3 p90 -93.67 35.95 1.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.154 0.502 . . . . 75.099999999999994 110.708 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.2 m -49.21 118.94 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 65.140000000000001 111.393 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.22 -11.31 72.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.172 -0.537 . . . . 62.240000000000002 112.805 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -108.39 10.63 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.826 0.346 . . . . 73.239999999999995 110.541 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -104.0 -62.85 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.144 -0.48 . . . . 72.450000000000003 111.151 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . 74.36 -99.43 1.09 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.469 -0.652 . . . . 71.409999999999997 111.469 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' NZ ' ' HB3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -148.82 109.96 4.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.966 0.412 . . . . 74.230000000000004 111.121 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -144.49 147.93 33.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.456 . . . . 63.5 110.225 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -63.34 -39.74 95.38 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.42 0.628 . . . . 63.539999999999999 109.852 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' A' ' 124' ' ' LYS . 30.2 mt -153.98 162.1 41.47 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.828 -1.078 . . . . 55.439999999999998 111.341 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.4 mt -132.82 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.983 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.785 HG23 HG12 ' A' ' 82' ' ' VAL . 13.1 m -113.17 123.62 50.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 74.109999999999999 110.337 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' VAL . 1.3 tm? -124.51 129.81 51.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.777 -0.453 . . . . 73.140000000000001 109.777 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.4 mt -152.46 169.16 23.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 60.100000000000001 111.506 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -95.06 131.63 40.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.833 -0.621 . . . . 71.019999999999996 110.537 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 117' ' ' LEU . 6.1 t -106.71 160.19 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.773 -0.194 . . . . 50.329999999999998 111.349 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.36 57.34 12.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 72.140000000000001 109.941 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 10.3 Cg_endo -53.95 139.98 69.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.821 1.681 . . . . 72.340000000000003 110.662 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' PRO . 35.9 t0 -165.91 117.01 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.429 0.529 . . . . 52.030000000000001 112.429 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.857 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . . . -170.43 144.73 2.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.481 -0.781 . . . . 62.539999999999999 109.392 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 73.3 Cg_endo -83.12 -14.56 35.05 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.483 -1.049 . . . . 74.340000000000003 111.759 0.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 70' ' ' ASP . 9.9 t -164.92 154.12 12.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.106 -0.952 . . . . 63.530000000000001 109.715 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -1.83 12.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.927 -0.579 . . . . 74.519999999999996 111.719 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -86.34 -45.13 11.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.395 -0.366 . . . . 74.129999999999995 111.756 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' H ' HG23 ' A' ' 67' ' ' THR . 36.3 t70 -144.4 96.63 5.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 73.140000000000001 109.787 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.23 57.13 4.61 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.347 2.031 . . . . 74.530000000000001 113.047 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -54.35 -37.43 64.91 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 121.038 -0.265 . . . . 73.439999999999998 111.489 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.685 ' HA ' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -149.41 77.21 1.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.11 0.957 . . . . 73.25 110.072 177.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.5 ttt180 -98.72 109.78 22.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.053 -1.43 . . . . 71.150000000000006 110.415 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.857 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 23.3 mt-10 -108.0 178.06 4.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.033 1.333 . . . . 75.439999999999998 110.61 -0.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.738 ' CD1' ' HB1' ' A' ' 65' ' ' ALA . 1.6 mp -75.64 -58.34 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.73 -0.841 . . . . 64.209999999999994 108.73 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 76' ' ' ILE . 1.4 mm? -140.56 -171.05 3.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.255 -1.339 . . . . 62.030000000000001 108.263 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 p80 176.27 156.92 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.4 -0.222 . . . . 65.329999999999998 110.4 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.731 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 1.2 t-105 -100.12 111.57 23.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.218 0.533 . . . . 73.400000000000006 110.041 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 16.3 m -127.93 125.34 39.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.503 -0.771 . . . . 71.140000000000001 110.704 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -147.66 125.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.497 -0.774 . . . . 70.329999999999998 110.441 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 57' ' ' THR . 27.4 m -126.66 174.44 10.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.053 0.454 . . . . 74.340000000000003 111.498 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.742 ' O ' HD22 ' A' ' 55' ' ' LEU . 13.8 p30 54.02 40.24 31.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.956 -1.02 . . . . 65.120000000000005 111.019 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.967 HD13 ' HA3' ' A' ' 94' ' ' GLY . 7.4 mm -77.89 122.23 85.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.976 -0.749 . . . . 72.239999999999995 108.976 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.74 127.77 25.67 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 121.934 1.756 . . . . 62.32 112.323 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.92 58.65 0.08 OUTLIER Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.416 0.448 . . . . 72.349999999999994 113.542 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -168.06 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.143 0.577 . . . . 64.25 109.664 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' C ' ' H ' ' A' ' 90' ' ' ASN . 36.5 m120 -135.13 -16.1 1.92 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 64.329999999999998 112.134 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 71.57 -36.23 0.35 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 72.150000000000006 111.338 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 88' ' ' ASN . 8.5 p30 -129.22 152.55 79.63 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.088 0.47 . . . . 72.230000000000004 110.254 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.828 ' HB2' HG21 ' A' ' 81' ' ' VAL . 80.4 Cg_endo -70.82 52.47 1.35 Allowed 'Trans proline' 0 N--CA 1.473 0.307 0 C-N-CA 123.572 2.848 . . . . 62.109999999999999 113.602 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -104.24 -1.92 26.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.483 -0.487 . . . . 75.400000000000006 111.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.21 -42.12 1.32 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.953 -0.642 . . . . 52.200000000000003 113.51 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.967 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.57 172.59 13.44 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 120.871 -0.68 . . . . 43.020000000000003 113.136 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.516 ' HB3' HD21 ' A' ' 83' ' ' ASN . 72.2 t60 -66.19 130.82 44.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.745 0.307 . . . . 73.019999999999996 111.73 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.731 ' HA ' HG12 ' A' ' 81' ' ' VAL . 36.8 m -87.21 102.63 14.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.837 -0.801 . . . . 62.43 108.837 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 147' ' ' PHE . 94.0 mt -62.68 -37.44 86.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.539 0.685 . . . . 73.329999999999998 109.655 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.56 127.28 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.711 -1.131 . . . . 72.319999999999993 108.653 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -55.38 152.34 8.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.285 0.846 . . . . 61.039999999999999 113.285 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 3.1 p90 -83.67 142.61 30.65 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.394 -0.821 . . . . 53.43 112.836 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 100' ' ' TYR . 5.2 m -158.35 113.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 64.209999999999994 111.346 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.83 2.81 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 44.329999999999998 112.297 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.449 ' OG ' HG13 ' A' ' 170' ' ' VAL . 29.3 t -172.03 49.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.925 0.343 . . . . 75.329999999999998 111.925 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.87 -75.68 0.61 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.465 -1.054 . . . . 75.409999999999997 110.465 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.712 ' HB2' HG21 ' A' ' 109' ' ' THR . 15.8 Cg_exo -74.17 123.5 8.35 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.941 2.427 . . . . 61.520000000000003 111.49 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.523 ' O ' HG22 ' A' ' 109' ' ' THR . 31.6 Cg_exo -59.01 159.35 21.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.862 2.375 . . . . 75.310000000000002 112.978 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 168' ' ' ASP . 18.4 pttp -43.66 -20.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.949 -0.569 . . . . 64.450000000000003 111.322 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 106' ' ' PRO . 29.8 t70 -50.42 -46.54 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.223 -0.444 . . . . 72.510000000000005 110.41 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.712 HG21 ' HB2' ' A' ' 105' ' ' PRO . 4.2 t -79.54 -4.04 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.152 -0.476 . . . . 73.040000000000006 111.519 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.75 -101.18 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.184 -1.167 . . . . 42.049999999999997 110.184 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 163' ' ' GLN . 17.5 tp -66.66 112.17 4.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.945 -0.391 . . . . 71.120000000000005 109.945 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 10.9 p80 -109.83 92.1 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.988 0.423 . . . . 73.430000000000007 110.303 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.502 ' NE ' ' H ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -58.67 130.57 47.5 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.62 -0.718 . . . . 75.430000000000007 110.583 -179.54 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.06 128.54 45.11 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 120.95 0.405 . . . . 72.519999999999996 109.916 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 161' ' ' TYR . 4.7 mm -115.86 141.83 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.446 -0.797 . . . . 71.349999999999994 111.286 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.25 141.46 48.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.937 -0.574 . . . . 72.099999999999994 110.245 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.707 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 5.5 tt -124.5 140.39 52.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.374 . . . . 74.219999999999999 110.72 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 117' ' ' LEU . 60.2 tp -130.29 134.04 46.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.668 -0.696 . . . . 73.430000000000007 110.583 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HA ' HG12 ' A' ' 157' ' ' ILE . 66.8 t80 -144.14 139.49 28.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.207 0.527 . . . . 65.439999999999998 111.295 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -68.78 135.35 51.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 44.229999999999997 111.544 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 121' ' ' GLN . 3.5 tp60 -119.8 127.62 52.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.576 -0.527 . . . . 42.140000000000001 109.576 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -109.09 -8.57 15.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.63 -0.714 . . . . 71.310000000000002 111.332 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.43 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 63.2 m-20 -125.81 148.86 49.0 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.817 0.341 . . . . 73.040000000000006 111.809 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.805 ' HD2' HD11 ' A' ' 55' ' ' LEU . 13.2 mmmm -76.69 149.15 36.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 53.340000000000003 110.14 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.62 143.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 111.994 0.368 . . . . 62.219999999999999 111.994 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -81.07 -16.15 54.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.655 -0.702 . . . . 73.409999999999997 111.355 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 95' ' ' HIS . 0.0 OUTLIER 4.81 60.65 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.295 1.591 . . . . 74.409999999999997 115.295 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 126' ' ' GLU . 25.7 p 51.78 150.9 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 115.213 1.56 . . . . 74.150000000000006 115.213 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.82 158.19 29.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.659 2.906 . . . . 74.109999999999999 112.532 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -58.79 141.33 53.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.247 -0.433 . . . . 70.230000000000004 111.58 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 131' ' ' ILE . 16.4 mm -119.63 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.117 0.484 . . . . 64.030000000000001 111.673 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.7 m -87.38 143.03 27.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.551 -0.75 . . . . 73.310000000000002 111.244 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -51.86 -37.21 51.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.001 0.429 . . . . 72.120000000000005 110.817 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.62 ' HA ' HD13 ' A' ' 177' ' ' ILE . 46.9 p -70.29 12.87 0.2 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.654 0.613 . . . . 73.409999999999997 112.654 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' THR . 14.7 t -68.48 123.94 22.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 74.450000000000003 110.507 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.555 ' H ' ' CA ' ' A' ' 179' ' ' GLY . 27.3 ttt-85 -62.89 165.67 6.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.221 -0.445 . . . . 63.100000000000001 111.344 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.424 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 11.6 m -37.34 155.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.121 -0.945 . . . . 72.140000000000001 111.873 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.0 -3.25 20.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.973 -0.632 . . . . 74.439999999999998 111.819 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -165.54 41.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.168 0.509 . . . . 74.329999999999998 111.128 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.29 -64.62 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.027 -1.101 . . . . 65.140000000000001 108.027 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.685 HD22 ' HA ' ' A' ' 73' ' ' TYR . 11.4 m-20 -73.0 114.9 11.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.484 -1.235 . . . . 75.540000000000006 109.636 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -148.21 135.65 20.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.001 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.548 HD22 ' HG3' ' A' ' 145' ' ' ARG . 19.0 p-10 -101.69 106.66 17.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 54.43 110.505 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -49.12 -37.05 20.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 35.329999999999998 111.243 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.548 ' HG3' HD22 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -49.4 -25.94 2.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.973 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -52.46 -52.64 53.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.623 -0.88 . . . . 73.200000000000003 108.623 177.354 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.581 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 4.6 m-85 -62.12 -29.58 70.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.058 -0.974 . . . . 72.439999999999998 110.194 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 145' ' ' ARG . . . -62.83 -37.05 85.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.457 -0.572 . . . . 63.140000000000001 109.457 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.17 39.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.708 -0.678 . . . . 74.129999999999995 111.182 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.581 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 3.7 ptpp? -66.58 -49.45 66.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.199 0.444 . . . . 75.420000000000002 112.199 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.698 ' ND1' HD21 ' A' ' 153' ' ' LEU . 22.0 t-160 -86.83 3.12 46.6 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.199 -0.313 . . . . 73.040000000000006 111.222 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 58.63 34.12 75.16 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.113 -0.565 . . . . 75.340000000000003 113.565 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.698 HD21 ' ND1' ' A' ' 151' ' ' HIS . 18.1 mt -68.27 16.55 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 122.739 0.415 . . . . 63.009999999999998 112.072 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -52.68 -33.8 42.56 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.549 -0.834 . . . . 61.43 112.765 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.7 78.74 0.13 Allowed Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.3 0.24 . . . . 71.420000000000002 111.441 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 154' ' ' GLY . 32.5 Cg_endo -61.56 130.4 31.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 121.526 1.484 . . . . 71.420000000000002 111.549 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 119' ' ' TYR . 26.9 pt -81.03 -34.85 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 120.603 -0.439 . . . . 72.530000000000001 110.126 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -150.35 161.03 43.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 111.466 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -161.09 173.76 14.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.784 -0.643 . . . . 62.5 110.528 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -171.03 135.14 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.581 -0.896 . . . . 63.240000000000002 108.581 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.665 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -136.97 149.01 47.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.586 -0.279 . . . . 73.329999999999998 111.657 -177.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 1.7 p90 -142.25 152.61 43.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.8 -0.636 . . . . 71.510000000000005 111.264 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 111' ' ' LEU . 60.1 mt-30 -113.98 124.85 53.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.669 -0.493 . . . . 72.530000000000001 109.669 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' HB3' ' HE1' ' A' ' 162' ' ' TYR . . . -155.18 148.51 24.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 74.310000000000002 111.694 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 7.2 pm0 -117.81 177.46 4.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.608 -0.724 . . . . 72.219999999999999 109.602 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.615 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -162.18 -135.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.05 -0.26 . . . . 74.019999999999996 110.409 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 169' ' ' TYR . 44.7 m-20 -144.3 164.23 31.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.014 0.435 . . . . 72.310000000000002 111.532 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.578 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 36.8 t70 -67.16 12.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.579 -0.737 . . . . 74.519999999999996 110.154 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 167' ' ' ASP . 45.7 t80 -84.4 -46.6 11.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.397 -0.819 . . . . 74.549999999999997 111.592 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' A' ' 171' ' ' PRO . 13.1 p -67.72 -34.31 6.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.523 0.564 . . . . 65.439999999999998 112.523 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' A' ' 170' ' ' VAL . 42.4 Cg_exo -58.12 -22.92 58.61 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.96 1.773 . . . . 75.040000000000006 111.882 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.83 -31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 73.329999999999998 111.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.29 -33.79 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.693 0.282 . . . . 73.129999999999995 111.291 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 177' ' ' ILE . 12.3 p30 -47.57 -36.34 10.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 63.009999999999998 110.727 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -52.09 -31.81 32.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 111.385 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 77.4 p -79.98 15.75 1.38 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.912 0.386 . . . . 70.230000000000004 111.666 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 134' ' ' THR . 10.6 mm -73.04 135.04 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.323 -0.398 . . . . 74.409999999999997 110.057 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.7 -21.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.275 0.843 . . . . 74.450000000000003 113.275 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.555 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.409 -1.217 . . . . 74.230000000000004 112.49 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 ttp . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.513 0.197 . . . . 71.239999999999995 110.603 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.0 m-20 -62.21 113.32 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 51.329999999999998 109.164 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.91 -71.53 0.76 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.925 0.713 . . . . 65.439999999999998 112.925 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -82.69 48.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.407 0.622 . . . . 60.409999999999997 112.05 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.9 p -120.21 143.32 35.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 75.230000000000004 110.992 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 58.5 Cg_endo -97.19 26.2 19.76 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 124.712 -0.954 . . . . 74.340000000000003 112.215 0.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.79 -41.76 98.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 72.340000000000003 110.967 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 9' ' ' LEU . 16.9 m -152.7 -51.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 113.409 0.892 . . . . 75.109999999999999 113.409 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 115' ' ' ILE . 55.0 tp -157.61 141.49 15.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.146 0.498 . . . . 75.329999999999998 112.275 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -74.9 36.53 0.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.89 -0.596 . . . . 73.420000000000002 110.948 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 13' ' ' PRO . . . 178.33 145.58 0.13 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.466 -0.333 . . . . 63.509999999999998 111.047 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 4' ' ' ILE . 55.8 t -92.54 102.38 6.59 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 74.239999999999995 111.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -72.97 136.88 25.73 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.868 2.379 . . . . 75.219999999999999 113.007 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.03 -28.83 67.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.909 -0.587 . . . . 52.25 110.108 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.54 -133.59 3.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.302 -0.863 . . . . 64.120000000000005 111.486 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.559 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t -163.7 177.57 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.719 . . . . 74.409999999999997 111.758 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 118' ' ' LEU . 26.6 mt -124.24 143.96 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.094 . . . . 54.200000000000003 108.084 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 5.7 mtpm? -107.64 102.85 12.06 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.381 -0.528 . . . . 44.030000000000001 111.58 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.685 ' HB ' HG22 ' A' ' 27' ' ' VAL . 63.1 t -103.18 110.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.485 -0.779 . . . . 73.129999999999995 109.633 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.694 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 62.7 mt -95.24 114.9 32.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.43 -0.805 . . . . 72.030000000000001 110.647 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -82.53 -85.23 0.11 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.155 -0.475 . . . . 72.239999999999995 112.1 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -68.15 2.97 6.11 Favored Glycine 0 N--CA 1.461 0.34 0 CA-C-N 116.117 -0.492 . . . . 75.319999999999993 113.596 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.694 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 13.6 t70 78.92 -41.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.232 -0.655 . . . . 75.340000000000003 109.232 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' GLY . 4.1 t70 -74.02 -27.93 61.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 71.400000000000006 109.725 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.5 pt? -124.93 -174.35 3.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.402 0.62 . . . . 73.230000000000004 112.157 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 18.2 pt-20 -156.97 157.79 35.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.319 -0.855 . . . . 63.509999999999998 111.038 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.2 m -85.35 143.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 71.319999999999993 111.689 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 50.1 mttp -144.2 126.81 16.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.466 0.65 . . . . 74.329999999999998 112.047 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.3 mp0 35.09 61.75 0.6 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.344 1.238 . . . . 73.209999999999994 114.344 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 16.94 55.62 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.859 -0.61 . . . . 43.109999999999999 114.247 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.616 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.89 156.52 8.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.104 0.478 . . . . 75.430000000000007 111.042 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 33' ' ' LEU . 28.7 tt0 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 73.409999999999997 110.125 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.4 mp -105.41 130.51 53.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.338 -0.392 . . . . 73.040000000000006 110.124 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -146.92 158.37 45.41 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.566 . . . . 75.549999999999997 110.502 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.82 121.98 3.62 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.257 -1.143 . . . . 73.340000000000003 113.266 0.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.8 p 44.44 25.9 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.842 -0.617 . . . . 60.130000000000003 112.551 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 39' ' ' LYS . 12.0 pt20 -80.3 0.1 34.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.098 0.475 . . . . 75.319999999999993 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 33' ' ' LEU . 35.8 m -73.24 26.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.879 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -106.15 -9.12 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 64.329999999999998 111.58 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -84.54 148.79 26.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.218 0.532 . . . . 70.219999999999999 111.79 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.4 pm0 -63.02 133.14 95.3 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.631 -0.713 . . . . 71.329999999999998 111.847 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 90.5 Cg_endo -85.37 128.74 3.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.868 2.379 . . . . 63.100000000000001 113.075 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 41.4 mm -103.32 105.92 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 64.549999999999997 110.419 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 17' ' ' ILE . 3.2 p -84.92 137.08 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.829 0.678 . . . . 71.040000000000006 112.829 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -165.33 137.0 4.09 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.84 0.311 . . . . 54.210000000000001 111.84 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.536 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p90 -107.53 12.51 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.283 -0.417 . . . . 75.510000000000005 109.995 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.3 t -31.95 115.91 0.18 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.103 -0.953 . . . . 73.5 112.204 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 108.7 -30.66 8.53 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 74.099999999999994 112.661 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 16' ' ' THR . 39.4 mt -85.12 -35.52 21.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.97 0.414 . . . . 64.519999999999996 110.663 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 16.1 pm0 -56.59 -171.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 74.25 110.165 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.16 -77.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.102 -1.047 . . . . 65.310000000000002 112.662 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -148.49 111.24 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.414 0.626 . . . . 72.129999999999995 110.867 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 m -157.34 147.34 20.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.632 -0.877 . . . . 71.129999999999995 108.632 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.69 -41.84 95.76 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.675 0.75 . . . . 61.240000000000002 109.606 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 35.7 mt -155.91 178.07 10.69 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.249 -1.341 . . . . 72.109999999999999 110.031 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 120' ' ' ARG . 89.3 mt -140.93 163.79 32.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.087 -0.708 . . . . 72.140000000000001 109.087 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 HG12 ' A' ' 82' ' ' VAL . 58.1 m -135.05 119.63 18.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 75.239999999999995 111.115 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 tm? -107.41 110.89 22.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.627 -0.715 . . . . 60.32 109.234 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 153' ' ' LEU . 81.0 mt -115.89 137.11 52.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 70.439999999999998 111.22 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.89 146.77 23.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.739 -0.664 . . . . 73.049999999999997 110.444 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 99.0 t -141.62 118.37 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 63.32 111.033 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.603 ' H ' ' HD3' ' A' ' 63' ' ' PRO . 22.2 t70 173.03 48.84 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.673 -1.149 . . . . 63.299999999999997 108.375 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HD3' ' H ' ' A' ' 62' ' ' ASP . 58.3 Cg_endo -70.0 83.87 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.045 1.83 . . . . 75.209999999999994 113.824 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -145.93 101.22 3.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.078 -0.965 . . . . 63.5 109.09 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -166.14 136.69 2.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 73.329999999999998 111.482 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 14.8 Cg_exo -71.12 -5.17 10.89 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 123.56 -1.433 . . . . 70.409999999999997 111.313 -0.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 146.29 7.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.888 . . . . 70.340000000000003 110.222 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.493 ' HD3' ' C ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -64.04 -15.47 59.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.466 . . . . 65.109999999999999 110.408 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -92.01 -23.32 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 74.420000000000002 111.979 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t70 -144.13 73.96 16.11 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 75.299999999999997 110.241 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.87 62.54 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.434 2.756 . . . . 74.239999999999995 112.406 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -48.86 -36.48 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.928 -0.578 . . . . 65.219999999999999 111.511 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -165.01 48.98 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 74.129999999999995 111.51 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HG2' ' CA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -81.2 144.06 31.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.226 -0.657 . . . . 75.0 109.226 177.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.454 ' CA ' ' HG2' ' A' ' 74' ' ' ARG . 39.0 mt-10 -89.91 163.74 14.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.044 0.938 . . . . 64.349999999999994 111.297 0.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 77' ' ' LEU . 21.2 mm -84.76 -129.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.182 -1.414 . . . . 75.120000000000005 107.182 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.658 ' H ' HG22 ' A' ' 76' ' ' ILE . 49.9 mt -86.84 151.67 23.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 0.0 OUTLIER -149.65 160.93 43.11 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 121.075 -0.25 . . . . 74.120000000000005 111.075 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.403 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 1.4 t-105 -100.31 79.8 2.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.659 0.743 . . . . 75.329999999999998 111.025 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 97' ' ' LEU . 24.5 p -94.67 133.25 38.53 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.664 -1.153 . . . . 74.129999999999995 110.92 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -144.72 138.42 22.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 120.728 -0.389 . . . . 73.340000000000003 111.19 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.009 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.21 167.74 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 62.100000000000001 110.645 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' HD22 ' A' ' 55' ' ' LEU . 1.7 m-20 64.24 33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.528 -0.305 . . . . 71.310000000000002 111.413 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.023 HD13 ' HA3' ' A' ' 94' ' ' GLY . 15.6 mm -80.78 124.14 81.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.613 -0.514 . . . . 73.209999999999994 109.613 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.442 ' HB2' ' OD1' ' A' ' 88' ' ' ASN . 51.5 Cg_exo -52.16 129.79 32.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.292 1.328 . . . . 71.409999999999997 110.98 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.42 50.03 0.29 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 114.739 0.656 . . . . 35.539999999999999 114.739 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t -176.73 32.56 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.402 0.601 . . . . 65.319999999999993 111.914 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 90' ' ' ASN . 13.5 m120 -113.19 0.55 14.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.567 0.222 . . . . 64.400000000000006 111.07 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 51.9 mt-10 68.14 -34.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 64.239999999999995 112.276 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' ASN . 4.0 p30 -133.81 155.45 80.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.529 . . . . 65.120000000000005 111.447 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 84' ' ' ILE . 91.9 Cg_endo -71.89 59.36 2.84 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.49 2.793 . . . . 54.409999999999997 113.267 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.1 m -104.29 -54.8 2.47 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.817 0.673 . . . . 63.539999999999999 112.817 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.11 -0.55 15.71 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.6 1.0 . . . . 64.150000000000006 115.6 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 1.023 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -100.34 176.43 27.8 Favored Glycine 0 N--CA 1.461 0.313 0 C-N-CA 120.423 -0.894 . . . . 73.120000000000005 113.258 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -70.46 121.34 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 74.109999999999999 111.284 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.596 ' HA ' HG13 ' A' ' 81' ' ' VAL . 43.7 m -80.99 96.94 7.26 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.638 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 43.7 mt -48.02 -50.13 28.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 109.549 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -141.86 107.97 5.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.834 -1.075 . . . . 63.32 108.249 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.566 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 44.7 t0 -41.91 144.57 0.41 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 73.200000000000003 112.966 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -60.59 139.85 57.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.89 -1.05 . . . . 74.430000000000007 112.137 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 14.4 p -148.15 113.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.586 -0.734 . . . . 74.030000000000001 110.651 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.11 18.79 3.14 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.204 -0.522 . . . . 44.149999999999999 113.194 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.611 ' O ' HG12 ' A' ' 170' ' ' VAL . 80.1 p -69.18 -64.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 73.030000000000001 111.083 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 163.7 15.33 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.516 -0.766 . . . . 62.149999999999999 112.601 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG2' HG21 ' A' ' 109' ' ' THR . 28.8 Cg_endo -60.88 160.49 25.18 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.046 2.497 . . . . 73.510000000000005 113.114 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 109' ' ' THR . 26.3 Cg_exo -63.6 161.3 32.37 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.665 2.91 . . . . 50.409999999999997 113.967 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -44.7 -37.81 3.97 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.342 -0.845 . . . . 64.219999999999999 111.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -50.83 -22.05 1.99 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.503 0.557 . . . . 65.099999999999994 112.503 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 106' ' ' PRO . 11.3 t -80.97 -25.45 37.32 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.558 0.948 . . . . 62.219999999999999 113.558 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.62 -163.91 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.577 -0.821 . . . . 62.020000000000003 112.444 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 39.7 tp -46.19 109.23 0.17 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.085 0.469 . . . . 62.109999999999999 111.745 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -113.2 142.52 45.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.732 -0.667 . . . . 72.540000000000006 109.691 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.584 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -95.55 88.08 4.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.704 . . . . 74.530000000000001 112.579 -177.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 9.8 t80 -73.5 120.13 18.67 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.127 -0.629 . . . . 74.109999999999999 109.513 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.837 HG21 HD13 ' A' ' 9' ' ' LEU . 25.9 mt -113.42 130.82 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 111.979 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -102.45 125.18 49.08 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.712 -0.676 . . . . 74.540000000000006 109.585 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 118' ' ' LEU . 6.5 tt -119.27 135.26 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 110.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.675 ' N ' HD23 ' A' ' 117' ' ' LEU . 64.6 tp -119.46 136.39 54.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.718 -0.674 . . . . 62.32 110.47 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 153' ' ' LEU . 64.0 t80 -144.14 135.67 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 65.230000000000004 111.029 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.621 ' HA ' HD23 ' A' ' 56' ' ' LEU . 94.8 mtt180 -64.83 130.39 43.29 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.787 -0.365 . . . . 71.310000000000002 110.185 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.749 ' NE2' HD11 ' A' ' 125' ' ' ILE . 26.8 tt0 -107.74 127.48 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.556 -0.535 . . . . 70.409999999999997 109.556 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -99.84 -39.02 8.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.6 0.593 . . . . 75.420000000000002 112.6 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -102.8 136.91 41.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.181 0.808 . . . . 74.120000000000005 113.181 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' HD22 ' A' ' 83' ' ' ASN . 22.8 tptm -72.13 114.19 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.261 -0.881 . . . . 74.019999999999996 109.787 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.749 HD11 ' NE2' ' A' ' 121' ' ' GLN . 5.3 pt -115.71 132.59 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.006 -0.543 . . . . 62.329999999999998 112.178 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -59.18 -53.09 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.276 0.56 . . . . 65.450000000000003 109.977 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.736 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.0 mm-40 60.72 38.45 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.159 -0.928 . . . . 73.310000000000002 111.531 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 127' ' ' GLU . 41.0 p 54.84 149.84 0.05 OUTLIER Pre-proline 0 C--O 1.223 -0.322 0 O-C-N 123.741 0.651 . . . . 70.239999999999995 112.632 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.45 147.37 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.16 2.573 . . . . 75.209999999999994 112.755 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.502 ' CG2' ' HB2' ' A' ' 96' ' ' SER . 1.4 m -58.44 119.61 7.3 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 110.471 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 42.0 mm -80.89 133.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.461 -0.336 . . . . 61.009999999999998 110.653 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 134' ' ' THR . 29.0 t -73.95 148.01 42.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.967 -0.561 . . . . 73.109999999999999 111.143 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.566 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 19.7 p-10 -62.92 -41.24 99.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 73.319999999999993 109.994 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 12.2 t -75.02 22.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.626 -0.716 . . . . 74.310000000000002 110.974 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 133' ' ' ASN . 2.9 t -62.33 119.55 9.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.404 0.621 . . . . 61.200000000000003 112.627 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 137' ' ' THR . 23.5 tpt180 -65.48 167.3 8.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.931 -1.032 . . . . 70.200000000000003 110.621 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.808 ' HA ' HD11 ' A' ' 140' ' ' LEU . 11.0 m -44.47 151.04 0.29 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 61.299999999999997 111.521 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 139' ' ' ARG . . . 116.14 -8.86 18.27 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.974 -0.631 . . . . 43.0 113.605 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.526 ' H ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -152.87 50.72 0.74 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.399 0.599 . . . . 70.310000000000002 111.288 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.808 HD11 ' HA ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -114.22 -56.82 2.35 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.617 -0.512 . . . . 62.32 109.617 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -62.91 119.79 10.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.703 -0.68 . . . . 70.299999999999997 111.165 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 175.46 133.48 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 72.140000000000001 110.081 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 146' ' ' ASP . 31.0 p30 -80.6 124.06 28.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.992 0.425 . . . . 73.120000000000005 111.915 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.91 96.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.453 -0.34 . . . . 53.240000000000002 111.808 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -46.49 -27.39 1.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 63.399999999999999 111.714 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 28.3 t70 -56.92 -42.75 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.602 -0.272 . . . . 72.420000000000002 111.47 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 24.3 m-85 -54.94 -38.14 67.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.59 0.71 . . . . 75.299999999999997 109.531 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -70.83 -41.13 71.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.078 -0.965 . . . . 54.100000000000001 110.55 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.39 -47.64 78.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 64.310000000000002 111.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.37 -53.25 59.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.056 0.761 . . . . 73.219999999999999 113.056 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.542 ' HB3' HD21 ' A' ' 153' ' ' LEU . 18.1 t-80 -94.69 11.64 30.55 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.8 -0.76 . . . . 61.340000000000003 111.716 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.51 94.61 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.676 -0.773 . . . . 74.340000000000003 113.837 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.781 HD13 HG21 ' A' ' 57' ' ' THR . 9.5 mt -79.78 16.02 1.24 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.618 -0.342 . . . . 74.299999999999997 110.469 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -36.65 -72.43 0.15 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.701 -0.681 . . . . 75.140000000000001 114.766 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.52 113.09 16.69 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 117.05 0.425 . . . . 61.5 111.316 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 134.82 10.55 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.805 2.337 . . . . 74.439999999999998 113.424 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.607 HD13 ' HG3' ' A' ' 120' ' ' ARG . 43.1 pt -75.85 -37.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.44 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 16' ' ' THR . . . -152.03 134.92 15.62 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.612 -0.267 . . . . 65.519999999999996 110.734 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -140.0 151.83 45.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 75.209999999999994 111.301 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.507 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.4 t-20 -154.15 142.37 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.698 -1.223 . . . . 73.540000000000006 107.698 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.648 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -146.8 162.99 37.45 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.461 0.541 . . . . 73.329999999999998 112.461 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p90 -154.28 153.81 32.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.263 -0.88 . . . . 73.340000000000003 110.875 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.495 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 52.3 mt-30 -110.86 135.07 51.97 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.953 -0.388 . . . . 71.120000000000005 109.953 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.417 ' CA ' HD12 ' A' ' 111' ' ' LEU . . . -155.47 149.48 25.58 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.918 1.081 . . . . 51.530000000000001 113.918 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.4 OUTLIER -137.61 157.34 46.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.359 -1.292 . . . . 71.200000000000003 107.825 177.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.92 167.53 20.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 74.030000000000001 111.864 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 169' ' ' TYR . 53.3 m-20 -56.68 150.12 16.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.328 -0.851 . . . . 74.409999999999997 111.327 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.651 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 19.3 t0 -54.79 -8.87 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 72.329999999999998 110.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.455 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 22.2 t80 -60.02 -40.98 91.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.905 -0.589 . . . . 75.329999999999998 111.221 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.703 HG13 ' NH1' ' A' ' 173' ' ' ARG . 21.5 t -63.66 -53.84 47.49 Favored Pre-proline 0 C--O 1.235 0.308 0 N-CA-C 109.464 -0.569 . . . . 74.549999999999997 109.464 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 50.9 Cg_exo -52.01 -31.62 44.88 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.872 1.715 . . . . 74.340000000000003 111.79 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 168' ' ' ASP . 50.7 mt -50.46 -34.52 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.495 -0.321 . . . . 75.129999999999995 110.431 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 1.015 ' O ' HG22 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.94 -37.69 14.94 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.647 -0.501 . . . . 73.129999999999995 109.647 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -56.46 -35.63 68.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.109 -0.496 . . . . 74.549999999999997 111.454 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 12.9 mptt -57.37 -33.23 67.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.368 -0.207 . . . . 62.200000000000003 111.422 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 1.015 HG22 ' O ' ' A' ' 173' ' ' ARG . 10.9 t -69.59 -10.3 57.61 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.617 -0.433 . . . . 74.329999999999998 111.254 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.637 ' CD1' HD11 ' A' ' 77' ' ' LEU . 83.8 mt -63.62 127.23 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.562 -0.29 . . . . 61.310000000000002 110.529 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.25 3.31 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.169 0.433 . . . . 74.519999999999996 112.169 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.396 -1.225 . . . . 44.240000000000002 112.519 -179.257 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' SD ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 tpp . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.552 -0.166 . . . . 73.030000000000001 110.552 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -64.12 103.47 0.61 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.188 0.305 . . . . 74.319999999999993 110.557 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -109.8 -72.86 0.7 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.891 0.7 . . . . 60.32 112.891 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -89.15 53.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.594 0.712 . . . . 52.549999999999997 111.588 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 10' ' ' ASP . 8.8 p -135.13 139.31 31.45 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.095 -0.957 . . . . 73.099999999999994 110.459 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 5' ' ' VAL . 78.0 Cg_endo -83.98 35.69 2.62 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.83 -1.321 . . . . 75.319999999999993 113.177 0.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.4 t0 -61.38 -52.56 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.238 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 7' ' ' ASP . 15.8 m -158.88 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 65.140000000000001 111.789 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.716 HD23 ' HD3' ' A' ' 13' ' ' PRO . 15.9 tp -157.34 140.22 15.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.319 0.581 . . . . 72.530000000000001 111.444 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 3.5 p-10 -58.82 -26.74 64.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 112.169 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.96 130.93 13.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 72.030000000000001 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 12' ' ' VAL . 8.2 p -65.82 115.12 19.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.571 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.716 ' HD3' HD23 ' A' ' 9' ' ' LEU . 31.7 Cg_endo -94.22 143.94 1.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.965 2.443 . . . . 74.239999999999995 112.174 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.9 -30.84 47.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.39 0.614 . . . . 41.009999999999998 110.026 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.3 -166.96 15.62 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.819 -1.082 . . . . 73.140000000000001 110.63 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 9.7 t -121.99 172.95 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.498 0.649 . . . . 74.209999999999994 111.183 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 158' ' ' ALA . 6.4 mt -105.47 128.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 75.439999999999998 110.426 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 3.2 mmmp? -73.8 107.07 5.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.915 -0.772 . . . . 70.340000000000003 108.915 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.2 t -123.0 109.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 60.210000000000001 110.689 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 25' ' ' LEU . 39.2 mt -100.93 123.11 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.183 -0.917 . . . . 62.009999999999998 109.871 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.98 -36.54 64.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.581 -0.736 . . . . 60.0 111.877 -178.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.81 -63.07 0.15 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 120.232 -0.985 . . . . 73.019999999999996 112.675 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -166.81 -61.21 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.522 -0.547 . . . . 73.329999999999998 109.522 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.98 -48.88 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 110.67 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.6 pp -69.57 147.74 50.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.415 0.626 . . . . 73.209999999999994 111.602 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 11.3 tt0 -143.37 144.95 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.525 -0.761 . . . . 75.25 110.699 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 19' ' ' VAL . 24.3 m -79.93 106.37 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 71.549999999999997 109.513 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 56.2 mttm -103.64 124.75 49.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.179 1.177 . . . . 70.540000000000006 114.179 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.4 mp0 26.9 67.45 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.985 1.476 . . . . 54.439999999999998 114.985 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' CA ' ' CD2' ' A' ' 161' ' ' TYR . . . 74.76 5.56 74.82 Favored Glycine 0 CA--C 1.51 -0.241 0 N-CA-C 115.083 0.793 . . . . 42.200000000000003 115.083 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -57.12 161.95 2.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.591 0.696 . . . . 70.239999999999995 110.029 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.491 ' C ' HD12 ' A' ' 33' ' ' LEU . 32.5 tt0 -109.8 143.71 39.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 72.510000000000005 110.389 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 32' ' ' GLU . 9.5 mp -116.35 120.16 37.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.76 -0.459 . . . . 74.510000000000005 109.76 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -150.49 163.92 22.36 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.846 -0.616 . . . . 72.109999999999999 110.082 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 94.4 Cg_endo -86.92 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.772 -1.345 . . . . 73.230000000000004 112.841 0.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.415 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 70.2 p -104.27 22.62 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.55 -0.295 . . . . 74.319999999999993 111.686 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -81.79 -7.64 59.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.317 -0.553 . . . . 70.209999999999994 110.061 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 24.6 m -91.29 26.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 72.25 111.642 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -85.71 -14.57 44.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 110.648 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.3 141.44 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.805 -0.634 . . . . 73.239999999999995 112.487 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.17 134.89 95.99 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 115.513 -0.767 . . . . 65.420000000000002 110.849 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.2 Cg_endo -73.5 135.88 22.85 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.881 2.388 . . . . 71.299999999999997 113.508 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 48.5 mm -107.19 125.83 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.352 . . . . 73.25 110.423 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.1 p -98.54 146.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.391 0.515 . . . . 65.239999999999995 112.391 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -165.12 146.49 7.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.132 0.492 . . . . 65.439999999999998 111.579 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HH2' HG21 ' A' ' 84' ' ' ILE . 5.2 p90 -121.39 29.9 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.402 -0.592 . . . . 71.310000000000002 109.402 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 t -43.29 131.21 4.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.603 -0.726 . . . . 55.210000000000001 110.696 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.16 -35.76 3.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 64.099999999999994 112.683 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -72.24 -33.87 67.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.557 0.694 . . . . 72.340000000000003 109.341 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.5 tt0 -58.06 142.08 47.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.163 -0.926 . . . . 74.400000000000006 109.194 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.29 -65.74 0.02 OUTLIER Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.036 -1.078 . . . . 45.200000000000003 112.863 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.74 109.34 4.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.838 0.352 . . . . 55.409999999999997 110.162 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m -158.36 141.17 14.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 110.528 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -70.15 -40.42 74.78 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.198 0.999 . . . . 63.329999999999998 108.328 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 83' ' ' ASN . 27.1 mt -155.16 161.26 41.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.76 -1.564 . . . . 74.230000000000004 109.269 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.9 mt -125.07 146.54 49.4 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.178 0.514 . . . . 61.420000000000002 110.358 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.726 HG21 HD21 ' A' ' 153' ' ' LEU . 4.2 m -106.91 127.35 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.744 . . . . 74.120000000000005 109.993 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.3 tm? -130.93 118.5 20.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.363 -0.606 . . . . 75.219999999999999 109.363 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 147' ' ' PHE . 70.4 mt -149.36 132.09 15.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.968 -0.693 . . . . 74.329999999999998 112.043 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 48.3 ttp -94.73 148.4 22.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.731 -0.841 . . . . 73.530000000000001 108.731 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.456 HG22 ' HB1' ' A' ' 144' ' ' ALA . 52.9 t -139.33 145.02 27.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.534 0.683 . . . . 74.129999999999995 112.57 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -175.9 82.93 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 114.067 -1.424 . . . . 74.310000000000002 109.361 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.52 84.39 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.8 2.333 . . . . 72.209999999999994 111.84 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.597 ' CB ' HH12 ' A' ' 113' ' ' ARG . 3.2 t0 -170.22 122.5 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.753 0.649 . . . . 73.349999999999994 112.753 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -173.13 130.74 0.58 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.97 -0.292 . . . . 72.310000000000002 111.554 175.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.06 -12.54 24.12 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.257 -1.56 . . . . 62.109999999999999 109.025 -4.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.4 t -151.99 142.82 22.95 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.992 -1.458 . . . . 72.010000000000005 109.661 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -58.87 -31.13 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.408 . . . . 75.329999999999998 110.751 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -60.32 -41.62 93.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.442 -0.799 . . . . 73.230000000000004 111.819 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 28.1 m-20 -138.1 71.3 48.05 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.449 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 27.6 Cg_exo -61.29 112.65 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.242 1.961 . . . . 72.019999999999996 111.122 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -101.27 -51.43 3.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.86 0.362 . . . . 71.019999999999996 111.631 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 18.3 p90 -116.24 24.81 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 75.099999999999994 109.997 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 1.3 tmt_? -73.84 138.03 44.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.154 -0.93 . . . . 63.25 109.643 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 143' ' ' ASN . 4.9 mm-40 -75.11 170.12 16.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.63 1.172 . . . . 64.109999999999999 111.346 0.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.756 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.8 tp -119.27 168.38 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 75.5 111.189 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' N ' HG13 ' A' ' 76' ' ' ILE . 73.2 mt -54.83 133.72 47.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.357 0.598 . . . . 65.150000000000006 111.747 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.8 -169.38 2.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.183 -0.917 . . . . 72.120000000000005 109.119 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.486 ' HA ' ' HE3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -98.6 104.47 16.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.219 -1.03 . . . . 71.340000000000003 108.219 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.729 ' HA ' HD23 ' A' ' 59' ' ' LEU . 1.5 m -119.0 117.37 28.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 73.120000000000005 110.985 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 96' ' ' SER . 1.7 t -141.73 130.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 74.010000000000005 109.405 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.801 HG21 ' HG3' ' A' ' 127' ' ' GLU . 32.2 m -141.69 166.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.057 0.456 . . . . 70.019999999999996 111.559 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.689 ' O ' HD22 ' A' ' 55' ' ' LEU . 22.9 p30 64.16 39.22 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.655 -1.157 . . . . 73.150000000000006 109.524 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.983 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.8 mm -77.2 115.44 48.94 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 114.408 -1.269 . . . . 72.310000000000002 108.991 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' SER . 51.0 Cg_exo -53.1 127.67 25.97 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.692 1.594 . . . . 74.519999999999996 111.774 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.43 69.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.33 -0.462 . . . . 73.439999999999998 112.854 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 85' ' ' PRO . 29.3 t 177.31 48.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.66 0.384 . . . . 65.530000000000001 110.097 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 90' ' ' ASN . 70.2 m-80 -135.68 -22.36 1.46 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.029 0.752 . . . . 60.149999999999999 113.029 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 70.87 -22.18 0.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.867 0.365 . . . . 74.200000000000003 110.784 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.537 ' H ' ' C ' ' A' ' 88' ' ' ASN . 10.3 p30 -152.17 158.16 33.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 115.873 -0.603 . . . . 64.530000000000001 109.575 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 44' ' ' VAL . 81.9 Cg_endo -70.92 48.2 0.81 Allowed 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 123.29 2.66 . . . . 73.439999999999998 114.307 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 t -97.53 -8.29 29.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.06 -0.656 . . . . 72.430000000000007 111.797 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.35 -40.74 1.46 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.585 -0.816 . . . . 72.5 114.26 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.983 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.21 171.87 7.65 Favored Glycine 0 N--CA 1.459 0.208 0 C-N-CA 120.847 -0.692 . . . . 74.040000000000006 113.037 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.646 ' CE1' HG23 ' A' ' 130' ' ' THR . 52.5 t60 -70.89 118.82 14.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.584 0.23 . . . . 74.439999999999998 111.455 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 81' ' ' VAL . 66.3 p -81.05 91.05 6.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.936 -0.764 . . . . 75.219999999999999 108.936 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 82' ' ' VAL . 10.6 mt -49.3 -52.4 27.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 63.219999999999999 110.048 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -137.08 117.41 13.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 53.329999999999998 108.885 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.484 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 50.6 t0 -55.78 151.08 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.767 0.667 . . . . 72.200000000000003 111.649 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.414 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.5 p90 -60.35 151.3 28.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 73.209999999999994 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.21 152.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.424 -0.353 . . . . 71.340000000000003 110.149 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' C ' HG12 ' A' ' 170' ' ' VAL . . . -46.19 -72.84 0.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.963 -0.637 . . . . 71.219999999999999 112.429 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -171.15 124.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 72.430000000000007 110.471 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -68.29 -49.15 47.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.524 -0.846 . . . . 62.420000000000002 111.511 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CB ' HG21 ' A' ' 109' ' ' THR . 2.7 Cg_exo -77.78 114.59 3.67 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.851 2.367 . . . . 73.409999999999997 112.017 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 109' ' ' THR . 26.6 Cg_exo -62.69 160.91 30.53 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.135 2.556 . . . . 62.43 111.861 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.546 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.98 -28.05 2.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.343 -0.389 . . . . 63.329999999999998 111.419 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.546 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 87.0 m-20 -51.64 -40.0 59.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 74.519999999999996 112.025 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 106' ' ' PRO . 14.7 t -71.06 -2.91 17.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.755 -0.378 . . . . 53.219999999999999 111.254 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 69.95 -126.72 17.64 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 116.106 -0.497 . . . . 73.329999999999998 113.673 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 163' ' ' GLN . 31.0 tp -66.96 145.48 55.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.8 0.809 . . . . 72.409999999999997 112.505 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 19.0 m80 -120.02 167.05 12.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.99 -1.459 . . . . 71.219999999999999 110.037 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.597 HH12 ' CB ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -141.0 75.4 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.972 -0.751 . . . . 73.109999999999999 108.972 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.38 120.79 22.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.581 -0.736 . . . . 73.439999999999998 109.659 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' A' ' 161' ' ' TYR . 11.9 mt -116.02 122.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.094 0.473 . . . . 54.219999999999999 112.025 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -91.01 130.57 36.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.43 -0.805 . . . . 74.420000000000002 109.064 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.3 tm? -119.27 136.19 54.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 64.540000000000006 110.168 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.6 tt -136.84 129.68 30.65 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.338 -0.392 . . . . 73.549999999999997 110.053 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.732 ' N ' HD23 ' A' ' 118' ' ' LEU . 62.8 t80 -144.16 143.65 31.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 71.140000000000001 110.971 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -63.13 119.99 10.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.848 -0.427 . . . . 55.520000000000003 109.848 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 7.0 tt0 -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.493 -0.558 . . . . 71.310000000000002 109.493 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -94.4 -31.08 14.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 61.25 111.047 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -98.16 129.99 44.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.81 -0.632 . . . . 70.319999999999993 111.19 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 125' ' ' ILE . 19.7 tptp -74.11 129.85 38.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.706 -0.479 . . . . 72.530000000000001 109.706 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 pt -141.95 137.6 30.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 61.409999999999997 112.045 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -79.49 -39.54 31.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.963 -0.562 . . . . 63.43 111.111 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.801 ' HG3' HG21 ' A' ' 82' ' ' VAL . 61.5 mm-40 56.69 39.65 29.62 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.531 0.567 . . . . 75.200000000000003 112.531 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 65.2 p 56.71 161.3 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.702 0.626 . . . . 70.299999999999997 112.171 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 76.6 Cg_exo -52.6 157.05 7.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.775 2.317 . . . . 75.329999999999998 113.515 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.646 HG23 ' CE1' ' A' ' 95' ' ' HIS . 12.2 p -59.51 120.54 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.444 -0.798 . . . . 75.510000000000005 112.085 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 131' ' ' ILE . 21.6 mm -83.91 127.2 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.715 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -63.69 140.77 58.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.976 -1.011 . . . . 64.340000000000003 112.322 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.731 ' OD1' HG23 ' A' ' 134' ' ' THR . 19.8 p30 -57.76 -47.88 81.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.255 0.55 . . . . 73.099999999999994 110.421 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.85 ' HA ' HD13 ' A' ' 177' ' ' ILE . 13.4 p -79.69 24.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.417 -0.81 . . . . 74.5 111.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.7 t -60.77 125.29 23.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.304 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 137' ' ' THR . 22.3 tpt180 -71.53 173.25 8.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.204 -0.907 . . . . 74.349999999999994 110.573 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 35.6 m -39.37 146.17 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.879 0.371 . . . . 72.25 111.32 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.29 -10.08 28.79 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.177 -0.535 . . . . 31.440000000000001 112.264 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 1.9 mmp_? -141.68 32.15 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.721 -0.282 . . . . 71.209999999999994 111.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 76' ' ' ILE . 29.5 mt -101.45 -55.8 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.247 0.546 . . . . 75.519999999999996 110.262 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -64.7 112.03 3.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 61.32 110.84 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -163.51 109.81 1.12 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.584 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 51.7 t30 -64.18 91.8 0.08 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.561 -0.745 . . . . 74.030000000000001 111.221 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -48.92 -40.63 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.41 0.624 . . . . 42.030000000000001 110.091 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.523 ' NH2' ' SD ' ' A' ' 1' ' ' MET . 11.1 tpt180 -46.62 -36.41 6.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.96 -1.018 . . . . 71.209999999999994 110.902 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.41 -42.46 53.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.382 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 59' ' ' LEU . 20.5 m-85 -48.91 -39.24 25.35 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.112 -0.495 . . . . 64.450000000000003 110.617 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.55 -35.57 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.645 -0.707 . . . . 62.240000000000002 109.833 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.92 -59.27 2.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.802 -0.636 . . . . 74.230000000000004 111.849 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 10.6 ptpt -63.82 -45.12 91.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.416 0.525 . . . . 75.310000000000002 112.416 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.605 ' CD2' ' HD3' ' A' ' 150' ' ' LYS . 58.3 m170 -91.61 8.19 37.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 75.129999999999995 110.589 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.63 25.0 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.79 -0.641 . . . . 73.540000000000006 114.183 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' THR . 14.6 mt -76.71 16.72 0.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.902 0.334 . . . . 65.209999999999994 111.902 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.53 -45.59 29.7 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.75 -0.738 . . . . 51.119999999999997 112.564 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -108.81 83.13 1.99 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.886 0.374 . . . . 72.040000000000006 110.116 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 44.3 Cg_endo -68.33 137.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.762 2.308 . . . . 65.219999999999999 113.456 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.57 HD11 HD22 ' A' ' 118' ' ' LEU . 30.6 pt -79.33 -33.41 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.235 -0.654 . . . . 74.129999999999995 109.235 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -142.34 142.87 32.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.665 -0.698 . . . . 64.230000000000004 110.734 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.614 ' HB3' ' HG3' ' A' ' 13' ' ' PRO . . . -153.58 157.88 40.36 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 74.230000000000004 109.215 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.457 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.2 t-20 -165.61 118.62 1.15 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.632 -0.507 . . . . 75.219999999999999 109.632 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -103.13 151.26 22.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.308 -0.86 . . . . 72.319999999999993 110.936 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 164' ' ' ALA . 3.7 t80 -145.96 130.64 17.96 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.422 -0.808 . . . . 73.310000000000002 111.005 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.499 ' HB3' HD11 ' A' ' 111' ' ' LEU . 46.1 mt-30 -110.59 134.75 52.12 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.894 -0.594 . . . . 75.540000000000006 110.366 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -157.81 152.9 25.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.106 0.41 . . . . 63.310000000000002 112.106 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.487 ' HG3' ' CD1' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -135.18 133.03 38.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.572 -1.269 . . . . 64.310000000000002 107.572 176.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.13 152.96 30.09 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.033 -0.358 . . . . 72.409999999999997 110.033 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.4 m-20 -52.84 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.742 0.782 . . . . 52.329999999999998 111.533 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.559 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.1 t70 -58.93 -3.29 0.32 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.141 -0.936 . . . . 72.030000000000001 111.078 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 167' ' ' ASP . 42.2 t80 -42.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 111.897 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.614 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 4.9 t -57.25 -51.83 78.75 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.184 -0.673 . . . . 62.119999999999997 109.184 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.3 Cg_exo -49.57 -18.7 2.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.523 2.149 . . . . 71.409999999999997 112.622 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 168' ' ' ASP . 73.1 mt -50.68 -41.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.395 -0.595 . . . . 73.150000000000006 109.395 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -55.19 -31.68 61.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.582 -0.736 . . . . 72.439999999999998 110.694 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -53.29 -43.05 67.2 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.426 -0.953 . . . . 71.409999999999997 108.426 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 168' ' ' ASP . 9.9 mptt -62.3 -31.04 71.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.381 -0.827 . . . . 64.25 110.09 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 178' ' ' VAL . 7.1 m -66.43 -26.68 67.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.393 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.5 mm -48.72 107.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 73.319999999999993 111.017 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 176' ' ' THR . 27.9 m -154.15 25.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.69 0.256 . . . . 71.230000000000004 111.69 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.665 -1.075 . . . . 65.140000000000001 112.597 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 ttp . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 110.153 -0.314 . . . . 74.209999999999994 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.581 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.2 p-10 -69.19 67.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.481 0.549 . . . . 71.5 112.481 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 54.6 t0 -71.0 -52.16 21.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 71.109999999999999 110.578 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 9' ' ' LEU . 9.7 pt -135.4 49.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.212 0.53 . . . . 73.430000000000007 111.099 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 2' ' ' ASP . 9.8 p -133.5 140.06 35.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.866 -0.607 . . . . 71.329999999999998 110.305 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.38 29.74 3.38 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.752 -1.353 . . . . 61.539999999999999 112.954 0.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.5 t70 -56.21 -47.26 78.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 74.349999999999994 109.839 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 7' ' ' ASP . 6.5 m -163.69 -41.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 75.150000000000006 111.452 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HD3' ' A' ' 13' ' ' PRO . 31.4 tp -157.1 158.84 37.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.843 0.354 . . . . 75.129999999999995 111.319 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -52.34 -46.58 66.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.394 -0.595 . . . . 70.329999999999998 109.394 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -152.59 146.71 25.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.642 -0.708 . . . . 53.439999999999998 110.369 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.92 118.54 33.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.067 0.395 . . . . 72.450000000000003 112.067 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.673 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.1 Cg_endo -90.06 -120.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 74.409999999999997 112.261 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -158.58 -43.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 51.350000000000001 110.345 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.52 -173.54 13.27 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.975 -0.631 . . . . 74.340000000000003 111.801 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -131.73 162.95 29.26 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.206 0.527 . . . . 71.329999999999998 111.052 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 44' ' ' VAL . 8.2 mt -105.31 137.75 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.21 -0.904 . . . . 75.430000000000007 110.758 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.1 mmmt -73.61 102.24 3.84 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.594 -0.521 . . . . 65.340000000000003 109.594 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 27' ' ' VAL . 88.7 t -110.07 109.84 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 119.994 -0.682 . . . . 62.009999999999998 109.726 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' LEU . 2.8 mp -100.38 124.03 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.661 -0.7 . . . . 73.430000000000007 109.771 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -76.74 -32.05 57.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.908 -0.587 . . . . 74.209999999999994 111.893 -178.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.13 -61.89 0.14 Allowed Glycine 0 N--CA 1.459 0.227 0 C-N-CA 120.767 -0.73 . . . . 73.230000000000004 112.175 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' CA ' HG21 ' A' ' 20' ' ' ILE . 32.6 t70 -173.42 -58.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 75.329999999999998 108.235 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -83.67 -45.15 13.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.944 -0.762 . . . . 72.209999999999994 108.944 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -69.67 131.6 44.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.25 -0.886 . . . . 70.510000000000005 112.389 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' ILE . 5.9 tt0 -135.91 146.78 47.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 72.099999999999994 110.245 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 19' ' ' VAL . 34.1 m -82.95 106.55 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.182 0.515 . . . . 74.310000000000002 111.912 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 11.6 mptt -74.57 92.5 2.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.307 0.575 . . . . 64.430000000000007 111.452 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.4 mp0 24.67 66.79 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 114.379 1.252 . . . . 74.319999999999993 114.379 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.07 -3.06 55.3 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 115.07 0.788 . . . . 53.219999999999999 115.07 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.458 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -58.84 167.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.33 0.565 . . . . 71.219999999999999 112.453 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' LEU . 4.0 tt0 -101.89 141.83 34.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.739 -1.119 . . . . 75.150000000000006 110.026 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 27' ' ' VAL . 10.7 mp -108.73 130.38 55.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 53.340000000000003 110.983 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.1 p -148.34 164.19 23.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.665 . . . . 52.030000000000001 110.542 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 64.3 Cg_endo -73.32 -40.76 1.13 Allowed 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.855 -1.31 . . . . 72.319999999999993 112.899 0.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.3 p -150.88 30.6 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.451 0.644 . . . . 62.530000000000001 110.837 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.584 ' OE1' HD13 ' A' ' 25' ' ' LEU . 15.5 pt20 -66.03 -2.88 4.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 55.130000000000003 110.463 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.74 -3.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.411 0.624 . . . . 70.430000000000007 109.937 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -65.72 6.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 75.219999999999999 112.282 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.18 148.72 48.27 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.048 0.451 . . . . 73.430000000000007 111.648 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -73.13 144.41 84.77 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.849 . . . . 64.129999999999995 113.14 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 72.9 Cg_endo -77.1 131.61 12.06 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.18 2.587 . . . . 74.299999999999997 113.928 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -105.29 117.24 50.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.079 -0.51 . . . . 52.030000000000001 110.049 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.92 HG23 HG21 ' A' ' 17' ' ' ILE . 2.7 p -88.85 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.783 0.66 . . . . 73.319999999999993 112.783 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 66.7 m -160.77 133.25 6.17 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.49 -0.323 . . . . 73.099999999999994 111.438 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 9.4 p90 -106.35 24.98 11.65 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.86 0.362 . . . . 75.549999999999997 110.787 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 m -43.29 118.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.777 -0.647 . . . . 65.340000000000003 111.367 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 104.67 -33.84 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.092 -0.504 . . . . 45.219999999999999 112.245 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 8.0 mp -75.33 -37.74 60.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.913 0.387 . . . . 53.530000000000001 110.409 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 48' ' ' GLY . 10.0 pm0 -49.86 153.08 1.37 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.145 -0.48 . . . . 55.450000000000003 109.918 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.41 -73.24 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.937 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -148.89 108.93 4.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.773 -0.454 . . . . 73.430000000000007 109.773 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 2.8 p -158.83 143.13 15.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 72.329999999999998 110.999 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 12.3 t-20 -74.09 -33.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.458 0.647 . . . . 73.019999999999996 109.328 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 83' ' ' ASN . 59.6 mt -157.32 178.38 10.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 74.150000000000006 110.632 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 120' ' ' ARG . 83.1 mt -142.44 165.02 28.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.696 -0.853 . . . . 65.420000000000002 108.696 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.888 HG23 HG12 ' A' ' 82' ' ' VAL . 26.7 m -136.93 123.4 20.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.507 0.194 . . . . 73.400000000000006 110.689 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.75 127.3 49.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.152 -0.477 . . . . 71.340000000000003 111.059 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 HD12 ' A' ' 97' ' ' LEU . 86.9 mt -146.79 141.03 26.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 73.420000000000002 111.278 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.8 ttm -94.28 129.55 40.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 61.43 109.629 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' C ' ' CD ' ' A' ' 63' ' ' PRO . 38.9 t -103.6 62.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.502 -0.317 . . . . 74.239999999999995 111.637 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 25.6 p-10 -112.45 46.55 0.3 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.066 0.395 . . . . 74.120000000000005 112.066 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' HH22 ' A' ' 113' ' ' ARG . 57.5 Cg_endo -70.5 84.8 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.327 2.018 . . . . 71.340000000000003 114.289 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -168.87 114.35 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.391 0.615 . . . . 73.120000000000005 110.711 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.574 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -170.75 139.58 1.34 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.076 -0.965 . . . . 61.299999999999997 110.933 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.7 Cg_exo -65.0 -18.4 6.47 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.986 -1.256 . . . . 73.349999999999994 110.994 -0.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 70' ' ' ASP . 10.0 t -165.17 146.48 7.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.169 -0.923 . . . . 65.439999999999998 110.036 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -49.3 -29.68 6.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.451 0.643 . . . . 75.349999999999994 110.481 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 1.3 mp0 -69.9 -31.87 69.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.577 -1.192 . . . . 71.209999999999994 112.948 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 71' ' ' PRO . 14.2 t0 -144.23 61.06 8.57 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 121.155 0.503 . . . . 55.240000000000002 110.031 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.561 ' CB ' ' HE ' ' A' ' 74' ' ' ARG . 7.5 Cg_exo -72.77 55.14 2.67 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.019 2.479 . . . . 74.329999999999998 113.627 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 70' ' ' ASP . 31.6 mttp -48.98 -54.8 14.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.405 0.52 . . . . 73.219999999999999 112.405 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -117.47 41.7 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.956 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' A' ' 71' ' ' PRO . 2.4 tmm_? -82.87 141.87 31.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 72.230000000000004 110.424 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' OE2' ' ND1' ' A' ' 78' ' ' HIS . 11.8 pt-20 -94.9 178.5 5.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.917 0.887 . . . . 61.520000000000003 111.126 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG12 ' CB ' ' A' ' 65' ' ' ALA . 13.0 mm -97.89 -120.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.673 . . . . 73.519999999999996 109.184 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 HG22 ' A' ' 135' ' ' THR . 4.4 mm? -89.97 174.31 7.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.972 -0.751 . . . . 51.119999999999997 108.972 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.44 ' ND1' ' OE2' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -172.91 165.16 5.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.574 0.225 . . . . 63.100000000000001 110.791 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.484 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -99.76 120.86 40.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.788 -0.819 . . . . 75.239999999999995 108.788 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.645 ' HB2' HD12 ' A' ' 97' ' ' LEU . 12.5 p -141.41 127.9 20.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 112.454 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -145.18 136.48 20.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.87 -0.605 . . . . 73.439999999999998 109.472 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.888 HG12 HG23 ' A' ' 57' ' ' THR . 31.3 m -138.11 166.62 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.554 -0.294 . . . . 71.040000000000006 111.112 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.644 ' O ' HD22 ' A' ' 55' ' ' LEU . 2.4 m120 63.68 33.15 13.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.363 -0.38 . . . . 63.32 110.502 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.005 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.0 mm -77.34 127.88 81.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.28 -0.568 . . . . 74.129999999999995 110.125 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -54.07 127.91 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.26 1.307 . . . . 74.239999999999995 109.931 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -64.17 56.75 0.07 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.146 0.819 . . . . 23.530000000000001 115.146 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 7.4 t 178.05 38.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 117.528 0.664 . . . . 64.120000000000005 111.572 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.408 ' O ' ' N ' ' A' ' 90' ' ' ASN . 25.6 m120 -119.87 13.84 12.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.845 0.313 . . . . 71.299999999999997 111.845 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' SER . 20.8 pt-20 39.2 26.54 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.397 0.517 . . . . 73.230000000000004 112.397 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 17.3 p30 169.94 151.21 0.15 Allowed Pre-proline 0 C--O 1.236 0.356 0 CA-C-O 121.12 0.486 . . . . 72.239999999999995 110.731 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 44' ' ' VAL . 83.3 Cg_endo -75.5 63.2 6.39 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 123.542 2.828 . . . . 61.210000000000001 112.86 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -104.12 -48.18 3.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.685 0.624 . . . . 74.340000000000003 112.685 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.44 -39.96 79.72 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 115.345 0.898 . . . . 42.229999999999997 115.345 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 1.005 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.52 171.74 8.43 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.65 -0.786 . . . . 63.009999999999998 114.044 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' VAL . 65.1 t60 -66.42 121.34 15.08 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.624 0.37 . . . . 73.409999999999997 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 31.7 t -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.876 -1.157 . . . . 62.030000000000001 107.876 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' CE1' ' A' ' 147' ' ' PHE . 74.4 mt -63.68 -50.96 67.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.939 -0.763 . . . . 75.049999999999997 108.939 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 131' ' ' ILE . . . -143.24 125.6 15.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.762 -1.108 . . . . 53.200000000000003 109.367 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 133' ' ' ASN . 37.4 t0 -52.67 145.92 11.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.583 0.586 . . . . 41.100000000000001 112.583 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -65.15 151.15 46.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.301 -0.863 . . . . 73.340000000000003 110.685 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 9.6 p -158.52 174.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 110.071 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -67.76 178.88 18.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.391 -0.909 . . . . 52.549999999999997 111.994 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 112' ' ' HIS . 66.6 m -55.33 159.01 2.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.869 0.335 . . . . 72.340000000000003 111.371 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -97.41 -57.32 1.06 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.827 -0.624 . . . . 61.310000000000002 113.263 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 109' ' ' THR . 88.8 Cg_endo -79.23 123.01 5.41 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.914 2.409 . . . . 65.019999999999996 113.58 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 24.6 Cg_exo -62.67 162.49 24.63 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.041 2.494 . . . . 71.420000000000002 112.754 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.82 -24.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.743 -0.662 . . . . 70.230000000000004 112.456 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.8 m-20 -51.95 -39.34 59.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.005 -0.278 . . . . 62.539999999999999 110.604 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 105' ' ' PRO . 9.1 t -72.83 -14.92 61.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.459 0.647 . . . . 72.430000000000007 109.596 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 -130.01 9.42 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.136 -0.938 . . . . 52.140000000000001 112.187 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 163' ' ' GLN . 16.1 tp -66.48 127.83 33.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.455 -0.373 . . . . 75.049999999999997 111.966 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 164' ' ' ALA . 49.0 m170 -83.61 97.95 9.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.363 -0.38 . . . . 64.099999999999994 111.3 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.612 HH22 ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -75.89 68.35 2.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.565 . . . . 72.340000000000003 109.473 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.1 m-85 -81.43 146.79 30.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.728 -0.669 . . . . 63.229999999999997 111.632 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 54.7 mt -144.41 140.88 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 112.689 0.625 . . . . 72.219999999999999 112.689 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -107.75 134.72 50.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.011 -0.995 . . . . 73.150000000000006 109.28 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 118' ' ' LEU . 5.5 tt -121.81 132.22 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.234 -0.284 . . . . 71.400000000000006 110.234 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.739 ' N ' HD23 ' A' ' 117' ' ' LEU . 49.9 tp -124.15 136.8 54.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.464 -0.335 . . . . 72.109999999999999 110.952 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' THR . 53.6 t80 -141.97 134.96 28.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 72.019999999999996 110.417 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.586 ' HA ' HD23 ' A' ' 56' ' ' LEU . 5.1 tmm_? -72.62 133.4 44.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.383 -0.599 . . . . 64.200000000000003 109.383 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 151' ' ' HIS . 6.6 tp-100 -115.07 149.3 37.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.46 0.648 . . . . 63.329999999999998 112.452 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 88.1 tt0 -122.47 -38.97 2.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.009 -0.996 . . . . 71.439999999999998 111.24 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -90.72 134.6 34.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.308 0.484 . . . . 72.450000000000003 112.308 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -82.89 111.65 18.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.224 0.535 . . . . 70.299999999999997 110.932 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.512 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 1.3 pt -105.02 154.53 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.057 -0.974 . . . . 50.009999999999998 112.259 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -81.47 -49.97 9.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.924 0.392 . . . . 61.329999999999998 110.555 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 59.71 36.62 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.776 1.028 . . . . 73.319999999999993 113.776 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.633 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 68.6 p 52.16 145.38 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 123.51 0.724 . . . . 71.420000000000002 112.798 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -44.05 143.07 3.48 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.494 2.129 . . . . 51.299999999999997 112.204 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.8 t -59.08 143.4 48.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.765 -0.652 . . . . 64.120000000000005 111.691 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 98' ' ' ALA . 6.6 tp -110.89 133.37 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.52 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 m -70.99 142.12 50.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.805 -0.634 . . . . 74.549999999999997 110.623 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 135' ' ' THR . 18.8 p-10 -51.87 -38.99 58.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.199 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.756 ' HA ' HD13 ' A' ' 177' ' ' ILE . 15.3 t -67.82 22.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.165 -0.47 . . . . 62.149999999999999 111.58 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.686 HG22 HD11 ' A' ' 77' ' ' LEU . 11.7 t -64.11 128.31 35.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.869 0.366 . . . . 33.210000000000001 110.233 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' CB ' ' HA3' ' A' ' 179' ' ' GLY . 32.5 ttt180 -92.94 173.75 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.612 0.597 . . . . 64.140000000000001 112.612 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ARG . 20.9 m -26.32 131.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.557 -1.201 . . . . 73.040000000000006 111.61 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.3 4.86 32.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.468 -0.872 . . . . 54.509999999999998 111.16 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -146.93 35.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.741 0.305 . . . . 72.409999999999997 110.296 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 142' ' ' PHE . 13.6 mt -111.11 -71.04 0.78 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.219 -0.446 . . . . 54.119999999999997 111.257 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -51.61 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.356 -0.384 . . . . 73.319999999999993 110.154 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 1.5 t80 -150.47 72.49 1.1 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.249 0.833 . . . . 75.349999999999994 113.249 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -52.58 114.22 1.31 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.925 0.393 . . . . 74.219999999999999 110.752 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -48.26 -34.88 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.451 0.537 . . . . 74.329999999999998 112.451 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.4 ptt180 -43.69 -33.34 1.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.225 0.536 . . . . 75.209999999999994 111.099 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 145' ' ' ARG . 19.1 t70 -52.52 -46.1 66.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.571 -0.74 . . . . 64.530000000000001 111.306 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.841 ' CE1' HD13 ' A' ' 97' ' ' LEU . 85.4 m-85 -53.28 -50.39 64.96 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.337 0.589 . . . . 65.409999999999997 110.905 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -56.25 -42.24 77.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.795 -0.639 . . . . 54.420000000000002 110.437 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.73 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 72.420000000000002 111.466 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.618 ' CG ' ' N ' ' A' ' 151' ' ' HIS . 45.8 pttt -75.2 -59.08 2.9 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.72 0.295 . . . . 73.430000000000007 111.535 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.618 ' N ' ' CG ' ' A' ' 150' ' ' LYS . 18.4 t-160 -80.7 4.97 17.03 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.055 0.391 . . . . 73.349999999999994 112.055 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.83 27.98 65.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.72 -0.752 . . . . 21.239999999999998 113.286 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.55 HD21 ' ND1' ' A' ' 151' ' ' HIS . 25.6 mt -66.65 17.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 111.771 0.286 . . . . 70.409999999999997 111.771 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.65 -61.77 3.6 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.999 -0.62 . . . . 75.230000000000004 113.477 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.77 109.33 4.92 Favored Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.723 0.262 . . . . 63.350000000000001 111.145 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' GLY . 57.6 Cg_endo -89.86 132.46 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.402 2.068 . . . . 62.439999999999998 112.563 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 118' ' ' LEU . 37.8 pt -80.95 -35.37 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 62.420000000000002 110.711 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 157' ' ' ILE . . . -157.88 149.83 22.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.46 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -148.48 159.09 44.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.424 0.63 . . . . 73.340000000000003 111.319 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -155.2 144.61 21.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.042 -1.466 . . . . 72.230000000000004 107.042 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -149.76 176.25 10.86 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.718 -0.393 . . . . 71.109999999999999 111.398 -176.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 10.2 p90 -167.68 150.58 5.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.982 -0.554 . . . . 62.009999999999998 110.82 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.566 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 43.6 mt-30 -110.66 124.23 51.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 63.439999999999998 109.852 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -156.16 140.64 16.8 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.696 -0.402 . . . . 62.310000000000002 112.002 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -98.7 149.98 22.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.47 -0.567 . . . . 64.120000000000005 109.47 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.33 137.17 25.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.852 0.358 . . . . 73.319999999999993 111.165 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -150.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.679 -0.691 . . . . 72.150000000000006 112.648 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 172' ' ' ILE . 49.7 t0 -84.79 -23.6 29.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.133 -0.94 . . . . 72.310000000000002 111.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.417 ' CE1' ' NH2' ' A' ' 173' ' ' ARG . 17.2 t80 -41.81 -54.76 3.27 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.82 0.304 . . . . 71.400000000000006 111.82 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.672 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 69.2 t -65.64 -57.25 14.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.388 -0.525 . . . . 71.439999999999998 110.235 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 88.5 Cg_exo -45.18 -31.58 6.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.985 1.79 . . . . 63.420000000000002 112.05 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 168' ' ' ASP . 61.4 mt -51.91 -37.35 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.885 0.374 . . . . 74.329999999999998 110.307 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.489 ' H ' ' HD2' ' A' ' 173' ' ' ARG . 0.2 OUTLIER -53.7 -33.6 55.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.775 -0.454 . . . . 52.409999999999997 109.775 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 177' ' ' ILE . 25.8 m120 -58.19 -31.65 67.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 64.430000000000007 111.031 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 2.6 mptp? -61.31 -13.57 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.29 -0.633 . . . . 61.200000000000003 109.29 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 176' ' ' THR . 17.2 m -98.32 8.23 45.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.318 -0.856 . . . . 75.329999999999998 111.292 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.756 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.4 mm -69.83 117.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.015 -0.365 . . . . 54.409999999999997 110.015 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.34 -27.91 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 113.523 0.934 . . . . 51.409999999999997 113.523 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.325 -1.264 . . . . 53.030000000000001 112.294 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mmm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 111.534 0.198 . . . . 73.329999999999998 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.78 112.2 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 71.129999999999995 110.981 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 12' ' ' VAL . 29.1 t70 -109.37 -57.15 2.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.853 -0.612 . . . . 72.420000000000002 112.242 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.574 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 12.9 pt -129.02 65.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.253 0.549 . . . . 74.340000000000003 111.085 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.2 p -141.37 143.92 32.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.028 -0.533 . . . . 52.009999999999998 111.17 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -76.16 22.27 2.73 Favored 'Cis proline' 0 C--N 1.358 1.039 0 C-N-CA 124.454 -1.061 . . . . 73.409999999999997 112.334 0.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.705 ' O ' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -49.51 -53.87 20.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.169 -0.923 . . . . 73.230000000000004 111.276 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 7' ' ' ASP . 2.8 m -165.79 -40.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.73 0.641 . . . . 71.209999999999994 112.73 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.479 HD23 ' HD3' ' A' ' 13' ' ' PRO . 22.8 tp -157.1 152.19 26.1 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.494 0.664 . . . . 52.439999999999998 112.372 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -60.54 -35.81 76.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.795 -0.639 . . . . 74.530000000000001 111.07 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.15 13.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 75.140000000000001 111.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 HG23 ' OD2' ' A' ' 3' ' ' ASP . 61.6 t -59.9 124.51 77.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.574 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.479 ' HD3' HD23 ' A' ' 9' ' ' LEU . 66.4 Cg_endo -85.66 -117.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.957 2.438 . . . . 73.120000000000005 112.724 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -168.72 -46.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 122.931 0.492 . . . . 74.430000000000007 109.741 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.83 -158.72 13.63 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.371 -0.692 . . . . 63.200000000000003 111.371 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 4.8 t -147.92 167.59 24.45 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.519 0.676 . . . . 75.099999999999994 111.488 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 118' ' ' LEU . 13.1 mt -105.5 152.97 7.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.333 -1.303 . . . . 65.319999999999993 108.416 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.0 mmpt? -108.48 102.4 11.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.103 -0.499 . . . . 73.400000000000006 110.601 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.786 ' HB ' HG22 ' A' ' 27' ' ' VAL . 35.3 t -105.92 109.93 29.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.451 HG12 ' HB3' ' A' ' 26' ' ' GLU . 67.6 mt -98.45 137.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.579 . . . . 74.319999999999993 110.846 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.83 -97.23 0.18 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.214 -0.903 . . . . 74.140000000000001 112.543 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -66.82 -44.59 88.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.601 -0.809 . . . . 75.430000000000007 113.544 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 174.34 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.272 -0.64 . . . . 61.32 109.272 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.22 -42.49 15.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.452 -0.795 . . . . 73.120000000000005 109.361 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.51 138.51 53.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.277 -0.874 . . . . 71.219999999999999 110.359 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 pt-20 -150.36 151.49 32.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.728 -1.123 . . . . 71.510000000000005 108.822 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.0 m -73.21 120.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.956 0.724 . . . . 63.210000000000001 112.956 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 3.4 mptp? -104.11 111.97 24.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.455 -0.793 . . . . 65.540000000000006 112.512 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.496 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.0 mp0 29.04 67.77 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.606 1.336 . . . . 72.299999999999997 114.606 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' HD1' ' A' ' 161' ' ' TYR . . . 76.92 5.17 84.2 Favored Glycine 0 N--CA 1.465 0.63 0 C-N-CA 121.043 -0.598 . . . . 51.100000000000001 112.844 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -47.62 147.07 1.94 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.697 -0.752 . . . . 70.25 111.933 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -101.76 131.72 47.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.459 -1.246 . . . . 63.420000000000002 109.85 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 9.6 mp -96.96 124.92 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.157 0.503 . . . . 61.509999999999998 111.166 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 p -149.87 145.09 18.38 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.496 -0.775 . . . . 75.450000000000003 109.688 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -83.78 -113.26 0.0 OUTLIER 'Cis proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.936 -1.277 . . . . 63.399999999999999 112.965 0.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.0 p -67.47 61.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.532 0.568 . . . . 72.230000000000004 112.532 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.8 pt20 -119.11 -3.57 10.62 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.746 0.307 . . . . 63.420000000000002 111.226 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 33' ' ' LEU . 30.9 m -78.22 32.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 110.921 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -105.64 -23.21 12.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.149 0.796 . . . . 71.319999999999993 113.149 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 39' ' ' LYS . 1.4 m-20 -71.5 139.91 49.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.265 0.555 . . . . 62.43 112.032 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.54 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.31 130.53 93.19 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 115.496 -0.775 . . . . 71.319999999999993 110.045 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.15 126.31 13.56 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.999 1.799 . . . . 71.040000000000006 112.442 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -107.95 109.51 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 75.120000000000005 110.678 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.3 p -81.45 138.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.165 0.431 . . . . 73.450000000000003 112.165 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -165.3 164.07 19.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.758 0.313 . . . . 14.02 110.734 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p90 -141.16 37.12 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.817 -0.628 . . . . 75.219999999999999 110.27 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.1 t -50.78 112.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 74.019999999999996 111.355 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.72 -14.64 61.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.114 -0.565 . . . . 71.519999999999996 112.935 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -78.53 -28.12 46.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 71.519999999999996 110.943 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -72.75 -82.92 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.936 0.398 . . . . 72.400000000000006 111.429 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.56 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 78.77 -52.83 3.97 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.155 -0.545 . . . . 74.230000000000004 111.969 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.64 109.03 4.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.823 0.344 . . . . 64.030000000000001 110.139 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -157.95 141.33 15.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 70.519999999999996 111.529 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -86.3 -40.58 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.915 0.864 . . . . 73.120000000000005 109.41 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -149.98 157.52 43.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.044 -1.435 . . . . 54.409999999999997 107.528 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.8 mt -128.46 144.49 51.15 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.32 -0.552 . . . . 75.310000000000002 111.023 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.791 HG21 ' CD2' ' A' ' 153' ' ' LEU . 24.3 m -115.85 132.52 56.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.408 -0.814 . . . . 73.140000000000001 110.541 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -133.37 131.44 40.07 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.257 0.348 . . . . 62.109999999999999 110.348 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 97' ' ' LEU . 51.0 mt -151.39 167.11 28.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.732 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.428 ' HG3' ' CB ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.88 146.03 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.633 -0.712 . . . . 73.319999999999993 109.469 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.866 HG22 HD23 ' A' ' 117' ' ' LEU . 6.1 t -131.28 49.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.056 0.455 . . . . 75.519999999999996 110.722 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 p30 -133.66 54.82 13.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.543 -0.753 . . . . 75.329999999999998 111.425 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.35 83.29 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.39 1.394 . . . . 75.510000000000005 112.048 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -150.18 109.11 3.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.19 -0.914 . . . . 61.299999999999997 110.211 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -167.54 137.83 2.32 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 110.348 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -78.38 -23.89 13.29 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.114 -1.203 . . . . 63.340000000000003 111.851 -0.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.8 t -145.86 140.85 27.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.366 -0.834 . . . . 72.310000000000002 111.064 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 68' ' ' ARG . 5.6 ttp-105 -52.59 -29.18 24.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 64.25 111.743 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 67' ' ' THR . 7.1 pt20 -80.0 -27.17 39.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.448 0.536 . . . . 71.0 112.448 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 67' ' ' THR . 5.4 m-20 -144.67 60.41 7.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-O 120.988 0.423 . . . . 51.409999999999997 111.711 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 56.8 Cg_endo -69.24 58.98 1.35 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.063 2.509 . . . . 71.519999999999996 112.876 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 8.7 ptpt -57.37 -47.72 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.175 0.805 . . . . 55.32 113.175 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.613 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -105.71 35.66 2.8 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.106 -0.638 . . . . 73.329999999999998 112.221 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 25.2 ttp180 -70.24 131.61 44.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.179 -0.674 . . . . 73.209999999999994 109.179 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 42.6 mt-10 -93.65 169.34 10.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 72.120000000000005 110.618 -0.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.777 HG23 ' N ' ' A' ' 77' ' ' LEU . 10.6 tp -110.4 -134.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.467 -0.197 . . . . 63.549999999999997 110.467 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.777 ' N ' HG23 ' A' ' 76' ' ' ILE . 96.1 mt -72.41 152.07 42.23 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.451 -0.574 . . . . 75.519999999999996 109.451 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.518 ' NE2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -163.87 157.07 18.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.722 0.267 . . . . 65.140000000000001 111.722 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 5.0 t-105 -99.96 117.65 34.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.915 -0.584 . . . . 74.040000000000006 109.978 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 6.1 p -141.13 134.45 29.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.995 -0.548 . . . . 61.020000000000003 112.073 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.829 HG11 ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -142.76 142.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 70.099999999999994 110.021 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 HG23 ' A' ' 57' ' ' THR . 14.5 m -140.85 159.14 23.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.475 0.546 . . . . 71.209999999999994 112.475 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.0 p30 62.36 35.87 14.76 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 114.567 -1.197 . . . . 73.340000000000003 111.185 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.966 HD13 ' HA3' ' A' ' 94' ' ' GLY . 3.6 mm -73.62 127.63 88.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 63.409999999999997 109.742 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 23.9 Cg_exo -63.5 126.87 18.5 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 121.958 1.772 . . . . 75.239999999999995 111.755 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.79 62.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.248 0.342 . . . . 53.240000000000002 113.602 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' PRO . 31.9 p -179.2 39.69 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.16 0.48 . . . . 74.010000000000005 110.942 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 90' ' ' ASN . 32.4 m120 -135.31 -4.05 2.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 111.816 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 67.62 -36.64 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.222 0.609 . . . . 73.200000000000003 112.5 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 88' ' ' ASN . 1.6 p30 -127.71 153.42 77.8 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 54.130000000000003 110.609 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.897 ' HA ' HG21 ' A' ' 84' ' ' ILE . 77.5 Cg_endo -70.78 47.08 0.68 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.646 2.897 . . . . 63.409999999999997 113.803 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.8 m -93.49 -40.32 10.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 61.140000000000001 112.147 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.07 -13.11 61.44 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.906 -0.588 . . . . 61.240000000000002 114.241 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.966 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -98.33 172.08 26.11 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.405 -0.902 . . . . 72.540000000000006 113.404 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.546 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.69 126.61 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 75.430000000000007 111.496 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.691 ' H ' HG22 ' A' ' 130' ' ' THR . 85.3 p -88.11 94.5 9.83 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.999 -0.546 . . . . 71.230000000000004 109.895 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.697 HD12 HD21 ' A' ' 59' ' ' LEU . 77.2 mt -50.06 -38.24 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 74.239999999999995 109.189 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -156.67 115.49 3.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.692 -1.14 . . . . 52.130000000000003 109.089 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 50.2 t0 -52.36 146.71 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.439 0.462 . . . . 64.310000000000002 111.982 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 47.7 p90 -69.81 129.61 40.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.598 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 13.7 p -158.61 174.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.326 -0.397 . . . . 72.040000000000006 110.217 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -72.04 -129.18 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.234 -0.984 . . . . 74.230000000000004 111.703 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 170' ' ' VAL . 47.6 t -175.48 -165.67 0.18 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.838 -0.801 . . . . 43.210000000000001 108.838 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 105' ' ' PRO . . . -128.58 54.89 0.77 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.766 -0.731 . . . . 74.329999999999998 111.65 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 104' ' ' GLY . 14.3 Cg_endo -87.96 120.7 1.39 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.499 2.133 . . . . 74.420000000000002 112.676 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 109' ' ' THR . 73.5 Cg_endo -74.31 162.11 39.09 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.79 2.327 . . . . 61.25 111.759 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 109' ' ' THR . 17.6 pttp -43.55 -45.64 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.443 -0.344 . . . . 62.25 111.764 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -63.4 5.95 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.159 0.429 . . . . 71.439999999999998 112.159 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 106' ' ' PRO . 13.0 t -75.14 -25.68 58.58 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.144 0.497 . . . . 73.519999999999996 110.196 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.9 -165.11 42.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 61.43 112.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.8 tp -71.33 111.56 6.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.867 0.365 . . . . 72.040000000000006 111.492 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -88.85 131.99 34.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.310000000000002 110.987 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -103.55 90.54 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.742 -0.663 . . . . 74.340000000000003 109.922 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 10.2 m-85 -74.94 136.48 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.407 . . . . 73.530000000000001 111.242 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 161' ' ' TYR . 35.0 mt -130.03 138.22 54.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.83 -0.623 . . . . 75.299999999999997 112.053 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -120.74 136.81 54.77 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.465 -0.789 . . . . 71.319999999999993 109.439 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 61' ' ' VAL . 2.3 pp -118.47 149.32 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 63.439999999999998 109.895 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 157' ' ' ILE . 2.8 tt -133.94 134.87 43.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 73.340000000000003 109.592 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.693 ' N ' HD23 ' A' ' 118' ' ' LEU . 53.3 t80 -139.88 136.71 34.22 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 72.230000000000004 111.448 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -73.7 124.71 26.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.752 -0.658 . . . . 71.319999999999993 109.71 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -110.78 145.31 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 75.099999999999994 112.351 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -118.63 -39.92 2.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.982 -1.008 . . . . 75.409999999999997 109.968 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -83.98 130.75 34.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.234 -0.439 . . . . 72.349999999999994 111.106 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -79.06 131.91 36.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.514 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -125.33 154.55 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.712 -0.676 . . . . 70.200000000000003 112.414 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -90.97 -33.79 15.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.747 -0.661 . . . . 70.420000000000002 111.786 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 36.76 36.27 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.12 1.155 . . . . 74.010000000000005 114.12 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p 59.11 159.49 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-O 121.154 0.502 . . . . 73.140000000000001 112.165 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -53.88 152.45 23.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.637 2.225 . . . . 64.019999999999996 113.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 96' ' ' SER . 22.9 p -59.02 127.15 30.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.192 -0.913 . . . . 74.420000000000002 110.707 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.482 HG13 ' NH1' ' A' ' 139' ' ' ARG . 20.4 mm -91.85 124.94 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 74.150000000000006 111.644 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.0 m -69.76 147.98 49.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.998 -1.001 . . . . 73.040000000000006 112.09 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.517 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 16.6 p30 -50.55 -43.63 56.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 74.510000000000005 111.427 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.836 ' HA ' HD13 ' A' ' 177' ' ' ILE . 9.7 t -68.71 21.91 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.481 0.549 . . . . 64.099999999999994 112.481 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.6 t -65.16 122.34 16.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 64.230000000000004 110.884 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.689 ' HD2' ' N ' ' A' ' 137' ' ' THR . 5.0 tmm_? -82.49 160.76 22.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.53 -0.759 . . . . 72.049999999999997 111.652 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.693 HG23 HD11 ' A' ' 140' ' ' LEU . 6.0 m -39.94 158.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.348 -0.842 . . . . 65.310000000000002 111.093 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.95 17.51 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 112.483 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' NH1' HG13 ' A' ' 131' ' ' ILE . 17.8 ttm180 -167.86 48.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.888 0.375 . . . . 71.230000000000004 110.731 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.693 HD11 HG23 ' A' ' 137' ' ' THR . 0.0 OUTLIER -114.65 -56.45 2.38 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.321 -0.399 . . . . 72.319999999999993 110.314 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.442 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 4.7 m-20 -63.81 66.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 111.691 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LEU . 14.3 t80 -138.77 121.72 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.522 -0.548 . . . . 61.119999999999997 109.522 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.6 122.28 15.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.215 0.531 . . . . 74.219999999999999 111.75 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.68 72.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.625 -0.716 . . . . 63.409999999999997 111.45 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -50.44 -35.14 27.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.459 . . . . 72.329999999999998 110.223 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.62 -44.12 91.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.426 0.631 . . . . 74.450000000000003 109.382 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 150' ' ' LYS . 1.2 t80 -62.9 -38.35 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 53.240000000000002 109.574 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 153' ' ' LEU . . . -65.36 -46.6 79.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.578 -0.737 . . . . 71.040000000000006 110.564 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.19 -55.08 23.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 52.25 110.624 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.553 ' HG3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.22 -48.13 83.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 62.420000000000002 110.583 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.553 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 2.9 m-70 -67.64 3.39 1.42 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 121.221 -0.191 . . . . 43.549999999999997 111.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 72.86 7.77 71.12 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.86 -0.686 . . . . 64.239999999999995 112.19 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.5 mt -72.14 16.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.392 0.277 . . . . 74.25 110.883 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.91 -69.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.432 -0.889 . . . . 54.5 112.127 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 21.2 pt-20 -80.39 120.03 78.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.579 0.228 . . . . 72.239999999999995 110.839 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.38 125.44 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.936 1.757 . . . . 73.310000000000002 112.077 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 118' ' ' LEU . 27.2 pt -76.26 -33.94 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.476 -0.49 . . . . 74.420000000000002 110.012 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -146.52 144.61 29.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.924 -0.58 . . . . 42.130000000000003 110.507 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -148.91 149.68 31.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.424 -0.353 . . . . 52.310000000000002 110.884 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.546 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.0 t-20 -150.97 148.98 29.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.928 -1.138 . . . . 72.319999999999993 107.928 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.551 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -152.34 165.73 34.07 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.462 -0.495 . . . . 74.310000000000002 111.272 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.4 p90 -154.14 152.92 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.582 -0.735 . . . . 74.209999999999994 110.778 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.68 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.41 -0.589 . . . . 51.549999999999997 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.16 138.72 15.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.273 0.559 . . . . 61.210000000000001 111.856 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -118.28 144.97 45.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 71.129999999999995 109.153 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.9 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.156 -0.313 . . . . 73.310000000000002 110.156 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -100.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.511 -0.768 . . . . 70.150000000000006 112.322 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t0 -147.78 21.48 1.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.658 0.742 . . . . 72.219999999999999 109.949 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -76.45 -47.95 21.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.676 -0.693 . . . . 75.450000000000003 111.359 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 103' ' ' SER . 60.2 t -43.02 -50.34 13.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.052 -0.522 . . . . 71.140000000000001 112.271 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 51.2 Cg_exo -57.84 -37.01 97.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.068 1.845 . . . . 71.25 112.392 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.0 mm -50.12 -39.86 16.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.057 0.456 . . . . 73.519999999999996 110.977 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -69.98 -30.18 67.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 74.099999999999994 111.212 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' PRO . 1.6 m120 -56.02 -14.94 2.9 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.512 -0.313 . . . . 73.230000000000004 110.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.52 -20.08 7.07 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.605 -0.517 . . . . 64.010000000000005 109.605 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.0 m -68.34 -28.01 66.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.69 -0.686 . . . . 75.349999999999994 110.783 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 134' ' ' THR . 35.6 mm -54.6 130.79 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.703 . . . . 52.539999999999999 111.978 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.635 HG22 ' OG1' ' A' ' 134' ' ' THR . 20.1 m -146.7 -14.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.066 0.765 . . . . 53.520000000000003 113.066 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.225 -1.32 . . . . 64.239999999999995 112.577 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.806 -0.442 . . . . 60.340000000000003 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 3.3 p-10 -67.41 72.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.606 -0.725 . . . . 73.400000000000006 109.596 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.09 -71.21 0.42 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.637 0.977 . . . . 72.430000000000007 113.637 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 11' ' ' ALA . 7.5 pt -97.11 46.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.528 0.68 . . . . 71.25 112.568 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.1 p -128.14 142.37 44.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.551 -0.749 . . . . 72.019999999999996 110.372 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HA ' HG23 ' A' ' 5' ' ' VAL . 64.0 Cg_endo -86.62 35.58 4.13 Favored 'Cis proline' 0 C--N 1.35 0.619 0 C-N-CA 124.115 -1.202 . . . . 74.549999999999997 112.932 0.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.561 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.7 t70 -64.33 -48.37 75.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 61.039999999999999 111.032 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 7' ' ' ASP . 3.6 m -160.36 -37.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.689 0.626 . . . . 62.130000000000003 112.689 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.522 HD23 ' HD3' ' A' ' 13' ' ' PRO . 48.9 tp -157.13 164.27 38.03 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.884 0.373 . . . . 64.430000000000007 110.899 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.88 -42.35 94.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.098 0.475 . . . . 72.439999999999998 110.095 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 4' ' ' ILE . . . -134.87 -174.59 3.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.491 -0.777 . . . . 53.350000000000001 111.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.0 p -110.29 111.96 57.46 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.96 -0.564 . . . . 52.32 111.555 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 9' ' ' LEU . 64.9 Cg_endo -83.95 -134.89 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.124 2.549 . . . . 64.299999999999997 112.117 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -150.46 -38.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.508 -0.314 . . . . 55.109999999999999 111.098 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -138.24 166.58 25.19 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.561 -0.828 . . . . 71.329999999999998 112.533 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -102.12 159.65 15.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.263 0.554 . . . . 53.240000000000002 111.506 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.524 HG21 HG13 ' A' ' 44' ' ' VAL . 4.7 mt -105.41 131.24 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.698 -0.853 . . . . 62.229999999999997 108.698 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.8 mtpm? -74.03 102.98 4.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.142 -0.481 . . . . 70.230000000000004 110.516 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.629 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 46.9 t -117.52 110.59 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.111 0.481 . . . . 75.349999999999994 110.654 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 25' ' ' LEU . 47.2 mt -99.52 131.48 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.048 -0.524 . . . . 70.409999999999997 110.34 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -72.31 -51.08 22.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.36 -0.382 . . . . 71.040000000000006 111.516 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 40' ' ' ASP . . . -126.1 -61.23 0.16 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.559 -0.829 . . . . 74.340000000000003 113.273 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.16 -59.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.028 0.442 . . . . 74.019999999999996 110.343 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -97.57 -38.5 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 111.071 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.71 135.62 50.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.396 0.617 . . . . 64.209999999999994 110.723 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -140.67 136.92 33.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.35 -0.841 . . . . 74.519999999999996 111.827 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.751 HG11 ' CD2' ' A' ' 162' ' ' TYR . 28.2 m -76.62 139.22 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.312 -0.858 . . . . 74.129999999999995 110.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HA ' HD21 ' A' ' 160' ' ' ASN . 41.6 pttt -155.12 122.32 5.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.857 1.058 . . . . 72.140000000000001 113.857 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.466 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 11.8 mp0 27.42 67.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.357 1.614 . . . . 72.030000000000001 115.357 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 161' ' ' TYR . . . 86.81 -7.98 77.69 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.993 -0.622 . . . . 61.32 114.3 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -50.44 129.93 22.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.597 0.236 . . . . 50.210000000000001 110.65 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -94.76 142.1 27.85 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.843 -0.428 . . . . 72.400000000000006 109.843 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.764 HD21 HD12 ' A' ' 25' ' ' LEU . 1.3 tp -101.86 127.99 48.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 51.420000000000002 110.995 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 66.9 p -149.91 157.42 37.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.478 -0.783 . . . . 70.409999999999997 109.692 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.5 Cg_exo -76.33 -47.88 0.29 Allowed 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.988 -1.255 . . . . 52.420000000000002 112.102 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 38' ' ' VAL . 74.2 p -151.46 25.69 0.69 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 64.329999999999998 111.395 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' A' ' 39' ' ' LYS . 3.8 pt20 -63.33 0.41 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.37 0.605 . . . . 72.25 111.039 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.692 HG12 HD23 ' A' ' 33' ' ' LEU . 35.4 m -74.21 32.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 111.605 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' CD ' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.55 -31.69 57.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.977 0.418 . . . . 61.420000000000002 111.139 -179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HB3' ' HA2' ' A' ' 22' ' ' GLY . 14.9 m-20 -87.16 142.86 27.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.498 0.555 . . . . 65.400000000000006 112.498 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.647 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.05 139.05 92.65 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 115.6 -0.727 . . . . 72.019999999999996 111.092 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.51 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 20.2 Cg_exo -63.19 126.6 18.19 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.724 1.616 . . . . 70.120000000000005 112.078 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 mm -108.39 112.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 64.040000000000006 110.24 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 HG21 ' A' ' 17' ' ' ILE . 57.2 t -86.07 142.23 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.554 0.576 . . . . 74.310000000000002 112.554 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.4 m -165.05 133.82 3.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.801 0.334 . . . . 53.049999999999997 111.253 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 15.0 p90 -108.66 32.41 4.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.44 0.638 . . . . 70.239999999999995 110.227 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.5 m -43.77 134.45 4.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 111.082 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.47 -29.86 4.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.86 -0.686 . . . . 71.019999999999996 112.975 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 49' ' ' LEU . 6.6 mp -80.73 -38.88 27.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.275 0.538 . . . . 73.450000000000003 110.25 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 13.1 tp10 -50.15 163.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.888 -0.597 . . . . 73.439999999999998 110.688 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 50' ' ' GLU . . . -170.12 -76.91 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.283 -0.727 . . . . 70.340000000000003 111.283 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -148.53 109.76 4.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.815 0.341 . . . . 71.400000000000006 110.295 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -151.31 141.72 22.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.028 -0.533 . . . . 71.310000000000002 110.02 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.89 -36.56 62.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.327 0.584 . . . . 52.310000000000002 109.474 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 83' ' ' ASN . 30.6 mt -155.28 164.84 38.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.998 -1.001 . . . . 73.120000000000005 110.455 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 35.0 mt -135.83 157.29 47.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.946 0.403 . . . . 65.409999999999997 110.92 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.527 HG23 ' NE2' ' A' ' 121' ' ' GLN . 0.7 OUTLIER -117.94 121.89 41.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 60.409999999999997 109.674 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.1 tm? -127.07 128.71 46.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.256 -0.646 . . . . 53.549999999999997 109.256 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.609 ' N ' HD13 ' A' ' 58' ' ' LEU . 43.5 mt -154.29 154.0 32.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.99 -0.284 . . . . 73.430000000000007 111.137 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -134.1 145.38 49.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.671 -0.492 . . . . 71.519999999999996 109.671 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 62' ' ' ASP . 8.8 t -150.62 164.76 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.867 1.062 . . . . 63.039999999999999 113.867 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.585 ' N ' HG12 ' A' ' 61' ' ' VAL . 46.6 t0 -172.85 86.08 0.41 Allowed Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 113.594 -1.639 . . . . 73.019999999999996 107.211 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.98 84.69 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 123.204 2.602 . . . . 72.010000000000005 115.342 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -170.49 124.05 0.68 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.134 -0.484 . . . . 64.040000000000006 111.896 177.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -170.31 136.95 1.27 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.453 -0.34 . . . . 70.120000000000005 111.731 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HG3' ' CE2' ' A' ' 73' ' ' TYR . 18.6 Cg_exo -66.26 -33.48 2.8 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.752 -1.353 . . . . 72.140000000000001 110.945 -0.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 3.5 t -130.21 157.34 42.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 64.140000000000001 109.872 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' NH2' ' A' ' 113' ' ' ARG . 23.8 ttt85 -58.37 -26.69 63.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.199 0.523 . . . . 65.219999999999999 109.785 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -78.2 -15.59 58.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.065 -0.97 . . . . 73.430000000000007 111.664 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 60.5 t0 -143.98 94.97 5.76 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.233 -0.439 . . . . 62.43 111.284 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 85.1 Cg_endo -80.78 50.51 3.59 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.123 2.549 . . . . 72.540000000000006 112.027 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 7.2 ttmt -58.6 -54.74 43.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.309 0.855 . . . . 71.120000000000005 113.309 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 66' ' ' PRO . 16.9 p90 -132.2 25.6 4.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.687 0.625 . . . . 70.019999999999996 112.687 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.742 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 2.8 tmm_? -58.19 134.7 56.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 72.010000000000005 109.694 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 73.5 mt-10 -90.31 178.22 6.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.542 1.137 . . . . 51.43 111.177 0.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.881 HD11 ' HB2' ' A' ' 65' ' ' ALA . 1.2 mp -98.04 -61.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.357 0.599 . . . . 51.409999999999997 109.962 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HG ' HG11 ' A' ' 101' ' ' VAL . 2.0 pt? -171.23 141.8 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.504 -0.925 . . . . 63.439999999999998 108.504 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.54 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 5.0 p-80 -137.57 176.01 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.581 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.63 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 7.4 t-105 -100.48 113.77 26.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.946 -0.761 . . . . 75.510000000000005 108.946 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.587 ' HA ' HD23 ' A' ' 59' ' ' LEU . 43.3 p -131.54 114.52 14.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.645 -0.707 . . . . 70.329999999999998 111.078 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.63 HG21 ' CZ2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -127.33 117.91 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 64.319999999999993 109.239 178.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HG3' ' A' ' 127' ' ' GLU . 21.8 m -114.87 164.8 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.332 -0.849 . . . . 64.230000000000004 111.758 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.616 HD21 ' CG ' ' A' ' 95' ' ' HIS . 24.8 p30 52.16 43.9 30.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 61.340000000000003 112.374 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.4 mm -75.43 118.06 67.95 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.89 -1.152 . . . . 72.540000000000006 107.89 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.45 125.72 18.56 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.689 1.593 . . . . 71.140000000000001 111.725 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.07 61.23 0.08 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.371 0.419 . . . . 51.100000000000001 113.656 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -171.09 39.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.419 0.688 . . . . 63.32 109.318 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 55.7 m-80 -130.08 -28.07 2.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.511 -0.768 . . . . 74.430000000000007 111.787 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.445 ' HA ' ' NE1' ' A' ' 46' ' ' TRP . 2.2 tt0 76.0 -9.24 1.48 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.071 0.463 . . . . 64.329999999999998 110.776 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -155.91 155.27 29.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.294 -0.866 . . . . 70.140000000000001 110.111 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 84' ' ' ILE . 84.4 Cg_endo -73.75 60.75 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.655 0 C-N-CA 123.684 2.922 . . . . 63.119999999999997 113.21 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -90.96 -55.08 3.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.188 0.81 . . . . 70.310000000000002 113.188 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -10.85 75.13 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 116.445 1.338 . . . . 72.109999999999999 116.445 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -71.19 164.42 53.76 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.789 -1.196 . . . . 73.140000000000001 113.662 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CG ' HD21 ' A' ' 83' ' ' ASN . 13.5 m80 -65.21 121.35 14.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.805 0.336 . . . . 61.509999999999998 111.597 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 130' ' ' THR . 8.9 m -87.81 89.38 7.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 61.009999999999998 111.305 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 127' ' ' GLU . 16.7 mt -61.66 -17.36 55.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.536 0.684 . . . . 72.340000000000003 111.339 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB3' ' OG ' ' A' ' 80' ' ' SER . . . -167.92 116.06 0.75 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.344 -0.844 . . . . 64.010000000000005 108.957 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.569 ' HB3' ' CA ' ' A' ' 133' ' ' ASN . 28.4 t0 -60.06 151.82 25.65 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.595 0.559 . . . . 61.229999999999997 111.992 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -70.12 148.38 48.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 64.019999999999996 112.394 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 103' ' ' SER . 10.3 p -135.31 133.0 52.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.827 -0.624 . . . . 71.329999999999998 110.03 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.63 66.95 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.412 -0.899 . . . . 53.420000000000002 112.819 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.4 m -164.83 127.65 2.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 73.010000000000005 111.123 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.87 -73.32 1.09 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.84 -0.618 . . . . 62.020000000000003 112.659 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 31.7 Cg_exo -57.84 133.57 56.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.848 2.366 . . . . 61.32 112.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 32.3 Cg_exo -58.38 151.59 59.91 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.107 2.538 . . . . 62.32 113.563 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 168' ' ' ASP . 21.8 pttm -46.12 -26.94 0.84 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.178 -0.919 . . . . 72.150000000000006 111.344 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.54 -30.36 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 72.109999999999999 110.462 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 2.3 t -92.16 -26.7 18.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.278 0.561 . . . . 51.409999999999997 109.804 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.35 -100.5 0.81 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.578 -0.737 . . . . 75.150000000000006 114.886 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.91 125.41 22.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.661 0.744 . . . . 74.329999999999998 112.976 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 26.3 m80 -116.04 123.01 46.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.622 -1.172 . . . . 73.010000000000005 110.097 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.526 ' NH2' ' NH1' ' A' ' 68' ' ' ARG . 36.8 mtm180 -94.47 85.25 4.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.811 -0.44 . . . . 62.340000000000003 109.811 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 103' ' ' SER . 29.6 m-85 -70.33 114.5 8.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.128 -0.629 . . . . 74.430000000000007 110.676 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 60' ' ' MET . 38.4 mm -104.97 121.98 57.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 110.261 -0.274 . . . . 73.109999999999999 110.261 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.507 ' CE2' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -102.54 128.51 49.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.856 0.462 . . . . 73.409999999999997 109.828 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.91 133.65 54.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 70.219999999999999 110.313 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.717 ' N ' HD13 ' A' ' 117' ' ' LEU . 33.7 tp -128.64 131.76 48.08 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.169 -0.469 . . . . 74.510000000000005 110.459 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 57' ' ' THR . 60.7 t80 -144.02 138.2 28.2 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.744 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HA ' HD23 ' A' ' 56' ' ' LEU . 12.7 ttp-105 -71.06 133.38 46.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.711 0.291 . . . . 63.020000000000003 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.527 ' NE2' HG23 ' A' ' 57' ' ' THR . 1.2 mt-30 -109.39 109.73 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 71.239999999999995 110.467 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.98 -43.46 11.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.045 -0.724 . . . . 75.510000000000005 109.045 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -90.83 122.18 33.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.916 -1.038 . . . . 41.450000000000003 110.34 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 55' ' ' LEU . 58.6 tttm -70.9 128.08 34.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.337 0.589 . . . . 60.520000000000003 111.385 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.74 132.65 59.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.972 -1.013 . . . . 51.420000000000002 110.541 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -56.35 -59.48 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 65.329999999999998 110.337 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.734 ' HG3' HG21 ' A' ' 82' ' ' VAL . 27.8 mm-40 58.33 32.64 22.31 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.397 -0.82 . . . . 73.129999999999995 113.192 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.529 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 39.9 p 49.38 171.62 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 113.079 0.77 . . . . 53.229999999999997 113.079 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 36.9 Cg_exo -61.51 158.33 37.01 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.146 2.564 . . . . 65.450000000000003 113.295 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 96' ' ' SER . 20.7 p -58.75 124.71 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.843 -0.617 . . . . 72.519999999999996 111.398 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.17 121.82 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 73.519999999999996 111.243 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -73.42 147.36 44.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.597 -0.729 . . . . 73.010000000000005 112.27 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.569 ' CA ' ' HB3' ' A' ' 99' ' ' ASP . 10.9 t-20 -55.11 -35.01 64.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.03 -0.532 . . . . 64.340000000000003 111.962 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.8 t -67.06 21.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.622 0.248 . . . . 65.319999999999993 111.483 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 133' ' ' ASN . 10.1 t -62.52 113.29 2.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.393 0.616 . . . . 63.130000000000003 111.089 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 41.8 ttt85 -89.08 173.21 8.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.849 . . . . 74.530000000000001 110.96 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 77.4 m -34.08 143.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.109 -0.496 . . . . 55.450000000000003 111.546 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.11 3.9 19.01 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.133 -0.556 . . . . 75.319999999999993 112.213 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -160.01 29.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.959 0.409 . . . . 74.5 110.775 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.278 0.561 . . . . 70.209999999999994 110.277 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -67.95 44.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.283 -0.872 . . . . 53.229999999999997 112.799 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 4.0 t80 -109.38 90.35 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.822 -0.436 . . . . 71.219999999999999 109.822 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.09 112.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 53.32 111.049 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 147' ' ' PHE . . . -57.63 -32.9 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.203 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -50.41 -32.71 18.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.384 -0.371 . . . . 63.439999999999998 111.07 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -56.12 -34.51 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.104 0.478 . . . . 71.430000000000007 110.284 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.4 m-85 -49.76 -38.11 32.52 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.559 0.695 . . . . 75.209999999999994 109.687 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.47 91.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.221 -0.899 . . . . 64.120000000000005 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.39 -48.34 42.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 65.219999999999999 111.949 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -59.01 -41.12 86.93 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.167 0.432 . . . . 74.420000000000002 112.167 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 9.6 t-80 -109.25 5.52 23.8 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.01 -0.676 . . . . 74.420000000000002 111.533 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 63.46 34.64 90.49 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.888 -0.673 . . . . 51.119999999999997 113.982 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 155' ' ' GLU . 11.3 mt -69.69 16.33 0.06 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.517 -0.402 . . . . 61.109999999999999 111.016 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -55.74 1.66 0.07 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 114.241 0.457 . . . . 71.530000000000001 114.241 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 153' ' ' LEU . 4.9 pt-20 -135.11 72.66 66.73 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.258 0.551 . . . . 65.140000000000001 110.154 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 31.9 Cg_exo -57.03 129.37 34.12 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.452 2.102 . . . . 70.299999999999997 112.131 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 118' ' ' LEU . 21.1 pt -79.9 -38.18 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.495 -0.557 . . . . 74.450000000000003 109.495 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.31 148.64 32.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 110.877 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -150.68 157.74 43.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.982 0.42 . . . . 70.239999999999995 111.568 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 28' ' ' LYS . 1.8 t-20 -157.19 145.07 19.09 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.415 -0.958 . . . . 54.420000000000002 108.415 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.562 ' CB ' HD13 ' A' ' 115' ' ' ILE . 17.9 p90 -155.03 157.46 37.64 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.759 -0.588 . . . . 75.150000000000006 111.945 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.751 ' CD2' HG11 ' A' ' 27' ' ' VAL . 5.6 p90 -153.54 163.78 39.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.613 -0.721 . . . . 65.209999999999994 111.24 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 44.5 mt-30 -122.53 124.89 44.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 62.210000000000001 110.469 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.14 152.11 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 75.319999999999993 112.411 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.458 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 8.2 pm0 -127.18 148.1 50.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.346 -0.983 . . . . 42.240000000000002 108.346 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -137.38 152.69 49.94 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.02 0.378 . . . . 75.140000000000001 112.02 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.5 m-20 -54.93 163.34 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.765 -0.652 . . . . 74.140000000000001 111.865 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.522 ' HA ' ' HG2' ' A' ' 171' ' ' PRO . 6.3 t0 -68.03 27.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.689 -0.687 . . . . 74.239999999999995 111.3 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 167' ' ' ASP . 21.2 t80 -82.28 -60.86 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.74 0.644 . . . . 74.329999999999998 112.74 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 14.6 p -62.14 -32.09 9.05 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 113.337 0.866 . . . . 64.549999999999997 113.337 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 81.7 Cg_exo -47.97 -30.02 13.03 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.74 1.626 . . . . 74.310000000000002 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.3 mm -49.35 -37.77 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.68 -0.691 . . . . 75.099999999999994 109.401 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -45.87 -42.79 12.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.471 -0.786 . . . . 71.310000000000002 109.953 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.495 ' HA ' HG12 ' A' ' 177' ' ' ILE . 35.7 m120 -58.28 -39.4 79.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 61.25 111.465 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.54 -28.25 63.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 72.25 110.492 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 178' ' ' VAL . 42.5 m -84.61 -4.13 58.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.954 -0.566 . . . . 63.100000000000001 112.335 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.528 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 33.0 mm -62.11 99.14 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.088 0.47 . . . . 73.140000000000001 111.006 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 176' ' ' THR . 61.6 t -100.83 -6.94 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.588 -0.733 . . . . 73.530000000000001 112.491 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.482 -1.177 . . . . 61.43 112.42 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 110.104 -0.332 . . . . 73.310000000000002 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 110.22 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 73.230000000000004 109.302 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 64.3 t0 -89.63 -70.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.571 . . . . 65.420000000000002 112.38 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.874 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.9 OUTLIER -127.8 58.94 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.389 0.614 . . . . 64.349999999999994 111.02 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.3 p -130.07 139.48 35.78 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 72.349999999999994 109.947 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.7 Cg_endo -85.57 35.13 3.64 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.139 -1.192 . . . . 74.239999999999995 113.113 0.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.874 ' HB3' HG22 ' A' ' 4' ' ' ILE . 8.8 t70 -62.67 -49.92 73.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.952 0.406 . . . . 73.340000000000003 110.42 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -163.65 -44.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.912 -0.586 . . . . 60.009999999999998 110.927 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' ILE . 29.2 tp -157.25 137.84 13.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.439999999999998 110.797 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.429 ' H ' HD12 ' A' ' 9' ' ' LEU . 2.8 p30 -66.56 13.93 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.364 0.505 . . . . 55.5 112.364 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -171.2 137.52 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.319 0.247 . . . . 75.030000000000001 110.643 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -72.67 112.24 14.32 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.796 0.331 . . . . 63.340000000000003 111.698 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -88.7 134.52 2.77 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.893 2.396 . . . . 65.439999999999998 112.761 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.52 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.461 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.82 -159.05 7.98 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.757 -0.656 . . . . 51.219999999999999 111.77 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -135.9 162.94 31.43 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.178 0.513 . . . . 43.130000000000003 111.31 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 44' ' ' VAL . 10.2 mt -105.31 135.17 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 70.219999999999999 110.484 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 30.9 mmmt -74.56 106.05 5.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.686 -0.688 . . . . 71.400000000000006 109.683 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 60.1 t -121.58 110.45 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.747 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.702 HG21 ' O ' ' A' ' 23' ' ' ASP . 3.0 mp -96.01 134.63 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.216 -0.902 . . . . 63.420000000000002 109.465 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -81.67 -85.34 0.1 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.67 -0.412 . . . . 71.319999999999993 111.782 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -67.58 -49.84 47.47 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.35 -0.928 . . . . 70.230000000000004 112.447 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.702 ' O ' HG21 ' A' ' 20' ' ' ILE . 34.9 t70 172.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.716 0.769 . . . . 74.150000000000006 109.019 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.58 -49.72 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.741 -1.118 . . . . 72.409999999999997 110.522 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.1 pt? -69.66 139.57 53.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.3 0.572 . . . . 55.310000000000002 111.581 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 27' ' ' VAL . 69.5 tt0 -120.82 150.01 41.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.267 -0.879 . . . . 64.409999999999997 111.857 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 10.5 m -98.7 119.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.85 -0.796 . . . . 74.140000000000001 108.85 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HD2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -139.08 128.58 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.757 0.789 . . . . 74.430000000000007 112.7 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.565 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.9 mp0 46.41 63.15 1.99 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.035 -1.438 . . . . 72.519999999999996 114.854 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 11.39 44.63 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 115.739 1.056 . . . . 74.310000000000002 115.739 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.24 139.48 35.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.779 0.789 . . . . 50.350000000000001 110.701 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.92 123.02 29.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.726 -0.472 . . . . 74.319999999999993 109.726 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 27' ' ' VAL . 9.9 mp -92.75 114.21 26.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.735 -0.386 . . . . 52.219999999999999 110.741 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -150.12 156.96 37.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 62.32 110.488 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.23 -100.4 0.0 OUTLIER 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.156 -1.185 . . . . 74.329999999999998 113.869 0.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -70.2 54.35 0.14 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.653 0.612 . . . . 74.420000000000002 112.653 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.0 pt20 -120.39 -6.32 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.98 0.419 . . . . 70.299999999999997 110.983 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.36 -6.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.12 -0.491 . . . . 74.439999999999998 111.911 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 -10.57 59.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.49 -0.323 . . . . 65.129999999999995 111.79 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 21' ' ' TYR . 87.3 m-20 -79.07 144.76 34.29 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.162 0.506 . . . . 54.340000000000003 112.193 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -76.31 138.47 67.93 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.697 -0.683 . . . . 64.099999999999994 109.878 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -78.88 126.88 7.46 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.319 2.013 . . . . 60.340000000000003 113.215 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.6 mm -104.25 105.93 19.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.015 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 17' ' ' ILE . 2.6 p -87.14 143.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 113.234 0.827 . . . . 62.450000000000003 113.234 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.9 m -162.24 132.55 4.77 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.023 0.44 . . . . 65.540000000000006 110.965 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.717 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -112.34 26.92 10.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.023 -0.535 . . . . 75.420000000000002 110.399 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 t -41.41 123.35 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 61.530000000000001 111.644 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.89 -29.64 7.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.06 -0.591 . . . . 73.409999999999997 113.28 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.15 -31.19 58.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.145 0.472 . . . . 70.409999999999997 111.336 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.717 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -70.48 -65.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.858 -0.61 . . . . 72.239999999999995 110.922 -179.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 65.76 -75.88 0.11 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.737 -0.665 . . . . 63.030000000000001 112.499 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -148.71 110.08 4.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 63.210000000000001 111.492 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -151.4 145.01 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.645 . . . . 65.219999999999999 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 8.8 t-20 -65.75 -39.5 91.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.775 0.798 . . . . 50.009999999999998 109.369 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 83' ' ' ASN . 46.2 mt -158.48 162.17 37.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.522 -1.217 . . . . 73.140000000000001 110.06 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 81.5 mt -128.85 142.48 50.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.774 0.321 . . . . 75.030000000000001 110.393 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.765 HG23 ' CG1' ' A' ' 82' ' ' VAL . 56.1 m -113.63 118.14 33.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 111.245 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.8 tm? -116.36 140.29 49.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.73 -0.47 . . . . 73.219999999999999 109.73 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 58' ' ' LEU . 89.5 mt -141.89 154.85 45.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.373 . . . . 70.129999999999995 111.207 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.442 ' HB3' ' HB3' ' A' ' 78' ' ' HIS . 23.5 ttt -117.63 124.38 48.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.674 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 40.7 t -108.96 132.74 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 109.778 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 7.9 t70 -176.94 62.07 0.19 Allowed Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.408 -0.96 . . . . 72.109999999999999 108.408 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD3' HG12 ' A' ' 61' ' ' VAL . 22.4 Cg_endo -91.59 83.39 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.692 1.595 . . . . 55.450000000000003 114.073 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -171.13 107.93 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.279 -0.873 . . . . 73.439999999999998 110.796 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.729 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.07 135.58 1.24 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 121.127 -0.229 . . . . 75.530000000000001 111.299 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.729 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 Cg_endo -52.28 -15.28 0.44 Allowed 'Cis proline' 0 C--N 1.356 0.957 0 C-N-CA 124.32 -1.116 . . . . 64.400000000000006 111.946 -2.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.521 ' N ' ' HA ' ' A' ' 65' ' ' ALA . 6.7 t -165.15 -175.89 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.505 -0.77 . . . . 74.450000000000003 110.003 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 64' ' ' ASP . 13.7 tpt180 -67.73 -34.9 77.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.03 0.443 . . . . 75.519999999999996 109.838 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -71.0 -45.21 64.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.506 -0.77 . . . . 65.010000000000005 112.957 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 67' ' ' THR . 49.0 t0 -108.8 103.15 50.92 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.628 -0.429 . . . . 73.340000000000003 111.11 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.22 52.92 2.99 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.66 2.24 . . . . 75.540000000000006 110.865 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -48.57 -31.48 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.909 -0.587 . . . . 73.329999999999998 110.287 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -166.47 56.17 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.328 -0.851 . . . . 71.239999999999995 109.736 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' C ' ' HD2' ' A' ' 74' ' ' ARG . 4.9 tmm_? -99.26 135.27 40.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.911 -1.495 . . . . 72.439999999999998 109.417 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 21.6 mp0 -76.15 177.81 6.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.711 0.804 . . . . 72.319999999999993 111.9 0.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.4 tp -109.75 -173.55 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.822 -1.177 . . . . 64.340000000000003 107.822 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.562 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.8 mt -64.99 120.37 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.078 0.399 . . . . 65.340000000000003 110.917 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' MET . 36.5 m170 -107.78 169.24 8.72 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.102 -0.239 . . . . 74.299999999999997 110.724 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.6 t-105 -100.01 85.27 3.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.741 0.782 . . . . 61.130000000000003 110.215 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -98.99 127.21 44.86 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.784 -1.098 . . . . 62.32 112.704 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -147.91 124.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.553 -0.748 . . . . 62.439999999999998 109.115 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.765 ' CG1' HG23 ' A' ' 57' ' ' THR . 23.6 m -138.13 -176.5 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.012 0.434 . . . . 70.400000000000006 111.732 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 55' ' ' LEU . 15.6 p30 52.13 37.26 21.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.962 -1.017 . . . . 74.400000000000006 109.518 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.032 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm -78.93 106.56 4.52 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 114.891 -1.05 . . . . 73.200000000000003 108.737 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 87' ' ' SER . 2.3 Cg_endo -48.13 129.04 17.95 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.759 1.64 . . . . 73.420000000000002 111.788 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.3 69.67 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 O-C-N 123.412 0.445 . . . . 63.350000000000001 113.823 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' PRO . 44.0 t 179.81 47.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.378 -0.601 . . . . 73.409999999999997 109.378 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 90' ' ' ASN . 17.2 m120 -135.16 -22.39 1.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.173 -0.921 . . . . 61.299999999999997 112.309 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 67.86 -15.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.869 0.322 . . . . 73.0 111.869 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 88' ' ' ASN . 5.3 p30 -153.84 156.45 32.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 109.666 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' ILE . 74.3 Cg_endo -70.54 56.67 1.75 Allowed 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.334 2.689 . . . . 64.510000000000005 113.975 -178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -104.15 -40.08 6.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.503 . . . . 73.230000000000004 112.02 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.43 -41.56 58.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.887 0.715 . . . . 45.240000000000002 114.887 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 1.032 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.07 170.35 14.71 Favored Glycine 0 N--CA 1.46 0.287 0 C-N-CA 120.993 -0.622 . . . . 63.439999999999998 113.179 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.484 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.14 121.28 18.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.876 -0.19 . . . . 75.150000000000006 111.296 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.705 ' HA ' HG13 ' A' ' 81' ' ' VAL . 95.8 p -82.09 116.22 21.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.837 -1.172 . . . . 52.219999999999999 107.837 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' HG3' ' A' ' 127' ' ' GLU . 11.2 mt -67.36 -55.01 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 72.140000000000001 109.968 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 131' ' ' ILE . . . -137.03 125.05 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.293 -0.867 . . . . 61.020000000000003 109.146 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 9.9 t0 -52.17 148.57 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.86 0.362 . . . . 45.329999999999998 111.318 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 37.6 p90 -65.03 128.74 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.261 0.553 . . . . 73.230000000000004 111.071 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.9 p -106.38 113.79 43.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.472 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.81 6.97 23.14 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.679 -0.772 . . . . 50.119999999999997 112.25 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 101' ' ' VAL . 38.2 t -59.98 -97.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.02 0.378 . . . . 75.109999999999999 112.02 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.24 161.88 37.82 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.928 -0.653 . . . . 52.210000000000001 112.254 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HB2' ' CE1' ' A' ' 112' ' ' HIS . 31.8 Cg_exo -60.72 137.59 74.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.932 2.421 . . . . 62.509999999999998 112.565 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 41.0 Cg_endo -66.76 161.26 42.73 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.727 2.285 . . . . 73.230000000000004 113.211 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -42.36 -23.28 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 112.026 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.2 m-20 -50.8 -35.4 31.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.514 -0.312 . . . . 74.099999999999994 111.582 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 12.4 t -103.75 8.8 37.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.335 -0.546 . . . . 63.049999999999997 110.968 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.488 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 54.45 -110.96 1.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 113.751 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 27.6 tp -63.83 162.38 13.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.437 0.637 . . . . 61.119999999999997 111.899 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 8.2 m-70 -147.04 144.62 29.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 72.319999999999993 109.303 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -109.05 108.65 19.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.022 -0.362 . . . . 73.209999999999994 110.022 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -104.55 133.31 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.523 -0.547 . . . . 74.450000000000003 109.523 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 9' ' ' LEU . 26.8 mt -132.96 147.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.192 0.52 . . . . 43.420000000000002 111.54 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -120.84 134.31 55.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.237 -0.892 . . . . 73.319999999999993 109.395 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 156' ' ' PRO . 18.5 tp -119.9 140.15 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.144 0.277 . . . . 64.430000000000007 110.475 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 158' ' ' ALA . 62.6 tp -134.79 135.49 41.84 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.39 -0.368 . . . . 63.43 111.09 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HA ' HG12 ' A' ' 157' ' ' ILE . 37.7 t80 -144.25 142.85 30.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 75.319999999999993 110.553 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.848 ' HG3' HD13 ' A' ' 157' ' ' ILE . 98.2 mtt180 -71.47 128.33 35.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 110.626 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 56.8 tp60 -103.91 115.15 29.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.534 -0.757 . . . . 73.040000000000006 110.437 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.04 -37.98 16.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.413 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -112.19 135.12 53.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.701 0.286 . . . . 33.329999999999998 111.253 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 26.2 tptp -65.42 119.33 10.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.928 -0.578 . . . . 62.340000000000003 111.471 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.73 131.89 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 75.099999999999994 109.754 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.16 -57.89 5.91 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 63.439999999999998 110.906 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.573 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 66.11 13.0 8.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.84 1.052 . . . . 72.430000000000007 113.84 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 25.2 p 51.21 162.98 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.613 0.968 . . . . 74.010000000000005 113.613 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 18.6 Cg_endo -58.24 151.4 60.07 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.88 2.387 . . . . 54.039999999999999 112.974 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 131' ' ' ILE . 89.1 m -60.0 151.3 26.65 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.008 0.744 . . . . 74.319999999999993 113.008 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.425 ' N ' HG22 ' A' ' 130' ' ' THR . 40.8 mm -121.93 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.802 -1.09 . . . . 72.019999999999996 109.595 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' THR . 27.6 t -71.12 148.31 47.56 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.643 0.258 . . . . 71.010000000000005 111.528 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.515 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 24.9 p30 -65.4 5.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.156 0.503 . . . . 75.439999999999998 110.348 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 132' ' ' SER . 64.5 p -114.26 15.19 18.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.497 -0.774 . . . . 51.450000000000003 111.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -62.82 133.91 55.44 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.555 -0.458 . . . . 45.210000000000001 110.698 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' A' ' 137' ' ' THR . 22.4 tpp180 -71.83 170.99 12.48 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.34 -0.391 . . . . 75.310000000000002 110.668 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 66.2 m -40.57 145.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.619 . . . . 43.439999999999998 110.231 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.33 -22.04 11.42 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.993 -0.843 . . . . 74.25 110.993 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -131.21 24.16 4.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 74.510000000000005 110.113 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 177' ' ' ILE . 37.2 mt -94.07 -56.37 2.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.53 0.681 . . . . 73.450000000000003 109.501 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' GLU . 37.1 m-20 -79.55 121.36 25.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 71.230000000000004 111.66 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' HE2' ' CZ ' ' A' ' 147' ' ' PHE . 5.7 t80 -167.79 115.87 0.76 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.938 -1.028 . . . . 74.530000000000001 109.993 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -71.44 110.65 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.736 -0.666 . . . . 44.149999999999999 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.65 -28.88 57.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.401 0.62 . . . . 73.129999999999995 110.073 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -52.63 -23.54 6.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 111.001 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.41 -46.94 81.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.878 0.37 . . . . 72.109999999999999 111.248 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.537 ' HA ' ' CD ' ' A' ' 150' ' ' LYS . 76.1 m-85 -45.33 -49.15 13.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.114 -0.494 . . . . 74.25 111.847 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.21 51.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.912 -0.586 . . . . 35.229999999999997 111.073 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.07 -51.85 6.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.306 0.484 . . . . 64.349999999999994 112.306 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -53.68 -50.55 65.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 73.510000000000005 111.817 -178.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 153' ' ' LEU . 33.7 m-70 -103.63 11.38 36.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.692 0.282 . . . . 75.510000000000005 111.494 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 53.26 28.93 36.12 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.619 -0.8 . . . . 73.329999999999998 112.722 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 11.6 mt -67.6 7.44 0.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.904 0.335 . . . . 75.120000000000005 111.904 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 153' ' ' LEU . . . -30.23 -59.96 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.375 -0.44 . . . . 40.409999999999997 113.836 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.31 112.69 19.88 Favored Pre-proline 0 N--CA 1.465 0.284 0 N-CA-C 111.631 0.234 . . . . 73.239999999999995 111.631 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 117' ' ' LEU . 69.7 Cg_endo -92.15 127.32 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.536 2.157 . . . . 73.109999999999999 112.888 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.848 HD13 ' HG3' ' A' ' 120' ' ' ARG . 42.9 pt -75.98 -34.65 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 70.25 110.452 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.599 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.14 149.7 26.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 51.43 111.246 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' CB ' ' CD2' ' A' ' 9' ' ' LEU . . . -151.49 154.41 36.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.804 -0.635 . . . . 74.409999999999997 110.081 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -152.46 133.61 14.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.245 -1.02 . . . . 71.430000000000007 108.245 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 115' ' ' ILE . 2.1 p90 -138.71 156.08 47.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.457 -0.338 . . . . 75.310000000000002 111.486 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.526 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 p90 -154.34 150.42 27.93 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 111.363 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -110.98 133.1 53.66 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.905 -0.589 . . . . 71.319999999999993 111.179 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.71 149.44 25.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.249 -0.887 . . . . 71.420000000000002 109.852 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -103.34 132.9 49.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.562 -0.533 . . . . 63.130000000000003 109.562 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.29 129.18 55.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.657 0.265 . . . . 64.319999999999993 110.768 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -62.29 -125.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.59 . . . . 71.340000000000003 111.942 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.618 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 22.7 t0 -129.77 -20.63 3.17 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.882 -0.599 . . . . 65.510000000000005 111.281 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.533 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 17.9 t80 -68.32 -69.22 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.142 0.793 . . . . 75.109999999999999 113.142 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 171' ' ' PRO . 7.5 p -50.01 -37.36 25.9 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 111.996 0.369 . . . . 74.430000000000007 111.996 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 170' ' ' VAL . 50.2 Cg_exo -54.03 -12.25 3.38 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.512 2.141 . . . . 73.329999999999998 111.688 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 175' ' ' LYS . 8.8 tp -45.77 -30.57 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.662 -0.699 . . . . 63.409999999999997 111.842 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -53.19 -46.76 69.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 119.906 -0.718 . . . . 71.030000000000001 109.513 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.424 ' HA ' HG13 ' A' ' 177' ' ' ILE . 44.6 t30 -63.83 -37.12 86.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.316 -0.624 . . . . 75.450000000000003 109.316 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.647 ' HB2' HD12 ' A' ' 172' ' ' ILE . 61.2 mttp -68.67 -27.97 66.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.576 -0.738 . . . . 71.450000000000003 110.18 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 176' ' ' THR . 18.9 m -97.1 13.1 30.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.929 -0.578 . . . . 74.230000000000004 112.524 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 31.6 mt -64.95 140.86 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 64.439999999999998 109.382 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.515 ' HA ' ' NH2' ' A' ' 136' ' ' ARG . 29.3 m -143.17 -25.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.72 1.007 . . . . 62.329999999999998 113.72 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.451 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.317 -1.269 . . . . 73.25 112.728 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.033 -0.358 . . . . 62.109999999999999 110.033 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 60.92 33.46 19.85 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.336 0.588 . . . . 73.439999999999998 111.248 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.7 t70 -67.47 -48.09 68.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 73.209999999999994 111.513 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.4 pt -114.95 44.7 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.245 0.545 . . . . 54.409999999999997 111.845 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.9 137.74 20.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.994 -0.548 . . . . 40.030000000000001 111.013 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -93.55 32.92 10.11 Favored 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.129 -1.196 . . . . 74.310000000000002 112.113 -0.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 t70 -51.45 -51.58 53.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 55.140000000000001 110.563 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.2 m -160.32 -35.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 72.420000000000002 111.706 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' CD1' HG21 ' A' ' 115' ' ' ILE . 27.6 tp -157.25 172.39 18.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 74.099999999999994 111.056 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 3' ' ' ASP . 9.4 p-10 -78.3 -38.04 43.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.089 -0.708 . . . . 72.200000000000003 109.089 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -152.55 131.65 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.611 -0.722 . . . . 71.319999999999993 109.905 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 7.2 p -59.82 126.4 83.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.134 0.42 . . . . 64.310000000000002 112.134 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.643 ' HG3' ' HB3' ' A' ' 159' ' ' ALA . 71.6 Cg_endo -96.22 -117.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.758 2.972 . . . . 74.239999999999995 111.9 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -166.46 -42.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.607 -0.269 . . . . 72.510000000000005 111.33 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 158.36 17.98 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.778 -0.725 . . . . 60.200000000000003 113.575 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.467 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.1 t -102.83 152.17 21.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.011 0.434 . . . . 64.310000000000002 110.48 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 118' ' ' LEU . 9.2 mt -105.73 123.4 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.962 -0.755 . . . . 74.129999999999995 108.962 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.3 OUTLIER -73.98 102.57 4.18 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.455 -0.793 . . . . 72.140000000000001 109.581 -178.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 27' ' ' VAL . 59.2 t -111.0 110.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 2.6 mp -104.54 128.5 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.794 -0.639 . . . . 73.420000000000002 111.302 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -96.64 -84.93 0.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.159 -0.928 . . . . 65.230000000000004 110.867 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -59.69 3.15 0.27 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.594 -0.73 . . . . 62.32 113.274 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER 85.37 -43.96 0.06 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.896 -1.149 . . . . 74.230000000000004 107.896 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.76 -37.39 19.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.999 -1.0 . . . . 72.140000000000001 108.712 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.31 163.14 25.14 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.215 -0.902 . . . . 74.049999999999997 112.496 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 23.2 tt0 -151.7 127.75 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.758 -1.11 . . . . 64.140000000000001 110.288 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.875 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.3 m -71.64 128.18 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.322 0.582 . . . . 63.530000000000001 111.711 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 73.4 mmtt -112.59 111.37 22.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.518 0.932 . . . . 72.140000000000001 113.518 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.446 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.6 mp0 31.06 67.54 0.13 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.804 1.409 . . . . 70.200000000000003 114.804 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.69 4.58 89.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.343 -0.456 . . . . 74.140000000000001 113.448 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -55.57 146.76 19.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.311 0.577 . . . . 63.119999999999997 112.297 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.37 140.85 32.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.98 -1.009 . . . . 72.340000000000003 111.191 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 38' ' ' VAL . 7.5 mp -106.27 132.4 52.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 71.209999999999994 110.761 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 8.8 p -140.66 161.72 52.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 109.849 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 83.8 Cg_endo -82.09 -33.16 3.12 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 124.142 -1.191 . . . . 65.25 113.404 0.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 36' ' ' THR . 85.1 m -156.65 42.92 0.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.285 0.564 . . . . 51.399999999999999 111.462 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.583 ' OE1' HD12 ' A' ' 25' ' ' LEU . 23.5 pt20 -92.76 0.23 57.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.413 0.625 . . . . 73.510000000000005 110.797 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 33' ' ' LEU . 28.0 m -68.65 -7.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.479 -0.782 . . . . 71.200000000000003 111.284 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -11.32 60.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.145 -0.479 . . . . 43.130000000000003 110.608 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.35 133.3 35.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 62.119999999999997 111.434 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -62.9 138.69 97.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 60.109999999999999 110.087 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.16 126.51 13.13 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 121.8 1.666 . . . . 74.129999999999995 112.516 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.5 mm -100.77 114.73 40.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 60.439999999999998 110.288 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.8 p -85.54 140.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.399 0.518 . . . . 72.120000000000005 112.399 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 14.4 m -161.98 139.21 8.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.952 0.406 . . . . 71.040000000000006 110.347 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.4 p90 -121.68 29.8 7.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 74.239999999999995 110.352 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.7 t -44.94 137.15 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 65.420000000000002 110.225 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.19 -32.51 3.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.654 -0.784 . . . . 63.450000000000003 112.239 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 16' ' ' THR . 96.2 mt -79.5 -41.29 27.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.708 0.766 . . . . 64.239999999999995 109.094 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.658 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.0 tt0 -53.52 105.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.698 -1.137 . . . . 73.230000000000004 110.558 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.3 -114.86 1.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.1 -1.2 . . . . 71.349999999999994 110.1 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -80.56 109.19 14.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.635 -0.826 . . . . 54.439999999999998 109.373 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.78 141.79 15.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.444 -0.344 . . . . 62.420000000000002 111.532 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 25.5 t-20 -89.26 -42.19 11.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.791 0.805 . . . . 74.109999999999999 109.583 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 76.9 mt -152.36 170.0 21.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.686 -1.143 . . . . 70.340000000000003 108.595 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.4 mt -138.38 153.15 48.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.466 -0.494 . . . . 64.120000000000005 111.764 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.875 HG23 HG12 ' A' ' 82' ' ' VAL . 31.5 m -121.42 130.62 53.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.743 -0.662 . . . . 74.109999999999999 110.215 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -128.87 123.91 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.253 -0.647 . . . . 71.239999999999995 109.253 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.578 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.6 mt -143.16 161.78 37.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 74.049999999999997 113.017 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.89 146.69 24.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.203 -1.362 . . . . 73.120000000000005 109.974 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 76.8 t -134.09 137.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.288 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' HH21 ' A' ' 68' ' ' ARG . 52.5 t0 83.32 59.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 114.945 -1.025 . . . . 71.439999999999998 111.52 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 57.4 Cg_endo -71.28 123.01 9.21 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.509 2.14 . . . . 75.239999999999995 111.9 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 25.8 p-10 -118.36 120.76 38.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.68 0.622 . . . . 74.209999999999994 112.68 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.742 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -170.65 135.98 1.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.434 0.531 . . . . 70.450000000000003 112.434 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 55.3 Cg_endo -74.2 -3.75 17.53 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.217 -1.576 . . . . 75.109999999999999 109.794 -2.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.8 t -165.01 156.72 15.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.967 -1.015 . . . . 44.340000000000003 110.373 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' HG2' ' CB ' ' A' ' 64' ' ' ASP . 6.5 mtp-105 -68.33 -12.74 61.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.812 -0.631 . . . . 74.310000000000002 110.951 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.32 -32.94 24.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.889 -0.596 . . . . 61.039999999999999 112.252 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -144.08 116.13 5.6 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-O 120.713 0.292 . . . . 43.409999999999997 110.471 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.09 52.5 4.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.039 2.493 . . . . 72.209999999999994 112.302 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 95.9 mttt -48.93 -27.29 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 75.099999999999994 111.637 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.742 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 25.3 p90 -155.55 29.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.299 0.571 . . . . 74.340000000000003 110.781 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 5.7 tmm_? -70.52 136.13 49.12 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.144 -1.058 . . . . 71.099999999999994 108.144 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 14.2 mp0 -88.61 159.09 18.04 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.236 1.014 . . . . 73.439999999999998 111.873 0.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' A' ' 73' ' ' TYR . 9.1 tp -97.37 171.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.442 -0.799 . . . . 74.109999999999999 109.696 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' CD2' HG11 ' A' ' 101' ' ' VAL . 13.9 tp -42.72 112.89 0.4 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.553 0.692 . . . . 64.310000000000002 110.297 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.22 160.28 15.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.572 -1.195 . . . . 61.140000000000001 113.285 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 10.5 t-105 -100.43 116.19 31.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.579 -1.267 . . . . 73.200000000000003 107.579 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.04 135.4 31.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.229 0.825 . . . . 72.219999999999999 113.229 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -140.66 138.5 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.58 -0.737 . . . . 70.420000000000002 110.893 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.875 HG12 HG23 ' A' ' 57' ' ' THR . 26.2 m -142.05 169.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.603 . . . . 72.239999999999995 112.44 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 24.8 p30 51.82 36.18 17.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.562 -1.199 . . . . 72.219999999999999 112.132 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.99 HG21 ' HA ' ' A' ' 91' ' ' PRO . 5.1 mm -69.02 125.81 92.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.715 -0.846 . . . . 64.319999999999993 108.715 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 87' ' ' SER . 34.0 Cg_exo -58.75 126.28 20.75 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 121.429 1.419 . . . . 74.329999999999998 110.902 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.81 60.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.321 0.488 . . . . 54.039999999999999 114.321 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 85' ' ' PRO . 75.1 m -174.97 43.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.935 0.494 . . . . 55.039999999999999 110.255 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.598 ' C ' ' H ' ' A' ' 90' ' ' ASN . 34.1 m120 -135.31 8.94 3.44 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.528 0.936 . . . . 65.530000000000001 113.528 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER 64.65 -26.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.062 0.393 . . . . 74.010000000000005 112.062 177.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.598 ' H ' ' C ' ' A' ' 88' ' ' ASN . 14.8 p30 -154.05 172.63 5.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.187 0.595 . . . . 73.310000000000002 109.932 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.99 ' HA ' HG21 ' A' ' 84' ' ' ILE . 6.1 Cg_exo -79.74 23.9 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.643 2.896 . . . . 51.539999999999999 115.529 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -79.63 1.11 27.39 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.856 -1.138 . . . . 53.509999999999998 112.985 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.11 2.1 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.495 -0.86 . . . . 34.310000000000002 113.609 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.929 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.7 176.49 10.98 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.229 -0.51 . . . . 45.310000000000002 113.669 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.782 ' CE1' HG23 ' A' ' 130' ' ' THR . 46.2 t60 -66.36 121.12 14.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.389 0.514 . . . . 73.019999999999996 112.389 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.1 p -86.26 89.32 7.81 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.924 -0.769 . . . . 64.439999999999998 108.924 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 147' ' ' PHE . 12.4 mt -50.28 -53.83 25.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 64.439999999999998 110.484 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.66 120.38 13.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.958 -1.019 . . . . 62.32 108.714 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.51 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 54.5 t0 -60.21 146.82 42.2 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.6 0.563 . . . . 74.109999999999999 112.084 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.511 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 21.2 p90 -66.38 142.82 57.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.892 -0.595 . . . . 74.430000000000007 110.295 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 133' ' ' ASN . 21.4 m -140.38 145.03 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.696 0.284 . . . . 75.5 111.528 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.512 ' O ' HG12 ' A' ' 170' ' ' VAL . . . -85.03 0.07 89.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.925 -0.655 . . . . 51.229999999999997 111.642 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 t -58.93 -91.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.561 -0.319 . . . . 70.109999999999999 110.604 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 -167.99 5.03 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.909 -0.662 . . . . 74.420000000000002 114.224 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HG2' ' NE2' ' A' ' 112' ' ' HIS . 44.8 Cg_endo -65.74 145.5 81.28 Favored 'Trans proline' 0 N--CA 1.476 0.477 0 C-N-CA 123.67 2.913 . . . . 72.299999999999997 113.107 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.58 160.68 48.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.066 2.51 . . . . 71.540000000000006 113.332 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 167' ' ' ASP . 35.8 ttmt -44.03 -25.09 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.092 -0.504 . . . . 73.150000000000006 111.055 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.46 -37.87 40.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 63.119999999999997 111.422 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.4 t -76.4 -19.44 58.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.525 -0.47 . . . . 73.120000000000005 111.839 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.92 -129.8 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.599 -0.81 . . . . 61.450000000000003 113.32 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 44.7 tp -67.49 135.28 52.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.01 0.744 . . . . 75.239999999999995 113.01 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.498 ' NE2' ' HG2' ' A' ' 105' ' ' PRO . 22.6 m80 -108.71 142.87 38.59 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.511 -0.768 . . . . 64.129999999999995 108.947 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.647 HH12 ' NE2' ' A' ' 163' ' ' GLN . 5.5 ptm85 -130.38 84.5 2.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.145 -0.687 . . . . 54.310000000000002 109.145 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.11 136.28 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.476 -0.784 . . . . 63.219999999999999 111.995 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 ' HD1' ' A' ' 161' ' ' TYR . 48.5 mt -113.99 137.02 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.753 -1.112 . . . . 74.430000000000007 111.034 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -99.91 141.97 32.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.132 -0.485 . . . . 64.150000000000006 110.294 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -128.24 129.74 46.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.544 -0.298 . . . . 74.209999999999994 110.447 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.832 ' HB2' HD11 ' A' ' 17' ' ' ILE . 2.7 tt -126.44 134.31 51.0 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.257 -0.428 . . . . 75.140000000000001 110.613 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 118' ' ' LEU . 49.9 t80 -144.01 148.52 35.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.913 0.387 . . . . 73.519999999999996 111.408 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HA ' HD23 ' A' ' 56' ' ' LEU . 54.1 ttp180 -83.43 134.68 34.86 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.628 -0.508 . . . . 75.230000000000004 109.628 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 9.9 tp60 -118.06 139.15 51.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.708 -0.224 . . . . 65.310000000000002 110.457 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -110.5 -34.79 6.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.415 -0.357 . . . . 71.420000000000002 110.96 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.09 130.4 43.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 74.019999999999996 111.107 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 23.3 tptm -73.08 143.04 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 70.219999999999999 110.566 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.433 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.9 OUTLIER -141.29 144.55 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 50.32 111.732 -179.14 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -86.73 -31.09 21.15 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.86 0.725 . . . . 70.340000000000003 109.733 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' ND2' ' A' ' 83' ' ' ASN . 0.4 OUTLIER 29.17 56.33 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.39 -1.277 . . . . 75.040000000000006 113.712 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.466 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 51.8 p 60.96 138.2 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 114.585 1.328 . . . . 75.120000000000005 114.585 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.03 158.24 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.996 3.131 . . . . 54.140000000000001 113.764 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.782 HG23 ' CE1' ' A' ' 95' ' ' HIS . 18.5 p -62.18 138.88 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.428 -0.805 . . . . 44.219999999999999 113.067 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.82 129.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.03 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 t -72.33 153.19 41.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.985 0.735 . . . . 70.540000000000006 112.985 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.852 ' HB2' HG12 ' A' ' 101' ' ' VAL . 17.3 p30 -57.92 -26.58 62.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.158 -0.928 . . . . 72.010000000000005 109.595 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 176' ' ' THR . 69.7 p -85.97 14.74 5.71 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.279 -0.873 . . . . 73.030000000000001 111.953 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.6 t -67.79 130.89 44.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 112.204 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.634 ' HG2' ' N ' ' A' ' 179' ' ' GLY . 17.2 mmm180 -77.37 173.21 12.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 73.420000000000002 110.501 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.649 HG23 HD11 ' A' ' 140' ' ' LEU . 32.3 m -54.25 159.55 1.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 75.150000000000006 110.144 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 137' ' ' THR . . . 116.22 -7.8 18.56 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.698 -0.763 . . . . 74.340000000000003 112.417 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' ' 139' ' ' ARG . 16.8 ttt85 -152.94 8.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.132 0.491 . . . . 75.049999999999997 110.956 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 141' ' ' ASN . 0.9 OUTLIER -88.72 -39.77 13.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.007 -0.738 . . . . 74.329999999999998 109.007 177.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.828 ' N ' HD12 ' A' ' 140' ' ' LEU . 73.7 m-20 -63.24 69.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.43 -0.805 . . . . 75.439999999999998 109.408 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 140' ' ' LEU . 60.0 t80 -127.73 128.81 46.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 74.209999999999994 111.741 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' A' ' 145' ' ' ARG . 17.8 p-10 -95.36 135.04 37.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 72.230000000000004 111.36 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.48 71.56 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.324 0.583 . . . . 51.119999999999997 110.435 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.978 ' NH1' ' HB2' ' A' ' 149' ' ' ALA . 26.3 tpt85 -43.81 -29.93 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.939 -1.028 . . . . 74.340000000000003 111.549 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' OD2' ' NZ ' ' A' ' 150' ' ' LYS . 13.6 t70 -60.17 -58.34 8.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.185 0.517 . . . . 75.25 110.392 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 97' ' ' LEU . 19.4 m-30 -64.79 -37.78 88.77 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.788 -0.642 . . . . 73.329999999999998 109.877 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.7 76.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 53.409999999999997 109.898 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.978 ' HB2' ' NH1' ' A' ' 145' ' ' ARG . . . -75.64 -53.75 8.07 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.396 0.517 . . . . 74.219999999999999 112.396 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.424 ' NZ ' ' OD2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -82.33 -51.13 8.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.18 0.807 . . . . 74.310000000000002 113.18 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -67.99 -0.46 4.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 120.086 -0.646 . . . . 70.530000000000001 110.741 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 61.09 31.41 76.62 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 114.956 0.742 . . . . 63.340000000000003 114.956 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CD1' HD12 ' A' ' 59' ' ' LEU . 10.8 mt -74.3 16.49 0.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.084 0.442 . . . . 72.200000000000003 111.376 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -47.94 -18.96 0.85 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.334 0.494 . . . . 62.100000000000001 114.334 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -135.16 93.31 17.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 117.309 0.555 . . . . 75.129999999999995 111.107 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.651 ' HB3' HD21 ' A' ' 117' ' ' LEU . 48.1 Cg_endo -67.76 134.3 32.09 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.384 2.056 . . . . 70.530000000000001 112.766 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 119' ' ' TYR . 24.9 pt -84.74 -34.98 9.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.274 -0.421 . . . . 70.530000000000001 110.553 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -139.24 147.09 41.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.123 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 17' ' ' ILE . . . -162.35 159.46 25.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 111.301 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.768 HD21 HG23 ' A' ' 27' ' ' VAL . 57.1 t30 -164.6 167.58 19.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.424 -1.325 . . . . 74.150000000000006 107.424 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.633 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -154.51 157.43 38.35 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.292 -0.563 . . . . 74.409999999999997 111.448 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.539 ' HB3' ' CB ' ' A' ' 27' ' ' VAL . 3.3 p90 -149.9 153.04 36.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.026 -0.534 . . . . 74.239999999999995 111.603 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.647 ' NE2' HH12 ' A' ' 113' ' ' ARG . 44.7 mt-30 -112.15 134.81 53.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.74 -0.664 . . . . 70.109999999999999 111.027 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.24 145.77 22.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.963 -0.562 . . . . 62.25 111.778 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 2.0 pm0 -133.94 156.87 47.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.033 -1.099 . . . . 71.109999999999999 108.033 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER -157.33 159.25 37.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 63.140000000000001 112.224 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.494 ' HA ' ' CE ' ' A' ' 107' ' ' LYS . 1.7 m-20 -71.15 157.13 38.69 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.652 -0.704 . . . . 73.150000000000006 110.516 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.566 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 14.5 t70 -48.75 -23.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.737 -0.665 . . . . 63.119999999999997 110.673 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.424 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 23.8 t80 -53.08 -38.22 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 55.229999999999997 110.99 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.629 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 73.7 t -68.16 -57.57 8.93 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.028 -0.669 . . . . 64.340000000000003 109.604 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 83.9 Cg_exo -44.99 -29.55 3.88 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.284 1.989 . . . . 74.450000000000003 111.921 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 168' ' ' ASP . 38.2 mm -47.67 -23.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.176 0.512 . . . . 74.109999999999999 109.791 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -44.49 -27.96 0.52 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.272 -0.876 . . . . 65.450000000000003 109.514 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 175' ' ' LYS . 12.7 p30 -46.11 -33.88 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.522 -0.763 . . . . 65.129999999999995 111.456 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 10.9 mptt -52.48 -30.78 31.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.776 0.322 . . . . 64.140000000000001 111.377 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 134' ' ' THR . 1.9 m -66.95 -28.05 67.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 75.129999999999995 110.361 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.623 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.3 mm -62.79 134.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 71.219999999999999 110.808 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.7 m -149.34 2.95 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.684 0.624 . . . . 75.430000000000007 112.684 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.634 ' N ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.466 -1.185 . . . . 41.530000000000001 112.871 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.673 0.273 . . . . 64.230000000000004 110.668 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -169.83 117.14 0.57 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.69 -0.686 . . . . 63.219999999999999 109.951 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.48 -71.04 0.67 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.817 0.673 . . . . 62.310000000000002 112.817 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.562 HD12 ' CG2' ' A' ' 8' ' ' VAL . 7.2 pt -121.17 63.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.295 0.569 . . . . 74.230000000000004 111.856 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' ASP . 12.7 p -128.55 138.66 33.55 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.689 -0.687 . . . . 75.109999999999999 110.341 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.6 Cg_endo -85.55 34.22 4.22 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.767 -1.347 . . . . 73.340000000000003 112.588 0.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 8' ' ' VAL . 62.5 t0 -57.74 -53.76 54.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 71.040000000000006 110.056 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 4' ' ' ILE . 20.1 m -162.72 -37.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.505 -0.771 . . . . 54.130000000000003 111.073 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.1 tp -157.08 140.64 15.84 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-O 121.432 0.634 . . . . 71.420000000000002 111.227 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 20.5 p-10 -75.79 6.19 5.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.812 -0.631 . . . . 72.340000000000003 112.009 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -157.7 133.94 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 61.25 111.343 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.8 p -85.93 109.86 25.88 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.213 -0.448 . . . . 72.099999999999994 112.09 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.8 Cg_endo -86.87 -130.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.303 2.669 . . . . 73.120000000000005 112.187 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -159.94 -41.19 0.05 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.427 -0.351 . . . . 64.140000000000001 110.697 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -161.58 20.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.953 -0.641 . . . . 63.200000000000003 112.44 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 5.1 t -150.37 170.02 20.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.077 0.465 . . . . 72.230000000000004 111.377 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -105.88 127.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 64.530000000000001 109.186 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.9 mmpt? -84.15 102.95 12.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 109.649 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.563 ' HB ' HG22 ' A' ' 27' ' ' VAL . 48.3 t -116.89 110.68 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.165 0.507 . . . . 64.230000000000004 109.709 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.633 HG21 ' O ' ' A' ' 23' ' ' ASP . 25.8 mt -92.08 143.35 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.7 -0.682 . . . . 64.310000000000002 109.951 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 2.4 t80 -84.83 -77.8 0.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.733 -0.787 . . . . 51.240000000000002 111.584 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.611 ' H ' ' CD1' ' A' ' 25' ' ' LEU . . . -99.83 -32.87 5.48 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.611 -0.804 . . . . 72.209999999999994 113.884 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.633 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -173.48 -75.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.444 0.535 . . . . 61.109999999999999 112.444 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -90.97 -40.16 11.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.178 0.513 . . . . 73.120000000000005 110.76 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD1' ' H ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -69.53 135.98 50.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.79 -0.641 . . . . 51.310000000000002 110.469 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 22.4 pt-20 -134.26 159.18 41.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.101 -0.5 . . . . 74.239999999999995 111.528 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.1 m -69.38 134.21 30.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 72.450000000000003 110.172 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -138.64 108.51 6.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 75.25 112.228 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.508 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.7 mp0 52.06 49.12 21.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.965 . . . . 50.450000000000003 113.603 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 161' ' ' TYR . . . 62.17 12.54 38.08 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 114.812 0.685 . . . . 35.009999999999998 114.812 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -55.09 157.51 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 117.483 0.642 . . . . 73.209999999999994 110.233 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -98.2 129.31 44.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 73.25 110.051 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.2 mp -92.78 112.83 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.557 0.694 . . . . 75.319999999999993 110.988 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 2.8 p -110.54 165.63 12.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.747 -1.115 . . . . 75.120000000000005 111.35 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 17.7 Cg_exo -67.39 -42.32 0.7 Allowed 'Cis proline' 0 C--N 1.352 0.733 0 C-N-CA 124.161 -1.183 . . . . 54.149999999999999 112.033 0.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -162.53 44.47 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 71.25 109.889 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.57 ' C ' ' H ' ' A' ' 39' ' ' LYS . 3.9 pt20 -76.75 -4.83 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.629 -0.714 . . . . 71.120000000000005 111.215 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.585 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 34.3 m -73.37 31.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.695 0.76 . . . . 52.520000000000003 110.082 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -93.37 6.0 49.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.688 -1.142 . . . . 73.109999999999999 112.498 -178.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -135.3 162.99 31.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.845 0.313 . . . . 64.239999999999995 111.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -72.31 146.0 88.78 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.138 -0.483 . . . . 70.299999999999997 111.519 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -95.33 126.96 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.146 2.564 . . . . 70.349999999999994 113.424 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.1 mm -80.17 128.4 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 64.510000000000005 110.932 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.468 HG13 ' HD2' ' A' ' 91' ' ' PRO . 4.1 p -100.22 137.17 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.917 0.339 . . . . 74.540000000000006 111.917 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -162.21 153.84 18.5 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.137 0.494 . . . . 64.430000000000007 111.366 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.735 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.8 p90 -128.59 34.4 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.839 0.828 . . . . 65.510000000000005 109.485 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 m -49.54 107.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.457 -1.247 . . . . 73.150000000000006 111.069 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.57 -33.88 5.3 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.768 -0.651 . . . . 55.049999999999997 111.489 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 2.4 mm? -76.89 -40.12 48.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.14 -0.689 . . . . 73.140000000000001 109.14 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.735 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 29.2 tt0 -65.92 111.48 3.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.879 -0.601 . . . . 63.119999999999997 109.649 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.97 -63.52 0.26 Allowed Glycine 0 C--N 1.324 -0.111 0 C-N-CA 120.812 -0.709 . . . . 74.549999999999997 112.33 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -148.27 111.04 4.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.38 -0.6 . . . . 74.420000000000002 109.38 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 120' ' ' ARG . 12.2 p -157.29 141.8 16.54 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.85 -0.34 . . . . 52.399999999999999 111.319 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 35.2 t30 -77.91 -33.61 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.538 0.685 . . . . 63.520000000000003 109.292 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -155.15 157.0 36.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.966 -1.015 . . . . 71.230000000000004 109.35 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.9 mt -127.03 152.4 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 73.409999999999997 110.976 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.643 HG23 HG12 ' A' ' 82' ' ' VAL . 95.0 m -121.51 134.01 55.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.054 -0.521 . . . . 54.549999999999997 110.154 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -136.42 132.96 36.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 64.540000000000006 109.638 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 97.1 mt -153.82 159.69 41.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.02 0.438 . . . . 51.340000000000003 111.884 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 114' ' ' TYR . 24.3 ttt -94.92 156.62 16.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 62.350000000000001 109.971 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 57.6 t -133.47 146.12 32.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 54.009999999999998 111.515 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 46.2 t0 65.01 40.69 0.28 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.303 -0.862 . . . . 72.510000000000005 111.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 76.4 Cg_exo -51.21 139.84 42.91 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.884 1.723 . . . . 62.109999999999999 111.587 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.76 122.66 36.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.51 0.559 . . . . 62.549999999999997 112.51 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.83 135.91 1.08 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.056 0.391 . . . . 64.519999999999996 112.056 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 13.2 Cg_exo -68.1 -32.56 3.47 Favored 'Cis proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.883 -1.299 . . . . 71.340000000000003 109.809 -3.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.8 t -141.26 140.25 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.336 -1.302 . . . . 32.399999999999999 108.932 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -56.12 -21.56 23.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.345 0.593 . . . . 75.400000000000006 110.606 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.265 -0.879 . . . . 72.519999999999996 111.234 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . 23.0 t70 -140.15 62.06 19.48 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-O 121.126 0.489 . . . . 75.200000000000003 110.272 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -67.84 53.8 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.458 2.772 . . . . 75.430000000000007 113.434 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -50.96 -52.17 45.15 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.888 0.329 . . . . 74.010000000000005 111.888 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.493 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 2.1 p90 -106.9 39.53 1.84 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.323 0.582 . . . . 62.020000000000003 111.081 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.538 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 3.7 tmm_? -79.29 139.96 37.7 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.781 -1.192 . . . . 74.230000000000004 107.781 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 25.6 mp0 -89.13 178.05 6.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.555 1.142 . . . . 74.150000000000006 112.594 0.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 77' ' ' LEU . 4.7 tp -105.98 -173.24 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.118 -0.946 . . . . 74.519999999999996 109.886 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.0 mp -68.03 64.46 0.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.99 0.424 . . . . 72.329999999999998 111.016 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -58.55 178.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.85 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.471 ' CZ2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t-105 -100.29 122.06 42.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.004 -0.739 . . . . 75.109999999999999 109.004 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 20.0 m -141.1 129.74 22.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 111.507 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -142.52 127.73 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 74.099999999999994 109.388 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 125' ' ' ILE . 19.6 m -129.86 166.07 28.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.402 0.62 . . . . 71.219999999999999 112.366 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.625 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.9 p30 52.95 44.88 29.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.25 -1.341 . . . . 62.409999999999997 112.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.976 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.9 mm -79.89 118.02 70.34 Favored Pre-proline 0 C--O 1.231 0.105 0 N-CA-C 108.328 -0.99 . . . . 63.530000000000001 108.328 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' SER . 45.6 Cg_exo -56.51 125.95 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.839 1.693 . . . . 54.240000000000002 112.003 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.74 73.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.386 -0.435 . . . . 72.510000000000005 113.143 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' PRO . 34.3 t 177.15 45.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.846 0.458 . . . . 71.530000000000001 110.034 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 54.8 m-80 -135.36 -28.23 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.201 0.815 . . . . 72.5 113.201 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 3.9 tt0 74.56 -0.59 3.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.304 0.573 . . . . 65.150000000000006 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 14.4 p30 -167.8 157.62 9.12 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.225 -0.898 . . . . 63.340000000000003 109.914 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.614 ' HA ' HG21 ' A' ' 84' ' ' ILE . 82.5 Cg_endo -77.34 53.84 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.9 2.4 . . . . 73.099999999999994 112.559 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.7 t -102.59 -5.09 24.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.865 -0.334 . . . . 65.219999999999999 111.669 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.19 -42.0 1.33 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.041 -0.6 . . . . 50.539999999999999 114.214 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.976 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.49 173.75 15.48 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.968 -0.634 . . . . 60.340000000000003 113.975 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.7 OUTLIER -65.8 119.21 10.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.077 0.399 . . . . 71.129999999999995 112.077 -178.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 130' ' ' THR . 43.7 m -82.53 90.28 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 74.420000000000002 109.498 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.784 HD13 ' HE2' ' A' ' 147' ' ' PHE . 15.1 mt -50.47 -28.69 8.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.594 -0.73 . . . . 63.130000000000003 111.004 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -165.13 93.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.178 -0.919 . . . . 73.409999999999997 108.86 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -41.85 140.24 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.425 0.631 . . . . 53.310000000000002 112.494 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -56.38 146.9 22.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 71.420000000000002 110.922 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 102' ' ' GLY . 14.8 p -156.91 161.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.942 0.401 . . . . 71.239999999999995 111.341 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -68.24 -176.62 11.19 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.636 -0.711 . . . . 52.219999999999999 113.011 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t -65.92 122.86 18.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 62.049999999999997 111.762 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -86.65 -48.88 4.31 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.478 -0.649 . . . . 34.219999999999999 111.478 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 51.1 Cg_exo -56.37 142.43 88.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.647 2.231 . . . . 71.140000000000001 113.124 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.608 ' O ' HG23 ' A' ' 109' ' ' THR . 18.1 Cg_endo -58.92 143.54 99.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.75 2.3 . . . . 73.230000000000004 112.025 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.504 ' HB3' ' C ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -46.21 -43.29 15.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.944 0.72 . . . . 71.409999999999997 112.944 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.99 0.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.714 0.635 . . . . 71.209999999999994 112.714 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 106' ' ' PRO . 75.9 p -78.64 -27.64 45.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.905 0.383 . . . . 51.200000000000003 110.913 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.41 -167.69 14.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.824 -0.703 . . . . 74.310000000000002 113.353 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -60.01 138.19 57.91 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 112.492 0.553 . . . . 35.409999999999997 112.492 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -106.39 129.91 54.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.117 -0.947 . . . . 75.329999999999998 109.032 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 ptm85 -112.23 120.13 40.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.15 0.5 . . . . 74.209999999999994 111.288 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' ' HE3' ' A' ' 60' ' ' MET . 6.1 m-85 -109.15 140.99 42.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.819 -0.628 . . . . 63.119999999999997 110.659 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 161' ' ' TYR . 24.6 mt -132.47 132.2 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.828 -0.804 . . . . 75.319999999999993 108.828 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -106.02 137.08 44.55 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.443 0.464 . . . . 65.230000000000004 111.493 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.785 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.5 tm? -127.08 137.8 53.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.874 -0.603 . . . . 71.340000000000003 109.812 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.785 ' N ' HD13 ' A' ' 117' ' ' LEU . 57.0 tp -128.25 137.4 51.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.772 0.429 . . . . 64.510000000000005 110.466 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.524 ' CD2' HD22 ' A' ' 153' ' ' LEU . 81.2 t80 -144.07 132.59 22.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.151 -0.477 . . . . 73.450000000000003 110.595 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 53' ' ' SER . 42.8 ttp180 -76.58 128.25 34.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 71.439999999999998 110.613 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.633 ' NE2' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -104.26 149.16 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.975 0.731 . . . . 74.299999999999997 112.975 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 30.2 tt0 -112.59 -55.49 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.686 -1.143 . . . . 75.319999999999993 109.857 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -100.19 131.38 46.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 73.319999999999993 110.717 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 9.7 tmtt? -59.55 125.08 22.19 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.004 -0.369 . . . . 71.340000000000003 110.004 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.83 HD11 ' HB ' ' A' ' 82' ' ' VAL . 5.5 pt -87.15 125.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 52.140000000000001 112.233 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.81 118.04 10.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.903 -1.518 . . . . 74.239999999999995 106.903 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.41 32.31 1.69 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.033 1.123 . . . . 60.140000000000001 114.033 -176.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 68.7 p 51.04 172.53 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 112.446 0.535 . . . . 73.010000000000005 112.446 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 50.4 Cg_exo -58.46 150.4 68.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.517 2.145 . . . . 62.009999999999998 114.037 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 96' ' ' SER . 25.5 p -60.91 132.18 53.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 72.540000000000006 110.809 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 32.4 mm -85.99 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.379 0.609 . . . . 74.209999999999994 112.224 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -73.46 141.32 46.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 70.510000000000005 111.983 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 134' ' ' THR . 22.3 p30 -56.42 -47.1 79.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.515 0.674 . . . . 63.219999999999999 110.427 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.555 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.3 t -84.49 22.93 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.066 -0.97 . . . . 51.439999999999998 111.451 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 177' ' ' ILE . 12.0 t -62.21 155.46 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.551 0.691 . . . . 25.109999999999999 112.121 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.569 ' HB2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 tpt180 -69.02 164.94 21.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.771 -1.104 . . . . 72.120000000000005 112.422 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 138' ' ' GLY . 4.4 m -53.13 175.28 0.03 OUTLIER 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.685 -0.689 . . . . 73.150000000000006 110.258 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.651 ' H ' HG22 ' A' ' 137' ' ' THR . . . 82.07 4.22 90.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 119.937 -1.125 . . . . 74.129999999999995 111.822 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.449 ' H ' HD12 ' A' ' 140' ' ' LEU . 28.7 mmt180 -139.81 45.71 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.262 0.553 . . . . 63.039999999999999 111.304 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -112.77 -63.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.187 -0.915 . . . . 71.239999999999995 108.784 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 73' ' ' TYR . 5.3 m-20 -63.39 121.38 13.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 74.010000000000005 111.447 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.565 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 40.8 t80 -176.94 109.38 0.08 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.82 -0.627 . . . . 75.430000000000007 111.306 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -68.63 120.98 15.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 111.921 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.74 -43.44 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 52.030000000000001 111.601 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' HH11 ' A' ' 145' ' ' ARG . 11.0 mtp-105 -45.15 -33.92 2.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.218 -0.447 . . . . 73.150000000000006 111.914 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.93 -49.33 50.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.591 0.71 . . . . 44.399999999999999 109.386 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.784 ' HE2' HD13 ' A' ' 97' ' ' LEU . 10.0 m-30 -62.14 -41.95 98.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.053 -0.976 . . . . 74.230000000000004 110.189 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.73 -46.38 87.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.805 0.336 . . . . 62.509999999999998 111.244 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.3 -51.73 41.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.913 -0.585 . . . . 71.420000000000002 112.458 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -75.36 -48.57 22.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.632 0.604 . . . . 61.039999999999999 112.632 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.645 ' NE2' HD12 ' A' ' 125' ' ' ILE . 7.8 m-70 -67.76 -10.85 56.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.94 -0.475 . . . . 72.340000000000003 110.724 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.22 67.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.092 -0.575 . . . . 74.230000000000004 113.155 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.524 HD22 ' CD2' ' A' ' 119' ' ' TYR . 7.4 mt -76.02 15.85 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.063 0.145 . . . . 63.210000000000001 111.195 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -35.29 -73.01 0.1 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.021 -0.609 . . . . 34.299999999999997 113.44 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 155' ' ' GLU . 11.4 pt-20 -74.67 112.46 17.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.544 0.172 . . . . 75.549999999999997 110.849 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 117' ' ' LEU . 65.5 Cg_endo -83.55 130.75 5.31 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.194 1.93 . . . . 73.510000000000005 113.116 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.725 HD11 ' HG ' ' A' ' 118' ' ' LEU . 38.8 pt -78.49 -34.7 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.916 -0.314 . . . . 73.319999999999993 111.426 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -151.05 151.0 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.207 0.447 . . . . 72.200000000000003 112.207 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.15 158.15 43.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 53.340000000000003 111.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.6 ' C ' ' CD1' ' A' ' 161' ' ' TYR . 43.4 t30 -158.97 175.09 13.99 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.004 -1.11 . . . . 75.129999999999995 108.004 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -157.95 155.53 29.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.686 0.675 . . . . 71.140000000000001 111.055 -178.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 1.4 t80 -155.94 131.84 9.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.13 0.572 . . . . 75.430000000000007 110.995 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mt-30 -115.86 138.63 50.98 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.282 -0.261 . . . . 71.030000000000001 111.455 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -155.43 153.18 29.95 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.062 0.764 . . . . 53.109999999999999 113.062 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -138.99 161.5 37.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.776 -0.824 . . . . 65.319999999999993 108.776 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.432 ' O ' ' CB ' ' A' ' 107' ' ' LYS . 1.7 t80 -165.61 168.75 16.06 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.191 -0.604 . . . . 71.010000000000005 111.36 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.504 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.8 t0 -79.46 -159.92 0.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.714 0.634 . . . . 64.209999999999994 110.912 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.5 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 50.2 t0 -69.0 -23.87 64.15 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.092 0.472 . . . . 64.209999999999994 111.036 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.4 t80 -42.88 -44.48 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 112.108 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 67.8 t -80.38 -54.39 0.83 Allowed Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 120.464 -0.494 . . . . 53.020000000000003 111.494 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 77.8 Cg_exo -48.39 -49.84 13.54 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.051 1.834 . . . . 51.399999999999999 112.644 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 168' ' ' ASP . 11.5 tt -46.01 -33.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.027 0.381 . . . . 74.420000000000002 112.027 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.03 -29.53 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 65.430000000000007 111.342 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.1 m-20 -56.51 -14.92 3.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.176 0.806 . . . . 74.409999999999997 113.176 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.36 -20.29 42.57 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.794 0.664 . . . . 74.340000000000003 112.794 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 p -88.1 16.59 5.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.864 0.69 . . . . 74.109999999999999 112.864 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 135' ' ' THR . 27.7 mm -72.46 124.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 122.037 -0.415 . . . . 64.510000000000005 110.296 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.58 -13.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.114 0.783 . . . . 74.409999999999997 113.114 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.555 -1.136 . . . . 64.319999999999993 112.301 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 109.938 -0.393 . . . . 73.140000000000001 109.938 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -70.5 64.38 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 65.319999999999993 111.458 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 5.5 t70 -71.18 -40.83 71.0 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.728 0.299 . . . . 54.219999999999999 111.196 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 9' ' ' LEU . 12.8 pt -149.24 48.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 65.319999999999993 110.615 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 2' ' ' ASP . 13.6 p -136.45 140.9 33.79 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.214 -0.903 . . . . 75.5 109.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 Cg_exo -78.28 26.43 2.5 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.205 -1.164 . . . . 70.329999999999998 113.591 0.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.5 t0 -54.56 -53.21 57.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.393 . . . . 73.129999999999995 110.431 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.5 m -161.32 -43.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.997 -0.547 . . . . 63.200000000000003 111.917 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 117' ' ' LEU . 62.2 tp -144.21 160.08 41.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.65 0.262 . . . . 75.209999999999994 110.851 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -60.43 -42.58 96.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.718 -0.793 . . . . 72.319999999999993 109.732 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -156.59 135.14 11.54 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.818 0.303 . . . . 54.140000000000001 111.818 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.39 125.88 80.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 72.010000000000005 110.995 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 45.7 Cg_endo -89.73 -145.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.892 2.395 . . . . 51.539999999999999 112.201 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.37 -31.05 6.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.842 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.36 -136.54 3.16 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.919 -0.582 . . . . 75.409999999999997 111.834 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.472 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 1.5 t -162.81 164.41 26.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 65.239999999999995 111.734 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.587 HD12 ' N ' ' A' ' 17' ' ' ILE . 3.1 mp -104.9 133.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.406 -0.961 . . . . 73.109999999999999 108.406 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 13.5 mmmm -83.62 101.96 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.442 -0.503 . . . . 71.540000000000006 109.707 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 94.2 t -108.86 108.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.599 0.714 . . . . 61.409999999999997 111.198 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 23' ' ' ASP . 1.8 mp -91.88 138.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 72.150000000000006 107.898 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -93.42 -46.96 7.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.937 0.717 . . . . 71.030000000000001 112.937 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' A' ' 25' ' ' LEU . . . -115.86 -48.39 0.5 Allowed Glycine 0 N--CA 1.459 0.175 0 C-N-CA 120.277 -0.963 . . . . 53.299999999999997 112.857 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -170.62 -80.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 110.261 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -82.31 -31.85 29.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.599 . . . . 75.420000000000002 109.384 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 129.08 38.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.687 0.756 . . . . 71.209999999999994 111.443 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 28.3 tt0 -125.61 150.77 47.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.702 -1.136 . . . . 72.439999999999998 110.836 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 27' ' ' VAL . 31.3 m -85.42 107.01 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 111.535 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 31' ' ' ASN . 1.5 mptm? -75.21 50.53 0.5 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.429 0.9 . . . . 64.439999999999998 113.429 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HA ' ' H ' ' A' ' 161' ' ' TYR . 3.4 mp0 59.31 69.67 0.7 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.667 0.988 . . . . 63.039999999999999 113.667 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 161' ' ' TYR . . . 100.38 -6.21 57.64 Favored Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 110.835 -0.906 . . . . 75.329999999999998 110.835 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.3 t-20 -59.14 139.02 57.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.932 -1.134 . . . . 72.109999999999999 110.868 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' C ' HD12 ' A' ' 33' ' ' LEU . 87.2 tt0 -102.72 138.02 40.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 73.219999999999999 110.24 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.1 mp -109.3 154.19 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 111.353 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -149.36 157.79 38.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 75.219999999999999 110.477 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.95 -51.88 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 124.093 -1.211 . . . . 50.200000000000003 112.77 0.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 36' ' ' THR . 6.2 m -143.41 35.81 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 72.129999999999995 110.836 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 11.9 pt20 -80.21 -4.37 52.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.6 . . . . 65.530000000000001 111.494 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.608 ' HB ' ' CE2' ' A' ' 21' ' ' TYR . 27.5 m -85.54 33.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.572 -0.74 . . . . 71.140000000000001 111.935 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.74 -30.08 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.848 1.055 . . . . 74.040000000000006 113.848 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 45.1 m-20 -72.33 152.62 41.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.825 0.676 . . . . 74.219999999999999 112.825 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -63.25 128.72 92.79 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.718 -0.674 . . . . 73.109999999999999 109.33 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 125.75 19.31 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.348 2.032 . . . . 74.409999999999997 114.243 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.18 111.09 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.5 -0.773 . . . . 70.540000000000006 109.936 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' CG2' ' A' ' 17' ' ' ILE . 6.0 p -93.55 142.02 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.365 . . . . 71.230000000000004 111.719 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 50.7 m -158.07 137.9 12.2 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.263 0.468 . . . . 64.040000000000006 112.263 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.735 ' HH2' HG21 ' A' ' 84' ' ' ILE . 3.5 p90 -115.84 23.26 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.263 -0.643 . . . . 75.409999999999997 109.263 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.2 m -40.31 120.96 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.395 -0.82 . . . . 70.510000000000005 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 91.08 -35.46 3.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.267 -0.492 . . . . 73.340000000000003 112.187 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.0 mm? -65.54 -20.86 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.87 0.367 . . . . 75.129999999999995 110.031 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 16.6 pm0 -67.57 -159.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.249 -0.649 . . . . 74.310000000000002 109.249 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.17 -66.6 0.48 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 119.96 -1.114 . . . . 62.399999999999999 113.083 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -149.42 106.88 3.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.086 0.47 . . . . 75.099999999999994 109.77 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.403 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 3.3 m -160.19 140.41 11.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.776 -0.647 . . . . 70.150000000000006 110.224 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -74.88 -38.17 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.733 -0.84 . . . . 74.109999999999999 108.733 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 22.5 mt -155.86 160.4 40.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.7 -1.136 . . . . 72.109999999999999 109.885 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 15.5 mt -122.08 151.8 40.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.974 -0.29 . . . . 73.030000000000001 110.527 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.685 HG23 HG12 ' A' ' 82' ' ' VAL . 91.4 m -129.01 114.41 16.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 112.027 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.3 tm? -106.78 134.29 50.15 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.54 -0.541 . . . . 74.030000000000001 109.54 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 58' ' ' LEU . 83.5 mt -144.75 171.58 14.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.166 0.508 . . . . 52.420000000000002 111.754 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.562 ' C ' ' SD ' ' A' ' 60' ' ' MET . 0.8 OUTLIER -133.64 123.13 24.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.176 -0.92 . . . . 74.209999999999994 108.638 178.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.602 HG13 HD22 ' A' ' 143' ' ' ASN . 48.3 t -130.87 102.09 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.123 0.487 . . . . 71.120000000000005 112.127 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -178.79 67.68 0.19 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.226 -0.897 . . . . 65.230000000000004 109.605 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 1.4 Cg_endo -45.48 129.0 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.254 1.97 . . . . 44.020000000000003 111.589 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -162.36 87.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.291 0.478 . . . . 72.219999999999999 112.291 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -171.61 133.54 0.84 Allowed Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 112.883 0.697 . . . . 52.049999999999997 112.883 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.6 Cg_exo -63.36 -20.45 5.17 Favored 'Cis proline' 0 C--N 1.354 0.822 0 C-N-CA 123.558 -1.434 . . . . 74.099999999999994 110.276 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 148.49 16.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.838 -1.074 . . . . 63.119999999999997 109.912 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -49.13 -31.8 8.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.676 0.75 . . . . 73.519999999999996 110.617 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.45 -32.83 74.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.927 -1.033 . . . . 74.140000000000001 111.956 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.6 t0 -144.91 98.37 4.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 75.420000000000002 111.072 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 72.5 Cg_endo -76.51 60.3 6.46 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.974 2.449 . . . . 75.329999999999998 111.901 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -47.17 -39.82 14.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.931 -0.577 . . . . 72.450000000000003 110.78 -178.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -148.0 48.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.721 0.772 . . . . 62.350000000000001 109.707 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -74.37 136.24 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.652 -1.158 . . . . 73.530000000000001 109.459 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 142' ' ' PHE . 1.1 pm0 -89.12 176.61 6.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.998 0.919 . . . . 74.140000000000001 112.013 0.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 140' ' ' LEU . 3.2 tp -114.46 -163.14 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.216 -0.902 . . . . 75.120000000000005 109.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.665 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.9 mp -65.04 135.9 56.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 6.6 p-80 -147.87 171.72 15.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 52.340000000000003 110.086 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.7 t90 -97.99 123.18 41.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 72.340000000000003 112.052 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 85.5 p -142.96 133.58 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.847 -0.615 . . . . 74.319999999999993 109.841 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 91' ' ' PRO . 21.3 t -149.24 117.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.6 . . . . 74.109999999999999 109.379 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 57' ' ' THR . 10.7 m -115.23 -173.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.724 0.774 . . . . 64.230000000000004 112.649 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.619 HD21 ' CG ' ' A' ' 95' ' ' HIS . 27.9 p30 44.21 43.45 5.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.996 -1.457 . . . . 73.25 113.166 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.735 HG21 ' HH2' ' A' ' 46' ' ' TRP . 2.4 mm -67.42 121.84 80.57 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.55 -1.278 . . . . 73.0 107.55 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.45 103.13 1.64 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.155 1.903 . . . . 75.540000000000006 115.189 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.89 -84.79 1.57 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 116.507 1.363 . . . . 42.229999999999997 116.507 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 89' ' ' GLU . 78.3 p -174.39 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 117.484 0.642 . . . . 64.230000000000004 111.642 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 90' ' ' ASN . 18.8 m120 -73.71 28.98 0.07 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.907 -0.588 . . . . 74.200000000000003 110.391 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 16.3 pt-20 44.52 5.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.928 -1.033 . . . . 62.43 112.952 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 88' ' ' ASN . 17.8 p30 -179.71 163.11 0.91 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.237 -0.653 . . . . 70.019999999999996 109.237 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 84' ' ' ILE . 66.6 Cg_endo -68.65 44.84 0.33 Allowed 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 122.872 2.381 . . . . 74.219999999999999 113.219 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 90' ' ' ASN . 22.1 t -69.36 -43.22 74.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.177 0.436 . . . . 74.439999999999998 112.177 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.75 10.13 32.35 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.912 -0.661 . . . . 73.540000000000006 114.264 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -86.58 166.51 37.92 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.661 -0.78 . . . . 64.030000000000001 114.093 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.31 104.78 0.8 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.865 0.32 . . . . 72.439999999999998 111.865 178.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.679 ' N ' HG22 ' A' ' 130' ' ' THR . 51.1 m -73.51 83.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.718 0.77 . . . . 75.319999999999993 109.047 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 55.2 mt -68.31 -20.86 64.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.149 -0.932 . . . . 73.409999999999997 110.496 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 78' ' ' HIS . . . -158.53 106.22 1.9 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.185 -0.916 . . . . 75.439999999999998 109.475 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -60.12 142.3 54.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 63.039999999999999 110.846 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 20.5 p90 -67.46 140.28 57.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 70.040000000000006 111.798 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.33 145.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 71.310000000000002 109.67 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.619 ' HA3' HG21 ' A' ' 170' ' ' VAL . . . -54.68 -47.0 72.99 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.896 -0.669 . . . . 61.140000000000001 113.394 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -173.52 98.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.964 0.382 . . . . 53.119999999999997 111.955 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.653 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -57.12 -50.1 66.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.068 -1.063 . . . . 54.340000000000003 110.664 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 38.4 Cg_endo -65.63 140.21 61.4 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.22 2.613 . . . . 43.240000000000002 112.385 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 109' ' ' THR . 37.8 Cg_exo -57.27 147.24 77.87 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.095 2.53 . . . . 61.210000000000001 113.374 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -45.96 -34.38 3.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.154 0.502 . . . . 71.409999999999997 111.502 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -51.8 -20.2 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.689 -0.687 . . . . 53.0 111.901 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.978 HG21 ' CE1' ' A' ' 112' ' ' HIS . 10.9 t -69.14 -17.2 63.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 73.319999999999993 111.071 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.83 -142.37 34.73 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.902 -0.59 . . . . 65.549999999999997 113.82 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.21 117.59 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.393 . . . . 71.430000000000007 111.7 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.978 ' CE1' HG21 ' A' ' 109' ' ' THR . 48.5 m-70 -82.79 -176.11 6.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.83 0.824 . . . . 74.230000000000004 111.325 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.978 HH12 HD11 ' A' ' 115' ' ' ILE . 65.6 ttt-85 -147.52 112.04 5.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.113 -1.81 . . . . 71.120000000000005 106.113 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 60' ' ' MET . 0.4 OUTLIER -118.32 134.74 54.78 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.603 -0.439 . . . . 72.209999999999994 111.653 -176.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.978 HD11 HH12 ' A' ' 113' ' ' ARG . 36.8 mt -130.84 121.36 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.573 -0.739 . . . . 75.299999999999997 111.933 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.557 ' C ' HD22 ' A' ' 117' ' ' LEU . 36.4 m-85 -100.92 131.44 46.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.429 -0.805 . . . . 71.530000000000001 109.154 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 9' ' ' LEU . 2.7 mm? -116.49 143.87 45.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.26 -0.427 . . . . 72.530000000000001 110.447 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 44.3 tp -126.99 131.2 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 63.229999999999997 109.886 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 53.1 m-85 -132.61 143.95 50.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.227 0.536 . . . . 64.439999999999998 111.226 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 18.7 tpp180 -77.15 117.03 18.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.554 -0.748 . . . . 70.340000000000003 109.523 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 39.4 tp60 -91.85 122.77 34.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.038 0.447 . . . . 74.329999999999998 110.101 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -90.94 -49.8 6.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.455 -0.793 . . . . 74.140000000000001 112.403 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -108.71 146.16 33.93 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.241 0.46 . . . . 62.25 112.241 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.9 tptm -64.69 123.32 19.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.587 -0.733 . . . . 70.430000000000007 110.091 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.598 HD12 ' NE2' ' A' ' 151' ' ' HIS . 3.1 pt -111.06 129.03 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 110.707 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 128' ' ' THR . 83.8 tt0 -53.45 -46.99 70.09 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.353 -0.61 . . . . 53.229999999999997 109.353 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.622 ' CG ' HD11 ' A' ' 97' ' ' LEU . 2.2 tp10 53.92 15.15 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.139 -0.937 . . . . 63.549999999999997 113.112 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 58.7 p 51.16 169.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 111.924 0.342 . . . . 74.150000000000006 111.924 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 52.1 Cg_exo -58.83 148.72 82.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.095 1.864 . . . . 75.129999999999995 113.406 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.679 HG22 ' N ' ' A' ' 96' ' ' SER . 17.2 p -58.38 136.94 57.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.18 -0.918 . . . . 70.420000000000002 110.752 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 38.6 mm -92.79 129.5 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 113.337 0.865 . . . . 74.329999999999998 113.337 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.537 ' HB3' HG22 ' A' ' 134' ' ' THR . 58.1 m -86.85 133.49 33.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.19 -1.368 . . . . 73.439999999999998 109.302 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -53.45 -26.16 19.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.912 -0.315 . . . . 74.299999999999997 111.383 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 9.3 t -64.83 -2.47 2.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.945 0.402 . . . . 71.439999999999998 111.055 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 135' ' ' THR . 13.0 t -64.3 108.4 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.253 0.549 . . . . 74.239999999999995 109.789 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HA ' HG22 ' A' ' 177' ' ' ILE . 37.9 ttt85 -65.14 171.17 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.68 -0.691 . . . . 73.450000000000003 112.315 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ARG . 50.4 m -28.29 136.82 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.245 -0.889 . . . . 65.519999999999996 111.577 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.94 5.84 14.86 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.772 -0.649 . . . . 65.219999999999999 111.927 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 140' ' ' LEU . 17.4 mmm180 -152.0 35.76 0.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.782 0.325 . . . . 63.32 111.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 76' ' ' ILE . 3.3 mp -109.86 -62.53 1.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.375 -0.375 . . . . 75.299999999999997 110.773 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 9.2 m-20 -61.57 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.699 -0.682 . . . . 62.109999999999999 112.535 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.573 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 11.5 t80 -144.17 118.1 9.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.399 . . . . 74.450000000000003 111.346 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.602 HD22 HG13 ' A' ' 61' ' ' VAL . 9.1 t-20 -85.41 131.0 34.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 52.119999999999997 110.489 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.04 -37.49 87.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.738 0.644 . . . . 75.319999999999993 112.738 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -44.02 -31.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 64.120000000000005 110.933 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.8 OUTLIER -47.05 -41.01 16.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.044 0.45 . . . . 74.430000000000007 110.63 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 66.2 m-85 -56.79 -38.83 73.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 110.639 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -63.28 -28.14 69.82 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.72 -0.673 . . . . 41.329999999999998 110.174 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.63 2.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 62.32 111.226 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 0.9 OUTLIER -54.08 -44.35 71.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.823 0.344 . . . . 74.340000000000003 110.961 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.598 ' NE2' HD12 ' A' ' 125' ' ' ILE . 29.5 m-70 -85.74 4.76 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.476 -0.329 . . . . 64.439999999999998 110.7 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 56.08 26.11 48.33 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.019 -0.537 . . . . 63.539999999999999 113.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 148' ' ' ALA . 19.6 mt -64.47 -25.86 68.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.434 -0.58 . . . . 61.210000000000001 109.434 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.64 -89.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.06 -0.973 . . . . 41.240000000000002 113.963 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' LEU . 21.9 pt-20 -73.06 125.72 90.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.088 0.403 . . . . 71.439999999999998 112.088 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 119' ' ' TYR . 60.3 Cg_endo -76.22 124.78 8.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.692 1.595 . . . . 35.409999999999997 110.34 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 119' ' ' TYR . 47.5 pt -71.5 -33.8 50.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.115 -0.634 . . . . 73.150000000000006 110.551 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -147.15 149.77 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.946 -0.302 . . . . 43.439999999999998 111.564 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.38 152.34 38.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 111.122 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.28 145.27 19.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.48 -1.304 . . . . 70.299999999999997 107.48 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.482 ' H ' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -149.03 176.84 10.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.882 0.327 . . . . 70.299999999999997 111.882 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.548 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.3 p90 -168.84 164.82 11.83 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.067 -0.515 . . . . 74.239999999999995 111.343 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -126.36 124.81 41.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.489 -0.56 . . . . 74.109999999999999 109.489 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.62 152.85 25.91 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.16 0.429 . . . . 71.439999999999998 112.16 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -109.08 136.49 48.51 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 34.25 109.348 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -125.5 135.07 51.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.699 -0.482 . . . . 61.439999999999998 109.699 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.84 173.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.316 0.579 . . . . 71.420000000000002 112.293 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -72.75 51.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.167 -0.924 . . . . 71.5 110.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -91.69 -46.57 7.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 64.519999999999996 110.872 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' HA3' ' A' ' 102' ' ' GLY . 53.4 t -80.82 -46.89 1.21 Allowed Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 113.162 0.801 . . . . 65.209999999999994 113.162 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.4 Cg_exo -46.06 -43.35 20.46 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.918 1.745 . . . . 71.120000000000005 111.748 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.1 mm -51.14 -39.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 74.420000000000002 110.076 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -53.32 -26.42 18.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.614 -0.721 . . . . 70.219999999999999 110.796 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -52.31 -42.68 64.02 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.543 0.211 . . . . 72.200000000000003 111.295 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -15.5 62.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.064 0.459 . . . . 63.32 110.498 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.8 m -92.37 -28.14 17.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.58 -0.736 . . . . 64.030000000000001 110.812 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.582 HG23 ' C ' ' A' ' 134' ' ' THR . 52.1 mt -56.51 119.74 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.962 -0.563 . . . . 74.450000000000003 110.956 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.87 37.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.895 0.379 . . . . 54.100000000000001 111.531 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.978 -1.457 . . . . 40.310000000000002 111.34 -179.126 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 10' ' ' ASP . 18.3 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.648 -0.501 . . . . 53.539999999999999 109.648 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -158.53 46.23 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.072 0.463 . . . . 74.030000000000001 110.837 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 4' ' ' ILE . 9.9 t0 -51.15 -64.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.774 -0.648 . . . . 75.030000000000001 112.19 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.5 pt -131.63 49.14 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.502 0.667 . . . . 53.210000000000001 111.361 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.9 p -111.61 142.32 26.35 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 65.299999999999997 110.203 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 56.2 Cg_endo -95.62 33.44 9.86 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.363 -1.099 . . . . 72.329999999999998 112.83 0.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.55 -42.82 82.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.219999999999999 109.741 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' ' 4' ' ' ILE . 27.5 m -154.38 -47.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.724 -0.671 . . . . 73.409999999999997 112.364 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 117' ' ' LEU . 25.2 tp -158.51 154.88 27.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.316 0.488 . . . . 61.450000000000003 112.316 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 1' ' ' MET . 12.9 p-10 -74.63 -1.97 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.346 -0.613 . . . . 62.219999999999999 109.346 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -144.86 -158.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.155 -0.93 . . . . 61.119999999999997 109.827 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.3 p -144.62 113.91 5.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 111.437 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 45.1 Cg_endo -88.75 -138.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.448 . . . . 74.239999999999995 112.519 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -153.31 -37.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 61.140000000000001 111.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.38 161.67 24.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.177 -1.011 . . . . 53.409999999999997 113.274 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 t -104.46 157.05 17.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 110.947 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.8 mp -104.01 135.25 42.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.889 -0.596 . . . . 72.299999999999997 109.605 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.9 mmmt -73.57 118.19 16.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.53 -0.305 . . . . 64.140000000000001 110.232 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 84.1 t -128.18 109.18 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.278 -0.638 . . . . 64.439999999999998 109.278 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 26' ' ' GLU . 37.2 mt -99.64 142.07 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 74.209999999999994 112.452 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.516 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 1.6 m-85 -101.57 -94.3 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.716 -0.674 . . . . 74.019999999999996 111.123 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.72 -50.22 68.29 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.157 -1.02 . . . . 74.239999999999995 111.586 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.4 t70 171.36 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.999 -0.741 . . . . 62.140000000000001 108.999 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 71.209999999999994 108.789 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.06 141.37 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.617 -1.174 . . . . 63.350000000000001 111.476 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 20' ' ' ILE . 13.2 pt-20 -149.04 153.73 38.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.83 -1.077 . . . . 74.120000000000005 110.752 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.572 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 35.8 m -82.56 133.69 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 65.319999999999993 109.899 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 14.7 pttm -153.35 130.02 10.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.055 0.931 . . . . 73.209999999999994 113.182 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.487 ' HA ' ' CE1' ' A' ' 161' ' ' TYR . 7.1 mp0 32.55 63.89 0.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.859 -1.519 . . . . 74.530000000000001 114.759 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.3 10.83 63.41 Favored Glycine 0 N--CA 1.454 -0.13 0 N-CA-C 114.876 0.71 . . . . 73.409999999999997 114.876 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -61.0 146.39 47.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.874 0.837 . . . . 65.319999999999993 109.906 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -96.5 126.28 41.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.92 -0.4 . . . . 75.319999999999993 109.92 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -93.07 108.9 20.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.137 0.494 . . . . 71.120000000000005 109.791 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -150.22 155.49 37.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.39 -0.823 . . . . 62.149999999999999 110.648 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -93.86 136.09 6.55 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.286 -1.131 . . . . 71.329999999999998 112.64 0.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 36' ' ' THR . 17.9 m 56.38 33.65 22.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.237 0.541 . . . . 74.219999999999999 110.649 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.87 -1.9 54.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.682 -0.69 . . . . 73.329999999999998 110.83 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.4 m -92.13 -14.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 73.400000000000006 112.289 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -74.39 5.8 4.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 73.519999999999996 111.094 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 53.2 m-20 -96.81 146.15 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.256 0.55 . . . . 75.049999999999997 111.737 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.63 132.33 94.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.189 -0.914 . . . . 64.329999999999998 111.796 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 89.6 Cg_endo -81.61 125.14 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.947 1.765 . . . . 64.319999999999993 112.227 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.9 mm -109.27 106.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 109.921 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG23 ' CZ3' ' A' ' 79' ' ' TRP . 57.9 t -89.94 136.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.337 0.495 . . . . 44.229999999999997 112.337 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 75.3 m -159.66 116.23 2.56 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.77 -0.65 . . . . 74.329999999999998 110.089 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 89' ' ' GLU . 16.1 p90 -91.77 32.4 1.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 74.310000000000002 110.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 m -46.85 128.43 10.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.338 -0.846 . . . . 55.149999999999999 110.586 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.19 -33.16 4.83 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.708 -0.678 . . . . 54.310000000000002 112.406 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -80.29 -26.39 38.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.432 . . . . 73.209999999999994 110.479 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 23.1 tt0 -59.33 158.89 8.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.852 -0.613 . . . . 72.409999999999997 110.983 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.85 33.1 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.216 -1.154 . . . . 75.230000000000004 110.216 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -48.15 109.55 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 74.109999999999999 110.44 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 p -149.23 142.6 25.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.327 -0.851 . . . . 75.450000000000003 109.582 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 8.3 t-20 -64.77 -38.76 92.08 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.58 0.705 . . . . 64.099999999999994 109.45 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 83' ' ' ASN . 82.1 mt -156.86 154.58 30.05 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.642 -1.163 . . . . 72.299999999999997 111.179 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.0 mt -120.67 150.9 40.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.579 -0.526 . . . . 64.129999999999995 109.579 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.551 HG23 HG12 ' A' ' 82' ' ' VAL . 88.5 m -122.24 114.32 20.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.776 0.322 . . . . 52.32 110.665 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.1 tm? -103.68 134.19 47.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.154 -0.684 . . . . 74.340000000000003 109.154 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 93.8 mt -141.04 152.51 44.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.349 0.595 . . . . 71.400000000000006 111.851 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.7 ttt -127.2 110.29 12.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.201 -0.909 . . . . 71.230000000000004 108.607 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.728 HG23 HD23 ' A' ' 117' ' ' LEU . 5.1 t -94.32 -133.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.025 -0.27 . . . . 71.540000000000006 111.712 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.725 ' H ' HG12 ' A' ' 61' ' ' VAL . 2.2 m-20 51.84 73.04 1.03 Allowed Pre-proline 0 CA--C 1.518 -0.256 0 N-CA-C 112.341 0.497 . . . . 71.219999999999999 112.341 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.621 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . 32.0 Cg_endo -62.19 129.4 26.91 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.737 1.625 . . . . 75.140000000000001 110.008 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -159.46 92.49 1.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.769 1.026 . . . . 63.549999999999997 113.769 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 76' ' ' ILE . . . -172.88 134.39 0.7 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 112.481 0.549 . . . . 64.230000000000004 112.481 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 65.3 Cg_endo -85.64 3.18 65.38 Favored 'Cis proline' 0 C--N 1.347 0.468 0 C-N-CA 124.315 -1.119 . . . . 72.239999999999995 110.243 -2.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 t -164.81 134.04 3.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.332 -1.304 . . . . 61.049999999999997 109.636 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.549 ' HD3' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -55.14 -24.05 24.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.852 0.358 . . . . 75.209999999999994 110.726 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.549 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -62.43 -41.18 98.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 75.150000000000006 110.417 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -144.7 109.51 4.8 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.101 -0.5 . . . . 74.209999999999994 111.231 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.64 63.83 4.72 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.5 2.133 . . . . 73.430000000000007 111.518 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 39.6 ttmt -47.91 -27.82 2.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.199 -0.455 . . . . 63.409999999999997 111.113 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.669 ' HE1' ' HB1' ' A' ' 65' ' ' ALA . 2.9 p90 -152.78 45.36 0.69 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.734 0.642 . . . . 74.519999999999996 112.734 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.621 ' NE ' ' HB2' ' A' ' 63' ' ' PRO . 25.9 ttm180 -66.82 139.57 57.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.534 -0.913 . . . . 63.520000000000003 108.534 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -106.64 165.55 11.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.55 1.14 . . . . 75.120000000000005 110.23 -0.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.778 HG22 ' N ' ' A' ' 77' ' ' LEU . 38.0 mm -80.55 176.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.233 0.457 . . . . 72.109999999999999 112.233 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.797 ' CD2' HD23 ' A' ' 140' ' ' LEU . 2.9 mm? -71.44 55.99 0.24 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.705 -0.68 . . . . 71.120000000000005 110.07 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 76' ' ' ILE . 6.5 p-80 -53.92 169.91 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 71.239999999999995 111.956 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 12.3 t90 -99.86 112.52 24.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.744 -0.662 . . . . 71.030000000000001 110.457 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 p -141.44 136.56 31.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.689 -0.687 . . . . 51.450000000000003 110.442 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 84' ' ' ILE . 25.3 t -139.76 142.49 32.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.994 -0.548 . . . . 75.409999999999997 109.909 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.919 HG21 ' HG3' ' A' ' 127' ' ' GLU . 16.4 m -137.71 163.52 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.581 0.585 . . . . 72.319999999999993 112.581 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.763 ' ND2' HG23 ' A' ' 82' ' ' VAL . 45.8 m-20 71.87 32.89 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.63 -1.168 . . . . 31.449999999999999 111.243 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.55 HD13 ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -76.96 111.96 19.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.102 -0.639 . . . . 52.549999999999997 109.695 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' SER . 47.9 Cg_exo -54.56 134.24 60.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.813 1.675 . . . . 62.43 110.75 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.91 70.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.949 -0.643 . . . . 72.239999999999995 112.839 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' PRO . 23.2 t 176.46 47.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.88 -0.785 . . . . 65.430000000000007 108.88 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 27.9 m120 -135.66 -29.86 1.03 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.76 . . . . 55.020000000000003 112.146 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' ASN . 12.7 pt-20 50.06 20.55 0.61 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.515 0.674 . . . . 72.040000000000006 110.201 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -170.25 148.01 2.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.643 -1.162 . . . . 72.319999999999993 109.654 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.09 49.42 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.796 2.331 . . . . 65.530000000000001 112.741 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -92.51 -56.02 3.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 74.040000000000006 111.5 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.32 33.73 1.33 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.823 -0.626 . . . . 72.030000000000001 113.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.55 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -133.81 159.12 23.6 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.864 -0.684 . . . . 54.409999999999997 113.238 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 130' ' ' THR . 78.3 t60 -68.73 116.69 9.52 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.253 0.221 . . . . 74.239999999999995 111.418 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.489 ' O ' HG22 ' A' ' 130' ' ' THR . 14.8 m -76.94 106.31 8.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.441 -0.948 . . . . 62.140000000000001 108.441 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 127' ' ' GLU . 4.9 mt -61.93 -54.57 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.376 -0.972 . . . . 73.530000000000001 108.376 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 78' ' ' HIS . . . -127.84 121.16 29.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.244 -1.343 . . . . 61.350000000000001 107.536 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.6 t0 -52.75 152.07 4.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.219 -0.446 . . . . 55.219999999999999 111.872 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -59.49 127.2 30.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.688 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.1 148.95 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.521 0.677 . . . . 72.329999999999998 112.355 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.83 72.01 0.45 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.224 -1.15 . . . . 71.420000000000002 110.224 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.814 ' HA ' HG12 ' A' ' 170' ' ' VAL . 28.3 t -169.73 -89.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.68 -0.489 . . . . 62.310000000000002 109.68 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.75 33.6 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.993 -0.623 . . . . 43.100000000000001 114.329 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 35.2 Cg_endo -64.02 154.65 69.13 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.404 2.736 . . . . 73.430000000000007 114.061 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.492 ' HA ' ' HG3' ' A' ' 171' ' ' PRO . 5.6 Cg_exo -78.14 163.42 27.97 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.555 2.837 . . . . 74.409999999999997 112.89 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 166' ' ' TYR . 64.8 tttm -38.4 -26.13 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.076 -0.511 . . . . 60.329999999999998 111.511 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' PRO . 10.8 t70 -50.56 -41.52 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 74.430000000000007 111.898 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 105' ' ' PRO . 13.9 t -73.73 -14.28 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.983 0.735 . . . . 70.120000000000005 112.983 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.05 -144.9 41.52 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.054 -1.07 . . . . 55.329999999999998 112.13 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 163' ' ' GLN . 43.8 tp -67.46 130.87 44.43 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.405 -0.468 . . . . 72.549999999999997 111.016 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 6.5 p80 -130.48 126.31 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 73.439999999999998 110.307 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -88.22 125.39 34.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.672 -0.694 . . . . 73.030000000000001 110.588 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -116.59 140.41 49.42 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.446 0.466 . . . . 75.450000000000003 110.231 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 161' ' ' TYR . 39.1 mt -123.91 125.51 71.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.554 0.692 . . . . 73.209999999999994 111.971 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.703 ' C ' HD22 ' A' ' 117' ' ' LEU . 20.6 m-85 -88.56 136.34 33.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.138 -0.937 . . . . 74.530000000000001 109.681 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.728 HD23 HG23 ' A' ' 61' ' ' VAL . 3.0 mm? -124.34 137.52 54.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 71.400000000000006 111.033 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 119' ' ' TYR . 4.7 tt -127.05 135.29 50.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.385 -0.598 . . . . 61.240000000000002 109.385 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.833 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.5 m-85 -132.29 143.46 49.91 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.138 -0.483 . . . . 61.240000000000002 111.159 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -72.45 139.58 47.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 72.319999999999993 109.278 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HB3' ' C ' ' A' ' 55' ' ' LEU . 4.5 tt0 -123.91 127.31 47.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 112.653 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -104.2 -38.89 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.258 -0.883 . . . . 75.239999999999995 109.085 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -107.05 129.28 54.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.326 -0.852 . . . . 75.099999999999994 110.947 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -67.51 152.32 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.853 -0.612 . . . . 74.230000000000004 111.927 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.607 HD13 ' HD2' ' A' ' 151' ' ' HIS . 2.4 pt -136.0 147.71 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.891 -0.595 . . . . 71.420000000000002 111.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -49.97 12.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.414 -0.357 . . . . 73.209999999999994 111.399 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.919 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 61.24 33.34 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 63.5 112.02 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.7 p 53.32 156.57 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 112.851 0.686 . . . . 71.439999999999998 112.851 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.32 148.6 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.622 2.215 . . . . 72.420000000000002 113.188 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.983 HG23 ' CE1' ' A' ' 95' ' ' HIS . 2.7 p -59.86 116.12 3.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 64.109999999999999 112.611 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 131' ' ' ILE . 7.4 mm -81.75 120.99 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.046 -0.724 . . . . 72.109999999999999 109.046 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.5 m -75.39 149.07 38.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 70.239999999999995 112.15 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.585 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 34.2 t30 -55.5 -36.38 66.61 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 121.411 0.624 . . . . 74.329999999999998 109.538 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 177' ' ' ILE . 33.4 p -78.39 8.78 4.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.552 -0.749 . . . . 74.510000000000005 111.727 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.55 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 1.7 m -64.1 131.59 47.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.642 0.258 . . . . 75.230000000000004 110.729 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 26.1 ttt85 -76.3 169.98 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 75.209999999999994 113.212 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 140' ' ' LEU . 88.5 m -49.77 160.37 0.31 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.4 -1.273 . . . . 63.310000000000002 112.037 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.516 ' H ' HD11 ' A' ' 140' ' ' LEU . . . 96.04 -38.22 3.18 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.994 -1.003 . . . . 64.25 112.038 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 23.3 mmt180 -82.82 -37.75 24.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 73.420000000000002 111.462 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.35 -50.37 71.7 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.602 0.593 . . . . 72.209999999999994 112.602 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.485 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 60.1 m-20 -44.26 68.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.82 1.415 . . . . 72.329999999999998 114.82 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 140' ' ' LEU . 23.4 t80 -149.9 126.7 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.893 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -78.76 100.14 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 111.183 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -47.61 -33.81 7.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 111.728 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.7 ttp85 -47.66 -35.11 8.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.736 0.303 . . . . 74.439999999999998 110.874 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -51.9 -40.63 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.885 0.374 . . . . 75.409999999999997 110.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.606 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 28.9 m-85 -46.83 -43.13 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.483 . . . . 63.149999999999999 110.086 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.76 -38.16 86.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.706 -0.679 . . . . 74.310000000000002 110.941 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.98 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 74.129999999999995 111.367 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -53.79 -51.28 63.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.517 -0.311 . . . . 55.530000000000001 111.173 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.607 ' HD2' HD13 ' A' ' 125' ' ' ILE . 28.9 t-80 -78.42 -5.7 53.13 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.536 -0.542 . . . . 73.010000000000005 109.536 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.67 69.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.661 -0.78 . . . . 74.329999999999998 112.236 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.625 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . 14.7 mt -63.05 -25.31 68.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.169 -0.678 . . . . 61.450000000000003 109.169 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 31.62 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.788 -1.096 . . . . 74.530000000000001 113.888 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' LEU . 9.9 pt-20 -73.63 124.17 90.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.47 0.544 . . . . 54.229999999999997 112.47 -177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 73.2 Cg_endo -81.51 137.33 10.25 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.438 2.092 . . . . 62.530000000000001 111.692 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 118' ' ' LEU . 37.6 pt -83.27 -35.23 11.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.3 0.571 . . . . 75.200000000000003 110.712 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.497 ' CB ' HD11 ' A' ' 17' ' ' ILE . . . -142.74 150.67 40.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 55.399999999999999 111.059 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -152.09 158.91 43.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.461 . . . . 73.239999999999995 111.931 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -154.82 122.34 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.541 -0.911 . . . . 73.409999999999997 108.541 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.543 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -126.85 157.33 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 73.129999999999995 112.163 -177.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 4.1 p90 -162.53 163.04 27.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 62.509999999999998 110.767 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -110.7 136.79 49.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.181 0.515 . . . . 71.0 111.282 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.6 134.91 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.375 -0.83 . . . . 70.109999999999999 110.411 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -106.87 149.0 27.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.022 -0.362 . . . . 75.239999999999995 110.022 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.644 ' CG ' HG11 ' A' ' 170' ' ' VAL . 18.3 m-30 -128.46 125.28 38.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 64.219999999999999 110.998 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.14 -135.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.525 -0.761 . . . . 74.209999999999994 111.303 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 7.1 t70 -94.99 -43.44 8.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.903 -0.589 . . . . 74.540000000000006 110.989 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.529 ' HA ' HD12 ' A' ' 172' ' ' ILE . 28.9 t80 -51.95 -29.82 22.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 73.030000000000001 110.83 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 103' ' ' SER . 23.3 t -71.38 -58.16 4.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.955 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.521 ' HG2' ' O ' ' A' ' 168' ' ' ASP . 18.0 Cg_endo -57.55 -28.45 81.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.641 2.227 . . . . 64.010000000000005 112.727 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 169' ' ' TYR . 65.2 mt -45.53 -39.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.591 0.234 . . . . 70.030000000000001 111.193 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 48.0 ttm-85 -46.91 -36.44 7.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 71.219999999999999 110.632 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.402 ' HA ' HG13 ' A' ' 177' ' ' ILE . 35.0 m120 -54.62 -34.47 62.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.67 -0.695 . . . . 51.219999999999999 111.692 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -53.83 -40.46 66.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.937 0.399 . . . . 71.430000000000007 111.362 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.2 m -77.45 0.81 21.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.604 0.594 . . . . 74.120000000000005 112.604 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.3 mt -70.4 129.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 75.010000000000005 111.933 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 177' ' ' ILE . 4.7 m -165.34 88.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.695 -0.684 . . . . 71.310000000000002 110.816 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 135' ' ' THR . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.779 -1.012 . . . . 71.230000000000004 112.086 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.135 -0.691 . . . . 74.340000000000003 109.135 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG12 ' A' ' 5' ' ' VAL . 6.0 p-10 37.41 50.3 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.927 0.394 . . . . 73.400000000000006 111.776 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 8.8 t70 -51.77 -54.8 24.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 70.340000000000003 110.695 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.1 pt -148.48 60.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.514 0.673 . . . . 63.350000000000001 109.959 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 2' ' ' ASP . 8.3 p -127.71 138.25 32.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 73.430000000000007 110.159 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 82.6 Cg_endo -85.0 34.02 3.92 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.974 -1.261 . . . . 74.109999999999999 112.858 0.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 59.6 t0 -59.4 -54.0 51.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.415 -0.357 . . . . 73.239999999999995 110.973 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.0 m -164.24 -32.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.03 -0.532 . . . . 75.530000000000001 111.986 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD23 ' HD3' ' A' ' 13' ' ' PRO . 35.3 tp -157.03 144.56 18.94 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.332 0.587 . . . . 71.450000000000003 112.028 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.37 -19.1 63.84 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.974 0.731 . . . . 64.439999999999998 112.974 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.599 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -161.22 135.46 7.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.523 0.194 . . . . 51.520000000000003 111.523 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -72.24 116.12 45.72 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.708 0.29 . . . . 74.239999999999995 111.521 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.3 Cg_endo -95.72 -125.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.687 2.925 . . . . 63.530000000000001 112.151 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.35 -42.05 0.06 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.456 -0.338 . . . . 65.430000000000007 110.923 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.11 173.48 14.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.641 -0.79 . . . . 54.140000000000001 112.733 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.8 t -121.59 161.69 21.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.435 0.636 . . . . 42.109999999999999 111.519 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 118' ' ' LEU . 8.1 mt -105.44 154.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.683 -1.144 . . . . 63.329999999999998 109.25 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.1 mmpt? -102.9 102.33 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.926 -0.579 . . . . 74.5 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.788 ' HB ' HG22 ' A' ' 27' ' ' VAL . 54.8 t -109.66 109.69 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.098 -0.704 . . . . 73.450000000000003 109.098 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 20' ' ' ILE . 2.5 mp -90.14 144.37 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.209 0.528 . . . . 71.239999999999995 111.082 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.75 -94.39 0.34 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.266 -0.879 . . . . 71.129999999999995 112.524 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.64 -43.52 99.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.068 -0.587 . . . . 60.210000000000001 113.522 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 20' ' ' ILE . 2.4 m-20 179.14 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.923 0.868 . . . . 70.530000000000001 109.811 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -98.52 -40.88 8.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.465 -1.243 . . . . 75.230000000000004 111.411 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.915 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.6 pt? -69.41 141.05 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 111.127 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 6.0 pm0 -139.28 148.75 43.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 75.109999999999999 110.101 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' A' ' 19' ' ' VAL . 9.3 m -62.46 147.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.279 -0.418 . . . . 72.239999999999995 111.842 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 70.0 mttt -140.93 103.44 4.48 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.953 0.723 . . . . 74.329999999999998 112.953 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.503 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.4 mp0 35.63 67.72 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.691 0.997 . . . . 72.120000000000005 113.691 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.95 -10.42 57.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.222 -0.513 . . . . 62.310000000000002 113.629 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 t-20 -47.0 129.67 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 63.340000000000003 110.985 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 163' ' ' GLN . 62.6 tt0 -102.79 132.63 48.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.46 -0.791 . . . . 71.030000000000001 111.246 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -100.86 135.49 42.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.087 0.47 . . . . 72.120000000000005 110.948 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.547 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 7.8 p -138.64 164.79 37.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.455 -0.793 . . . . 74.439999999999998 109.974 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 84.9 Cg_endo -81.85 -29.31 5.97 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.303 -1.124 . . . . 64.120000000000005 113.155 0.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.2 t -161.45 35.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.154 0.502 . . . . 71.219999999999999 111.315 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -84.42 0.27 50.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.310000000000002 110.025 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 33' ' ' LEU . 33.4 m -83.91 -3.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.736 -1.12 . . . . 74.129999999999995 112.646 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -65.88 6.19 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.856 0.317 . . . . 75.409999999999997 111.856 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -96.89 145.84 25.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.39 0.614 . . . . 71.140000000000001 111.749 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.686 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.4 pm0 -62.75 130.83 94.07 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 54.420000000000002 109.318 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 15.3 Cg_exo -69.0 126.09 13.36 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.721 1.614 . . . . 34.329999999999998 112.664 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -100.13 105.27 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.752 -0.462 . . . . 70.299999999999997 109.752 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 91' ' ' PRO . 6.0 p -82.41 140.81 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.525 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 33.1 m -164.98 121.91 1.52 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.672 0.272 . . . . 64.219999999999999 111.679 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 6.1 p90 -84.87 29.38 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.127 -0.694 . . . . 75.439999999999998 109.127 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' SER . 11.1 t -46.29 123.14 4.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.2 -0.909 . . . . 70.310000000000002 110.738 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.95 -24.83 30.64 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.481 -0.648 . . . . 52.020000000000003 111.481 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 16' ' ' THR . 6.6 mp -87.68 -37.17 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.608 0.242 . . . . 74.209999999999994 110.75 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -50.27 138.39 16.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.802 -0.359 . . . . 71.099999999999994 110.761 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.13 -71.78 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.831 -0.699 . . . . 60.200000000000003 111.909 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -148.73 108.94 4.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 72.140000000000001 110.366 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 p -158.1 141.53 15.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.194 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -73.16 -38.9 66.03 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.584 0.707 . . . . 74.430000000000007 109.513 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 26.2 mt -155.8 162.4 40.49 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.867 -1.061 . . . . 43.399999999999999 109.961 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD12 ' CZ2' ' A' ' 46' ' ' TRP . 80.6 mt -128.27 168.04 16.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.778 0.323 . . . . 73.219999999999999 110.42 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.879 HG23 HG12 ' A' ' 82' ' ' VAL . 99.1 m -143.47 133.11 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.426 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -127.77 138.62 52.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.957 -0.565 . . . . 75.109999999999999 110.032 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 58' ' ' LEU . 52.3 mt -149.04 131.66 15.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.775 0.657 . . . . 72.439999999999998 112.775 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 114' ' ' TYR . 37.8 ttm -94.84 122.18 37.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.139 -0.937 . . . . 74.409999999999997 108.797 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 62' ' ' ASP . 4.9 t -109.13 -131.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.712 0.264 . . . . 72.299999999999997 111.712 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.637 ' H ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.84 80.94 0.27 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 121.278 0.561 . . . . 74.439999999999998 111.162 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.9 84.49 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.297 1.998 . . . . 51.409999999999997 112.405 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -126.23 87.57 2.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 70.409999999999997 110.564 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.6 135.14 1.09 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 72.019999999999996 110.858 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 15.4 Cg_exo -67.67 -18.37 9.21 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.752 -1.353 . . . . 64.150000000000006 109.501 -1.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.9 t -157.25 131.7 8.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.781 -1.554 . . . . 74.340000000000003 107.934 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 4.3 tmm_? -50.97 -31.92 19.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.454 0.645 . . . . 74.329999999999998 109.832 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.41 -37.97 89.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.192 -0.913 . . . . 61.329999999999998 111.766 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.727 ' H ' HG23 ' A' ' 67' ' ' THR . 2.0 m-20 -141.21 72.16 27.04 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-O 121.195 0.521 . . . . 75.510000000000005 109.744 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 13.8 Cg_exo -67.04 65.48 0.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.105 2.537 . . . . 63.020000000000003 112.692 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -48.69 -45.88 39.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.587 -0.733 . . . . 75.219999999999999 112.346 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.458 ' HE1' ' HB1' ' A' ' 65' ' ' ALA . 0.1 OUTLIER -123.04 44.98 2.52 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.087 0.403 . . . . 71.010000000000005 112.087 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -70.69 133.0 46.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 64.549999999999997 110.896 179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 144' ' ' ALA . 86.9 mt-10 -91.32 178.47 5.96 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.478 0.711 . . . . 74.239999999999995 110.465 -0.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.715 HG21 ' HA3' ' A' ' 104' ' ' GLY . 7.3 tp -113.85 176.35 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.789 -0.641 . . . . 73.230000000000004 109.591 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.626 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.8 mm? -49.0 117.56 2.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.58 -0.526 . . . . 72.519999999999996 109.58 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.7 173.64 10.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.739 -0.664 . . . . 75.299999999999997 110.296 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.566 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.5 t-105 -99.51 113.1 25.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 74.239999999999995 111.007 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 14.4 m -131.85 128.22 38.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.594 -0.73 . . . . 74.530000000000001 109.848 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.49 143.06 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.233 0.54 . . . . 73.430000000000007 110.225 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.879 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.52 161.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.771 -0.649 . . . . 70.219999999999999 112.29 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 95' ' ' HIS . 23.4 p30 55.57 43.06 28.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.677 -1.147 . . . . 61.009999999999998 112.522 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.019 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.0 mm -83.01 130.65 56.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.926 -0.768 . . . . 65.510000000000005 108.926 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.04 128.88 30.51 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 121.454 1.436 . . . . 65.540000000000006 111.111 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.85 57.74 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.642 0.617 . . . . 74.219999999999999 114.642 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.5 p -178.69 36.91 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.579 0.689 . . . . 44.530000000000001 111.378 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 90' ' ' ASN . 30.5 m120 -121.3 -2.0 9.62 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.49 -0.323 . . . . 64.040000000000006 110.93 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 70.05 -38.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 51.399999999999999 111.387 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 88' ' ' ASN . 13.6 p30 -129.32 155.63 79.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.967 0.413 . . . . 74.109999999999999 110.391 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 84' ' ' ILE . 92.6 Cg_endo -71.59 55.52 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.226 2.617 . . . . 54.329999999999998 113.289 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.7 t -97.16 -54.97 3.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.342 0.497 . . . . 72.540000000000006 112.342 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.59 -10.75 25.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 115.21 0.844 . . . . 63.109999999999999 115.21 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 1.019 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -96.51 173.11 29.49 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.268 -0.968 . . . . 71.519999999999996 113.647 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.498 ' HB2' HD21 ' A' ' 83' ' ' ASN . 5.9 m80 -68.35 128.82 37.96 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.618 0.599 . . . . 72.510000000000005 112.618 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.971 ' H ' HG22 ' A' ' 130' ' ' THR . 86.1 p -96.5 97.25 9.27 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.379 -0.373 . . . . 74.430000000000007 110.288 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 147' ' ' PHE . 79.4 mt -56.94 -40.04 75.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 64.049999999999997 109.787 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.87 120.69 8.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.563 -1.199 . . . . 73.530000000000001 109.1 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.649 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 47.8 t0 -59.96 148.46 35.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 64.329999999999998 112.676 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 17.3 p90 -70.29 152.7 43.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.719 -0.673 . . . . 71.140000000000001 110.682 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.42 166.51 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 60.310000000000002 111.244 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.91 3.38 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.855 -0.611 . . . . 42.32 112.839 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.3 p -162.94 105.63 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 71.409999999999997 110.454 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.715 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -53.05 -47.38 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.533 -0.758 . . . . 64.230000000000004 113.044 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HB2' HG21 ' A' ' 109' ' ' THR . 74.9 Cg_endo -78.26 129.01 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.418 2.079 . . . . 63.450000000000003 112.217 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.58 158.87 53.57 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.731 2.287 . . . . 73.310000000000002 113.566 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 5.0 pttp -39.89 -27.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.119 -0.946 . . . . 64.140000000000001 112.158 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -50.38 -34.12 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.126 -0.488 . . . . 75.349999999999994 111.627 -178.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 105' ' ' PRO . 6.8 t -93.62 4.7 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.566 -0.454 . . . . 52.5 111.433 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.17 -98.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.206 -0.452 . . . . 71.25 112.865 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 163' ' ' GLN . 53.3 tp -61.0 145.23 51.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.575 0.703 . . . . 64.420000000000002 111.416 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 166' ' ' TYR . 17.3 m-70 -139.75 114.02 9.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.191 -1.04 . . . . 73.439999999999998 108.191 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.568 ' HG3' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -100.3 123.87 45.06 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.283 -0.636 . . . . 72.310000000000002 109.283 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.402 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 35.6 m-85 -119.64 138.46 53.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.967 0.413 . . . . 73.409999999999997 110.353 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 58.7 mt -122.66 122.3 65.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.311 -0.859 . . . . 74.439999999999998 111.923 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -98.9 137.28 37.69 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.748 -0.66 . . . . 73.129999999999995 109.86 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.1 tm? -123.97 138.28 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.552 -0.536 . . . . 74.450000000000003 109.552 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.834 ' N ' HD13 ' A' ' 117' ' ' LEU . 65.3 tp -120.66 141.54 50.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 122.578 0.351 . . . . 62.539999999999999 110.744 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.584 ' CD2' HD22 ' A' ' 153' ' ' LEU . 37.7 t80 -142.44 136.73 29.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.868 -0.606 . . . . 74.299999999999997 111.047 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' A' ' 122' ' ' GLU . 4.9 tmm_? -79.51 121.25 24.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.785 -0.45 . . . . 74.109999999999999 109.785 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.628 HE22 HG12 ' A' ' 125' ' ' ILE . 1.9 tt0 -98.93 130.85 45.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.014 0.435 . . . . 74.310000000000002 110.871 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.41 ' HB2' ' NH1' ' A' ' 120' ' ' ARG . 65.1 tt0 -99.07 -41.28 7.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.834 -0.621 . . . . 54.450000000000003 110.202 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -111.92 130.6 55.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 75.530000000000001 110.949 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.23 146.84 52.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 65.540000000000006 112.085 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.628 HG12 HE22 ' A' ' 121' ' ' GLN . 22.3 pt -126.68 140.24 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.957 -0.565 . . . . 62.32 110.783 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.1 -44.17 60.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.087 0.47 . . . . 75.310000000000002 111.66 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.767 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 29.7 38.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.154 1.168 . . . . 53.539999999999999 114.154 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 p 56.91 158.34 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.803 0.668 . . . . 74.409999999999997 112.803 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.2 158.26 9.79 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.73 2.286 . . . . 70.540000000000006 113.11 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.971 HG22 ' H ' ' A' ' 96' ' ' SER . 41.2 p -58.89 131.19 50.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.318 -0.855 . . . . 65.510000000000005 111.963 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 139' ' ' ARG . 40.9 mm -103.56 124.96 58.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.522 0.201 . . . . 62.530000000000001 110.491 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 99' ' ' ASP . 47.8 t -80.2 154.99 27.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.268 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.649 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.1 p30 -52.69 -35.14 54.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 53.240000000000002 110.137 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 176' ' ' THR . 12.2 t -68.56 11.49 0.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.231 -0.895 . . . . 74.530000000000001 112.503 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' ILE . 15.0 t -62.02 132.39 52.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.79 0.329 . . . . 72.209999999999994 110.681 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' HG3' ' N ' ' A' ' 137' ' ' THR . 44.1 tpt85 -58.03 159.56 5.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 111.71 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.487 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 27.8 m -51.57 146.95 6.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 75.150000000000006 110.119 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.34 4.73 17.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 73.049999999999997 111.758 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HD2' HG21 ' A' ' 131' ' ' ILE . 45.9 ttm-85 -144.05 37.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 110.776 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' ASN . 0.3 OUTLIER -114.92 -56.97 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 75.230000000000004 110.605 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.568 ' H ' ' HG ' ' A' ' 140' ' ' LEU . 16.6 m-20 -62.24 67.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.07 -0.513 . . . . 72.420000000000002 111.986 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 146' ' ' ASP . 44.4 t80 -140.4 131.35 26.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.017 0.437 . . . . 75.530000000000001 111.061 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -71.05 108.02 4.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 74.530000000000001 109.458 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.466 ' H ' ' CD ' ' A' ' 75' ' ' GLU . . . -52.27 -40.28 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.303 0.573 . . . . 61.119999999999997 111.464 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.587 HH12 ' HG ' ' A' ' 117' ' ' LEU . 1.6 tpt180 -57.4 -28.68 63.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.438 -0.801 . . . . 74.219999999999999 111.996 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 6.0 t70 -48.72 -47.48 41.22 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.882 -0.784 . . . . 64.120000000000005 108.882 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 97' ' ' LEU . 12.2 m-30 -59.14 -40.05 84.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.151 -0.931 . . . . 73.230000000000004 109.852 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.646 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.762 -0.654 . . . . 71.120000000000005 111.15 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.74 24.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.063 -0.517 . . . . 71.409999999999997 111.887 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.605 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -68.7 -44.23 74.38 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.841 0.682 . . . . 71.340000000000003 112.841 -178.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 4.9 m-70 -72.69 7.77 1.78 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 110.734 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.24 2.78 63.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.117 -0.563 . . . . 62.530000000000001 112.332 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 148' ' ' ALA . 3.2 mt -68.71 16.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.543 0.211 . . . . 43.310000000000002 110.589 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.21 -66.24 1.25 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.874 -0.679 . . . . 54.450000000000003 112.189 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.52 122.18 84.63 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.036 -0.357 . . . . 73.409999999999997 110.036 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.773 ' HB3' HD21 ' A' ' 117' ' ' LEU . 89.0 Cg_endo -87.72 127.94 2.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.513 2.142 . . . . 72.430000000000007 113.014 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.547 HD11 ' HG ' ' A' ' 118' ' ' LEU . 43.3 pt -77.04 -34.14 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.127 0.489 . . . . 71.219999999999999 110.209 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.67 157.86 37.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 74.450000000000003 110.851 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.449 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -154.16 171.34 19.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.008 0.433 . . . . 64.310000000000002 111.156 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.8 t-20 -170.58 133.57 1.02 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.079 -1.082 . . . . 71.409999999999997 108.079 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.534 ' CE1' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -135.4 158.41 44.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.76 -0.2 . . . . 64.010000000000005 111.466 -177.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.661 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.9 p90 -146.6 156.83 43.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.974 -0.557 . . . . 62.409999999999997 112.338 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.568 ' HG2' ' HG3' ' A' ' 113' ' ' ARG . 14.2 mt-30 -119.09 124.68 47.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.128 -0.942 . . . . 75.329999999999998 109.759 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 166' ' ' TYR . . . -156.68 138.43 14.22 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.635 -0.426 . . . . 64.239999999999995 111.498 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.446 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 6.5 pm0 -100.17 135.52 41.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.27 -0.641 . . . . 60.210000000000001 109.27 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.866 ' HB3' HG11 ' A' ' 170' ' ' VAL . 6.2 m-85 -121.21 142.64 49.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.341 -0.391 . . . . 74.239999999999995 111.814 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.4 m-20 -66.24 -168.21 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.191 -0.913 . . . . 60.43 113.022 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t70 -85.9 -32.77 21.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.986 -1.006 . . . . 74.450000000000003 111.57 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.499 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.6 t80 -61.14 -32.58 72.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.521 0.563 . . . . 74.030000000000001 112.521 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.992 HG13 ' HD3' ' A' ' 171' ' ' PRO . 1.5 p -72.29 -48.79 9.79 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.761 1.023 . . . . 72.349999999999994 113.761 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.992 ' HD3' HG13 ' A' ' 170' ' ' VAL . 20.0 Cg_endo -59.25 -17.22 38.22 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.777 1.651 . . . . 74.439999999999998 112.519 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.542 HD11 ' HD2' ' A' ' 175' ' ' LYS . 10.9 tp -46.15 -30.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.012 0.434 . . . . 72.129999999999995 111.156 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 173' ' ' ARG . 10.6 tpp85 -44.79 -25.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 71.25 110.588 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.3 p30 -50.5 -36.22 32.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.957 -0.565 . . . . 65.109999999999999 111.339 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.542 ' HD2' HD11 ' A' ' 172' ' ' ILE . 8.4 mtpm? -56.7 -22.19 33.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.368 . . . . 73.129999999999995 111.128 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.473 HG22 ' OG1' ' A' ' 134' ' ' THR . 16.6 m -74.96 -7.89 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.802 -0.635 . . . . 74.540000000000006 111.457 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' THR . 44.2 mm -68.52 79.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 74.209999999999994 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.419 ' HA ' ' CD ' ' A' ' 136' ' ' ARG . 28.6 m -139.33 13.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.41 0.522 . . . . 51.149999999999999 112.41 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-O 118.125 -1.375 . . . . 71.239999999999995 112.932 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.392 -0.225 . . . . 64.409999999999997 110.392 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' OD2' ' NH2' ' A' ' 145' ' ' ARG . 6.4 m-20 -68.87 112.61 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 55.439999999999998 110.526 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.18 -71.12 0.77 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.598 0.592 . . . . 61.399999999999999 112.598 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.578 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 6.9 pt -99.39 65.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 72.230000000000004 112.266 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 6' ' ' PRO . 8.8 p -141.61 143.53 29.8 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.07 -0.514 . . . . 73.230000000000004 110.659 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 5' ' ' VAL . 8.0 Cg_exo -73.57 17.81 2.65 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 124.905 -0.873 . . . . 62.32 112.626 0.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.578 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 2.3 m-20 -45.8 -59.23 2.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.851 . . . . 72.400000000000006 111.941 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.0 m -161.79 -40.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 40.450000000000003 111.54 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 161' ' ' TYR . 47.0 tp -151.24 135.26 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.36 0.6 . . . . 73.140000000000001 111.951 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -75.48 37.46 0.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 73.340000000000003 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 179.03 -148.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.608 -0.724 . . . . 61.420000000000002 109.856 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.5 p -152.33 119.2 3.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.55 0.215 . . . . 60.109999999999999 110.85 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.586 ' HD3' HD23 ' A' ' 9' ' ' LEU . 49.9 Cg_endo -97.13 135.91 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.077 2.518 . . . . 65.329999999999998 112.77 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -24.89 67.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 74.450000000000003 110.334 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.54 -129.64 1.75 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.414 -0.812 . . . . 71.109999999999999 111.487 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -164.32 159.58 20.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.513 . . . . 75.430000000000007 109.614 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.24 135.0 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.218 -0.446 . . . . 65.310000000000002 110.963 -179.06 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -77.69 102.3 7.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.386 -0.598 . . . . 73.219999999999999 109.386 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 97.6 t -107.97 110.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.402 0.62 . . . . 62.109999999999999 109.735 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' LEU . 61.3 mt -101.5 124.49 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 71.209999999999994 110.264 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 1.3 m-85 -73.98 -40.01 63.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.333 -0.849 . . . . 74.329999999999998 112.112 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -126.38 -55.14 0.15 Allowed Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.179 -1.01 . . . . 75.530000000000001 112.754 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -179.69 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 72.530000000000001 108.328 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -93.08 -45.13 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.725 -1.125 . . . . 70.420000000000002 109.214 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.3 pt? -69.22 138.5 54.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.768 -0.651 . . . . 71.510000000000005 109.375 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' CD ' ' NZ ' ' A' ' 28' ' ' LYS . 53.4 tt0 -143.74 139.05 29.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.072 -0.967 . . . . 65.420000000000002 111.001 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 16.0 m -86.57 106.81 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.22 0.533 . . . . 61.009999999999998 110.645 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' CD ' ' A' ' 26' ' ' GLU . 27.1 mttp -98.44 119.84 37.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.064 0.935 . . . . 75.310000000000002 112.949 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.6 mp0 30.28 67.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.566 -1.652 . . . . 72.129999999999995 115.049 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.42 8.81 76.56 Favored Glycine 0 C--N 1.329 0.184 0 N-CA-C 115.528 0.971 . . . . 74.510000000000005 115.528 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.76 149.92 21.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.864 0.832 . . . . 74.109999999999999 110.742 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -91.25 133.4 35.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 72.540000000000006 109.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 10.3 mp -106.0 126.34 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 61.539999999999999 110.648 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 17.0 p -143.79 160.88 48.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.467 -0.788 . . . . 63.509999999999998 109.937 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.1 Cg_exo -75.98 -40.03 1.28 Allowed 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.522 -1.032 . . . . 72.030000000000001 112.908 0.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.7 p -151.98 28.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 64.239999999999995 111.591 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 1.8 pt20 -60.0 -10.4 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.521 0.677 . . . . 62.340000000000003 109.999 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 164' ' ' ALA . 34.5 m -82.97 25.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.962 -1.017 . . . . 75.140000000000001 110.858 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -75.99 -21.19 57.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.285 -0.871 . . . . 74.209999999999994 111.085 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -107.76 152.52 24.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.155 0.503 . . . . 72.329999999999998 111.481 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -63.98 146.39 97.3 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.449 -0.796 . . . . 64.209999999999994 111.793 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.614 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 94.7 Cg_endo -79.13 129.24 8.7 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.695 2.264 . . . . 71.310000000000002 112.805 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.3 mm -104.19 117.65 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.509 -0.182 . . . . 62.539999999999999 110.509 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.9 t -86.55 142.5 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 71.219999999999999 111.788 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -156.38 145.02 20.06 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.125 0.488 . . . . 72.450000000000003 110.668 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 3.3 p90 -126.32 35.34 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.187 0.518 . . . . 74.439999999999998 110.904 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -47.7 125.57 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 72.209999999999994 110.529 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -28.56 8.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 62.420000000000002 112.931 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -79.23 -42.18 26.55 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 109.228 -0.656 . . . . 75.219999999999999 109.228 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.707 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 31.6 tt0 -59.32 167.25 1.91 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.571 -0.74 . . . . 73.430000000000007 110.171 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . -177.48 -71.33 0.06 OUTLIER Glycine 0 C--O 1.229 -0.202 0 C-N-CA 120.708 -0.758 . . . . 64.109999999999999 112.14 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -148.86 109.74 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.124 0.488 . . . . 65.0 110.721 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 37.6 m -157.09 141.95 16.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 44.439999999999998 109.57 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.01 -38.08 85.33 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.643 0.735 . . . . 74.25 109.482 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 83' ' ' ASN . 64.6 mt -155.47 175.99 13.17 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.494 -1.23 . . . . 64.120000000000005 110.519 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 22.1 mt -146.71 158.91 44.01 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.222 -0.445 . . . . 72.439999999999998 109.944 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.675 HG23 HG12 ' A' ' 82' ' ' VAL . 3.2 m -123.21 127.79 49.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.226 -0.443 . . . . 54.450000000000003 111.119 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -123.84 117.58 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.454 -1.314 . . . . 74.319999999999993 107.454 178.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 80' ' ' SER . 86.0 mt -132.77 139.96 47.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.464 0.542 . . . . 34.32 112.464 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 78' ' ' HIS . 46.5 ttm -94.74 134.37 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.639 -0.875 . . . . 74.439999999999998 108.639 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.39 136.0 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.308 -0.406 . . . . 54.539999999999999 111.022 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 5.2 t70 164.53 94.43 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 115.414 -0.812 . . . . 72.040000000000006 110.281 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.56 84.02 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.583 1.522 . . . . 72.150000000000006 110.833 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 84.49 1.64 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.766 0.654 . . . . 73.329999999999998 112.766 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.3 133.71 1.07 Allowed Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.45 -0.5 . . . . 54.030000000000001 112.28 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.696 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 Cg_exo -57.63 -23.34 1.82 Allowed 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 122.997 -1.668 . . . . 71.340000000000003 108.893 -3.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -161.93 143.57 11.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 113.889 -1.505 . . . . 74.439999999999998 108.706 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 53.1 ttp180 -53.69 -17.59 2.38 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.226 0.536 . . . . 73.530000000000001 111.185 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -72.49 -32.44 66.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.397 -0.82 . . . . 72.239999999999995 111.445 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.2 t0 -143.83 63.33 11.8 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 108.82 -0.807 . . . . 65.530000000000001 108.82 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 53.8 Cg_endo -72.3 51.74 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.23 2.62 . . . . 74.439999999999998 112.857 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -51.35 -44.11 61.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.391 -0.368 . . . . 63.020000000000003 111.945 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE1' HD13 ' A' ' 76' ' ' ILE . 15.6 p90 -108.22 34.76 3.44 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.523 -0.471 . . . . 71.430000000000007 111.629 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.518 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 35.8 ttp85 -76.44 144.49 39.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.814 -0.439 . . . . 72.340000000000003 109.814 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 29.8 mp0 -92.28 142.69 27.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.759 0.823 . . . . 63.539999999999999 110.602 0.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' CE1' ' A' ' 73' ' ' TYR . 5.6 tp -72.47 174.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.771 -0.372 . . . . 72.349999999999994 110.241 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' HB2' HG11 ' A' ' 101' ' ' VAL . 3.2 mm? -52.15 133.46 33.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.428 0.633 . . . . 64.340000000000003 111.33 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.469 ' HA ' ' SD ' ' A' ' 60' ' ' MET . 2.0 p-80 -129.64 157.05 43.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.861 -1.063 . . . . 73.329999999999998 109.458 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -99.35 117.67 34.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 54.329999999999998 109.923 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.698 ' HB3' HD12 ' A' ' 97' ' ' LEU . 74.3 m -141.38 138.02 32.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.443 0.639 . . . . 64.430000000000007 111.7 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.521 HG12 ' CD1' ' A' ' 84' ' ' ILE . 11.9 t -143.52 123.21 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 114.666 -1.152 . . . . 63.509999999999998 108.666 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 97' ' ' LEU . 18.7 m -123.71 -177.4 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.066 -0.515 . . . . 74.319999999999993 110.367 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.788 ' OD1' HG23 ' A' ' 82' ' ' VAL . 7.1 m120 62.82 30.2 16.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 109.951 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.977 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -77.86 108.99 8.45 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.184 -0.606 . . . . 65.420000000000002 109.673 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 87' ' ' SER . 19.2 Cg_endo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.43 1.42 . . . . 74.040000000000006 110.69 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.05 71.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.433 -0.413 . . . . 62.420000000000002 113.655 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' PRO . 32.3 m -175.16 43.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.297 0.639 . . . . 71.329999999999998 110.179 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 19.0 m120 -135.78 -26.59 1.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.412 0.893 . . . . 74.120000000000005 113.412 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 9.0 tt0 77.57 -16.42 0.65 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.314 0.578 . . . . 74.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 88' ' ' ASN . 19.9 p30 -150.96 154.43 34.3 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.142 -0.935 . . . . 70.129999999999995 110.386 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 45.67 1.75 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.374 2.716 . . . . 71.140000000000001 112.994 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -103.97 -1.96 26.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 61.32 111.829 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.2 -14.89 13.58 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.751 -0.738 . . . . 71.340000000000003 114.338 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.977 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -87.97 177.24 46.19 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.572 -0.823 . . . . 71.239999999999995 113.637 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -68.23 114.29 6.58 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.812 0.301 . . . . 60.329999999999998 111.812 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.513 ' O ' HG22 ' A' ' 130' ' ' THR . 30.7 m -70.84 96.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.947 -0.76 . . . . 71.420000000000002 108.947 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.82 HD21 HG22 ' A' ' 82' ' ' VAL . 24.6 mt -60.51 -59.52 5.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 75.409999999999997 110.503 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.61 125.17 35.52 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.25 -0.886 . . . . 51.119999999999997 109.223 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -59.96 156.15 15.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.596 0.712 . . . . 74.150000000000006 112.614 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 3.3 t80 -68.59 141.99 55.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.822 -1.081 . . . . 74.150000000000006 112.138 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 77' ' ' LEU . 7.4 p -142.87 113.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 72.439999999999998 109.866 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.39 -64.62 1.31 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.891 -0.671 . . . . 74.510000000000005 112.981 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.3 p 178.85 98.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 72.400000000000006 110.487 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.614 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -72.83 -35.62 58.33 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.066 -0.587 . . . . 73.510000000000005 113.573 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 38.6 Cg_exo -62.27 143.14 93.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.149 2.566 . . . . 51.32 113.294 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.48 144.85 99.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.223 2.616 . . . . 74.5 113.165 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -48.92 -22.36 0.83 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.455 -0.793 . . . . 64.319999999999993 111.642 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.3 m-20 -50.82 -29.93 12.98 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.57 0.581 . . . . 74.329999999999998 112.57 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 112' ' ' HIS . 12.9 t -70.62 -15.22 62.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.326 0.584 . . . . 71.25 110.418 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.68 -138.01 24.26 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 113.105 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.7 tp -65.27 118.95 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.413 -0.394 . . . . 60.310000000000002 111.991 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 109' ' ' THR . 94.3 m-70 -79.93 148.07 31.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -114.04 58.98 0.68 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 75.329999999999998 110.805 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 54.4 m-85 -69.14 132.72 47.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.49 0.662 . . . . 75.140000000000001 112.357 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.728 HG23 ' HD1' ' A' ' 161' ' ' TYR . 63.8 mt -122.25 134.31 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.102 . . . . 65.019999999999996 110.672 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 14.0 m-30 -104.21 137.79 41.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.061 -0.348 . . . . 65.010000000000005 110.061 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.0 tm? -119.69 131.97 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.699 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.731 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.0 tt -131.81 122.69 26.18 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.751 0.31 . . . . 60.130000000000003 111.633 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.668 ' N ' HD23 ' A' ' 118' ' ' LEU . 30.6 t80 -144.92 141.85 29.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.363 -0.38 . . . . 61.229999999999997 111.678 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.639 ' HA ' HD23 ' A' ' 56' ' ' LEU . 16.6 mtm105 -63.2 144.8 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.566 0.222 . . . . 74.409999999999997 111.295 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 30.4 tp60 -117.62 124.83 49.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.822 -0.807 . . . . 74.219999999999999 108.822 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.666 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -86.38 -38.97 16.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 73.450000000000003 112.753 -178.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -110.18 150.07 29.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.278 0.844 . . . . 74.400000000000006 113.278 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 1.7 tppp? -72.64 133.59 44.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.941 -1.027 . . . . 73.230000000000004 110.496 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.628 HD12 ' NE2' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -135.67 144.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 63.240000000000002 111.43 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -44.03 23.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.135 0.493 . . . . 74.420000000000002 110.848 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.643 ' HG3' HG21 ' A' ' 82' ' ' VAL . 47.8 mm-40 54.71 40.43 31.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.318 0.859 . . . . 64.239999999999995 113.318 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p 53.37 154.17 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 N-CA-C 113.673 0.99 . . . . 72.439999999999998 113.673 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.48 158.22 8.11 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.094 2.529 . . . . 41.109999999999999 113.009 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 96' ' ' SER . 23.8 p -58.86 122.45 13.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 72.439999999999998 111.164 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 131' ' ' ILE . 23.9 mm -94.45 121.11 44.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.42 0.629 . . . . 70.340000000000003 111.751 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.7 m -73.68 135.88 43.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.896 -1.047 . . . . 74.519999999999996 111.156 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 135' ' ' THR . 19.2 p-10 -58.71 -43.48 90.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.989 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 177' ' ' ILE . 41.0 p -70.09 22.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 112.189 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.9 t -74.1 133.56 42.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 72.549999999999997 111.285 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.903 ' HD2' HG22 ' A' ' 177' ' ' ILE . 14.8 mmm-85 -58.05 173.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.877 0.846 . . . . 75.409999999999997 112.873 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -41.04 157.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.148 -1.387 . . . . 63.229999999999997 113.036 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.71 -36.83 1.21 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.048 -0.978 . . . . 73.530000000000001 112.948 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -86.24 26.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.018 0.409 . . . . 72.530000000000001 111.324 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.2 mp -114.29 -54.82 2.56 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.06 -0.718 . . . . 71.129999999999995 109.06 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -53.75 121.98 8.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.425 -0.807 . . . . 73.329999999999998 110.924 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.461 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 9.8 t80 -173.53 123.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 74.230000000000004 110.488 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 17.1 p-10 -84.67 117.14 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 61.140000000000001 111.913 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.02 74.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 73.530000000000001 110.408 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' NH2' ' OD2' ' A' ' 2' ' ' ASP . 87.8 mtt180 -43.91 -36.89 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.623 -0.717 . . . . 74.439999999999998 111.406 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.445 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 24.5 t70 -49.41 -53.92 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.39 0.614 . . . . 73.230000000000004 110.498 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 5.3 m-30 -63.63 -34.53 78.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.495 -0.775 . . . . 73.0 110.482 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -59.81 -44.18 94.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.38 -0.6 . . . . 51.240000000000002 109.38 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.26 -57.32 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 71.140000000000001 111.908 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HG3' ' CD2' ' A' ' 151' ' ' HIS . 3.0 ptmm? -60.87 -53.14 60.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.717 0.265 . . . . 73.420000000000002 111.717 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.628 ' NE2' HD12 ' A' ' 125' ' ' ILE . 46.2 m170 -69.42 -12.15 61.42 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.478 -0.489 . . . . 74.310000000000002 111.178 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.11 25.21 71.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 71.239999999999995 112.34 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 10.6 mt -64.16 16.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.835 0.454 . . . . 74.230000000000004 111.759 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -51.77 -21.31 7.0 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.035 -0.602 . . . . 72.239999999999995 113.224 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.05 95.93 14.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.227 0.537 . . . . 74.530000000000001 110.579 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.558 ' HB3' HD21 ' A' ' 117' ' ' LEU . 78.9 Cg_endo -78.29 141.57 18.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.065 2.51 . . . . 74.430000000000007 114.106 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 119' ' ' TYR . 35.8 pt -82.79 -36.33 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 63.100000000000001 110.659 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -141.19 145.14 35.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.439999999999998 111.543 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.17 39.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.445 -0.798 . . . . 74.230000000000004 109.33 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 2.4 t-20 -171.12 127.28 0.69 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.264 -1.013 . . . . 72.329999999999998 108.264 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.728 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -115.8 156.86 25.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.912 -0.585 . . . . 74.25 111.047 -177.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 3.3 p90 -139.41 136.94 35.21 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.725 -0.671 . . . . 74.409999999999997 110.175 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 39.8 mt-30 -122.1 124.45 43.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.819 -0.628 . . . . 74.349999999999994 109.699 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -155.99 151.14 26.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 71.530000000000001 110.713 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.421 HE22 HG22 ' A' ' 34' ' ' THR . 7.0 pm0 -111.33 133.76 53.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.146 178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -115.57 131.39 56.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.305 -0.628 . . . . 54.149999999999999 109.305 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 169' ' ' TYR . 72.9 m-20 -66.53 -178.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 74.420000000000002 112.413 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.47 28.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.542 -0.754 . . . . 64.200000000000003 111.959 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 167' ' ' ASP . 28.3 t80 -97.05 -45.71 6.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 63.119999999999997 110.526 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.602 ' CG2' ' HD3' ' A' ' 171' ' ' PRO . 16.0 m -60.38 -35.17 24.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 112.836 0.68 . . . . 72.5 112.836 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.602 ' HD3' ' CG2' ' A' ' 170' ' ' VAL . 73.1 Cg_exo -51.49 -35.61 56.14 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.187 1.258 . . . . 73.209999999999994 111.034 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.567 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 66.8 mt -48.31 -42.45 11.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 63.25 110.227 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 173' ' ' ARG . 1.9 tpm_? -57.22 -37.91 72.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.252 -0.886 . . . . 74.319999999999993 111.235 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 177' ' ' ILE . 8.4 p30 -65.73 -35.19 80.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.434 -0.506 . . . . 60.420000000000002 110.789 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -57.6 -27.42 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.282 -0.567 . . . . 75.400000000000006 109.597 179.281 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 m -73.68 -0.12 14.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.623 -0.717 . . . . 72.310000000000002 111.587 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.903 HG22 ' HD2' ' A' ' 136' ' ' ARG . 66.4 mt -64.64 129.74 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.803 -0.181 . . . . 50.350000000000001 110.584 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 177' ' ' ILE . 2.4 m -176.4 69.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 122.894 0.478 . . . . 73.430000000000007 111.297 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 118.768 -1.018 . . . . 62.200000000000003 112.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.643 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 45.8 ttm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.075 -0.343 . . . . 73.019999999999996 110.075 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 72.9 m-20 59.53 56.72 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 111.445 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -75.57 -62.64 1.51 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.205 -0.452 . . . . 64.430000000000007 111.501 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' LEU . 18.5 pt -104.22 51.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.357 0.599 . . . . 73.239999999999995 111.014 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' HA ' ' A' ' 6' ' ' PRO . 11.1 p -135.56 139.94 32.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.639 -0.709 . . . . 52.219999999999999 109.862 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HA ' HG23 ' A' ' 5' ' ' VAL . 86.5 Cg_endo -82.15 37.7 1.33 Allowed 'Cis proline' 0 C--N 1.346 0.447 0 C-N-CA 123.744 -1.357 . . . . 72.140000000000001 112.762 0.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.8 t0 -64.73 -50.88 65.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.34 . . . . 65.430000000000007 110.471 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.8 m -163.74 -36.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.642 0.608 . . . . 65.129999999999995 112.642 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 4' ' ' ILE . 29.7 tp -157.31 164.23 37.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.093 0.473 . . . . 73.239999999999995 112.182 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -67.85 -38.0 82.58 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.869 0.366 . . . . 73.230000000000004 110.621 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -146.32 128.92 16.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 55.109999999999999 110.594 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 12' ' ' VAL . 8.7 p -60.53 123.78 75.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.339 0.496 . . . . 74.510000000000005 112.339 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HB3' ' HG2' ' A' ' 156' ' ' PRO . 46.0 Cg_endo -87.58 -121.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.37 2.714 . . . . 74.209999999999994 112.295 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -163.42 -45.96 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.075 -0.511 . . . . 63.439999999999998 110.186 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.93 -135.07 8.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.874 -0.679 . . . . 54.119999999999997 112.474 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 9.7 t -164.12 177.42 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 73.340000000000003 110.834 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.815 HG22 HG23 ' A' ' 19' ' ' VAL . 53.0 mt -124.3 128.56 73.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.981 -0.554 . . . . 62.140000000000001 110.895 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.8 mmpt? -86.87 108.77 18.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.433 -0.803 . . . . 72.430000000000007 109.372 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.815 HG23 HG22 ' A' ' 17' ' ' ILE . 74.7 t -124.68 110.9 26.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.122 0.487 . . . . 73.099999999999994 110.434 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 26' ' ' GLU . 29.1 mt -96.25 137.94 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 64.25 110.937 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -86.53 0.32 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 75.549999999999997 111.77 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -69.54 -45.91 57.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.854 -0.688 . . . . 61.219999999999999 113.809 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 174.41 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.162 -0.681 . . . . 64.420000000000002 109.162 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -91.86 -42.97 9.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.179 -0.919 . . . . 73.349999999999994 109.33 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.5 137.22 52.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.179 -0.919 . . . . 74.109999999999999 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 23.7 pt-20 -140.85 159.65 41.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.693 -1.139 . . . . 73.430000000000007 109.772 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 19' ' ' VAL . 10.8 m -80.34 119.11 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.32 0.581 . . . . 62.340000000000003 111.307 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 41.1 mttp -120.87 113.22 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.723 -0.671 . . . . 53.450000000000003 111.822 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.8 mp0 46.43 67.08 0.82 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.54 1.311 . . . . 74.340000000000003 114.54 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.51 16.22 14.93 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.301 0.481 . . . . 62.32 114.301 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -51.77 145.47 9.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.131 0.491 . . . . 75.430000000000007 110.875 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -91.76 116.39 28.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.223 -0.899 . . . . 73.340000000000003 110.533 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -92.84 118.0 30.64 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.513 -0.475 . . . . 65.450000000000003 110.141 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 p -150.51 154.95 36.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.758 -0.656 . . . . 72.140000000000001 111.006 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 36' ' ' THR . 93.2 Cg_endo -89.19 -93.78 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 C-N-CA 124.039 -1.234 . . . . 75.510000000000005 111.267 -0.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 p -75.05 47.97 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.787 0.803 . . . . 75.299999999999997 109.631 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HA ' ' HZ1' ' A' ' 39' ' ' LYS . 42.4 tt0 -107.66 -2.78 19.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 71.420000000000002 110.734 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 164' ' ' ALA . 30.8 m -101.14 27.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 65.439999999999998 112.038 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HZ1' ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.18 -40.6 62.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.095 0.474 . . . . 62.340000000000003 110.642 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 29.2 m-20 -71.79 138.91 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.612 -0.722 . . . . 53.549999999999997 112.146 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.8 pm0 -66.98 152.57 95.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.245 -0.889 . . . . 35.119999999999997 111.503 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.1 Cg_endo -81.97 126.94 5.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.786 2.324 . . . . 74.319999999999993 112.829 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 43.5 mm -107.07 106.08 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 65.5 110.215 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 19' ' ' VAL . 10.4 p -79.02 143.23 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.732 0.641 . . . . 75.010000000000005 112.732 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' LYS . 36.9 m -165.46 152.32 10.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.018 0.437 . . . . 71.200000000000003 111.784 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 3.4 p90 -124.7 34.2 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.689 0.757 . . . . 74.409999999999997 109.556 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -44.42 121.9 2.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 75.530000000000001 111.197 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.44 -28.15 7.86 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.952 -0.642 . . . . 61.119999999999997 113.699 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 7.1 mp -75.68 -36.3 60.11 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.564 0.682 . . . . 71.230000000000004 110.096 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -51.55 158.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.409 -0.814 . . . . 71.409999999999997 109.994 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.38 -64.56 0.05 OUTLIER Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.423 -0.894 . . . . 71.150000000000006 112.135 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -148.16 109.35 4.32 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 61.329999999999998 108.845 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -157.72 141.84 16.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.276 -0.875 . . . . 75.219999999999999 111.215 -178.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -77.13 -45.04 28.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.325 -0.991 . . . . 65.439999999999998 108.325 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD22 ' O ' ' A' ' 83' ' ' ASN . 80.0 mt -154.64 163.45 40.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.871 -1.513 . . . . 64.340000000000003 109.076 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 32.7 mt -129.66 153.62 47.94 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.804 -0.443 . . . . 64.140000000000001 109.804 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 HG12 ' A' ' 82' ' ' VAL . 4.8 m -117.77 114.73 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 64.530000000000001 110.394 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -108.1 119.37 39.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.67 -0.863 . . . . 73.230000000000004 108.67 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 153' ' ' LEU . 66.8 mt -150.24 151.86 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.949 -0.7 . . . . 72.439999999999998 112.442 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' A' ' 78' ' ' HIS . 3.9 ppp? -94.99 154.91 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.268 -0.878 . . . . 73.200000000000003 109.177 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 62' ' ' ASP . 46.1 t -132.56 163.22 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.048 0.452 . . . . 73.219999999999999 111.725 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 61' ' ' VAL . 21.9 t70 64.18 54.91 1.53 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 74.5 110.187 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 35.1 Cg_exo -36.0 140.07 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.02 2.48 . . . . 64.439999999999998 112.22 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.05 85.53 2.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.623 0.601 . . . . 74.319999999999993 112.623 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.13 136.28 1.27 Allowed Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 112.301 0.482 . . . . 43.210000000000001 112.301 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 17.0 Cg_exo -68.36 -28.12 5.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.633 -1.403 . . . . 73.519999999999996 111.626 -1.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.882 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.4 t -150.03 150.11 31.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.14 -0.936 . . . . 75.409999999999997 111.123 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.9 -23.36 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.293 -0.867 . . . . 65.420000000000002 109.823 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.92 -39.82 29.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 71.510000000000005 112.619 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.882 ' H ' HG23 ' A' ' 67' ' ' THR . 8.4 t0 -144.37 81.08 11.55 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-O 120.613 0.244 . . . . 75.129999999999995 110.614 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 6.3 Cg_exo -77.75 55.82 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.116 2.544 . . . . 73.019999999999996 111.935 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 15.4 ptpt -48.9 -47.44 43.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.151 0.426 . . . . 63.240000000000002 112.151 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 1.7 p90 -114.34 33.42 5.3 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.489 -0.484 . . . . 74.140000000000001 111.081 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 63' ' ' PRO . 9.9 ttm180 -54.9 132.26 46.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.032 -1.099 . . . . 74.439999999999998 108.032 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 10.4 tp10 -103.26 166.67 10.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.871 1.668 . . . . 64.239999999999995 109.906 -0.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.552 HG23 ' HG ' ' A' ' 77' ' ' LEU . 7.6 tp -94.51 -45.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.747 -0.835 . . . . 72.109999999999999 108.747 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 103' ' ' SER . 3.2 pp -174.96 146.75 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.883 -1.053 . . . . 64.409999999999997 108.777 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 19.4 p-80 -158.73 176.6 12.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.579 -0.282 . . . . 75.329999999999998 110.386 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.548 ' CH2' HG12 ' A' ' 44' ' ' VAL . 12.2 t90 -102.91 125.28 49.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.034 0.445 . . . . 75.299999999999997 111.238 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 27.2 p -141.55 133.56 27.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 64.549999999999997 111.035 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 84' ' ' ILE . 16.1 t -147.8 132.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.225 -0.443 . . . . 70.209999999999994 110.275 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG12 HG23 ' A' ' 57' ' ' THR . 19.8 m -137.16 171.14 16.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.78 0.324 . . . . 75.209999999999994 110.973 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.631 ' H ' ' NE2' ' A' ' 121' ' ' GLN . 5.8 m-20 73.88 25.82 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.718 -0.674 . . . . 53.219999999999999 110.527 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -72.35 115.16 36.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.382 -0.927 . . . . 74.099999999999994 110.215 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 129.21 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.795 1.663 . . . . 73.439999999999998 110.659 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.92 62.79 0.05 OUTLIER Glycine 0 CA--C 1.525 0.683 0 O-C-N 123.52 0.512 . . . . 62.329999999999998 113.441 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -173.95 37.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.675 0.79 . . . . 64.25 108.942 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 90' ' ' ASN . 33.6 m120 -135.24 -10.33 2.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.864 -0.607 . . . . 72.409999999999997 112.489 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 71.88 -32.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.87 0.367 . . . . 41.409999999999997 111.264 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -153.69 166.14 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.450000000000003 110.546 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 69.8 Cg_endo -67.93 43.96 0.27 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.62 2.88 . . . . 65.040000000000006 113.508 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 t -74.04 -38.28 64.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 65.299999999999997 110.014 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.63 5.34 35.03 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.874 -0.603 . . . . 55.420000000000002 112.648 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -80.76 160.89 43.65 Favored Glycine 0 N--CA 1.454 -0.111 0 C-N-CA 120.746 -0.74 . . . . 44.130000000000003 112.394 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 106.75 4.03 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.249 0.524 . . . . 62.350000000000001 111.262 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 130' ' ' THR . 47.7 m -73.68 100.76 3.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 73.420000000000002 108.672 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HG3' ' A' ' 127' ' ' GLU . 87.4 mt -58.39 -50.25 74.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.579 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.77 122.45 20.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.329 -0.396 . . . . 75.109999999999999 111.016 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -48.63 132.68 17.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.797 -0.638 . . . . 74.230000000000004 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' A' ' 100' ' ' TYR . 1.9 p90 -76.53 126.1 30.4 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.013 0.435 . . . . 75.209999999999994 110.522 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 HD13 ' A' ' 77' ' ' LEU . 1.2 m -148.05 159.81 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.857 -0.61 . . . . 60.420000000000002 111.061 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 173' ' ' ARG . . . -58.15 111.9 3.48 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.677 -0.692 . . . . 65.319999999999993 113.049 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.741 ' HA ' HD11 ' A' ' 77' ' ' LEU . 48.8 m -63.65 95.47 0.11 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.273 0.229 . . . . 75.319999999999993 110.815 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 170' ' ' VAL . . . -56.61 101.67 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.067 -0.515 . . . . 73.329999999999998 113.027 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' NE2' ' A' ' 112' ' ' HIS . 87.8 Cg_endo -104.35 139.65 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.695 2.93 . . . . 62.119999999999997 112.912 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 109' ' ' THR . 11.9 Cg_endo -55.35 134.24 62.72 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.181 1.254 . . . . 75.430000000000007 109.586 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -42.08 -35.83 1.0 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.446 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -60.63 -42.53 97.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.928 -1.033 . . . . 73.409999999999997 112.803 -178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.472 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 3.6 t -72.56 -33.28 66.69 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.083 -0.386 . . . . 71.200000000000003 111.568 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.95 -88.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.531 0.972 . . . . 72.450000000000003 115.531 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.0 tp -66.88 122.4 17.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.824 1.046 . . . . 73.329999999999998 113.824 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 105' ' ' PRO . 2.9 m-70 -97.46 137.03 37.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.513 -0.767 . . . . 64.140000000000001 110.185 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 5.9 mmt85 -104.8 118.02 35.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.288 -0.634 . . . . 64.140000000000001 109.288 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.87 133.57 54.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.177 0.513 . . . . 64.319999999999993 111.952 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 161' ' ' TYR . 28.3 mm -125.74 121.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.058 -0.973 . . . . 64.409999999999997 108.868 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.33 131.94 51.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 74.420000000000002 110.771 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 156' ' ' PRO . 14.8 tp -126.81 130.93 51.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 71.010000000000005 110.435 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 158' ' ' ALA . 52.5 tp -124.75 122.47 37.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.855 -0.611 . . . . 64.519999999999996 110.682 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.453 ' HD2' HD23 ' A' ' 153' ' ' LEU . 37.0 t80 -134.62 138.24 44.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 75.239999999999995 109.777 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 53' ' ' SER . 37.3 ttp180 -68.95 124.53 23.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 73.420000000000002 111.72 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 83' ' ' ASN . 14.4 tt0 -87.99 107.31 18.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.713 -0.847 . . . . 65.150000000000006 108.713 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -73.89 -37.12 64.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.007 -0.542 . . . . 74.349999999999994 111.192 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -121.66 141.82 50.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.513 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 83' ' ' ASN . 3.8 tppp? -62.62 111.52 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.255 -0.276 . . . . 63.409999999999997 110.255 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' CE1' ' A' ' 151' ' ' HIS . 6.1 pt -90.73 128.21 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.667 -0.494 . . . . 74.230000000000004 109.667 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.63 -46.85 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.929 0.714 . . . . 53.530000000000001 112.929 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.612 ' HG3' HD21 ' A' ' 97' ' ' LEU . 4.9 mm-40 61.67 -117.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 75.239999999999995 109.675 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 127' ' ' GLU . 17.9 p -162.77 160.19 19.54 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.378 -0.601 . . . . 74.150000000000006 109.378 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.59 154.88 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.189 1.926 . . . . 64.230000000000004 111.738 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 96' ' ' SER . 1.9 m -58.42 125.58 23.91 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.056 -0.35 . . . . 74.219999999999999 110.056 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 131' ' ' ILE . 15.9 mm -90.69 126.24 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 71.230000000000004 112.178 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.4 m -82.94 134.86 35.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.063 -0.971 . . . . 64.019999999999996 109.727 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' A' ' 101' ' ' VAL . 15.0 p-10 -51.0 -40.94 59.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 61.039999999999999 111.273 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.683 ' OG1' HG22 ' A' ' 178' ' ' VAL . 9.9 t -65.47 4.04 0.6 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.184 -0.462 . . . . 60.32 111.895 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.45 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 11.3 t -64.12 135.45 56.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.159 0.504 . . . . 72.310000000000002 110.255 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB2' ' HA2' ' A' ' 179' ' ' GLY . 8.9 ttt85 -84.98 173.24 10.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.813 -0.63 . . . . 64.409999999999997 110.765 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.44 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 1.9 m -35.72 151.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.259 -0.882 . . . . 62.340000000000003 112.187 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.19 2.7 19.91 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.984 -0.627 . . . . 73.409999999999997 113.573 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -169.75 44.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.237 0.518 . . . . 73.0 110.377 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -114.27 -59.66 1.99 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.984 -0.553 . . . . 72.510000000000005 111.984 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.586 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 17.0 m-20 -65.07 42.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.657 0.984 . . . . 75.430000000000007 113.657 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 2.0 t80 -99.31 111.34 23.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 71.209999999999994 109.812 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.61 HD21 ' HB3' ' A' ' 145' ' ' ARG . 30.1 t30 -66.35 129.88 41.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.666 -0.697 . . . . 65.329999999999998 111.404 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . . . -72.24 -35.12 68.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.64 0.607 . . . . 75.519999999999996 112.64 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.643 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 30.1 ttm180 -47.04 -39.27 12.52 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.39 -0.524 . . . . 73.430000000000007 110.85 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.69 -37.71 63.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.185 -0.461 . . . . 72.209999999999994 110.894 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 1.6 m-85 -49.65 -40.54 40.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.365 0.602 . . . . 63.329999999999998 109.407 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.16 86.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 54.549999999999997 110.818 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.9 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 25.41 111.606 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.1 -43.27 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.371 0.508 . . . . 75.530000000000001 112.371 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.837 ' CE1' HD12 ' A' ' 125' ' ' ILE . 66.0 m-70 -91.4 1.48 57.09 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 70.420000000000002 110.912 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.4 32.65 73.23 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 121.108 -0.568 . . . . 51.530000000000001 113.662 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 59' ' ' LEU . 8.3 mt -70.32 16.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 110.733 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -64.33 -4.08 11.32 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.059 -0.519 . . . . 45.130000000000003 113.153 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 20.3 pt-20 -134.34 72.55 70.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.716 0.769 . . . . 64.030000000000001 109.018 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.554 ' HG3' HD11 ' A' ' 117' ' ' LEU . 42.1 Cg_endo -68.18 131.14 22.85 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.154 2.569 . . . . 75.310000000000002 113.874 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.0 pt -75.51 -34.46 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 74.239999999999995 109.276 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.801 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.06 146.25 30.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.543 -0.753 . . . . 64.430000000000007 110.141 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 117' ' ' LEU . . . -158.69 159.38 35.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 64.310000000000002 110.521 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.665 ' ND2' HG23 ' A' ' 27' ' ' VAL . 59.1 t30 -170.48 175.37 4.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.207 -1.035 . . . . 72.230000000000004 108.207 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.856 ' HB3' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -155.42 167.05 31.65 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.181 -0.608 . . . . 74.019999999999996 111.589 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -162.03 150.62 15.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.702 -0.681 . . . . 63.409999999999997 110.258 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 113' ' ' ARG . 57.9 mt-30 -124.64 138.16 54.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 73.540000000000006 110.378 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -155.11 138.89 16.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.834 -0.621 . . . . 74.219999999999999 110.373 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -100.43 138.08 37.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.086 -0.338 . . . . 53.299999999999997 110.086 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -127.63 126.58 42.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 110.135 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.3 m-20 -62.73 -174.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.324 0.583 . . . . 52.310000000000002 110.448 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 13.9 t70 -72.82 32.68 0.07 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.59 -0.732 . . . . 63.130000000000003 109.752 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 167' ' ' ASP . 20.2 t80 -91.14 -53.69 4.26 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.339 -0.846 . . . . 75.219999999999999 111.752 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 28.3 m -59.81 -31.01 8.34 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 112.917 0.71 . . . . 65.129999999999995 112.917 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 83.7 Cg_exo -48.83 -21.41 3.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.51 1.473 . . . . 72.319999999999993 111.427 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 169' ' ' TYR . 11.8 tt -51.7 -38.93 22.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.886 -0.597 . . . . 61.240000000000002 109.868 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.473 ' CD ' ' H ' ' A' ' 102' ' ' GLY . 85.2 mtt-85 -58.18 -34.97 70.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 74.400000000000006 109.881 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.404 ' O ' HG12 ' A' ' 177' ' ' ILE . 7.8 m120 -62.19 -41.31 98.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.15 -0.685 . . . . 74.340000000000003 109.15 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -59.09 -17.24 24.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 74.329999999999998 109.831 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 176' ' ' THR . 18.0 m -88.21 6.12 38.27 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.981 -0.554 . . . . 54.200000000000003 111.778 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.2 mm -74.07 124.36 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.919 -0.128 . . . . 73.120000000000005 111.11 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.683 HG22 ' OG1' ' A' ' 134' ' ' THR . 18.4 m -127.51 -21.3 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.365 1.246 . . . . 62.329999999999998 114.365 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.245 0.795 0 CA-C-O 118.126 -1.375 . . . . 53.240000000000002 112.679 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.802 -0.444 . . . . 72.340000000000003 109.802 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -66.83 119.17 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.071 -0.344 . . . . 74.030000000000001 110.071 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.19 -71.2 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.426 0.528 . . . . 72.420000000000002 112.426 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 13.3 pt -125.37 59.95 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.616 0.722 . . . . 73.310000000000002 110.804 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 6' ' ' PRO . 12.3 p -128.75 140.89 39.82 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.141 -0.936 . . . . 75.049999999999997 110.642 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.8 Cg_endo -85.29 33.13 4.77 Favored 'Cis proline' 0 C--N 1.35 0.606 0 C-N-CA 123.849 -1.313 . . . . 72.450000000000003 112.632 0.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.9 t0 -57.14 -54.54 45.6 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.219 -0.659 . . . . 63.409999999999997 109.219 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.9 m -160.5 -39.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.419 -0.81 . . . . 75.409999999999997 111.676 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.8 tp -157.41 143.03 17.37 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.094 0.473 . . . . 71.530000000000001 111.458 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -78.84 25.73 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.821 -0.55 . . . . 63.240000000000002 110.333 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -175.36 156.02 1.95 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.037 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -90.59 113.52 58.02 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.721 0.267 . . . . 54.420000000000002 111.721 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 87.9 Cg_endo -85.0 134.03 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.646 2.231 . . . . 73.549999999999997 112.482 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 157' ' ' ILE . . . -60.62 -39.62 88.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.09 -0.504 . . . . 75.239999999999995 110.562 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -135.09 3.32 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.683 -0.689 . . . . 63.509999999999998 111.483 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 t -161.29 176.94 10.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.45 -0.574 . . . . 75.319999999999993 109.45 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 44' ' ' VAL . 13.6 mt -116.65 135.79 55.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.551 -0.295 . . . . 52.240000000000002 111.016 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 45' ' ' SER . 31.0 mmmt -73.92 102.31 4.06 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.438 -1.319 . . . . 74.230000000000004 107.438 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.704 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.7 t -117.28 110.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 73.519999999999996 109.654 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.678 HG21 ' O ' ' A' ' 23' ' ' ASP . 22.6 mt -99.61 126.7 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.472 -0.785 . . . . 71.200000000000003 110.185 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.423 ' CD2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.48 -77.48 0.1 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.134 -0.939 . . . . 74.420000000000002 110.61 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.86 -61.49 1.76 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.773 -0.727 . . . . 61.210000000000001 112.627 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.678 ' O ' HG21 ' A' ' 20' ' ' ILE . 3.7 m-20 -161.12 -53.75 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.374 0.607 . . . . 61.229999999999997 109.667 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -100.41 -37.34 8.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.268 -0.878 . . . . 72.439999999999998 111.24 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.2 pt? -69.27 124.6 24.27 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.998 0.904 . . . . 74.019999999999996 110.687 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -113.15 139.87 48.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.989 -1.46 . . . . 44.409999999999997 110.71 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 19' ' ' VAL . 33.1 m -73.51 108.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.519 0.676 . . . . 63.020000000000003 110.343 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 6.3 mmpt? -86.01 82.41 8.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.96 0.726 . . . . 72.030000000000001 112.96 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 13.8 mp0 29.84 67.33 0.11 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.424 1.268 . . . . 72.439999999999998 114.424 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.87 -21.44 29.74 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.933 -0.651 . . . . 74.519999999999996 112.913 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.82 145.63 2.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.394 0.616 . . . . 63.140000000000001 112.348 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' A' ' 163' ' ' GLN . 88.9 tt0 -110.72 136.05 50.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.856 -1.065 . . . . 75.329999999999998 110.291 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.618 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -98.1 142.5 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.781 0.324 . . . . 64.530000000000001 111.156 178.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.2 p -150.17 146.33 19.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.883 -0.599 . . . . 72.310000000000002 109.791 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.93 -115.24 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 124.08 -1.217 . . . . 71.120000000000005 112.636 0.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.8 p -72.02 48.38 0.17 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.775 0.287 . . . . 53.130000000000003 111.775 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 6.0 pt20 -99.98 0.01 40.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.368 0.604 . . . . 72.349999999999994 109.82 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 33' ' ' LEU . 34.4 m -87.45 21.65 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.197 -0.911 . . . . 62.509999999999998 110.957 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -70.72 -34.13 71.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 71.219999999999999 111.711 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.41 135.18 35.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.745 0.307 . . . . 74.120000000000005 111.422 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -68.44 152.48 96.57 Favored Pre-proline 0 C--N 1.335 -0.023 0 N-CA-C 109.691 -0.485 . . . . 65.140000000000001 109.691 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.75 126.61 15.64 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.046 1.831 . . . . 73.299999999999997 113.673 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 47.0 mm -96.85 107.33 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.967 -0.753 . . . . 72.349999999999994 108.967 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 17' ' ' ILE . 3.9 p -78.72 139.93 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.433 0.901 . . . . 70.019999999999996 113.433 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 57.7 m -164.9 134.07 3.55 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.161 -0.472 . . . . 71.519999999999996 110.359 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 2.4 p90 -114.24 35.95 3.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.484 0.659 . . . . 72.010000000000005 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -36.4 98.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.013 -0.994 . . . . 72.109999999999999 113.117 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.32 -15.16 41.46 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 116.075 -0.511 . . . . 70.409999999999997 114.251 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.23 -20.4 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.511 0.656 . . . . 73.049999999999997 110.703 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.743 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -71.35 -61.59 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.65 0.738 . . . . 74.209999999999994 109.403 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -64.24 4.34 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 109.522 -1.431 . . . . 51.43 109.522 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 2.0 ttmp? -149.1 116.79 6.23 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.199 -0.5 . . . . 73.120000000000005 110.134 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 p -157.02 141.57 16.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.216 0.531 . . . . 65.430000000000007 112.345 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 22.1 t30 -83.45 -36.66 24.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 74.400000000000006 109.061 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 25.3 mt -158.11 169.8 23.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.333 -1.303 . . . . 64.150000000000006 108.737 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 69.4 mt -141.57 159.82 41.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.922 0.391 . . . . 61.439999999999998 111.656 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 119' ' ' TYR . 2.1 m -121.56 132.82 54.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.271 -0.877 . . . . 64.349999999999994 108.77 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -127.84 132.56 49.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 73.150000000000006 109.59 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 58' ' ' LEU . 54.9 mt -145.97 129.79 17.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.877 -0.329 . . . . 73.439999999999998 111.018 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.06 135.49 45.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.106 -1.072 . . . . 64.530000000000001 108.106 178.236 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HD3' ' A' ' 63' ' ' PRO . 10.2 t -147.43 143.53 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.941 0.877 . . . . 62.310000000000002 112.6 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 55.9 t0 -160.24 81.27 2.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 113.988 -1.46 . . . . 51.229999999999997 107.065 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.692 ' HD3' HG12 ' A' ' 61' ' ' VAL . 37.4 Cg_endo -66.97 84.2 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.625 1.55 . . . . 71.340000000000003 112.47 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' CG ' ' HG2' ' A' ' 68' ' ' ARG . 31.3 m-20 -169.36 84.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.547 -0.751 . . . . 63.299999999999997 110.003 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -153.48 137.33 10.52 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.726 -0.842 . . . . 33.509999999999998 108.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.695 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 4.7 Cg_exo -77.31 -16.39 25.36 Favored 'Cis proline' 0 CA--C 1.515 -0.447 0 C-N-CA 124.287 -1.131 . . . . 65.329999999999998 111.927 0.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.3 t -138.77 140.72 38.73 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.468 -0.787 . . . . 71.430000000000007 110.867 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' HG2' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -45.94 -26.92 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.864 -1.062 . . . . 72.540000000000006 111.296 -178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -93.96 -45.14 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.52 1.304 . . . . 73.0 114.52 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.843 ' H ' HG23 ' A' ' 67' ' ' THR . 1.3 m-20 -112.64 83.01 5.27 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 113.174 0.805 . . . . 63.140000000000001 113.174 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 63.7 Cg_endo -71.57 51.76 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.236 2.624 . . . . 74.150000000000006 111.696 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HG2' ' CD ' ' A' ' 66' ' ' PRO . 17.7 ptpt -48.66 -33.59 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 63.350000000000001 111.885 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 6.2 p90 -138.68 45.46 2.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.437 0.637 . . . . 75.140000000000001 111.743 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -73.74 138.51 44.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.457 -0.942 . . . . 75.519999999999996 108.457 177.161 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 29.3 mp0 -91.71 178.3 5.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.772 0.829 . . . . 72.239999999999995 111.385 0.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.631 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.6 tp -106.67 169.81 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.536 -1.211 . . . . 52.100000000000001 109.409 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.8 mp -45.87 125.04 5.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.578 0.228 . . . . 72.129999999999995 110.593 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -124.96 171.98 9.77 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.085 0.469 . . . . 74.230000000000004 111.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 6.7 t-105 -100.16 121.83 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.355 -0.839 . . . . 72.239999999999995 109.866 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -141.49 137.17 31.91 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.437 0.532 . . . . 53.329999999999998 112.437 -177.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 84' ' ' ILE . 2.1 t -141.48 149.79 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.514 -0.312 . . . . 73.510000000000005 110.885 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.525 HG21 ' HG3' ' A' ' 127' ' ' GLU . 22.2 m -142.05 155.66 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.988 0.366 . . . . 75.109999999999999 111.988 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.447 ' C ' HD22 ' A' ' 55' ' ' LEU . 5.4 m-20 72.07 37.55 0.99 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.122 -0.49 . . . . 74.5 112.262 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -83.71 116.0 62.44 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 119.436 -0.906 . . . . 73.140000000000001 109.624 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 87' ' ' SER . 35.5 Cg_endo -66.77 126.78 15.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 121.816 1.677 . . . . 70.400000000000006 111.676 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.35 71.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.903 -0.589 . . . . 60.5 114.103 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 85' ' ' PRO . 91.8 p -178.27 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.032 0.416 . . . . 70.549999999999997 110.999 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -135.4 -2.47 2.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.327 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.668 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 13.1 pt-20 40.94 34.01 0.25 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.038 -0.528 . . . . 74.219999999999999 111.991 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 p30 175.48 152.62 0.31 Allowed Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 121.34 0.59 . . . . 52.439999999999998 110.761 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 44' ' ' VAL . 95.9 Cg_endo -74.68 61.17 5.34 Favored 'Trans proline' 0 CA--C 1.527 0.173 0 C-N-CA 123.339 2.693 . . . . 61.240000000000002 112.93 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 m -96.78 -55.3 2.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.348 0.87 . . . . 65.409999999999997 113.348 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.82 -40.97 89.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.032 0.773 . . . . 12.449999999999999 115.032 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -57.61 157.8 14.49 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.68 -0.771 . . . . 74.420000000000002 114.134 -178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.932 ' CE1' HG23 ' A' ' 130' ' ' THR . 80.3 t60 -61.63 125.6 24.37 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.079 0.551 . . . . 74.120000000000005 111.095 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.9 m -83.87 97.25 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.658 -0.868 . . . . 64.129999999999995 108.658 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' GLU . 13.0 mt -54.16 -48.83 70.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.471 -0.937 . . . . 73.530000000000001 108.471 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 117.62 8.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.494 -1.23 . . . . 73.510000000000005 108.822 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.7 t0 -54.39 152.48 6.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.65 0.594 . . . . 65.239999999999995 111.556 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 79' ' ' TRP . 0.3 OUTLIER -70.48 129.26 38.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.31 -0.405 . . . . 71.310000000000002 110.342 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.5 p -130.02 113.73 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.56 0.695 . . . . 73.450000000000003 110.873 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.46 72.97 2.74 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.427 -0.806 . . . . 51.140000000000001 113.455 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 29.8 p -171.03 11.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.891 1.071 . . . . 53.409999999999997 113.891 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.631 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -55.38 -84.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.229 -0.986 . . . . 75.319999999999993 112.258 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.927 ' CB ' HG21 ' A' ' 109' ' ' THR . 23.8 Cg_exo -64.54 105.85 0.66 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.144 1.896 . . . . 70.310000000000002 111.389 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 109' ' ' THR . 18.3 Cg_endo -59.37 160.54 19.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.235 1.957 . . . . 60.409999999999997 112.428 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 167' ' ' ASP . 7.7 ttmm -39.69 -41.0 1.01 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.296 -0.866 . . . . 71.219999999999999 111.303 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.06 -39.21 55.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.308 -0.86 . . . . 52.210000000000001 112.223 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.927 HG21 ' CB ' ' A' ' 105' ' ' PRO . 14.0 t -70.73 -7.02 41.76 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.813 0.339 . . . . 73.340000000000003 111.572 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.18 -119.47 18.75 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.099 -0.572 . . . . 64.310000000000002 114.225 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 163' ' ' GLN . 29.3 tp -58.06 119.84 7.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.802 1.038 . . . . 74.099999999999994 113.802 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 32.4 m170 -88.11 91.92 8.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.596 -0.729 . . . . 73.219999999999999 111.081 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.588 ' HD2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -76.82 63.86 2.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 75.230000000000004 110.125 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.7 m-85 -65.73 131.62 46.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.248 -0.433 . . . . 63.240000000000002 111.057 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 161' ' ' TYR . 33.9 mt -127.25 122.17 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.765 -0.652 . . . . 63.140000000000001 111.657 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 3.9 m-30 -90.4 145.95 24.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.876 -0.602 . . . . 72.329999999999998 110.207 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -134.69 131.88 38.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.948 -0.39 . . . . 75.310000000000002 109.948 179.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 157' ' ' ILE . 1.5 tt -126.27 131.47 51.88 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.954 -0.387 . . . . 74.409999999999997 109.954 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.711 ' N ' HD23 ' A' ' 118' ' ' LEU . 65.7 t80 -131.75 139.24 48.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.476 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.654 HH12 ' HB3' ' A' ' 122' ' ' GLU . 0.6 OUTLIER -71.89 130.54 41.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 73.439999999999998 110.513 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.547 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -116.03 148.52 40.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.627 0.251 . . . . 64.439999999999998 111.231 -178.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.654 ' HB3' HH12 ' A' ' 120' ' ' ARG . 23.2 pt-20 -148.03 17.66 1.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.178 0.514 . . . . 75.409999999999997 110.941 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 5.8 m120 -143.91 129.13 18.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.053 -0.976 . . . . 42.399999999999999 108.415 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -76.64 111.58 12.29 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.78 -0.768 . . . . 64.349999999999994 111.202 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.2 pt -103.68 128.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.812 -1.085 . . . . 74.010000000000005 110.661 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -56.17 -57.67 11.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.411 0.624 . . . . 54.409999999999997 110.954 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.666 ' HB3' HD22 ' A' ' 97' ' ' LEU . 21.9 mm-40 63.09 31.87 15.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.985 -1.007 . . . . 71.329999999999998 112.763 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 44.5 p 57.72 151.6 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 112.631 0.604 . . . . 73.230000000000004 112.631 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -45.21 157.58 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.471 2.781 . . . . 75.140000000000001 113.561 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.932 HG23 ' CE1' ' A' ' 95' ' ' HIS . 8.2 p -62.5 131.1 48.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.524 -0.762 . . . . 74.109999999999999 112.524 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 135' ' ' THR . 45.3 mm -104.56 118.49 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.929 -0.767 . . . . 50.539999999999999 108.929 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.3 t -69.46 153.1 44.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 73.299999999999997 111.77 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.487 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.5 p30 -54.42 -29.36 48.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.552 -0.749 . . . . 53.520000000000003 110.296 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 p -78.12 21.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.718 -0.674 . . . . 71.019999999999996 111.554 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.49 ' HB ' HG22 ' A' ' 131' ' ' ILE . 8.5 t -62.71 126.47 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.311 0.577 . . . . 74.230000000000004 111.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 178' ' ' VAL . 39.3 ttt180 -89.01 173.31 8.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.5 -0.773 . . . . 71.140000000000001 111.242 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.598 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m -36.87 150.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.492 -0.777 . . . . 62.049999999999997 112.457 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.13 25.43 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.017 -0.611 . . . . 74.400000000000006 112.972 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 55.8 ttt180 -163.96 37.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.252 0.549 . . . . 73.409999999999997 111.03 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 137' ' ' THR . 7.2 mp -82.52 -64.06 1.25 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.437 -1.32 . . . . 63.509999999999998 107.437 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 141' ' ' ASN . 0.7 OUTLIER -68.6 117.73 10.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.914 -1.143 . . . . 65.120000000000005 107.914 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.46 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 21.5 t80 -170.77 80.19 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.331 -0.395 . . . . 74.0 111.305 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.447 HD22 ' HB3' ' A' ' 145' ' ' ARG . 16.3 p-10 -62.36 117.34 6.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.139 -0.482 . . . . 71.5 111.899 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 59' ' ' LEU . . . -55.53 -25.25 36.49 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.266 0.555 . . . . 64.230000000000004 109.861 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HB3' HD22 ' A' ' 143' ' ' ASN . 1.3 tpp180 -46.57 -32.47 3.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.111 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 1.5 t70 -61.26 -56.47 20.21 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.147 -0.686 . . . . 61.329999999999998 109.147 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CE2' HD13 ' A' ' 97' ' ' LEU . 3.5 m-30 -56.4 -35.31 67.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.94 -0.573 . . . . 74.450000000000003 109.737 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -65.55 -41.5 92.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.45 -0.795 . . . . 71.019999999999996 109.592 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.89 -55.01 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.922 -0.581 . . . . 50.020000000000003 110.826 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.575 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 2.1 ptpp? -59.14 -45.15 91.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 71.319999999999993 111.763 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 89.6 m-70 -92.58 9.0 36.51 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.751 -0.38 . . . . 74.109999999999999 111.75 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 56.59 30.09 58.64 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.767 -0.73 . . . . 72.329999999999998 113.371 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HA ' ' CE1' ' A' ' 119' ' ' TYR . 13.3 mt -71.95 16.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.812 -0.228 . . . . 63.030000000000001 111.048 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.04 -63.75 1.92 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.323 -0.465 . . . . 43.409999999999997 114.002 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.17 112.29 15.05 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.726 0.263 . . . . 74.239999999999995 111.671 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 66.9 Cg_endo -79.97 123.35 5.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.094 1.863 . . . . 72.310000000000002 112.52 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 1.011 HD11 HD22 ' A' ' 118' ' ' LEU . 50.3 pt -74.87 -33.5 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.571 -0.452 . . . . 72.510000000000005 110.411 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.52 139.65 15.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.316 -0.402 . . . . 73.129999999999995 110.762 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -142.78 159.99 41.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.935 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.469 ' ND2' HG23 ' A' ' 27' ' ' VAL . 1.3 t-20 -161.38 123.38 2.97 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.563 -0.903 . . . . 72.109999999999999 108.563 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.505 ' CD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.81 169.54 11.44 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.984 -0.553 . . . . 74.219999999999999 111.698 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 2.1 p90 -164.1 160.95 22.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 72.099999999999994 109.996 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 111' ' ' LEU . 8.6 pt20 -132.65 129.0 38.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.516 -0.311 . . . . 71.400000000000006 110.848 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.44 140.4 17.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.317 -0.402 . . . . 73.230000000000004 111.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.86 133.03 43.74 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.547 -0.538 . . . . 74.140000000000001 109.547 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -105.83 113.72 27.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.239 0.542 . . . . 73.349999999999994 110.293 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.637 ' O ' ' NZ ' ' A' ' 107' ' ' LYS . 31.1 m-20 -49.81 -52.53 31.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.238 -0.892 . . . . 63.350000000000001 112.751 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -167.48 45.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.325 -0.55 . . . . 75.219999999999999 111.661 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 31.8 t80 -101.37 -40.58 7.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 73.519999999999996 111.553 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 1.042 HG13 ' HD3' ' A' ' 171' ' ' PRO . 0.1 OUTLIER -53.2 -47.46 95.86 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.924 1.083 . . . . 75.019999999999996 113.924 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 1.042 ' HD3' HG13 ' A' ' 170' ' ' VAL . 77.4 Cg_exo -53.01 -50.52 13.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.88 1.72 . . . . 60.200000000000003 113.521 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 172' ' ' ILE . 1.7 mp -45.83 -55.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 62.299999999999997 110.84 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 12.1 tpp180 -56.32 -44.66 80.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 110.39 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -51.87 -38.74 57.19 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.044 -0.525 . . . . 64.25 111.327 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 6.5 mmpt? -55.13 -29.68 58.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.430000000000007 110.964 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -67.64 -29.8 69.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 73.519999999999996 111.994 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.85 103.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.485 -0.325 . . . . 73.010000000000005 110.902 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.416 ' C ' ' HD2' ' A' ' 136' ' ' ARG . 34.1 m -148.39 1.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.389 0.514 . . . . 74.200000000000003 112.389 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.641 -1.089 . . . . 51.140000000000001 112.224 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 3' ' ' ASP . 49.9 ttm . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.442 -0.207 . . . . 74.120000000000005 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER -61.17 68.77 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.705 0.402 . . . . 74.439999999999998 111.555 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 1' ' ' MET . 9.6 t70 -106.95 -71.02 0.77 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.674 0.62 . . . . 72.25 112.674 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 9' ' ' LEU . 14.7 pt -80.84 41.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.558 0.694 . . . . 73.219999999999999 111.847 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 11.2 p -114.04 138.92 23.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.606 -0.724 . . . . 75.120000000000005 111.361 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 59.8 Cg_endo -93.57 39.42 4.67 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.388 -1.088 . . . . 73.310000000000002 112.594 -0.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.661 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 t70 -58.2 -44.41 88.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.437 -0.347 . . . . 74.200000000000003 110.412 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -165.75 -36.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.968 -0.56 . . . . 72.200000000000003 111.811 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 4' ' ' ILE . 18.7 tp -157.08 175.01 14.64 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.669 -0.493 . . . . 73.549999999999997 109.669 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 6.6 p-10 -69.0 -52.44 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.42 -1.326 . . . . 75.409999999999997 107.42 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 137.82 22.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 74.430000000000007 110.739 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.89 129.23 87.79 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 111.861 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -88.61 -138.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.089 2.526 . . . . 65.209999999999994 111.904 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.42 -29.7 7.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.519 -0.31 . . . . 43.310000000000002 111.214 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -159.94 -175.58 31.07 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.909 -0.476 . . . . 34.520000000000003 111.909 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 2.2 t -117.82 163.12 17.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.341 0.591 . . . . 74.129999999999995 112.069 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 44' ' ' VAL . 4.0 mt -105.57 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.185 -0.916 . . . . 51.140000000000001 109.691 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.2 mmmm -82.38 102.97 11.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.563 -0.289 . . . . 74.150000000000006 110.596 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.6 t -110.24 110.82 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.318 -0.623 . . . . 72.230000000000004 109.318 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 23' ' ' ASP . 44.2 mt -96.57 130.92 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.566 . . . . 62.219999999999999 110.071 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 40' ' ' ASP . 2.8 t80 -103.17 -15.14 16.12 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 112.362 0.505 . . . . 74.109999999999999 112.362 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.16 2.93 7.83 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.181 0.832 . . . . 64.129999999999995 115.181 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 20' ' ' ILE . 24.1 t70 76.19 20.81 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.372 -1.344 . . . . 50.439999999999998 107.372 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -175.16 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 112.753 -2.021 . . . . 74.140000000000001 107.134 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' O ' HG23 ' A' ' 20' ' ' ILE . 36.4 mt -69.62 136.02 50.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.984 -1.007 . . . . 63.009999999999998 108.976 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 73.0 tt0 -126.61 143.6 51.17 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.227 0.825 . . . . 72.329999999999998 113.227 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.8 m -86.66 140.34 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.824 -0.626 . . . . 75.519999999999996 110.284 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 10.7 mptt -131.67 114.77 15.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.483 0.549 . . . . 53.420000000000002 112.483 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 9.3 mp0 25.09 67.21 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.297 1.221 . . . . 73.540000000000006 114.297 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.56 6.28 89.04 Favored Glycine 0 C--N 1.33 0.225 0 N-CA-C 114.28 0.472 . . . . 61.109999999999999 114.28 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 18.9 t30 -55.99 131.07 46.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.849 0.357 . . . . 73.439999999999998 110.789 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -89.54 136.04 33.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 43.149999999999999 109.673 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 8.1 mp -92.73 138.99 31.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.319 . . . . 74.099999999999994 111.208 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -147.6 154.91 45.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 75.519999999999996 110.562 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.46 -52.62 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.826 -1.323 . . . . 63.229999999999997 112.879 0.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -120.38 28.92 7.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.747 0.784 . . . . 72.439999999999998 110.484 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 3.1 pt20 -80.98 -6.54 58.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.22 -0.9 . . . . 62.119999999999997 110.635 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.69 32.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.485 -0.78 . . . . 73.450000000000003 111.227 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -96.93 -38.11 9.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.819 1.044 . . . . 73.519999999999996 113.819 -177.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -82.64 143.93 30.64 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.071 0.767 . . . . 75.329999999999998 113.071 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.49 153.09 83.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.474 -1.239 . . . . 75.010000000000005 111.659 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.77 126.79 6.75 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.492 2.128 . . . . 72.549999999999997 112.745 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 51.6 mm -108.09 117.74 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 64.099999999999994 109.698 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.6 p -91.42 142.02 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.11 0.781 . . . . 45.149999999999999 113.11 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 68.5 m -161.43 113.73 1.83 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.848 -0.614 . . . . 73.340000000000003 109.46 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 1.3 p90 -93.67 35.95 1.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.154 0.502 . . . . 75.099999999999994 110.708 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.2 m -49.21 118.94 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 65.140000000000001 111.393 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.22 -11.31 72.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.172 -0.537 . . . . 62.240000000000002 112.805 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -108.39 10.63 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.826 0.346 . . . . 73.239999999999995 110.541 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -104.0 -62.85 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.144 -0.48 . . . . 72.450000000000003 111.151 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . 74.36 -99.43 1.09 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.469 -0.652 . . . . 71.409999999999997 111.469 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' NZ ' ' HB3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -148.82 109.96 4.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.966 0.412 . . . . 74.230000000000004 111.121 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -144.49 147.93 33.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.456 . . . . 63.5 110.225 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -63.34 -39.74 95.38 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.42 0.628 . . . . 63.539999999999999 109.852 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' A' ' 124' ' ' LYS . 30.2 mt -153.98 162.1 41.47 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.828 -1.078 . . . . 55.439999999999998 111.341 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.4 mt -132.82 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.983 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.785 HG23 HG12 ' A' ' 82' ' ' VAL . 13.1 m -113.17 123.62 50.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 74.109999999999999 110.337 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' VAL . 1.3 tm? -124.51 129.81 51.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.777 -0.453 . . . . 73.140000000000001 109.777 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.4 mt -152.46 169.16 23.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 60.100000000000001 111.506 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -95.06 131.63 40.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.833 -0.621 . . . . 71.019999999999996 110.537 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 117' ' ' LEU . 6.1 t -106.71 160.19 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.773 -0.194 . . . . 50.329999999999998 111.349 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.36 57.34 12.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 72.140000000000001 109.941 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 10.3 Cg_endo -53.95 139.98 69.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.821 1.681 . . . . 72.340000000000003 110.662 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' PRO . 35.9 t0 -165.91 117.01 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.429 0.529 . . . . 52.030000000000001 112.429 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.857 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . . . -170.43 144.73 2.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.481 -0.781 . . . . 62.539999999999999 109.392 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 73.3 Cg_endo -83.12 -14.56 35.05 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.483 -1.049 . . . . 74.340000000000003 111.759 0.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 70' ' ' ASP . 9.9 t -164.92 154.12 12.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.106 -0.952 . . . . 63.530000000000001 109.715 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -1.83 12.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.927 -0.579 . . . . 74.519999999999996 111.719 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -86.34 -45.13 11.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.395 -0.366 . . . . 74.129999999999995 111.756 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' H ' HG23 ' A' ' 67' ' ' THR . 36.3 t70 -144.4 96.63 5.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 73.140000000000001 109.787 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.23 57.13 4.61 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.347 2.031 . . . . 74.530000000000001 113.047 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -54.35 -37.43 64.91 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 121.038 -0.265 . . . . 73.439999999999998 111.489 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.685 ' HA ' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -149.41 77.21 1.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.11 0.957 . . . . 73.25 110.072 177.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.5 ttt180 -98.72 109.78 22.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.053 -1.43 . . . . 71.150000000000006 110.415 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.857 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 23.3 mt-10 -108.0 178.06 4.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.033 1.333 . . . . 75.439999999999998 110.61 -0.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.738 ' CD1' ' HB1' ' A' ' 65' ' ' ALA . 1.6 mp -75.64 -58.34 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.73 -0.841 . . . . 64.209999999999994 108.73 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 76' ' ' ILE . 1.4 mm? -140.56 -171.05 3.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.255 -1.339 . . . . 62.030000000000001 108.263 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 p80 176.27 156.92 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.4 -0.222 . . . . 65.329999999999998 110.4 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.731 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 1.2 t-105 -100.12 111.57 23.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.218 0.533 . . . . 73.400000000000006 110.041 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 16.3 m -127.93 125.34 39.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.503 -0.771 . . . . 71.140000000000001 110.704 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -147.66 125.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.497 -0.774 . . . . 70.329999999999998 110.441 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 57' ' ' THR . 27.4 m -126.66 174.44 10.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.053 0.454 . . . . 74.340000000000003 111.498 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.742 ' O ' HD22 ' A' ' 55' ' ' LEU . 13.8 p30 54.02 40.24 31.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.956 -1.02 . . . . 65.120000000000005 111.019 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.967 HD13 ' HA3' ' A' ' 94' ' ' GLY . 7.4 mm -77.89 122.23 85.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.976 -0.749 . . . . 72.239999999999995 108.976 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.74 127.77 25.67 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 121.934 1.756 . . . . 62.32 112.323 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.92 58.65 0.08 OUTLIER Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.416 0.448 . . . . 72.349999999999994 113.542 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -168.06 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.143 0.577 . . . . 64.25 109.664 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' C ' ' H ' ' A' ' 90' ' ' ASN . 36.5 m120 -135.13 -16.1 1.92 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 64.329999999999998 112.134 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 71.57 -36.23 0.35 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 72.150000000000006 111.338 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 88' ' ' ASN . 8.5 p30 -129.22 152.55 79.63 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.088 0.47 . . . . 72.230000000000004 110.254 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.828 ' HB2' HG21 ' A' ' 81' ' ' VAL . 80.4 Cg_endo -70.82 52.47 1.35 Allowed 'Trans proline' 0 N--CA 1.473 0.307 0 C-N-CA 123.572 2.848 . . . . 62.109999999999999 113.602 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -104.24 -1.92 26.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.483 -0.487 . . . . 75.400000000000006 111.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.21 -42.12 1.32 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.953 -0.642 . . . . 52.200000000000003 113.51 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.967 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.57 172.59 13.44 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 120.871 -0.68 . . . . 43.020000000000003 113.136 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.516 ' HB3' HD21 ' A' ' 83' ' ' ASN . 72.2 t60 -66.19 130.82 44.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.745 0.307 . . . . 73.019999999999996 111.73 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.731 ' HA ' HG12 ' A' ' 81' ' ' VAL . 36.8 m -87.21 102.63 14.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.837 -0.801 . . . . 62.43 108.837 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 147' ' ' PHE . 94.0 mt -62.68 -37.44 86.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.539 0.685 . . . . 73.329999999999998 109.655 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.56 127.28 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.711 -1.131 . . . . 72.319999999999993 108.653 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -55.38 152.34 8.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.285 0.846 . . . . 61.039999999999999 113.285 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 3.1 p90 -83.67 142.61 30.65 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.394 -0.821 . . . . 53.43 112.836 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 100' ' ' TYR . 5.2 m -158.35 113.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 64.209999999999994 111.346 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.83 2.81 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 44.329999999999998 112.297 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.449 ' OG ' HG13 ' A' ' 170' ' ' VAL . 29.3 t -172.03 49.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.925 0.343 . . . . 75.329999999999998 111.925 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.87 -75.68 0.61 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.465 -1.054 . . . . 75.409999999999997 110.465 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.712 ' HB2' HG21 ' A' ' 109' ' ' THR . 15.8 Cg_exo -74.17 123.5 8.35 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.941 2.427 . . . . 61.520000000000003 111.49 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.523 ' O ' HG22 ' A' ' 109' ' ' THR . 31.6 Cg_exo -59.01 159.35 21.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.862 2.375 . . . . 75.310000000000002 112.978 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 168' ' ' ASP . 18.4 pttp -43.66 -20.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.949 -0.569 . . . . 64.450000000000003 111.322 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 106' ' ' PRO . 29.8 t70 -50.42 -46.54 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.223 -0.444 . . . . 72.510000000000005 110.41 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.712 HG21 ' HB2' ' A' ' 105' ' ' PRO . 4.2 t -79.54 -4.04 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.152 -0.476 . . . . 73.040000000000006 111.519 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.75 -101.18 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.184 -1.167 . . . . 42.049999999999997 110.184 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 163' ' ' GLN . 17.5 tp -66.66 112.17 4.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.945 -0.391 . . . . 71.120000000000005 109.945 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 10.9 p80 -109.83 92.1 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.988 0.423 . . . . 73.430000000000007 110.303 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.502 ' NE ' ' H ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -58.67 130.57 47.5 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.62 -0.718 . . . . 75.430000000000007 110.583 -179.54 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.06 128.54 45.11 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 120.95 0.405 . . . . 72.519999999999996 109.916 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 161' ' ' TYR . 4.7 mm -115.86 141.83 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.446 -0.797 . . . . 71.349999999999994 111.286 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.25 141.46 48.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.937 -0.574 . . . . 72.099999999999994 110.245 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.707 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 5.5 tt -124.5 140.39 52.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.374 . . . . 74.219999999999999 110.72 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 117' ' ' LEU . 60.2 tp -130.29 134.04 46.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.668 -0.696 . . . . 73.430000000000007 110.583 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HA ' HG12 ' A' ' 157' ' ' ILE . 66.8 t80 -144.14 139.49 28.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.207 0.527 . . . . 65.439999999999998 111.295 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -68.78 135.35 51.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 44.229999999999997 111.544 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 121' ' ' GLN . 3.5 tp60 -119.8 127.62 52.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.576 -0.527 . . . . 42.140000000000001 109.576 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -109.09 -8.57 15.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.63 -0.714 . . . . 71.310000000000002 111.332 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.43 ' O ' ' NE2' ' A' ' 121' ' ' GLN . 63.2 m-20 -125.81 148.86 49.0 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.817 0.341 . . . . 73.040000000000006 111.809 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.805 ' HD2' HD11 ' A' ' 55' ' ' LEU . 13.2 mmmm -76.69 149.15 36.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 53.340000000000003 110.14 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.62 143.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 111.994 0.368 . . . . 62.219999999999999 111.994 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -81.07 -16.15 54.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.655 -0.702 . . . . 73.409999999999997 111.355 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 95' ' ' HIS . 0.0 OUTLIER 4.81 60.65 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.295 1.591 . . . . 74.409999999999997 115.295 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 126' ' ' GLU . 25.7 p 51.78 150.9 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 115.213 1.56 . . . . 74.150000000000006 115.213 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.82 158.19 29.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.659 2.906 . . . . 74.109999999999999 112.532 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -58.79 141.33 53.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.247 -0.433 . . . . 70.230000000000004 111.58 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 131' ' ' ILE . 16.4 mm -119.63 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.117 0.484 . . . . 64.030000000000001 111.673 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.7 m -87.38 143.03 27.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.551 -0.75 . . . . 73.310000000000002 111.244 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -51.86 -37.21 51.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.001 0.429 . . . . 72.120000000000005 110.817 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.62 ' HA ' HD13 ' A' ' 177' ' ' ILE . 46.9 p -70.29 12.87 0.2 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.654 0.613 . . . . 73.409999999999997 112.654 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' THR . 14.7 t -68.48 123.94 22.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 74.450000000000003 110.507 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.555 ' H ' ' CA ' ' A' ' 179' ' ' GLY . 27.3 ttt-85 -62.89 165.67 6.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.221 -0.445 . . . . 63.100000000000001 111.344 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.424 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 11.6 m -37.34 155.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.121 -0.945 . . . . 72.140000000000001 111.873 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.0 -3.25 20.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.973 -0.632 . . . . 74.439999999999998 111.819 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -165.54 41.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.168 0.509 . . . . 74.329999999999998 111.128 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.29 -64.62 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.027 -1.101 . . . . 65.140000000000001 108.027 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.685 HD22 ' HA ' ' A' ' 73' ' ' TYR . 11.4 m-20 -73.0 114.9 11.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.484 -1.235 . . . . 75.540000000000006 109.636 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -148.21 135.65 20.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.001 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.548 HD22 ' HG3' ' A' ' 145' ' ' ARG . 19.0 p-10 -101.69 106.66 17.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 54.43 110.505 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -49.12 -37.05 20.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 35.329999999999998 111.243 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.548 ' HG3' HD22 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -49.4 -25.94 2.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.973 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -52.46 -52.64 53.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.623 -0.88 . . . . 73.200000000000003 108.623 177.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.581 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 4.6 m-85 -62.12 -29.58 70.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.058 -0.974 . . . . 72.439999999999998 110.194 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 145' ' ' ARG . . . -62.83 -37.05 85.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.457 -0.572 . . . . 63.140000000000001 109.457 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.17 39.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.708 -0.678 . . . . 74.129999999999995 111.182 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.581 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 3.7 ptpp? -66.58 -49.45 66.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.199 0.444 . . . . 75.420000000000002 112.199 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.698 ' ND1' HD21 ' A' ' 153' ' ' LEU . 22.0 t-160 -86.83 3.12 46.6 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.199 -0.313 . . . . 73.040000000000006 111.222 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 58.63 34.12 75.16 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.113 -0.565 . . . . 75.340000000000003 113.565 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.698 HD21 ' ND1' ' A' ' 151' ' ' HIS . 18.1 mt -68.27 16.55 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 122.739 0.415 . . . . 63.009999999999998 112.072 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -52.68 -33.8 42.56 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.549 -0.834 . . . . 61.43 112.765 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.7 78.74 0.13 Allowed Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.3 0.24 . . . . 71.420000000000002 111.441 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 154' ' ' GLY . 32.5 Cg_endo -61.56 130.4 31.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 121.526 1.484 . . . . 71.420000000000002 111.549 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 119' ' ' TYR . 26.9 pt -81.03 -34.85 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 120.603 -0.439 . . . . 72.530000000000001 110.126 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -150.35 161.03 43.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 111.466 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -161.09 173.76 14.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.784 -0.643 . . . . 62.5 110.528 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -171.03 135.14 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.581 -0.896 . . . . 63.240000000000002 108.581 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.665 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -136.97 149.01 47.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.586 -0.279 . . . . 73.329999999999998 111.657 -177.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 1.7 p90 -142.25 152.61 43.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.8 -0.636 . . . . 71.510000000000005 111.264 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 111' ' ' LEU . 60.1 mt-30 -113.98 124.85 53.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.669 -0.493 . . . . 72.530000000000001 109.669 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' HB3' ' HE1' ' A' ' 162' ' ' TYR . . . -155.18 148.51 24.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 74.310000000000002 111.694 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 7.2 pm0 -117.81 177.46 4.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.608 -0.724 . . . . 72.219999999999999 109.602 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.615 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -162.18 -135.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.05 -0.26 . . . . 74.019999999999996 110.409 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 169' ' ' TYR . 44.7 m-20 -144.3 164.23 31.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.014 0.435 . . . . 72.310000000000002 111.532 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.578 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 36.8 t70 -67.16 12.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.579 -0.737 . . . . 74.519999999999996 110.154 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 167' ' ' ASP . 45.7 t80 -84.4 -46.6 11.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.397 -0.819 . . . . 74.549999999999997 111.592 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' A' ' 171' ' ' PRO . 13.1 p -67.72 -34.31 6.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.523 0.564 . . . . 65.439999999999998 112.523 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' A' ' 170' ' ' VAL . 42.4 Cg_exo -58.12 -22.92 58.61 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.96 1.773 . . . . 75.040000000000006 111.882 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.83 -31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 73.329999999999998 111.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.29 -33.79 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.693 0.282 . . . . 73.129999999999995 111.291 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 177' ' ' ILE . 12.3 p30 -47.57 -36.34 10.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 63.009999999999998 110.727 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -52.09 -31.81 32.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 111.385 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 77.4 p -79.98 15.75 1.38 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.912 0.386 . . . . 70.230000000000004 111.666 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 134' ' ' THR . 10.6 mm -73.04 135.04 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.323 -0.398 . . . . 74.409999999999997 110.057 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.7 -21.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.275 0.843 . . . . 74.450000000000003 113.275 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.555 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.409 -1.217 . . . . 74.230000000000004 112.49 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.418 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.0 m-20 . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 109.164 -0.68 . . . . 51.329999999999998 109.164 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.91 -71.53 0.76 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.925 0.713 . . . . 65.439999999999998 112.925 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -82.69 48.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.407 0.622 . . . . 60.409999999999997 112.05 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.9 p -120.21 143.32 35.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 75.230000000000004 110.992 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 58.5 Cg_endo -97.19 26.2 19.76 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 124.712 -0.954 . . . . 74.340000000000003 112.215 0.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.79 -41.76 98.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 72.340000000000003 110.967 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 9' ' ' LEU . 16.9 m -152.7 -51.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 113.409 0.892 . . . . 75.109999999999999 113.409 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 115' ' ' ILE . 55.0 tp -157.61 141.49 15.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.146 0.498 . . . . 75.329999999999998 112.275 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -74.9 36.53 0.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.89 -0.596 . . . . 73.420000000000002 110.948 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 13' ' ' PRO . . . 178.33 145.58 0.13 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.466 -0.333 . . . . 63.509999999999998 111.047 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 4' ' ' ILE . 55.8 t -92.54 102.38 6.59 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 74.239999999999995 111.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -72.97 136.88 25.73 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.868 2.379 . . . . 75.219999999999999 113.007 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.03 -28.83 67.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.909 -0.587 . . . . 52.25 110.108 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.54 -133.59 3.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.302 -0.863 . . . . 64.120000000000005 111.486 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.559 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t -163.7 177.57 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.719 . . . . 74.409999999999997 111.758 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 118' ' ' LEU . 26.6 mt -124.24 143.96 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.094 . . . . 54.200000000000003 108.084 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 5.7 mtpm? -107.64 102.85 12.06 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.381 -0.528 . . . . 44.030000000000001 111.58 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.685 ' HB ' HG22 ' A' ' 27' ' ' VAL . 63.1 t -103.18 110.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.485 -0.779 . . . . 73.129999999999995 109.633 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.694 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 62.7 mt -95.24 114.9 32.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.43 -0.805 . . . . 72.030000000000001 110.647 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -82.53 -85.23 0.11 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.155 -0.475 . . . . 72.239999999999995 112.1 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -68.15 2.97 6.11 Favored Glycine 0 N--CA 1.461 0.34 0 CA-C-N 116.117 -0.492 . . . . 75.319999999999993 113.596 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.694 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 13.6 t70 78.92 -41.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.232 -0.655 . . . . 75.340000000000003 109.232 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' GLY . 4.1 t70 -74.02 -27.93 61.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 71.400000000000006 109.725 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.5 pt? -124.93 -174.35 3.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.402 0.62 . . . . 73.230000000000004 112.157 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 18.2 pt-20 -156.97 157.79 35.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.319 -0.855 . . . . 63.509999999999998 111.038 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.2 m -85.35 143.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 71.319999999999993 111.689 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 50.1 mttp -144.2 126.81 16.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.466 0.65 . . . . 74.329999999999998 112.047 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.3 mp0 35.09 61.75 0.6 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.344 1.238 . . . . 73.209999999999994 114.344 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 16.94 55.62 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.859 -0.61 . . . . 43.109999999999999 114.247 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.616 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.89 156.52 8.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.104 0.478 . . . . 75.430000000000007 111.042 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 33' ' ' LEU . 28.7 tt0 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 73.409999999999997 110.125 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.4 mp -105.41 130.51 53.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.338 -0.392 . . . . 73.040000000000006 110.124 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -146.92 158.37 45.41 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.566 . . . . 75.549999999999997 110.502 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.82 121.98 3.62 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.257 -1.143 . . . . 73.340000000000003 113.266 0.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.8 p 44.44 25.9 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.842 -0.617 . . . . 60.130000000000003 112.551 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 39' ' ' LYS . 12.0 pt20 -80.3 0.1 34.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.098 0.475 . . . . 75.319999999999993 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 33' ' ' LEU . 35.8 m -73.24 26.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.879 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -106.15 -9.12 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 64.329999999999998 111.58 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -84.54 148.79 26.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.218 0.532 . . . . 70.219999999999999 111.79 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.4 pm0 -63.02 133.14 95.3 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.631 -0.713 . . . . 71.329999999999998 111.847 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 90.5 Cg_endo -85.37 128.74 3.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.868 2.379 . . . . 63.100000000000001 113.075 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 41.4 mm -103.32 105.92 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 64.549999999999997 110.419 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 17' ' ' ILE . 3.2 p -84.92 137.08 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.829 0.678 . . . . 71.040000000000006 112.829 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -165.33 137.0 4.09 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.84 0.311 . . . . 54.210000000000001 111.84 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.536 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p90 -107.53 12.51 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.283 -0.417 . . . . 75.510000000000005 109.995 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.3 t -31.95 115.91 0.18 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.103 -0.953 . . . . 73.5 112.204 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 108.7 -30.66 8.53 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 74.099999999999994 112.661 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 16' ' ' THR . 39.4 mt -85.12 -35.52 21.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.97 0.414 . . . . 64.519999999999996 110.663 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 16.1 pm0 -56.59 -171.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 74.25 110.165 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.16 -77.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.102 -1.047 . . . . 65.310000000000002 112.662 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -148.49 111.24 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.414 0.626 . . . . 72.129999999999995 110.867 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 m -157.34 147.34 20.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.632 -0.877 . . . . 71.129999999999995 108.632 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -64.69 -41.84 95.76 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.675 0.75 . . . . 61.240000000000002 109.606 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 35.7 mt -155.91 178.07 10.69 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.249 -1.341 . . . . 72.109999999999999 110.031 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 120' ' ' ARG . 89.3 mt -140.93 163.79 32.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.087 -0.708 . . . . 72.140000000000001 109.087 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 HG12 ' A' ' 82' ' ' VAL . 58.1 m -135.05 119.63 18.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 75.239999999999995 111.115 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 tm? -107.41 110.89 22.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.627 -0.715 . . . . 60.32 109.234 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 153' ' ' LEU . 81.0 mt -115.89 137.11 52.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 70.439999999999998 111.22 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.89 146.77 23.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.739 -0.664 . . . . 73.049999999999997 110.444 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 99.0 t -141.62 118.37 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 63.32 111.033 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.603 ' H ' ' HD3' ' A' ' 63' ' ' PRO . 22.2 t70 173.03 48.84 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.673 -1.149 . . . . 63.299999999999997 108.375 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HD3' ' H ' ' A' ' 62' ' ' ASP . 58.3 Cg_endo -70.0 83.87 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.045 1.83 . . . . 75.209999999999994 113.824 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -145.93 101.22 3.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.078 -0.965 . . . . 63.5 109.09 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -166.14 136.69 2.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 73.329999999999998 111.482 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 14.8 Cg_exo -71.12 -5.17 10.89 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 123.56 -1.433 . . . . 70.409999999999997 111.313 -0.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 146.29 7.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.888 . . . . 70.340000000000003 110.222 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' HD2' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -64.04 -15.47 59.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.466 . . . . 65.109999999999999 110.408 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.693 HE21 ' HD2' ' A' ' 68' ' ' ARG . 88.2 mm-40 -92.01 -23.32 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 74.420000000000002 111.979 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t70 -144.13 73.96 16.11 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 75.299999999999997 110.241 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.87 62.54 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.434 2.756 . . . . 74.239999999999995 112.406 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -48.86 -36.48 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.928 -0.578 . . . . 65.219999999999999 111.511 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 5.9 p90 -165.01 48.98 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 74.129999999999995 111.51 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HG2' ' CA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -81.2 144.06 31.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.226 -0.657 . . . . 75.0 109.226 177.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.454 ' CA ' ' HG2' ' A' ' 74' ' ' ARG . 39.0 mt-10 -89.91 163.74 14.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.044 0.938 . . . . 64.349999999999994 111.297 0.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 77' ' ' LEU . 21.2 mm -84.76 -129.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.182 -1.414 . . . . 75.120000000000005 107.182 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.658 ' H ' HG22 ' A' ' 76' ' ' ILE . 49.9 mt -86.84 151.67 23.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 0.0 OUTLIER -149.65 160.93 43.11 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 121.075 -0.25 . . . . 74.120000000000005 111.075 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.403 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 1.4 t-105 -100.31 79.8 2.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.659 0.743 . . . . 75.329999999999998 111.025 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 97' ' ' LEU . 24.5 p -94.67 133.25 38.53 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.664 -1.153 . . . . 74.129999999999995 110.92 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -144.72 138.42 22.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 120.728 -0.389 . . . . 73.340000000000003 111.19 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.009 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.21 167.74 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 62.100000000000001 110.645 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' HD22 ' A' ' 55' ' ' LEU . 1.7 m-20 64.24 33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.528 -0.305 . . . . 71.310000000000002 111.413 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.023 HD13 ' HA3' ' A' ' 94' ' ' GLY . 15.6 mm -80.78 124.14 81.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.613 -0.514 . . . . 73.209999999999994 109.613 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.595 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 51.5 Cg_exo -52.16 129.79 32.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.292 1.328 . . . . 71.409999999999997 110.98 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.42 50.03 0.29 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 114.739 0.656 . . . . 35.539999999999999 114.739 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t -176.73 32.56 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.402 0.601 . . . . 65.319999999999993 111.914 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.595 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 51.4 m-20 -113.19 0.55 14.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.567 0.222 . . . . 64.400000000000006 111.07 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 51.9 mt-10 68.14 -34.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 64.239999999999995 112.276 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' ASN . 4.0 p30 -133.81 155.45 80.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.529 . . . . 65.120000000000005 111.447 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 84' ' ' ILE . 91.9 Cg_endo -71.89 59.36 2.84 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.49 2.793 . . . . 54.409999999999997 113.267 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.1 m -104.29 -54.8 2.47 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.817 0.673 . . . . 63.539999999999999 112.817 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.11 -0.55 15.71 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.6 1.0 . . . . 64.150000000000006 115.6 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 1.023 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -100.34 176.43 27.8 Favored Glycine 0 N--CA 1.461 0.313 0 C-N-CA 120.423 -0.894 . . . . 73.120000000000005 113.258 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -70.46 121.34 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 74.109999999999999 111.284 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.596 ' HA ' HG13 ' A' ' 81' ' ' VAL . 43.7 m -80.99 96.94 7.26 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.638 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 43.7 mt -48.02 -50.13 28.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 109.549 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -141.86 107.97 5.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.834 -1.075 . . . . 63.32 108.249 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.566 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 44.7 t0 -41.91 144.57 0.41 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 73.200000000000003 112.966 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -60.59 139.85 57.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.89 -1.05 . . . . 74.430000000000007 112.137 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 14.4 p -148.15 113.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.586 -0.734 . . . . 74.030000000000001 110.651 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.11 18.79 3.14 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.204 -0.522 . . . . 44.149999999999999 113.194 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.611 ' O ' HG12 ' A' ' 170' ' ' VAL . 80.1 p -69.18 -64.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 73.030000000000001 111.083 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 163.7 15.33 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.516 -0.766 . . . . 62.149999999999999 112.601 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG2' HG21 ' A' ' 109' ' ' THR . 28.8 Cg_endo -60.88 160.49 25.18 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.046 2.497 . . . . 73.510000000000005 113.114 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 109' ' ' THR . 26.3 Cg_exo -63.6 161.3 32.37 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.665 2.91 . . . . 50.409999999999997 113.967 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -44.7 -37.81 3.97 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.342 -0.845 . . . . 64.219999999999999 111.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -50.83 -22.05 1.99 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.503 0.557 . . . . 65.099999999999994 112.503 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 106' ' ' PRO . 11.3 t -80.97 -25.45 37.32 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.558 0.948 . . . . 62.219999999999999 113.558 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.62 -163.91 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.577 -0.821 . . . . 62.020000000000003 112.444 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 39.7 tp -46.19 109.23 0.17 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.085 0.469 . . . . 62.109999999999999 111.745 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -113.2 142.52 45.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.732 -0.667 . . . . 72.540000000000006 109.691 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.584 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -95.55 88.08 4.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.704 . . . . 74.530000000000001 112.579 -177.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 9.8 t80 -73.5 120.13 18.67 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.127 -0.629 . . . . 74.109999999999999 109.513 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.837 HG21 HD13 ' A' ' 9' ' ' LEU . 25.9 mt -113.42 130.82 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 111.979 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -102.45 125.18 49.08 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.712 -0.676 . . . . 74.540000000000006 109.585 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 118' ' ' LEU . 6.5 tt -119.27 135.26 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 110.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.675 ' N ' HD23 ' A' ' 117' ' ' LEU . 64.6 tp -119.46 136.39 54.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.718 -0.674 . . . . 62.32 110.47 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 153' ' ' LEU . 64.0 t80 -144.14 135.67 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 65.230000000000004 111.029 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.621 ' HA ' HD23 ' A' ' 56' ' ' LEU . 94.8 mtt180 -64.83 130.39 43.29 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.787 -0.365 . . . . 71.310000000000002 110.185 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.749 ' NE2' HD11 ' A' ' 125' ' ' ILE . 26.8 tt0 -107.74 127.48 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.556 -0.535 . . . . 70.409999999999997 109.556 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -99.84 -39.02 8.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.6 0.593 . . . . 75.420000000000002 112.6 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -102.8 136.91 41.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.181 0.808 . . . . 74.120000000000005 113.181 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' HD22 ' A' ' 83' ' ' ASN . 22.8 tptm -72.13 114.19 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.261 -0.881 . . . . 74.019999999999996 109.787 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.749 HD11 ' NE2' ' A' ' 121' ' ' GLN . 5.3 pt -115.71 132.59 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.006 -0.543 . . . . 62.329999999999998 112.178 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -59.18 -53.09 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.276 0.56 . . . . 65.450000000000003 109.977 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.736 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.0 mm-40 60.72 38.45 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.159 -0.928 . . . . 73.310000000000002 111.531 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 127' ' ' GLU . 41.0 p 54.84 149.84 0.05 OUTLIER Pre-proline 0 C--O 1.223 -0.322 0 O-C-N 123.741 0.651 . . . . 70.239999999999995 112.632 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.45 147.37 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.16 2.573 . . . . 75.209999999999994 112.755 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.502 ' CG2' ' HB2' ' A' ' 96' ' ' SER . 1.4 m -58.44 119.61 7.3 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 110.471 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 42.0 mm -80.89 133.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.461 -0.336 . . . . 61.009999999999998 110.653 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 134' ' ' THR . 29.0 t -73.95 148.01 42.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.967 -0.561 . . . . 73.109999999999999 111.143 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.566 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 19.7 p-10 -62.92 -41.24 99.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 73.319999999999993 109.994 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 12.2 t -75.02 22.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.626 -0.716 . . . . 74.310000000000002 110.974 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 133' ' ' ASN . 2.9 t -62.33 119.55 9.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.404 0.621 . . . . 61.200000000000003 112.627 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 137' ' ' THR . 23.5 tpt180 -65.48 167.3 8.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.931 -1.032 . . . . 70.200000000000003 110.621 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.808 ' HA ' HD11 ' A' ' 140' ' ' LEU . 11.0 m -44.47 151.04 0.29 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 61.299999999999997 111.521 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 139' ' ' ARG . . . 116.14 -8.86 18.27 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.974 -0.631 . . . . 43.0 113.605 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.526 ' H ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -152.87 50.72 0.74 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.399 0.599 . . . . 70.310000000000002 111.288 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.808 HD11 ' HA ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -114.22 -56.82 2.35 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.617 -0.512 . . . . 62.32 109.617 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.0 OUTLIER -62.91 119.79 10.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.703 -0.68 . . . . 70.299999999999997 111.165 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 175.46 133.48 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 72.140000000000001 110.081 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.588 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -80.6 124.06 28.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.992 0.425 . . . . 73.120000000000005 111.915 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.91 96.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.453 -0.34 . . . . 53.240000000000002 111.808 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -46.49 -27.39 1.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 63.399999999999999 111.714 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.588 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 28.3 t70 -56.92 -42.75 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.602 -0.272 . . . . 72.420000000000002 111.47 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 24.3 m-85 -54.94 -38.14 67.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.59 0.71 . . . . 75.299999999999997 109.531 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -70.83 -41.13 71.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.078 -0.965 . . . . 54.100000000000001 110.55 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.39 -47.64 78.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 64.310000000000002 111.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.37 -53.25 59.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.056 0.761 . . . . 73.219999999999999 113.056 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.542 ' HB3' HD21 ' A' ' 153' ' ' LEU . 18.1 t-80 -94.69 11.64 30.55 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.8 -0.76 . . . . 61.340000000000003 111.716 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.51 94.61 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.676 -0.773 . . . . 74.340000000000003 113.837 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.781 HD13 HG21 ' A' ' 57' ' ' THR . 9.5 mt -79.78 16.02 1.24 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.618 -0.342 . . . . 74.299999999999997 110.469 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -36.65 -72.43 0.15 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.701 -0.681 . . . . 75.140000000000001 114.766 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.52 113.09 16.69 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 117.05 0.425 . . . . 61.5 111.316 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 134.82 10.55 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.805 2.337 . . . . 74.439999999999998 113.424 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.607 HD13 ' HG3' ' A' ' 120' ' ' ARG . 43.1 pt -75.85 -37.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.44 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 16' ' ' THR . . . -152.03 134.92 15.62 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.612 -0.267 . . . . 65.519999999999996 110.734 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -140.0 151.83 45.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 75.209999999999994 111.301 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.507 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.4 t-20 -154.15 142.37 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.698 -1.223 . . . . 73.540000000000006 107.698 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.648 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -146.8 162.99 37.45 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.461 0.541 . . . . 73.329999999999998 112.461 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p90 -154.28 153.81 32.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.263 -0.88 . . . . 73.340000000000003 110.875 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.495 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 52.3 mt-30 -110.86 135.07 51.97 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.953 -0.388 . . . . 71.120000000000005 109.953 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.417 ' CA ' HD12 ' A' ' 111' ' ' LEU . . . -155.47 149.48 25.58 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.918 1.081 . . . . 51.530000000000001 113.918 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.4 OUTLIER -137.61 157.34 46.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.359 -1.292 . . . . 71.200000000000003 107.825 177.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.92 167.53 20.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 74.030000000000001 111.864 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 169' ' ' TYR . 53.3 m-20 -56.68 150.12 16.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.328 -0.851 . . . . 74.409999999999997 111.327 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.651 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 19.3 t0 -54.79 -8.87 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 72.329999999999998 110.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.455 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 22.2 t80 -60.02 -40.98 91.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.905 -0.589 . . . . 75.329999999999998 111.221 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.703 HG13 ' NH1' ' A' ' 173' ' ' ARG . 21.5 t -63.66 -53.84 47.49 Favored Pre-proline 0 C--O 1.235 0.308 0 N-CA-C 109.464 -0.569 . . . . 74.549999999999997 109.464 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 50.9 Cg_exo -52.01 -31.62 44.88 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.872 1.715 . . . . 74.340000000000003 111.79 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 168' ' ' ASP . 50.7 mt -50.46 -34.52 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.495 -0.321 . . . . 75.129999999999995 110.431 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 1.015 ' O ' HG22 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.94 -37.69 14.94 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.647 -0.501 . . . . 73.129999999999995 109.647 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -56.46 -35.63 68.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.109 -0.496 . . . . 74.549999999999997 111.454 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 12.9 mptt -57.37 -33.23 67.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.368 -0.207 . . . . 62.200000000000003 111.422 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 1.015 HG22 ' O ' ' A' ' 173' ' ' ARG . 10.9 t -69.59 -10.3 57.61 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.617 -0.433 . . . . 74.329999999999998 111.254 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.637 ' CD1' HD11 ' A' ' 77' ' ' LEU . 83.8 mt -63.62 127.23 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.562 -0.29 . . . . 61.310000000000002 110.529 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.25 3.31 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.169 0.433 . . . . 74.519999999999996 112.169 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.396 -1.225 . . . . 44.240000000000002 112.519 -179.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.463 0.202 0 N-CA-C 110.557 -0.164 . . . . 74.319999999999993 110.557 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -109.8 -72.86 0.7 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.891 0.7 . . . . 60.32 112.891 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -89.15 53.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.594 0.712 . . . . 52.549999999999997 111.588 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 10' ' ' ASP . 8.8 p -135.13 139.31 31.45 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.095 -0.957 . . . . 73.099999999999994 110.459 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 5' ' ' VAL . 78.0 Cg_endo -83.98 35.69 2.62 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.83 -1.321 . . . . 75.319999999999993 113.177 0.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.4 t0 -61.38 -52.56 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.238 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 7' ' ' ASP . 15.8 m -158.88 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 65.140000000000001 111.789 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.716 HD23 ' HD3' ' A' ' 13' ' ' PRO . 15.9 tp -157.34 140.22 15.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.319 0.581 . . . . 72.530000000000001 111.444 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 3.5 p-10 -58.82 -26.74 64.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 112.169 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.96 130.93 13.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 72.030000000000001 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 12' ' ' VAL . 8.2 p -65.82 115.12 19.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.571 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.716 ' HD3' HD23 ' A' ' 9' ' ' LEU . 31.7 Cg_endo -94.22 143.94 1.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.965 2.443 . . . . 74.239999999999995 112.174 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.9 -30.84 47.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.39 0.614 . . . . 41.009999999999998 110.026 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.3 -166.96 15.62 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.819 -1.082 . . . . 73.140000000000001 110.63 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 9.7 t -121.99 172.95 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.498 0.649 . . . . 74.209999999999994 111.183 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 158' ' ' ALA . 6.4 mt -105.47 128.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 75.439999999999998 110.426 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 3.2 mmmp? -73.8 107.07 5.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.915 -0.772 . . . . 70.340000000000003 108.915 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.2 t -123.0 109.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 60.210000000000001 110.689 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 25' ' ' LEU . 39.2 mt -100.93 123.11 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.183 -0.917 . . . . 62.009999999999998 109.871 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.98 -36.54 64.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.581 -0.736 . . . . 60.0 111.877 -178.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.81 -63.07 0.15 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 120.232 -0.985 . . . . 73.019999999999996 112.675 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -166.81 -61.21 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.522 -0.547 . . . . 73.329999999999998 109.522 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.98 -48.88 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 110.67 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.6 pp -69.57 147.74 50.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.415 0.626 . . . . 73.209999999999994 111.602 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 11.3 tt0 -143.37 144.95 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.525 -0.761 . . . . 75.25 110.699 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 19' ' ' VAL . 24.3 m -79.93 106.37 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 71.549999999999997 109.513 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 56.2 mttm -103.64 124.75 49.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.179 1.177 . . . . 70.540000000000006 114.179 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.4 mp0 26.9 67.45 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.985 1.476 . . . . 54.439999999999998 114.985 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' CA ' ' CD2' ' A' ' 161' ' ' TYR . . . 74.76 5.56 74.82 Favored Glycine 0 CA--C 1.51 -0.241 0 N-CA-C 115.083 0.793 . . . . 42.200000000000003 115.083 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -57.12 161.95 2.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.591 0.696 . . . . 70.239999999999995 110.029 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.509 ' CD ' HE22 ' A' ' 165' ' ' GLN . 32.5 tt0 -109.8 143.71 39.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 72.510000000000005 110.389 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 32' ' ' GLU . 9.5 mp -116.35 120.16 37.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.76 -0.459 . . . . 74.510000000000005 109.76 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -150.49 163.92 22.36 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.846 -0.616 . . . . 72.109999999999999 110.082 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 94.4 Cg_endo -86.92 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.772 -1.345 . . . . 73.230000000000004 112.841 0.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.415 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 70.2 p -104.27 22.62 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.55 -0.295 . . . . 74.319999999999993 111.686 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -81.79 -7.64 59.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.317 -0.553 . . . . 70.209999999999994 110.061 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.514 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 24.6 m -91.29 26.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 72.25 111.642 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.49 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -85.71 -14.57 44.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 110.648 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.3 141.44 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.805 -0.634 . . . . 73.239999999999995 112.487 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.17 134.89 95.99 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 115.513 -0.767 . . . . 65.420000000000002 110.849 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.2 Cg_endo -73.5 135.88 22.85 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.881 2.388 . . . . 71.299999999999997 113.508 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 48.5 mm -107.19 125.83 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.352 . . . . 73.25 110.423 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.1 p -98.54 146.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.391 0.515 . . . . 65.239999999999995 112.391 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -165.12 146.49 7.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.132 0.492 . . . . 65.439999999999998 111.579 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HH2' HG21 ' A' ' 84' ' ' ILE . 5.2 p90 -121.39 29.9 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.402 -0.592 . . . . 71.310000000000002 109.402 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 t -43.29 131.21 4.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.603 -0.726 . . . . 55.210000000000001 110.696 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.16 -35.76 3.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 64.099999999999994 112.683 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -72.24 -33.87 67.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.557 0.694 . . . . 72.340000000000003 109.341 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.5 tt0 -58.06 142.08 47.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.163 -0.926 . . . . 74.400000000000006 109.194 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.29 -65.74 0.02 OUTLIER Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.036 -1.078 . . . . 45.200000000000003 112.863 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.74 109.34 4.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.838 0.352 . . . . 55.409999999999997 110.162 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m -158.36 141.17 14.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 110.528 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -70.15 -40.42 74.78 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.198 0.999 . . . . 63.329999999999998 108.328 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 83' ' ' ASN . 27.1 mt -155.16 161.26 41.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.76 -1.564 . . . . 74.230000000000004 109.269 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.9 mt -125.07 146.54 49.4 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.178 0.514 . . . . 61.420000000000002 110.358 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.726 HG21 HD21 ' A' ' 153' ' ' LEU . 4.2 m -106.91 127.35 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.744 . . . . 74.120000000000005 109.993 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.3 tm? -130.93 118.5 20.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.363 -0.606 . . . . 75.219999999999999 109.363 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 147' ' ' PHE . 70.4 mt -149.36 132.09 15.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.968 -0.693 . . . . 74.329999999999998 112.043 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 48.3 ttp -94.73 148.4 22.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.731 -0.841 . . . . 73.530000000000001 108.731 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.456 HG22 ' HB1' ' A' ' 144' ' ' ALA . 52.9 t -139.33 145.02 27.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.534 0.683 . . . . 74.129999999999995 112.57 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -175.9 82.93 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 114.067 -1.424 . . . . 74.310000000000002 109.361 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.52 84.39 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.8 2.333 . . . . 72.209999999999994 111.84 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.597 ' CB ' HH12 ' A' ' 113' ' ' ARG . 3.2 t0 -170.22 122.5 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.753 0.649 . . . . 73.349999999999994 112.753 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -173.13 130.74 0.58 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.97 -0.292 . . . . 72.310000000000002 111.554 175.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.06 -12.54 24.12 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.257 -1.56 . . . . 62.109999999999999 109.025 -4.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.4 t -151.99 142.82 22.95 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.992 -1.458 . . . . 72.010000000000005 109.661 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -58.87 -31.13 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.408 . . . . 75.329999999999998 110.751 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -60.32 -41.62 93.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.442 -0.799 . . . . 73.230000000000004 111.819 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 28.1 m-20 -138.1 71.3 48.05 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.449 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 27.6 Cg_exo -61.29 112.65 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.242 1.961 . . . . 72.019999999999996 111.122 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -101.27 -51.43 3.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.86 0.362 . . . . 71.019999999999996 111.631 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 18.3 p90 -116.24 24.81 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 75.099999999999994 109.997 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 1.3 tmt_? -73.84 138.03 44.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.154 -0.93 . . . . 63.25 109.643 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 143' ' ' ASN . 4.9 mm-40 -75.11 170.12 16.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.63 1.172 . . . . 64.109999999999999 111.346 0.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.756 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.8 tp -119.27 168.38 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 75.5 111.189 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' N ' HG13 ' A' ' 76' ' ' ILE . 73.2 mt -54.83 133.72 47.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.357 0.598 . . . . 65.150000000000006 111.747 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.8 -169.38 2.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.183 -0.917 . . . . 72.120000000000005 109.119 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.486 ' HA ' ' HE3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -98.6 104.47 16.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.219 -1.03 . . . . 71.340000000000003 108.219 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.729 ' HA ' HD23 ' A' ' 59' ' ' LEU . 1.5 m -119.0 117.37 28.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 73.120000000000005 110.985 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 96' ' ' SER . 1.7 t -141.73 130.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 74.010000000000005 109.405 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.801 HG21 ' HG3' ' A' ' 127' ' ' GLU . 32.2 m -141.69 166.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.057 0.456 . . . . 70.019999999999996 111.559 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.689 ' O ' HD22 ' A' ' 55' ' ' LEU . 22.9 p30 64.16 39.22 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.655 -1.157 . . . . 73.150000000000006 109.524 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.983 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.8 mm -77.2 115.44 48.94 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 114.408 -1.269 . . . . 72.310000000000002 108.991 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' SER . 51.0 Cg_exo -53.1 127.67 25.97 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.692 1.594 . . . . 74.519999999999996 111.774 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.43 69.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.33 -0.462 . . . . 73.439999999999998 112.854 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 85' ' ' PRO . 29.3 t 177.31 48.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.66 0.384 . . . . 65.530000000000001 110.097 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 90' ' ' ASN . 70.2 m-80 -135.68 -22.36 1.46 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.029 0.752 . . . . 60.149999999999999 113.029 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 70.87 -22.18 0.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.867 0.365 . . . . 74.200000000000003 110.784 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.537 ' H ' ' C ' ' A' ' 88' ' ' ASN . 10.3 p30 -152.17 158.16 33.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 115.873 -0.603 . . . . 64.530000000000001 109.575 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 44' ' ' VAL . 81.9 Cg_endo -70.92 48.2 0.81 Allowed 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 123.29 2.66 . . . . 73.439999999999998 114.307 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 t -97.53 -8.29 29.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.06 -0.656 . . . . 72.430000000000007 111.797 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.35 -40.74 1.46 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.585 -0.816 . . . . 72.5 114.26 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.983 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.21 171.87 7.65 Favored Glycine 0 N--CA 1.459 0.208 0 C-N-CA 120.847 -0.692 . . . . 74.040000000000006 113.037 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.646 ' CE1' HG23 ' A' ' 130' ' ' THR . 52.5 t60 -70.89 118.82 14.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.584 0.23 . . . . 74.439999999999998 111.455 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 81' ' ' VAL . 66.3 p -81.05 91.05 6.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.936 -0.764 . . . . 75.219999999999999 108.936 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 82' ' ' VAL . 10.6 mt -49.3 -52.4 27.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 63.219999999999999 110.048 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -137.08 117.41 13.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 53.329999999999998 108.885 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.484 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 50.6 t0 -55.78 151.08 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.767 0.667 . . . . 72.200000000000003 111.649 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.414 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.5 p90 -60.35 151.3 28.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 73.209999999999994 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.21 152.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.424 -0.353 . . . . 71.340000000000003 110.149 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.457 ' C ' HG12 ' A' ' 170' ' ' VAL . . . -46.19 -72.84 0.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.963 -0.637 . . . . 71.219999999999999 112.429 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -171.15 124.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 72.430000000000007 110.471 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -68.29 -49.15 47.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.524 -0.846 . . . . 62.420000000000002 111.511 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CB ' HG21 ' A' ' 109' ' ' THR . 2.7 Cg_exo -77.78 114.59 3.67 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.851 2.367 . . . . 73.409999999999997 112.017 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 109' ' ' THR . 26.6 Cg_exo -62.69 160.91 30.53 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.135 2.556 . . . . 62.43 111.861 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.546 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.98 -28.05 2.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.343 -0.389 . . . . 63.329999999999998 111.419 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.546 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 87.0 m-20 -51.64 -40.0 59.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 74.519999999999996 112.025 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 106' ' ' PRO . 14.7 t -71.06 -2.91 17.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.755 -0.378 . . . . 53.219999999999999 111.254 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 69.95 -126.72 17.64 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 116.106 -0.497 . . . . 73.329999999999998 113.673 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 163' ' ' GLN . 31.0 tp -66.96 145.48 55.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.8 0.809 . . . . 72.409999999999997 112.505 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 19.0 m80 -120.02 167.05 12.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.99 -1.459 . . . . 71.219999999999999 110.037 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.597 HH12 ' CB ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -141.0 75.4 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.972 -0.751 . . . . 73.109999999999999 108.972 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.38 120.79 22.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.581 -0.736 . . . . 73.439999999999998 109.659 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' A' ' 161' ' ' TYR . 11.9 mt -116.02 122.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.094 0.473 . . . . 54.219999999999999 112.025 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -91.01 130.57 36.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.43 -0.805 . . . . 74.420000000000002 109.064 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.3 tm? -119.27 136.19 54.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 64.540000000000006 110.168 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.6 tt -136.84 129.68 30.65 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.338 -0.392 . . . . 73.549999999999997 110.053 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.732 ' N ' HD23 ' A' ' 118' ' ' LEU . 62.8 t80 -144.16 143.65 31.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 71.140000000000001 110.971 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -63.13 119.99 10.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.848 -0.427 . . . . 55.520000000000003 109.848 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 7.0 tt0 -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.493 -0.558 . . . . 71.310000000000002 109.493 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' C ' HD22 ' A' ' 123' ' ' ASN . 30.4 tt0 -94.4 -31.08 14.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 61.25 111.047 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.6 m120 -98.16 129.99 44.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.81 -0.632 . . . . 70.319999999999993 111.19 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 125' ' ' ILE . 19.7 tptp -74.11 129.85 38.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.706 -0.479 . . . . 72.530000000000001 109.706 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 pt -141.95 137.6 30.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 61.409999999999997 112.045 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -79.49 -39.54 31.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.963 -0.562 . . . . 63.43 111.111 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.801 ' HG3' HG21 ' A' ' 82' ' ' VAL . 61.5 mm-40 56.69 39.65 29.62 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.531 0.567 . . . . 75.200000000000003 112.531 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 65.2 p 56.71 161.3 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.702 0.626 . . . . 70.299999999999997 112.171 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 76.6 Cg_exo -52.6 157.05 7.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.775 2.317 . . . . 75.329999999999998 113.515 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.646 HG23 ' CE1' ' A' ' 95' ' ' HIS . 12.2 p -59.51 120.54 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.444 -0.798 . . . . 75.510000000000005 112.085 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 131' ' ' ILE . 21.6 mm -83.91 127.2 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.715 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -63.69 140.77 58.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.976 -1.011 . . . . 64.340000000000003 112.322 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.731 ' OD1' HG23 ' A' ' 134' ' ' THR . 19.8 p30 -57.76 -47.88 81.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.255 0.55 . . . . 73.099999999999994 110.421 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.85 ' HA ' HD13 ' A' ' 177' ' ' ILE . 13.4 p -79.69 24.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.417 -0.81 . . . . 74.5 111.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.7 t -60.77 125.29 23.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.304 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 137' ' ' THR . 22.3 tpt180 -71.53 173.25 8.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.204 -0.907 . . . . 74.349999999999994 110.573 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 35.6 m -39.37 146.17 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.879 0.371 . . . . 72.25 111.32 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.29 -10.08 28.79 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.177 -0.535 . . . . 31.440000000000001 112.264 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 1.9 mmp_? -141.68 32.15 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.721 -0.282 . . . . 71.209999999999994 111.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 76' ' ' ILE . 29.5 mt -101.45 -55.8 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.247 0.546 . . . . 75.519999999999996 110.262 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.8 m120 -64.7 112.03 3.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 61.32 110.84 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -163.51 109.81 1.12 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.584 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 51.7 t30 -64.18 91.8 0.08 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.561 -0.745 . . . . 74.030000000000001 111.221 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -48.92 -40.63 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.41 0.624 . . . . 42.030000000000001 110.091 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -46.62 -36.41 6.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.96 -1.018 . . . . 71.209999999999994 110.902 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.41 -42.46 53.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.382 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 59' ' ' LEU . 20.5 m-85 -48.91 -39.24 25.35 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.112 -0.495 . . . . 64.450000000000003 110.617 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.55 -35.57 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.645 -0.707 . . . . 62.240000000000002 109.833 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.92 -59.27 2.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.802 -0.636 . . . . 74.230000000000004 111.849 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 10.6 ptpt -63.82 -45.12 91.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.416 0.525 . . . . 75.310000000000002 112.416 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.605 ' CD2' ' HD3' ' A' ' 150' ' ' LYS . 58.3 m170 -91.61 8.19 37.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 75.129999999999995 110.589 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.63 25.0 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.79 -0.641 . . . . 73.540000000000006 114.183 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' THR . 14.6 mt -76.71 16.72 0.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.902 0.334 . . . . 65.209999999999994 111.902 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.53 -45.59 29.7 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.75 -0.738 . . . . 51.119999999999997 112.564 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -108.81 83.13 1.99 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.886 0.374 . . . . 72.040000000000006 110.116 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 44.3 Cg_endo -68.33 137.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.762 2.308 . . . . 65.219999999999999 113.456 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.57 HD11 HD22 ' A' ' 118' ' ' LEU . 30.6 pt -79.33 -33.41 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.235 -0.654 . . . . 74.129999999999995 109.235 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -142.34 142.87 32.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.665 -0.698 . . . . 64.230000000000004 110.734 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.614 ' HB3' ' HG3' ' A' ' 13' ' ' PRO . . . -153.58 157.88 40.36 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 74.230000000000004 109.215 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.457 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.2 t-20 -165.61 118.62 1.15 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.632 -0.507 . . . . 75.219999999999999 109.632 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -103.13 151.26 22.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.308 -0.86 . . . . 72.319999999999993 110.936 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 164' ' ' ALA . 3.7 t80 -145.96 130.64 17.96 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.422 -0.808 . . . . 73.310000000000002 111.005 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.499 ' HB3' HD11 ' A' ' 111' ' ' LEU . 46.1 mt-30 -110.59 134.75 52.12 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.894 -0.594 . . . . 75.540000000000006 110.366 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -157.81 152.9 25.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.106 0.41 . . . . 63.310000000000002 112.106 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.509 HE22 ' CD ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -135.18 133.03 38.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.572 -1.269 . . . . 64.310000000000002 107.572 176.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.13 152.96 30.09 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.033 -0.358 . . . . 72.409999999999997 110.033 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.4 m-20 -52.84 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.742 0.782 . . . . 52.329999999999998 111.533 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.559 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.1 t70 -58.93 -3.29 0.32 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.141 -0.936 . . . . 72.030000000000001 111.078 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 167' ' ' ASP . 42.2 t80 -42.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 111.897 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.614 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 4.9 t -57.25 -51.83 78.75 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.184 -0.673 . . . . 62.119999999999997 109.184 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.3 Cg_exo -49.57 -18.7 2.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.523 2.149 . . . . 71.409999999999997 112.622 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 168' ' ' ASP . 73.1 mt -50.68 -41.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.395 -0.595 . . . . 73.150000000000006 109.395 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -55.19 -31.68 61.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.582 -0.736 . . . . 72.439999999999998 110.694 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -53.29 -43.05 67.2 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.426 -0.953 . . . . 71.409999999999997 108.426 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 168' ' ' ASP . 9.9 mptt -62.3 -31.04 71.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.381 -0.827 . . . . 64.25 110.09 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 178' ' ' VAL . 7.1 m -66.43 -26.68 67.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.393 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.5 mm -48.72 107.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 73.319999999999993 111.017 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 176' ' ' THR . 27.9 m -154.15 25.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.69 0.256 . . . . 71.230000000000004 111.69 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.665 -1.075 . . . . 65.140000000000001 112.597 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.581 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.2 p-10 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 112.481 0.549 . . . . 71.5 112.481 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 54.6 t0 -71.0 -52.16 21.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 71.109999999999999 110.578 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 9' ' ' LEU . 9.7 pt -135.4 49.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.212 0.53 . . . . 73.430000000000007 111.099 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 2' ' ' ASP . 9.8 p -133.5 140.06 35.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.866 -0.607 . . . . 71.329999999999998 110.305 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.533 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.38 29.74 3.38 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.752 -1.353 . . . . 61.539999999999999 112.954 0.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.5 t70 -56.21 -47.26 78.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 74.349999999999994 109.839 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 7' ' ' ASP . 6.5 m -163.69 -41.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 75.150000000000006 111.452 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HD3' ' A' ' 13' ' ' PRO . 31.4 tp -157.1 158.84 37.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.843 0.354 . . . . 75.129999999999995 111.319 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -52.34 -46.58 66.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.394 -0.595 . . . . 70.329999999999998 109.394 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -152.59 146.71 25.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.642 -0.708 . . . . 53.439999999999998 110.369 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.92 118.54 33.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.067 0.395 . . . . 72.450000000000003 112.067 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.673 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.1 Cg_endo -90.06 -120.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 74.409999999999997 112.261 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -158.58 -43.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 51.350000000000001 110.345 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.52 -173.54 13.27 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.975 -0.631 . . . . 74.340000000000003 111.801 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -131.73 162.95 29.26 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.206 0.527 . . . . 71.329999999999998 111.052 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 44' ' ' VAL . 8.2 mt -105.31 137.75 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.21 -0.904 . . . . 75.430000000000007 110.758 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.1 mmmt -73.61 102.24 3.84 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.594 -0.521 . . . . 65.340000000000003 109.594 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 27' ' ' VAL . 88.7 t -110.07 109.84 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 119.994 -0.682 . . . . 62.009999999999998 109.726 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' LEU . 2.8 mp -100.38 124.03 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.661 -0.7 . . . . 73.430000000000007 109.771 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -76.74 -32.05 57.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.908 -0.587 . . . . 74.209999999999994 111.893 -178.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.13 -61.89 0.14 Allowed Glycine 0 N--CA 1.459 0.227 0 C-N-CA 120.767 -0.73 . . . . 73.230000000000004 112.175 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.421 ' CA ' HG21 ' A' ' 20' ' ' ILE . 32.6 t70 -173.42 -58.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 75.329999999999998 108.235 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -83.67 -45.15 13.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.944 -0.762 . . . . 72.209999999999994 108.944 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -69.67 131.6 44.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.25 -0.886 . . . . 70.510000000000005 112.389 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' ILE . 5.9 tt0 -135.91 146.78 47.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 72.099999999999994 110.245 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 19' ' ' VAL . 34.1 m -82.95 106.55 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.182 0.515 . . . . 74.310000000000002 111.912 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 11.6 mptt -74.57 92.5 2.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.307 0.575 . . . . 64.430000000000007 111.452 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.4 mp0 24.67 66.79 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 114.379 1.252 . . . . 74.319999999999993 114.379 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.07 -3.06 55.3 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 115.07 0.788 . . . . 53.219999999999999 115.07 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.458 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -58.84 167.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.33 0.565 . . . . 71.219999999999999 112.453 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' LEU . 4.0 tt0 -101.89 141.83 34.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.739 -1.119 . . . . 75.150000000000006 110.026 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 27' ' ' VAL . 10.7 mp -108.73 130.38 55.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 53.340000000000003 110.983 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.1 p -148.34 164.19 23.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.665 . . . . 52.030000000000001 110.542 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 64.3 Cg_endo -73.32 -40.76 1.13 Allowed 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.855 -1.31 . . . . 72.319999999999993 112.899 0.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.3 p -150.88 30.6 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.451 0.644 . . . . 62.530000000000001 110.837 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.584 ' OE1' HD13 ' A' ' 25' ' ' LEU . 15.5 pt20 -66.03 -2.88 4.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 55.130000000000003 110.463 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.74 -3.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.411 0.624 . . . . 70.430000000000007 109.937 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -65.72 6.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 75.219999999999999 112.282 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CG ' HE22 ' A' ' 41' ' ' GLN . 14.1 t0 -136.18 148.72 48.27 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.048 0.451 . . . . 73.430000000000007 111.648 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.0 pm0 -73.13 144.41 84.77 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.849 . . . . 64.129999999999995 113.14 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 72.9 Cg_endo -77.1 131.61 12.06 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.18 2.587 . . . . 74.299999999999997 113.928 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -105.29 117.24 50.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.079 -0.51 . . . . 52.030000000000001 110.049 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.92 HG23 HG21 ' A' ' 17' ' ' ILE . 2.7 p -88.85 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.783 0.66 . . . . 73.319999999999993 112.783 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 66.7 m -160.77 133.25 6.17 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.49 -0.323 . . . . 73.099999999999994 111.438 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 9.4 p90 -106.35 24.98 11.65 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.86 0.362 . . . . 75.549999999999997 110.787 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 m -43.29 118.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.777 -0.647 . . . . 65.340000000000003 111.367 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 104.67 -33.84 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.092 -0.504 . . . . 45.219999999999999 112.245 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 8.0 mp -75.33 -37.74 60.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.913 0.387 . . . . 53.530000000000001 110.409 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 48' ' ' GLY . 10.0 pm0 -49.86 153.08 1.37 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.145 -0.48 . . . . 55.450000000000003 109.918 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.41 -73.24 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.937 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -148.89 108.93 4.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.773 -0.454 . . . . 73.430000000000007 109.773 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 2.8 p -158.83 143.13 15.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 72.329999999999998 110.999 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 10.7 t30 -74.09 -33.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.458 0.647 . . . . 73.019999999999996 109.328 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 83' ' ' ASN . 59.6 mt -157.32 178.38 10.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 74.150000000000006 110.632 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 120' ' ' ARG . 83.1 mt -142.44 165.02 28.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.696 -0.853 . . . . 65.420000000000002 108.696 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.888 HG23 HG12 ' A' ' 82' ' ' VAL . 26.7 m -136.93 123.4 20.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.507 0.194 . . . . 73.400000000000006 110.689 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.75 127.3 49.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.152 -0.477 . . . . 71.340000000000003 111.059 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 HD12 ' A' ' 97' ' ' LEU . 86.9 mt -146.79 141.03 26.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 73.420000000000002 111.278 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.8 ttm -94.28 129.55 40.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 61.43 109.629 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' C ' ' CD ' ' A' ' 63' ' ' PRO . 38.9 t -103.6 62.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.502 -0.317 . . . . 74.239999999999995 111.637 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 25.6 p-10 -112.45 46.55 0.3 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.066 0.395 . . . . 74.120000000000005 112.066 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' HH22 ' A' ' 113' ' ' ARG . 57.5 Cg_endo -70.5 84.8 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.327 2.018 . . . . 71.340000000000003 114.289 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -168.87 114.35 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.391 0.615 . . . . 73.120000000000005 110.711 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.574 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -170.75 139.58 1.34 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.076 -0.965 . . . . 61.299999999999997 110.933 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.7 Cg_exo -65.0 -18.4 6.47 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.986 -1.256 . . . . 73.349999999999994 110.994 -0.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 70' ' ' ASP . 10.0 t -165.17 146.48 7.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.169 -0.923 . . . . 65.439999999999998 110.036 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -49.3 -29.68 6.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.451 0.643 . . . . 75.349999999999994 110.481 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.403 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 1.3 mp0 -69.9 -31.87 69.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.577 -1.192 . . . . 71.209999999999994 112.948 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 71' ' ' PRO . 14.2 t0 -144.23 61.06 8.57 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 121.155 0.503 . . . . 55.240000000000002 110.031 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.561 ' CB ' ' HE ' ' A' ' 74' ' ' ARG . 7.5 Cg_exo -72.77 55.14 2.67 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.019 2.479 . . . . 74.329999999999998 113.627 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 70' ' ' ASP . 31.6 mttp -48.98 -54.8 14.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.405 0.52 . . . . 73.219999999999999 112.405 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -117.47 41.7 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.956 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' A' ' 71' ' ' PRO . 2.4 tmm_? -82.87 141.87 31.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 72.230000000000004 110.424 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' OE2' ' ND1' ' A' ' 78' ' ' HIS . 11.8 pt-20 -94.9 178.5 5.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.917 0.887 . . . . 61.520000000000003 111.126 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.574 HG12 ' CB ' ' A' ' 65' ' ' ALA . 13.0 mm -97.89 -120.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.673 . . . . 73.519999999999996 109.184 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 HG22 ' A' ' 135' ' ' THR . 4.4 mm? -89.97 174.31 7.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.972 -0.751 . . . . 51.119999999999997 108.972 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.44 ' ND1' ' OE2' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -172.91 165.16 5.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.574 0.225 . . . . 63.100000000000001 110.791 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.484 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -99.76 120.86 40.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.788 -0.819 . . . . 75.239999999999995 108.788 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.645 ' HB2' HD12 ' A' ' 97' ' ' LEU . 12.5 p -141.41 127.9 20.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 112.454 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -145.18 136.48 20.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.87 -0.605 . . . . 73.439999999999998 109.472 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.888 HG12 HG23 ' A' ' 57' ' ' THR . 31.3 m -138.11 166.62 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.554 -0.294 . . . . 71.040000000000006 111.112 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.644 ' O ' HD22 ' A' ' 55' ' ' LEU . 2.4 m120 63.68 33.15 13.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.363 -0.38 . . . . 63.32 110.502 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.005 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.0 mm -77.34 127.88 81.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.28 -0.568 . . . . 74.129999999999995 110.125 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 34.8 Cg_exo -54.07 127.91 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.26 1.307 . . . . 74.239999999999995 109.931 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -64.17 56.75 0.07 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.146 0.819 . . . . 23.530000000000001 115.146 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 7.4 t 178.05 38.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 117.528 0.664 . . . . 64.120000000000005 111.572 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 69.6 m-80 -119.87 13.84 12.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.845 0.313 . . . . 71.299999999999997 111.845 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' SER . 20.8 pt-20 39.2 26.54 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.397 0.517 . . . . 73.230000000000004 112.397 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 17.3 p30 169.94 151.21 0.15 Allowed Pre-proline 0 C--O 1.236 0.356 0 CA-C-O 121.12 0.486 . . . . 72.239999999999995 110.731 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 44' ' ' VAL . 83.3 Cg_endo -75.5 63.2 6.39 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 123.542 2.828 . . . . 61.210000000000001 112.86 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -104.12 -48.18 3.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.685 0.624 . . . . 74.340000000000003 112.685 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.44 -39.96 79.72 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 115.345 0.898 . . . . 42.229999999999997 115.345 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 1.005 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.52 171.74 8.43 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.65 -0.786 . . . . 63.009999999999998 114.044 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' VAL . 65.1 t60 -66.42 121.34 15.08 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.624 0.37 . . . . 73.409999999999997 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 31.7 t -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.876 -1.157 . . . . 62.030000000000001 107.876 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' CE1' ' A' ' 147' ' ' PHE . 74.4 mt -63.68 -50.96 67.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.939 -0.763 . . . . 75.049999999999997 108.939 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 131' ' ' ILE . . . -143.24 125.6 15.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.762 -1.108 . . . . 53.200000000000003 109.367 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 133' ' ' ASN . 37.4 t0 -52.67 145.92 11.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.583 0.586 . . . . 41.100000000000001 112.583 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -65.15 151.15 46.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.301 -0.863 . . . . 73.340000000000003 110.685 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 9.6 p -158.52 174.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 110.071 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -67.76 178.88 18.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.391 -0.909 . . . . 52.549999999999997 111.994 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 112' ' ' HIS . 66.6 m -55.33 159.01 2.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.869 0.335 . . . . 72.340000000000003 111.371 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -97.41 -57.32 1.06 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.827 -0.624 . . . . 61.310000000000002 113.263 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 109' ' ' THR . 88.8 Cg_endo -79.23 123.01 5.41 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.914 2.409 . . . . 65.019999999999996 113.58 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 24.6 Cg_exo -62.67 162.49 24.63 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.041 2.494 . . . . 71.420000000000002 112.754 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.82 -24.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.743 -0.662 . . . . 70.230000000000004 112.456 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.8 m-20 -51.95 -39.34 59.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.005 -0.278 . . . . 62.539999999999999 110.604 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 105' ' ' PRO . 9.1 t -72.83 -14.92 61.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.459 0.647 . . . . 72.430000000000007 109.596 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 -130.01 9.42 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.136 -0.938 . . . . 52.140000000000001 112.187 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 163' ' ' GLN . 16.1 tp -66.48 127.83 33.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.455 -0.373 . . . . 75.049999999999997 111.966 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 164' ' ' ALA . 49.0 m170 -83.61 97.95 9.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.363 -0.38 . . . . 64.099999999999994 111.3 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.612 HH22 ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -75.89 68.35 2.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.565 . . . . 72.340000000000003 109.473 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.1 m-85 -81.43 146.79 30.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.728 -0.669 . . . . 63.229999999999997 111.632 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 54.7 mt -144.41 140.88 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 112.689 0.625 . . . . 72.219999999999999 112.689 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -107.75 134.72 50.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.011 -0.995 . . . . 73.150000000000006 109.28 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 118' ' ' LEU . 5.5 tt -121.81 132.22 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.234 -0.284 . . . . 71.400000000000006 110.234 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.739 ' N ' HD23 ' A' ' 117' ' ' LEU . 49.9 tp -124.15 136.8 54.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.464 -0.335 . . . . 72.109999999999999 110.952 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' THR . 53.6 t80 -141.97 134.96 28.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 72.019999999999996 110.417 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.586 ' HA ' HD23 ' A' ' 56' ' ' LEU . 5.1 tmm_? -72.62 133.4 44.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.383 -0.599 . . . . 64.200000000000003 109.383 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 151' ' ' HIS . 6.6 tp-100 -115.07 149.3 37.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.46 0.648 . . . . 63.329999999999998 112.452 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 88.1 tt0 -122.47 -38.97 2.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.009 -0.996 . . . . 71.439999999999998 111.24 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.72 134.6 34.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.308 0.484 . . . . 72.450000000000003 112.308 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -82.89 111.65 18.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.224 0.535 . . . . 70.299999999999997 110.932 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.512 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 1.3 pt -105.02 154.53 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.057 -0.974 . . . . 50.009999999999998 112.259 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -81.47 -49.97 9.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.924 0.392 . . . . 61.329999999999998 110.555 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 59.71 36.62 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.776 1.028 . . . . 73.319999999999993 113.776 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.633 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 68.6 p 52.16 145.38 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 123.51 0.724 . . . . 71.420000000000002 112.798 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -44.05 143.07 3.48 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.494 2.129 . . . . 51.299999999999997 112.204 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.8 t -59.08 143.4 48.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.765 -0.652 . . . . 64.120000000000005 111.691 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 98' ' ' ALA . 6.6 tp -110.89 133.37 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.52 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 m -70.99 142.12 50.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.805 -0.634 . . . . 74.549999999999997 110.623 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 135' ' ' THR . 18.8 p-10 -51.87 -38.99 58.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.199 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.756 ' HA ' HD13 ' A' ' 177' ' ' ILE . 15.3 t -67.82 22.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.165 -0.47 . . . . 62.149999999999999 111.58 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.686 HG22 HD11 ' A' ' 77' ' ' LEU . 11.7 t -64.11 128.31 35.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.869 0.366 . . . . 33.210000000000001 110.233 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' CB ' ' HA3' ' A' ' 179' ' ' GLY . 32.5 ttt180 -92.94 173.75 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.612 0.597 . . . . 64.140000000000001 112.612 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ARG . 20.9 m -26.32 131.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.557 -1.201 . . . . 73.040000000000006 111.61 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.3 4.86 32.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.468 -0.872 . . . . 54.509999999999998 111.16 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -146.93 35.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.741 0.305 . . . . 72.409999999999997 110.296 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 142' ' ' PHE . 13.6 mt -111.11 -71.04 0.78 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.219 -0.446 . . . . 54.119999999999997 111.257 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -51.61 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.356 -0.384 . . . . 73.319999999999993 110.154 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 1.5 t80 -150.47 72.49 1.1 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.249 0.833 . . . . 75.349999999999994 113.249 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -52.58 114.22 1.31 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.925 0.393 . . . . 74.219999999999999 110.752 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -48.26 -34.88 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.451 0.537 . . . . 74.329999999999998 112.451 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.4 ptt180 -43.69 -33.34 1.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.225 0.536 . . . . 75.209999999999994 111.099 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 145' ' ' ARG . 19.1 t70 -52.52 -46.1 66.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.571 -0.74 . . . . 64.530000000000001 111.306 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.841 ' CE1' HD13 ' A' ' 97' ' ' LEU . 85.4 m-85 -53.28 -50.39 64.96 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.337 0.589 . . . . 65.409999999999997 110.905 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -56.25 -42.24 77.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.795 -0.639 . . . . 54.420000000000002 110.437 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.73 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 72.420000000000002 111.466 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.618 ' CG ' ' N ' ' A' ' 151' ' ' HIS . 45.8 pttt -75.2 -59.08 2.9 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.72 0.295 . . . . 73.430000000000007 111.535 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.618 ' N ' ' CG ' ' A' ' 150' ' ' LYS . 18.4 t-160 -80.7 4.97 17.03 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.055 0.391 . . . . 73.349999999999994 112.055 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.83 27.98 65.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.72 -0.752 . . . . 21.239999999999998 113.286 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.55 HD21 ' ND1' ' A' ' 151' ' ' HIS . 25.6 mt -66.65 17.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 111.771 0.286 . . . . 70.409999999999997 111.771 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.65 -61.77 3.6 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.999 -0.62 . . . . 75.230000000000004 113.477 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.77 109.33 4.92 Favored Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.723 0.262 . . . . 63.350000000000001 111.145 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' GLY . 57.6 Cg_endo -89.86 132.46 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.402 2.068 . . . . 62.439999999999998 112.563 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 118' ' ' LEU . 37.8 pt -80.95 -35.37 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 62.420000000000002 110.711 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 157' ' ' ILE . . . -157.88 149.83 22.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.46 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -148.48 159.09 44.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.424 0.63 . . . . 73.340000000000003 111.319 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -155.2 144.61 21.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.042 -1.466 . . . . 72.230000000000004 107.042 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -149.76 176.25 10.86 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.718 -0.393 . . . . 71.109999999999999 111.398 -176.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 10.2 p90 -167.68 150.58 5.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.982 -0.554 . . . . 62.009999999999998 110.82 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.566 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 43.6 mt-30 -110.66 124.23 51.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 63.439999999999998 109.852 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -156.16 140.64 16.8 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.696 -0.402 . . . . 62.310000000000002 112.002 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -98.7 149.98 22.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.47 -0.567 . . . . 64.120000000000005 109.47 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.33 137.17 25.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.852 0.358 . . . . 73.319999999999993 111.165 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -150.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.679 -0.691 . . . . 72.150000000000006 112.648 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 172' ' ' ILE . 49.7 t0 -84.79 -23.6 29.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.133 -0.94 . . . . 72.310000000000002 111.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.417 ' CE1' ' NH2' ' A' ' 173' ' ' ARG . 17.2 t80 -41.81 -54.76 3.27 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.82 0.304 . . . . 71.400000000000006 111.82 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.672 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 69.2 t -65.64 -57.25 14.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.388 -0.525 . . . . 71.439999999999998 110.235 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 88.5 Cg_exo -45.18 -31.58 6.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.985 1.79 . . . . 63.420000000000002 112.05 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 168' ' ' ASP . 61.4 mt -51.91 -37.35 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.885 0.374 . . . . 74.329999999999998 110.307 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.489 ' H ' ' HD2' ' A' ' 173' ' ' ARG . 0.2 OUTLIER -53.7 -33.6 55.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.775 -0.454 . . . . 52.409999999999997 109.775 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 177' ' ' ILE . 69.0 m-80 -58.19 -31.65 67.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 64.430000000000007 111.031 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 2.6 mptp? -61.31 -13.57 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.29 -0.633 . . . . 61.200000000000003 109.29 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 176' ' ' THR . 17.2 m -98.32 8.23 45.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.318 -0.856 . . . . 75.329999999999998 111.292 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.756 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.4 mm -69.83 117.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.015 -0.365 . . . . 54.409999999999997 110.015 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.34 -27.91 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 113.523 0.934 . . . . 51.409999999999997 113.523 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.325 -1.264 . . . . 53.030000000000001 112.294 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.851 0.358 . . . . 71.129999999999995 110.981 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 12' ' ' VAL . 29.1 t70 -109.37 -57.15 2.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.853 -0.612 . . . . 72.420000000000002 112.242 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.574 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 12.9 pt -129.02 65.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.253 0.549 . . . . 74.340000000000003 111.085 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.2 p -141.37 143.92 32.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.028 -0.533 . . . . 52.009999999999998 111.17 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -76.16 22.27 2.73 Favored 'Cis proline' 0 C--N 1.358 1.039 0 C-N-CA 124.454 -1.061 . . . . 73.409999999999997 112.334 0.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.705 ' O ' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -49.51 -53.87 20.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.169 -0.923 . . . . 73.230000000000004 111.276 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 7' ' ' ASP . 2.8 m -165.79 -40.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.73 0.641 . . . . 71.209999999999994 112.73 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 HD23 ' HD3' ' A' ' 13' ' ' PRO . 22.8 tp -157.1 152.19 26.1 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.494 0.664 . . . . 52.439999999999998 112.372 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -60.54 -35.81 76.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.795 -0.639 . . . . 74.530000000000001 111.07 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.15 13.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 75.140000000000001 111.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.436 HG23 ' OD2' ' A' ' 3' ' ' ASP . 61.6 t -59.9 124.51 77.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.574 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.479 ' HD3' HD23 ' A' ' 9' ' ' LEU . 66.4 Cg_endo -85.66 -117.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.957 2.438 . . . . 73.120000000000005 112.724 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -168.72 -46.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 122.931 0.492 . . . . 74.430000000000007 109.741 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.83 -158.72 13.63 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.371 -0.692 . . . . 63.200000000000003 111.371 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 4.8 t -147.92 167.59 24.45 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.519 0.676 . . . . 75.099999999999994 111.488 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 118' ' ' LEU . 13.1 mt -105.5 152.97 7.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.333 -1.303 . . . . 65.319999999999993 108.416 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.0 mmpt? -108.48 102.4 11.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.103 -0.499 . . . . 73.400000000000006 110.601 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.786 ' HB ' HG22 ' A' ' 27' ' ' VAL . 35.3 t -105.92 109.93 29.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.451 HG12 ' HB3' ' A' ' 26' ' ' GLU . 67.6 mt -98.45 137.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.579 . . . . 74.319999999999993 110.846 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.83 -97.23 0.18 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.214 -0.903 . . . . 74.140000000000001 112.543 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -66.82 -44.59 88.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.601 -0.809 . . . . 75.430000000000007 113.544 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 174.34 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.272 -0.64 . . . . 61.32 109.272 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.22 -42.49 15.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.452 -0.795 . . . . 73.120000000000005 109.361 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.51 138.51 53.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.277 -0.874 . . . . 71.219999999999999 110.359 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 pt-20 -150.36 151.49 32.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.728 -1.123 . . . . 71.510000000000005 108.822 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.0 m -73.21 120.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.956 0.724 . . . . 63.210000000000001 112.956 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 3.4 mptp? -104.11 111.97 24.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.455 -0.793 . . . . 65.540000000000006 112.512 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.496 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.0 mp0 29.04 67.77 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.606 1.336 . . . . 72.299999999999997 114.606 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' HD1' ' A' ' 161' ' ' TYR . . . 76.92 5.17 84.2 Favored Glycine 0 N--CA 1.465 0.63 0 C-N-CA 121.043 -0.598 . . . . 51.100000000000001 112.844 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.48 HD22 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -47.62 147.07 1.94 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.697 -0.752 . . . . 70.25 111.933 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -101.76 131.72 47.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.459 -1.246 . . . . 63.420000000000002 109.85 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 9.6 mp -96.96 124.92 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.157 0.503 . . . . 61.509999999999998 111.166 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 p -149.87 145.09 18.38 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.496 -0.775 . . . . 75.450000000000003 109.688 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -83.78 -113.26 0.0 OUTLIER 'Cis proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.936 -1.277 . . . . 63.399999999999999 112.965 0.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.0 p -67.47 61.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.532 0.568 . . . . 72.230000000000004 112.532 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.8 pt20 -119.11 -3.57 10.62 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.746 0.307 . . . . 63.420000000000002 111.226 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 33' ' ' LEU . 30.9 m -78.22 32.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 110.921 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -105.64 -23.21 12.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.149 0.796 . . . . 71.319999999999993 113.149 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 39' ' ' LYS . 1.4 m-20 -71.5 139.91 49.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.265 0.555 . . . . 62.43 112.032 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.54 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.31 130.53 93.19 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 115.496 -0.775 . . . . 71.319999999999993 110.045 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.15 126.31 13.56 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.999 1.799 . . . . 71.040000000000006 112.442 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -107.95 109.51 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 75.120000000000005 110.678 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.3 p -81.45 138.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.165 0.431 . . . . 73.450000000000003 112.165 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -165.3 164.07 19.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.758 0.313 . . . . 14.02 110.734 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p90 -141.16 37.12 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.817 -0.628 . . . . 75.219999999999999 110.27 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.1 t -50.78 112.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 74.019999999999996 111.355 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.72 -14.64 61.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.114 -0.565 . . . . 71.519999999999996 112.935 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -78.53 -28.12 46.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 71.519999999999996 110.943 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -72.75 -82.92 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.936 0.398 . . . . 72.400000000000006 111.429 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.56 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 78.77 -52.83 3.97 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.155 -0.545 . . . . 74.230000000000004 111.969 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.64 109.03 4.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.823 0.344 . . . . 64.030000000000001 110.139 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -157.95 141.33 15.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 70.519999999999996 111.529 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -86.3 -40.58 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.915 0.864 . . . . 73.120000000000005 109.41 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -149.98 157.52 43.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.044 -1.435 . . . . 54.409999999999997 107.528 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.8 mt -128.46 144.49 51.15 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.32 -0.552 . . . . 75.310000000000002 111.023 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.791 HG21 ' CD2' ' A' ' 153' ' ' LEU . 24.3 m -115.85 132.52 56.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.408 -0.814 . . . . 73.140000000000001 110.541 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -133.37 131.44 40.07 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.257 0.348 . . . . 62.109999999999999 110.348 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 97' ' ' LEU . 51.0 mt -151.39 167.11 28.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.732 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.428 ' HG3' ' CB ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.88 146.03 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.633 -0.712 . . . . 73.319999999999993 109.469 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.866 HG22 HD23 ' A' ' 117' ' ' LEU . 6.1 t -131.28 49.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.056 0.455 . . . . 75.519999999999996 110.722 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 p30 -133.66 54.82 13.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.543 -0.753 . . . . 75.329999999999998 111.425 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.35 83.29 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.39 1.394 . . . . 75.510000000000005 112.048 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -150.18 109.11 3.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.19 -0.914 . . . . 61.299999999999997 110.211 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -167.54 137.83 2.32 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 110.348 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -78.38 -23.89 13.29 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.114 -1.203 . . . . 63.340000000000003 111.851 -0.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.8 t -145.86 140.85 27.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.366 -0.834 . . . . 72.310000000000002 111.064 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 68' ' ' ARG . 5.6 ttp-105 -52.59 -29.18 24.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 64.25 111.743 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 67' ' ' THR . 8.1 pt20 -80.0 -27.17 39.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.448 0.536 . . . . 71.0 112.448 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 67' ' ' THR . 5.4 m-20 -144.67 60.41 7.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-O 120.988 0.423 . . . . 51.409999999999997 111.711 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 56.8 Cg_endo -69.24 58.98 1.35 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.063 2.509 . . . . 71.519999999999996 112.876 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 8.7 ptpt -57.37 -47.72 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.175 0.805 . . . . 55.32 113.175 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.613 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -105.71 35.66 2.8 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.106 -0.638 . . . . 73.329999999999998 112.221 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 25.2 ttp180 -70.24 131.61 44.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.179 -0.674 . . . . 73.209999999999994 109.179 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 42.6 mt-10 -93.65 169.34 10.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 72.120000000000005 110.618 -0.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.777 HG23 ' N ' ' A' ' 77' ' ' LEU . 10.6 tp -110.4 -134.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.467 -0.197 . . . . 63.549999999999997 110.467 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.777 ' N ' HG23 ' A' ' 76' ' ' ILE . 96.1 mt -72.41 152.07 42.23 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.451 -0.574 . . . . 75.519999999999996 109.451 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.518 ' NE2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -163.87 157.07 18.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.722 0.267 . . . . 65.140000000000001 111.722 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 5.0 t-105 -99.96 117.65 34.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.915 -0.584 . . . . 74.040000000000006 109.978 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 6.1 p -141.13 134.45 29.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.995 -0.548 . . . . 61.020000000000003 112.073 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.829 HG11 ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -142.76 142.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 70.099999999999994 110.021 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 HG23 ' A' ' 57' ' ' THR . 14.5 m -140.85 159.14 23.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.475 0.546 . . . . 71.209999999999994 112.475 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.0 p30 62.36 35.87 14.76 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 114.567 -1.197 . . . . 73.340000000000003 111.185 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.966 HD13 ' HA3' ' A' ' 94' ' ' GLY . 3.6 mm -73.62 127.63 88.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 63.409999999999997 109.742 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 23.9 Cg_exo -63.5 126.87 18.5 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 121.958 1.772 . . . . 75.239999999999995 111.755 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.79 62.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.248 0.342 . . . . 53.240000000000002 113.602 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' PRO . 31.9 p -179.2 39.69 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.16 0.48 . . . . 74.010000000000005 110.942 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.31 -4.05 2.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 111.816 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 67.62 -36.64 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.222 0.609 . . . . 73.200000000000003 112.5 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 88' ' ' ASN . 1.6 p30 -127.71 153.42 77.8 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 54.130000000000003 110.609 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.897 ' HA ' HG21 ' A' ' 84' ' ' ILE . 77.5 Cg_endo -70.78 47.08 0.68 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.646 2.897 . . . . 63.409999999999997 113.803 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.8 m -93.49 -40.32 10.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 61.140000000000001 112.147 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.07 -13.11 61.44 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.906 -0.588 . . . . 61.240000000000002 114.241 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.966 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -98.33 172.08 26.11 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.405 -0.902 . . . . 72.540000000000006 113.404 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.546 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.69 126.61 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 75.430000000000007 111.496 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.691 ' H ' HG22 ' A' ' 130' ' ' THR . 85.3 p -88.11 94.5 9.83 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.999 -0.546 . . . . 71.230000000000004 109.895 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.697 HD12 HD21 ' A' ' 59' ' ' LEU . 77.2 mt -50.06 -38.24 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 74.239999999999995 109.189 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -156.67 115.49 3.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.692 -1.14 . . . . 52.130000000000003 109.089 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 50.2 t0 -52.36 146.71 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.439 0.462 . . . . 64.310000000000002 111.982 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 47.7 p90 -69.81 129.61 40.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.598 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 13.7 p -158.61 174.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.326 -0.397 . . . . 72.040000000000006 110.217 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -72.04 -129.18 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.234 -0.984 . . . . 74.230000000000004 111.703 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 170' ' ' VAL . 47.6 t -175.48 -165.67 0.18 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.838 -0.801 . . . . 43.210000000000001 108.838 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 105' ' ' PRO . . . -128.58 54.89 0.77 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.766 -0.731 . . . . 74.329999999999998 111.65 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 104' ' ' GLY . 14.3 Cg_endo -87.96 120.7 1.39 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.499 2.133 . . . . 74.420000000000002 112.676 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 109' ' ' THR . 73.5 Cg_endo -74.31 162.11 39.09 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.79 2.327 . . . . 61.25 111.759 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 109' ' ' THR . 17.6 pttp -43.55 -45.64 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.443 -0.344 . . . . 62.25 111.764 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -63.4 5.95 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.159 0.429 . . . . 71.439999999999998 112.159 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 106' ' ' PRO . 13.0 t -75.14 -25.68 58.58 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.144 0.497 . . . . 73.519999999999996 110.196 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.9 -165.11 42.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 61.43 112.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.8 tp -71.33 111.56 6.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.867 0.365 . . . . 72.040000000000006 111.492 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -88.85 131.99 34.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.310000000000002 110.987 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -103.55 90.54 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.742 -0.663 . . . . 74.340000000000003 109.922 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 10.2 m-85 -74.94 136.48 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.407 . . . . 73.530000000000001 111.242 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 161' ' ' TYR . 35.0 mt -130.03 138.22 54.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.83 -0.623 . . . . 75.299999999999997 112.053 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -120.74 136.81 54.77 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.465 -0.789 . . . . 71.319999999999993 109.439 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 61' ' ' VAL . 2.3 pp -118.47 149.32 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 63.439999999999998 109.895 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 157' ' ' ILE . 2.8 tt -133.94 134.87 43.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 73.340000000000003 109.592 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.693 ' N ' HD23 ' A' ' 118' ' ' LEU . 53.3 t80 -139.88 136.71 34.22 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 72.230000000000004 111.448 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -73.7 124.71 26.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.752 -0.658 . . . . 71.319999999999993 109.71 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -110.78 145.31 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 75.099999999999994 112.351 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -118.63 -39.92 2.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.982 -1.008 . . . . 75.409999999999997 109.968 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.98 130.75 34.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.234 -0.439 . . . . 72.349999999999994 111.106 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -79.06 131.91 36.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.514 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -125.33 154.55 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.712 -0.676 . . . . 70.200000000000003 112.414 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -90.97 -33.79 15.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.747 -0.661 . . . . 70.420000000000002 111.786 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 36.76 36.27 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.12 1.155 . . . . 74.010000000000005 114.12 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p 59.11 159.49 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-O 121.154 0.502 . . . . 73.140000000000001 112.165 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -53.88 152.45 23.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.637 2.225 . . . . 64.019999999999996 113.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 96' ' ' SER . 22.9 p -59.02 127.15 30.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.192 -0.913 . . . . 74.420000000000002 110.707 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.482 HG13 ' NH1' ' A' ' 139' ' ' ARG . 20.4 mm -91.85 124.94 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 74.150000000000006 111.644 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.0 m -69.76 147.98 49.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.998 -1.001 . . . . 73.040000000000006 112.09 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.517 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 16.6 p30 -50.55 -43.63 56.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 74.510000000000005 111.427 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.836 ' HA ' HD13 ' A' ' 177' ' ' ILE . 9.7 t -68.71 21.91 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.481 0.549 . . . . 64.099999999999994 112.481 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.6 t -65.16 122.34 16.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 64.230000000000004 110.884 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.689 ' HD2' ' N ' ' A' ' 137' ' ' THR . 5.0 tmm_? -82.49 160.76 22.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.53 -0.759 . . . . 72.049999999999997 111.652 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.693 HG23 HD11 ' A' ' 140' ' ' LEU . 6.0 m -39.94 158.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.348 -0.842 . . . . 65.310000000000002 111.093 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.95 17.51 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 112.483 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' NH1' HG13 ' A' ' 131' ' ' ILE . 17.8 ttm180 -167.86 48.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.888 0.375 . . . . 71.230000000000004 110.731 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.693 HD11 HG23 ' A' ' 137' ' ' THR . 0.0 OUTLIER -114.65 -56.45 2.38 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.321 -0.399 . . . . 72.319999999999993 110.314 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.1 m120 -63.81 66.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 111.691 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LEU . 14.3 t80 -138.77 121.72 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.522 -0.548 . . . . 61.119999999999997 109.522 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.642 HD22 ' HB2' ' A' ' 146' ' ' ASP . 22.3 t30 -63.6 122.28 15.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.215 0.531 . . . . 74.219999999999999 111.75 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.68 72.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.625 -0.716 . . . . 63.409999999999997 111.45 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -50.44 -35.14 27.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.459 . . . . 72.329999999999998 110.223 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.642 ' HB2' HD22 ' A' ' 143' ' ' ASN . 34.1 t70 -64.62 -44.12 91.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.426 0.631 . . . . 74.450000000000003 109.382 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 150' ' ' LYS . 1.2 t80 -62.9 -38.35 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 53.240000000000002 109.574 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 153' ' ' LEU . . . -65.36 -46.6 79.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.578 -0.737 . . . . 71.040000000000006 110.564 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.19 -55.08 23.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 52.25 110.624 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.553 ' HG3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.22 -48.13 83.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 62.420000000000002 110.583 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.553 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 38.4 m170 -67.64 3.39 1.42 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 121.221 -0.191 . . . . 43.549999999999997 111.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 72.86 7.77 71.12 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.86 -0.686 . . . . 64.239999999999995 112.19 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.5 mt -72.14 16.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.392 0.277 . . . . 74.25 110.883 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.91 -69.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.432 -0.889 . . . . 54.5 112.127 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 21.2 pt-20 -80.39 120.03 78.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.579 0.228 . . . . 72.239999999999995 110.839 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.38 125.44 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.936 1.757 . . . . 73.310000000000002 112.077 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 118' ' ' LEU . 27.2 pt -76.26 -33.94 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.476 -0.49 . . . . 74.420000000000002 110.012 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -146.52 144.61 29.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.924 -0.58 . . . . 42.130000000000003 110.507 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -148.91 149.68 31.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.424 -0.353 . . . . 52.310000000000002 110.884 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.546 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.0 t-20 -150.97 148.98 29.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.928 -1.138 . . . . 72.319999999999993 107.928 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.551 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -152.34 165.73 34.07 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.462 -0.495 . . . . 74.310000000000002 111.272 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.4 p90 -154.14 152.92 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.582 -0.735 . . . . 74.209999999999994 110.778 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.68 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.41 -0.589 . . . . 51.549999999999997 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.16 138.72 15.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.273 0.559 . . . . 61.210000000000001 111.856 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -118.28 144.97 45.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 71.129999999999995 109.153 178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.9 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.156 -0.313 . . . . 73.310000000000002 110.156 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -100.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.511 -0.768 . . . . 70.150000000000006 112.322 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t0 -147.78 21.48 1.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.658 0.742 . . . . 72.219999999999999 109.949 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -76.45 -47.95 21.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.676 -0.693 . . . . 75.450000000000003 111.359 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 103' ' ' SER . 60.2 t -43.02 -50.34 13.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.052 -0.522 . . . . 71.140000000000001 112.271 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 51.2 Cg_exo -57.84 -37.01 97.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.068 1.845 . . . . 71.25 112.392 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.0 mm -50.12 -39.86 16.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.057 0.456 . . . . 73.519999999999996 110.977 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -69.98 -30.18 67.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 74.099999999999994 111.212 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' PRO . 1.6 m120 -56.02 -14.94 2.9 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.512 -0.313 . . . . 73.230000000000004 110.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.52 -20.08 7.07 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.605 -0.517 . . . . 64.010000000000005 109.605 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.0 m -68.34 -28.01 66.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.69 -0.686 . . . . 75.349999999999994 110.783 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 134' ' ' THR . 35.6 mm -54.6 130.79 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.703 . . . . 52.539999999999999 111.978 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.635 HG22 ' OG1' ' A' ' 134' ' ' THR . 20.1 m -146.7 -14.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.066 0.765 . . . . 53.520000000000003 113.066 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.225 -1.32 . . . . 64.239999999999995 112.577 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.541 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 3.3 p-10 . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 109.596 -0.52 . . . . 73.400000000000006 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.09 -71.21 0.42 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.637 0.977 . . . . 72.430000000000007 113.637 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 11' ' ' ALA . 7.5 pt -97.11 46.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.528 0.68 . . . . 71.25 112.568 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.1 p -128.14 142.37 44.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.551 -0.749 . . . . 72.019999999999996 110.372 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HA ' HG23 ' A' ' 5' ' ' VAL . 64.0 Cg_endo -86.62 35.58 4.13 Favored 'Cis proline' 0 C--N 1.35 0.619 0 C-N-CA 124.115 -1.202 . . . . 74.549999999999997 112.932 0.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.561 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.7 t70 -64.33 -48.37 75.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 61.039999999999999 111.032 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 7' ' ' ASP . 3.6 m -160.36 -37.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.689 0.626 . . . . 62.130000000000003 112.689 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.522 HD23 ' HD3' ' A' ' 13' ' ' PRO . 48.9 tp -157.13 164.27 38.03 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.884 0.373 . . . . 64.430000000000007 110.899 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.88 -42.35 94.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.098 0.475 . . . . 72.439999999999998 110.095 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 4' ' ' ILE . . . -134.87 -174.59 3.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.491 -0.777 . . . . 53.350000000000001 111.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.0 p -110.29 111.96 57.46 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.96 -0.564 . . . . 52.32 111.555 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 9' ' ' LEU . 64.9 Cg_endo -83.95 -134.89 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.124 2.549 . . . . 64.299999999999997 112.117 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -150.46 -38.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.508 -0.314 . . . . 55.109999999999999 111.098 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -138.24 166.58 25.19 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.561 -0.828 . . . . 71.329999999999998 112.533 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -102.12 159.65 15.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.263 0.554 . . . . 53.240000000000002 111.506 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.524 HG21 HG13 ' A' ' 44' ' ' VAL . 4.7 mt -105.41 131.24 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.698 -0.853 . . . . 62.229999999999997 108.698 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.8 mtpm? -74.03 102.98 4.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.142 -0.481 . . . . 70.230000000000004 110.516 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.629 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 46.9 t -117.52 110.59 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.111 0.481 . . . . 75.349999999999994 110.654 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 25' ' ' LEU . 47.2 mt -99.52 131.48 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.048 -0.524 . . . . 70.409999999999997 110.34 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -72.31 -51.08 22.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.36 -0.382 . . . . 71.040000000000006 111.516 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 40' ' ' ASP . . . -126.1 -61.23 0.16 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.559 -0.829 . . . . 74.340000000000003 113.273 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.16 -59.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.028 0.442 . . . . 74.019999999999996 110.343 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -97.57 -38.5 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 111.071 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.71 135.62 50.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.396 0.617 . . . . 64.209999999999994 110.723 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -140.67 136.92 33.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.35 -0.841 . . . . 74.519999999999996 111.827 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.751 HG11 ' CD2' ' A' ' 162' ' ' TYR . 28.2 m -76.62 139.22 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.312 -0.858 . . . . 74.129999999999995 110.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HA ' HD21 ' A' ' 160' ' ' ASN . 41.6 pttt -155.12 122.32 5.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.857 1.058 . . . . 72.140000000000001 113.857 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.466 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 11.8 mp0 27.42 67.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.357 1.614 . . . . 72.030000000000001 115.357 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 161' ' ' TYR . . . 86.81 -7.98 77.69 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.993 -0.622 . . . . 61.32 114.3 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -50.44 129.93 22.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.597 0.236 . . . . 50.210000000000001 110.65 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -94.76 142.1 27.85 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.843 -0.428 . . . . 72.400000000000006 109.843 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.764 HD21 HD12 ' A' ' 25' ' ' LEU . 1.3 tp -101.86 127.99 48.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 51.420000000000002 110.995 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 66.9 p -149.91 157.42 37.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.478 -0.783 . . . . 70.409999999999997 109.692 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.5 Cg_exo -76.33 -47.88 0.29 Allowed 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.988 -1.255 . . . . 52.420000000000002 112.102 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 38' ' ' VAL . 74.2 p -151.46 25.69 0.69 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 64.329999999999998 111.395 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' A' ' 39' ' ' LYS . 13.8 pt20 -63.33 0.41 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.37 0.605 . . . . 72.25 111.039 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.692 HG12 HD23 ' A' ' 33' ' ' LEU . 35.4 m -74.21 32.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 111.605 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.435 ' CD ' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.55 -31.69 57.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.977 0.418 . . . . 61.420000000000002 111.139 -179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HB3' ' HA2' ' A' ' 22' ' ' GLY . 14.9 m-20 -87.16 142.86 27.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.498 0.555 . . . . 65.400000000000006 112.498 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.647 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.05 139.05 92.65 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 115.6 -0.727 . . . . 72.019999999999996 111.092 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.51 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 20.2 Cg_exo -63.19 126.6 18.19 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.724 1.616 . . . . 70.120000000000005 112.078 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 mm -108.39 112.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 64.040000000000006 110.24 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 HG21 ' A' ' 17' ' ' ILE . 57.2 t -86.07 142.23 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.554 0.576 . . . . 74.310000000000002 112.554 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.4 m -165.05 133.82 3.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.801 0.334 . . . . 53.049999999999997 111.253 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 15.0 p90 -108.66 32.41 4.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.44 0.638 . . . . 70.239999999999995 110.227 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.5 m -43.77 134.45 4.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 111.082 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.47 -29.86 4.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.86 -0.686 . . . . 71.019999999999996 112.975 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 49' ' ' LEU . 6.6 mp -80.73 -38.88 27.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.275 0.538 . . . . 73.450000000000003 110.25 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 13.1 tp10 -50.15 163.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.888 -0.597 . . . . 73.439999999999998 110.688 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 50' ' ' GLU . . . -170.12 -76.91 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.283 -0.727 . . . . 70.340000000000003 111.283 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -148.53 109.76 4.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.815 0.341 . . . . 71.400000000000006 110.295 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -151.31 141.72 22.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.028 -0.533 . . . . 71.310000000000002 110.02 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.89 -36.56 62.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.327 0.584 . . . . 52.310000000000002 109.474 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 83' ' ' ASN . 30.6 mt -155.28 164.84 38.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.998 -1.001 . . . . 73.120000000000005 110.455 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 35.0 mt -135.83 157.29 47.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.946 0.403 . . . . 65.409999999999997 110.92 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.527 HG23 ' NE2' ' A' ' 121' ' ' GLN . 0.7 OUTLIER -117.94 121.89 41.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 60.409999999999997 109.674 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.1 tm? -127.07 128.71 46.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.256 -0.646 . . . . 53.549999999999997 109.256 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.609 ' N ' HD13 ' A' ' 58' ' ' LEU . 43.5 mt -154.29 154.0 32.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.99 -0.284 . . . . 73.430000000000007 111.137 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -134.1 145.38 49.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.671 -0.492 . . . . 71.519999999999996 109.671 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 62' ' ' ASP . 8.8 t -150.62 164.76 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.867 1.062 . . . . 63.039999999999999 113.867 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.585 ' N ' HG12 ' A' ' 61' ' ' VAL . 46.6 t0 -172.85 86.08 0.41 Allowed Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 113.594 -1.639 . . . . 73.019999999999996 107.211 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.98 84.69 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 123.204 2.602 . . . . 72.010000000000005 115.342 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -170.49 124.05 0.68 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.134 -0.484 . . . . 64.040000000000006 111.896 177.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -170.31 136.95 1.27 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.453 -0.34 . . . . 70.120000000000005 111.731 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HG3' ' CE2' ' A' ' 73' ' ' TYR . 18.6 Cg_exo -66.26 -33.48 2.8 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.752 -1.353 . . . . 72.140000000000001 110.945 -0.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 3.5 t -130.21 157.34 42.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 64.140000000000001 109.872 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' NH2' ' A' ' 113' ' ' ARG . 23.8 ttt85 -58.37 -26.69 63.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.199 0.523 . . . . 65.219999999999999 109.785 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -78.2 -15.59 58.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.065 -0.97 . . . . 73.430000000000007 111.664 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 60.5 t0 -143.98 94.97 5.76 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.233 -0.439 . . . . 62.43 111.284 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 85.1 Cg_endo -80.78 50.51 3.59 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.123 2.549 . . . . 72.540000000000006 112.027 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 7.2 ttmt -58.6 -54.74 43.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.309 0.855 . . . . 71.120000000000005 113.309 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 66' ' ' PRO . 16.9 p90 -132.2 25.6 4.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.687 0.625 . . . . 70.019999999999996 112.687 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.742 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 2.8 tmm_? -58.19 134.7 56.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 72.010000000000005 109.694 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 73.5 mt-10 -90.31 178.22 6.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.542 1.137 . . . . 51.43 111.177 0.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.881 HD11 ' HB2' ' A' ' 65' ' ' ALA . 1.2 mp -98.04 -61.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.357 0.599 . . . . 51.409999999999997 109.962 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HG ' HG11 ' A' ' 101' ' ' VAL . 2.0 pt? -171.23 141.8 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.504 -0.925 . . . . 63.439999999999998 108.504 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.54 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 5.0 p-80 -137.57 176.01 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.581 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.63 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 7.4 t-105 -100.48 113.77 26.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.946 -0.761 . . . . 75.510000000000005 108.946 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.587 ' HA ' HD23 ' A' ' 59' ' ' LEU . 43.3 p -131.54 114.52 14.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.645 -0.707 . . . . 70.329999999999998 111.078 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.63 HG21 ' CZ2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -127.33 117.91 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 64.319999999999993 109.239 178.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HG3' ' A' ' 127' ' ' GLU . 21.8 m -114.87 164.8 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.332 -0.849 . . . . 64.230000000000004 111.758 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.616 HD21 ' CG ' ' A' ' 95' ' ' HIS . 24.8 p30 52.16 43.9 30.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 61.340000000000003 112.374 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.4 mm -75.43 118.06 67.95 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.89 -1.152 . . . . 72.540000000000006 107.89 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.45 125.72 18.56 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.689 1.593 . . . . 71.140000000000001 111.725 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.07 61.23 0.08 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.371 0.419 . . . . 51.100000000000001 113.656 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -171.09 39.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.419 0.688 . . . . 63.32 109.318 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 55.7 m-80 -130.08 -28.07 2.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.511 -0.768 . . . . 74.430000000000007 111.787 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.445 ' HA ' ' NE1' ' A' ' 46' ' ' TRP . 2.2 tt0 76.0 -9.24 1.48 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.071 0.463 . . . . 64.329999999999998 110.776 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -155.91 155.27 29.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.294 -0.866 . . . . 70.140000000000001 110.111 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 84' ' ' ILE . 84.4 Cg_endo -73.75 60.75 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.655 0 C-N-CA 123.684 2.922 . . . . 63.119999999999997 113.21 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -90.96 -55.08 3.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.188 0.81 . . . . 70.310000000000002 113.188 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -10.85 75.13 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 116.445 1.338 . . . . 72.109999999999999 116.445 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -71.19 164.42 53.76 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.789 -1.196 . . . . 73.140000000000001 113.662 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CG ' HD21 ' A' ' 83' ' ' ASN . 13.5 m80 -65.21 121.35 14.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.805 0.336 . . . . 61.509999999999998 111.597 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 130' ' ' THR . 8.9 m -87.81 89.38 7.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 61.009999999999998 111.305 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 127' ' ' GLU . 16.7 mt -61.66 -17.36 55.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.536 0.684 . . . . 72.340000000000003 111.339 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB3' ' OG ' ' A' ' 80' ' ' SER . . . -167.92 116.06 0.75 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.344 -0.844 . . . . 64.010000000000005 108.957 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.569 ' HB3' ' CA ' ' A' ' 133' ' ' ASN . 28.4 t0 -60.06 151.82 25.65 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.595 0.559 . . . . 61.229999999999997 111.992 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -70.12 148.38 48.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 64.019999999999996 112.394 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 103' ' ' SER . 10.3 p -135.31 133.0 52.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.827 -0.624 . . . . 71.329999999999998 110.03 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.63 66.95 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.412 -0.899 . . . . 53.420000000000002 112.819 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.4 m -164.83 127.65 2.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 73.010000000000005 111.123 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.87 -73.32 1.09 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.84 -0.618 . . . . 62.020000000000003 112.659 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 31.7 Cg_exo -57.84 133.57 56.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.848 2.366 . . . . 61.32 112.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 32.3 Cg_exo -58.38 151.59 59.91 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.107 2.538 . . . . 62.32 113.563 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 168' ' ' ASP . 21.8 pttm -46.12 -26.94 0.84 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.178 -0.919 . . . . 72.150000000000006 111.344 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.54 -30.36 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 72.109999999999999 110.462 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 2.3 t -92.16 -26.7 18.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.278 0.561 . . . . 51.409999999999997 109.804 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.35 -100.5 0.81 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.578 -0.737 . . . . 75.150000000000006 114.886 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.91 125.41 22.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.661 0.744 . . . . 74.329999999999998 112.976 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 69.1 m-70 -116.04 123.01 46.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.622 -1.172 . . . . 73.010000000000005 110.097 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.526 ' NH2' ' NH1' ' A' ' 68' ' ' ARG . 36.8 mtm180 -94.47 85.25 4.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.811 -0.44 . . . . 62.340000000000003 109.811 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 103' ' ' SER . 29.6 m-85 -70.33 114.5 8.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.128 -0.629 . . . . 74.430000000000007 110.676 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 60' ' ' MET . 38.4 mm -104.97 121.98 57.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 110.261 -0.274 . . . . 73.109999999999999 110.261 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.507 ' CE2' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -102.54 128.51 49.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.856 0.462 . . . . 73.409999999999997 109.828 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.91 133.65 54.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 70.219999999999999 110.313 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.717 ' N ' HD13 ' A' ' 117' ' ' LEU . 33.7 tp -128.64 131.76 48.08 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.169 -0.469 . . . . 74.510000000000005 110.459 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 57' ' ' THR . 60.7 t80 -144.02 138.2 28.2 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.744 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HA ' HD23 ' A' ' 56' ' ' LEU . 12.7 ttp-105 -71.06 133.38 46.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.711 0.291 . . . . 63.020000000000003 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.527 ' NE2' HG23 ' A' ' 57' ' ' THR . 1.2 mt-30 -109.39 109.73 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 71.239999999999995 110.467 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.98 -43.46 11.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.045 -0.724 . . . . 75.510000000000005 109.045 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.626 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.0 OUTLIER -90.83 122.18 33.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.916 -1.038 . . . . 41.450000000000003 110.34 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 55' ' ' LEU . 58.6 tttm -70.9 128.08 34.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.337 0.589 . . . . 60.520000000000003 111.385 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.74 132.65 59.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.972 -1.013 . . . . 51.420000000000002 110.541 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -56.35 -59.48 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 65.329999999999998 110.337 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.734 ' HG3' HG21 ' A' ' 82' ' ' VAL . 27.8 mm-40 58.33 32.64 22.31 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.397 -0.82 . . . . 73.129999999999995 113.192 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.529 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 39.9 p 49.38 171.62 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 113.079 0.77 . . . . 53.229999999999997 113.079 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 36.9 Cg_exo -61.51 158.33 37.01 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.146 2.564 . . . . 65.450000000000003 113.295 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 96' ' ' SER . 20.7 p -58.75 124.71 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.843 -0.617 . . . . 72.519999999999996 111.398 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.17 121.82 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 73.519999999999996 111.243 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -73.42 147.36 44.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.597 -0.729 . . . . 73.010000000000005 112.27 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.569 ' CA ' ' HB3' ' A' ' 99' ' ' ASP . 10.9 t-20 -55.11 -35.01 64.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.03 -0.532 . . . . 64.340000000000003 111.962 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.8 t -67.06 21.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.622 0.248 . . . . 65.319999999999993 111.483 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 133' ' ' ASN . 10.1 t -62.52 113.29 2.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.393 0.616 . . . . 63.130000000000003 111.089 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 41.8 ttt85 -89.08 173.21 8.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.849 . . . . 74.530000000000001 110.96 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 77.4 m -34.08 143.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.109 -0.496 . . . . 55.450000000000003 111.546 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.11 3.9 19.01 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.133 -0.556 . . . . 75.319999999999993 112.213 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -160.01 29.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.959 0.409 . . . . 74.5 110.775 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.278 0.561 . . . . 70.209999999999994 110.277 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 5.9 m120 -67.95 44.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.283 -0.872 . . . . 53.229999999999997 112.799 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 4.0 t80 -109.38 90.35 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.822 -0.436 . . . . 71.219999999999999 109.822 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.09 112.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 53.32 111.049 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 147' ' ' PHE . . . -57.63 -32.9 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.203 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -50.41 -32.71 18.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.384 -0.371 . . . . 63.439999999999998 111.07 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -56.12 -34.51 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.104 0.478 . . . . 71.430000000000007 110.284 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.4 m-85 -49.76 -38.11 32.52 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.559 0.695 . . . . 75.209999999999994 109.687 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.47 91.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.221 -0.899 . . . . 64.120000000000005 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.39 -48.34 42.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 65.219999999999999 111.949 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -59.01 -41.12 86.93 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.167 0.432 . . . . 74.420000000000002 112.167 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 46.3 t60 -109.25 5.52 23.8 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.01 -0.676 . . . . 74.420000000000002 111.533 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 63.46 34.64 90.49 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.888 -0.673 . . . . 51.119999999999997 113.982 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 155' ' ' GLU . 11.3 mt -69.69 16.33 0.06 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.517 -0.402 . . . . 61.109999999999999 111.016 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -55.74 1.66 0.07 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 114.241 0.457 . . . . 71.530000000000001 114.241 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 153' ' ' LEU . 4.9 pt-20 -135.11 72.66 66.73 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.258 0.551 . . . . 65.140000000000001 110.154 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 31.9 Cg_exo -57.03 129.37 34.12 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.452 2.102 . . . . 70.299999999999997 112.131 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 118' ' ' LEU . 21.1 pt -79.9 -38.18 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.495 -0.557 . . . . 74.450000000000003 109.495 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.31 148.64 32.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 110.877 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -150.68 157.74 43.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.982 0.42 . . . . 70.239999999999995 111.568 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 28' ' ' LYS . 1.8 t-20 -157.19 145.07 19.09 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.415 -0.958 . . . . 54.420000000000002 108.415 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.562 ' CB ' HD13 ' A' ' 115' ' ' ILE . 17.9 p90 -155.03 157.46 37.64 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.759 -0.588 . . . . 75.150000000000006 111.945 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.751 ' CD2' HG11 ' A' ' 27' ' ' VAL . 5.6 p90 -153.54 163.78 39.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.613 -0.721 . . . . 65.209999999999994 111.24 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 44.5 mt-30 -122.53 124.89 44.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 62.210000000000001 110.469 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.14 152.11 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 75.319999999999993 112.411 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -127.18 148.1 50.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.346 -0.983 . . . . 42.240000000000002 108.346 177.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -137.38 152.69 49.94 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.02 0.378 . . . . 75.140000000000001 112.02 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.5 m-20 -54.93 163.34 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.765 -0.652 . . . . 74.140000000000001 111.865 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.522 ' HA ' ' HG2' ' A' ' 171' ' ' PRO . 6.3 t0 -68.03 27.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.689 -0.687 . . . . 74.239999999999995 111.3 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 167' ' ' ASP . 21.2 t80 -82.28 -60.86 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.74 0.644 . . . . 74.329999999999998 112.74 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 14.6 p -62.14 -32.09 9.05 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 113.337 0.866 . . . . 64.549999999999997 113.337 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 81.7 Cg_exo -47.97 -30.02 13.03 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.74 1.626 . . . . 74.310000000000002 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.3 mm -49.35 -37.77 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.68 -0.691 . . . . 75.099999999999994 109.401 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -45.87 -42.79 12.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.471 -0.786 . . . . 71.310000000000002 109.953 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.495 ' HA ' HG12 ' A' ' 177' ' ' ILE . 72.1 m-80 -58.28 -39.4 79.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 61.25 111.465 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.54 -28.25 63.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 72.25 110.492 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 178' ' ' VAL . 42.5 m -84.61 -4.13 58.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.954 -0.566 . . . . 63.100000000000001 112.335 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.528 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 33.0 mm -62.11 99.14 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.088 0.47 . . . . 73.140000000000001 111.006 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 176' ' ' THR . 61.6 t -100.83 -6.94 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.588 -0.733 . . . . 73.530000000000001 112.491 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.482 -1.177 . . . . 61.43 112.42 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.523 -0.071 0 N-CA-C 109.302 -0.629 . . . . 73.230000000000004 109.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 64.3 t0 -89.63 -70.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.571 . . . . 65.420000000000002 112.38 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.874 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.9 OUTLIER -127.8 58.94 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.389 0.614 . . . . 64.349999999999994 111.02 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.3 p -130.07 139.48 35.78 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 72.349999999999994 109.947 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.7 Cg_endo -85.57 35.13 3.64 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.139 -1.192 . . . . 74.239999999999995 113.113 0.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.874 ' HB3' HG22 ' A' ' 4' ' ' ILE . 8.8 t70 -62.67 -49.92 73.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.952 0.406 . . . . 73.340000000000003 110.42 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -163.65 -44.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.912 -0.586 . . . . 60.009999999999998 110.927 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' ILE . 29.2 tp -157.25 137.84 13.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.439999999999998 110.797 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.429 ' H ' HD12 ' A' ' 9' ' ' LEU . 2.8 p30 -66.56 13.93 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.364 0.505 . . . . 55.5 112.364 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -171.2 137.52 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.319 0.247 . . . . 75.030000000000001 110.643 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -72.67 112.24 14.32 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.796 0.331 . . . . 63.340000000000003 111.698 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -88.7 134.52 2.77 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.893 2.396 . . . . 65.439999999999998 112.761 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.52 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.461 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.82 -159.05 7.98 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.757 -0.656 . . . . 51.219999999999999 111.77 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -135.9 162.94 31.43 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.178 0.513 . . . . 43.130000000000003 111.31 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 44' ' ' VAL . 10.2 mt -105.31 135.17 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 70.219999999999999 110.484 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 30.9 mmmt -74.56 106.05 5.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.686 -0.688 . . . . 71.400000000000006 109.683 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 60.1 t -121.58 110.45 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.747 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.702 HG21 ' O ' ' A' ' 23' ' ' ASP . 3.0 mp -96.01 134.63 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.216 -0.902 . . . . 63.420000000000002 109.465 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -81.67 -85.34 0.1 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.67 -0.412 . . . . 71.319999999999993 111.782 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -67.58 -49.84 47.47 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.35 -0.928 . . . . 70.230000000000004 112.447 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.702 ' O ' HG21 ' A' ' 20' ' ' ILE . 34.9 t70 172.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.716 0.769 . . . . 74.150000000000006 109.019 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.58 -49.72 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.741 -1.118 . . . . 72.409999999999997 110.522 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.1 pt? -69.66 139.57 53.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.3 0.572 . . . . 55.310000000000002 111.581 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 27' ' ' VAL . 69.5 tt0 -120.82 150.01 41.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.267 -0.879 . . . . 64.409999999999997 111.857 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 10.5 m -98.7 119.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.85 -0.796 . . . . 74.140000000000001 108.85 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HD2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -139.08 128.58 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.757 0.789 . . . . 74.430000000000007 112.7 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.565 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.9 mp0 46.41 63.15 1.99 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.035 -1.438 . . . . 72.519999999999996 114.854 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 11.39 44.63 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 115.739 1.056 . . . . 74.310000000000002 115.739 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.24 139.48 35.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.779 0.789 . . . . 50.350000000000001 110.701 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.92 123.02 29.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.726 -0.472 . . . . 74.319999999999993 109.726 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 27' ' ' VAL . 9.9 mp -92.75 114.21 26.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.735 -0.386 . . . . 52.219999999999999 110.741 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -150.12 156.96 37.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 62.32 110.488 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.23 -100.4 0.0 OUTLIER 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.156 -1.185 . . . . 74.329999999999998 113.869 0.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -70.2 54.35 0.14 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.653 0.612 . . . . 74.420000000000002 112.653 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.0 pt20 -120.39 -6.32 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.98 0.419 . . . . 70.299999999999997 110.983 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.36 -6.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.12 -0.491 . . . . 74.439999999999998 111.911 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 -10.57 59.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.49 -0.323 . . . . 65.129999999999995 111.79 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 21' ' ' TYR . 87.3 m-20 -79.07 144.76 34.29 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.162 0.506 . . . . 54.340000000000003 112.193 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -76.31 138.47 67.93 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.697 -0.683 . . . . 64.099999999999994 109.878 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -78.88 126.88 7.46 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.319 2.013 . . . . 60.340000000000003 113.215 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.6 mm -104.25 105.93 19.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.015 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 17' ' ' ILE . 2.6 p -87.14 143.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 113.234 0.827 . . . . 62.450000000000003 113.234 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.9 m -162.24 132.55 4.77 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.023 0.44 . . . . 65.540000000000006 110.965 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.717 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -112.34 26.92 10.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.023 -0.535 . . . . 75.420000000000002 110.399 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 t -41.41 123.35 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 61.530000000000001 111.644 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.89 -29.64 7.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.06 -0.591 . . . . 73.409999999999997 113.28 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.15 -31.19 58.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.145 0.472 . . . . 70.409999999999997 111.336 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.717 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -70.48 -65.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.858 -0.61 . . . . 72.239999999999995 110.922 -179.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 65.76 -75.88 0.11 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.737 -0.665 . . . . 63.030000000000001 112.499 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -148.71 110.08 4.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 63.210000000000001 111.492 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -151.4 145.01 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.645 . . . . 65.219999999999999 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 11.2 t30 -65.75 -39.5 91.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.775 0.798 . . . . 50.009999999999998 109.369 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 83' ' ' ASN . 46.2 mt -158.48 162.17 37.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.522 -1.217 . . . . 73.140000000000001 110.06 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 81.5 mt -128.85 142.48 50.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.774 0.321 . . . . 75.030000000000001 110.393 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.765 HG23 ' CG1' ' A' ' 82' ' ' VAL . 56.1 m -113.63 118.14 33.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 111.245 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.8 tm? -116.36 140.29 49.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.73 -0.47 . . . . 73.219999999999999 109.73 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 58' ' ' LEU . 89.5 mt -141.89 154.85 45.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.373 . . . . 70.129999999999995 111.207 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.442 ' HB3' ' HB3' ' A' ' 78' ' ' HIS . 23.5 ttt -117.63 124.38 48.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.674 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 40.7 t -108.96 132.74 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 109.778 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 7.9 t70 -176.94 62.07 0.19 Allowed Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.408 -0.96 . . . . 72.109999999999999 108.408 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD3' HG12 ' A' ' 61' ' ' VAL . 22.4 Cg_endo -91.59 83.39 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.692 1.595 . . . . 55.450000000000003 114.073 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -171.13 107.93 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.279 -0.873 . . . . 73.439999999999998 110.796 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.729 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.07 135.58 1.24 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 121.127 -0.229 . . . . 75.530000000000001 111.299 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.729 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 Cg_endo -52.28 -15.28 0.44 Allowed 'Cis proline' 0 C--N 1.356 0.957 0 C-N-CA 124.32 -1.116 . . . . 64.400000000000006 111.946 -2.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.521 ' N ' ' HA ' ' A' ' 65' ' ' ALA . 6.7 t -165.15 -175.89 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.505 -0.77 . . . . 74.450000000000003 110.003 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 64' ' ' ASP . 13.7 tpt180 -67.73 -34.9 77.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.03 0.443 . . . . 75.519999999999996 109.838 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -71.0 -45.21 64.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.506 -0.77 . . . . 65.010000000000005 112.957 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 67' ' ' THR . 49.0 t0 -108.8 103.15 50.92 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.628 -0.429 . . . . 73.340000000000003 111.11 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.22 52.92 2.99 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.66 2.24 . . . . 75.540000000000006 110.865 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -48.57 -31.48 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.909 -0.587 . . . . 73.329999999999998 110.287 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.574 ' HB2' HD21 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -166.47 56.17 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.328 -0.851 . . . . 71.239999999999995 109.736 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.461 ' C ' ' HD2' ' A' ' 74' ' ' ARG . 4.9 tmm_? -99.26 135.27 40.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.911 -1.495 . . . . 72.439999999999998 109.417 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 21.6 mp0 -76.15 177.81 6.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.711 0.804 . . . . 72.319999999999993 111.9 0.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.4 tp -109.75 -173.55 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.822 -1.177 . . . . 64.340000000000003 107.822 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.562 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.8 mt -64.99 120.37 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.078 0.399 . . . . 65.340000000000003 110.917 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' MET . 36.5 m170 -107.78 169.24 8.72 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.102 -0.239 . . . . 74.299999999999997 110.724 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.6 t-105 -100.01 85.27 3.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.741 0.782 . . . . 61.130000000000003 110.215 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -98.99 127.21 44.86 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.784 -1.098 . . . . 62.32 112.704 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -147.91 124.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.553 -0.748 . . . . 62.439999999999998 109.115 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.765 ' CG1' HG23 ' A' ' 57' ' ' THR . 23.6 m -138.13 -176.5 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.012 0.434 . . . . 70.400000000000006 111.732 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 55' ' ' LEU . 15.6 p30 52.13 37.26 21.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.962 -1.017 . . . . 74.400000000000006 109.518 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.032 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm -78.93 106.56 4.52 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 114.891 -1.05 . . . . 73.200000000000003 108.737 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HG2' HD21 ' A' ' 88' ' ' ASN . 2.3 Cg_endo -48.13 129.04 17.95 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.759 1.64 . . . . 73.420000000000002 111.788 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.3 69.67 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 O-C-N 123.412 0.445 . . . . 63.350000000000001 113.823 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' PRO . 44.0 t 179.81 47.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.378 -0.601 . . . . 73.409999999999997 109.378 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 90' ' ' ASN . 55.0 m-80 -135.16 -22.39 1.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.173 -0.921 . . . . 61.299999999999997 112.309 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 67.86 -15.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.869 0.322 . . . . 73.0 111.869 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 88' ' ' ASN . 5.3 p30 -153.84 156.45 32.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 109.666 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' ILE . 74.3 Cg_endo -70.54 56.67 1.75 Allowed 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.334 2.689 . . . . 64.510000000000005 113.975 -178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -104.15 -40.08 6.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.503 . . . . 73.230000000000004 112.02 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.43 -41.56 58.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.887 0.715 . . . . 45.240000000000002 114.887 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 1.032 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.07 170.35 14.71 Favored Glycine 0 N--CA 1.46 0.287 0 C-N-CA 120.993 -0.622 . . . . 63.439999999999998 113.179 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.484 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.14 121.28 18.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.876 -0.19 . . . . 75.150000000000006 111.296 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.705 ' HA ' HG13 ' A' ' 81' ' ' VAL . 95.8 p -82.09 116.22 21.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.837 -1.172 . . . . 52.219999999999999 107.837 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' HG3' ' A' ' 127' ' ' GLU . 11.2 mt -67.36 -55.01 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 72.140000000000001 109.968 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 131' ' ' ILE . . . -137.03 125.05 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.293 -0.867 . . . . 61.020000000000003 109.146 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 9.9 t0 -52.17 148.57 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.86 0.362 . . . . 45.329999999999998 111.318 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 37.6 p90 -65.03 128.74 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.261 0.553 . . . . 73.230000000000004 111.071 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.9 p -106.38 113.79 43.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.472 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.81 6.97 23.14 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.679 -0.772 . . . . 50.119999999999997 112.25 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 101' ' ' VAL . 38.2 t -59.98 -97.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.02 0.378 . . . . 75.109999999999999 112.02 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.24 161.88 37.82 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.928 -0.653 . . . . 52.210000000000001 112.254 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HB2' ' CE1' ' A' ' 112' ' ' HIS . 31.8 Cg_exo -60.72 137.59 74.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.932 2.421 . . . . 62.509999999999998 112.565 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 41.0 Cg_endo -66.76 161.26 42.73 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.727 2.285 . . . . 73.230000000000004 113.211 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -42.36 -23.28 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 112.026 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.2 m-20 -50.8 -35.4 31.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.514 -0.312 . . . . 74.099999999999994 111.582 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 12.4 t -103.75 8.8 37.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.335 -0.546 . . . . 63.049999999999997 110.968 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.488 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 54.45 -110.96 1.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 113.751 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 27.6 tp -63.83 162.38 13.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.437 0.637 . . . . 61.119999999999997 111.899 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 8.2 m-70 -147.04 144.62 29.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 72.319999999999993 109.303 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -109.05 108.65 19.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.022 -0.362 . . . . 73.209999999999994 110.022 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -104.55 133.31 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.523 -0.547 . . . . 74.450000000000003 109.523 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 9' ' ' LEU . 26.8 mt -132.96 147.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.192 0.52 . . . . 43.420000000000002 111.54 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -120.84 134.31 55.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.237 -0.892 . . . . 73.319999999999993 109.395 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 156' ' ' PRO . 18.5 tp -119.9 140.15 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.144 0.277 . . . . 64.430000000000007 110.475 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 158' ' ' ALA . 62.6 tp -134.79 135.49 41.84 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.39 -0.368 . . . . 63.43 111.09 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HA ' HG12 ' A' ' 157' ' ' ILE . 37.7 t80 -144.25 142.85 30.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 75.319999999999993 110.553 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.848 ' HG3' HD13 ' A' ' 157' ' ' ILE . 98.2 mtt180 -71.47 128.33 35.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 110.626 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 56.8 tp60 -103.91 115.15 29.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.534 -0.757 . . . . 73.040000000000006 110.437 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.451 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 37.2 tt0 -87.04 -37.98 16.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.413 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -112.19 135.12 53.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.701 0.286 . . . . 33.329999999999998 111.253 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 26.2 tptp -65.42 119.33 10.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.928 -0.578 . . . . 62.340000000000003 111.471 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.73 131.89 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 75.099999999999994 109.754 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.16 -57.89 5.91 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 63.439999999999998 110.906 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.573 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 66.11 13.0 8.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.84 1.052 . . . . 72.430000000000007 113.84 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 25.2 p 51.21 162.98 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.613 0.968 . . . . 74.010000000000005 113.613 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 18.6 Cg_endo -58.24 151.4 60.07 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.88 2.387 . . . . 54.039999999999999 112.974 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 131' ' ' ILE . 89.1 m -60.0 151.3 26.65 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.008 0.744 . . . . 74.319999999999993 113.008 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.425 ' N ' HG22 ' A' ' 130' ' ' THR . 40.8 mm -121.93 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.802 -1.09 . . . . 72.019999999999996 109.595 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' THR . 27.6 t -71.12 148.31 47.56 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.643 0.258 . . . . 71.010000000000005 111.528 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.515 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 24.9 p30 -65.4 5.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.156 0.503 . . . . 75.439999999999998 110.348 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 132' ' ' SER . 64.5 p -114.26 15.19 18.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.497 -0.774 . . . . 51.450000000000003 111.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -62.82 133.91 55.44 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.555 -0.458 . . . . 45.210000000000001 110.698 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' A' ' 137' ' ' THR . 22.4 tpp180 -71.83 170.99 12.48 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.34 -0.391 . . . . 75.310000000000002 110.668 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 66.2 m -40.57 145.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.619 . . . . 43.439999999999998 110.231 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.33 -22.04 11.42 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.993 -0.843 . . . . 74.25 110.993 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -131.21 24.16 4.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 74.510000000000005 110.113 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 177' ' ' ILE . 37.2 mt -94.07 -56.37 2.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.53 0.681 . . . . 73.450000000000003 109.501 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.574 HD21 ' HB2' ' A' ' 73' ' ' TYR . 4.3 m120 -79.55 121.36 25.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 71.230000000000004 111.66 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.41 ' HE2' ' CZ ' ' A' ' 147' ' ' PHE . 5.7 t80 -167.79 115.87 0.76 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.938 -1.028 . . . . 74.530000000000001 109.993 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -71.44 110.65 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.736 -0.666 . . . . 44.149999999999999 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.65 -28.88 57.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.401 0.62 . . . . 73.129999999999995 110.073 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -52.63 -23.54 6.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 111.001 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.41 -46.94 81.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.878 0.37 . . . . 72.109999999999999 111.248 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.537 ' HA ' ' CD ' ' A' ' 150' ' ' LYS . 76.1 m-85 -45.33 -49.15 13.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.114 -0.494 . . . . 74.25 111.847 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.21 51.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.912 -0.586 . . . . 35.229999999999997 111.073 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.07 -51.85 6.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.306 0.484 . . . . 64.349999999999994 112.306 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -53.68 -50.55 65.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 73.510000000000005 111.817 -178.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 153' ' ' LEU . 33.7 m-70 -103.63 11.38 36.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.692 0.282 . . . . 75.510000000000005 111.494 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 53.26 28.93 36.12 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.619 -0.8 . . . . 73.329999999999998 112.722 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 11.6 mt -67.6 7.44 0.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.904 0.335 . . . . 75.120000000000005 111.904 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 153' ' ' LEU . . . -30.23 -59.96 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.375 -0.44 . . . . 40.409999999999997 113.836 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.31 112.69 19.88 Favored Pre-proline 0 N--CA 1.465 0.284 0 N-CA-C 111.631 0.234 . . . . 73.239999999999995 111.631 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 117' ' ' LEU . 69.7 Cg_endo -92.15 127.32 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.536 2.157 . . . . 73.109999999999999 112.888 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.848 HD13 ' HG3' ' A' ' 120' ' ' ARG . 42.9 pt -75.98 -34.65 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 70.25 110.452 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.599 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.14 149.7 26.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 51.43 111.246 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' CB ' ' CD2' ' A' ' 9' ' ' LEU . . . -151.49 154.41 36.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.804 -0.635 . . . . 74.409999999999997 110.081 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -152.46 133.61 14.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.245 -1.02 . . . . 71.430000000000007 108.245 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 115' ' ' ILE . 2.1 p90 -138.71 156.08 47.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.457 -0.338 . . . . 75.310000000000002 111.486 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.526 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 p90 -154.34 150.42 27.93 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 111.363 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -110.98 133.1 53.66 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.905 -0.589 . . . . 71.319999999999993 111.179 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.71 149.44 25.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.249 -0.887 . . . . 71.420000000000002 109.852 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.562 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -103.34 132.9 49.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.562 -0.533 . . . . 63.130000000000003 109.562 178.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.29 129.18 55.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.657 0.265 . . . . 64.319999999999993 110.768 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -62.29 -125.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.59 . . . . 71.340000000000003 111.942 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.618 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 22.7 t0 -129.77 -20.63 3.17 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.882 -0.599 . . . . 65.510000000000005 111.281 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.533 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 17.9 t80 -68.32 -69.22 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.142 0.793 . . . . 75.109999999999999 113.142 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 171' ' ' PRO . 7.5 p -50.01 -37.36 25.9 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 111.996 0.369 . . . . 74.430000000000007 111.996 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 170' ' ' VAL . 50.2 Cg_exo -54.03 -12.25 3.38 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.512 2.141 . . . . 73.329999999999998 111.688 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 175' ' ' LYS . 8.8 tp -45.77 -30.57 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.662 -0.699 . . . . 63.409999999999997 111.842 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -53.19 -46.76 69.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 119.906 -0.718 . . . . 71.030000000000001 109.513 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.424 ' HA ' HG13 ' A' ' 177' ' ' ILE . 44.6 t30 -63.83 -37.12 86.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.316 -0.624 . . . . 75.450000000000003 109.316 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.647 ' HB2' HD12 ' A' ' 172' ' ' ILE . 61.2 mttp -68.67 -27.97 66.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.576 -0.738 . . . . 71.450000000000003 110.18 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 176' ' ' THR . 18.9 m -97.1 13.1 30.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.929 -0.578 . . . . 74.230000000000004 112.524 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 31.6 mt -64.95 140.86 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 64.439999999999998 109.382 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.515 ' HA ' ' NH2' ' A' ' 136' ' ' ARG . 29.3 m -143.17 -25.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.72 1.007 . . . . 62.329999999999998 113.72 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.451 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.317 -1.269 . . . . 73.25 112.728 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.336 0.588 . . . . 73.439999999999998 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.7 t70 -67.47 -48.09 68.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 73.209999999999994 111.513 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.4 pt -114.95 44.7 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.245 0.545 . . . . 54.409999999999997 111.845 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.9 137.74 20.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.994 -0.548 . . . . 40.030000000000001 111.013 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -93.55 32.92 10.11 Favored 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.129 -1.196 . . . . 74.310000000000002 112.113 -0.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 t70 -51.45 -51.58 53.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 55.140000000000001 110.563 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.2 m -160.32 -35.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 72.420000000000002 111.706 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' CD1' HG21 ' A' ' 115' ' ' ILE . 27.6 tp -157.25 172.39 18.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 74.099999999999994 111.056 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 3' ' ' ASP . 9.4 p-10 -78.3 -38.04 43.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.089 -0.708 . . . . 72.200000000000003 109.089 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.475 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -152.55 131.65 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.611 -0.722 . . . . 71.319999999999993 109.905 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 7.2 p -59.82 126.4 83.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.134 0.42 . . . . 64.310000000000002 112.134 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.643 ' HG3' ' HB3' ' A' ' 159' ' ' ALA . 71.6 Cg_endo -96.22 -117.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.758 2.972 . . . . 74.239999999999995 111.9 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -166.46 -42.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.607 -0.269 . . . . 72.510000000000005 111.33 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 158.36 17.98 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.778 -0.725 . . . . 60.200000000000003 113.575 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.467 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.1 t -102.83 152.17 21.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.011 0.434 . . . . 64.310000000000002 110.48 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 118' ' ' LEU . 9.2 mt -105.73 123.4 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.962 -0.755 . . . . 74.129999999999995 108.962 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.3 OUTLIER -73.98 102.57 4.18 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.455 -0.793 . . . . 72.140000000000001 109.581 -178.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 27' ' ' VAL . 59.2 t -111.0 110.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 2.6 mp -104.54 128.5 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.794 -0.639 . . . . 73.420000000000002 111.302 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -96.64 -84.93 0.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.159 -0.928 . . . . 65.230000000000004 110.867 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -59.69 3.15 0.27 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.594 -0.73 . . . . 62.32 113.274 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER 85.37 -43.96 0.06 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.896 -1.149 . . . . 74.230000000000004 107.896 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.76 -37.39 19.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.999 -1.0 . . . . 72.140000000000001 108.712 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.31 163.14 25.14 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.215 -0.902 . . . . 74.049999999999997 112.496 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 23.2 tt0 -151.7 127.75 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.758 -1.11 . . . . 64.140000000000001 110.288 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.875 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.3 m -71.64 128.18 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.322 0.582 . . . . 63.530000000000001 111.711 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 73.4 mmtt -112.59 111.37 22.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.518 0.932 . . . . 72.140000000000001 113.518 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.446 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 7.4 mp0 31.06 67.54 0.13 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.804 1.409 . . . . 70.200000000000003 114.804 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.69 4.58 89.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.343 -0.456 . . . . 74.140000000000001 113.448 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -55.57 146.76 19.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.311 0.577 . . . . 63.119999999999997 112.297 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.37 140.85 32.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.98 -1.009 . . . . 72.340000000000003 111.191 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 38' ' ' VAL . 7.5 mp -106.27 132.4 52.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 71.209999999999994 110.761 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 8.8 p -140.66 161.72 52.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 109.849 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 83.8 Cg_endo -82.09 -33.16 3.12 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 124.142 -1.191 . . . . 65.25 113.404 0.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 36' ' ' THR . 85.1 m -156.65 42.92 0.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.285 0.564 . . . . 51.399999999999999 111.462 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.583 ' OE1' HD12 ' A' ' 25' ' ' LEU . 23.5 pt20 -92.76 0.23 57.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.413 0.625 . . . . 73.510000000000005 110.797 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 33' ' ' LEU . 28.0 m -68.65 -7.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.479 -0.782 . . . . 71.200000000000003 111.284 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -11.32 60.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.145 -0.479 . . . . 43.130000000000003 110.608 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.35 133.3 35.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 62.119999999999997 111.434 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -62.9 138.69 97.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 60.109999999999999 110.087 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.16 126.51 13.13 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 121.8 1.666 . . . . 74.129999999999995 112.516 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.5 mm -100.77 114.73 40.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 60.439999999999998 110.288 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.8 p -85.54 140.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.399 0.518 . . . . 72.120000000000005 112.399 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 14.4 m -161.98 139.21 8.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.952 0.406 . . . . 71.040000000000006 110.347 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.4 p90 -121.68 29.8 7.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 74.239999999999995 110.352 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.7 t -44.94 137.15 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 65.420000000000002 110.225 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.19 -32.51 3.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.654 -0.784 . . . . 63.450000000000003 112.239 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 16' ' ' THR . 96.2 mt -79.5 -41.29 27.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.708 0.766 . . . . 64.239999999999995 109.094 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.658 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.0 tt0 -53.52 105.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.698 -1.137 . . . . 73.230000000000004 110.558 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.3 -114.86 1.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.1 -1.2 . . . . 71.349999999999994 110.1 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -80.56 109.19 14.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.635 -0.826 . . . . 54.439999999999998 109.373 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.78 141.79 15.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.444 -0.344 . . . . 62.420000000000002 111.532 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.7 t30 -89.26 -42.19 11.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.791 0.805 . . . . 74.109999999999999 109.583 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 76.9 mt -152.36 170.0 21.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.686 -1.143 . . . . 70.340000000000003 108.595 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.4 mt -138.38 153.15 48.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.466 -0.494 . . . . 64.120000000000005 111.764 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.875 HG23 HG12 ' A' ' 82' ' ' VAL . 31.5 m -121.42 130.62 53.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.743 -0.662 . . . . 74.109999999999999 110.215 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -128.87 123.91 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.253 -0.647 . . . . 71.239999999999995 109.253 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.578 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.6 mt -143.16 161.78 37.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 74.049999999999997 113.017 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.89 146.69 24.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.203 -1.362 . . . . 73.120000000000005 109.974 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 76.8 t -134.09 137.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.288 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' HH21 ' A' ' 68' ' ' ARG . 52.5 t0 83.32 59.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 114.945 -1.025 . . . . 71.439999999999998 111.52 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 57.4 Cg_endo -71.28 123.01 9.21 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.509 2.14 . . . . 75.239999999999995 111.9 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 25.8 p-10 -118.36 120.76 38.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.68 0.622 . . . . 74.209999999999994 112.68 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.742 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -170.65 135.98 1.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.434 0.531 . . . . 70.450000000000003 112.434 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 55.3 Cg_endo -74.2 -3.75 17.53 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.217 -1.576 . . . . 75.109999999999999 109.794 -2.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.8 t -165.01 156.72 15.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.967 -1.015 . . . . 44.340000000000003 110.373 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' HG2' ' CB ' ' A' ' 64' ' ' ASP . 6.5 mtp-105 -68.33 -12.74 61.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.812 -0.631 . . . . 74.310000000000002 110.951 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.32 -32.94 24.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.889 -0.596 . . . . 61.039999999999999 112.252 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -144.08 116.13 5.6 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-O 120.713 0.292 . . . . 43.409999999999997 110.471 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.09 52.5 4.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.039 2.493 . . . . 72.209999999999994 112.302 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 95.9 mttt -48.93 -27.29 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 75.099999999999994 111.637 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.742 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 25.3 p90 -155.55 29.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.299 0.571 . . . . 74.340000000000003 110.781 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 5.7 tmm_? -70.52 136.13 49.12 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.144 -1.058 . . . . 71.099999999999994 108.144 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 14.2 mp0 -88.61 159.09 18.04 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.236 1.014 . . . . 73.439999999999998 111.873 0.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' A' ' 73' ' ' TYR . 9.1 tp -97.37 171.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.442 -0.799 . . . . 74.109999999999999 109.696 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' CD2' HG11 ' A' ' 101' ' ' VAL . 13.9 tp -42.72 112.89 0.4 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.553 0.692 . . . . 64.310000000000002 110.297 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.22 160.28 15.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.572 -1.195 . . . . 61.140000000000001 113.285 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 10.5 t-105 -100.43 116.19 31.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.579 -1.267 . . . . 73.200000000000003 107.579 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.04 135.4 31.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.229 0.825 . . . . 72.219999999999999 113.229 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -140.66 138.5 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.58 -0.737 . . . . 70.420000000000002 110.893 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.875 HG12 HG23 ' A' ' 57' ' ' THR . 26.2 m -142.05 169.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.603 . . . . 72.239999999999995 112.44 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 24.8 p30 51.82 36.18 17.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.562 -1.199 . . . . 72.219999999999999 112.132 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.99 HG21 ' HA ' ' A' ' 91' ' ' PRO . 5.1 mm -69.02 125.81 92.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.715 -0.846 . . . . 64.319999999999993 108.715 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HB2' HD21 ' A' ' 88' ' ' ASN . 34.0 Cg_exo -58.75 126.28 20.75 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 121.429 1.419 . . . . 74.329999999999998 110.902 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.81 60.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.321 0.488 . . . . 54.039999999999999 114.321 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 85' ' ' PRO . 75.1 m -174.97 43.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.935 0.494 . . . . 55.039999999999999 110.255 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.598 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.1 m-80 -135.31 8.94 3.44 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.528 0.936 . . . . 65.530000000000001 113.528 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER 64.65 -26.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.062 0.393 . . . . 74.010000000000005 112.062 177.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.598 ' H ' ' C ' ' A' ' 88' ' ' ASN . 14.8 p30 -154.05 172.63 5.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.187 0.595 . . . . 73.310000000000002 109.932 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.99 ' HA ' HG21 ' A' ' 84' ' ' ILE . 6.1 Cg_exo -79.74 23.9 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.643 2.896 . . . . 51.539999999999999 115.529 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -79.63 1.11 27.39 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.856 -1.138 . . . . 53.509999999999998 112.985 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.11 2.1 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.495 -0.86 . . . . 34.310000000000002 113.609 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.929 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.7 176.49 10.98 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.229 -0.51 . . . . 45.310000000000002 113.669 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.782 ' CE1' HG23 ' A' ' 130' ' ' THR . 46.2 t60 -66.36 121.12 14.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.389 0.514 . . . . 73.019999999999996 112.389 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.1 p -86.26 89.32 7.81 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.924 -0.769 . . . . 64.439999999999998 108.924 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 147' ' ' PHE . 12.4 mt -50.28 -53.83 25.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 64.439999999999998 110.484 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.66 120.38 13.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.958 -1.019 . . . . 62.32 108.714 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.51 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 54.5 t0 -60.21 146.82 42.2 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.6 0.563 . . . . 74.109999999999999 112.084 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.511 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 21.2 p90 -66.38 142.82 57.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.892 -0.595 . . . . 74.430000000000007 110.295 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 133' ' ' ASN . 21.4 m -140.38 145.03 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.696 0.284 . . . . 75.5 111.528 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.512 ' O ' HG12 ' A' ' 170' ' ' VAL . . . -85.03 0.07 89.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.925 -0.655 . . . . 51.229999999999997 111.642 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 t -58.93 -91.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.561 -0.319 . . . . 70.109999999999999 110.604 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 -167.99 5.03 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.909 -0.662 . . . . 74.420000000000002 114.224 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 44.8 Cg_endo -65.74 145.5 81.28 Favored 'Trans proline' 0 N--CA 1.476 0.477 0 C-N-CA 123.67 2.913 . . . . 72.299999999999997 113.107 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.58 160.68 48.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.066 2.51 . . . . 71.540000000000006 113.332 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 167' ' ' ASP . 35.8 ttmt -44.03 -25.09 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.092 -0.504 . . . . 73.150000000000006 111.055 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.46 -37.87 40.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 63.119999999999997 111.422 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.414 ' CG2' ' CE1' ' A' ' 112' ' ' HIS . 11.4 t -76.4 -19.44 58.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.525 -0.47 . . . . 73.120000000000005 111.839 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.92 -129.8 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.599 -0.81 . . . . 61.450000000000003 113.32 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 44.7 tp -67.49 135.28 52.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.01 0.744 . . . . 75.239999999999995 113.01 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.698 ' CE1' ' HG2' ' A' ' 105' ' ' PRO . 67.1 m-70 -108.71 142.87 38.59 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.511 -0.768 . . . . 64.129999999999995 108.947 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.647 HH12 ' NE2' ' A' ' 163' ' ' GLN . 5.5 ptm85 -130.38 84.5 2.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.145 -0.687 . . . . 54.310000000000002 109.145 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.11 136.28 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.476 -0.784 . . . . 63.219999999999999 111.995 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 ' HD1' ' A' ' 161' ' ' TYR . 48.5 mt -113.99 137.02 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.753 -1.112 . . . . 74.430000000000007 111.034 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -99.91 141.97 32.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.132 -0.485 . . . . 64.150000000000006 110.294 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -128.24 129.74 46.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.544 -0.298 . . . . 74.209999999999994 110.447 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.832 ' HB2' HD11 ' A' ' 17' ' ' ILE . 2.7 tt -126.44 134.31 51.0 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.257 -0.428 . . . . 75.140000000000001 110.613 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 118' ' ' LEU . 49.9 t80 -144.01 148.52 35.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.913 0.387 . . . . 73.519999999999996 111.408 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HA ' HD23 ' A' ' 56' ' ' LEU . 54.1 ttp180 -83.43 134.68 34.86 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.628 -0.508 . . . . 75.230000000000004 109.628 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -118.06 139.15 51.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.708 -0.224 . . . . 65.310000000000002 110.457 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -110.5 -34.79 6.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.415 -0.357 . . . . 71.420000000000002 110.96 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.413 ' N ' HD22 ' A' ' 123' ' ' ASN . 2.4 m120 -96.09 130.4 43.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 74.019999999999996 111.107 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 23.3 tptm -73.08 143.04 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 70.219999999999999 110.566 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD12 ' CE1' ' A' ' 151' ' ' HIS . 0.9 OUTLIER -141.29 144.55 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 50.32 111.732 -179.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -86.73 -31.09 21.15 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.86 0.725 . . . . 70.340000000000003 109.733 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' ND2' ' A' ' 83' ' ' ASN . 0.4 OUTLIER 29.17 56.33 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.39 -1.277 . . . . 75.040000000000006 113.712 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.466 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 51.8 p 60.96 138.2 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 114.585 1.328 . . . . 75.120000000000005 114.585 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.03 158.24 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.996 3.131 . . . . 54.140000000000001 113.764 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.782 HG23 ' CE1' ' A' ' 95' ' ' HIS . 18.5 p -62.18 138.88 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.428 -0.805 . . . . 44.219999999999999 113.067 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.82 129.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.03 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 t -72.33 153.19 41.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.985 0.735 . . . . 70.540000000000006 112.985 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.852 ' HB2' HG12 ' A' ' 101' ' ' VAL . 17.3 p30 -57.92 -26.58 62.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.158 -0.928 . . . . 72.010000000000005 109.595 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 176' ' ' THR . 69.7 p -85.97 14.74 5.71 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.279 -0.873 . . . . 73.030000000000001 111.953 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.6 t -67.79 130.89 44.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 112.204 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.634 ' HG2' ' N ' ' A' ' 179' ' ' GLY . 17.2 mmm180 -77.37 173.21 12.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 73.420000000000002 110.501 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.649 HG23 HD11 ' A' ' 140' ' ' LEU . 32.3 m -54.25 159.55 1.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 75.150000000000006 110.144 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 137' ' ' THR . . . 116.22 -7.8 18.56 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.698 -0.763 . . . . 74.340000000000003 112.417 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' ' 139' ' ' ARG . 16.8 ttt85 -152.94 8.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.132 0.491 . . . . 75.049999999999997 110.956 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 141' ' ' ASN . 0.9 OUTLIER -88.72 -39.77 13.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.007 -0.738 . . . . 74.329999999999998 109.007 177.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.828 ' N ' HD12 ' A' ' 140' ' ' LEU . 4.3 m120 -63.24 69.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.43 -0.805 . . . . 75.439999999999998 109.408 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 140' ' ' LEU . 60.0 t80 -127.73 128.81 46.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 74.209999999999994 111.741 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' A' ' 145' ' ' ARG . 17.8 p-10 -95.36 135.04 37.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 72.230000000000004 111.36 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.48 71.56 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.324 0.583 . . . . 51.119999999999997 110.435 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.978 ' NH1' ' HB2' ' A' ' 149' ' ' ALA . 26.3 tpt85 -43.81 -29.93 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.939 -1.028 . . . . 74.340000000000003 111.549 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' OD2' ' NZ ' ' A' ' 150' ' ' LYS . 13.6 t70 -60.17 -58.34 8.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.185 0.517 . . . . 75.25 110.392 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 97' ' ' LEU . 19.4 m-30 -64.79 -37.78 88.77 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.788 -0.642 . . . . 73.329999999999998 109.877 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.7 76.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 53.409999999999997 109.898 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.978 ' HB2' ' NH1' ' A' ' 145' ' ' ARG . . . -75.64 -53.75 8.07 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.396 0.517 . . . . 74.219999999999999 112.396 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.424 ' NZ ' ' OD2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -82.33 -51.13 8.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.18 0.807 . . . . 74.310000000000002 113.18 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.485 ' CE1' HD12 ' A' ' 125' ' ' ILE . 30.4 m170 -67.99 -0.46 4.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 120.086 -0.646 . . . . 70.530000000000001 110.741 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 61.09 31.41 76.62 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 114.956 0.742 . . . . 63.340000000000003 114.956 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CD1' HD12 ' A' ' 59' ' ' LEU . 10.8 mt -74.3 16.49 0.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.084 0.442 . . . . 72.200000000000003 111.376 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -47.94 -18.96 0.85 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.334 0.494 . . . . 62.100000000000001 114.334 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -135.16 93.31 17.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 117.309 0.555 . . . . 75.129999999999995 111.107 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.651 ' HB3' HD21 ' A' ' 117' ' ' LEU . 48.1 Cg_endo -67.76 134.3 32.09 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.384 2.056 . . . . 70.530000000000001 112.766 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 119' ' ' TYR . 24.9 pt -84.74 -34.98 9.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.274 -0.421 . . . . 70.530000000000001 110.553 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -139.24 147.09 41.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.123 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 17' ' ' ILE . . . -162.35 159.46 25.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 111.301 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.768 HD21 HG23 ' A' ' 27' ' ' VAL . 57.1 t30 -164.6 167.58 19.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.424 -1.325 . . . . 74.150000000000006 107.424 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.633 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -154.51 157.43 38.35 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.292 -0.563 . . . . 74.409999999999997 111.448 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.539 ' HB3' ' CB ' ' A' ' 27' ' ' VAL . 3.3 p90 -149.9 153.04 36.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.026 -0.534 . . . . 74.239999999999995 111.603 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.647 ' NE2' HH12 ' A' ' 113' ' ' ARG . 44.7 mt-30 -112.15 134.81 53.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.74 -0.664 . . . . 70.109999999999999 111.027 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.24 145.77 22.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.963 -0.562 . . . . 62.25 111.778 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 2.0 pm0 -133.94 156.87 47.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.033 -1.099 . . . . 71.109999999999999 108.033 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER -157.33 159.25 37.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 63.140000000000001 112.224 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.494 ' HA ' ' CE ' ' A' ' 107' ' ' LYS . 1.7 m-20 -71.15 157.13 38.69 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.652 -0.704 . . . . 73.150000000000006 110.516 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.566 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 14.5 t70 -48.75 -23.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.737 -0.665 . . . . 63.119999999999997 110.673 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.424 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 23.8 t80 -53.08 -38.22 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 55.229999999999997 110.99 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.629 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 73.7 t -68.16 -57.57 8.93 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.028 -0.669 . . . . 64.340000000000003 109.604 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 83.9 Cg_exo -44.99 -29.55 3.88 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.284 1.989 . . . . 74.450000000000003 111.921 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 168' ' ' ASP . 38.2 mm -47.67 -23.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.176 0.512 . . . . 74.109999999999999 109.791 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -44.49 -27.96 0.52 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.272 -0.876 . . . . 65.450000000000003 109.514 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 175' ' ' LYS . 12.7 p30 -46.11 -33.88 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.522 -0.763 . . . . 65.129999999999995 111.456 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 10.9 mptt -52.48 -30.78 31.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.776 0.322 . . . . 64.140000000000001 111.377 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 134' ' ' THR . 1.9 m -66.95 -28.05 67.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 75.129999999999995 110.361 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.623 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.3 mm -62.79 134.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 71.219999999999999 110.808 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.7 m -149.34 2.95 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.684 0.624 . . . . 75.430000000000007 112.684 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.634 ' N ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.466 -1.185 . . . . 41.530000000000001 112.871 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.951 -0.389 . . . . 63.219999999999999 109.951 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.48 -71.04 0.67 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.817 0.673 . . . . 62.310000000000002 112.817 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.562 HD12 ' CG2' ' A' ' 8' ' ' VAL . 7.2 pt -121.17 63.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.295 0.569 . . . . 74.230000000000004 111.856 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' ASP . 12.7 p -128.55 138.66 33.55 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.689 -0.687 . . . . 75.109999999999999 110.341 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.6 Cg_endo -85.55 34.22 4.22 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.767 -1.347 . . . . 73.340000000000003 112.588 0.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 8' ' ' VAL . 62.5 t0 -57.74 -53.76 54.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 71.040000000000006 110.056 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 4' ' ' ILE . 20.1 m -162.72 -37.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.505 -0.771 . . . . 54.130000000000003 111.073 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.1 tp -157.08 140.64 15.84 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-O 121.432 0.634 . . . . 71.420000000000002 111.227 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 20.5 p-10 -75.79 6.19 5.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.812 -0.631 . . . . 72.340000000000003 112.009 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -157.7 133.94 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 61.25 111.343 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.8 p -85.93 109.86 25.88 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.213 -0.448 . . . . 72.099999999999994 112.09 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.8 Cg_endo -86.87 -130.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.303 2.669 . . . . 73.120000000000005 112.187 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -159.94 -41.19 0.05 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.427 -0.351 . . . . 64.140000000000001 110.697 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -161.58 20.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.953 -0.641 . . . . 63.200000000000003 112.44 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 5.1 t -150.37 170.02 20.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.077 0.465 . . . . 72.230000000000004 111.377 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -105.88 127.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 64.530000000000001 109.186 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.9 mmpt? -84.15 102.95 12.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 109.649 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.563 ' HB ' HG22 ' A' ' 27' ' ' VAL . 48.3 t -116.89 110.68 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.165 0.507 . . . . 64.230000000000004 109.709 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.633 HG21 ' O ' ' A' ' 23' ' ' ASP . 25.8 mt -92.08 143.35 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.7 -0.682 . . . . 64.310000000000002 109.951 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 2.4 t80 -84.83 -77.8 0.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.733 -0.787 . . . . 51.240000000000002 111.584 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.611 ' H ' ' CD1' ' A' ' 25' ' ' LEU . . . -99.83 -32.87 5.48 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.611 -0.804 . . . . 72.209999999999994 113.884 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.633 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -173.48 -75.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.444 0.535 . . . . 61.109999999999999 112.444 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -90.97 -40.16 11.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.178 0.513 . . . . 73.120000000000005 110.76 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD1' ' H ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -69.53 135.98 50.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.79 -0.641 . . . . 51.310000000000002 110.469 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 22.4 pt-20 -134.26 159.18 41.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.101 -0.5 . . . . 74.239999999999995 111.528 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.1 m -69.38 134.21 30.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 72.450000000000003 110.172 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -138.64 108.51 6.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 75.25 112.228 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.508 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.7 mp0 52.06 49.12 21.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.965 . . . . 50.450000000000003 113.603 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 161' ' ' TYR . . . 62.17 12.54 38.08 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 114.812 0.685 . . . . 35.009999999999998 114.812 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -55.09 157.51 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 117.483 0.642 . . . . 73.209999999999994 110.233 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -98.2 129.31 44.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 73.25 110.051 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.74 HD23 HE21 ' A' ' 37' ' ' GLN . 5.2 mp -92.78 112.83 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.557 0.694 . . . . 75.319999999999993 110.988 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 2.8 p -110.54 165.63 12.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.747 -1.115 . . . . 75.120000000000005 111.35 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 17.7 Cg_exo -67.39 -42.32 0.7 Allowed 'Cis proline' 0 C--N 1.352 0.733 0 C-N-CA 124.161 -1.183 . . . . 54.149999999999999 112.033 0.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -162.53 44.47 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 71.25 109.889 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.74 HE21 HD23 ' A' ' 33' ' ' LEU . 17.7 pt20 -76.75 -4.83 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.629 -0.714 . . . . 71.120000000000005 111.215 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.585 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 34.3 m -73.37 31.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.695 0.76 . . . . 52.520000000000003 110.082 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.57 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -93.37 6.0 49.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.688 -1.142 . . . . 73.109999999999999 112.498 -178.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -135.3 162.99 31.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.845 0.313 . . . . 64.239999999999995 111.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -72.31 146.0 88.78 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.138 -0.483 . . . . 70.299999999999997 111.519 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -95.33 126.96 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.146 2.564 . . . . 70.349999999999994 113.424 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.1 mm -80.17 128.4 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 64.510000000000005 110.932 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.468 HG13 ' HD2' ' A' ' 91' ' ' PRO . 4.1 p -100.22 137.17 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.917 0.339 . . . . 74.540000000000006 111.917 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -162.21 153.84 18.5 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.137 0.494 . . . . 64.430000000000007 111.366 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.735 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.8 p90 -128.59 34.4 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.839 0.828 . . . . 65.510000000000005 109.485 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 m -49.54 107.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.457 -1.247 . . . . 73.150000000000006 111.069 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.57 -33.88 5.3 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.768 -0.651 . . . . 55.049999999999997 111.489 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 2.4 mm? -76.89 -40.12 48.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.14 -0.689 . . . . 73.140000000000001 109.14 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.735 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 29.2 tt0 -65.92 111.48 3.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.879 -0.601 . . . . 63.119999999999997 109.649 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.97 -63.52 0.26 Allowed Glycine 0 C--N 1.324 -0.111 0 C-N-CA 120.812 -0.709 . . . . 74.549999999999997 112.33 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -148.27 111.04 4.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.38 -0.6 . . . . 74.420000000000002 109.38 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 120' ' ' ARG . 12.2 p -157.29 141.8 16.54 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.85 -0.34 . . . . 52.399999999999999 111.319 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 35.2 t30 -77.91 -33.61 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.538 0.685 . . . . 63.520000000000003 109.292 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -155.15 157.0 36.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.966 -1.015 . . . . 71.230000000000004 109.35 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.9 mt -127.03 152.4 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 73.409999999999997 110.976 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.643 HG23 HG12 ' A' ' 82' ' ' VAL . 95.0 m -121.51 134.01 55.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.054 -0.521 . . . . 54.549999999999997 110.154 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -136.42 132.96 36.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 64.540000000000006 109.638 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 97.1 mt -153.82 159.69 41.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.02 0.438 . . . . 51.340000000000003 111.884 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 114' ' ' TYR . 24.3 ttt -94.92 156.62 16.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 62.350000000000001 109.971 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 57.6 t -133.47 146.12 32.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 54.009999999999998 111.515 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 46.2 t0 65.01 40.69 0.28 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.303 -0.862 . . . . 72.510000000000005 111.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 76.4 Cg_exo -51.21 139.84 42.91 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.884 1.723 . . . . 62.109999999999999 111.587 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.76 122.66 36.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.51 0.559 . . . . 62.549999999999997 112.51 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.83 135.91 1.08 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.056 0.391 . . . . 64.519999999999996 112.056 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 13.2 Cg_exo -68.1 -32.56 3.47 Favored 'Cis proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.883 -1.299 . . . . 71.340000000000003 109.809 -3.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.8 t -141.26 140.25 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.336 -1.302 . . . . 32.399999999999999 108.932 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -56.12 -21.56 23.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.345 0.593 . . . . 75.400000000000006 110.606 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.265 -0.879 . . . . 72.519999999999996 111.234 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . 23.0 t70 -140.15 62.06 19.48 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-O 121.126 0.489 . . . . 75.200000000000003 110.272 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -67.84 53.8 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.458 2.772 . . . . 75.430000000000007 113.434 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -50.96 -52.17 45.15 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.888 0.329 . . . . 74.010000000000005 111.888 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.61 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 2.1 p90 -106.9 39.53 1.84 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.323 0.582 . . . . 62.020000000000003 111.081 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.538 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 3.7 tmm_? -79.29 139.96 37.7 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.781 -1.192 . . . . 74.230000000000004 107.781 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 25.6 mp0 -89.13 178.05 6.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.555 1.142 . . . . 74.150000000000006 112.594 0.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 77' ' ' LEU . 4.7 tp -105.98 -173.24 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.118 -0.946 . . . . 74.519999999999996 109.886 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.0 mp -68.03 64.46 0.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.99 0.424 . . . . 72.329999999999998 111.016 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -58.55 178.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.85 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.471 ' CZ2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t-105 -100.29 122.06 42.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.004 -0.739 . . . . 75.109999999999999 109.004 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 20.0 m -141.1 129.74 22.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 111.507 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -142.52 127.73 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 74.099999999999994 109.388 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 125' ' ' ILE . 19.6 m -129.86 166.07 28.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.402 0.62 . . . . 71.219999999999999 112.366 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.625 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.9 p30 52.95 44.88 29.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.25 -1.341 . . . . 62.409999999999997 112.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.976 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.9 mm -79.89 118.02 70.34 Favored Pre-proline 0 C--O 1.231 0.105 0 N-CA-C 108.328 -0.99 . . . . 63.530000000000001 108.328 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' SER . 45.6 Cg_exo -56.51 125.95 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.839 1.693 . . . . 54.240000000000002 112.003 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.74 73.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.386 -0.435 . . . . 72.510000000000005 113.143 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' PRO . 34.3 t 177.15 45.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.846 0.458 . . . . 71.530000000000001 110.034 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 54.8 m-80 -135.36 -28.23 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.201 0.815 . . . . 72.5 113.201 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 3.9 tt0 74.56 -0.59 3.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.304 0.573 . . . . 65.150000000000006 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 14.4 p30 -167.8 157.62 9.12 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.225 -0.898 . . . . 63.340000000000003 109.914 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.614 ' HA ' HG21 ' A' ' 84' ' ' ILE . 82.5 Cg_endo -77.34 53.84 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.9 2.4 . . . . 73.099999999999994 112.559 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.7 t -102.59 -5.09 24.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.865 -0.334 . . . . 65.219999999999999 111.669 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.19 -42.0 1.33 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.041 -0.6 . . . . 50.539999999999999 114.214 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.976 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.49 173.75 15.48 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.968 -0.634 . . . . 60.340000000000003 113.975 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.7 OUTLIER -65.8 119.21 10.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.077 0.399 . . . . 71.129999999999995 112.077 -178.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 130' ' ' THR . 43.7 m -82.53 90.28 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 74.420000000000002 109.498 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.784 HD13 ' HE2' ' A' ' 147' ' ' PHE . 15.1 mt -50.47 -28.69 8.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.594 -0.73 . . . . 63.130000000000003 111.004 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -165.13 93.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.178 -0.919 . . . . 73.409999999999997 108.86 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -41.85 140.24 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.425 0.631 . . . . 53.310000000000002 112.494 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -56.38 146.9 22.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 71.420000000000002 110.922 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 102' ' ' GLY . 14.8 p -156.91 161.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.942 0.401 . . . . 71.239999999999995 111.341 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -68.24 -176.62 11.19 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.636 -0.711 . . . . 52.219999999999999 113.011 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t -65.92 122.86 18.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 62.049999999999997 111.762 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -86.65 -48.88 4.31 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.478 -0.649 . . . . 34.219999999999999 111.478 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 51.1 Cg_exo -56.37 142.43 88.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.647 2.231 . . . . 71.140000000000001 113.124 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.608 ' O ' HG23 ' A' ' 109' ' ' THR . 18.1 Cg_endo -58.92 143.54 99.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.75 2.3 . . . . 73.230000000000004 112.025 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.504 ' HB3' ' C ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -46.21 -43.29 15.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.944 0.72 . . . . 71.409999999999997 112.944 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.99 0.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.714 0.635 . . . . 71.209999999999994 112.714 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 106' ' ' PRO . 75.9 p -78.64 -27.64 45.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.905 0.383 . . . . 51.200000000000003 110.913 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.41 -167.69 14.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.824 -0.703 . . . . 74.310000000000002 113.353 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -60.01 138.19 57.91 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 112.492 0.553 . . . . 35.409999999999997 112.492 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -106.39 129.91 54.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.117 -0.947 . . . . 75.329999999999998 109.032 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 ptm85 -112.23 120.13 40.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.15 0.5 . . . . 74.209999999999994 111.288 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' ' HE3' ' A' ' 60' ' ' MET . 6.1 m-85 -109.15 140.99 42.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.819 -0.628 . . . . 63.119999999999997 110.659 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 161' ' ' TYR . 24.6 mt -132.47 132.2 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.828 -0.804 . . . . 75.319999999999993 108.828 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -106.02 137.08 44.55 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.443 0.464 . . . . 65.230000000000004 111.493 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.785 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.5 tm? -127.08 137.8 53.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.874 -0.603 . . . . 71.340000000000003 109.812 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.785 ' N ' HD13 ' A' ' 117' ' ' LEU . 57.0 tp -128.25 137.4 51.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.772 0.429 . . . . 64.510000000000005 110.466 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.524 ' CD2' HD22 ' A' ' 153' ' ' LEU . 81.2 t80 -144.07 132.59 22.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.151 -0.477 . . . . 73.450000000000003 110.595 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 53' ' ' SER . 42.8 ttp180 -76.58 128.25 34.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 71.439999999999998 110.613 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.633 ' NE2' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -104.26 149.16 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.975 0.731 . . . . 74.299999999999997 112.975 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 30.2 tt0 -112.59 -55.49 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.686 -1.143 . . . . 75.319999999999993 109.857 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.7 m120 -100.19 131.38 46.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 73.319999999999993 110.717 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 9.7 tmtt? -59.55 125.08 22.19 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.004 -0.369 . . . . 71.340000000000003 110.004 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.845 HD12 ' CE1' ' A' ' 151' ' ' HIS . 5.5 pt -87.15 125.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 52.140000000000001 112.233 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.81 118.04 10.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.903 -1.518 . . . . 74.239999999999995 106.903 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.41 32.31 1.69 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.033 1.123 . . . . 60.140000000000001 114.033 -176.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 68.7 p 51.04 172.53 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 112.446 0.535 . . . . 73.010000000000005 112.446 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 50.4 Cg_exo -58.46 150.4 68.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.517 2.145 . . . . 62.009999999999998 114.037 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 96' ' ' SER . 25.5 p -60.91 132.18 53.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 72.540000000000006 110.809 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 32.4 mm -85.99 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.379 0.609 . . . . 74.209999999999994 112.224 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -73.46 141.32 46.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 70.510000000000005 111.983 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 134' ' ' THR . 22.3 p30 -56.42 -47.1 79.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.515 0.674 . . . . 63.219999999999999 110.427 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.555 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.3 t -84.49 22.93 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.066 -0.97 . . . . 51.439999999999998 111.451 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 177' ' ' ILE . 12.0 t -62.21 155.46 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.551 0.691 . . . . 25.109999999999999 112.121 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.569 ' HB2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 tpt180 -69.02 164.94 21.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.771 -1.104 . . . . 72.120000000000005 112.422 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 138' ' ' GLY . 4.4 m -53.13 175.28 0.03 OUTLIER 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.685 -0.689 . . . . 73.150000000000006 110.258 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.651 ' H ' HG22 ' A' ' 137' ' ' THR . . . 82.07 4.22 90.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 119.937 -1.125 . . . . 74.129999999999995 111.822 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.449 ' H ' HD12 ' A' ' 140' ' ' LEU . 28.7 mmt180 -139.81 45.71 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.262 0.553 . . . . 63.039999999999999 111.304 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -112.77 -63.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.187 -0.915 . . . . 71.239999999999995 108.784 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.2 m120 -63.39 121.38 13.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 74.010000000000005 111.447 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.565 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 40.8 t80 -176.94 109.38 0.08 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.82 -0.627 . . . . 75.430000000000007 111.306 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -68.63 120.98 15.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 111.921 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.74 -43.44 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 52.030000000000001 111.601 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' HH11 ' A' ' 145' ' ' ARG . 11.0 mtp-105 -45.15 -33.92 2.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.218 -0.447 . . . . 73.150000000000006 111.914 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.93 -49.33 50.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.591 0.71 . . . . 44.399999999999999 109.386 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.784 ' HE2' HD13 ' A' ' 97' ' ' LEU . 10.0 m-30 -62.14 -41.95 98.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.053 -0.976 . . . . 74.230000000000004 110.189 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.73 -46.38 87.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.805 0.336 . . . . 62.509999999999998 111.244 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.3 -51.73 41.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.913 -0.585 . . . . 71.420000000000002 112.458 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -75.36 -48.57 22.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.632 0.604 . . . . 61.039999999999999 112.632 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.845 ' CE1' HD12 ' A' ' 125' ' ' ILE . 52.9 m170 -67.76 -10.85 56.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.94 -0.475 . . . . 72.340000000000003 110.724 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.22 67.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.092 -0.575 . . . . 74.230000000000004 113.155 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.524 HD22 ' CD2' ' A' ' 119' ' ' TYR . 7.4 mt -76.02 15.85 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.063 0.145 . . . . 63.210000000000001 111.195 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -35.29 -73.01 0.1 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.021 -0.609 . . . . 34.299999999999997 113.44 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 155' ' ' GLU . 11.4 pt-20 -74.67 112.46 17.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.544 0.172 . . . . 75.549999999999997 110.849 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 117' ' ' LEU . 65.5 Cg_endo -83.55 130.75 5.31 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.194 1.93 . . . . 73.510000000000005 113.116 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.725 HD11 ' HG ' ' A' ' 118' ' ' LEU . 38.8 pt -78.49 -34.7 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.916 -0.314 . . . . 73.319999999999993 111.426 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -151.05 151.0 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.207 0.447 . . . . 72.200000000000003 112.207 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.15 158.15 43.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 53.340000000000003 111.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.6 ' C ' ' CD1' ' A' ' 161' ' ' TYR . 0.8 OUTLIER -158.97 175.09 13.99 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.004 -1.11 . . . . 75.129999999999995 108.004 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -157.95 155.53 29.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.686 0.675 . . . . 71.140000000000001 111.055 -178.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 1.4 t80 -155.94 131.84 9.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.13 0.572 . . . . 75.430000000000007 110.995 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mt-30 -115.86 138.63 50.98 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.282 -0.261 . . . . 71.030000000000001 111.455 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -155.43 153.18 29.95 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.062 0.764 . . . . 53.109999999999999 113.062 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.99 161.5 37.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.776 -0.824 . . . . 65.319999999999993 108.776 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.432 ' O ' ' CB ' ' A' ' 107' ' ' LYS . 1.7 t80 -165.61 168.75 16.06 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.191 -0.604 . . . . 71.010000000000005 111.36 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.504 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.8 t0 -79.46 -159.92 0.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.714 0.634 . . . . 64.209999999999994 110.912 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.5 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 50.2 t0 -69.0 -23.87 64.15 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.092 0.472 . . . . 64.209999999999994 111.036 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.4 t80 -42.88 -44.48 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 112.108 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 67.8 t -80.38 -54.39 0.83 Allowed Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 120.464 -0.494 . . . . 53.020000000000003 111.494 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 77.8 Cg_exo -48.39 -49.84 13.54 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.051 1.834 . . . . 51.399999999999999 112.644 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 168' ' ' ASP . 11.5 tt -46.01 -33.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.027 0.381 . . . . 74.420000000000002 112.027 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.03 -29.53 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 65.430000000000007 111.342 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 177' ' ' ILE . 2.1 m120 -56.51 -14.92 3.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.176 0.806 . . . . 74.409999999999997 113.176 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.36 -20.29 42.57 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.794 0.664 . . . . 74.340000000000003 112.794 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 p -88.1 16.59 5.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.864 0.69 . . . . 74.109999999999999 112.864 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 135' ' ' THR . 27.7 mm -72.46 124.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 122.037 -0.415 . . . . 64.510000000000005 110.296 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.58 -13.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.114 0.783 . . . . 74.409999999999997 113.114 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.555 -1.136 . . . . 64.319999999999993 112.301 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.654 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 120.795 0.331 . . . . 65.319999999999993 111.458 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 5.5 t70 -71.18 -40.83 71.0 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.728 0.299 . . . . 54.219999999999999 111.196 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 9' ' ' LEU . 12.8 pt -149.24 48.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 65.319999999999993 110.615 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 2' ' ' ASP . 13.6 p -136.45 140.9 33.79 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.214 -0.903 . . . . 75.5 109.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 Cg_exo -78.28 26.43 2.5 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.205 -1.164 . . . . 70.329999999999998 113.591 0.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.5 t0 -54.56 -53.21 57.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.393 . . . . 73.129999999999995 110.431 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.5 m -161.32 -43.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.997 -0.547 . . . . 63.200000000000003 111.917 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 117' ' ' LEU . 62.2 tp -144.21 160.08 41.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.65 0.262 . . . . 75.209999999999994 110.851 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -60.43 -42.58 96.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.718 -0.793 . . . . 72.319999999999993 109.732 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -156.59 135.14 11.54 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.818 0.303 . . . . 54.140000000000001 111.818 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.39 125.88 80.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 72.010000000000005 110.995 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 45.7 Cg_endo -89.73 -145.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.892 2.395 . . . . 51.539999999999999 112.201 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.37 -31.05 6.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.842 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.36 -136.54 3.16 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.919 -0.582 . . . . 75.409999999999997 111.834 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.472 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 1.5 t -162.81 164.41 26.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 65.239999999999995 111.734 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.587 HD12 ' N ' ' A' ' 17' ' ' ILE . 3.1 mp -104.9 133.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.406 -0.961 . . . . 73.109999999999999 108.406 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 13.5 mmmm -83.62 101.96 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.442 -0.503 . . . . 71.540000000000006 109.707 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 94.2 t -108.86 108.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.599 0.714 . . . . 61.409999999999997 111.198 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 23' ' ' ASP . 1.8 mp -91.88 138.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 72.150000000000006 107.898 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -93.42 -46.96 7.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.937 0.717 . . . . 71.030000000000001 112.937 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' A' ' 25' ' ' LEU . . . -115.86 -48.39 0.5 Allowed Glycine 0 N--CA 1.459 0.175 0 C-N-CA 120.277 -0.963 . . . . 53.299999999999997 112.857 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -170.62 -80.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 110.261 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -82.31 -31.85 29.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.599 . . . . 75.420000000000002 109.384 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 129.08 38.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.687 0.756 . . . . 71.209999999999994 111.443 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 28.3 tt0 -125.61 150.77 47.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.702 -1.136 . . . . 72.439999999999998 110.836 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 27' ' ' VAL . 31.3 m -85.42 107.01 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 111.535 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 31' ' ' ASN . 1.5 mptm? -75.21 50.53 0.5 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.429 0.9 . . . . 64.439999999999998 113.429 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.703 HE21 ' ND2' ' A' ' 160' ' ' ASN . 9.5 mp0 59.31 69.67 0.7 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.667 0.988 . . . . 63.039999999999999 113.667 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 161' ' ' TYR . . . 100.38 -6.21 57.64 Favored Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 110.835 -0.906 . . . . 75.329999999999998 110.835 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.465 ' ND2' HD11 ' A' ' 33' ' ' LEU . 1.4 t30 -59.14 139.02 57.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.932 -1.134 . . . . 72.109999999999999 110.868 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' C ' HD12 ' A' ' 33' ' ' LEU . 87.2 tt0 -102.72 138.02 40.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 73.219999999999999 110.24 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.1 mp -109.3 154.19 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 111.353 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -149.36 157.79 38.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 75.219999999999999 110.477 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.95 -51.88 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 124.093 -1.211 . . . . 50.200000000000003 112.77 0.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 36' ' ' THR . 6.2 m -143.41 35.81 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 72.129999999999995 110.836 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 11.9 pt20 -80.21 -4.37 52.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.6 . . . . 65.530000000000001 111.494 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.608 ' HB ' ' CE2' ' A' ' 21' ' ' TYR . 27.5 m -85.54 33.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.572 -0.74 . . . . 71.140000000000001 111.935 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.74 -30.08 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.848 1.055 . . . . 74.040000000000006 113.848 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 45.1 m-20 -72.33 152.62 41.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.825 0.676 . . . . 74.219999999999999 112.825 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.629 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -63.25 128.72 92.79 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.718 -0.674 . . . . 73.109999999999999 109.33 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 125.75 19.31 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.348 2.032 . . . . 74.409999999999997 114.243 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.18 111.09 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.5 -0.773 . . . . 70.540000000000006 109.936 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' CG2' ' A' ' 17' ' ' ILE . 6.0 p -93.55 142.02 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.365 . . . . 71.230000000000004 111.719 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 50.7 m -158.07 137.9 12.2 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.263 0.468 . . . . 64.040000000000006 112.263 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.735 ' HH2' HG21 ' A' ' 84' ' ' ILE . 3.5 p90 -115.84 23.26 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.263 -0.643 . . . . 75.409999999999997 109.263 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.2 m -40.31 120.96 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.395 -0.82 . . . . 70.510000000000005 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 91.08 -35.46 3.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.267 -0.492 . . . . 73.340000000000003 112.187 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.0 mm? -65.54 -20.86 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.87 0.367 . . . . 75.129999999999995 110.031 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 16.6 pm0 -67.57 -159.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.249 -0.649 . . . . 74.310000000000002 109.249 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.17 -66.6 0.48 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 119.96 -1.114 . . . . 62.399999999999999 113.083 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -149.42 106.88 3.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.086 0.47 . . . . 75.099999999999994 109.77 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.403 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 3.3 m -160.19 140.41 11.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.776 -0.647 . . . . 70.150000000000006 110.224 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -74.88 -38.17 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.733 -0.84 . . . . 74.109999999999999 108.733 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 22.5 mt -155.86 160.4 40.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.7 -1.136 . . . . 72.109999999999999 109.885 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 15.5 mt -122.08 151.8 40.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.974 -0.29 . . . . 73.030000000000001 110.527 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.685 HG23 HG12 ' A' ' 82' ' ' VAL . 91.4 m -129.01 114.41 16.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 112.027 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.3 tm? -106.78 134.29 50.15 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.54 -0.541 . . . . 74.030000000000001 109.54 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 58' ' ' LEU . 83.5 mt -144.75 171.58 14.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.166 0.508 . . . . 52.420000000000002 111.754 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.562 ' C ' ' SD ' ' A' ' 60' ' ' MET . 0.8 OUTLIER -133.64 123.13 24.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.176 -0.92 . . . . 74.209999999999994 108.638 178.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.87 102.09 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.123 0.487 . . . . 71.120000000000005 112.127 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -178.79 67.68 0.19 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.226 -0.897 . . . . 65.230000000000004 109.605 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 1.4 Cg_endo -45.48 129.0 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.254 1.97 . . . . 44.020000000000003 111.589 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -162.36 87.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.291 0.478 . . . . 72.219999999999999 112.291 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.639 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -171.61 133.54 0.84 Allowed Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 112.883 0.697 . . . . 52.049999999999997 112.883 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.6 Cg_exo -63.36 -20.45 5.17 Favored 'Cis proline' 0 C--N 1.354 0.822 0 C-N-CA 123.558 -1.434 . . . . 74.099999999999994 110.276 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 148.49 16.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.838 -1.074 . . . . 63.119999999999997 109.912 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -49.13 -31.8 8.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.676 0.75 . . . . 73.519999999999996 110.617 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.45 -32.83 74.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.927 -1.033 . . . . 74.140000000000001 111.956 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.6 t0 -144.91 98.37 4.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 75.420000000000002 111.072 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 72.5 Cg_endo -76.51 60.3 6.46 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.974 2.449 . . . . 75.329999999999998 111.901 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -47.17 -39.82 14.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.931 -0.577 . . . . 72.450000000000003 110.78 -178.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.544 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 4.7 p90 -148.0 48.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.721 0.772 . . . . 62.350000000000001 109.707 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -74.37 136.24 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.652 -1.158 . . . . 73.530000000000001 109.459 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 142' ' ' PHE . 1.1 pm0 -89.12 176.61 6.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.998 0.919 . . . . 74.140000000000001 112.013 0.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 140' ' ' LEU . 3.2 tp -114.46 -163.14 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.216 -0.902 . . . . 75.120000000000005 109.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.665 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.9 mp -65.04 135.9 56.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.43 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 6.6 p-80 -147.87 171.72 15.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 52.340000000000003 110.086 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.7 t90 -97.99 123.18 41.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 72.340000000000003 112.052 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 85.5 p -142.96 133.58 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.847 -0.615 . . . . 74.319999999999993 109.841 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 91' ' ' PRO . 21.3 t -149.24 117.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.6 . . . . 74.109999999999999 109.379 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 57' ' ' THR . 10.7 m -115.23 -173.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.724 0.774 . . . . 64.230000000000004 112.649 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.619 HD21 ' CG ' ' A' ' 95' ' ' HIS . 27.9 p30 44.21 43.45 5.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.996 -1.457 . . . . 73.25 113.166 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.843 HG22 HD22 ' A' ' 88' ' ' ASN . 2.4 mm -67.42 121.84 80.57 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.55 -1.278 . . . . 73.0 107.55 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.45 103.13 1.64 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.155 1.903 . . . . 75.540000000000006 115.189 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.89 -84.79 1.57 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 116.507 1.363 . . . . 42.229999999999997 116.507 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 89' ' ' GLU . 78.3 p -174.39 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 117.484 0.642 . . . . 64.230000000000004 111.642 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.843 HD22 HG22 ' A' ' 84' ' ' ILE . 38.9 m-80 -73.71 28.98 0.07 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.907 -0.588 . . . . 74.200000000000003 110.391 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 16.3 pt-20 44.52 5.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.928 -1.033 . . . . 62.43 112.952 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 88' ' ' ASN . 17.8 p30 -179.71 163.11 0.91 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.237 -0.653 . . . . 70.019999999999996 109.237 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 84' ' ' ILE . 66.6 Cg_endo -68.65 44.84 0.33 Allowed 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 122.872 2.381 . . . . 74.219999999999999 113.219 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 90' ' ' ASN . 22.1 t -69.36 -43.22 74.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.177 0.436 . . . . 74.439999999999998 112.177 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.75 10.13 32.35 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.912 -0.661 . . . . 73.540000000000006 114.264 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -86.58 166.51 37.92 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.661 -0.78 . . . . 64.030000000000001 114.093 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.31 104.78 0.8 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.865 0.32 . . . . 72.439999999999998 111.865 178.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.679 ' N ' HG22 ' A' ' 130' ' ' THR . 51.1 m -73.51 83.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.718 0.77 . . . . 75.319999999999993 109.047 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 55.2 mt -68.31 -20.86 64.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.149 -0.932 . . . . 73.409999999999997 110.496 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 78' ' ' HIS . . . -158.53 106.22 1.9 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.185 -0.916 . . . . 75.439999999999998 109.475 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -60.12 142.3 54.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 63.039999999999999 110.846 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 20.5 p90 -67.46 140.28 57.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 70.040000000000006 111.798 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.33 145.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 71.310000000000002 109.67 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.619 ' HA3' HG21 ' A' ' 170' ' ' VAL . . . -54.68 -47.0 72.99 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.896 -0.669 . . . . 61.140000000000001 113.394 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -173.52 98.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.964 0.382 . . . . 53.119999999999997 111.955 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.653 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -57.12 -50.1 66.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.068 -1.063 . . . . 54.340000000000003 110.664 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 38.4 Cg_endo -65.63 140.21 61.4 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.22 2.613 . . . . 43.240000000000002 112.385 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 109' ' ' THR . 37.8 Cg_exo -57.27 147.24 77.87 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.095 2.53 . . . . 61.210000000000001 113.374 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -45.96 -34.38 3.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.154 0.502 . . . . 71.409999999999997 111.502 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -51.8 -20.2 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.689 -0.687 . . . . 53.0 111.901 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.978 HG21 ' CE1' ' A' ' 112' ' ' HIS . 10.9 t -69.14 -17.2 63.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 73.319999999999993 111.071 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.83 -142.37 34.73 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.902 -0.59 . . . . 65.549999999999997 113.82 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.21 117.59 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.393 . . . . 71.430000000000007 111.7 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.978 ' CE1' HG21 ' A' ' 109' ' ' THR . 48.5 m-70 -82.79 -176.11 6.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.83 0.824 . . . . 74.230000000000004 111.325 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.978 HH12 HD11 ' A' ' 115' ' ' ILE . 65.6 ttt-85 -147.52 112.04 5.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.113 -1.81 . . . . 71.120000000000005 106.113 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 60' ' ' MET . 0.4 OUTLIER -118.32 134.74 54.78 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.603 -0.439 . . . . 72.209999999999994 111.653 -176.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.978 HD11 HH12 ' A' ' 113' ' ' ARG . 36.8 mt -130.84 121.36 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.573 -0.739 . . . . 75.299999999999997 111.933 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.557 ' C ' HD22 ' A' ' 117' ' ' LEU . 36.4 m-85 -100.92 131.44 46.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.429 -0.805 . . . . 71.530000000000001 109.154 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 9' ' ' LEU . 2.7 mm? -116.49 143.87 45.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.26 -0.427 . . . . 72.530000000000001 110.447 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 44.3 tp -126.99 131.2 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 63.229999999999997 109.886 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 53.1 m-85 -132.61 143.95 50.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.227 0.536 . . . . 64.439999999999998 111.226 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 18.7 tpp180 -77.15 117.03 18.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.554 -0.748 . . . . 70.340000000000003 109.523 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 39.4 tp60 -91.85 122.77 34.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.038 0.447 . . . . 74.329999999999998 110.101 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -90.94 -49.8 6.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.455 -0.793 . . . . 74.140000000000001 112.403 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.71 146.16 33.93 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.241 0.46 . . . . 62.25 112.241 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.9 tptm -64.69 123.32 19.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.587 -0.733 . . . . 70.430000000000007 110.091 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.598 HD12 ' NE2' ' A' ' 151' ' ' HIS . 3.1 pt -111.06 129.03 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 110.707 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 128' ' ' THR . 83.8 tt0 -53.45 -46.99 70.09 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.353 -0.61 . . . . 53.229999999999997 109.353 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.622 ' CG ' HD11 ' A' ' 97' ' ' LEU . 2.2 tp10 53.92 15.15 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.139 -0.937 . . . . 63.549999999999997 113.112 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 58.7 p 51.16 169.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 111.924 0.342 . . . . 74.150000000000006 111.924 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 52.1 Cg_exo -58.83 148.72 82.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.095 1.864 . . . . 75.129999999999995 113.406 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.679 HG22 ' N ' ' A' ' 96' ' ' SER . 17.2 p -58.38 136.94 57.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.18 -0.918 . . . . 70.420000000000002 110.752 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 38.6 mm -92.79 129.5 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 113.337 0.865 . . . . 74.329999999999998 113.337 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.537 ' HB3' HG22 ' A' ' 134' ' ' THR . 58.1 m -86.85 133.49 33.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.19 -1.368 . . . . 73.439999999999998 109.302 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -53.45 -26.16 19.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.912 -0.315 . . . . 74.299999999999997 111.383 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 9.3 t -64.83 -2.47 2.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.945 0.402 . . . . 71.439999999999998 111.055 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 135' ' ' THR . 13.0 t -64.3 108.4 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.253 0.549 . . . . 74.239999999999995 109.789 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HA ' HG22 ' A' ' 177' ' ' ILE . 37.9 ttt85 -65.14 171.17 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.68 -0.691 . . . . 73.450000000000003 112.315 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ARG . 50.4 m -28.29 136.82 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.245 -0.889 . . . . 65.519999999999996 111.577 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.94 5.84 14.86 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.772 -0.649 . . . . 65.219999999999999 111.927 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 140' ' ' LEU . 17.4 mmm180 -152.0 35.76 0.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.782 0.325 . . . . 63.32 111.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 76' ' ' ILE . 3.3 mp -109.86 -62.53 1.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.375 -0.375 . . . . 75.299999999999997 110.773 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 2.0 m120 -61.57 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.699 -0.682 . . . . 62.109999999999999 112.535 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.573 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 11.5 t80 -144.17 118.1 9.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.399 . . . . 74.450000000000003 111.346 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.529 HD21 ' CB ' ' A' ' 145' ' ' ARG . 28.6 t30 -85.41 131.0 34.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 52.119999999999997 110.489 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.04 -37.49 87.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.738 0.644 . . . . 75.319999999999993 112.738 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.529 ' CB ' HD21 ' A' ' 143' ' ' ASN . 30.5 ttp180 -44.02 -31.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 64.120000000000005 110.933 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.8 OUTLIER -47.05 -41.01 16.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.044 0.45 . . . . 74.430000000000007 110.63 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 66.2 m-85 -56.79 -38.83 73.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 110.639 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -63.28 -28.14 69.82 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.72 -0.673 . . . . 41.329999999999998 110.174 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.63 2.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 62.32 111.226 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 0.9 OUTLIER -54.08 -44.35 71.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.823 0.344 . . . . 74.340000000000003 110.961 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.598 ' NE2' HD12 ' A' ' 125' ' ' ILE . 29.5 m-70 -85.74 4.76 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.476 -0.329 . . . . 64.439999999999998 110.7 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 56.08 26.11 48.33 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.019 -0.537 . . . . 63.539999999999999 113.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 148' ' ' ALA . 19.6 mt -64.47 -25.86 68.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.434 -0.58 . . . . 61.210000000000001 109.434 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.64 -89.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.06 -0.973 . . . . 41.240000000000002 113.963 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' LEU . 21.9 pt-20 -73.06 125.72 90.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.088 0.403 . . . . 71.439999999999998 112.088 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 119' ' ' TYR . 60.3 Cg_endo -76.22 124.78 8.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.692 1.595 . . . . 35.409999999999997 110.34 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 119' ' ' TYR . 47.5 pt -71.5 -33.8 50.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.115 -0.634 . . . . 73.150000000000006 110.551 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -147.15 149.77 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.946 -0.302 . . . . 43.439999999999998 111.564 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.38 152.34 38.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 111.122 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.703 ' ND2' HE21 ' A' ' 29' ' ' GLN . 1.7 t-20 -157.28 145.27 19.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.48 -1.304 . . . . 70.299999999999997 107.48 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.482 ' H ' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -149.03 176.84 10.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.882 0.327 . . . . 70.299999999999997 111.882 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.548 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.3 p90 -168.84 164.82 11.83 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.067 -0.515 . . . . 74.239999999999995 111.343 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -126.36 124.81 41.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.489 -0.56 . . . . 74.109999999999999 109.489 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.62 152.85 25.91 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.16 0.429 . . . . 71.439999999999998 112.16 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.628 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -109.08 136.49 48.51 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 34.25 109.348 178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -125.5 135.07 51.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.699 -0.482 . . . . 61.439999999999998 109.699 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.84 173.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.316 0.579 . . . . 71.420000000000002 112.293 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -72.75 51.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.167 -0.924 . . . . 71.5 110.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -91.69 -46.57 7.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 64.519999999999996 110.872 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' HA3' ' A' ' 102' ' ' GLY . 53.4 t -80.82 -46.89 1.21 Allowed Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 113.162 0.801 . . . . 65.209999999999994 113.162 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.4 Cg_exo -46.06 -43.35 20.46 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.918 1.745 . . . . 71.120000000000005 111.748 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.1 mm -51.14 -39.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 74.420000000000002 110.076 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -53.32 -26.42 18.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.614 -0.721 . . . . 70.219999999999999 110.796 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -52.31 -42.68 64.02 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.543 0.211 . . . . 72.200000000000003 111.295 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -15.5 62.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.064 0.459 . . . . 63.32 110.498 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.8 m -92.37 -28.14 17.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.58 -0.736 . . . . 64.030000000000001 110.812 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.582 HG23 ' C ' ' A' ' 134' ' ' THR . 52.1 mt -56.51 119.74 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.962 -0.563 . . . . 74.450000000000003 110.956 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.87 37.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.895 0.379 . . . . 54.100000000000001 111.531 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.978 -1.457 . . . . 40.310000000000002 111.34 -179.126 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.072 0.463 . . . . 74.030000000000001 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 4' ' ' ILE . 9.9 t0 -51.15 -64.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.774 -0.648 . . . . 75.030000000000001 112.19 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.5 pt -131.63 49.14 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.502 0.667 . . . . 53.210000000000001 111.361 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.9 p -111.61 142.32 26.35 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 65.299999999999997 110.203 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 56.2 Cg_endo -95.62 33.44 9.86 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.363 -1.099 . . . . 72.329999999999998 112.83 0.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.55 -42.82 82.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.219999999999999 109.741 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' ' 4' ' ' ILE . 27.5 m -154.38 -47.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.724 -0.671 . . . . 73.409999999999997 112.364 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 117' ' ' LEU . 25.2 tp -158.51 154.88 27.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.316 0.488 . . . . 61.450000000000003 112.316 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.63 -1.97 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.346 -0.613 . . . . 62.219999999999999 109.346 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.546 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -144.86 -158.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.155 -0.93 . . . . 61.119999999999997 109.827 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.3 p -144.62 113.91 5.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 111.437 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 45.1 Cg_endo -88.75 -138.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.448 . . . . 74.239999999999995 112.519 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -153.31 -37.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 61.140000000000001 111.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.38 161.67 24.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.177 -1.011 . . . . 53.409999999999997 113.274 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 t -104.46 157.05 17.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 110.947 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.8 mp -104.01 135.25 42.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.889 -0.596 . . . . 72.299999999999997 109.605 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.9 mmmt -73.57 118.19 16.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.53 -0.305 . . . . 64.140000000000001 110.232 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 84.1 t -128.18 109.18 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.278 -0.638 . . . . 64.439999999999998 109.278 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 26' ' ' GLU . 37.2 mt -99.64 142.07 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 74.209999999999994 112.452 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.516 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 1.6 m-85 -101.57 -94.3 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.716 -0.674 . . . . 74.019999999999996 111.123 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.72 -50.22 68.29 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.157 -1.02 . . . . 74.239999999999995 111.586 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.4 t70 171.36 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.999 -0.741 . . . . 62.140000000000001 108.999 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 71.209999999999994 108.789 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.06 141.37 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.617 -1.174 . . . . 63.350000000000001 111.476 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 20' ' ' ILE . 13.2 pt-20 -149.04 153.73 38.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.83 -1.077 . . . . 74.120000000000005 110.752 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.572 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 35.8 m -82.56 133.69 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 65.319999999999993 109.899 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 14.7 pttm -153.35 130.02 10.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.055 0.931 . . . . 73.209999999999994 113.182 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.487 ' HA ' ' CE1' ' A' ' 161' ' ' TYR . 7.1 mp0 32.55 63.89 0.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.859 -1.519 . . . . 74.530000000000001 114.759 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.3 10.83 63.41 Favored Glycine 0 N--CA 1.454 -0.13 0 N-CA-C 114.876 0.71 . . . . 73.409999999999997 114.876 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -61.0 146.39 47.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.874 0.837 . . . . 65.319999999999993 109.906 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -96.5 126.28 41.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.92 -0.4 . . . . 75.319999999999993 109.92 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -93.07 108.9 20.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.137 0.494 . . . . 71.120000000000005 109.791 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -150.22 155.49 37.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.39 -0.823 . . . . 62.149999999999999 110.648 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -93.86 136.09 6.55 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.286 -1.131 . . . . 71.329999999999998 112.64 0.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 36' ' ' THR . 17.9 m 56.38 33.65 22.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.237 0.541 . . . . 74.219999999999999 110.649 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -93.87 -1.9 54.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.682 -0.69 . . . . 73.329999999999998 110.83 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.4 m -92.13 -14.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 73.400000000000006 112.289 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -74.39 5.8 4.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 73.519999999999996 111.094 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 53.2 m-20 -96.81 146.15 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.256 0.55 . . . . 75.049999999999997 111.737 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.63 132.33 94.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.189 -0.914 . . . . 64.329999999999998 111.796 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 89.6 Cg_endo -81.61 125.14 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.947 1.765 . . . . 64.319999999999993 112.227 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.9 mm -109.27 106.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 109.921 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.437 HG23 ' CZ3' ' A' ' 79' ' ' TRP . 57.9 t -89.94 136.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.337 0.495 . . . . 44.229999999999997 112.337 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 75.3 m -159.66 116.23 2.56 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.77 -0.65 . . . . 74.329999999999998 110.089 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 89' ' ' GLU . 16.1 p90 -91.77 32.4 1.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 74.310000000000002 110.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 m -46.85 128.43 10.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.338 -0.846 . . . . 55.149999999999999 110.586 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.19 -33.16 4.83 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.708 -0.678 . . . . 54.310000000000002 112.406 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -80.29 -26.39 38.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.432 . . . . 73.209999999999994 110.479 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 23.1 tt0 -59.33 158.89 8.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.852 -0.613 . . . . 72.409999999999997 110.983 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.85 33.1 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.216 -1.154 . . . . 75.230000000000004 110.216 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -48.15 109.55 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 74.109999999999999 110.44 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 p -149.23 142.6 25.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.327 -0.851 . . . . 75.450000000000003 109.582 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 9.1 t30 -64.77 -38.76 92.08 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.58 0.705 . . . . 64.099999999999994 109.45 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 83' ' ' ASN . 82.1 mt -156.86 154.58 30.05 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.642 -1.163 . . . . 72.299999999999997 111.179 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.0 mt -120.67 150.9 40.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.579 -0.526 . . . . 64.129999999999995 109.579 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.551 HG23 HG12 ' A' ' 82' ' ' VAL . 88.5 m -122.24 114.32 20.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.776 0.322 . . . . 52.32 110.665 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.1 tm? -103.68 134.19 47.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.154 -0.684 . . . . 74.340000000000003 109.154 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 93.8 mt -141.04 152.51 44.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.349 0.595 . . . . 71.400000000000006 111.851 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.7 ttt -127.2 110.29 12.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.201 -0.909 . . . . 71.230000000000004 108.607 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.728 HG23 HD23 ' A' ' 117' ' ' LEU . 5.1 t -94.32 -133.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.025 -0.27 . . . . 71.540000000000006 111.712 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.725 ' H ' HG12 ' A' ' 61' ' ' VAL . 2.2 m-20 51.84 73.04 1.03 Allowed Pre-proline 0 CA--C 1.518 -0.256 0 N-CA-C 112.341 0.497 . . . . 71.219999999999999 112.341 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.621 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . 32.0 Cg_endo -62.19 129.4 26.91 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.737 1.625 . . . . 75.140000000000001 110.008 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -159.46 92.49 1.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.769 1.026 . . . . 63.549999999999997 113.769 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 76' ' ' ILE . . . -172.88 134.39 0.7 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 112.481 0.549 . . . . 64.230000000000004 112.481 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 65.3 Cg_endo -85.64 3.18 65.38 Favored 'Cis proline' 0 C--N 1.347 0.468 0 C-N-CA 124.315 -1.119 . . . . 72.239999999999995 110.243 -2.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 t -164.81 134.04 3.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.332 -1.304 . . . . 61.049999999999997 109.636 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.549 ' HD3' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -55.14 -24.05 24.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.852 0.358 . . . . 75.209999999999994 110.726 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.549 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -62.43 -41.18 98.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 75.150000000000006 110.417 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -144.7 109.51 4.8 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.101 -0.5 . . . . 74.209999999999994 111.231 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.64 63.83 4.72 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.5 2.133 . . . . 73.430000000000007 111.518 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 39.6 ttmt -47.91 -27.82 2.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.199 -0.455 . . . . 63.409999999999997 111.113 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.669 ' HE1' ' HB1' ' A' ' 65' ' ' ALA . 2.9 p90 -152.78 45.36 0.69 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.734 0.642 . . . . 74.519999999999996 112.734 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.621 ' NE ' ' HB2' ' A' ' 63' ' ' PRO . 25.9 ttm180 -66.82 139.57 57.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.534 -0.913 . . . . 63.520000000000003 108.534 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -106.64 165.55 11.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.55 1.14 . . . . 75.120000000000005 110.23 -0.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.778 HG22 ' N ' ' A' ' 77' ' ' LEU . 38.0 mm -80.55 176.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.233 0.457 . . . . 72.109999999999999 112.233 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.797 ' CD2' HD23 ' A' ' 140' ' ' LEU . 2.9 mm? -71.44 55.99 0.24 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.705 -0.68 . . . . 71.120000000000005 110.07 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 76' ' ' ILE . 6.5 p-80 -53.92 169.91 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 71.239999999999995 111.956 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 12.3 t90 -99.86 112.52 24.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.744 -0.662 . . . . 71.030000000000001 110.457 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 p -141.44 136.56 31.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.689 -0.687 . . . . 51.450000000000003 110.442 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 84' ' ' ILE . 25.3 t -139.76 142.49 32.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.994 -0.548 . . . . 75.409999999999997 109.909 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.919 HG21 ' HG3' ' A' ' 127' ' ' GLU . 16.4 m -137.71 163.52 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.581 0.585 . . . . 72.319999999999993 112.581 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.763 ' ND2' HG23 ' A' ' 82' ' ' VAL . 45.8 m-20 71.87 32.89 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.63 -1.168 . . . . 31.449999999999999 111.243 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.55 HD13 ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -76.96 111.96 19.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.102 -0.639 . . . . 52.549999999999997 109.695 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' SER . 47.9 Cg_exo -54.56 134.24 60.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.813 1.675 . . . . 62.43 110.75 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.91 70.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.949 -0.643 . . . . 72.239999999999995 112.839 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' PRO . 23.2 t 176.46 47.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.88 -0.785 . . . . 65.430000000000007 108.88 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 68.7 m-80 -135.66 -29.86 1.03 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.76 . . . . 55.020000000000003 112.146 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' ASN . 12.7 pt-20 50.06 20.55 0.61 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.515 0.674 . . . . 72.040000000000006 110.201 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -170.25 148.01 2.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.643 -1.162 . . . . 72.319999999999993 109.654 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.09 49.42 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.796 2.331 . . . . 65.530000000000001 112.741 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -92.51 -56.02 3.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 74.040000000000006 111.5 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.32 33.73 1.33 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.823 -0.626 . . . . 72.030000000000001 113.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.55 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -133.81 159.12 23.6 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.864 -0.684 . . . . 54.409999999999997 113.238 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 130' ' ' THR . 78.3 t60 -68.73 116.69 9.52 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.253 0.221 . . . . 74.239999999999995 111.418 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.489 ' O ' HG22 ' A' ' 130' ' ' THR . 14.8 m -76.94 106.31 8.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.441 -0.948 . . . . 62.140000000000001 108.441 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 127' ' ' GLU . 4.9 mt -61.93 -54.57 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.376 -0.972 . . . . 73.530000000000001 108.376 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 78' ' ' HIS . . . -127.84 121.16 29.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.244 -1.343 . . . . 61.350000000000001 107.536 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.6 t0 -52.75 152.07 4.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.219 -0.446 . . . . 55.219999999999999 111.872 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -59.49 127.2 30.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.688 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.1 148.95 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.521 0.677 . . . . 72.329999999999998 112.355 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.83 72.01 0.45 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.224 -1.15 . . . . 71.420000000000002 110.224 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.814 ' HA ' HG12 ' A' ' 170' ' ' VAL . 28.3 t -169.73 -89.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.68 -0.489 . . . . 62.310000000000002 109.68 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.75 33.6 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.993 -0.623 . . . . 43.100000000000001 114.329 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 35.2 Cg_endo -64.02 154.65 69.13 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.404 2.736 . . . . 73.430000000000007 114.061 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.492 ' HA ' ' HG3' ' A' ' 171' ' ' PRO . 5.6 Cg_exo -78.14 163.42 27.97 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.555 2.837 . . . . 74.409999999999997 112.89 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 166' ' ' TYR . 64.8 tttm -38.4 -26.13 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.076 -0.511 . . . . 60.329999999999998 111.511 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' PRO . 10.8 t70 -50.56 -41.52 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 74.430000000000007 111.898 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 105' ' ' PRO . 13.9 t -73.73 -14.28 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.983 0.735 . . . . 70.120000000000005 112.983 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.05 -144.9 41.52 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.054 -1.07 . . . . 55.329999999999998 112.13 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 163' ' ' GLN . 43.8 tp -67.46 130.87 44.43 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.405 -0.468 . . . . 72.549999999999997 111.016 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 6.5 p80 -130.48 126.31 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 73.439999999999998 110.307 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -88.22 125.39 34.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.672 -0.694 . . . . 73.030000000000001 110.588 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -116.59 140.41 49.42 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.446 0.466 . . . . 75.450000000000003 110.231 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 161' ' ' TYR . 39.1 mt -123.91 125.51 71.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.554 0.692 . . . . 73.209999999999994 111.971 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.703 ' C ' HD22 ' A' ' 117' ' ' LEU . 20.6 m-85 -88.56 136.34 33.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.138 -0.937 . . . . 74.530000000000001 109.681 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.728 HD23 HG23 ' A' ' 61' ' ' VAL . 3.0 mm? -124.34 137.52 54.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 71.400000000000006 111.033 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 119' ' ' TYR . 4.7 tt -127.05 135.29 50.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.385 -0.598 . . . . 61.240000000000002 109.385 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.833 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.5 m-85 -132.29 143.46 49.91 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.138 -0.483 . . . . 61.240000000000002 111.159 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -72.45 139.58 47.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 72.319999999999993 109.278 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HB3' ' C ' ' A' ' 55' ' ' LEU . 4.5 tt0 -123.91 127.31 47.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 112.653 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -104.2 -38.89 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.258 -0.883 . . . . 75.239999999999995 109.085 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.05 129.28 54.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.326 -0.852 . . . . 75.099999999999994 110.947 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -67.51 152.32 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.853 -0.612 . . . . 74.230000000000004 111.927 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.607 HD13 ' HD2' ' A' ' 151' ' ' HIS . 2.4 pt -136.0 147.71 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.891 -0.595 . . . . 71.420000000000002 111.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -49.97 12.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.414 -0.357 . . . . 73.209999999999994 111.399 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.919 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 61.24 33.34 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 63.5 112.02 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.7 p 53.32 156.57 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 112.851 0.686 . . . . 71.439999999999998 112.851 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.32 148.6 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.622 2.215 . . . . 72.420000000000002 113.188 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.983 HG23 ' CE1' ' A' ' 95' ' ' HIS . 2.7 p -59.86 116.12 3.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 64.109999999999999 112.611 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 131' ' ' ILE . 7.4 mm -81.75 120.99 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.046 -0.724 . . . . 72.109999999999999 109.046 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.5 m -75.39 149.07 38.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 70.239999999999995 112.15 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.585 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 34.2 t30 -55.5 -36.38 66.61 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 121.411 0.624 . . . . 74.329999999999998 109.538 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 177' ' ' ILE . 33.4 p -78.39 8.78 4.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.552 -0.749 . . . . 74.510000000000005 111.727 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.55 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 1.7 m -64.1 131.59 47.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.642 0.258 . . . . 75.230000000000004 110.729 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 26.1 ttt85 -76.3 169.98 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 75.209999999999994 113.212 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 140' ' ' LEU . 88.5 m -49.77 160.37 0.31 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.4 -1.273 . . . . 63.310000000000002 112.037 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.516 ' H ' HD11 ' A' ' 140' ' ' LEU . . . 96.04 -38.22 3.18 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.994 -1.003 . . . . 64.25 112.038 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 23.3 mmt180 -82.82 -37.75 24.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 73.420000000000002 111.462 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.35 -50.37 71.7 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.602 0.593 . . . . 72.209999999999994 112.602 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.65 HD21 ' HB2' ' A' ' 73' ' ' TYR . 7.2 m120 -44.26 68.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.82 1.415 . . . . 72.329999999999998 114.82 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 140' ' ' LEU . 23.4 t80 -149.9 126.7 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.893 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 145' ' ' ARG . 0.6 OUTLIER -78.76 100.14 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 111.183 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -47.61 -33.81 7.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 111.728 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.59 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 49.7 ttp85 -47.66 -35.11 8.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.736 0.303 . . . . 74.439999999999998 110.874 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -51.9 -40.63 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.885 0.374 . . . . 75.409999999999997 110.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.606 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 28.9 m-85 -46.83 -43.13 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.483 . . . . 63.149999999999999 110.086 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.76 -38.16 86.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.706 -0.679 . . . . 74.310000000000002 110.941 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.98 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 74.129999999999995 111.367 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -53.79 -51.28 63.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.517 -0.311 . . . . 55.530000000000001 111.173 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.607 ' HD2' HD13 ' A' ' 125' ' ' ILE . 28.9 t-80 -78.42 -5.7 53.13 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.536 -0.542 . . . . 73.010000000000005 109.536 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.67 69.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.661 -0.78 . . . . 74.329999999999998 112.236 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.625 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . 14.7 mt -63.05 -25.31 68.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.169 -0.678 . . . . 61.450000000000003 109.169 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 31.62 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.788 -1.096 . . . . 74.530000000000001 113.888 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' LEU . 9.9 pt-20 -73.63 124.17 90.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.47 0.544 . . . . 54.229999999999997 112.47 -177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 73.2 Cg_endo -81.51 137.33 10.25 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.438 2.092 . . . . 62.530000000000001 111.692 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 118' ' ' LEU . 37.6 pt -83.27 -35.23 11.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.3 0.571 . . . . 75.200000000000003 110.712 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.497 ' CB ' HD11 ' A' ' 17' ' ' ILE . . . -142.74 150.67 40.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 55.399999999999999 111.059 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -152.09 158.91 43.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.461 . . . . 73.239999999999995 111.931 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -154.82 122.34 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.541 -0.911 . . . . 73.409999999999997 108.541 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.543 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -126.85 157.33 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 73.129999999999995 112.163 -177.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 4.1 p90 -162.53 163.04 27.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 62.509999999999998 110.767 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -110.7 136.79 49.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.181 0.515 . . . . 71.0 111.282 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.6 134.91 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.375 -0.83 . . . . 70.109999999999999 110.411 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.636 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -106.87 149.0 27.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.022 -0.362 . . . . 75.239999999999995 110.022 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.644 ' CG ' HG11 ' A' ' 170' ' ' VAL . 18.3 m-30 -128.46 125.28 38.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 64.219999999999999 110.998 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.14 -135.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.525 -0.761 . . . . 74.209999999999994 111.303 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 7.1 t70 -94.99 -43.44 8.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.903 -0.589 . . . . 74.540000000000006 110.989 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.529 ' HA ' HD12 ' A' ' 172' ' ' ILE . 28.9 t80 -51.95 -29.82 22.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 73.030000000000001 110.83 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 103' ' ' SER . 23.3 t -71.38 -58.16 4.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.955 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.521 ' HG2' ' O ' ' A' ' 168' ' ' ASP . 18.0 Cg_endo -57.55 -28.45 81.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.641 2.227 . . . . 64.010000000000005 112.727 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 169' ' ' TYR . 65.2 mt -45.53 -39.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.591 0.234 . . . . 70.030000000000001 111.193 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 48.0 ttm-85 -46.91 -36.44 7.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 71.219999999999999 110.632 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.402 ' HA ' HG13 ' A' ' 177' ' ' ILE . 76.0 m-80 -54.62 -34.47 62.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.67 -0.695 . . . . 51.219999999999999 111.692 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -53.83 -40.46 66.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.937 0.399 . . . . 71.430000000000007 111.362 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.2 m -77.45 0.81 21.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.604 0.594 . . . . 74.120000000000005 112.604 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.3 mt -70.4 129.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 75.010000000000005 111.933 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 177' ' ' ILE . 4.7 m -165.34 88.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.695 -0.684 . . . . 71.310000000000002 110.816 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 135' ' ' THR . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.779 -1.012 . . . . 71.230000000000004 112.086 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG12 ' A' ' 5' ' ' VAL . 6.0 p-10 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.927 0.394 . . . . 73.400000000000006 111.776 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 8.8 t70 -51.77 -54.8 24.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 70.340000000000003 110.695 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.1 pt -148.48 60.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.514 0.673 . . . . 63.350000000000001 109.959 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 2' ' ' ASP . 8.3 p -127.71 138.25 32.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 73.430000000000007 110.159 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 82.6 Cg_endo -85.0 34.02 3.92 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.974 -1.261 . . . . 74.109999999999999 112.858 0.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 59.6 t0 -59.4 -54.0 51.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.415 -0.357 . . . . 73.239999999999995 110.973 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.0 m -164.24 -32.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.03 -0.532 . . . . 75.530000000000001 111.986 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD23 ' HD3' ' A' ' 13' ' ' PRO . 35.3 tp -157.03 144.56 18.94 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.332 0.587 . . . . 71.450000000000003 112.028 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.37 -19.1 63.84 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.974 0.731 . . . . 64.439999999999998 112.974 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.599 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -161.22 135.46 7.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.523 0.194 . . . . 51.520000000000003 111.523 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -72.24 116.12 45.72 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.708 0.29 . . . . 74.239999999999995 111.521 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.3 Cg_endo -95.72 -125.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.687 2.925 . . . . 63.530000000000001 112.151 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.35 -42.05 0.06 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.456 -0.338 . . . . 65.430000000000007 110.923 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.11 173.48 14.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.641 -0.79 . . . . 54.140000000000001 112.733 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.8 t -121.59 161.69 21.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.435 0.636 . . . . 42.109999999999999 111.519 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 118' ' ' LEU . 8.1 mt -105.44 154.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.683 -1.144 . . . . 63.329999999999998 109.25 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.1 mmpt? -102.9 102.33 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.926 -0.579 . . . . 74.5 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.788 ' HB ' HG22 ' A' ' 27' ' ' VAL . 54.8 t -109.66 109.69 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.098 -0.704 . . . . 73.450000000000003 109.098 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 20' ' ' ILE . 2.5 mp -90.14 144.37 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.209 0.528 . . . . 71.239999999999995 111.082 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.75 -94.39 0.34 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.266 -0.879 . . . . 71.129999999999995 112.524 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.64 -43.52 99.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.068 -0.587 . . . . 60.210000000000001 113.522 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 20' ' ' ILE . 2.4 m-20 179.14 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.923 0.868 . . . . 70.530000000000001 109.811 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -98.52 -40.88 8.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.465 -1.243 . . . . 75.230000000000004 111.411 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.915 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.6 pt? -69.41 141.05 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 111.127 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 6.0 pm0 -139.28 148.75 43.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 75.109999999999999 110.101 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' A' ' 19' ' ' VAL . 9.3 m -62.46 147.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.279 -0.418 . . . . 72.239999999999995 111.842 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.49 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 70.0 mttt -140.93 103.44 4.48 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.953 0.723 . . . . 74.329999999999998 112.953 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.503 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 10.2 mp0 35.63 67.72 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.691 0.997 . . . . 72.120000000000005 113.691 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.95 -10.42 57.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.222 -0.513 . . . . 62.310000000000002 113.629 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 t30 -47.0 129.67 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 63.340000000000003 110.985 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 163' ' ' GLN . 62.6 tt0 -102.79 132.63 48.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.46 -0.791 . . . . 71.030000000000001 111.246 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HG ' HE21 ' A' ' 37' ' ' GLN . 0.1 OUTLIER -100.86 135.49 42.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.087 0.47 . . . . 72.120000000000005 110.948 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.547 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 7.8 p -138.64 164.79 37.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.455 -0.793 . . . . 74.439999999999998 109.974 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 84.9 Cg_endo -81.85 -29.31 5.97 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.303 -1.124 . . . . 64.120000000000005 113.155 0.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.2 t -161.45 35.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.154 0.502 . . . . 71.219999999999999 111.315 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.525 ' NE2' HD13 ' A' ' 25' ' ' LEU . 15.2 pt20 -84.42 0.27 50.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.310000000000002 110.025 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 33' ' ' LEU . 33.4 m -83.91 -3.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.736 -1.12 . . . . 74.129999999999995 112.646 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -65.88 6.19 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.856 0.317 . . . . 75.409999999999997 111.856 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -96.89 145.84 25.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.39 0.614 . . . . 71.140000000000001 111.749 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.686 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.4 pm0 -62.75 130.83 94.07 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 54.420000000000002 109.318 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 15.3 Cg_exo -69.0 126.09 13.36 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.721 1.614 . . . . 34.329999999999998 112.664 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -100.13 105.27 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.752 -0.462 . . . . 70.299999999999997 109.752 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 91' ' ' PRO . 6.0 p -82.41 140.81 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.525 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 33.1 m -164.98 121.91 1.52 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.672 0.272 . . . . 64.219999999999999 111.679 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 6.1 p90 -84.87 29.38 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.127 -0.694 . . . . 75.439999999999998 109.127 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' SER . 11.1 t -46.29 123.14 4.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.2 -0.909 . . . . 70.310000000000002 110.738 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.95 -24.83 30.64 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.481 -0.648 . . . . 52.020000000000003 111.481 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 16' ' ' THR . 6.6 mp -87.68 -37.17 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.608 0.242 . . . . 74.209999999999994 110.75 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -50.27 138.39 16.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.802 -0.359 . . . . 71.099999999999994 110.761 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.13 -71.78 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.831 -0.699 . . . . 60.200000000000003 111.909 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -148.73 108.94 4.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 72.140000000000001 110.366 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 p -158.1 141.53 15.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.194 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -73.16 -38.9 66.03 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.584 0.707 . . . . 74.430000000000007 109.513 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 26.2 mt -155.8 162.4 40.49 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.867 -1.061 . . . . 43.399999999999999 109.961 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD12 ' CZ2' ' A' ' 46' ' ' TRP . 80.6 mt -128.27 168.04 16.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.778 0.323 . . . . 73.219999999999999 110.42 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.879 HG23 HG12 ' A' ' 82' ' ' VAL . 99.1 m -143.47 133.11 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.426 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -127.77 138.62 52.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.957 -0.565 . . . . 75.109999999999999 110.032 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 58' ' ' LEU . 52.3 mt -149.04 131.66 15.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.775 0.657 . . . . 72.439999999999998 112.775 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 114' ' ' TYR . 37.8 ttm -94.84 122.18 37.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.139 -0.937 . . . . 74.409999999999997 108.797 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 62' ' ' ASP . 4.9 t -109.13 -131.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.712 0.264 . . . . 72.299999999999997 111.712 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.637 ' H ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.84 80.94 0.27 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 121.278 0.561 . . . . 74.439999999999998 111.162 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.9 84.49 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.297 1.998 . . . . 51.409999999999997 112.405 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -126.23 87.57 2.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 70.409999999999997 110.564 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.6 135.14 1.09 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 72.019999999999996 110.858 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 15.4 Cg_exo -67.67 -18.37 9.21 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.752 -1.353 . . . . 64.150000000000006 109.501 -1.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.9 t -157.25 131.7 8.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.781 -1.554 . . . . 74.340000000000003 107.934 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 4.3 tmm_? -50.97 -31.92 19.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.454 0.645 . . . . 74.329999999999998 109.832 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.41 -37.97 89.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.192 -0.913 . . . . 61.329999999999998 111.766 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.727 ' H ' HG23 ' A' ' 67' ' ' THR . 2.0 m-20 -141.21 72.16 27.04 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-O 121.195 0.521 . . . . 75.510000000000005 109.744 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 13.8 Cg_exo -67.04 65.48 0.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.105 2.537 . . . . 63.020000000000003 112.692 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -48.69 -45.88 39.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.587 -0.733 . . . . 75.219999999999999 112.346 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.649 ' HB2' HD21 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -123.04 44.98 2.52 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.087 0.403 . . . . 71.010000000000005 112.087 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -70.69 133.0 46.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 64.549999999999997 110.896 179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 144' ' ' ALA . 86.9 mt-10 -91.32 178.47 5.96 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.478 0.711 . . . . 74.239999999999995 110.465 -0.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.715 HG21 ' HA3' ' A' ' 104' ' ' GLY . 7.3 tp -113.85 176.35 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.789 -0.641 . . . . 73.230000000000004 109.591 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.626 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.8 mm? -49.0 117.56 2.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.58 -0.526 . . . . 72.519999999999996 109.58 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.7 173.64 10.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.739 -0.664 . . . . 75.299999999999997 110.296 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.566 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.5 t-105 -99.51 113.1 25.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 74.239999999999995 111.007 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 14.4 m -131.85 128.22 38.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.594 -0.73 . . . . 74.530000000000001 109.848 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.49 143.06 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.233 0.54 . . . . 73.430000000000007 110.225 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.879 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.52 161.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.771 -0.649 . . . . 70.219999999999999 112.29 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 95' ' ' HIS . 23.4 p30 55.57 43.06 28.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.677 -1.147 . . . . 61.009999999999998 112.522 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.019 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.0 mm -83.01 130.65 56.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.926 -0.768 . . . . 65.510000000000005 108.926 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 31.5 Cg_exo -58.04 128.88 30.51 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 121.454 1.436 . . . . 65.540000000000006 111.111 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.85 57.74 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.642 0.617 . . . . 74.219999999999999 114.642 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.5 p -178.69 36.91 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.579 0.689 . . . . 44.530000000000001 111.378 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.7 m-80 -121.3 -2.0 9.62 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.49 -0.323 . . . . 64.040000000000006 110.93 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 70.05 -38.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 51.399999999999999 111.387 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 88' ' ' ASN . 13.6 p30 -129.32 155.63 79.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.967 0.413 . . . . 74.109999999999999 110.391 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 84' ' ' ILE . 92.6 Cg_endo -71.59 55.52 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.226 2.617 . . . . 54.329999999999998 113.289 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.7 t -97.16 -54.97 3.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.342 0.497 . . . . 72.540000000000006 112.342 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.59 -10.75 25.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 115.21 0.844 . . . . 63.109999999999999 115.21 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 1.019 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -96.51 173.11 29.49 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.268 -0.968 . . . . 71.519999999999996 113.647 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.498 ' HB2' HD21 ' A' ' 83' ' ' ASN . 5.9 m80 -68.35 128.82 37.96 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.618 0.599 . . . . 72.510000000000005 112.618 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.971 ' H ' HG22 ' A' ' 130' ' ' THR . 86.1 p -96.5 97.25 9.27 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.379 -0.373 . . . . 74.430000000000007 110.288 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 147' ' ' PHE . 79.4 mt -56.94 -40.04 75.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 64.049999999999997 109.787 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.87 120.69 8.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.563 -1.199 . . . . 73.530000000000001 109.1 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.649 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 47.8 t0 -59.96 148.46 35.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 64.329999999999998 112.676 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 17.3 p90 -70.29 152.7 43.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.719 -0.673 . . . . 71.140000000000001 110.682 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.42 166.51 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 60.310000000000002 111.244 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.91 3.38 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.855 -0.611 . . . . 42.32 112.839 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.3 p -162.94 105.63 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 71.409999999999997 110.454 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.715 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -53.05 -47.38 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.533 -0.758 . . . . 64.230000000000004 113.044 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HB2' HG21 ' A' ' 109' ' ' THR . 74.9 Cg_endo -78.26 129.01 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.418 2.079 . . . . 63.450000000000003 112.217 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.58 158.87 53.57 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.731 2.287 . . . . 73.310000000000002 113.566 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 5.0 pttp -39.89 -27.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.119 -0.946 . . . . 64.140000000000001 112.158 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -50.38 -34.12 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.126 -0.488 . . . . 75.349999999999994 111.627 -178.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 105' ' ' PRO . 6.8 t -93.62 4.7 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.566 -0.454 . . . . 52.5 111.433 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.17 -98.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.206 -0.452 . . . . 71.25 112.865 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 163' ' ' GLN . 53.3 tp -61.0 145.23 51.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.575 0.703 . . . . 64.420000000000002 111.416 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 166' ' ' TYR . 17.3 m-70 -139.75 114.02 9.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.191 -1.04 . . . . 73.439999999999998 108.191 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.568 ' HG3' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -100.3 123.87 45.06 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.283 -0.636 . . . . 72.310000000000002 109.283 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.402 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 35.6 m-85 -119.64 138.46 53.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.967 0.413 . . . . 73.409999999999997 110.353 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 58.7 mt -122.66 122.3 65.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.311 -0.859 . . . . 74.439999999999998 111.923 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -98.9 137.28 37.69 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.748 -0.66 . . . . 73.129999999999995 109.86 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.1 tm? -123.97 138.28 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.552 -0.536 . . . . 74.450000000000003 109.552 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.834 ' N ' HD13 ' A' ' 117' ' ' LEU . 65.3 tp -120.66 141.54 50.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 122.578 0.351 . . . . 62.539999999999999 110.744 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.584 ' CD2' HD22 ' A' ' 153' ' ' LEU . 37.7 t80 -142.44 136.73 29.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.868 -0.606 . . . . 74.299999999999997 111.047 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' A' ' 122' ' ' GLU . 4.9 tmm_? -79.51 121.25 24.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.785 -0.45 . . . . 74.109999999999999 109.785 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.628 HE22 HG12 ' A' ' 125' ' ' ILE . 1.9 tt0 -98.93 130.85 45.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.014 0.435 . . . . 74.310000000000002 110.871 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.41 ' HB2' ' NH1' ' A' ' 120' ' ' ARG . 65.1 tt0 -99.07 -41.28 7.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.834 -0.621 . . . . 54.450000000000003 110.202 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -111.92 130.6 55.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 75.530000000000001 110.949 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.23 146.84 52.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 65.540000000000006 112.085 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.628 HG12 HE22 ' A' ' 121' ' ' GLN . 22.3 pt -126.68 140.24 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.957 -0.565 . . . . 62.32 110.783 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.1 -44.17 60.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.087 0.47 . . . . 75.310000000000002 111.66 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.767 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 29.7 38.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.154 1.168 . . . . 53.539999999999999 114.154 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 p 56.91 158.34 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.803 0.668 . . . . 74.409999999999997 112.803 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.2 158.26 9.79 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.73 2.286 . . . . 70.540000000000006 113.11 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.971 HG22 ' H ' ' A' ' 96' ' ' SER . 41.2 p -58.89 131.19 50.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.318 -0.855 . . . . 65.510000000000005 111.963 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 139' ' ' ARG . 40.9 mm -103.56 124.96 58.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.522 0.201 . . . . 62.530000000000001 110.491 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 99' ' ' ASP . 47.8 t -80.2 154.99 27.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.268 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.649 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.1 p30 -52.69 -35.14 54.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 53.240000000000002 110.137 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 176' ' ' THR . 12.2 t -68.56 11.49 0.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.231 -0.895 . . . . 74.530000000000001 112.503 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' ILE . 15.0 t -62.02 132.39 52.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.79 0.329 . . . . 72.209999999999994 110.681 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.487 ' HG3' ' N ' ' A' ' 137' ' ' THR . 44.1 tpt85 -58.03 159.56 5.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 111.71 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.487 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 27.8 m -51.57 146.95 6.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 75.150000000000006 110.119 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.34 4.73 17.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 73.049999999999997 111.758 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HD2' HG21 ' A' ' 131' ' ' ILE . 45.9 ttm-85 -144.05 37.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 110.776 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' ASN . 0.3 OUTLIER -114.92 -56.97 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 75.230000000000004 110.605 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.649 HD21 ' HB2' ' A' ' 73' ' ' TYR . 3.0 m120 -62.24 67.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.07 -0.513 . . . . 72.420000000000002 111.986 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 146' ' ' ASP . 44.4 t80 -140.4 131.35 26.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.017 0.437 . . . . 75.530000000000001 111.061 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -71.05 108.02 4.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 74.530000000000001 109.458 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.466 ' H ' ' CD ' ' A' ' 75' ' ' GLU . . . -52.27 -40.28 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.303 0.573 . . . . 61.119999999999997 111.464 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.587 HH12 ' HG ' ' A' ' 117' ' ' LEU . 1.6 tpt180 -57.4 -28.68 63.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.438 -0.801 . . . . 74.219999999999999 111.996 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 6.0 t70 -48.72 -47.48 41.22 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.882 -0.784 . . . . 64.120000000000005 108.882 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 97' ' ' LEU . 12.2 m-30 -59.14 -40.05 84.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.151 -0.931 . . . . 73.230000000000004 109.852 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.646 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.762 -0.654 . . . . 71.120000000000005 111.15 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.74 24.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.063 -0.517 . . . . 71.409999999999997 111.887 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.605 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -68.7 -44.23 74.38 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.841 0.682 . . . . 71.340000000000003 112.841 -178.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 34.2 m170 -72.69 7.77 1.78 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 110.734 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.24 2.78 63.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.117 -0.563 . . . . 62.530000000000001 112.332 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 148' ' ' ALA . 3.2 mt -68.71 16.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.543 0.211 . . . . 43.310000000000002 110.589 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.21 -66.24 1.25 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.874 -0.679 . . . . 54.450000000000003 112.189 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.52 122.18 84.63 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.036 -0.357 . . . . 73.409999999999997 110.036 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.773 ' HB3' HD21 ' A' ' 117' ' ' LEU . 89.0 Cg_endo -87.72 127.94 2.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.513 2.142 . . . . 72.430000000000007 113.014 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.547 HD11 ' HG ' ' A' ' 118' ' ' LEU . 43.3 pt -77.04 -34.14 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.127 0.489 . . . . 71.219999999999999 110.209 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.67 157.86 37.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 74.450000000000003 110.851 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.449 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -154.16 171.34 19.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.008 0.433 . . . . 64.310000000000002 111.156 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.8 t-20 -170.58 133.57 1.02 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.079 -1.082 . . . . 71.409999999999997 108.079 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.534 ' CE1' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -135.4 158.41 44.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.76 -0.2 . . . . 64.010000000000005 111.466 -177.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.661 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.9 p90 -146.6 156.83 43.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.974 -0.557 . . . . 62.409999999999997 112.338 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.568 ' HG2' ' HG3' ' A' ' 113' ' ' ARG . 14.2 mt-30 -119.09 124.68 47.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.128 -0.942 . . . . 75.329999999999998 109.759 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 166' ' ' TYR . . . -156.68 138.43 14.22 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.635 -0.426 . . . . 64.239999999999995 111.498 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.599 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.17 135.52 41.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.27 -0.641 . . . . 60.210000000000001 109.27 178.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.866 ' HB3' HG11 ' A' ' 170' ' ' VAL . 6.2 m-85 -121.21 142.64 49.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.341 -0.391 . . . . 74.239999999999995 111.814 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.4 m-20 -66.24 -168.21 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.191 -0.913 . . . . 60.43 113.022 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t70 -85.9 -32.77 21.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.986 -1.006 . . . . 74.450000000000003 111.57 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.499 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.6 t80 -61.14 -32.58 72.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.521 0.563 . . . . 74.030000000000001 112.521 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.992 HG13 ' HD3' ' A' ' 171' ' ' PRO . 1.5 p -72.29 -48.79 9.79 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.761 1.023 . . . . 72.349999999999994 113.761 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.992 ' HD3' HG13 ' A' ' 170' ' ' VAL . 20.0 Cg_endo -59.25 -17.22 38.22 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.777 1.651 . . . . 74.439999999999998 112.519 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.542 HD11 ' HD2' ' A' ' 175' ' ' LYS . 10.9 tp -46.15 -30.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.012 0.434 . . . . 72.129999999999995 111.156 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 173' ' ' ARG . 10.6 tpp85 -44.79 -25.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 71.25 110.588 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.3 p30 -50.5 -36.22 32.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.957 -0.565 . . . . 65.109999999999999 111.339 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.542 ' HD2' HD11 ' A' ' 172' ' ' ILE . 8.4 mtpm? -56.7 -22.19 33.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.368 . . . . 73.129999999999995 111.128 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.473 HG22 ' OG1' ' A' ' 134' ' ' THR . 16.6 m -74.96 -7.89 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.802 -0.635 . . . . 74.540000000000006 111.457 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' THR . 44.2 mm -68.52 79.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 74.209999999999994 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.419 ' HA ' ' CD ' ' A' ' 136' ' ' ARG . 28.6 m -139.33 13.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.41 0.522 . . . . 51.149999999999999 112.41 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-O 118.125 -1.375 . . . . 71.239999999999995 112.932 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' OD2' ' NH2' ' A' ' 145' ' ' ARG . 6.4 m-20 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 110.526 -0.176 . . . . 55.439999999999998 110.526 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.18 -71.12 0.77 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.598 0.592 . . . . 61.399999999999999 112.598 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.578 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 6.9 pt -99.39 65.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 72.230000000000004 112.266 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 6' ' ' PRO . 8.8 p -141.61 143.53 29.8 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.07 -0.514 . . . . 73.230000000000004 110.659 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 5' ' ' VAL . 8.0 Cg_exo -73.57 17.81 2.65 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 124.905 -0.873 . . . . 62.32 112.626 0.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.578 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 2.3 m-20 -45.8 -59.23 2.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.851 . . . . 72.400000000000006 111.941 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.0 m -161.79 -40.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 40.450000000000003 111.54 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 161' ' ' TYR . 47.0 tp -151.24 135.26 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.36 0.6 . . . . 73.140000000000001 111.951 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -75.48 37.46 0.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 73.340000000000003 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 179.03 -148.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.608 -0.724 . . . . 61.420000000000002 109.856 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.5 p -152.33 119.2 3.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.55 0.215 . . . . 60.109999999999999 110.85 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.586 ' HD3' HD23 ' A' ' 9' ' ' LEU . 49.9 Cg_endo -97.13 135.91 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.077 2.518 . . . . 65.329999999999998 112.77 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -24.89 67.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 74.450000000000003 110.334 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.54 -129.64 1.75 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.414 -0.812 . . . . 71.109999999999999 111.487 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t -164.32 159.58 20.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.513 . . . . 75.430000000000007 109.614 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.24 135.0 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.218 -0.446 . . . . 65.310000000000002 110.963 -179.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -77.69 102.3 7.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.386 -0.598 . . . . 73.219999999999999 109.386 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 97.6 t -107.97 110.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.402 0.62 . . . . 62.109999999999999 109.735 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' LEU . 61.3 mt -101.5 124.49 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 71.209999999999994 110.264 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 1.3 m-85 -73.98 -40.01 63.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.333 -0.849 . . . . 74.329999999999998 112.112 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -126.38 -55.14 0.15 Allowed Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.179 -1.01 . . . . 75.530000000000001 112.754 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -179.69 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 72.530000000000001 108.328 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -93.08 -45.13 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.725 -1.125 . . . . 70.420000000000002 109.214 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.3 pt? -69.22 138.5 54.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.768 -0.651 . . . . 71.510000000000005 109.375 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.462 ' CD ' ' NZ ' ' A' ' 28' ' ' LYS . 53.4 tt0 -143.74 139.05 29.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.072 -0.967 . . . . 65.420000000000002 111.001 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 16.0 m -86.57 106.81 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.22 0.533 . . . . 61.009999999999998 110.645 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' CD ' ' A' ' 26' ' ' GLU . 27.1 mttp -98.44 119.84 37.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.064 0.935 . . . . 75.310000000000002 112.949 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 9.8 mp0 30.28 67.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.566 -1.652 . . . . 72.129999999999995 115.049 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.42 8.81 76.56 Favored Glycine 0 C--N 1.329 0.184 0 N-CA-C 115.528 0.971 . . . . 74.510000000000005 115.528 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.76 149.92 21.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.864 0.832 . . . . 74.109999999999999 110.742 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -91.25 133.4 35.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 72.540000000000006 109.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 10.3 mp -106.0 126.34 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 61.539999999999999 110.648 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 17.0 p -143.79 160.88 48.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.467 -0.788 . . . . 63.509999999999998 109.937 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.1 Cg_exo -75.98 -40.03 1.28 Allowed 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.522 -1.032 . . . . 72.030000000000001 112.908 0.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.7 p -151.98 28.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 64.239999999999995 111.591 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 1.8 pt20 -60.0 -10.4 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.521 0.677 . . . . 62.340000000000003 109.999 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 164' ' ' ALA . 34.5 m -82.97 25.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.962 -1.017 . . . . 75.140000000000001 110.858 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.526 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -75.99 -21.19 57.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.285 -0.871 . . . . 74.209999999999994 111.085 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -107.76 152.52 24.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.155 0.503 . . . . 72.329999999999998 111.481 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -63.98 146.39 97.3 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.449 -0.796 . . . . 64.209999999999994 111.793 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.614 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 94.7 Cg_endo -79.13 129.24 8.7 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.695 2.264 . . . . 71.310000000000002 112.805 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.3 mm -104.19 117.65 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.509 -0.182 . . . . 62.539999999999999 110.509 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.9 t -86.55 142.5 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 71.219999999999999 111.788 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -156.38 145.02 20.06 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.125 0.488 . . . . 72.450000000000003 110.668 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 3.3 p90 -126.32 35.34 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.187 0.518 . . . . 74.439999999999998 110.904 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -47.7 125.57 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 72.209999999999994 110.529 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -28.56 8.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 62.420000000000002 112.931 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -79.23 -42.18 26.55 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 109.228 -0.656 . . . . 75.219999999999999 109.228 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.707 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 31.6 tt0 -59.32 167.25 1.91 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.571 -0.74 . . . . 73.430000000000007 110.171 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . -177.48 -71.33 0.06 OUTLIER Glycine 0 C--O 1.229 -0.202 0 C-N-CA 120.708 -0.758 . . . . 64.109999999999999 112.14 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -148.86 109.74 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.124 0.488 . . . . 65.0 110.721 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 37.6 m -157.09 141.95 16.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 44.439999999999998 109.57 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t30 -67.01 -38.08 85.33 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.643 0.735 . . . . 74.25 109.482 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 83' ' ' ASN . 64.6 mt -155.47 175.99 13.17 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.494 -1.23 . . . . 64.120000000000005 110.519 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 22.1 mt -146.71 158.91 44.01 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.222 -0.445 . . . . 72.439999999999998 109.944 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.675 HG23 HG12 ' A' ' 82' ' ' VAL . 3.2 m -123.21 127.79 49.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.226 -0.443 . . . . 54.450000000000003 111.119 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -123.84 117.58 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.454 -1.314 . . . . 74.319999999999993 107.454 178.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 80' ' ' SER . 86.0 mt -132.77 139.96 47.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.464 0.542 . . . . 34.32 112.464 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 78' ' ' HIS . 46.5 ttm -94.74 134.37 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.639 -0.875 . . . . 74.439999999999998 108.639 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.39 136.0 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.308 -0.406 . . . . 54.539999999999999 111.022 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 5.2 t70 164.53 94.43 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 115.414 -0.812 . . . . 72.040000000000006 110.281 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.56 84.02 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.583 1.522 . . . . 72.150000000000006 110.833 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 84.49 1.64 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.766 0.654 . . . . 73.329999999999998 112.766 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.3 133.71 1.07 Allowed Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.45 -0.5 . . . . 54.030000000000001 112.28 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.696 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 Cg_exo -57.63 -23.34 1.82 Allowed 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 122.997 -1.668 . . . . 71.340000000000003 108.893 -3.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.451 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 12.2 t -161.93 143.57 11.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 113.889 -1.505 . . . . 74.439999999999998 108.706 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 53.1 ttp180 -53.69 -17.59 2.38 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.226 0.536 . . . . 73.530000000000001 111.185 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 1.8 mp0 -72.49 -32.44 66.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.397 -0.82 . . . . 72.239999999999995 111.445 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.2 t0 -143.83 63.33 11.8 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 108.82 -0.807 . . . . 65.530000000000001 108.82 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 53.8 Cg_endo -72.3 51.74 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.23 2.62 . . . . 74.439999999999998 112.857 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -51.35 -44.11 61.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.391 -0.368 . . . . 63.020000000000003 111.945 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE1' HD13 ' A' ' 76' ' ' ILE . 15.6 p90 -108.22 34.76 3.44 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.523 -0.471 . . . . 71.430000000000007 111.629 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.518 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 35.8 ttp85 -76.44 144.49 39.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.814 -0.439 . . . . 72.340000000000003 109.814 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 29.8 mp0 -92.28 142.69 27.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.759 0.823 . . . . 63.539999999999999 110.602 0.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' CE1' ' A' ' 73' ' ' TYR . 5.6 tp -72.47 174.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.771 -0.372 . . . . 72.349999999999994 110.241 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.554 ' HB2' HG11 ' A' ' 101' ' ' VAL . 3.2 mm? -52.15 133.46 33.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.428 0.633 . . . . 64.340000000000003 111.33 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.469 ' HA ' ' SD ' ' A' ' 60' ' ' MET . 2.0 p-80 -129.64 157.05 43.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.861 -1.063 . . . . 73.329999999999998 109.458 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -99.35 117.67 34.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 54.329999999999998 109.923 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.698 ' HB3' HD12 ' A' ' 97' ' ' LEU . 74.3 m -141.38 138.02 32.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.443 0.639 . . . . 64.430000000000007 111.7 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.521 HG12 ' CD1' ' A' ' 84' ' ' ILE . 11.9 t -143.52 123.21 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 114.666 -1.152 . . . . 63.509999999999998 108.666 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 97' ' ' LEU . 18.7 m -123.71 -177.4 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.066 -0.515 . . . . 74.319999999999993 110.367 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.788 ' OD1' HG23 ' A' ' 82' ' ' VAL . 7.1 m120 62.82 30.2 16.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 109.951 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.977 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -77.86 108.99 8.45 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.184 -0.606 . . . . 65.420000000000002 109.673 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 87' ' ' SER . 19.2 Cg_endo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.43 1.42 . . . . 74.040000000000006 110.69 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.05 71.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.433 -0.413 . . . . 62.420000000000002 113.655 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' PRO . 32.3 m -175.16 43.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.297 0.639 . . . . 71.329999999999998 110.179 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 57.2 m-80 -135.78 -26.59 1.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.412 0.893 . . . . 74.120000000000005 113.412 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 9.0 tt0 77.57 -16.42 0.65 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.314 0.578 . . . . 74.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 88' ' ' ASN . 19.9 p30 -150.96 154.43 34.3 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.142 -0.935 . . . . 70.129999999999995 110.386 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 45.67 1.75 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.374 2.716 . . . . 71.140000000000001 112.994 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -103.97 -1.96 26.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 61.32 111.829 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.2 -14.89 13.58 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.751 -0.738 . . . . 71.340000000000003 114.338 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.977 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -87.97 177.24 46.19 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.572 -0.823 . . . . 71.239999999999995 113.637 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -68.23 114.29 6.58 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.812 0.301 . . . . 60.329999999999998 111.812 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.513 ' O ' HG22 ' A' ' 130' ' ' THR . 30.7 m -70.84 96.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.947 -0.76 . . . . 71.420000000000002 108.947 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.82 HD21 HG22 ' A' ' 82' ' ' VAL . 24.6 mt -60.51 -59.52 5.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 75.409999999999997 110.503 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.61 125.17 35.52 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.25 -0.886 . . . . 51.119999999999997 109.223 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -59.96 156.15 15.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.596 0.712 . . . . 74.150000000000006 112.614 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 3.3 t80 -68.59 141.99 55.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.822 -1.081 . . . . 74.150000000000006 112.138 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 77' ' ' LEU . 7.4 p -142.87 113.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 72.439999999999998 109.866 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.39 -64.62 1.31 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.891 -0.671 . . . . 74.510000000000005 112.981 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.3 p 178.85 98.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 72.400000000000006 110.487 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.614 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -72.83 -35.62 58.33 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.066 -0.587 . . . . 73.510000000000005 113.573 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 38.6 Cg_exo -62.27 143.14 93.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.149 2.566 . . . . 51.32 113.294 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.48 144.85 99.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.223 2.616 . . . . 74.5 113.165 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -48.92 -22.36 0.83 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.455 -0.793 . . . . 64.319999999999993 111.642 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.3 m-20 -50.82 -29.93 12.98 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.57 0.581 . . . . 74.329999999999998 112.57 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 112' ' ' HIS . 12.9 t -70.62 -15.22 62.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.326 0.584 . . . . 71.25 110.418 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.68 -138.01 24.26 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 113.105 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.7 tp -65.27 118.95 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.413 -0.394 . . . . 60.310000000000002 111.991 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 109' ' ' THR . 94.3 m-70 -79.93 148.07 31.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -114.04 58.98 0.68 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 75.329999999999998 110.805 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 54.4 m-85 -69.14 132.72 47.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.49 0.662 . . . . 75.140000000000001 112.357 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.728 HG23 ' HD1' ' A' ' 161' ' ' TYR . 63.8 mt -122.25 134.31 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.102 . . . . 65.019999999999996 110.672 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 14.0 m-30 -104.21 137.79 41.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.061 -0.348 . . . . 65.010000000000005 110.061 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.0 tm? -119.69 131.97 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.699 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.731 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.0 tt -131.81 122.69 26.18 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.751 0.31 . . . . 60.130000000000003 111.633 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.668 ' N ' HD23 ' A' ' 118' ' ' LEU . 30.6 t80 -144.92 141.85 29.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.363 -0.38 . . . . 61.229999999999997 111.678 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.639 ' HA ' HD23 ' A' ' 56' ' ' LEU . 16.6 mtm105 -63.2 144.8 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.566 0.222 . . . . 74.409999999999997 111.295 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 30.4 tp60 -117.62 124.83 49.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.822 -0.807 . . . . 74.219999999999999 108.822 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.666 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -86.38 -38.97 16.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 73.450000000000003 112.753 -178.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -110.18 150.07 29.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.278 0.844 . . . . 74.400000000000006 113.278 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 1.7 tppp? -72.64 133.59 44.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.941 -1.027 . . . . 73.230000000000004 110.496 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.628 HD12 ' NE2' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -135.67 144.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 63.240000000000002 111.43 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -44.03 23.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.135 0.493 . . . . 74.420000000000002 110.848 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.643 ' HG3' HG21 ' A' ' 82' ' ' VAL . 47.8 mm-40 54.71 40.43 31.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.318 0.859 . . . . 64.239999999999995 113.318 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p 53.37 154.17 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 N-CA-C 113.673 0.99 . . . . 72.439999999999998 113.673 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.48 158.22 8.11 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.094 2.529 . . . . 41.109999999999999 113.009 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 96' ' ' SER . 23.8 p -58.86 122.45 13.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 72.439999999999998 111.164 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 131' ' ' ILE . 23.9 mm -94.45 121.11 44.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.42 0.629 . . . . 70.340000000000003 111.751 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.7 m -73.68 135.88 43.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.896 -1.047 . . . . 74.519999999999996 111.156 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 135' ' ' THR . 19.2 p-10 -58.71 -43.48 90.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.989 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 177' ' ' ILE . 41.0 p -70.09 22.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 112.189 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.9 t -74.1 133.56 42.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 72.549999999999997 111.285 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.903 ' HD2' HG22 ' A' ' 177' ' ' ILE . 14.8 mmm-85 -58.05 173.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.877 0.846 . . . . 75.409999999999997 112.873 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -41.04 157.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.148 -1.387 . . . . 63.229999999999997 113.036 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.71 -36.83 1.21 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.048 -0.978 . . . . 73.530000000000001 112.948 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -86.24 26.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.018 0.409 . . . . 72.530000000000001 111.324 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.2 mp -114.29 -54.82 2.56 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.06 -0.718 . . . . 71.129999999999995 109.06 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 3.2 m120 -53.75 121.98 8.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.425 -0.807 . . . . 73.329999999999998 110.924 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.461 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 9.8 t80 -173.53 123.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 74.230000000000004 110.488 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 17.1 p-10 -84.67 117.14 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 61.140000000000001 111.913 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.02 74.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 73.530000000000001 110.408 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.451 ' NH2' ' OD2' ' A' ' 2' ' ' ASP . 87.8 mtt180 -43.91 -36.89 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.623 -0.717 . . . . 74.439999999999998 111.406 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.445 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 24.5 t70 -49.41 -53.92 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.39 0.614 . . . . 73.230000000000004 110.498 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 5.3 m-30 -63.63 -34.53 78.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.495 -0.775 . . . . 73.0 110.482 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -59.81 -44.18 94.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.38 -0.6 . . . . 51.240000000000002 109.38 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.26 -57.32 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 71.140000000000001 111.908 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HG3' ' CD2' ' A' ' 151' ' ' HIS . 3.0 ptmm? -60.87 -53.14 60.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.717 0.265 . . . . 73.420000000000002 111.717 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.628 ' NE2' HD12 ' A' ' 125' ' ' ILE . 46.2 m170 -69.42 -12.15 61.42 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.478 -0.489 . . . . 74.310000000000002 111.178 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.11 25.21 71.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 71.239999999999995 112.34 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 10.6 mt -64.16 16.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.835 0.454 . . . . 74.230000000000004 111.759 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -51.77 -21.31 7.0 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.035 -0.602 . . . . 72.239999999999995 113.224 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.05 95.93 14.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.227 0.537 . . . . 74.530000000000001 110.579 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.558 ' HB3' HD21 ' A' ' 117' ' ' LEU . 78.9 Cg_endo -78.29 141.57 18.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.065 2.51 . . . . 74.430000000000007 114.106 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 119' ' ' TYR . 35.8 pt -82.79 -36.33 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 63.100000000000001 110.659 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -141.19 145.14 35.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.439999999999998 111.543 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.17 39.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.445 -0.798 . . . . 74.230000000000004 109.33 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 2.4 t-20 -171.12 127.28 0.69 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.264 -1.013 . . . . 72.329999999999998 108.264 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.728 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -115.8 156.86 25.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.912 -0.585 . . . . 74.25 111.047 -177.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 3.3 p90 -139.41 136.94 35.21 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.725 -0.671 . . . . 74.409999999999997 110.175 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 39.8 mt-30 -122.1 124.45 43.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.819 -0.628 . . . . 74.349999999999994 109.699 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -155.99 151.14 26.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 71.530000000000001 110.713 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.627 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -111.33 133.76 53.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.146 178.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -115.57 131.39 56.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.305 -0.628 . . . . 54.149999999999999 109.305 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 169' ' ' TYR . 72.9 m-20 -66.53 -178.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 74.420000000000002 112.413 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.47 28.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.542 -0.754 . . . . 64.200000000000003 111.959 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 167' ' ' ASP . 28.3 t80 -97.05 -45.71 6.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 63.119999999999997 110.526 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.602 ' CG2' ' HD3' ' A' ' 171' ' ' PRO . 16.0 m -60.38 -35.17 24.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 112.836 0.68 . . . . 72.5 112.836 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.602 ' HD3' ' CG2' ' A' ' 170' ' ' VAL . 73.1 Cg_exo -51.49 -35.61 56.14 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.187 1.258 . . . . 73.209999999999994 111.034 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.567 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 66.8 mt -48.31 -42.45 11.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 63.25 110.227 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 173' ' ' ARG . 1.9 tpm_? -57.22 -37.91 72.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.252 -0.886 . . . . 74.319999999999993 111.235 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 177' ' ' ILE . 8.4 p30 -65.73 -35.19 80.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.434 -0.506 . . . . 60.420000000000002 110.789 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -57.6 -27.42 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.282 -0.567 . . . . 75.400000000000006 109.597 179.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 m -73.68 -0.12 14.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.623 -0.717 . . . . 72.310000000000002 111.587 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.903 HG22 ' HD2' ' A' ' 136' ' ' ARG . 66.4 mt -64.64 129.74 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.803 -0.181 . . . . 50.350000000000001 110.584 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 177' ' ' ILE . 2.4 m -176.4 69.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 122.894 0.478 . . . . 73.430000000000007 111.297 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 118.768 -1.018 . . . . 62.200000000000003 112.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 72.9 m-20 . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 111.445 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -75.57 -62.64 1.51 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.205 -0.452 . . . . 64.430000000000007 111.501 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' LEU . 18.5 pt -104.22 51.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.357 0.599 . . . . 73.239999999999995 111.014 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' HA ' ' A' ' 6' ' ' PRO . 11.1 p -135.56 139.94 32.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.639 -0.709 . . . . 52.219999999999999 109.862 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HA ' HG23 ' A' ' 5' ' ' VAL . 86.5 Cg_endo -82.15 37.7 1.33 Allowed 'Cis proline' 0 C--N 1.346 0.447 0 C-N-CA 123.744 -1.357 . . . . 72.140000000000001 112.762 0.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.8 t0 -64.73 -50.88 65.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.34 . . . . 65.430000000000007 110.471 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.8 m -163.74 -36.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.642 0.608 . . . . 65.129999999999995 112.642 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 4' ' ' ILE . 29.7 tp -157.31 164.23 37.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.093 0.473 . . . . 73.239999999999995 112.182 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -67.85 -38.0 82.58 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.869 0.366 . . . . 73.230000000000004 110.621 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -146.32 128.92 16.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 55.109999999999999 110.594 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 12' ' ' VAL . 8.7 p -60.53 123.78 75.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.339 0.496 . . . . 74.510000000000005 112.339 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 46.0 Cg_endo -87.58 -121.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.37 2.714 . . . . 74.209999999999994 112.295 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -163.42 -45.96 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.075 -0.511 . . . . 63.439999999999998 110.186 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.93 -135.07 8.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.874 -0.679 . . . . 54.119999999999997 112.474 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 9.7 t -164.12 177.42 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 73.340000000000003 110.834 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.815 HG22 HG23 ' A' ' 19' ' ' VAL . 53.0 mt -124.3 128.56 73.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.981 -0.554 . . . . 62.140000000000001 110.895 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.8 mmpt? -86.87 108.77 18.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.433 -0.803 . . . . 72.430000000000007 109.372 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.815 HG23 HG22 ' A' ' 17' ' ' ILE . 74.7 t -124.68 110.9 26.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.122 0.487 . . . . 73.099999999999994 110.434 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 26' ' ' GLU . 29.1 mt -96.25 137.94 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 64.25 110.937 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -86.53 0.32 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 75.549999999999997 111.77 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -69.54 -45.91 57.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.854 -0.688 . . . . 61.219999999999999 113.809 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 174.41 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.162 -0.681 . . . . 64.420000000000002 109.162 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -91.86 -42.97 9.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.179 -0.919 . . . . 73.349999999999994 109.33 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.5 137.22 52.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.179 -0.919 . . . . 74.109999999999999 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 23.7 pt-20 -140.85 159.65 41.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.693 -1.139 . . . . 73.430000000000007 109.772 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 19' ' ' VAL . 10.8 m -80.34 119.11 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.32 0.581 . . . . 62.340000000000003 111.307 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 41.1 mttp -120.87 113.22 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.723 -0.671 . . . . 53.450000000000003 111.822 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.8 mp0 46.43 67.08 0.82 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.54 1.311 . . . . 74.340000000000003 114.54 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.51 16.22 14.93 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.301 0.481 . . . . 62.32 114.301 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -51.77 145.47 9.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.131 0.491 . . . . 75.430000000000007 110.875 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -91.76 116.39 28.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.223 -0.899 . . . . 73.340000000000003 110.533 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -92.84 118.0 30.64 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.513 -0.475 . . . . 65.450000000000003 110.141 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 p -150.51 154.95 36.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.758 -0.656 . . . . 72.140000000000001 111.006 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 36' ' ' THR . 93.2 Cg_endo -89.19 -93.78 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 C-N-CA 124.039 -1.234 . . . . 75.510000000000005 111.267 -0.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 p -75.05 47.97 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.787 0.803 . . . . 75.299999999999997 109.631 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HA ' ' HZ1' ' A' ' 39' ' ' LYS . 42.4 tt0 -107.66 -2.78 19.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 71.420000000000002 110.734 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 164' ' ' ALA . 30.8 m -101.14 27.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 65.439999999999998 112.038 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HZ1' ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.18 -40.6 62.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.095 0.474 . . . . 62.340000000000003 110.642 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.44 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 29.2 m-20 -71.79 138.91 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.612 -0.722 . . . . 53.549999999999997 112.146 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.8 pm0 -66.98 152.57 95.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.245 -0.889 . . . . 35.119999999999997 111.503 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.1 Cg_endo -81.97 126.94 5.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.786 2.324 . . . . 74.319999999999993 112.829 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 43.5 mm -107.07 106.08 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 65.5 110.215 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 19' ' ' VAL . 10.4 p -79.02 143.23 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.732 0.641 . . . . 75.010000000000005 112.732 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' LYS . 36.9 m -165.46 152.32 10.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.018 0.437 . . . . 71.200000000000003 111.784 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 3.4 p90 -124.7 34.2 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.689 0.757 . . . . 74.409999999999997 109.556 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -44.42 121.9 2.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 75.530000000000001 111.197 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.44 -28.15 7.86 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.952 -0.642 . . . . 61.119999999999997 113.699 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 7.1 mp -75.68 -36.3 60.11 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.564 0.682 . . . . 71.230000000000004 110.096 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -51.55 158.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.409 -0.814 . . . . 71.409999999999997 109.994 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.38 -64.56 0.05 OUTLIER Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.423 -0.894 . . . . 71.150000000000006 112.135 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -148.16 109.35 4.32 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 61.329999999999998 108.845 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -157.72 141.84 16.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.276 -0.875 . . . . 75.219999999999999 111.215 -178.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -77.13 -45.04 28.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.325 -0.991 . . . . 65.439999999999998 108.325 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD22 ' O ' ' A' ' 83' ' ' ASN . 80.0 mt -154.64 163.45 40.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.871 -1.513 . . . . 64.340000000000003 109.076 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 32.7 mt -129.66 153.62 47.94 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.804 -0.443 . . . . 64.140000000000001 109.804 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 HG12 ' A' ' 82' ' ' VAL . 4.8 m -117.77 114.73 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 64.530000000000001 110.394 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -108.1 119.37 39.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.67 -0.863 . . . . 73.230000000000004 108.67 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 153' ' ' LEU . 66.8 mt -150.24 151.86 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.949 -0.7 . . . . 72.439999999999998 112.442 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' A' ' 78' ' ' HIS . 3.9 ppp? -94.99 154.91 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.268 -0.878 . . . . 73.200000000000003 109.177 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 62' ' ' ASP . 46.1 t -132.56 163.22 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.048 0.452 . . . . 73.219999999999999 111.725 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 61' ' ' VAL . 21.9 t70 64.18 54.91 1.53 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 74.5 110.187 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 35.1 Cg_exo -36.0 140.07 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.02 2.48 . . . . 64.439999999999998 112.22 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.05 85.53 2.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.623 0.601 . . . . 74.319999999999993 112.623 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.13 136.28 1.27 Allowed Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 112.301 0.482 . . . . 43.210000000000001 112.301 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 17.0 Cg_exo -68.36 -28.12 5.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.633 -1.403 . . . . 73.519999999999996 111.626 -1.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.882 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.4 t -150.03 150.11 31.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.14 -0.936 . . . . 75.409999999999997 111.123 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.9 -23.36 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.293 -0.867 . . . . 65.420000000000002 109.823 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.92 -39.82 29.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 71.510000000000005 112.619 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.882 ' H ' HG23 ' A' ' 67' ' ' THR . 8.4 t0 -144.37 81.08 11.55 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-O 120.613 0.244 . . . . 75.129999999999995 110.614 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 6.3 Cg_exo -77.75 55.82 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.116 2.544 . . . . 73.019999999999996 111.935 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 15.4 ptpt -48.9 -47.44 43.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.151 0.426 . . . . 63.240000000000002 112.151 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 1.7 p90 -114.34 33.42 5.3 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.489 -0.484 . . . . 74.140000000000001 111.081 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 63' ' ' PRO . 9.9 ttm180 -54.9 132.26 46.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.032 -1.099 . . . . 74.439999999999998 108.032 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 10.4 tp10 -103.26 166.67 10.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.871 1.668 . . . . 64.239999999999995 109.906 -0.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.552 HG23 ' HG ' ' A' ' 77' ' ' LEU . 7.6 tp -94.51 -45.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.747 -0.835 . . . . 72.109999999999999 108.747 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 103' ' ' SER . 3.2 pp -174.96 146.75 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.883 -1.053 . . . . 64.409999999999997 108.777 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 19.4 p-80 -158.73 176.6 12.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.579 -0.282 . . . . 75.329999999999998 110.386 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.548 ' CH2' HG12 ' A' ' 44' ' ' VAL . 12.2 t90 -102.91 125.28 49.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.034 0.445 . . . . 75.299999999999997 111.238 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 27.2 p -141.55 133.56 27.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 64.549999999999997 111.035 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 84' ' ' ILE . 16.1 t -147.8 132.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.225 -0.443 . . . . 70.209999999999994 110.275 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.564 HG12 HG23 ' A' ' 57' ' ' THR . 19.8 m -137.16 171.14 16.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.78 0.324 . . . . 75.209999999999994 110.973 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.686 ' ND2' HE22 ' A' ' 121' ' ' GLN . 1.3 m120 73.88 25.82 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.718 -0.674 . . . . 53.219999999999999 110.527 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -72.35 115.16 36.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.382 -0.927 . . . . 74.099999999999994 110.215 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 129.21 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.795 1.663 . . . . 73.439999999999998 110.659 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.92 62.79 0.05 OUTLIER Glycine 0 CA--C 1.525 0.683 0 O-C-N 123.52 0.512 . . . . 62.329999999999998 113.441 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -173.95 37.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.675 0.79 . . . . 64.25 108.942 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.24 -10.33 2.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.864 -0.607 . . . . 72.409999999999997 112.489 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 71.88 -32.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.87 0.367 . . . . 41.409999999999997 111.264 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -153.69 166.14 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.450000000000003 110.546 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 69.8 Cg_endo -67.93 43.96 0.27 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.62 2.88 . . . . 65.040000000000006 113.508 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 t -74.04 -38.28 64.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 65.299999999999997 110.014 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.63 5.34 35.03 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.874 -0.603 . . . . 55.420000000000002 112.648 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -80.76 160.89 43.65 Favored Glycine 0 N--CA 1.454 -0.111 0 C-N-CA 120.746 -0.74 . . . . 44.130000000000003 112.394 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 106.75 4.03 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.249 0.524 . . . . 62.350000000000001 111.262 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 130' ' ' THR . 47.7 m -73.68 100.76 3.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 73.420000000000002 108.672 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HG3' ' A' ' 127' ' ' GLU . 87.4 mt -58.39 -50.25 74.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.579 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.77 122.45 20.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.329 -0.396 . . . . 75.109999999999999 111.016 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -48.63 132.68 17.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.797 -0.638 . . . . 74.230000000000004 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CD1' ' O ' ' A' ' 100' ' ' TYR . 1.9 p90 -76.53 126.1 30.4 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.013 0.435 . . . . 75.209999999999994 110.522 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 HD13 ' A' ' 77' ' ' LEU . 1.2 m -148.05 159.81 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.857 -0.61 . . . . 60.420000000000002 111.061 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 173' ' ' ARG . . . -58.15 111.9 3.48 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.677 -0.692 . . . . 65.319999999999993 113.049 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.741 ' HA ' HD11 ' A' ' 77' ' ' LEU . 48.8 m -63.65 95.47 0.11 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.273 0.229 . . . . 75.319999999999993 110.815 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 170' ' ' VAL . . . -56.61 101.67 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.067 -0.515 . . . . 73.329999999999998 113.027 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' NE2' ' A' ' 112' ' ' HIS . 87.8 Cg_endo -104.35 139.65 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.695 2.93 . . . . 62.119999999999997 112.912 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 109' ' ' THR . 11.9 Cg_endo -55.35 134.24 62.72 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.181 1.254 . . . . 75.430000000000007 109.586 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -42.08 -35.83 1.0 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.446 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -60.63 -42.53 97.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.928 -1.033 . . . . 73.409999999999997 112.803 -178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.472 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 3.6 t -72.56 -33.28 66.69 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.083 -0.386 . . . . 71.200000000000003 111.568 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.95 -88.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.531 0.972 . . . . 72.450000000000003 115.531 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.0 tp -66.88 122.4 17.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.824 1.046 . . . . 73.329999999999998 113.824 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 105' ' ' PRO . 2.9 m-70 -97.46 137.03 37.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.513 -0.767 . . . . 64.140000000000001 110.185 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.447 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 5.9 mmt85 -104.8 118.02 35.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.288 -0.634 . . . . 64.140000000000001 109.288 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.87 133.57 54.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.177 0.513 . . . . 64.319999999999993 111.952 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 161' ' ' TYR . 28.3 mm -125.74 121.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.058 -0.973 . . . . 64.409999999999997 108.868 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.33 131.94 51.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 74.420000000000002 110.771 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 156' ' ' PRO . 14.8 tp -126.81 130.93 51.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 71.010000000000005 110.435 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 158' ' ' ALA . 52.5 tp -124.75 122.47 37.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.855 -0.611 . . . . 64.519999999999996 110.682 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.453 ' HD2' HD23 ' A' ' 153' ' ' LEU . 37.0 t80 -134.62 138.24 44.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 75.239999999999995 109.777 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 53' ' ' SER . 37.3 ttp180 -68.95 124.53 23.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 73.420000000000002 111.72 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.686 HE22 ' ND2' ' A' ' 83' ' ' ASN . 39.7 tt0 -87.99 107.31 18.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.713 -0.847 . . . . 65.150000000000006 108.713 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.516 ' C ' HD22 ' A' ' 123' ' ' ASN . 2.0 tp10 -73.89 -37.12 64.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.007 -0.542 . . . . 74.349999999999994 111.192 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.516 HD22 ' C ' ' A' ' 122' ' ' GLU . 4.4 m120 -121.66 141.82 50.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.513 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.562 ' HA ' HE21 ' A' ' 121' ' ' GLN . 3.8 tppp? -62.62 111.52 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.255 -0.276 . . . . 63.409999999999997 110.255 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' CE1' ' A' ' 151' ' ' HIS . 6.1 pt -90.73 128.21 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.667 -0.494 . . . . 74.230000000000004 109.667 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.63 -46.85 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.929 0.714 . . . . 53.530000000000001 112.929 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.612 ' HG3' HD21 ' A' ' 97' ' ' LEU . 4.9 mm-40 61.67 -117.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 75.239999999999995 109.675 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 127' ' ' GLU . 17.9 p -162.77 160.19 19.54 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.378 -0.601 . . . . 74.150000000000006 109.378 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.59 154.88 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.189 1.926 . . . . 64.230000000000004 111.738 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 96' ' ' SER . 1.9 m -58.42 125.58 23.91 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.056 -0.35 . . . . 74.219999999999999 110.056 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 131' ' ' ILE . 15.9 mm -90.69 126.24 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 71.230000000000004 112.178 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.4 m -82.94 134.86 35.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.063 -0.971 . . . . 64.019999999999996 109.727 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' A' ' 101' ' ' VAL . 15.0 p-10 -51.0 -40.94 59.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 61.039999999999999 111.273 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.683 ' OG1' HG22 ' A' ' 178' ' ' VAL . 9.9 t -65.47 4.04 0.6 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.184 -0.462 . . . . 60.32 111.895 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.45 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 11.3 t -64.12 135.45 56.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.159 0.504 . . . . 72.310000000000002 110.255 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB2' ' HA2' ' A' ' 179' ' ' GLY . 8.9 ttt85 -84.98 173.24 10.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.813 -0.63 . . . . 64.409999999999997 110.765 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.44 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 1.9 m -35.72 151.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.259 -0.882 . . . . 62.340000000000003 112.187 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.19 2.7 19.91 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.984 -0.627 . . . . 73.409999999999997 113.573 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -169.75 44.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.237 0.518 . . . . 73.0 110.377 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -114.27 -59.66 1.99 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.984 -0.553 . . . . 72.510000000000005 111.984 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.586 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 2.4 m120 -65.07 42.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.657 0.984 . . . . 75.430000000000007 113.657 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 2.0 t80 -99.31 111.34 23.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 71.209999999999994 109.812 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.61 HD21 ' HB3' ' A' ' 145' ' ' ARG . 30.1 t30 -66.35 129.88 41.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.666 -0.697 . . . . 65.329999999999998 111.404 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . . . -72.24 -35.12 68.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.64 0.607 . . . . 75.519999999999996 112.64 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.61 ' HB3' HD21 ' A' ' 143' ' ' ASN . 30.1 ttm180 -47.04 -39.27 12.52 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.39 -0.524 . . . . 73.430000000000007 110.85 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.69 -37.71 63.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.185 -0.461 . . . . 72.209999999999994 110.894 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 1.6 m-85 -49.65 -40.54 40.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.365 0.602 . . . . 63.329999999999998 109.407 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.16 86.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 54.549999999999997 110.818 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.9 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 25.41 111.606 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.1 -43.27 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.371 0.508 . . . . 75.530000000000001 112.371 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.837 ' CE1' HD12 ' A' ' 125' ' ' ILE . 66.0 m-70 -91.4 1.48 57.09 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 70.420000000000002 110.912 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.4 32.65 73.23 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 121.108 -0.568 . . . . 51.530000000000001 113.662 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 59' ' ' LEU . 8.3 mt -70.32 16.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 110.733 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -64.33 -4.08 11.32 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.059 -0.519 . . . . 45.130000000000003 113.153 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 20.3 pt-20 -134.34 72.55 70.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.716 0.769 . . . . 64.030000000000001 109.018 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.554 ' HG3' HD11 ' A' ' 117' ' ' LEU . 42.1 Cg_endo -68.18 131.14 22.85 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.154 2.569 . . . . 75.310000000000002 113.874 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.0 pt -75.51 -34.46 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 74.239999999999995 109.276 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.801 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.06 146.25 30.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.543 -0.753 . . . . 64.430000000000007 110.141 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 117' ' ' LEU . . . -158.69 159.38 35.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 64.310000000000002 110.521 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.665 ' ND2' HG23 ' A' ' 27' ' ' VAL . 59.1 t30 -170.48 175.37 4.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.207 -1.035 . . . . 72.230000000000004 108.207 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.856 ' HB3' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -155.42 167.05 31.65 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.181 -0.608 . . . . 74.019999999999996 111.589 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -162.03 150.62 15.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.702 -0.681 . . . . 63.409999999999997 110.258 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 113' ' ' ARG . 57.9 mt-30 -124.64 138.16 54.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 73.540000000000006 110.378 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -155.11 138.89 16.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.834 -0.621 . . . . 74.219999999999999 110.373 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.716 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.43 138.08 37.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.086 -0.338 . . . . 53.299999999999997 110.086 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -127.63 126.58 42.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 110.135 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.3 m-20 -62.73 -174.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.324 0.583 . . . . 52.310000000000002 110.448 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 13.9 t70 -72.82 32.68 0.07 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.59 -0.732 . . . . 63.130000000000003 109.752 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 167' ' ' ASP . 20.2 t80 -91.14 -53.69 4.26 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.339 -0.846 . . . . 75.219999999999999 111.752 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 28.3 m -59.81 -31.01 8.34 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 112.917 0.71 . . . . 65.129999999999995 112.917 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 83.7 Cg_exo -48.83 -21.41 3.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.51 1.473 . . . . 72.319999999999993 111.427 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 169' ' ' TYR . 11.8 tt -51.7 -38.93 22.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.886 -0.597 . . . . 61.240000000000002 109.868 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.473 ' CD ' ' H ' ' A' ' 102' ' ' GLY . 85.2 mtt-85 -58.18 -34.97 70.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 74.400000000000006 109.881 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.509 HD21 ' HA3' ' A' ' 104' ' ' GLY . 35.1 m-20 -62.19 -41.31 98.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.15 -0.685 . . . . 74.340000000000003 109.15 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -59.09 -17.24 24.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 74.329999999999998 109.831 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 176' ' ' THR . 18.0 m -88.21 6.12 38.27 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.981 -0.554 . . . . 54.200000000000003 111.778 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.2 mm -74.07 124.36 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.919 -0.128 . . . . 73.120000000000005 111.11 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.683 HG22 ' OG1' ' A' ' 134' ' ' THR . 18.4 m -127.51 -21.3 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.365 1.246 . . . . 62.329999999999998 114.365 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.245 0.795 0 CA-C-O 118.126 -1.375 . . . . 53.240000000000002 112.679 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.071 -0.344 . . . . 74.030000000000001 110.071 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.19 -71.2 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.426 0.528 . . . . 72.420000000000002 112.426 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 13.3 pt -125.37 59.95 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.616 0.722 . . . . 73.310000000000002 110.804 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 6' ' ' PRO . 12.3 p -128.75 140.89 39.82 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.141 -0.936 . . . . 75.049999999999997 110.642 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.8 Cg_endo -85.29 33.13 4.77 Favored 'Cis proline' 0 C--N 1.35 0.606 0 C-N-CA 123.849 -1.313 . . . . 72.450000000000003 112.632 0.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.9 t0 -57.14 -54.54 45.6 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.219 -0.659 . . . . 63.409999999999997 109.219 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.9 m -160.5 -39.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.419 -0.81 . . . . 75.409999999999997 111.676 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.8 tp -157.41 143.03 17.37 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.094 0.473 . . . . 71.530000000000001 111.458 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -78.84 25.73 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.821 -0.55 . . . . 63.240000000000002 110.333 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -175.36 156.02 1.95 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.037 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -90.59 113.52 58.02 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.721 0.267 . . . . 54.420000000000002 111.721 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 87.9 Cg_endo -85.0 134.03 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.646 2.231 . . . . 73.549999999999997 112.482 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 157' ' ' ILE . . . -60.62 -39.62 88.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.09 -0.504 . . . . 75.239999999999995 110.562 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -135.09 3.32 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.683 -0.689 . . . . 63.509999999999998 111.483 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 t -161.29 176.94 10.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.45 -0.574 . . . . 75.319999999999993 109.45 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 44' ' ' VAL . 13.6 mt -116.65 135.79 55.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.551 -0.295 . . . . 52.240000000000002 111.016 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 45' ' ' SER . 31.0 mmmt -73.92 102.31 4.06 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.438 -1.319 . . . . 74.230000000000004 107.438 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.704 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.7 t -117.28 110.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 73.519999999999996 109.654 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.678 HG21 ' O ' ' A' ' 23' ' ' ASP . 22.6 mt -99.61 126.7 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.472 -0.785 . . . . 71.200000000000003 110.185 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.423 ' CD2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.48 -77.48 0.1 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.134 -0.939 . . . . 74.420000000000002 110.61 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.86 -61.49 1.76 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.773 -0.727 . . . . 61.210000000000001 112.627 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.678 ' O ' HG21 ' A' ' 20' ' ' ILE . 3.7 m-20 -161.12 -53.75 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.374 0.607 . . . . 61.229999999999997 109.667 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -100.41 -37.34 8.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.268 -0.878 . . . . 72.439999999999998 111.24 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.2 pt? -69.27 124.6 24.27 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.998 0.904 . . . . 74.019999999999996 110.687 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -113.15 139.87 48.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.989 -1.46 . . . . 44.409999999999997 110.71 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 19' ' ' VAL . 33.1 m -73.51 108.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.519 0.676 . . . . 63.020000000000003 110.343 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 6.3 mmpt? -86.01 82.41 8.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.96 0.726 . . . . 72.030000000000001 112.96 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 13.8 mp0 29.84 67.33 0.11 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.424 1.268 . . . . 72.439999999999998 114.424 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.87 -21.44 29.74 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.933 -0.651 . . . . 74.519999999999996 112.913 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.82 145.63 2.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.394 0.616 . . . . 63.140000000000001 112.348 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' A' ' 163' ' ' GLN . 88.9 tt0 -110.72 136.05 50.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.856 -1.065 . . . . 75.329999999999998 110.291 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.618 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -98.1 142.5 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.781 0.324 . . . . 64.530000000000001 111.156 178.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.2 p -150.17 146.33 19.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.883 -0.599 . . . . 72.310000000000002 109.791 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.93 -115.24 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 124.08 -1.217 . . . . 71.120000000000005 112.636 0.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.8 p -72.02 48.38 0.17 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.775 0.287 . . . . 53.130000000000003 111.775 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.48 HE21 ' HG ' ' A' ' 33' ' ' LEU . 19.2 pt20 -99.98 0.01 40.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.368 0.604 . . . . 72.349999999999994 109.82 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 33' ' ' LEU . 34.4 m -87.45 21.65 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.197 -0.911 . . . . 62.509999999999998 110.957 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -70.72 -34.13 71.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 71.219999999999999 111.711 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.41 135.18 35.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.745 0.307 . . . . 74.120000000000005 111.422 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -68.44 152.48 96.57 Favored Pre-proline 0 C--N 1.335 -0.023 0 N-CA-C 109.691 -0.485 . . . . 65.140000000000001 109.691 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.75 126.61 15.64 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.046 1.831 . . . . 73.299999999999997 113.673 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 47.0 mm -96.85 107.33 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.967 -0.753 . . . . 72.349999999999994 108.967 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 17' ' ' ILE . 3.9 p -78.72 139.93 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.433 0.901 . . . . 70.019999999999996 113.433 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 57.7 m -164.9 134.07 3.55 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.161 -0.472 . . . . 71.519999999999996 110.359 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 2.4 p90 -114.24 35.95 3.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.484 0.659 . . . . 72.010000000000005 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -36.4 98.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.013 -0.994 . . . . 72.109999999999999 113.117 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.32 -15.16 41.46 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 116.075 -0.511 . . . . 70.409999999999997 114.251 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.23 -20.4 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.511 0.656 . . . . 73.049999999999997 110.703 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.743 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -71.35 -61.59 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.65 0.738 . . . . 74.209999999999994 109.403 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -64.24 4.34 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 109.522 -1.431 . . . . 51.43 109.522 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 2.0 ttmp? -149.1 116.79 6.23 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.199 -0.5 . . . . 73.120000000000005 110.134 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 p -157.02 141.57 16.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.216 0.531 . . . . 65.430000000000007 112.345 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 22.1 t30 -83.45 -36.66 24.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 74.400000000000006 109.061 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 25.3 mt -158.11 169.8 23.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.333 -1.303 . . . . 64.150000000000006 108.737 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 69.4 mt -141.57 159.82 41.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.922 0.391 . . . . 61.439999999999998 111.656 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 119' ' ' TYR . 2.1 m -121.56 132.82 54.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.271 -0.877 . . . . 64.349999999999994 108.77 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -127.84 132.56 49.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 73.150000000000006 109.59 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 58' ' ' LEU . 54.9 mt -145.97 129.79 17.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.877 -0.329 . . . . 73.439999999999998 111.018 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.06 135.49 45.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.106 -1.072 . . . . 64.530000000000001 108.106 178.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HD3' ' A' ' 63' ' ' PRO . 10.2 t -147.43 143.53 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.941 0.877 . . . . 62.310000000000002 112.6 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.552 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 55.9 t0 -160.24 81.27 2.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 113.988 -1.46 . . . . 51.229999999999997 107.065 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.692 ' HD3' HG12 ' A' ' 61' ' ' VAL . 37.4 Cg_endo -66.97 84.2 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.625 1.55 . . . . 71.340000000000003 112.47 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' CG ' ' HG2' ' A' ' 68' ' ' ARG . 31.3 m-20 -169.36 84.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.547 -0.751 . . . . 63.299999999999997 110.003 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -153.48 137.33 10.52 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.726 -0.842 . . . . 33.509999999999998 108.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.695 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 4.7 Cg_exo -77.31 -16.39 25.36 Favored 'Cis proline' 0 CA--C 1.515 -0.447 0 C-N-CA 124.287 -1.131 . . . . 65.329999999999998 111.927 0.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.3 t -138.77 140.72 38.73 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.468 -0.787 . . . . 71.430000000000007 110.867 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.517 ' HG2' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -45.94 -26.92 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.864 -1.062 . . . . 72.540000000000006 111.296 -178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -93.96 -45.14 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.52 1.304 . . . . 73.0 114.52 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.843 ' H ' HG23 ' A' ' 67' ' ' THR . 1.3 m-20 -112.64 83.01 5.27 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 113.174 0.805 . . . . 63.140000000000001 113.174 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 63.7 Cg_endo -71.57 51.76 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.236 2.624 . . . . 74.150000000000006 111.696 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HG2' ' CD ' ' A' ' 66' ' ' PRO . 17.7 ptpt -48.66 -33.59 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 63.350000000000001 111.885 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 6.2 p90 -138.68 45.46 2.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.437 0.637 . . . . 75.140000000000001 111.743 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -73.74 138.51 44.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.457 -0.942 . . . . 75.519999999999996 108.457 177.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 29.3 mp0 -91.71 178.3 5.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.772 0.829 . . . . 72.239999999999995 111.385 0.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.631 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.6 tp -106.67 169.81 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.536 -1.211 . . . . 52.100000000000001 109.409 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.8 mp -45.87 125.04 5.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.578 0.228 . . . . 72.129999999999995 110.593 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -124.96 171.98 9.77 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.085 0.469 . . . . 74.230000000000004 111.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 6.7 t-105 -100.16 121.83 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.355 -0.839 . . . . 72.239999999999995 109.866 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -141.49 137.17 31.91 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.437 0.532 . . . . 53.329999999999998 112.437 -177.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 84' ' ' ILE . 2.1 t -141.48 149.79 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.514 -0.312 . . . . 73.510000000000005 110.885 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.525 HG21 ' HG3' ' A' ' 127' ' ' GLU . 22.2 m -142.05 155.66 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.988 0.366 . . . . 75.109999999999999 111.988 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.598 ' N ' HD22 ' A' ' 83' ' ' ASN . 1.0 OUTLIER 72.07 37.55 0.99 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.122 -0.49 . . . . 74.5 112.262 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -83.71 116.0 62.44 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 119.436 -0.906 . . . . 73.140000000000001 109.624 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 35.5 Cg_endo -66.77 126.78 15.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 121.816 1.677 . . . . 70.400000000000006 111.676 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.35 71.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.903 -0.589 . . . . 60.5 114.103 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 85' ' ' PRO . 91.8 p -178.27 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.032 0.416 . . . . 70.549999999999997 110.999 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 85' ' ' PRO . 65.5 m-20 -135.4 -2.47 2.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.327 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.668 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 13.1 pt-20 40.94 34.01 0.25 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.038 -0.528 . . . . 74.219999999999999 111.991 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 p30 175.48 152.62 0.31 Allowed Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 121.34 0.59 . . . . 52.439999999999998 110.761 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 44' ' ' VAL . 95.9 Cg_endo -74.68 61.17 5.34 Favored 'Trans proline' 0 CA--C 1.527 0.173 0 C-N-CA 123.339 2.693 . . . . 61.240000000000002 112.93 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 m -96.78 -55.3 2.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.348 0.87 . . . . 65.409999999999997 113.348 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.82 -40.97 89.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.032 0.773 . . . . 12.449999999999999 115.032 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -57.61 157.8 14.49 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.68 -0.771 . . . . 74.420000000000002 114.134 -178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.932 ' CE1' HG23 ' A' ' 130' ' ' THR . 80.3 t60 -61.63 125.6 24.37 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.079 0.551 . . . . 74.120000000000005 111.095 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.9 m -83.87 97.25 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.658 -0.868 . . . . 64.129999999999995 108.658 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' GLU . 13.0 mt -54.16 -48.83 70.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.471 -0.937 . . . . 73.530000000000001 108.471 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 117.62 8.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.494 -1.23 . . . . 73.510000000000005 108.822 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.7 t0 -54.39 152.48 6.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.65 0.594 . . . . 65.239999999999995 111.556 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 79' ' ' TRP . 0.3 OUTLIER -70.48 129.26 38.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.31 -0.405 . . . . 71.310000000000002 110.342 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.5 p -130.02 113.73 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.56 0.695 . . . . 73.450000000000003 110.873 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.46 72.97 2.74 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.427 -0.806 . . . . 51.140000000000001 113.455 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 29.8 p -171.03 11.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.891 1.071 . . . . 53.409999999999997 113.891 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.631 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -55.38 -84.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.229 -0.986 . . . . 75.319999999999993 112.258 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.927 ' CB ' HG21 ' A' ' 109' ' ' THR . 23.8 Cg_exo -64.54 105.85 0.66 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.144 1.896 . . . . 70.310000000000002 111.389 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 109' ' ' THR . 18.3 Cg_endo -59.37 160.54 19.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.235 1.957 . . . . 60.409999999999997 112.428 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 167' ' ' ASP . 7.7 ttmm -39.69 -41.0 1.01 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.296 -0.866 . . . . 71.219999999999999 111.303 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.06 -39.21 55.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.308 -0.86 . . . . 52.210000000000001 112.223 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.927 HG21 ' CB ' ' A' ' 105' ' ' PRO . 14.0 t -70.73 -7.02 41.76 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.813 0.339 . . . . 73.340000000000003 111.572 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.18 -119.47 18.75 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.099 -0.572 . . . . 64.310000000000002 114.225 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 163' ' ' GLN . 29.3 tp -58.06 119.84 7.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.802 1.038 . . . . 74.099999999999994 113.802 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 32.4 m170 -88.11 91.92 8.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.596 -0.729 . . . . 73.219999999999999 111.081 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.588 ' HD2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -76.82 63.86 2.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 75.230000000000004 110.125 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.7 m-85 -65.73 131.62 46.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.248 -0.433 . . . . 63.240000000000002 111.057 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 161' ' ' TYR . 33.9 mt -127.25 122.17 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.765 -0.652 . . . . 63.140000000000001 111.657 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 3.9 m-30 -90.4 145.95 24.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.876 -0.602 . . . . 72.329999999999998 110.207 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -134.69 131.88 38.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.948 -0.39 . . . . 75.310000000000002 109.948 179.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 157' ' ' ILE . 1.5 tt -126.27 131.47 51.88 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.954 -0.387 . . . . 74.409999999999997 109.954 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.711 ' N ' HD23 ' A' ' 118' ' ' LEU . 65.7 t80 -131.75 139.24 48.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.476 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.654 HH12 ' HB3' ' A' ' 122' ' ' GLU . 0.6 OUTLIER -71.89 130.54 41.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 73.439999999999998 110.513 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.547 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -116.03 148.52 40.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.627 0.251 . . . . 64.439999999999998 111.231 -178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.654 ' HB3' HH12 ' A' ' 120' ' ' ARG . 23.2 pt-20 -148.03 17.66 1.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.178 0.514 . . . . 75.409999999999997 110.941 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 5.8 m120 -143.91 129.13 18.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.053 -0.976 . . . . 42.399999999999999 108.415 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -76.64 111.58 12.29 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.78 -0.768 . . . . 64.349999999999994 111.202 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.492 ' CG1' HD21 ' A' ' 83' ' ' ASN . 9.2 pt -103.68 128.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.812 -1.085 . . . . 74.010000000000005 110.661 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -56.17 -57.67 11.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.411 0.624 . . . . 54.409999999999997 110.954 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.666 ' HB3' HD22 ' A' ' 97' ' ' LEU . 21.9 mm-40 63.09 31.87 15.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.985 -1.007 . . . . 71.329999999999998 112.763 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 44.5 p 57.72 151.6 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 112.631 0.604 . . . . 73.230000000000004 112.631 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -45.21 157.58 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.471 2.781 . . . . 75.140000000000001 113.561 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.932 HG23 ' CE1' ' A' ' 95' ' ' HIS . 8.2 p -62.5 131.1 48.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.524 -0.762 . . . . 74.109999999999999 112.524 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 135' ' ' THR . 45.3 mm -104.56 118.49 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.929 -0.767 . . . . 50.539999999999999 108.929 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.3 t -69.46 153.1 44.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 73.299999999999997 111.77 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.487 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.5 p30 -54.42 -29.36 48.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.552 -0.749 . . . . 53.520000000000003 110.296 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 p -78.12 21.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.718 -0.674 . . . . 71.019999999999996 111.554 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.49 ' HB ' HG22 ' A' ' 131' ' ' ILE . 8.5 t -62.71 126.47 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.311 0.577 . . . . 74.230000000000004 111.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 178' ' ' VAL . 39.3 ttt180 -89.01 173.31 8.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.5 -0.773 . . . . 71.140000000000001 111.242 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.598 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m -36.87 150.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.492 -0.777 . . . . 62.049999999999997 112.457 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.13 25.43 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.017 -0.611 . . . . 74.400000000000006 112.972 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 55.8 ttt180 -163.96 37.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.252 0.549 . . . . 73.409999999999997 111.03 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 137' ' ' THR . 7.2 mp -82.52 -64.06 1.25 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.437 -1.32 . . . . 63.509999999999998 107.437 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -68.6 117.73 10.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.914 -1.143 . . . . 65.120000000000005 107.914 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.46 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 21.5 t80 -170.77 80.19 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.331 -0.395 . . . . 74.0 111.305 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.447 HD22 ' HB3' ' A' ' 145' ' ' ARG . 16.3 p-10 -62.36 117.34 6.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.139 -0.482 . . . . 71.5 111.899 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 59' ' ' LEU . . . -55.53 -25.25 36.49 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.266 0.555 . . . . 64.230000000000004 109.861 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HB3' HD22 ' A' ' 143' ' ' ASN . 1.3 tpp180 -46.57 -32.47 3.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.111 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.575 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 1.5 t70 -61.26 -56.47 20.21 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.147 -0.686 . . . . 61.329999999999998 109.147 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CE2' HD13 ' A' ' 97' ' ' LEU . 3.5 m-30 -56.4 -35.31 67.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.94 -0.573 . . . . 74.450000000000003 109.737 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -65.55 -41.5 92.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.45 -0.795 . . . . 71.019999999999996 109.592 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.89 -55.01 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.922 -0.581 . . . . 50.020000000000003 110.826 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.575 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 2.1 ptpp? -59.14 -45.15 91.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 71.319999999999993 111.763 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 89.6 m-70 -92.58 9.0 36.51 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.751 -0.38 . . . . 74.109999999999999 111.75 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 56.59 30.09 58.64 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.767 -0.73 . . . . 72.329999999999998 113.371 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HA ' ' CE1' ' A' ' 119' ' ' TYR . 13.3 mt -71.95 16.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.812 -0.228 . . . . 63.030000000000001 111.048 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.04 -63.75 1.92 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.323 -0.465 . . . . 43.409999999999997 114.002 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.17 112.29 15.05 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.726 0.263 . . . . 74.239999999999995 111.671 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 66.9 Cg_endo -79.97 123.35 5.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.094 1.863 . . . . 72.310000000000002 112.52 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 1.011 HD11 HD22 ' A' ' 118' ' ' LEU . 50.3 pt -74.87 -33.5 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.571 -0.452 . . . . 72.510000000000005 110.411 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.52 139.65 15.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.316 -0.402 . . . . 73.129999999999995 110.762 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -142.78 159.99 41.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.935 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.469 ' ND2' HG23 ' A' ' 27' ' ' VAL . 1.3 t-20 -161.38 123.38 2.97 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.563 -0.903 . . . . 72.109999999999999 108.563 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.505 ' CD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.81 169.54 11.44 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.984 -0.553 . . . . 74.219999999999999 111.698 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 2.1 p90 -164.1 160.95 22.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 72.099999999999994 109.996 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 111' ' ' LEU . 1.3 pt20 -132.65 129.0 38.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.516 -0.311 . . . . 71.400000000000006 110.848 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.44 140.4 17.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.317 -0.402 . . . . 73.230000000000004 111.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.86 133.03 43.74 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.547 -0.538 . . . . 74.140000000000001 109.547 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -105.83 113.72 27.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.239 0.542 . . . . 73.349999999999994 110.293 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.637 ' O ' ' NZ ' ' A' ' 107' ' ' LYS . 31.1 m-20 -49.81 -52.53 31.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.238 -0.892 . . . . 63.350000000000001 112.751 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -167.48 45.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.325 -0.55 . . . . 75.219999999999999 111.661 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 31.8 t80 -101.37 -40.58 7.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 73.519999999999996 111.553 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 1.042 HG13 ' HD3' ' A' ' 171' ' ' PRO . 0.1 OUTLIER -53.2 -47.46 95.86 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.924 1.083 . . . . 75.019999999999996 113.924 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 1.042 ' HD3' HG13 ' A' ' 170' ' ' VAL . 77.4 Cg_exo -53.01 -50.52 13.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.88 1.72 . . . . 60.200000000000003 113.521 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 172' ' ' ILE . 1.7 mp -45.83 -55.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 62.299999999999997 110.84 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 12.1 tpp180 -56.32 -44.66 80.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 110.39 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -51.87 -38.74 57.19 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.044 -0.525 . . . . 64.25 111.327 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 6.5 mmpt? -55.13 -29.68 58.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.430000000000007 110.964 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -67.64 -29.8 69.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 73.519999999999996 111.994 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.85 103.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.485 -0.325 . . . . 73.010000000000005 110.902 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.416 ' C ' ' HD2' ' A' ' 136' ' ' ARG . 34.1 m -148.39 1.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.389 0.514 . . . . 74.200000000000003 112.389 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.641 -1.089 . . . . 51.140000000000001 112.224 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 111.555 0.205 . . . . 74.439999999999998 111.555 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -106.95 -71.02 0.77 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.674 0.62 . . . . 72.25 112.674 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 9' ' ' LEU . 14.7 pt -80.84 41.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.558 0.694 . . . . 73.219999999999999 111.847 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 11.2 p -114.04 138.92 23.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.606 -0.724 . . . . 75.120000000000005 111.361 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 59.8 Cg_endo -93.57 39.42 4.67 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.388 -1.088 . . . . 73.310000000000002 112.594 -0.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.661 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 t70 -58.2 -44.41 88.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.437 -0.347 . . . . 74.200000000000003 110.412 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -165.75 -36.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.968 -0.56 . . . . 72.200000000000003 111.811 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 4' ' ' ILE . 18.7 tp -157.08 175.01 14.64 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.669 -0.493 . . . . 73.549999999999997 109.669 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 6.6 p-10 -69.0 -52.44 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.42 -1.326 . . . . 75.409999999999997 107.42 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 137.82 22.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 74.430000000000007 110.739 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.89 129.23 87.79 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 111.861 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -88.61 -138.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.089 2.526 . . . . 65.209999999999994 111.904 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.42 -29.7 7.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.519 -0.31 . . . . 43.310000000000002 111.214 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -159.94 -175.58 31.07 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.909 -0.476 . . . . 34.520000000000003 111.909 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 2.2 t -117.82 163.12 17.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.341 0.591 . . . . 74.129999999999995 112.069 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 44' ' ' VAL . 4.0 mt -105.57 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.185 -0.916 . . . . 51.140000000000001 109.691 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.2 mmmm -82.38 102.97 11.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.563 -0.289 . . . . 74.150000000000006 110.596 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.6 t -110.24 110.82 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.318 -0.623 . . . . 72.230000000000004 109.318 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 23' ' ' ASP . 44.2 mt -96.57 130.92 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.566 . . . . 62.219999999999999 110.071 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 40' ' ' ASP . 2.8 t80 -103.17 -15.14 16.12 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 112.362 0.505 . . . . 74.109999999999999 112.362 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.16 2.93 7.83 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.181 0.832 . . . . 64.129999999999995 115.181 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 20' ' ' ILE . 24.1 t70 76.19 20.81 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.372 -1.344 . . . . 50.439999999999998 107.372 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -175.16 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 112.753 -2.021 . . . . 74.140000000000001 107.134 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.655 ' O ' HG23 ' A' ' 20' ' ' ILE . 36.4 mt -69.62 136.02 50.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.984 -1.007 . . . . 63.009999999999998 108.976 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 73.0 tt0 -126.61 143.6 51.17 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.227 0.825 . . . . 72.329999999999998 113.227 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.8 m -86.66 140.34 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.824 -0.626 . . . . 75.519999999999996 110.284 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 10.7 mptt -131.67 114.77 15.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.483 0.549 . . . . 53.420000000000002 112.483 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 9.3 mp0 25.09 67.21 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.297 1.221 . . . . 73.540000000000006 114.297 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.56 6.28 89.04 Favored Glycine 0 C--N 1.33 0.225 0 N-CA-C 114.28 0.472 . . . . 61.109999999999999 114.28 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 18.9 t30 -55.99 131.07 46.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.849 0.357 . . . . 73.439999999999998 110.789 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -89.54 136.04 33.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 43.149999999999999 109.673 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 8.1 mp -92.73 138.99 31.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.319 . . . . 74.099999999999994 111.208 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -147.6 154.91 45.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 75.519999999999996 110.562 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.46 -52.62 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.826 -1.323 . . . . 63.229999999999997 112.879 0.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -120.38 28.92 7.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.747 0.784 . . . . 72.439999999999998 110.484 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 3.1 pt20 -80.98 -6.54 58.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.22 -0.9 . . . . 62.119999999999997 110.635 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.69 32.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.485 -0.78 . . . . 73.450000000000003 111.227 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -96.93 -38.11 9.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.819 1.044 . . . . 73.519999999999996 113.819 -177.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -82.64 143.93 30.64 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.071 0.767 . . . . 75.329999999999998 113.071 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.49 153.09 83.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.474 -1.239 . . . . 75.010000000000005 111.659 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.77 126.79 6.75 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.492 2.128 . . . . 72.549999999999997 112.745 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 51.6 mm -108.09 117.74 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 64.099999999999994 109.698 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.6 p -91.42 142.02 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.11 0.781 . . . . 45.149999999999999 113.11 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 68.5 m -161.43 113.73 1.83 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.848 -0.614 . . . . 73.340000000000003 109.46 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 1.3 p90 -93.67 35.95 1.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.154 0.502 . . . . 75.099999999999994 110.708 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.2 m -49.21 118.94 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 65.140000000000001 111.393 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.22 -11.31 72.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.172 -0.537 . . . . 62.240000000000002 112.805 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -108.39 10.63 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.826 0.346 . . . . 73.239999999999995 110.541 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -104.0 -62.85 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.144 -0.48 . . . . 72.450000000000003 111.151 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . 74.36 -99.43 1.09 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.469 -0.652 . . . . 71.409999999999997 111.469 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' NZ ' ' HB3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -148.82 109.96 4.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.966 0.412 . . . . 74.230000000000004 111.121 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -144.49 147.93 33.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.456 . . . . 63.5 110.225 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.464 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 31.5 t30 -63.34 -39.74 95.38 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.42 0.628 . . . . 63.539999999999999 109.852 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' A' ' 124' ' ' LYS . 30.2 mt -153.98 162.1 41.47 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.828 -1.078 . . . . 55.439999999999998 111.341 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.4 mt -132.82 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.983 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.785 HG23 HG12 ' A' ' 82' ' ' VAL . 13.1 m -113.17 123.62 50.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 74.109999999999999 110.337 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' VAL . 1.3 tm? -124.51 129.81 51.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.777 -0.453 . . . . 73.140000000000001 109.777 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.4 mt -152.46 169.16 23.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 60.100000000000001 111.506 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -95.06 131.63 40.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.833 -0.621 . . . . 71.019999999999996 110.537 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 117' ' ' LEU . 6.1 t -106.71 160.19 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.773 -0.194 . . . . 50.329999999999998 111.349 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.36 57.34 12.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 72.140000000000001 109.941 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 10.3 Cg_endo -53.95 139.98 69.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.821 1.681 . . . . 72.340000000000003 110.662 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' PRO . 35.9 t0 -165.91 117.01 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.429 0.529 . . . . 52.030000000000001 112.429 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.857 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . . . -170.43 144.73 2.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.481 -0.781 . . . . 62.539999999999999 109.392 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 73.3 Cg_endo -83.12 -14.56 35.05 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.483 -1.049 . . . . 74.340000000000003 111.759 0.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 70' ' ' ASP . 9.9 t -164.92 154.12 12.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.106 -0.952 . . . . 63.530000000000001 109.715 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.687 ' NE ' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.59 -1.83 12.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.927 -0.579 . . . . 74.519999999999996 111.719 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.687 HE21 ' NE ' ' A' ' 68' ' ' ARG . 85.0 mm-40 -86.34 -45.13 11.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.395 -0.366 . . . . 74.129999999999995 111.756 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.407 ' H ' HG23 ' A' ' 67' ' ' THR . 36.3 t70 -144.4 96.63 5.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 73.140000000000001 109.787 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.23 57.13 4.61 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.347 2.031 . . . . 74.530000000000001 113.047 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -54.35 -37.43 64.91 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 121.038 -0.265 . . . . 73.439999999999998 111.489 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.636 ' HB2' HD21 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -149.41 77.21 1.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.11 0.957 . . . . 73.25 110.072 177.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.5 ttt180 -98.72 109.78 22.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.053 -1.43 . . . . 71.150000000000006 110.415 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.857 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 23.3 mt-10 -108.0 178.06 4.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.033 1.333 . . . . 75.439999999999998 110.61 -0.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.738 ' CD1' ' HB1' ' A' ' 65' ' ' ALA . 1.6 mp -75.64 -58.34 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.73 -0.841 . . . . 64.209999999999994 108.73 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 76' ' ' ILE . 1.4 mm? -140.56 -171.05 3.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.255 -1.339 . . . . 62.030000000000001 108.263 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 p80 176.27 156.92 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.4 -0.222 . . . . 65.329999999999998 110.4 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.731 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 1.2 t-105 -100.12 111.57 23.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.218 0.533 . . . . 73.400000000000006 110.041 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 16.3 m -127.93 125.34 39.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.503 -0.771 . . . . 71.140000000000001 110.704 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -147.66 125.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.497 -0.774 . . . . 70.329999999999998 110.441 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 57' ' ' THR . 27.4 m -126.66 174.44 10.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.053 0.454 . . . . 74.340000000000003 111.498 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.742 ' O ' HD22 ' A' ' 55' ' ' LEU . 13.8 p30 54.02 40.24 31.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.956 -1.02 . . . . 65.120000000000005 111.019 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.967 HD13 ' HA3' ' A' ' 94' ' ' GLY . 7.4 mm -77.89 122.23 85.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.976 -0.749 . . . . 72.239999999999995 108.976 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.74 127.77 25.67 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 121.934 1.756 . . . . 62.32 112.323 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.92 58.65 0.08 OUTLIER Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.416 0.448 . . . . 72.349999999999994 113.542 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -168.06 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.143 0.577 . . . . 64.25 109.664 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.475 ' C ' ' H ' ' A' ' 90' ' ' ASN . 73.1 m-80 -135.13 -16.1 1.92 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 64.329999999999998 112.134 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 71.57 -36.23 0.35 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 72.150000000000006 111.338 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 88' ' ' ASN . 8.5 p30 -129.22 152.55 79.63 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.088 0.47 . . . . 72.230000000000004 110.254 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.828 ' HB2' HG21 ' A' ' 81' ' ' VAL . 80.4 Cg_endo -70.82 52.47 1.35 Allowed 'Trans proline' 0 N--CA 1.473 0.307 0 C-N-CA 123.572 2.848 . . . . 62.109999999999999 113.602 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -104.24 -1.92 26.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.483 -0.487 . . . . 75.400000000000006 111.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.21 -42.12 1.32 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.953 -0.642 . . . . 52.200000000000003 113.51 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.967 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.57 172.59 13.44 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 120.871 -0.68 . . . . 43.020000000000003 113.136 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.516 ' HB3' HD21 ' A' ' 83' ' ' ASN . 72.2 t60 -66.19 130.82 44.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.745 0.307 . . . . 73.019999999999996 111.73 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.731 ' HA ' HG12 ' A' ' 81' ' ' VAL . 36.8 m -87.21 102.63 14.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.837 -0.801 . . . . 62.43 108.837 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 147' ' ' PHE . 94.0 mt -62.68 -37.44 86.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.539 0.685 . . . . 73.329999999999998 109.655 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.56 127.28 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.711 -1.131 . . . . 72.319999999999993 108.653 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -55.38 152.34 8.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.285 0.846 . . . . 61.039999999999999 113.285 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 3.1 p90 -83.67 142.61 30.65 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.394 -0.821 . . . . 53.43 112.836 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 100' ' ' TYR . 5.2 m -158.35 113.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 64.209999999999994 111.346 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.83 2.81 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 44.329999999999998 112.297 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.449 ' OG ' HG13 ' A' ' 170' ' ' VAL . 29.3 t -172.03 49.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.925 0.343 . . . . 75.329999999999998 111.925 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.87 -75.68 0.61 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.465 -1.054 . . . . 75.409999999999997 110.465 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.712 ' HB2' HG21 ' A' ' 109' ' ' THR . 15.8 Cg_exo -74.17 123.5 8.35 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.941 2.427 . . . . 61.520000000000003 111.49 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.523 ' O ' HG22 ' A' ' 109' ' ' THR . 31.6 Cg_exo -59.01 159.35 21.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.862 2.375 . . . . 75.310000000000002 112.978 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 168' ' ' ASP . 18.4 pttp -43.66 -20.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.949 -0.569 . . . . 64.450000000000003 111.322 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 106' ' ' PRO . 29.8 t70 -50.42 -46.54 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.223 -0.444 . . . . 72.510000000000005 110.41 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.712 HG21 ' HB2' ' A' ' 105' ' ' PRO . 4.2 t -79.54 -4.04 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.152 -0.476 . . . . 73.040000000000006 111.519 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.75 -101.18 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.184 -1.167 . . . . 42.049999999999997 110.184 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 163' ' ' GLN . 17.5 tp -66.66 112.17 4.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.945 -0.391 . . . . 71.120000000000005 109.945 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 10.9 p80 -109.83 92.1 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.988 0.423 . . . . 73.430000000000007 110.303 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.502 ' NE ' ' H ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -58.67 130.57 47.5 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.62 -0.718 . . . . 75.430000000000007 110.583 -179.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.06 128.54 45.11 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 120.95 0.405 . . . . 72.519999999999996 109.916 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 161' ' ' TYR . 4.7 mm -115.86 141.83 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.446 -0.797 . . . . 71.349999999999994 111.286 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.25 141.46 48.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.937 -0.574 . . . . 72.099999999999994 110.245 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.707 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 5.5 tt -124.5 140.39 52.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.374 . . . . 74.219999999999999 110.72 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 117' ' ' LEU . 60.2 tp -130.29 134.04 46.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.668 -0.696 . . . . 73.430000000000007 110.583 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HA ' HG12 ' A' ' 157' ' ' ILE . 66.8 t80 -144.14 139.49 28.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.207 0.527 . . . . 65.439999999999998 111.295 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -68.78 135.35 51.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 44.229999999999997 111.544 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 121' ' ' GLN . 3.5 tp60 -119.8 127.62 52.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.576 -0.527 . . . . 42.140000000000001 109.576 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.499 ' C ' HD22 ' A' ' 123' ' ' ASN . 62.9 tt0 -109.09 -8.57 15.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.63 -0.714 . . . . 71.310000000000002 111.332 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.499 HD22 ' C ' ' A' ' 122' ' ' GLU . 4.3 m120 -125.81 148.86 49.0 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.817 0.341 . . . . 73.040000000000006 111.809 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.805 ' HD2' HD11 ' A' ' 55' ' ' LEU . 13.2 mmmm -76.69 149.15 36.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 53.340000000000003 110.14 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.62 143.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 111.994 0.368 . . . . 62.219999999999999 111.994 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -81.07 -16.15 54.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.655 -0.702 . . . . 73.409999999999997 111.355 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 95' ' ' HIS . 0.0 OUTLIER 4.81 60.65 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.295 1.591 . . . . 74.409999999999997 115.295 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 126' ' ' GLU . 25.7 p 51.78 150.9 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 115.213 1.56 . . . . 74.150000000000006 115.213 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.82 158.19 29.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.659 2.906 . . . . 74.109999999999999 112.532 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -58.79 141.33 53.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.247 -0.433 . . . . 70.230000000000004 111.58 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 131' ' ' ILE . 16.4 mm -119.63 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.117 0.484 . . . . 64.030000000000001 111.673 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.7 m -87.38 143.03 27.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.551 -0.75 . . . . 73.310000000000002 111.244 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -51.86 -37.21 51.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.001 0.429 . . . . 72.120000000000005 110.817 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.62 ' HA ' HD13 ' A' ' 177' ' ' ILE . 46.9 p -70.29 12.87 0.2 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.654 0.613 . . . . 73.409999999999997 112.654 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' THR . 14.7 t -68.48 123.94 22.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 74.450000000000003 110.507 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.555 ' H ' ' CA ' ' A' ' 179' ' ' GLY . 27.3 ttt-85 -62.89 165.67 6.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.221 -0.445 . . . . 63.100000000000001 111.344 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.424 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 11.6 m -37.34 155.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.121 -0.945 . . . . 72.140000000000001 111.873 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.0 -3.25 20.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.973 -0.632 . . . . 74.439999999999998 111.819 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -165.54 41.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.168 0.509 . . . . 74.329999999999998 111.128 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.29 -64.62 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.027 -1.101 . . . . 65.140000000000001 108.027 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.636 HD21 ' HB2' ' A' ' 73' ' ' TYR . 2.1 m120 -73.0 114.9 11.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.484 -1.235 . . . . 75.540000000000006 109.636 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -148.21 135.65 20.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.001 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.548 HD22 ' HG3' ' A' ' 145' ' ' ARG . 19.0 p-10 -101.69 106.66 17.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 54.43 110.505 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -49.12 -37.05 20.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 35.329999999999998 111.243 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.548 ' HG3' HD22 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -49.4 -25.94 2.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.973 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -52.46 -52.64 53.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.623 -0.88 . . . . 73.200000000000003 108.623 177.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.581 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 4.6 m-85 -62.12 -29.58 70.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.058 -0.974 . . . . 72.439999999999998 110.194 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 145' ' ' ARG . . . -62.83 -37.05 85.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.457 -0.572 . . . . 63.140000000000001 109.457 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.17 39.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.708 -0.678 . . . . 74.129999999999995 111.182 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.581 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 3.7 ptpp? -66.58 -49.45 66.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.199 0.444 . . . . 75.420000000000002 112.199 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.698 ' ND1' HD21 ' A' ' 153' ' ' LEU . 22.0 t-160 -86.83 3.12 46.6 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.199 -0.313 . . . . 73.040000000000006 111.222 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 58.63 34.12 75.16 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.113 -0.565 . . . . 75.340000000000003 113.565 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.698 HD21 ' ND1' ' A' ' 151' ' ' HIS . 18.1 mt -68.27 16.55 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 122.739 0.415 . . . . 63.009999999999998 112.072 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -52.68 -33.8 42.56 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.549 -0.834 . . . . 61.43 112.765 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.7 78.74 0.13 Allowed Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.3 0.24 . . . . 71.420000000000002 111.441 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 154' ' ' GLY . 32.5 Cg_endo -61.56 130.4 31.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 121.526 1.484 . . . . 71.420000000000002 111.549 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 119' ' ' TYR . 26.9 pt -81.03 -34.85 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 120.603 -0.439 . . . . 72.530000000000001 110.126 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -150.35 161.03 43.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 111.466 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -161.09 173.76 14.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.784 -0.643 . . . . 62.5 110.528 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -171.03 135.14 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.581 -0.896 . . . . 63.240000000000002 108.581 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.665 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -136.97 149.01 47.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.586 -0.279 . . . . 73.329999999999998 111.657 -177.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 1.7 p90 -142.25 152.61 43.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.8 -0.636 . . . . 71.510000000000005 111.264 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 111' ' ' LEU . 60.1 mt-30 -113.98 124.85 53.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.669 -0.493 . . . . 72.530000000000001 109.669 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' HB3' ' HE1' ' A' ' 162' ' ' TYR . . . -155.18 148.51 24.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 74.310000000000002 111.694 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.81 177.46 4.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.608 -0.724 . . . . 72.219999999999999 109.602 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.615 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -162.18 -135.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.05 -0.26 . . . . 74.019999999999996 110.409 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 169' ' ' TYR . 44.7 m-20 -144.3 164.23 31.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.014 0.435 . . . . 72.310000000000002 111.532 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.578 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 36.8 t70 -67.16 12.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.579 -0.737 . . . . 74.519999999999996 110.154 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 167' ' ' ASP . 45.7 t80 -84.4 -46.6 11.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.397 -0.819 . . . . 74.549999999999997 111.592 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' A' ' 171' ' ' PRO . 13.1 p -67.72 -34.31 6.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.523 0.564 . . . . 65.439999999999998 112.523 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' A' ' 170' ' ' VAL . 42.4 Cg_exo -58.12 -22.92 58.61 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.96 1.773 . . . . 75.040000000000006 111.882 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.83 -31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 73.329999999999998 111.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.29 -33.79 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.693 0.282 . . . . 73.129999999999995 111.291 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 177' ' ' ILE . 12.3 p30 -47.57 -36.34 10.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 63.009999999999998 110.727 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -52.09 -31.81 32.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 111.385 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 77.4 p -79.98 15.75 1.38 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.912 0.386 . . . . 70.230000000000004 111.666 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 134' ' ' THR . 10.6 mm -73.04 135.04 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.323 -0.398 . . . . 74.409999999999997 110.057 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.7 -21.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.275 0.843 . . . . 74.450000000000003 113.275 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.555 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.409 -1.217 . . . . 74.230000000000004 112.49 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 ttp . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.513 0.197 . . . . 71.239999999999995 110.603 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.418 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.0 m-20 -62.21 113.32 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.164 -0.68 . . . . 51.329999999999998 109.164 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.91 -71.53 0.76 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.925 0.713 . . . . 65.439999999999998 112.925 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -82.69 48.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.407 0.622 . . . . 60.409999999999997 112.05 -179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 9.9 p -120.21 143.32 35.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 75.230000000000004 110.992 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 58.5 Cg_endo -97.19 26.2 19.76 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 124.712 -0.954 . . . . 74.340000000000003 112.215 0.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.79 -41.76 98.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 72.340000000000003 110.967 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 9' ' ' LEU . 16.9 m -152.7 -51.53 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 113.409 0.892 . . . . 75.109999999999999 113.409 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 115' ' ' ILE . 55.0 tp -157.61 141.49 15.87 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.146 0.498 . . . . 75.329999999999998 112.275 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -74.9 36.53 0.11 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.89 -0.596 . . . . 73.420000000000002 110.948 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 13' ' ' PRO . . . 178.33 145.58 0.13 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.466 -0.333 . . . . 63.509999999999998 111.047 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 4' ' ' ILE . 55.8 t -92.54 102.38 6.59 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.283 -0.417 . . . . 74.239999999999995 111.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -72.97 136.88 25.73 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.868 2.379 . . . . 75.219999999999999 113.007 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.03 -28.83 67.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.909 -0.587 . . . . 52.25 110.108 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.54 -133.59 3.15 Favored Glycine 0 CA--C 1.521 0.418 0 CA-C-N 115.302 -0.863 . . . . 64.120000000000005 111.486 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.559 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 10.2 t -163.7 177.57 8.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.611 0.719 . . . . 74.409999999999997 111.758 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 118' ' ' LEU . 26.6 mt -124.24 143.96 35.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.094 . . . . 54.200000000000003 108.084 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 5.7 mtpm? -107.64 102.85 12.06 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.381 -0.528 . . . . 44.030000000000001 111.58 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.685 ' HB ' HG22 ' A' ' 27' ' ' VAL . 63.1 t -103.18 110.59 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.485 -0.779 . . . . 73.129999999999995 109.633 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.694 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 62.7 mt -95.24 114.9 32.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.43 -0.805 . . . . 72.030000000000001 110.647 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -82.53 -85.23 0.11 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.155 -0.475 . . . . 72.239999999999995 112.1 -178.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -68.15 2.97 6.11 Favored Glycine 0 N--CA 1.461 0.34 0 CA-C-N 116.117 -0.492 . . . . 75.319999999999993 113.596 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.694 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 13.6 t70 78.92 -41.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.232 -0.655 . . . . 75.340000000000003 109.232 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' GLY . 4.1 t70 -74.02 -27.93 61.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.155 -0.929 . . . . 71.400000000000006 109.725 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.5 pt? -124.93 -174.35 3.02 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.402 0.62 . . . . 73.230000000000004 112.157 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 18.2 pt-20 -156.97 157.79 35.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.319 -0.855 . . . . 63.509999999999998 111.038 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.2 m -85.35 143.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.958 0.408 . . . . 71.319999999999993 111.689 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 50.1 mttp -144.2 126.81 16.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.466 0.65 . . . . 74.329999999999998 112.047 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.3 mp0 35.09 61.75 0.6 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.344 1.238 . . . . 73.209999999999994 114.344 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.38 16.94 55.62 Favored Glycine 0 CA--C 1.512 -0.155 0 CA-C-N 115.859 -0.61 . . . . 43.109999999999999 114.247 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.616 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -57.89 156.52 8.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.104 0.478 . . . . 75.430000000000007 111.042 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 33' ' ' LEU . 28.7 tt0 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 73.409999999999997 110.125 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.4 mp -105.41 130.51 53.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.338 -0.392 . . . . 73.040000000000006 110.124 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -146.92 158.37 45.41 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.566 . . . . 75.549999999999997 110.502 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -92.82 121.98 3.62 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.257 -1.143 . . . . 73.340000000000003 113.266 0.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.8 p 44.44 25.9 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.842 -0.617 . . . . 60.130000000000003 112.551 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 39' ' ' LYS . 12.0 pt20 -80.3 0.1 34.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.098 0.475 . . . . 75.319999999999993 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' A' ' 33' ' ' LEU . 35.8 m -73.24 26.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.879 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -106.15 -9.12 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.959 -0.564 . . . . 64.329999999999998 111.58 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -84.54 148.79 26.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.218 0.532 . . . . 70.219999999999999 111.79 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.4 pm0 -63.02 133.14 95.3 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.631 -0.713 . . . . 71.329999999999998 111.847 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 90.5 Cg_endo -85.37 128.74 3.6 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.868 2.379 . . . . 63.100000000000001 113.075 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 41.4 mm -103.32 105.92 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 64.549999999999997 110.419 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 17' ' ' ILE . 3.2 p -84.92 137.08 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.829 0.678 . . . . 71.040000000000006 112.829 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.6 m -165.33 137.0 4.09 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.84 0.311 . . . . 54.210000000000001 111.84 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.536 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p90 -107.53 12.51 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.283 -0.417 . . . . 75.510000000000005 109.995 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.3 t -31.95 115.91 0.18 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.103 -0.953 . . . . 73.5 112.204 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 108.7 -30.66 8.53 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 74.099999999999994 112.661 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 16' ' ' THR . 39.4 mt -85.12 -35.52 21.72 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.97 0.414 . . . . 64.519999999999996 110.663 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 16.1 pm0 -56.59 -171.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.764 -0.653 . . . . 74.25 110.165 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.16 -77.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.102 -1.047 . . . . 65.310000000000002 112.662 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -148.49 111.24 4.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.414 0.626 . . . . 72.129999999999995 110.867 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 m -157.34 147.34 20.67 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.632 -0.877 . . . . 71.129999999999995 108.632 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -64.69 -41.84 95.76 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.675 0.75 . . . . 61.240000000000002 109.606 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 35.7 mt -155.91 178.07 10.69 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.249 -1.341 . . . . 72.109999999999999 110.031 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 120' ' ' ARG . 89.3 mt -140.93 163.79 32.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.087 -0.708 . . . . 72.140000000000001 109.087 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 1.009 HG23 HG12 ' A' ' 82' ' ' VAL . 58.1 m -135.05 119.63 18.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.836 0.35 . . . . 75.239999999999995 111.115 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 tm? -107.41 110.89 22.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.627 -0.715 . . . . 60.32 109.234 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.545 HD11 HD12 ' A' ' 153' ' ' LEU . 81.0 mt -115.89 137.11 52.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 70.439999999999998 111.22 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.488 ' HG3' ' HB2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.89 146.77 23.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.739 -0.664 . . . . 73.049999999999997 110.444 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 99.0 t -141.62 118.37 7.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.391 0.615 . . . . 63.32 111.033 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.603 ' H ' ' HD3' ' A' ' 63' ' ' PRO . 22.2 t70 173.03 48.84 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.673 -1.149 . . . . 63.299999999999997 108.375 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HD3' ' H ' ' A' ' 62' ' ' ASP . 58.3 Cg_endo -70.0 83.87 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.045 1.83 . . . . 75.209999999999994 113.824 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -145.93 101.22 3.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.078 -0.965 . . . . 63.5 109.09 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -166.14 136.69 2.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.934 0.397 . . . . 73.329999999999998 111.482 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 14.8 Cg_exo -71.12 -5.17 10.89 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 123.56 -1.433 . . . . 70.409999999999997 111.313 -0.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 146.29 7.34 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.245 -0.888 . . . . 70.340000000000003 110.222 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' HD2' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -64.04 -15.47 59.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.078 0.466 . . . . 65.109999999999999 110.408 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.693 HE21 ' HD2' ' A' ' 68' ' ' ARG . 88.2 mm-40 -92.01 -23.32 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.728 -0.669 . . . . 74.420000000000002 111.979 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 10.1 t70 -144.13 73.96 16.11 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.823 0.344 . . . . 75.299999999999997 110.241 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.87 62.54 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.434 2.756 . . . . 74.239999999999995 112.406 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -48.86 -36.48 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.928 -0.578 . . . . 65.219999999999999 111.511 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 5.9 p90 -165.01 48.98 0.1 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.11 0.481 . . . . 74.129999999999995 111.51 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HG2' ' CA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -81.2 144.06 31.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.226 -0.657 . . . . 75.0 109.226 177.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.454 ' CA ' ' HG2' ' A' ' 74' ' ' ARG . 39.0 mt-10 -89.91 163.74 14.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.044 0.938 . . . . 64.349999999999994 111.297 0.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.658 HG22 ' H ' ' A' ' 77' ' ' LEU . 21.2 mm -84.76 -129.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 107.182 -1.414 . . . . 75.120000000000005 107.182 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.658 ' H ' HG22 ' A' ' 76' ' ' ILE . 49.9 mt -86.84 151.67 23.14 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 0.0 OUTLIER -149.65 160.93 43.11 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 121.075 -0.25 . . . . 74.120000000000005 111.075 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.403 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 1.4 t-105 -100.31 79.8 2.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.659 0.743 . . . . 75.329999999999998 111.025 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 97' ' ' LEU . 24.5 p -94.67 133.25 38.53 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.664 -1.153 . . . . 74.129999999999995 110.92 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -144.72 138.42 22.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 120.728 -0.389 . . . . 73.340000000000003 111.19 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.009 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.21 167.74 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.191 -0.459 . . . . 62.100000000000001 110.645 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' O ' HD22 ' A' ' 55' ' ' LEU . 1.7 m-20 64.24 33.12 11.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.528 -0.305 . . . . 71.310000000000002 111.413 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.023 HD13 ' HA3' ' A' ' 94' ' ' GLY . 15.6 mm -80.78 124.14 81.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.613 -0.514 . . . . 73.209999999999994 109.613 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.595 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 51.5 Cg_exo -52.16 129.79 32.6 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.292 1.328 . . . . 71.409999999999997 110.98 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 56' ' ' LEU . . . -67.42 50.03 0.29 Allowed Glycine 0 CA--C 1.521 0.444 0 N-CA-C 114.739 0.656 . . . . 35.539999999999999 114.739 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t -176.73 32.56 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.402 0.601 . . . . 65.319999999999993 111.914 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.595 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 51.4 m-20 -113.19 0.55 14.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.567 0.222 . . . . 64.400000000000006 111.07 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 88' ' ' ASN . 51.9 mt-10 68.14 -34.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 64.239999999999995 112.276 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' ASN . 4.0 p30 -133.81 155.45 80.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.529 . . . . 65.120000000000005 111.447 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.624 ' HA ' HG21 ' A' ' 84' ' ' ILE . 91.9 Cg_endo -71.89 59.36 2.84 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.49 2.793 . . . . 54.409999999999997 113.267 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.1 m -104.29 -54.8 2.47 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.817 0.673 . . . . 63.539999999999999 112.817 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.11 -0.55 15.71 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 115.6 1.0 . . . . 64.150000000000006 115.6 -177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 1.023 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -100.34 176.43 27.8 Favored Glycine 0 N--CA 1.461 0.313 0 C-N-CA 120.423 -0.894 . . . . 73.120000000000005 113.258 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -70.46 121.34 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 74.109999999999999 111.284 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.596 ' HA ' HG13 ' A' ' 81' ' ' VAL . 43.7 m -80.99 96.94 7.26 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.336 -0.616 . . . . 73.450000000000003 109.336 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.638 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 43.7 mt -48.02 -50.13 28.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.304 0.573 . . . . 73.420000000000002 109.549 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -141.86 107.97 5.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.834 -1.075 . . . . 63.32 108.249 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.566 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 44.7 t0 -41.91 144.57 0.41 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.966 0.728 . . . . 73.200000000000003 112.966 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -60.59 139.85 57.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.89 -1.05 . . . . 74.430000000000007 112.137 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.592 ' O ' HG13 ' A' ' 101' ' ' VAL . 14.4 p -148.15 113.75 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.586 -0.734 . . . . 74.030000000000001 110.651 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.11 18.79 3.14 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 121.204 -0.522 . . . . 44.149999999999999 113.194 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.611 ' O ' HG12 ' A' ' 170' ' ' VAL . 80.1 p -69.18 -64.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.31 0.576 . . . . 73.030000000000001 111.083 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 163.7 15.33 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.516 -0.766 . . . . 62.149999999999999 112.601 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG2' HG21 ' A' ' 109' ' ' THR . 28.8 Cg_endo -60.88 160.49 25.18 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.046 2.497 . . . . 73.510000000000005 113.114 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 109' ' ' THR . 26.3 Cg_exo -63.6 161.3 32.37 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.665 2.91 . . . . 50.409999999999997 113.967 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -44.7 -37.81 3.97 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.342 -0.845 . . . . 64.219999999999999 111.828 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -50.83 -22.05 1.99 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.503 0.557 . . . . 65.099999999999994 112.503 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 106' ' ' PRO . 11.3 t -80.97 -25.45 37.32 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.558 0.948 . . . . 62.219999999999999 113.558 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 57.62 -163.91 7.47 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.577 -0.821 . . . . 62.020000000000003 112.444 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 39.7 tp -46.19 109.23 0.17 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.085 0.469 . . . . 62.109999999999999 111.745 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -113.2 142.52 45.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.732 -0.667 . . . . 72.540000000000006 109.691 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.584 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -95.55 88.08 4.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.704 . . . . 74.530000000000001 112.579 -177.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 9.8 t80 -73.5 120.13 18.67 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.127 -0.629 . . . . 74.109999999999999 109.513 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.837 HG21 HD13 ' A' ' 9' ' ' LEU . 25.9 mt -113.42 130.82 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.894 -0.594 . . . . 65.129999999999995 111.979 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -102.45 125.18 49.08 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.712 -0.676 . . . . 74.540000000000006 109.585 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 118' ' ' LEU . 6.5 tt -119.27 135.26 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.378 . . . . 74.409999999999997 110.498 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.675 ' N ' HD23 ' A' ' 117' ' ' LEU . 64.6 tp -119.46 136.39 54.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.718 -0.674 . . . . 62.32 110.47 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 153' ' ' LEU . 64.0 t80 -144.14 135.67 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.734 -0.666 . . . . 65.230000000000004 111.029 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.621 ' HA ' HD23 ' A' ' 56' ' ' LEU . 94.8 mtt180 -64.83 130.39 43.29 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.787 -0.365 . . . . 71.310000000000002 110.185 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.749 ' NE2' HD11 ' A' ' 125' ' ' ILE . 26.8 tt0 -107.74 127.48 53.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.556 -0.535 . . . . 70.409999999999997 109.556 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -99.84 -39.02 8.41 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.6 0.593 . . . . 75.420000000000002 112.6 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -102.8 136.91 41.76 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.181 0.808 . . . . 74.120000000000005 113.181 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' HD22 ' A' ' 83' ' ' ASN . 22.8 tptm -72.13 114.19 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.261 -0.881 . . . . 74.019999999999996 109.787 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.749 HD11 ' NE2' ' A' ' 121' ' ' GLN . 5.3 pt -115.71 132.59 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.006 -0.543 . . . . 62.329999999999998 112.178 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -59.18 -53.09 62.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.276 0.56 . . . . 65.450000000000003 109.977 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.736 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.0 mm-40 60.72 38.45 18.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.159 -0.928 . . . . 73.310000000000002 111.531 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 127' ' ' GLU . 41.0 p 54.84 149.84 0.05 OUTLIER Pre-proline 0 C--O 1.223 -0.322 0 O-C-N 123.741 0.651 . . . . 70.239999999999995 112.632 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.45 147.37 0.97 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.16 2.573 . . . . 75.209999999999994 112.755 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.502 ' CG2' ' HB2' ' A' ' 96' ' ' SER . 1.4 m -58.44 119.61 7.3 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 110.471 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 42.0 mm -80.89 133.06 30.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.461 -0.336 . . . . 61.009999999999998 110.653 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 134' ' ' THR . 29.0 t -73.95 148.01 42.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.967 -0.561 . . . . 73.109999999999999 111.143 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.566 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 19.7 p-10 -62.92 -41.24 99.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 73.319999999999993 109.994 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 12.2 t -75.02 22.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.626 -0.716 . . . . 74.310000000000002 110.974 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 133' ' ' ASN . 2.9 t -62.33 119.55 9.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.404 0.621 . . . . 61.200000000000003 112.627 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 137' ' ' THR . 23.5 tpt180 -65.48 167.3 8.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.931 -1.032 . . . . 70.200000000000003 110.621 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.808 ' HA ' HD11 ' A' ' 140' ' ' LEU . 11.0 m -44.47 151.04 0.29 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.012 -0.54 . . . . 61.299999999999997 111.521 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 139' ' ' ARG . . . 116.14 -8.86 18.27 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.974 -0.631 . . . . 43.0 113.605 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.526 ' H ' HD12 ' A' ' 140' ' ' LEU . 0.9 OUTLIER -152.87 50.72 0.74 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 117.399 0.599 . . . . 70.310000000000002 111.288 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.808 HD11 ' HA ' ' A' ' 137' ' ' THR . 1.0 OUTLIER -114.22 -56.82 2.35 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.617 -0.512 . . . . 62.32 109.617 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.0 OUTLIER -62.91 119.79 10.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.703 -0.68 . . . . 70.299999999999997 111.165 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.3 t80 175.46 133.48 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.957 -0.565 . . . . 72.140000000000001 110.081 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.588 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -80.6 124.06 28.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.992 0.425 . . . . 73.120000000000005 111.915 -179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.91 96.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.453 -0.34 . . . . 53.240000000000002 111.808 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -46.49 -27.39 1.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 63.399999999999999 111.714 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.588 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 28.3 t70 -56.92 -42.75 80.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.602 -0.272 . . . . 72.420000000000002 111.47 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 24.3 m-85 -54.94 -38.14 67.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.59 0.71 . . . . 75.299999999999997 109.531 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -70.83 -41.13 71.9 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.078 -0.965 . . . . 54.100000000000001 110.55 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.39 -47.64 78.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.279 -0.419 . . . . 64.310000000000002 111.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.37 -53.25 59.82 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.056 0.761 . . . . 73.219999999999999 113.056 -178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.542 ' HB3' HD21 ' A' ' 153' ' ' LEU . 18.1 t-80 -94.69 11.64 30.55 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 119.8 -0.76 . . . . 61.340000000000003 111.716 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.51 94.61 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.676 -0.773 . . . . 74.340000000000003 113.837 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.781 HD13 HG21 ' A' ' 57' ' ' THR . 9.5 mt -79.78 16.02 1.24 Allowed 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.618 -0.342 . . . . 74.299999999999997 110.469 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -36.65 -72.43 0.15 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.701 -0.681 . . . . 75.140000000000001 114.766 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.52 113.09 16.69 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 117.05 0.425 . . . . 61.5 111.316 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.19 134.82 10.55 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.805 2.337 . . . . 74.439999999999998 113.424 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.607 HD13 ' HG3' ' A' ' 120' ' ' ARG . 43.1 pt -75.85 -37.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.44 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 16' ' ' THR . . . -152.03 134.92 15.62 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.612 -0.267 . . . . 65.519999999999996 110.734 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -140.0 151.83 45.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 75.209999999999994 111.301 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.507 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.4 t-20 -154.15 142.37 20.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.698 -1.223 . . . . 73.540000000000006 107.698 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.648 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -146.8 162.99 37.45 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.461 0.541 . . . . 73.329999999999998 112.461 -176.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.4 p90 -154.28 153.81 32.32 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.263 -0.88 . . . . 73.340000000000003 110.875 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.495 ' HG2' ' HB3' ' A' ' 113' ' ' ARG . 52.3 mt-30 -110.86 135.07 51.97 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.953 -0.388 . . . . 71.120000000000005 109.953 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.417 ' CA ' HD12 ' A' ' 111' ' ' LEU . . . -155.47 149.48 25.58 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.918 1.081 . . . . 51.530000000000001 113.918 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.4 OUTLIER -137.61 157.34 46.71 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.359 -1.292 . . . . 71.200000000000003 107.825 177.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.92 167.53 20.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 74.030000000000001 111.864 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 169' ' ' TYR . 53.3 m-20 -56.68 150.12 16.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.328 -0.851 . . . . 74.409999999999997 111.327 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.651 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 19.3 t0 -54.79 -8.87 0.28 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 72.329999999999998 110.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.455 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 22.2 t80 -60.02 -40.98 91.2 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.905 -0.589 . . . . 75.329999999999998 111.221 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.703 HG13 ' NH1' ' A' ' 173' ' ' ARG . 21.5 t -63.66 -53.84 47.49 Favored Pre-proline 0 C--O 1.235 0.308 0 N-CA-C 109.464 -0.569 . . . . 74.549999999999997 109.464 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 50.9 Cg_exo -52.01 -31.62 44.88 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.872 1.715 . . . . 74.340000000000003 111.79 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 168' ' ' ASP . 50.7 mt -50.46 -34.52 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 116.495 -0.321 . . . . 75.129999999999995 110.431 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 1.015 ' O ' HG22 ' A' ' 176' ' ' THR . 0.0 OUTLIER -47.94 -37.69 14.94 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.647 -0.501 . . . . 73.129999999999995 109.647 178.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -56.46 -35.63 68.13 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.109 -0.496 . . . . 74.549999999999997 111.454 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 12.9 mptt -57.37 -33.23 67.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.368 -0.207 . . . . 62.200000000000003 111.422 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 1.015 HG22 ' O ' ' A' ' 173' ' ' ARG . 10.9 t -69.59 -10.3 57.61 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.617 -0.433 . . . . 74.329999999999998 111.254 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.637 ' CD1' HD11 ' A' ' 77' ' ' LEU . 83.8 mt -63.62 127.23 23.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.562 -0.29 . . . . 61.310000000000002 110.529 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.25 3.31 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.169 0.433 . . . . 74.519999999999996 112.169 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.271 0 CA-C-O 118.396 -1.225 . . . . 44.240000000000002 112.519 -179.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' SD ' ' NH2' ' A' ' 145' ' ' ARG . 61.1 tpp . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.552 -0.166 . . . . 73.030000000000001 110.552 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -64.12 103.47 0.61 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.188 0.305 . . . . 74.319999999999993 110.557 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -109.8 -72.86 0.7 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.891 0.7 . . . . 60.32 112.891 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.3 pt -89.15 53.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.594 0.712 . . . . 52.549999999999997 111.588 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HB ' ' HA ' ' A' ' 10' ' ' ASP . 8.8 p -135.13 139.31 31.45 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.095 -0.957 . . . . 73.099999999999994 110.459 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HA ' HG23 ' A' ' 5' ' ' VAL . 78.0 Cg_endo -83.98 35.69 2.62 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.83 -1.321 . . . . 75.319999999999993 113.177 0.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.4 t0 -61.38 -52.56 64.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.238 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 7' ' ' ASP . 15.8 m -158.88 -39.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 65.140000000000001 111.789 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.716 HD23 ' HD3' ' A' ' 13' ' ' PRO . 15.9 tp -157.34 140.22 15.12 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.319 0.581 . . . . 72.530000000000001 111.444 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 3.5 p-10 -58.82 -26.74 64.42 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 112.169 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.96 130.93 13.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.743 0.306 . . . . 72.030000000000001 111.407 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 12' ' ' VAL . 8.2 p -65.82 115.12 19.68 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.15 -0.477 . . . . 61.5 110.571 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.716 ' HD3' HD23 ' A' ' 9' ' ' LEU . 31.7 Cg_endo -94.22 143.94 1.72 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.965 2.443 . . . . 74.239999999999995 112.174 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.9 -30.84 47.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.39 0.614 . . . . 41.009999999999998 110.026 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -154.3 -166.96 15.62 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.819 -1.082 . . . . 73.140000000000001 110.63 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 9.7 t -121.99 172.95 7.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.498 0.649 . . . . 74.209999999999994 111.183 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.59 HG13 ' HB1' ' A' ' 158' ' ' ALA . 6.4 mt -105.47 128.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 75.439999999999998 110.426 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 3.2 mmmp? -73.8 107.07 5.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.915 -0.772 . . . . 70.340000000000003 108.915 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 27' ' ' VAL . 61.2 t -123.0 109.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 60.210000000000001 110.689 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 25' ' ' LEU . 39.2 mt -100.93 123.11 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.183 -0.917 . . . . 62.009999999999998 109.871 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.98 -36.54 64.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.581 -0.736 . . . . 60.0 111.877 -178.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.81 -63.07 0.15 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 120.232 -0.985 . . . . 73.019999999999996 112.675 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -166.81 -61.21 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.522 -0.547 . . . . 73.329999999999998 109.522 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.98 -48.88 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 110.67 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.6 pp -69.57 147.74 50.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.415 0.626 . . . . 73.209999999999994 111.602 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 11.3 tt0 -143.37 144.95 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.525 -0.761 . . . . 75.25 110.699 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 19' ' ' VAL . 24.3 m -79.93 106.37 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.513 -0.551 . . . . 71.549999999999997 109.513 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 56.2 mttm -103.64 124.75 49.4 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.179 1.177 . . . . 70.540000000000006 114.179 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.4 mp0 26.9 67.45 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.985 1.476 . . . . 54.439999999999998 114.985 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' CA ' ' CD2' ' A' ' 161' ' ' TYR . . . 74.76 5.56 74.82 Favored Glycine 0 CA--C 1.51 -0.241 0 N-CA-C 115.083 0.793 . . . . 42.200000000000003 115.083 176.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -57.12 161.95 2.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.591 0.696 . . . . 70.239999999999995 110.029 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.509 ' CD ' HE22 ' A' ' 165' ' ' GLN . 32.5 tt0 -109.8 143.71 39.26 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 72.510000000000005 110.389 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 32' ' ' GLU . 9.5 mp -116.35 120.16 37.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.76 -0.459 . . . . 74.510000000000005 109.76 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.0 OUTLIER -150.49 163.92 22.36 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.846 -0.616 . . . . 72.109999999999999 110.082 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 94.4 Cg_endo -86.92 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.772 -1.345 . . . . 73.230000000000004 112.841 0.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.415 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 70.2 p -104.27 22.62 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.55 -0.295 . . . . 74.319999999999993 111.686 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -81.79 -7.64 59.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.317 -0.553 . . . . 70.209999999999994 110.061 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 24.6 m -91.29 26.23 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.893 -0.594 . . . . 72.25 111.642 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.49 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -85.71 -14.57 44.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 110.648 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.3 141.44 28.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.805 -0.634 . . . . 73.239999999999995 112.487 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.17 134.89 95.99 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 115.513 -0.767 . . . . 65.420000000000002 110.849 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.2 Cg_endo -73.5 135.88 22.85 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.881 2.388 . . . . 71.299999999999997 113.508 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 48.5 mm -107.19 125.83 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.427 -0.352 . . . . 73.25 110.423 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.1 p -98.54 146.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.391 0.515 . . . . 65.239999999999995 112.391 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -165.12 146.49 7.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.132 0.492 . . . . 65.439999999999998 111.579 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HH2' HG21 ' A' ' 84' ' ' ILE . 5.2 p90 -121.39 29.9 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.402 -0.592 . . . . 71.310000000000002 109.402 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 t -43.29 131.21 4.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.603 -0.726 . . . . 55.210000000000001 110.696 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.16 -35.76 3.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 64.099999999999994 112.683 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -72.24 -33.87 67.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.557 0.694 . . . . 72.340000000000003 109.341 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.5 tt0 -58.06 142.08 47.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.163 -0.926 . . . . 74.400000000000006 109.194 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.29 -65.74 0.02 OUTLIER Glycine 0 C--O 1.228 -0.223 0 C-N-CA 120.036 -1.078 . . . . 45.200000000000003 112.863 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -148.74 109.34 4.21 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.838 0.352 . . . . 55.409999999999997 110.162 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m -158.36 141.17 14.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.104 -0.498 . . . . 71.430000000000007 110.528 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -70.15 -40.42 74.78 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.198 0.999 . . . . 63.329999999999998 108.328 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 83' ' ' ASN . 27.1 mt -155.16 161.26 41.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.76 -1.564 . . . . 74.230000000000004 109.269 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 60.9 mt -125.07 146.54 49.4 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.178 0.514 . . . . 61.420000000000002 110.358 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.726 HG21 HD21 ' A' ' 153' ' ' LEU . 4.2 m -106.91 127.35 53.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.744 . . . . 74.120000000000005 109.993 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' VAL . 1.3 tm? -130.93 118.5 20.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.363 -0.606 . . . . 75.219999999999999 109.363 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD13 ' CG ' ' A' ' 147' ' ' PHE . 70.4 mt -149.36 132.09 15.96 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 119.968 -0.693 . . . . 74.329999999999998 112.043 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 48.3 ttp -94.73 148.4 22.32 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.731 -0.841 . . . . 73.530000000000001 108.731 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.456 HG22 ' HB1' ' A' ' 144' ' ' ALA . 52.9 t -139.33 145.02 27.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.534 0.683 . . . . 74.129999999999995 112.57 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -175.9 82.93 0.29 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 114.067 -1.424 . . . . 74.310000000000002 109.361 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.52 84.39 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.8 2.333 . . . . 72.209999999999994 111.84 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.597 ' CB ' HH12 ' A' ' 113' ' ' ARG . 3.2 t0 -170.22 122.5 0.67 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.753 0.649 . . . . 73.349999999999994 112.753 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 1.034 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -173.13 130.74 0.58 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.97 -0.292 . . . . 72.310000000000002 111.554 175.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.06 -12.54 24.12 Favored 'Cis proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.257 -1.56 . . . . 62.109999999999999 109.025 -4.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.4 t -151.99 142.82 22.95 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.992 -1.458 . . . . 72.010000000000005 109.661 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -58.87 -31.13 68.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.958 0.408 . . . . 75.329999999999998 110.751 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -60.32 -41.62 93.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.442 -0.799 . . . . 73.230000000000004 111.819 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 28.1 m-20 -138.1 71.3 48.05 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.449 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 27.6 Cg_exo -61.29 112.65 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.242 1.961 . . . . 72.019999999999996 111.122 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -101.27 -51.43 3.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.86 0.362 . . . . 71.019999999999996 111.631 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.034 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 18.3 p90 -116.24 24.81 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 75.099999999999994 109.997 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 1.3 tmt_? -73.84 138.03 44.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.154 -0.93 . . . . 63.25 109.643 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 143' ' ' ASN . 4.9 mm-40 -75.11 170.12 16.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.63 1.172 . . . . 64.109999999999999 111.346 0.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.756 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.8 tp -119.27 168.38 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.456 -0.338 . . . . 75.5 111.189 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' N ' HG13 ' A' ' 76' ' ' ILE . 73.2 mt -54.83 133.72 47.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.357 0.598 . . . . 65.150000000000006 111.747 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER -135.8 -169.38 2.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.183 -0.917 . . . . 72.120000000000005 109.119 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.486 ' HA ' ' HE3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -98.6 104.47 16.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.219 -1.03 . . . . 71.340000000000003 108.219 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.729 ' HA ' HD23 ' A' ' 59' ' ' LEU . 1.5 m -119.0 117.37 28.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.634 -0.712 . . . . 73.120000000000005 110.985 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 96' ' ' SER . 1.7 t -141.73 130.18 22.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 74.010000000000005 109.405 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.801 HG21 ' HG3' ' A' ' 127' ' ' GLU . 32.2 m -141.69 166.95 16.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.057 0.456 . . . . 70.019999999999996 111.559 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.689 ' O ' HD22 ' A' ' 55' ' ' LEU . 22.9 p30 64.16 39.22 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.655 -1.157 . . . . 73.150000000000006 109.524 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.983 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.8 mm -77.2 115.44 48.94 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 114.408 -1.269 . . . . 72.310000000000002 108.991 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' SER . 51.0 Cg_exo -53.1 127.67 25.97 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.692 1.594 . . . . 74.519999999999996 111.774 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.43 69.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.33 -0.462 . . . . 73.439999999999998 112.854 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 85' ' ' PRO . 29.3 t 177.31 48.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.66 0.384 . . . . 65.530000000000001 110.097 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 90' ' ' ASN . 70.2 m-80 -135.68 -22.36 1.46 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.029 0.752 . . . . 60.149999999999999 113.029 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 70.87 -22.18 0.19 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.867 0.365 . . . . 74.200000000000003 110.784 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.537 ' H ' ' C ' ' A' ' 88' ' ' ASN . 10.3 p30 -152.17 158.16 33.77 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 115.873 -0.603 . . . . 64.530000000000001 109.575 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 44' ' ' VAL . 81.9 Cg_endo -70.92 48.2 0.81 Allowed 'Trans proline' 0 N--CA 1.479 0.634 0 C-N-CA 123.29 2.66 . . . . 73.439999999999998 114.307 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.9 t -97.53 -8.29 29.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.06 -0.656 . . . . 72.430000000000007 111.797 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.35 -40.74 1.46 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.585 -0.816 . . . . 72.5 114.26 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.983 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.21 171.87 7.65 Favored Glycine 0 N--CA 1.459 0.208 0 C-N-CA 120.847 -0.692 . . . . 74.040000000000006 113.037 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.646 ' CE1' HG23 ' A' ' 130' ' ' THR . 52.5 t60 -70.89 118.82 14.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.584 0.23 . . . . 74.439999999999998 111.455 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 81' ' ' VAL . 66.3 p -81.05 91.05 6.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.936 -0.764 . . . . 75.219999999999999 108.936 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 82' ' ' VAL . 10.6 mt -49.3 -52.4 27.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.999 0.428 . . . . 63.219999999999999 110.048 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -137.08 117.41 13.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 53.329999999999998 108.885 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.484 ' HA ' ' CZ3' ' A' ' 79' ' ' TRP . 50.6 t0 -55.78 151.08 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.767 0.667 . . . . 72.200000000000003 111.649 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.414 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.5 p90 -60.35 151.3 28.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 73.209999999999994 110.1 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.21 152.97 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.424 -0.353 . . . . 71.340000000000003 110.149 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' C ' HG12 ' A' ' 170' ' ' VAL . . . -46.19 -72.84 0.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.963 -0.637 . . . . 71.219999999999999 112.429 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -171.15 124.31 0.61 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 72.430000000000007 110.471 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -68.29 -49.15 47.83 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.524 -0.846 . . . . 62.420000000000002 111.511 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' CB ' HG21 ' A' ' 109' ' ' THR . 2.7 Cg_exo -77.78 114.59 3.67 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.851 2.367 . . . . 73.409999999999997 112.017 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 109' ' ' THR . 26.6 Cg_exo -62.69 160.91 30.53 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.135 2.556 . . . . 62.43 111.861 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.546 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.98 -28.05 2.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.343 -0.389 . . . . 63.329999999999998 111.419 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.546 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 87.0 m-20 -51.64 -40.0 59.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 74.519999999999996 112.025 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 106' ' ' PRO . 14.7 t -71.06 -2.91 17.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.755 -0.378 . . . . 53.219999999999999 111.254 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 69.95 -126.72 17.64 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 116.106 -0.497 . . . . 73.329999999999998 113.673 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 163' ' ' GLN . 31.0 tp -66.96 145.48 55.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.8 0.809 . . . . 72.409999999999997 112.505 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 19.0 m80 -120.02 167.05 12.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.99 -1.459 . . . . 71.219999999999999 110.037 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.597 HH12 ' CB ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -141.0 75.4 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.972 -0.751 . . . . 73.109999999999999 108.972 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.38 120.79 22.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.581 -0.736 . . . . 73.439999999999998 109.659 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' A' ' 161' ' ' TYR . 11.9 mt -116.02 122.48 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.094 0.473 . . . . 54.219999999999999 112.025 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -91.01 130.57 36.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.43 -0.805 . . . . 74.420000000000002 109.064 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.3 tm? -119.27 136.19 54.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.419 -0.355 . . . . 64.540000000000006 110.168 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.6 tt -136.84 129.68 30.65 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.338 -0.392 . . . . 73.549999999999997 110.053 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.732 ' N ' HD23 ' A' ' 118' ' ' LEU . 62.8 t80 -144.16 143.65 31.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.273 -0.421 . . . . 71.140000000000001 110.971 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -63.13 119.99 10.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.848 -0.427 . . . . 55.520000000000003 109.848 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 7.0 tt0 -91.19 112.38 24.26 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.493 -0.558 . . . . 71.310000000000002 109.493 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' C ' HD22 ' A' ' 123' ' ' ASN . 30.4 tt0 -94.4 -31.08 14.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 61.25 111.047 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.6 m120 -98.16 129.99 44.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.81 -0.632 . . . . 70.319999999999993 111.19 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 125' ' ' ILE . 19.7 tptp -74.11 129.85 38.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.706 -0.479 . . . . 72.530000000000001 109.706 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.487 ' N ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 pt -141.95 137.6 30.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 61.409999999999997 112.045 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -79.49 -39.54 31.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.963 -0.562 . . . . 63.43 111.111 179.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.801 ' HG3' HG21 ' A' ' 82' ' ' VAL . 61.5 mm-40 56.69 39.65 29.62 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.531 0.567 . . . . 75.200000000000003 112.531 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 65.2 p 56.71 161.3 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.702 0.626 . . . . 70.299999999999997 112.171 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 76.6 Cg_exo -52.6 157.05 7.83 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.775 2.317 . . . . 75.329999999999998 113.515 -179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.646 HG23 ' CE1' ' A' ' 95' ' ' HIS . 12.2 p -59.51 120.54 9.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.444 -0.798 . . . . 75.510000000000005 112.085 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 131' ' ' ILE . 21.6 mm -83.91 127.2 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.715 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.3 m -63.69 140.77 58.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.976 -1.011 . . . . 64.340000000000003 112.322 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.731 ' OD1' HG23 ' A' ' 134' ' ' THR . 19.8 p30 -57.76 -47.88 81.23 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.255 0.55 . . . . 73.099999999999994 110.421 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.85 ' HA ' HD13 ' A' ' 177' ' ' ILE . 13.4 p -79.69 24.02 0.4 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.417 -0.81 . . . . 74.5 111.99 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.7 t -60.77 125.29 23.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.304 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 137' ' ' THR . 22.3 tpt180 -71.53 173.25 8.24 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.204 -0.907 . . . . 74.349999999999994 110.573 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 136' ' ' ARG . 35.6 m -39.37 146.17 0.1 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.879 0.371 . . . . 72.25 111.32 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.29 -10.08 28.79 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.177 -0.535 . . . . 31.440000000000001 112.264 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 139' ' ' ARG . 1.9 mmp_? -141.68 32.15 1.64 Allowed 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.721 -0.282 . . . . 71.209999999999994 111.075 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.435 ' HB3' HD12 ' A' ' 76' ' ' ILE . 29.5 mt -101.45 -55.8 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.247 0.546 . . . . 75.519999999999996 110.262 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.8 m120 -64.7 112.03 3.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 61.32 110.84 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -163.51 109.81 1.12 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.994 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.584 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 51.7 t30 -64.18 91.8 0.08 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.561 -0.745 . . . . 74.030000000000001 111.221 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HB1' HG22 ' A' ' 61' ' ' VAL . . . -48.92 -40.63 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.41 0.624 . . . . 42.030000000000001 110.091 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.523 ' NH2' ' SD ' ' A' ' 1' ' ' MET . 11.1 tpt180 -46.62 -36.41 6.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.96 -1.018 . . . . 71.209999999999994 110.902 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.41 -42.46 53.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.382 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.749 ' CG ' HD13 ' A' ' 59' ' ' LEU . 20.5 m-85 -48.91 -39.24 25.35 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 116.112 -0.495 . . . . 64.450000000000003 110.617 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.55 -35.57 72.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.645 -0.707 . . . . 62.240000000000002 109.833 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.92 -59.27 2.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.802 -0.636 . . . . 74.230000000000004 111.849 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.605 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 10.6 ptpt -63.82 -45.12 91.01 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.416 0.525 . . . . 75.310000000000002 112.416 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.605 ' CD2' ' HD3' ' A' ' 150' ' ' LYS . 58.3 m170 -91.61 8.19 37.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.875 0.369 . . . . 75.129999999999995 110.589 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.63 25.0 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.79 -0.641 . . . . 73.540000000000006 114.183 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' THR . 14.6 mt -76.71 16.72 0.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.902 0.334 . . . . 65.209999999999994 111.902 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.53 -45.59 29.7 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.75 -0.738 . . . . 51.119999999999997 112.564 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -108.81 83.13 1.99 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.886 0.374 . . . . 72.040000000000006 110.116 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 44.3 Cg_endo -68.33 137.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.762 2.308 . . . . 65.219999999999999 113.456 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.57 HD11 HD22 ' A' ' 118' ' ' LEU . 30.6 pt -79.33 -33.41 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.235 -0.654 . . . . 74.129999999999995 109.235 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -142.34 142.87 32.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.665 -0.698 . . . . 64.230000000000004 110.734 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.614 ' HB3' ' HG3' ' A' ' 13' ' ' PRO . . . -153.58 157.88 40.36 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.215 -0.661 . . . . 74.230000000000004 109.215 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.457 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.2 t-20 -165.61 118.62 1.15 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.632 -0.507 . . . . 75.219999999999999 109.632 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -103.13 151.26 22.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.308 -0.86 . . . . 72.319999999999993 110.936 -179.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 164' ' ' ALA . 3.7 t80 -145.96 130.64 17.96 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.422 -0.808 . . . . 73.310000000000002 111.005 -177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.499 ' HB3' HD11 ' A' ' 111' ' ' LEU . 46.1 mt-30 -110.59 134.75 52.12 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.894 -0.594 . . . . 75.540000000000006 110.366 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -157.81 152.9 25.62 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.106 0.41 . . . . 63.310000000000002 112.106 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.509 HE22 ' CD ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -135.18 133.03 38.69 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.572 -1.269 . . . . 64.310000000000002 107.572 176.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.13 152.96 30.09 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.033 -0.358 . . . . 72.409999999999997 110.033 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.4 m-20 -52.84 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.742 0.782 . . . . 52.329999999999998 111.533 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.559 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 32.1 t70 -58.93 -3.29 0.32 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.141 -0.936 . . . . 72.030000000000001 111.078 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 167' ' ' ASP . 42.2 t80 -42.77 -70.05 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 111.897 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.614 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 4.9 t -57.25 -51.83 78.75 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.184 -0.673 . . . . 62.119999999999997 109.184 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.614 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.3 Cg_exo -49.57 -18.7 2.68 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.523 2.149 . . . . 71.409999999999997 112.622 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 168' ' ' ASP . 73.1 mt -50.68 -41.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.395 -0.595 . . . . 73.150000000000006 109.395 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -55.19 -31.68 61.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.582 -0.736 . . . . 72.439999999999998 110.694 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -53.29 -43.05 67.2 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.426 -0.953 . . . . 71.409999999999997 108.426 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.493 ' NZ ' ' OD1' ' A' ' 168' ' ' ASP . 9.9 mptt -62.3 -31.04 71.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.381 -0.827 . . . . 64.25 110.09 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 178' ' ' VAL . 7.1 m -66.43 -26.68 67.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.439999999999998 110.393 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.85 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.5 mm -48.72 107.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 73.319999999999993 111.017 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 176' ' ' THR . 27.9 m -154.15 25.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 111.69 0.256 . . . . 71.230000000000004 111.69 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.665 -1.075 . . . . 65.140000000000001 112.597 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 ttp . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 110.153 -0.314 . . . . 74.209999999999994 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.581 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.2 p-10 -69.19 67.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.481 0.549 . . . . 71.5 112.481 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 54.6 t0 -71.0 -52.16 21.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 71.109999999999999 110.578 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 9' ' ' LEU . 9.7 pt -135.4 49.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.212 0.53 . . . . 73.430000000000007 111.099 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 2' ' ' ASP . 9.8 p -133.5 140.06 35.8 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.866 -0.607 . . . . 71.329999999999998 110.305 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.38 29.74 3.38 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.752 -1.353 . . . . 61.539999999999999 112.954 0.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.5 t70 -56.21 -47.26 78.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.839 -0.43 . . . . 74.349999999999994 109.839 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 7' ' ' ASP . 6.5 m -163.69 -41.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.59 -0.732 . . . . 75.150000000000006 111.452 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.673 HD23 ' HD3' ' A' ' 13' ' ' PRO . 31.4 tp -157.1 158.84 37.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.843 0.354 . . . . 75.129999999999995 111.319 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -52.34 -46.58 66.14 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.394 -0.595 . . . . 70.329999999999998 109.394 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -152.59 146.71 25.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.642 -0.708 . . . . 53.439999999999998 110.369 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.92 118.54 33.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.067 0.395 . . . . 72.450000000000003 112.067 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.673 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.1 Cg_endo -90.06 -120.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 74.409999999999997 112.261 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -158.58 -43.66 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 51.350000000000001 110.345 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.52 -173.54 13.27 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.975 -0.631 . . . . 74.340000000000003 111.801 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -131.73 162.95 29.26 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.206 0.527 . . . . 71.329999999999998 111.052 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 44' ' ' VAL . 8.2 mt -105.31 137.75 33.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.21 -0.904 . . . . 75.430000000000007 110.758 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.1 mmmt -73.61 102.24 3.84 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.594 -0.521 . . . . 65.340000000000003 109.594 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 27' ' ' VAL . 88.7 t -110.07 109.84 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 119.994 -0.682 . . . . 62.009999999999998 109.726 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' LEU . 2.8 mp -100.38 124.03 53.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.661 -0.7 . . . . 73.430000000000007 109.771 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.661 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -76.74 -32.05 57.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.908 -0.587 . . . . 74.209999999999994 111.893 -178.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.13 -61.89 0.14 Allowed Glycine 0 N--CA 1.459 0.227 0 C-N-CA 120.767 -0.73 . . . . 73.230000000000004 112.175 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' CA ' HG21 ' A' ' 20' ' ' ILE . 32.6 t70 -173.42 -58.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 75.329999999999998 108.235 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -83.67 -45.15 13.75 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.944 -0.762 . . . . 72.209999999999994 108.944 176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -69.67 131.6 44.86 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.25 -0.886 . . . . 70.510000000000005 112.389 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 20' ' ' ILE . 5.9 tt0 -135.91 146.78 47.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 72.099999999999994 110.245 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.634 HG22 ' HB ' ' A' ' 19' ' ' VAL . 34.1 m -82.95 106.55 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.182 0.515 . . . . 74.310000000000002 111.912 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 28' ' ' LYS . 11.6 mptt -74.57 92.5 2.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.307 0.575 . . . . 64.430000000000007 111.452 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 9.4 mp0 24.67 66.79 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 114.379 1.252 . . . . 74.319999999999993 114.379 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.07 -3.06 55.3 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 115.07 0.788 . . . . 53.219999999999999 115.07 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.458 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -58.84 167.77 1.47 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.33 0.565 . . . . 71.219999999999999 112.453 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' LEU . 4.0 tt0 -101.89 141.83 34.14 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.739 -1.119 . . . . 75.150000000000006 110.026 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 27' ' ' VAL . 10.7 mp -108.73 130.38 55.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.984 0.421 . . . . 53.340000000000003 110.983 178.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 1.1 p -148.34 164.19 23.07 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.736 -0.665 . . . . 52.030000000000001 110.542 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 64.3 Cg_endo -73.32 -40.76 1.13 Allowed 'Cis proline' 0 C--N 1.351 0.672 0 C-N-CA 123.855 -1.31 . . . . 72.319999999999993 112.899 0.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.3 p -150.88 30.6 0.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.451 0.644 . . . . 62.530000000000001 110.837 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.584 ' OE1' HD13 ' A' ' 25' ' ' LEU . 15.5 pt20 -66.03 -2.88 4.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.913 -0.585 . . . . 55.130000000000003 110.463 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.3 m -68.74 -3.66 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.411 0.624 . . . . 70.430000000000007 109.937 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -65.72 6.23 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.305 -0.861 . . . . 75.219999999999999 112.282 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CG ' HE22 ' A' ' 41' ' ' GLN . 14.1 t0 -136.18 148.72 48.27 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.048 0.451 . . . . 73.430000000000007 111.648 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.0 pm0 -73.13 144.41 84.77 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.333 -0.849 . . . . 64.129999999999995 113.14 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 72.9 Cg_endo -77.1 131.61 12.06 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.18 2.587 . . . . 74.299999999999997 113.928 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -105.29 117.24 50.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.079 -0.51 . . . . 52.030000000000001 110.049 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.92 HG23 HG21 ' A' ' 17' ' ' ILE . 2.7 p -88.85 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.783 0.66 . . . . 73.319999999999993 112.783 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 66.7 m -160.77 133.25 6.17 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.49 -0.323 . . . . 73.099999999999994 111.438 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 9.4 p90 -106.35 24.98 11.65 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.86 0.362 . . . . 75.549999999999997 110.787 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 m -43.29 118.19 1.27 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.777 -0.647 . . . . 65.340000000000003 111.367 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 104.67 -33.84 6.25 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.092 -0.504 . . . . 45.219999999999999 112.245 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 8.0 mp -75.33 -37.74 60.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.913 0.387 . . . . 53.530000000000001 110.409 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 48' ' ' GLY . 10.0 pm0 -49.86 153.08 1.37 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.145 -0.48 . . . . 55.450000000000003 109.918 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.41 -73.24 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.679 -0.772 . . . . 74.310000000000002 111.937 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -148.89 108.93 4.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.773 -0.454 . . . . 73.430000000000007 109.773 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.404 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 2.8 p -158.83 143.13 15.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.949 -0.569 . . . . 72.329999999999998 110.999 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 10.7 t30 -74.09 -33.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.458 0.647 . . . . 73.019999999999996 109.328 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 83' ' ' ASN . 59.6 mt -157.32 178.38 10.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.106 -0.952 . . . . 74.150000000000006 110.632 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 120' ' ' ARG . 83.1 mt -142.44 165.02 28.55 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.696 -0.853 . . . . 65.420000000000002 108.696 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.888 HG23 HG12 ' A' ' 82' ' ' VAL . 26.7 m -136.93 123.4 20.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.507 0.194 . . . . 73.400000000000006 110.689 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.75 127.3 49.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.152 -0.477 . . . . 71.340000000000003 111.059 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.648 HD21 HD12 ' A' ' 97' ' ' LEU . 86.9 mt -146.79 141.03 26.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 73.420000000000002 111.278 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.8 ttm -94.28 129.55 40.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.054 -0.521 . . . . 61.43 109.629 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' C ' ' CD ' ' A' ' 63' ' ' PRO . 38.9 t -103.6 62.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.502 -0.317 . . . . 74.239999999999995 111.637 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.438 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 25.6 p-10 -112.45 46.55 0.3 Allowed Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.066 0.395 . . . . 74.120000000000005 112.066 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' HH22 ' A' ' 113' ' ' ARG . 57.5 Cg_endo -70.5 84.8 0.75 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.327 2.018 . . . . 71.340000000000003 114.289 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -168.87 114.35 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.391 0.615 . . . . 73.120000000000005 110.711 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.574 ' CB ' HG12 ' A' ' 76' ' ' ILE . . . -170.75 139.58 1.34 Allowed Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 115.076 -0.965 . . . . 61.299999999999997 110.933 -178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.7 Cg_exo -65.0 -18.4 6.47 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.986 -1.256 . . . . 73.349999999999994 110.994 -0.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 70' ' ' ASP . 10.0 t -165.17 146.48 7.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.169 -0.923 . . . . 65.439999999999998 110.036 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -49.3 -29.68 6.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.451 0.643 . . . . 75.349999999999994 110.481 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.403 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 1.3 mp0 -69.9 -31.87 69.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.577 -1.192 . . . . 71.209999999999994 112.948 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 71' ' ' PRO . 14.2 t0 -144.23 61.06 8.57 Favored Pre-proline 0 N--CA 1.469 0.485 0 CA-C-O 121.155 0.503 . . . . 55.240000000000002 110.031 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.561 ' CB ' ' HE ' ' A' ' 74' ' ' ARG . 7.5 Cg_exo -72.77 55.14 2.67 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.019 2.479 . . . . 74.329999999999998 113.627 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 70' ' ' ASP . 31.6 mttp -48.98 -54.8 14.09 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.405 0.52 . . . . 73.219999999999999 112.405 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -117.47 41.7 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.417 . . . . 74.109999999999999 110.956 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HE ' ' CB ' ' A' ' 71' ' ' PRO . 2.4 tmm_? -82.87 141.87 31.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.715 -0.675 . . . . 72.230000000000004 110.424 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' OE2' ' ND1' ' A' ' 78' ' ' HIS . 11.8 pt-20 -94.9 178.5 5.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.917 0.887 . . . . 61.520000000000003 111.126 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG12 ' CB ' ' A' ' 65' ' ' ALA . 13.0 mm -97.89 -120.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.673 . . . . 73.519999999999996 109.184 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD11 HG22 ' A' ' 135' ' ' THR . 4.4 mm? -89.97 174.31 7.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.972 -0.751 . . . . 51.119999999999997 108.972 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.44 ' ND1' ' OE2' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -172.91 165.16 5.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.574 0.225 . . . . 63.100000000000001 110.791 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.484 ' HE3' ' HA ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -99.76 120.86 40.41 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.788 -0.819 . . . . 75.239999999999995 108.788 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.645 ' HB2' HD12 ' A' ' 97' ' ' LEU . 12.5 p -141.41 127.9 20.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 75.549999999999997 112.454 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.4 OUTLIER -145.18 136.48 20.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.87 -0.605 . . . . 73.439999999999998 109.472 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.888 HG12 HG23 ' A' ' 57' ' ' THR . 31.3 m -138.11 166.62 23.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.554 -0.294 . . . . 71.040000000000006 111.112 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.644 ' O ' HD22 ' A' ' 55' ' ' LEU . 2.4 m120 63.68 33.15 13.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.363 -0.38 . . . . 63.32 110.502 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.005 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.0 mm -77.34 127.88 81.89 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.28 -0.568 . . . . 74.129999999999995 110.125 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 34.8 Cg_exo -54.07 127.91 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.26 1.307 . . . . 74.239999999999995 109.931 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -64.17 56.75 0.07 OUTLIER Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.146 0.819 . . . . 23.530000000000001 115.146 -178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 7.4 t 178.05 38.14 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 117.528 0.664 . . . . 64.120000000000005 111.572 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 85' ' ' PRO . 69.6 m-80 -119.87 13.84 12.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.845 0.313 . . . . 71.299999999999997 111.845 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 45' ' ' SER . 20.8 pt-20 39.2 26.54 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.397 0.517 . . . . 73.230000000000004 112.397 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 89' ' ' GLU . 17.3 p30 169.94 151.21 0.15 Allowed Pre-proline 0 C--O 1.236 0.356 0 CA-C-O 121.12 0.486 . . . . 72.239999999999995 110.731 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 44' ' ' VAL . 83.3 Cg_endo -75.5 63.2 6.39 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 123.542 2.828 . . . . 61.210000000000001 112.86 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.0 t -104.12 -48.18 3.95 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.685 0.624 . . . . 74.340000000000003 112.685 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -69.44 -39.96 79.72 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 115.345 0.898 . . . . 42.229999999999997 115.345 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 1.005 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -61.52 171.74 8.43 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.65 -0.786 . . . . 63.009999999999998 114.044 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 82' ' ' VAL . 65.1 t60 -66.42 121.34 15.08 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.624 0.37 . . . . 73.409999999999997 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 31.7 t -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.876 -1.157 . . . . 62.030000000000001 107.876 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' CE1' ' A' ' 147' ' ' PHE . 74.4 mt -63.68 -50.96 67.19 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.939 -0.763 . . . . 75.049999999999997 108.939 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 131' ' ' ILE . . . -143.24 125.6 15.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 114.762 -1.108 . . . . 53.200000000000003 109.367 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 133' ' ' ASN . 37.4 t0 -52.67 145.92 11.16 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.583 0.586 . . . . 41.100000000000001 112.583 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -65.15 151.15 46.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.301 -0.863 . . . . 73.340000000000003 110.685 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 9.6 p -158.52 174.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 110.071 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -67.76 178.88 18.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.391 -0.909 . . . . 52.549999999999997 111.994 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 112' ' ' HIS . 66.6 m -55.33 159.01 2.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.869 0.335 . . . . 72.340000000000003 111.371 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -97.41 -57.32 1.06 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.827 -0.624 . . . . 61.310000000000002 113.263 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 109' ' ' THR . 88.8 Cg_endo -79.23 123.01 5.41 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.914 2.409 . . . . 65.019999999999996 113.58 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 24.6 Cg_exo -62.67 162.49 24.63 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.041 2.494 . . . . 71.420000000000002 112.754 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.499 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -39.82 -24.22 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.743 -0.662 . . . . 70.230000000000004 112.456 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.8 m-20 -51.95 -39.34 59.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.005 -0.278 . . . . 62.539999999999999 110.604 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 105' ' ' PRO . 9.1 t -72.83 -14.92 61.61 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.459 0.647 . . . . 72.430000000000007 109.596 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 -130.01 9.42 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.136 -0.938 . . . . 52.140000000000001 112.187 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 163' ' ' GLN . 16.1 tp -66.48 127.83 33.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.455 -0.373 . . . . 75.049999999999997 111.966 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 164' ' ' ALA . 49.0 m170 -83.61 97.95 9.34 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.363 -0.38 . . . . 64.099999999999994 111.3 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.612 HH22 ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -75.89 68.35 2.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.473 -0.565 . . . . 72.340000000000003 109.473 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.1 m-85 -81.43 146.79 30.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.728 -0.669 . . . . 63.229999999999997 111.632 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 54.7 mt -144.41 140.88 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 112.689 0.625 . . . . 72.219999999999999 112.689 -178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -107.75 134.72 50.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.011 -0.995 . . . . 73.150000000000006 109.28 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.739 HD23 ' N ' ' A' ' 118' ' ' LEU . 5.5 tt -121.81 132.22 54.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.234 -0.284 . . . . 71.400000000000006 110.234 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.739 ' N ' HD23 ' A' ' 117' ' ' LEU . 49.9 tp -124.15 136.8 54.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.464 -0.335 . . . . 72.109999999999999 110.952 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' THR . 53.6 t80 -141.97 134.96 28.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 72.019999999999996 110.417 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.586 ' HA ' HD23 ' A' ' 56' ' ' LEU . 5.1 tmm_? -72.62 133.4 44.66 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.383 -0.599 . . . . 64.200000000000003 109.383 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 151' ' ' HIS . 6.6 tp-100 -115.07 149.3 37.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.46 0.648 . . . . 63.329999999999998 112.452 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 88.1 tt0 -122.47 -38.97 2.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.009 -0.996 . . . . 71.439999999999998 111.24 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -90.72 134.6 34.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.308 0.484 . . . . 72.450000000000003 112.308 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -82.89 111.65 18.97 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.224 0.535 . . . . 70.299999999999997 110.932 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.512 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 1.3 pt -105.02 154.53 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.057 -0.974 . . . . 50.009999999999998 112.259 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.633 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -81.47 -49.97 9.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.924 0.392 . . . . 61.329999999999998 110.555 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 59.71 36.62 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.776 1.028 . . . . 73.319999999999993 113.776 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.633 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 68.6 p 52.16 145.38 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.432 0 C-N-CA 123.51 0.724 . . . . 71.420000000000002 112.798 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -44.05 143.07 3.48 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.494 2.129 . . . . 51.299999999999997 112.204 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.8 t -59.08 143.4 48.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.765 -0.652 . . . . 64.120000000000005 111.691 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.686 HG22 ' HA ' ' A' ' 98' ' ' ALA . 6.6 tp -110.89 133.37 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.52 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.2 m -70.99 142.12 50.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.805 -0.634 . . . . 74.549999999999997 110.623 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 135' ' ' THR . 18.8 p-10 -51.87 -38.99 58.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.199 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.756 ' HA ' HD13 ' A' ' 177' ' ' ILE . 15.3 t -67.82 22.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.165 -0.47 . . . . 62.149999999999999 111.58 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.686 HG22 HD11 ' A' ' 77' ' ' LEU . 11.7 t -64.11 128.31 35.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.869 0.366 . . . . 33.210000000000001 110.233 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' CB ' ' HA3' ' A' ' 179' ' ' GLY . 32.5 ttt180 -92.94 173.75 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.612 0.597 . . . . 64.140000000000001 112.612 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' ARG . 20.9 m -26.32 131.75 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.557 -1.201 . . . . 73.040000000000006 111.61 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.3 4.86 32.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.468 -0.872 . . . . 54.509999999999998 111.16 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -146.93 35.79 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.741 0.305 . . . . 72.409999999999997 110.296 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 142' ' ' PHE . 13.6 mt -111.11 -71.04 0.78 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.219 -0.446 . . . . 54.119999999999997 111.257 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -51.61 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.356 -0.384 . . . . 73.319999999999993 110.154 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CZ ' ' CZ ' ' A' ' 147' ' ' PHE . 1.5 t80 -150.47 72.49 1.1 Allowed 'General case' 0 C--O 1.233 0.216 0 N-CA-C 113.249 0.833 . . . . 75.349999999999994 113.249 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -52.58 114.22 1.31 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.925 0.393 . . . . 74.219999999999999 110.752 179.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -48.26 -34.88 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.451 0.537 . . . . 74.329999999999998 112.451 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 26.4 ptt180 -43.69 -33.34 1.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.225 0.536 . . . . 75.209999999999994 111.099 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 145' ' ' ARG . 19.1 t70 -52.52 -46.1 66.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.571 -0.74 . . . . 64.530000000000001 111.306 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.841 ' CE1' HD13 ' A' ' 97' ' ' LEU . 85.4 m-85 -53.28 -50.39 64.96 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.337 0.589 . . . . 65.409999999999997 110.905 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -56.25 -42.24 77.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.795 -0.639 . . . . 54.420000000000002 110.437 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.73 98.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.925 -0.58 . . . . 72.420000000000002 111.466 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.618 ' CG ' ' N ' ' A' ' 151' ' ' HIS . 45.8 pttt -75.2 -59.08 2.9 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.72 0.295 . . . . 73.430000000000007 111.535 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.618 ' N ' ' CG ' ' A' ' 150' ' ' LYS . 18.4 t-160 -80.7 4.97 17.03 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.055 0.391 . . . . 73.349999999999994 112.055 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.83 27.98 65.12 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.72 -0.752 . . . . 21.239999999999998 113.286 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.55 HD21 ' ND1' ' A' ' 151' ' ' HIS . 25.6 mt -66.65 17.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 111.771 0.286 . . . . 70.409999999999997 111.771 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.65 -61.77 3.6 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.999 -0.62 . . . . 75.230000000000004 113.477 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -70.77 109.33 4.92 Favored Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.723 0.262 . . . . 63.350000000000001 111.145 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' GLY . 57.6 Cg_endo -89.86 132.46 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.402 2.068 . . . . 62.439999999999998 112.563 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 118' ' ' LEU . 37.8 pt -80.95 -35.37 14.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 62.420000000000002 110.711 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.419 ' N ' HG13 ' A' ' 157' ' ' ILE . . . -157.88 149.83 22.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.46 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -148.48 159.09 44.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.424 0.63 . . . . 73.340000000000003 111.319 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -155.2 144.61 21.16 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.042 -1.466 . . . . 72.230000000000004 107.042 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 115' ' ' ILE . 0.6 OUTLIER -149.76 176.25 10.86 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.718 -0.393 . . . . 71.109999999999999 111.398 -176.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 10.2 p90 -167.68 150.58 5.95 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.982 -0.554 . . . . 62.009999999999998 110.82 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.566 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . 43.6 mt-30 -110.66 124.23 51.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.505 -0.77 . . . . 63.439999999999998 109.852 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 112' ' ' HIS . . . -156.16 140.64 16.8 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.696 -0.402 . . . . 62.310000000000002 112.002 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -98.7 149.98 22.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.47 -0.567 . . . . 64.120000000000005 109.47 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.33 137.17 25.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.852 0.358 . . . . 73.319999999999993 111.165 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 -150.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.679 -0.691 . . . . 72.150000000000006 112.648 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.502 ' O ' HG13 ' A' ' 172' ' ' ILE . 49.7 t0 -84.79 -23.6 29.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.133 -0.94 . . . . 72.310000000000002 111.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.417 ' CE1' ' NH2' ' A' ' 173' ' ' ARG . 17.2 t80 -41.81 -54.76 3.27 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 111.82 0.304 . . . . 71.400000000000006 111.82 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.672 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 69.2 t -65.64 -57.25 14.8 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.388 -0.525 . . . . 71.439999999999998 110.235 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 88.5 Cg_exo -45.18 -31.58 6.15 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.985 1.79 . . . . 63.420000000000002 112.05 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 168' ' ' ASP . 61.4 mt -51.91 -37.35 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.885 0.374 . . . . 74.329999999999998 110.307 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.489 ' H ' ' HD2' ' A' ' 173' ' ' ARG . 0.2 OUTLIER -53.7 -33.6 55.99 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.775 -0.454 . . . . 52.409999999999997 109.775 179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 177' ' ' ILE . 69.0 m-80 -58.19 -31.65 67.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 64.430000000000007 111.031 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 172' ' ' ILE . 2.6 mptp? -61.31 -13.57 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.29 -0.633 . . . . 61.200000000000003 109.29 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 176' ' ' THR . 17.2 m -98.32 8.23 45.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.318 -0.856 . . . . 75.329999999999998 111.292 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.756 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.4 mm -69.83 117.5 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.015 -0.365 . . . . 54.409999999999997 110.015 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.34 -27.91 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 113.523 0.934 . . . . 51.409999999999997 113.523 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.325 -1.264 . . . . 53.030000000000001 112.294 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mmm . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 111.534 0.198 . . . . 73.329999999999998 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.78 112.2 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 71.129999999999995 110.981 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 12' ' ' VAL . 29.1 t70 -109.37 -57.15 2.21 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.853 -0.612 . . . . 72.420000000000002 112.242 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.574 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 12.9 pt -129.02 65.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.253 0.549 . . . . 74.340000000000003 111.085 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.2 p -141.37 143.92 32.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.028 -0.533 . . . . 52.009999999999998 111.17 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HA ' HG23 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -76.16 22.27 2.73 Favored 'Cis proline' 0 C--N 1.358 1.039 0 C-N-CA 124.454 -1.061 . . . . 73.409999999999997 112.334 0.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.705 ' O ' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -49.51 -53.87 20.95 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.169 -0.923 . . . . 73.230000000000004 111.276 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 7' ' ' ASP . 2.8 m -165.79 -40.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.73 0.641 . . . . 71.209999999999994 112.73 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.479 HD23 ' HD3' ' A' ' 13' ' ' PRO . 22.8 tp -157.1 152.19 26.1 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.494 0.664 . . . . 52.439999999999998 112.372 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -60.54 -35.81 76.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.795 -0.639 . . . . 74.530000000000001 111.07 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.15 13.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 75.140000000000001 111.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 HG23 ' OD2' ' A' ' 3' ' ' ASP . 61.6 t -59.9 124.51 77.06 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.145 -0.48 . . . . 74.530000000000001 111.574 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.479 ' HD3' HD23 ' A' ' 9' ' ' LEU . 66.4 Cg_endo -85.66 -117.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.957 2.438 . . . . 73.120000000000005 112.724 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -168.72 -46.09 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 122.931 0.492 . . . . 74.430000000000007 109.741 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -112.83 -158.72 13.63 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.371 -0.692 . . . . 63.200000000000003 111.371 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 4.8 t -147.92 167.59 24.45 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.519 0.676 . . . . 75.099999999999994 111.488 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.626 HD11 ' HB2' ' A' ' 118' ' ' LEU . 13.1 mt -105.5 152.97 7.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.333 -1.303 . . . . 65.319999999999993 108.416 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.0 mmpt? -108.48 102.4 11.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.103 -0.499 . . . . 73.400000000000006 110.601 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.786 ' HB ' HG22 ' A' ' 27' ' ' VAL . 35.3 t -105.92 109.93 29.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.966 -0.753 . . . . 62.200000000000003 108.966 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.451 HG12 ' HB3' ' A' ' 26' ' ' GLU . 67.6 mt -98.45 137.33 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.579 . . . . 74.319999999999993 110.846 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -95.83 -97.23 0.18 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.214 -0.903 . . . . 74.140000000000001 112.543 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.618 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -66.82 -44.59 88.82 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.601 -0.809 . . . . 75.430000000000007 113.544 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 174.34 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.272 -0.64 . . . . 61.32 109.272 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.22 -42.49 15.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.452 -0.795 . . . . 73.120000000000005 109.361 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.51 138.51 53.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.277 -0.874 . . . . 71.219999999999999 110.359 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 25.9 pt-20 -150.36 151.49 32.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.728 -1.123 . . . . 71.510000000000005 108.822 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.786 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.0 m -73.21 120.07 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 112.956 0.724 . . . . 63.210000000000001 112.956 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 3.4 mptp? -104.11 111.97 24.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.455 -0.793 . . . . 65.540000000000006 112.512 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.496 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 8.0 mp0 29.04 67.77 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.606 1.336 . . . . 72.299999999999997 114.606 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' N ' ' HD1' ' A' ' 161' ' ' TYR . . . 76.92 5.17 84.2 Favored Glycine 0 N--CA 1.465 0.63 0 C-N-CA 121.043 -0.598 . . . . 51.100000000000001 112.844 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.48 HD22 ' HA ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -47.62 147.07 1.94 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.697 -0.752 . . . . 70.25 111.933 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -101.76 131.72 47.89 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.459 -1.246 . . . . 63.420000000000002 109.85 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.581 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 9.6 mp -96.96 124.92 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.157 0.503 . . . . 61.509999999999998 111.166 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 p -149.87 145.09 18.38 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.496 -0.775 . . . . 75.450000000000003 109.688 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -83.78 -113.26 0.0 OUTLIER 'Cis proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.936 -1.277 . . . . 63.399999999999999 112.965 0.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.0 p -67.47 61.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.532 0.568 . . . . 72.230000000000004 112.532 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.8 pt20 -119.11 -3.57 10.62 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.746 0.307 . . . . 63.420000000000002 111.226 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 33' ' ' LEU . 30.9 m -78.22 32.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 110.921 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -105.64 -23.21 12.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.149 0.796 . . . . 71.319999999999993 113.149 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 39' ' ' LYS . 1.4 m-20 -71.5 139.91 49.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.265 0.555 . . . . 62.43 112.032 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.54 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.31 130.53 93.19 Favored Pre-proline 0 C--O 1.234 0.281 0 CA-C-N 115.496 -0.775 . . . . 71.319999999999993 110.045 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.15 126.31 13.56 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.999 1.799 . . . . 71.040000000000006 112.442 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 50.6 mm -107.95 109.51 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 75.120000000000005 110.678 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.3 p -81.45 138.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.165 0.431 . . . . 73.450000000000003 112.165 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 74.9 m -165.3 164.07 19.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.758 0.313 . . . . 14.02 110.734 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p90 -141.16 37.12 1.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.817 -0.628 . . . . 75.219999999999999 110.27 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.1 t -50.78 112.23 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.51 . . . . 74.019999999999996 111.355 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.72 -14.64 61.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.114 -0.565 . . . . 71.519999999999996 112.935 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -78.53 -28.12 46.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.695 0.283 . . . . 71.519999999999996 110.943 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' CD ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -72.75 -82.92 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.936 0.398 . . . . 72.400000000000006 111.429 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.56 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 78.77 -52.83 3.97 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.155 -0.545 . . . . 74.230000000000004 111.969 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -148.64 109.03 4.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.823 0.344 . . . . 64.030000000000001 110.139 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.0 p -157.95 141.33 15.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.186 -0.461 . . . . 70.519999999999996 111.529 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -86.3 -40.58 15.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.915 0.864 . . . . 73.120000000000005 109.41 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -149.98 157.52 43.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.044 -1.435 . . . . 54.409999999999997 107.528 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.8 mt -128.46 144.49 51.15 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.32 -0.552 . . . . 75.310000000000002 111.023 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.791 HG21 ' CD2' ' A' ' 153' ' ' LEU . 24.3 m -115.85 132.52 56.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.408 -0.814 . . . . 73.140000000000001 110.541 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -133.37 131.44 40.07 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.257 0.348 . . . . 62.109999999999999 110.348 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.697 HD21 HD12 ' A' ' 97' ' ' LEU . 51.0 mt -151.39 167.11 28.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.732 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.428 ' HG3' ' CB ' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -94.88 146.03 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.633 -0.712 . . . . 73.319999999999993 109.469 178.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.866 HG22 HD23 ' A' ' 117' ' ' LEU . 6.1 t -131.28 49.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.056 0.455 . . . . 75.519999999999996 110.722 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 p30 -133.66 54.82 13.67 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.543 -0.753 . . . . 75.329999999999998 111.425 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.35 83.29 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 121.39 1.394 . . . . 75.510000000000005 112.048 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ASP . 0.7 OUTLIER -150.18 109.11 3.88 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.19 -0.914 . . . . 61.299999999999997 110.211 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -167.54 137.83 2.32 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 41.409999999999997 110.348 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 3.4 Cg_exo -78.38 -23.89 13.29 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 124.114 -1.203 . . . . 63.340000000000003 111.851 -0.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.8 t -145.86 140.85 27.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.366 -0.834 . . . . 72.310000000000002 111.064 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 68' ' ' ARG . 5.6 ttp-105 -52.59 -29.18 24.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.701 -0.681 . . . . 64.25 111.743 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.487 ' HG2' ' OG1' ' A' ' 67' ' ' THR . 8.1 pt20 -80.0 -27.17 39.63 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.448 0.536 . . . . 71.0 112.448 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 67' ' ' THR . 5.4 m-20 -144.67 60.41 7.41 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-O 120.988 0.423 . . . . 51.409999999999997 111.711 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 56.8 Cg_endo -69.24 58.98 1.35 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.063 2.509 . . . . 71.519999999999996 112.876 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 8.7 ptpt -57.37 -47.72 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.175 0.805 . . . . 55.32 113.175 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.613 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -105.71 35.66 2.8 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.106 -0.638 . . . . 73.329999999999998 112.221 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 25.2 ttp180 -70.24 131.61 44.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.179 -0.674 . . . . 73.209999999999994 109.179 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 42.6 mt-10 -93.65 169.34 10.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 72.120000000000005 110.618 -0.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.777 HG23 ' N ' ' A' ' 77' ' ' LEU . 10.6 tp -110.4 -134.53 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 110.467 -0.197 . . . . 63.549999999999997 110.467 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.777 ' N ' HG23 ' A' ' 76' ' ' ILE . 96.1 mt -72.41 152.07 42.23 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.451 -0.574 . . . . 75.519999999999996 109.451 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.518 ' NE2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -163.87 157.07 18.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.722 0.267 . . . . 65.140000000000001 111.722 -179.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 5.0 t-105 -99.96 117.65 34.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.915 -0.584 . . . . 74.040000000000006 109.978 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 6.1 p -141.13 134.45 29.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.995 -0.548 . . . . 61.020000000000003 112.073 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.829 HG11 ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -142.76 142.75 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 70.099999999999994 110.021 179.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 HG23 ' A' ' 57' ' ' THR . 14.5 m -140.85 159.14 23.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 112.475 0.546 . . . . 71.209999999999994 112.475 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.0 p30 62.36 35.87 14.76 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 114.567 -1.197 . . . . 73.340000000000003 111.185 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.966 HD13 ' HA3' ' A' ' 94' ' ' GLY . 3.6 mm -73.62 127.63 88.33 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 63.409999999999997 109.742 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' SER . 23.9 Cg_exo -63.5 126.87 18.5 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 121.958 1.772 . . . . 75.239999999999995 111.755 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.79 62.74 0.01 OUTLIER Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.248 0.342 . . . . 53.240000000000002 113.602 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' PRO . 31.9 p -179.2 39.69 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.16 0.48 . . . . 74.010000000000005 110.942 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.31 -4.05 2.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.255 -0.429 . . . . 72.530000000000001 111.816 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 67.62 -36.64 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.222 0.609 . . . . 73.200000000000003 112.5 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 88' ' ' ASN . 1.6 p30 -127.71 153.42 77.8 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 54.130000000000003 110.609 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.897 ' HA ' HG21 ' A' ' 84' ' ' ILE . 77.5 Cg_endo -70.78 47.08 0.68 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.646 2.897 . . . . 63.409999999999997 113.803 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.8 m -93.49 -40.32 10.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 61.140000000000001 112.147 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.07 -13.11 61.44 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.906 -0.588 . . . . 61.240000000000002 114.241 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.966 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -98.33 172.08 26.11 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.405 -0.902 . . . . 72.540000000000006 113.404 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.546 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.69 126.61 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 75.430000000000007 111.496 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.691 ' H ' HG22 ' A' ' 130' ' ' THR . 85.3 p -88.11 94.5 9.83 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.999 -0.546 . . . . 71.230000000000004 109.895 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.697 HD12 HD21 ' A' ' 59' ' ' LEU . 77.2 mt -50.06 -38.24 37.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.54 0.686 . . . . 74.239999999999995 109.189 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -156.67 115.49 3.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.692 -1.14 . . . . 52.130000000000003 109.089 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 50.2 t0 -52.36 146.71 9.04 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.439 0.462 . . . . 64.310000000000002 111.982 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 47.7 p90 -69.81 129.61 40.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.598 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 102' ' ' GLY . 13.7 p -158.61 174.79 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.326 -0.397 . . . . 72.040000000000006 110.217 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.654 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -72.04 -129.18 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.234 -0.984 . . . . 74.230000000000004 111.703 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 170' ' ' VAL . 47.6 t -175.48 -165.67 0.18 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.838 -0.801 . . . . 43.210000000000001 108.838 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.547 ' N ' ' HD3' ' A' ' 105' ' ' PRO . . . -128.58 54.89 0.77 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.766 -0.731 . . . . 74.329999999999998 111.65 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 104' ' ' GLY . 14.3 Cg_endo -87.96 120.7 1.39 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.499 2.133 . . . . 74.420000000000002 112.676 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 109' ' ' THR . 73.5 Cg_endo -74.31 162.11 39.09 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.79 2.327 . . . . 61.25 111.759 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 109' ' ' THR . 17.6 pttp -43.55 -45.64 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.443 -0.344 . . . . 62.25 111.764 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -63.4 5.95 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.159 0.429 . . . . 71.439999999999998 112.159 -179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 106' ' ' PRO . 13.0 t -75.14 -25.68 58.58 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.144 0.497 . . . . 73.519999999999996 110.196 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.9 -165.11 42.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.565 -0.826 . . . . 61.43 112.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.8 tp -71.33 111.56 6.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.867 0.365 . . . . 72.040000000000006 111.492 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -88.85 131.99 34.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.310000000000002 110.987 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -103.55 90.54 3.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.742 -0.663 . . . . 74.340000000000003 109.922 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . 10.2 m-85 -74.94 136.48 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.954 0.407 . . . . 73.530000000000001 111.242 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 161' ' ' TYR . 35.0 mt -130.03 138.22 54.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.83 -0.623 . . . . 75.299999999999997 112.053 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -120.74 136.81 54.77 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.465 -0.789 . . . . 71.319999999999993 109.439 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 61' ' ' VAL . 2.3 pp -118.47 149.32 41.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.042 -0.526 . . . . 63.439999999999998 109.895 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 157' ' ' ILE . 2.8 tt -133.94 134.87 43.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 73.340000000000003 109.592 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.693 ' N ' HD23 ' A' ' 118' ' ' LEU . 53.3 t80 -139.88 136.71 34.22 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 72.230000000000004 111.448 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -73.7 124.71 26.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.752 -0.658 . . . . 71.319999999999993 109.71 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -110.78 145.31 38.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 75.099999999999994 112.351 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -118.63 -39.92 2.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.982 -1.008 . . . . 75.409999999999997 109.968 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.98 130.75 34.88 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.234 -0.439 . . . . 72.349999999999994 111.106 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -79.06 131.91 36.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.514 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -125.33 154.55 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.712 -0.676 . . . . 70.200000000000003 112.414 -178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -90.97 -33.79 15.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.747 -0.661 . . . . 70.420000000000002 111.786 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 36.76 36.27 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.12 1.155 . . . . 74.010000000000005 114.12 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 7.7 p 59.11 159.49 0.1 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-O 121.154 0.502 . . . . 73.140000000000001 112.165 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -53.88 152.45 23.08 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.637 2.225 . . . . 64.019999999999996 113.451 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 96' ' ' SER . 22.9 p -59.02 127.15 30.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.192 -0.913 . . . . 74.420000000000002 110.707 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.482 HG13 ' NH1' ' A' ' 139' ' ' ARG . 20.4 mm -91.85 124.94 44.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 74.150000000000006 111.644 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.0 m -69.76 147.98 49.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.998 -1.001 . . . . 73.040000000000006 112.09 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.517 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 16.6 p30 -50.55 -43.63 56.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.868 -0.606 . . . . 74.510000000000005 111.427 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.836 ' HA ' HD13 ' A' ' 177' ' ' ILE . 9.7 t -68.71 21.91 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.481 0.549 . . . . 64.099999999999994 112.481 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.6 t -65.16 122.34 16.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.282 0.563 . . . . 64.230000000000004 110.884 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.689 ' HD2' ' N ' ' A' ' 137' ' ' THR . 5.0 tmm_? -82.49 160.76 22.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.53 -0.759 . . . . 72.049999999999997 111.652 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.693 HG23 HD11 ' A' ' 140' ' ' LEU . 6.0 m -39.94 158.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.348 -0.842 . . . . 65.310000000000002 111.093 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.95 17.51 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 112.483 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' NH1' HG13 ' A' ' 131' ' ' ILE . 17.8 ttm180 -167.86 48.4 0.05 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.888 0.375 . . . . 71.230000000000004 110.731 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.693 HD11 HG23 ' A' ' 137' ' ' THR . 0.0 OUTLIER -114.65 -56.45 2.38 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.321 -0.399 . . . . 72.319999999999993 110.314 179.338 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.603 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.1 m120 -63.81 66.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.853 -0.612 . . . . 73.120000000000005 111.691 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 140' ' ' LEU . 14.3 t80 -138.77 121.72 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.522 -0.548 . . . . 61.119999999999997 109.522 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.642 HD22 ' HB2' ' A' ' 146' ' ' ASP . 22.3 t30 -63.6 122.28 15.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.215 0.531 . . . . 74.219999999999999 111.75 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.06 -44.68 72.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.625 -0.716 . . . . 63.409999999999997 111.45 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -50.44 -35.14 27.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.459 . . . . 72.329999999999998 110.223 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.642 ' HB2' HD22 ' A' ' 143' ' ' ASN . 34.1 t70 -64.62 -44.12 91.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.426 0.631 . . . . 74.450000000000003 109.382 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.531 ' CD1' ' HD3' ' A' ' 150' ' ' LYS . 1.2 t80 -62.9 -38.35 90.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 53.240000000000002 109.574 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 153' ' ' LEU . . . -65.36 -46.6 79.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.578 -0.737 . . . . 71.040000000000006 110.564 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.19 -55.08 23.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 52.25 110.624 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.553 ' HG3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -60.22 -48.13 83.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 62.420000000000002 110.583 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.553 ' N ' ' HG3' ' A' ' 150' ' ' LYS . 38.4 m170 -67.64 3.39 1.42 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 121.221 -0.191 . . . . 43.549999999999997 111.33 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 72.86 7.77 71.12 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.86 -0.686 . . . . 64.239999999999995 112.19 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.791 ' CD2' HG21 ' A' ' 57' ' ' THR . 9.5 mt -72.14 16.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.392 0.277 . . . . 74.25 110.883 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -45.91 -69.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.432 -0.889 . . . . 54.5 112.127 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 21.2 pt-20 -80.39 120.03 78.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.579 0.228 . . . . 72.239999999999995 110.839 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -84.38 125.44 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.936 1.757 . . . . 73.310000000000002 112.077 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 118' ' ' LEU . 27.2 pt -76.26 -33.94 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.476 -0.49 . . . . 74.420000000000002 110.012 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -146.52 144.61 29.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.924 -0.58 . . . . 42.130000000000003 110.507 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -148.91 149.68 31.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.424 -0.353 . . . . 52.310000000000002 110.884 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.546 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 2.0 t-20 -150.97 148.98 29.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.928 -1.138 . . . . 72.319999999999993 107.928 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.551 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -152.34 165.73 34.07 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.462 -0.495 . . . . 74.310000000000002 111.272 -178.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.535 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.4 p90 -154.14 152.92 30.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.582 -0.735 . . . . 74.209999999999994 110.778 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -110.68 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.41 -0.589 . . . . 51.549999999999997 109.41 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.16 138.72 15.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.273 0.559 . . . . 61.210000000000001 111.856 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -118.28 144.97 45.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.255 -0.884 . . . . 71.129999999999995 109.153 178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.9 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.156 -0.313 . . . . 73.310000000000002 110.156 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -100.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.511 -0.768 . . . . 70.150000000000006 112.322 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t0 -147.78 21.48 1.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.658 0.742 . . . . 72.219999999999999 109.949 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -76.45 -47.95 21.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.676 -0.693 . . . . 75.450000000000003 111.359 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 103' ' ' SER . 60.2 t -43.02 -50.34 13.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.052 -0.522 . . . . 71.140000000000001 112.271 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 51.2 Cg_exo -57.84 -37.01 97.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.068 1.845 . . . . 71.25 112.392 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 51.0 mm -50.12 -39.86 16.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.057 0.456 . . . . 73.519999999999996 110.977 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -69.98 -30.18 67.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 74.099999999999994 111.212 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 171' ' ' PRO . 1.6 m120 -56.02 -14.94 2.9 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.512 -0.313 . . . . 73.230000000000004 110.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.52 -20.08 7.07 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.605 -0.517 . . . . 64.010000000000005 109.605 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 42.0 m -68.34 -28.01 66.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.69 -0.686 . . . . 75.349999999999994 110.783 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.836 HD13 ' HA ' ' A' ' 134' ' ' THR . 35.6 mm -54.6 130.79 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.652 -0.703 . . . . 52.539999999999999 111.978 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.635 HG22 ' OG1' ' A' ' 134' ' ' THR . 20.1 m -146.7 -14.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.066 0.765 . . . . 53.520000000000003 113.066 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 118.225 -1.32 . . . . 64.239999999999995 112.577 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 tpp . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.806 -0.442 . . . . 60.340000000000003 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . 3.3 p-10 -67.41 72.58 0.13 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.606 -0.725 . . . . 73.400000000000006 109.596 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.09 -71.21 0.42 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.637 0.977 . . . . 72.430000000000007 113.637 -177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 11' ' ' ALA . 7.5 pt -97.11 46.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.528 0.68 . . . . 71.25 112.568 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 6' ' ' PRO . 7.1 p -128.14 142.37 44.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.551 -0.749 . . . . 72.019999999999996 110.372 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HA ' HG23 ' A' ' 5' ' ' VAL . 64.0 Cg_endo -86.62 35.58 4.13 Favored 'Cis proline' 0 C--N 1.35 0.619 0 C-N-CA 124.115 -1.202 . . . . 74.549999999999997 112.932 0.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.561 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.7 t70 -64.33 -48.37 75.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 61.039999999999999 111.032 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 7' ' ' ASP . 3.6 m -160.36 -37.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.689 0.626 . . . . 62.130000000000003 112.689 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.522 HD23 ' HD3' ' A' ' 13' ' ' PRO . 48.9 tp -157.13 164.27 38.03 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.884 0.373 . . . . 64.430000000000007 110.899 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.88 -42.35 94.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.098 0.475 . . . . 72.439999999999998 110.095 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 4' ' ' ILE . . . -134.87 -174.59 3.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.491 -0.777 . . . . 53.350000000000001 111.187 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.0 p -110.29 111.96 57.46 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.96 -0.564 . . . . 52.32 111.555 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.522 ' HD3' HD23 ' A' ' 9' ' ' LEU . 64.9 Cg_endo -83.95 -134.89 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.124 2.549 . . . . 64.299999999999997 112.117 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -150.46 -38.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.508 -0.314 . . . . 55.109999999999999 111.098 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -138.24 166.58 25.19 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.561 -0.828 . . . . 71.329999999999998 112.533 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -102.12 159.65 15.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.263 0.554 . . . . 53.240000000000002 111.506 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.524 HG21 HG13 ' A' ' 44' ' ' VAL . 4.7 mt -105.41 131.24 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.698 -0.853 . . . . 62.229999999999997 108.698 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 6.8 mtpm? -74.03 102.98 4.35 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.142 -0.481 . . . . 70.230000000000004 110.516 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.629 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 46.9 t -117.52 110.59 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.111 0.481 . . . . 75.349999999999994 110.654 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 25' ' ' LEU . 47.2 mt -99.52 131.48 46.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.048 -0.524 . . . . 70.409999999999997 110.34 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.51 ' CE1' ' HG3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -72.31 -51.08 22.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.36 -0.382 . . . . 71.040000000000006 111.516 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 40' ' ' ASP . . . -126.1 -61.23 0.16 Allowed Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.559 -0.829 . . . . 74.340000000000003 113.273 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.16 -59.94 0.14 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.028 0.442 . . . . 74.019999999999996 110.343 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -97.57 -38.5 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 111.071 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.71 135.62 50.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.396 0.617 . . . . 64.209999999999994 110.723 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 32.2 tt0 -140.67 136.92 33.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.35 -0.841 . . . . 74.519999999999996 111.827 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.751 HG11 ' CD2' ' A' ' 162' ' ' TYR . 28.2 m -76.62 139.22 19.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.312 -0.858 . . . . 74.129999999999995 110.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HA ' HD21 ' A' ' 160' ' ' ASN . 41.6 pttt -155.12 122.32 5.54 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 113.857 1.058 . . . . 72.140000000000001 113.857 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.466 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 11.8 mp0 27.42 67.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.357 1.614 . . . . 72.030000000000001 115.357 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' N ' ' CD2' ' A' ' 161' ' ' TYR . . . 86.81 -7.98 77.69 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.993 -0.622 . . . . 61.32 114.3 176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -50.44 129.93 22.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.597 0.236 . . . . 50.210000000000001 110.65 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -94.76 142.1 27.85 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 109.843 -0.428 . . . . 72.400000000000006 109.843 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.764 HD21 HD12 ' A' ' 25' ' ' LEU . 1.3 tp -101.86 127.99 48.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.94 0.4 . . . . 51.420000000000002 110.995 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 66.9 p -149.91 157.42 37.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.478 -0.783 . . . . 70.409999999999997 109.692 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.5 Cg_exo -76.33 -47.88 0.29 Allowed 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.988 -1.255 . . . . 52.420000000000002 112.102 0.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 38' ' ' VAL . 74.2 p -151.46 25.69 0.69 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.108 0.48 . . . . 64.329999999999998 111.395 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' A' ' 39' ' ' LYS . 13.8 pt20 -63.33 0.41 0.68 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.37 0.605 . . . . 72.25 111.039 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.692 HG12 HD23 ' A' ' 33' ' ' LEU . 35.4 m -74.21 32.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.49 -0.777 . . . . 74.409999999999997 111.605 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' CD ' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.55 -31.69 57.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.977 0.418 . . . . 61.420000000000002 111.139 -179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HB3' ' HA2' ' A' ' 22' ' ' GLY . 14.9 m-20 -87.16 142.86 27.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.498 0.555 . . . . 65.400000000000006 112.498 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.647 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.05 139.05 92.65 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 115.6 -0.727 . . . . 72.019999999999996 111.092 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.51 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 20.2 Cg_exo -63.19 126.6 18.19 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.724 1.616 . . . . 70.120000000000005 112.078 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 mm -108.39 112.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 64.040000000000006 110.24 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 HG21 ' A' ' 17' ' ' ILE . 57.2 t -86.07 142.23 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.554 0.576 . . . . 74.310000000000002 112.554 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 58.4 m -165.05 133.82 3.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.801 0.334 . . . . 53.049999999999997 111.253 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 15.0 p90 -108.66 32.41 4.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.44 0.638 . . . . 70.239999999999995 110.227 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.5 m -43.77 134.45 4.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.396 -0.82 . . . . 72.230000000000004 111.082 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.47 -29.86 4.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.86 -0.686 . . . . 71.019999999999996 112.975 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 49' ' ' LEU . 6.6 mp -80.73 -38.88 27.98 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.275 0.538 . . . . 73.450000000000003 110.25 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 13.1 tp10 -50.15 163.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.888 -0.597 . . . . 73.439999999999998 110.688 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.435 ' N ' ' HG3' ' A' ' 50' ' ' GLU . . . -170.12 -76.91 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.283 -0.727 . . . . 70.340000000000003 111.283 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -148.53 109.76 4.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.815 0.341 . . . . 71.400000000000006 110.295 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 m -151.31 141.72 22.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.028 -0.533 . . . . 71.310000000000002 110.02 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -74.89 -36.56 62.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.327 0.584 . . . . 52.310000000000002 109.474 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 83' ' ' ASN . 30.6 mt -155.28 164.84 38.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.998 -1.001 . . . . 73.120000000000005 110.455 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 35.0 mt -135.83 157.29 47.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.946 0.403 . . . . 65.409999999999997 110.92 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.527 HG23 ' NE2' ' A' ' 121' ' ' GLN . 0.7 OUTLIER -117.94 121.89 41.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 60.409999999999997 109.674 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.1 tm? -127.07 128.71 46.7 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.256 -0.646 . . . . 53.549999999999997 109.256 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.609 ' N ' HD13 ' A' ' 58' ' ' LEU . 43.5 mt -154.29 154.0 32.64 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.99 -0.284 . . . . 73.430000000000007 111.137 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -134.1 145.38 49.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.671 -0.492 . . . . 71.519999999999996 109.671 177.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 62' ' ' ASP . 8.8 t -150.62 164.76 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.867 1.062 . . . . 63.039999999999999 113.867 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.585 ' N ' HG12 ' A' ' 61' ' ' VAL . 46.6 t0 -172.85 86.08 0.41 Allowed Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 113.594 -1.639 . . . . 73.019999999999996 107.211 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.98 84.69 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.458 0 C-N-CA 123.204 2.602 . . . . 72.010000000000005 115.342 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -170.49 124.05 0.68 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.134 -0.484 . . . . 64.040000000000006 111.896 177.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 76' ' ' ILE . . . -170.31 136.95 1.27 Allowed Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.453 -0.34 . . . . 70.120000000000005 111.731 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HG3' ' CE2' ' A' ' 73' ' ' TYR . 18.6 Cg_exo -66.26 -33.48 2.8 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.752 -1.353 . . . . 72.140000000000001 110.945 -0.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.504 ' HA ' ' HB ' ' A' ' 109' ' ' THR . 3.5 t -130.21 157.34 42.75 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 64.140000000000001 109.872 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.526 ' NH1' ' NH2' ' A' ' 113' ' ' ARG . 23.8 ttt85 -58.37 -26.69 63.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.199 0.523 . . . . 65.219999999999999 109.785 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -78.2 -15.59 58.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.065 -0.97 . . . . 73.430000000000007 111.664 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 60.5 t0 -143.98 94.97 5.76 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.233 -0.439 . . . . 62.43 111.284 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 85.1 Cg_endo -80.78 50.51 3.59 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.123 2.549 . . . . 72.540000000000006 112.027 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.52 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 7.2 ttmt -58.6 -54.74 43.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.309 0.855 . . . . 71.120000000000005 113.309 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 66' ' ' PRO . 16.9 p90 -132.2 25.6 4.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.687 0.625 . . . . 70.019999999999996 112.687 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.742 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 2.8 tmm_? -58.19 134.7 56.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.694 -0.484 . . . . 72.010000000000005 109.694 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 73.5 mt-10 -90.31 178.22 6.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.542 1.137 . . . . 51.43 111.177 0.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.881 HD11 ' HB2' ' A' ' 65' ' ' ALA . 1.2 mp -98.04 -61.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.357 0.599 . . . . 51.409999999999997 109.962 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HG ' HG11 ' A' ' 101' ' ' VAL . 2.0 pt? -171.23 141.8 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.504 -0.925 . . . . 63.439999999999998 108.504 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.54 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 5.0 p-80 -137.57 176.01 9.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.925 0.393 . . . . 74.230000000000004 111.581 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.63 ' CZ2' HG21 ' A' ' 81' ' ' VAL . 7.4 t-105 -100.48 113.77 26.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.946 -0.761 . . . . 75.510000000000005 108.946 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.587 ' HA ' HD23 ' A' ' 59' ' ' LEU . 43.3 p -131.54 114.52 14.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.645 -0.707 . . . . 70.329999999999998 111.078 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.63 HG21 ' CZ2' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -127.33 117.91 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.239 -0.652 . . . . 64.319999999999993 109.239 178.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.734 HG21 ' HG3' ' A' ' 127' ' ' GLU . 21.8 m -114.87 164.8 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.332 -0.849 . . . . 64.230000000000004 111.758 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.616 HD21 ' CG ' ' A' ' 95' ' ' HIS . 24.8 p30 52.16 43.9 30.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.087 -0.96 . . . . 61.340000000000003 112.374 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 4.4 mm -75.43 118.06 67.95 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.89 -1.152 . . . . 72.540000000000006 107.89 176.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.45 125.72 18.56 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.689 1.593 . . . . 71.140000000000001 111.725 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.07 61.23 0.08 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.371 0.419 . . . . 51.100000000000001 113.656 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -171.09 39.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.419 0.688 . . . . 63.32 109.318 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 55.7 m-80 -130.08 -28.07 2.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.511 -0.768 . . . . 74.430000000000007 111.787 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.445 ' HA ' ' NE1' ' A' ' 46' ' ' TRP . 2.2 tt0 76.0 -9.24 1.48 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.071 0.463 . . . . 64.329999999999998 110.776 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -155.91 155.27 29.13 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.294 -0.866 . . . . 70.140000000000001 110.111 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HA ' HG21 ' A' ' 84' ' ' ILE . 84.4 Cg_endo -73.75 60.75 4.44 Favored 'Trans proline' 0 N--CA 1.479 0.655 0 C-N-CA 123.684 2.922 . . . . 63.119999999999997 113.21 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.0 t -90.96 -55.08 3.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.188 0.81 . . . . 70.310000000000002 113.188 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.8 -10.85 75.13 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 116.445 1.338 . . . . 72.109999999999999 116.445 -176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -71.19 164.42 53.76 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.789 -1.196 . . . . 73.140000000000001 113.662 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.616 ' CG ' HD21 ' A' ' 83' ' ' ASN . 13.5 m80 -65.21 121.35 14.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.805 0.336 . . . . 61.509999999999998 111.597 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.736 ' H ' HG22 ' A' ' 130' ' ' THR . 8.9 m -87.81 89.38 7.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 61.009999999999998 111.305 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 127' ' ' GLU . 16.7 mt -61.66 -17.36 55.15 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.536 0.684 . . . . 72.340000000000003 111.339 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HB3' ' OG ' ' A' ' 80' ' ' SER . . . -167.92 116.06 0.75 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.344 -0.844 . . . . 64.010000000000005 108.957 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.569 ' HB3' ' CA ' ' A' ' 133' ' ' ASN . 28.4 t0 -60.06 151.82 25.65 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.595 0.559 . . . . 61.229999999999997 111.992 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -70.12 148.38 48.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.294 0.569 . . . . 64.019999999999996 112.394 -179.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.585 HG22 ' H ' ' A' ' 103' ' ' SER . 10.3 p -135.31 133.0 52.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.827 -0.624 . . . . 71.329999999999998 110.03 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.44 -31.63 66.95 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.412 -0.899 . . . . 53.420000000000002 112.819 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 101' ' ' VAL . 34.4 m -164.83 127.65 2.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 73.010000000000005 111.123 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.87 -73.32 1.09 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.84 -0.618 . . . . 62.020000000000003 112.659 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 31.7 Cg_exo -57.84 133.57 56.95 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.848 2.366 . . . . 61.32 112.773 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 32.3 Cg_exo -58.38 151.59 59.91 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.107 2.538 . . . . 62.32 113.563 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 168' ' ' ASP . 21.8 pttm -46.12 -26.94 0.84 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.178 -0.919 . . . . 72.150000000000006 111.344 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.54 -30.36 12.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.095 -0.502 . . . . 72.109999999999999 110.462 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.504 ' HB ' ' HA ' ' A' ' 67' ' ' THR . 2.3 t -92.16 -26.7 18.12 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.278 0.561 . . . . 51.409999999999997 109.804 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.35 -100.5 0.81 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-N 115.578 -0.737 . . . . 75.150000000000006 114.886 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.91 125.41 22.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.661 0.744 . . . . 74.329999999999998 112.976 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.492 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 69.1 m-70 -116.04 123.01 46.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.622 -1.172 . . . . 73.010000000000005 110.097 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.526 ' NH2' ' NH1' ' A' ' 68' ' ' ARG . 36.8 mtm180 -94.47 85.25 4.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.811 -0.44 . . . . 62.340000000000003 109.811 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.45 ' OH ' ' HA ' ' A' ' 103' ' ' SER . 29.6 m-85 -70.33 114.5 8.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.128 -0.629 . . . . 74.430000000000007 110.676 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 60' ' ' MET . 38.4 mm -104.97 121.98 57.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 N-CA-C 110.261 -0.274 . . . . 73.109999999999999 110.261 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.507 ' CE2' HG11 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -102.54 128.51 49.16 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.856 0.462 . . . . 73.409999999999997 109.828 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -122.91 133.65 54.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 70.219999999999999 110.313 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.717 ' N ' HD13 ' A' ' 117' ' ' LEU . 33.7 tp -128.64 131.76 48.08 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.169 -0.469 . . . . 74.510000000000005 110.459 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 57' ' ' THR . 60.7 t80 -144.02 138.2 28.2 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.744 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HA ' HD23 ' A' ' 56' ' ' LEU . 12.7 ttp-105 -71.06 133.38 46.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.711 0.291 . . . . 63.020000000000003 110.702 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.527 ' NE2' HG23 ' A' ' 57' ' ' THR . 1.2 mt-30 -109.39 109.73 20.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.1 -0.5 . . . . 71.239999999999995 110.467 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.98 -43.46 11.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.045 -0.724 . . . . 75.510000000000005 109.045 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.626 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.0 OUTLIER -90.83 122.18 33.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.916 -1.038 . . . . 41.450000000000003 110.34 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HA ' HD12 ' A' ' 55' ' ' LEU . 58.6 tttm -70.9 128.08 34.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.337 0.589 . . . . 60.520000000000003 111.385 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.74 132.65 59.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.972 -1.013 . . . . 51.420000000000002 110.541 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -56.35 -59.48 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.137 0.494 . . . . 65.329999999999998 110.337 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.734 ' HG3' HG21 ' A' ' 82' ' ' VAL . 27.8 mm-40 58.33 32.64 22.31 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.397 -0.82 . . . . 73.129999999999995 113.192 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.529 ' HB ' ' CD ' ' A' ' 129' ' ' PRO . 39.9 p 49.38 171.62 0.02 OUTLIER Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 113.079 0.77 . . . . 53.229999999999997 113.079 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 128' ' ' THR . 36.9 Cg_exo -61.51 158.33 37.01 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.146 2.564 . . . . 65.450000000000003 113.295 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 96' ' ' SER . 20.7 p -58.75 124.71 20.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.843 -0.617 . . . . 72.519999999999996 111.398 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.4 mm -87.17 121.82 38.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 73.519999999999996 111.243 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.0 t -73.42 147.36 44.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.597 -0.729 . . . . 73.010000000000005 112.27 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.569 ' CA ' ' HB3' ' A' ' 99' ' ' ASP . 10.9 t-20 -55.11 -35.01 64.17 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.03 -0.532 . . . . 64.340000000000003 111.962 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.8 t -67.06 21.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.622 0.248 . . . . 65.319999999999993 111.483 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 133' ' ' ASN . 10.1 t -62.52 113.29 2.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.393 0.616 . . . . 63.130000000000003 111.089 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.528 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 41.8 ttt85 -89.08 173.21 8.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.331 -0.849 . . . . 74.530000000000001 110.96 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 77.4 m -34.08 143.59 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.109 -0.496 . . . . 55.450000000000003 111.546 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.11 3.9 19.01 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.133 -0.556 . . . . 75.319999999999993 112.213 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 13.1 mmm-85 -160.01 29.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.959 0.409 . . . . 74.5 110.775 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.65 -58.14 2.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.278 0.561 . . . . 70.209999999999994 110.277 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 5.9 m120 -67.95 44.93 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.283 -0.872 . . . . 53.229999999999997 112.799 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.609 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 4.0 t80 -109.38 90.35 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.822 -0.436 . . . . 71.219999999999999 109.822 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.09 112.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.536 . . . . 53.32 111.049 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 147' ' ' PHE . . . -57.63 -32.9 67.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.203 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -50.41 -32.71 18.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.384 -0.371 . . . . 63.439999999999998 111.07 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -56.12 -34.51 66.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.104 0.478 . . . . 71.430000000000007 110.284 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.609 ' CE1' ' CZ ' ' A' ' 142' ' ' PHE . 1.4 m-85 -49.76 -38.11 32.52 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.559 0.695 . . . . 75.209999999999994 109.687 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.59 -45.47 91.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.221 -0.899 . . . . 64.120000000000005 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.39 -48.34 42.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 65.219999999999999 111.949 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -59.01 -41.12 86.93 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.167 0.432 . . . . 74.420000000000002 112.167 -178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.486 ' N ' ' HD3' ' A' ' 150' ' ' LYS . 46.3 t60 -109.25 5.52 23.8 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.01 -0.676 . . . . 74.420000000000002 111.533 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 63.46 34.64 90.49 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.888 -0.673 . . . . 51.119999999999997 113.982 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 155' ' ' GLU . 11.3 mt -69.69 16.33 0.06 Allowed 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.517 -0.402 . . . . 61.109999999999999 111.016 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -55.74 1.66 0.07 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 114.241 0.457 . . . . 71.530000000000001 114.241 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 153' ' ' LEU . 4.9 pt-20 -135.11 72.66 66.73 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.258 0.551 . . . . 65.140000000000001 110.154 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 31.9 Cg_exo -57.03 129.37 34.12 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.452 2.102 . . . . 70.299999999999997 112.131 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 118' ' ' LEU . 21.1 pt -79.9 -38.18 18.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.495 -0.557 . . . . 74.450000000000003 109.495 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.713 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.31 148.64 32.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.889 -0.596 . . . . 74.340000000000003 110.877 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -150.68 157.74 43.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.982 0.42 . . . . 70.239999999999995 111.568 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 28' ' ' LYS . 1.8 t-20 -157.19 145.07 19.09 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 108.415 -0.958 . . . . 54.420000000000002 108.415 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.562 ' CB ' HD13 ' A' ' 115' ' ' ILE . 17.9 p90 -155.03 157.46 37.64 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.759 -0.588 . . . . 75.150000000000006 111.945 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.751 ' CD2' HG11 ' A' ' 27' ' ' VAL . 5.6 p90 -153.54 163.78 39.37 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.613 -0.721 . . . . 65.209999999999994 111.24 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 44.5 mt-30 -122.53 124.89 44.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 62.210000000000001 110.469 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.14 152.11 29.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.411 0.523 . . . . 75.319999999999993 112.411 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.601 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -127.18 148.1 50.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 108.346 -0.983 . . . . 42.240000000000002 108.346 177.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -137.38 152.69 49.94 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.02 0.378 . . . . 75.140000000000001 112.02 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.5 m-20 -54.93 163.34 1.03 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.765 -0.652 . . . . 74.140000000000001 111.865 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.522 ' HA ' ' HG2' ' A' ' 171' ' ' PRO . 6.3 t0 -68.03 27.71 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.689 -0.687 . . . . 74.239999999999995 111.3 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 167' ' ' ASP . 21.2 t80 -82.28 -60.86 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.74 0.644 . . . . 74.329999999999998 112.74 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 14.6 p -62.14 -32.09 9.05 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 113.337 0.866 . . . . 64.549999999999997 113.337 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 81.7 Cg_exo -47.97 -30.02 13.03 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 121.74 1.626 . . . . 74.310000000000002 111.091 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.3 mm -49.35 -37.77 11.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.68 -0.691 . . . . 75.099999999999994 109.401 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -45.87 -42.79 12.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.471 -0.786 . . . . 71.310000000000002 109.953 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.495 ' HA ' HG12 ' A' ' 177' ' ' ILE . 72.1 m-80 -58.28 -39.4 79.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.669 -0.696 . . . . 61.25 111.465 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -57.54 -28.25 63.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.905 0.383 . . . . 72.25 110.492 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 178' ' ' VAL . 42.5 m -84.61 -4.13 58.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.954 -0.566 . . . . 63.100000000000001 112.335 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.528 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 33.0 mm -62.11 99.14 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.088 0.47 . . . . 73.140000000000001 111.006 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 176' ' ' THR . 61.6 t -100.83 -6.94 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.588 -0.733 . . . . 73.530000000000001 112.491 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.482 -1.177 . . . . 61.43 112.42 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 110.104 -0.332 . . . . 73.310000000000002 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -68.67 110.22 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 73.230000000000004 109.302 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.53 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 64.3 t0 -89.63 -70.87 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.571 . . . . 65.420000000000002 112.38 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.874 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.9 OUTLIER -127.8 58.94 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.389 0.614 . . . . 64.349999999999994 111.02 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 7.3 p -130.07 139.48 35.78 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.627 -0.715 . . . . 72.349999999999994 109.947 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.7 Cg_endo -85.57 35.13 3.64 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.139 -1.192 . . . . 74.239999999999995 113.113 0.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.874 ' HB3' HG22 ' A' ' 4' ' ' ILE . 8.8 t70 -62.67 -49.92 73.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.952 0.406 . . . . 73.340000000000003 110.42 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -163.65 -44.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.912 -0.586 . . . . 60.009999999999998 110.927 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 115' ' ' ILE . 29.2 tp -157.25 137.84 13.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 64.439999999999998 110.797 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.429 ' H ' HD12 ' A' ' 9' ' ' LEU . 2.8 p30 -66.56 13.93 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.364 0.505 . . . . 55.5 112.364 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -171.2 137.52 1.15 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 122.319 0.247 . . . . 75.030000000000001 110.643 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -72.67 112.24 14.32 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-O 120.796 0.331 . . . . 63.340000000000003 111.698 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -88.7 134.52 2.77 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.893 2.396 . . . . 65.439999999999998 112.761 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.43 -36.52 71.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.461 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.82 -159.05 7.98 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.757 -0.656 . . . . 51.219999999999999 111.77 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -135.9 162.94 31.43 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.178 0.513 . . . . 43.130000000000003 111.31 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.833 HG21 HG23 ' A' ' 44' ' ' VAL . 10.2 mt -105.31 135.17 44.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.292 -0.867 . . . . 70.219999999999999 110.484 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 30.9 mmmt -74.56 106.05 5.97 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.686 -0.688 . . . . 71.400000000000006 109.683 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 60.1 t -121.58 110.45 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.747 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.702 HG21 ' O ' ' A' ' 23' ' ' ASP . 3.0 mp -96.01 134.63 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.216 -0.902 . . . . 63.420000000000002 109.465 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -81.67 -85.34 0.1 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.67 -0.412 . . . . 71.319999999999993 111.782 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' H ' HD21 ' A' ' 25' ' ' LEU . . . -67.58 -49.84 47.47 Favored Glycine 0 C--O 1.229 -0.17 0 C-N-CA 120.35 -0.928 . . . . 70.230000000000004 112.447 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.702 ' O ' HG21 ' A' ' 20' ' ' ILE . 34.9 t70 172.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.716 0.769 . . . . 74.150000000000006 109.019 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.58 -49.72 5.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.741 -1.118 . . . . 72.409999999999997 110.522 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.1 pt? -69.66 139.57 53.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.3 0.572 . . . . 55.310000000000002 111.581 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 27' ' ' VAL . 69.5 tt0 -120.82 150.01 41.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.267 -0.879 . . . . 64.409999999999997 111.857 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 162' ' ' TYR . 10.5 m -98.7 119.53 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.85 -0.796 . . . . 74.140000000000001 108.85 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HD2' ' OD1' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -139.08 128.58 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.757 0.789 . . . . 74.430000000000007 112.7 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.565 ' HA ' ' CE2' ' A' ' 161' ' ' TYR . 6.9 mp0 46.41 63.15 1.99 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.035 -1.438 . . . . 72.519999999999996 114.854 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.03 11.39 44.63 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 115.739 1.056 . . . . 74.310000000000002 115.739 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' OD1' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -54.24 139.48 35.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.779 0.789 . . . . 50.350000000000001 110.701 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.92 123.02 29.52 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.726 -0.472 . . . . 74.319999999999993 109.726 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 27' ' ' VAL . 9.9 mp -92.75 114.21 26.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.735 -0.386 . . . . 52.219999999999999 110.741 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -150.12 156.96 37.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 62.32 110.488 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.23 -100.4 0.0 OUTLIER 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.156 -1.185 . . . . 74.329999999999998 113.869 0.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -70.2 54.35 0.14 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.653 0.612 . . . . 74.420000000000002 112.653 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.409 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 18.0 pt20 -120.39 -6.32 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.98 0.419 . . . . 70.299999999999997 110.983 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.36 -6.69 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.12 -0.491 . . . . 74.439999999999998 111.911 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.44 -10.57 59.48 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.49 -0.323 . . . . 65.129999999999995 111.79 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 21' ' ' TYR . 87.3 m-20 -79.07 144.76 34.29 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.162 0.506 . . . . 54.340000000000003 112.193 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.607 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -76.31 138.47 67.93 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.697 -0.683 . . . . 64.099999999999994 109.878 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -78.88 126.88 7.46 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.319 2.013 . . . . 60.340000000000003 113.215 -179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.6 mm -104.25 105.93 19.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.015 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.833 HG23 HG21 ' A' ' 17' ' ' ILE . 2.6 p -87.14 143.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 113.234 0.827 . . . . 62.450000000000003 113.234 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.9 m -162.24 132.55 4.77 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 121.023 0.44 . . . . 65.540000000000006 110.965 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.717 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -112.34 26.92 10.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.023 -0.535 . . . . 75.420000000000002 110.399 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 t -41.41 123.35 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 61.530000000000001 111.644 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.89 -29.64 7.28 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.06 -0.591 . . . . 73.409999999999997 113.28 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.7 mp -76.15 -31.19 58.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.145 0.472 . . . . 70.409999999999997 111.336 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.717 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -70.48 -65.98 0.66 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.858 -0.61 . . . . 72.239999999999995 110.922 -179.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 65.76 -75.88 0.11 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.737 -0.665 . . . . 63.030000000000001 112.499 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -148.71 110.08 4.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 63.210000000000001 111.492 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.6 p -151.4 145.01 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.78 -0.645 . . . . 65.219999999999999 109.342 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 11.2 t30 -65.75 -39.5 91.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.775 0.798 . . . . 50.009999999999998 109.369 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.68 HD22 ' O ' ' A' ' 83' ' ' ASN . 46.2 mt -158.48 162.17 37.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.522 -1.217 . . . . 73.140000000000001 110.06 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 81.5 mt -128.85 142.48 50.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.774 0.321 . . . . 75.030000000000001 110.393 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.765 HG23 ' CG1' ' A' ' 82' ' ' VAL . 56.1 m -113.63 118.14 33.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 111.245 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.8 tm? -116.36 140.29 49.5 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.73 -0.47 . . . . 73.219999999999999 109.73 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.843 ' N ' HD13 ' A' ' 58' ' ' LEU . 89.5 mt -141.89 154.85 45.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.373 . . . . 70.129999999999995 111.207 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.442 ' HB3' ' HB3' ' A' ' 78' ' ' HIS . 23.5 ttt -117.63 124.38 48.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.674 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 40.7 t -108.96 132.74 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.319999999999993 109.778 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 7.9 t70 -176.94 62.07 0.19 Allowed Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.408 -0.96 . . . . 72.109999999999999 108.408 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD3' HG12 ' A' ' 61' ' ' VAL . 22.4 Cg_endo -91.59 83.39 0.31 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.692 1.595 . . . . 55.450000000000003 114.073 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -171.13 107.93 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.279 -0.873 . . . . 73.439999999999998 110.796 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.729 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.07 135.58 1.24 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 121.127 -0.229 . . . . 75.530000000000001 111.299 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.729 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 Cg_endo -52.28 -15.28 0.44 Allowed 'Cis proline' 0 C--N 1.356 0.957 0 C-N-CA 124.32 -1.116 . . . . 64.400000000000006 111.946 -2.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.521 ' N ' ' HA ' ' A' ' 65' ' ' ALA . 6.7 t -165.15 -175.89 3.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.505 -0.77 . . . . 74.450000000000003 110.003 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' A' ' 64' ' ' ASP . 13.7 tpt180 -67.73 -34.9 77.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.03 0.443 . . . . 75.519999999999996 109.838 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -71.0 -45.21 64.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.506 -0.77 . . . . 65.010000000000005 112.957 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.501 ' H ' HG23 ' A' ' 67' ' ' THR . 49.0 t0 -108.8 103.15 50.92 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.628 -0.429 . . . . 73.340000000000003 111.11 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -86.22 52.92 2.99 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.66 2.24 . . . . 75.540000000000006 110.865 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -48.57 -31.48 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.909 -0.587 . . . . 73.329999999999998 110.287 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.574 ' HB2' HD21 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -166.47 56.17 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.328 -0.851 . . . . 71.239999999999995 109.736 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.461 ' C ' ' HD2' ' A' ' 74' ' ' ARG . 4.9 tmm_? -99.26 135.27 40.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.911 -1.495 . . . . 72.439999999999998 109.417 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 21.6 mp0 -76.15 177.81 6.88 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.711 0.804 . . . . 72.319999999999993 111.9 0.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 77' ' ' LEU . 5.4 tp -109.75 -173.55 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.822 -1.177 . . . . 64.340000000000003 107.822 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.562 ' H ' HG13 ' A' ' 76' ' ' ILE . 96.8 mt -64.99 120.37 12.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.078 0.399 . . . . 65.340000000000003 110.917 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' MET . 36.5 m170 -107.78 169.24 8.72 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.102 -0.239 . . . . 74.299999999999997 110.724 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.459 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.6 t-105 -100.01 85.27 3.02 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.741 0.782 . . . . 61.130000000000003 110.215 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 p -98.99 127.21 44.86 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.784 -1.098 . . . . 62.32 112.704 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -147.91 124.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.553 -0.748 . . . . 62.439999999999998 109.115 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.765 ' CG1' HG23 ' A' ' 57' ' ' THR . 23.6 m -138.13 -176.5 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.012 0.434 . . . . 70.400000000000006 111.732 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.68 ' O ' HD22 ' A' ' 55' ' ' LEU . 15.6 p30 52.13 37.26 21.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.962 -1.017 . . . . 74.400000000000006 109.518 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.032 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm -78.93 106.56 4.52 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 114.891 -1.05 . . . . 73.200000000000003 108.737 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HG2' HD21 ' A' ' 88' ' ' ASN . 2.3 Cg_endo -48.13 129.04 17.95 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.759 1.64 . . . . 73.420000000000002 111.788 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.3 69.67 0.01 OUTLIER Glycine 0 CA--C 1.526 0.754 0 O-C-N 123.412 0.445 . . . . 63.350000000000001 113.823 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' PRO . 44.0 t 179.81 47.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.378 -0.601 . . . . 73.409999999999997 109.378 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 90' ' ' ASN . 55.0 m-80 -135.16 -22.39 1.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.173 -0.921 . . . . 61.299999999999997 112.309 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 67.86 -15.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.869 0.322 . . . . 73.0 111.869 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 88' ' ' ASN . 5.3 p30 -153.84 156.45 32.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 109.666 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 84' ' ' ILE . 74.3 Cg_endo -70.54 56.67 1.75 Allowed 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 123.334 2.689 . . . . 64.510000000000005 113.975 -178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -104.15 -40.08 6.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.441 -0.503 . . . . 73.230000000000004 112.02 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.43 -41.56 58.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 114.887 0.715 . . . . 45.240000000000002 114.887 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 1.032 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.07 170.35 14.71 Favored Glycine 0 N--CA 1.46 0.287 0 C-N-CA 120.993 -0.622 . . . . 63.439999999999998 113.179 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.484 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -71.14 121.28 18.04 Favored 'General case' 0 CA--C 1.513 -0.451 0 O-C-N 122.876 -0.19 . . . . 75.150000000000006 111.296 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.705 ' HA ' HG13 ' A' ' 81' ' ' VAL . 95.8 p -82.09 116.22 21.58 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.837 -1.172 . . . . 52.219999999999999 107.837 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' HG3' ' A' ' 127' ' ' GLU . 11.2 mt -67.36 -55.01 15.56 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.039 0.447 . . . . 72.140000000000001 109.968 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 131' ' ' ILE . . . -137.03 125.05 22.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.293 -0.867 . . . . 61.020000000000003 109.146 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 9.9 t0 -52.17 148.57 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.86 0.362 . . . . 45.329999999999998 111.318 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 37.6 p90 -65.03 128.74 37.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.261 0.553 . . . . 73.230000000000004 111.071 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.576 ' O ' HG13 ' A' ' 101' ' ' VAL . 9.9 p -106.38 113.79 43.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.472 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.81 6.97 23.14 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.679 -0.772 . . . . 50.119999999999997 112.25 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 101' ' ' VAL . 38.2 t -59.98 -97.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.02 0.378 . . . . 75.109999999999999 112.02 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.24 161.88 37.82 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.928 -0.653 . . . . 52.210000000000001 112.254 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HB2' ' CE1' ' A' ' 112' ' ' HIS . 31.8 Cg_exo -60.72 137.59 74.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.932 2.421 . . . . 62.509999999999998 112.565 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 167' ' ' ASP . 41.0 Cg_endo -66.76 161.26 42.73 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.727 2.285 . . . . 73.230000000000004 113.211 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -42.36 -23.28 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.185 -0.916 . . . . 73.120000000000005 112.026 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.2 m-20 -50.8 -35.4 31.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.514 -0.312 . . . . 74.099999999999994 111.582 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.491 ' HB ' ' HB ' ' A' ' 67' ' ' THR . 12.4 t -103.75 8.8 37.26 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.335 -0.546 . . . . 63.049999999999997 110.968 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.488 ' O ' ' CE1' ' A' ' 112' ' ' HIS . . . 54.45 -110.96 1.81 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 113.751 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.486 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 27.6 tp -63.83 162.38 13.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.437 0.637 . . . . 61.119999999999997 111.899 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 110' ' ' GLY . 8.2 m-70 -147.04 144.62 29.25 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.384 -0.826 . . . . 72.319999999999993 109.303 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -109.05 108.65 19.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.022 -0.362 . . . . 73.209999999999994 110.022 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -104.55 133.31 49.63 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.523 -0.547 . . . . 74.450000000000003 109.523 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 9' ' ' LEU . 26.8 mt -132.96 147.51 31.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.192 0.52 . . . . 43.420000000000002 111.54 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -120.84 134.31 55.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.237 -0.892 . . . . 73.319999999999993 109.395 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.685 HD11 ' HB3' ' A' ' 156' ' ' PRO . 18.5 tp -119.9 140.15 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.144 0.277 . . . . 64.430000000000007 110.475 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 158' ' ' ALA . 62.6 tp -134.79 135.49 41.84 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.39 -0.368 . . . . 63.43 111.09 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HA ' HG12 ' A' ' 157' ' ' ILE . 37.7 t80 -144.25 142.85 30.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.968 -0.56 . . . . 75.319999999999993 110.553 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.848 ' HG3' HD13 ' A' ' 157' ' ' ILE . 98.2 mtt180 -71.47 128.33 35.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 110.626 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 56.8 tp60 -103.91 115.15 29.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.534 -0.757 . . . . 73.040000000000006 110.437 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.451 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 37.2 tt0 -87.04 -37.98 16.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.231 -0.44 . . . . 74.349999999999994 111.413 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -112.19 135.12 53.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.701 0.286 . . . . 33.329999999999998 111.253 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 26.2 tptp -65.42 119.33 10.81 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.928 -0.578 . . . . 62.340000000000003 111.471 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.73 131.89 45.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.419 -0.81 . . . . 75.099999999999994 109.754 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -49.16 -57.89 5.91 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.856 0.36 . . . . 63.439999999999998 110.906 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.573 ' HG2' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 66.11 13.0 8.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 113.84 1.052 . . . . 72.430000000000007 113.84 177.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.56 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 25.2 p 51.21 162.98 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.613 0.968 . . . . 74.010000000000005 113.613 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 18.6 Cg_endo -58.24 151.4 60.07 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.88 2.387 . . . . 54.039999999999999 112.974 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 131' ' ' ILE . 89.1 m -60.0 151.3 26.65 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.008 0.744 . . . . 74.319999999999993 113.008 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.425 ' N ' HG22 ' A' ' 130' ' ' THR . 40.8 mm -121.93 129.93 75.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.802 -1.09 . . . . 72.019999999999996 109.595 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' THR . 27.6 t -71.12 148.31 47.56 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.643 0.258 . . . . 71.010000000000005 111.528 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.515 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 24.9 p30 -65.4 5.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.156 0.503 . . . . 75.439999999999998 110.348 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 132' ' ' SER . 64.5 p -114.26 15.19 18.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.497 -0.774 . . . . 51.450000000000003 111.336 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.0 t -62.82 133.91 55.44 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.555 -0.458 . . . . 45.210000000000001 110.698 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' A' ' 137' ' ' THR . 22.4 tpp180 -71.83 170.99 12.48 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.34 -0.391 . . . . 75.310000000000002 110.668 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 66.2 m -40.57 145.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.619 . . . . 43.439999999999998 110.231 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.33 -22.04 11.42 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 110.993 -0.843 . . . . 74.25 110.993 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtt85 -131.21 24.16 4.87 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.845 0.355 . . . . 74.510000000000005 110.113 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 177' ' ' ILE . 37.2 mt -94.07 -56.37 2.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.53 0.681 . . . . 73.450000000000003 109.501 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.574 HD21 ' HB2' ' A' ' 73' ' ' TYR . 4.3 m120 -79.55 121.36 25.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.725 -1.125 . . . . 71.230000000000004 111.66 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.41 ' HE2' ' CZ ' ' A' ' 147' ' ' PHE . 5.7 t80 -167.79 115.87 0.76 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.938 -1.028 . . . . 74.530000000000001 109.993 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -71.44 110.65 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.736 -0.666 . . . . 44.149999999999999 111.561 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.65 -28.88 57.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.401 0.62 . . . . 73.129999999999995 110.073 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -52.63 -23.54 6.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 111.001 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.41 -46.94 81.07 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.878 0.37 . . . . 72.109999999999999 111.248 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.537 ' HA ' ' CD ' ' A' ' 150' ' ' LYS . 76.1 m-85 -45.33 -49.15 13.06 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.114 -0.494 . . . . 74.25 111.847 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.21 51.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.912 -0.586 . . . . 35.229999999999997 111.073 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.07 -51.85 6.77 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.306 0.484 . . . . 64.349999999999994 112.306 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -53.68 -50.55 65.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 73.510000000000005 111.817 -178.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.528 ' HB2' ' HG ' ' A' ' 153' ' ' LEU . 33.7 m-70 -103.63 11.38 36.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.692 0.282 . . . . 75.510000000000005 111.494 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 53.26 28.93 36.12 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.619 -0.8 . . . . 73.329999999999998 112.722 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.528 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 11.6 mt -67.6 7.44 0.48 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.904 0.335 . . . . 75.120000000000005 111.904 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 153' ' ' LEU . . . -30.23 -59.96 0.21 Allowed Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.375 -0.44 . . . . 40.409999999999997 113.836 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.31 112.69 19.88 Favored Pre-proline 0 N--CA 1.465 0.284 0 N-CA-C 111.631 0.234 . . . . 73.239999999999995 111.631 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.685 ' HB3' HD11 ' A' ' 117' ' ' LEU . 69.7 Cg_endo -92.15 127.32 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.536 2.157 . . . . 73.109999999999999 112.888 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.848 HD13 ' HG3' ' A' ' 120' ' ' ARG . 42.9 pt -75.98 -34.65 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.875 0.369 . . . . 70.25 110.452 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.599 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.14 149.7 26.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 51.43 111.246 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' CB ' ' CD2' ' A' ' 9' ' ' LEU . . . -151.49 154.41 36.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.804 -0.635 . . . . 74.409999999999997 110.081 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -152.46 133.61 14.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.245 -1.02 . . . . 71.430000000000007 108.245 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.692 ' HB3' HG23 ' A' ' 115' ' ' ILE . 2.1 p90 -138.71 156.08 47.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.457 -0.338 . . . . 75.310000000000002 111.486 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.526 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 p90 -154.34 150.42 27.93 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.171 -0.468 . . . . 73.230000000000004 111.363 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -110.98 133.1 53.66 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.905 -0.589 . . . . 71.319999999999993 111.179 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.71 149.44 25.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.249 -0.887 . . . . 71.420000000000002 109.852 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.562 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -103.34 132.9 49.22 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.562 -0.533 . . . . 63.130000000000003 109.562 178.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -109.29 129.18 55.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.657 0.265 . . . . 64.319999999999993 110.768 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 106' ' ' PRO . 1.0 OUTLIER -62.29 -125.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.901 -0.59 . . . . 71.340000000000003 111.942 -179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.618 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 22.7 t0 -129.77 -20.63 3.17 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.882 -0.599 . . . . 65.510000000000005 111.281 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.533 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 17.9 t80 -68.32 -69.22 0.34 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.142 0.793 . . . . 75.109999999999999 113.142 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.735 HG12 ' HD3' ' A' ' 171' ' ' PRO . 7.5 p -50.01 -37.36 25.9 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 111.996 0.369 . . . . 74.430000000000007 111.996 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.735 ' HD3' HG12 ' A' ' 170' ' ' VAL . 50.2 Cg_exo -54.03 -12.25 3.38 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.512 2.141 . . . . 73.329999999999998 111.688 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 175' ' ' LYS . 8.8 tp -45.77 -30.57 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 115.662 -0.699 . . . . 63.409999999999997 111.842 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -53.19 -46.76 69.12 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 119.906 -0.718 . . . . 71.030000000000001 109.513 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.424 ' HA ' HG13 ' A' ' 177' ' ' ILE . 44.6 t30 -63.83 -37.12 86.18 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.316 -0.624 . . . . 75.450000000000003 109.316 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.647 ' HB2' HD12 ' A' ' 172' ' ' ILE . 61.2 mttp -68.67 -27.97 66.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.576 -0.738 . . . . 71.450000000000003 110.18 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 176' ' ' THR . 18.9 m -97.1 13.1 30.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.929 -0.578 . . . . 74.230000000000004 112.524 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.519 ' CG2' ' HA ' ' A' ' 136' ' ' ARG . 31.6 mt -64.95 140.86 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.382 -0.599 . . . . 64.439999999999998 109.382 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.515 ' HA ' ' NH2' ' A' ' 136' ' ' ARG . 29.3 m -143.17 -25.42 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 113.72 1.007 . . . . 62.329999999999998 113.72 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.451 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.317 -1.269 . . . . 73.25 112.728 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 110.033 -0.358 . . . . 62.109999999999999 110.033 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 60.92 33.46 19.85 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.336 0.588 . . . . 73.439999999999998 111.248 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.7 t70 -67.47 -48.09 68.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 73.209999999999994 111.513 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 9' ' ' LEU . 8.4 pt -114.95 44.7 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.245 0.545 . . . . 54.409999999999997 111.845 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.9 137.74 20.93 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.994 -0.548 . . . . 40.030000000000001 111.013 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -93.55 32.92 10.11 Favored 'Cis proline' 0 C--N 1.348 0.534 0 C-N-CA 124.129 -1.196 . . . . 74.310000000000002 112.113 -0.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' HG13 ' A' ' 8' ' ' VAL . 10.1 t70 -51.45 -51.58 53.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 55.140000000000001 110.563 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.2 m -160.32 -35.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.044 -0.526 . . . . 72.420000000000002 111.706 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' CD1' HG21 ' A' ' 115' ' ' ILE . 27.6 tp -157.25 172.39 18.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 74.099999999999994 111.056 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 3' ' ' ASP . 9.4 p-10 -78.3 -38.04 43.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.089 -0.708 . . . . 72.200000000000003 109.089 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.475 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -152.55 131.65 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.611 -0.722 . . . . 71.319999999999993 109.905 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 7.2 p -59.82 126.4 83.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 112.134 0.42 . . . . 64.310000000000002 112.134 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.643 ' HG3' ' HB3' ' A' ' 159' ' ' ALA . 71.6 Cg_endo -96.22 -117.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.758 2.972 . . . . 74.239999999999995 111.9 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -166.46 -42.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.607 -0.269 . . . . 72.510000000000005 111.33 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 158.36 17.98 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.778 -0.725 . . . . 60.200000000000003 113.575 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.467 ' O ' HD11 ' A' ' 49' ' ' LEU . 3.1 t -102.83 152.17 21.58 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.011 0.434 . . . . 64.310000000000002 110.48 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 118' ' ' LEU . 9.2 mt -105.73 123.4 60.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.962 -0.755 . . . . 74.129999999999995 108.962 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.3 OUTLIER -73.98 102.57 4.18 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.455 -0.793 . . . . 72.140000000000001 109.581 -178.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 27' ' ' VAL . 59.2 t -111.0 110.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 2.6 mp -104.54 128.5 58.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.794 -0.639 . . . . 73.420000000000002 111.302 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.489 ' C ' ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -96.64 -84.93 0.35 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.159 -0.928 . . . . 65.230000000000004 110.867 -179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' ASP . . . -59.69 3.15 0.27 Allowed Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.594 -0.73 . . . . 62.32 113.274 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' ' CG2' ' A' ' 20' ' ' ILE . 0.2 OUTLIER 85.37 -43.96 0.06 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.896 -1.149 . . . . 74.230000000000004 107.896 -177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.76 -37.39 19.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.999 -1.0 . . . . 72.140000000000001 108.712 176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 37' ' ' GLN . 0.2 OUTLIER -79.31 163.14 25.14 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.215 -0.902 . . . . 74.049999999999997 112.496 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 23.2 tt0 -151.7 127.75 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.758 -1.11 . . . . 64.140000000000001 110.288 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.875 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.3 m -71.64 128.18 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.322 0.582 . . . . 63.530000000000001 111.711 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.569 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 73.4 mmtt -112.59 111.37 22.14 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.518 0.932 . . . . 72.140000000000001 113.518 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.446 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 7.4 mp0 31.06 67.54 0.13 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.804 1.409 . . . . 70.200000000000003 114.804 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.69 4.58 89.4 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.343 -0.456 . . . . 74.140000000000001 113.448 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -55.57 146.76 19.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.311 0.577 . . . . 63.119999999999997 112.297 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -98.37 140.85 32.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.98 -1.009 . . . . 72.340000000000003 111.191 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 38' ' ' VAL . 7.5 mp -106.27 132.4 52.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.991 0.424 . . . . 71.209999999999994 110.761 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 8.8 p -140.66 161.72 52.93 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 75.329999999999998 109.849 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 83.8 Cg_endo -82.09 -33.16 3.12 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 124.142 -1.191 . . . . 65.25 113.404 0.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.694 HG22 ' O ' ' A' ' 36' ' ' THR . 85.1 m -156.65 42.92 0.37 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.285 0.564 . . . . 51.399999999999999 111.462 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.583 ' OE1' HD12 ' A' ' 25' ' ' LEU . 23.5 pt20 -92.76 0.23 57.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.413 0.625 . . . . 73.510000000000005 110.797 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 33' ' ' LEU . 28.0 m -68.65 -7.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.479 -0.782 . . . . 71.200000000000003 111.284 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 -11.32 60.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.145 -0.479 . . . . 43.130000000000003 110.608 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.35 133.3 35.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 62.119999999999997 111.434 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -62.9 138.69 97.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.754 -0.657 . . . . 60.109999999999999 110.087 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.16 126.51 13.13 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 121.8 1.666 . . . . 74.129999999999995 112.516 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.5 mm -100.77 114.73 40.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 60.439999999999998 110.288 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.479 HG13 ' HD2' ' A' ' 91' ' ' PRO . 3.8 p -85.54 140.75 15.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.399 0.518 . . . . 72.120000000000005 112.399 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 14.4 m -161.98 139.21 8.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.952 0.406 . . . . 71.040000000000006 110.347 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.658 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.4 p90 -121.68 29.8 7.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 74.239999999999995 110.352 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.7 t -44.94 137.15 4.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.701 -0.681 . . . . 65.420000000000002 110.225 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.19 -32.51 3.54 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.654 -0.784 . . . . 63.450000000000003 112.239 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 16' ' ' THR . 96.2 mt -79.5 -41.29 27.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.708 0.766 . . . . 64.239999999999995 109.094 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.658 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 18.0 tt0 -53.52 105.98 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.698 -1.137 . . . . 73.230000000000004 110.558 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.3 -114.86 1.28 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.1 -1.2 . . . . 71.349999999999994 110.1 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -80.56 109.19 14.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.635 -0.826 . . . . 54.439999999999998 109.373 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.78 141.79 15.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.444 -0.344 . . . . 62.420000000000002 111.532 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 30.7 t30 -89.26 -42.19 11.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.791 0.805 . . . . 74.109999999999999 109.583 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 76.9 mt -152.36 170.0 21.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.686 -1.143 . . . . 70.340000000000003 108.595 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 84.4 mt -138.38 153.15 48.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.466 -0.494 . . . . 64.120000000000005 111.764 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.875 HG23 HG12 ' A' ' 82' ' ' VAL . 31.5 m -121.42 130.62 53.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.743 -0.662 . . . . 74.109999999999999 110.215 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -128.87 123.91 33.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.253 -0.647 . . . . 71.239999999999995 109.253 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.578 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.6 mt -143.16 161.78 37.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.681 0.753 . . . . 74.049999999999997 113.017 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.89 146.69 24.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.203 -1.362 . . . . 73.120000000000005 109.974 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 76.8 t -134.09 137.11 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.288 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' HH21 ' A' ' 68' ' ' ARG . 52.5 t0 83.32 59.11 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 CA-C-N 114.945 -1.025 . . . . 71.439999999999998 111.52 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' CG ' ' HG3' ' A' ' 75' ' ' GLU . 57.4 Cg_endo -71.28 123.01 9.21 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.509 2.14 . . . . 75.239999999999995 111.9 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 25.8 p-10 -118.36 120.76 38.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.68 0.622 . . . . 74.209999999999994 112.68 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.742 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -170.65 135.98 1.13 Allowed Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.434 0.531 . . . . 70.450000000000003 112.434 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 55.3 Cg_endo -74.2 -3.75 17.53 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.217 -1.576 . . . . 75.109999999999999 109.794 -2.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.8 t -165.01 156.72 15.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.967 -1.015 . . . . 44.340000000000003 110.373 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' HG2' ' CB ' ' A' ' 64' ' ' ASP . 6.5 mtp-105 -68.33 -12.74 61.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.812 -0.631 . . . . 74.310000000000002 110.951 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -84.32 -32.94 24.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.889 -0.596 . . . . 61.039999999999999 112.252 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 64.1 t0 -144.08 116.13 5.6 Favored Pre-proline 0 CA--C 1.529 0.142 0 CA-C-O 120.713 0.292 . . . . 43.409999999999997 110.471 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.09 52.5 4.19 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.039 2.493 . . . . 72.209999999999994 112.302 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HB2' ' HD3' ' A' ' 66' ' ' PRO . 95.9 mttt -48.93 -27.29 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 75.099999999999994 111.637 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.742 ' CE1' ' HB1' ' A' ' 65' ' ' ALA . 25.3 p90 -155.55 29.22 0.38 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.299 0.571 . . . . 74.340000000000003 110.781 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 5.7 tmm_? -70.52 136.13 49.12 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.144 -1.058 . . . . 71.099999999999994 108.144 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 14.2 mp0 -88.61 159.09 18.04 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 124.236 1.014 . . . . 73.439999999999998 111.873 0.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' A' ' 73' ' ' TYR . 9.1 tp -97.37 171.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.442 -0.799 . . . . 74.109999999999999 109.696 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' CD2' HG11 ' A' ' 101' ' ' VAL . 13.9 tp -42.72 112.89 0.4 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.553 0.692 . . . . 64.310000000000002 110.297 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -104.22 160.28 15.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.572 -1.195 . . . . 61.140000000000001 113.285 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 10.5 t-105 -100.43 116.19 31.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.579 -1.267 . . . . 73.200000000000003 107.579 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.04 135.4 31.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.229 0.825 . . . . 72.219999999999999 113.229 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -140.66 138.5 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.58 -0.737 . . . . 70.420000000000002 110.893 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.875 HG12 HG23 ' A' ' 57' ' ' THR . 26.2 m -142.05 169.12 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.367 0.603 . . . . 72.239999999999995 112.44 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 24.8 p30 51.82 36.18 17.35 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.562 -1.199 . . . . 72.219999999999999 112.132 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.99 HG21 ' HA ' ' A' ' 91' ' ' PRO . 5.1 mm -69.02 125.81 92.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.715 -0.846 . . . . 64.319999999999993 108.715 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HB2' HD21 ' A' ' 88' ' ' ASN . 34.0 Cg_exo -58.75 126.28 20.75 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 121.429 1.419 . . . . 74.329999999999998 110.902 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.81 60.79 0.05 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.321 0.488 . . . . 54.039999999999999 114.321 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 85' ' ' PRO . 75.1 m -174.97 43.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.935 0.494 . . . . 55.039999999999999 110.255 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.598 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.1 m-80 -135.31 8.94 3.44 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 113.528 0.936 . . . . 65.530000000000001 113.528 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER 64.65 -26.9 0.09 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.062 0.393 . . . . 74.010000000000005 112.062 177.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.598 ' H ' ' C ' ' A' ' 88' ' ' ASN . 14.8 p30 -154.05 172.63 5.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.187 0.595 . . . . 73.310000000000002 109.932 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.99 ' HA ' HG21 ' A' ' 84' ' ' ILE . 6.1 Cg_exo -79.74 23.9 0.65 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.643 2.896 . . . . 51.539999999999999 115.529 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -79.63 1.11 27.39 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 118.856 -1.138 . . . . 53.509999999999998 112.985 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.11 2.1 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.495 -0.86 . . . . 34.310000000000002 113.609 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.929 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.7 176.49 10.98 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.229 -0.51 . . . . 45.310000000000002 113.669 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.782 ' CE1' HG23 ' A' ' 130' ' ' THR . 46.2 t60 -66.36 121.12 14.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.389 0.514 . . . . 73.019999999999996 112.389 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.1 p -86.26 89.32 7.81 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.924 -0.769 . . . . 64.439999999999998 108.924 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 147' ' ' PHE . 12.4 mt -50.28 -53.83 25.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.694 -0.684 . . . . 64.439999999999998 110.484 -178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.66 120.38 13.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.958 -1.019 . . . . 62.32 108.714 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.51 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 54.5 t0 -60.21 146.82 42.2 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.6 0.563 . . . . 74.109999999999999 112.084 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.511 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 21.2 p90 -66.38 142.82 57.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.892 -0.595 . . . . 74.430000000000007 110.295 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 133' ' ' ASN . 21.4 m -140.38 145.03 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.696 0.284 . . . . 75.5 111.528 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.512 ' O ' HG12 ' A' ' 170' ' ' VAL . . . -85.03 0.07 89.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.925 -0.655 . . . . 51.229999999999997 111.642 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 t -58.93 -91.29 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.561 -0.319 . . . . 70.109999999999999 110.604 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 -167.99 5.03 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.909 -0.662 . . . . 74.420000000000002 114.224 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 44.8 Cg_endo -65.74 145.5 81.28 Favored 'Trans proline' 0 N--CA 1.476 0.477 0 C-N-CA 123.67 2.913 . . . . 72.299999999999997 113.107 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.58 160.68 48.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.066 2.51 . . . . 71.540000000000006 113.332 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.494 ' CE ' ' HA ' ' A' ' 167' ' ' ASP . 35.8 ttmt -44.03 -25.09 0.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.092 -0.504 . . . . 73.150000000000006 111.055 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -50.46 -37.87 40.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.887 -0.597 . . . . 63.119999999999997 111.422 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.414 ' CG2' ' CE1' ' A' ' 112' ' ' HIS . 11.4 t -76.4 -19.44 58.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.525 -0.47 . . . . 73.120000000000005 111.839 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.92 -129.8 9.29 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.599 -0.81 . . . . 61.450000000000003 113.32 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 44.7 tp -67.49 135.28 52.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.01 0.744 . . . . 75.239999999999995 113.01 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.698 ' CE1' ' HG2' ' A' ' 105' ' ' PRO . 67.1 m-70 -108.71 142.87 38.59 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.511 -0.768 . . . . 64.129999999999995 108.947 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.647 HH12 ' NE2' ' A' ' 163' ' ' GLN . 5.5 ptm85 -130.38 84.5 2.2 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.145 -0.687 . . . . 54.310000000000002 109.145 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.11 136.28 33.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.476 -0.784 . . . . 63.219999999999999 111.995 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.633 HG23 ' HD1' ' A' ' 161' ' ' TYR . 48.5 mt -113.99 137.02 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.753 -1.112 . . . . 74.430000000000007 111.034 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -99.91 141.97 32.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.132 -0.485 . . . . 64.150000000000006 110.294 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -128.24 129.74 46.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.544 -0.298 . . . . 74.209999999999994 110.447 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.832 ' HB2' HD11 ' A' ' 17' ' ' ILE . 2.7 tt -126.44 134.31 51.0 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.257 -0.428 . . . . 75.140000000000001 110.613 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.681 ' N ' HD23 ' A' ' 118' ' ' LEU . 49.9 t80 -144.01 148.52 35.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.913 0.387 . . . . 73.519999999999996 111.408 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HA ' HD23 ' A' ' 56' ' ' LEU . 54.1 ttp180 -83.43 134.68 34.86 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.628 -0.508 . . . . 75.230000000000004 109.628 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -118.06 139.15 51.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.708 -0.224 . . . . 65.310000000000002 110.457 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' HA ' ' HB3' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -110.5 -34.79 6.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.415 -0.357 . . . . 71.420000000000002 110.96 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.413 ' N ' HD22 ' A' ' 123' ' ' ASN . 2.4 m120 -96.09 130.4 43.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.867 0.365 . . . . 74.019999999999996 111.107 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 23.3 tptm -73.08 143.04 47.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 70.219999999999999 110.566 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD12 ' CE1' ' A' ' 151' ' ' HIS . 0.9 OUTLIER -141.29 144.55 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.803 -0.635 . . . . 50.32 111.732 -179.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 128' ' ' THR . 1.1 pp20? -86.73 -31.09 21.15 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.86 0.725 . . . . 70.340000000000003 109.733 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.46 ' OE2' ' ND2' ' A' ' 83' ' ' ASN . 0.4 OUTLIER 29.17 56.33 0.13 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.39 -1.277 . . . . 75.040000000000006 113.712 178.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.466 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 51.8 p 60.96 138.2 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 114.585 1.328 . . . . 75.120000000000005 114.585 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.03 158.24 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.996 3.131 . . . . 54.140000000000001 113.764 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.782 HG23 ' CE1' ' A' ' 95' ' ' HIS . 18.5 p -62.18 138.88 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.428 -0.805 . . . . 44.219999999999999 113.067 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.82 129.58 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.03 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.2 t -72.33 153.19 41.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.985 0.735 . . . . 70.540000000000006 112.985 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.852 ' HB2' HG12 ' A' ' 101' ' ' VAL . 17.3 p30 -57.92 -26.58 62.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.158 -0.928 . . . . 72.010000000000005 109.595 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 176' ' ' THR . 69.7 p -85.97 14.74 5.71 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.279 -0.873 . . . . 73.030000000000001 111.953 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.6 t -67.79 130.89 44.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 112.204 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.634 ' HG2' ' N ' ' A' ' 179' ' ' GLY . 17.2 mmm180 -77.37 173.21 12.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.431 -0.804 . . . . 73.420000000000002 110.501 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.649 HG23 HD11 ' A' ' 140' ' ' LEU . 32.3 m -54.25 159.55 1.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.35 -0.386 . . . . 75.150000000000006 110.144 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 137' ' ' THR . . . 116.22 -7.8 18.56 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.698 -0.763 . . . . 74.340000000000003 112.417 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.551 HH11 ' HG3' ' A' ' 139' ' ' ARG . 16.8 ttt85 -152.94 8.69 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.132 0.491 . . . . 75.049999999999997 110.956 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 141' ' ' ASN . 0.9 OUTLIER -88.72 -39.77 13.73 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.007 -0.738 . . . . 74.329999999999998 109.007 177.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.828 ' N ' HD12 ' A' ' 140' ' ' LEU . 4.3 m120 -63.24 69.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.43 -0.805 . . . . 75.439999999999998 109.408 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 140' ' ' LEU . 60.0 t80 -127.73 128.81 46.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.128 -0.487 . . . . 74.209999999999994 111.741 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' A' ' 145' ' ' ARG . 17.8 p-10 -95.36 135.04 37.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.604 -0.725 . . . . 72.230000000000004 111.36 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.48 71.56 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.324 0.583 . . . . 51.119999999999997 110.435 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.978 ' NH1' ' HB2' ' A' ' 149' ' ' ALA . 26.3 tpt85 -43.81 -29.93 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.939 -1.028 . . . . 74.340000000000003 111.549 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' OD2' ' NZ ' ' A' ' 150' ' ' LYS . 13.6 t70 -60.17 -58.34 8.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.185 0.517 . . . . 75.25 110.392 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.621 ' CE2' HD13 ' A' ' 97' ' ' LEU . 19.4 m-30 -64.79 -37.78 88.77 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.788 -0.642 . . . . 73.329999999999998 109.877 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.7 76.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 53.409999999999997 109.898 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.978 ' HB2' ' NH1' ' A' ' 145' ' ' ARG . . . -75.64 -53.75 8.07 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.396 0.517 . . . . 74.219999999999999 112.396 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.424 ' NZ ' ' OD2' ' A' ' 146' ' ' ASP . 0.1 OUTLIER -82.33 -51.13 8.18 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.18 0.807 . . . . 74.310000000000002 113.18 -177.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.485 ' CE1' HD12 ' A' ' 125' ' ' ILE . 30.4 m170 -67.99 -0.46 4.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 120.086 -0.646 . . . . 70.530000000000001 110.741 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 61.09 31.41 76.62 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 114.956 0.742 . . . . 63.340000000000003 114.956 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CD1' HD12 ' A' ' 59' ' ' LEU . 10.8 mt -74.3 16.49 0.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 117.084 0.442 . . . . 72.200000000000003 111.376 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -47.94 -18.96 0.85 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 114.334 0.494 . . . . 62.100000000000001 114.334 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -135.16 93.31 17.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 117.309 0.555 . . . . 75.129999999999995 111.107 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.651 ' HB3' HD21 ' A' ' 117' ' ' LEU . 48.1 Cg_endo -67.76 134.3 32.09 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.384 2.056 . . . . 70.530000000000001 112.766 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 119' ' ' TYR . 24.9 pt -84.74 -34.98 9.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.274 -0.421 . . . . 70.530000000000001 110.553 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -139.24 147.09 41.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.123 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 17' ' ' ILE . . . -162.35 159.46 25.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 111.301 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.768 HD21 HG23 ' A' ' 27' ' ' VAL . 57.1 t30 -164.6 167.58 19.1 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.424 -1.325 . . . . 74.150000000000006 107.424 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.633 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -154.51 157.43 38.35 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.292 -0.563 . . . . 74.409999999999997 111.448 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.539 ' HB3' ' CB ' ' A' ' 27' ' ' VAL . 3.3 p90 -149.9 153.04 36.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.026 -0.534 . . . . 74.239999999999995 111.603 -178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.647 ' NE2' HH12 ' A' ' 113' ' ' ARG . 44.7 mt-30 -112.15 134.81 53.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.74 -0.664 . . . . 70.109999999999999 111.027 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.24 145.77 22.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.963 -0.562 . . . . 62.25 111.778 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . 2.0 pm0 -133.94 156.87 47.36 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.033 -1.099 . . . . 71.109999999999999 108.033 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 171' ' ' PRO . 0.3 OUTLIER -157.33 159.25 37.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 63.140000000000001 112.224 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.494 ' HA ' ' CE ' ' A' ' 107' ' ' LYS . 1.7 m-20 -71.15 157.13 38.69 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.652 -0.704 . . . . 73.150000000000006 110.516 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.566 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 14.5 t70 -48.75 -23.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.737 -0.665 . . . . 63.119999999999997 110.673 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.424 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 23.8 t80 -53.08 -38.22 62.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 55.229999999999997 110.99 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.629 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 73.7 t -68.16 -57.57 8.93 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 120.028 -0.669 . . . . 64.340000000000003 109.604 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 83.9 Cg_exo -44.99 -29.55 3.88 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.284 1.989 . . . . 74.450000000000003 111.921 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 168' ' ' ASP . 38.2 mm -47.67 -23.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.176 0.512 . . . . 74.109999999999999 109.791 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -44.49 -27.96 0.52 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.272 -0.876 . . . . 65.450000000000003 109.514 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 175' ' ' LYS . 12.7 p30 -46.11 -33.88 3.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.522 -0.763 . . . . 65.129999999999995 111.456 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.423 ' HD2' ' OD1' ' A' ' 174' ' ' ASN . 10.9 mptt -52.48 -30.78 31.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.776 0.322 . . . . 64.140000000000001 111.377 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.776 HG22 HG22 ' A' ' 134' ' ' THR . 1.9 m -66.95 -28.05 67.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.958 -0.565 . . . . 75.129999999999995 110.361 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.623 HD13 ' HA ' ' A' ' 134' ' ' THR . 27.3 mm -62.79 134.14 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 71.219999999999999 110.808 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 28.7 m -149.34 2.95 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 112.684 0.624 . . . . 75.430000000000007 112.684 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.634 ' N ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.245 0 CA-C-O 118.466 -1.185 . . . . 41.530000000000001 112.871 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.673 0.273 . . . . 64.230000000000004 110.668 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.443 ' HB2' HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -169.83 117.14 0.57 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.69 -0.686 . . . . 63.219999999999999 109.951 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -92.48 -71.04 0.67 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.817 0.673 . . . . 62.310000000000002 112.817 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.562 HD12 ' CG2' ' A' ' 8' ' ' VAL . 7.2 pt -121.17 63.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.295 0.569 . . . . 74.230000000000004 111.856 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' ASP . 12.7 p -128.55 138.66 33.55 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 115.689 -0.687 . . . . 75.109999999999999 110.341 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 67.6 Cg_endo -85.55 34.22 4.22 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.767 -1.347 . . . . 73.340000000000003 112.588 0.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.545 ' O ' HG13 ' A' ' 8' ' ' VAL . 62.5 t0 -57.74 -53.76 54.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 71.040000000000006 110.056 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 4' ' ' ILE . 20.1 m -162.72 -37.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.505 -0.771 . . . . 54.130000000000003 111.073 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.1 tp -157.08 140.64 15.84 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-O 121.432 0.634 . . . . 71.420000000000002 111.227 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 20.5 p-10 -75.79 6.19 5.32 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.812 -0.631 . . . . 72.340000000000003 112.009 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -157.7 133.94 9.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.297 . . . . 61.25 111.343 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.8 p -85.93 109.86 25.88 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 116.213 -0.448 . . . . 72.099999999999994 112.09 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.8 Cg_endo -86.87 -130.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.303 2.669 . . . . 73.120000000000005 112.187 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -159.94 -41.19 0.05 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.427 -0.351 . . . . 64.140000000000001 110.697 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.55 -161.58 20.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.953 -0.641 . . . . 63.200000000000003 112.44 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 5.1 t -150.37 170.02 20.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.077 0.465 . . . . 72.230000000000004 111.377 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -105.88 127.52 60.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.404 -0.816 . . . . 64.530000000000001 109.186 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.9 mmpt? -84.15 102.95 12.97 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 74.010000000000005 109.649 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.563 ' HB ' HG22 ' A' ' 27' ' ' VAL . 48.3 t -116.89 110.68 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.165 0.507 . . . . 64.230000000000004 109.709 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.633 HG21 ' O ' ' A' ' 23' ' ' ASP . 25.8 mt -92.08 143.35 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.7 -0.682 . . . . 64.310000000000002 109.951 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 38' ' ' VAL . 2.4 t80 -84.83 -77.8 0.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.733 -0.787 . . . . 51.240000000000002 111.584 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.611 ' H ' ' CD1' ' A' ' 25' ' ' LEU . . . -99.83 -32.87 5.48 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.611 -0.804 . . . . 72.209999999999994 113.884 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.633 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -173.48 -75.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.444 0.535 . . . . 61.109999999999999 112.444 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -90.97 -40.16 11.84 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.178 0.513 . . . . 73.120000000000005 110.76 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD1' ' H ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -69.53 135.98 50.78 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.79 -0.641 . . . . 51.310000000000002 110.469 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 22.4 pt-20 -134.26 159.18 41.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.101 -0.5 . . . . 74.239999999999995 111.528 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.563 HG22 ' HB ' ' A' ' 19' ' ' VAL . 4.1 m -69.38 134.21 30.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.537 -0.756 . . . . 72.450000000000003 110.172 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -138.64 108.51 6.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 75.25 112.228 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.508 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 3.7 mp0 52.06 49.12 21.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.965 . . . . 50.450000000000003 113.603 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 161' ' ' TYR . . . 62.17 12.54 38.08 Favored Glycine 0 C--O 1.23 -0.141 0 N-CA-C 114.812 0.685 . . . . 35.009999999999998 114.812 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -55.09 157.51 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 117.483 0.642 . . . . 73.209999999999994 110.233 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -98.2 129.31 44.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 73.25 110.051 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.74 HD23 HE21 ' A' ' 37' ' ' GLN . 5.2 mp -92.78 112.83 24.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.557 0.694 . . . . 75.319999999999993 110.988 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 2.8 p -110.54 165.63 12.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.747 -1.115 . . . . 75.120000000000005 111.35 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 17.7 Cg_exo -67.39 -42.32 0.7 Allowed 'Cis proline' 0 C--N 1.352 0.733 0 C-N-CA 124.161 -1.183 . . . . 54.149999999999999 112.033 0.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -162.53 44.47 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.75 -0.659 . . . . 71.25 109.889 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.74 HE21 HD23 ' A' ' 33' ' ' LEU . 17.7 pt20 -76.75 -4.83 45.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.629 -0.714 . . . . 71.120000000000005 111.215 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.585 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 34.3 m -73.37 31.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.695 0.76 . . . . 52.520000000000003 110.082 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' H ' ' C ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -93.37 6.0 49.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.688 -1.142 . . . . 73.109999999999999 112.498 -178.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -135.3 162.99 31.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.845 0.313 . . . . 64.239999999999995 111.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -72.31 146.0 88.78 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.138 -0.483 . . . . 70.299999999999997 111.519 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -95.33 126.96 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.146 2.564 . . . . 70.349999999999994 113.424 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.1 mm -80.17 128.4 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.373 -0.376 . . . . 64.510000000000005 110.932 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.468 HG13 ' HD2' ' A' ' 91' ' ' PRO . 4.1 p -100.22 137.17 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.917 0.339 . . . . 74.540000000000006 111.917 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -162.21 153.84 18.5 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 121.137 0.494 . . . . 64.430000000000007 111.366 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.735 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 1.8 p90 -128.59 34.4 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.839 0.828 . . . . 65.510000000000005 109.485 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 m -49.54 107.26 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.457 -1.247 . . . . 73.150000000000006 111.069 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.57 -33.88 5.3 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.768 -0.651 . . . . 55.049999999999997 111.489 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 2.4 mm? -76.89 -40.12 48.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.14 -0.689 . . . . 73.140000000000001 109.14 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.735 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 29.2 tt0 -65.92 111.48 3.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.879 -0.601 . . . . 63.119999999999997 109.649 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.97 -63.52 0.26 Allowed Glycine 0 C--N 1.324 -0.111 0 C-N-CA 120.812 -0.709 . . . . 74.549999999999997 112.33 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' HE3' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -148.27 111.04 4.78 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.38 -0.6 . . . . 74.420000000000002 109.38 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.511 ' HB3' ' CD ' ' A' ' 120' ' ' ARG . 12.2 p -157.29 141.8 16.54 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.85 -0.34 . . . . 52.399999999999999 111.319 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 35.2 t30 -77.91 -33.61 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.538 0.685 . . . . 63.520000000000003 109.292 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -155.15 157.0 36.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.966 -1.015 . . . . 71.230000000000004 109.35 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.9 mt -127.03 152.4 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.72 -0.392 . . . . 73.409999999999997 110.976 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.643 HG23 HG12 ' A' ' 82' ' ' VAL . 95.0 m -121.51 134.01 55.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.054 -0.521 . . . . 54.549999999999997 110.154 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -136.42 132.96 36.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.984 -0.553 . . . . 64.540000000000006 109.638 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 97.1 mt -153.82 159.69 41.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.02 0.438 . . . . 51.340000000000003 111.884 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 114' ' ' TYR . 24.3 ttt -94.92 156.62 16.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.544 -0.753 . . . . 62.350000000000001 109.971 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 115' ' ' ILE . 57.6 t -133.47 146.12 32.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 54.009999999999998 111.515 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' HD3' ' A' ' 63' ' ' PRO . 46.2 t0 65.01 40.69 0.28 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.303 -0.862 . . . . 72.510000000000005 111.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.659 ' HD3' ' N ' ' A' ' 62' ' ' ASP . 76.4 Cg_exo -51.21 139.84 42.91 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.884 1.723 . . . . 62.109999999999999 111.587 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -125.76 122.66 36.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.51 0.559 . . . . 62.549999999999997 112.51 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.517 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -170.83 135.91 1.08 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.056 0.391 . . . . 64.519999999999996 112.056 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 105' ' ' PRO . 13.2 Cg_exo -68.1 -32.56 3.47 Favored 'Cis proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.883 -1.299 . . . . 71.340000000000003 109.809 -3.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.8 t -141.26 140.25 33.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.336 -1.302 . . . . 32.399999999999999 108.932 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -56.12 -21.56 23.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.345 0.593 . . . . 75.400000000000006 110.606 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.51 -33.47 62.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.265 -0.879 . . . . 72.519999999999996 111.234 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . 23.0 t70 -140.15 62.06 19.48 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-O 121.126 0.489 . . . . 75.200000000000003 110.272 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -67.84 53.8 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.458 2.772 . . . . 75.430000000000007 113.434 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 18.3 ptpt -50.96 -52.17 45.15 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.888 0.329 . . . . 74.010000000000005 111.888 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.61 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 2.1 p90 -106.9 39.53 1.84 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.323 0.582 . . . . 62.020000000000003 111.081 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.538 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 3.7 tmm_? -79.29 139.96 37.7 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.781 -1.192 . . . . 74.230000000000004 107.781 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 25.6 mp0 -89.13 178.05 6.47 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.555 1.142 . . . . 74.150000000000006 112.594 0.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.589 HG13 ' H ' ' A' ' 77' ' ' LEU . 4.7 tp -105.98 -173.24 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.118 -0.946 . . . . 74.519999999999996 109.886 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.751 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.0 mp -68.03 64.46 0.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.99 0.424 . . . . 72.329999999999998 111.016 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -58.55 178.09 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 73.230000000000004 110.85 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.471 ' CZ2' ' CG2' ' A' ' 81' ' ' VAL . 1.2 t-105 -100.29 122.06 42.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.004 -0.739 . . . . 75.109999999999999 109.004 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 20.0 m -141.1 129.74 22.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 111.507 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -142.52 127.73 16.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 74.099999999999994 109.388 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 125' ' ' ILE . 19.6 m -129.86 166.07 28.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.402 0.62 . . . . 71.219999999999999 112.366 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.625 HD21 ' HB2' ' A' ' 95' ' ' HIS . 15.9 p30 52.95 44.88 29.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.25 -1.341 . . . . 62.409999999999997 112.153 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.976 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.9 mm -79.89 118.02 70.34 Favored Pre-proline 0 C--O 1.231 0.105 0 N-CA-C 108.328 -0.99 . . . . 63.530000000000001 108.328 177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' SER . 45.6 Cg_exo -56.51 125.95 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 121.839 1.693 . . . . 54.240000000000002 112.003 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -57.74 73.69 0.01 OUTLIER Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.386 -0.435 . . . . 72.510000000000005 113.143 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' PRO . 34.3 t 177.15 45.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.846 0.458 . . . . 71.530000000000001 110.034 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 54.8 m-80 -135.36 -28.23 1.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.201 0.815 . . . . 72.5 113.201 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 3.9 tt0 74.56 -0.59 3.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.304 0.573 . . . . 65.150000000000006 110.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 14.4 p30 -167.8 157.62 9.12 Favored Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.225 -0.898 . . . . 63.340000000000003 109.914 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.614 ' HA ' HG21 ' A' ' 84' ' ' ILE . 82.5 Cg_endo -77.34 53.84 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.9 2.4 . . . . 73.099999999999994 112.559 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.7 t -102.59 -5.09 24.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.865 -0.334 . . . . 65.219999999999999 111.669 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.19 -42.0 1.33 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.041 -0.6 . . . . 50.539999999999999 114.214 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.976 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -64.49 173.75 15.48 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.968 -0.634 . . . . 60.340000000000003 113.975 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.625 ' HB2' HD21 ' A' ' 83' ' ' ASN . 0.7 OUTLIER -65.8 119.21 10.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.077 0.399 . . . . 71.129999999999995 112.077 -178.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.594 ' N ' HG22 ' A' ' 130' ' ' THR . 43.7 m -82.53 90.28 6.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.827 -0.624 . . . . 74.420000000000002 109.498 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.784 HD13 ' HE2' ' A' ' 147' ' ' PHE . 15.1 mt -50.47 -28.69 8.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.594 -0.73 . . . . 63.130000000000003 111.004 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 131' ' ' ILE . . . -165.13 93.39 0.61 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.178 -0.919 . . . . 73.409999999999997 108.86 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -41.85 140.24 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.425 0.631 . . . . 53.310000000000002 112.494 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -56.38 146.9 22.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.141 -0.936 . . . . 71.420000000000002 110.922 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.523 HG22 ' N ' ' A' ' 102' ' ' GLY . 14.8 p -156.91 161.64 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.942 0.401 . . . . 71.239999999999995 111.341 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 101' ' ' VAL . . . -68.24 -176.62 11.19 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.636 -0.711 . . . . 52.219999999999999 113.011 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t -65.92 122.86 18.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.713 0.292 . . . . 62.049999999999997 111.762 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -86.65 -48.88 4.31 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.478 -0.649 . . . . 34.219999999999999 111.478 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 66' ' ' PRO . 51.1 Cg_exo -56.37 142.43 88.56 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.647 2.231 . . . . 71.140000000000001 113.124 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.608 ' O ' HG23 ' A' ' 109' ' ' THR . 18.1 Cg_endo -58.92 143.54 99.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.75 2.3 . . . . 73.230000000000004 112.025 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.504 ' HB3' ' C ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -46.21 -43.29 15.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.944 0.72 . . . . 71.409999999999997 112.944 -179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.99 0.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.714 0.635 . . . . 71.209999999999994 112.714 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 106' ' ' PRO . 75.9 p -78.64 -27.64 45.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.905 0.383 . . . . 51.200000000000003 110.913 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.41 -167.69 14.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.824 -0.703 . . . . 74.310000000000002 113.353 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.5 tp -60.01 138.19 57.91 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 112.492 0.553 . . . . 35.409999999999997 112.492 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -106.39 129.91 54.3 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.117 -0.947 . . . . 75.329999999999998 109.032 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 113' ' ' ARG . 2.0 ptm85 -112.23 120.13 40.7 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.15 0.5 . . . . 74.209999999999994 111.288 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' ' HE3' ' A' ' 60' ' ' MET . 6.1 m-85 -109.15 140.99 42.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.819 -0.628 . . . . 63.119999999999997 110.659 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 161' ' ' TYR . 24.6 mt -132.47 132.2 60.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.828 -0.804 . . . . 75.319999999999993 108.828 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -106.02 137.08 44.55 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.443 0.464 . . . . 65.230000000000004 111.493 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.785 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.5 tm? -127.08 137.8 53.09 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.874 -0.603 . . . . 71.340000000000003 109.812 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.785 ' N ' HD13 ' A' ' 117' ' ' LEU . 57.0 tp -128.25 137.4 51.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.772 0.429 . . . . 64.510000000000005 110.466 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.524 ' CD2' HD22 ' A' ' 153' ' ' LEU . 81.2 t80 -144.07 132.59 22.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.151 -0.477 . . . . 73.450000000000003 110.595 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 53' ' ' SER . 42.8 ttp180 -76.58 128.25 34.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.547 -0.461 . . . . 71.439999999999998 110.613 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.633 ' NE2' HG23 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -104.26 149.16 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.975 0.731 . . . . 74.299999999999997 112.975 -179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 30.2 tt0 -112.59 -55.49 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.686 -1.143 . . . . 75.319999999999993 109.857 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 123' ' ' ASN . 1.7 m120 -100.19 131.38 46.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 73.319999999999993 110.717 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 9.7 tmtt? -59.55 125.08 22.19 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.004 -0.369 . . . . 71.340000000000003 110.004 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.845 HD12 ' CE1' ' A' ' 151' ' ' HIS . 5.5 pt -87.15 125.32 40.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 52.140000000000001 112.233 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -67.81 118.04 10.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.903 -1.518 . . . . 74.239999999999995 106.903 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -141.41 32.31 1.69 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.033 1.123 . . . . 60.140000000000001 114.033 -176.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 68.7 p 51.04 172.53 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 112.446 0.535 . . . . 73.010000000000005 112.446 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 50.4 Cg_exo -58.46 150.4 68.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.517 2.145 . . . . 62.009999999999998 114.037 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 96' ' ' SER . 25.5 p -60.91 132.18 53.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.53 -1.214 . . . . 72.540000000000006 110.809 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 32.4 mm -85.99 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.379 0.609 . . . . 74.209999999999994 112.224 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -73.46 141.32 46.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.924 -1.035 . . . . 70.510000000000005 111.983 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 134' ' ' THR . 22.3 p30 -56.42 -47.1 79.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.515 0.674 . . . . 63.219999999999999 110.427 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.555 ' N ' ' OD1' ' A' ' 133' ' ' ASN . 13.3 t -84.49 22.93 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.066 -0.97 . . . . 51.439999999999998 111.451 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 177' ' ' ILE . 12.0 t -62.21 155.46 24.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.551 0.691 . . . . 25.109999999999999 112.121 -177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.569 ' HB2' ' CA ' ' A' ' 179' ' ' GLY . 9.4 tpt180 -69.02 164.94 21.22 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.771 -1.104 . . . . 72.120000000000005 112.422 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 138' ' ' GLY . 4.4 m -53.13 175.28 0.03 OUTLIER 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.685 -0.689 . . . . 73.150000000000006 110.258 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.651 ' H ' HG22 ' A' ' 137' ' ' THR . . . 82.07 4.22 90.32 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 119.937 -1.125 . . . . 74.129999999999995 111.822 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.449 ' H ' HD12 ' A' ' 140' ' ' LEU . 28.7 mmt180 -139.81 45.71 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.262 0.553 . . . . 63.039999999999999 111.304 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.6 mp -112.77 -63.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.187 -0.915 . . . . 71.239999999999995 108.784 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 141' ' ' ASN . 1.2 m120 -63.39 121.38 13.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.491 -0.777 . . . . 74.010000000000005 111.447 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.565 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 40.8 t80 -176.94 109.38 0.08 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.82 -0.627 . . . . 75.430000000000007 111.306 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -68.63 120.98 15.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.705 -0.68 . . . . 74.340000000000003 111.921 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.74 -43.44 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.093 -0.503 . . . . 52.030000000000001 111.601 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.4 ' HB2' HH11 ' A' ' 145' ' ' ARG . 11.0 mtp-105 -45.15 -33.92 2.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.218 -0.447 . . . . 73.150000000000006 111.914 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.93 -49.33 50.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.591 0.71 . . . . 44.399999999999999 109.386 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.784 ' HE2' HD13 ' A' ' 97' ' ' LEU . 10.0 m-30 -62.14 -41.95 98.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.053 -0.976 . . . . 74.230000000000004 110.189 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -58.73 -46.38 87.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.805 0.336 . . . . 62.509999999999998 111.244 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.3 -51.73 41.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.913 -0.585 . . . . 71.420000000000002 112.458 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -75.36 -48.57 22.42 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.632 0.604 . . . . 61.039999999999999 112.632 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.845 ' CE1' HD12 ' A' ' 125' ' ' ILE . 52.9 m170 -67.76 -10.85 56.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.94 -0.475 . . . . 72.340000000000003 110.724 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.22 67.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.092 -0.575 . . . . 74.230000000000004 113.155 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.524 HD22 ' CD2' ' A' ' 119' ' ' TYR . 7.4 mt -76.02 15.85 0.5 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 122.063 0.145 . . . . 63.210000000000001 111.195 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -35.29 -73.01 0.1 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.021 -0.609 . . . . 34.299999999999997 113.44 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 155' ' ' GLU . 11.4 pt-20 -74.67 112.46 17.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.544 0.172 . . . . 75.549999999999997 110.849 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.763 ' HB3' HD21 ' A' ' 117' ' ' LEU . 65.5 Cg_endo -83.55 130.75 5.31 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.194 1.93 . . . . 73.510000000000005 113.116 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.725 HD11 ' HG ' ' A' ' 118' ' ' LEU . 38.8 pt -78.49 -34.7 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.916 -0.314 . . . . 73.319999999999993 111.426 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -151.05 151.0 31.39 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.207 0.447 . . . . 72.200000000000003 112.207 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.445 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.15 158.15 43.85 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 53.340000000000003 111.533 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.6 ' C ' ' CD1' ' A' ' 161' ' ' TYR . 0.8 OUTLIER -158.97 175.09 13.99 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.004 -1.11 . . . . 75.129999999999995 108.004 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -157.95 155.53 29.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.686 0.675 . . . . 71.140000000000001 111.055 -178.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 1.4 t80 -155.94 131.84 9.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.13 0.572 . . . . 75.430000000000007 110.995 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mt-30 -115.86 138.63 50.98 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.282 -0.261 . . . . 71.030000000000001 111.455 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 162' ' ' TYR . . . -155.43 153.18 29.95 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.062 0.764 . . . . 53.109999999999999 113.062 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.99 161.5 37.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.776 -0.824 . . . . 65.319999999999993 108.776 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.432 ' O ' ' CB ' ' A' ' 107' ' ' LYS . 1.7 t80 -165.61 168.75 16.06 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 120.191 -0.604 . . . . 71.010000000000005 111.36 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.504 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.8 t0 -79.46 -159.92 0.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.714 0.634 . . . . 64.209999999999994 110.912 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.5 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 50.2 t0 -69.0 -23.87 64.15 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.092 0.472 . . . . 64.209999999999994 111.036 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.406 ' O ' HG22 ' A' ' 172' ' ' ILE . 31.4 t80 -42.88 -44.48 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 112.108 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.598 ' HB ' ' HD3' ' A' ' 171' ' ' PRO . 67.8 t -80.38 -54.39 0.83 Allowed Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 120.464 -0.494 . . . . 53.020000000000003 111.494 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 77.8 Cg_exo -48.39 -49.84 13.54 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.051 1.834 . . . . 51.399999999999999 112.644 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 168' ' ' ASP . 11.5 tt -46.01 -33.92 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.027 0.381 . . . . 74.420000000000002 112.027 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.03 -29.53 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.139 0.495 . . . . 65.430000000000007 111.342 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 177' ' ' ILE . 2.1 m120 -56.51 -14.92 3.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.176 0.806 . . . . 74.409999999999997 113.176 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.36 -20.29 42.57 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.794 0.664 . . . . 74.340000000000003 112.794 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.0 p -88.1 16.59 5.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.864 0.69 . . . . 74.109999999999999 112.864 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 135' ' ' THR . 27.7 mm -72.46 124.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 122.037 -0.415 . . . . 64.510000000000005 110.296 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.58 -13.19 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 113.114 0.783 . . . . 74.409999999999997 113.114 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.569 ' CA ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-O 118.555 -1.136 . . . . 64.319999999999993 112.301 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 109.938 -0.393 . . . . 73.140000000000001 109.938 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -70.5 64.38 0.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 65.319999999999993 111.458 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.577 ' HB3' ' HA ' ' A' ' 11' ' ' ALA . 5.5 t70 -71.18 -40.83 71.0 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.728 0.299 . . . . 54.219999999999999 111.196 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 9' ' ' LEU . 12.8 pt -149.24 48.03 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 65.319999999999993 110.615 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 2' ' ' ASP . 13.6 p -136.45 140.9 33.79 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.214 -0.903 . . . . 75.5 109.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 5.2 Cg_exo -78.28 26.43 2.5 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 124.205 -1.164 . . . . 70.329999999999998 113.591 0.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.5 t0 -54.56 -53.21 57.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.924 0.393 . . . . 73.129999999999995 110.431 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.5 m -161.32 -43.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.997 -0.547 . . . . 63.200000000000003 111.917 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 117' ' ' LEU . 62.2 tp -144.21 160.08 41.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.65 0.262 . . . . 75.209999999999994 110.851 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -60.43 -42.58 96.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.718 -0.793 . . . . 72.319999999999993 109.732 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HA ' ' HB3' ' A' ' 3' ' ' ASP . . . -156.59 135.14 11.54 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 111.818 0.303 . . . . 54.140000000000001 111.818 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.39 125.88 80.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.117 -0.492 . . . . 72.010000000000005 110.995 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 45.7 Cg_endo -89.73 -145.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.892 2.395 . . . . 51.539999999999999 112.201 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.37 -31.05 6.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.842 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.36 -136.54 3.16 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.919 -0.582 . . . . 75.409999999999997 111.834 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.472 ' HA ' ' H ' ' A' ' 159' ' ' ALA . 1.5 t -162.81 164.41 26.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 65.239999999999995 111.734 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.587 HD12 ' N ' ' A' ' 17' ' ' ILE . 3.1 mp -104.9 133.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.406 -0.961 . . . . 73.109999999999999 108.406 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 13.5 mmmm -83.62 101.96 11.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.442 -0.503 . . . . 71.540000000000006 109.707 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 94.2 t -108.86 108.47 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-O 121.599 0.714 . . . . 61.409999999999997 111.198 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 23' ' ' ASP . 1.8 mp -91.88 138.22 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.898 -1.149 . . . . 72.150000000000006 107.898 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -93.42 -46.96 7.1 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 112.937 0.717 . . . . 71.030000000000001 112.937 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' A' ' 25' ' ' LEU . . . -115.86 -48.39 0.5 Allowed Glycine 0 N--CA 1.459 0.175 0 C-N-CA 120.277 -0.963 . . . . 53.299999999999997 112.857 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' O ' HG21 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -170.62 -80.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 110.261 -179.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -82.31 -31.85 29.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.599 . . . . 75.420000000000002 109.384 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 129.08 38.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.687 0.756 . . . . 71.209999999999994 111.443 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 28.3 tt0 -125.61 150.77 47.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.702 -1.136 . . . . 72.439999999999998 110.836 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 27' ' ' VAL . 31.3 m -85.42 107.01 15.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 111.535 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 31' ' ' ASN . 1.5 mptm? -75.21 50.53 0.5 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.429 0.9 . . . . 64.439999999999998 113.429 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.703 HE21 ' ND2' ' A' ' 160' ' ' ASN . 9.5 mp0 59.31 69.67 0.7 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.667 0.988 . . . . 63.039999999999999 113.667 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 161' ' ' TYR . . . 100.38 -6.21 57.64 Favored Glycine 0 CA--C 1.504 -0.616 0 N-CA-C 110.835 -0.906 . . . . 75.329999999999998 110.835 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.465 ' ND2' HD11 ' A' ' 33' ' ' LEU . 1.4 t30 -59.14 139.02 57.33 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.932 -1.134 . . . . 72.109999999999999 110.868 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' C ' HD12 ' A' ' 33' ' ' LEU . 87.2 tt0 -102.72 138.02 40.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 73.219999999999999 110.24 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.1 mp -109.3 154.19 22.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 111.353 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -149.36 157.79 38.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 75.219999999999999 110.477 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -81.95 -51.88 0.15 OUTLIER 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 124.093 -1.211 . . . . 50.200000000000003 112.77 0.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 36' ' ' THR . 6.2 m -143.41 35.81 1.33 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.193 0.521 . . . . 72.129999999999995 110.836 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 11.9 pt20 -80.21 -4.37 52.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.6 . . . . 65.530000000000001 111.494 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.608 ' HB ' ' CE2' ' A' ' 21' ' ' TYR . 27.5 m -85.54 33.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.572 -0.74 . . . . 71.140000000000001 111.935 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.74 -30.08 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.848 1.055 . . . . 74.040000000000006 113.848 -178.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 45.1 m-20 -72.33 152.62 41.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.825 0.676 . . . . 74.219999999999999 112.825 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -63.25 128.72 92.79 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.718 -0.674 . . . . 73.109999999999999 109.33 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 125.75 19.31 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.348 2.032 . . . . 74.409999999999997 114.243 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.18 111.09 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.5 -0.773 . . . . 70.540000000000006 109.936 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' CG2' ' A' ' 17' ' ' ILE . 6.0 p -93.55 142.02 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.396 -0.365 . . . . 71.230000000000004 111.719 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 50.7 m -158.07 137.9 12.2 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.263 0.468 . . . . 64.040000000000006 112.263 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.735 ' HH2' HG21 ' A' ' 84' ' ' ILE . 3.5 p90 -115.84 23.26 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.263 -0.643 . . . . 75.409999999999997 109.263 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.2 m -40.31 120.96 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.395 -0.82 . . . . 70.510000000000005 110.921 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 50' ' ' GLU . . . 91.08 -35.46 3.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.267 -0.492 . . . . 73.340000000000003 112.187 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.0 mm? -65.54 -20.86 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.87 0.367 . . . . 75.129999999999995 110.031 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' SER . 16.6 pm0 -67.57 -159.14 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.249 -0.649 . . . . 74.310000000000002 109.249 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.17 -66.6 0.48 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 119.96 -1.114 . . . . 62.399999999999999 113.083 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -149.42 106.88 3.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.086 0.47 . . . . 75.099999999999994 109.77 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.403 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 3.3 m -160.19 140.41 11.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.776 -0.647 . . . . 70.150000000000006 110.224 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -74.88 -38.17 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.733 -0.84 . . . . 74.109999999999999 108.733 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 22.5 mt -155.86 160.4 40.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.7 -1.136 . . . . 72.109999999999999 109.885 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 15.5 mt -122.08 151.8 40.5 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.974 -0.29 . . . . 73.030000000000001 110.527 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.685 HG23 HG12 ' A' ' 82' ' ' VAL . 91.4 m -129.01 114.41 16.38 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.928 0.394 . . . . 74.030000000000001 112.027 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.3 tm? -106.78 134.29 50.15 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 109.54 -0.541 . . . . 74.030000000000001 109.54 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 58' ' ' LEU . 83.5 mt -144.75 171.58 14.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.166 0.508 . . . . 52.420000000000002 111.754 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.562 ' C ' ' SD ' ' A' ' 60' ' ' MET . 0.8 OUTLIER -133.64 123.13 24.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.176 -0.92 . . . . 74.209999999999994 108.638 178.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.87 102.09 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.123 0.487 . . . . 71.120000000000005 112.127 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -178.79 67.68 0.19 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.226 -0.897 . . . . 65.230000000000004 109.605 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 1.4 Cg_endo -45.48 129.0 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.254 1.97 . . . . 44.020000000000003 111.589 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -162.36 87.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.291 0.478 . . . . 72.219999999999999 112.291 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.639 ' CB ' ' HB ' ' A' ' 76' ' ' ILE . . . -171.61 133.54 0.84 Allowed Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 112.883 0.697 . . . . 52.049999999999997 112.883 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 24.6 Cg_exo -63.36 -20.45 5.17 Favored 'Cis proline' 0 C--N 1.354 0.822 0 C-N-CA 123.558 -1.434 . . . . 74.099999999999994 110.276 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 148.49 16.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.838 -1.074 . . . . 63.119999999999997 109.912 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -49.13 -31.8 8.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.676 0.75 . . . . 73.519999999999996 110.617 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -63.45 -32.83 74.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.927 -1.033 . . . . 74.140000000000001 111.956 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 61.6 t0 -144.91 98.37 4.8 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.1 0.476 . . . . 75.420000000000002 111.072 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 72.5 Cg_endo -76.51 60.3 6.46 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.974 2.449 . . . . 75.329999999999998 111.901 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.456 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -47.17 -39.82 14.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.931 -0.577 . . . . 72.450000000000003 110.78 -178.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.544 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 4.7 p90 -148.0 48.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.721 0.772 . . . . 62.350000000000001 109.707 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -74.37 136.24 42.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.652 -1.158 . . . . 73.530000000000001 109.459 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 142' ' ' PHE . 1.1 pm0 -89.12 176.61 6.91 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.998 0.919 . . . . 74.140000000000001 112.013 0.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.835 ' CD1' HD23 ' A' ' 140' ' ' LEU . 3.2 tp -114.46 -163.14 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.216 -0.902 . . . . 75.120000000000005 109.851 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.665 ' H ' HG13 ' A' ' 76' ' ' ILE . 5.9 mp -65.04 135.9 56.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.058 -0.349 . . . . 72.530000000000001 110.058 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 6.6 p-80 -147.87 171.72 15.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.308 -0.405 . . . . 52.340000000000003 110.086 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.636 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 7.7 t90 -97.99 123.18 41.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 72.340000000000003 112.052 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.401 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 85.5 p -142.96 133.58 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.847 -0.615 . . . . 74.319999999999993 109.841 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 91' ' ' PRO . 21.3 t -149.24 117.25 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.6 . . . . 74.109999999999999 109.379 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HG23 ' A' ' 57' ' ' THR . 10.7 m -115.23 -173.61 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.724 0.774 . . . . 64.230000000000004 112.649 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.619 HD21 ' CG ' ' A' ' 95' ' ' HIS . 27.9 p30 44.21 43.45 5.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 113.996 -1.457 . . . . 73.25 113.166 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.843 HG22 HD22 ' A' ' 88' ' ' ASN . 2.4 mm -67.42 121.84 80.57 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 107.55 -1.278 . . . . 73.0 107.55 177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.45 103.13 1.64 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.155 1.903 . . . . 75.540000000000006 115.189 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.89 -84.79 1.57 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 116.507 1.363 . . . . 42.229999999999997 116.507 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.571 ' C ' ' H ' ' A' ' 89' ' ' GLU . 78.3 p -174.39 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 117.484 0.642 . . . . 64.230000000000004 111.642 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.843 HD22 HG22 ' A' ' 84' ' ' ILE . 38.9 m-80 -73.71 28.98 0.07 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.907 -0.588 . . . . 74.200000000000003 110.391 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 16.3 pt-20 44.52 5.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.928 -1.033 . . . . 62.43 112.952 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 88' ' ' ASN . 17.8 p30 -179.71 163.11 0.91 Allowed Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.237 -0.653 . . . . 70.019999999999996 109.237 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 84' ' ' ILE . 66.6 Cg_endo -68.65 44.84 0.33 Allowed 'Trans proline' 0 N--CA 1.476 0.467 0 C-N-CA 122.872 2.381 . . . . 74.219999999999999 113.219 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 90' ' ' ASN . 22.1 t -69.36 -43.22 74.05 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.177 0.436 . . . . 74.439999999999998 112.177 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.75 10.13 32.35 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.912 -0.661 . . . . 73.540000000000006 114.264 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -86.58 166.51 37.92 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.661 -0.78 . . . . 64.030000000000001 114.093 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.619 ' CG ' HD21 ' A' ' 83' ' ' ASN . 0.1 OUTLIER -64.31 104.78 0.8 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.865 0.32 . . . . 72.439999999999998 111.865 178.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.679 ' N ' HG22 ' A' ' 130' ' ' THR . 51.1 m -73.51 83.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.718 0.77 . . . . 75.319999999999993 109.047 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.714 HD13 ' CZ ' ' A' ' 147' ' ' PHE . 55.2 mt -68.31 -20.86 64.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.149 -0.932 . . . . 73.409999999999997 110.496 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 78' ' ' HIS . . . -158.53 106.22 1.9 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.185 -0.916 . . . . 75.439999999999998 109.475 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -60.12 142.3 54.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.051 0.453 . . . . 63.039999999999999 110.846 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.636 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 20.5 p90 -67.46 140.28 57.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 70.040000000000006 111.798 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.33 145.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.619 -0.719 . . . . 71.310000000000002 109.67 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.619 ' HA3' HG21 ' A' ' 170' ' ' VAL . . . -54.68 -47.0 72.99 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.896 -0.669 . . . . 61.140000000000001 113.394 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -173.52 98.18 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.964 0.382 . . . . 53.119999999999997 111.955 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.653 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -57.12 -50.1 66.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.068 -1.063 . . . . 54.340000000000003 110.664 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' HG2' ' CE1' ' A' ' 112' ' ' HIS . 38.4 Cg_endo -65.63 140.21 61.4 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.22 2.613 . . . . 43.240000000000002 112.385 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.707 ' O ' HG22 ' A' ' 109' ' ' THR . 37.8 Cg_exo -57.27 147.24 77.87 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.095 2.53 . . . . 61.210000000000001 113.374 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -45.96 -34.38 3.92 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.154 0.502 . . . . 71.409999999999997 111.502 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -51.8 -20.2 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.689 -0.687 . . . . 53.0 111.901 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.978 HG21 ' CE1' ' A' ' 112' ' ' HIS . 10.9 t -69.14 -17.2 63.8 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 73.319999999999993 111.071 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.83 -142.37 34.73 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.902 -0.59 . . . . 65.549999999999997 113.82 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.21 117.59 6.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.393 . . . . 71.430000000000007 111.7 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.978 ' CE1' HG21 ' A' ' 109' ' ' THR . 48.5 m-70 -82.79 -176.11 6.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.83 0.824 . . . . 74.230000000000004 111.325 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.978 HH12 HD11 ' A' ' 115' ' ' ILE . 65.6 ttt-85 -147.52 112.04 5.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.113 -1.81 . . . . 71.120000000000005 106.113 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 60' ' ' MET . 0.4 OUTLIER -118.32 134.74 54.78 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.603 -0.439 . . . . 72.209999999999994 111.653 -176.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.978 HD11 HH12 ' A' ' 113' ' ' ARG . 36.8 mt -130.84 121.36 49.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.573 -0.739 . . . . 75.299999999999997 111.933 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.557 ' C ' HD22 ' A' ' 117' ' ' LEU . 36.4 m-85 -100.92 131.44 46.8 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.429 -0.805 . . . . 71.530000000000001 109.154 177.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 9' ' ' LEU . 2.7 mm? -116.49 143.87 45.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.26 -0.427 . . . . 72.530000000000001 110.447 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 158' ' ' ALA . 44.3 tp -126.99 131.2 51.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 63.229999999999997 109.886 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 53.1 m-85 -132.61 143.95 50.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.227 0.536 . . . . 64.439999999999998 111.226 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 18.7 tpp180 -77.15 117.03 18.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.554 -0.748 . . . . 70.340000000000003 109.523 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.601 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 39.4 tp60 -91.85 122.77 34.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.038 0.447 . . . . 74.329999999999998 110.101 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -90.94 -49.8 6.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.455 -0.793 . . . . 74.140000000000001 112.403 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.71 146.16 33.93 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.241 0.46 . . . . 62.25 112.241 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.9 tptm -64.69 123.32 19.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.587 -0.733 . . . . 70.430000000000007 110.091 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.598 HD12 ' NE2' ' A' ' 151' ' ' HIS . 3.1 pt -111.06 129.03 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.203 -0.453 . . . . 70.530000000000001 110.707 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 128' ' ' THR . 83.8 tt0 -53.45 -46.99 70.09 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.353 -0.61 . . . . 53.229999999999997 109.353 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.622 ' CG ' HD11 ' A' ' 97' ' ' LEU . 2.2 tp10 53.92 15.15 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.139 -0.937 . . . . 63.549999999999997 113.112 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 129' ' ' PRO . 58.7 p 51.16 169.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 111.924 0.342 . . . . 74.150000000000006 111.924 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 52.1 Cg_exo -58.83 148.72 82.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.095 1.864 . . . . 75.129999999999995 113.406 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.679 HG22 ' N ' ' A' ' 96' ' ' SER . 17.2 p -58.38 136.94 57.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.18 -0.918 . . . . 70.420000000000002 110.752 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 97' ' ' LEU . 38.6 mm -92.79 129.5 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 113.337 0.865 . . . . 74.329999999999998 113.337 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.537 ' HB3' HG22 ' A' ' 134' ' ' THR . 58.1 m -86.85 133.49 33.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.19 -1.368 . . . . 73.439999999999998 109.302 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -53.45 -26.16 19.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.912 -0.315 . . . . 74.299999999999997 111.383 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.582 ' C ' HG23 ' A' ' 177' ' ' ILE . 9.3 t -64.83 -2.47 2.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.945 0.402 . . . . 71.439999999999998 111.055 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 135' ' ' THR . 13.0 t -64.3 108.4 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.253 0.549 . . . . 74.239999999999995 109.789 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HA ' HG22 ' A' ' 177' ' ' ILE . 37.9 ttt85 -65.14 171.17 3.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.68 -0.691 . . . . 73.450000000000003 112.315 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ARG . 50.4 m -28.29 136.82 0.02 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.245 -0.889 . . . . 65.519999999999996 111.577 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.94 5.84 14.86 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.772 -0.649 . . . . 65.219999999999999 111.927 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 140' ' ' LEU . 17.4 mmm180 -152.0 35.76 0.54 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.782 0.325 . . . . 63.32 111.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.835 HD23 ' CD1' ' A' ' 76' ' ' ILE . 3.3 mp -109.86 -62.53 1.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.375 -0.375 . . . . 75.299999999999997 110.773 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 2.0 m120 -61.57 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.699 -0.682 . . . . 62.109999999999999 112.535 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.573 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 11.5 t80 -144.17 118.1 9.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.939 0.399 . . . . 74.450000000000003 111.346 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.529 HD21 ' CB ' ' A' ' 145' ' ' ARG . 28.6 t30 -85.41 131.0 34.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 52.119999999999997 110.489 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.04 -37.49 87.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.738 0.644 . . . . 75.319999999999993 112.738 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.529 ' CB ' HD21 ' A' ' 143' ' ' ASN . 30.5 ttp180 -44.02 -31.12 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 64.120000000000005 110.933 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.563 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.8 OUTLIER -47.05 -41.01 16.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.044 0.45 . . . . 74.430000000000007 110.63 179.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.714 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 66.2 m-85 -56.79 -38.83 73.07 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.759 -0.655 . . . . 73.329999999999998 110.639 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -63.28 -28.14 69.82 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.72 -0.673 . . . . 41.329999999999998 110.174 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.63 2.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 62.32 111.226 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 0.9 OUTLIER -54.08 -44.35 71.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.823 0.344 . . . . 74.340000000000003 110.961 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.598 ' NE2' HD12 ' A' ' 125' ' ' ILE . 29.5 m-70 -85.74 4.76 35.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.476 -0.329 . . . . 64.439999999999998 110.7 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 56.08 26.11 48.33 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.019 -0.537 . . . . 63.539999999999999 113.384 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 148' ' ' ALA . 19.6 mt -64.47 -25.86 68.19 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.434 -0.58 . . . . 61.210000000000001 109.434 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 40.64 -89.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.06 -0.973 . . . . 41.240000000000002 113.963 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 153' ' ' LEU . 21.9 pt-20 -73.06 125.72 90.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.088 0.403 . . . . 71.439999999999998 112.088 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.41 ' HA ' ' CD2' ' A' ' 119' ' ' TYR . 60.3 Cg_endo -76.22 124.78 8.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.692 1.595 . . . . 35.409999999999997 110.34 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 119' ' ' TYR . 47.5 pt -71.5 -33.8 50.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.115 -0.634 . . . . 73.150000000000006 110.551 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -147.15 149.77 33.64 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.946 -0.302 . . . . 43.439999999999998 111.564 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 16' ' ' THR . . . -147.38 152.34 38.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 111.122 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.703 ' ND2' HE21 ' A' ' 29' ' ' GLN . 1.7 t-20 -157.28 145.27 19.13 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.48 -1.304 . . . . 70.299999999999997 107.48 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.482 ' H ' ' HA ' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -149.03 176.84 10.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.882 0.327 . . . . 70.299999999999997 111.882 -177.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.548 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 2.3 p90 -168.84 164.82 11.83 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.067 -0.515 . . . . 74.239999999999995 111.343 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -126.36 124.81 41.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.489 -0.56 . . . . 74.109999999999999 109.489 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.62 152.85 25.91 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.16 0.429 . . . . 71.439999999999998 112.16 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.628 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -109.08 136.49 48.51 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.348 -0.612 . . . . 34.25 109.348 178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -125.5 135.07 51.91 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.699 -0.482 . . . . 61.439999999999998 109.699 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -60.84 173.75 0.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.316 0.579 . . . . 71.420000000000002 112.293 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -72.75 51.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.167 -0.924 . . . . 71.5 110.75 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -91.69 -46.57 7.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.156 0.503 . . . . 64.519999999999996 110.872 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.619 HG21 ' HA3' ' A' ' 102' ' ' GLY . 53.4 t -80.82 -46.89 1.21 Allowed Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 113.162 0.801 . . . . 65.209999999999994 113.162 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 170' ' ' VAL . 73.4 Cg_exo -46.06 -43.35 20.46 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.918 1.745 . . . . 71.120000000000005 111.748 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 40.1 mm -51.14 -39.28 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.924 -0.58 . . . . 74.420000000000002 110.076 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -53.32 -26.42 18.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.614 -0.721 . . . . 70.219999999999999 110.796 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -52.31 -42.68 64.02 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.543 0.211 . . . . 72.200000000000003 111.295 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -15.5 62.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.064 0.459 . . . . 63.32 110.498 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.8 m -92.37 -28.14 17.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.58 -0.736 . . . . 64.030000000000001 110.812 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.582 HG23 ' C ' ' A' ' 134' ' ' THR . 52.1 mt -56.51 119.74 2.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.962 -0.563 . . . . 74.450000000000003 110.956 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.87 37.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.895 0.379 . . . . 54.100000000000001 111.531 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.978 -1.457 . . . . 40.310000000000002 111.34 -179.126 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 10' ' ' ASP . 18.3 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.648 -0.501 . . . . 53.539999999999999 109.648 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -158.53 46.23 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.072 0.463 . . . . 74.030000000000001 110.837 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' OD1' HG23 ' A' ' 4' ' ' ILE . 9.9 t0 -51.15 -64.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.774 -0.648 . . . . 75.030000000000001 112.19 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.526 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.5 pt -131.63 49.14 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.502 0.667 . . . . 53.210000000000001 111.361 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 6' ' ' PRO . 11.9 p -111.61 142.32 26.35 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.298 -0.865 . . . . 65.299999999999997 110.203 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 56.2 Cg_endo -95.62 33.44 9.86 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 C-N-CA 124.363 -1.099 . . . . 72.329999999999998 112.83 0.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -67.55 -42.82 82.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.082 0.468 . . . . 75.219999999999999 109.741 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' HD12 ' A' ' 4' ' ' ILE . 27.5 m -154.38 -47.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.724 -0.671 . . . . 73.409999999999997 112.364 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 117' ' ' LEU . 25.2 tp -158.51 154.88 27.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.316 0.488 . . . . 61.450000000000003 112.316 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 1' ' ' MET . 12.9 p-10 -74.63 -1.97 23.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.346 -0.613 . . . . 62.219999999999999 109.346 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.546 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -144.86 -158.54 0.9 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.155 -0.93 . . . . 61.119999999999997 109.827 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.3 p -144.62 113.91 5.11 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 75.319999999999993 111.437 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 45.1 Cg_endo -88.75 -138.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.448 . . . . 74.239999999999995 112.519 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -153.31 -37.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 61.140000000000001 111.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.38 161.67 24.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.177 -1.011 . . . . 53.409999999999997 113.274 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 t -104.46 157.05 17.42 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.869 0.366 . . . . 71.219999999999999 110.947 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 17' ' ' ILE . 1.8 mp -104.01 135.25 42.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.889 -0.596 . . . . 72.299999999999997 109.605 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 45' ' ' SER . 29.9 mmmt -73.57 118.19 16.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.53 -0.305 . . . . 64.140000000000001 110.232 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 84.1 t -128.18 109.18 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.278 -0.638 . . . . 64.439999999999998 109.278 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 26' ' ' GLU . 37.2 mt -99.64 142.07 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 74.209999999999994 112.452 -178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.516 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 1.6 m-85 -101.57 -94.3 0.29 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.716 -0.674 . . . . 74.019999999999996 111.123 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.72 -50.22 68.29 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.157 -1.02 . . . . 74.239999999999995 111.586 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.4 t70 171.36 -81.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.999 -0.741 . . . . 62.140000000000001 108.999 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.789 -0.819 . . . . 71.209999999999994 108.789 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.954 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -82.06 141.37 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.617 -1.174 . . . . 63.350000000000001 111.476 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HB3' HG12 ' A' ' 20' ' ' ILE . 13.2 pt-20 -149.04 153.73 38.28 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.83 -1.077 . . . . 74.120000000000005 110.752 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.572 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 35.8 m -82.56 133.69 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 65.319999999999993 109.899 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 14.7 pttm -153.35 130.02 10.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.055 0.931 . . . . 73.209999999999994 113.182 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.487 ' HA ' ' CE1' ' A' ' 161' ' ' TYR . 7.1 mp0 32.55 63.89 0.28 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.859 -1.519 . . . . 74.530000000000001 114.759 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.3 10.83 63.41 Favored Glycine 0 N--CA 1.454 -0.13 0 N-CA-C 114.876 0.71 . . . . 73.409999999999997 114.876 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' ND2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -61.0 146.39 47.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.874 0.837 . . . . 65.319999999999993 109.906 179.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -96.5 126.28 41.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.92 -0.4 . . . . 75.319999999999993 109.92 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -93.07 108.9 20.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.137 0.494 . . . . 71.120000000000005 109.791 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -150.22 155.49 37.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.39 -0.823 . . . . 62.149999999999999 110.648 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -93.86 136.09 6.55 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.286 -1.131 . . . . 71.329999999999998 112.64 0.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 36' ' ' THR . 17.9 m 56.38 33.65 22.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.237 0.541 . . . . 74.219999999999999 110.649 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -93.87 -1.9 54.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.682 -0.69 . . . . 73.329999999999998 110.83 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.4 m -92.13 -14.18 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.566 -0.743 . . . . 73.400000000000006 112.289 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' NZ ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -74.39 5.8 4.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 73.519999999999996 111.094 -179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 53.2 m-20 -96.81 146.15 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.256 0.55 . . . . 75.049999999999997 111.737 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.7 pm0 -62.63 132.33 94.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.189 -0.914 . . . . 64.329999999999998 111.796 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 89.6 Cg_endo -81.61 125.14 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.947 1.765 . . . . 64.319999999999993 112.227 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 49.9 mm -109.27 106.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 109.921 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG23 ' CZ3' ' A' ' 79' ' ' TRP . 57.9 t -89.94 136.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.337 0.495 . . . . 44.229999999999997 112.337 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.583 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 75.3 m -159.66 116.23 2.56 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.77 -0.65 . . . . 74.329999999999998 110.089 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 89' ' ' GLU . 16.1 p90 -91.77 32.4 1.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 74.310000000000002 110.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.3 m -46.85 128.43 10.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.338 -0.846 . . . . 55.149999999999999 110.586 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.19 -33.16 4.83 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.708 -0.678 . . . . 54.310000000000002 112.406 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -80.29 -26.39 38.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.432 . . . . 73.209999999999994 110.479 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 23.1 tt0 -59.33 158.89 8.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.852 -0.613 . . . . 72.409999999999997 110.983 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.85 33.1 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.216 -1.154 . . . . 75.230000000000004 110.216 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -48.15 109.55 0.24 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 74.109999999999999 110.44 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.9 p -149.23 142.6 25.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.327 -0.851 . . . . 75.450000000000003 109.582 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 9.1 t30 -64.77 -38.76 92.08 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.58 0.705 . . . . 64.099999999999994 109.45 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 83' ' ' ASN . 82.1 mt -156.86 154.58 30.05 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.642 -1.163 . . . . 72.299999999999997 111.179 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 96.0 mt -120.67 150.9 40.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.579 -0.526 . . . . 64.129999999999995 109.579 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.551 HG23 HG12 ' A' ' 82' ' ' VAL . 88.5 m -122.24 114.32 20.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.776 0.322 . . . . 52.32 110.665 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 59' ' ' LEU . 2.1 tm? -103.68 134.19 47.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.154 -0.684 . . . . 74.340000000000003 109.154 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 58' ' ' LEU . 93.8 mt -141.04 152.51 44.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.349 0.595 . . . . 71.400000000000006 111.851 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.7 ttt -127.2 110.29 12.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.201 -0.909 . . . . 71.230000000000004 108.607 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.728 HG23 HD23 ' A' ' 117' ' ' LEU . 5.1 t -94.32 -133.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.025 -0.27 . . . . 71.540000000000006 111.712 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.725 ' H ' HG12 ' A' ' 61' ' ' VAL . 2.2 m-20 51.84 73.04 1.03 Allowed Pre-proline 0 CA--C 1.518 -0.256 0 N-CA-C 112.341 0.497 . . . . 71.219999999999999 112.341 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.621 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . 32.0 Cg_endo -62.19 129.4 26.91 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 121.737 1.625 . . . . 75.140000000000001 110.008 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -159.46 92.49 1.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.769 1.026 . . . . 63.549999999999997 113.769 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.755 ' CB ' HD11 ' A' ' 76' ' ' ILE . . . -172.88 134.39 0.7 Allowed Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 112.481 0.549 . . . . 64.230000000000004 112.481 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 72' ' ' LYS . 65.3 Cg_endo -85.64 3.18 65.38 Favored 'Cis proline' 0 C--N 1.347 0.468 0 C-N-CA 124.315 -1.119 . . . . 72.239999999999995 110.243 -2.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 t -164.81 134.04 3.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.332 -1.304 . . . . 61.049999999999997 109.636 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.549 ' HD3' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -55.14 -24.05 24.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.852 0.358 . . . . 75.209999999999994 110.726 -178.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.549 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -62.43 -41.18 98.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 75.150000000000006 110.417 178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -144.7 109.51 4.8 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.101 -0.5 . . . . 74.209999999999994 111.231 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.64 63.83 4.72 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.5 2.133 . . . . 73.430000000000007 111.518 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 66' ' ' PRO . 39.6 ttmt -47.91 -27.82 2.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.199 -0.455 . . . . 63.409999999999997 111.113 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.669 ' HE1' ' HB1' ' A' ' 65' ' ' ALA . 2.9 p90 -152.78 45.36 0.69 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.734 0.642 . . . . 74.519999999999996 112.734 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.621 ' NE ' ' HB2' ' A' ' 63' ' ' PRO . 25.9 ttm180 -66.82 139.57 57.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.534 -0.913 . . . . 63.520000000000003 108.534 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -106.64 165.55 11.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.55 1.14 . . . . 75.120000000000005 110.23 -0.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.778 HG22 ' N ' ' A' ' 77' ' ' LEU . 38.0 mm -80.55 176.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 112.233 0.457 . . . . 72.109999999999999 112.233 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.797 ' CD2' HD23 ' A' ' 140' ' ' LEU . 2.9 mm? -71.44 55.99 0.24 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.705 -0.68 . . . . 71.120000000000005 110.07 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 76' ' ' ILE . 6.5 p-80 -53.92 169.91 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 71.239999999999995 111.956 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 12.3 t90 -99.86 112.52 24.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.744 -0.662 . . . . 71.030000000000001 110.457 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.6 p -141.44 136.56 31.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.689 -0.687 . . . . 51.450000000000003 110.442 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 84' ' ' ILE . 25.3 t -139.76 142.49 32.31 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.994 -0.548 . . . . 75.409999999999997 109.909 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.919 HG21 ' HG3' ' A' ' 127' ' ' GLU . 16.4 m -137.71 163.52 30.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.581 0.585 . . . . 72.319999999999993 112.581 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.763 ' ND2' HG23 ' A' ' 82' ' ' VAL . 45.8 m-20 71.87 32.89 1.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.63 -1.168 . . . . 31.449999999999999 111.243 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.55 HD13 ' HA3' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -76.96 111.96 19.68 Favored Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 120.102 -0.639 . . . . 52.549999999999997 109.695 179.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' SER . 47.9 Cg_exo -54.56 134.24 60.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 121.813 1.675 . . . . 62.43 110.75 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.91 70.44 0.01 OUTLIER Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.949 -0.643 . . . . 72.239999999999995 112.839 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 85' ' ' PRO . 23.2 t 176.46 47.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.88 -0.785 . . . . 65.430000000000007 108.88 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 68.7 m-80 -135.66 -29.86 1.03 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.76 . . . . 55.020000000000003 112.146 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 88' ' ' ASN . 12.7 pt-20 50.06 20.55 0.61 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.515 0.674 . . . . 72.040000000000006 110.201 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -170.25 148.01 2.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.643 -1.162 . . . . 72.319999999999993 109.654 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.09 49.42 1.32 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.796 2.331 . . . . 65.530000000000001 112.741 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -92.51 -56.02 3.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.145 0.498 . . . . 74.040000000000006 111.5 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.32 33.73 1.33 Allowed Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.823 -0.626 . . . . 72.030000000000001 113.738 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.55 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -133.81 159.12 23.6 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.864 -0.684 . . . . 54.409999999999997 113.238 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.983 ' CE1' HG23 ' A' ' 130' ' ' THR . 78.3 t60 -68.73 116.69 9.52 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.253 0.221 . . . . 74.239999999999995 111.418 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.489 ' O ' HG22 ' A' ' 130' ' ' THR . 14.8 m -76.94 106.31 8.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.441 -0.948 . . . . 62.140000000000001 108.441 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.83 HD22 ' HB3' ' A' ' 127' ' ' GLU . 4.9 mt -61.93 -54.57 40.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.376 -0.972 . . . . 73.530000000000001 108.376 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 78' ' ' HIS . . . -127.84 121.16 29.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.244 -1.343 . . . . 61.350000000000001 107.536 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.6 t0 -52.75 152.07 4.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.219 -0.446 . . . . 55.219999999999999 111.872 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -59.49 127.2 30.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.897 -0.592 . . . . 72.420000000000002 109.688 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.1 148.95 16.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.521 0.677 . . . . 72.329999999999998 112.355 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.83 72.01 0.45 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.224 -1.15 . . . . 71.420000000000002 110.224 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.814 ' HA ' HG12 ' A' ' 170' ' ' VAL . 28.3 t -169.73 -89.3 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.68 -0.489 . . . . 62.310000000000002 109.68 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.75 33.6 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.993 -0.623 . . . . 43.100000000000001 114.329 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 35.2 Cg_endo -64.02 154.65 69.13 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.404 2.736 . . . . 73.430000000000007 114.061 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.492 ' HA ' ' HG3' ' A' ' 171' ' ' PRO . 5.6 Cg_exo -78.14 163.42 27.97 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.555 2.837 . . . . 74.409999999999997 112.89 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 166' ' ' TYR . 64.8 tttm -38.4 -26.13 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.076 -0.511 . . . . 60.329999999999998 111.511 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' PRO . 10.8 t70 -50.56 -41.52 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.874 -0.603 . . . . 74.430000000000007 111.898 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.418 HG21 ' HG2' ' A' ' 105' ' ' PRO . 13.9 t -73.73 -14.28 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.983 0.735 . . . . 70.120000000000005 112.983 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 58.05 -144.9 41.52 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.054 -1.07 . . . . 55.329999999999998 112.13 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 163' ' ' GLN . 43.8 tp -67.46 130.87 44.43 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.405 -0.468 . . . . 72.549999999999997 111.016 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 112' ' ' HIS . 6.5 p80 -130.48 126.31 36.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 73.439999999999998 110.307 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 -88.22 125.39 34.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.672 -0.694 . . . . 73.030000000000001 110.588 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -116.59 140.41 49.42 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.446 0.466 . . . . 75.450000000000003 110.231 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 161' ' ' TYR . 39.1 mt -123.91 125.51 71.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.554 0.692 . . . . 73.209999999999994 111.971 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.703 ' C ' HD22 ' A' ' 117' ' ' LEU . 20.6 m-85 -88.56 136.34 33.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.138 -0.937 . . . . 74.530000000000001 109.681 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.728 HD23 HG23 ' A' ' 61' ' ' VAL . 3.0 mm? -124.34 137.52 54.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 71.400000000000006 111.033 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.833 HD23 ' N ' ' A' ' 119' ' ' TYR . 4.7 tt -127.05 135.29 50.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.385 -0.598 . . . . 61.240000000000002 109.385 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.833 ' N ' HD23 ' A' ' 118' ' ' LEU . 8.5 m-85 -132.29 143.46 49.91 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.138 -0.483 . . . . 61.240000000000002 111.159 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -72.45 139.58 47.81 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.278 -0.638 . . . . 72.319999999999993 109.278 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HB3' ' C ' ' A' ' 55' ' ' LEU . 4.5 tt0 -123.91 127.31 47.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.483 0.658 . . . . 74.510000000000005 112.653 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -104.2 -38.89 6.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.258 -0.883 . . . . 75.239999999999995 109.085 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -107.05 129.28 54.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.326 -0.852 . . . . 75.099999999999994 110.947 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -67.51 152.32 45.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.853 -0.612 . . . . 74.230000000000004 111.927 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.607 HD13 ' HD2' ' A' ' 151' ' ' HIS . 2.4 pt -136.0 147.71 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.891 -0.595 . . . . 71.420000000000002 111.228 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -49.97 12.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.414 -0.357 . . . . 73.209999999999994 111.399 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.919 ' HG3' HG21 ' A' ' 82' ' ' VAL . 6.4 mm-40 61.24 33.34 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 63.5 112.02 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 75.7 p 53.32 156.57 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.611 0 N-CA-C 112.851 0.686 . . . . 71.439999999999998 112.851 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.32 148.6 1.16 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.622 2.215 . . . . 72.420000000000002 113.188 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.983 HG23 ' CE1' ' A' ' 95' ' ' HIS . 2.7 p -59.86 116.12 3.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 64.109999999999999 112.611 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 131' ' ' ILE . 7.4 mm -81.75 120.99 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.046 -0.724 . . . . 72.109999999999999 109.046 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.5 m -75.39 149.07 38.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.102 -0.499 . . . . 70.239999999999995 112.15 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.585 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 34.2 t30 -55.5 -36.38 66.61 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 121.411 0.624 . . . . 74.329999999999998 109.538 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 177' ' ' ILE . 33.4 p -78.39 8.78 4.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.552 -0.749 . . . . 74.510000000000005 111.727 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.55 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 1.7 m -64.1 131.59 47.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.642 0.258 . . . . 75.230000000000004 110.729 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.55 ' HA ' ' CG2' ' A' ' 177' ' ' ILE . 26.1 ttt85 -76.3 169.98 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.875 0.845 . . . . 75.209999999999994 113.212 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 140' ' ' LEU . 88.5 m -49.77 160.37 0.31 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.4 -1.273 . . . . 63.310000000000002 112.037 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.516 ' H ' HD11 ' A' ' 140' ' ' LEU . . . 96.04 -38.22 3.18 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 114.994 -1.003 . . . . 64.25 112.038 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 139' ' ' ARG . 23.3 mmt180 -82.82 -37.75 24.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 73.420000000000002 111.462 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.797 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.35 -50.37 71.7 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.602 0.593 . . . . 72.209999999999994 112.602 -179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.65 HD21 ' HB2' ' A' ' 73' ' ' TYR . 7.2 m120 -44.26 68.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.82 1.415 . . . . 72.329999999999998 114.82 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' N ' ' O ' ' A' ' 140' ' ' LEU . 23.4 t80 -149.9 126.7 11.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 73.420000000000002 110.893 178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 145' ' ' ARG . 0.6 OUTLIER -78.76 100.14 6.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.056 -0.52 . . . . 73.140000000000001 111.183 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -47.61 -33.81 7.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 111.728 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.59 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 49.7 ttp85 -47.66 -35.11 8.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.736 0.303 . . . . 74.439999999999998 110.874 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -51.9 -40.63 60.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.885 0.374 . . . . 75.409999999999997 110.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.606 ' CZ ' HD13 ' A' ' 97' ' ' LEU . 28.9 m-85 -46.83 -43.13 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.483 . . . . 63.149999999999999 110.086 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -61.76 -38.16 86.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.706 -0.679 . . . . 74.310000000000002 110.941 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.98 -58.21 3.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 74.129999999999995 111.367 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' NZ ' ' OE1' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -53.79 -51.28 63.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.517 -0.311 . . . . 55.530000000000001 111.173 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.607 ' HD2' HD13 ' A' ' 125' ' ' ILE . 28.9 t-80 -78.42 -5.7 53.13 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.536 -0.542 . . . . 73.010000000000005 109.536 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.28 24.67 69.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.661 -0.78 . . . . 74.329999999999998 112.236 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.625 ' HB3' ' CD2' ' A' ' 119' ' ' TYR . 14.7 mt -63.05 -25.31 68.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.169 -0.678 . . . . 61.450000000000003 109.169 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 31.62 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.788 -1.096 . . . . 74.530000000000001 113.888 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' LEU . 9.9 pt-20 -73.63 124.17 90.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 112.47 0.544 . . . . 54.229999999999997 112.47 -177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 73.2 Cg_endo -81.51 137.33 10.25 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.438 2.092 . . . . 62.530000000000001 111.692 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 118' ' ' LEU . 37.6 pt -83.27 -35.23 11.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-O 121.3 0.571 . . . . 75.200000000000003 110.712 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.497 ' CB ' HD11 ' A' ' 17' ' ' ILE . . . -142.74 150.67 40.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 55.399999999999999 111.059 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -152.09 158.91 43.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.069 0.461 . . . . 73.239999999999995 111.931 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -154.82 122.34 5.7 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.541 -0.911 . . . . 73.409999999999997 108.541 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.543 ' HD2' HG23 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -126.85 157.33 39.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 73.129999999999995 112.163 -177.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 4.1 p90 -162.53 163.04 27.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.785 -0.643 . . . . 62.509999999999998 110.767 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.527 ' HB2' HD11 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -110.7 136.79 49.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.181 0.515 . . . . 71.0 111.282 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.6 134.91 12.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.375 -0.83 . . . . 70.109999999999999 110.411 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.636 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -106.87 149.0 27.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 110.022 -0.362 . . . . 75.239999999999995 110.022 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.644 ' CG ' HG11 ' A' ' 170' ' ' VAL . 18.3 m-30 -128.46 125.28 38.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 64.219999999999999 110.998 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.14 -135.8 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.525 -0.761 . . . . 74.209999999999994 111.303 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 7.1 t70 -94.99 -43.44 8.15 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.903 -0.589 . . . . 74.540000000000006 110.989 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.529 ' HA ' HD12 ' A' ' 172' ' ' ILE . 28.9 t80 -51.95 -29.82 22.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.024 0.44 . . . . 73.030000000000001 110.83 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 103' ' ' SER . 23.3 t -71.38 -58.16 4.02 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.955 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.521 ' HG2' ' O ' ' A' ' 168' ' ' ASP . 18.0 Cg_endo -57.55 -28.45 81.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.641 2.227 . . . . 64.010000000000005 112.727 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 169' ' ' TYR . 65.2 mt -45.53 -39.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 120.591 0.234 . . . . 70.030000000000001 111.193 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 48.0 ttm-85 -46.91 -36.44 7.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 71.219999999999999 110.632 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.402 ' HA ' HG13 ' A' ' 177' ' ' ILE . 76.0 m-80 -54.62 -34.47 62.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.67 -0.695 . . . . 51.219999999999999 111.692 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -53.83 -40.46 66.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.937 0.399 . . . . 71.430000000000007 111.362 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.2 m -77.45 0.81 21.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.604 0.594 . . . . 74.120000000000005 112.604 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.3 mt -70.4 129.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.919 0.39 . . . . 75.010000000000005 111.933 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 177' ' ' ILE . 4.7 m -165.34 88.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.695 -0.684 . . . . 71.310000000000002 110.816 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 135' ' ' THR . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.779 -1.012 . . . . 71.230000000000004 112.086 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.135 -0.691 . . . . 74.340000000000003 109.135 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG12 ' A' ' 5' ' ' VAL . 6.0 p-10 37.41 50.3 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.927 0.394 . . . . 73.400000000000006 111.776 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.599 ' CB ' ' HA ' ' A' ' 11' ' ' ALA . 8.8 t70 -51.77 -54.8 24.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 70.340000000000003 110.695 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.537 HD12 ' CG2' ' A' ' 8' ' ' VAL . 3.1 pt -148.48 60.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.514 0.673 . . . . 63.350000000000001 109.959 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 2' ' ' ASP . 8.3 p -127.71 138.25 32.47 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.392 -0.822 . . . . 73.430000000000007 110.159 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 82.6 Cg_endo -85.0 34.02 3.92 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.974 -1.261 . . . . 74.109999999999999 112.858 0.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 59.6 t0 -59.4 -54.0 51.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.415 -0.357 . . . . 73.239999999999995 110.973 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.0 m -164.24 -32.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.03 -0.532 . . . . 75.530000000000001 111.986 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD23 ' HD3' ' A' ' 13' ' ' PRO . 35.3 tp -157.03 144.56 18.94 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.332 0.587 . . . . 71.450000000000003 112.028 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -69.37 -19.1 63.84 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.974 0.731 . . . . 64.439999999999998 112.974 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.599 ' HA ' ' CB ' ' A' ' 3' ' ' ASP . . . -161.22 135.46 7.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 111.523 0.194 . . . . 51.520000000000003 111.523 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -72.24 116.12 45.72 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 120.708 0.29 . . . . 74.239999999999995 111.521 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD3' HD23 ' A' ' 9' ' ' LEU . 42.3 Cg_endo -95.72 -125.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.687 2.925 . . . . 63.530000000000001 112.151 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -158.35 -42.05 0.06 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.456 -0.338 . . . . 65.430000000000007 110.923 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.11 173.48 14.86 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.641 -0.79 . . . . 54.140000000000001 112.733 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.8 t -121.59 161.69 21.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.435 0.636 . . . . 42.109999999999999 111.519 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 118' ' ' LEU . 8.1 mt -105.44 154.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.683 -1.144 . . . . 63.329999999999998 109.25 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HA ' ' CE ' ' A' ' 18' ' ' LYS . 3.1 mmpt? -102.9 102.33 12.41 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.926 -0.579 . . . . 74.5 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.788 ' HB ' HG22 ' A' ' 27' ' ' VAL . 54.8 t -109.66 109.69 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.098 -0.704 . . . . 73.450000000000003 109.098 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 20' ' ' ILE . 2.5 mp -90.14 144.37 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-O 121.209 0.528 . . . . 71.239999999999995 111.082 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.75 -94.39 0.34 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.266 -0.879 . . . . 71.129999999999995 112.524 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -61.64 -43.52 99.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.068 -0.587 . . . . 60.210000000000001 113.522 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 20' ' ' ILE . 2.4 m-20 179.14 -58.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.923 0.868 . . . . 70.530000000000001 109.811 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -98.52 -40.88 8.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.465 -1.243 . . . . 75.230000000000004 111.411 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.915 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.6 pt? -69.41 141.05 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 74.540000000000006 111.127 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 6.0 pm0 -139.28 148.75 43.43 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 75.109999999999999 110.101 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.788 HG22 ' HB ' ' A' ' 19' ' ' VAL . 9.3 m -62.46 147.41 11.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.279 -0.418 . . . . 72.239999999999995 111.842 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 70.0 mttt -140.93 103.44 4.48 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.953 0.723 . . . . 74.329999999999998 112.953 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.503 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 10.2 mp0 35.63 67.72 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.691 0.997 . . . . 72.120000000000005 113.691 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.95 -10.42 57.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.222 -0.513 . . . . 62.310000000000002 113.629 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 1.7 t30 -47.0 129.67 12.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.942 0.401 . . . . 63.340000000000003 110.985 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 163' ' ' GLN . 62.6 tt0 -102.79 132.63 48.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.46 -0.791 . . . . 71.030000000000001 111.246 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HG ' HE21 ' A' ' 37' ' ' GLN . 0.1 OUTLIER -100.86 135.49 42.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.087 0.47 . . . . 72.120000000000005 110.948 179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.547 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 7.8 p -138.64 164.79 37.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.455 -0.793 . . . . 74.439999999999998 109.974 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 84.9 Cg_endo -81.85 -29.31 5.97 Favored 'Cis proline' 0 C--N 1.351 0.662 0 C-N-CA 124.303 -1.124 . . . . 64.120000000000005 113.155 0.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 10.2 t -161.45 35.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.154 0.502 . . . . 71.219999999999999 111.315 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.525 ' NE2' HD13 ' A' ' 25' ' ' LEU . 15.2 pt20 -84.42 0.27 50.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.310000000000002 110.025 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 33' ' ' LEU . 33.4 m -83.91 -3.61 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.736 -1.12 . . . . 74.129999999999995 112.646 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -65.88 6.19 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.856 0.317 . . . . 75.409999999999997 111.856 -179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -96.89 145.84 25.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.39 0.614 . . . . 71.140000000000001 111.749 179.38 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.686 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.4 pm0 -62.75 130.83 94.07 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.156 -0.929 . . . . 54.420000000000002 109.318 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 15.3 Cg_exo -69.0 126.09 13.36 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 121.721 1.614 . . . . 34.329999999999998 112.664 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -100.13 105.27 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.752 -0.462 . . . . 70.299999999999997 109.752 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 91' ' ' PRO . 6.0 p -82.41 140.81 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.525 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 33.1 m -164.98 121.91 1.52 Allowed 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.672 0.272 . . . . 64.219999999999999 111.679 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 6.1 p90 -84.87 29.38 0.63 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.127 -0.694 . . . . 75.439999999999998 109.127 177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' SER . 11.1 t -46.29 123.14 4.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.2 -0.909 . . . . 70.310000000000002 110.738 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.95 -24.83 30.64 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.481 -0.648 . . . . 52.020000000000003 111.481 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 16' ' ' THR . 6.6 mp -87.68 -37.17 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.608 0.242 . . . . 74.209999999999994 110.75 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -50.27 138.39 16.65 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.802 -0.359 . . . . 71.099999999999994 110.761 -179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.13 -71.78 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.831 -0.699 . . . . 60.200000000000003 111.909 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -148.73 108.94 4.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 72.140000000000001 110.366 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 p -158.1 141.53 15.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.194 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -73.16 -38.9 66.03 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.584 0.707 . . . . 74.430000000000007 109.513 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 121' ' ' GLN . 26.2 mt -155.8 162.4 40.49 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.867 -1.061 . . . . 43.399999999999999 109.961 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD12 ' CZ2' ' A' ' 46' ' ' TRP . 80.6 mt -128.27 168.04 16.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.778 0.323 . . . . 73.219999999999999 110.42 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.879 HG23 HG12 ' A' ' 82' ' ' VAL . 99.1 m -143.47 133.11 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.426 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -127.77 138.62 52.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.957 -0.565 . . . . 75.109999999999999 110.032 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.689 ' N ' HD13 ' A' ' 58' ' ' LEU . 52.3 mt -149.04 131.66 15.87 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.775 0.657 . . . . 72.439999999999998 112.775 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.402 ' SD ' ' HD2' ' A' ' 114' ' ' TYR . 37.8 ttm -94.84 122.18 37.2 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.139 -0.937 . . . . 74.409999999999997 108.797 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 62' ' ' ASP . 4.9 t -109.13 -131.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.712 0.264 . . . . 72.299999999999997 111.712 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.637 ' H ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.84 80.94 0.27 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 121.278 0.561 . . . . 74.439999999999998 111.162 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.9 84.49 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.297 1.998 . . . . 51.409999999999997 112.405 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -126.23 87.57 2.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 70.409999999999997 110.564 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.6 135.14 1.09 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 72.019999999999996 110.858 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 15.4 Cg_exo -67.67 -18.37 9.21 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.752 -1.353 . . . . 64.150000000000006 109.501 -1.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 70' ' ' ASP . 5.9 t -157.25 131.7 8.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 113.781 -1.554 . . . . 74.340000000000003 107.934 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 4.3 tmm_? -50.97 -31.92 19.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.454 0.645 . . . . 74.329999999999998 109.832 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -63.41 -37.97 89.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.192 -0.913 . . . . 61.329999999999998 111.766 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.727 ' H ' HG23 ' A' ' 67' ' ' THR . 2.0 m-20 -141.21 72.16 27.04 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-O 121.195 0.521 . . . . 75.510000000000005 109.744 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 13.8 Cg_exo -67.04 65.48 0.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.105 2.537 . . . . 63.020000000000003 112.692 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -48.69 -45.88 39.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.587 -0.733 . . . . 75.219999999999999 112.346 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.649 ' HB2' HD21 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -123.04 44.98 2.52 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.087 0.403 . . . . 71.010000000000005 112.087 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER -70.69 133.0 46.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.553 -0.294 . . . . 64.549999999999997 110.896 179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 144' ' ' ALA . 86.9 mt-10 -91.32 178.47 5.96 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.478 0.711 . . . . 74.239999999999995 110.465 -0.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.715 HG21 ' HA3' ' A' ' 104' ' ' GLY . 7.3 tp -113.85 176.35 2.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.789 -0.641 . . . . 73.230000000000004 109.591 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.626 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.8 mm? -49.0 117.56 2.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.58 -0.526 . . . . 72.519999999999996 109.58 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.7 173.64 10.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.739 -0.664 . . . . 75.299999999999997 110.296 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.566 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 2.5 t-105 -99.51 113.1 25.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 74.239999999999995 111.007 -177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 14.4 m -131.85 128.22 38.23 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.594 -0.73 . . . . 74.530000000000001 109.848 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.49 143.06 28.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.233 0.54 . . . . 73.430000000000007 110.225 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.879 HG12 HG23 ' A' ' 57' ' ' THR . 29.5 m -142.52 161.92 18.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.771 -0.649 . . . . 70.219999999999999 112.29 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 95' ' ' HIS . 23.4 p30 55.57 43.06 28.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.677 -1.147 . . . . 61.009999999999998 112.522 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.019 HD13 ' HA3' ' A' ' 94' ' ' GLY . 2.0 mm -83.01 130.65 56.6 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.926 -0.768 . . . . 65.510000000000005 108.926 177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HB2' ' ND2' ' A' ' 88' ' ' ASN . 31.5 Cg_exo -58.04 128.88 30.51 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 121.454 1.436 . . . . 65.540000000000006 111.111 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.85 57.74 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.642 0.617 . . . . 74.219999999999999 114.642 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.5 p -178.69 36.91 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 117.579 0.689 . . . . 44.530000000000001 111.378 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.7 m-80 -121.3 -2.0 9.62 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.49 -0.323 . . . . 64.040000000000006 110.93 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 70.05 -38.86 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 51.399999999999999 111.387 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 88' ' ' ASN . 13.6 p30 -129.32 155.63 79.72 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.967 0.413 . . . . 74.109999999999999 110.391 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 84' ' ' ILE . 92.6 Cg_endo -71.59 55.52 2.12 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.226 2.617 . . . . 54.329999999999998 113.289 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.7 t -97.16 -54.97 3.0 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.342 0.497 . . . . 72.540000000000006 112.342 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.59 -10.75 25.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 115.21 0.844 . . . . 63.109999999999999 115.21 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 1.019 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -96.51 173.11 29.49 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.268 -0.968 . . . . 71.519999999999996 113.647 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.498 ' HB2' HD21 ' A' ' 83' ' ' ASN . 5.9 m80 -68.35 128.82 37.96 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.618 0.599 . . . . 72.510000000000005 112.618 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.971 ' H ' HG22 ' A' ' 130' ' ' THR . 86.1 p -96.5 97.25 9.27 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.379 -0.373 . . . . 74.430000000000007 110.288 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 147' ' ' PHE . 79.4 mt -56.94 -40.04 75.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 64.049999999999997 109.787 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -148.87 120.69 8.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.563 -1.199 . . . . 73.530000000000001 109.1 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.649 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 47.8 t0 -59.96 148.46 35.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 64.329999999999998 112.676 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.566 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 17.3 p90 -70.29 152.7 43.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.719 -0.673 . . . . 71.140000000000001 110.682 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.42 166.51 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 60.310000000000002 111.244 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.91 3.38 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.855 -0.611 . . . . 42.32 112.839 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 93.3 p -162.94 105.63 1.04 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.938 0.399 . . . . 71.409999999999997 110.454 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.715 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -53.05 -47.38 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.533 -0.758 . . . . 64.230000000000004 113.044 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HB2' HG21 ' A' ' 109' ' ' THR . 74.9 Cg_endo -78.26 129.01 9.29 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.418 2.079 . . . . 63.450000000000003 112.217 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.58 158.87 53.57 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.731 2.287 . . . . 73.310000000000002 113.566 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.51 ' NZ ' ' OD1' ' A' ' 108' ' ' ASP . 5.0 pttp -39.89 -27.9 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.119 -0.946 . . . . 64.140000000000001 112.158 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.51 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 1.0 OUTLIER -50.38 -34.12 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.126 -0.488 . . . . 75.349999999999994 111.627 -178.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 105' ' ' PRO . 6.8 t -93.62 4.7 53.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.566 -0.454 . . . . 52.5 111.433 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.17 -98.28 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 116.206 -0.452 . . . . 71.25 112.865 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 163' ' ' GLN . 53.3 tp -61.0 145.23 51.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.575 0.703 . . . . 64.420000000000002 111.416 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 166' ' ' TYR . 17.3 m-70 -139.75 114.02 9.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.191 -1.04 . . . . 73.439999999999998 108.191 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.568 ' HG3' ' HG2' ' A' ' 163' ' ' GLN . 0.0 OUTLIER -100.3 123.87 45.06 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.283 -0.636 . . . . 72.310000000000002 109.283 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.402 ' HD2' ' SD ' ' A' ' 60' ' ' MET . 35.6 m-85 -119.64 138.46 53.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.967 0.413 . . . . 73.409999999999997 110.353 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 161' ' ' TYR . 58.7 mt -122.66 122.3 65.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.311 -0.859 . . . . 74.439999999999998 111.923 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -98.9 137.28 37.69 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.748 -0.66 . . . . 73.129999999999995 109.86 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 118' ' ' LEU . 1.1 tm? -123.97 138.28 54.49 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.552 -0.536 . . . . 74.450000000000003 109.552 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.834 ' N ' HD13 ' A' ' 117' ' ' LEU . 65.3 tp -120.66 141.54 50.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 122.578 0.351 . . . . 62.539999999999999 110.744 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.584 ' CD2' HD22 ' A' ' 153' ' ' LEU . 37.7 t80 -142.44 136.73 29.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.868 -0.606 . . . . 74.299999999999997 111.047 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' A' ' 122' ' ' GLU . 4.9 tmm_? -79.51 121.25 24.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.785 -0.45 . . . . 74.109999999999999 109.785 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.628 HE22 HG12 ' A' ' 125' ' ' ILE . 1.9 tt0 -98.93 130.85 45.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.014 0.435 . . . . 74.310000000000002 110.871 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.41 ' HB2' ' NH1' ' A' ' 120' ' ' ARG . 65.1 tt0 -99.07 -41.28 7.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.834 -0.621 . . . . 54.450000000000003 110.202 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -111.92 130.6 55.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.993 -0.549 . . . . 75.530000000000001 110.949 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.23 146.84 52.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.722 -0.672 . . . . 65.540000000000006 112.085 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.628 HG12 HE22 ' A' ' 121' ' ' GLN . 22.3 pt -126.68 140.24 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.957 -0.565 . . . . 62.32 110.783 178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.1 -44.17 60.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.087 0.47 . . . . 75.310000000000002 111.66 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.767 ' HG2' HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER 29.7 38.28 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.154 1.168 . . . . 53.539999999999999 114.154 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 33.9 p 56.91 158.34 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.803 0.668 . . . . 74.409999999999997 112.803 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.2 158.26 9.79 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.73 2.286 . . . . 70.540000000000006 113.11 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.971 HG22 ' H ' ' A' ' 96' ' ' SER . 41.2 p -58.89 131.19 50.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.318 -0.855 . . . . 65.510000000000005 111.963 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 139' ' ' ARG . 40.9 mm -103.56 124.96 58.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.522 0.201 . . . . 62.530000000000001 110.491 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 99' ' ' ASP . 47.8 t -80.2 154.99 27.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.268 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.649 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.1 p30 -52.69 -35.14 54.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 53.240000000000002 110.137 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.473 ' OG1' HG22 ' A' ' 176' ' ' THR . 12.2 t -68.56 11.49 0.18 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.231 -0.895 . . . . 74.530000000000001 112.503 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' ILE . 15.0 t -62.02 132.39 52.76 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.79 0.329 . . . . 72.209999999999994 110.681 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.487 ' HG3' ' N ' ' A' ' 137' ' ' THR . 44.1 tpt85 -58.03 159.56 5.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 111.71 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.487 ' N ' ' HG3' ' A' ' 136' ' ' ARG . 27.8 m -51.57 146.95 6.85 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 75.150000000000006 110.119 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.34 4.73 17.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.618 -0.801 . . . . 73.049999999999997 111.758 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.561 ' HD2' HG21 ' A' ' 131' ' ' ILE . 45.9 ttm-85 -144.05 37.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 110.776 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' HG ' ' H ' ' A' ' 141' ' ' ASN . 0.3 OUTLIER -114.92 -56.97 2.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.014 -0.539 . . . . 75.230000000000004 110.605 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.649 HD21 ' HB2' ' A' ' 73' ' ' TYR . 3.0 m120 -62.24 67.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.07 -0.513 . . . . 72.420000000000002 111.986 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 146' ' ' ASP . 44.4 t80 -140.4 131.35 26.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.017 0.437 . . . . 75.530000000000001 111.061 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -71.05 108.02 4.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.76 -0.655 . . . . 74.530000000000001 109.458 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.466 ' H ' ' CD ' ' A' ' 75' ' ' GLU . . . -52.27 -40.28 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.303 0.573 . . . . 61.119999999999997 111.464 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.587 HH12 ' HG ' ' A' ' 117' ' ' LEU . 1.6 tpt180 -57.4 -28.68 63.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.438 -0.801 . . . . 74.219999999999999 111.996 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 6.0 t70 -48.72 -47.48 41.22 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.882 -0.784 . . . . 64.120000000000005 108.882 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CD2' HD13 ' A' ' 97' ' ' LEU . 12.2 m-30 -59.14 -40.05 84.28 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.151 -0.931 . . . . 73.230000000000004 109.852 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.646 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -61.15 -43.58 98.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.762 -0.654 . . . . 71.120000000000005 111.15 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -72.4 -50.74 24.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.063 -0.517 . . . . 71.409999999999997 111.887 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.605 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -68.7 -44.23 74.38 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.841 0.682 . . . . 71.340000000000003 112.841 -178.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 34.2 m170 -72.69 7.77 1.78 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 110.734 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.24 2.78 63.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.117 -0.563 . . . . 62.530000000000001 112.332 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 148' ' ' ALA . 3.2 mt -68.71 16.06 0.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.543 0.211 . . . . 43.310000000000002 110.589 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.21 -66.24 1.25 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.874 -0.679 . . . . 54.450000000000003 112.189 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -78.52 122.18 84.63 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 110.036 -0.357 . . . . 73.409999999999997 110.036 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.773 ' HB3' HD21 ' A' ' 117' ' ' LEU . 89.0 Cg_endo -87.72 127.94 2.37 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.513 2.142 . . . . 72.430000000000007 113.014 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.547 HD11 ' HG ' ' A' ' 118' ' ' LEU . 43.3 pt -77.04 -34.14 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.127 0.489 . . . . 71.219999999999999 110.209 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.438 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -155.67 157.86 37.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.0 -0.545 . . . . 74.450000000000003 110.851 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.449 ' HB2' HD22 ' A' ' 117' ' ' LEU . . . -154.16 171.34 19.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.008 0.433 . . . . 64.310000000000002 111.156 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.416 ' HB2' ' H ' ' A' ' 17' ' ' ILE . 1.8 t-20 -170.58 133.57 1.02 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.079 -1.082 . . . . 71.409999999999997 108.079 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.534 ' CE1' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -135.4 158.41 44.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.76 -0.2 . . . . 64.010000000000005 111.466 -177.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.661 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 1.9 p90 -146.6 156.83 43.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.974 -0.557 . . . . 62.409999999999997 112.338 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.568 ' HG2' ' HG3' ' A' ' 113' ' ' ARG . 14.2 mt-30 -119.09 124.68 47.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.128 -0.942 . . . . 75.329999999999998 109.759 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 166' ' ' TYR . . . -156.68 138.43 14.22 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.635 -0.426 . . . . 64.239999999999995 111.498 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.599 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.17 135.52 41.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.27 -0.641 . . . . 60.210000000000001 109.27 178.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.866 ' HB3' HG11 ' A' ' 170' ' ' VAL . 6.2 m-85 -121.21 142.64 49.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.341 -0.391 . . . . 74.239999999999995 111.814 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' C ' ' HB3' ' A' ' 107' ' ' LYS . 1.4 m-20 -66.24 -168.21 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.191 -0.913 . . . . 60.43 113.022 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 171' ' ' PRO . 32.6 t70 -85.9 -32.77 21.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.986 -1.006 . . . . 74.450000000000003 111.57 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.499 ' O ' HG22 ' A' ' 172' ' ' ILE . 20.6 t80 -61.14 -32.58 72.28 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.521 0.563 . . . . 74.030000000000001 112.521 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.992 HG13 ' HD3' ' A' ' 171' ' ' PRO . 1.5 p -72.29 -48.79 9.79 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 113.761 1.023 . . . . 72.349999999999994 113.761 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.992 ' HD3' HG13 ' A' ' 170' ' ' VAL . 20.0 Cg_endo -59.25 -17.22 38.22 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.777 1.651 . . . . 74.439999999999998 112.519 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.542 HD11 ' HD2' ' A' ' 175' ' ' LYS . 10.9 tp -46.15 -30.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.012 0.434 . . . . 72.129999999999995 111.156 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 173' ' ' ARG . 10.6 tpp85 -44.79 -25.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.845 -0.616 . . . . 71.25 110.588 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 177' ' ' ILE . 18.3 p30 -50.5 -36.22 32.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.957 -0.565 . . . . 65.109999999999999 111.339 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.542 ' HD2' HD11 ' A' ' 172' ' ' ILE . 8.4 mtpm? -56.7 -22.19 33.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.368 . . . . 73.129999999999995 111.128 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.473 HG22 ' OG1' ' A' ' 134' ' ' THR . 16.6 m -74.96 -7.89 54.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.802 -0.635 . . . . 74.540000000000006 111.457 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 135' ' ' THR . 44.2 mm -68.52 79.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 74.209999999999994 110.43 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.419 ' HA ' ' CD ' ' A' ' 136' ' ' ARG . 28.6 m -139.33 13.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.41 0.522 . . . . 51.149999999999999 112.41 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-O 118.125 -1.375 . . . . 71.239999999999995 112.932 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.392 -0.225 . . . . 64.409999999999997 110.392 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' OD2' ' NH2' ' A' ' 145' ' ' ARG . 6.4 m-20 -68.87 112.61 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.518 -0.31 . . . . 55.439999999999998 110.526 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.18 -71.12 0.77 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.598 0.592 . . . . 61.399999999999999 112.598 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.578 ' C ' ' HB2' ' A' ' 7' ' ' ASP . 6.9 pt -99.39 65.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.12 0.486 . . . . 72.230000000000004 112.266 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' A' ' 6' ' ' PRO . 8.8 p -141.61 143.53 29.8 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.07 -0.514 . . . . 73.230000000000004 110.659 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 5' ' ' VAL . 8.0 Cg_exo -73.57 17.81 2.65 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 124.905 -0.873 . . . . 62.32 112.626 0.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.578 ' HB2' ' C ' ' A' ' 4' ' ' ILE . 2.3 m-20 -45.8 -59.23 2.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.329 -0.851 . . . . 72.400000000000006 111.941 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 7' ' ' ASP . 10.0 m -161.79 -40.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 40.450000000000003 111.54 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 161' ' ' TYR . 47.0 tp -151.24 135.26 16.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.36 0.6 . . . . 73.140000000000001 111.951 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -75.48 37.46 0.14 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.808 -0.633 . . . . 73.340000000000003 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 179.03 -148.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.608 -0.724 . . . . 61.420000000000002 109.856 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.5 p -152.33 119.2 3.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.55 0.215 . . . . 60.109999999999999 110.85 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.586 ' HD3' HD23 ' A' ' 9' ' ' LEU . 49.9 Cg_endo -97.13 135.91 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.077 2.518 . . . . 65.329999999999998 112.77 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.95 -24.89 67.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.118 -0.492 . . . . 74.450000000000003 110.334 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.54 -129.64 1.75 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.414 -0.812 . . . . 71.109999999999999 111.487 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t -164.32 159.58 20.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.513 . . . . 75.430000000000007 109.614 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -105.24 135.0 45.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.218 -0.446 . . . . 65.310000000000002 110.963 -179.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -77.69 102.3 7.04 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.386 -0.598 . . . . 73.219999999999999 109.386 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 27' ' ' VAL . 97.6 t -107.97 110.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 121.402 0.62 . . . . 62.109999999999999 109.735 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 25' ' ' LEU . 61.3 mt -101.5 124.49 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 71.209999999999994 110.264 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 42' ' ' PRO . 1.3 m-85 -73.98 -40.01 63.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.333 -0.849 . . . . 74.329999999999998 112.112 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.677 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -126.38 -55.14 0.15 Allowed Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.179 -1.01 . . . . 75.530000000000001 112.754 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -179.69 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 72.530000000000001 108.328 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -93.08 -45.13 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.725 -1.125 . . . . 70.420000000000002 109.214 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.3 pt? -69.22 138.5 54.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.768 -0.651 . . . . 71.510000000000005 109.375 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' CD ' ' NZ ' ' A' ' 28' ' ' LYS . 53.4 tt0 -143.74 139.05 29.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.072 -0.967 . . . . 65.420000000000002 111.001 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 19' ' ' VAL . 16.0 m -86.57 106.81 16.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.22 0.533 . . . . 61.009999999999998 110.645 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' CD ' ' A' ' 26' ' ' GLU . 27.1 mttp -98.44 119.84 37.83 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.064 0.935 . . . . 75.310000000000002 112.949 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 9.8 mp0 30.28 67.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.566 -1.652 . . . . 72.129999999999995 115.049 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.42 8.81 76.56 Favored Glycine 0 C--N 1.329 0.184 0 N-CA-C 115.528 0.971 . . . . 74.510000000000005 115.528 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 31' ' ' ASN . 0.0 OUTLIER -57.76 149.92 21.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.864 0.832 . . . . 74.109999999999999 110.742 179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -91.25 133.4 35.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 72.540000000000006 109.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 10.3 mp -106.0 126.34 52.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.419 . . . . 61.539999999999999 110.648 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 35' ' ' PRO . 17.0 p -143.79 160.88 48.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.467 -0.788 . . . . 63.509999999999998 109.937 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 34' ' ' THR . 3.1 Cg_exo -75.98 -40.03 1.28 Allowed 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.522 -1.032 . . . . 72.030000000000001 112.908 0.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.7 p -151.98 28.55 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 64.239999999999995 111.591 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 1.8 pt20 -60.0 -10.4 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.521 0.677 . . . . 62.340000000000003 109.999 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.72 HG11 ' CB ' ' A' ' 164' ' ' ALA . 34.5 m -82.97 25.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.962 -1.017 . . . . 75.140000000000001 110.858 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' NZ ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -75.99 -21.19 57.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.285 -0.871 . . . . 74.209999999999994 111.085 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -107.76 152.52 24.25 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.155 0.503 . . . . 72.329999999999998 111.481 179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.8 pm0 -63.98 146.39 97.3 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.449 -0.796 . . . . 64.209999999999994 111.793 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.614 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 94.7 Cg_endo -79.13 129.24 8.7 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.695 2.264 . . . . 71.310000000000002 112.805 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 44.3 mm -104.19 117.65 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.509 -0.182 . . . . 62.539999999999999 110.509 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.9 t -86.55 142.5 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 71.219999999999999 111.788 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.3 m -156.38 145.02 20.06 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.125 0.488 . . . . 72.450000000000003 110.668 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.707 ' CD1' ' HB2' ' A' ' 50' ' ' GLU . 3.3 p90 -126.32 35.34 4.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.187 0.518 . . . . 74.439999999999998 110.904 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 t -47.7 125.57 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 72.209999999999994 110.529 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.79 -28.56 8.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 62.420000000000002 112.931 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 4.1 mm? -79.23 -42.18 26.55 Favored 'General case' 0 N--CA 1.461 0.122 0 N-CA-C 109.228 -0.656 . . . . 75.219999999999999 109.228 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.707 ' HB2' ' CD1' ' A' ' 46' ' ' TRP . 31.6 tt0 -59.32 167.25 1.91 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.571 -0.74 . . . . 73.430000000000007 110.171 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . -177.48 -71.33 0.06 OUTLIER Glycine 0 C--O 1.229 -0.202 0 C-N-CA 120.708 -0.758 . . . . 64.109999999999999 112.14 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -148.86 109.74 4.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.124 0.488 . . . . 65.0 110.721 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' HD2' ' A' ' 120' ' ' ARG . 37.6 m -157.09 141.95 16.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 44.439999999999998 109.57 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t30 -67.01 -38.08 85.33 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.643 0.735 . . . . 74.25 109.482 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 83' ' ' ASN . 64.6 mt -155.47 175.99 13.17 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.494 -1.23 . . . . 64.120000000000005 110.519 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 22.1 mt -146.71 158.91 44.01 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.222 -0.445 . . . . 72.439999999999998 109.944 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.675 HG23 HG12 ' A' ' 82' ' ' VAL . 3.2 m -123.21 127.79 49.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.226 -0.443 . . . . 54.450000000000003 111.119 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -123.84 117.58 25.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.454 -1.314 . . . . 74.319999999999993 107.454 178.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 80' ' ' SER . 86.0 mt -132.77 139.96 47.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.464 0.542 . . . . 34.32 112.464 -177.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 78' ' ' HIS . 46.5 ttm -94.74 134.37 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.639 -0.875 . . . . 74.439999999999998 108.639 177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.39 136.0 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.308 -0.406 . . . . 54.539999999999999 111.022 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 5.2 t70 164.53 94.43 0.02 OUTLIER Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 115.414 -0.812 . . . . 72.040000000000006 110.281 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.56 84.02 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.583 1.522 . . . . 72.150000000000006 110.833 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 84.49 1.64 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 112.766 0.654 . . . . 73.329999999999998 112.766 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.3 133.71 1.07 Allowed Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.45 -0.5 . . . . 54.030000000000001 112.28 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.696 ' C ' ' HA ' ' A' ' 65' ' ' ALA . 35.6 Cg_exo -57.63 -23.34 1.82 Allowed 'Cis proline' 0 C--N 1.353 0.784 0 C-N-CA 122.997 -1.668 . . . . 71.340000000000003 108.893 -3.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.451 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 12.2 t -161.93 143.57 11.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 113.889 -1.505 . . . . 74.439999999999998 108.706 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 53.1 ttp180 -53.69 -17.59 2.38 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.226 0.536 . . . . 73.530000000000001 111.185 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 69' ' ' GLN . 1.8 mp0 -72.49 -32.44 66.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.397 -0.82 . . . . 72.239999999999995 111.445 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' PRO . 62.2 t0 -143.83 63.33 11.8 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 108.82 -0.807 . . . . 65.530000000000001 108.82 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HB2' ' CB ' ' A' ' 74' ' ' ARG . 53.8 Cg_endo -72.3 51.74 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.23 2.62 . . . . 74.439999999999998 112.857 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -51.35 -44.11 61.97 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.391 -0.368 . . . . 63.020000000000003 111.945 -179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.55 ' CE1' HD13 ' A' ' 76' ' ' ILE . 15.6 p90 -108.22 34.76 3.44 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.523 -0.471 . . . . 71.430000000000007 111.629 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.518 ' CB ' ' HB2' ' A' ' 71' ' ' PRO . 35.8 ttp85 -76.44 144.49 39.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.814 -0.439 . . . . 72.340000000000003 109.814 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 74' ' ' ARG . 29.8 mp0 -92.28 142.69 27.19 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.759 0.823 . . . . 63.539999999999999 110.602 0.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' CE1' ' A' ' 73' ' ' TYR . 5.6 tp -72.47 174.34 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 120.771 -0.372 . . . . 72.349999999999994 110.241 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' HB2' HG11 ' A' ' 101' ' ' VAL . 3.2 mm? -52.15 133.46 33.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.428 0.633 . . . . 64.340000000000003 111.33 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.469 ' HA ' ' SD ' ' A' ' 60' ' ' MET . 2.0 p-80 -129.64 157.05 43.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.861 -1.063 . . . . 73.329999999999998 109.458 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -99.35 117.67 34.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 54.329999999999998 109.923 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.698 ' HB3' HD12 ' A' ' 97' ' ' LEU . 74.3 m -141.38 138.02 32.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.443 0.639 . . . . 64.430000000000007 111.7 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.521 HG12 ' CD1' ' A' ' 84' ' ' ILE . 11.9 t -143.52 123.21 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 114.666 -1.152 . . . . 63.509999999999998 108.666 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.82 HG22 HD21 ' A' ' 97' ' ' LEU . 18.7 m -123.71 -177.4 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.066 -0.515 . . . . 74.319999999999993 110.367 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.788 ' OD1' HG23 ' A' ' 82' ' ' VAL . 7.1 m120 62.82 30.2 16.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 109.951 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.977 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -77.86 108.99 8.45 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.184 -0.606 . . . . 65.420000000000002 109.673 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' A' ' 87' ' ' SER . 19.2 Cg_endo -59.23 124.35 15.41 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.43 1.42 . . . . 74.040000000000006 110.69 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.05 71.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.433 -0.413 . . . . 62.420000000000002 113.655 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 85' ' ' PRO . 32.3 m -175.16 43.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.297 0.639 . . . . 71.329999999999998 110.179 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 57.2 m-80 -135.78 -26.59 1.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.412 0.893 . . . . 74.120000000000005 113.412 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 88' ' ' ASN . 9.0 tt0 77.57 -16.42 0.65 Allowed 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.314 0.578 . . . . 74.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 88' ' ' ASN . 19.9 p30 -150.96 154.43 34.3 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 115.142 -0.935 . . . . 70.129999999999995 110.386 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 45.67 1.75 Allowed 'Trans proline' 0 N--CA 1.474 0.355 0 C-N-CA 123.374 2.716 . . . . 71.140000000000001 112.994 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -103.97 -1.96 26.79 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.829 0.307 . . . . 61.32 111.829 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.2 -14.89 13.58 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.751 -0.738 . . . . 71.340000000000003 114.338 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.977 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -87.97 177.24 46.19 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.572 -0.823 . . . . 71.239999999999995 113.637 -178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -68.23 114.29 6.58 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.812 0.301 . . . . 60.329999999999998 111.812 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.513 ' O ' HG22 ' A' ' 130' ' ' THR . 30.7 m -70.84 96.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.947 -0.76 . . . . 71.420000000000002 108.947 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.82 HD21 HG22 ' A' ' 82' ' ' VAL . 24.6 mt -60.51 -59.52 5.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 75.409999999999997 110.503 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -129.61 125.17 35.52 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.25 -0.886 . . . . 51.119999999999997 109.223 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -59.96 156.15 15.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.596 0.712 . . . . 74.150000000000006 112.614 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 101' ' ' VAL . 3.3 t80 -68.59 141.99 55.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.822 -1.081 . . . . 74.150000000000006 112.138 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 77' ' ' LEU . 7.4 p -142.87 113.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.941 -0.572 . . . . 72.439999999999998 109.866 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.39 -64.62 1.31 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.891 -0.671 . . . . 74.510000000000005 112.981 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.3 p 178.85 98.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.883 0.373 . . . . 72.400000000000006 110.487 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.614 ' N ' ' CD ' ' A' ' 105' ' ' PRO . . . -72.83 -35.62 58.33 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.066 -0.587 . . . . 73.510000000000005 113.573 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 104' ' ' GLY . 38.6 Cg_exo -62.27 143.14 93.65 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.149 2.566 . . . . 51.32 113.294 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.48 144.85 99.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.223 2.616 . . . . 74.5 113.165 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -48.92 -22.36 0.83 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.455 -0.793 . . . . 64.319999999999993 111.642 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 107' ' ' LYS . 2.3 m-20 -50.82 -29.93 12.98 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.57 0.581 . . . . 74.329999999999998 112.57 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.559 HG21 ' CE1' ' A' ' 112' ' ' HIS . 12.9 t -70.62 -15.22 62.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.326 0.584 . . . . 71.25 110.418 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 73.68 -138.01 24.26 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.337 -0.847 . . . . 64.340000000000003 113.105 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.7 tp -65.27 118.95 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.413 -0.394 . . . . 60.310000000000002 111.991 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.559 ' CE1' HG21 ' A' ' 109' ' ' THR . 94.3 m-70 -79.93 148.07 31.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.334 -0.617 . . . . 63.32 109.334 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -114.04 58.98 0.68 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.592 0.234 . . . . 75.329999999999998 110.805 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 62' ' ' ASP . 54.4 m-85 -69.14 132.72 47.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.49 0.662 . . . . 75.140000000000001 112.357 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.728 HG23 ' HD1' ' A' ' 161' ' ' TYR . 63.8 mt -122.25 134.31 65.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.777 -1.102 . . . . 65.019999999999996 110.672 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 14.0 m-30 -104.21 137.79 41.62 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.061 -0.348 . . . . 65.010000000000005 110.061 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 118' ' ' LEU . 2.0 tm? -119.69 131.97 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.699 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.731 ' N ' HD13 ' A' ' 117' ' ' LEU . 3.0 tt -131.81 122.69 26.18 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 120.751 0.31 . . . . 60.130000000000003 111.633 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.668 ' N ' HD23 ' A' ' 118' ' ' LEU . 30.6 t80 -144.92 141.85 29.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.363 -0.38 . . . . 61.229999999999997 111.678 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.639 ' HA ' HD23 ' A' ' 56' ' ' LEU . 16.6 mtm105 -63.2 144.8 56.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.566 0.222 . . . . 74.409999999999997 111.295 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 30.4 tp60 -117.62 124.83 49.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.822 -0.807 . . . . 74.219999999999999 108.822 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.666 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -86.38 -38.97 16.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 73.450000000000003 112.753 -178.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -110.18 150.07 29.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.278 0.844 . . . . 74.400000000000006 113.278 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 125' ' ' ILE . 1.7 tppp? -72.64 133.59 44.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.941 -1.027 . . . . 73.230000000000004 110.496 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.628 HD12 ' NE2' ' A' ' 151' ' ' HIS . 0.6 OUTLIER -135.67 144.67 33.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.535 -0.757 . . . . 63.240000000000002 111.43 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 -44.03 23.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.135 0.493 . . . . 74.420000000000002 110.848 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.643 ' HG3' HG21 ' A' ' 82' ' ' VAL . 47.8 mm-40 54.71 40.43 31.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.318 0.859 . . . . 64.239999999999995 113.318 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.1 p 53.37 154.17 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 N-CA-C 113.673 0.99 . . . . 72.439999999999998 113.673 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.48 158.22 8.11 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.094 2.529 . . . . 41.109999999999999 113.009 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 96' ' ' SER . 23.8 p -58.86 122.45 13.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.769 -0.65 . . . . 72.439999999999998 111.164 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 131' ' ' ILE . 23.9 mm -94.45 121.11 44.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.42 0.629 . . . . 70.340000000000003 111.751 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 74.7 m -73.68 135.88 43.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.896 -1.047 . . . . 74.519999999999996 111.156 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 135' ' ' THR . 19.2 p-10 -58.71 -43.48 90.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.111 -0.495 . . . . 72.25 110.989 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 177' ' ' ILE . 41.0 p -70.09 22.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 112.189 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 133' ' ' ASN . 14.9 t -74.1 133.56 42.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 72.549999999999997 111.285 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.903 ' HD2' HG22 ' A' ' 177' ' ' ILE . 14.8 mmm-85 -58.05 173.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.877 0.846 . . . . 75.409999999999997 112.873 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -41.04 157.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.148 -1.387 . . . . 63.229999999999997 113.036 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.71 -36.83 1.21 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.048 -0.978 . . . . 73.530000000000001 112.948 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 11.4 mtp85 -86.24 26.94 0.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.018 0.409 . . . . 72.530000000000001 111.324 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.2 mp -114.29 -54.82 2.56 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.06 -0.718 . . . . 71.129999999999995 109.06 179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 73' ' ' TYR . 3.2 m120 -53.75 121.98 8.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.425 -0.807 . . . . 73.329999999999998 110.924 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.461 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 9.8 t80 -173.53 123.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 74.230000000000004 110.488 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 17.1 p-10 -84.67 117.14 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.724 -0.671 . . . . 61.140000000000001 111.913 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.28 -39.02 74.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.165 0.507 . . . . 73.530000000000001 110.408 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.451 ' NH2' ' OD2' ' A' ' 2' ' ' ASP . 87.8 mtt180 -43.91 -36.89 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.623 -0.717 . . . . 74.439999999999998 111.406 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.445 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 24.5 t70 -49.41 -53.92 20.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.39 0.614 . . . . 73.230000000000004 110.498 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 150' ' ' LYS . 5.3 m-30 -63.63 -34.53 78.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.495 -0.775 . . . . 73.0 110.482 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 153' ' ' LEU . . . -59.81 -44.18 94.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.38 -0.6 . . . . 51.240000000000002 109.38 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.26 -57.32 10.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.638 -0.71 . . . . 71.140000000000001 111.908 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HG3' ' CD2' ' A' ' 151' ' ' HIS . 3.0 ptmm? -60.87 -53.14 60.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.717 0.265 . . . . 73.420000000000002 111.717 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.628 ' NE2' HD12 ' A' ' 125' ' ' ILE . 46.2 m170 -69.42 -12.15 61.42 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.478 -0.489 . . . . 74.310000000000002 111.178 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 74.11 25.21 71.75 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 71.239999999999995 112.34 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 151' ' ' HIS . 10.6 mt -64.16 16.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.835 0.454 . . . . 74.230000000000004 111.759 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -51.77 -21.31 7.0 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.035 -0.602 . . . . 72.239999999999995 113.224 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.05 95.93 14.76 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 121.227 0.537 . . . . 74.530000000000001 110.579 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.558 ' HB3' HD21 ' A' ' 117' ' ' LEU . 78.9 Cg_endo -78.29 141.57 18.32 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.065 2.51 . . . . 74.430000000000007 114.106 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 119' ' ' TYR . 35.8 pt -82.79 -36.33 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.885 -0.598 . . . . 63.100000000000001 110.659 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 118' ' ' LEU . . . -141.19 145.14 35.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.216 0.531 . . . . 74.439999999999998 111.543 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -147.67 162.17 39.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.445 -0.798 . . . . 74.230000000000004 109.33 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 116' ' ' PHE . 2.4 t-20 -171.12 127.28 0.69 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.264 -1.013 . . . . 72.329999999999998 108.264 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.728 ' HD1' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -115.8 156.86 25.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.912 -0.585 . . . . 74.25 111.047 -177.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 3.3 p90 -139.41 136.94 35.21 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.725 -0.671 . . . . 74.409999999999997 110.175 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 39.8 mt-30 -122.1 124.45 43.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.819 -0.628 . . . . 74.349999999999994 109.699 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.72 ' CB ' HG11 ' A' ' 38' ' ' VAL . . . -155.99 151.14 26.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.644 -0.707 . . . . 71.530000000000001 110.713 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.627 ' NE2' ' H ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -111.33 133.76 53.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.409 -0.36 . . . . 73.25 110.146 178.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -115.57 131.39 56.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.305 -0.628 . . . . 54.149999999999999 109.305 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 169' ' ' TYR . 72.9 m-20 -66.53 -178.64 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 74.420000000000002 112.413 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.47 28.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.542 -0.754 . . . . 64.200000000000003 111.959 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 167' ' ' ASP . 28.3 t80 -97.05 -45.71 6.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 63.119999999999997 110.526 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.602 ' CG2' ' HD3' ' A' ' 171' ' ' PRO . 16.0 m -60.38 -35.17 24.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 112.836 0.68 . . . . 72.5 112.836 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.602 ' HD3' ' CG2' ' A' ' 170' ' ' VAL . 73.1 Cg_exo -51.49 -35.61 56.14 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.187 1.258 . . . . 73.209999999999994 111.034 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.567 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 66.8 mt -48.31 -42.45 11.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.808 -0.633 . . . . 63.25 110.227 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HA ' ' HE ' ' A' ' 173' ' ' ARG . 1.9 tpm_? -57.22 -37.91 72.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.252 -0.886 . . . . 74.319999999999993 111.235 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.404 ' O ' HG13 ' A' ' 177' ' ' ILE . 8.4 p30 -65.73 -35.19 80.03 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.434 -0.506 . . . . 60.420000000000002 110.789 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -57.6 -27.42 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.282 -0.567 . . . . 75.400000000000006 109.597 179.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.2 m -73.68 -0.12 14.56 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.623 -0.717 . . . . 72.310000000000002 111.587 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.903 HG22 ' HD2' ' A' ' 136' ' ' ARG . 66.4 mt -64.64 129.74 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.803 -0.181 . . . . 50.350000000000001 110.584 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 177' ' ' ILE . 2.4 m -176.4 69.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 122.894 0.478 . . . . 73.430000000000007 111.297 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.251 1.185 0 CA-C-O 118.768 -1.018 . . . . 62.200000000000003 112.783 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.643 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 45.8 ttm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.075 -0.343 . . . . 73.019999999999996 110.075 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 72.9 m-20 59.53 56.72 3.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 111.445 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -75.57 -62.64 1.51 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.205 -0.452 . . . . 64.430000000000007 111.501 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' LEU . 18.5 pt -104.22 51.51 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.357 0.599 . . . . 73.239999999999995 111.014 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG23 ' HA ' ' A' ' 6' ' ' PRO . 11.1 p -135.56 139.94 32.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.639 -0.709 . . . . 52.219999999999999 109.862 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HA ' HG23 ' A' ' 5' ' ' VAL . 86.5 Cg_endo -82.15 37.7 1.33 Allowed 'Cis proline' 0 C--N 1.346 0.447 0 C-N-CA 123.744 -1.357 . . . . 72.140000000000001 112.762 0.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.642 ' O ' HG13 ' A' ' 8' ' ' VAL . 67.8 t0 -64.73 -50.88 65.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.451 -0.34 . . . . 65.430000000000007 110.471 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 7' ' ' ASP . 7.8 m -163.74 -36.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.642 0.608 . . . . 65.129999999999995 112.642 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 4' ' ' ILE . 29.7 tp -157.31 164.23 37.84 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.093 0.473 . . . . 73.239999999999995 112.182 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -67.85 -38.0 82.58 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.869 0.366 . . . . 73.230000000000004 110.621 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . -146.32 128.92 16.08 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.749 -0.66 . . . . 55.109999999999999 110.594 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 12' ' ' VAL . 8.7 p -60.53 123.78 75.52 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 112.339 0.496 . . . . 74.510000000000005 112.339 -179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 46.0 Cg_endo -87.58 -121.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.37 2.714 . . . . 74.209999999999994 112.295 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -163.42 -45.96 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.075 -0.511 . . . . 63.439999999999998 110.186 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.93 -135.07 8.23 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.874 -0.679 . . . . 54.119999999999997 112.474 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HB1' ' A' ' 158' ' ' ALA . 9.7 t -164.12 177.42 8.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 73.340000000000003 110.834 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.815 HG22 HG23 ' A' ' 19' ' ' VAL . 53.0 mt -124.3 128.56 73.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.981 -0.554 . . . . 62.140000000000001 110.895 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' A' ' 26' ' ' GLU . 4.8 mmpt? -86.87 108.77 18.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.433 -0.803 . . . . 72.430000000000007 109.372 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.815 HG23 HG22 ' A' ' 17' ' ' ILE . 74.7 t -124.68 110.9 26.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.122 0.487 . . . . 73.099999999999994 110.434 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 26' ' ' GLU . 29.1 mt -96.25 137.94 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 64.25 110.937 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.7 -86.53 0.32 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 75.549999999999997 111.77 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 25' ' ' LEU . . . -69.54 -45.91 57.5 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.854 -0.688 . . . . 61.219999999999999 113.809 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 174.41 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.162 -0.681 . . . . 64.420000000000002 109.162 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -91.86 -42.97 9.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.179 -0.919 . . . . 73.349999999999994 109.33 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.924 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -69.5 137.22 52.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.179 -0.919 . . . . 74.109999999999999 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 23.7 pt-20 -140.85 159.65 41.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.693 -1.139 . . . . 73.430000000000007 109.772 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.783 HG22 ' HB ' ' A' ' 19' ' ' VAL . 10.8 m -80.34 119.11 29.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.32 0.581 . . . . 62.340000000000003 111.307 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' H ' ' CG ' ' A' ' 31' ' ' ASN . 41.1 mttp -120.87 113.22 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.723 -0.671 . . . . 53.450000000000003 111.822 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' N ' ' CD ' ' A' ' 29' ' ' GLN . 8.8 mp0 46.43 67.08 0.82 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.54 1.311 . . . . 74.340000000000003 114.54 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.51 16.22 14.93 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 114.301 0.481 . . . . 62.32 114.301 177.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -51.77 145.47 9.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.131 0.491 . . . . 75.430000000000007 110.875 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -91.76 116.39 28.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.223 -0.899 . . . . 73.340000000000003 110.533 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 33' ' ' LEU . 8.8 mp -92.84 118.0 30.64 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.513 -0.475 . . . . 65.450000000000003 110.141 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 p -150.51 154.95 36.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.758 -0.656 . . . . 72.140000000000001 111.006 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 36' ' ' THR . 93.2 Cg_endo -89.19 -93.78 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.532 0 C-N-CA 124.039 -1.234 . . . . 75.510000000000005 111.267 -0.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.411 ' H ' ' HG2' ' A' ' 35' ' ' PRO . 22.8 p -75.05 47.97 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.787 0.803 . . . . 75.299999999999997 109.631 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' HA ' ' HZ1' ' A' ' 39' ' ' LYS . 42.4 tt0 -107.66 -2.78 19.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.187 -0.915 . . . . 71.420000000000002 110.734 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 164' ' ' ALA . 30.8 m -101.14 27.66 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 65.439999999999998 112.038 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.503 ' HZ1' ' HA ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.18 -40.6 62.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.095 0.474 . . . . 62.340000000000003 110.642 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 29.2 m-20 -71.79 138.91 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.612 -0.722 . . . . 53.549999999999997 112.146 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 2.8 pm0 -66.98 152.57 95.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.245 -0.889 . . . . 35.119999999999997 111.503 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' GLN . 1.1 Cg_endo -81.97 126.94 5.25 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.786 2.324 . . . . 74.319999999999993 112.829 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 43.5 mm -107.07 106.08 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 65.5 110.215 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.708 ' HA ' HG22 ' A' ' 19' ' ' VAL . 10.4 p -79.02 143.23 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.732 0.641 . . . . 75.010000000000005 112.732 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' LYS . 36.9 m -165.46 152.32 10.26 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.018 0.437 . . . . 71.200000000000003 111.784 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ2' ' CD1' ' A' ' 56' ' ' LEU . 3.4 p90 -124.7 34.2 5.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.689 0.757 . . . . 74.409999999999997 109.556 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.1 t -44.42 121.9 2.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 75.530000000000001 111.197 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.44 -28.15 7.86 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.952 -0.642 . . . . 61.119999999999997 113.699 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 46' ' ' TRP . 7.1 mp -75.68 -36.3 60.11 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.564 0.682 . . . . 71.230000000000004 110.096 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -51.55 158.81 0.84 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.409 -0.814 . . . . 71.409999999999997 109.994 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.38 -64.56 0.05 OUTLIER Glycine 0 C--O 1.229 -0.166 0 C-N-CA 120.423 -0.894 . . . . 71.150000000000006 112.135 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -148.16 109.35 4.32 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 61.329999999999998 108.845 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -157.72 141.84 16.02 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.276 -0.875 . . . . 75.219999999999999 111.215 -178.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -77.13 -45.04 28.19 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.325 -0.991 . . . . 65.439999999999998 108.325 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD22 ' O ' ' A' ' 83' ' ' ASN . 80.0 mt -154.64 163.45 40.21 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 113.871 -1.513 . . . . 64.340000000000003 109.076 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 32.7 mt -129.66 153.62 47.94 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.804 -0.443 . . . . 64.140000000000001 109.804 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 HG12 ' A' ' 82' ' ' VAL . 4.8 m -117.77 114.73 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 64.530000000000001 110.394 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -108.1 119.37 39.29 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.67 -0.863 . . . . 73.230000000000004 108.67 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD12 ' CD1' ' A' ' 153' ' ' LEU . 66.8 mt -150.24 151.86 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.949 -0.7 . . . . 72.439999999999998 112.442 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' A' ' 78' ' ' HIS . 3.9 ppp? -94.99 154.91 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.268 -0.878 . . . . 73.200000000000003 109.177 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 62' ' ' ASP . 46.1 t -132.56 163.22 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.048 0.452 . . . . 73.219999999999999 111.725 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 61' ' ' VAL . 21.9 t70 64.18 54.91 1.53 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 74.5 110.187 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HB2' ' HG3' ' A' ' 74' ' ' ARG . 35.1 Cg_exo -36.0 140.07 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.02 2.48 . . . . 64.439999999999998 112.22 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.05 85.53 2.43 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.623 0.601 . . . . 74.319999999999993 112.623 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' HA ' ' C ' ' A' ' 66' ' ' PRO . . . -170.13 136.28 1.27 Allowed Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 112.301 0.482 . . . . 43.210000000000001 112.301 178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 17.0 Cg_exo -68.36 -28.12 5.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.633 -1.403 . . . . 73.519999999999996 111.626 -1.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.882 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.4 t -150.03 150.11 31.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.14 -0.936 . . . . 75.409999999999997 111.123 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.9 -23.36 44.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.293 -0.867 . . . . 65.420000000000002 109.823 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -79.92 -39.82 29.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 71.510000000000005 112.619 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.882 ' H ' HG23 ' A' ' 67' ' ' THR . 8.4 t0 -144.37 81.08 11.55 Favored Pre-proline 0 N--CA 1.465 0.318 0 CA-C-O 120.613 0.244 . . . . 75.129999999999995 110.614 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 6.3 Cg_exo -77.75 55.82 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.116 2.544 . . . . 73.019999999999996 111.935 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 15.4 ptpt -48.9 -47.44 43.28 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.151 0.426 . . . . 63.240000000000002 112.151 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 1.7 p90 -114.34 33.42 5.3 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.489 -0.484 . . . . 74.140000000000001 111.081 178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 63' ' ' PRO . 9.9 ttm180 -54.9 132.26 46.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.032 -1.099 . . . . 74.439999999999998 108.032 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 10.4 tp10 -103.26 166.67 10.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.871 1.668 . . . . 64.239999999999995 109.906 -0.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.552 HG23 ' HG ' ' A' ' 77' ' ' LEU . 7.6 tp -94.51 -45.9 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.747 -0.835 . . . . 72.109999999999999 108.747 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD11 ' HA ' ' A' ' 103' ' ' SER . 3.2 pp -174.96 146.75 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.883 -1.053 . . . . 64.409999999999997 108.777 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 19.4 p-80 -158.73 176.6 12.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.579 -0.282 . . . . 75.329999999999998 110.386 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.548 ' CH2' HG12 ' A' ' 44' ' ' VAL . 12.2 t90 -102.91 125.28 49.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.034 0.445 . . . . 75.299999999999997 111.238 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 97' ' ' LEU . 27.2 p -141.55 133.56 27.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.004 -0.544 . . . . 64.549999999999997 111.035 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.527 HG12 ' CD1' ' A' ' 84' ' ' ILE . 16.1 t -147.8 132.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.225 -0.443 . . . . 70.209999999999994 110.275 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.564 HG12 HG23 ' A' ' 57' ' ' THR . 19.8 m -137.16 171.14 16.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.78 0.324 . . . . 75.209999999999994 110.973 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.686 ' ND2' HE22 ' A' ' 121' ' ' GLN . 1.3 m120 73.88 25.82 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.718 -0.674 . . . . 53.219999999999999 110.527 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -72.35 115.16 36.27 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 119.382 -0.927 . . . . 74.099999999999994 110.215 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 129.21 26.89 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 121.795 1.663 . . . . 73.439999999999998 110.659 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.92 62.79 0.05 OUTLIER Glycine 0 CA--C 1.525 0.683 0 O-C-N 123.52 0.512 . . . . 62.329999999999998 113.441 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -173.95 37.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.675 0.79 . . . . 64.25 108.942 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.4 m-80 -135.24 -10.33 2.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.864 -0.607 . . . . 72.409999999999997 112.489 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 71.88 -32.45 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.87 0.367 . . . . 41.409999999999997 111.264 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -153.69 166.14 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 74.450000000000003 110.546 -179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HA ' ' CG2' ' A' ' 84' ' ' ILE . 69.8 Cg_endo -67.93 43.96 0.27 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 123.62 2.88 . . . . 65.040000000000006 113.508 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.3 t -74.04 -38.28 64.06 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 65.299999999999997 110.014 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.63 5.34 35.03 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.874 -0.603 . . . . 55.420000000000002 112.648 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 84' ' ' ILE . . . -80.76 160.89 43.65 Favored Glycine 0 N--CA 1.454 -0.111 0 C-N-CA 120.746 -0.74 . . . . 44.130000000000003 112.394 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -71.4 106.75 4.03 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.249 0.524 . . . . 62.350000000000001 111.262 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.664 ' O ' HG23 ' A' ' 130' ' ' THR . 47.7 m -73.68 100.76 3.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.672 -0.862 . . . . 73.420000000000002 108.672 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HG3' ' A' ' 127' ' ' GLU . 87.4 mt -58.39 -50.25 74.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.579 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.77 122.45 20.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.329 -0.396 . . . . 75.109999999999999 111.016 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -48.63 132.68 17.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.797 -0.638 . . . . 74.230000000000004 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' CD1' ' O ' ' A' ' 100' ' ' TYR . 1.9 p90 -76.53 126.1 30.4 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.013 0.435 . . . . 75.209999999999994 110.522 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.514 HG23 HD13 ' A' ' 77' ' ' LEU . 1.2 m -148.05 159.81 7.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.857 -0.61 . . . . 60.420000000000002 111.061 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.473 ' H ' ' CD ' ' A' ' 173' ' ' ARG . . . -58.15 111.9 3.48 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.677 -0.692 . . . . 65.319999999999993 113.049 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.741 ' HA ' HD11 ' A' ' 77' ' ' LEU . 48.8 m -63.65 95.47 0.11 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.273 0.229 . . . . 75.319999999999993 110.815 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' HG23 ' A' ' 170' ' ' VAL . . . -56.61 101.67 0.16 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.067 -0.515 . . . . 73.329999999999998 113.027 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HB3' ' NE2' ' A' ' 112' ' ' HIS . 87.8 Cg_endo -104.35 139.65 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.695 2.93 . . . . 62.119999999999997 112.912 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 109' ' ' THR . 11.9 Cg_endo -55.35 134.24 62.72 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.181 1.254 . . . . 75.430000000000007 109.586 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -42.08 -35.83 1.0 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.446 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -60.63 -42.53 97.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.928 -1.033 . . . . 73.409999999999997 112.803 -178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.472 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 3.6 t -72.56 -33.28 66.69 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 122.083 -0.386 . . . . 71.200000000000003 111.568 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 52.95 -88.16 0.01 OUTLIER Glycine 0 CA--C 1.528 0.892 0 N-CA-C 115.531 0.972 . . . . 72.450000000000003 115.531 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.0 tp -66.88 122.4 17.62 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.824 1.046 . . . . 73.329999999999998 113.824 -176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 105' ' ' PRO . 2.9 m-70 -97.46 137.03 37.04 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.513 -0.767 . . . . 64.140000000000001 110.185 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.447 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 5.9 mmt85 -104.8 118.02 35.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.288 -0.634 . . . . 64.140000000000001 109.288 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.87 133.57 54.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.177 0.513 . . . . 64.319999999999993 111.952 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 161' ' ' TYR . 28.3 mm -125.74 121.98 61.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.058 -0.973 . . . . 64.409999999999997 108.868 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.33 131.94 51.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 74.420000000000002 110.771 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 156' ' ' PRO . 14.8 tp -126.81 130.93 51.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.869 -0.605 . . . . 71.010000000000005 110.435 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 158' ' ' ALA . 52.5 tp -124.75 122.47 37.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.855 -0.611 . . . . 64.519999999999996 110.682 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.453 ' HD2' HD23 ' A' ' 153' ' ' LEU . 37.0 t80 -134.62 138.24 44.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 75.239999999999995 109.777 179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD2' ' HB3' ' A' ' 53' ' ' SER . 37.3 ttp180 -68.95 124.53 23.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.601 . . . . 73.420000000000002 111.72 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.686 HE22 ' ND2' ' A' ' 83' ' ' ASN . 39.7 tt0 -87.99 107.31 18.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.713 -0.847 . . . . 65.150000000000006 108.713 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.516 ' C ' HD22 ' A' ' 123' ' ' ASN . 2.0 tp10 -73.89 -37.12 64.79 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.007 -0.542 . . . . 74.349999999999994 111.192 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.516 HD22 ' C ' ' A' ' 122' ' ' GLU . 4.4 m120 -121.66 141.82 50.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.513 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.562 ' HA ' HE21 ' A' ' 121' ' ' GLN . 3.8 tppp? -62.62 111.52 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.255 -0.276 . . . . 63.409999999999997 110.255 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.837 HD12 ' CE1' ' A' ' 151' ' ' HIS . 6.1 pt -90.73 128.21 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.667 -0.494 . . . . 74.230000000000004 109.667 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.63 -46.85 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.929 0.714 . . . . 53.530000000000001 112.929 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.612 ' HG3' HD21 ' A' ' 97' ' ' LEU . 4.9 mm-40 61.67 -117.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.675 -0.491 . . . . 75.239999999999995 109.675 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 127' ' ' GLU . 17.9 p -162.77 160.19 19.54 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.378 -0.601 . . . . 74.150000000000006 109.378 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.59 154.88 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.189 1.926 . . . . 64.230000000000004 111.738 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 96' ' ' SER . 1.9 m -58.42 125.58 23.91 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.056 -0.35 . . . . 74.219999999999999 110.056 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 131' ' ' ILE . 15.9 mm -90.69 126.24 43.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 71.230000000000004 112.178 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 68.4 m -82.94 134.86 35.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.063 -0.971 . . . . 64.019999999999996 109.727 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.483 ' HB2' HG21 ' A' ' 101' ' ' VAL . 15.0 p-10 -51.0 -40.94 59.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.849 0.357 . . . . 61.039999999999999 111.273 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.683 ' OG1' HG22 ' A' ' 178' ' ' VAL . 9.9 t -65.47 4.04 0.6 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.184 -0.462 . . . . 60.32 111.895 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.45 ' HA ' ' C ' ' A' ' 179' ' ' GLY . 11.3 t -64.12 135.45 56.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.159 0.504 . . . . 72.310000000000002 110.255 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.561 ' HB2' ' HA2' ' A' ' 179' ' ' GLY . 8.9 ttt85 -84.98 173.24 10.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.813 -0.63 . . . . 64.409999999999997 110.765 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.44 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 1.9 m -35.72 151.76 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.259 -0.882 . . . . 62.340000000000003 112.187 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.19 2.7 19.91 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.984 -0.627 . . . . 73.409999999999997 113.573 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -169.75 44.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.237 0.518 . . . . 73.0 110.377 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -114.27 -59.66 1.99 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.984 -0.553 . . . . 72.510000000000005 111.984 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.586 ' HA ' ' N ' ' A' ' 75' ' ' GLU . 2.4 m120 -65.07 42.35 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.657 0.984 . . . . 75.430000000000007 113.657 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' CE1' ' A' ' 147' ' ' PHE . 2.0 t80 -99.31 111.34 23.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 71.209999999999994 109.812 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.61 HD21 ' HB3' ' A' ' 145' ' ' ARG . 30.1 t30 -66.35 129.88 41.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.666 -0.697 . . . . 65.329999999999998 111.404 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 147' ' ' PHE . . . -72.24 -35.12 68.74 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.64 0.607 . . . . 75.519999999999996 112.64 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.643 ' NH1' ' SD ' ' A' ' 1' ' ' MET . 30.1 ttm180 -47.04 -39.27 12.52 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.39 -0.524 . . . . 73.430000000000007 110.85 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -53.69 -37.71 63.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.185 -0.461 . . . . 72.209999999999994 110.894 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 144' ' ' ALA . 1.6 m-85 -49.65 -40.54 40.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.365 0.602 . . . . 63.329999999999998 109.407 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.45 -37.16 86.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 54.549999999999997 110.818 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.9 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.991 -0.549 . . . . 25.41 111.606 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.1 -43.27 74.81 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.371 0.508 . . . . 75.530000000000001 112.371 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.837 ' CE1' HD12 ' A' ' 125' ' ' ILE . 66.0 m-70 -91.4 1.48 57.09 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.73 -0.388 . . . . 70.420000000000002 110.912 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 59.4 32.65 73.23 Favored Glycine 0 C--O 1.229 -0.191 0 C-N-CA 121.108 -0.568 . . . . 51.530000000000001 113.662 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 59' ' ' LEU . 8.3 mt -70.32 16.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 110.733 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -64.33 -4.08 11.32 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.059 -0.519 . . . . 45.130000000000003 113.153 -178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' HG3' ' CE1' ' A' ' 119' ' ' TYR . 20.3 pt-20 -134.34 72.55 70.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.716 0.769 . . . . 64.030000000000001 109.018 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.554 ' HG3' HD11 ' A' ' 117' ' ' LEU . 42.1 Cg_endo -68.18 131.14 22.85 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.154 2.569 . . . . 75.310000000000002 113.874 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 34.0 pt -75.51 -34.46 29.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 74.239999999999995 109.276 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.801 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -146.06 146.25 30.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.543 -0.753 . . . . 64.430000000000007 110.141 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 117' ' ' LEU . . . -158.69 159.38 35.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.384 -0.371 . . . . 64.310000000000002 110.521 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.665 ' ND2' HG23 ' A' ' 27' ' ' VAL . 59.1 t30 -170.48 175.37 4.77 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.207 -1.035 . . . . 72.230000000000004 108.207 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.856 ' HB3' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -155.42 167.05 31.65 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.181 -0.608 . . . . 74.019999999999996 111.589 -177.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.524 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -162.03 150.62 15.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.702 -0.681 . . . . 63.409999999999997 110.258 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 113' ' ' ARG . 57.9 mt-30 -124.64 138.16 54.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 73.540000000000006 110.378 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 38' ' ' VAL . . . -155.11 138.89 16.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.834 -0.621 . . . . 74.219999999999999 110.373 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.716 ' H ' ' NE2' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -100.43 138.08 37.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.086 -0.338 . . . . 53.299999999999997 110.086 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -127.63 126.58 42.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 110.135 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 169' ' ' TYR . 1.3 m-20 -62.73 -174.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.324 0.583 . . . . 52.310000000000002 110.448 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 13.9 t70 -72.82 32.68 0.07 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.59 -0.732 . . . . 63.130000000000003 109.752 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 167' ' ' ASP . 20.2 t80 -91.14 -53.69 4.26 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.339 -0.846 . . . . 75.219999999999999 111.752 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.595 ' N ' ' CD ' ' A' ' 171' ' ' PRO . 28.3 m -59.81 -31.01 8.34 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 112.917 0.71 . . . . 65.129999999999995 112.917 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 170' ' ' VAL . 83.7 Cg_exo -48.83 -21.41 3.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.51 1.473 . . . . 72.319999999999993 111.427 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 169' ' ' TYR . 11.8 tt -51.7 -38.93 22.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.886 -0.597 . . . . 61.240000000000002 109.868 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.473 ' CD ' ' H ' ' A' ' 102' ' ' GLY . 85.2 mtt-85 -58.18 -34.97 70.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.202 0.525 . . . . 74.400000000000006 109.881 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.509 HD21 ' HA3' ' A' ' 104' ' ' GLY . 35.1 m-20 -62.19 -41.31 98.24 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.15 -0.685 . . . . 74.340000000000003 109.15 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -59.09 -17.24 24.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 74.329999999999998 109.831 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 176' ' ' THR . 18.0 m -88.21 6.12 38.27 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.981 -0.554 . . . . 54.200000000000003 111.778 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 134' ' ' THR . 29.2 mm -74.07 124.36 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.919 -0.128 . . . . 73.120000000000005 111.11 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.683 HG22 ' OG1' ' A' ' 134' ' ' THR . 18.4 m -127.51 -21.3 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.365 1.246 . . . . 62.329999999999998 114.365 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.245 0.795 0 CA-C-O 118.126 -1.375 . . . . 53.240000000000002 112.679 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.802 -0.444 . . . . 72.340000000000003 109.802 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -66.83 119.17 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.071 -0.344 . . . . 74.030000000000001 110.071 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -103.19 -71.2 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.426 0.528 . . . . 72.420000000000002 112.426 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.505 ' CG1' ' O ' ' A' ' 9' ' ' LEU . 13.3 pt -125.37 59.95 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.616 0.722 . . . . 73.310000000000002 110.804 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' HA ' ' A' ' 6' ' ' PRO . 12.3 p -128.75 140.89 39.82 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 115.141 -0.936 . . . . 75.049999999999997 110.642 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.8 Cg_endo -85.29 33.13 4.77 Favored 'Cis proline' 0 C--N 1.35 0.606 0 C-N-CA 123.849 -1.313 . . . . 72.450000000000003 112.632 0.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.9 t0 -57.14 -54.54 45.6 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.219 -0.659 . . . . 63.409999999999997 109.219 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 7' ' ' ASP . 4.9 m -160.5 -39.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.419 -0.81 . . . . 75.409999999999997 111.676 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 11' ' ' ALA . 22.8 tp -157.41 143.03 17.37 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.094 0.473 . . . . 71.530000000000001 111.458 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -78.84 25.73 0.26 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.821 -0.55 . . . . 63.240000000000002 110.333 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -175.36 156.02 1.95 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.079 -0.51 . . . . 74.519999999999996 110.037 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 12' ' ' VAL . 7.4 p -90.59 113.52 58.02 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 111.721 0.267 . . . . 54.420000000000002 111.721 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 156' ' ' PRO . 87.9 Cg_endo -85.0 134.03 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.646 2.231 . . . . 73.549999999999997 112.482 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 157' ' ' ILE . . . -60.62 -39.62 88.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.09 -0.504 . . . . 75.239999999999995 110.562 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.49 -135.09 3.32 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.683 -0.689 . . . . 63.509999999999998 111.483 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 t -161.29 176.94 10.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.45 -0.574 . . . . 75.319999999999993 109.45 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 44' ' ' VAL . 13.6 mt -116.65 135.79 55.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.551 -0.295 . . . . 52.240000000000002 111.016 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 45' ' ' SER . 31.0 mmmt -73.92 102.31 4.06 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 107.438 -1.319 . . . . 74.230000000000004 107.438 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.704 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.7 t -117.28 110.73 32.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.082 -0.508 . . . . 73.519999999999996 109.654 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.678 HG21 ' O ' ' A' ' 23' ' ' ASP . 22.6 mt -99.61 126.7 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.472 -0.785 . . . . 71.200000000000003 110.185 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.423 ' CD2' HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.48 -77.48 0.1 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.134 -0.939 . . . . 74.420000000000002 110.61 -179.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.86 -61.49 1.76 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.773 -0.727 . . . . 61.210000000000001 112.627 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.678 ' O ' HG21 ' A' ' 20' ' ' ILE . 3.7 m-20 -161.12 -53.75 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.374 0.607 . . . . 61.229999999999997 109.667 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -100.41 -37.34 8.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.268 -0.878 . . . . 72.439999999999998 111.24 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.755 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.2 pt? -69.27 124.6 24.27 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.998 0.904 . . . . 74.019999999999996 110.687 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -113.15 139.87 48.39 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.989 -1.46 . . . . 44.409999999999997 110.71 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.704 HG22 ' HB ' ' A' ' 19' ' ' VAL . 33.1 m -73.51 108.65 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.519 0.676 . . . . 63.020000000000003 110.343 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 28' ' ' LYS . 6.3 mmpt? -86.01 82.41 8.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.96 0.726 . . . . 72.030000000000001 112.96 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 13.8 mp0 29.84 67.33 0.11 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.424 1.268 . . . . 72.439999999999998 114.424 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.87 -21.44 29.74 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.933 -0.651 . . . . 74.519999999999996 112.913 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.82 145.63 2.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.394 0.616 . . . . 63.140000000000001 112.348 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' A' ' 163' ' ' GLN . 88.9 tt0 -110.72 136.05 50.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.856 -1.065 . . . . 75.329999999999998 110.291 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.618 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -98.1 142.5 29.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.781 0.324 . . . . 64.530000000000001 111.156 178.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.2 p -150.17 146.33 19.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.883 -0.599 . . . . 72.310000000000002 109.791 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.93 -115.24 0.0 OUTLIER 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 124.08 -1.217 . . . . 71.120000000000005 112.636 0.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.8 p -72.02 48.38 0.17 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 111.775 0.287 . . . . 53.130000000000003 111.775 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.48 HE21 ' HG ' ' A' ' 33' ' ' LEU . 19.2 pt20 -99.98 0.01 40.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.368 0.604 . . . . 72.349999999999994 109.82 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 33' ' ' LEU . 34.4 m -87.45 21.65 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.197 -0.911 . . . . 62.509999999999998 110.957 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' H ' ' CD ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -70.72 -34.13 71.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 71.219999999999999 111.711 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.41 135.18 35.21 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.745 0.307 . . . . 74.120000000000005 111.422 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 pm0 -68.44 152.48 96.57 Favored Pre-proline 0 C--N 1.335 -0.023 0 N-CA-C 109.691 -0.485 . . . . 65.140000000000001 109.691 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.75 126.61 15.64 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.046 1.831 . . . . 73.299999999999997 113.673 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 47.0 mm -96.85 107.33 19.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.967 -0.753 . . . . 72.349999999999994 108.967 177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.672 HG23 HG21 ' A' ' 17' ' ' ILE . 3.9 p -78.72 139.93 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 113.433 0.901 . . . . 70.019999999999996 113.433 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 57.7 m -164.9 134.07 3.55 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 116.161 -0.472 . . . . 71.519999999999996 110.359 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.743 ' CD1' ' HG3' ' A' ' 50' ' ' GLU . 2.4 p90 -114.24 35.95 3.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.484 0.659 . . . . 72.010000000000005 109.839 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -36.4 98.05 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.013 -0.994 . . . . 72.109999999999999 113.117 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.32 -15.16 41.46 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 116.075 -0.511 . . . . 70.409999999999997 114.251 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.23 -20.4 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.511 0.656 . . . . 73.049999999999997 110.703 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.743 ' HG3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -71.35 -61.59 1.71 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.65 0.738 . . . . 74.209999999999994 109.403 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -64.24 4.34 Favored Glycine 0 CA--C 1.497 -1.036 0 N-CA-C 109.522 -1.431 . . . . 51.43 109.522 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 2.0 ttmp? -149.1 116.79 6.23 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.199 -0.5 . . . . 73.120000000000005 110.134 177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.1 p -157.02 141.57 16.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.216 0.531 . . . . 65.430000000000007 112.345 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 22.1 t30 -83.45 -36.66 24.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 74.400000000000006 109.061 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' CB ' ' HB3' ' A' ' 121' ' ' GLN . 25.3 mt -158.11 169.8 23.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.333 -1.303 . . . . 64.150000000000006 108.737 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 69.4 mt -141.57 159.82 41.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.922 0.391 . . . . 61.439999999999998 111.656 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 119' ' ' TYR . 2.1 m -121.56 132.82 54.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.271 -0.877 . . . . 64.349999999999994 108.77 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 59' ' ' LEU . 1.2 tm? -127.84 132.56 49.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.59 -0.522 . . . . 73.150000000000006 109.59 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 58' ' ' LEU . 54.9 mt -145.97 129.79 17.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.877 -0.329 . . . . 73.439999999999998 111.018 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' N ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.06 135.49 45.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.106 -1.072 . . . . 64.530000000000001 108.106 178.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.692 HG12 ' HD3' ' A' ' 63' ' ' PRO . 10.2 t -147.43 143.53 19.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.941 0.877 . . . . 62.310000000000002 112.6 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' HB2' ' HA ' ' A' ' 114' ' ' TYR . 55.9 t0 -160.24 81.27 2.32 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 113.988 -1.46 . . . . 51.229999999999997 107.065 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.692 ' HD3' HG12 ' A' ' 61' ' ' VAL . 37.4 Cg_endo -66.97 84.2 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.625 1.55 . . . . 71.340000000000003 112.47 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' CG ' ' HG2' ' A' ' 68' ' ' ARG . 31.3 m-20 -169.36 84.67 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.547 -0.751 . . . . 63.299999999999997 110.003 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . -153.48 137.33 10.52 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 108.726 -0.842 . . . . 33.509999999999998 108.726 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.695 ' HG3' ' CZ ' ' A' ' 73' ' ' TYR . 4.7 Cg_exo -77.31 -16.39 25.36 Favored 'Cis proline' 0 CA--C 1.515 -0.447 0 C-N-CA 124.287 -1.131 . . . . 65.329999999999998 111.927 0.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 70' ' ' ASP . 2.3 t -138.77 140.72 38.73 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.468 -0.787 . . . . 71.430000000000007 110.867 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.517 ' HG2' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -45.94 -26.92 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.864 -1.062 . . . . 72.540000000000006 111.296 -178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -93.96 -45.14 7.74 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.52 1.304 . . . . 73.0 114.52 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.843 ' H ' HG23 ' A' ' 67' ' ' THR . 1.3 m-20 -112.64 83.01 5.27 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 113.174 0.805 . . . . 63.140000000000001 113.174 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 63.7 Cg_endo -71.57 51.76 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 123.236 2.624 . . . . 74.150000000000006 111.696 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HG2' ' CD ' ' A' ' 66' ' ' PRO . 17.7 ptpt -48.66 -33.59 10.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 63.350000000000001 111.885 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.695 ' CZ ' ' HG3' ' A' ' 66' ' ' PRO . 6.2 p90 -138.68 45.46 2.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.437 0.637 . . . . 75.140000000000001 111.743 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -73.74 138.51 44.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.457 -0.942 . . . . 75.519999999999996 108.457 177.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . 29.3 mp0 -91.71 178.3 5.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.772 0.829 . . . . 72.239999999999995 111.385 0.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.631 HG21 ' HA3' ' A' ' 104' ' ' GLY . 6.6 tp -106.67 169.81 2.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.536 -1.211 . . . . 52.100000000000001 109.409 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 77' ' ' LEU . 3.8 mp -45.87 125.04 5.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.578 0.228 . . . . 72.129999999999995 110.593 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -124.96 171.98 9.77 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.085 0.469 . . . . 74.230000000000004 111.541 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 100' ' ' TYR . 6.7 t-105 -100.16 121.83 42.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.355 -0.839 . . . . 72.239999999999995 109.866 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -141.49 137.17 31.91 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.437 0.532 . . . . 53.329999999999998 112.437 -177.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 84' ' ' ILE . 2.1 t -141.48 149.79 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.514 -0.312 . . . . 73.510000000000005 110.885 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.525 HG21 ' HG3' ' A' ' 127' ' ' GLU . 22.2 m -142.05 155.66 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.988 0.366 . . . . 75.109999999999999 111.988 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.598 ' N ' HD22 ' A' ' 83' ' ' ASN . 1.0 OUTLIER 72.07 37.55 0.99 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.122 -0.49 . . . . 74.5 112.262 178.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.988 HD13 ' HA3' ' A' ' 94' ' ' GLY . 1.2 mm -83.71 116.0 62.44 Favored Pre-proline 0 N--CA 1.467 0.408 0 C-N-CA 119.436 -0.906 . . . . 73.140000000000001 109.624 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.515 ' HG2' ' ND2' ' A' ' 88' ' ' ASN . 35.5 Cg_endo -66.77 126.78 15.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 121.816 1.677 . . . . 70.400000000000006 111.676 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -55.35 71.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.903 -0.589 . . . . 60.5 114.103 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 85' ' ' PRO . 91.8 p -178.27 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.032 0.416 . . . . 70.549999999999997 110.999 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 85' ' ' PRO . 65.5 m-20 -135.4 -2.47 2.48 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.327 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.668 ' HA ' ' CD1' ' A' ' 46' ' ' TRP . 13.1 pt-20 40.94 34.01 0.25 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.038 -0.528 . . . . 74.219999999999999 111.991 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 p30 175.48 152.62 0.31 Allowed Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 121.34 0.59 . . . . 52.439999999999998 110.761 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 44' ' ' VAL . 95.9 Cg_endo -74.68 61.17 5.34 Favored 'Trans proline' 0 CA--C 1.527 0.173 0 C-N-CA 123.339 2.693 . . . . 61.240000000000002 112.93 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.7 m -96.78 -55.3 2.93 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.348 0.87 . . . . 65.409999999999997 113.348 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.82 -40.97 89.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 115.032 0.773 . . . . 12.449999999999999 115.032 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.988 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -57.61 157.8 14.49 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.68 -0.771 . . . . 74.420000000000002 114.134 -178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.932 ' CE1' HG23 ' A' ' 130' ' ' THR . 80.3 t60 -61.63 125.6 24.37 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.079 0.551 . . . . 74.120000000000005 111.095 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.9 m -83.87 97.25 9.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.658 -0.868 . . . . 64.129999999999995 108.658 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' GLU . 13.0 mt -54.16 -48.83 70.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.471 -0.937 . . . . 73.530000000000001 108.471 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -146.13 117.62 8.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.494 -1.23 . . . . 73.510000000000005 108.822 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.487 ' HB3' ' N ' ' A' ' 133' ' ' ASN . 42.7 t0 -54.39 152.48 6.43 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.65 0.594 . . . . 65.239999999999995 111.556 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.462 ' HA ' ' HB2' ' A' ' 79' ' ' TRP . 0.3 OUTLIER -70.48 129.26 38.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.31 -0.405 . . . . 71.310000000000002 110.342 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 101' ' ' VAL . 7.5 p -130.02 113.73 27.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.56 0.695 . . . . 73.450000000000003 110.873 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -83.46 72.97 2.74 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.427 -0.806 . . . . 51.140000000000001 113.455 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 29.8 p -171.03 11.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.891 1.071 . . . . 53.409999999999997 113.891 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.631 ' HA3' HG21 ' A' ' 76' ' ' ILE . . . -55.38 -84.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.229 -0.986 . . . . 75.319999999999993 112.258 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.927 ' CB ' HG21 ' A' ' 109' ' ' THR . 23.8 Cg_exo -64.54 105.85 0.66 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.144 1.896 . . . . 70.310000000000002 111.389 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 109' ' ' THR . 18.3 Cg_endo -59.37 160.54 19.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.235 1.957 . . . . 60.409999999999997 112.428 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 167' ' ' ASP . 7.7 ttmm -39.69 -41.0 1.01 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.296 -0.866 . . . . 71.219999999999999 111.303 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.06 -39.21 55.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.308 -0.86 . . . . 52.210000000000001 112.223 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.927 HG21 ' CB ' ' A' ' 105' ' ' PRO . 14.0 t -70.73 -7.02 41.76 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.813 0.339 . . . . 73.340000000000003 111.572 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 61.18 -119.47 18.75 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.099 -0.572 . . . . 64.310000000000002 114.225 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 163' ' ' GLN . 29.3 tp -58.06 119.84 7.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 113.802 1.038 . . . . 74.099999999999994 113.802 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.59 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 32.4 m170 -88.11 91.92 8.95 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.596 -0.729 . . . . 73.219999999999999 111.081 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.588 ' HD2' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -76.82 63.86 2.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.859 0.362 . . . . 75.230000000000004 110.125 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CD1' ' HB3' ' A' ' 112' ' ' HIS . 3.7 m-85 -65.73 131.62 46.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.248 -0.433 . . . . 63.240000000000002 111.057 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.505 HG23 ' CD1' ' A' ' 161' ' ' TYR . 33.9 mt -127.25 122.17 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.765 -0.652 . . . . 63.140000000000001 111.657 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 160' ' ' ASN . 3.9 m-30 -90.4 145.95 24.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.876 -0.602 . . . . 72.329999999999998 110.207 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.696 HD13 ' N ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -134.69 131.88 38.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.948 -0.39 . . . . 75.310000000000002 109.948 179.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 157' ' ' ILE . 1.5 tt -126.27 131.47 51.88 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.954 -0.387 . . . . 74.409999999999997 109.954 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.711 ' N ' HD23 ' A' ' 118' ' ' LEU . 65.7 t80 -131.75 139.24 48.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.972 0.415 . . . . 63.409999999999997 110.476 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.654 HH12 ' HB3' ' A' ' 122' ' ' GLU . 0.6 OUTLIER -71.89 130.54 41.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.041 -0.527 . . . . 73.439999999999998 110.513 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.547 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -116.03 148.52 40.09 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.627 0.251 . . . . 64.439999999999998 111.231 -178.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.654 ' HB3' HH12 ' A' ' 120' ' ' ARG . 23.2 pt-20 -148.03 17.66 1.1 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.178 0.514 . . . . 75.409999999999997 110.941 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 5.8 m120 -143.91 129.13 18.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.053 -0.976 . . . . 42.399999999999999 108.415 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -76.64 111.58 12.29 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.78 -0.768 . . . . 64.349999999999994 111.202 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.492 ' CG1' HD21 ' A' ' 83' ' ' ASN . 9.2 pt -103.68 128.55 56.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.812 -1.085 . . . . 74.010000000000005 110.661 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -56.17 -57.67 11.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.411 0.624 . . . . 54.409999999999997 110.954 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.666 ' HB3' HD22 ' A' ' 97' ' ' LEU . 21.9 mm-40 63.09 31.87 15.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.985 -1.007 . . . . 71.329999999999998 112.763 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.416 ' O ' ' NE2' ' A' ' 95' ' ' HIS . 44.5 p 57.72 151.6 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 112.631 0.604 . . . . 73.230000000000004 112.631 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -45.21 157.58 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.471 2.781 . . . . 75.140000000000001 113.561 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.932 HG23 ' CE1' ' A' ' 95' ' ' HIS . 8.2 p -62.5 131.1 48.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.524 -0.762 . . . . 74.109999999999999 112.524 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.49 HG22 ' HB ' ' A' ' 135' ' ' THR . 45.3 mm -104.56 118.49 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.929 -0.767 . . . . 50.539999999999999 108.929 177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.3 t -69.46 153.1 44.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.303 0.573 . . . . 73.299999999999997 111.77 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.487 ' N ' ' HB3' ' A' ' 99' ' ' ASP . 14.5 p30 -54.42 -29.36 48.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.552 -0.749 . . . . 53.520000000000003 110.296 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 p -78.12 21.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.718 -0.674 . . . . 71.019999999999996 111.554 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.49 ' HB ' HG22 ' A' ' 131' ' ' ILE . 8.5 t -62.71 126.47 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.311 0.577 . . . . 74.230000000000004 111.189 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 178' ' ' VAL . 39.3 ttt180 -89.01 173.31 8.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.5 -0.773 . . . . 71.140000000000001 111.242 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.598 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m -36.87 150.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.492 -0.777 . . . . 62.049999999999997 112.457 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.68 3.13 25.43 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.017 -0.611 . . . . 74.400000000000006 112.972 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 139' ' ' ARG . 55.8 ttt180 -163.96 37.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.252 0.549 . . . . 73.409999999999997 111.03 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.598 HD11 ' HA ' ' A' ' 137' ' ' THR . 7.2 mp -82.52 -64.06 1.25 Allowed 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.437 -1.32 . . . . 63.509999999999998 107.437 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -68.6 117.73 10.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.914 -1.143 . . . . 65.120000000000005 107.914 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.46 ' HZ ' ' CE1' ' A' ' 147' ' ' PHE . 21.5 t80 -170.77 80.19 0.08 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.331 -0.395 . . . . 74.0 111.305 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.447 HD22 ' HB3' ' A' ' 145' ' ' ARG . 16.3 p-10 -62.36 117.34 6.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.139 -0.482 . . . . 71.5 111.899 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 59' ' ' LEU . . . -55.53 -25.25 36.49 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.266 0.555 . . . . 64.230000000000004 109.861 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HB3' HD22 ' A' ' 143' ' ' ASN . 1.3 tpp180 -46.57 -32.47 3.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.111 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.575 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 1.5 t70 -61.26 -56.47 20.21 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.147 -0.686 . . . . 61.329999999999998 109.147 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.638 ' CE2' HD13 ' A' ' 97' ' ' LEU . 3.5 m-30 -56.4 -35.31 67.61 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.94 -0.573 . . . . 74.450000000000003 109.737 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 153' ' ' LEU . . . -65.55 -41.5 92.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.45 -0.795 . . . . 71.019999999999996 109.592 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.89 -55.01 16.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.922 -0.581 . . . . 50.020000000000003 110.826 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.575 ' NZ ' ' OD1' ' A' ' 146' ' ' ASP . 2.1 ptpp? -59.14 -45.15 91.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 71.319999999999993 111.763 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.454 ' HE2' ' CD ' ' A' ' 127' ' ' GLU . 89.6 m-70 -92.58 9.0 36.51 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 120.751 -0.38 . . . . 74.109999999999999 111.75 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 56.59 30.09 58.64 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.767 -0.73 . . . . 72.329999999999998 113.371 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.569 ' HA ' ' CE1' ' A' ' 119' ' ' TYR . 13.3 mt -71.95 16.16 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.812 -0.228 . . . . 63.030000000000001 111.048 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -43.04 -63.75 1.92 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.323 -0.465 . . . . 43.409999999999997 114.002 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.17 112.29 15.05 Favored Pre-proline 0 N--CA 1.467 0.399 0 CA-C-N 116.726 0.263 . . . . 74.239999999999995 111.671 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 66.9 Cg_endo -79.97 123.35 5.13 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.094 1.863 . . . . 72.310000000000002 112.52 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 1.011 HD11 HD22 ' A' ' 118' ' ' LEU . 50.3 pt -74.87 -33.5 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.571 -0.452 . . . . 72.510000000000005 110.411 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.52 139.65 15.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.316 -0.402 . . . . 73.129999999999995 110.762 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -142.78 159.99 41.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 74.450000000000003 109.935 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.469 ' ND2' HG23 ' A' ' 27' ' ' VAL . 1.3 t-20 -161.38 123.38 2.97 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.563 -0.903 . . . . 72.109999999999999 108.563 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.505 ' CD1' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -123.81 169.54 11.44 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.984 -0.553 . . . . 74.219999999999999 111.698 -177.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 2.1 p90 -164.1 160.95 22.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.834 -0.621 . . . . 72.099999999999994 109.996 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.521 ' HB2' HD11 ' A' ' 111' ' ' LEU . 1.3 pt20 -132.65 129.0 38.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.516 -0.311 . . . . 71.400000000000006 110.848 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.44 140.4 17.3 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.317 -0.402 . . . . 73.230000000000004 111.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.86 133.03 43.74 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.547 -0.538 . . . . 74.140000000000001 109.547 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -105.83 113.72 27.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.239 0.542 . . . . 73.349999999999994 110.293 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.637 ' O ' ' NZ ' ' A' ' 107' ' ' LYS . 31.1 m-20 -49.81 -52.53 31.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.238 -0.892 . . . . 63.350000000000001 112.751 -177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -167.48 45.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.325 -0.55 . . . . 75.219999999999999 111.661 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 31.8 t80 -101.37 -40.58 7.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.84 -0.618 . . . . 73.519999999999996 111.553 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 1.042 HG13 ' HD3' ' A' ' 171' ' ' PRO . 0.1 OUTLIER -53.2 -47.46 95.86 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.924 1.083 . . . . 75.019999999999996 113.924 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 1.042 ' HD3' HG13 ' A' ' 170' ' ' VAL . 77.4 Cg_exo -53.01 -50.52 13.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.88 1.72 . . . . 60.200000000000003 113.521 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 172' ' ' ILE . 1.7 mp -45.83 -55.2 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 62.299999999999997 110.84 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 103' ' ' SER . 12.1 tpp180 -56.32 -44.66 80.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 110.39 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -51.87 -38.74 57.19 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.044 -0.525 . . . . 64.25 111.327 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 6.5 mmpt? -55.13 -29.68 58.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.430000000000007 110.964 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 3.3 m -67.64 -29.8 69.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 73.519999999999996 111.994 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.85 103.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.485 -0.325 . . . . 73.010000000000005 110.902 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.416 ' C ' ' HD2' ' A' ' 136' ' ' ARG . 34.1 m -148.39 1.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.389 0.514 . . . . 74.200000000000003 112.389 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.641 -1.089 . . . . 51.140000000000001 112.224 -178.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' N ' ' A' ' 3' ' ' ASP . 49.9 ttm . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.442 -0.207 . . . . 74.120000000000005 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 0.4 OUTLIER -61.17 68.77 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.705 0.402 . . . . 74.439999999999998 111.555 -179.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 1' ' ' MET . 9.6 t70 -106.95 -71.02 0.77 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.674 0.62 . . . . 72.25 112.674 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 9' ' ' LEU . 14.7 pt -80.84 41.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.558 0.694 . . . . 73.219999999999999 111.847 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' PRO . 11.2 p -114.04 138.92 23.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.606 -0.724 . . . . 75.120000000000005 111.361 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 59.8 Cg_endo -93.57 39.42 4.67 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.388 -1.088 . . . . 73.310000000000002 112.594 -0.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.661 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 t70 -58.2 -44.41 88.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.437 -0.347 . . . . 74.200000000000003 110.412 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 7' ' ' ASP . 5.9 m -165.75 -36.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.968 -0.56 . . . . 72.200000000000003 111.811 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 4' ' ' ILE . 18.7 tp -157.08 175.01 14.64 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.669 -0.493 . . . . 73.549999999999997 109.669 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 6.6 p-10 -69.0 -52.44 28.74 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.42 -1.326 . . . . 75.409999999999997 107.42 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.13 137.82 22.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 74.430000000000007 110.739 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.89 129.23 87.79 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 111.861 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HB2' ' H ' ' A' ' 14' ' ' ALA . 42.3 Cg_endo -88.61 -138.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.089 2.526 . . . . 65.209999999999994 111.904 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' H ' ' HB2' ' A' ' 13' ' ' PRO . . . -113.42 -29.7 7.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.519 -0.31 . . . . 43.310000000000002 111.214 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 158' ' ' ALA . . . -159.94 -175.58 31.07 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.909 -0.476 . . . . 34.520000000000003 111.909 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 2.2 t -117.82 163.12 17.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.341 0.591 . . . . 74.129999999999995 112.069 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 44' ' ' VAL . 4.0 mt -105.57 147.27 11.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.185 -0.916 . . . . 51.140000000000001 109.691 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 45' ' ' SER . 12.2 mmmm -82.38 102.97 11.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.563 -0.289 . . . . 74.150000000000006 110.596 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 27' ' ' VAL . 95.6 t -110.24 110.82 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.318 -0.623 . . . . 72.230000000000004 109.318 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 23' ' ' ASP . 44.2 mt -96.57 130.92 44.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.566 . . . . 62.219999999999999 110.071 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CE2' ' O ' ' A' ' 40' ' ' ASP . 2.8 t80 -103.17 -15.14 16.12 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 112.362 0.505 . . . . 74.109999999999999 112.362 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.16 2.93 7.83 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.181 0.832 . . . . 64.129999999999995 115.181 -177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 20' ' ' ILE . 24.1 t70 76.19 20.81 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.372 -1.344 . . . . 50.439999999999998 107.372 -176.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -175.16 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 112.753 -2.021 . . . . 74.140000000000001 107.134 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.655 ' O ' HG23 ' A' ' 20' ' ' ILE . 36.4 mt -69.62 136.02 50.69 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.984 -1.007 . . . . 63.009999999999998 108.976 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' OE2' ' CE ' ' A' ' 18' ' ' LYS . 73.0 tt0 -126.61 143.6 51.17 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.227 0.825 . . . . 72.329999999999998 113.227 -176.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.62 HG22 ' HB ' ' A' ' 19' ' ' VAL . 3.8 m -86.66 140.34 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.824 -0.626 . . . . 75.519999999999996 110.284 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 31' ' ' ASN . 10.7 mptt -131.67 114.77 15.19 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.483 0.549 . . . . 53.420000000000002 112.483 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 29' ' ' GLN . 9.3 mp0 25.09 67.21 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.297 1.221 . . . . 73.540000000000006 114.297 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.56 6.28 89.04 Favored Glycine 0 C--N 1.33 0.225 0 N-CA-C 114.28 0.472 . . . . 61.109999999999999 114.28 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 28' ' ' LYS . 18.9 t30 -55.99 131.07 46.35 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.849 0.357 . . . . 73.439999999999998 110.789 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -89.54 136.04 33.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 43.149999999999999 109.673 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' GLN . 8.1 mp -92.73 138.99 31.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.769 0.319 . . . . 74.099999999999994 111.208 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -147.6 154.91 45.21 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 75.519999999999996 110.562 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.46 -52.62 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.826 -1.323 . . . . 63.229999999999997 112.879 0.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 m -120.38 28.92 7.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.747 0.784 . . . . 72.439999999999998 110.484 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.646 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 3.1 pt20 -80.98 -6.54 58.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.22 -0.9 . . . . 62.119999999999997 110.635 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -74.69 32.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.485 -0.78 . . . . 73.450000000000003 111.227 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -96.93 -38.11 9.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.819 1.044 . . . . 73.519999999999996 113.819 -177.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' CE2' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -82.64 143.93 30.64 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.071 0.767 . . . . 75.329999999999998 113.071 -179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 1.9 pm0 -63.49 153.09 83.97 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 114.474 -1.239 . . . . 75.010000000000005 111.659 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.77 126.79 6.75 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.492 2.128 . . . . 72.549999999999997 112.745 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 51.6 mm -108.09 117.74 54.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 64.099999999999994 109.698 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 ' HD2' ' A' ' 91' ' ' PRO . 5.6 p -91.42 142.02 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.11 0.781 . . . . 45.149999999999999 113.11 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 68.5 m -161.43 113.73 1.83 Allowed 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.848 -0.614 . . . . 73.340000000000003 109.46 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 50' ' ' GLU . 1.3 p90 -93.67 35.95 1.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.154 0.502 . . . . 75.099999999999994 110.708 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.2 m -49.21 118.94 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.532 -0.758 . . . . 65.140000000000001 111.393 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.22 -11.31 72.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.172 -0.537 . . . . 62.240000000000002 112.805 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 49' ' ' LEU . 2.9 mm? -108.39 10.63 27.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.826 0.346 . . . . 73.239999999999995 110.541 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -104.0 -62.85 1.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.144 -0.48 . . . . 72.450000000000003 111.151 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.477 ' N ' ' HG2' ' A' ' 50' ' ' GLU . . . 74.36 -99.43 1.09 Allowed Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.469 -0.652 . . . . 71.409999999999997 111.469 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' NZ ' ' HB3' ' A' ' 52' ' ' LYS . 0.3 OUTLIER -148.82 109.96 4.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.966 0.412 . . . . 74.230000000000004 111.121 178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.7 m -144.49 147.93 33.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.456 . . . . 63.5 110.225 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.464 ' ND2' ' HG ' ' A' ' 55' ' ' LEU . 31.5 t30 -63.34 -39.74 95.38 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.42 0.628 . . . . 63.539999999999999 109.852 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' A' ' 124' ' ' LYS . 30.2 mt -153.98 162.1 41.47 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.828 -1.078 . . . . 55.439999999999998 111.341 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 84' ' ' ILE . 91.4 mt -132.82 150.26 52.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.957 0.408 . . . . 74.519999999999996 109.983 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.785 HG23 HG12 ' A' ' 82' ' ' VAL . 13.1 m -113.17 123.62 50.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.104 -0.498 . . . . 74.109999999999999 110.337 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.897 ' HB3' HG23 ' A' ' 81' ' ' VAL . 1.3 tm? -124.51 129.81 51.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.777 -0.453 . . . . 73.140000000000001 109.777 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.658 ' N ' HD13 ' A' ' 58' ' ' LEU . 96.4 mt -152.46 169.16 23.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 60.100000000000001 111.506 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -95.06 131.63 40.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.833 -0.621 . . . . 71.019999999999996 110.537 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 117' ' ' LEU . 6.1 t -106.71 160.19 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.773 -0.194 . . . . 50.329999999999998 111.349 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' N ' HG12 ' A' ' 61' ' ' VAL . 8.6 t70 54.36 57.34 12.38 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.249 0.547 . . . . 72.140000000000001 109.941 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 10.3 Cg_endo -53.95 139.98 69.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.821 1.681 . . . . 72.340000000000003 110.662 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 105' ' ' PRO . 35.9 t0 -165.91 117.01 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.429 0.529 . . . . 52.030000000000001 112.429 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.857 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . . . -170.43 144.73 2.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.481 -0.781 . . . . 62.539999999999999 109.392 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 73.3 Cg_endo -83.12 -14.56 35.05 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 124.483 -1.049 . . . . 74.340000000000003 111.759 0.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 70' ' ' ASP . 9.9 t -164.92 154.12 12.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.106 -0.952 . . . . 63.530000000000001 109.715 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.687 ' NE ' HE21 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -70.59 -1.83 12.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.927 -0.579 . . . . 74.519999999999996 111.719 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.687 HE21 ' NE ' ' A' ' 68' ' ' ARG . 85.0 mm-40 -86.34 -45.13 11.51 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.395 -0.366 . . . . 74.129999999999995 111.756 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' H ' HG23 ' A' ' 67' ' ' THR . 36.3 t70 -144.4 96.63 5.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 73.140000000000001 109.787 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.23 57.13 4.61 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.347 2.031 . . . . 74.530000000000001 113.047 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -54.35 -37.43 64.91 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 121.038 -0.265 . . . . 73.439999999999998 111.489 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.636 ' HB2' HD21 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -149.41 77.21 1.34 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 122.11 0.957 . . . . 73.25 110.072 177.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 72.5 ttt180 -98.72 109.78 22.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.053 -1.43 . . . . 71.150000000000006 110.415 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.857 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . 23.3 mt-10 -108.0 178.06 4.63 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.033 1.333 . . . . 75.439999999999998 110.61 -0.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.738 ' CD1' ' HB1' ' A' ' 65' ' ' ALA . 1.6 mp -75.64 -58.34 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.73 -0.841 . . . . 64.209999999999994 108.73 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 76' ' ' ILE . 1.4 mm? -140.56 -171.05 3.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.255 -1.339 . . . . 62.030000000000001 108.263 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 p80 176.27 156.92 0.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.4 -0.222 . . . . 65.329999999999998 110.4 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.731 ' CD2' ' HB3' ' A' ' 100' ' ' TYR . 1.2 t-105 -100.12 111.57 23.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.218 0.533 . . . . 73.400000000000006 110.041 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 16.3 m -127.93 125.34 39.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.503 -0.771 . . . . 71.140000000000001 110.704 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -147.66 125.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.497 -0.774 . . . . 70.329999999999998 110.441 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG12 HG23 ' A' ' 57' ' ' THR . 27.4 m -126.66 174.44 10.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.053 0.454 . . . . 74.340000000000003 111.498 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.742 ' O ' HD22 ' A' ' 55' ' ' LEU . 13.8 p30 54.02 40.24 31.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.956 -1.02 . . . . 65.120000000000005 111.019 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.967 HD13 ' HA3' ' A' ' 94' ' ' GLY . 7.4 mm -77.89 122.23 85.26 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 108.976 -0.749 . . . . 72.239999999999995 108.976 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.74 127.77 25.67 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 121.934 1.756 . . . . 62.32 112.323 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -64.92 58.65 0.08 OUTLIER Glycine 0 CA--C 1.528 0.863 0 O-C-N 123.416 0.448 . . . . 72.349999999999994 113.542 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.8 m -168.06 36.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.143 0.577 . . . . 64.25 109.664 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.475 ' C ' ' H ' ' A' ' 90' ' ' ASN . 73.1 m-80 -135.13 -16.1 1.92 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.145 -0.48 . . . . 64.329999999999998 112.134 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 71.57 -36.23 0.35 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 72.150000000000006 111.338 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 88' ' ' ASN . 8.5 p30 -129.22 152.55 79.63 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.088 0.47 . . . . 72.230000000000004 110.254 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.828 ' HB2' HG21 ' A' ' 81' ' ' VAL . 80.4 Cg_endo -70.82 52.47 1.35 Allowed 'Trans proline' 0 N--CA 1.473 0.307 0 C-N-CA 123.572 2.848 . . . . 62.109999999999999 113.602 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.4 m -104.24 -1.92 26.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.483 -0.487 . . . . 75.400000000000006 111.481 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.21 -42.12 1.32 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.953 -0.642 . . . . 52.200000000000003 113.51 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.967 ' HA3' HD13 ' A' ' 84' ' ' ILE . . . -63.57 172.59 13.44 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 120.871 -0.68 . . . . 43.020000000000003 113.136 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.516 ' HB3' HD21 ' A' ' 83' ' ' ASN . 72.2 t60 -66.19 130.82 44.54 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.745 0.307 . . . . 73.019999999999996 111.73 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.731 ' HA ' HG12 ' A' ' 81' ' ' VAL . 36.8 m -87.21 102.63 14.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.837 -0.801 . . . . 62.43 108.837 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' CE2' ' A' ' 147' ' ' PHE . 94.0 mt -62.68 -37.44 86.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.539 0.685 . . . . 73.329999999999998 109.655 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.56 127.28 8.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.711 -1.131 . . . . 72.319999999999993 108.653 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -55.38 152.34 8.73 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.285 0.846 . . . . 61.039999999999999 113.285 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.731 ' HB3' ' CD2' ' A' ' 79' ' ' TRP . 3.1 p90 -83.67 142.61 30.65 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.394 -0.821 . . . . 53.43 112.836 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 100' ' ' TYR . 5.2 m -158.35 113.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.007 -0.542 . . . . 64.209999999999994 111.346 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.09 63.83 2.81 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 44.329999999999998 112.297 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.449 ' OG ' HG13 ' A' ' 170' ' ' VAL . 29.3 t -172.03 49.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.925 0.343 . . . . 75.329999999999998 111.925 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.87 -75.68 0.61 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 110.465 -1.054 . . . . 75.409999999999997 110.465 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.712 ' HB2' HG21 ' A' ' 109' ' ' THR . 15.8 Cg_exo -74.17 123.5 8.35 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.941 2.427 . . . . 61.520000000000003 111.49 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.523 ' O ' HG22 ' A' ' 109' ' ' THR . 31.6 Cg_exo -59.01 159.35 21.97 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.862 2.375 . . . . 75.310000000000002 112.978 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 168' ' ' ASP . 18.4 pttp -43.66 -20.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.949 -0.569 . . . . 64.450000000000003 111.322 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 106' ' ' PRO . 29.8 t70 -50.42 -46.54 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.223 -0.444 . . . . 72.510000000000005 110.41 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.712 HG21 ' HB2' ' A' ' 105' ' ' PRO . 4.2 t -79.54 -4.04 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.152 -0.476 . . . . 73.040000000000006 111.519 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.75 -101.18 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.184 -1.167 . . . . 42.049999999999997 110.184 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' A' ' 163' ' ' GLN . 17.5 tp -66.66 112.17 4.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.945 -0.391 . . . . 71.120000000000005 109.945 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 10.9 p80 -109.83 92.1 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.988 0.423 . . . . 73.430000000000007 110.303 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.502 ' NE ' ' H ' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -58.67 130.57 47.5 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.62 -0.718 . . . . 75.430000000000007 110.583 -179.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.06 128.54 45.11 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 120.95 0.405 . . . . 72.519999999999996 109.916 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.665 HG23 ' HB3' ' A' ' 161' ' ' TYR . 4.7 mm -115.86 141.83 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.446 -0.797 . . . . 71.349999999999994 111.286 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -116.25 141.46 48.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.937 -0.574 . . . . 72.099999999999994 110.245 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.707 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 5.5 tt -124.5 140.39 52.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.374 . . . . 74.219999999999999 110.72 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 117' ' ' LEU . 60.2 tp -130.29 134.04 46.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.668 -0.696 . . . . 73.430000000000007 110.583 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.494 ' HA ' HG12 ' A' ' 157' ' ' ILE . 66.8 t80 -144.14 139.49 28.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.207 0.527 . . . . 65.439999999999998 111.295 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -68.78 135.35 51.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.838 -0.619 . . . . 44.229999999999997 111.544 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 121' ' ' GLN . 3.5 tp60 -119.8 127.62 52.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.576 -0.527 . . . . 42.140000000000001 109.576 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.499 ' C ' HD22 ' A' ' 123' ' ' ASN . 62.9 tt0 -109.09 -8.57 15.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.63 -0.714 . . . . 71.310000000000002 111.332 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.499 HD22 ' C ' ' A' ' 122' ' ' GLU . 4.3 m120 -125.81 148.86 49.0 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.817 0.341 . . . . 73.040000000000006 111.809 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.805 ' HD2' HD11 ' A' ' 55' ' ' LEU . 13.2 mmmm -76.69 149.15 36.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 53.340000000000003 110.14 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -144.62 143.79 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 111.994 0.368 . . . . 62.219999999999999 111.994 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -81.07 -16.15 54.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.655 -0.702 . . . . 73.409999999999997 111.355 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 95' ' ' HIS . 0.0 OUTLIER 4.81 60.65 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 115.295 1.591 . . . . 74.409999999999997 115.295 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 126' ' ' GLU . 25.7 p 51.78 150.9 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 115.213 1.56 . . . . 74.150000000000006 115.213 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -59.82 158.19 29.97 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.659 2.906 . . . . 74.109999999999999 112.532 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -58.79 141.33 53.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.247 -0.433 . . . . 70.230000000000004 111.58 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 131' ' ' ILE . 16.4 mm -119.63 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.117 0.484 . . . . 64.030000000000001 111.673 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.7 m -87.38 143.03 27.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.551 -0.75 . . . . 73.310000000000002 111.244 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -51.86 -37.21 51.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.001 0.429 . . . . 72.120000000000005 110.817 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.62 ' HA ' HD13 ' A' ' 177' ' ' ILE . 46.9 p -70.29 12.87 0.2 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.654 0.613 . . . . 73.409999999999997 112.654 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 135' ' ' THR . 14.7 t -68.48 123.94 22.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 74.450000000000003 110.507 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.555 ' H ' ' CA ' ' A' ' 179' ' ' GLY . 27.3 ttt-85 -62.89 165.67 6.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.221 -0.445 . . . . 63.100000000000001 111.344 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.424 ' H ' ' HG2' ' A' ' 136' ' ' ARG . 11.6 m -37.34 155.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.121 -0.945 . . . . 72.140000000000001 111.873 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.0 -3.25 20.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.973 -0.632 . . . . 74.439999999999998 111.819 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -165.54 41.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.168 0.509 . . . . 74.329999999999998 111.128 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.29 -64.62 1.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.027 -1.101 . . . . 65.140000000000001 108.027 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.636 HD21 ' HB2' ' A' ' 73' ' ' TYR . 2.1 m120 -73.0 114.9 11.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.484 -1.235 . . . . 75.540000000000006 109.636 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -148.21 135.65 20.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 74.409999999999997 111.001 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.548 HD22 ' HG3' ' A' ' 145' ' ' ARG . 19.0 p-10 -101.69 106.66 17.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 54.43 110.505 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -49.12 -37.05 20.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.842 0.353 . . . . 35.329999999999998 111.243 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.548 ' HG3' HD22 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -49.4 -25.94 2.88 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.973 -179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -52.46 -52.64 53.19 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.623 -0.88 . . . . 73.200000000000003 108.623 177.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.581 ' HA ' ' CG ' ' A' ' 150' ' ' LYS . 4.6 m-85 -62.12 -29.58 70.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.058 -0.974 . . . . 72.439999999999998 110.194 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 145' ' ' ARG . . . -62.83 -37.05 85.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.457 -0.572 . . . . 63.140000000000001 109.457 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.17 39.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.708 -0.678 . . . . 74.129999999999995 111.182 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.581 ' CG ' ' HA ' ' A' ' 147' ' ' PHE . 3.7 ptpp? -66.58 -49.45 66.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.199 0.444 . . . . 75.420000000000002 112.199 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.698 ' ND1' HD21 ' A' ' 153' ' ' LEU . 22.0 t-160 -86.83 3.12 46.6 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.199 -0.313 . . . . 73.040000000000006 111.222 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 154' ' ' GLY . . . 58.63 34.12 75.16 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.113 -0.565 . . . . 75.340000000000003 113.565 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.698 HD21 ' ND1' ' A' ' 151' ' ' HIS . 18.1 mt -68.27 16.55 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 122.739 0.415 . . . . 63.009999999999998 112.072 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 152' ' ' GLY . . . -52.68 -33.8 42.56 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.549 -0.834 . . . . 61.43 112.765 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.7 78.74 0.13 Allowed Pre-proline 0 CA--C 1.532 0.279 0 C-N-CA 122.3 0.24 . . . . 71.420000000000002 111.441 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' A' ' 154' ' ' GLY . 32.5 Cg_endo -61.56 130.4 31.52 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 121.526 1.484 . . . . 71.420000000000002 111.549 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 119' ' ' TYR . 26.9 pt -81.03 -34.85 13.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 120.603 -0.439 . . . . 72.530000000000001 110.126 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 118' ' ' LEU . . . -150.35 161.03 43.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 111.466 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -161.09 173.76 14.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.784 -0.643 . . . . 62.5 110.528 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -171.03 135.14 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.581 -0.896 . . . . 63.240000000000002 108.581 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.665 ' HB3' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -136.97 149.01 47.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.586 -0.279 . . . . 73.329999999999998 111.657 -177.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 162' ' ' TYR . 1.7 p90 -142.25 152.61 43.22 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.8 -0.636 . . . . 71.510000000000005 111.264 -178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.453 ' HB3' HD11 ' A' ' 111' ' ' LEU . 60.1 mt-30 -113.98 124.85 53.15 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.669 -0.493 . . . . 72.530000000000001 109.669 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' HB3' ' HE1' ' A' ' 162' ' ' TYR . . . -155.18 148.51 24.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.009 0.433 . . . . 74.310000000000002 111.694 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.81 177.46 4.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.608 -0.724 . . . . 72.219999999999999 109.602 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.615 ' CE1' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -162.18 -135.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.05 -0.26 . . . . 74.019999999999996 110.409 -179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 169' ' ' TYR . 44.7 m-20 -144.3 164.23 31.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.014 0.435 . . . . 72.310000000000002 111.532 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.578 ' C ' ' HD2' ' A' ' 171' ' ' PRO . 36.8 t70 -67.16 12.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.579 -0.737 . . . . 74.519999999999996 110.154 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 167' ' ' ASP . 45.7 t80 -84.4 -46.6 11.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.397 -0.819 . . . . 74.549999999999997 111.592 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' A' ' 171' ' ' PRO . 13.1 p -67.72 -34.31 6.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.523 0.564 . . . . 65.439999999999998 112.523 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' A' ' 170' ' ' VAL . 42.4 Cg_exo -58.12 -22.92 58.61 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.96 1.773 . . . . 75.040000000000006 111.882 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 79.2 mt -45.83 -31.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 73.329999999999998 111.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.29 -33.79 2.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.693 0.282 . . . . 73.129999999999995 111.291 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 177' ' ' ILE . 12.3 p30 -47.57 -36.34 10.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 63.009999999999998 110.727 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -52.09 -31.81 32.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 111.385 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 77.4 p -79.98 15.75 1.38 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.912 0.386 . . . . 70.230000000000004 111.666 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 134' ' ' THR . 10.6 mm -73.04 135.04 28.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.323 -0.398 . . . . 74.409999999999997 110.057 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.7 -21.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 113.275 0.843 . . . . 74.450000000000003 113.275 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.555 ' CA ' ' H ' ' A' ' 136' ' ' ARG . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.409 -1.217 . . . . 74.230000000000004 112.49 -178.329 . . . . . . . . 1 1 . 1 stop_ save_